Source,Target,Pvalue_Adjusted
AATK,Acute myelomonocytic leukemia,0.7880542567584415
AATK,Ovarian Mucinous Adenocarcinoma,0.7880542567584415
AATK,Metastatic melanoma,0.7940665326856218
AATK,Psoriasis,0.8019075543217649
AATK,Adenocarcinoma of lung (disorder),0.8098851543361193
AATK,Ovarian Adenocarcinoma,0.7765582368651238
AATK,Anxiety Disorder,0.8507213163251659
AATK,Lung Adenocarcinoma,0.9350723667380212
AATK,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
AATK,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
AATK,Usher syndrome type 1 ORPHA:231169,0.2661730864557679
AATK,Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120,0.5867963421058087
AATK,Infant acute respiratory distress syndrome ORPHA:70587,0.5867963421058087
AATK,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144,0.5867963421058087
AATK,Spinocerebellar ataxia type 13 ORPHA:98768,0.5867963421058087
AATK,Familial short QT syndrome ORPHA:51083,0.795266832401002
AATK,Adult hypophosphatasia ORPHA:247676,0.8922466888454011
AATK,Childhood-onset hypophosphatasia ORPHA:247667,0.8922466888454011
AATK,Infantile hypophosphatasia ORPHA:247651,0.8922466888454011
AATK,Odontohypophosphatasia ORPHA:247685,0.8922466888454011
AATK,Perinatal lethal hypophosphatasia ORPHA:247623,0.8922466888454011
AATK,Prenatal benign hypophosphatasia ORPHA:247638,0.8922466888454011
AATK,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
AATK,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
AATK,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
AATK,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
AATK,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
AATK,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
AATK,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
ABCA7,Neurofibrillary degeneration (morphologic abnormality),0.7880542567584415
ABCA7,Disease Exacerbation,0.7880542567584415
ABCA7,Muscle Hypertonia,0.7880542567584415
ABCA7,Familial lichen amyloidosis,0.7880542567584415
ABCA7,Spasmodic movement,0.7880542567584415
ABCA7,Involuntary jerking movements,0.7880542567584415
ABCA7,Eosinophil count procedure,0.7880542567584415
ABCA7,Eosinophil count result,0.7880542567584415
ABCA7,Agitation,0.7880542567584415
ABCA7,Abnormal social behavior,0.7880542567584415
ABCA7,Abnormal social interactions,0.7880542567584415
ABCA7,Deposits immunoreactive to beta-amyloid protein,0.7880542567584415
ABCA7,Presenile dementia,0.7880542567584415
ABCA7,Myoclonus,0.7880542567584415
ABCA7,Alzheimer's Disease,0.7880542567584415
ABCA7,Autoimmune Diseases,0.7880542567584415
ABCA7,Sjogren's Syndrome,0.7880542567584415
ABCA7,Language Disorders,0.7880542567584415
ABCA7,Plaque Amyloid,0.8009048756462318
ABCA7,Primary Sj??gren's syndrome,0.8019075543217649
ABCA7,Cerebral atrophy,0.8019075543217649
ABCA7,Multiple Sclerosis,0.8019075543217649
ABCA7,Neutrophil count (procedure),0.8019075543217649
ABCA7,Senile Plaques,0.8019075543217649
ABCA7,Hallucinations,0.8101097852323003
ABCA7,Social disinhibition,0.8145035474981049
ABCA7,Blood basophil count (lab test),0.8190761496232595
ABCA7,Impaired cognition,0.8190761496232595
ABCA7,Alzheimer's Disease Focal Onset,0.8232134984476662
ABCA7,Acute Confusional Senile Dementia,0.8232134984476662
ABCA7,Alzheimer Disease Late Onset,0.8402911822757345
ABCA7,Mild cognitive disorder,0.8402911822757345
ABCA7,Confusion,0.8402911822757345
ABCA7,Memory impairment,0.8474481237156937
ABCA7,Parkinsonian Disorders,0.8486035047899471
ABCA7,Hallucinations Sensory,0.8648405521677974
ABCA7,Alzheimer Disease Early Onset,0.8648405521677974
ABCA7,Amyloidosis,0.8672189956534445
ABCA7,Forgetful,0.8690346447728063
ABCA7,Memory Loss,0.8769418330148872
ABCA7,Parkinson Disease,0.8772392350816924
ABCA7,Familial Alzheimer Disease (FAD),0.8786853464107758
ABCA7,Age related macular degeneration,0.8980854850210683
ABCA7,Seizures,0.9478210444156088
ABCA7,Epilepsy,0.963331724428282
ABCA7,Oculovestibuloauditory Syndrome,0.7765582368651238
ABCA7,Oculomotor Apraxia,0.7765582368651238
ABCA7,Semantic Dementia,0.7765582368651238
ABCA7,Senile Plaques,0.7765582368651238
ABCA7,Parkinson Disease,0.8182883735985873
ABCA7,Hallucinations,0.8337953215113012
ABCA7,Mental Retardation,0.8337953215113012
ABCA7,Alzheimer Disease,0.8457525389282121
ABCA7,Cerebral Cortical Atrophy,0.861756360478846
ABCA7,Dysgraphia,0.861756360478846
ABCA7,Senile Dementia,0.861756360478846
ABCA7,Language Disorders,0.861756360478846
ABCA7,Aphasia,0.8903301324869451
ABCA7,Mental Depression,0.8903630091389316
ABCA7,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
ABCA7,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
ABCA7,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
ABCA7,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
ABCA7,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
ABCA7,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
ABCA7,Barth syndrome ORPHA:111,0.0414176838632111
ABCA7,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
ABCA7,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
ABCA7,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
ABCA7,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
ABCA7,Combined oxidative phosphorylation defect type 27 ORPHA:477774,0.1991445465001551
ABCA7,Gamma-glutamyl transpeptidase deficiency ORPHA:33573,0.1991445465001551
ABCA7,Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228,0.1991445465001551
ABCA7,Coats plus syndrome ORPHA:313838,0.1991445465001551
ABCA7,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.2386105733903937
ABCA7,Charcot-Marie-Tooth disease type 2B2 ORPHA:101101,0.3832844616405875
ABCA7,Ataxia-oculomotor apraxia type 4 ORPHA:459033,0.3832844616405875
ABCA7,Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738,0.3832844616405875
ABCA7,Gray platelet syndrome ORPHA:721,0.3832844616405875
ABCA7,Osteogenesis imperfecta type 5 ORPHA:216828,0.3832844616405875
ABCA7,Glycogen storage disease due to liver phosphorylase kinase deficiency ORPHA:264580,0.3832844616405875
ABCA7,Familial focal epilepsy with variable foci ORPHA:98820,0.3832844616405875
ABCA7,Combined immunodeficiency due to STIM1 deficiency ORPHA:317430,0.5867963421058087
ABCA7,Autosomal dominant Charcot-Marie-Tooth disease type 2M ORPHA:228179,0.7929682744768703
ABCA7,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B ORPHA:100044,0.7929682744768703
ABCA7,Fetal akinesia-cerebral and retinal hemorrhage syndrome ORPHA:363409,0.7929682744768703
ABCA7,Porphyria variegata ORPHA:79473,0.7929682744768703
ABCA7,Nephrogenic diabetes insipidus ORPHA:223,0.7929682744768703
ABCA7,Pseudo-von Willebrand disease ORPHA:52530,0.8922466888454011
ABCA7,NON RARE IN EUROPE: Alzheimer disease ORPHA:238616,0.8922466888454011
ABCA7,Human adenovirus 11+34 encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 34 maturation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 35 IVa2,0.8999095837312036
ABCA7,Human mastadenovirus B encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 14 IVa2 protein (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 55 pIVa2 50.9 kDa protein,0.8999095837312036
ABCA7,Human adenovirus 66 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ABCA7,Human mastadenovirus E encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus E4 protein IVa2,0.8999095837312036
ABCA7,Human adenovirus 23 IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 3+7 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 54 pIVa2,0.8999095837312036
ABCA7,Human adenovirus 67 pIVa2,0.8999095837312036
ABCA7,Human adenovirus 11a IVa2,0.8999095837312036
ABCA7,Human adenovirus 63 IVa2 protein (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 22 IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 64 IVa2 protein,0.8999095837312036
ABCA7,Human adenovirus D37 pIVa2 (gene: pIVa2),0.8999095837312036
ABCA7,Human adenovirus 65 pIVa2,0.8999095837312036
ABCA7,Human adenovirus Chiba_E086/2012 pIVa2 (gene: pIVa2),0.8999095837312036
ABCA7,Human adenovirus D8 pIVa2 protein (gene: pIVa2),0.8999095837312036
ABCA7,Human mastadenovirus A encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 12 maturation protein (protein IVA2),0.8999095837312036
ABCA7,Human mastadenovirus C encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 2 IVa2,0.8999095837312036
ABCA7,Human adenovirus 16 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 6 maturation protein pIVa2 (gene: pIVa2),0.8999095837312036
ABCA7,Human mastadenovirus A IVa2,0.8999095837312036
ABCA7,Titi monkey adenovirus ECC-2011 IVa2,0.8999095837312036
ABCA7,Human adenovirus 49 pIVa2,0.8999095837312036
ABCA7,Human adenovirus 19 pIVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 71 maturation protein (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 56 IVa2 protein (gene: IVa2),0.8999095837312036
ABCA7,Human mastadenovirus D encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus D10 pIVa2 (gene: pIVa2),0.8999095837312036
ABCA7,Papiine alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
ABCA7,Human adenovirus 36 IVa2,0.8999095837312036
ABCA7,Human adenovirus 58 IVa2 (gene: pIVa2),0.8999095837312036
ABCA7,Human adenovirus 43 encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 52 IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 68 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 1 IVa2,0.8999095837312036
ABCA7,Human adenovirus 46 IVa2,0.8999095837312036
ABCA7,Human adenovirus 5 IVa2,0.8999095837312036
ABCA7,Human adenovirus 7 IVa2,0.8999095837312036
ABCA7,Human adenovirus 18 IVa2 protein (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 41 IVa2,0.8999095837312036
ABCA7,Human adenovirus 61 pIVa2,0.8999095837312036
ABCA7,Human adenovirus B3 protein IVa2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 7d2 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ABCA7,Human adenovirus 21 maturation protein IVa2 (gene: IVa2),0.9057542447893764
ABCA7,Human adenovirus 50 maturation protein IVa2 (gene: IVa2),0.9057542447893764
ABCA7,Human mastadenovirus F encapsidation protein IVa2 (gene: IVa2),0.9057542447893764
ABCG1,Malignant neoplasm of breast,0.4084380369379369
ABCG1,Breast Carcinoma,0.7333611688795861
ABCG1,Colorectal Carcinoma,0.7765852775619541
ABCG1,Non-Small Cell Lung Carcinoma,0.7765852775619541
ABCG1,Hypercholesterolemia,0.7765852775619541
ABCG1,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
ABCG1,Colorectal Neoplasms,0.7765852775619541
ABCG1,Vascular Diseases,0.7765852775619541
ABCG1,Malignant neoplasm of prostate,0.7880542567584415
ABCG1,Colorectal Cancer,0.7880542567584415
ABCG1,Prostate carcinoma,0.7880542567584415
ABCG1,Mesothelioma,0.7880542567584415
ABCG1,Serum total cholesterol measurement,0.7880542567584415
ABCG1,Eclampsia,0.7880542567584415
ABCG1,As If Personality,0.7880542567584415
ABCG1,Hypertriglyceridemic Waist,0.7880542567584415
ABCG1,Pulmonary Alveolar Proteinosis,0.7880542567584415
ABCG1,Lipoidosis,0.7880542567584415
ABCG1,Gout,0.7880542567584415
ABCG1,Coronary Arteriosclerosis,0.7880542567584415
ABCG1,Arteriosclerosis,0.7880542567584415
ABCG1,Atherosclerosis,0.7880542567584415
ABCG1,Alzheimer's Disease,0.7880542567584415
ABCG1,Cardiovascular Diseases,0.7880542567584415
ABCG1,Diabetes,0.7880542567584415
ABCG1,Diabetes Mellitus,0.7880542567584415
ABCG1,Chronic myeloproliferative disorder,0.7945683314244791
ABCG1,Liver Cirrhosis Experimental,0.8014900279306119
ABCG1,MAJOR AFFECTIVE DISORDER 8,0.8019075543217649
ABCG1,MAJOR AFFECTIVE DISORDER 9,0.8019075543217649
ABCG1,MAJOR AFFECTIVE DISORDER 7,0.8019075543217649
ABCG1,Myocardial Infarction,0.8019075543217649
ABCG1,AMYOTROPHIC LATERAL SCLEROSIS 6 (disorder),0.8019075543217649
ABCG1,Kidney Failure Chronic,0.8019075543217649
ABCG1,Lung diseases,0.8019075543217649
ABCG1,Narcolepsy,0.8067197998685076
ABCG1,Extramedullary Hematopoiesis (disorder),0.8098851543361193
ABCG1,Eating Disorders,0.8101097852323003
ABCG1,MAJOR AFFECTIVE DISORDER 4,0.8101097852323003
ABCG1,MAJOR AFFECTIVE DISORDER 6,0.8101097852323003
ABCG1,Myeloproliferative disease,0.8138488881521341
ABCG1,AMYOTROPHIC LATERAL SCLEROSIS 1 AUTOSOMAL RECESSIVE,0.8138488881521341
ABCG1,MAJOR AFFECTIVE DISORDER 1,0.8145035474981049
ABCG1,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
ABCG1,Triglycerides measurement,0.8232134984476662
ABCG1,Amyotrophic Lateral Sclerosis Sporadic,0.8270909867833504
ABCG1,AMYOTROPHIC LATERAL SCLEROSIS 1,0.8402911822757345
ABCG1,PITUITARY ADENOMA PREDISPOSITION (disorder),0.8402911822757345
ABCG1,MAJOR AFFECTIVE DISORDER 2,0.8402911822757345
ABCG1,Peripheral Neuropathy,0.8402911822757345
ABCG1,Hyperlipoproteinemia Type IIa,0.8402911822757345
ABCG1,Endothelial dysfunction,0.8402911822757345
ABCG1,Down Syndrome,0.8420665668584452
ABCG1,Smell Perception,0.843190898187174
ABCG1,Weight Gain,0.8584283190330553
ABCG1,Metabolic Syndrome X,0.8610447277138289
ABCG1,Myocardial Ischemia,0.8648405521677974
ABCG1,Amyloidosis,0.8672189956534445
ABCG1,Coronary Artery Disease,0.887595340546704
ABCG1,Pulmonary Fibrosis,0.8911256045597441
ABCG1,Age related macular degeneration,0.8980854850210683
ABCG1,Obesity,0.8989612563669234
ABCG1,Bipolar Disorder,0.900167961295542
ABCG1,Trisomy,0.9029289778792944
ABCG1,Mood Disorders,0.9093740881835894
ABCG1,Coronary heart disease,0.9119978323790848
ABCG1,Gout,0.7765582368651238
ABCG1,Gouty Arthritis,0.7765582368651238
ABCG1,Eating Disorders,0.7765582368651238
ABCG1,Lateral Sclerosis,0.8444537302152433
ABCG1,Bipolar Disorder,0.943322675973118
ABCG1,Colorectal Neoplasms,0.9510372690456612
ABCG1,Kidney Failure,0.9658957825498884
ABCG1,Colorectal Cancer,0.9832345076528324
ABCG1,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857,0.7929682744768703
ABCG1,Estrogen resistance syndrome ORPHA:785,0.8922466888454011
ABCG1,Human adenovirus 11+34 encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 34 maturation protein IVa2 (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 35 IVa2,0.8999095837312036
ABCG1,Human mastadenovirus B encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 14 IVa2 protein (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 55 pIVa2 50.9 kDa protein,0.8999095837312036
ABCG1,Human adenovirus 23 IVa2 (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 67 pIVa2,0.8999095837312036
ABCG1,Human adenovirus 11a IVa2,0.8999095837312036
ABCG1,Human adenovirus 63 IVa2 protein (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 22 IVa2 (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 64 IVa2 protein,0.8999095837312036
ABCG1,Human adenovirus D37 pIVa2 (gene: pIVa2),0.8999095837312036
ABCG1,Human adenovirus 65 pIVa2,0.8999095837312036
ABCG1,Human adenovirus Chiba_E086/2012 pIVa2 (gene: pIVa2),0.8999095837312036
ABCG1,Human mastadenovirus A encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 12 maturation protein (protein IVA2),0.8999095837312036
ABCG1,Human mastadenovirus C encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ABCG1,Human adenovirus 2 IVa2,0.8999095837312036
ABCG1,Human adenovirus 6 maturation protein pIVa2 (gene: pIVa2),0.8999095837312036
ABCG1,Human mastadenovirus A IVa2,0.8999095837312036
ABCG1,Titi monkey adenovirus ECC-2011 IVa2,0.8999095837312036
ACAP3,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
ACAP3,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
ACAP3,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
ACAP3,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
ACAP3,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
ACAP3,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
ACAP3,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
ACAP3,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
ACAP3,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
ACAP3,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
ACAP3,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
ACAP3,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
ACAP3,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
ACAP3,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
ACAP3,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
ACAP3,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
ACAP3,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
ACAP3,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.1040670578681756
ACAP3,Albers Schonberg osteopetrosis ORPHA:53,0.1040670578681756
ACAP3,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.1040670578681756
ACAP3,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.1040670578681756
ACAP3,BAP1-related tumor predisposition syndrome ORPHA:289539,0.1040670578681756
ACAP3,Cerebellar-facial-dental syndrome ORPHA:444072,0.1040670578681756
ACAP3,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.1040670578681756
ACAP3,Kufor-Rakeb syndrome ORPHA:306674,0.1040670578681756
ACAP3,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.1040670578681756
ACAP3,Steinert myotonic dystrophy ORPHA:273,0.1040670578681756
ACAP3,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.1040670578681756
ACAP3,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.1040670578681756
ACAP3,D-2-hydroxyglutaric aciduria ORPHA:79315,0.1054066549396977
ACAP3,Smith-Magenis syndrome ORPHA:819,0.1117946631214258
ACAP3,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069,0.1991445465001551
ACAP3,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433,0.1991445465001551
ACAP3,Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899,0.1991445465001551
ACAP3,CLN4B disease ORPHA:228343,0.1991445465001551
ACAP3,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144,0.1991445465001551
ACAP3,Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257,0.1991445465001551
ACAP3,Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215,0.1991445465001551
ACAP3,Hurler syndrome ORPHA:93473,0.1991445465001551
ACAP3,Hurler-Scheie syndrome ORPHA:93476,0.1991445465001551
ACAP3,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401,0.1991445465001551
ACAP3,POMT1-related  limb-girdle muscular dystrophy R11 ORPHA:86812,0.1991445465001551
ACAP3,Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361,0.1991445465001551
ACAP3,Scheie syndrome ORPHA:93474,0.1991445465001551
ACAP3,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569,0.1991445465001551
ACAP3,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.1991445465001551
ACAP3,Lethal congenital contracture syndrome type 3 ORPHA:137783,0.1991445465001551
ACAP3,17p11.2 microduplication syndrome ORPHA:1713,0.3832844616405875
ACAP3,Distal 16p11.2 microdeletion syndrome ORPHA:261222,0.3832844616405875
ACAP3,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316,0.3832844616405875
ACAP3,Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620,0.3832844616405875
ACAP3,PMP22-RAI1 contiguous gene duplication syndrome ORPHA:477817,0.3832844616405875
ACAP3,Proximal 16p11.2 microdeletion syndrome ORPHA:261197,0.3832844616405875
ACAP3,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency ORPHA:329249,0.3832844616405875
ACAP3,Congenital muscular dystrophy with intellectual disability ORPHA:370968,0.3977968344535308
ACAP3,Uveal melanoma ORPHA:39044,0.3977968344535308
ACAP3,Wolf-Hirschhorn syndrome ORPHA:280,0.4100904865085126
ACAP3,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome ORPHA:459061,0.5867963421058087
ACAP3,Peutz-Jeghers syndrome ORPHA:2869,0.5867963421058087
ACAP3,Isolated focal cortical dysplasia type IIa ORPHA:269001,0.5867963421058087
ACAP3,AKT2-related familial partial lipodystrophy ORPHA:79085,0.7929682744768703
ACAP3,Familial LCAT deficiency ORPHA:79293,0.7929682744768703
ACAP3,Fish-eye disease ORPHA:79292,0.7929682744768703
ACAP3,Hypoinsulinemic hypoglycemia and body hemihypertrophy ORPHA:293964,0.7929682744768703
ACAP3,Primary lateral sclerosis ORPHA:35689,0.7929682744768703
ACAP3,Spastic paraplegia type 7 ORPHA:99013,0.7929682744768703
ACAP3,Cutis laxa with severe pulmonary gastrointestinal and urinary anomalies ORPHA:221145,0.8922466888454011
ACAP3,MORM syndrome ORPHA:75858,0.8922466888454011
ACAP3,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
ACAP3,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
ACAP3,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
ACAP3,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
ACAP3,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
ACAP3,Human adenovirus 1 fiber,0.8999095837312036
ACAP3,Human adenovirus 5 fiber,0.8999095837312036
ACAP3,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
ACAP3,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
ACAP3,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
ACAP3,Horsepox virus HSPV011a,0.8999095837312036
ACAP3,Nipah henipavirus P phosphoprotein,0.8999095837312036
ACAP3,Cowpox virus CPXV213 protein (gene: CPXV213 CDS),0.8999095837312036
ACAP3,Cowpox virus CPXV027 protein (gene: CPXV027 CDS),0.8999095837312036
ACAP3,Titi monkey adenovirus ECC-2011 fiber,0.8999095837312036
ACAP3,Vaccinia virus hypothetical protein,0.8999095837312036
ACAP3,Ectromelia virus ERPV ankyrin and nfkb inhibitor,0.8999095837312036
ACAP3,Vaccinia virus Ankara 72.4k ankyrin repeat protein f1,0.8999095837312036
ACAP3,Cowpox virus CPXV011 protein (gene: CPXV011 CDS),0.8999095837312036
ACAP3,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.8999095837312036
ACAP3,Horsepox virus HSPV022 (ankyrin-like protein,0.8999095837312036
ACAP3,Provisional),0.8999095837312036
ACAP3,Human mastadenovirus E fiber (gene: L5),0.8999095837312036
ACAP3,Human adenovirus E4 fiber protein,0.8999095837312036
ACAP3,Monkeypox virus ankyrin-like protein,0.8999095837312036
ACAP3,Horsepox virus HSPV033c (ankyrin repeats),0.8999095837312036
ACAP3,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.8999095837312036
ACAP3,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
ACAP3,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
ACAP3,Variola virus hypothetical protein (gene: D6L),0.8999095837312036
ACAP3,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
ACAP3,Vaccinia virus ankyrin-like protein (gene: C9L),0.8999095837312036
ACAP3,Horsepox virus HSPV201a (ankyrin repeats),0.8999095837312036
ACAP3,Yaba-like disease virus 147R protein (gene: 147R),0.9018002218631122
ACAP3,Cowpox virus CPXV041 protein (gene: CPXV041 CDS),0.9057542447893764
ACAP3,Horsepox virus HSPV035 (ankyrin repeats),0.9057542447893764
ACAP3,Horsepox virus HSPV004 (ankyrin repeats),0.9057542447893764
ACAP3,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: C1L),0.9057542447893764
ACAP3,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
ACAP3,Vaccinia virus ankyrin-like protein (gene: K1L),0.9057542447893764
ACAP3,Horsepox virus HSPV196 (ankyrin-like protein,0.9057542447893764
ACAP3,Provisional),0.9057542447893764
ACAP3,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
ACAP3,Variola virus hypothetical protein (gene: B19R),0.9057542447893764
ACAP3,Vaccinia virus Ankara CP77 Host range protein f1,0.9057542447893764
ACAP3,Vaccinia virus Ankara Host range protein,0.9057542447893764
ACAP3,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.9057542447893764
ACAP3,Variola virus hypothetical protein (gene: B21R),0.9057542447893764
ACAP3,Ectromelia virus ERPV ankyrin,0.9057542447893764
ACAP3,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
ACAP3,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.9057542447893764
ACAP3,Vaccinia virus ankyrin-like protein (gene: B18R),0.9057542447893764
ACAP3,Variola virus hypothetical protein (gene: D7L),0.9057542447893764
ACAP3,Horsepox virus HSPV033b (Ankyrin repeats),0.9058994261255549
ACAP3,Variola virus hypothetical protein (gene: G3R),0.9058994261255549
ACAP3,Orf virus ORF126 ankyrin repeat protein,0.9071659214187592
ACAP3,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9115856929326512
ACAP3,Monkeypox virus Zaire-96-I-16 B17R (gene: B17R),0.915880438522078
ACAP3,Horsepox virus HSPV020b (ankyrin repeats),0.915880438522078
ACAP3,Horsepox virus HSPV005b (ankyrin repeats),0.915880438522078
ACAP3,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.9176018655958595
ACAP3,Horsepox virus HSPV005c (Ankyrin repeats),0.9176018655958595
ACAP3,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L),0.9224878266317492
ACAP3,Cowpox virus CPXV019 protein (gene: CPXV019 CDS),0.9237501457186692
ACAP3,Yaba-like disease virus 8L protein (gene: 8L),0.9237501457186692
ACAP3,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
ACAP3,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.9237501457186692
ACAP3,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.9237501457186692
ACAP3,Vaccinia virus Ankara CP77 host range protein f4,0.9237501457186692
ACAP3,Vaccinia virus Ankara 67.9k ankyrin repeat protein,0.9287050575620676
ACAP3,Cowpox virus CPXV008 protein (gene: CPXV008 CDS),0.9287050575620676
ACAP3,Horsepox virus HSPV014b (ankyrin repeats),0.9287050575620676
ACAP3,Horsepox virus HSPV014c (ankyrin repeats),0.9287050575620676
ACAP3,Vaccinia virus ankyin-like protein (gene: M1L),0.9287050575620676
ACAP3,Yaba-like disease virus 146R protein (gene: 146R),0.9318782091866168
ACAP3,Vaccinia virus Ankara CP77 host range protein f2,0.9364561700418303
ACAP3,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.9366403811337995
ACAP3,Variola virus hypothetical protein (gene: B6R),0.9383505321091749
ACAP3,Vaccinia virus ankyrin-like protein,0.9383505321091749
ACAP3,Orf virus ORF129 ankyrin repeat protein,0.9386073090182748
ACAP3,Cowpox virus CPXV017 protein (gene: CPXV017 CDS),0.9397923093369096
ACAP3,Variola virus ankyin-like protein (gene: O1L),0.9397923093369096
ACAP3,Horsepox virus HSPV194 (ankyrin repeats),0.9397923093369096
ACAP3,Cowpox virus CPXV006 protein (gene: CPXV006 CDS),0.9397923093369096
ACAP3,Horsepox virus HSPV012 (ankyrin-like protein,0.9397923093369096
ACAP3,Provisional),0.9397923093369096
ACAP3,Cowpox virus CPXV220 protein (gene: CPXV220 CDS),0.9563208507960556
ACOT7,Malignant neoplasm of ovary,0.7333611688795861
ACOT7,Ovarian Carcinoma,0.7333611688795861
ACOT7,Liver carcinoma,0.7880542567584415
ACOT7,Epithelial ovarian cancer,0.7880542567584415
ACOT7,Glioblastoma,0.7880542567584415
ACOT7,Neoplasms,0.7880542567584415
ACOT7,Childhood Glioblastoma,0.7880542567584415
ACOT7,Adult Glioblastoma,0.7880542567584415
ACOT7,Whooping cough due to unspecified organism,0.7880542567584415
ACOT7,Pertussis,0.7880542567584415
ACOT7,Epilepsy Temporal Lobe,0.98328107300087
ACOT7,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
ACOT7,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.1068643725150898
ACOT7,Familial congenital mirror movements ORPHA:238722,0.2120485863056726
ACOT7,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570,0.3832844616405875
ACOT7,Ichthyosis-prematurity syndrome ORPHA:88621,0.3832844616405875
ACOT7,Neu-Laxova syndrome ORPHA:2671,0.5867963421058087
ACOT7,Myoclonus-dystonia syndrome ORPHA:36899,0.606625035400596
ACOT7,Anterior segment developmental anomaly ORPHA:88632,0.7929682744768703
ACOT7,Congenital primary aphakia ORPHA:83461,0.7929682744768703
ACOT7,Essential fructosuria ORPHA:2056,0.7929682744768703
ACOT7,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848,0.7929682744768703
ACOT7,MEDNIK syndrome ORPHA:171851,0.7929682744768703
ACOT7,Multiple benign circumferential skin creases on limbs ORPHA:2505,0.7929682744768703
ACOT7,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency ORPHA:331176,0.8922466888454011
ACOT7,Distal 17p13.3 microdeletion syndrome ORPHA:261257,0.8922466888454011
ACOT7,Hemolytic anemia due to glucophosphate isomerase deficiency ORPHA:712,0.8922466888454011
ACOT7,Phosphoserine aminotransferase deficiency infantile/juvenile form ORPHA:284417,0.8922466888454011
ACOT7,Smith-Lemli-Opitz syndrome ORPHA:818,0.8922466888454011
ADA,Malignant neoplasm of breast,0.4084380369379369
ADA,Breast Carcinoma,0.7333611688795861
ADA,Diffuse Large B-Cell Lymphoma,0.7333611688795861
ADA,Carcinogenesis,0.7333611688795861
ADA,B-Cell Lymphomas,0.7333611688795861
ADA,leukemia,0.7333611688795861
ADA,Reticulosarcoma,0.7765852775619541
ADA,Sideroblastic anemia,0.7765852775619541
ADA,MYELODYSPLASTIC SYNDROME,0.7765852775619541
ADA,HIV Encephalopathy,0.7765852775619541
ADA,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
ADA,HIV encephalitis,0.7765852775619541
ADA,Middle East Respiratory Syndrome,0.7880542567584415
ADA,Malignant neoplasm of lung,0.7880542567584415
ADA,Malignant neoplasm of prostate,0.7880542567584415
ADA,Lymphopenia,0.7880542567584415
ADA,Chronic heart failure,0.7880542567584415
ADA,T-Cell Lymphoma,0.7880542567584415
ADA,Glioblastoma,0.7880542567584415
ADA,Prostate carcinoma,0.7880542567584415
ADA,Pulmonary Edema,0.7880542567584415
ADA,Peptic Ulcer,0.7880542567584415
ADA,Primary immune deficiency disorder,0.7880542567584415
ADA,Hydatidiform Mole,0.7880542567584415
ADA,Immunologic Deficiency Syndromes,0.7880542567584415
ADA,Malignant Neoplasms,0.7880542567584415
ADA,melanoma,0.7880542567584415
ADA,Lung Neoplasms,0.7880542567584415
ADA,Retinal Diseases,0.7880542567584415
ADA,Lymphadenopathy,0.7880542567584415
ADA,Body fluid retention,0.7880542567584415
ADA,Chronic lung disease,0.7880542567584415
ADA,Diffusely thickened skin,0.7880542567584415
ADA,Severe B lymphocytopenia,0.7880542567584415
ADA,Absence of B cells,0.7880542567584415
ADA,Congenital hypoplastic anemia,0.7880542567584415
ADA,Diarrhea,0.7880542567584415
ADA,Recurrent upper respiratory tract infection,0.7880542567584415
ADA,Thick skin,0.7880542567584415
ADA,Histiocytic sarcoma,0.7880542567584415
ADA,Vesicular Stomatitis,0.7880542567584415
ADA,Skin Carcinogenesis,0.7880542567584415
ADA,Recurrent opportunistic infections,0.7880542567584415
ADA,Pulmonary Valve Insufficiency,0.7880542567584415
ADA,Pulmonary Alveolar Proteinosis,0.7880542567584415
ADA,Lymphocytosis,0.7880542567584415
ADA,Severe Combined Immunodeficiency,0.7880542567584415
ADA,Anterior rib cupping,0.7880542567584415
ADA,Macrocytosis,0.7880542567584415
ADA,Low Vision,0.7880542567584415
ADA,pricking of skin,0.7880542567584415
ADA,Dementia,0.7880542567584415
ADA,Somatic mosaicism,0.7880542567584415
ADA,Other specified peritonitis,0.7880542567584415
ADA,Lupus Erythematosus Systemic,0.7880542567584415
ADA,Childhood Glioblastoma,0.7880542567584415
ADA,Acquired Immunodeficiency Syndrome,0.7880542567584415
ADA,Adult Glioblastoma,0.7880542567584415
ADA,Recurrent pulmonary infections,0.7880542567584415
ADA,Multiple pulmonary infections,0.7880542567584415
ADA,Trypanosomiasis,0.7880542567584415
ADA,Bone marrow myeloid dysplasia,0.7880542567584415
ADA,Acute leukemia,0.7880542567584415
ADA,Presenile dementia,0.7880542567584415
ADA,Recurrent pneumonia,0.7880542567584415
ADA,Acute lymphocytic leukemia,0.7880542567584415
ADA,Pancytopenia,0.7880542567584415
ADA,GALACTOSIALIDOSIS,0.7880542567584415
ADA,Increased IgE level,0.7880542567584415
ADA,Autoimmune Diseases,0.7880542567584415
ADA,Ketosis,0.7880542567584415
ADA,Rheumatoid Arthritis,0.7880542567584415
ADA,Post MI,0.7880542567584415
ADA,Diabetes,0.7880542567584415
ADA,Anemia Hemolytic Congenital,0.7880542567584415
ADA,Venous Engorgement,0.7880542567584415
ADA,Active Hyperemia,0.7880542567584415
ADA,B lymphocytopenia,0.7880542567584415
ADA,Desquamation of skin soon after birth,0.7880542567584415
ADA,IgM deficiency,0.7880542567584415
ADA,Reactive Hyperemia,0.7880542567584415
ADA,Diabetes Mellitus,0.7880542567584415
ADA,Abnormality of the skeletal system,0.7880542567584415
ADA,Uveitis,0.7880542567584415
ADA,Leptospirosis,0.7880542567584415
ADA,Hyperglycemia,0.7880542567584415
ADA,Huntington Disease,0.7880542567584415
ADA,Symmetrical dyschromatosis of extremities,0.7880542567584415
ADA,Adenosine deaminase deficiency,0.7880542567584415
ADA,Dermatofibrosarcoma,0.7880542567584415
ADA,Diffuse mesangial sclerosis (disorder),0.7880542567584415
ADA,Edema,0.7880542567584415
ADA,Vasculitis,0.7880542567584415
ADA,Recurrent fungal infections,0.7880542567584415
ADA,Myeloid Leukemia Chronic,0.7880542567584415
ADA,Post-kala-azar dermal leishmaniasis,0.7880542567584415
ADA,T-Lymphocytopenia,0.7908231553833205
ADA,Recurrent viral infection,0.8009048756462318
ADA,Peyronie Disease,0.8009048756462318
ADA,Liver Cirrhosis Experimental,0.8014900279306119
ADA,Xerosis,0.8019075543217649
ADA,Pre-Eclampsia,0.8019075543217649
ADA,Hairy Cell Leukemia,0.8019075543217649
ADA,Pneumonitis,0.8019075543217649
ADA,Kidney Failure Chronic,0.8019075543217649
ADA,Autistic Disorder,0.8019075543217649
ADA,Dry skin,0.8019075543217649
ADA,Lung diseases,0.8019075543217649
ADA,Severe combined immunodeficiency due to adenosine deaminase deficiency,0.8019075543217649
ADA,Infectious disease of lung,0.8019075543217649
ADA,Degenerative polyarthritis,0.8019075543217649
ADA,Wiskott-Aldrich Syndrome,0.8019075543217649
ADA,Tuberculosis Meningeal,0.8067197998685076
ADA,Chromosome 8 trisomy,0.8067197998685076
ADA,Idiopathic thrombocytopenia,0.8098851543361193
ADA,Cockayne Syndrome,0.8101097852323003
ADA,Dyslipidemias,0.8138488881521341
ADA,Hyperemia,0.8138488881521341
ADA,Reactive airway disease,0.8138488881521341
ADA,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
ADA,XERODERMA PIGMENTOSUM COMPLEMENTATION GROUP C,0.8145035474981049
ADA,Autoimmune thrombocytopenia,0.8168901801930506
ADA,Platyspondyly,0.8168901801930506
ADA,Fever,0.8168901801930506
ADA,Recurrent otitis media,0.8168901801930506
ADA,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
ADA,Impaired cognition,0.8190761496232595
ADA,Chronic granulomatous disease,0.8190761496232595
ADA,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
ADA,Dermatofibrosarcoma Protuberans,0.8190761496232595
ADA,Giant Cell Fibroblastoma,0.8190761496232595
ADA,Omenn Syndrome,0.8190761496232595
ADA,Inflammation,0.8212681436603975
ADA,X-Linked Combined Immunodeficiency Diseases,0.8212681436603975
ADA,Pleural Tuberculosis,0.8212681436603975
ADA,Polyarteritis Nodosa,0.8212681436603975
ADA,Nephrotic Syndrome,0.8232134984476662
ADA,Immune thrombocytopenic purpura,0.8232134984476662
ADA,Hypersensitivity,0.8232134984476662
ADA,Cognition Disorders,0.8270909867833504
ADA,Malignant Peripheral Nerve Sheath Tumor,0.8272008757995397
ADA,Combined immunodeficiency,0.8272008757995397
ADA,Hemorrhage,0.8272008757995397
ADA,Pneumonia,0.834094492023826
ADA,Wheezing,0.834094492023826
ADA,Splenomegaly,0.8402911822757345
ADA,Spinal Cord Diseases,0.8402911822757345
ADA,Amyotrophic Lateral Sclerosis,0.8402911822757345
ADA,Immune System Diseases,0.8402911822757345
ADA,Chronic diarrhea,0.8402911822757345
ADA,Autoimmune hemolytic anemia,0.8402911822757345
ADA,Paranasal Sinus Diseases,0.8402911822757345
ADA,Granulomatous Disease Chronic X-Linked,0.8402911822757345
ADA,Skin Diseases Genetic,0.8402911822757345
ADA,Sparse or absent eyebrows,0.8402911822757345
ADA,Sparse/absent eyebrows,0.8402911822757345
ADA,Absence of eyebrow,0.8402911822757345
ADA,Aplasia/Hypoplasia of the eyebrow,0.8402911822757345
ADA,Exfoliative dermatitis,0.8402911822757345
ADA,Hypertensive disease,0.8474481237156937
ADA,Lymphoproliferative Disorders,0.8508164886128737
ADA,Alopecia,0.8523465762428218
ADA,Inflammatory dermatosis,0.8554819098734854
ADA,Metabolic Syndrome X,0.8610447277138289
ADA,Abnormality of pelvic girdle bone morphology,0.8610447277138289
ADA,Immunoglobulin A deficiency (disorder),0.8648405521677974
ADA,Recurrent bacterial infection,0.8648405521677974
ADA,Increased susceptibility to bacterial infections,0.8648405521677974
ADA,Prone to bacterial infection,0.8648405521677974
ADA,Sinusitis,0.876210765330195
ADA,Choriocarcinoma,0.8769418330148872
ADA,Eosinophilia,0.8769418330148872
ADA,Dermatitis,0.8815127642200768
ADA,Undifferentiated leukemia,0.8851456306720444
ADA,Leishmaniasis,0.8851456306720444
ADA,hiv-infection/aids,0.8867509400747969
ADA,Hepatomegaly,0.887595340546704
ADA,Coronary Artery Disease,0.887595340546704
ADA,Anemia Diamond-Blackfan,0.887595340546704
ADA,Pruritus,0.8911256045597441
ADA,Pediatric Obesity,0.8911256045597441
ADA,Malignant Pleural Mesothelioma,0.8935933996254593
ADA,Measles,0.8938510789776706
ADA,Congestive heart failure,0.8976039441125321
ADA,Obesity,0.8989612563669234
ADA,Acute Undifferentiated Leukemia,0.900167961295542
ADA,Pleural Effusion Malignant,0.9039108388826153
ADA,Maturity onset diabetes mellitus in young,0.9119978323790848
ADA,Anoxia,0.9184153253162451
ADA,Anemia Sickle Cell,0.9252532782268056
ADA,Bronchopulmonary Dysplasia,0.9446671211493156
ADA,Intellectual Disability,0.9478210444156088
ADA,Anemia Hemolytic,0.951016614400691
ADA,Essential Hypertension,0.9557184806547836
ADA,Autism Spectrum Disorders,0.9639249377588224
ADA,Asthma,0.9672478180546946
ADA,Impaired glucose tolerance,0.9734506818882446
ADA,Hashimoto Disease,0.9855010111136676
ADA,Undergrowth,0.9884235744717738
ADA,Failure to gain weight,0.9896536639644284
ADA,Pediatric failure to thrive,0.9896536639644284
ADA,Omenn Syndrome,0.7765582368651238
ADA,Spinal Cord Diseases,0.7765582368651238
ADA,Severe Combined Immunodeficiency Disease,0.7765582368651238
ADA,Eosinophilia,0.7765582368651238
ADA,Mesangial Sclerosis,0.7765582368651238
ADA,Lymphoma,0.7765582368651238
ADA,Hyperemia,0.7765582368651238
ADA,Otitis Media,0.8115918568696846
ADA,Autoimmune Hemolytic Anemia,0.8165359516083085
ADA,Immune Thrombocytopenic Purpura,0.8611702959552964
ADA,B-Cell Lymphoma,0.861756360478846
ADA,Exfoliative Dermatitis,0.861756360478846
ADA,Dermatitis,0.861756360478846
ADA,Thyroiditis,0.861756360478846
ADA,Pancreatic Adenocarcinoma,0.8706864397989688
ADA,Lung Cancer,0.8706864397989688
ADA,Hypothyroidism,0.8879896755141929
ADA,Sinusitis,0.8897718769742773
ADA,Lung Neoplasms,0.8903301324869451
ADA,Autism,0.911896615143974
ADA,Alopecia,0.9367173114041438
ADA,Anemia,0.9369188149054885
ADA,Asthma,0.9832345076528324
ADA,Nephrotic Syndrome,0.9832345076528324
ADA,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.3832844616405875
ADA,Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277,0.7929682744768703
ADA,Omenn syndrome ORPHA:39041,0.8447648476081987
ADA,Hydranencephaly ORPHA:2177,0.8922466888454011
ADA,NDE1-related microhydranencephaly ORPHA:443162,0.8922466888454011
ADAM8,Malignant neoplasm of breast,0.4084380369379369
ADAM8,Breast Carcinoma,0.7333611688795861
ADAM8,Carcinogenesis,0.7333611688795861
ADAM8,Adenocarcinoma,0.750391252594775
ADAM8,Malignant neoplasm of pancreas,0.7688485284765829
ADAM8,Colorectal Carcinoma,0.7765852775619541
ADAM8,Pancreatic carcinoma,0.7765852775619541
ADAM8,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
ADAM8,Pancreatic Neoplasm,0.7765852775619541
ADAM8,Mammary Neoplasms,0.7880542567584415
ADAM8,Glioma,0.7880542567584415
ADAM8,Malignant neoplasm of lung,0.7880542567584415
ADAM8,Malignant neoplasm of prostate,0.7880542567584415
ADAM8,Colorectal Cancer,0.7880542567584415
ADAM8,Prostate carcinoma,0.7880542567584415
ADAM8,Primary malignant neoplasm of lung,0.7880542567584415
ADAM8,Neoplasm Metastasis,0.7880542567584415
ADAM8,Carcinoma of lung,0.7880542567584415
ADAM8,Triple Negative Breast Neoplasms,0.7880542567584415
ADAM8,Lung Neoplasms,0.7880542567584415
ADAM8,Coronary Arteriosclerosis,0.7880542567584415
ADAM8,Arteriosclerosis,0.7880542567584415
ADAM8,Atherosclerosis,0.7880542567584415
ADAM8,Squamous cell carcinoma,0.7880542567584415
ADAM8,Rheumatoid Arthritis,0.7880542567584415
ADAM8,Airway Obstruction,0.7880542567584415
ADAM8,Allergic disposition,0.8019075543217649
ADAM8,Pneumonitis,0.8019075543217649
ADAM8,Myocardial Infarction,0.8019075543217649
ADAM8,Synovitis,0.8019075543217649
ADAM8,Liver diseases,0.8140222479282434
ADAM8,CNS disorder,0.8168901801930506
ADAM8,Superficial ulcer,0.8168901801930506
ADAM8,bone destruction,0.8232134984476662
ADAM8,Pneumonia,0.834094492023826
ADAM8,Drug-Induced Liver Disease,0.8523465762428218
ADAM8,Hepatitis Toxic,0.8548862007194026
ADAM8,Chemical and Drug Induced Liver Injury,0.8548862007194026
ADAM8,Chemically-Induced Liver Toxicity,0.8548862007194026
ADAM8,Drug-Induced Acute Liver Injury,0.8548862007194026
ADAM8,Hepatitis Drug-Induced,0.8578473133580928
ADAM8,Chronic Obstructive Airway Disease,0.8648405521677974
ADAM8,Brain Tumor Primary,0.9189398569397552
ADAM8,Asthma,0.9672478180546946
ADAM8,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
ADAM8,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
ADAM8,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
ADAM8,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
ADAM8,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
ADAM8,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
ADAM8,Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813,0.1054066549396977
ADAM8,Aicardi-Goutieres syndrome ORPHA:51,0.1294848460749822
ADAM8,Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549,0.1991445465001551
ADAM8,Alpha-mannosidosis adult form ORPHA:309288,0.1991445465001551
ADAM8,Alpha-mannosidosis infantile form ORPHA:309282,0.1991445465001551
ADAM8,Autosomal dominant dopa-responsive dystonia ORPHA:98808,0.1991445465001551
ADAM8,Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713,0.1991445465001551
ADAM8,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.1991445465001551
ADAM8,GTP cyclohydrolase I deficiency ORPHA:2102,0.1991445465001551
ADAM8,Gamma-glutamyl transpeptidase deficiency ORPHA:33573,0.1991445465001551
ADAM8,NIK deficiency ORPHA:447731,0.1991445465001551
ADAM8,Waldenstrom macroglobulinemia ORPHA:33226,0.1991445465001551
ADAM8,Stormorken-Sjaastad-Langslet syndrome ORPHA:3204,0.1991445465001551
ADAM8,Dehydrated hereditary stomatocytosis ORPHA:3202,0.2047219337649946
ADAM8,Takayasu arteritis ORPHA:3287,0.2047219337649946
ADAM8,Autosomal recessive malignant osteopetrosis ORPHA:667,0.2120485863056726
ADAM8,Combined immunodeficiency-enteropathy spectrum ORPHA:436252,0.3832844616405875
ADAM8,Gray platelet syndrome ORPHA:721,0.3832844616405875
ADAM8,Multiple intestinal atresia ORPHA:2300,0.3832844616405875
ADAM8,Osteogenesis imperfecta type 5 ORPHA:216828,0.3832844616405875
ADAM8,Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198,0.3832844616405875
ADAM8,Revesz syndrome ORPHA:3088,0.3832844616405875
ADAM8,Metaphyseal anadysplasia ORPHA:1040,0.3832844616405875
ADAM8,Dysosteosclerosis ORPHA:1782,0.3832844616405875
ADAM8,Autosomal dominant severe congenital neutropenia ORPHA:486,0.3891940933600213
ADAM8,Epidermodysplasia verruciformis ORPHA:302,0.3891940933600213
ADAM8,Charcot-Marie-Tooth disease type 1C ORPHA:101083,0.5867963421058087
ADAM8,Congenital isolated ACTH deficiency ORPHA:199296,0.5867963421058087
ADAM8,Neutrophil immunodeficiency syndrome ORPHA:183707,0.5867963421058087
ADAM8,Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298,0.5867963421058087
ADAM8,Familial hemophagocytic lymphohistiocytosis ORPHA:540,0.5959529547720634
ADAM8,BENTA disease ORPHA:464336,0.7929682744768703
ADAM8,Cherubism ORPHA:184,0.7929682744768703
ADAM8,Odonto-onycho-dermal dysplasia ORPHA:2721,0.7929682744768703
ADAM8,Persistent polyclonal B-cell lymphocytosis ORPHA:300324,0.7929682744768703
ADAM8,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.7929682744768703
ADAM8,Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237,0.7929682744768703
ADAM8,Recurrent infection due to specific granule deficiency ORPHA:169142,0.7929682744768703
ADAM8,Common variable immunodeficiency ORPHA:1572,0.8564946241562607
ADAM8,Blau syndrome ORPHA:90340,0.8922466888454011
ADAM8,Nasopharyngeal carcinoma ORPHA:150,0.8922466888454011
ADAM8,Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248,0.8922466888454011
ADARB1,Non-Small Cell Lung Carcinoma,0.7765852775619541
ADARB1,Malignant neoplasm of lung,0.7880542567584415
ADARB1,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
ADARB1,Liver carcinoma,0.7880542567584415
ADARB1,Hepatocarcinogenesis,0.7880542567584415
ADARB1,Glioblastoma,0.7880542567584415
ADARB1,Astrocytoma,0.7880542567584415
ADARB1,Primary malignant neoplasm of lung,0.7880542567584415
ADARB1,Hepatitis D Infection,0.7880542567584415
ADARB1,Carcinoma of lung,0.7880542567584415
ADARB1,Malignant neoplasm of liver,0.7880542567584415
ADARB1,Sclerocystic Ovaries,0.7880542567584415
ADARB1,Mental disorders,0.7880542567584415
ADARB1,Abnormal behavior,0.7880542567584415
ADARB1,Hodgkin Disease,0.7880542567584415
ADARB1,Brain Neoplasms,0.7880542567584415
ADARB1,Sarcoma,0.7880542567584415
ADARB1,Lupus Erythematosus Systemic,0.7880542567584415
ADARB1,Alzheimer's Disease,0.7880542567584415
ADARB1,Liver neoplasms,0.8019075543217649
ADARB1,Schizophrenia,0.8067197998685076
ADARB1,Liver Cirrhosis,0.8232134984476662
ADARB1,Glioblastoma Multiforme,0.8342163953428735
ADARB1,Amyotrophic Lateral Sclerosis,0.8402911822757345
ADARB1,Other specified transient cerebral ischemias,0.8402911822757345
ADARB1,Migraine Disorders,0.8648405521677974
ADARB1,Transient Ischemic Attack,0.8816060628973529
ADARB1,Bipolar I disorder,0.882453254162044
ADARB1,Body mass index,0.8867509400747969
ADARB1,Finding of body mass index,0.8867509400747969
ADARB1,Hyperactive behavior,0.8878860377518915
ADARB1,Obesity,0.8989612563669234
ADARB1,Bipolar Disorder,0.900167961295542
ADARB1,Mood Disorders,0.9093740881835894
ADARB1,Polycystic Ovary Syndrome,0.9174808175273056
ADARB1,Psychotic Disorders,0.939985154445373
ADARB1,Behcet Syndrome,0.9446671211493156
ADARB1,Unipolar Depression,0.9455834988784428
ADARB1,Major Depressive Disorder,0.9658628445524134
ADARB1,Sclerocystic Ovaries,0.7765582368651238
ADARB1,Psychosis,0.7765582368651238
ADARB1,Polycystic Ovary Syndrome,0.7765582368651238
ADARB1,Schizophrenia,0.7860378120955526
ADARB1,Diabetes Mellitus,0.919442421650838
ADARB1,Bipolar Disorder,0.943322675973118
AGPAT2,Malignant neoplasm of ovary,0.7333611688795861
AGPAT2,Growth hormone excess,0.7333611688795861
AGPAT2,Ovarian Carcinoma,0.7333611688795861
AGPAT2,Malignant neoplasm of pancreas,0.7688485284765829
AGPAT2,Tall stature,0.7765852775619541
AGPAT2,Pancreatic carcinoma,0.7765852775619541
AGPAT2,Nephrolithiasis,0.7765852775619541
AGPAT2,Advanced bone age,0.7765852775619541
AGPAT2,Russell-Silver syndrome,0.7765852775619541
AGPAT2,Triangular face,0.7765852775619541
AGPAT2,Endometrial Carcinoma,0.7765852775619541
AGPAT2,Long foot,0.7880542567584415
AGPAT2,Osteosarcoma,0.7880542567584415
AGPAT2,Osteosarcoma of bone,0.7880542567584415
AGPAT2,Adenocarcinoma of pancreas,0.7880542567584415
AGPAT2,Spastic paraplegia 17,0.7880542567584415
AGPAT2,Congenital Generalized Lipodystrophy Type 2,0.7880542567584415
AGPAT2,Sclerocystic Ovaries,0.7880542567584415
AGPAT2,Hyperplasia of supraorbital margins,0.7880542567584415
AGPAT2,Hyperplasia of supraorbital ridge,0.7880542567584415
AGPAT2,Hypertrophy of supraorbital margins,0.7880542567584415
AGPAT2,Hypertrophy of supraorbital ridge,0.7880542567584415
AGPAT2,Prominent supraorbital ridges,0.7880542567584415
AGPAT2,Large hand,0.7880542567584415
AGPAT2,Large auricle,0.7880542567584415
AGPAT2,Large pinnae,0.7880542567584415
AGPAT2,Macrotia,0.7880542567584415
AGPAT2,Hypertrophy of lower jaw,0.7880542567584415
AGPAT2,mandibular excess (physical finding),0.7880542567584415
AGPAT2,Mandibular hyperplasia,0.7880542567584415
AGPAT2,Increased appetite (finding),0.7880542567584415
AGPAT2,Abnormal pigmentation,0.7880542567584415
AGPAT2,Hyperphagia,0.7880542567584415
AGPAT2,Increased size of the mandible,0.7880542567584415
AGPAT2,Decreased serum leptin,0.7880542567584415
AGPAT2,Class III malocclusion,0.7880542567584415
AGPAT2,Acromegaly,0.7880542567584415
AGPAT2,Fanconi-Bickel Syndrome,0.7880542567584415
AGPAT2,Lipoatrophic Diabetes Mellitus,0.7880542567584415
AGPAT2,Serum triglycerides raised,0.7880542567584415
AGPAT2,Diabetes,0.7880542567584415
AGPAT2,Diabetes Mellitus,0.7880542567584415
AGPAT2,Bone Cysts,0.7880542567584415
AGPAT2,Myeloid Leukemia Chronic,0.7880542567584415
AGPAT2,Skeletal muscle hypertrophy,0.7908231553833205
AGPAT2,Hyperinsulinism,0.8019075543217649
AGPAT2,Familial generalized lipodystrophy,0.8019075543217649
AGPAT2,Decreased fertility in females,0.8019075543217649
AGPAT2,Precocious Puberty,0.8019075543217649
AGPAT2,ovarian neoplasm,0.8067197998685076
AGPAT2,Broad foot,0.8168901801930506
AGPAT2,Liver Cirrhosis,0.8232134984476662
AGPAT2,Acanthosis Nigricans,0.8232134984476662
AGPAT2,Hereditary Motor and Sensory-Neuropathy Type II,0.8270909867833504
AGPAT2,Splenomegaly,0.8402911822757345
AGPAT2,Mental deficiency,0.8402911822757345
AGPAT2,Steatohepatitis,0.8402911822757345
AGPAT2,Peripheral motor neuropathy,0.8402911822757345
AGPAT2,Liver Dysfunction,0.8402911822757345
AGPAT2,Lipoatrophy,0.8402911822757345
AGPAT2,Acute pancreatitis,0.8474481237156937
AGPAT2,Generalized hirsutism,0.8584283190330553
AGPAT2,Metabolic Syndrome X,0.8610447277138289
AGPAT2,Fatty Liver,0.8628363180844141
AGPAT2,Hypertrophy of clitoris,0.8648405521677974
AGPAT2,Subclinical abnormal liver function tests,0.8648405521677974
AGPAT2,Transaminases increased,0.8648405521677974
AGPAT2,Elevated liver enzymes,0.8648405521677974
AGPAT2,Increased liver function tests,0.8648405521677974
AGPAT2,Liver enzymes abnormal,0.8648405521677974
AGPAT2,Liver function tests abnormal finding,0.8648405521677974
AGPAT2,Elevated hepatic transaminases,0.8648405521677974
AGPAT2,Dull intelligence,0.8757755363384367
AGPAT2,Low intelligence,0.8757755363384367
AGPAT2,Mental impairment,0.876210765330195
AGPAT2,Malignant neoplasm of endometrium,0.8769418330148872
AGPAT2,Uterine Corpus Cancer,0.8771562273432176
AGPAT2,Hirsutism,0.8774809019744603
AGPAT2,Hepatomegaly,0.887595340546704
AGPAT2,Poor school performance,0.8913141512402477
AGPAT2,Obesity,0.8989612563669234
AGPAT2,Insulin Resistance,0.9098977259629772
AGPAT2,Polycystic Ovary Syndrome,0.9174808175273056
AGPAT2,Mental Retardation,0.922229272318747
AGPAT2,Sweating,0.9307095582633488
AGPAT2,Hyperhidrosis disorder,0.9307095582633488
AGPAT2,Increased sweating,0.9307095582633488
AGPAT2,Umbilical hernia,0.9457739154209
AGPAT2,Hypertrophic Cardiomyopathy,0.9459312971127588
AGPAT2,Lipodystrophy,0.946564927793026
AGPAT2,Intellectual Disability,0.9478210444156088
AGPAT2,Trichohepatoenteric Syndrome,0.94939825643792
AGPAT2,Liver Failure,0.9816840072553962
AGPAT2,Nephrolithiasis,0.7765582368651238
AGPAT2,Congenital Lipodystrophy,0.7765582368651238
AGPAT2,Immunologic Deficiency Syndromes,0.7765582368651238
AGPAT2,Somatotropin Deficiency,0.7765582368651238
AGPAT2,Lipoatrophy,0.7765582368651238
AGPAT2,Renal Glomerular Disease,0.7765582368651238
AGPAT2,Polycystic Ovary Syndrome,0.7765582368651238
AGPAT2,Precocious Puberty,0.7765582368651238
AGPAT2,Isolated Somatotropin Deficiency,0.7860378120955526
AGPAT2,Secondary Physiologic Amenorrhea,0.7860378120955526
AGPAT2,Osteopenia,0.8115918568696846
AGPAT2,Pancreatitis,0.8115918568696846
AGPAT2,Macrotia,0.8115918568696846
AGPAT2,Hypertrophy Of Clitoris,0.8115918568696846
AGPAT2,Malocclusion,0.8115918568696846
AGPAT2,Lipodystrophy,0.8115918568696846
AGPAT2,Atrial Fibrillation,0.8115918568696846
AGPAT2,Kidney Disease,0.8210988731657684
AGPAT2,Talipes Transversoplanus,0.829560580336605
AGPAT2,Fatty Liver,0.8321692755697452
AGPAT2,Mental Retardation,0.8337953215113012
AGPAT2,Acanthosis Nigricans,0.8611702959552964
AGPAT2,Myocardial Infarction,0.861756360478846
AGPAT2,Hyperinsulinism,0.861756360478846
AGPAT2,Ventricular Hypertrophy,0.861756360478846
AGPAT2,Osteoporosis,0.8903301324869451
AGPAT2,Pulmonary Arterial Hypertension,0.8903630091389316
AGPAT2,Diabetes Mellitus,0.919442421650838
AGPAT2,Scoliosis,0.924275664330454
AGPAT2,Atherosclerosis,0.941216656523771
AGPAT2,Nervous System Diseases,0.9492120794677584
AGPAT2,Congestive Heart Failure,0.9543024119762946
AGPAT2,Liver Failure,0.9543024119762946
AGPAT2,Hypertrophic Cardiomyopathy,0.9726837163662044
AGPAT2,Renal Insufficiency,0.9726837163662044
AGPAT2,Congenital Exomphalos,0.980894832851993
AGPAT2,Cirrhosis,0.9832345076528324
AGPAT2,Myopathy,0.986561188259959
AGPAT2,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
AGPAT2,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
AGPAT2,CLN11 disease ORPHA:314629,0.1040670578681756
AGPAT2,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.1040670578681756
AGPAT2,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.1054066549396977
AGPAT2,Marinesco-Sjogren syndrome ORPHA:559,0.1054066549396977
AGPAT2,Adrenomyeloneuropathy ORPHA:139399,0.1991445465001551
AGPAT2,CLN10 disease ORPHA:228337,0.1991445465001551
AGPAT2,Neutral lipid storage myopathy ORPHA:98908,0.1991445465001551
AGPAT2,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.1991445465001551
AGPAT2,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.1991445465001551
AGPAT2,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.1991445465001551
AGPAT2,CADDS ORPHA:369942,0.1991445465001551
AGPAT2,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3832844616405875
AGPAT2,Galactokinase deficiency ORPHA:79237,0.3832844616405875
AGPAT2,Dysosteosclerosis ORPHA:1782,0.3832844616405875
AGPAT2,Rare isolated myopia ORPHA:98619,0.3832844616405875
AGPAT2,5-oxoprolinase deficiency ORPHA:33572,0.5867963421058087
AGPAT2,Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964,0.5867963421058087
AGPAT2,Congenital bile acid synthesis defect type 1 ORPHA:79301,0.5867963421058087
AGPAT2,Congenital factor XII deficiency ORPHA:330,0.5867963421058087
AGPAT2,F12-related hereditary angioedema with normal C1Inh ORPHA:100054,0.5867963421058087
AGPAT2,Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927,0.5867963421058087
AGPAT2,Mucopolysaccharidosis type 7 ORPHA:584,0.5867963421058087
AGPAT2,Sanfilippo syndrome type B ORPHA:79270,0.5867963421058087
AGPAT2,Embryonal rhabdomyosarcoma ORPHA:99757,0.7929682744768703
AGPAT2,Ethylmalonic encephalopathy ORPHA:51188,0.7929682744768703
AGPAT2,Fucosidosis ORPHA:349,0.7929682744768703
AGPAT2,Glycogen storage disease due to acid maltase deficiency infantile onset ORPHA:308552,0.7929682744768703
AGPAT2,Glycogen storage disease due to acid maltase deficiency late-onset ORPHA:420429,0.7929682744768703
AGPAT2,Leukocyte adhesion deficiency type II ORPHA:99843,0.7929682744768703
AGPAT2,NON RARE IN EUROPE: Paget disease of bone ORPHA:280110,0.7929682744768703
AGPAT2,Congenital generalized lipodystrophy ORPHA:528,0.8105918570729571
AGPAT2,Argininosuccinic aciduria ORPHA:23,0.8922466888454011
AGPAT2,Autosomal recessive spastic paraplegia type 76 ORPHA:488594,0.8922466888454011
AHNAK2,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,0.7880542567584415
AHNAK2,Lupus Erythematosus,0.9145387439550552
AHNAK2,Bilateral perisylvian polymicrogyria ORPHA:98889,0.1068643725150898
AHNAK2,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.1991445465001551
AHNAK2,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.1991445465001551
AHNAK2,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.1991445465001551
AHNAK2,Frank-Ter Haar syndrome ORPHA:137834,0.1991445465001551
AHNAK2,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.1991445465001551
AHNAK2,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.1991445465001551
AHNAK2,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.1991445465001551
AHNAK2,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.1991445465001551
AHNAK2,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.1991445465001551
AHNAK2,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.1991445465001551
AHNAK2,19p13.3 microduplication syndrome ORPHA:447980,0.3832844616405875
AHNAK2,Alopecia universalis ORPHA:701,0.3832844616405875
AHNAK2,Atrichia with papular lesions ORPHA:86819,0.3832844616405875
AHNAK2,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867,0.3832844616405875
AHNAK2,Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580,0.3832844616405875
AHNAK2,Malan overgrowth syndrome ORPHA:420179,0.3832844616405875
AHNAK2,Marshall-Smith syndrome ORPHA:561,0.3832844616405875
AHNAK2,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126,0.3832844616405875
AHNAK2,Non-immune hydrops fetalis ORPHA:363999,0.3832844616405875
AHNAK2,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.5867963421058087
AHNAK2,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.5867963421058087
AHNAK2,Charcot-Marie-Tooth disease type 4C ORPHA:99949,0.5867963421058087
AHNAK2,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.5867963421058087
AHNAK2,Isolated biliary atresia ORPHA:30391,0.5867963421058087
AHNAK2,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.5867963421058087
AHNAK2,Aplasia cutis congenita ORPHA:1114,0.5959529547720634
AHNAK2,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.7929682744768703
AHNAK2,ABeta amyloidosis Arctic type ORPHA:324723,0.7929682744768703
AHNAK2,ABeta amyloidosis Dutch type ORPHA:100006,0.7929682744768703
AHNAK2,ABeta amyloidosis Iowa type ORPHA:324708,0.7929682744768703
AHNAK2,ABeta amyloidosis Italian type ORPHA:324713,0.7929682744768703
AHNAK2,ABetaA21G amyloidosis ORPHA:324718,0.7929682744768703
AHNAK2,ABetaL34V amyloidosis ORPHA:324703,0.7929682744768703
AHNAK2,Atelosteogenesis type I ORPHA:1190,0.7929682744768703
AHNAK2,Atelosteogenesis type III ORPHA:56305,0.7929682744768703
AHNAK2,Boomerang dysplasia ORPHA:1263,0.7929682744768703
AHNAK2,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.7929682744768703
AHNAK2,Familial Alzheimer-like prion disease ORPHA:280397,0.7929682744768703
AHNAK2,Fatal familial insomnia ORPHA:466,0.7929682744768703
AHNAK2,Gerstmann-Straussler-Scheinker syndrome ORPHA:356,0.7929682744768703
AHNAK2,Huntington disease-like 1 ORPHA:157941,0.7929682744768703
AHNAK2,Inherited Creutzfeldt-Jakob disease ORPHA:282166,0.7929682744768703
AHNAK2,Kuru ORPHA:454745,0.7929682744768703
AHNAK2,Larsen syndrome ORPHA:503,0.7929682744768703
AHNAK2,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.7929682744768703
AHNAK2,Lymphedema-posterior choanal atresia syndrome ORPHA:99141,0.7929682744768703
AHNAK2,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.7929682744768703
AHNAK2,Nance-Horan syndrome ORPHA:627,0.7929682744768703
AHNAK2,PrP systemic amyloidosis ORPHA:397606,0.7929682744768703
AHNAK2,RIN2 syndrome ORPHA:217335,0.7929682744768703
AHNAK2,Scalp-ear-nipple syndrome ORPHA:2036,0.7929682744768703
AHNAK2,Sporadic fatal insomnia ORPHA:586130,0.7929682744768703
AHNAK2,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.7929682744768703
AHNAK2,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.7929682744768703
AHNAK2,Papillary renal cell carcinoma ORPHA:319298,0.7929682744768703
AHNAK2,Erythrokeratodermia variabilis ORPHA:317,0.7929682744768703
AHNAK2,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.8922466888454011
AHNAK2,Bamforth-Lazarus syndrome ORPHA:1226,0.8922466888454011
AHNAK2,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354,0.8922466888454011
AHNAK2,Chondrodysplasia-disorder of sex development syndrome ORPHA:1422,0.8922466888454011
AHNAK2,HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077,0.8922466888454011
AHNAK2,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.8922466888454011
AHNAK2,Isolated hyperchlorhidrosis ORPHA:542657,0.8922466888454011
AHNAK2,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.8922466888454011
AHNAK2,NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462,0.8922466888454011
AHNAK2,Neurofibromatosis type 2 ORPHA:637,0.8922466888454011
AHNAK2,Palmoplantar keratoderma Nagashima type ORPHA:140966,0.8922466888454011
AHNAK2,Griscelli syndrome type 3 ORPHA:79478,0.8922466888454011
AHNAK2,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.8922466888454011
AHNAK2,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.8922466888454011
AHNAK2,Unverricht-Lundborg disease ORPHA:308,0.8922466888454011
AHNAK2,Athyreosis ORPHA:95713,0.8922466888454011
AHNAK2,Glaucoma secondary to spherophakia/ectopia lentis and megalocornea ORPHA:238763,0.8922466888454011
AKAP8,Malignant neoplasm of breast,0.4084380369379369
AKAP8,Autistic Disorder,0.8019075543217649
AKAP8,Unipolar Depression,0.9455834988784428
AKAP8,Major Depressive Disorder,0.9658628445524134
AKAP8,Mental Depression,0.8903630091389316
AKAP8,Breast Cancer,0.8903630091389316
AKAP8,CAMOS syndrome ORPHA:83472,0.1991445465001551
AKAP8,QRICH1-related intellectual disability-chondrodysplasia syndrome ORPHA:580940,0.3832844616405875
AKR1C4,Malignant neoplasm of breast,0.4084380369379369
AKR1C4,Carcinoma of bladder,0.4084380369379369
AKR1C4,Bladder Neoplasm,0.4084380369379369
AKR1C4,Malignant neoplasm of urinary bladder,0.5071083164302358
AKR1C4,Breast Carcinoma,0.7333611688795861
AKR1C4,Leukemia Myelocytic Acute,0.7765852775619541
AKR1C4,Malignant neoplasm of prostate,0.7880542567584415
AKR1C4,Prostate carcinoma,0.7880542567584415
AKR1C4,Dementia,0.7880542567584415
AKR1C4,Mild dementia,0.7880542567584415
AKR1C4,Paranoid ideation,0.7880542567584415
AKR1C4,Presenile dementia,0.7880542567584415
AKR1C4,Alzheimer's Disease,0.7880542567584415
AKR1C4,Polycythemia Vera,0.7880542567584415
AKR1C4,Manic Disorder,0.7880542567584415
AKR1C4,Manic,0.7880542567584415
AKR1C4,Virus Diseases,0.7880542567584415
AKR1C4,Bacterial Infections,0.7908231553833205
AKR1C4,Thrombocythemia Essential,0.8009048756462318
AKR1C4,46 XY Disorders of Sex Development,0.8009048756462318
AKR1C4,Alcoholic Intoxication Chronic,0.8019075543217649
AKR1C4,Depression Bipolar,0.8019075543217649
AKR1C4,Primary Sj??gren's syndrome,0.8019075543217649
AKR1C4,Chronic Lymphocytic Leukemia,0.8019075543217649
AKR1C4,Senile Plaques,0.8019075543217649
AKR1C4,Impaired cognition,0.8190761496232595
AKR1C4,Paranoia,0.8212681436603975
AKR1C4,Triglycerides measurement,0.8232134984476662
AKR1C4,Cognition Disorders,0.8270909867833504
AKR1C4,Congenital Abnormality,0.8402911822757345
AKR1C4,Anemia,0.8584283190330553
AKR1C4,Kartagener Syndrome,0.8608860081595284
AKR1C4,Cerebrovascular accident,0.8648405521677974
AKR1C4,Cerebellar degeneration,0.8838621755797691
AKR1C4,Persistent infection,0.8851456306720444
AKR1C4,Bipolar Disorder,0.900167961295542
AKR1C4,46 XY Disorder Of Sex Development,0.7765582368651238
AKR1C4,46 XY Sex Reversal,0.7765582368651238
AKR1C4,Manic Disorder,0.7765582368651238
AKR1C4,Paranoia,0.8115918568696846
AKR1C4,Ambiguous Genitalia,0.8611702959552964
AKR1C4,Male Pseudohermaphroditism,0.861756360478846
AKR1C4,Cryptorchidism,0.861756360478846
AKR1C4,Bipolar Disorder,0.943322675973118
AKR1C4,Alkaptonuria ORPHA:56,0.1991445465001551
AKR1C4,46XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752,0.3832844616405875
AKR1C4,Rotor syndrome ORPHA:3111,0.7929682744768703
AKR1C4,Dubin-Johnson syndrome ORPHA:234,0.7929682744768703
AKR1C4,Congenital factor XIII deficiency ORPHA:331,0.7929682744768703
AKR1C4,Atypical hemolytic uremic syndrome with anti-factor H antibodies ORPHA:93581,0.8922466888454011
AKR1C4,C3 glomerulopathy ORPHA:329918,0.8922466888454011
AKR1C4,Familial afibrinogenemia ORPHA:98880,0.8922466888454011
AKR1C4,Familial dysfibrinogenemia ORPHA:98881,0.8922466888454011
AKR1C4,Familial hypodysfibrinogenemia ORPHA:248408,0.8922466888454011
AKR1C4,Familial hypofibrinogenemia ORPHA:101041,0.8922466888454011
AKR1C4,46XY disorder of sex development due to 5-alpha-reductase 2 deficiency ORPHA:753,0.8922466888454011
AKR1C4,AApoAII amyloidosis ORPHA:238269,0.8922466888454011
AKR1C4,AFib amyloidosis ORPHA:93562,0.8922466888454011
AKR1C4,Caroli disease ORPHA:53035,0.8922466888454011
AKR1C4,Congenital analbuminemia ORPHA:86816,0.8922466888454011
AKR1C4,Congenital bile acid synthesis defect type 2 ORPHA:79303,0.8922466888454011
AKR1C4,Congenital factor II deficiency ORPHA:325,0.8922466888454011
AKR1C4,Congenital factor XI deficiency ORPHA:329,0.8922466888454011
AKR1C4,Congenital high-molecular-weight kininogen deficiency ORPHA:483,0.8922466888454011
AKR1C4,Corticosteroid-binding globulin deficiency ORPHA:199247,0.8922466888454011
AKR1C4,Dihydropyrimidinuria ORPHA:38874,0.8922466888454011
AKR1C4,Familial apolipoprotein A5 deficiency ORPHA:530849,0.8922466888454011
AKR1C4,Fanconi-Bickel syndrome ORPHA:2088,0.8922466888454011
AKR1C4,Hawkinsinuria ORPHA:2118,0.8922466888454011
AKR1C4,Hemochromatosis type 3 ORPHA:225123,0.8922466888454011
AKR1C4,Hereditary fructose intolerance ORPHA:469,0.8922466888454011
AKR1C4,Hereditary thrombophilia due to congenital antithrombin deficiency ORPHA:82,0.8922466888454011
AKR1C4,Hyperlipidemia due to hepatic triacylglycerol lipase deficiency ORPHA:140905,0.8922466888454011
AKR1C4,Hypertryptophanemia ORPHA:2224,0.8922466888454011
AKR1C4,IRIDA syndrome ORPHA:209981,0.8922466888454011
AKR1C4,NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency ORPHA:209893,0.8922466888454011
AKR1C4,NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia ORPHA:276271,0.8922466888454011
AKR1C4,Severe hereditary thrombophilia due to congenital protein C deficiency ORPHA:745,0.8922466888454011
AKR1C4,Tyrosinemia type 2 ORPHA:28378,0.8922466888454011
AKR1C4,Tyrosinemia type 3 ORPHA:69723,0.8922466888454011
AKR1C4,Urocanic aciduria ORPHA:210128,0.8922466888454011
AKR1C4,46XY disorder of sex development due to testicular 1720-desmolase deficiency ORPHA:443087,0.8922466888454011
AKR1C4,Cerebral sinovenous thrombosis ORPHA:329217,0.8922466888454011
AKR1C4,Cholesterol-ester transfer protein deficiency ORPHA:79506,0.8922466888454011
AKR1C4,NON RARE IN EUROPE: Hyperlipoproteinemia type 4 ORPHA:413,0.8922466888454011
AKR1C4,Immunodeficiency due to a late component of complement deficiency ORPHA:169150,0.8922466888454011
AKR1C4,Intrahepatic cholestasis of pregnancy ORPHA:69665,0.8922466888454011
AKR1C4,Primary Fanconi renotubular syndrome ORPHA:3337,0.8922466888454011
AKR1C4,NON RARE IN EUROPE: Non rare thrombophilia ORPHA:64738,0.8922466888454011
AKR1C4,C3 glomerulonephritis ORPHA:329931,0.8922466888454011
AKR1C4,Sitosterolemia ORPHA:2882,0.8922466888454011
AKR1C4,Ataxia with vitamin E deficiency ORPHA:96,0.8922466888454011
AKR1C4,Benign recurrent intrahepatic cholestasis type 2 ORPHA:99961,0.8922466888454011
AKR1C4,Camptodactyly-arthropathy-coxa-vara-pericarditis syndrome ORPHA:2848,0.8922466888454011
AKR1C4,Congenital prekallikrein deficiency ORPHA:749,0.8922466888454011
AKR1C4,Crigler-Najjar syndrome type 1 ORPHA:79234,0.8922466888454011
AKR1C4,Crigler-Najjar syndrome type 2 ORPHA:79235,0.8922466888454011
AKR1C4,Cystinuria type B ORPHA:93613,0.8922466888454011
AKR1C4,Enzalutamide toxicity ORPHA:529828,0.8922466888454011
AKR1C4,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ia ORPHA:79258,0.8922466888454011
AKR1C4,Glycogen storage disease due to hepatic glycogen synthase deficiency ORPHA:2089,0.8922466888454011
AKR1C4,Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency ORPHA:217467,0.8922466888454011
AKR1C4,Hypercholesterolemia due to cholesterol 7alpha-hydroxylase deficiency ORPHA:209902,0.8922466888454011
AKR1C4,Hypoplasminogenemia ORPHA:722,0.8922466888454011
AKR1C4,Idiopathic hypercalciuria ORPHA:2197,0.8922466888454011
AKR1C4,Letrozole toxicity ORPHA:529831,0.8922466888454011
AKR1C4,Mild hemophilia B ORPHA:169799,0.8922466888454011
AKR1C4,Moderately severe hemophilia B ORPHA:169796,0.8922466888454011
AKR1C4,NON RARE IN EUROPE: Gilbert syndrome ORPHA:357,0.8922466888454011
AKR1C4,NON RARE IN EUROPE: Trimethylaminuria ORPHA:35056,0.8922466888454011
AKR1C4,Ornithine transcarbamylase deficiency ORPHA:664,0.8922466888454011
AKR1C4,PLG-related hereditary angioedema with normal C1Inh ORPHA:537072,0.8922466888454011
AKR1C4,Primary hyperoxaluria type 1 ORPHA:93598,0.8922466888454011
AKR1C4,Progressive familial intrahepatic cholestasis type 2 ORPHA:79304,0.8922466888454011
AKR1C4,Severe hemophilia B ORPHA:169793,0.8922466888454011
AKR1C4,Severe primary trimethylaminuria ORPHA:468726,0.8922466888454011
AKR1C4,Symptomatic form of hemophilia B in female carriers ORPHA:177929,0.8922466888454011
AKR1C4,Transient familial neonatal hyperbilirubinemia ORPHA:2312,0.8922466888454011
AKR1C4,Dense deposit disease ORPHA:93571,0.8922466888454011
ANGEL2,Myhre syndrome ORPHA:2588,0.7929682744768703
ANGEL2,ALG13-CDG ORPHA:324422,0.8922466888454011
ANGEL2,Ataxia-telangiectasia ORPHA:100,0.8922466888454011
ANGEL2,Ataxia-telangiectasia variant ORPHA:370109,0.8922466888454011
ANGEL2,Pierpont syndrome ORPHA:487825,0.8922466888454011
ANP32B,Malignant neoplasm of breast,0.4084380369379369
ANP32B,Reticulocyte count (procedure),0.5071083164302358
ANP32B,Breast Carcinoma,0.7333611688795861
ANP32B,Carcinogenesis,0.7333611688795861
ANP32B,B-Cell Lymphomas,0.7333611688795861
ANP32B,leukemia,0.7333611688795861
ANP32B,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
ANP32B,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
ANP32B,Colorectal Carcinoma,0.7765852775619541
ANP32B,Leukemogenesis,0.7765852775619541
ANP32B,Adenoma,0.7765852775619541
ANP32B,Glioma,0.7880542567584415
ANP32B,IMMUNE SUPPRESSION,0.7880542567584415
ANP32B,Colorectal Cancer,0.7880542567584415
ANP32B,Glioblastoma,0.7880542567584415
ANP32B,Neoplasm Metastasis,0.7880542567584415
ANP32B,Monoclonal Gammopathy of Undetermined Significance,0.7880542567584415
ANP32B,Red Blood Cell Count measurement,0.7880542567584415
ANP32B,Hematologic Neoplasms,0.7880542567584415
ANP32B,Multiple Myeloma,0.7880542567584415
ANP32B,Malignant neoplasm of stomach,0.7880542567584415
ANP32B,Hodgkin Disease,0.7880542567584415
ANP32B,Tumor Progression,0.7880542567584415
ANP32B,Lupus Erythematosus Systemic,0.7880542567584415
ANP32B,Coronary Arteriosclerosis,0.7880542567584415
ANP32B,Granulomatosis with polyangiitis,0.7880542567584415
ANP32B,Periodontitis,0.7880542567584415
ANP32B,Stomach Carcinoma,0.7880542567584415
ANP32B,Autoimmune Diseases,0.7880542567584415
ANP32B,Squamous cell carcinoma,0.7880542567584415
ANP32B,Solid Neoplasm,0.7880542567584415
ANP32B,Rheumatoid Arthritis,0.7880542567584415
ANP32B,Rhinosinusitis,0.7880542567584415
ANP32B,Rheumatism,0.7880542567584415
ANP32B,Malignant Glioma,0.7880542567584415
ANP32B,Multiple Sclerosis,0.8019075543217649
ANP32B,Waldenstrom Macroglobulinemia,0.8019075543217649
ANP32B,Psoriasis,0.8019075543217649
ANP32B,Myocardial Infarction,0.8019075543217649
ANP32B,Seborrheic dermatitis,0.8019075543217649
ANP32B,Adenocarcinoma of large intestine,0.8019075543217649
ANP32B,Chronic Lymphocytic Leukemia,0.8019075543217649
ANP32B,Degenerative polyarthritis,0.8019075543217649
ANP32B,Autoimmune thrombocytopenia,0.8168901801930506
ANP32B,Osteopenia,0.8212681436603975
ANP32B,Immune thrombocytopenic purpura,0.8232134984476662
ANP32B,Common Variable Immunodeficiency,0.8402911822757345
ANP32B,Thrombocytopenia due to platelet alloimmunization,0.8610447277138289
ANP32B,Dermatitis Atopic,0.8867509400747969
ANP32B,Coronary Artery Disease,0.887595340546704
ANP32B,Eczema,0.909484944705772
ANP32B,Coronary heart disease,0.9119978323790848
ANP32B,Acquired Hypogammaglobulinemia,0.9154499654632742
ANP32B,Asthma,0.9672478180546946
ANP32B,Colitis,0.9738491767258852
ANP32B,Lupus Nephritis,0.9896536639644284
ANP32B,Hermansky-Pudlak syndrome type 7 ORPHA:231531,0.3832844616405875
ANP32B,AICA-ribosiduria ORPHA:250977,0.8922466888454011
ANP32B,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome ORPHA:494444,0.8922466888454011
ANP32B,Oculopharyngeal muscular dystrophy ORPHA:270,0.8922466888454011
ANP32B,Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome ORPHA:477814,0.8922466888454011
ANP32B,Ribose-5-P isomerase deficiency ORPHA:440706,0.8922466888454011
ANP32B,Myxoid/round cell liposarcoma ORPHA:99967,0.8922466888454011
ANP32B,Leber plus disease ORPHA:99718,0.8922466888454011
ANP32B,Autosomal dominant Charcot-Marie-Tooth disease type 2B ORPHA:99936,0.8922466888454011
ANP32B,Histiocytoid cardiomyopathy ORPHA:137675,0.8922466888454011
ANP32B,MT-ATP6-related mitochondrial spastic paraplegia ORPHA:320360,0.8922466888454011
ANP32B,NARP syndrome ORPHA:644,0.8922466888454011
ANP32B,Poikiloderma with neutropenia ORPHA:221046,0.8922466888454011
ANP32B,Periodic paralysis with later-onset distal motor neuropathy ORPHA:397750,0.8922466888454011
ANP32B,Isolated ATP synthase deficiency ORPHA:254913,0.8939858547904395
ANP32B,MERRF ORPHA:551,0.896422440954666
ANP32B,Leber hereditary optic neuropathy ORPHA:104,0.8977183736895791
ANP32B,Mitochondrial DNA-associated Leigh syndrome ORPHA:255210,0.8977183736895791
ANP32B,MELAS ORPHA:550,0.9025296114347576
AOC3,Adenocarcinoma,0.750391252594775
AOC3,Colorectal Carcinoma,0.7765852775619541
AOC3,Vascular Diseases,0.7765852775619541
AOC3,Colorectal Cancer,0.7880542567584415
AOC3,Lymphocytic infiltration,0.7880542567584415
AOC3,Nodular glomerulosclerosis,0.7880542567584415
AOC3,melanoma,0.7880542567584415
AOC3,Chronic lung disease,0.7880542567584415
AOC3,AURAL ATRESIA CONGENITAL,0.7880542567584415
AOC3,Arteriosclerosis,0.7880542567584415
AOC3,Atherosclerosis,0.7880542567584415
AOC3,Invasive Carcinoma,0.7880542567584415
AOC3,Alzheimer's Disease,0.7880542567584415
AOC3,Aortic Aneurysm Ruptured,0.7880542567584415
AOC3,Cerebral Amyloid Angiopathy,0.7880542567584415
AOC3,MYOPATHY MYOFIBRILLAR DESMIN-RELATED,0.7880542567584415
AOC3,Diabetes,0.7880542567584415
AOC3,Diabetes Mellitus,0.7880542567584415
AOC3,Uveitis,0.7880542567584415
AOC3,Cytomegalovirus Infections,0.7880542567584415
AOC3,Aortic Aneurysm,0.7880542567584415
AOC3,Pneumonitis,0.8019075543217649
AOC3,Psoriasis,0.8019075543217649
AOC3,Kidney Diseases,0.8019075543217649
AOC3,Sclerosis,0.8019075543217649
AOC3,Paratuberculosis,0.8138488881521341
AOC3,Proliferative diabetic retinopathy,0.8145035474981049
AOC3,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
AOC3,Chronic Kidney Insufficiency,0.8145035474981049
AOC3,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
AOC3,Lymphoproliferative Disorder of the Skin,0.8190761496232595
AOC3,Inflammatory abnormality of the eye,0.8232134984476662
AOC3,Adult type dermatomyositis,0.8272008757995397
AOC3,Pneumonia,0.834094492023826
AOC3,Hypertensive disease,0.8474481237156937
AOC3,Reperfusion Injury,0.8584283190330553
AOC3,Diabetes Mellitus Experimental,0.8642802827048847
AOC3,Streptozotocin Diabetes,0.8642802827048847
AOC3,Alloxan Diabetes,0.8642802827048847
AOC3,Dermatomyositis,0.8648405521677974
AOC3,Intracranial Aneurysm,0.8648405521677974
AOC3,Cerebrovascular accident,0.8648405521677974
AOC3,Amyloidosis,0.8672189956534445
AOC3,Uremia,0.882453254162044
AOC3,Diabetic Angiopathies,0.8867509400747969
AOC3,Age related macular degeneration,0.8980854850210683
AOC3,Obesity,0.8989612563669234
AOC3,Neuropathy,0.914995991166204
AOC3,Diabetic Nephropathy,0.9390727893210336
AOC3,Chronic Kidney Diseases,0.9393256300017014
AOC3,Arthritis,0.9431511078237256
AOC3,Myopathy,0.9557184806547836
AOC3,Metabolic Diseases,0.9564633032157428
AOC3,Myositis,0.9658628445524134
AOC3,Diabetic Nephropathy,0.7765582368651238
AOC3,Paratuberculosis,0.7765582368651238
AOC3,Hypertension,0.7765582368651238
AOC3,Glomerulosclerosis,0.7765582368651238
AOC3,Kidney Disease,0.8210988731657684
AOC3,Diabetes Mellitus,0.919442421650838
AOC3,Renal Insufficiency,0.9726837163662044
AOC3,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.1054066549396977
AOC3,Diencephalic-mesencephalic junction dysplasia ORPHA:319192,0.5867963421058087
AOC3,Acetazolamide-responsive myotonia ORPHA:99736,0.7929682744768703
AOC3,CIDEC-related familial partial lipodystrophy ORPHA:435651,0.7929682744768703
AOC3,Hyperkalemic periodic paralysis ORPHA:682,0.7929682744768703
AOC3,Myotonia fluctuans ORPHA:99734,0.7929682744768703
AOC3,Myotonia permanens ORPHA:99735,0.7929682744768703
AOC3,Paramyotonia congenita of Von Eulenburg ORPHA:684,0.7929682744768703
AOC3,Adult hypophosphatasia ORPHA:247676,0.8922466888454011
AOC3,Childhood-onset hypophosphatasia ORPHA:247667,0.8922466888454011
AOC3,Infantile hypophosphatasia ORPHA:247651,0.8922466888454011
AOC3,Odontohypophosphatasia ORPHA:247685,0.8922466888454011
AOC3,PLIN1-related familial partial lipodystrophy ORPHA:280356,0.8922466888454011
AOC3,Perinatal lethal hypophosphatasia ORPHA:247623,0.8922466888454011
AOC3,Prenatal benign hypophosphatasia ORPHA:247638,0.8922466888454011
AOC3,Classical-like Ehlers-Danlos syndrome type 1 ORPHA:230839,0.8922466888454011
AOC3,Pancreatic insufficiency-anemia-hyperostosis syndrome ORPHA:199337,0.8922466888454011
AOC3,Transient infantile hypertriglyceridemia and hepatosteatosis ORPHA:300293,0.8922466888454011
APC2,Malignant neoplasm of breast,0.4084380369379369
APC2,Adenomatous Polyposis Coli,0.5196624042573144
APC2,Breast Carcinoma,0.7333611688795861
APC2,Carcinogenesis,0.7333611688795861
APC2,Malignant neoplasm of ovary,0.7333611688795861
APC2,Ovarian Carcinoma,0.7333611688795861
APC2,Adenocarcinoma,0.750391252594775
APC2,Relative macrocephaly,0.7765852775619541
APC2,Tall stature,0.7765852775619541
APC2,Colorectal Carcinoma,0.7765852775619541
APC2,Colon Carcinoma,0.7765852775619541
APC2,Advanced bone age,0.7765852775619541
APC2,Malignant tumor of colon,0.7765852775619541
APC2,Atrial Premature Complexes,0.7765852775619541
APC2,Colorectal Neoplasms,0.7765852775619541
APC2,Adenoma,0.7765852775619541
APC2,Mammary Neoplasms,0.7880542567584415
APC2,Hyperplasia of nose,0.7880542567584415
APC2,Hypertrophy of nose,0.7880542567584415
APC2,Large nose,0.7880542567584415
APC2,Colorectal Cancer,0.7880542567584415
APC2,Frontal bossing,0.7880542567584415
APC2,Large auricle,0.7880542567584415
APC2,Large pinnae,0.7880542567584415
APC2,Macrotia,0.7880542567584415
APC2,Aplasia/Hypoplasia of the corpus callosum,0.7880542567584415
APC2,Hypertrophy of lower jaw,0.7880542567584415
APC2,mandibular excess (physical finding),0.7880542567584415
APC2,Mandibular hyperplasia,0.7880542567584415
APC2,Conductive hearing loss,0.7880542567584415
APC2,Increased size of the mandible,0.7880542567584415
APC2,Bulging forehead,0.7880542567584415
APC2,Prominent forehead,0.7880542567584415
APC2,Tumor Progression,0.7880542567584415
APC2,Premature tooth eruption,0.7880542567584415
APC2,Class III malocclusion,0.7880542567584415
APC2,Feeding difficulties in infancy,0.7880542567584415
APC2,Alzheimer's Disease,0.7880542567584415
APC2,Anteverted nostril,0.7880542567584415
APC2,Cognitive delay,0.7880542567584415
APC2,Sotos' syndrome,0.7880542567584415
APC2,Increased head circumference,0.7880542567584415
APC2,Huntington Disease,0.7880542567584415
APC2,Pineal Gland Neoplasm,0.7880542567584415
APC2,Global developmental delay,0.7880542567584415
APC2,Mental and motor retardation,0.7880542567584415
APC2,Teratocarcinoma,0.8019075543217649
APC2,Long face,0.8019075543217649
APC2,Abnormality of immune system physiology,0.8019075543217649
APC2,Precocious Puberty,0.8019075543217649
APC2,Adenocarcinoma of lung (disorder),0.8098851543361193
APC2,Big calvaria,0.8098851543361193
APC2,Increased size of skull,0.8098851543361193
APC2,Difficulty speaking,0.8138488881521341
APC2,Problems speaking,0.8138488881521341
APC2,Poor speech,0.8168901801930506
APC2,Downward slant of palpebral fissure,0.8168901801930506
APC2,Hypoglycemia,0.8232134984476662
APC2,Turridolichocephaly,0.8368219249856942
APC2,Narrow cranium shape,0.8368219249856942
APC2,Narrow head shape,0.8368219249856942
APC2,Narrow skull shape,0.8368219249856942
APC2,Long narrow head,0.8402911822757345
APC2,Alzheimer Disease Late Onset,0.8402911822757345
APC2,Dilated ventricles (finding),0.8402911822757345
APC2,Mental deficiency,0.8402911822757345
APC2,Dull intelligence,0.8757755363384367
APC2,Low intelligence,0.8757755363384367
APC2,Inflammatory Bowel Diseases,0.8815127642200768
APC2,Mammary Neoplasms Human,0.8815127642200768
APC2,Orbital separation excessive,0.8851456306720444
APC2,High forehead,0.8867509400747969
APC2,Hyperactive behavior,0.8878860377518915
APC2,Poor school performance,0.8913141512402477
APC2,Obesity,0.8989612563669234
APC2,Depressed nasal ridge,0.9083161862856644
APC2,Byzanthine arch palate,0.9119978323790848
APC2,Muscle hypotonia,0.9124568647908072
APC2,Mental Retardation,0.922229272318747
APC2,Intellectual Disability,0.9478210444156088
APC2,Colitis,0.9738491767258852
APC2,Sacrococcygeal Teratoma,0.7765582368651238
APC2,Hypoglycemia,0.7765582368651238
APC2,Developmental Delay,0.7765582368651238
APC2,Macrocephaly,0.7765582368651238
APC2,Precocious Puberty,0.7765582368651238
APC2,Urogenital Abnormalities,0.8115918568696846
APC2,Nervous System Neoplasms,0.8115918568696846
APC2,Frontal Bossing,0.8115918568696846
APC2,Macrotia,0.8115918568696846
APC2,Accessory Kidney,0.8115918568696846
APC2,Malocclusion,0.8115918568696846
APC2,Hearing Loss,0.8115918568696846
APC2,Craniosynostosis,0.8115918568696846
APC2,Mammary Neoplasms,0.8165359516083085
APC2,Mental Retardation,0.8337953215113012
APC2,Developmental Dysplasia Of The Hip,0.8356859041719433
APC2,Marfan Syndrome,0.8477374749042494
APC2,Vesicoureteral Reflux,0.8611702959552964
APC2,Multiple Renal Cysts,0.861756360478846
APC2,Cryptorchidism,0.861756360478846
APC2,Inflammatory Bowel Disease,0.861756360478846
APC2,Cardiovascular Abnormalities,0.8662301945830305
APC2,Heart Septal Defects,0.8903301324869451
APC2,Breast Cancer,0.8903630091389316
APC2,Strabismus,0.8908485337686392
APC2,Scoliosis,0.924275664330454
APC2,Micrognathism,0.9398381935810408
APC2,Breast Carcinoma,0.9398381935810408
APC2,Dolichocephaly,0.9398381935810408
APC2,Colorectal Neoplasms,0.9510372690456612
APC2,High Palate,0.9578111936867284
APC2,Hypospadias,0.974502015052702
APC2,Obesity,0.9832345076528324
APC2,Colorectal Cancer,0.9832345076528324
APC2,Patent Ductus Arteriosus,0.9946608061329084
APC2,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
APC2,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
APC2,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
APC2,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
APC2,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
APC2,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.1040670578681756
APC2,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.1040670578681756
APC2,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.1040670578681756
APC2,Familial infantile myoclonic epilepsy ORPHA:352582,0.1991445465001551
APC2,Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406,0.1991445465001551
APC2,Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620,0.3832844616405875
APC2,DOORS syndrome ORPHA:79500,0.5867963421058087
APC2,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587,0.5867963421058087
APC2,Primary dystonia DYT4 type ORPHA:98805,0.5867963421058087
APC2,Progressive myoclonic epilepsy with dystonia ORPHA:352596,0.5867963421058087
APC2,Right sided atrial isomerism ORPHA:97548,0.5867963421058087
APC2,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727,0.5867963421058087
APC2,Gorlin syndrome ORPHA:377,0.5867963421058087
APC2,Idiopathic central precocious puberty ORPHA:169615,0.5867963421058087
APC2,Early infantile epileptic encephalopathy ORPHA:1934,0.7593059616185558
APC2,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171,0.7929682744768703
APC2,Rapid-onset dystonia-parkinsonism ORPHA:71517,0.7929682744768703
APC2,Congenitally uncorrected transposition of the great arteries ORPHA:860,0.7929682744768703
APC2,Sotos syndrome ORPHA:821,0.7929682744768703
APC2,Ventriculomegaly-cystic kidney disease ORPHA:443988,0.8922466888454011
APC2,Horizontal gaze palsy with progressive scoliosis ORPHA:2744,0.8922466888454011
APC2,Myoclonic-astatic epilepsy ORPHA:1942,0.8922466888454011
APC2,NKX6-2-related autosomal recessive hypomyelinating leukodystrophy ORPHA:527497,0.8922466888454011
APC2,Influenza A virus (A/New York/599/1996(H3N2)) matrix protein 1 (gene: M1),0.9397923093369096
APC2,Influenza A virus (A/New York/602/1996(H3N2)) matrix protein 1 (gene: M1),0.9397923093369096
APC2,Influenza A virus (A/Northern Territory/60/1968(H3N2)) matrix protein 1 (gene: M1),0.9397923093369096
APC2,Influenza A virus (A/Korea/426/1968(H2N2)) membrane protein M1 (gene: M1),0.9397923093369096
APC2,Influenza A virus (A/Shanghai/02/2013(H7N9)) matrix protein 1 (gene: M1),0.9397923093369096
ARHGAP11B,Acute myeloid leukemia with t(6,0.5867963421058087
ARHGAP11B,9)(p23,0.5867963421058087
ARHGAP11B,q34) ORPHA:402014,0.7929682744768703
ARHGAP11B,Autosomal recessive chorioretinopathy-microcephaly syndrome ORPHA:2518,0.8922466888454011
ARHGAP11B,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462,0.8922466888454011
ARHGAP11B,NON RARE IN EUROPE: Primary ovarian failure ORPHA:619,0.8922466888454011
ARHGAP11B,ANE syndrome ORPHA:157954,0.8922466888454011
ARHGAP11B,Chuvash erythrocytosis ORPHA:238557,0.8922466888454011
ARHGAP11B,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.8922466888454011
ARHGAP11B,Von Hippel-Lindau disease ORPHA:892,0.8922466888454011
ARHGAP11B,Cone dystrophy with supernormal rod response ORPHA:209932,0.8922466888454011
ARHGAP11B,Congenital lactase deficiency ORPHA:53690,0.8922466888454011
ARHGAP11B,Microcephaly-intellectual disability-sensorineural hearing loss-epilepsy-abnormal muscle tone syndrome ORPHA:457351,0.9039465713743752
ARHGAP29,Malignant neoplasm of breast,0.4084380369379369
ARHGAP29,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
ARHGAP29,Cleft palate with cleft lip,0.7880542567584415
ARHGAP29,Lymphoma Lymphocytic Intermediate,0.7880542567584415
ARHGAP29,Malnutrition,0.6734982286750932
ARHGAP29,Cleft Palate And Bilateral Cleft Lip,0.7311975666200533
ARHGAP29,Velopharyngeal Insufficiency,0.7765582368651238
ARHGAP29,Cleft Lip With Or Without Cleft Palate,0.7765582368651238
ARHGAP29,Oropharyngeal Dysphagia,0.7765582368651238
ARHGAP29,Hypoplasia Of The Maxilla,0.7765582368651238
ARHGAP29,Lymphoma Lymphocytic Intermediate,0.7765582368651238
ARHGAP29,Otitis Media,0.8115918568696846
ARHGAP29,Malignant Lymphoma Lymphocytic Intermediate Differentiation,0.8115918568696846
ARHGAP29,Hearing Loss,0.8115918568696846
ARHGAP29,Breast Cancer,0.8903630091389316
ARHGAP29,Cleft lip/palate ORPHA:199306,0.2567797333165013
ARHGAP29,Non-immune hydrops fetalis ORPHA:363999,0.3832844616405875
ARHGAP29,1p31p32 microdeletion syndrome ORPHA:401986,0.5867963421058087
ARHGAP29,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.5867963421058087
ARHGAP29,Charcot-Marie-Tooth disease type 4C ORPHA:99949,0.5867963421058087
ARHGAP29,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.5867963421058087
ARHGAP29,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.5867963421058087
ARHGAP29,Atrial septal defect ostium primum type ORPHA:99106,0.7929682744768703
ARHGAP29,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135,0.7929682744768703
ARHGAP29,Chondrosarcoma ORPHA:55880,0.7929682744768703
ARHGAP29,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.7929682744768703
ARHGAP29,Craniolenticulosutural dysplasia ORPHA:50814,0.7929682744768703
ARHGAP29,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.7929682744768703
ARHGAP29,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179,0.7929682744768703
ARHGAP29,Lymphedema-posterior choanal atresia syndrome ORPHA:99141,0.7929682744768703
ARHGAP29,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.7929682744768703
ARHGAP29,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274,0.7929682744768703
ARHGAP29,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.7929682744768703
ARHGAP29,Papillary renal cell carcinoma ORPHA:319298,0.7929682744768703
ARHGAP29,Pulmonary venoocclusive disease ORPHA:31837,0.7929682744768703
ARHGAP29,Autosomal dominant slowed nerve conduction velocity ORPHA:140481,0.8922466888454011
ARHGAP29,Hereditary papillary renal cell carcinoma ORPHA:47044,0.8922466888454011
ARHGAP29,Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561,0.8922466888454011
ARHGAP29,NON RARE IN EUROPE: Autosomal dominant ichthyosis vulgaris ORPHA:462,0.8922466888454011
ARHGAP29,Osteofibrous dysplasia ORPHA:488265,0.8922466888454011
ARHGAP29,Congenital diaphragmatic hernia ORPHA:2140,0.8922466888454011
ARHGAP29,Griscelli syndrome type 3 ORPHA:79478,0.8922466888454011
ARHGAP29,Neonatal inflammatory skin and bowel disease ORPHA:294023,0.8922466888454011
ARHGAP29,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.8922466888454011
ARHGAP29,Trichorhinophalangeal syndrome type 2 ORPHA:502,0.8922466888454011
ARHGAP29,Auriculocondylar syndrome ORPHA:137888,0.8922466888454011
ARHGAP29,Goldmann-Favre syndrome ORPHA:53540,0.8922466888454011
ARHGAP29,Juvenile cataract-microcornea-renal glucosuria syndrome ORPHA:247794,0.8922466888454011
ARHGAP29,Autosomal recessive polycystic kidney disease ORPHA:731,0.8922466888454011
ARHGAP29,Myelodysplastic syndrome ORPHA:52688,0.8922466888454011
ARHGAP29,Human respirovirus 3 phosphoprotein,0.8999095837312036
ARID3B,Malignant neoplasm of breast,0.4084380369379369
ARID3B,Breast Carcinoma,0.7333611688795861
ARID3B,Carcinogenesis,0.7333611688795861
ARID3B,Malignant neoplasm of ovary,0.7333611688795861
ARID3B,Ovarian Carcinoma,0.7333611688795861
ARID3B,Mammary Neoplasms,0.7880542567584415
ARID3B,Invasive carcinoma of breast,0.7880542567584415
ARID3B,Malignant Head and Neck Neoplasm,0.7880542567584415
ARID3B,Neoplasm Metastasis,0.7880542567584415
ARID3B,Neuroblastoma,0.7880542567584415
ARID3B,Central neuroblastoma,0.7880542567584415
ARID3B,Tumor Initiation,0.7880542567584415
ARID3B,Retinoblastoma,0.7880542567584415
ARID3B,ovarian neoplasm,0.8067197998685076
ARID3B,Goldenhar Syndrome,0.7765582368651238
ARID3B,Endometriosis,0.9726139569926774
ARID3B,Congenital non-communicating hydrocephalus ORPHA:269510,0.3832844616405875
ARID3B,Spinocerebellar ataxia type 40 ORPHA:423275,0.3832844616405875
ARID3B,Huntington disease ORPHA:399,0.3832844616405875
ARID3B,NUT midline carcinoma ORPHA:443167,0.7929682744768703
ARID3B,Familial medullary thyroid carcinoma ORPHA:99361,0.7929682744768703
ARID3B,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ORPHA:363972,0.8922466888454011
ARID3B,Partial hydatidiform mole ORPHA:254693,0.8922466888454011
ARID3B,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis with severe ocular involvement ORPHA:2196,0.8922466888454011
ARID3B,Tatton-Brown-Rahman syndrome ORPHA:404443,0.8922466888454011
ARID5A,Leukemia,0.7765582368651238
ARID5A,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
ARID5A,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
ARID5A,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
ARID5A,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
ARID5A,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
ARID5A,Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813,0.1054066549396977
ARID5A,Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549,0.1991445465001551
ARID5A,Alpha-mannosidosis adult form ORPHA:309288,0.1991445465001551
ARID5A,Alpha-mannosidosis infantile form ORPHA:309282,0.1991445465001551
ARID5A,Camurati-Engelmann disease ORPHA:1328,0.1991445465001551
ARID5A,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.1991445465001551
ARID5A,Infantile inflammatory bowel disease with neurological involvement ORPHA:565788,0.1991445465001551
ARID5A,NIK deficiency ORPHA:447731,0.1991445465001551
ARID5A,Stormorken-Sjaastad-Langslet syndrome ORPHA:3204,0.1991445465001551
ARID5A,Autosomal recessive malignant osteopetrosis ORPHA:667,0.2120485863056726
ARID5A,Hermansky-Pudlak syndrome type 7 ORPHA:231531,0.3832844616405875
ARID5A,NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751,0.3832844616405875
ARID5A,Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198,0.3832844616405875
ARID5A,Revesz syndrome ORPHA:3088,0.3832844616405875
ARID5A,Ependymoma ORPHA:251636,0.3832844616405875
ARID5A,RELA fusion-positive ependymoma ORPHA:530792,0.3832844616405875
ARID5A,Pediatric systemic lupus erythematosus ORPHA:93552,0.3832844616405875
ARID5A,Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428,0.5867963421058087
ARID5A,Combined immunodeficiency due to STIM1 deficiency ORPHA:317430,0.5867963421058087
ARID5A,Hereditary pediatric Behcet-like disease ORPHA:476102,0.5867963421058087
ARID5A,Obesity due to pro-opiomelanocortin deficiency ORPHA:71526,0.5867963421058087
ARID5A,Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298,0.5867963421058087
ARID5A,Birdshot chorioretinopathy ORPHA:179,0.7929682744768703
ARID5A,Combined immunodeficiency due to OX40 deficiency ORPHA:431149,0.7929682744768703
ARID5A,Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277,0.7929682744768703
ARID5A,Tubular aggregate myopathy ORPHA:2593,0.7929682744768703
ARID5A,Charcot-Marie-Tooth disease type 1D ORPHA:101084,0.8922466888454011
ARID5A,Charcot-Marie-Tooth disease type 4E ORPHA:99951,0.8922466888454011
ARID5A,High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement ORPHA:480541,0.8922466888454011
ARL4C,Carcinogenesis,0.7333611688795861
ARL4C,Adenocarcinoma,0.750391252594775
ARL4C,Colorectal Carcinoma,0.7765852775619541
ARL4C,Lymphoma,0.7765852775619541
ARL4C,Malignant neoplasm of lung,0.7880542567584415
ARL4C,Colorectal Cancer,0.7880542567584415
ARL4C,Primary malignant neoplasm of lung,0.7880542567584415
ARL4C,Neoplasm Metastasis,0.7880542567584415
ARL4C,Carcinoma of lung,0.7880542567584415
ARL4C,Immunologic Deficiency Syndromes,0.7880542567584415
ARL4C,Bile duct carcinoma,0.7880542567584415
ARL4C,Myeloid Leukemia Chronic,0.7880542567584415
ARL4C,leiomyosarcoma,0.8026798872257774
ARL4C,HIV Infections,0.8145035474981049
ARL4C,Mental Depression,0.8769418330148872
ARL4C,Disseminated Malignant Neoplasm,0.8867509400747969
ARL4C,Depressive disorder,0.9103315000053974
ARL4C,Mucopolysaccharidosis type 2 attenuated form ORPHA:217093,0.1991445465001551
ARL4C,Mucopolysaccharidosis type 2 severe form ORPHA:217085,0.1991445465001551
ARL4C,Brachydactyly type B2 ORPHA:140908,0.3832844616405875
ARL4C,Stapes ankylosis with broad thumbs and toes ORPHA:140917,0.3832844616405875
ARL4C,Tarsal-carpal coalition syndrome ORPHA:1412,0.3832844616405875
ARL4C,Early-onset Lafora body disease ORPHA:324290,0.5867963421058087
ARL4C,Fuhrmann syndrome ORPHA:2854,0.5867963421058087
ARL4C,Phocomelia Schinzel type ORPHA:2879,0.5867963421058087
ARMC6,High density lipoprotein measurement,0.7880542567584415
ARMC6,Galactokinase deficiency ORPHA:79237,0.3832844616405875
ARMC6,Ichthyosis-prematurity syndrome ORPHA:88621,0.3832844616405875
ARMC6,TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642,0.3832844616405875
ARMC6,Testicular regression syndrome ORPHA:983,0.3832844616405875
ARMC6,Acute intermittent porphyria ORPHA:79276,0.5867963421058087
ARMC6,Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815,0.5867963421058087
ARMC6,Combined oxidative phosphorylation defect type 23 ORPHA:444013,0.5867963421058087
ARMC6,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694,0.5867963421058087
ARMC6,Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790,0.5867963421058087
ARMC6,RFVT2-related riboflavin transporter deficiency ORPHA:572543,0.5867963421058087
ARMC6,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome ORPHA:363444,0.5867963421058087
ARMC6,Transketolase deficiency ORPHA:488618,0.5867963421058087
ARMC6,Familial melanoma ORPHA:618,0.6873535151929783
ARMC6,8q24.3 microdeletion syndrome ORPHA:508488,0.7929682744768703
ARMC6,Auditory neuropathy-optic atrophy syndrome ORPHA:542585,0.7929682744768703
ARMC6,Bjornstad syndrome ORPHA:123,0.7929682744768703
ARMC6,DDX41-related hematologic malignancy predisposition syndrome ORPHA:488647,0.7929682744768703
ARMC6,Disseminated superficial actinic porokeratosis ORPHA:79152,0.7929682744768703
ARMC6,Essential fructosuria ORPHA:2056,0.7929682744768703
ARMC6,GMPPB-related  limb-girdle muscular dystrophy R19 ORPHA:363623,0.7929682744768703
ARMC6,GRACILE syndrome ORPHA:53693,0.7929682744768703
ARMC6,Glutaryl-CoA dehydrogenase deficiency ORPHA:25,0.7929682744768703
ARMC6,Hyperimmunoglobulinemia D with periodic fever ORPHA:343,0.7929682744768703
ARMC6,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome ORPHA:508498,0.7929682744768703
ARMC6,Macrocephaly-developmental delay syndrome ORPHA:397612,0.7929682744768703
ARMC6,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome ORPHA:363649,0.7929682744768703
ARMC6,Methylmalonic aciduria due to transcobalamin receptor defect ORPHA:280183,0.7929682744768703
ARMC6,Mevalonic aciduria ORPHA:29,0.7929682744768703
ARMC6,NTHL1-related attenuated familial adenomatous polyposis ORPHA:454840,0.7929682744768703
ARMC6,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470,0.7929682744768703
ARMC6,PYCR2-related microcephaly-progressive leukoencephalopathy ORPHA:481152,0.7929682744768703
ARMC6,Renal tubulopathy-encephalopathy-liver failure syndrome ORPHA:254902,0.7929682744768703
ARMC6,Short stature-brachydactyly-obesity-global developmental delay syndrome ORPHA:464288,0.7929682744768703
ARMC6,Schwannomatosis ORPHA:93921,0.795266832401002
ARMC6,ALG1-CDG ORPHA:79327,0.8922466888454011
ARMC6,Autosomal recessive cerebelloparenchymal disorder type 3 ORPHA:1170,0.8922466888454011
ARMC6,CODAS syndrome ORPHA:1458,0.8922466888454011
ARMC6,Combined oxidative phosphorylation defect type 17 ORPHA:369913,0.8922466888454011
ARMC6,Isolated sedoheptulokinase deficiency ORPHA:440713,0.8922466888454011
ARMC6,Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome ORPHA:457284,0.8922466888454011
ARMC6,3-methylglutaconic aciduria type 7 ORPHA:445038,0.8922466888454011
ARMC6,CLN4A disease ORPHA:228340,0.8922466888454011
ARMC6,CLN6 disease ORPHA:228363,0.8922466888454011
ASMTL,Leukemia Myelocytic Acute,0.7765852775619541
ASMTL,Acute Myeloid Leukemia M1,0.7880542567584415
ASMTL,Acute Myeloid Leukemia (AML-M2),0.7880542567584415
ASMTL,Carney Complex,0.8168901801930506
ASMTL,Intellectual Disability,0.9478210444156088
ASMTL,Leukemia,0.7765582368651238
ASMTL,Myeloid Leukemia,0.8356859041719433
ATG16L2,Crohn Disease,0.7880542567584415
ATG16L2,Crohn Disease,0.8903630091389316
ATG16L2,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
ATG16L2,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
ATG16L2,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
ATG16L2,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
ATG16L2,Barth syndrome ORPHA:111,0.0414176838632111
ATG16L2,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
ATG16L2,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
ATG16L2,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
ATG16L2,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
ATG16L2,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
ATG16L2,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.1040670578681756
ATG16L2,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.1054066549396977
ATG16L2,2q37 microdeletion syndrome ORPHA:1001,0.1991445465001551
ATG16L2,Combined oxidative phosphorylation defect type 27 ORPHA:477774,0.1991445465001551
ATG16L2,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144,0.1991445465001551
ATG16L2,NIK deficiency ORPHA:447731,0.1991445465001551
ATG16L2,Coats plus syndrome ORPHA:313838,0.1991445465001551
ATG16L2,Dehydrated hereditary stomatocytosis ORPHA:3202,0.2047219337649946
ATG16L2,CLN3 disease ORPHA:228346,0.3832844616405875
ATG16L2,Classic galactosemia ORPHA:79239,0.3832844616405875
ATG16L2,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome ORPHA:352662,0.3832844616405875
ATG16L2,Craniosynostosis-dental anomalies ORPHA:284149,0.3832844616405875
ATG16L2,Grange syndrome ORPHA:79094,0.3832844616405875
ATG16L2,Gray platelet syndrome ORPHA:721,0.3832844616405875
ATG16L2,Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606,0.3832844616405875
ATG16L2,Osteogenesis imperfecta type 5 ORPHA:216828,0.3832844616405875
ATG16L2,Glycogen storage disease due to liver phosphorylase kinase deficiency ORPHA:264580,0.3832844616405875
ATG16L2,Hermansky-Pudlak syndrome with pulmonary fibrosis ORPHA:231500,0.3832844616405875
ATG16L2,Familial focal epilepsy with variable foci ORPHA:98820,0.3832844616405875
ATG16L2,Laron syndrome with immunodeficiency ORPHA:220465,0.5867963421058087
ATG16L2,Pityriasis rubra pilaris ORPHA:2897,0.5867963421058087
ATG16L2,Nodular fasciitis ORPHA:477742,0.5867963421058087
ATG16L2,Autosomal dominant multiple pterygium syndrome ORPHA:65743,0.7929682744768703
ATG16L2,Cherubism ORPHA:184,0.7929682744768703
ATG16L2,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome ORPHA:538574,0.7929682744768703
ATG16L2,Primary sclerosing cholangitis ORPHA:171,0.7929682744768703
ATG16L2,Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267,0.8922466888454011
ATG16L2,Combined malonic and methylmalonic acidemia ORPHA:289504,0.8922466888454011
ATG16L2,Histidinemia ORPHA:2157,0.8922466888454011
ATG16L2,Native American myopathy ORPHA:168572,0.8922466888454011
ATG16L2,Predisposition to invasive fungal disease due to CARD9 deficiency ORPHA:457088,0.8922466888454011
ATG16L2,Pseudo-von Willebrand disease ORPHA:52530,0.8922466888454011
ATG16L2,Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia ORPHA:313808,0.8922466888454011
ATG16L2,Congenital vertebral-cardiac-renal anomalies syndrome ORPHA:521438,0.8922466888454011
ATG16L2,Hereditary clear cell renal cell carcinoma ORPHA:422526,0.8922466888454011
ATG16L2,Autoimmune polyendocrinopathy type 1 ORPHA:3453,0.8922466888454011
ATG16L2,Severe combined immunodeficiency due to IKK2 deficiency ORPHA:397787,0.8922466888454011
ATG4A,Malignant neoplasm of breast,0.4084380369379369
ATG4A,Breast Carcinoma,0.7333611688795861
ATG4A,Malignant neoplasm of ovary,0.7333611688795861
ATG4A,Ovarian Carcinoma,0.7333611688795861
ATG4A,Crohn Disease,0.7880542567584415
ATG4A,CEDNIK syndrome ORPHA:66631,0.5867963421058087
ATG4A,Carnitine-acylcarnitine translocase deficiency ORPHA:159,0.5867963421058087
ATG4A,Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714,0.5867963421058087
ATG4A,Neutral lipid storage disease with ichthyosis ORPHA:98907,0.5867963421058087
ATG4A,Aspartylglucosaminuria ORPHA:93,0.7929682744768703
ATG4A,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815,0.7929682744768703
ATG4A,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency ORPHA:308425,0.7929682744768703
ATG4A,Autosomal erythropoietic protoporphyria ORPHA:79278,0.8922466888454011
ATG4A,X-linked intellectual disability Nascimento type ORPHA:163956,0.8922466888454011
ATG4A,Leukoencephalopathy-dystonia-motor neuropathy syndrome ORPHA:163684,0.8922466888454011
ATG4A,Mitochondrial pyruvate carrier deficiency ORPHA:447784,0.8922466888454011
ATP2C2,Malignant neoplasm of breast,0.4084380369379369
ATP2C2,Breast Carcinoma,0.7333611688795861
ATP2C2,Carcinogenesis,0.7333611688795861
ATP2C2,Specific language impairment,0.7880542567584415
ATP2C2,Surfactant protein D measurement,0.7880542567584415
ATP2C2,Dyslexia,0.7880542567584415
ATP2C2,Language Disorders,0.7880542567584415
ATP2C2,Chronic Obstructive Airway Disease,0.8648405521677974
ATP2C2,Attention deficit hyperactivity disorder,0.9770263358372888
ATP2C2,Leukemia,0.7765582368651238
ATP2C2,Chronic Obstructive Pulmonary Disease,0.966063509695942
ATP2C2,Attention Deficit Hyperactivity Disorder,0.980894832851993
ATP2C2,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.1040670578681756
ATP2C2,Van der Woude syndrome ORPHA:888,0.1991445465001551
ATP2C2,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.1991445465001551
ATP2C2,Autosomal recessive cerebral atrophy ORPHA:363969,0.1991445465001551
ATP2C2,Congenital intrauterine infection-like syndrome ORPHA:1229,0.1991445465001551
ATP2C2,Congenital tufting enteropathy ORPHA:92050,0.1991445465001551
ATP2C2,EEM syndrome ORPHA:1897,0.1991445465001551
ATP2C2,Hypotrichosis with juvenile macular degeneration ORPHA:1573,0.1991445465001551
ATP2C2,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.1991445465001551
ATP2C2,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.1991445465001551
ATP2C2,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.1991445465001551
ATP2C2,Generalized pseudohypoaldosteronism type 1 ORPHA:171876,0.3832844616405875
ATP2C2,Liddle syndrome ORPHA:526,0.3832844616405875
ATP2C2,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3832844616405875
ATP2C2,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3832844616405875
ATP2C2,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3832844616405875
ATP2C2,Syndromic congenital sodium diarrhea ORPHA:563708,0.3832844616405875
ATP2C2,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.3832844616405875
ATP2C2,Idiopathic pulmonary fibrosis ORPHA:2032,0.5047266821728011
ATP2C2,Localized junctional epidermolysis bullosa ORPHA:251393,0.5867963421058087
ATP2C2,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.5867963421058087
ATP2C2,Idiopathic bronchiectasis ORPHA:60033,0.5867963421058087
ATP2C2,Mullerian aplasia and hyperandrogenism ORPHA:247768,0.5867963421058087
ATP2C2,Neuropathy with hearing impairment ORPHA:139512,0.5867963421058087
ATP2C2,SERKAL syndrome ORPHA:139466,0.5867963421058087
ATP2C2,Systemic primary carnitine deficiency ORPHA:158,0.5867963421058087
ATP2C2,Microvillus inclusion disease ORPHA:2290,0.5867963421058087
ATP2C2,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.5867963421058087
ATP2C2,Hypocalcified amelogenesis imperfecta ORPHA:100032,0.5959529547720634
ATP2C2,Autosomal recessive distal renal tubular acidosis ORPHA:402041,0.7929682744768703
ATP2C2,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.7929682744768703
ATP2C2,Autosomal recessive spastic paraplegia type 35 ORPHA:171629,0.7929682744768703
ATP2C2,Ectodermal dysplasia-syndactyly syndrome ORPHA:247820,0.7929682744768703
ATP2C2,Epithelial recurrent erosion dystrophy ORPHA:293381,0.7929682744768703
ATP2C2,Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308,0.7929682744768703
ATP2C2,Ichthyosis-hypotrichosis syndrome ORPHA:91132,0.7929682744768703
ATP2C2,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.7929682744768703
ATP2C2,MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949,0.7929682744768703
ATP2C2,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.7929682744768703
ATP2C2,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.7929682744768703
ATP2C2,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.7929682744768703
ATP2C2,Uncombable hair syndrome ORPHA:1410,0.7929682744768703
ATP2C2,Congenital sodium diarrhea ORPHA:103908,0.8922466888454011
ATP2C2,Diffuse panbronchiolitis ORPHA:171700,0.8922466888454011
ATP2C2,Cystic fibrosis ORPHA:586,0.8922466888454011
ATP2C2,Posterior polymorphous corneal dystrophy ORPHA:98973,0.8922466888454011
ATP6V0D1,Lyme Disease,0.7880542567584415
ATP6V0D1,Schizophrenia,0.8067197998685076
ATP6V0D1,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
ATP6V0D1,CLN11 disease ORPHA:314629,0.1040670578681756
ATP6V0D1,Marinesco-Sjogren syndrome ORPHA:559,0.1054066549396977
ATP6V0D1,Beta-propeller protein-associated neurodegeneration ORPHA:329284,0.1991445465001551
ATP6V0D1,CCDC115-CDG ORPHA:468684,0.1991445465001551
ATP6V0D1,CLN10 disease ORPHA:228337,0.1991445465001551
ATP6V0D1,Mucolipidosis type IV ORPHA:578,0.1991445465001551
ATP6V0D1,Metachromatic leukodystrophy adult form ORPHA:309271,0.3832844616405875
ATP6V0D1,Metachromatic leukodystrophy juvenile form ORPHA:309263,0.3832844616405875
ATP6V0D1,Metachromatic leukodystrophy late infantile form ORPHA:309256,0.3832844616405875
ATP6V0D1,ACys amyloidosis ORPHA:100008,0.3832844616405875
ATP6V0D1,Clear cell renal carcinoma ORPHA:319276,0.3832844616405875
ATP6V0D1,Mucolipidosis type III gamma ORPHA:423470,0.3832844616405875
ATP6V0D1,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ORPHA:480864,0.3832844616405875
ATP6V0D1,Atypical Gaucher disease due to saposin C deficiency ORPHA:309252,0.5867963421058087
ATP6V0D1,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.5867963421058087
ATP6V0D1,Encephalopathy due to prosaposin deficiency ORPHA:139406,0.5867963421058087
ATP6V0D1,Galactosialidosis ORPHA:351,0.5867963421058087
ATP6V0D1,Genetic hyperferritinemia without iron overload ORPHA:254704,0.5867963421058087
ATP6V0D1,Hereditary hyperferritinemia-cataract syndrome ORPHA:163,0.5867963421058087
ATP6V0D1,L-ferritin deficiency ORPHA:440731,0.5867963421058087
ATP6V0D1,Neuroferritinopathy ORPHA:157846,0.5867963421058087
ATP6V0D1,Infantile Krabbe disease ORPHA:206436,0.5867963421058087
ATP6V0D1,Yunis-Varon syndrome ORPHA:3472,0.5867963421058087
ATP6V0D1,Infantile nephropathic cystinosis ORPHA:411629,0.7929682744768703
ATP6V0D1,Juvenile nephropathic cystinosis ORPHA:411634,0.7929682744768703
ATP6V0D1,Ocular cystinosis ORPHA:411641,0.7929682744768703
ATP6V0D1,Transaldolase deficiency ORPHA:101028,0.7929682744768703
ATP6V0D1,Autosomal dominant deafness-onychodystrophy syndrome ORPHA:79499,0.8922466888454011
ATP6V0D1,Fetal Gaucher disease ORPHA:85212,0.8922466888454011
ATP6V0D1,Gaucher disease type 2 ORPHA:77260,0.8922466888454011
ATP6V0D1,Gaucher disease type 3 ORPHA:77261,0.8922466888454011
ATP6V0D1,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072,0.8922466888454011
ATP6V0D1,NON RARE IN EUROPE: Parkinson disease ORPHA:319705,0.8922466888454011
ATP6V0D1,Niemann-Pick disease type A ORPHA:77292,0.8922466888454011
ATP6V0D1,Niemann-Pick disease type B ORPHA:77293,0.8922466888454011
ATP6V0D1,Glycogen storage disease with severe cardiomyopathy due to glycogenin deficiency ORPHA:263297,0.8922466888454011
ATP6V0D1,Polyglucosan body myopathy type 2 ORPHA:456369,0.8922466888454011
ATP6V0D1,Proximal myopathy with extrapyramidal signs ORPHA:401768,0.8922466888454011
ATP6V0D1,NON RARE IN EUROPE: Hidradenitis suppurativa ORPHA:387,0.8922466888454011
ATP6V0D1,Behavioral variant of frontotemporal dementia ORPHA:275864,0.8953775799945711
ATP8A1,Non-Small Cell Lung Carcinoma,0.7765852775619541
ATP8A1,Cytokine Measurement,0.8690346447728063
ATP8A1,Distal monosomy 1q ORPHA:36367,0.1040670578681756
ATP8A1,Succinic semialdehyde dehydrogenase deficiency ORPHA:22,0.1991445465001551
ATP8A1,Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379,0.3832844616405875
ATP8A1,SHORT syndrome ORPHA:3163,0.3832844616405875
ATP8A1,Pseudohypoaldosteronism type 2D ORPHA:300525,0.5867963421058087
ATP8A1,Complex lethal osteochondrodysplasia ORPHA:457378,0.7929682744768703
ATP8A1,Renal pseudohypoaldosteronism type 1 ORPHA:171871,0.8922466888454011
B3GALT4,Ehlers-Danlos Syndrome,0.8497448945325101
B3GALT4,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
B3GALT4,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
B3GALT4,CCDC115-CDG ORPHA:468684,0.1991445465001551
B3GALT4,Revesz syndrome ORPHA:3088,0.3832844616405875
BAG2,Carcinogenesis,0.7333611688795861
BAG2,Adult polyglucosan body disease ORPHA:206583,0.7929682744768703
BAG2,Glycogen storage disease due to glycogen branching enzyme deficiency adult neuromuscular form ORPHA:308712,0.7929682744768703
BAG2,Glycogen storage disease due to glycogen branching enzyme deficiency childhood combined hepatic and myopathic form ORPHA:308684,0.7929682744768703
BAG2,Glycogen storage disease due to glycogen branching enzyme deficiency childhood neuromuscular form ORPHA:308698,0.7929682744768703
BAG2,Glycogen storage disease due to glycogen branching enzyme deficiency congenital neuromuscular form ORPHA:308670,0.7929682744768703
BAG2,Glycogen storage disease due to glycogen branching enzyme deficiency fatal perinatal neuromuscular form ORPHA:308655,0.7929682744768703
BAG2,Glycogen storage disease due to glycogen branching enzyme deficiency non progressive hepatic form ORPHA:308638,0.7929682744768703
BAG2,Glycogen storage disease due to glycogen branching enzyme deficiency progressive hepatic form ORPHA:308621,0.7929682744768703
BAG2,Salivirus NG-J1 3D,0.8999095837312036
BAG2,Nipah henipavirus P phosphoprotein,0.8999095837312036
BAIAP2,Carcinogenesis,0.7333611688795861
BAIAP2,Uric acid measurement (procedure),0.7765852775619541
BAIAP2,Mental disorders,0.7880542567584415
BAIAP2,Abnormal behavior,0.7880542567584415
BAIAP2,Memory performance,0.7880542567584415
BAIAP2,Gout,0.7880542567584415
BAIAP2,Impaired cognition,0.8190761496232595
BAIAP2,Cognition Disorders,0.8270909867833504
BAIAP2,Seizures,0.9478210444156088
BAIAP2,Autism Spectrum Disorders,0.9639249377588224
BAIAP2,Attention deficit hyperactivity disorder,0.9770263358372888
BAIAP2,Gout,0.7765582368651238
BAIAP2,Gouty Arthritis,0.7765582368651238
BAIAP2,Anxiety Disorder,0.8507213163251659
BAIAP2,Mental Depression,0.8903630091389316
BAIAP2,Mood Disorder,0.9726139569926774
BAIAP2,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
BAIAP2,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.1040670578681756
BAIAP2,Bilateral perisylvian polymicrogyria ORPHA:98889,0.1068643725150898
BAIAP2,Pyruvate carboxylase deficiency benign type ORPHA:353320,0.1991445465001551
BAIAP2,Pyruvate carboxylase deficiency infantile type ORPHA:353308,0.1991445465001551
BAIAP2,Pyruvate carboxylase deficiency severe neonatal type ORPHA:353314,0.1991445465001551
BAIAP2,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.5867963421058087
BAIAP2,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.5867963421058087
BAIAP2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
BAIAP2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
BAIAP2,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
BAIAP2,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
BAIAP2,Influenza B virus nonstructural protein 1 (gene: NS1),0.8999095837312036
BAIAP2,Reston ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
BAIAP2,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) hemagglutinin (gene: HA),0.8999095837312036
BAIAP2,Macacine alphaherpesvirus 1 large tegument protein (gene: UL36),0.8999095837312036
BAIAP2,Bundibugyo ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
BAIAP2,Dengue virus 1 membrane glycoprotein M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Dengue virus 2 membrane glycoprotein M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
BAIAP2,Variola virus hypothetical protein (gene: A49L),0.8999095837312036
BAIAP2,Dengue virus 3 membrane glycoprotein M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Dengue virus 4 membrane glycoprotein M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Ebola virus - Mayinga Zaire 1976 virion spike glycoprotein precursor (gene: GP),0.8999095837312036
BAIAP2,Zaire ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
BAIAP2,Dengue virus 1 membrane glycoprotein precursor M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Dengue virus 4 membrane glycoprotein precursor M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Dengue virus 2 membrane glycoprotein precursor M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Dengue virus 3 membrane glycoprotein precursor M (gene: flavivirus polyprotein),0.8999095837312036
BAIAP2,Lake Victoria marburgvirus - DRC1999 glycoprotein (gene: GP),0.8999095837312036
BAIAP2,Yaba monkey tumor virus sulfhydryl oxidase,0.8999095837312036
BAIAP2,Monkeypox virus cowpox A-type inclusion protein,0.8999095837312036
BAIAP2,Ravn virus - Ravn Kenya 1987 glycoprotein (gene: GP),0.8999095837312036
BAIAP2,Influenza A virus (A/California/04/2009(H1N1)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/California/07/2009(H1N1)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/Korea/426/1968(H2N2)) PB1 polymerase subunit (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/New York/392/2004(H3N2)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/New York/599/1996(H3N2)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/New York/602/1996(H3N2)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/Northern Territory/60/1968(H3N2)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/Shanghai/02/2013(H7N9)) polymerase PB1 (gene: PB1),0.8999095837312036
BAIAP2,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) polymerase (gene: PB1),0.8999095837312036
BAIAP2,Marburg marburgvirus glycoprotein (gene: GP),0.8999095837312036
BAIAP2,Lake Victoria marburgvirus - Leiden glycoprotein (gene: GP),0.9057542447893764
BAIAP2,Marburg virus - Musoke Kenya 1980 glycoprotein (gene: GP),0.9057542447893764
BAIAP2,Lake Victoria marburgvirus - Angola2005 glycoprotein (gene: GP),0.9287050575620676
BAIAP2,Mumps virus phoshoprotein (gene: V/P),0.9597398910543528
BAIAP2,Mumps virus genotype G phosphoprotein (gene: P),0.9626366082099888
BAIAP3,Carcinogenesis,0.7333611688795861
BAIAP3,Anxiety Disorders,0.946564927793026
BAIAP3,Anxiety,0.9708740267329932
BAIAP3,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.1040670578681756
BAIAP3,Amelocerebrohypohidrotic syndrome ORPHA:1946,0.8922466888454011
BCL2L10,Malignant neoplasm of breast,0.4084380369379369
BCL2L10,Breast Carcinoma,0.7333611688795861
BCL2L10,Diffuse Large B-Cell Lymphoma,0.7333611688795861
BCL2L10,Carcinogenesis,0.7333611688795861
BCL2L10,B-Cell Lymphomas,0.7333611688795861
BCL2L10,leukemia,0.7333611688795861
BCL2L10,Leukemia Myelocytic Acute,0.7765852775619541
BCL2L10,MYELODYSPLASTIC SYNDROME,0.7765852775619541
BCL2L10,Leukemogenesis,0.7765852775619541
BCL2L10,Malignant neoplasm of lung,0.7880542567584415
BCL2L10,Malignant neoplasm of prostate,0.7880542567584415
BCL2L10,de novo myelodysplastic syndromes,0.7880542567584415
BCL2L10,Liver carcinoma,0.7880542567584415
BCL2L10,Colorectal Cancer,0.7880542567584415
BCL2L10,Adult Myelodysplastic Syndrome,0.7880542567584415
BCL2L10,Prostate carcinoma,0.7880542567584415
BCL2L10,Neoplasm Metastasis,0.7880542567584415
BCL2L10,Epithelioma,0.7880542567584415
BCL2L10,Multiple Myeloma,0.7880542567584415
BCL2L10,Malignant neoplasm of stomach,0.7880542567584415
BCL2L10,Lymphoma Follicular,0.7880542567584415
BCL2L10,Acute leukemia,0.7880542567584415
BCL2L10,Stomach Carcinoma,0.7880542567584415
BCL2L10,Small cell carcinoma of lung,0.7880542567584415
BCL2L10,Metastatic Neoplasm,0.7880542567584415
BCL2L10,Affective Disorders Psychotic,0.7880542567584415
BCL2L10,Childhood Myelodysplastic Syndrome,0.7880542567584415
BCL2L10,Toxic Epidermal Necrolysis,0.8019075543217649
BCL2L11,Malignant neoplasm of breast,0.4084380369379369
BCL2L11,Adenomatous Polyposis Coli,0.5196624042573144
BCL2L11,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
BCL2L11,Breast Carcinoma,0.7333611688795861
BCL2L11,Carcinogenesis,0.7333611688795861
BCL2L11,Malignant neoplasm of ovary,0.7333611688795861
BCL2L11,B-Cell Lymphomas,0.7333611688795861
BCL2L11,Non-Functioning Pituitary Gland Neoplasm,0.7333611688795861
BCL2L11,leukemia,0.7333611688795861
BCL2L11,Ovarian Carcinoma,0.7333611688795861
BCL2L11,Adenocarcinoma,0.750391252594775
BCL2L11,Malignant neoplasm of pancreas,0.7688485284765829
BCL2L11,Colorectal Carcinoma,0.7765852775619541
BCL2L11,Pancreatic carcinoma,0.7765852775619541
BCL2L11,Gastrointestinal Stromal Tumors,0.7765852775619541
BCL2L11,Colon Carcinoma,0.7765852775619541
BCL2L11,Leukemia Myelocytic Acute,0.7765852775619541
BCL2L11,Malignant tumor of colon,0.7765852775619541
BCL2L11,Atrial Premature Complexes,0.7765852775619541
BCL2L11,Lymphoma,0.7765852775619541
BCL2L11,Leukemogenesis,0.7765852775619541
BCL2L11,Non-Small Cell Lung Carcinoma,0.7765852775619541
BCL2L11,Colorectal Neoplasms,0.7765852775619541
BCL2L11,Adenoma,0.7765852775619541
BCL2L11,Mammary Neoplasms,0.7880542567584415
BCL2L11,Malignant neoplasm of lung,0.7880542567584415
BCL2L11,Malignant neoplasm of prostate,0.7880542567584415
BCL2L11,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
BCL2L11,Lymphoma Non-Hodgkin,0.7880542567584415
BCL2L11,Liver carcinoma,0.7880542567584415
BCL2L11,Malignant Head and Neck Neoplasm,0.7880542567584415
BCL2L11,Osteosarcoma,0.7880542567584415
BCL2L11,Colorectal Cancer,0.7880542567584415
BCL2L11,T-Cell Lymphoma,0.7880542567584415
BCL2L11,Glioblastoma,0.7880542567584415
BCL2L11,Osteosarcoma of bone,0.7880542567584415
BCL2L11,Prostate carcinoma,0.7880542567584415
BCL2L11,Primary malignant neoplasm of lung,0.7880542567584415
BCL2L11,Neoplasm Metastasis,0.7880542567584415
BCL2L11,Epithelioma,0.7880542567584415
BCL2L11,Carcinoma of lung,0.7880542567584415
BCL2L11,Squamous cell carcinoma of the head and neck,0.7880542567584415
BCL2L11,Neuroblastoma,0.7880542567584415
BCL2L11,Central neuroblastoma,0.7880542567584415
BCL2L11,Monocyte count procedure,0.7880542567584415
BCL2L11,Monocyte count result,0.7880542567584415
BCL2L11,Immunologic Deficiency Syndromes,0.7880542567584415
BCL2L11,melanoma,0.7880542567584415
BCL2L11,Multiple Myeloma,0.7880542567584415
BCL2L11,Lung Neoplasms,0.7880542567584415
BCL2L11,Extraskeletal Myxoid Chondrosarcoma,0.7880542567584415
BCL2L11,Glucocorticoid Receptor Deficiency,0.7880542567584415
BCL2L11,Eosinophil count procedure,0.7880542567584415
BCL2L11,Eosinophil count result,0.7880542567584415
BCL2L11,Prolactinoma,0.7880542567584415
BCL2L11,Refractory Hodgkin Lymphoma,0.7880542567584415
BCL2L11,Burkitt Lymphoma,0.7880542567584415
BCL2L11,Hodgkin Disease,0.7880542567584415
BCL2L11,Sarcoma,0.7880542567584415
BCL2L11,Lupus Erythematosus Systemic,0.7880542567584415
BCL2L11,Renal Cell Carcinoma,0.7880542567584415
BCL2L11,Lymphoma Follicular,0.7880542567584415
BCL2L11,Alzheimer's Disease,0.7880542567584415
BCL2L11,Acute lymphocytic leukemia,0.7880542567584415
BCL2L11,Hepatitis C,0.7880542567584415
BCL2L11,Solid Neoplasm,0.7880542567584415
BCL2L11,Rheumatoid Arthritis,0.7880542567584415
BCL2L11,Carcinoid Tumor,0.7880542567584415
BCL2L11,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.7880542567584415
BCL2L11,Small cell carcinoma of lung,0.7880542567584415
BCL2L11,Huntington Disease,0.7880542567584415
BCL2L11,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
BCL2L11,Adult Lymphoma,0.7880542567584415
BCL2L11,Childhood Lymphoma,0.7880542567584415
BCL2L11,Gonadal Dysgenesis 45X,0.7880542567584415
BCL2L11,Myeloid Leukemia Chronic,0.7880542567584415
BCL2L11,Myeloid Leukemia,0.7880542567584415
BCL2L11,B-CELL MALIGNANCY LOW-GRADE,0.7880542567584415
BCL2L11,Ovarian Diseases,0.8019075543217649
BCL2L11,Chronic Lymphocytic Leukemia,0.8019075543217649
BCL2L11,Adenocarcinoma of lung (disorder),0.8098851543361193
BCL2L11,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
BCL2L11,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
BCL2L11,Blood basophil count (lab test),0.8190761496232595
BCL2L11,Autoimmune Lymphoproliferative Syndrome,0.8190761496232595
BCL2L11,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
BCL2L11,Primary sclerosing cholangitis,0.8212681436603975
BCL2L11,Infection,0.8272008757995397
BCL2L11,Cholangitis Sclerosing,0.8337767145465158
BCL2L11,Tuberculosis,0.8368219249856942
BCL2L11,Pituitary Neoplasms,0.8368219249856942
BCL2L11,Traditional Serrated Adenoma,0.8402911822757345
BCL2L11,Growth Hormone-Secreting Pituitary Adenoma,0.8402911822757345
BCL2L11,Dysautonomia Familial,0.8402911822757345
BCL2L11,Severe Sepsis,0.843190898187174
BCL2L11,Lymphoproliferative Disorders,0.8508164886128737
BCL2L11,Female Breast Carcinoma,0.8523465762428218
BCL2L11,Malignant neoplasm of female breast,0.8578473133580928
BCL2L11,Progressive cGVHD,0.8610447277138289
BCL2L11,Renal carcinoma,0.8648405521677974
BCL2L11,Leukemia B-Cell,0.8648405521677974
BCL2L11,Neuroendocrine Tumors,0.887595340546704
BCL2L11,Addictive Behavior,0.9015731019095328
BCL2L11,Trisomy,0.9029289778792944
BCL2L11,Progressive Neoplastic Disease,0.9265708351135048
BCL2L11,Carcinoid tumor no ICD-O subtype,0.9393256300017014
BCL2L11,Sclerosing Cholangitis,0.7765582368651238
BCL2L11,Prostate Cancer,0.7765582368651238
BCL2L11,Lymphocytic Leukemia,0.7765582368651238
BCL2L11,Prostate Cancer Hereditary,0.7765582368651238
BCL2L11,Cholangitis,0.8885757656973042
BCL2L11,Diabetes Mellitus,0.919442421650838
BCL2L11,Breast Carcinoma,0.9398381935810408
BCL2L11,Human gammaherpesvirus 4 hypothetical protein (gene: BHRF1),0.8999095837312036
BCL2L11,Human herpesvirus 4 type 2 BHRF1,0.8999095837312036
BCL2L11,Vaccinia virus Hypothetical protein (gene: F1L),0.8999095837312036
BCL2L11,Vaccinia virus Ankara apoptosis inhibitor,0.8999095837312036
BCL2L11,Human herpesvirus 4 type 2 BALF1,0.8999095837312036
BCL7B,Adenocarcinoma,0.750391252594775
BCL7B,Uric acid measurement (procedure),0.7765852775619541
BCL7B,C-reactive protein measurement,0.7880542567584415
BCL7B,Lung Neoplasms,0.7880542567584415
BCL7B,High density lipoprotein measurement,0.7880542567584415
BCL7B,Williams Syndrome,0.7880542567584415
BCL7B,Metabolic Syndrome X,0.8610447277138289
BCL7B,Calcification of coronary artery,0.9377696084218796
BCL7B,Gout,0.7765582368651238
BCL7B,Gouty Arthritis,0.7765582368651238
BCL7B,Hermansky-Pudlak syndrome type 7 ORPHA:231531,0.3832844616405875
BCL7B,CEDNIK syndrome ORPHA:66631,0.5867963421058087
BCL7B,Williams syndrome ORPHA:904,0.8922466888454011
BCLAF1,Carcinoma of bladder,0.4084380369379369
BCLAF1,Bladder Neoplasm,0.4084380369379369
BCLAF1,Malignant neoplasm of urinary bladder,0.5071083164302358
BCLAF1,Carcinogenesis,0.7333611688795861
BCLAF1,Colon Carcinoma,0.7765852775619541
BCLAF1,Leukemia Myelocytic Acute,0.7765852775619541
BCLAF1,Malignant tumor of colon,0.7765852775619541
BCLAF1,Lymphoma Non-Hodgkin,0.7880542567584415
BCLAF1,Small cell carcinoma of lung,0.7880542567584415
BCLAF1,Cytomegalovirus Infections,0.7880542567584415
BCLAF1,Muscular Dystrophy Emery-Dreifuss,0.8212681436603975
BCLAF1,Lung Carcinoma,0.8139950454942313
BCLAF1,Vocal cord and pharyngeal distal myopathy ORPHA:600,0.3832844616405875
BCLAF1,Non-specific syndromic intellectual disability ORPHA:528084,0.5867963421058087
BCLAF1,1q44 microdeletion syndrome ORPHA:238769,0.5867963421058087
BCLAF1,Alazami syndrome ORPHA:319671,0.5867963421058087
BCLAF1,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:330050,0.5867963421058087
BCLAF1,X-linked intellectual disability-short stature-overweight syndrome ORPHA:457240,0.5867963421058087
BCLAF1,Angiocentric glioma ORPHA:251671,0.5867963421058087
BCLAF1,Neuroendocrine tumor of stomach ORPHA:100075,0.5867963421058087
BCLAF1,Acute myeloblastic leukemia with maturation ORPHA:98834,0.5867963421058087
BCLAF1,Joubert syndrome with ocular defect ORPHA:220493,0.606625035400596
BCLAF1,Differentiated thyroid carcinoma ORPHA:146,0.7929682744768703
BCLAF1,Joubert syndrome with Jeune asphyxiating thoracic dystrophy ORPHA:397715,0.7929682744768703
BCLAF1,12q15q21.1 microdeletion syndrome ORPHA:289513,0.7929682744768703
BCLAF1,16p13.2 microdeletion syndrome ORPHA:500055,0.7929682744768703
BCLAF1,Autosomal recessive spastic paraplegia type 71 ORPHA:401840,0.7929682744768703
BCLAF1,B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome ORPHA:567502,0.7929682744768703
BCLAF1,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome ORPHA:504476,0.7929682744768703
BCLAF1,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome ORPHA:508542,0.7929682744768703
BCLAF1,Ferro-cerebro-cutaneous syndrome ORPHA:397922,0.7929682744768703
BCLAF1,Multiple congenital anomalies-hypotonia-seizures syndrome type 2 ORPHA:300496,0.7929682744768703
BCLAF1,Paroxysmal nocturnal hemoglobinuria ORPHA:447,0.7929682744768703
BCLAF1,Severe myopia-generalized joint laxity-short stature syndrome ORPHA:527450,0.7929682744768703
BCLAF1,Xq25 microduplication syndrome ORPHA:521258,0.7929682744768703
BCLAF1,Autosomal thrombocytopenia with normal platelets ORPHA:168629,0.795266832401002
BCLAF1,Extraskeletal Ewing sarcoma ORPHA:370334,0.795266832401002
BCLAF1,Systemic mastocytosis with associated hematologic neoplasm ORPHA:98849,0.795266832401002
BCLAF1,Autosomal dominant optic atrophy classic form ORPHA:98673,0.8922466888454011
BCLAF1,5p13 microduplication syndrome ORPHA:329802,0.8922466888454011
BCLAF1,Absence of fingerprints-congenital milia syndrome ORPHA:1658,0.8922466888454011
BCLAF1,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome ORPHA:444463,0.8922466888454011
BCLAF1,Autosomal dominant spastic paraplegia type 4 ORPHA:100985,0.8922466888454011
BCLAF1,Autosomal recessive spastic paraplegia type 60 ORPHA:401800,0.8922466888454011
BCLAF1,Autosomal recessive spastic paraplegia type 69 ORPHA:401830,0.8922466888454011
BCLAF1,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome ORPHA:500150,0.8922466888454011
BCLAF1,Buschke-Ollendorff syndrome ORPHA:1306,0.8922466888454011
BCLAF1,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion ORPHA:284169,0.8922466888454011
BCLAF1,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation ORPHA:466950,0.8922466888454011
BCLAF1,Fragile X syndrome ORPHA:908,0.8922466888454011
BCLAF1,Fragile X-associated tremor/ataxia syndrome ORPHA:93256,0.8922466888454011
BCLAF1,HNRNPDL-related  limb-girdle muscular dystrophy D3 ORPHA:55596,0.8922466888454011
BCLAF1,Huriez syndrome ORPHA:384,0.8922466888454011
BCLAF1,Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome ORPHA:529965,0.8922466888454011
BCLAF1,Isolated congenital adermatoglyphia ORPHA:289465,0.8922466888454011
BCLAF1,Isolated osteopoikilosis ORPHA:166119,0.8922466888454011
BCLAF1,Melorheostosis with osteopoikilosis ORPHA:1879,0.8922466888454011
BCLAF1,Pseudohypoaldosteronism type 2E ORPHA:300530,0.8922466888454011
BCLAF1,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome ORPHA:502434,0.8922466888454011
BCLAF1,Symptomatic form of fragile X syndrome in female carrier ORPHA:449291,0.8922466888454011
BCLAF1,Toriello-Carey syndrome ORPHA:3338,0.8922466888454011
BCLAF1,Toriello-Lacassie-Droste syndrome ORPHA:3339,0.8922466888454011
BCLAF1,Werner syndrome ORPHA:902,0.8922466888454011
BCLAF1,Woodhouse-Sakati syndrome ORPHA:3464,0.8922466888454011
BCLAF1,X-linked intellectual disability-hypotonia-movement disorder syndrome ORPHA:457260,0.8922466888454011
BCLAF1,Xq27.3q28 duplication syndrome ORPHA:261483,0.8922466888454011
BCLAF1,17q24.2 microdeletion syndrome ORPHA:529962,0.8922466888454011
BCLAF1,NON RARE IN EUROPE: Melanoma ORPHA:411533,0.8922466888454011
BCLAF1,Melanoma of soft tissue ORPHA:97338,0.8922466888454011
BCLAF1,Proximal spinal muscular atrophy type 1 ORPHA:83330,0.8922466888454011
BCLAF1,Proximal spinal muscular atrophy type 2 ORPHA:83418,0.8922466888454011
BCLAF1,Proximal spinal muscular atrophy type 3 ORPHA:83419,0.8922466888454011
BCLAF1,Cornelia de Lange syndrome ORPHA:199,0.8922466888454011
BCLAF1,Infantile nephronophthisis ORPHA:93591,0.8922466888454011
BCLAF1,Senior-Loken syndrome ORPHA:3156,0.8922466888454011
BCLAF1,15q11q13 microduplication syndrome ORPHA:238446,0.8922466888454011
BCLAF1,Angelman syndrome due to a point mutation ORPHA:411511,0.8922466888454011
BCLAF1,Angelman syndrome due to paternal uniparental disomy of chromosome 15 ORPHA:98795,0.8922466888454011
BCLAF1,Autosomal dominant optic atrophy plus syndrome ORPHA:1215,0.8922466888454011
BCLAF1,Cardiospondylocarpofacial syndrome ORPHA:3238,0.8922466888454011
BCLAF1,Familial acute necrotizing encephalopathy ORPHA:88619,0.8922466888454011
BCLAF1,Fatty acyl-CoA reductase 1 deficiency ORPHA:438178,0.8922466888454011
BCLAF1,Klippel-Trenaunay syndrome ORPHA:90308,0.8922466888454011
BCLAF1,Microcephaly-thin corpus callosum-intellectual disability syndrome ORPHA:397951,0.8922466888454011
BCLAF1,NON RARE IN EUROPE: Specific language impairment ORPHA:458713,0.8922466888454011
BCLAF1,12q14 microdeletion syndrome ORPHA:94063,0.8922466888454011
BRSK2,Malignant neoplasm of pancreas,0.7688485284765829
BRSK2,Pancreatic carcinoma,0.7765852775619541
BRSK2,Alzheimer's Disease,0.7880542567584415
BRSK2,Limbic Encephalitis,0.7880542567584415
BRSK2,Small cell carcinoma of lung,0.7880542567584415
BRSK2,Non-Syndromic Intellectual Disability,0.6734982286750932
BRSK2,Neurodevelopmental Disorders,0.7765582368651238
BRSK2,Developmental Delay,0.7765582368651238
BRSK2,Mental Retardation,0.8337953215113012
BRSK2,Apraxia,0.8457525389282121
BRSK2,Cryptorchidism,0.861756360478846
BRSK2,Autism,0.911896615143974
BRSK2,Attention Deficit Hyperactivity Disorder,0.980894832851993
BRSK2,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
BRSK2,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
BRSK2,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
BRSK2,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.1040670578681756
BRSK2,MASA syndrome ORPHA:2466,0.1040670578681756
BRSK2,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.1040670578681756
BRSK2,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.1040670578681756
BRSK2,Bilateral generalized polymicrogyria ORPHA:208447,0.1991445465001551
BRSK2,Benign hereditary chorea ORPHA:1429,0.1991445465001551
BRSK2,Familial infantile myoclonic epilepsy ORPHA:352582,0.1991445465001551
BRSK2,Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406,0.1991445465001551
BRSK2,Usher syndrome type 1 ORPHA:231169,0.2661730864557679
BRSK2,Interstitial lung disease due to ABCA3 deficiency ORPHA:440402,0.3832844616405875
BRSK2,9q33.3q34.11 microdeletion syndrome ORPHA:495818,0.3832844616405875
BRSK2,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency ORPHA:276580,0.5867963421058087
BRSK2,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency ORPHA:79644,0.5867963421058087
BRSK2,DOORS syndrome ORPHA:79500,0.5867963421058087
BRSK2,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency ORPHA:276603,0.5867963421058087
BRSK2,Familial gastric type 1 neuroendocrine tumor ORPHA:464756,0.5867963421058087
BRSK2,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587,0.5867963421058087
BRSK2,Intermediate DEND syndrome ORPHA:99989,0.5867963421058087
BRSK2,Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540,0.5867963421058087
BRSK2,Primary dystonia DYT4 type ORPHA:98805,0.5867963421058087
BRSK2,Progressive myoclonic epilepsy type 8 ORPHA:424027,0.5867963421058087
BRSK2,Progressive myoclonic epilepsy with dystonia ORPHA:352596,0.5867963421058087
BRSK2,Right sided atrial isomerism ORPHA:97548,0.5867963421058087
BRSK2,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727,0.5867963421058087
BRSK2,Autosomal dominant otospondylomegaepiphyseal dysplasia ORPHA:166100,0.5867963421058087
BRSK2,Congenital fibrosis of extraocular muscles ORPHA:45358,0.5867963421058087
BRSK2,Idiopathic central precocious puberty ORPHA:169615,0.5867963421058087
BRSK2,Permanent neonatal diabetes mellitus ORPHA:99885,0.5959529547720634
BRSK2,Early infantile epileptic encephalopathy ORPHA:1934,0.7593059616185558
BRSK2,Autosomal dominant non-syndromic intellectual disability ORPHA:178469,0.7929682744768703
BRSK2,DEND syndrome ORPHA:79134,0.7929682744768703
BRSK2,Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944,0.7929682744768703
BRSK2,Autosomal dominant keratitis ORPHA:2334,0.7929682744768703
BRSK2,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097,0.7929682744768703
BRSK2,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055,0.7929682744768703
BRSK2,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171,0.7929682744768703
BRSK2,Charcot-Marie-Tooth disease type 2H ORPHA:101102,0.7929682744768703
BRSK2,Charcot-Marie-Tooth disease type 4A ORPHA:99948,0.7929682744768703
BRSK2,Foveal hypoplasia-presenile cataract syndrome ORPHA:2253,0.7929682744768703
BRSK2,Isolated optic nerve hypoplasia/aplasia ORPHA:137902,0.7929682744768703
BRSK2,Monosomy 9q22.3 ORPHA:77301,0.7929682744768703
BRSK2,Morning glory disc anomaly ORPHA:35737,0.7929682744768703
BRSK2,Polymicrogyria due to TUBB2B mutation ORPHA:300573,0.7929682744768703
BRSK2,Rapid-onset dystonia-parkinsonism ORPHA:71517,0.7929682744768703
BRSK2,Schilbach-Rott syndrome ORPHA:2353,0.7929682744768703
BRSK2,Spinocerebellar ataxia type 14 ORPHA:98763,0.7929682744768703
BRSK2,Congenitally uncorrected transposition of the great arteries ORPHA:860,0.7929682744768703
BRSK2,Autosomal dominant hyperinsulinism due to SUR1 deficiency ORPHA:276575,0.8922466888454011
BRSK2,Autosomal recessive hyperinsulinism due to SUR1 deficiency ORPHA:79643,0.8922466888454011
BRSK2,Autosomal spastic paraplegia type 72 ORPHA:401849,0.8922466888454011
BRSK2,Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency ORPHA:276598,0.8922466888454011
BRSK2,Distal arthrogryposis type 5D ORPHA:329457,0.8922466888454011
BRSK2,Oculoauricular syndrome Schorderet type ORPHA:157962,0.8922466888454011
BRSK2,Renal coloboma syndrome ORPHA:1475,0.8922466888454011
BRSK2,Infantile convulsions and choreoathetosis ORPHA:31709,0.8922466888454011
BRSK2,Usher syndrome type 2 ORPHA:231178,0.8922466888454011
BRSK2,Presynaptic congenital myasthenic syndromes ORPHA:98914,0.8922466888454011
BRSK2,Normosmic congenital hypogonadotropic hypogonadism ORPHA:432,0.8922466888454011
BRSK2,Autosomal dominant Charcot-Marie-Tooth disease type 2E ORPHA:99939,0.8922466888454011
BRSK2,Autosomal spastic paraplegia type 30 ORPHA:101010,0.8922466888454011
BRSK2,Charcot-Marie-Tooth disease type 1F ORPHA:101085,0.8922466888454011
BRSK2,Charcot-Marie-Tooth disease type 2B5 ORPHA:228374,0.8922466888454011
BRSK2,Classic progressive supranuclear palsy syndrome ORPHA:240071,0.8922466888454011
BRSK2,Huntington disease-like 2 ORPHA:98934,0.8922466888454011
BRSK2,KCNQ2-related epileptic encephalopathy ORPHA:439218,0.8922466888454011
BRSK2,Primary dystonia DYT2 type ORPHA:99657,0.8922466888454011
BRSK2,Progressive myoclonic epilepsy type 7 ORPHA:435438,0.8922466888454011
BRSK2,Progressive supranuclear palsy-corticobasal syndrome ORPHA:240103,0.8922466888454011
BRSK2,Progressive supranuclear palsy-parkinsonism syndrome ORPHA:240085,0.8922466888454011
BRSK2,Progressive supranuclear palsy-progressive non-fluent aphasia syndrome ORPHA:240112,0.8922466888454011
BRSK2,Progressive supranuclear palsy-pure akinesia with gait freezing syndrome ORPHA:240094,0.8922466888454011
BRSK2,Spinocerebellar ataxia type 42 ORPHA:458803,0.8922466888454011
BRSK2,Occipital pachygyria and polymicrogyria ORPHA:280640,0.8922466888454011
BRSK2,PEHO syndrome ORPHA:2836,0.8922466888454011
BRSK2,NON RARE IN EUROPE: Hereditary essential tremor ORPHA:862,0.8922466888454011
BRSK2,Dysequilibrium syndrome ORPHA:1766,0.8922466888454011
BRSK2,Childhood absence epilepsy ORPHA:64280,0.8922466888454011
BRSK2,Malignant migrating focal seizures of infancy ORPHA:293181,0.8953775799945711
BRSK2,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
BRSK2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
BRSK2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
BRSK2,Human gammaherpesvirus 8 ORF72,0.8999095837312036
BRSK2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
BRSK2,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
BRSK2,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
BRSK2,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
BRSK2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
BRSK2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
BRSK2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
BRSK2,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
BRSK2,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
BRSK2,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
BRSK2,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
BRSK2,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
BTN2A2,Encephalomyelitis,0.8019075543217649
BTN2A2,Schizophrenia,0.8067197998685076
BTN2A2,Cockayne Syndrome,0.8101097852323003
BTN2A2,Intelligence,0.9093740881835894
BTN2A2,Coronary heart disease,0.9119978323790848
BTN2A2,Xeroderma Pigmentosum,0.9377481698983606
BTN2A2,Autism Spectrum Disorders,0.9639249377588224
BTN2A2,Schizophrenia,0.7860378120955526
BTN2A2,Coronary Heart Disease,0.861756360478846
BTN2A2,Development Disorder,0.9726139569926774
BTN2A2,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
BTN2A2,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.8999095837312036
BTN2A2,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
BTN2A2,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
BTN2A2,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
BTN2A2,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
BTN2A2,Human mastadenovirus A E3 CR1-beta1,0.8999095837312036
BTN2A2,Human adenovirus 41 E3 31.6K,0.915880438522078
BTN2A2,Human adenovirus 18 CR1-beta protein (gene: E3),0.9197295331382644
BTN2A2,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9237501457186692
BTRC,Malignant neoplasm of breast,0.4084380369379369
BTRC,Adenomatous Polyposis Coli,0.5196624042573144
BTRC,Breast Carcinoma,0.7333611688795861
BTRC,Carcinogenesis,0.7333611688795861
BTRC,Malignant neoplasm of pancreas,0.7688485284765829
BTRC,Hepatoblastoma,0.7765852775619541
BTRC,Colorectal Carcinoma,0.7765852775619541
BTRC,Pancreatic carcinoma,0.7765852775619541
BTRC,Leukemia Myelocytic Acute,0.7765852775619541
BTRC,Lymphoma,0.7765852775619541
BTRC,Malignant neoplasm of lung,0.7880542567584415
BTRC,Liver carcinoma,0.7880542567584415
BTRC,Colorectal Cancer,0.7880542567584415
BTRC,Glioblastoma,0.7880542567584415
BTRC,Prostate carcinoma,0.7880542567584415
BTRC,Astrocytoma,0.7880542567584415
BTRC,Primary malignant neoplasm of lung,0.7880542567584415
BTRC,Neoplasm Metastasis,0.7880542567584415
BTRC,Carcinoma Endometrioid,0.7880542567584415
BTRC,Prostatic Neoplasms,0.7880542567584415
BTRC,Carcinoma of lung,0.7880542567584415
BTRC,Triple Negative Breast Neoplasms,0.7880542567584415
BTRC,Central neuroblastoma,0.7880542567584415
BTRC,melanoma,0.7880542567584415
BTRC,Ectrodactyly,0.7880542567584415
BTRC,Multiple Myeloma,0.7880542567584415
BTRC,Lung Neoplasms,0.7880542567584415
BTRC,Malignant neoplasm of stomach,0.7880542567584415
BTRC,Nasopharyngeal carcinoma,0.7880542567584415
BTRC,Syndactyly of fingers,0.7880542567584415
BTRC,Oligodactyly,0.7880542567584415
BTRC,Neuroectodermal Tumor Primitive,0.7880542567584415
BTRC,Stomach Carcinoma,0.7880542567584415
BTRC,Huntington Disease,0.7880542567584415
BTRC,Stomach Neoplasms,0.8044379824544406
BTRC,Colonic Neoplasms,0.8212681436603975
BTRC,Multiple tumors,0.8272008757995397
BTRC,Patent ductus arteriosus,0.8402911822757345
BTRC,Medulloblastoma,0.8548862007194026
BTRC,Papillary thyroid carcinoma,0.8757755363384367
BTRC,Ectrodactyly,0.7765582368651238
BTRC,Isolated Split Hand-Split Foot Malformation,0.7765582368651238
BTRC,Aniridia,0.7765582368651238
BTRC,Oligodactyly,0.8115918568696846
BTRC,Hearing Loss,0.8115918568696846
BTRC,Syndactyly Of Fingers,0.8903630091389316
BTRC,Atypical juvenile parkinsonism ORPHA:391411,0.5867963421058087
BTRC,Isolated split hand-split foot malformation ORPHA:2440,0.606625035400596
BTRC,Human respirovirus 3 phosphoprotein,0.8999095837312036
BTRC,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
BTRC,Yaba-like disease virus 141R protein (gene: 141R),0.8999095837312036
BTRC,Human immunodeficiency virus 2 vpx protein,0.8999095837312036
BTRC,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
BTRC,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
BTRC,Ectromelia virus ERPV hemagglutinin,0.8999095837312036
BTRC,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
BTRC,Vaccinia virus Ankara double-stranded RNA binding protein,0.9057542447893764
BTRC,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9237501457186692
C11ORF52,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
C11ORF52,Van der Woude syndrome ORPHA:888,0.1991445465001551
C11ORF52,Apparent mineralocorticoid excess ORPHA:320,0.1991445465001551
C11ORF52,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.1991445465001551
C11ORF52,Congenital intrauterine infection-like syndrome ORPHA:1229,0.1991445465001551
C11ORF52,Congenital tufting enteropathy ORPHA:92050,0.1991445465001551
C11ORF52,Isolated neonatal sclerosing cholangitis ORPHA:480556,0.1991445465001551
C11ORF52,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.1991445465001551
C11ORF52,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.1991445465001551
C11ORF52,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.1991445465001551
C11ORF52,Familial hypercholanemia ORPHA:238475,0.2047219337649946
C11ORF52,Cleft lip/palate ORPHA:199306,0.2567797333165013
C11ORF52,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3832844616405875
C11ORF52,Familial hyperprolactinemia ORPHA:397685,0.3832844616405875
C11ORF52,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3832844616405875
C11ORF52,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.3832844616405875
C11ORF52,Bifid uvula ORPHA:99771,0.3832844616405875
C11ORF52,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.3832844616405875
C11ORF52,Cleft hard palate ORPHA:101023,0.3832844616405875
C11ORF52,Cleft velum ORPHA:99772,0.3832844616405875
C11ORF52,Submucosal cleft palate ORPHA:155878,0.3832844616405875
C11ORF52,Alopecia-intellectual disability syndrome ORPHA:2850,0.3832844616405875
C11ORF52,NON RARE IN EUROPE: Hypodontia ORPHA:2227,0.4621817429362311
C11ORF52,Lethal acantholytic erosive disorder ORPHA:158687,0.5867963421058087
C11ORF52,Acute neonatal citrullinemia type I ORPHA:247546,0.5867963421058087
C11ORF52,Adult-onset citrullinemia type I ORPHA:247573,0.5867963421058087
C11ORF52,Bartsocas-Papas syndrome ORPHA:1234,0.5867963421058087
C11ORF52,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.5867963421058087
C11ORF52,CHAND syndrome ORPHA:1401,0.5867963421058087
C11ORF52,Carvajal syndrome ORPHA:65282,0.5867963421058087
C11ORF52,Cholangiocarcinoma ORPHA:70567,0.5867963421058087
C11ORF52,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.5867963421058087
C11ORF52,Low isolated anorectal malformation ORPHA:171215,0.5867963421058087
C11ORF52,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744,0.5867963421058087
C11ORF52,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.5867963421058087
C11ORF52,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.5867963421058087
C11ORF52,X-linked recessive ocular albinism ORPHA:54,0.5867963421058087
C11ORF52,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.5867963421058087
C11ORF52,Hereditary diffuse gastric cancer ORPHA:26106,0.5867963421058087
C11ORF52,Ollier disease ORPHA:296,0.5867963421058087
C11ORF52,Autosomal recessive distal renal tubular acidosis ORPHA:402041,0.7929682744768703
C11ORF52,Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937,0.7929682744768703
C11ORF52,Autosomal dominant brachyolmia ORPHA:93304,0.7929682744768703
C11ORF52,Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216,0.7929682744768703
C11ORF52,Autosomal recessive extra-oral halitosis ORPHA:562538,0.7929682744768703
C11ORF52,Congenital bile acid synthesis defect type 4 ORPHA:79095,0.7929682744768703
C11ORF52,Familial digital arthropathy-brachydactyly ORPHA:85169,0.7929682744768703
C11ORF52,Metatropic dysplasia ORPHA:2635,0.7929682744768703
C11ORF52,Naxos disease ORPHA:34217,0.7929682744768703
C11ORF52,Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382,0.7929682744768703
C11ORF52,Parastremmatic dwarfism ORPHA:2646,0.7929682744768703
C11ORF52,Scapuloperoneal spinal muscular atrophy ORPHA:431255,0.7929682744768703
C11ORF52,Spondyloepiphyseal dysplasia Maroteaux type ORPHA:263482,0.7929682744768703
C11ORF52,Spondylometaphyseal dysplasia Kozlowski type ORPHA:93314,0.7929682744768703
C11ORF52,Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992,0.7929682744768703
C11ORF52,3-hydroxy-3-methylglutaryl-CoA synthase deficiency ORPHA:35701,0.8922466888454011
C11ORF52,AA amyloidosis ORPHA:85445,0.8922466888454011
C11ORF52,Adenylosuccinate synthetase-like 1-related distal myopathy ORPHA:482601,0.8922466888454011
C11ORF52,Brain demyelination due to methionine adenosyltransferase deficiency ORPHA:168598,0.8922466888454011
C11ORF52,Isolated sulfite oxidase deficiency ORPHA:99731,0.8922466888454011
C11ORF52,Monoamine oxidase A deficiency ORPHA:3057,0.8922466888454011
C11ORF52,OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594,0.8922466888454011
C11ORF52,REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330,0.8922466888454011
C11ORF52,Maffucci syndrome ORPHA:163634,0.8922466888454011
C11ORF52,Pachydermoperiostosis ORPHA:2796,0.8922466888454011
C11ORF52,Bifunctional enzyme deficiency ORPHA:300,0.8922466888454011
C11ORF52,Kaposiform hemangioendothelioma ORPHA:2122,0.8922466888454011
C11ORF52,Tufted angioma ORPHA:1063,0.8922466888454011
C11ORF52,Hereditary methemoglobinemia ORPHA:621,0.8922466888454011
C17ORF99,Hemochromatosis type 3 ORPHA:225123,0.8922466888454011
C17ORF99,Rh deficiency syndrome ORPHA:71275,0.8922466888454011
C17ORF99,Classic congenital lipoid adrenal hyperplasia due to STAR deficency ORPHA:325524,0.8922466888454011
C17ORF99,Hyper-IgM syndrome type 2 ORPHA:101089,0.8922466888454011
C17ORF99,Non-classic congenital lipoid adrenal hyperplasia due to STAR deficency ORPHA:325529,0.8922466888454011
C2CD2L,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
C2CD2L,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
C2CD2L,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499,0.5867963421058087
C2CD2L,COG1-CDG ORPHA:263508,0.5867963421058087
C2CD2L,External auditory canal aplasia/hypoplasia ORPHA:141074,0.5867963421058087
C2CD2L,Pityriasis rubra pilaris ORPHA:2897,0.5867963421058087
C2CD2L,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.5867963421058087
CAMK2N2,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
CAMK2N2,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
CAMK2N2,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
CAMK2N2,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
CAMK2N2,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.1040670578681756
CAMK2N2,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.1040670578681756
CAMK2N2,MASA syndrome ORPHA:2466,0.1040670578681756
CAMK2N2,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.1040670578681756
CAMK2N2,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.1040670578681756
CAMK2N2,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.1068643725150898
CAMK2N2,Bilateral generalized polymicrogyria ORPHA:208447,0.1991445465001551
CAMK2N2,Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664,0.1991445465001551
CAMK2N2,Familial infantile myoclonic epilepsy ORPHA:352582,0.1991445465001551
CAMK2N2,Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406,0.1991445465001551
CAMK2N2,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570,0.3832844616405875
CAMK2N2,9q33.3q34.11 microdeletion syndrome ORPHA:495818,0.3832844616405875
CAMK2N2,Autosomal recessive dopa-responsive dystonia ORPHA:101150,0.5867963421058087
CAMK2N2,Autosomal recessive spastic paraplegia type 26 ORPHA:101006,0.5867963421058087
CAMK2N2,Mazabraud syndrome ORPHA:57782,0.5867963421058087
CAMK2N2,McCune-Albright syndrome ORPHA:562,0.5867963421058087
CAMK2N2,Monostotic fibrous dysplasia ORPHA:93277,0.5867963421058087
CAMK2N2,Polyostotic fibrous dysplasia ORPHA:93276,0.5867963421058087
CAMK2N2,Progressive myoclonic epilepsy type 8 ORPHA:424027,0.5867963421058087
CAMK2N2,Progressive osseous heteroplasia ORPHA:2762,0.5867963421058087
CAMK2N2,Pseudohypoparathyroidism type 1A ORPHA:79443,0.5867963421058087
CAMK2N2,Pseudohypoparathyroidism type 1C ORPHA:79444,0.5867963421058087
CAMK2N2,Pseudopseudohypoparathyroidism ORPHA:79445,0.5867963421058087
CAMK2N2,Right sided atrial isomerism ORPHA:97548,0.5867963421058087
CAMK2N2,Congenital fibrosis of extraocular muscles ORPHA:45358,0.5867963421058087
CAMK2N2,Myoclonus-dystonia syndrome ORPHA:36899,0.606625035400596
CAMK2N2,Anterior segment developmental anomaly ORPHA:88632,0.7929682744768703
CAMK2N2,Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944,0.7929682744768703
CAMK2N2,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097,0.7929682744768703
CAMK2N2,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055,0.7929682744768703
CAMK2N2,Charcot-Marie-Tooth disease type 2H ORPHA:101102,0.7929682744768703
CAMK2N2,Charcot-Marie-Tooth disease type 4A ORPHA:99948,0.7929682744768703
CAMK2N2,Congenital primary aphakia ORPHA:83461,0.7929682744768703
CAMK2N2,Mulibrey nanism ORPHA:2576,0.7929682744768703
CAMK2N2,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome ORPHA:231720,0.7929682744768703
CBL,Malignant neoplasm of breast,0.4084380369379369
CBL,Reticulocyte count (procedure),0.5071083164302358
CBL,Breast Carcinoma,0.7333611688795861
CBL,Carcinogenesis,0.7333611688795861
CBL,B-Cell Lymphomas,0.7333611688795861
CBL,leukemia,0.7333611688795861
CBL,Adenocarcinoma,0.750391252594775
CBL,Malignant neoplasm of pancreas,0.7688485284765829
CBL,Pancreatic carcinoma,0.7765852775619541
CBL,Gastrointestinal Stromal Tumors,0.7765852775619541
CBL,Leukemia Myelocytic Acute,0.7765852775619541
CBL,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CBL,Lymphoma,0.7765852775619541
CBL,Non-Small Cell Lung Carcinoma,0.7765852775619541
CBL,Refractory anemia without ringed sideroblasts without excess blasts,0.7765852775619541
CBL,Myelomonocytic leukemia,0.7765852775619541
CBL,Triangular face,0.7765852775619541
CBL,Vascular Diseases,0.7765852775619541
CBL,Glioma,0.7880542567584415
CBL,Malignant neoplasm of lung,0.7880542567584415
CBL,Myelodysplastic-Myeloproliferative Diseases,0.7880542567584415
CBL,Refractory anemias,0.7880542567584415
CBL,Mastocytosis Systemic,0.7880542567584415
CBL,Glioblastoma,0.7880542567584415
CBL,Frontal bossing,0.7880542567584415
CBL,Neoplasm Metastasis,0.7880542567584415
CBL,Bloom Syndrome,0.7880542567584415
CBL,Prostatic Neoplasms,0.7880542567584415
CBL,Squamous cell carcinoma of the head and neck,0.7880542567584415
CBL,Platelet Count measurement,0.7880542567584415
CBL,Turner Syndrome Male,0.7880542567584415
CBL,Hematologic Neoplasms,0.7880542567584415
CBL,Juvenile Myelomonocytic Leukemia,0.7880542567584415
CBL,Ewings sarcoma,0.7880542567584415
CBL,Malignant neoplasm of stomach,0.7880542567584415
CBL,Joint laxity,0.7880542567584415
CBL,Large auricle,0.7880542567584415
CBL,Large pinnae,0.7880542567584415
CBL,Macrotia,0.7880542567584415
CBL,Lymphocytosis,0.7880542567584415
CBL,Refractory anaemia with excess blasts,0.7880542567584415
CBL,Neuroepithelioma Peripheral,0.7880542567584415
CBL,Fine hair,0.7880542567584415
CBL,Lupus Erythematosus Systemic,0.7880542567584415
CBL,Monosomy,0.7880542567584415
CBL,secondary acute myeloid leukemia,0.7880542567584415
CBL,Abdominal Cryptorchidism,0.7880542567584415
CBL,Inguinal Cryptorchidism,0.7880542567584415
CBL,Acute leukemia,0.7880542567584415
CBL,Congenital chromosomal disease,0.7880542567584415
CBL,Platelet hematocrit measurement,0.7880542567584415
CBL,Acute lymphocytic leukemia,0.7880542567584415
CBL,Stomach Carcinoma,0.7880542567584415
CBL,Cognitive delay,0.7880542567584415
CBL,Polycythemia Vera,0.7880542567584415
CBL,Unilateral Cryptorchidism,0.7880542567584415
CBL,Core binding factor acute myeloid leukemia,0.7880542567584415
CBL,Jacobsen Distal 11q Deletion Syndrome,0.7880542567584415
CBL,Hyperglycemia,0.7880542567584415
CBL,Preleukemia,0.7880542567584415
CBL,Global developmental delay,0.7880542567584415
CBL,Thrombocytosis,0.7880542567584415
CBL,Vasculitis,0.7880542567584415
CBL,Myeloid Leukemia Chronic,0.7880542567584415
CBL,Mental and motor retardation,0.7880542567584415
CBL,Chronic myeloproliferative disorder,0.7945683314244791
CBL,Thrombocythemia Essential,0.8009048756462318
CBL,Noonan Syndrome,0.8019075543217649
CBL,Bilateral Cryptorchidism,0.8019075543217649
CBL,Acquired cubitus valgus,0.8019075543217649
CBL,Wide spaced nipples,0.8019075543217649
CBL,Child Development Disorders Specific,0.8019075543217649
CBL,Child Development Deviations,0.8019075543217649
CBL,Chronic Lymphocytic Leukemia,0.8019075543217649
CBL,Encephalomyelitis,0.8019075543217649
CBL,Posteriorly rotated ear,0.8026798872257774
CBL,Lupus Erythematosus,0.8067197998685076
CBL,Lymphoma T-Cell Cutaneous,0.8098851543361193
CBL,Lupus Erythematosus Discoid,0.8098851543361193
CBL,Blast Phase,0.8114747041691183
CBL,Myeloproliferative disease,0.8138488881521341
CBL,Depressed philtrum,0.8138488881521341
CBL,Gastrointestinal Neoplasms,0.8145035474981049
CBL,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
CBL,Deep philtrum,0.8145035474981049
CBL,Delayed speech and language development,0.8168901801930506
CBL,Overlap syndrome,0.8168901801930506
CBL,Downward slant of palpebral fissure,0.8168901801930506
CBL,Lupus Vulgaris,0.8232134984476662
CBL,Leukemia Myeloid Chronic Atypical BCR-ABL Negative,0.8270909867833504
CBL,Growth Disorders,0.8368219249856942
CBL,Human immunodeficiency virus type 2 [HIV-2] infection in conditions classified elsewhere and of unspecified site,0.8402911822757345
CBL,Systemic Scleroderma,0.8402911822757345
CBL,Speech impairment,0.8402911822757345
CBL,Mitral regurgitation mild,0.8402911822757345
CBL,Ewings sarcoma-primitive neuroectodermal tumor (PNET),0.8402911822757345
CBL,Isochromosomes,0.8402911822757345
CBL,Sparse hair,0.8402911822757345
CBL,Thin sparse hair,0.8402911822757345
CBL,Cryptorchidism,0.8402911822757345
CBL,Birthmark,0.8402911822757345
CBL,Language Delay,0.8402911822757345
CBL,Abetalipoproteinemia,0.8402911822757345
CBL,Cafe-au-Lait Spots,0.8402911822757345
CBL,Other specified transient cerebral ischemias,0.8402911822757345
CBL,Moyamoya disease 1,0.8402911822757345
CBL,Generalized hypotonia,0.843190898187174
CBL,Male sterility,0.843190898187174
CBL,Mitral Valve Insufficiency,0.843190898187174
CBL,Speech Delay,0.8474481237156937
CBL,Lymphoproliferative Disorders,0.8508164886128737
CBL,Neck webbing,0.8523465762428218
CBL,Moyamoya Disease,0.8554819098734854
CBL,Leukemia Myelomonocytic Chronic,0.8576420926340393
CBL,Bicuspid aortic valve,0.8578473133580928
CBL,Concave bridge of nose,0.8578473133580928
CBL,Depressed nasal root/bridge,0.8578473133580928
CBL,Depressed nasal bridge,0.8584283190330553
CBL,Range of joint movement increased,0.8584283190330553
CBL,Thick vermilion border,0.8610447277138289
CBL,Cardiac defects,0.8648405521677974
CBL,Low set ears,0.8700543109506378
CBL,Subfertility Male,0.8745234584149799
CBL,Primary Myelofibrosis,0.876210765330195
CBL,Transient Ischemic Attack,0.8816060628973529
CBL,Orbital separation excessive,0.8851456306720444
CBL,Congenital Epicanthus,0.8867509400747969
CBL,Pectus excavatum,0.8980854850210683
CBL,Cytopenia,0.9001392794088324
CBL,Congenital anemia,0.9015731019095328
CBL,Epileptic encephalopathy,0.917543617287358
CBL,Developmental Disabilities,0.929814249105729
CBL,Hydrops Fetalis,0.9390727893210336
CBL,Long philtrum,0.9459312971127588
CBL,Intellectual Disability,0.9478210444156088
CBL,Short neck,0.954882372756482
CBL,Aortic Valve Stenosis,0.957487573707278
CBL,Blepharoptosis,0.9770263358372888
CBL,Genetic Diseases Inborn,0.9926099929361648
CBL,Male infertility,0.9960101498067662
CBL,Hematologic Neoplasms,0.7765582368651238
CBL,Myelomonocytic Leukemia,0.7765582368651238
CBL,Systemic Mastocytosis,0.7765582368651238
CBL,Cubitus Valgus,0.7765582368651238
CBL,Myelodysplastic Syndrome,0.7765582368651238
CBL,Developmental Delay,0.7765582368651238
CBL,Leukemia,0.7765582368651238
CBL,Frontal Bossing,0.8115918568696846
CBL,Macrotia,0.8115918568696846
CBL,Vasculitis,0.8115918568696846
CBL,Noonan Syndrome,0.8115918568696846
CBL,Movement Disorders,0.829560580336605
CBL,Neck Webbing,0.8337953215113012
CBL,Mental Retardation,0.8337953215113012
CBL,Cryptorchidism,0.861756360478846
CBL,Aortic Valve Sclerosis,0.861756360478846
CBL,Posteriorly Rotated Ear,0.8903301324869451
CBL,Bicuspid Aortic Valve,0.9166047043368432
CBL,Development Disorder,0.9726139569926774
CBL,Dysmorphic Features,0.9726139569926774
CBL,Congenital Epicanthus,0.974502015052702
CBL,Ptosis,0.9832345076528324
CBL,Congenital Pectus Excavatum,0.9832345076528324
CBL,Acromelic frontonasal dysplasia ORPHA:1827,0.1040670578681756
CBL,Distal 22q11.2 microdeletion syndrome ORPHA:261330,0.3832844616405875
CBL,Dyschromatosis symmetrica hereditaria ORPHA:41,0.3832844616405875
CBL,Huntington disease ORPHA:399,0.3832844616405875
CBL,15q24 microdeletion syndrome ORPHA:94065,0.5867963421058087
CBL,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454,0.5867963421058087
CBL,SIN3A-related intellectual disability syndrome due to a point mutation ORPHA:500166,0.5867963421058087
CBL,Angiocentric glioma ORPHA:251671,0.5867963421058087
CBL,Juvenile myelomonocytic leukemia ORPHA:86834,0.6196505963261838
CBL,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency ORPHA:353284,0.7929682744768703
CBL,Temtamy preaxial brachydactyly syndrome ORPHA:363417,0.7929682744768703
CBL,Cardiofaciocutaneous syndrome ORPHA:1340,0.795266832401002
CBL,Aggressive systemic mastocytosis ORPHA:98850,0.8029813443753846
CBL,Acute myeloid leukemia with t(8,0.8922466888454011
CBL,16)(p11,0.8922466888454011
CBL,p13) translocation ORPHA:370026,0.8922466888454011
CBL,Chuvash erythrocytosis ORPHA:238557,0.8922466888454011
CBL,Noonan syndrome-like disorder with juvenile myelomonocytic leukemia ORPHA:363972,0.8922466888454011
CBL,Rubinstein-Taybi syndrome due to 16p13.3 microdeletion ORPHA:353281,0.8922466888454011
CBL,Rubinstein-Taybi syndrome due to CREBBP mutations ORPHA:353277,0.8922466888454011
CBL,Von Hippel-Lindau disease ORPHA:892,0.9025296114347576
CBL,Human T-lymphotropic virus 3 envelope (gene: env),0.8999095837312036
CBL,Human T-cell lymphotropic virus type 2b env,0.8999095837312036
CBL,Human T-lymphotropic virus 4 envelope glycoprotein (gene: env),0.8999095837312036
CBL,Human adenovirus 11+34 encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
CBL,Human adenovirus 34 maturation protein IVa2 (gene: IVa2),0.8999095837312036
CBL,Human adenovirus 35 IVa2,0.8999095837312036
CBL,Human T-lymphotropic virus 2 p21E envelope protein,0.8999095837312036
CBL,Human mastadenovirus B encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
CBL,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
CBL,Human T-cell leukemia virus type I gp46 SU (gene: env),0.8999095837312036
CBL,Human T-lymphotropic virus 2 hypothetical protein (env propeptide),0.8999095837312036
CBL,Rio Bravo virus anchored core protein C,0.8999095837312036
CBL,Human adenovirus 66 maturation protein IVA2 (gene: IVa2),0.8999095837312036
CBL,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
CBL,Human mastadenovirus E encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
CBL,Human adenovirus E4 protein IVa2,0.8999095837312036
CBL,Rio Bravo virus core protein C,0.8999095837312036
CBL,Modoc virus capsid protein,0.8999095837312036
CBL,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
CBL,Human adenovirus 3+7 maturation protein IVA2 (gene: IVa2),0.8999095837312036
CBL,Orf virus ORF057 putative protein-tyrosine phosphatase,0.8999095837312036
CBL,Reston ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
CBL,Human respirovirus 3 phosphoprotein,0.8999095837312036
CBL,Human adenovirus 54 pIVa2,0.8999095837312036
CBL,Human rhinovirus A20 2C,0.8999095837312036
CBL,Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147),0.8999095837312036
CBL,Human adenovirus D8 pIVa2 protein (gene: pIVa2),0.8999095837312036
CBL,Human parainfluenza virus 1 strain Washington/1964 phosphoprotein (gene: P),0.8999095837312036
CBL,Human respirovirus 1 phosphoprotein (gene: P),0.8999095837312036
CBL,Louping ill virus putative enchored capsid (core) protein,0.8999095837312036
CBL,Modoc virus anchored capsid protein,0.8999095837312036
CBL,Yellow fever virus core protein C,0.8999095837312036
CBL,Powassan virus anchored core protein C,0.8999095837312036
CBL,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
CBL,Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146),0.8999095837312036
CBL,Langat virus capsid protein,0.8999095837312036
CBL,Human T-cell leukemia virus type I p21 TM (gene: env),0.8999095837312036
CBL,Sudan ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
CBL,Sudan ebolavirus - Nakisamata structural glycoprotein (gene: GP),0.8999095837312036
CBL,Alkhumra hemorrhagic fever virus core protein C,0.8999095837312036
CBL,Alkhumra hemorrhagic fever virus anchored core protein C,0.8999095837312036
CBL,Powassan virus core protein C,0.8999095837312036
CBL,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
CBL,Orf virus ORF026 putative IMV redox protein,0.8999095837312036
CBL,Human immunodeficiency virus envelope glycoprotein (gene: env),0.8999095837312036
CBL,Vaccinia virus Ankara 72.4k ankyrin repeat protein f1,0.8999095837312036
CBL,Monkeypox virus ankyrin-like protein,0.8999095837312036
CBL,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.8999095837312036
CBL,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
CBL,Variola virus hypothetical protein (gene: D6L),0.8999095837312036
CBL,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
CBL,Human adenovirus 64 E3 48.9 kDa protein,0.8999095837312036
CBL,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
CBL,Norovirus GI/Hu/JP/2007/GI.P3_GI.3/Shimizu/KK2866 full_polyprotein 1..1799,0.9057542447893764
CBL,Ectromelia virus ERPV ankyrin,0.9057542447893764
CBL,Human adenovirus D37 48.9 kDa (gene: E3),0.9057542447893764
CBL,Horsepox virus HSPV033b (Ankyrin repeats),0.9057542447893764
CBL,Variola virus hypothetical protein (gene: G3R),0.9057542447893764
CBL,Orf virus ORF129 ankyrin repeat protein,0.9383505321091749
CBL,Cowpox virus CPXV006 protein (gene: CPXV006 CDS),0.9397923093369096
CBS,Malignant neoplasm of breast,0.4084380369379369
CBS,Adenomatous Polyposis Coli,0.5196624042573144
CBS,Breast Carcinoma,0.7333611688795861
CBS,Carcinogenesis,0.7333611688795861
CBS,Malignant neoplasm of ovary,0.7333611688795861
CBS,Cerebellar malformation,0.7333611688795861
CBS,leukemia,0.7333611688795861
CBS,Ovarian Carcinoma,0.7333611688795861
CBS,Reduced tensile strength of hair,0.7333611688795861
CBS,Fractured hair,0.7333611688795861
CBS,Fragile hair,0.7333611688795861
CBS,Brittle hair,0.7495999465637118
CBS,Reticulosarcoma,0.7765852775619541
CBS,Tall stature,0.7765852775619541
CBS,Colorectal Carcinoma,0.7765852775619541
CBS,Colon Carcinoma,0.7765852775619541
CBS,Leukemia Myelocytic Acute,0.7765852775619541
CBS,Malignant tumor of colon,0.7765852775619541
CBS,Arterial thrombosis,0.7765852775619541
CBS,Leukemogenesis,0.7765852775619541
CBS,Amblyopia,0.7765852775619541
CBS,Vascular Diseases,0.7765852775619541
CBS,Malignant neoplasm of lung,0.7880542567584415
CBS,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
CBS,Malignant neoplasm of prostate,0.7880542567584415
CBS,Low Grade Lymphoma (neoplasm),0.7880542567584415
CBS,Lymphoma Non-Hodgkin,0.7880542567584415
CBS,Liver carcinoma,0.7880542567584415
CBS,Mycoses,0.7880542567584415
CBS,Aneurysm Dissecting,0.7880542567584415
CBS,Thromboembolism,0.7880542567584415
CBS,Colorectal Cancer,0.7880542567584415
CBS,Epithelial ovarian cancer,0.7880542567584415
CBS,Glioblastoma,0.7880542567584415
CBS,Prostate carcinoma,0.7880542567584415
CBS,Primary malignant neoplasm of lung,0.7880542567584415
CBS,Neoplasm Metastasis,0.7880542567584415
CBS,Carcinoma of lung,0.7880542567584415
CBS,Squamous cell carcinoma of the head and neck,0.7880542567584415
CBS,Hyperhomocysteinemia,0.7880542567584415
CBS,Immunologic Deficiency Syndromes,0.7880542567584415
CBS,melanoma,0.7880542567584415
CBS,Multiple Myeloma,0.7880542567584415
CBS,Lung Neoplasms,0.7880542567584415
CBS,Neoplasms,0.7880542567584415
CBS,Selenium measurement,0.7880542567584415
CBS,Malignant neoplasm of stomach,0.7880542567584415
CBS,Sparse scalp hair,0.7880542567584415
CBS,Folic Acid Deficiency,0.7880542567584415
CBS,Increase in blood pressure,0.7880542567584415
CBS,Sinus Thrombosis Intracranial,0.7880542567584415
CBS,Abnormality of amino acid metabolism,0.7880542567584415
CBS,Embolism and Thrombosis,0.7880542567584415
CBS,Varying degree of multiple fractures,0.7880542567584415
CBS,Frequent fractures,0.7880542567584415
CBS,Increased fracture rate,0.7880542567584415
CBS,Fractures Multiple,0.7880542567584415
CBS,Vitamin B 6 Deficiency,0.7880542567584415
CBS,Generalized osteoporosis with pathologic fractures,0.7880542567584415
CBS,Coronary Arteriosclerosis,0.7880542567584415
CBS,Infant Premature,0.7880542567584415
CBS,Arteriosclerosis,0.7880542567584415
CBS,Atherosclerosis,0.7880542567584415
CBS,Alzheimer's Disease,0.7880542567584415
CBS,Acute lymphocytic leukemia,0.7880542567584415
CBS,Pulmonary Embolism,0.7880542567584415
CBS,Stomach Carcinoma,0.7880542567584415
CBS,High Grade Lymphoma (neoplasm),0.7880542567584415
CBS,Leishmaniasis New World,0.7880542567584415
CBS,Cardiovascular Diseases,0.7880542567584415
CBS,Neural Tube Defects,0.7880542567584415
CBS,Glaucoma,0.7880542567584415
CBS,Hypermethioninemia,0.7880542567584415
CBS,Demyelinating Diseases,0.7880542567584415
CBS,Diabetes,0.7880542567584415
CBS,Biconcave vertebral bodies,0.7880542567584415
CBS,Cancer Relapse,0.7880542567584415
CBS,Drug-induced depressive state,0.7880542567584415
CBS,Homocysteinemia,0.7880542567584415
CBS,Diabetes Mellitus,0.7880542567584415
CBS,Malignant hyperpyrexia due to anesthesia,0.7880542567584415
CBS,Huntington Disease,0.7880542567584415
CBS,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
CBS,Cystathionine beta-Synthase Deficiency Disease,0.7880542567584415
CBS,Disproportionate tall stature,0.7880542567584415
CBS,Lymphoma Diffuse,0.7880542567584415
CBS,Malignant neoplasm of colon stage IV,0.7908231553833205
CBS,Homocysteine measurement,0.7908231553833205
CBS,Renal Artery Stenosis,0.8019075543217649
CBS,Lymphoma Mixed-Cell,0.8019075543217649
CBS,Myocardial Infarction,0.8019075543217649
CBS,Diffuse Mixed-Cell Lymphoma,0.8019075543217649
CBS,Meningomyelocele,0.8019075543217649
CBS,Hepatic methionine adenosyltransferase deficiency,0.8019075543217649
CBS,Limitation of joint mobility,0.8019075543217649
CBS,Autistic Disorder,0.8019075543217649
CBS,Arachnodactyly,0.8019075543217649
CBS,Lymphoma Undifferentiated,0.8019075543217649
CBS,Lens dislocation,0.8019075543217649
CBS,Arteriopathic disease,0.8019075543217649
CBS,Liver neoplasms,0.8019075543217649
CBS,Lymphoma Intermediate-Grade,0.8019075543217649
CBS,Knee joint valgus deformity,0.8067197998685076
CBS,ovarian neoplasm,0.8067197998685076
CBS,Schizophrenia,0.8067197998685076
CBS,Ectopia Lentis,0.8098851543361193
CBS,Homocystinuria,0.8098851543361193
CBS,Personality Disorders,0.8098851543361193
CBS,Hypopigmentation disorder,0.8138488881521341
CBS,Inborn Errors of Metabolism,0.8138488881521341
CBS,Lymphoma Small Noncleaved-Cell,0.8138488881521341
CBS,Oral candidiasis,0.8145035474981049
CBS,Pancreatitis,0.8168901801930506
CBS,Congenital pectus carinatum,0.8168901801930506
CBS,Impaired cognition,0.8190761496232595
CBS,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CBS,Connective Tissue Diseases,0.8212681436603975
CBS,Thrombophilia,0.8232134984476662
CBS,Cognition Disorders,0.8270909867833504
CBS,Neurodegenerative Disorders,0.8272008757995397
CBS,Spina Bifida,0.8272008757995397
CBS,Meningioma benign no ICD-O subtype,0.8272008757995397
CBS,Venous Thrombosis,0.8363138748299018
CBS,Subarachnoid Hemorrhage,0.8402911822757345
CBS,Arterial Occlusive Diseases,0.8402911822757345
CBS,Curvature of spine,0.8402911822757345
CBS,Cardiac Arrest,0.8402911822757345
CBS,Adrenoleukodystrophy,0.8402911822757345
CBS,Peroxisomal Disorders,0.8402911822757345
CBS,Mental deficiency,0.8402911822757345
CBS,Steatohepatitis,0.8402911822757345
CBS,Aortic Aneurysm Thoracic,0.8402911822757345
CBS,Acquired scoliosis,0.8402911822757345
CBS,Endothelial dysfunction,0.8402911822757345
CBS,Down Syndrome,0.8420665668584452
CBS,Hypertensive disease,0.8474481237156937
CBS,Cutis marmorata,0.8486035047899471
CBS,Ehlers-Danlos Syndrome,0.8497448945325101
CBS,Central nervous system demyelination,0.8523465762428218
CBS,Premature coronary artery disease,0.8578473133580928
CBS,Deep Vein Thrombosis,0.8584283190330553
CBS,Fatty Liver,0.8628363180844141
CBS,Intracranial Aneurysm,0.8648405521677974
CBS,Cerebrovascular accident,0.8648405521677974
CBS,Joint stiffness,0.8648405521677974
CBS,Chronic Obstructive Airway Disease,0.8648405521677974
CBS,Tooth Crowding,0.8648405521677974
CBS,Tooth mass arch size discrepancy,0.8648405521677974
CBS,Tooth size discrepancy,0.8648405521677974
CBS,Congenital aneurysm of ascending aorta,0.8648405521677974
CBS,Inadequate arch length for tooth size,0.8648405521677974
CBS,Factor V Leiden mutation,0.8745234584149799
CBS,Acute Megakaryocytic Leukemias,0.8745234584149799
CBS,Dull intelligence,0.8757755363384367
CBS,Low intelligence,0.8757755363384367
CBS,Cataract,0.8769418330148872
CBS,Hernia Inguinal,0.8769418330148872
CBS,Mental Depression,0.8769418330148872
CBS,Mitral Valve Prolapse Syndrome,0.8774809019744603
CBS,Inflammatory Bowel Diseases,0.8815127642200768
CBS,Congenital arteriovenous malformation,0.8815127642200768
CBS,Coronary Artery Disease,0.887595340546704
CBS,Hyperactive behavior,0.8878860377518915
CBS,Poor school performance,0.8913141512402477
CBS,Meningioma,0.8973454964837912
CBS,Brain Ischemia,0.8980854850210683
CBS,Pectus excavatum,0.8980854850210683
CBS,Obesity,0.8989612563669234
CBS,Heart Diseases,0.8989612563669234
CBS,Bipolar Disorder,0.900167961295542
CBS,Frontotemporal dementia,0.9024758035783405
CBS,Cerebral Ischemia,0.9083161862856644
CBS,Congenital Heart Defects,0.9098977259629772
CBS,Depressive disorder,0.9103315000053974
CBS,Byzanthine arch palate,0.9119978323790848
CBS,Coronary heart disease,0.9119978323790848
CBS,Kyphoscoliosis deformity of spine,0.9146732238562176
CBS,Hyperkyphosis,0.9154499654632742
CBS,Septicemia,0.917543617287358
CBS,Malnutrition,0.9184153253162451
CBS,Sepsis,0.9189398569397552
CBS,Mental Retardation,0.922229272318747
CBS,Anemia Sickle Cell,0.9252532782268056
CBS,Kyphosis deformity of spine,0.9288355565549664
CBS,Renal Insufficiency,0.946564927793026
CBS,Intellectual Disability,0.9478210444156088
CBS,Seizures,0.9478210444156088
CBS,Myopia,0.9506863447189738
CBS,Congenital heart disease,0.9540608878641196
CBS,Pheochromocytoma,0.9557184806547836
CBS,Cerebral Infarction,0.9564633032157428
CBS,Epilepsy,0.963331724428282
CBS,Osteoporosis,0.9639249377588224
CBS,Malnutrition,0.6734982286750932
CBS,Hyperhomocysteinemia,0.7311975666200533
CBS,Stroke,0.7765582368651238
CBS,Melanoma,0.7765582368651238
CBS,Lens Subluxation,0.7765582368651238
CBS,Hypopigmentation Disorder,0.7765582368651238
CBS,Homocystinuria,0.7765582368651238
CBS,Psychosis,0.7765582368651238
CBS,Hypertension,0.7765582368651238
CBS,Retinal Detachment,0.7765582368651238
CBS,Developmental Delay,0.7765582368651238
CBS,Lymphoma,0.7765582368651238
CBS,Subcutaneous Hemorrhage,0.7765582368651238
CBS,Diffuse Lymphoma,0.7765582368651238
CBS,Personality Disorders,0.7765582368651238
CBS,Schizophrenia,0.7860378120955526
CBS,Anorexia,0.8091514409416879
CBS,Pancreatitis,0.8115918568696846
CBS,Optic Atrophy,0.8115918568696846
CBS,High Grade Lymphoma,0.8115918568696846
CBS,Intermediate Grade Lymphoma,0.8115918568696846
CBS,Low Grade Lymphoma,0.8115918568696846
CBS,Reticulosarcoma,0.8115918568696846
CBS,Hemiplegia/hemiparesis,0.8115918568696846
CBS,Esophageal Varix,0.8115918568696846
CBS,Ectopia Lentis,0.8210988731657684
CBS,Cutis Marmorata,0.831108575640545
CBS,Fatty Liver,0.8321692755697452
CBS,Mental Retardation,0.8337953215113012
CBS,Marfan Syndrome,0.8477374749042494
CBS,Non-Hodgkin Lymphoma,0.8611702959552964
CBS,Myocardial Infarction,0.861756360478846
CBS,Congenital Arteriovenous Malformation,0.861756360478846
CBS,Arachnodactyly,0.861756360478846
CBS,Osteoporosis,0.8903301324869451
CBS,Urticaria,0.8903301324869451
CBS,Thoracic Aortic Aneurysm And Aortic Dissection,0.8903630091389316
CBS,Glaucoma,0.8903630091389316
CBS,Mental Depression,0.8903630091389316
CBS,Congenital Pectus Carinatum,0.9024492468099392
CBS,Acquired Kyphoscoliosis,0.9145387439550552
CBS,Congenital Kyphoscoliosis,0.9147194468246628
CBS,Diabetes Mellitus,0.919442421650838
CBS,Scoliosis,0.924275664330454
CBS,Cardiovascular Diseases,0.924275664330454
CBS,Mitral Valve Prolapse,0.9318760199717074
CBS,Bipolar Disorder,0.943322675973118
CBS,High Palate,0.9578111936867284
CBS,Cataract,0.974502015052702
CBS,Myopia,0.9832345076528324
CBS,Congenital Pectus Excavatum,0.9832345076528324
CBS,Dyschromatosis universalis hereditaria ORPHA:241,0.3832844616405875
CBS,Familial pseudohyperkalemia ORPHA:90044,0.3832844616405875
CBS,Neu-Laxova syndrome ORPHA:2671,0.5867963421058087
CBS,3-phosphoglycerate dehydrogenase deficiency infantile/juvenile form ORPHA:79351,0.7929682744768703
CBS,Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333,0.7929682744768703
CBS,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354,0.7929682744768703
CBS,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361,0.7929682744768703
CBS,Atypical glycine encephalopathy ORPHA:289863,0.795266832401002
CBS,Infantile glycine encephalopathy ORPHA:289860,0.795266832401002
CBS,Classic homocystinuria ORPHA:394,0.8922466888454011
CBS,Neonatal glycine encephalopathy ORPHA:289857,0.8922466888454011
CCDC102A,Brachydactyly type B2 ORPHA:140908,0.3832844616405875
CCDC102A,Spondylo-ocular syndrome ORPHA:85194,0.3832844616405875
CCDC102A,Stapes ankylosis with broad thumbs and toes ORPHA:140917,0.3832844616405875
CCDC102A,Tarsal-carpal coalition syndrome ORPHA:1412,0.3832844616405875
CCDC102A,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.5867963421058087
CCDC102A,Caudal regression sequence ORPHA:3027,0.8922466888454011
CCK,Malignant neoplasm of breast,0.4084380369379369
CCK,Breast Carcinoma,0.7333611688795861
CCK,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CCK,Carcinogenesis,0.7333611688795861
CCK,Malignant neoplasm of ovary,0.7333611688795861
CCK,Ovarian Carcinoma,0.7333611688795861
CCK,Adenocarcinoma,0.750391252594775
CCK,Malignant neoplasm of pancreas,0.7688485284765829
CCK,Colorectal Carcinoma,0.7765852775619541
CCK,Pancreatic carcinoma,0.7765852775619541
CCK,Gastrointestinal Stromal Tumors,0.7765852775619541
CCK,Colon Carcinoma,0.7765852775619541
CCK,androgen independent prostate cancer,0.7765852775619541
CCK,Malignant tumor of colon,0.7765852775619541
CCK,Esophageal carcinoma,0.7765852775619541
CCK,Lymphoma,0.7765852775619541
CCK,Non-Small Cell Lung Carcinoma,0.7765852775619541
CCK,Hypercholesterolemia,0.7765852775619541
CCK,Pancreatic Neoplasm,0.7765852775619541
CCK,Cholera Infantum,0.7765852775619541
CCK,Pancreatic intraepithelial neoplasia,0.7765852775619541
CCK,Adenoma,0.7765852775619541
CCK,Intestinal Cancer,0.7765852775619541
CCK,Esophageal Neoplasms,0.7765852775619541
CCK,Glioma,0.7880542567584415
CCK,Malignant neoplasm of lung,0.7880542567584415
CCK,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
CCK,Malignant neoplasm of prostate,0.7880542567584415
CCK,Lymphoma Non-Hodgkin,0.7880542567584415
CCK,Biliary Tract Neoplasm,0.7880542567584415
CCK,Liver carcinoma,0.7880542567584415
CCK,Pancreatitis Alcoholic,0.7880542567584415
CCK,Malignant neoplasm of esophagus,0.7880542567584415
CCK,Osteosarcoma,0.7880542567584415
CCK,Thyroid carcinoma,0.7880542567584415
CCK,Cholelithiasis,0.7880542567584415
CCK,Colorectal Cancer,0.7880542567584415
CCK,Rhabdomyosarcoma,0.7880542567584415
CCK,Osteosarcoma of bone,0.7880542567584415
CCK,Prostate carcinoma,0.7880542567584415
CCK,Astrocytoma,0.7880542567584415
CCK,insulinoma,0.7880542567584415
CCK,Neoplasm Metastasis,0.7880542567584415
CCK,Functional Gastrointestinal Disorders,0.7880542567584415
CCK,Neuroepithelioma,0.7880542567584415
CCK,Neuroblastoma,0.7880542567584415
CCK,Lymphocytic infiltration,0.7880542567584415
CCK,Central neuroblastoma,0.7880542567584415
CCK,Malignant Neoplasms,0.7880542567584415
CCK,Ewings sarcoma,0.7880542567584415
CCK,Adenocarcinoma of pancreas,0.7880542567584415
CCK,Lung Neoplasms,0.7880542567584415
CCK,Gastrointestinal Diseases,0.7880542567584415
CCK,Neoplasms,0.7880542567584415
CCK,Gall Bladder Diseases,0.7880542567584415
CCK,Unconscious State,0.7880542567584415
CCK,Malignant neoplasm of stomach,0.7880542567584415
CCK,Mental disorders,0.7880542567584415
CCK,Myxoid cyst,0.7880542567584415
CCK,Abnormal behavior,0.7880542567584415
CCK,Brain Neoplasms,0.7880542567584415
CCK,Pancreatitis Chronic,0.7880542567584415
CCK,Nasopharyngeal carcinoma,0.7880542567584415
CCK,Sarcoma,0.7880542567584415
CCK,Primary Effusion Lymphoma,0.7880542567584415
CCK,Neuroectodermal Tumor Primitive,0.7880542567584415
CCK,Alzheimer's Disease,0.7880542567584415
CCK,Stomach Carcinoma,0.7880542567584415
CCK,Anorexia,0.7880542567584415
CCK,Round cell tumor,0.7880542567584415
CCK,Nicotine withdrawal,0.7880542567584415
CCK,Cholecystolithiasis,0.7880542567584415
CCK,Chronic constipation,0.7880542567584415
CCK,Diabetes Mellitus,0.7880542567584415
CCK,Biliary Tract Cancer,0.7880542567584415
CCK,Small cell carcinoma of lung,0.7880542567584415
CCK,Dyskinesia Medication-Induced,0.7880542567584415
CCK,Waxy flexibility,0.7880542567584415
CCK,Manic,0.7880542567584415
CCK,Dyskinesia Drug-Induced,0.7880542567584415
CCK,Alcohol Withdrawal Delirium,0.7908231553833205
CCK,AICARDI-GOUTIERES SYNDROME 1,0.8009048756462318
CCK,Panic Attacks,0.8009048756462318
CCK,Alcoholic Intoxication Chronic,0.8019075543217649
CCK,Teratocarcinoma,0.8019075543217649
CCK,Alcohol abuse,0.8019075543217649
CCK,Malignant neoplasm of gallbladder,0.8019075543217649
CCK,Physical Activity Measurement,0.8019075543217649
CCK,Catalepsy,0.8019075543217649
CCK,leiomyosarcoma,0.8026798872257774
CCK,Schizophrenia,0.8067197998685076
CCK,Carcinoma Small Cell,0.8098851543361193
CCK,Adenocarcinoma of lung (disorder),0.8098851543361193
CCK,Convulsions,0.8098851543361193
CCK,Herpes Simplex Infections,0.8098851543361193
CCK,Encephalopathy Toxic,0.8098851543361193
CCK,Toxic Encephalitis,0.8098851543361193
CCK,Hallucinations,0.8101097852323003
CCK,Liver diseases,0.8140222479282434
CCK,Other cataract,0.8145035474981049
CCK,Absence Seizures,0.8168901801930506
CCK,Pancreatitis,0.8168901801930506
CCK,Fever,0.8168901801930506
CCK,PANIC DISORDER 1,0.8168901801930506
CCK,Generalized seizures,0.8190761496232595
CCK,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CCK,Decrease in appetite,0.8190761496232595
CCK,Neurotoxicity Syndromes,0.8190761496232595
CCK,Seizures Focal,0.8190761496232595
CCK,Inflammation,0.8212681436603975
CCK,Hyperkinesia Generalized,0.8212681436603975
CCK,Gastric Adenocarcinoma,0.8232134984476662
CCK,Gallbladder Carcinoma,0.8232134984476662
CCK,Meningioma benign no ICD-O subtype,0.8272008757995397
CCK,Neurobehavioral Manifestations,0.834094492023826
CCK,Recurrent tumor,0.8368219249856942
CCK,Gastroesophageal reflux disease,0.8368219249856942
CCK,Panic Disorder,0.8402911822757345
CCK,Alcohol withdrawal syndrome,0.8402911822757345
CCK,Celiac Disease,0.8402911822757345
CCK,Liver Dysfunction,0.8402911822757345
CCK,Single Seizure,0.8402911822757345
CCK,Seizures Auditory,0.8402911822757345
CCK,Seizures Clonic,0.8402911822757345
CCK,Seizures Sensory,0.8402911822757345
CCK,Seizures Somatosensory,0.8402911822757345
CCK,Vertiginous seizure,0.8402911822757345
CCK,Atonic Absence Seizures,0.8402911822757345
CCK,Generalized Absence Seizures,0.8402911822757345
CCK,Gustatory seizure,0.8402911822757345
CCK,Jacksonian Seizure,0.8402911822757345
CCK,Non-epileptic convulsion,0.8402911822757345
CCK,Nonepileptic Seizures,0.8402911822757345
CCK,Olfactory seizure,0.8402911822757345
CCK,Epileptic Seizures,0.843190898187174
CCK,Tonic Seizures,0.8474481237156937
CCK,Convulsive Seizures,0.8578473133580928
CCK,Epileptic drop attack,0.8648405521677974
CCK,Tonic - clonic seizures,0.8648405521677974
CCK,Complex partial seizures,0.8648405521677974
CCK,Medullary carcinoma of thyroid,0.8757755363384367
CCK,gliosarcoma,0.8769418330148872
CCK,Parkinson Disease,0.8772392350816924
CCK,Body mass index,0.8867509400747969
CCK,Finding of body mass index,0.8867509400747969
CCK,Heart failure,0.8867509400747969
CCK,Neuroendocrine Tumors,0.887595340546704
CCK,Hyperactive behavior,0.8878860377518915
CCK,Meningioma,0.8973454964837912
CCK,Congestive heart failure,0.8976039441125321
CCK,Obesity,0.8989612563669234
CCK,Visual seizure,0.900167961295542
CCK,Bipolar Disorder,0.900167961295542
CCK,Myoclonic Seizures,0.914995991166204
CCK,Polycystic Ovary Syndrome,0.9174808175273056
CCK,Irritable Bowel Syndrome,0.9265708351135048
CCK,Gastric ulcer,0.929235785949896
CCK,Anxiety Disorders,0.946564927793026
CCK,Seizures,0.9478210444156088
CCK,Tumor Angiogenesis,0.9656926709728724
CCK,Anxiety,0.9708740267329932
CCK,Functional Gastrointestinal Disorders,0.7765582368651238
CCK,Gastrointestinal Diseases,0.7765582368651238
CCK,Dyskinesia,0.7765582368651238
CCK,Manic Disorder,0.7765582368651238
CCK,Catalepsy,0.7860378120955526
CCK,Schizophrenia,0.7860378120955526
CCK,Anorexia,0.8091514409416879
CCK,Pancreatitis,0.8115918568696846
CCK,Gastric Ulcer,0.8115918568696846
CCK,Hypotonic Seizures,0.8601151608808731
CCK,Seizure,0.861756360478846
CCK,Jacksonian Seizure,0.861756360478846
CCK,Clonic Seizures,0.8903301324869451
CCK,Autosomal recessive spastic paraplegia type 75 ORPHA:459056,0.8922466888454011
CCK,Craniosynostosis-microretrognathia-severe intellectual disability syndrome ORPHA:565858,0.8922466888454011
CCK,Gollop-Wolfgang complex ORPHA:1986,0.8922466888454011
CCK,Menstrual cycle-dependent periodic fever ORPHA:498251,0.8922466888454011
CCK,Mesoaxial synostotic syndactyly with phalangeal reduction ORPHA:157801,0.8922466888454011
CCK,Tibial aplasia-ectrodactyly syndrome ORPHA:3329,0.8922466888454011
CCNA2,Malignant neoplasm of breast,0.4084380369379369
CCNA2,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CCNA2,Breast Carcinoma,0.7333611688795861
CCNA2,Carcinogenesis,0.7333611688795861
CCNA2,Malignant neoplasm of ovary,0.7333611688795861
CCNA2,leukemia,0.7333611688795861
CCNA2,Ovarian Carcinoma,0.7333611688795861
CCNA2,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
CCNA2,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
CCNA2,Adenocarcinoma,0.750391252594775
CCNA2,Malignant neoplasm of pancreas,0.7688485284765829
CCNA2,Colorectal Carcinoma,0.7765852775619541
CCNA2,Pancreatic carcinoma,0.7765852775619541
CCNA2,Colon Carcinoma,0.7765852775619541
CCNA2,androgen independent prostate cancer,0.7765852775619541
CCNA2,Malignant tumor of colon,0.7765852775619541
CCNA2,Esophageal carcinoma,0.7765852775619541
CCNA2,Non-Small Cell Lung Carcinoma,0.7765852775619541
CCNA2,Colorectal Neoplasms,0.7765852775619541
CCNA2,Endometrial Carcinoma,0.7765852775619541
CCNA2,Esophageal Neoplasms,0.7765852775619541
CCNA2,Mammary Neoplasms,0.7880542567584415
CCNA2,Malignant neoplasm of lung,0.7880542567584415
CCNA2,Malignant neoplasm of prostate,0.7880542567584415
CCNA2,Liver carcinoma,0.7880542567584415
CCNA2,Invasive carcinoma of breast,0.7880542567584415
CCNA2,Malignant neoplasm of esophagus,0.7880542567584415
CCNA2,Osteosarcoma,0.7880542567584415
CCNA2,Acute Promyelocytic Leukemia,0.7880542567584415
CCNA2,Colorectal Cancer,0.7880542567584415
CCNA2,Vulval intraepithelial neoplasia,0.7880542567584415
CCNA2,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
CCNA2,Multiple malignancy,0.7880542567584415
CCNA2,Hepatocarcinogenesis,0.7880542567584415
CCNA2,Glioblastoma,0.7880542567584415
CCNA2,Osteosarcoma of bone,0.7880542567584415
CCNA2,Prostate carcinoma,0.7880542567584415
CCNA2,Neoplasm Metastasis,0.7880542567584415
CCNA2,Malignant neoplasm of liver,0.7880542567584415
CCNA2,Multiple Myeloma,0.7880542567584415
CCNA2,Retinal Diseases,0.7880542567584415
CCNA2,Primary Malignant Liver Neoplasm,0.7880542567584415
CCNA2,Malignant neoplasm of stomach,0.7880542567584415
CCNA2,Ganglioglioma,0.7880542567584415
CCNA2,Malformations of Cortical Development,0.7880542567584415
CCNA2,Adenocarcinoma of colon,0.7880542567584415
CCNA2,Renal Cell Carcinoma,0.7880542567584415
CCNA2,Coronary Arteriosclerosis,0.7880542567584415
CCNA2,Acute leukemia,0.7880542567584415
CCNA2,Arteriosclerosis,0.7880542567584415
CCNA2,Atherosclerosis,0.7880542567584415
CCNA2,Chondrosarcoma,0.7880542567584415
CCNA2,Stomach Carcinoma,0.7880542567584415
CCNA2,Early Hepatocellular Carcinoma,0.7880542567584415
CCNA2,Rheumatoid Arthritis,0.7880542567584415
CCNA2,Metaphyseal chondrodysplasia,0.7880542567584415
CCNA2,Sjogren's Syndrome,0.7880542567584415
CCNA2,Chronic inflammatory disorder,0.7880542567584415
CCNA2,PACHYONYCHIA CONGENITA 3,0.7880542567584415
CCNA2,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
CCNA2,Dejerine-Sottas Disease (disorder),0.7880542567584415
CCNA2,Hepatic necrosis,0.7880542567584415
CCNA2,Mental Retardation Psychosocial,0.7880542567584415
CCNA2,Ulcer,0.7880542567584415
CCNA2,Experimental Organism Basal Cell Carcinoma,0.8009048756462318
CCNA2,Liver Cirrhosis Experimental,0.8014900279306119
CCNA2,Profound Mental Retardation,0.8019075543217649
CCNA2,Psoriasis,0.8019075543217649
CCNA2,Myocardial Infarction,0.8019075543217649
CCNA2,Embryonal Carcinoma,0.8019075543217649
CCNA2,Liver neoplasms,0.8019075543217649
CCNA2,Stomach Neoplasms,0.8044379824544406
CCNA2,ovarian neoplasm,0.8067197998685076
CCNA2,Schizophrenia,0.8067197998685076
CCNA2,Herpes Simplex Infections,0.8098851543361193
CCNA2,Fibrosis,0.8145035474981049
CCNA2,Proliferative diabetic retinopathy,0.8145035474981049
CCNA2,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
CCNA2,Myocarditis,0.8190761496232595
CCNA2,Plexiform Neurofibroma,0.8270909867833504
CCNA2,DOSAGE-SENSITIVE SEX REVERSAL,0.8272008757995397
CCNA2,Fibrosis Liver,0.8272008757995397
CCNA2,Chronic leukemia (category),0.8272008757995397
CCNA2,Carcinoma Transitional Cell,0.8368219249856942
CCNA2,Systemic Scleroderma,0.8402911822757345
CCNA2,Mental deficiency,0.8402911822757345
CCNA2,Thymoma,0.8402911822757345
CCNA2,Hepatitis B,0.841396342333011
CCNA2,Restenosis,0.8508164886128737
CCNA2,Giant Cell Tumors,0.8554819098734854
CCNA2,Exanthema,0.8619324281003841
CCNA2,Myocardial Ischemia,0.8648405521677974
CCNA2,Retinopathy of Prematurity,0.8774809019744603
CCNA2,Neurofibromatosis 2,0.887595340546704
CCNA2,Hyperactive behavior,0.8878860377518915
CCNA2,Barrett Esophagus,0.8980854850210683
CCNA2,Heart Diseases,0.8989612563669234
CCNA2,Septicemia,0.917543617287358
CCNA2,Sepsis,0.9189398569397552
CCNA2,Idiopathic Pulmonary Fibrosis,0.9393256300017014
CCNA2,Mixed Salivary Gland Tumor,0.9401670107659288
CCNA2,Intellectual Disability,0.9478210444156088
CCNA2,Ischemic cardiomyopathy,0.94939825643792
CCNA2,Cardiomyopathies,0.9557184806547836
CCNA2,Endometriosis,0.960644037248553
CCNA2,Neurofibromatosis 1,0.9896536639644284
CCNA2,Carcinoma Of The Head And Neck,0.4532988396145482
CCNA2,Schizophrenia,0.7860378120955526
CCNA2,Mental Retardation,0.8337953215113012
CCNA2,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
CCNA2,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
CCNA2,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
CCNA2,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
CCNA2,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
CCNA2,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
CCNA2,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
CCNA2,Filippi syndrome ORPHA:3255,0.0155394890951578
CCNA2,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
CCNA2,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
CCNA2,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
CCNA2,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
CCNA2,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
CCNA2,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
CCNA2,Stromme syndrome ORPHA:506307,0.0155394890951578
CCNA2,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
CCNA2,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
CCNA2,Citrullinemia type II ORPHA:247585,0.0414176838632111
CCNA2,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
CCNA2,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
CCNA2,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
CCNA2,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
CCNA2,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
CCNA2,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
CCNA2,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
CCNA2,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
CCNA2,Small cell lung cancer ORPHA:70573,0.0429491792829903
CCNA2,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.1040670578681756
CCNA2,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1040670578681756
CCNA2,Hyper-IgM syndrome type 5 ORPHA:101092,0.1040670578681756
CCNA2,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.1040670578681756
CCNA2,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.1040670578681756
CCNA2,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.1040670578681756
CCNA2,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.1040670578681756
CCNA2,Hydrolethalus ORPHA:2189,0.1054066549396977
CCNA2,Dedifferentiated liposarcoma ORPHA:99970,0.1068643725150898
CCNA2,Well-differentiated liposarcoma ORPHA:99971,0.1068643725150898
CCNA2,46XX gonadal dysgenesis ORPHA:243,0.1419890644363008
CCNA2,46XY complete gonadal dysgenesis ORPHA:242,0.1479888965090844
CCNA2,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.1991445465001551
CCNA2,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.1991445465001551
CCNA2,Denys-Drash syndrome ORPHA:220,0.1991445465001551
CCNA2,Frasier syndrome ORPHA:347,0.1991445465001551
CCNA2,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.1991445465001551
CCNA2,Hereditary coproporphyria ORPHA:79273,0.1991445465001551
CCNA2,Jawad syndrome ORPHA:313795,0.1991445465001551
CCNA2,Meacham syndrome ORPHA:3097,0.1991445465001551
CCNA2,Linear nevus sebaceus syndrome ORPHA:2612,0.2047219337649946
CCNA2,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993,0.3832844616405875
CCNA2,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430,0.3832844616405875
CCNA2,Nephroblastoma ORPHA:654,0.4491081214880772
CCNA2,Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026,0.5867963421058087
CCNA2,Autosomal dominant spastic paraplegia type 13 ORPHA:100994,0.5867963421058087
CCNA2,Chudley-McCullough syndrome ORPHA:314597,0.5867963421058087
CCNA2,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288,0.5867963421058087
CCNA2,Primary peritoneal carcinoma ORPHA:168829,0.5867963421058087
CCNA2,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.5867963421058087
CCNA2,Muir-Torre syndrome ORPHA:587,0.5867963421058087
CCNA2,Osteosarcoma ORPHA:668,0.5867963421058087
CCNA2,Familial pancreatic carcinoma ORPHA:1333,0.6599133692748571
CCNA2,Fanconi anemia ORPHA:84,0.7593059616185558
CCNA2,Combined immunodeficiency with granulomatosis ORPHA:157949,0.7929682744768703
CCNA2,Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206,0.7929682744768703
CCNA2,Bloom syndrome ORPHA:125,0.7929682744768703
CCNA2,DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470,0.7929682744768703
CCNA2,Exercise-induced hyperinsulinism ORPHA:165991,0.7929682744768703
CCNA2,Ketoacidosis due to monocarboxylate transporter-1 deficiency ORPHA:438075,0.7929682744768703
CCNA2,Metabolic myopathy due to lactate transporter defect ORPHA:171690,0.7929682744768703
CCNA2,VACTERL with hydrocephalus ORPHA:3412,0.7929682744768703
CCNA2,ICF syndrome ORPHA:2268,0.795266832401002
CCNA2,Seckel syndrome ORPHA:808,0.8211968342881582
CCNA2,Autosomal recessive primary microcephaly ORPHA:2512,0.8922466888454011
CCNA2,Roberts syndrome ORPHA:3103,0.8922466888454011
CCNA2,Constitutional mismatch repair deficiency syndrome ORPHA:252202,0.8922466888454011
CCNA2,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCNA2,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
CCNA2,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
CCNA2,Provisional),0.8999095837312036
CCNA2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNA2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNA2,Human gammaherpesvirus 8 ORF72,0.8999095837312036
CCNA2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNA2,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNA2,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
CCNA2,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
CCNA2,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCNA2,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
CCNA2,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCNA2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CCNA2,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
CCNA2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CCNA2,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
CCNA2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNA2,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNA2,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNA2,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.8999095837312036
CCNA2,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNA2,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNA2,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNA2,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
CCNA2,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
CCNA2,Yaba-like disease virus 142R protein (gene: 142R),0.8999095837312036
CCNA2,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
CCNA2,Monkeypox virus ser/thr kinase,0.8999095837312036
CCNA2,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
CCNA2,Human papillomavirus type 53 early protein (gene: E7),0.8999095837312036
CCNA2,Banna virus strain JKT-6423 Vp7,0.8999095837312036
CCNA2,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCNA2,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
CCNA2,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
CCNA2,Variola virus hypothetical protein (gene: B1R),0.8999095837312036
CCNA2,Vaccinia virus Ankara serine/threonine-protein kinase-like,0.8999095837312036
CCNA2,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
CCNA2,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.8999095837312036
CCNA2,Vaccinia virus ser/thr kinase (gene: B1R),0.8999095837312036
CCNA2,Vaccinia virus Ankara Serine/threonine-protein kinase,0.8999095837312036
CCNA2,Monkeypox virus ser/thr protein kinase-like protein,0.8999095837312036
CCNA2,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.8999095837312036
CCNA2,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.8999095837312036
CCNA2,Yaba monkey tumor virus 142R,0.8999095837312036
CCNA2,Monkeypox virus Zaire-96-I-16 B11R (gene: B11R),0.8999095837312036
CCNA2,Human papillomavirus type 34 early protein (gene: E7),0.8999095837312036
CCNA2,Horsepox virus HSPV189 (Serine/threonine protein kinase),0.8999095837312036
CCNB1,Malignant neoplasm of breast,0.4084380369379369
CCNB1,Carcinoma of bladder,0.4084380369379369
CCNB1,Bladder Neoplasm,0.4084380369379369
CCNB1,Malignant neoplasm of urinary bladder,0.5071083164302358
CCNB1,Adenomatous Polyposis Coli,0.5196624042573144
CCNB1,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CCNB1,Breast Carcinoma,0.7333611688795861
CCNB1,Carcinogenesis,0.7333611688795861
CCNB1,Malignant neoplasm of ovary,0.7333611688795861
CCNB1,B-Cell Lymphomas,0.7333611688795861
CCNB1,leukemia,0.7333611688795861
CCNB1,Ovarian Carcinoma,0.7333611688795861
CCNB1,Colorectal Carcinoma,0.7765852775619541
CCNB1,Gastrointestinal Stromal Tumors,0.7765852775619541
CCNB1,Colon Carcinoma,0.7765852775619541
CCNB1,Leukemia Myelocytic Acute,0.7765852775619541
CCNB1,Malignant tumor of colon,0.7765852775619541
CCNB1,Esophageal carcinoma,0.7765852775619541
CCNB1,Cervix carcinoma,0.7765852775619541
CCNB1,Non-Small Cell Lung Carcinoma,0.7765852775619541
CCNB1,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CCNB1,Colorectal Neoplasms,0.7765852775619541
CCNB1,Endometrial Carcinoma,0.7765852775619541
CCNB1,Esophageal Neoplasms,0.7765852775619541
CCNB1,Malignant tumor of cervix,0.7768809924982332
CCNB1,Mammary Neoplasms,0.7880542567584415
CCNB1,Glioma,0.7880542567584415
CCNB1,Malignant neoplasm of lung,0.7880542567584415
CCNB1,Malignant neoplasm of prostate,0.7880542567584415
CCNB1,Promyelocytic leukemia,0.7880542567584415
CCNB1,Liver carcinoma,0.7880542567584415
CCNB1,Malignant neoplasm tonsil,0.7880542567584415
CCNB1,Malignant neoplasm of esophagus,0.7880542567584415
CCNB1,Malignant Head and Neck Neoplasm,0.7880542567584415
CCNB1,Osteosarcoma,0.7880542567584415
CCNB1,Acute Promyelocytic Leukemia,0.7880542567584415
CCNB1,Ataxia Telangiectasia,0.7880542567584415
CCNB1,Colorectal Cancer,0.7880542567584415
CCNB1,Epithelial ovarian cancer,0.7880542567584415
CCNB1,Tonsillar Carcinoma,0.7880542567584415
CCNB1,Vulval intraepithelial neoplasia,0.7880542567584415
CCNB1,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
CCNB1,Leukemia T-Cell,0.7880542567584415
CCNB1,Glioblastoma,0.7880542567584415
CCNB1,Osteosarcoma of bone,0.7880542567584415
CCNB1,Prostate carcinoma,0.7880542567584415
CCNB1,Embryonal Neoplasm,0.7880542567584415
CCNB1,Primary malignant neoplasm of lung,0.7880542567584415
CCNB1,cervical cancer,0.7880542567584415
CCNB1,Neoplasm Metastasis,0.7880542567584415
CCNB1,Epithelioma,0.7880542567584415
CCNB1,Prostatic Neoplasms,0.7880542567584415
CCNB1,Carcinoma of lung,0.7880542567584415
CCNB1,Malignant neoplasm of liver,0.7880542567584415
CCNB1,Neuroblastoma,0.7880542567584415
CCNB1,Central neuroblastoma,0.7880542567584415
CCNB1,melanoma,0.7880542567584415
CCNB1,Multiple Myeloma,0.7880542567584415
CCNB1,Adrenal Cortical Adenoma,0.7880542567584415
CCNB1,Malignant neoplasm of stomach,0.7880542567584415
CCNB1,Sclerocystic Ovaries,0.7880542567584415
CCNB1,Ganglioglioma,0.7880542567584415
CCNB1,Congenital contractural arachnodactyly,0.7880542567584415
CCNB1,Benign Prostatic Hyperplasia,0.7880542567584415
CCNB1,Malformations of Cortical Development,0.7880542567584415
CCNB1,Brain Neoplasms,0.7880542567584415
CCNB1,Nasopharyngeal carcinoma,0.7880542567584415
CCNB1,Esophageal Diseases,0.7880542567584415
CCNB1,Renal Cell Carcinoma,0.7880542567584415
CCNB1,Lymphoma Follicular,0.7880542567584415
CCNB1,Retinoblastoma,0.7880542567584415
CCNB1,Stomach Carcinoma,0.7880542567584415
CCNB1,CARCINOMA OF VULVA,0.7880542567584415
CCNB1,Fanconi Anemia,0.7880542567584415
CCNB1,Squamous cell carcinoma,0.7880542567584415
CCNB1,Rheumatoid Arthritis,0.7880542567584415
CCNB1,Tonsillitis,0.7880542567584415
CCNB1,Dejerine-Sottas Disease (disorder),0.7880542567584415
CCNB1,Squamous cell carcinoma of vulva,0.7908231553833205
CCNB1,HER2-positive carcinoma of breast,0.7908231553833205
CCNB1,Disruptive Impulse Control and Conduct Disorders,0.8019075543217649
CCNB1,Luminal A Breast Carcinoma,0.8019075543217649
CCNB1,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8019075543217649
CCNB1,Degenerative polyarthritis,0.8019075543217649
CCNB1,Type II Mucolipidosis,0.8019075543217649
CCNB1,HIV Infections,0.8145035474981049
CCNB1,Luminal B Breast Carcinoma,0.8190761496232595
CCNB1,Colonic Neoplasms,0.8212681436603975
CCNB1,Gastric Adenocarcinoma,0.8232134984476662
CCNB1,Malignant neoplasm of vulva,0.8232134984476662
CCNB1,DOSAGE-SENSITIVE SEX REVERSAL,0.8272008757995397
CCNB1,Glioblastoma Multiforme,0.8342163953428735
CCNB1,Cholangiocarcinoma,0.8402911822757345
CCNB1,Disease due to Parvoviridae,0.8402911822757345
CCNB1,Restenosis,0.8508164886128737
CCNB1,Medulloblastoma,0.8548862007194026
CCNB1,Squamous cell carcinoma of esophagus,0.8610447277138289
CCNB1,Choriocarcinoma,0.8769418330148872
CCNB1,Shigella Infections,0.8815127642200768
CCNB1,Aplasia Cutis Congenita,0.8911256045597441
CCNB1,Secondary malignant neoplasm of lymph node,0.900167961295542
CCNB1,Visual seizure,0.900167961295542
CCNB1,Polycystic Ovary Syndrome,0.9174808175273056
CCNB1,Pituitary Diseases,0.93156380601526
CCNB1,Endometriosis,0.960644037248553
CCNB1,Carcinoma Of The Head And Neck,0.4532988396145482
CCNB1,Sclerocystic Ovaries,0.7765582368651238
CCNB1,Liver Carcinoma,0.7765582368651238
CCNB1,Polycystic Ovary Syndrome,0.7765582368651238
CCNB1,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
CCNB1,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
CCNB1,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
CCNB1,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
CCNB1,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
CCNB1,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
CCNB1,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
CCNB1,Currarino syndrome ORPHA:1552,0.0155394890951578
CCNB1,Filippi syndrome ORPHA:3255,0.0155394890951578
CCNB1,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
CCNB1,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
CCNB1,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
CCNB1,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
CCNB1,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
CCNB1,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
CCNB1,Stromme syndrome ORPHA:506307,0.0155394890951578
CCNB1,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
CCNB1,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
CCNB1,Citrullinemia type II ORPHA:247585,0.0414176838632111
CCNB1,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
CCNB1,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
CCNB1,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
CCNB1,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
CCNB1,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
CCNB1,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
CCNB1,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
CCNB1,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
CCNB1,Small cell lung cancer ORPHA:70573,0.0429491792829903
CCNB1,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1040670578681756
CCNB1,Hyper-IgM syndrome type 5 ORPHA:101092,0.1040670578681756
CCNB1,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.1040670578681756
CCNB1,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.1040670578681756
CCNB1,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.1040670578681756
CCNB1,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.1040670578681756
CCNB1,Hydrolethalus ORPHA:2189,0.1054066549396977
CCNB1,Dedifferentiated liposarcoma ORPHA:99970,0.1068643725150898
CCNB1,Well-differentiated liposarcoma ORPHA:99971,0.1068643725150898
CCNB1,46XX gonadal dysgenesis ORPHA:243,0.1419890644363008
CCNB1,46XY complete gonadal dysgenesis ORPHA:242,0.1479888965090844
CCNB1,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.1991445465001551
CCNB1,Autosomal recessive cutis laxa type 2B ORPHA:357064,0.1991445465001551
CCNB1,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.1991445465001551
CCNB1,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.1991445465001551
CCNB1,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.1991445465001551
CCNB1,Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664,0.1991445465001551
CCNB1,Jawad syndrome ORPHA:313795,0.1991445465001551
CCNB1,PYCR1-related De Barsy syndrome ORPHA:293633,0.1991445465001551
CCNB1,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.1991445465001551
CCNB1,Linear nevus sebaceus syndrome ORPHA:2612,0.2047219337649946
CCNB1,Familial congenital mirror movements ORPHA:238722,0.2120485863056726
CCNB1,Autosomal recessive spastic paraplegia type 62 ORPHA:401785,0.3832844616405875
CCNB1,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993,0.3832844616405875
CCNB1,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430,0.3832844616405875
CCNB1,Neu-Laxova syndrome ORPHA:2671,0.5867963421058087
CCNB1,Acquired partial lipodystrophy ORPHA:79087,0.5867963421058087
CCNB1,Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026,0.5867963421058087
CCNB1,Autosomal dominant spastic paraplegia type 13 ORPHA:100994,0.5867963421058087
CCNB1,Charcot-Marie-Tooth disease type 4B1 ORPHA:99955,0.5867963421058087
CCNB1,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288,0.5867963421058087
CCNB1,Progressive myoclonic epilepsy type 9 ORPHA:457265,0.5867963421058087
CCNB1,Muir-Torre syndrome ORPHA:587,0.5867963421058087
CCNB1,3-phosphoglycerate dehydrogenase deficiency infantile/juvenile form ORPHA:79351,0.7929682744768703
CCNB1,ALDH18A1-related De Barsy syndrome ORPHA:35664,0.7929682744768703
CCNB1,ALG8-CDG ORPHA:79325,0.7929682744768703
CCNB1,Autosomal dominant spastic paraplegia type 9A ORPHA:447753,0.7929682744768703
CCNB1,Autosomal dominant spastic paraplegia type 9B ORPHA:447757,0.7929682744768703
CCNB1,Autosomal recessive spastic paraplegia type 9B ORPHA:447760,0.7929682744768703
CCNB1,Exercise-induced hyperinsulinism ORPHA:165991,0.7929682744768703
CCNB1,Familial clubfoot due to 5q31 microdeletion ORPHA:293144,0.7929682744768703
CCNB1,Familial clubfoot due to PITX1 point mutation ORPHA:293150,0.7929682744768703
CCNB1,Ketoacidosis due to monocarboxylate transporter-1 deficiency ORPHA:438075,0.7929682744768703
CCNB1,Metabolic myopathy due to lactate transporter defect ORPHA:171690,0.7929682744768703
CCNB1,Mirror-image polydactyly ORPHA:498494,0.7929682744768703
CCNB1,S-adenosylhomocysteine hydrolase deficiency ORPHA:88618,0.7929682744768703
CCNB1,STT3A-CDG ORPHA:370921,0.7929682744768703
CCNB1,Brachydactyly-elbow wrist dysplasia syndrome ORPHA:1275,0.7929682744768703
CCNB1,Familial isolated congenital asplenia ORPHA:101351,0.7929682744768703
CCNB1,Geroderma osteodysplastica ORPHA:2078,0.7929682744768703
CCNB1,Autosomal recessive Kenny-Caffey syndrome ORPHA:93324,0.8922466888454011
CCNB1,Brain calcification Rajab type ORPHA:178506,0.8922466888454011
CCNB1,Combined immunodeficiency due to TFRC deficiency ORPHA:476113,0.8922466888454011
CCNB1,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome ORPHA:496756,0.8922466888454011
CCNB1,Phosphoserine aminotransferase deficiency infantile/juvenile form ORPHA:284417,0.8922466888454011
CCNB1,Sanjad-Sakati syndrome ORPHA:2323,0.8922466888454011
CCNB1,Autosomal dominant Charcot-Marie-Tooth disease type 2D ORPHA:99938,0.8922466888454011
CCNB1,Cardiomyopathy-hypotonia-lactic acidosis syndrome ORPHA:91130,0.8922466888454011
CCNB1,RARS-related autosomal recessive hypomyelinating leukodystrophy ORPHA:438114,0.8922466888454011
CCNB1,Triose phosphate-isomerase deficiency ORPHA:868,0.8922466888454011
CCNB1,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCNB1,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
CCNB1,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
CCNB1,Provisional),0.8999095837312036
CCNB1,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB1,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB1,Human gammaherpesvirus 8 ORF72,0.8999095837312036
CCNB1,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB1,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNB1,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
CCNB1,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
CCNB1,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCNB1,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
CCNB1,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCNB1,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CCNB1,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
CCNB1,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CCNB1,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
CCNB1,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB1,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB1,Human papillomavirus 122 transforming protein E7 (gene: E7),0.8999095837312036
CCNB1,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNB1,Human papillomavirus 111 E7 protein (gene: E7),0.8999095837312036
CCNB1,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.8999095837312036
CCNB1,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNB1,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNB1,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNB1,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
CCNB1,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
CCNB1,Yaba-like disease virus 142R protein (gene: 142R),0.8999095837312036
CCNB1,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
CCNB1,Human papillomavirus 159 E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 81 E7 protein (gene: E7),0.8999095837312036
CCNB1,Monkeypox virus ser/thr kinase,0.8999095837312036
CCNB1,Human papillomavirus type 62 putative transforming protein E7 (gene: E7),0.8999095837312036
CCNB1,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
CCNB1,Human papillomavirus type 53 early protein (gene: E7),0.8999095837312036
CCNB1,Banna virus strain JKT-6423 Vp7,0.8999095837312036
CCNB1,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCNB1,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
CCNB1,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
CCNB1,Human papillomavirus 113 E7 protein (gene: E7),0.8999095837312036
CCNB1,Variola virus hypothetical protein (gene: B1R),0.8999095837312036
CCNB1,Vaccinia virus Ankara serine/threonine-protein kinase-like,0.8999095837312036
CCNB1,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
CCNB1,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.8999095837312036
CCNB1,Vaccinia virus ser/thr kinase (gene: B1R),0.8999095837312036
CCNB1,Vaccinia virus Ankara Serine/threonine-protein kinase,0.8999095837312036
CCNB1,Human papillomavirus 9 early protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 97 E7 protein,0.8999095837312036
CCNB1,Monkeypox virus ser/thr protein kinase-like protein,0.8999095837312036
CCNB1,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.8999095837312036
CCNB1,Alphapapillomavirus 7 E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 18 E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 59 ORF putative E7,0.8999095837312036
CCNB1,Human papillomavirus type 39 E7 (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 54 transforming protein (gene: E7),0.8999095837312036
CCNB1,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.8999095837312036
CCNB1,Yaba monkey tumor virus 142R,0.8999095837312036
CCNB1,Monkeypox virus Zaire-96-I-16 B11R (gene: B11R),0.8999095837312036
CCNB1,Human papillomavirus 110 E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 34 early protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 45 early protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 68 E7 (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 26 early protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 82 E7,0.8999095837312036
CCNB1,Human papillomavirus 104 E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 49 E7 protein (gene: E7),0.8999095837312036
CCNB1,Mupapillomavirus 1 E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 67 E7,0.8999095837312036
CCNB1,Human papillomavirus 15 early protein (gene: E7),0.8999095837312036
CCNB1,Horsepox virus HSPV189 (Serine/threonine protein kinase),0.8999095837312036
CCNB1,Human papillomavirus type 68b E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus 17 early protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 32 early protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 69 E7,0.8999095837312036
CCNB1,Human papillomavirus type 68a E7 protein,0.8999095837312036
CCNB1,Human papillomavirus type 30 early protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus FA75/KI88-03 E7 protein (gene: E7),0.8999095837312036
CCNB1,Human papillomavirus type 16 transforming protein (gene: E7),0.8999095837312036
CCNB1,Orf virus ORF130 putative serine/threonine protein kinase,0.8999095837312036
CCNB1,Human papillomavirus 107 E7 protein (gene: E7),0.8999095837312036
CCNB1,Vaccinia virus ser/thr protein kinase-like protein (gene: B12R),0.8999095837312036
CCNB1,Human papillomavirus type 52 early protein (gene: E7),0.9057542447893764
CCNB2,Malignant neoplasm of breast,0.4084380369379369
CCNB2,Carcinoma of bladder,0.4084380369379369
CCNB2,Bladder Neoplasm,0.4084380369379369
CCNB2,Malignant neoplasm of urinary bladder,0.5071083164302358
CCNB2,Breast Carcinoma,0.7333611688795861
CCNB2,Carcinogenesis,0.7333611688795861
CCNB2,Adenocarcinoma,0.750391252594775
CCNB2,Laryngeal Squamous Cell Carcinoma,0.7765852775619541
CCNB2,Non-Small Cell Lung Carcinoma,0.7765852775619541
CCNB2,Adenoma,0.7765852775619541
CCNB2,Glioma,0.7880542567584415
CCNB2,Malignant neoplasm of lung,0.7880542567584415
CCNB2,Ataxia Telangiectasia,0.7880542567584415
CCNB2,Primary malignant neoplasm of lung,0.7880542567584415
CCNB2,Neoplasm Metastasis,0.7880542567584415
CCNB2,Carcinoma of lung,0.7880542567584415
CCNB2,Lung Neoplasms,0.7880542567584415
CCNB2,Squamous cell carcinoma,0.7880542567584415
CCNB2,invasive cancer,0.7880542567584415
CCNB2,Liver Cirrhosis Experimental,0.8014900279306119
CCNB2,Adenocarcinoma of lung (disorder),0.8098851543361193
CCNB2,Pituitary Adenoma,0.834094492023826
CCNB2,Pituitary Neoplasms,0.8368219249856942
CCNB2,Liver Carcinoma,0.7765582368651238
CCNB2,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
CCNB2,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
CCNB2,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
CCNB2,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
CCNB2,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
CCNB2,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
CCNB2,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
CCNB2,Currarino syndrome ORPHA:1552,0.0155394890951578
CCNB2,Filippi syndrome ORPHA:3255,0.0155394890951578
CCNB2,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
CCNB2,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
CCNB2,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
CCNB2,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
CCNB2,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
CCNB2,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
CCNB2,Stromme syndrome ORPHA:506307,0.0155394890951578
CCNB2,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
CCNB2,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
CCNB2,Citrullinemia type II ORPHA:247585,0.0414176838632111
CCNB2,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
CCNB2,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
CCNB2,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
CCNB2,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
CCNB2,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
CCNB2,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
CCNB2,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
CCNB2,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
CCNB2,Small cell lung cancer ORPHA:70573,0.0429491792829903
CCNB2,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.1040670578681756
CCNB2,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1040670578681756
CCNB2,Hyper-IgM syndrome type 5 ORPHA:101092,0.1040670578681756
CCNB2,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.1040670578681756
CCNB2,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.1040670578681756
CCNB2,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.1040670578681756
CCNB2,Hydrolethalus ORPHA:2189,0.1054066549396977
CCNB2,Dedifferentiated liposarcoma ORPHA:99970,0.1068643725150898
CCNB2,Well-differentiated liposarcoma ORPHA:99971,0.1068643725150898
CCNB2,46XY complete gonadal dysgenesis ORPHA:242,0.1479888965090844
CCNB2,Autosomal recessive cutis laxa type 2B ORPHA:357064,0.1991445465001551
CCNB2,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.1991445465001551
CCNB2,Denys-Drash syndrome ORPHA:220,0.1991445465001551
CCNB2,Frasier syndrome ORPHA:347,0.1991445465001551
CCNB2,Jawad syndrome ORPHA:313795,0.1991445465001551
CCNB2,Meacham syndrome ORPHA:3097,0.1991445465001551
CCNB2,PYCR1-related De Barsy syndrome ORPHA:293633,0.1991445465001551
CCNB2,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.1991445465001551
CCNB2,Familial prostate cancer ORPHA:1331,0.2844858212863536
CCNB2,Autosomal recessive spastic paraplegia type 62 ORPHA:401785,0.3832844616405875
CCNB2,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993,0.3832844616405875
CCNB2,Li-Fraumeni syndrome ORPHA:524,0.3891940933600213
CCNB2,Nephroblastoma ORPHA:654,0.4491081214880772
CCNB2,Chudley-McCullough syndrome ORPHA:314597,0.5867963421058087
CCNB2,Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030,0.5867963421058087
CCNB2,Osteosarcoma ORPHA:668,0.5867963421058087
CCNB2,Fanconi anemia ORPHA:84,0.7593059616185558
CCNB2,Adrenocortical carcinoma ORPHA:1501,0.7929682744768703
CCNB2,Choroid plexus carcinoma ORPHA:251899,0.7929682744768703
CCNB2,Papilloma of choroid plexus ORPHA:2807,0.7929682744768703
CCNB2,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCNB2,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
CCNB2,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
CCNB2,Provisional),0.8999095837312036
CCNB2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB2,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
CCNB2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CCNB2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CCNB2,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
CCNB2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB2,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNB2,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
CCNB2,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
CCND3,Malignant neoplasm of breast,0.4084380369379369
CCND3,Carcinoma of bladder,0.4084380369379369
CCND3,Bladder Neoplasm,0.4084380369379369
CCND3,Malignant neoplasm of urinary bladder,0.5071083164302358
CCND3,Reticulocyte count (procedure),0.5071083164302358
CCND3,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CCND3,Breast Carcinoma,0.7333611688795861
CCND3,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CCND3,Carcinogenesis,0.7333611688795861
CCND3,B-Cell Lymphomas,0.7333611688795861
CCND3,leukemia,0.7333611688795861
CCND3,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
CCND3,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
CCND3,Adenocarcinoma,0.750391252594775
CCND3,Malignant neoplasm of pancreas,0.7688485284765829
CCND3,Colorectal Carcinoma,0.7765852775619541
CCND3,Pancreatic carcinoma,0.7765852775619541
CCND3,Laryngeal Squamous Cell Carcinoma,0.7765852775619541
CCND3,Gastrointestinal Stromal Tumors,0.7765852775619541
CCND3,Leukemia Myelocytic Acute,0.7765852775619541
CCND3,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CCND3,Lymphoma,0.7765852775619541
CCND3,Endometrial Neoplasms,0.7765852775619541
CCND3,Non-Small Cell Lung Carcinoma,0.7765852775619541
CCND3,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CCND3,Adenoma,0.7765852775619541
CCND3,Thyroid Neoplasm,0.7765852775619541
CCND3,Endometrial Carcinoma,0.7765852775619541
CCND3,Mammary Neoplasms,0.7880542567584415
CCND3,Glioma,0.7880542567584415
CCND3,Malignant neoplasm of lung,0.7880542567584415
CCND3,Malignant neoplasm of prostate,0.7880542567584415
CCND3,Refractory anemias,0.7880542567584415
CCND3,Lymphoma Non-Hodgkin,0.7880542567584415
CCND3,Liver carcinoma,0.7880542567584415
CCND3,Osteosarcoma,0.7880542567584415
CCND3,Thyroid carcinoma,0.7880542567584415
CCND3,Colorectal Cancer,0.7880542567584415
CCND3,T-Cell Lymphoma,0.7880542567584415
CCND3,Glioblastoma,0.7880542567584415
CCND3,Osteosarcoma of bone,0.7880542567584415
CCND3,Prostate carcinoma,0.7880542567584415
CCND3,Primary malignant neoplasm of lung,0.7880542567584415
CCND3,insulinoma,0.7880542567584415
CCND3,Acute myelomonocytic leukemia,0.7880542567584415
CCND3,Prostatic Neoplasms,0.7880542567584415
CCND3,Monoclonal Gammopathy of Undetermined Significance,0.7880542567584415
CCND3,Carcinoma of lung,0.7880542567584415
CCND3,Red Blood Cell Count measurement,0.7880542567584415
CCND3,Monocyte count procedure,0.7880542567584415
CCND3,Monocyte count result,0.7880542567584415
CCND3,Malignant Neoplasms,0.7880542567584415
CCND3,melanoma,0.7880542567584415
CCND3,Ewings sarcoma,0.7880542567584415
CCND3,Multiple Myeloma,0.7880542567584415
CCND3,Gastric lymphoma,0.7880542567584415
CCND3,High density lipoprotein measurement,0.7880542567584415
CCND3,Burkitt Lymphoma,0.7880542567584415
CCND3,Childhood T Acute Lymphoblastic Leukemia,0.7880542567584415
CCND3,Mean corpuscular hemoglobin concentration determination,0.7880542567584415
CCND3,Tumor Progression,0.7880542567584415
CCND3,Sarcoma,0.7880542567584415
CCND3,Lymphoma Follicular,0.7880542567584415
CCND3,Retinoblastoma,0.7880542567584415
CCND3,Mean Corpuscular Volume (result),0.7880542567584415
CCND3,Squamous cell carcinoma,0.7880542567584415
CCND3,Rheumatoid Arthritis,0.7880542567584415
CCND3,Familial Partial Lipodystrophy Type 2,0.7880542567584415
CCND3,Crohn Disease,0.7880542567584415
CCND3,Myeloid Leukemia Chronic,0.7880542567584415
CCND3,Smoldering myeloma,0.7880542567584415
CCND3,Malignant Glioma,0.7880542567584415
CCND3,Hemoglobin measurement,0.7880542567584415
CCND3,Secondary malignant neoplasm of liver,0.7908231553833205
CCND3,Adult Non-Hodgkin Lymphoma,0.7908231553833205
CCND3,Red cell distribution width determination,0.8019075543217649
CCND3,Waldenstrom Macroglobulinemia,0.8019075543217649
CCND3,RDW - Red blood cell distribution width result,0.8019075543217649
CCND3,Childhood Non-Hodgkin Lymphoma,0.8019075543217649
CCND3,Malignant lymphoma - lymphoplasmacytic,0.8019075543217649
CCND3,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
CCND3,Endometrial Hyperplasia,0.8145035474981049
CCND3,Salivary duct carcinoma,0.8145035474981049
CCND3,Paresis,0.8642802827048847
CCND3,Inflammatory Bowel Diseases,0.8815127642200768
CCND3,Muscle Weakness,0.9512505437112568
CCND3,Lymphoblastic Leukemia,0.7765582368651238
CCND3,Malignant Neoplasm,0.8115918568696846
CCND3,Inflammatory Bowel Disease,0.861756360478846
CCND3,Crohn Disease,0.8903630091389316
CCND3,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
CCND3,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
CCND3,Incontinentia pigmenti ORPHA:464,0.0414176838632111
CCND3,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
CCND3,Camurati-Engelmann disease ORPHA:1328,0.1991445465001551
CCND3,Infantile inflammatory bowel disease with neurological involvement ORPHA:565788,0.1991445465001551
CCND3,Stormorken-Sjaastad-Langslet syndrome ORPHA:3204,0.1991445465001551
CCND3,Dehydrated hereditary stomatocytosis ORPHA:3202,0.2047219337649946
CCND3,Brachydactyly type B2 ORPHA:140908,0.3832844616405875
CCND3,Hermansky-Pudlak syndrome type 8 ORPHA:231537,0.3832844616405875
CCND3,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ORPHA:480864,0.3832844616405875
CCND3,Stapes ankylosis with broad thumbs and toes ORPHA:140917,0.3832844616405875
CCND3,Tarsal-carpal coalition syndrome ORPHA:1412,0.3832844616405875
CCND3,Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428,0.5867963421058087
CCND3,Becker nevus syndrome ORPHA:64755,0.7929682744768703
CCND3,Developmental malformations-deafness-dystonia syndrome ORPHA:79107,0.7929682744768703
CCND3,Congenital erythropoietic porphyria ORPHA:79277,0.7929682744768703
CCND3,Bleeding diathesis due to thromboxane synthesis deficiency ORPHA:220443,0.8922466888454011
CCND3,Primary familial polycythemia ORPHA:90042,0.8922466888454011
CCND3,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCND3,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
CCND3,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
CCND3,Provisional),0.8999095837312036
CCND3,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCND3,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCND3,Human gammaherpesvirus 8 ORF72,0.8999095837312036
CCND3,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCND3,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCND3,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
CCND3,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
CCND3,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCND3,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
CCND3,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCND3,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CCND3,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
CCND3,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CCND3,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
CCND3,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCND3,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCND3,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCND3,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.8999095837312036
CCND3,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCND3,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCND3,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCND3,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
CCND3,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
CCND3,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
CCND3,Monkeypox virus ser/thr kinase,0.8999095837312036
CCND3,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
CCND3,Banna virus strain JKT-6423 Vp7,0.8999095837312036
CCND3,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCND3,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
CCND3,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
CCND3,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
CCNE1,Malignant neoplasm of breast,0.4084380369379369
CCNE1,Carcinoma of bladder,0.4084380369379369
CCNE1,Bladder Neoplasm,0.4084380369379369
CCNE1,Malignant neoplasm of urinary bladder,0.5071083164302358
CCNE1,Adenomatous Polyposis Coli,0.5196624042573144
CCNE1,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CCNE1,Breast Carcinoma,0.7333611688795861
CCNE1,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CCNE1,Carcinogenesis,0.7333611688795861
CCNE1,Malignant neoplasm of ovary,0.7333611688795861
CCNE1,B-Cell Lymphomas,0.7333611688795861
CCNE1,leukemia,0.7333611688795861
CCNE1,Ovarian Carcinoma,0.7333611688795861
CCNE1,Adenocarcinoma,0.750391252594775
CCNE1,Colorectal Carcinoma,0.7765852775619541
CCNE1,Leukemogenesis,0.7765852775619541
CCNE1,Non-Small Cell Lung Carcinoma,0.7765852775619541
CCNE1,Pancreatic Neoplasm,0.7765852775619541
CCNE1,Carcinoma breast stage IV,0.7765852775619541
CCNE1,Adenoma,0.7765852775619541
CCNE1,Thyroid Neoplasm,0.7765852775619541
CCNE1,Endometrial Carcinoma,0.7765852775619541
CCNE1,Mammary Neoplasms,0.7880542567584415
CCNE1,Glioma,0.7880542567584415
CCNE1,Liver carcinoma,0.7880542567584415
CCNE1,Osteosarcoma,0.7880542567584415
CCNE1,Colorectal Cancer,0.7880542567584415
CCNE1,Epithelial ovarian cancer,0.7880542567584415
CCNE1,Glioblastoma,0.7880542567584415
CCNE1,Osteosarcoma of bone,0.7880542567584415
CCNE1,Disease Exacerbation,0.7880542567584415
CCNE1,Neoplasm Metastasis,0.7880542567584415
CCNE1,Carcinoma Endometrioid,0.7880542567584415
CCNE1,Neuroblastoma,0.7880542567584415
CCNE1,Central neuroblastoma,0.7880542567584415
CCNE1,Malignant Neoplasms,0.7880542567584415
CCNE1,Multiple Myeloma,0.7880542567584415
CCNE1,Lung Neoplasms,0.7880542567584415
CCNE1,Malignant neoplasm of stomach,0.7880542567584415
CCNE1,Adult Hepatocellular Carcinoma,0.7880542567584415
CCNE1,Tumor Progression,0.7880542567584415
CCNE1,Sarcoma,0.7880542567584415
CCNE1,Retinoblastoma,0.7880542567584415
CCNE1,Congenital chromosomal disease,0.7880542567584415
CCNE1,Stomach Carcinoma,0.7880542567584415
CCNE1,Fanconi Anemia,0.7880542567584415
CCNE1,Squamous cell carcinoma,0.7880542567584415
CCNE1,Classical Hodgkin's Lymphoma,0.7880542567584415
CCNE1,Carcinoid Tumor,0.7880542567584415
CCNE1,Fallopian Tube Carcinoma,0.7908231553833205
CCNE1,ovarian neoplasm,0.8067197998685076
CCNE1,Fibrosis,0.8145035474981049
CCNE1,Neoplasm of uncertain or unknown behavior of ovary,0.8232134984476662
CCNE1,Fibrosis Liver,0.8272008757995397
CCNE1,Carcinoma Transitional Cell,0.8368219249856942
CCNE1,Medullomyoblastoma,0.8402911822757345
CCNE1,Melanotic medulloblastoma,0.8402911822757345
CCNE1,Hypertensive disease,0.8474481237156937
CCNE1,Medulloblastoma,0.8548862007194026
CCNE1,Desmoplastic Medulloblastoma,0.8584283190330553
CCNE1,Squamous cell carcinoma of esophagus,0.8610447277138289
CCNE1,Malignant neoplasm of endometrium,0.8769418330148872
CCNE1,Uterine Corpus Cancer,0.8771562273432176
CCNE1,Adult Medulloblastoma,0.8774809019744603
CCNE1,Inflammatory Bowel Diseases,0.8815127642200768
CCNE1,Mammary Neoplasms Human,0.8815127642200768
CCNE1,Neuroendocrine Tumors,0.887595340546704
CCNE1,Secondary malignant neoplasm of lymph node,0.900167961295542
CCNE1,Cystadenocarcinoma Serous,0.9154499654632742
CCNE1,Childhood Medulloblastoma,0.9262273158806068
CCNE1,Urothelial Carcinoma,0.9441119274323576
CCNE1,Carcinoma Of The Head And Neck,0.4532988396145482
CCNE1,Ovarian Neoplasm,0.7765582368651238
CCNE1,Liver Carcinoma,0.7765582368651238
CCNE1,Ovarian Carcinoma,0.7765582368651238
CCNE1,Ovarian Cancer,0.7797212851906329
CCNE1,Bladder Neoplasm,0.8115918568696846
CCNE1,Urinary Bladder Cancer,0.8115918568696846
CCNE1,Malignant Neoplasm,0.8115918568696846
CCNE1,Mammary Neoplasms,0.8165359516083085
CCNE1,Marfan Syndrome,0.8477374749042494
CCNE1,Medullomyoblastoma,0.861756360478846
CCNE1,Breast Cancer,0.8903630091389316
CCNE1,Medulloblastoma,0.9024492468099392
CCNE1,Breast Carcinoma,0.9398381935810408
CCNE1,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
CCNE1,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
CCNE1,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
CCNE1,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
CCNE1,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
CCNE1,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.1040670578681756
CCNE1,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.1991445465001551
CCNE1,Hereditary coproporphyria ORPHA:79273,0.1991445465001551
CCNE1,Athabaskan brainstem dysgenesis syndrome ORPHA:69739,0.5867963421058087
CCNE1,Bosley-Salih-Alorainy syndrome ORPHA:69737,0.5867963421058087
CCNE1,Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893,0.7929682744768703
CCNE1,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCNE1,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
CCNE1,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
CCNE1,Provisional),0.8999095837312036
CCNE1,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNE1,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNE1,Human gammaherpesvirus 8 ORF72,0.8999095837312036
CCNE1,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNE1,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNE1,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
CCNE1,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
CCNE1,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCNE1,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
CCNE1,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CCNE1,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CCNE1,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
CCNE1,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CCNE1,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
CCNE1,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNE1,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CCNE1,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNE1,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.8999095837312036
CCNE1,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNE1,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNE1,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CCNE1,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
CCNE1,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
CCNE1,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
CCNE1,Monkeypox virus ser/thr kinase,0.8999095837312036
CCNE1,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
CCNE1,Banna virus strain JKT-6423 Vp7,0.8999095837312036
CCNE1,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CCNE1,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
CCNE1,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
CCNE1,Variola virus hypothetical protein (gene: B1R),0.8999095837312036
CCNE1,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
CCNE1,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.8999095837312036
CCP110,Malignant neoplasm of lung,0.7880542567584415
CCP110,Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement,0.7880542567584415
CCP110,Primary malignant neoplasm of lung,0.7880542567584415
CCP110,Carcinoma of lung,0.7880542567584415
CCP110,Chronic myeloproliferative disorder,0.7945683314244791
CCP110,Myeloproliferative disease,0.8138488881521341
CCP110,Multiple Chronic Conditions,0.882453254162044
CCP110,Vocal cord and pharyngeal distal myopathy ORPHA:600,0.3832844616405875
CCP110,Non-specific syndromic intellectual disability ORPHA:528084,0.5867963421058087
CCP110,Angiocentric glioma ORPHA:251671,0.5867963421058087
CCP110,Joubert syndrome with ocular defect ORPHA:220493,0.606625035400596
CCP110,Joubert syndrome with Jeune asphyxiating thoracic dystrophy ORPHA:397715,0.7929682744768703
CCP110,Autosomal recessive spastic paraplegia type 54 ORPHA:320380,0.7929682744768703
CCP110,Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065,0.7929682744768703
CCP110,Short rib-polydactyly syndrome Majewski type ORPHA:93269,0.7929682744768703
CCP110,Jeune syndrome ORPHA:474,0.8105918570729571
CCP110,Joubert syndrome ORPHA:475,0.8922466888454011
CCP110,Short rib-polydactyly syndrome Beemer-Langer type ORPHA:93268,0.8922466888454011
CCP110,Senior-Loken syndrome ORPHA:3156,0.8922466888454011
CCP110,Retinitis pigmentosa ORPHA:791,0.8922466888454011
CCP110,Orofaciodigital syndrome type 2 ORPHA:2751,0.8922466888454011
CCP110,Spastic paraplegia-severe developmental delay-epilepsy syndrome ORPHA:464282,0.8922466888454011
CD14,Malignant neoplasm of breast,0.4084380369379369
CD14,Carcinoma of bladder,0.4084380369379369
CD14,Bladder Neoplasm,0.4084380369379369
CD14,Malignant neoplasm of urinary bladder,0.5071083164302358
CD14,Breast Carcinoma,0.7333611688795861
CD14,Carcinogenesis,0.7333611688795861
CD14,Thromboangiitis Obliterans,0.7333611688795861
CD14,B-Cell Lymphomas,0.7333611688795861
CD14,leukemia,0.7333611688795861
CD14,Malignant neoplasm of pancreas,0.7688485284765829
CD14,Asymptomatic human immunodeficiency virus infection,0.7765852775619541
CD14,Colorectal Carcinoma,0.7765852775619541
CD14,Pancreatic carcinoma,0.7765852775619541
CD14,Leukemia Myelocytic Acute,0.7765852775619541
CD14,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CD14,Lymphoma,0.7765852775619541
CD14,Non-Small Cell Lung Carcinoma,0.7765852775619541
CD14,Hypercholesterolemia,0.7765852775619541
CD14,Colorectal Neoplasms,0.7765852775619541
CD14,Acute asthma,0.7765852775619541
CD14,Adenoma,0.7765852775619541
CD14,Vascular Diseases,0.7765852775619541
CD14,Lymphoma Extranodal NK-T-Cell,0.7765852775619541
CD14,Mammary Neoplasms,0.7880542567584415
CD14,Monocytic leukemia,0.7880542567584415
CD14,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
CD14,Chronic Fatigue Syndrome,0.7880542567584415
CD14,Malignant neoplasm of prostate,0.7880542567584415
CD14,stage non-small cell lung cancer,0.7880542567584415
CD14,Lymphoma Non-Hodgkin,0.7880542567584415
CD14,IMMUNE SUPPRESSION,0.7880542567584415
CD14,Liver carcinoma,0.7880542567584415
CD14,Pancreatitis Alcoholic,0.7880542567584415
CD14,Osteosarcoma,0.7880542567584415
CD14,Acute Promyelocytic Leukemia,0.7880542567584415
CD14,Colorectal Cancer,0.7880542567584415
CD14,Chronic heart failure,0.7880542567584415
CD14,Glioblastoma,0.7880542567584415
CD14,Osteosarcoma of bone,0.7880542567584415
CD14,Prostate carcinoma,0.7880542567584415
CD14,Nephroblastoma,0.7880542567584415
CD14,Sudden infant death syndrome,0.7880542567584415
CD14,Neoplasm Metastasis,0.7880542567584415
CD14,Prion Diseases,0.7880542567584415
CD14,Acute myelomonocytic leukemia,0.7880542567584415
CD14,Peptic Ulcer,0.7880542567584415
CD14,Prostatic Neoplasms,0.7880542567584415
CD14,Acute Myeloid Leukemia M1,0.7880542567584415
CD14,Mesothelioma,0.7880542567584415
CD14,Neuroblastoma,0.7880542567584415
CD14,Choroideremia,0.7880542567584415
CD14,Multiple Myeloma,0.7880542567584415
CD14,Mycoplasma Infections,0.7880542567584415
CD14,Dysgerminoma,0.7880542567584415
CD14,Refractory cytopenia with multilineage dysplasia,0.7880542567584415
CD14,Campylobacter jejuni infection,0.7880542567584415
CD14,Malignant neoplasm of stomach,0.7880542567584415
CD14,Diarrhea,0.7880542567584415
CD14,Recurrent upper respiratory tract infection,0.7880542567584415
CD14,Histiocytic sarcoma,0.7880542567584415
CD14,Congenital contractural arachnodactyly,0.7880542567584415
CD14,Giant Cell Tumor of Bone,0.7880542567584415
CD14,Invasive Ductal Breast Carcinoma,0.7880542567584415
CD14,Traveler's diarrhea,0.7880542567584415
CD14,Very Low Birth Weight,0.7880542567584415
CD14,Pancreatitis Chronic,0.7880542567584415
CD14,M5b Acute differentiated monocytic leukemia,0.7880542567584415
CD14,pricking of skin,0.7880542567584415
CD14,Infection caused by Helicobacter pylori,0.7880542567584415
CD14,Status Asthmaticus,0.7880542567584415
CD14,Childhood nephrotic syndrome,0.7880542567584415
CD14,Corneal infection,0.7880542567584415
CD14,Food Allergy,0.7880542567584415
CD14,Gram-Negative Bacterial Infections,0.7880542567584415
CD14,Lupus Erythematosus Systemic,0.7880542567584415
CD14,Gout,0.7880542567584415
CD14,Renal Cell Carcinoma,0.7880542567584415
CD14,secondary acute myeloid leukemia,0.7880542567584415
CD14,Acquired Immunodeficiency Syndrome,0.7880542567584415
CD14,heavy drinking,0.7880542567584415
CD14,Gangrene,0.7880542567584415
CD14,Invasive meningococcal disease,0.7880542567584415
CD14,Coronary Arteriosclerosis,0.7880542567584415
CD14,Acute leukemia,0.7880542567584415
CD14,Infant Premature,0.7880542567584415
CD14,Arteriosclerosis,0.7880542567584415
CD14,Atherosclerosis,0.7880542567584415
CD14,Alzheimer's Disease,0.7880542567584415
CD14,Periodontitis,0.7880542567584415
CD14,TNF receptor-associated periodic fever syndrome (TRAPS),0.7880542567584415
CD14,Acute lymphocytic leukemia,0.7880542567584415
CD14,Burning Mouth Syndrome,0.7880542567584415
CD14,Choledochal Cyst,0.7880542567584415
CD14,Leukemic Infiltration,0.7880542567584415
CD14,Stomach Carcinoma,0.7880542567584415
CD14,Immediate hypersensitivity,0.7880542567584415
CD14,Autoimmune Diseases,0.7880542567584415
CD14,Juvenile psoriatic arthritis,0.7880542567584415
CD14,Hepatitis C,0.7880542567584415
CD14,Acute myocardial infarction,0.7880542567584415
CD14,Cardiovascular Diseases,0.7880542567584415
CD14,Age-related cataract,0.7880542567584415
CD14,Immune Reconstitution Inflammatory Syndrome,0.7880542567584415
CD14,Acute periodontitis,0.7880542567584415
CD14,Rheumatoid Arthritis,0.7880542567584415
CD14,Juvenile-Onset Still Disease,0.7880542567584415
CD14,Coronary Occlusion,0.7880542567584415
CD14,Genital ulcers,0.7880542567584415
CD14,Coinfection,0.7880542567584415
CD14,Airway Obstruction,0.7880542567584415
CD14,Ankylosing spondylitis,0.7880542567584415
CD14,Uveitis,0.7880542567584415
CD14,Septicaemia due to gram-negative organism unspecified,0.7880542567584415
CD14,Bacterial sepsis,0.7880542567584415
CD14,Malignant histiocytosis,0.7880542567584415
CD14,Patent ductus arteriosus - persisting type,0.7880542567584415
CD14,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.7880542567584415
CD14,Sjogren's Syndrome,0.7880542567584415
CD14,Periodontitis Juvenile,0.7880542567584415
CD14,Severe periodontitis,0.7880542567584415
CD14,Crohn Disease,0.7880542567584415
CD14,Myelodysplasia,0.7880542567584415
CD14,Multiple Organ Failure,0.7880542567584415
CD14,Nasal allergies,0.7880542567584415
CD14,Non-ST Elevated Myocardial Infarction,0.7880542567584415
CD14,Cholestasis,0.7880542567584415
CD14,Cytomegalovirus Infections,0.7880542567584415
CD14,Virus Diseases,0.7880542567584415
CD14,Myeloid Leukemia Chronic,0.7880542567584415
CD14,Myeloid Leukemia,0.7880542567584415
CD14,Osteoporosis Postmenopausal,0.7880542567584415
CD14,Bacterial Infections,0.7908231553833205
CD14,Peri-Implantitis,0.7908231553833205
CD14,Juvenile arthritis,0.8009048756462318
CD14,Hemangioma,0.8009048756462318
CD14,Jaundice Obstructive,0.8009048756462318
CD14,Eczema Herpeticum,0.8009048756462318
CD14,Pouchitis,0.8009048756462318
CD14,IGA Glomerulonephritis,0.8019075543217649
CD14,Hyperinsulinism,0.8019075543217649
CD14,Chronic Periodontitis,0.8019075543217649
CD14,Allergic disposition,0.8019075543217649
CD14,Primary Sj??gren's syndrome,0.8019075543217649
CD14,Alcohol abuse,0.8019075543217649
CD14,Cerebral atrophy,0.8019075543217649
CD14,Multiple Sclerosis,0.8019075543217649
CD14,Pneumonitis,0.8019075543217649
CD14,Psoriasis,0.8019075543217649
CD14,Myocardial Infarction,0.8019075543217649
CD14,Superficial spreading malignant melanoma of skin,0.8019075543217649
CD14,Tumor Necrosis Factor Receptor 1-Associated Periodic Syndrome,0.8019075543217649
CD14,Decreased Concentration,0.8019075543217649
CD14,Systemic Inflammatory Response Syndrome,0.8019075543217649
CD14,Paroxysmal nocturnal hemoglobinuria,0.8019075543217649
CD14,Signs and Symptoms Respiratory,0.8019075543217649
CD14,Chronic Lymphocytic Leukemia,0.8019075543217649
CD14,Synovitis,0.8019075543217649
CD14,Infectious disease of lung,0.8019075543217649
CD14,Degenerative polyarthritis,0.8019075543217649
CD14,Gingival Diseases,0.8026798872257774
CD14,Acute Coronary Syndrome,0.8037546774788534
CD14,Histiocytosis Langerhans-Cell,0.8067197998685076
CD14,Lupus Erythematosus,0.8067197998685076
CD14,Nonalcoholic Steatohepatitis,0.8067197998685076
CD14,Melioidosis,0.8067197998685076
CD14,Angina Unstable,0.8067197998685076
CD14,Respiratory Tract Infections,0.8067197998685076
CD14,Brain Injuries Focal,0.8067197998685076
CD14,Chromosome 8 trisomy,0.8067197998685076
CD14,Injuries Acute Brain,0.8067197998685076
CD14,Brain Injuries,0.8067197998685076
CD14,Brain Lacerations,0.8067197998685076
CD14,Schizophrenia,0.8067197998685076
CD14,Lupus Erythematosus Discoid,0.8098851543361193
CD14,Chronic Infantile Neurological Cutaneous and Articular Syndrome,0.8098851543361193
CD14,Appendicitis,0.8098851543361193
CD14,West Nile viral infection,0.8101097852323003
CD14,Acute GVH disease,0.8101097852323003
CD14,Hereditary hemochromatosis,0.8138488881521341
CD14,Liver diseases,0.8140222479282434
CD14,Fibrosis,0.8145035474981049
CD14,HIV Infections,0.8145035474981049
CD14,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
CD14,Upper Respiratory Infections,0.8145035474981049
CD14,Pancreatitis,0.8168901801930506
CD14,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
CD14,Stable angina,0.8168901801930506
CD14,Ulcerative Colitis,0.8190761496232595
CD14,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
CD14,Multiple Sclerosis Relapsing-Remitting,0.8190761496232595
CD14,Bronchial Hyperreactivity,0.8190761496232595
CD14,Gastrointestinal Carcinoid Tumor,0.8190761496232595
CD14,Mucosa-Associated Lymphoid Tissue Lymphoma,0.8190761496232595
CD14,Impaired cognition,0.8190761496232595
CD14,Chronic granulomatous disease,0.8190761496232595
CD14,Graft-vs-Host Disease,0.8190761496232595
CD14,Peritonitis,0.8190761496232595
CD14,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CD14,Chromosome 5 trisomy 5q,0.8212681436603975
CD14,Periapical Periodontitis,0.8212681436603975
CD14,Juvenile rheumatoid arthritis,0.8212681436603975
CD14,Liver Cirrhosis,0.8232134984476662
CD14,Monocytosis,0.8232134984476662
CD14,Myelodysplastic Syndrome with Isolated del(5q),0.8232134984476662
CD14,Lupus Vulgaris,0.8232134984476662
CD14,Hypersensitivity,0.8232134984476662
CD14,MIXED LINEAGE LEUKEMIA,0.8232134984476662
CD14,Hirschsprung Disease,0.8232134984476662
CD14,Amyotrophic Lateral Sclerosis Sporadic,0.8270909867833504
CD14,Periodontal Diseases,0.8270909867833504
CD14,5q-syndrome,0.8270909867833504
CD14,Infection,0.8272008757995397
CD14,Fibrosis Liver,0.8272008757995397
CD14,Meningitis Bacterial,0.8272008757995397
CD14,Pneumonia,0.834094492023826
CD14,Wheezing,0.834094492023826
CD14,Pituitary Adenoma,0.834094492023826
CD14,Subfertility,0.834094492023826
CD14,Tuberculosis,0.8368219249856942
CD14,Cholestasis in newborn,0.8402911822757345
CD14,Cholangiocarcinoma,0.8402911822757345
CD14,Amyotrophic Lateral Sclerosis,0.8402911822757345
CD14,Patent ductus arteriosus,0.8402911822757345
CD14,Systemic Scleroderma,0.8402911822757345
CD14,Oligoarticular Juvenile Idiopathic Arthritis,0.8402911822757345
CD14,Optic Neuritis,0.8402911822757345
CD14,Adrenoleukodystrophy,0.8402911822757345
CD14,Steatohepatitis,0.8402911822757345
CD14,Common Variable Immunodeficiency,0.8402911822757345
CD14,Pneumococcal Infections,0.8402911822757345
CD14,Hyperlipoproteinemia Type IIa,0.8402911822757345
CD14,Celiac Disease,0.8402911822757345
CD14,Icterus,0.8402911822757345
CD14,Rhinitis,0.8402911822757345
CD14,Infectious Otitis Media,0.8402911822757345
CD14,Otitis Media,0.8402911822757345
CD14,Sarcoidosis Pulmonary,0.8402911822757345
CD14,Obstructive nephropathy,0.8402911822757345
CD14,Hepatitis B,0.841396342333011
CD14,Severe Sepsis,0.843190898187174
CD14,Acute pancreatitis,0.8474481237156937
CD14,Carotid Atherosclerosis,0.8497448945325101
CD14,Restenosis,0.8508164886128737
CD14,Cirrhosis,0.8554819098734854
CD14,X-linked agammaglobulinemia,0.8584283190330553
CD14,Allergic sensitization,0.8584283190330553
CD14,Metabolic Syndrome X,0.8610447277138289
CD14,Squamous cell carcinoma of esophagus,0.8610447277138289
CD14,Tuberculosis Pulmonary,0.8610447277138289
CD14,Cerebrovascular accident,0.8648405521677974
CD14,Myocardial Ischemia,0.8648405521677974
CD14,Carotid Stenosis,0.8648405521677974
CD14,Chronic Obstructive Airway Disease,0.8648405521677974
CD14,Respiratory Tract Diseases,0.8648405521677974
CD14,Severe Dengue,0.8648405521677974
CD14,Amyloidosis,0.8672189956534445
CD14,Hepatitis B Chronic,0.8745234584149799
CD14,Cataract,0.8769418330148872
CD14,Encephalitis St. Louis,0.8769418330148872
CD14,Arthropathy,0.8769418330148872
CD14,Lichen Planus Oral,0.8769418330148872
CD14,Necrotizing Enterocolitis,0.8769418330148872
CD14,Parkinson Disease,0.8772392350816924
CD14,Childhood asthma,0.8774809019744603
CD14,Inflammatory Bowel Diseases,0.8815127642200768
CD14,Bronchiolitis,0.8815127642200768
CD14,Dermatitis Atopic,0.8867509400747969
CD14,Pain,0.887595340546704
CD14,Middle Cerebral Artery Occlusion,0.887595340546704
CD14,Allergic asthma,0.887595340546704
CD14,Coronary Artery Disease,0.887595340546704
CD14,Aplasia Cutis Congenita,0.8911256045597441
CD14,Guillain-Barre Syndrome,0.8959157818691486
CD14,Congestive heart failure,0.8976039441125321
CD14,Obesity,0.8989612563669234
CD14,Malignant Fibrous Histiocytoma,0.8989612563669234
CD14,Mitral Valve Stenosis,0.8989612563669234
CD14,Leprosy,0.9001392794088324
CD14,Respiration Disorders,0.900167961295542
CD14,Fatigue,0.9029289778792944
CD14,Peripheral Vascular Diseases,0.9039108388826153
CD14,Cerebral Ischemia,0.9083161862856644
CD14,Eczema,0.909484944705772
CD14,Coronary heart disease,0.9119978323790848
CD14,Lymphoma Large-Cell Follicular,0.9119978323790848
CD14,Alcoholic Liver Diseases,0.914995991166204
CD14,Mucocutaneous Lymph Node Syndrome,0.914995991166204
CD14,Septicemia,0.917543617287358
CD14,Sepsis,0.9189398569397552
CD14,Malaria Falciparum,0.9193385822373632
CD14,Gaucher Disease,0.9214835359141188
CD14,Allergic rhinitis (disorder),0.922577745415874
CD14,Liver Cirrhosis Alcoholic,0.9262273158806068
CD14,Sarcoidosis,0.929235785949896
CD14,Complete atrioventricular block,0.929814249105729
CD14,Overweight,0.929814249105729
CD14,Cerebrovascular Disorders,0.9387505562433404
CD14,Chronic Kidney Diseases,0.9393256300017014
CD14,Biliary Atresia,0.9401670107659288
CD14,Hepatitis C Chronic,0.9432051631882106
CD14,Graves Disease,0.94939825643792
CD14,Malaria,0.9512505437112568
CD14,Liver Failure Acute,0.9527677537004838
CD14,Peripheral Arterial Diseases,0.9557184806547836
CD14,Cerebral Infarction,0.9564633032157428
CD14,Aortic Aneurysm Abdominal,0.9578035687879456
CD14,Asthma,0.9672478180546946
CD14,Agenesis of corpus callosum,0.9701053690483854
CD14,Hypercholesterolemia Familial,0.9707275133033936
CD14,Impaired glucose tolerance,0.9734506818882446
CD14,Weight decreased,0.9740616963450036
CD14,Cystic Fibrosis,0.9874278479946328
CD14,Non-alcoholic Fatty Liver Disease,0.9924277189223056
CD14,Gout,0.7765582368651238
CD14,Juvenile Arthritis,0.7765582368651238
CD14,Polyarthritis Rheumatoid Factor Positive,0.7765582368651238
CD14,Liver Cirrhosis,0.7765582368651238
CD14,Seronegative Polyarthritis,0.7765582368651238
CD14,Still Disease,0.7765582368651238
CD14,Liver Fibrosis,0.8903301324869451
CD14,Arthritis,0.9046917974656596
CD14,Non-Alcoholic Fatty Liver Disease,0.951883341147811
CD14,Eczema,0.9658957825498884
CD14,Asthma,0.9832345076528324
CD14,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.1040670578681756
CD14,Heme oxygenase-1 deficiency ORPHA:562509,0.1040670578681756
CD14,Thrombomodulin-related bleeding disorder ORPHA:436169,0.1040670578681756
CD14,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.1054066549396977
CD14,ACys amyloidosis ORPHA:100008,0.3832844616405875
CD14,Charcot-Marie-Tooth disease type 4D ORPHA:99950,0.3832844616405875
CD14,Clear cell renal carcinoma ORPHA:319276,0.3832844616405875
CD14,Duane retraction syndrome with congenital deafness ORPHA:529574,0.3832844616405875
CD14,Fructose-16-bisphosphatase deficiency ORPHA:348,0.3832844616405875
CD14,Hemochromatosis type 4 ORPHA:139491,0.3832844616405875
CD14,Mucolipidosis type III gamma ORPHA:423470,0.3832844616405875
CD14,Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774,0.3832844616405875
CD14,Metaphyseal anadysplasia ORPHA:1040,0.3832844616405875
CD14,Pediatric systemic lupus erythematosus ORPHA:93552,0.3832844616405875
CD14,ABri amyloidosis ORPHA:97345,0.5867963421058087
CD14,ADan amyloidosis ORPHA:97346,0.5867963421058087
CD14,Atypical Gaucher disease due to saposin C deficiency ORPHA:309252,0.5867963421058087
CD14,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581,0.5867963421058087
CD14,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569,0.5867963421058087
CD14,Ayme-Gripp syndrome ORPHA:1272,0.5867963421058087
CD14,Encephalopathy due to prosaposin deficiency ORPHA:139406,0.5867963421058087
CD14,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854,0.5867963421058087
CD14,Genetic hyperferritinemia without iron overload ORPHA:254704,0.5867963421058087
CD14,Hereditary hyperferritinemia-cataract syndrome ORPHA:163,0.5867963421058087
CD14,L-ferritin deficiency ORPHA:440731,0.5867963421058087
CD14,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898,0.5867963421058087
CD14,Mitochondrial DNA depletion syndrome myopathic form ORPHA:254875,0.5867963421058087
CD14,NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907,0.5867963421058087
CD14,Neuroferritinopathy ORPHA:157846,0.5867963421058087
CD14,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies ORPHA:397758,0.5867963421058087
CD14,Tangier disease ORPHA:31150,0.5867963421058087
CD14,Infantile Krabbe disease ORPHA:206436,0.5867963421058087
CD14,Chronic mucocutaneous candidiasis ORPHA:1334,0.606625035400596
CD14,Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480,0.7929682744768703
CD14,Alpha-1-antitrypsin deficiency ORPHA:60,0.7929682744768703
CD14,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589,0.7929682744768703
CD14,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574,0.7929682744768703
CD14,Cerebrotendinous xanthomatosis ORPHA:909,0.7929682744768703
CD14,Farber disease ORPHA:333,0.7929682744768703
CD14,Fowler vasculopaty ORPHA:221126,0.7929682744768703
CD14,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation ORPHA:178396,0.7929682744768703
CD14,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547,0.7929682744768703
CD14,RNF13-related severe early-onset epileptic encephalopathy ORPHA:544503,0.7929682744768703
CD14,Recurrent Neisseria infections due to factor D deficiency ORPHA:169467,0.7929682744768703
CD14,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome ORPHA:2590,0.7929682744768703
CD14,Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115,0.7929682744768703
CD14,Congenital factor XIII deficiency ORPHA:331,0.7929682744768703
CD14,ALys amyloidosis ORPHA:93561,0.8922466888454011
CD14,C1 inhibitor deficiency ORPHA:459353,0.8922466888454011
CD14,Cholesteryl ester storage disease ORPHA:75234,0.8922466888454011
CD14,Congenital factor V deficiency ORPHA:326,0.8922466888454011
CD14,Congenital myopathy Paradas type ORPHA:199329,0.8922466888454011
CD14,Diaphragmatic hernia-short bowel-asplenia syndrome ORPHA:527468,0.8922466888454011
CD14,Distal myopathy with anterior tibial onset ORPHA:178400,0.8922466888454011
CD14,Dysferlin-related  limb-girdle muscular dystrophy R2 ORPHA:268,0.8922466888454011
CD14,East Texas bleeding disorder ORPHA:391320,0.8922466888454011
CD14,Enamel-renal syndrome ORPHA:1031,0.8922466888454011
CD14,Hereditary angioedema type 1 ORPHA:100050,0.8922466888454011
CD14,Hereditary angioedema type 2 ORPHA:100051,0.8922466888454011
CD14,Keratolytic winter erythema ORPHA:50943,0.8922466888454011
CD14,Lysinuric protein intolerance ORPHA:470,0.8922466888454011
CD14,Miyoshi myopathy ORPHA:45448,0.8922466888454011
CD14,Osteopetrosis with renal tubular acidosis ORPHA:2785,0.8922466888454011
CD14,Susceptibility to localized juvenile periodontitis ORPHA:447740,0.8922466888454011
CD14,Wolman disease ORPHA:75233,0.8922466888454011
CD14,Hereditary renal hypouricemia ORPHA:94088,0.8922466888454011
CD14,Intermittent hydrarthrosis ORPHA:329967,0.8922466888454011
CD14,NON RARE IN EUROPE: Alzheimer disease ORPHA:238616,0.8922466888454011
CD14,Hemoglobin M disease ORPHA:330041,0.8922466888454011
CD14,Hyperandrogenism due to cortisone reductase deficiency ORPHA:168588,0.8922466888454011
CD14,Immunodeficiency due to a classical component pathway complement deficiency ORPHA:169147,0.8922466888454011
CD14,Autosomal dominant hyper-IgE syndrome ORPHA:2314,0.8922466888454011
CD14,Autosomal recessive primary immunodeficiency with defective spontaneous natural killer cell cytotoxicity ORPHA:437552,0.8922466888454011
CD14,Beta-thalassemia intermedia ORPHA:231222,0.8922466888454011
CD14,Beta-thalassemia major ORPHA:231214,0.8922466888454011
CD14,Chronic lymphoproliferative disorder of natural killer cells ORPHA:512017,0.8922466888454011
CD14,Dominant beta-thalassemia ORPHA:231226,0.8922466888454011
CD14,Early-onset calcifying leukoencephalopathy-skeletal dysplasia ORPHA:556985,0.8922466888454011
CD14,Hemoglobin C disease ORPHA:2132,0.8922466888454011
CD14,Hemoglobin C-beta-thalassemia syndrome ORPHA:231242,0.8922466888454011
CD14,Hemoglobin D disease ORPHA:90039,0.8922466888454011
CD14,Hemoglobin E disease ORPHA:2133,0.8922466888454011
CD14,Hemoglobin E-beta-thalassemia syndrome ORPHA:231249,0.8922466888454011
CD14,STAT3-related early-onset multisystem autoimmune disease ORPHA:438159,0.8922466888454011
CD14,Sickle cell anemia ORPHA:232,0.8922466888454011
CD14,Sickle cell-beta-thalassemia disease syndrome ORPHA:251359,0.8922466888454011
CD14,Sickle cell-hemoglobin C disease syndrome ORPHA:251365,0.8922466888454011
CD14,Sickle cell-hemoglobin D disease syndrome ORPHA:251370,0.8922466888454011
CD14,Sickle cell-hemoglobin E disease syndrome ORPHA:251375,0.8922466888454011
CD14,T-cell large granular lymphocyte leukemia ORPHA:86872,0.8922466888454011
CD14,Nasu-Hakola disease ORPHA:2770,0.8922466888454011
CD14,Autosomal systemic lupus erythematosus ORPHA:300345,0.8922466888454011
CD52,leukemia,0.7333611688795861
CD52,Leukemia Myelocytic Acute,0.7765852775619541
CD52,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CD52,Lymphoma,0.7765852775619541
CD52,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CD52,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
CD52,Promyelocytic leukemia,0.7880542567584415
CD52,Mastocytosis Systemic,0.7880542567584415
CD52,Acute Promyelocytic Leukemia,0.7880542567584415
CD52,Leukemia T-Cell,0.7880542567584415
CD52,Hematologic Neoplasms,0.7880542567584415
CD52,Multiple Myeloma,0.7880542567584415
CD52,Acute lymphocytic leukemia,0.7880542567584415
CD52,Autoimmune Diseases,0.7880542567584415
CD52,Diabetes,0.7880542567584415
CD52,Diabetes Mellitus,0.7880542567584415
CD52,Chronic lymphocytic leukaemia refractory,0.7880542567584415
CD52,Leukemia T-Cell Chronic,0.8019075543217649
CD52,Waldenstrom Macroglobulinemia,0.8019075543217649
CD52,Chronic Lymphocytic Leukemia,0.8019075543217649
CD52,Encephalomyelitis,0.8019075543217649
CD52,Acute GVH disease,0.8101097852323003
CD52,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
CD52,T-Cell Prolymphocytic Leukemia,0.8145035474981049
CD52,Graft-vs-Host Disease,0.8190761496232595
CD52,Hypereosinophilia,0.8190761496232595
CD52,Idiopathic Hypereosinophilic Syndrome,0.8190761496232595
CD52,Tuberculosis,0.8368219249856942
CD52,Prolymphocytic Leukemia,0.8402911822757345
CD52,Polyarthritis,0.8523465762428218
CD52,Peripheral T-Cell Lymphoma,0.876210765330195
CD52,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
CD52,Aicardi-Goutieres syndrome ORPHA:51,0.1294848460749822
CD52,Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549,0.1991445465001551
CD52,Autosomal dominant dopa-responsive dystonia ORPHA:98808,0.1991445465001551
CD52,Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713,0.1991445465001551
CD52,GTP cyclohydrolase I deficiency ORPHA:2102,0.1991445465001551
CD52,Waldenstrom macroglobulinemia ORPHA:33226,0.1991445465001551
CD52,Takayasu arteritis ORPHA:3287,0.2047219337649946
CD52,Autosomal recessive malignant osteopetrosis ORPHA:667,0.2120485863056726
CD52,Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566,0.3832844616405875
CD52,Congenital non-communicating hydrocephalus ORPHA:269510,0.3832844616405875
CD52,Revesz syndrome ORPHA:3088,0.3832844616405875
CD52,Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003,0.3832844616405875
CD52,Spinocerebellar ataxia type 40 ORPHA:423275,0.3832844616405875
CD52,Variant ABeta2M amyloidosis ORPHA:314652,0.3832844616405875
CD52,Epidermodysplasia verruciformis ORPHA:302,0.3891940933600213
CD52,Galactose mutarotase deficiency ORPHA:570422,0.5867963421058087
CD52,Laron syndrome with immunodeficiency ORPHA:220465,0.5867963421058087
CD52,Neutrophil immunodeficiency syndrome ORPHA:183707,0.5867963421058087
CD52,Obesity due to pro-opiomelanocortin deficiency ORPHA:71526,0.5867963421058087
CD52,WHIM syndrome ORPHA:51636,0.5867963421058087
CD52,Cystic leukoencephalopathy without megalencephaly ORPHA:85136,0.5867963421058087
CD52,Familial hemophagocytic lymphohistiocytosis ORPHA:540,0.5959529547720634
CD52,Aland Islands eye disease ORPHA:178333,0.7929682744768703
CD52,BENTA disease ORPHA:464336,0.7929682744768703
CD52,Combined immunodeficiency due to OX40 deficiency ORPHA:431149,0.7929682744768703
CD52,Griscelli syndrome type 2 ORPHA:79477,0.7929682744768703
CD52,Hyperinsulinism due to UCP2 deficiency ORPHA:276556,0.7929682744768703
CD52,Persistent polyclonal B-cell lymphocytosis ORPHA:300324,0.7929682744768703
CD52,Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237,0.7929682744768703
CD52,T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078,0.7929682744768703
CD52,X-linked severe congenital neutropenia ORPHA:86788,0.7929682744768703
CD52,X-linked thrombocytopenia with normal platelets ORPHA:852,0.7929682744768703
CD52,Acute basophilic leukemia ORPHA:86849,0.7929682744768703
CD52,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome ORPHA:538574,0.7929682744768703
CD52,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632,0.7929682744768703
CD52,Complete hydatidiform mole ORPHA:254688,0.795266832401002
CD52,Autosomal agammaglobulinemia ORPHA:33110,0.8029813443753846
CD52,Omenn syndrome ORPHA:39041,0.8447648476081987
CD52,Common variable immunodeficiency ORPHA:1572,0.8564946241562607
CD52,Brain dopamine-serotonin vesicular transport disease ORPHA:352649,0.8922466888454011
CD52,Charcot-Marie-Tooth disease type 1D ORPHA:101084,0.8922466888454011
CD52,Charcot-Marie-Tooth disease type 4E ORPHA:99951,0.8922466888454011
CD52,Combined immunodeficiency due to CD27 deficiency ORPHA:238505,0.8922466888454011
CD52,Combined immunodeficiency due to DOCK8 deficiency ORPHA:217390,0.8922466888454011
CD52,Combined immunodeficiency due to IL21R deficiency ORPHA:357329,0.8922466888454011
CD52,Combined immunodeficiency due to ZAP70 deficiency ORPHA:911,0.8922466888454011
CD52,DOCK2 deficiency ORPHA:447737,0.8922466888454011
CD52,Hereditary central diabetes insipidus ORPHA:30925,0.8922466888454011
CD52,Hyper-IgM syndrome type 3 ORPHA:101090,0.8922466888454011
CD52,Hyperzincemia and hypercalprotectinemia ORPHA:251523,0.8922466888454011
CD52,Leukocyte adhesion deficiency type I ORPHA:99842,0.8922466888454011
CD52,Leukocyte adhesion deficiency type III ORPHA:99844,0.8922466888454011
CD52,NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050,0.8922466888454011
CD52,Pancytopenia due to IKZF1 mutations ORPHA:317473,0.8922466888454011
CD52,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126,0.8922466888454011
CD52,Renin-angiotensin-aldosterone system-blocker-induced angioedema ORPHA:100057,0.8922466888454011
CD52,Severe combined immunodeficiency due to LCK deficiency ORPHA:280142,0.8922466888454011
CD52,Short stature due to growth hormone qualitative anomaly ORPHA:629,0.8922466888454011
CD52,Spondyloenchondrodysplasia ORPHA:1855,0.8922466888454011
CD52,T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276,0.8922466888454011
CD52,Isolated growth hormone deficiency type II ORPHA:231679,0.8922466888454011
CD52,Stevens-Johnson syndrome ORPHA:36426,0.8922466888454011
CD52,Wiskott-Aldrich syndrome ORPHA:906,0.8922466888454011
CD52,Adult-onset myasthenia gravis ORPHA:391490,0.8922466888454011
CD52,Giant cell arteritis ORPHA:397,0.8922466888454011
CD52,Narcolepsy type 2 ORPHA:83465,0.8922466888454011
CD52,Diffuse cutaneous systemic sclerosis ORPHA:220393,0.8922466888454011
CD52,NON RARE IN EUROPE: Ulcerative colitis ORPHA:771,0.8922466888454011
CD52,NON RARE IN EUROPE: Multiple sclerosis ORPHA:802,0.8922466888454011
CD52,Narcolepsy type 1 ORPHA:2073,0.8922466888454011
CD52,Primary biliary cholangitis ORPHA:186,0.8922466888454011
CD52,Systemic lupus erythematosus ORPHA:536,0.8922466888454011
CD52,Recurrent infections associated with rare immunoglobulin isotypes deficiency ORPHA:183675,0.8922466888454011
CD52,T-B+ severe combined immunodeficiency due to CD3delta/CD3epsilon/CD3zeta ORPHA:169160,0.8922466888454011
CD52,Autosomal dominant thrombocytopenia with platelet secretion defect ORPHA:466806,0.8922466888454011
CD52,C syndrome ORPHA:1308,0.8922466888454011
CD52,Chronic beryllium disease ORPHA:133,0.8922466888454011
CD52,Fatal post-viral neurodegenerative disorder ORPHA:391343,0.8922466888454011
CD52,Graham Little-Piccardi-Lassueur syndrome ORPHA:505,0.8922466888454011
CD52,Immunodeficiency due to CD25 deficiency ORPHA:169100,0.8922466888454011
CD52,Isolated delta-storage pool disease ORPHA:248340,0.8922466888454011
CD52,Jacobsen syndrome ORPHA:2308,0.8922466888454011
CD52,Limited systemic sclerosis ORPHA:220407,0.8922466888454011
CD52,Mendelian susceptibility to mycobacterial diseases due to complete IL12RB1 deficiency ORPHA:319552,0.8922466888454011
CD52,Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency ORPHA:319600,0.8922466888454011
CD52,NON RARE IN EUROPE: Rheumatoid arthritis ORPHA:284130,0.8922466888454011
CD52,Paris-Trousseau thrombocytopenia ORPHA:851,0.8922466888454011
CD52,Peripheral primitive neuroectodermal tumor ORPHA:370348,0.8922466888454011
CD52,Severe combined immunodeficiency due to LAT deficiency ORPHA:504523,0.8922466888454011
CD52,Subcutaneous panniculitis-like T-cell lymphoma ORPHA:86884,0.8922466888454011
CD52,T-B+ severe combined immunodeficiency due to CD45 deficiency ORPHA:169157,0.8922466888454011
CD52,T-cell immunodeficiency with epidermodysplasia verruciformis ORPHA:324294,0.8922466888454011
CD52,TCR-alpha-beta-positive T-cell deficiency ORPHA:397959,0.8922466888454011
CD52,X-linked agammaglobulinemia ORPHA:47,0.8922466888454011
CD52,X-linked lymphoproliferative disease due to SH2D1A deficiency ORPHA:538931,0.8922466888454011
CD52,Bullous pemphigoid ORPHA:703,0.8922466888454011
CD52,Classic mycosis fungoides ORPHA:2584,0.8922466888454011
CD52,Limbic encephalitis with LGI1 antibodies ORPHA:163908,0.8922466888454011
CD52,Pediatric multiple sclerosis ORPHA:477738,0.8922466888454011
CD52,Sezary syndrome ORPHA:3162,0.8922466888454011
CD52,Sarcoidosis ORPHA:797,0.8922466888454011
CD52,Spinocerebellar ataxia with axonal neuropathy type 2 ORPHA:64753,0.8922466888454011
CD52,Chronic granulomatous disease ORPHA:379,0.8922466888454011
CD52,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome ORPHA:238569,0.8922466888454011
CD52,NON RARE IN EUROPE: Celiac disease ORPHA:555,0.8922466888454011
CD52,NON RARE IN EUROPE: Diabetes mellitus type 1 ORPHA:243377,0.8922466888454011
CD52,Autoimmune lymphoproliferative syndrome ORPHA:3261,0.8922466888454011
CD52,Granulomatosis with polyangiitis ORPHA:900,0.8922466888454011
CD52,Idiopathic aplastic anemia ORPHA:88,0.8922466888454011
CD52,Oligoarticular juvenile idiopathic arthritis ORPHA:85410,0.8922466888454011
CD52,Rheumatoid factor-negative polyarticular juvenile idiopathic arthritis ORPHA:85408,0.8922466888454011
CD52,NON RARE IN EUROPE: Crohn disease ORPHA:206,0.8939858547904395
CD52,B-cell chronic lymphocytic leukemia ORPHA:67038,0.896422440954666
CD52,Behcet disease ORPHA:117,0.9025296114347576
CDA,Malignant neoplasm of breast,0.4084380369379369
CDA,Breast Carcinoma,0.7333611688795861
CDA,Carcinogenesis,0.7333611688795861
CDA,leukemia,0.7333611688795861
CDA,Malignant neoplasm of pancreas,0.7688485284765829
CDA,Colorectal Carcinoma,0.7765852775619541
CDA,Pancreatic carcinoma,0.7765852775619541
CDA,Leukemia Myelocytic Acute,0.7765852775619541
CDA,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CDA,Lymphoma,0.7765852775619541
CDA,Non-Small Cell Lung Carcinoma,0.7765852775619541
CDA,Mammary Neoplasms,0.7880542567584415
CDA,Monocytic leukemia,0.7880542567584415
CDA,Liver carcinoma,0.7880542567584415
CDA,Colorectal Cancer,0.7880542567584415
CDA,Spondylarthritis,0.7880542567584415
CDA,Neuroblastoma,0.7880542567584415
CDA,Central neuroblastoma,0.7880542567584415
CDA,Osteoarthritis Spine,0.7880542567584415
CDA,Malignant neoplasm of stomach,0.7880542567584415
CDA,Diarrhea,0.7880542567584415
CDA,Hemolytic-Uremic Syndrome,0.7880542567584415
CDA,Malignant mesothelioma,0.7880542567584415
CDA,M5b Acute differentiated monocytic leukemia,0.7880542567584415
CDA,Infection caused by Helicobacter pylori,0.7880542567584415
CDA,Stromal Neoplasm,0.7880542567584415
CDA,Lupus Erythematosus Systemic,0.7880542567584415
CDA,Hyalinosis Systemic,0.7880542567584415
CDA,Acute leukemia,0.7880542567584415
CDA,Mean Corpuscular Volume (result),0.7880542567584415
CDA,Alzheimer's Disease,0.7880542567584415
CDA,Stomach Carcinoma,0.7880542567584415
CDA,Sickle Cell Dactylitis,0.7880542567584415
CDA,Palmar-plantar erythrodysesthesia syndrome,0.7880542567584415
CDA,Solid Neoplasm,0.7880542567584415
CDA,Congenital dyserythropoietic anemia type II,0.7880542567584415
CDA,Myelodysplasia,0.7880542567584415
CDA,Congenital dyserythropoietic anemia,0.7908231553833205
CDA,Plaque Amyloid,0.8009048756462318
CDA,Leukopenia,0.8019075543217649
CDA,Thrombocytopenia,0.8019075543217649
CDA,Degenerative polyarthritis,0.8019075543217649
CDA,Senile Plaques,0.8019075543217649
CDA,HIV Infections,0.8145035474981049
CDA,Avellino corneal dystrophy,0.8270909867833504
CDA,Retroviridae Infections,0.8272008757995397
CDA,Intervertebral Disc Degeneration,0.841396342333011
CDA,Hepatitis B,0.841396342333011
CDA,Down Syndrome,0.8420665668584452
CDA,Anemia,0.8584283190330553
CDA,Progressive cGVHD,0.8610447277138289
CDA,Xeroderma Pigmentosum Complementation Group D,0.8642802827048847
CDA,Acute Megakaryocytic Leukemias,0.8745234584149799
CDA,Mammary Neoplasms Human,0.8815127642200768
CDA,Malnutrition,0.9184153253162451
CDA,Progressive Neoplastic Disease,0.9265708351135048
CDA,Neutropenia,0.9387505562433404
CDA,Mammary Neoplasms,0.8165359516083085
CDA,Marfan Syndrome,0.8477374749042494
CDA,Breast Cancer,0.8903630091389316
CDA,Breast Carcinoma,0.9398381935810408
CDA,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
CDA,Heme oxygenase-1 deficiency ORPHA:562509,0.1040670578681756
CDA,Thrombomodulin-related bleeding disorder ORPHA:436169,0.1040670578681756
CDA,Hemochromatosis type 5 ORPHA:447792,0.3832844616405875
CDA,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.5867963421058087
CDA,Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635,0.5867963421058087
CDA,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787,0.5867963421058087
CDA,Galactosialidosis ORPHA:351,0.5867963421058087
CDA,Neutral lipid storage disease with ichthyosis ORPHA:98907,0.5867963421058087
CDA,Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.606625035400596
CDA,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589,0.7929682744768703
CDA,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574,0.7929682744768703
CDA,Epithelial basement membrane dystrophy ORPHA:98956,0.7929682744768703
CDA,FTH1-related iron overload ORPHA:247790,0.7929682744768703
CDA,Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369,0.7929682744768703
CDA,Granular corneal dystrophy type I ORPHA:98962,0.7929682744768703
CDA,Granular corneal dystrophy type II ORPHA:98963,0.7929682744768703
CDA,Lattice corneal dystrophy type I ORPHA:98964,0.7929682744768703
CDA,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547,0.7929682744768703
CDA,Reis-Bucklers corneal dystrophy ORPHA:98961,0.7929682744768703
CDA,Thiel-Behnke corneal dystrophy ORPHA:98960,0.7929682744768703
CDA,Congenital myopathy Paradas type ORPHA:199329,0.8922466888454011
CDA,Distal myopathy with anterior tibial onset ORPHA:178400,0.8922466888454011
CDA,Dysferlin-related  limb-girdle muscular dystrophy R2 ORPHA:268,0.8922466888454011
CDA,Miyoshi myopathy ORPHA:45448,0.8922466888454011
CDC25C,Malignant neoplasm of breast,0.4084380369379369
CDC25C,Breast Carcinoma,0.7333611688795861
CDC25C,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CDC25C,Carcinogenesis,0.7333611688795861
CDC25C,Malignant neoplasm of ovary,0.7333611688795861
CDC25C,leukemia,0.7333611688795861
CDC25C,Malignant neoplasm of pancreas,0.7688485284765829
CDC25C,Hepatoblastoma,0.7765852775619541
CDC25C,Colorectal Carcinoma,0.7765852775619541
CDC25C,Pancreatic carcinoma,0.7765852775619541
CDC25C,Colon Carcinoma,0.7765852775619541
CDC25C,Leukemia Myelocytic Acute,0.7765852775619541
CDC25C,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CDC25C,Malignant tumor of colon,0.7765852775619541
CDC25C,Lymphoma,0.7765852775619541
CDC25C,Non-Small Cell Lung Carcinoma,0.7765852775619541
CDC25C,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CDC25C,Colorectal Neoplasms,0.7765852775619541
CDC25C,Endometrial Carcinoma,0.7765852775619541
CDC25C,Glioma,0.7880542567584415
CDC25C,Malignant neoplasm of lung,0.7880542567584415
CDC25C,Malignant neoplasm of prostate,0.7880542567584415
CDC25C,Liver carcinoma,0.7880542567584415
CDC25C,Ataxia Telangiectasia,0.7880542567584415
CDC25C,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
CDC25C,Prostate carcinoma,0.7880542567584415
CDC25C,Primary malignant neoplasm of lung,0.7880542567584415
CDC25C,Prostatic Neoplasms,0.7880542567584415
CDC25C,Carcinoma of lung,0.7880542567584415
CDC25C,Malignant neoplasm of liver,0.7880542567584415
CDC25C,Turner Syndrome Male,0.7880542567584415
CDC25C,melanoma,0.7880542567584415
CDC25C,Multiple Myeloma,0.7880542567584415
CDC25C,Hodgkin Disease,0.7880542567584415
CDC25C,Nasopharyngeal carcinoma,0.7880542567584415
CDC25C,Retinoblastoma,0.7880542567584415
CDC25C,Stomach Carcinoma,0.7880542567584415
CDC25C,Squamous cell carcinoma,0.7880542567584415
CDC25C,Solid Neoplasm,0.7880542567584415
CDC25C,Polycystic liver disease,0.7880542567584415
CDC25C,Indolent Non-Hodgkin Lymphoma,0.8019075543217649
CDC25C,Liver neoplasms,0.8019075543217649
CDC25C,Stomach Neoplasms,0.8044379824544406
CDC25C,Schizophrenia,0.8067197998685076
CDC25C,Polycystic Kidney Diseases,0.8168901801930506
CDC25C,Gastrointestinal Carcinoid Tumor,0.8190761496232595
CDC25C,Pituitary Adenoma,0.834094492023826
CDC25C,Ataxia,0.8402911822757345
CDC25C,Cerebellar Ataxia,0.906476206143938
CDC25C,Liver Carcinoma,0.7765582368651238
CDC25C,Schizophrenia,0.7860378120955526
CDC25C,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
CDC25C,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
CDC25C,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
CDC25C,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
CDC25C,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
CDC25C,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
CDC25C,Currarino syndrome ORPHA:1552,0.0155394890951578
CDC25C,Filippi syndrome ORPHA:3255,0.0155394890951578
CDC25C,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
CDC25C,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
CDC25C,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
CDC25C,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
CDC25C,Stromme syndrome ORPHA:506307,0.0155394890951578
CDC25C,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
CDC25C,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
CDC25C,Citrullinemia type II ORPHA:247585,0.0414176838632111
CDC25C,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
CDC25C,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
CDC25C,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
CDC25C,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
CDC25C,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
CDC25C,Small cell lung cancer ORPHA:70573,0.0429491792829903
CDC25C,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.1040670578681756
CDC25C,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1040670578681756
CDC25C,Hydrolethalus ORPHA:2189,0.1054066549396977
CDC25C,Dedifferentiated liposarcoma ORPHA:99970,0.1068643725150898
CDC25C,Well-differentiated liposarcoma ORPHA:99971,0.1068643725150898
CDC25C,46XX gonadal dysgenesis ORPHA:243,0.1419890644363008
CDC25C,46XY complete gonadal dysgenesis ORPHA:242,0.1479888965090844
CDC25C,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.1991445465001551
CDC25C,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.1991445465001551
CDC25C,Denys-Drash syndrome ORPHA:220,0.1991445465001551
CDC25C,Frasier syndrome ORPHA:347,0.1991445465001551
CDC25C,Jawad syndrome ORPHA:313795,0.1991445465001551
CDC25C,Meacham syndrome ORPHA:3097,0.1991445465001551
CDC25C,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.1991445465001551
CDC25C,Familial prostate cancer ORPHA:1331,0.2844858212863536
CDC25C,Li-Fraumeni syndrome ORPHA:524,0.3891940933600213
CDC25C,Primary peritoneal carcinoma ORPHA:168829,0.5867963421058087
CDC25C,46XY partial gonadal dysgenesis ORPHA:251510,0.8668760866668862
CDC25C,Atrial septal defect-atrioventricular conduction defects syndrome ORPHA:1479,0.8922466888454011
CDC25C,Hypothyroidism due to deficient transcription factors involved in pituitary development or function ORPHA:226307,0.8922466888454011
CDC34,Esophageal carcinoma,0.7765852775619541
CDC34,Esophageal Neoplasms,0.7765852775619541
CDC34,Liver carcinoma,0.7880542567584415
CDC34,Malignant neoplasm of esophagus,0.7880542567584415
CDC34,intracranial glioma,0.7880542567584415
CDC34,Primary malignant neoplasm of lung,0.7880542567584415
CDC34,Carcinoma of lung,0.7880542567584415
CDC34,Pemphigus and fogo selvagem,0.7880542567584415
CDC34,Papillary Renal Cell Carcinoma,0.7880542567584415
CDC34,Papillary renal cell carcinoma sporadic,0.7880542567584415
CDC34,Herpes Simplex Infections,0.8098851543361193
CDC34,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
CDC34,Early-onset posterior subcapsular cataract ORPHA:441447,0.220389120533256
CDC34,Autosomal recessive cerebellar ataxia due to STUB1 deficiency ORPHA:412057,0.5867963421058087
CDC34,Peutz-Jeghers syndrome ORPHA:2869,0.5867963421058087
CDC34,Adult-onset autosomal recessive sideroblastic anemia ORPHA:255132,0.8922466888454011
CDC34,Childhood-onset spasticity with hyperglycinemia ORPHA:401866,0.8922466888454011
CDC34,Human herpesvirus 3 strain Dumas ring-finger protein,0.8999095837312036
CDC34,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.8999095837312036
CDC42BPB,Malignant neoplasm of breast,0.4084380369379369
CDC42BPB,Breast Carcinoma,0.7333611688795861
CDC42BPB,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CDC42BPB,Myotonic Dystrophy,0.7880542567584415
CDC42BPB,Infiltrating duct carcinoma of female breast,0.7880542567584415
CDC42BPB,Large cell carcinoma of lung,0.7967714690735718
CDC42BPB,Adenocarcinoma of large intestine,0.8019075543217649
CDC42BPB,Adult Diffuse Large B-Cell Lymphoma,0.8402911822757345
CDC42BPB,Childhood Diffuse Large B-Cell Lymphoma,0.8402911822757345
CDC42BPB,Neurodevelopmental Disorders,0.9015731019095328
CDC42BPB,Infiltrating Duct Carcinoma Of Female Breast,0.7765582368651238
CDC42BPB,Neurodevelopmental Disorders,0.7765582368651238
CDC42BPB,Diffuse Lymphoma,0.7765582368651238
CDC42BPB,Mental Depression,0.8903630091389316
CDC42BPB,Colorectal Cancer,0.9832345076528324
CDC42BPB,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
CDC42BPB,Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253,0.1040670578681756
CDC42BPB,Monosomy 22q13.3 ORPHA:48652,0.1040670578681756
CDC42BPB,Bilateral perisylvian polymicrogyria ORPHA:98889,0.1068643725150898
CDC42BPB,Saldino-Mainzer syndrome ORPHA:140969,0.1991445465001551
CDC42BPB,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.1991445465001551
CDC42BPB,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.1991445465001551
CDC42BPB,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.1991445465001551
CDC42BPB,Frank-Ter Haar syndrome ORPHA:137834,0.1991445465001551
CDC42BPB,Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851,0.1991445465001551
CDC42BPB,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.1991445465001551
CDC42BPB,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.1991445465001551
CDC42BPB,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.1991445465001551
CDC42BPB,Pyruvate carboxylase deficiency benign type ORPHA:353320,0.1991445465001551
CDC42BPB,Pyruvate carboxylase deficiency infantile type ORPHA:353308,0.1991445465001551
CDC42BPB,Pyruvate carboxylase deficiency severe neonatal type ORPHA:353314,0.1991445465001551
CDC42BPB,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.1991445465001551
CDC42BPB,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.1991445465001551
CDC42BPB,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.1991445465001551
CDC42BPB,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.1991445465001551
CDC42BPB,Synaptic congenital myasthenic syndromes ORPHA:98915,0.1991445465001551
CDC42BPB,Familial hypercholanemia ORPHA:238475,0.2047219337649946
CDC42BPB,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E ORPHA:93114,0.3832844616405875
CDC42BPB,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867,0.3832844616405875
CDC42BPB,Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580,0.3832844616405875
CDC42BPB,Hereditary folate malabsorption ORPHA:90045,0.3832844616405875
CDC42BPB,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126,0.3832844616405875
CDC42BPB,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.3832844616405875
CDC42BPB,Dermatofibrosarcoma protuberans ORPHA:31112,0.3832844616405875
CDC42BPB,Shprintzen-Goldberg syndrome ORPHA:2462,0.3832844616405875
CDC42BPB,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3832844616405875
CDC42BPB,Idiopathic pulmonary fibrosis ORPHA:2032,0.5047266821728011
CDC42BPB,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.5867963421058087
CDC42BPB,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.5867963421058087
CDC42BPB,Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335,0.5867963421058087
CDC42BPB,CLCN4-related X-linked intellectual disability syndrome ORPHA:485350,0.5867963421058087
CDC42BPB,Dentatorubral pallidoluysian atrophy ORPHA:101,0.5867963421058087
CDC42BPB,Isolated congenital breast hypoplasia/aplasia ORPHA:180188,0.5867963421058087
CDC42BPB,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.5867963421058087
CDC42BPB,Multiple myeloma ORPHA:29073,0.5867963421058087
CDC42BPB,Pierson syndrome ORPHA:2670,0.5867963421058087
CDC42BPB,Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298,0.5867963421058087
CDC42BPB,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.5867963421058087
CDC42BPB,Wolfram-like syndrome ORPHA:411590,0.5867963421058087
CDC42BPB,X-linked creatine transporter deficiency ORPHA:52503,0.5867963421058087
CDC42BPB,Carpenter syndrome ORPHA:65759,0.5867963421058087
CDC42BPB,Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359,0.5867963421058087
CDC42BPB,Hereditary diffuse gastric cancer ORPHA:26106,0.5867963421058087
CDC42BPB,Aplasia cutis congenita ORPHA:1114,0.5959529547720634
CDC42BPB,Juvenile nephronophthisis ORPHA:93592,0.6335420546867965
CDC42BPB,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.6873535151929783
CDC42BPB,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.6873535151929783
CDC42BPB,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.7007232363756918
CDC42BPB,ABeta amyloidosis Arctic type ORPHA:324723,0.7929682744768703
CDC42BPB,ABeta amyloidosis Dutch type ORPHA:100006,0.7929682744768703
CDC42BPB,ABeta amyloidosis Iowa type ORPHA:324708,0.7929682744768703
CDC42BPB,ABeta amyloidosis Italian type ORPHA:324713,0.7929682744768703
CDC42BPB,ABetaA21G amyloidosis ORPHA:324718,0.7929682744768703
CDC42BPB,ABetaL34V amyloidosis ORPHA:324703,0.7929682744768703
CDC42BPB,Acrokeratosis verruciformis of Hopf ORPHA:79151,0.7929682744768703
CDC42BPB,Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16 ORPHA:280333,0.7929682744768703
CDC42BPB,Atelosteogenesis type I ORPHA:1190,0.7929682744768703
CDC42BPB,Atelosteogenesis type III ORPHA:56305,0.7929682744768703
CDC42BPB,Atrophoderma vermiculata ORPHA:79100,0.7929682744768703
CDC42BPB,Autosomal spastic paraplegia type 58 ORPHA:397946,0.7929682744768703
CDC42BPB,Boomerang dysplasia ORPHA:1263,0.7929682744768703
CDC42BPB,Darier disease ORPHA:218,0.7929682744768703
CDC42BPB,Dent disease type 2 ORPHA:93623,0.7929682744768703
CDC42BPB,Familial hypocalciuric hypercalcemia type 2 ORPHA:101049,0.7929682744768703
CDC42BPB,Keipert syndrome ORPHA:2662,0.7929682744768703
CDC42BPB,LAMA5-related multisystemic syndrome ORPHA:521450,0.7929682744768703
CDC42BPB,Larsen syndrome ORPHA:503,0.7929682744768703
CDC42BPB,Legius syndrome ORPHA:137605,0.7929682744768703
CDC42BPB,Lethal osteosclerotic bone dysplasia ORPHA:1832,0.7929682744768703
CDC42BPB,Muscle-eye-brain disease with bilateral multicystic leucodystrophy ORPHA:370997,0.7929682744768703
CDC42BPB,Nance-Horan syndrome ORPHA:627,0.7929682744768703
CDC42BPB,Oculocerebrorenal syndrome of Lowe ORPHA:534,0.7929682744768703
CDC42BPB,Phakomatosis cesiomarmorata ORPHA:79484,0.7929682744768703
CDC42BPB,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.7929682744768703
CDC42BPB,Autosomal dominant hypocalcemia ORPHA:428,0.7929682744768703
CDC42BPB,Pulmonary venoocclusive disease ORPHA:31837,0.7929682744768703
CDC42BPB,Total early-onset cataract ORPHA:98994,0.8922466888454011
CDC42BPB,Autosomal dominant Charcot-Marie-Tooth disease type 2O ORPHA:284232,0.8922466888454011
CDC42BPB,Autosomal dominant neovascular inflammatory vitreoretinopathy ORPHA:329211,0.8922466888454011
CDC42BPB,DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:209341,0.8922466888454011
CDC42BPB,Familial generalized lentiginosis ORPHA:231040,0.8922466888454011
CDC42BPB,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.8922466888454011
CDC42BPB,Familial progressive hyperpigmentation ORPHA:79146,0.8922466888454011
CDC42BPB,Growth delay due to insulin-like growth factor I resistance ORPHA:73273,0.8922466888454011
CDC42BPB,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961,0.8922466888454011
CDC42BPB,Phakomatosis cesioflammea ORPHA:79483,0.8922466888454011
CDC42BPB,Unverricht-Lundborg disease ORPHA:308,0.8922466888454011
CDC42BPB,Epithelioid hemangioendothelioma ORPHA:157791,0.8922466888454011
CDC42BPB,Cystic fibrosis ORPHA:586,0.8922466888454011
CDC42BPB,Periventricular nodular heterotopia ORPHA:98892,0.8922466888454011
CDC42BPB,Action myoclonus-renal failure syndrome ORPHA:163696,0.8922466888454011
CDC42BPB,Drug- or toxin-induced pulmonary arterial hypertension ORPHA:275786,0.8922466888454011
CDC42BPB,Keratosis follicularis spinulosa decalvans ORPHA:2340,0.8922466888454011
CDC42BPB,Human gammaherpesvirus 8 ORF72,0.8999095837312036
CDC42BPB,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDC42BPB,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CDC42BPB,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CDC42BPB,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
CDH1,Malignant neoplasm of breast,0.4084380369379369
CDH1,Carcinoma of bladder,0.4084380369379369
CDH1,Bladder Neoplasm,0.4084380369379369
CDH1,Malignant neoplasm of urinary bladder,0.5071083164302358
CDH1,Reticulocyte count (procedure),0.5071083164302358
CDH1,Adenomatous Polyposis Coli,0.5196624042573144
CDH1,Breast Carcinoma,0.7333611688795861
CDH1,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CDH1,Carcinogenesis,0.7333611688795861
CDH1,Malignant neoplasm of ovary,0.7333611688795861
CDH1,B-Cell Lymphomas,0.7333611688795861
CDH1,leukemia,0.7333611688795861
CDH1,Ovarian Carcinoma,0.7333611688795861
CDH1,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
CDH1,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
CDH1,Adenocarcinoma,0.750391252594775
CDH1,Malignant neoplasm of pancreas,0.7688485284765829
CDH1,Colorectal Carcinoma,0.7765852775619541
CDH1,Pancreatic carcinoma,0.7765852775619541
CDH1,Gastrointestinal Stromal Tumors,0.7765852775619541
CDH1,Colon Carcinoma,0.7765852775619541
CDH1,Leukemia Myelocytic Acute,0.7765852775619541
CDH1,Nephrolithiasis,0.7765852775619541
CDH1,Metaplasia,0.7765852775619541
CDH1,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CDH1,Malignant tumor of colon,0.7765852775619541
CDH1,Atrial Premature Complexes,0.7765852775619541
CDH1,Esophageal carcinoma,0.7765852775619541
CDH1,Lymphoma,0.7765852775619541
CDH1,Leukemogenesis,0.7765852775619541
CDH1,Endometrial Neoplasms,0.7765852775619541
CDH1,Cervix carcinoma,0.7765852775619541
CDH1,Non-Small Cell Lung Carcinoma,0.7765852775619541
CDH1,Prostatic Intraepithelial Neoplasias,0.7765852775619541
CDH1,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CDH1,Colorectal Neoplasms,0.7765852775619541
CDH1,Gastrinoma,0.7765852775619541
CDH1,Pancreatic Neoplasm,0.7765852775619541
CDH1,Carcinoma breast stage IV,0.7765852775619541
CDH1,Adenoma,0.7765852775619541
CDH1,Thyroid Neoplasm,0.7765852775619541
CDH1,Endometrial Carcinoma,0.7765852775619541
CDH1,Esophageal Neoplasms,0.7765852775619541
CDH1,Malignant tumor of cervix,0.7768809924982332
CDH1,Mammary Neoplasms,0.7880542567584415
CDH1,Glioma,0.7880542567584415
CDH1,Malignant neoplasm of lung,0.7880542567584415
CDH1,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
CDH1,Malignant neoplasm of prostate,0.7880542567584415
CDH1,Rotting teeth,0.7880542567584415
CDH1,Liver carcinoma,0.7880542567584415
CDH1,Invasive carcinoma of breast,0.7880542567584415
CDH1,Malignant neoplasm tonsil,0.7880542567584415
CDH1,Malignant neoplasm of esophagus,0.7880542567584415
CDH1,Thyroid carcinoma,0.7880542567584415
CDH1,intracranial glioma,0.7880542567584415
CDH1,Dental caries,0.7880542567584415
CDH1,Colorectal Cancer,0.7880542567584415
CDH1,Epithelial ovarian cancer,0.7880542567584415
CDH1,Tonsillar Carcinoma,0.7880542567584415
CDH1,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
CDH1,Hepatocarcinogenesis,0.7880542567584415
CDH1,Prostate carcinoma,0.7880542567584415
CDH1,Astrocytoma,0.7880542567584415
CDH1,Nephroblastoma,0.7880542567584415
CDH1,Disease Exacerbation,0.7880542567584415
CDH1,Primary malignant neoplasm of lung,0.7880542567584415
CDH1,cervical cancer,0.7880542567584415
CDH1,Neoplasm Metastasis,0.7880542567584415
CDH1,Abnormality of vision,0.7880542567584415
CDH1,Epithelioma,0.7880542567584415
CDH1,Carcinoma Endometrioid,0.7880542567584415
CDH1,Prostatic Neoplasms,0.7880542567584415
CDH1,Monoclonal Gammopathy of Undetermined Significance,0.7880542567584415
CDH1,Carcinoma of lung,0.7880542567584415
CDH1,Squamous cell carcinoma of the head and neck,0.7880542567584415
CDH1,Triple Negative Breast Neoplasms,0.7880542567584415
CDH1,Mesothelioma,0.7880542567584415
CDH1,Malignant neoplasm of liver,0.7880542567584415
CDH1,Familial lichen amyloidosis,0.7880542567584415
CDH1,Ductal Carcinoma,0.7880542567584415
CDH1,Malignant Neoplasms,0.7880542567584415
CDH1,Hematologic Neoplasms,0.7880542567584415
CDH1,Malignant neoplasm of nasopharynx,0.7880542567584415
CDH1,melanoma,0.7880542567584415
CDH1,Multiple Myeloma,0.7880542567584415
CDH1,Lung Neoplasms,0.7880542567584415
CDH1,Gastric lymphoma,0.7880542567584415
CDH1,Lobular carcinoma in situ of breast,0.7880542567584415
CDH1,Metastatic malignant neoplasm to brain,0.7880542567584415
CDH1,Prolactinoma,0.7880542567584415
CDH1,Mycoplasma Infections,0.7880542567584415
CDH1,Metastatic Prostate Carcinoma,0.7880542567584415
CDH1,Dysgerminoma,0.7880542567584415
CDH1,Ovarian papillary adenocarcinoma,0.7880542567584415
CDH1,Malignant neoplasm of stomach,0.7880542567584415
CDH1,Transitional cell carcinoma of bladder,0.7880542567584415
CDH1,Optic Atrophy Autosomal Dominant,0.7880542567584415
CDH1,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
CDH1,Cancer of Nasopharynx,0.7880542567584415
CDH1,Sebaceous Adenocarcinoma,0.7880542567584415
CDH1,Adult Hepatocellular Carcinoma,0.7880542567584415
CDH1,OTOFACIOCERVICAL SYNDROME 1,0.7880542567584415
CDH1,Papillary cystic tumor,0.7880542567584415
CDH1,Congenital contractural arachnodactyly,0.7880542567584415
CDH1,Malignant mesothelioma,0.7880542567584415
CDH1,Well Differentiated Oligodendroglioma,0.7880542567584415
CDH1,Cleft palate with cleft lip,0.7880542567584415
CDH1,Invasive Ductal Breast Carcinoma,0.7880542567584415
CDH1,Brain Neoplasms,0.7880542567584415
CDH1,Secondary malignant neoplasm of ovary,0.7880542567584415
CDH1,Apocrine Carcinoma,0.7880542567584415
CDH1,Chronic cholecystitis,0.7880542567584415
CDH1,Cleft palate and bilateral cleft lip,0.7880542567584415
CDH1,Distichiasis,0.7880542567584415
CDH1,Intestinal adenocarcinoma,0.7880542567584415
CDH1,Krukenberg Tumor,0.7880542567584415
CDH1,Malignant neoplasm of large intestine,0.7880542567584415
CDH1,Nasopharyngeal carcinoma,0.7880542567584415
CDH1,Conductive hearing loss,0.7880542567584415
CDH1,Hepatitis B Virus-Related Hepatocellular Carcinoma,0.7880542567584415
CDH1,Mucoepidermoid Carcinoma,0.7880542567584415
CDH1,oligodendroglioma,0.7880542567584415
CDH1,Infection caused by Helicobacter pylori,0.7880542567584415
CDH1,Glaucoma Open-Angle,0.7880542567584415
CDH1,Tumor Progression,0.7880542567584415
CDH1,Adenocarcinoma of colon,0.7880542567584415
CDH1,ACTH-Secreting Pituitary Adenoma,0.7880542567584415
CDH1,Renal Cell Carcinoma,0.7880542567584415
CDH1,Rectal Neoplasms,0.7880542567584415
CDH1,ECTRODACTYLY ECTODERMAL DYSPLASIA AND CLEFT LIP/PALATE SYNDROME 1,0.7880542567584415
CDH1,Syndactyly of fingers,0.7880542567584415
CDH1,Congenital euryblepharon,0.7880542567584415
CDH1,Kabuki syndrome eyelids,0.7880542567584415
CDH1,Tumor Initiation,0.7880542567584415
CDH1,Mean Corpuscular Volume (result),0.7880542567584415
CDH1,Atherosclerosis,0.7880542567584415
CDH1,Invasive Carcinoma,0.7880542567584415
CDH1,Congenital chromosomal disease,0.7880542567584415
CDH1,Alzheimer's Disease,0.7880542567584415
CDH1,Neoplastic Syndromes Hereditary,0.7880542567584415
CDH1,Stomach Carcinoma,0.7880542567584415
CDH1,Carcinoma of urinary bladder superficial,0.7880542567584415
CDH1,High Grade Lymphoma (neoplasm),0.7880542567584415
CDH1,Pancreatic Intraductal Papillary Mucinous Neoplasm Gastric-Type,0.7880542567584415
CDH1,OROFACIAL CLEFT 1,0.7880542567584415
CDH1,Fanconi Anemia,0.7880542567584415
CDH1,gallbladder neoplasm,0.7880542567584415
CDH1,Squamous cell carcinoma,0.7880542567584415
CDH1,Uterine Cervical Neoplasm,0.7880542567584415
CDH1,Solid Neoplasm,0.7880542567584415
CDH1,Carcinoma in situ of uterine cervix,0.7880542567584415
CDH1,Gastritis Atrophic,0.7880542567584415
CDH1,Cleft upper lip,0.7880542567584415
CDH1,Papillary Renal Cell Carcinoma,0.7880542567584415
CDH1,Biliary Tract Cancer,0.7880542567584415
CDH1,Adenoma of large intestine,0.7880542567584415
CDH1,Salivary gland carcinoma,0.7880542567584415
CDH1,Helicobacter Infections,0.7880542567584415
CDH1,Peg-shaped teeth,0.7880542567584415
CDH1,Pointed tooth,0.7880542567584415
CDH1,Nasopharyngeal Neoplasms,0.7880542567584415
CDH1,Carcinoma,0.7880542567584415
CDH1,Li-Fraumeni Syndrome,0.7880542567584415
CDH1,Small cell carcinoma of lung,0.7880542567584415
CDH1,Crohn Disease,0.7880542567584415
CDH1,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
CDH1,Invasive Lobular Breast Carcinoma,0.7880542567584415
CDH1,Intrahepatic Cholangiocarcinoma,0.7880542567584415
CDH1,Prostate cancer familial,0.7880542567584415
CDH1,Cytomegalovirus Infections,0.7880542567584415
CDH1,Virus Diseases,0.7880542567584415
CDH1,Myeloid Leukemia Chronic,0.7880542567584415
CDH1,Benign neoplasm of stomach,0.7880542567584415
CDH1,Carcinoma in situ of stomach,0.7880542567584415
CDH1,Neoplasm of uncertain or unknown behavior of stomach,0.7880542567584415
CDH1,Ulcer,0.7880542567584415
CDH1,Metastasis from malignant tumor of prostate,0.7908231553833205
CDH1,Primary malignant neoplasm,0.7908231553833205
CDH1,Lobular Neoplasia,0.7908231553833205
CDH1,Carcinoma Spindle-Cell,0.7950434752274518
CDH1,Nerve Degeneration,0.8009048756462318
CDH1,Undifferentiated carcinoma,0.8019075543217649
CDH1,Neoplasms Neuroepithelial,0.8019075543217649
CDH1,Fibrolamellar Hepatocellular Carcinoma,0.8019075543217649
CDH1,Pseudomyxoma Peritonei,0.8019075543217649
CDH1,Hereditary Malignant Neoplasm,0.8019075543217649
CDH1,Pemphigus Vulgaris,0.8019075543217649
CDH1,Vitiligo,0.8019075543217649
CDH1,Breast cancer lobular,0.8019075543217649
CDH1,Cervical Squamous Cell Carcinoma,0.8019075543217649
CDH1,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8019075543217649
CDH1,Adenocarcinoma of large intestine,0.8019075543217649
CDH1,Malignant neoplasm of gallbladder,0.8019075543217649
CDH1,Chronic Lymphocytic Leukemia,0.8019075543217649
CDH1,Cervical Adenocarcinoma,0.8019075543217649
CDH1,Hereditary Diffuse Gastric Cancer,0.8019075543217649
CDH1,Non-infiltrating lobular carcinoma,0.8019075543217649
CDH1,Precancerous Conditions,0.8026504676141903
CDH1,leiomyosarcoma,0.8026798872257774
CDH1,Stomach Neoplasms,0.8044379824544406
CDH1,Malignant neoplasm of salivary gland,0.8067197998685076
CDH1,Ovarian adenocarcinoma,0.8067197998685076
CDH1,ovarian neoplasm,0.8067197998685076
CDH1,Adenocarcinoma of lung (disorder),0.8098851543361193
CDH1,Blast Phase,0.8114747041691183
CDH1,Breast adenocarcinoma,0.8138488881521341
CDH1,Hereditary non-polyposis colorectal cancer syndrome,0.8138488881521341
CDH1,Gastrointestinal Neoplasms,0.8145035474981049
CDH1,Paget Disease Extramammary,0.8145035474981049
CDH1,Carcinoma Signet Ring Cell,0.8168901801930506
CDH1,Ulcerative Colitis,0.8190761496232595
CDH1,Carcinomatosis,0.8190761496232595
CDH1,Mucosa-Associated Lymphoid Tissue Lymphoma,0.8190761496232595
CDH1,Lip and Oral Cavity Carcinoma,0.8190761496232595
CDH1,Verrucous carcinoma,0.8190761496232595
CDH1,Extrahepatic Cholangiocarcinoma,0.8190761496232595
CDH1,Luminal B Breast Carcinoma,0.8190761496232595
CDH1,Colonic Neoplasms,0.8212681436603975
CDH1,Inflammation,0.8212681436603975
CDH1,precancerous lesions,0.8232134984476662
CDH1,Liver Cirrhosis,0.8232134984476662
CDH1,Sarcoma Spindle Cell,0.8232134984476662
CDH1,Cleft Lip with or without Cleft Palate,0.8232134984476662
CDH1,Neoplasm Invasiveness,0.8232134984476662
CDH1,Epstein-Barr Virus Infections,0.8232134984476662
CDH1,polyps,0.8232134984476662
CDH1,Endometriosis of ovary,0.8270909867833504
CDH1,Infection,0.8272008757995397
CDH1,Meningioma benign no ICD-O subtype,0.8272008757995397
CDH1,Pituitary Adenoma,0.834094492023826
CDH1,Pituitary Neoplasms,0.8368219249856942
CDH1,Lymphatic Metastasis,0.8368219249856942
CDH1,Carcinoma Transitional Cell,0.8368219249856942
CDH1,Hereditary Nonpolyposis Colorectal Neoplasms,0.8402911822757345
CDH1,Mammary Carcinoma Animal,0.8402911822757345
CDH1,Animal Mammary Neoplasms,0.8402911822757345
CDH1,Cholangiocarcinoma,0.8402911822757345
CDH1,Laryngeal neoplasm,0.8402911822757345
CDH1,Micronychia (disorder),0.8402911822757345
CDH1,Anaplastic carcinoma,0.8402911822757345
CDH1,Thymoma,0.8402911822757345
CDH1,Colorectal cancer metastatic,0.8402911822757345
CDH1,Hepatitis B,0.841396342333011
CDH1,Sporadic Breast Carcinoma,0.8474481237156937
CDH1,Familial multiple trichoepitheliomata,0.8523465762428218
CDH1,Medulloblastoma,0.8548862007194026
CDH1,Cirrhosis,0.8554819098734854
CDH1,Squamous cell carcinoma of esophagus,0.8610447277138289
CDH1,Renal carcinoma,0.8648405521677974
CDH1,Anaplasia,0.8648405521677974
CDH1,Condition Preneoplastic,0.8648405521677974
CDH1,Liver Neoplasms Experimental,0.8648405521677974
CDH1,Experimental Hepatoma,0.8648405521677974
CDH1,Familial (FPAH),0.8648405521677974
CDH1,Hepatoma Novikoff,0.8648405521677974
CDH1,Carcinoma Lobular,0.8648405521677974
CDH1,Oncocytic Neoplasm,0.8648405521677974
CDH1,Hepatoma Morris,0.8711129600224142
CDH1,Hepatitis B Chronic,0.8745234584149799
CDH1,Papillary thyroid carcinoma,0.8757755363384367
CDH1,Hyperplasia,0.876210765330195
CDH1,Hepatitis Chronic,0.8769418330148872
CDH1,Adenocarcinoma Of Esophagus,0.8769418330148872
CDH1,Low grade glioma,0.8769418330148872
CDH1,Malignant neoplasm of endometrium,0.8769418330148872
CDH1,Kidney Calculi,0.8769418330148872
CDH1,Uterine Corpus Cancer,0.8771562273432176
CDH1,Childhood asthma,0.8774809019744603
CDH1,Cytogenetically normal acute myeloid leukemia,0.8774809019744603
CDH1,Kidney Neoplasm,0.8774809019744603
CDH1,Hereditary Nonpolyposis Colorectal Cancer,0.8790903385143003
CDH1,Mammary Ductal Carcinoma,0.8806784681730055
CDH1,Mammary Neoplasms Human,0.8815127642200768
CDH1,Malignant neoplasm of kidney,0.8818220091065441
CDH1,Oxyphilic Adenoma,0.882453254162044
CDH1,Orbital separation excessive,0.8851456306720444
CDH1,Carcinoma Papillary,0.887080330932516
CDH1,Hereditary pancreatitis,0.887595340546704
CDH1,Hyperactive behavior,0.8878860377518915
CDH1,Pulmonary Fibrosis,0.8911256045597441
CDH1,Familial primary gastric lymphoma,0.8942113186235617
CDH1,Malignant neoplasm of mouth,0.8946938397586319
CDH1,Meningioma,0.8973454964837912
CDH1,Marginal Zone B-Cell Lymphoma,0.8980854850210683
CDH1,Secondary malignant neoplasm of lymph node,0.900167961295542
CDH1,Eczema,0.909484944705772
CDH1,Neoplasms Experimental,0.9098977259629772
CDH1,Salivary Gland Neoplasms,0.9117936912777788
CDH1,synovial sarcoma,0.9119978323790848
CDH1,Squamous cell carcinoma of tongue,0.9119978323790848
CDH1,Abnormality of metabolism/homeostasis,0.914995991166204
CDH1,Hurthle Cell Tumor,0.914995991166204
CDH1,Curvature of digit,0.9154499654632742
CDH1,Congenital clinodactyly,0.9193385822373632
CDH1,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),0.9262273158806068
CDH1,Irritable Bowel Syndrome,0.9265708351135048
CDH1,Cyst,0.929235785949896
CDH1,Gastritis,0.9399783595775548
CDH1,Secondary malignant neoplasm of bone,0.946564927793026
CDH1,Hypodontia,0.9534337109847604
CDH1,Nodule,0.9561991866282916
CDH1,Neoplastic Cell Transformation,0.9578035687879456
CDH1,Endometriosis,0.960644037248553
CDH1,Cutaneous Melanoma,0.9639249377588224
CDH1,Asthma,0.9672478180546946
CDH1,Breast Cancer Familial,0.9707275133033936
CDH1,Mammary Neoplasms Experimental,0.9738491767258852
CDH1,Adenoid Cystic Carcinoma,0.9896536639644284
CDH1,Cardiomyopathy Familial Idiopathic,0.999617369136378
CDH1,Malnutrition,0.6734982286750932
CDH1,Cleft Palate And Bilateral Cleft Lip,0.7311975666200533
CDH1,Ovarian Neoplasm,0.7765582368651238
CDH1,Velopharyngeal Insufficiency,0.7765582368651238
CDH1,Prostate Cancer,0.7765582368651238
CDH1,Melanoma,0.7765582368651238
CDH1,Prostatic Neoplasms,0.7765582368651238
CDH1,Oropharyngeal Dysphagia,0.7765582368651238
CDH1,Prostate Cancer Hereditary,0.7765582368651238
CDH1,Ovarian Papillary Adenocarcinoma,0.7765582368651238
CDH1,Dysgerminoma,0.7765582368651238
CDH1,Hereditary Cancer Syndrome,0.7765582368651238
CDH1,Congenital Euryblepharon,0.7765582368651238
CDH1,Hereditary Breast Cancer,0.7765582368651238
CDH1,Hypoplasia Of The Maxilla,0.7765582368651238
CDH1,Ductal Carcinoma,0.7765582368651238
CDH1,Ovarian Carcinoma,0.7765582368651238
CDH1,Stomach Neoplasms,0.7765582368651238
CDH1,Invasive Duct And Lobular Carcinoma,0.7765582368651238
CDH1,Ovarian Cancer,0.7797212851906329
CDH1,Endometrial Neoplasms,0.7860378120955526
CDH1,Benign Neoplasm Of Stomach,0.8115918568696846
CDH1,Peg-Shaped Teeth,0.8115918568696846
CDH1,Otitis Media,0.8115918568696846
CDH1,Bladder Neoplasm,0.8115918568696846
CDH1,Gastritis,0.8115918568696846
CDH1,Urinary Bladder Cancer,0.8115918568696846
CDH1,Nasopharyngeal Carcinoma,0.8115918568696846
CDH1,Hearing Loss,0.8115918568696846
CDH1,Endometrial Carcinoma,0.8115918568696846
CDH1,Anaplastic Carcinoma,0.8115918568696846
CDH1,Mammary Neoplasms,0.8165359516083085
CDH1,Colonic Neoplasms,0.8210988731657684
CDH1,Malignant Melanoma Of Skin,0.8356859041719433
CDH1,Neural Tube Defect,0.8457525389282121
CDH1,Marfan Syndrome,0.8477374749042494
CDH1,Thyroid Carcinoma,0.8611702959552964
CDH1,Pancreatic Neoplasm,0.861756360478846
CDH1,Hereditary Nonpolyposis Colorectal Cancer,0.861756360478846
CDH1,Gastric Cancer,0.861756360478846
CDH1,Stomach Carcinoma,0.861756360478846
CDH1,Mesothelioma,0.861756360478846
CDH1,Ovarian Epithelial Carcinoma,0.861756360478846
CDH1,Malignant Neoplasm Of Salivary Gland,0.861756360478846
CDH1,Ulcerative Colitis,0.861756360478846
CDH1,Salivary Gland Neoplasm,0.8827958376161968
CDH1,Pancreatic Cancer,0.8903301324869451
CDH1,Syndactyly Of Fingers,0.8903630091389316
CDH1,Breast Cancer,0.8903630091389316
CDH1,Carcinoma,0.9069867032339078
CDH1,Adenocarcinoma,0.9350723667380212
CDH1,Breast Carcinoma,0.9398381935810408
CDH1,Colorectal Neoplasms,0.9510372690456612
CDH1,Imperforate Anus,0.974502015052702
CDH1,Colorectal Cancer,0.9832345076528324
CDH1,Clinodactyly,0.9832345076528324
CDH1,Hypodontia,0.986561188259959
CDH1,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
CDH1,Van der Woude syndrome ORPHA:888,0.1991445465001551
CDH1,Apparent mineralocorticoid excess ORPHA:320,0.1991445465001551
CDH1,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.1991445465001551
CDH1,Autosomal recessive cerebral atrophy ORPHA:363969,0.1991445465001551
CDH1,Congenital intrauterine infection-like syndrome ORPHA:1229,0.1991445465001551
CDH1,Congenital tufting enteropathy ORPHA:92050,0.1991445465001551
CDH1,EEM syndrome ORPHA:1897,0.1991445465001551
CDH1,Familial expansile osteolysis ORPHA:85195,0.1991445465001551
CDH1,Hypotrichosis with juvenile macular degeneration ORPHA:1573,0.1991445465001551
CDH1,Isolated neonatal sclerosing cholangitis ORPHA:480556,0.1991445465001551
CDH1,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.1991445465001551
CDH1,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.1991445465001551
CDH1,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.1991445465001551
CDH1,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1991445465001551
CDH1,Cleft lip/palate ORPHA:199306,0.2567797333165013
CDH1,Generalized pseudohypoaldosteronism type 1 ORPHA:171876,0.3832844616405875
CDH1,Liddle syndrome ORPHA:526,0.3832844616405875
CDH1,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3832844616405875
CDH1,Familial hyperprolactinemia ORPHA:397685,0.3832844616405875
CDH1,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3832844616405875
CDH1,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3832844616405875
CDH1,Syndromic congenital sodium diarrhea ORPHA:563708,0.3832844616405875
CDH1,Bifid uvula ORPHA:99771,0.3832844616405875
CDH1,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.3832844616405875
CDH1,Cleft hard palate ORPHA:101023,0.3832844616405875
CDH1,Cleft velum ORPHA:99772,0.3832844616405875
CDH1,Submucosal cleft palate ORPHA:155878,0.3832844616405875
CDH1,Cleft lip and alveolus ORPHA:141291,0.3891940933600213
CDH1,Isolated cleft lip ORPHA:199302,0.3891940933600213
CDH1,Lethal acantholytic erosive disorder ORPHA:158687,0.5867963421058087
CDH1,Bartsocas-Papas syndrome ORPHA:1234,0.5867963421058087
CDH1,Benign recurrent intrahepatic cholestasis type 1 ORPHA:99960,0.5867963421058087
CDH1,CHAND syndrome ORPHA:1401,0.5867963421058087
CDH1,Carvajal syndrome ORPHA:65282,0.5867963421058087
CDH1,Cholangiocarcinoma ORPHA:70567,0.5867963421058087
CDH1,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.5867963421058087
CDH1,Idiopathic bronchiectasis ORPHA:60033,0.5867963421058087
CDH1,Low isolated anorectal malformation ORPHA:171215,0.5867963421058087
CDH1,Mullerian aplasia and hyperandrogenism ORPHA:247768,0.5867963421058087
CDH1,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744,0.5867963421058087
CDH1,SERKAL syndrome ORPHA:139466,0.5867963421058087
CDH1,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.5867963421058087
CDH1,Systemic primary carnitine deficiency ORPHA:158,0.5867963421058087
CDH1,X-linked recessive ocular albinism ORPHA:54,0.5867963421058087
CDH1,Congenital bilateral absence of vas deferens ORPHA:48,0.5867963421058087
CDH1,Microvillus inclusion disease ORPHA:2290,0.5867963421058087
CDH1,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.5867963421058087
CDH1,Hereditary diffuse gastric cancer ORPHA:26106,0.5867963421058087
CDH1,Hypocalcified amelogenesis imperfecta ORPHA:100032,0.5959529547720634
CDH1,Apert syndrome ORPHA:87,0.7929682744768703
CDH1,Autosomal recessive spastic paraplegia type 35 ORPHA:171629,0.7929682744768703
CDH1,Cranio-osteoarthropathy ORPHA:1525,0.7929682744768703
CDH1,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555,0.7929682744768703
CDH1,Ectodermal dysplasia-syndactyly syndrome ORPHA:247820,0.7929682744768703
CDH1,Epidermolysis bullosa simplex due to exophilin 5 deficiency ORPHA:412189,0.7929682744768703
CDH1,FGFR2-related bent bone dysplasia ORPHA:313855,0.7929682744768703
CDH1,Familial scaphocephaly syndrome McGillivray type ORPHA:168624,0.7929682744768703
CDH1,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334,0.7929682744768703
CDH1,Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308,0.7929682744768703
CDH1,Glucose-galactose malabsorption ORPHA:35710,0.7929682744768703
CDH1,Harlequin ichthyosis ORPHA:457,0.7929682744768703
CDH1,Ichthyosis-hypotrichosis syndrome ORPHA:91132,0.7929682744768703
CDH1,Isolated congenital digital clubbing ORPHA:217059,0.7929682744768703
CDH1,Jackson-Weiss syndrome ORPHA:1540,0.7929682744768703
CDH1,Keratoderma hereditarium mutilans ORPHA:494,0.7929682744768703
CDH1,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698,0.7929682744768703
CDH1,Pfeiffer syndrome type 2 ORPHA:93259,0.7929682744768703
CDH1,Pfeiffer syndrome type 3 ORPHA:93260,0.7929682744768703
CDH1,Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286,0.7929682744768703
CDH1,Serrated polyposis syndrome ORPHA:157798,0.7929682744768703
CDH1,Xanthinuria type I ORPHA:93601,0.7929682744768703
CDH1,Neonatal severe primary hyperparathyroidism ORPHA:417,0.7929682744768703
CDH1,Palmoplantar keratoderma-deafness syndrome ORPHA:2202,0.7929682744768703
CDH1,Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992,0.7929682744768703
CDH1,Hereditary breast cancer ORPHA:227535,0.8329982337461243
CDH1,Pulmonary alveolar microlithiasis ORPHA:60025,0.8922466888454011
CDH1,Diffuse panbronchiolitis ORPHA:171700,0.8922466888454011
CDH1,NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651,0.8922466888454011
CDH1,Pachydermoperiostosis ORPHA:2796,0.8922466888454011
CDH1,Posterior polymorphous corneal dystrophy ORPHA:98973,0.8922466888454011
CDH1,Hypotrichosis simplex ORPHA:55654,0.8922466888454011
CDH1,Aquagenic palmoplantar keratoderma ORPHA:498359,0.8922466888454011
CDH1,Glutamate-cysteine ligase deficiency ORPHA:33574,0.8922466888454011
CDH1,Seborrhea-like dermatitis with psoriasiform elements ORPHA:168606,0.8922466888454011
CDH1,Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
CDH1,Dengue virus 3 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
CDH1,Cowpox virus CPXV209 protein (gene: CPXV209 CDS),0.8999095837312036
CDH1,Rio Bravo virus envelope protein,0.8999095837312036
CDH1,Human adenovirus 56 CR1 beta protein (gene: E3),0.8999095837312036
CDH1,Vaccinia virus IL-beta-binding protein (gene: VACWR-B15R),0.8999095837312036
CDH1,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
CDH1,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
CDH1,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
CDH1,Vaccinia virus Ankara Interleukin-1 beta receptor,0.8999095837312036
CDH1,Molluscum contagiosum virus subtype 1 MC033L (gene: MC033L),0.9057542447893764
CDH1,Yaba-like disease virus 123R protein (gene: 123R),0.9103786566415374
CDH1,Yaba monkey tumor virus IEV and EEV membrane glycoprotein,0.9397923093369096
CDH1,Molluscum contagiosum virus subtype 1 MC143R (gene: MC143R),0.9450424991150602
CDH15,Mastocytosis Systemic,0.7880542567584415
CDH15,Colorectal Cancer,0.7880542567584415
CDH15,Rhabdomyosarcoma,0.7880542567584415
CDH15,Sudden infant death syndrome,0.7880542567584415
CDH15,Familial lichen amyloidosis,0.7880542567584415
CDH15,Sclerocystic Ovaries,0.7880542567584415
CDH15,Medium-chain acyl-coenzyme A dehydrogenase deficiency,0.7880542567584415
CDH15,Renal Cell Carcinoma,0.7880542567584415
CDH15,Indolent Systemic Mastocytosis,0.7880542567584415
CDH15,Alcoholic Intoxication Chronic,0.8019075543217649
CDH15,Hypoglycemia,0.8232134984476662
CDH15,Vomiting,0.8270909867833504
CDH15,Anaphylaxis (non medication),0.8402911822757345
CDH15,Mental deficiency,0.8402911822757345
CDH15,Exanthema,0.8619324281003841
CDH15,Dull intelligence,0.8757755363384367
CDH15,Low intelligence,0.8757755363384367
CDH15,Heart failure,0.8867509400747969
CDH15,Poor school performance,0.8913141512402477
CDH15,Polycystic Ovary Syndrome,0.9174808175273056
CDH15,Severe mental retardation (I.Q. 20-34),0.917543617287358
CDH15,Mental Retardation,0.922229272318747
CDH15,Intellectual Disability,0.9478210444156088
CDH15,Endometriosis,0.960644037248553
CDH15,Non-Syndromic Intellectual Disability,0.6734982286750932
CDH15,Sclerocystic Ovaries,0.7765582368651238
CDH15,Polycystic Ovary Syndrome,0.7765582368651238
CDH15,Mental Retardation,0.8337953215113012
CDH15,Autosomal dominant non-syndromic intellectual disability ORPHA:178469,0.7929682744768703
CDH15,Fetal akinesia deformation sequence ORPHA:994,0.8922466888454011
CDH15,Postsynaptic congenital myasthenic syndromes ORPHA:98913,0.8922466888454011
CDH15,Carney complex-trismus-pseudocamptodactyly syndrome ORPHA:319340,0.8922466888454011
CDH15,Cataract-glaucoma syndrome ORPHA:162,0.8922466888454011
CDH15,Congenital myopathy with reduced type 2 muscle fibers ORPHA:544602,0.8922466888454011
CDH15,Lethal multiple pterygium syndrome ORPHA:33108,0.8922466888454011
CDH15,Trismus-pseudocamptodactyly syndrome ORPHA:3377,0.8922466888454011
CDH3,Malignant neoplasm of breast,0.4084380369379369
CDH3,Breast Carcinoma,0.7333611688795861
CDH3,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
CDH3,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
CDH3,Reduced tensile strength of hair,0.7333611688795861
CDH3,Fractured hair,0.7333611688795861
CDH3,Fragile hair,0.7333611688795861
CDH3,Brittle hair,0.7495999465637118
CDH3,Adenocarcinoma,0.750391252594775
CDH3,Malignant neoplasm of pancreas,0.7688485284765829
CDH3,Colorectal Carcinoma,0.7765852775619541
CDH3,Pancreatic carcinoma,0.7765852775619541
CDH3,Retinal pigment epithelial abnormality,0.7765852775619541
CDH3,Abnormality of retinal pigmentation,0.7765852775619541
CDH3,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CDH3,Colorectal Neoplasms,0.7765852775619541
CDH3,Adenoma,0.7765852775619541
CDH3,Tooth problem,0.7765852775619541
CDH3,Mammary Neoplasms,0.7880542567584415
CDH3,Abnormality of the dentition,0.7880542567584415
CDH3,Malignant neoplasm of prostate,0.7880542567584415
CDH3,Rotting teeth,0.7880542567584415
CDH3,Dental caries,0.7880542567584415
CDH3,Colorectal Cancer,0.7880542567584415
CDH3,Epithelial ovarian cancer,0.7880542567584415
CDH3,Prostate carcinoma,0.7880542567584415
CDH3,Neoplasm Metastasis,0.7880542567584415
CDH3,Sparse body hair,0.7880542567584415
CDH3,Abnormality of vision,0.7880542567584415
CDH3,Prostatic Neoplasms,0.7880542567584415
CDH3,Familial lichen amyloidosis,0.7880542567584415
CDH3,Cone-Rod Dystrophies,0.7880542567584415
CDH3,melanoma,0.7880542567584415
CDH3,Ectrodactyly,0.7880542567584415
CDH3,Retinal Diseases,0.7880542567584415
CDH3,Sparse scalp hair,0.7880542567584415
CDH3,Selective tooth agenesis,0.7880542567584415
CDH3,Absence of a tooth,0.7880542567584415
CDH3,Malignant mesothelioma,0.7880542567584415
CDH3,Severe Combined Immunodeficiency,0.7880542567584415
CDH3,Fine hair,0.7880542567584415
CDH3,Mucoepidermoid Carcinoma,0.7880542567584415
CDH3,Renal Cell Carcinoma,0.7880542567584415
CDH3,Syndactyly of fingers,0.7880542567584415
CDH3,Pili Torti,0.7880542567584415
CDH3,Squamous cell carcinoma,0.7880542567584415
CDH3,invasive cancer,0.7880542567584415
CDH3,Cone dystrophy,0.7880542567584415
CDH3,Sparse eyelashes,0.7880542567584415
CDH3,Adenoma of large intestine,0.7880542567584415
CDH3,Crohn Disease,0.7880542567584415
CDH3,Sparse and thin eyebrow,0.7967714690735718
CDH3,Hypotrichosis,0.8019075543217649
CDH3,Absent eyebrow,0.8019075543217649
CDH3,Agenesis of eyebrows,0.8019075543217649
CDH3,Aplasia of eyebrows,0.8019075543217649
CDH3,Madarosis of eyebrow,0.8019075543217649
CDH3,Multiple Sclerosis,0.8019075543217649
CDH3,Red cell distribution width determination,0.8019075543217649
CDH3,Reduced visual acuity,0.8019075543217649
CDH3,RDW - Red blood cell distribution width result,0.8019075543217649
CDH3,Abnormality of macular pigmentation,0.8019075543217649
CDH3,Macular pigmentary changes,0.8019075543217649
CDH3,Blindness Legal,0.8019075543217649
CDH3,Hereditary macular dystrophy,0.8019075543217649
CDH3,Blindness,0.8098851543361193
CDH3,Decreased width of tooth,0.8168901801930506
CDH3,Ulcerative Colitis,0.8190761496232595
CDH3,Microdontia (disorder),0.8190761496232595
CDH3,Decreased size of teeth,0.8232134984476662
CDH3,Split-Hand/Foot Malformation,0.8232134984476662
CDH3,Nail abnormality,0.8270909867833504
CDH3,Corpus Luteum Cyst,0.8272008757995397
CDH3,Macular dystrophy,0.8272008757995397
CDH3,Contracture of joint of hand,0.8402911822757345
CDH3,Nail Diseases,0.8402911822757345
CDH3,Split hand foot deformity 1,0.8402911822757345
CDH3,Widely spaced teeth,0.8402911822757345
CDH3,Claw hand,0.8648405521677974
CDH3,Ectodermal Dysplasia,0.8648405521677974
CDH3,Macular degeneration,0.8769418330148872
CDH3,Congenital Camptodactyly,0.8774809019744603
CDH3,Short stature,0.8815127642200768
CDH3,Age related macular degeneration,0.8980854850210683
CDH3,Ovarian Cysts,0.8989612563669234
CDH3,Syndactyly,0.914995991166204
CDH3,Intellectual Disability,0.9478210444156088
CDH3,Endometriosis,0.960644037248553
CDH3,Ectrodactyly,0.7765582368651238
CDH3,Melanocytic Nevus,0.7765582368651238
CDH3,Nystagmus,0.7765582368651238
CDH3,Disorder Of Eye,0.7765582368651238
CDH3,Retinal Diseases,0.8115918568696846
CDH3,Absent Eyebrow,0.8115918568696846
CDH3,Hypotrichosis,0.8115918568696846
CDH3,Colorectal Adenoma,0.8115918568696846
CDH3,Congenital Camptodactyly,0.8115918568696846
CDH3,Macular Dystrophy,0.8115918568696846
CDH3,Skeletal Dysplasia,0.8182883735985873
CDH3,Osteochondrodysplasia,0.8210988731657684
CDH3,Colonic Neoplasms,0.8210988731657684
CDH3,Corpus Luteum Cyst,0.8476516371290275
CDH3,Ectodermal Dysplasia,0.8566038214826551
CDH3,Ulcerative Colitis,0.861756360478846
CDH3,Ovarian Cysts,0.861756360478846
CDH3,Microdontia,0.861756360478846
CDH3,Syndactyly Of Fingers,0.8903630091389316
CDH3,Strabismus,0.8908485337686392
CDH3,Hyperkeratosis,0.9436990979382386
CDH3,Colorectal Neoplasms,0.9510372690456612
CDH3,Dwarfism,0.9510372690456612
CDH3,Syndactyly,0.9543024119762946
CDH3,Multiple Sclerosis,0.980894832851993
CDH3,Colorectal Cancer,0.9832345076528324
CDH3,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
CDH3,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
CDH3,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
CDH3,Van der Woude syndrome ORPHA:888,0.1991445465001551
CDH3,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.1991445465001551
CDH3,Congenital tufting enteropathy ORPHA:92050,0.1991445465001551
CDH3,EEM syndrome ORPHA:1897,0.1991445465001551
CDH3,Hypotrichosis with juvenile macular degeneration ORPHA:1573,0.1991445465001551
CDH3,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.1991445465001551
CDH3,Cleft lip/palate ORPHA:199306,0.2567797333165013
CDH3,Generalized pseudohypoaldosteronism type 1 ORPHA:171876,0.3832844616405875
CDH3,Liddle syndrome ORPHA:526,0.3832844616405875
CDH3,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3832844616405875
CDH3,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3832844616405875
CDH3,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3832844616405875
CDH3,Syndromic congenital sodium diarrhea ORPHA:563708,0.3832844616405875
CDH3,Bifid uvula ORPHA:99771,0.3832844616405875
CDH3,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.3832844616405875
CDH3,Cleft hard palate ORPHA:101023,0.3832844616405875
CDH3,Cleft velum ORPHA:99772,0.3832844616405875
CDH3,Submucosal cleft palate ORPHA:155878,0.3832844616405875
CDH3,Cleft lip and alveolus ORPHA:141291,0.3891940933600213
CDH3,Isolated cleft lip ORPHA:199302,0.3891940933600213
CDH3,NON RARE IN EUROPE: Hypodontia ORPHA:2227,0.4621817429362311
CDH3,Localized junctional epidermolysis bullosa ORPHA:251393,0.5867963421058087
CDH3,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034,0.5867963421058087
CDH3,Mullerian aplasia and hyperandrogenism ORPHA:247768,0.5867963421058087
CDH3,Neuropathy with hearing impairment ORPHA:139512,0.5867963421058087
CDH3,SERKAL syndrome ORPHA:139466,0.5867963421058087
CDH3,Sebocystomatosis ORPHA:841,0.5867963421058087
CDH3,Tricho-dento-osseous syndrome ORPHA:3352,0.5867963421058087
CDH3,X-linked recessive ocular albinism ORPHA:54,0.5867963421058087
CDH3,Hypocalcified amelogenesis imperfecta ORPHA:100032,0.5959529547720634
CDH3,Autosomal recessive distal renal tubular acidosis ORPHA:402041,0.7929682744768703
CDH3,Pachyonychia congenita ORPHA:2309,0.7929682744768703
CDH3,Apert syndrome ORPHA:87,0.7929682744768703
CDH3,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555,0.7929682744768703
CDH3,Ectodermal dysplasia-syndactyly syndrome ORPHA:247820,0.7929682744768703
CDH3,FGFR2-related bent bone dysplasia ORPHA:313855,0.7929682744768703
CDH3,Familial scaphocephaly syndrome McGillivray type ORPHA:168624,0.7929682744768703
CDH3,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334,0.7929682744768703
CDH3,Harlequin ichthyosis ORPHA:457,0.7929682744768703
CDH3,Hereditary hypotrichosis with recurrent skin vesicles ORPHA:217407,0.7929682744768703
CDH3,Jackson-Weiss syndrome ORPHA:1540,0.7929682744768703
CDH3,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.7929682744768703
CDH3,Netherton syndrome ORPHA:634,0.7929682744768703
CDH3,Pfeiffer syndrome type 2 ORPHA:93259,0.7929682744768703
CDH3,Pfeiffer syndrome type 3 ORPHA:93260,0.7929682744768703
CDH3,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.7929682744768703
CDH3,Bladder exstrophy ORPHA:93930,0.7929682744768703
CDH3,Oligodontia ORPHA:99798,0.8778481542696168
CDH3,Ectodermal dysplasia-skin fragility syndrome ORPHA:158668,0.8922466888454011
CDH3,Fraser syndrome ORPHA:2052,0.8922466888454011
CDH3,NON RARE IN EUROPE: Idiopathic infantile nystagmus ORPHA:651,0.8922466888454011
CDH3,Congenital hereditary facial paralysis-variable hearing loss syndrome ORPHA:306530,0.8922466888454011
CDH3,Nail-patella syndrome ORPHA:2614,0.8922466888454011
CDH3,Nail-patella-like renal disease ORPHA:2613,0.8922466888454011
CDKN1A,Malignant neoplasm of breast,0.4084380369379369
CDKN1A,Carcinoma of bladder,0.4084380369379369
CDKN1A,Bladder Neoplasm,0.4084380369379369
CDKN1A,Malignant neoplasm of urinary bladder,0.5071083164302358
CDKN1A,Adenomatous Polyposis Coli,0.5196624042573144
CDKN1A,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CDKN1A,Breast Carcinoma,0.7333611688795861
CDKN1A,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CDKN1A,Carcinogenesis,0.7333611688795861
CDKN1A,Malignant neoplasm of ovary,0.7333611688795861
CDKN1A,B-Cell Lymphomas,0.7333611688795861
CDKN1A,Growth hormone excess,0.7333611688795861
CDKN1A,Superinfection,0.7333611688795861
CDKN1A,Non-Functioning Pituitary Gland Neoplasm,0.7333611688795861
CDKN1A,leukemia,0.7333611688795861
CDKN1A,Ovarian Carcinoma,0.7333611688795861
CDKN1A,Parathyroid hyperplasia,0.7495999465637118
CDKN1A,Adenocarcinoma,0.750391252594775
CDKN1A,Malignant neoplasm of pancreas,0.7688485284765829
CDKN1A,Hepatoblastoma,0.7765852775619541
CDKN1A,Mitochondrial Respiratory Chain Deficiencies,0.7765852775619541
CDKN1A,Colorectal Carcinoma,0.7765852775619541
CDKN1A,Pancreatic carcinoma,0.7765852775619541
CDKN1A,Pituitary growth hormone cell adenoma,0.7765852775619541
CDKN1A,Laryngeal Squamous Cell Carcinoma,0.7765852775619541
CDKN1A,Gastrointestinal Stromal Tumors,0.7765852775619541
CDKN1A,Colon Carcinoma,0.7765852775619541
CDKN1A,Leukemia Myelocytic Acute,0.7765852775619541
CDKN1A,Right Ventricular Hypertrophy,0.7765852775619541
CDKN1A,Subcutaneous lipoma,0.7765852775619541
CDKN1A,Fasting hyperinsulinemia,0.7765852775619541
CDKN1A,androgen independent prostate cancer,0.7765852775619541
CDKN1A,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
CDKN1A,Hyperinsulinemic hypoglycemia,0.7765852775619541
CDKN1A,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CDKN1A,Malignant tumor of colon,0.7765852775619541
CDKN1A,Malignant neoplasm of body of stomach,0.7765852775619541
CDKN1A,Malignant tumor of greater curve of stomach,0.7765852775619541
CDKN1A,Malignant tumor of lesser curve of stomach,0.7765852775619541
CDKN1A,Esophageal carcinoma,0.7765852775619541
CDKN1A,Lymphoma,0.7765852775619541
CDKN1A,Leukemogenesis,0.7765852775619541
CDKN1A,Endometrial Neoplasms,0.7765852775619541
CDKN1A,Cervix carcinoma,0.7765852775619541
CDKN1A,Non-Small Cell Lung Carcinoma,0.7765852775619541
CDKN1A,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CDKN1A,Myelomonocytic leukemia,0.7765852775619541
CDKN1A,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CDKN1A,Colorectal Neoplasms,0.7765852775619541
CDKN1A,Pancreatic intraepithelial neoplasia,0.7765852775619541
CDKN1A,Adenoma,0.7765852775619541
CDKN1A,Intestinal Cancer,0.7765852775619541
CDKN1A,Thyroid Neoplasm,0.7765852775619541
CDKN1A,Rhabdoid Tumor of the Kidney,0.7765852775619541
CDKN1A,Cholangitis,0.7765852775619541
CDKN1A,Nevus,0.7765852775619541
CDKN1A,Endometrial Carcinoma,0.7765852775619541
CDKN1A,Esophageal Neoplasms,0.7765852775619541
CDKN1A,Malignant tumor of cervix,0.7768809924982332
CDKN1A,Mammary Neoplasms,0.7880542567584415
CDKN1A,Glioma,0.7880542567584415
CDKN1A,Monocytic leukemia,0.7880542567584415
CDKN1A,Malignant neoplasm of lung,0.7880542567584415
CDKN1A,Malignant neoplasm of prostate,0.7880542567584415
CDKN1A,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
CDKN1A,Juvenile polyp,0.7880542567584415
CDKN1A,Hyperparathyroidism Secondary,0.7880542567584415
CDKN1A,Refractory anemias,0.7880542567584415
CDKN1A,Lymphoma Non-Hodgkin,0.7880542567584415
CDKN1A,Zollinger-Ellison syndrome,0.7880542567584415
CDKN1A,Promyelocytic leukemia,0.7880542567584415
CDKN1A,Liver carcinoma,0.7880542567584415
CDKN1A,Invasive carcinoma of breast,0.7880542567584415
CDKN1A,Elevated circulating parathyroid hormone level,0.7880542567584415
CDKN1A,Malignant neoplasm of esophagus,0.7880542567584415
CDKN1A,Malignant Head and Neck Neoplasm,0.7880542567584415
CDKN1A,Osteosarcoma,0.7880542567584415
CDKN1A,Rhabdoid Tumor,0.7880542567584415
CDKN1A,Thyroid carcinoma,0.7880542567584415
CDKN1A,intracranial glioma,0.7880542567584415
CDKN1A,Acute Promyelocytic Leukemia,0.7880542567584415
CDKN1A,Ataxia Telangiectasia,0.7880542567584415
CDKN1A,Colorectal Cancer,0.7880542567584415
CDKN1A,Epithelial ovarian cancer,0.7880542567584415
CDKN1A,Rhabdomyosarcoma,0.7880542567584415
CDKN1A,Leukemia T-Cell,0.7880542567584415
CDKN1A,Multiple malignancy,0.7880542567584415
CDKN1A,Hepatocarcinogenesis,0.7880542567584415
CDKN1A,Glioblastoma,0.7880542567584415
CDKN1A,Osteosarcoma of bone,0.7880542567584415
CDKN1A,Prostate carcinoma,0.7880542567584415
CDKN1A,Astrocytoma,0.7880542567584415
CDKN1A,Parathyroid Adenoma,0.7880542567584415
CDKN1A,Primary malignant neoplasm of lung,0.7880542567584415
CDKN1A,insulinoma,0.7880542567584415
CDKN1A,cervical cancer,0.7880542567584415
CDKN1A,Neoplasm Metastasis,0.7880542567584415
CDKN1A,Bloom Syndrome,0.7880542567584415
CDKN1A,Malignant neoplasm of testis,0.7880542567584415
CDKN1A,Peptic Ulcer,0.7880542567584415
CDKN1A,Prostatic Neoplasms,0.7880542567584415
CDKN1A,Carcinoma of lung,0.7880542567584415
CDKN1A,Cockayne Syndrome Type I,0.7880542567584415
CDKN1A,Malignant neoplasm of thyroid,0.7880542567584415
CDKN1A,Squamous cell carcinoma of the head and neck,0.7880542567584415
CDKN1A,Mesothelioma,0.7880542567584415
CDKN1A,Neuroblastoma,0.7880542567584415
CDKN1A,Hyperhomocysteinemia,0.7880542567584415
CDKN1A,Central neuroblastoma,0.7880542567584415
CDKN1A,Serum total cholesterol measurement,0.7880542567584415
CDKN1A,Interstitial Cystitis,0.7880542567584415
CDKN1A,Nodular glomerulosclerosis,0.7880542567584415
CDKN1A,Biliary cirrhosis,0.7880542567584415
CDKN1A,Malignant Neoplasms,0.7880542567584415
CDKN1A,Hematologic Neoplasms,0.7880542567584415
CDKN1A,melanoma,0.7880542567584415
CDKN1A,Intestinal Neoplasms,0.7880542567584415
CDKN1A,Adenocarcinoma of pancreas,0.7880542567584415
CDKN1A,Multiple Myeloma,0.7880542567584415
CDKN1A,Lung Neoplasms,0.7880542567584415
CDKN1A,Episodic abdominal pain,0.7880542567584415
CDKN1A,Intermittent abdominal pain,0.7880542567584415
CDKN1A,Adenoviral infections,0.7880542567584415
CDKN1A,Prolactinoma,0.7880542567584415
CDKN1A,Metastatic Prostate Carcinoma,0.7880542567584415
CDKN1A,Adrenal Cortical Adenoma,0.7880542567584415
CDKN1A,Melanocytic nevus,0.7880542567584415
CDKN1A,Angiofibroma,0.7880542567584415
CDKN1A,Malignant neoplasm of stomach,0.7880542567584415
CDKN1A,Burkitt Lymphoma,0.7880542567584415
CDKN1A,Optic Atrophy Autosomal Dominant,0.7880542567584415
CDKN1A,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
CDKN1A,Diarrhea,0.7880542567584415
CDKN1A,Sebaceous Adenocarcinoma,0.7880542567584415
CDKN1A,Adult Hepatocellular Carcinoma,0.7880542567584415
CDKN1A,Viral hepatitis,0.7880542567584415
CDKN1A,Hypopharyngeal Neoplasms,0.7880542567584415
CDKN1A,Lupus-like syndrome,0.7880542567584415
CDKN1A,Hypercalcemia,0.7880542567584415
CDKN1A,Papillary serous cystadenocarcinoma,0.7880542567584415
CDKN1A,Malignant mesothelioma,0.7880542567584415
CDKN1A,Hodgkin Disease,0.7880542567584415
CDKN1A,Esophagitis,0.7880542567584415
CDKN1A,Invasive Ductal Breast Carcinoma,0.7880542567584415
CDKN1A,Brain Neoplasms,0.7880542567584415
CDKN1A,Adenomyoma,0.7880542567584415
CDKN1A,Common wart,0.7880542567584415
CDKN1A,Nasopharyngeal carcinoma,0.7880542567584415
CDKN1A,M5b Acute differentiated monocytic leukemia,0.7880542567584415
CDKN1A,Malignant Testicular Germ Cell Tumor,0.7880542567584415
CDKN1A,Dementia,0.7880542567584415
CDKN1A,Glaucoma Open-Angle,0.7880542567584415
CDKN1A,Tumor Progression,0.7880542567584415
CDKN1A,Adenocarcinoma of colon,0.7880542567584415
CDKN1A,Atypical polypoid adenomyoma,0.7880542567584415
CDKN1A,Sarcoma,0.7880542567584415
CDKN1A,Lupus Erythematosus Systemic,0.7880542567584415
CDKN1A,Fuchs Endothelial Dystrophy,0.7880542567584415
CDKN1A,Monosomy,0.7880542567584415
CDKN1A,Renal Cell Carcinoma,0.7880542567584415
CDKN1A,Benign melanocytic nevus,0.7880542567584415
CDKN1A,ECTRODACTYLY ECTODERMAL DYSPLASIA AND CLEFT LIP/PALATE SYNDROME 1,0.7880542567584415
CDKN1A,Lymphoma Follicular,0.7880542567584415
CDKN1A,Anal intraepithelial neoplasia,0.7880542567584415
CDKN1A,Bile Duct Neoplasms,0.7880542567584415
CDKN1A,Corneal fibrosis,0.7880542567584415
CDKN1A,Presenile dementia,0.7880542567584415
CDKN1A,Retinoblastoma,0.7880542567584415
CDKN1A,Primary Effusion Lymphoma,0.7880542567584415
CDKN1A,Arteriosclerosis,0.7880542567584415
CDKN1A,Atherosclerosis,0.7880542567584415
CDKN1A,Acromegaly,0.7880542567584415
CDKN1A,Alzheimer's Disease,0.7880542567584415
CDKN1A,Acute lymphocytic leukemia,0.7880542567584415
CDKN1A,Systemic Anaplastic Large Cell Lymphoma,0.7880542567584415
CDKN1A,Hyperoxia,0.7880542567584415
CDKN1A,Chondrosarcoma,0.7880542567584415
CDKN1A,Stomach Carcinoma,0.7880542567584415
CDKN1A,Carcinoma of urinary bladder superficial,0.7880542567584415
CDKN1A,Autoimmune Diseases,0.7880542567584415
CDKN1A,Hepatitis C,0.7880542567584415
CDKN1A,Fanconi Anemia,0.7880542567584415
CDKN1A,Glaucoma,0.7880542567584415
CDKN1A,Liver and Intrahepatic Bile Duct Epithelial Neoplasm,0.7880542567584415
CDKN1A,Liver and Intrahepatic Bile Duct Neoplasm,0.7880542567584415
CDKN1A,Olfactory Neuroblastoma,0.7880542567584415
CDKN1A,Squamous cell carcinoma,0.7880542567584415
CDKN1A,Single tumor,0.7880542567584415
CDKN1A,Uterine Cervical Neoplasm,0.7880542567584415
CDKN1A,Solid Neoplasm,0.7880542567584415
CDKN1A,Classical Hodgkin's Lymphoma,0.7880542567584415
CDKN1A,invasive cancer,0.7880542567584415
CDKN1A,Rheumatoid Arthritis,0.7880542567584415
CDKN1A,Hyperparathyroidism,0.7880542567584415
CDKN1A,Diabetes,0.7880542567584415
CDKN1A,Diabetes Mellitus,0.7880542567584415
CDKN1A,Carcinoid Tumor,0.7880542567584415
CDKN1A,Lyme Disease,0.7880542567584415
CDKN1A,Li-Fraumeni Syndrome,0.7880542567584415
CDKN1A,Hyperglycemia,0.7880542567584415
CDKN1A,Small cell carcinoma of lung,0.7880542567584415
CDKN1A,Huntington Disease,0.7880542567584415
CDKN1A,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
CDKN1A,PACHYONYCHIA CONGENITA 3,0.7880542567584415
CDKN1A,Anaplastic thyroid carcinoma,0.7880542567584415
CDKN1A,Condyloma,0.7880542567584415
CDKN1A,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
CDKN1A,Intrahepatic Cholangiocarcinoma,0.7880542567584415
CDKN1A,Follicular adenoma,0.7880542567584415
CDKN1A,Metastatic Neoplasm,0.7880542567584415
CDKN1A,Hypertrophy of kidney,0.7880542567584415
CDKN1A,Mature B-Cell Non-Hodgkin Lymphoma,0.7880542567584415
CDKN1A,Virus Diseases,0.7880542567584415
CDKN1A,Myeloid Leukemia Chronic,0.7880542567584415
CDKN1A,Myeloid Leukemia,0.7880542567584415
CDKN1A,Primary central nervous system lymphoma,0.7880542567584415
CDKN1A,Disease due to Papilloma virus,0.7880542567584415
CDKN1A,Papillomatosis,0.7880542567584415
CDKN1A,Primary Cutaneous Anaplastic Large Cell Lymphoma,0.7880542567584415
CDKN1A,Malignant Glioma,0.7880542567584415
CDKN1A,Ulcer,0.7880542567584415
CDKN1A,Laryngeal Diseases,0.7908231553833205
CDKN1A,Central Serous Chorioretinopathy,0.7908231553833205
CDKN1A,Metastasis from malignant tumor of prostate,0.7908231553833205
CDKN1A,Papilloma Squamous Cell,0.7908231553833205
CDKN1A,Differentiating Neuroblastoma,0.7908231553833205
CDKN1A,Hypertrophy,0.7908231553833205
CDKN1A,Liver Cirrhosis Experimental,0.8014900279306119
CDKN1A,Undifferentiated carcinoma,0.8019075543217649
CDKN1A,Oropharynx (excludes nasopharynx),0.8019075543217649
CDKN1A,Nijmegen Breakage Syndrome,0.8019075543217649
CDKN1A,Teratocarcinoma,0.8019075543217649
CDKN1A,Pancreatic carcinoma familial,0.8019075543217649
CDKN1A,Psoriasis,0.8019075543217649
CDKN1A,Myocardial Infarction,0.8019075543217649
CDKN1A,Cholesteatoma,0.8019075543217649
CDKN1A,Granuloma,0.8019075543217649
CDKN1A,Melanocytic nevus of skin,0.8019075543217649
CDKN1A,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8019075543217649
CDKN1A,Adenocarcinoma of large intestine,0.8019075543217649
CDKN1A,Multiple Endocrine Neoplasia Type 1,0.8019075543217649
CDKN1A,Lung diseases,0.8019075543217649
CDKN1A,Fibrosarcoma,0.8019075543217649
CDKN1A,Chronic Lymphocytic Leukemia,0.8019075543217649
CDKN1A,Skin Erosion,0.8019075543217649
CDKN1A,Muscular Dystrophy Facioscapulohumeral,0.8019075543217649
CDKN1A,Degenerative polyarthritis,0.8019075543217649
CDKN1A,Hereditary Diffuse Gastric Cancer,0.8019075543217649
CDKN1A,Liver neoplasms,0.8019075543217649
CDKN1A,Human papilloma virus infection,0.8019075543217649
CDKN1A,Kidney Diseases,0.8019075543217649
CDKN1A,Cervix Diseases,0.8019075543217649
CDKN1A,Perianal Squamous Intraepithelial Neoplasia,0.8019075543217649
CDKN1A,Precancerous Conditions,0.8026504676141903
CDKN1A,Stomach Neoplasms,0.8044379824544406
CDKN1A,Histiocytosis Langerhans-Cell,0.8067197998685076
CDKN1A,Malignant neoplasm of salivary gland,0.8067197998685076
CDKN1A,Lupus Erythematosus,0.8067197998685076
CDKN1A,Nonalcoholic Steatohepatitis,0.8067197998685076
CDKN1A,ovarian neoplasm,0.8067197998685076
CDKN1A,Adenocarcinoma of lung (disorder),0.8098851543361193
CDKN1A,Lupus Erythematosus Discoid,0.8098851543361193
CDKN1A,Herpes Simplex Infections,0.8098851543361193
CDKN1A,Fluid overload,0.8098851543361193
CDKN1A,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
CDKN1A,Dysplastic Nevus,0.8138488881521341
CDKN1A,Breast adenocarcinoma,0.8138488881521341
CDKN1A,GASTRIC CANCER INTESTINAL,0.8138488881521341
CDKN1A,Liver diseases,0.8140222479282434
CDKN1A,Fibrosis,0.8145035474981049
CDKN1A,Hamartoma,0.8145035474981049
CDKN1A,HIV Infections,0.8145035474981049
CDKN1A,Renal hypertension,0.8145035474981049
CDKN1A,Polycystic Kidney Diseases,0.8168901801930506
CDKN1A,Ulcerative Colitis,0.8190761496232595
CDKN1A,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
CDKN1A,Lip and Oral Cavity Carcinoma,0.8190761496232595
CDKN1A,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CDKN1A,Bowen's Disease,0.8190761496232595
CDKN1A,Endometrial adenocarcinoma,0.8190761496232595
CDKN1A,Primary biliary cirrhosis,0.8212681436603975
CDKN1A,Colonic Neoplasms,0.8212681436603975
CDKN1A,Inflammation,0.8212681436603975
CDKN1A,Mouth Neoplasms,0.8232134984476662
CDKN1A,precancerous lesions,0.8232134984476662
CDKN1A,Liver Cirrhosis,0.8232134984476662
CDKN1A,Carcinoma Neuroendocrine,0.8232134984476662
CDKN1A,Gastric Adenocarcinoma,0.8232134984476662
CDKN1A,Lupus Vulgaris,0.8232134984476662
CDKN1A,Thyroid Gland Follicular Adenoma,0.8232134984476662
CDKN1A,polyps,0.8232134984476662
CDKN1A,Triglycerides measurement,0.8232134984476662
CDKN1A,Astrocytoma low grade,0.8270909867833504
CDKN1A,Ocular Hypertension,0.8270909867833504
CDKN1A,Actinic keratosis,0.8272008757995397
CDKN1A,Adrenal Gland Neoplasms,0.8272008757995397
CDKN1A,Fibrosis Liver,0.8272008757995397
CDKN1A,Lipoid nephrosis,0.834094492023826
CDKN1A,Glioblastoma Multiforme,0.8342163953428735
CDKN1A,Pituitary Neoplasms,0.8368219249856942
CDKN1A,Carcinoma Transitional Cell,0.8368219249856942
CDKN1A,Adenocarcinoma of rectum,0.8368219249856942
CDKN1A,Premature aging syndrome,0.8402911822757345
CDKN1A,Chronic viral hepatitis,0.8402911822757345
CDKN1A,Cardiac Arrest,0.8402911822757345
CDKN1A,Pulmonary Cystic Fibrosis,0.8402911822757345
CDKN1A,Papilloma,0.8402911822757345
CDKN1A,Steatohepatitis,0.8402911822757345
CDKN1A,Cervical Intraepithelial Neoplasia,0.8402911822757345
CDKN1A,Bronchogenic Carcinoma,0.8402911822757345
CDKN1A,Chondrodysplasia,0.8402911822757345
CDKN1A,Hepatitis B,0.841396342333011
CDKN1A,Down Syndrome,0.8420665668584452
CDKN1A,HIV Coinfection,0.843190898187174
CDKN1A,Hypertensive disease,0.8474481237156937
CDKN1A,keratoacanthoma,0.8486035047899471
CDKN1A,Cirrhosis,0.8554819098734854
CDKN1A,Bone Diseases,0.8578473133580928
CDKN1A,Anemia,0.8584283190330553
CDKN1A,Rectal Carcinoma,0.8584283190330553
CDKN1A,Reperfusion Injury,0.8584283190330553
CDKN1A,Squamous cell carcinoma of esophagus,0.8610447277138289
CDKN1A,Testicular Germ Cell Tumor,0.8648405521677974
CDKN1A,Renal carcinoma,0.8648405521677974
CDKN1A,Leukemia B-Cell,0.8648405521677974
CDKN1A,Papillary thyroid carcinoma,0.8757755363384367
CDKN1A,Cholestasis Extrahepatic,0.876210765330195
CDKN1A,Adenocarcinoma Of Esophagus,0.8769418330148872
CDKN1A,Malignant neoplasm of endometrium,0.8769418330148872
CDKN1A,Uterine Corpus Cancer,0.8771562273432176
CDKN1A,Parkinson Disease,0.8772392350816924
CDKN1A,Kidney Neoplasm,0.8774809019744603
CDKN1A,Inflammatory Bowel Diseases,0.8815127642200768
CDKN1A,Malignant neoplasm of kidney,0.8818220091065441
CDKN1A,Dermatitis Atopic,0.8867509400747969
CDKN1A,Heart failure,0.8867509400747969
CDKN1A,Malignant neoplasm of mouth,0.8946938397586319
CDKN1A,Meningioma,0.8973454964837912
CDKN1A,Congestive heart failure,0.8976039441125321
CDKN1A,Acoustic Neuroma,0.8980854850210683
CDKN1A,Obesity,0.8989612563669234
CDKN1A,Squamous cell carcinoma of skin,0.8989612563669234
CDKN1A,Secondary malignant neoplasm of lymph node,0.900167961295542
CDKN1A,Pulmonary Hypertension,0.9103315000053974
CDKN1A,synovial sarcoma,0.9119978323790848
CDKN1A,Soft Tissue Neoplasms,0.9146732238562176
CDKN1A,Cicatrix Hypertrophic,0.914995991166204
CDKN1A,Polycystic Ovary Syndrome,0.9174808175273056
CDKN1A,Hamman-Rich syndrome,0.9262273158806068
CDKN1A,Sarcoidosis,0.929235785949896
CDKN1A,Werner Syndrome,0.929814249105729
CDKN1A,Fibroid Tumor,0.9373358316580888
CDKN1A,Carcinoma of larynx,0.9377696084218796
CDKN1A,Diabetic Nephropathy,0.9390727893210336
CDKN1A,Idiopathic Pulmonary Fibrosis,0.9393256300017014
CDKN1A,Arthritis,0.9431511078237256
CDKN1A,Kaposi Sarcoma,0.9435654233359168
CDKN1A,Urothelial Carcinoma,0.9441119274323576
CDKN1A,Hepatitis A,0.9459312971127588
CDKN1A,Uterine Fibroids,0.9557184806547836
CDKN1A,Squamous cell carcinoma of lung,0.9564633032157428
CDKN1A,Acute Erythroblastic Leukemia,0.9639249377588224
CDKN1A,Tumor Angiogenesis,0.9656926709728724
CDKN1A,Asthma,0.9672478180546946
CDKN1A,Cystic Fibrosis,0.9874278479946328
CDKN1A,Adrenocortical Adenoma,0.4532988396145482
CDKN1A,Insulinoma,0.4532988396145482
CDKN1A,Adrenocortical Carcinoma,0.4532988396145482
CDKN1A,Multiple Endocrine Neoplasia,0.4532988396145482
CDKN1A,Parathyroid Hyperplasia,0.4532988396145482
CDKN1A,Glucagonoma,0.4532988396145482
CDKN1A,Angiofibroma,0.4904280964420943
CDKN1A,Zollinger-Ellison Syndrome,0.5957016454669307
CDKN1A,Subcutaneous Lipoma,0.6734982286750932
CDKN1A,Thymoma,0.7765582368651238
CDKN1A,Prolactinoma,0.7765582368651238
CDKN1A,Parathyroid Adenoma,0.7765582368651238
CDKN1A,Peptic Ulcer,0.7765582368651238
CDKN1A,Diabetic Nephropathy,0.7765582368651238
CDKN1A,Esophagitis,0.7765582368651238
CDKN1A,Prostate Cancer,0.7765582368651238
CDKN1A,Hyperinsulinemic Hypoglycemia,0.7765582368651238
CDKN1A,Hyperparathyroidism,0.7765582368651238
CDKN1A,Prostatic Neoplasms,0.7765582368651238
CDKN1A,Hypercalcemia,0.7765582368651238
CDKN1A,Pituitary Adenoma,0.7765582368651238
CDKN1A,Ischemic Stroke,0.7765582368651238
CDKN1A,Intestinal Cancer,0.7765582368651238
CDKN1A,Papillomatosis,0.7765582368651238
CDKN1A,Stomach Neoplasms,0.7765582368651238
CDKN1A,Glomerulosclerosis,0.7765582368651238
CDKN1A,Facioscapulohumeral Muscular Dystrophy,0.7765582368651238
CDKN1A,Thyroid Gland Follicular Adenoma,0.7860378120955526
CDKN1A,Cholestasis,0.8115918568696846
CDKN1A,Bladder Neoplasm,0.8115918568696846
CDKN1A,Intestinal Neoplasms,0.8115918568696846
CDKN1A,Urinary Bladder Cancer,0.8115918568696846
CDKN1A,Atrial Fibrillation,0.8115918568696846
CDKN1A,Malignant Neoplasm,0.8115918568696846
CDKN1A,Paroxysmal Atrial Fibrillation,0.8115918568696846
CDKN1A,Colonic Neoplasms,0.8210988731657684
CDKN1A,Kidney Disease,0.8210988731657684
CDKN1A,Papilloma,0.829560580336605
CDKN1A,Gastric Cancer,0.861756360478846
CDKN1A,Lung Cancer,0.8706864397989688
CDKN1A,Malignant Mesothelioma,0.8877197959767673
CDKN1A,Lung Neoplasms,0.8903301324869451
CDKN1A,Breast Carcinoma,0.9398381935810408
CDKN1A,Esophagus Neoplasm,0.9832345076528324
CDKN1A,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
CDKN1A,Heme oxygenase-1 deficiency ORPHA:562509,0.1040670578681756
CDKN1A,Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851,0.1991445465001551
CDKN1A,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,0.3891940933600213
CDKN1A,Niemann-Pick disease type C adult neurologic onset ORPHA:216986,0.5867963421058087
CDKN1A,Niemann-Pick disease type C juvenile neurologic onset ORPHA:216981,0.5867963421058087
CDKN1A,Niemann-Pick disease type C late infantile neurologic onset ORPHA:216978,0.5867963421058087
CDKN1A,Niemann-Pick disease type C severe early infantile neurologic onset ORPHA:216975,0.5867963421058087
CDKN1A,Niemann-Pick disease type C severe perinatal form ORPHA:216972,0.5867963421058087
CDKN1C,Malignant neoplasm of breast,0.4084380369379369
CDKN1C,Carcinoma of bladder,0.4084380369379369
CDKN1C,Bladder Neoplasm,0.4084380369379369
CDKN1C,Malignant neoplasm of urinary bladder,0.5071083164302358
CDKN1C,Breast Carcinoma,0.7333611688795861
CDKN1C,Hydatidiform Mole Partial,0.7333611688795861
CDKN1C,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CDKN1C,Carcinogenesis,0.7333611688795861
CDKN1C,Malignant neoplasm of ovary,0.7333611688795861
CDKN1C,B-Cell Lymphomas,0.7333611688795861
CDKN1C,Cerebellar malformation,0.7333611688795861
CDKN1C,leukemia,0.7333611688795861
CDKN1C,Ovarian Carcinoma,0.7333611688795861
CDKN1C,Adenocarcinoma,0.750391252594775
CDKN1C,Malignant neoplasm of pancreas,0.7688485284765829
CDKN1C,Hepatoblastoma,0.7765852775619541
CDKN1C,Relative macrocephaly,0.7765852775619541
CDKN1C,Beckwith-Wiedemann Syndrome,0.7765852775619541
CDKN1C,Adrenocortical cytomegaly,0.7765852775619541
CDKN1C,Overgrowth of external genitalia,0.7765852775619541
CDKN1C,Pancreatic hyperplasia,0.7765852775619541
CDKN1C,Colorectal Carcinoma,0.7765852775619541
CDKN1C,Pancreatic carcinoma,0.7765852775619541
CDKN1C,Colon Carcinoma,0.7765852775619541
CDKN1C,Leukemia Myelocytic Acute,0.7765852775619541
CDKN1C,Nephrolithiasis,0.7765852775619541
CDKN1C,HEMIHYPERPLASIA ISOLATED,0.7765852775619541
CDKN1C,MENTAL RETARDATION X-LINKED SNYDER-ROBINSON TYPE,0.7765852775619541
CDKN1C,Advanced bone age,0.7765852775619541
CDKN1C,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
CDKN1C,Hyperinsulinemic hypoglycemia,0.7765852775619541
CDKN1C,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CDKN1C,Malignant tumor of colon,0.7765852775619541
CDKN1C,Asymmetric overgrowth,0.7765852775619541
CDKN1C,Posterior helix pit,0.7765852775619541
CDKN1C,Esophageal carcinoma,0.7765852775619541
CDKN1C,Neonatal hypoglycemia,0.7765852775619541
CDKN1C,Endometrial Neoplasms,0.7765852775619541
CDKN1C,Non-Small Cell Lung Carcinoma,0.7765852775619541
CDKN1C,Small adrenal gland,0.7765852775619541
CDKN1C,Adrenal hypoplasia,0.7765852775619541
CDKN1C,Congenital exomphalos,0.7765852775619541
CDKN1C,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CDKN1C,Russell-Silver syndrome,0.7765852775619541
CDKN1C,Complete hydatidiform mole,0.7765852775619541
CDKN1C,Pancreatic Neoplasm,0.7765852775619541
CDKN1C,Adenoma,0.7765852775619541
CDKN1C,Thyroid Neoplasm,0.7765852775619541
CDKN1C,Nevus,0.7765852775619541
CDKN1C,Endometrial Carcinoma,0.7765852775619541
CDKN1C,Renal cortical cysts,0.7765852775619541
CDKN1C,Transient neonatal diabetes mellitus,0.7765852775619541
CDKN1C,Congenital hemihypertrophy,0.7765852775619541
CDKN1C,Esophageal Neoplasms,0.7765852775619541
CDKN1C,Mammary Neoplasms,0.7880542567584415
CDKN1C,Glioma,0.7880542567584415
CDKN1C,Malignant neoplasm of lung,0.7880542567584415
CDKN1C,Malignant neoplasm of prostate,0.7880542567584415
CDKN1C,Low Grade Lymphoma (neoplasm),0.7880542567584415
CDKN1C,Congenital omphalocele,0.7880542567584415
CDKN1C,Liver carcinoma,0.7880542567584415
CDKN1C,Overgrowth Syndrome,0.7880542567584415
CDKN1C,Malignant neoplasm of esophagus,0.7880542567584415
CDKN1C,Rhabdoid Tumor,0.7880542567584415
CDKN1C,Triploidy syndrome,0.7880542567584415
CDKN1C,Colorectal Cancer,0.7880542567584415
CDKN1C,Epithelial ovarian cancer,0.7880542567584415
CDKN1C,Rhabdomyosarcoma,0.7880542567584415
CDKN1C,HYDATIDIFORM MOLE RECURRENT 1,0.7880542567584415
CDKN1C,Leukemia T-Cell,0.7880542567584415
CDKN1C,Diastasis recti,0.7880542567584415
CDKN1C,Glioblastoma,0.7880542567584415
CDKN1C,Prostate carcinoma,0.7880542567584415
CDKN1C,Nephroblastoma,0.7880542567584415
CDKN1C,Frontal bossing,0.7880542567584415
CDKN1C,Primary malignant neoplasm of lung,0.7880542567584415
CDKN1C,insulinoma,0.7880542567584415
CDKN1C,Neoplasm Metastasis,0.7880542567584415
CDKN1C,Enlarged kidney,0.7880542567584415
CDKN1C,Carcinoma of lung,0.7880542567584415
CDKN1C,Fetal overgrowth,0.7880542567584415
CDKN1C,Generalized overgrowth,0.7880542567584415
CDKN1C,Overgrowth,0.7880542567584415
CDKN1C,Squamous cell carcinoma of the head and neck,0.7880542567584415
CDKN1C,Mesothelioma,0.7880542567584415
CDKN1C,Neuroblastoma,0.7880542567584415
CDKN1C,Hydatidiform Mole,0.7880542567584415
CDKN1C,Central neuroblastoma,0.7880542567584415
CDKN1C,Port-Wine Stain,0.7880542567584415
CDKN1C,Malignant Neoplasms,0.7880542567584415
CDKN1C,melanoma,0.7880542567584415
CDKN1C,Eclampsia,0.7880542567584415
CDKN1C,Lung Neoplasms,0.7880542567584415
CDKN1C,Glucocorticoid Receptor Deficiency,0.7880542567584415
CDKN1C,Neoplasms,0.7880542567584415
CDKN1C,Renal glomerular disease,0.7880542567584415
CDKN1C,Adrenal Cortical Adenoma,0.7880542567584415
CDKN1C,Melanocytic nevus,0.7880542567584415
CDKN1C,Cleft palate isolated,0.7880542567584415
CDKN1C,Gonadoblastoma,0.7880542567584415
CDKN1C,Large late-closing fontanelle,0.7880542567584415
CDKN1C,Wide bregma sutures,0.7880542567584415
CDKN1C,Large bregma sutures,0.7880542567584415
CDKN1C,Large fontanelle,0.7880542567584415
CDKN1C,SPLIT-HAND/FOOT MALFORMATION 4,0.7880542567584415
CDKN1C,Hypercalcemia,0.7880542567584415
CDKN1C,Prominent metopic ridge,0.7880542567584415
CDKN1C,Simple Endometrial Hyperplasia,0.7880542567584415
CDKN1C,Complex Endometrial Hyperplasia,0.7880542567584415
CDKN1C,Malignant neoplasm of large intestine,0.7880542567584415
CDKN1C,Nasopharyngeal carcinoma,0.7880542567584415
CDKN1C,Bulging forehead,0.7880542567584415
CDKN1C,Prominent forehead,0.7880542567584415
CDKN1C,Williams Syndrome,0.7880542567584415
CDKN1C,Infection caused by Helicobacter pylori,0.7880542567584415
CDKN1C,Tumor Progression,0.7880542567584415
CDKN1C,Sarcoma,0.7880542567584415
CDKN1C,Lupus Erythematosus Systemic,0.7880542567584415
CDKN1C,X-linked Adrenal Hypoplasia,0.7880542567584415
CDKN1C,Increased calcium level in kidney,0.7880542567584415
CDKN1C,Benign melanocytic nevus,0.7880542567584415
CDKN1C,Rectal Neoplasms,0.7880542567584415
CDKN1C,Prominent back of the head,0.7880542567584415
CDKN1C,Prominent occiput,0.7880542567584415
CDKN1C,Lymphoma Follicular,0.7880542567584415
CDKN1C,Cleft Palate,0.7880542567584415
CDKN1C,Retinoblastoma,0.7880542567584415
CDKN1C,Arteriosclerosis,0.7880542567584415
CDKN1C,Atherosclerosis,0.7880542567584415
CDKN1C,Congenital chromosomal disease,0.7880542567584415
CDKN1C,Gestational Trophoblastic Neoplasms,0.7880542567584415
CDKN1C,Acute lymphocytic leukemia,0.7880542567584415
CDKN1C,Small midface,0.7880542567584415
CDKN1C,Decreased projection of midface,0.7880542567584415
CDKN1C,Hypotrophic midface,0.7880542567584415
CDKN1C,Midface retrusion,0.7880542567584415
CDKN1C,Placental dysfunction,0.7880542567584415
CDKN1C,Diabetes Mellitus Transient Neonatal 1,0.7880542567584415
CDKN1C,Squamous cell carcinoma,0.7880542567584415
CDKN1C,Diabetes,0.7880542567584415
CDKN1C,Diabetes Mellitus,0.7880542567584415
CDKN1C,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
CDKN1C,Tumors of Adrenal Cortex,0.7880542567584415
CDKN1C,Pyle metaphyseal dysplasia,0.7880542567584415
CDKN1C,Atypical Endometrial Hyperplasia,0.7880542567584415
CDKN1C,Prominent eyes,0.7880542567584415
CDKN1C,Protruding eyes,0.7880542567584415
CDKN1C,Prominent globes,0.7880542567584415
CDKN1C,Malignant Glioma,0.7880542567584415
CDKN1C,Exophthalmos,0.7908231553833205
CDKN1C,Primary malignant neoplasm,0.7908231553833205
CDKN1C,Nephrocalcinosis,0.8009048756462318
CDKN1C,IGA Glomerulonephritis,0.8019075543217649
CDKN1C,Hyperinsulinism,0.8019075543217649
CDKN1C,Disorders of Sex Development,0.8019075543217649
CDKN1C,Abnormal development of end part of bone,0.8019075543217649
CDKN1C,Epiphyseal dysplasia,0.8019075543217649
CDKN1C,SIMPSON-GOLABI-BEHMEL SYNDROME TYPE 1,0.8019075543217649
CDKN1C,Multiple Sclerosis,0.8019075543217649
CDKN1C,Thrombocytopenia,0.8019075543217649
CDKN1C,Myocardial Infarction,0.8019075543217649
CDKN1C,Glomerulosclerosis (disorder),0.8019075543217649
CDKN1C,Liver neoplasms,0.8019075543217649
CDKN1C,Kidney Diseases,0.8019075543217649
CDKN1C,Pseudohypoparathyroidism,0.8019075543217649
CDKN1C,ovarian neoplasm,0.8067197998685076
CDKN1C,Schizophrenia,0.8067197998685076
CDKN1C,Lymphoma T-Cell Cutaneous,0.8098851543361193
CDKN1C,Isolated somatotropin deficiency,0.8101097852323003
CDKN1C,Blast Phase,0.8114747041691183
CDKN1C,Adult Acute Lymphocytic Leukemia,0.8145035474981049
CDKN1C,Endometrial Hyperplasia,0.8145035474981049
CDKN1C,Adenocarcinoma Tubular,0.8168901801930506
CDKN1C,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
CDKN1C,Mucosa-Associated Lymphoid Tissue Lymphoma,0.8190761496232595
CDKN1C,Lip and Oral Cavity Carcinoma,0.8190761496232595
CDKN1C,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CDKN1C,Dandy-Walker Syndrome,0.8190761496232595
CDKN1C,Gestational trophoblastic disease,0.8232134984476662
CDKN1C,Congenital hypoplasia of penis,0.8232134984476662
CDKN1C,Adrenocortical carcinoma,0.8232134984476662
CDKN1C,Postnatal growth retardation,0.8270909867833504
CDKN1C,Adrenal gland hypofunction,0.8270909867833504
CDKN1C,Adrenal Gland Neoplasms,0.8272008757995397
CDKN1C,Micromelia,0.8363138748299018
CDKN1C,Embryonal Rhabdomyosarcoma,0.8368219249856942
CDKN1C,Congenital Abnormality,0.8402911822757345
CDKN1C,Adrenal cortical hypofunction,0.8402911822757345
CDKN1C,Macroglossia,0.8402911822757345
CDKN1C,Agenesis,0.8402911822757345
CDKN1C,Osteogenesis Imperfecta,0.8402911822757345
CDKN1C,Cryptorchidism,0.8402911822757345
CDKN1C,Hypogonadism,0.8402911822757345
CDKN1C,HELLP Syndrome,0.8402911822757345
CDKN1C,Oral Cavity Carcinoma,0.8402911822757345
CDKN1C,Down Syndrome,0.8420665668584452
CDKN1C,Hypercalciuria,0.8554819098734854
CDKN1C,Vesico-Ureteral Reflux,0.8576420926340393
CDKN1C,Neoplasm Residual,0.8578473133580928
CDKN1C,Concave bridge of nose,0.8578473133580928
CDKN1C,Depressed nasal root/bridge,0.8578473133580928
CDKN1C,Rectal Carcinoma,0.8584283190330553
CDKN1C,Small testicle,0.8584283190330553
CDKN1C,Depressed nasal bridge,0.8584283190330553
CDKN1C,Carcinoma Cribriform,0.8648405521677974
CDKN1C,Carcinoma Granular Cell,0.8648405521677974
CDKN1C,Adenocarcinoma Basal Cell,0.8648405521677974
CDKN1C,Chronic Obstructive Airway Disease,0.8648405521677974
CDKN1C,Prader-Willi Syndrome,0.8648405521677974
CDKN1C,Conn Syndrome,0.8690346447728063
CDKN1C,Low set ears,0.8700543109506378
CDKN1C,Adenocarcinoma Oxyphilic,0.8745234584149799
CDKN1C,Delayed bone age,0.8769418330148872
CDKN1C,Choriocarcinoma,0.8769418330148872
CDKN1C,Muscular Dystrophy Duchenne,0.8815127642200768
CDKN1C,Short stature,0.8815127642200768
CDKN1C,Hydrocephalus,0.8851456306720444
CDKN1C,Hepatomegaly,0.887595340546704
CDKN1C,Secondary malignant neoplasm of lymph node,0.900167961295542
CDKN1C,Infant Small for Gestational Age,0.9083161862856644
CDKN1C,Congenital ear anomaly NOS (disorder),0.9098977259629772
CDKN1C,Dwarfism,0.9098977259629772
CDKN1C,Thickened facial skin with coarse facial features,0.9103315000053974
CDKN1C,Intrauterine retardation,0.9111864999692114
CDKN1C,Coarse facial features,0.9117936912777788
CDKN1C,Muscle hypotonia,0.9124568647908072
CDKN1C,Cardiomegaly,0.9184153253162451
CDKN1C,Fetal Growth Retardation,0.9307095582633488
CDKN1C,Small nose,0.937361082398064
CDKN1C,Short nose,0.9390727893210336
CDKN1C,Penile hypospadias,0.9393256300017014
CDKN1C,Hydronephrosis,0.9457739154209
CDKN1C,Intellectual Disability,0.9478210444156088
CDKN1C,Hypospadias,0.94939825643792
CDKN1C,Uranostaphyloschisis,0.9534337109847604
CDKN1C,Cardiomyopathies,0.9557184806547836
CDKN1C,Asthma,0.9672478180546946
CDKN1C,Adrenocortical Carcinoma,0.4532988396145482
CDKN1C,Beckwith-Wiedemann Syndrome,0.4904280964420943
CDKN1C,Gonadoblastoma,0.6734982286750932
CDKN1C,Nephrolithiasis,0.7765582368651238
CDKN1C,Congenital Hemihypertrophy,0.7765582368651238
CDKN1C,Hepatoblastoma,0.7765582368651238
CDKN1C,Melanoma,0.7765582368651238
CDKN1C,Silver-Russell Syndrome,0.7765582368651238
CDKN1C,Endometrial Hyperplasia,0.7765582368651238
CDKN1C,Hypercalcemia,0.7765582368651238
CDKN1C,Nephroblastoma,0.7765582368651238
CDKN1C,Phakomatosis Pigmentovascularis,0.7765582368651238
CDKN1C,Hypoglycemia,0.7765582368651238
CDKN1C,Somatotropin Deficiency,0.7765582368651238
CDKN1C,Russell-Silver Syndrome,0.7765582368651238
CDKN1C,Renal Glomerular Disease,0.7765582368651238
CDKN1C,Isolated Somatotropin Deficiency,0.7860378120955526
CDKN1C,Endometrial Neoplasms,0.7860378120955526
CDKN1C,Schizophrenia,0.7860378120955526
CDKN1C,Pyle Metaphyseal Dysplasia,0.8082616889285628
CDKN1C,Frontal Bossing,0.8115918568696846
CDKN1C,Congenital Omphalocele,0.8115918568696846
CDKN1C,Proptosis,0.8115918568696846
CDKN1C,Nephrocalcinosis,0.8115918568696846
CDKN1C,Penis Agenesis,0.8115918568696846
CDKN1C,Epiphyseal Dysplasia,0.8115918568696846
CDKN1C,Endometrial Carcinoma,0.8115918568696846
CDKN1C,Vesicoureteral Reflux,0.8611702959552964
CDKN1C,Cryptorchidism,0.861756360478846
CDKN1C,Micromelia,0.861756360478846
CDKN1C,Lung Cancer,0.8706864397989688
CDKN1C,Macroglossia,0.8879896755141929
CDKN1C,Lung Neoplasms,0.8903301324869451
CDKN1C,Carcinoma,0.9069867032339078
CDKN1C,Cardiomyopathy,0.9145387439550552
CDKN1C,Hypogonadism,0.9259420053407031
CDKN1C,Adenocarcinoma,0.9350723667380212
CDKN1C,Dwarfism,0.9510372690456612
CDKN1C,Hypospadias,0.974502015052702
CDKN1C,Hydronephrosis,0.9870402800551054
CDKN1C,Classic Hodgkin lymphoma nodular sclerosis type ORPHA:98843,0.1991445465001551
CDKN1C,Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120,0.5867963421058087
CDKN1C,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144,0.5867963421058087
CDKN1C,Silver-Russell syndrome due to a point mutation ORPHA:397590,0.5959529547720634
CDKN1C,IMAGe syndrome ORPHA:85173,0.7929682744768703
CDKN1C,Familial short QT syndrome ORPHA:51083,0.795266832401002
CDKN2B,Malignant neoplasm of breast,0.4084380369379369
CDKN2B,Carcinoma of bladder,0.4084380369379369
CDKN2B,Bladder Neoplasm,0.4084380369379369
CDKN2B,Malignant neoplasm of urinary bladder,0.5071083164302358
CDKN2B,Adenomatous Polyposis Coli,0.5196624042573144
CDKN2B,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CDKN2B,Breast Carcinoma,0.7333611688795861
CDKN2B,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CDKN2B,Carcinogenesis,0.7333611688795861
CDKN2B,Malignant neoplasm of ovary,0.7333611688795861
CDKN2B,B-Cell Lymphomas,0.7333611688795861
CDKN2B,Growth hormone excess,0.7333611688795861
CDKN2B,Non-Functioning Pituitary Gland Neoplasm,0.7333611688795861
CDKN2B,leukemia,0.7333611688795861
CDKN2B,Ovarian Carcinoma,0.7333611688795861
CDKN2B,Parathyroid hyperplasia,0.7495999465637118
CDKN2B,Adenocarcinoma,0.750391252594775
CDKN2B,Malignant neoplasm of pancreas,0.7688485284765829
CDKN2B,Hepatoblastoma,0.7765852775619541
CDKN2B,Colorectal Carcinoma,0.7765852775619541
CDKN2B,Pancreatic carcinoma,0.7765852775619541
CDKN2B,Pituitary growth hormone cell adenoma,0.7765852775619541
CDKN2B,Laryngeal Squamous Cell Carcinoma,0.7765852775619541
CDKN2B,Gastrointestinal Stromal Tumors,0.7765852775619541
CDKN2B,Leukemia Myelocytic Acute,0.7765852775619541
CDKN2B,Subcutaneous lipoma,0.7765852775619541
CDKN2B,Fasting hyperinsulinemia,0.7765852775619541
CDKN2B,Melanoma astrocytoma syndrome,0.7765852775619541
CDKN2B,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
CDKN2B,Hyperinsulinemic hypoglycemia,0.7765852775619541
CDKN2B,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CDKN2B,Malignant tumor of colon,0.7765852775619541
CDKN2B,Esophageal carcinoma,0.7765852775619541
CDKN2B,Lymphoma,0.7765852775619541
CDKN2B,Leukemogenesis,0.7765852775619541
CDKN2B,Cervix carcinoma,0.7765852775619541
CDKN2B,Non-Small Cell Lung Carcinoma,0.7765852775619541
CDKN2B,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CDKN2B,Refractory anemia without ringed sideroblasts without excess blasts,0.7765852775619541
CDKN2B,Colorectal Neoplasms,0.7765852775619541
CDKN2B,Gastrinoma,0.7765852775619541
CDKN2B,Pancreatic Neoplasm,0.7765852775619541
CDKN2B,Adenoma,0.7765852775619541
CDKN2B,Thyroid Neoplasm,0.7765852775619541
CDKN2B,Rhabdoid Tumor of the Kidney,0.7765852775619541
CDKN2B,Nevus,0.7765852775619541
CDKN2B,Endometrial Carcinoma,0.7765852775619541
CDKN2B,Esophageal Neoplasms,0.7765852775619541
CDKN2B,Mammary Neoplasms,0.7880542567584415
CDKN2B,Glioma,0.7880542567584415
CDKN2B,Malignant neoplasm of lung,0.7880542567584415
CDKN2B,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
CDKN2B,Malignant neoplasm of prostate,0.7880542567584415
CDKN2B,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
CDKN2B,Abnormality of the lymphatic system,0.7880542567584415
CDKN2B,Refractory anemias,0.7880542567584415
CDKN2B,stage non-small cell lung cancer,0.7880542567584415
CDKN2B,Lymphoma Non-Hodgkin,0.7880542567584415
CDKN2B,Zollinger-Ellison syndrome,0.7880542567584415
CDKN2B,de novo myelodysplastic syndromes,0.7880542567584415
CDKN2B,Liver carcinoma,0.7880542567584415
CDKN2B,Invasive carcinoma of breast,0.7880542567584415
CDKN2B,Malignant Meningioma,0.7880542567584415
CDKN2B,Elevated circulating parathyroid hormone level,0.7880542567584415
CDKN2B,Malignant neoplasm of esophagus,0.7880542567584415
CDKN2B,Osteosarcoma,0.7880542567584415
CDKN2B,Rhabdoid Tumor,0.7880542567584415
CDKN2B,Thyroid carcinoma,0.7880542567584415
CDKN2B,Acute Promyelocytic Leukemia,0.7880542567584415
CDKN2B,Aneurysm Dissecting,0.7880542567584415
CDKN2B,Colorectal Cancer,0.7880542567584415
CDKN2B,Epithelial ovarian cancer,0.7880542567584415
CDKN2B,Rhabdomyosarcoma,0.7880542567584415
CDKN2B,Leukemia Plasma Cell,0.7880542567584415
CDKN2B,T-Cell Lymphoma,0.7880542567584415
CDKN2B,Leukemia T-Cell,0.7880542567584415
CDKN2B,Hepatocarcinogenesis,0.7880542567584415
CDKN2B,Mycosis fungoides/Sezary syndrome NOS,0.7880542567584415
CDKN2B,Glioblastoma,0.7880542567584415
CDKN2B,Prostate carcinoma,0.7880542567584415
CDKN2B,Astrocytoma,0.7880542567584415
CDKN2B,Parathyroid Adenoma,0.7880542567584415
CDKN2B,Primary malignant neoplasm of lung,0.7880542567584415
CDKN2B,insulinoma,0.7880542567584415
CDKN2B,Neoplasm Metastasis,0.7880542567584415
CDKN2B,Epithelioma,0.7880542567584415
CDKN2B,Peptic Ulcer,0.7880542567584415
CDKN2B,Monoclonal Gammopathy of Undetermined Significance,0.7880542567584415
CDKN2B,Carcinoma of lung,0.7880542567584415
CDKN2B,Malignant neoplasm of thyroid,0.7880542567584415
CDKN2B,Squamous cell carcinoma of the head and neck,0.7880542567584415
CDKN2B,Mesothelioma,0.7880542567584415
CDKN2B,Neuroblastoma,0.7880542567584415
CDKN2B,Central neuroblastoma,0.7880542567584415
CDKN2B,Malignant Neoplasms,0.7880542567584415
CDKN2B,Hematologic Neoplasms,0.7880542567584415
CDKN2B,melanoma,0.7880542567584415
CDKN2B,Familial Atypical Mole Melanoma Syndrome,0.7880542567584415
CDKN2B,Juvenile Myelomonocytic Leukemia,0.7880542567584415
CDKN2B,Ewings sarcoma,0.7880542567584415
CDKN2B,Adenocarcinoma of pancreas,0.7880542567584415
CDKN2B,Multiple Myeloma,0.7880542567584415
CDKN2B,Lung Neoplasms,0.7880542567584415
CDKN2B,Episodic abdominal pain,0.7880542567584415
CDKN2B,Intermittent abdominal pain,0.7880542567584415
CDKN2B,Prolactinoma,0.7880542567584415
CDKN2B,Neoplasms,0.7880542567584415
CDKN2B,Adrenal Cortical Adenoma,0.7880542567584415
CDKN2B,Melanocytic nevus,0.7880542567584415
CDKN2B,Angiofibroma,0.7880542567584415
CDKN2B,Opisthorchis Viverrini-Related Cholangiocarcinoma,0.7880542567584415
CDKN2B,Malignant neoplasm of stomach,0.7880542567584415
CDKN2B,Burkitt Lymphoma,0.7880542567584415
CDKN2B,Diarrhea,0.7880542567584415
CDKN2B,Myxoid cyst,0.7880542567584415
CDKN2B,Skin Carcinogenesis,0.7880542567584415
CDKN2B,Mature T ALL,0.7880542567584415
CDKN2B,Hypercalcemia,0.7880542567584415
CDKN2B,Malignant mesothelioma,0.7880542567584415
CDKN2B,Hodgkin Disease,0.7880542567584415
CDKN2B,Esophagitis,0.7880542567584415
CDKN2B,Refractory anaemia with excess blasts,0.7880542567584415
CDKN2B,Childhood T Acute Lymphoblastic Leukemia,0.7880542567584415
CDKN2B,Well Differentiated Oligodendroglioma,0.7880542567584415
CDKN2B,Brain Neoplasms,0.7880542567584415
CDKN2B,Supratentorial Neoplasms,0.7880542567584415
CDKN2B,Malignant neoplasm of border of tongue,0.7880542567584415
CDKN2B,Malignant neoplasm of dorsal surface of tongue,0.7880542567584415
CDKN2B,Malignant neoplasm of ventral surface of tongue,0.7880542567584415
CDKN2B,Malignant tumor of base of tongue,0.7880542567584415
CDKN2B,Malignant tumor of junctional zone of tongue,0.7880542567584415
CDKN2B,malignant tumor of lingual tonsil,0.7880542567584415
CDKN2B,Myxoid chondrosarcoma,0.7880542567584415
CDKN2B,Malignant neoplasm of large intestine,0.7880542567584415
CDKN2B,Nasopharyngeal carcinoma,0.7880542567584415
CDKN2B,oligodendroglioma,0.7880542567584415
CDKN2B,Glaucoma Open-Angle,0.7880542567584415
CDKN2B,Tumor Progression,0.7880542567584415
CDKN2B,Sarcoma,0.7880542567584415
CDKN2B,Abnormality of the hair,0.7880542567584415
CDKN2B,Abnormality of the hair shaft,0.7880542567584415
CDKN2B,Hematological Disease,0.7880542567584415
CDKN2B,Monosomy,0.7880542567584415
CDKN2B,Renal Cell Carcinoma,0.7880542567584415
CDKN2B,secondary acute myeloid leukemia,0.7880542567584415
CDKN2B,Keratosis,0.7880542567584415
CDKN2B,Lymphoma Follicular,0.7880542567584415
CDKN2B,Lymphatic Diseases,0.7880542567584415
CDKN2B,Coronary Arteriosclerosis,0.7880542567584415
CDKN2B,Acute leukemia,0.7880542567584415
CDKN2B,Retinoblastoma,0.7880542567584415
CDKN2B,Arteriosclerosis,0.7880542567584415
CDKN2B,Atherosclerosis,0.7880542567584415
CDKN2B,Acromegaly,0.7880542567584415
CDKN2B,Congenital chromosomal disease,0.7880542567584415
CDKN2B,Periodontitis,0.7880542567584415
CDKN2B,Freckles,0.7880542567584415
CDKN2B,Acute lymphocytic leukemia,0.7880542567584415
CDKN2B,Chondrosarcoma,0.7880542567584415
CDKN2B,Stomach Carcinoma,0.7880542567584415
CDKN2B,CARCINOMA OF VULVA,0.7880542567584415
CDKN2B,Hepatitis C,0.7880542567584415
CDKN2B,Hyperlipidemia Familial Combined,0.7880542567584415
CDKN2B,Cardiovascular Diseases,0.7880542567584415
CDKN2B,Glaucoma,0.7880542567584415
CDKN2B,Squamous cell carcinoma,0.7880542567584415
CDKN2B,Acute periodontitis,0.7880542567584415
CDKN2B,Solid Neoplasm,0.7880542567584415
CDKN2B,Hyperparathyroidism,0.7880542567584415
CDKN2B,Diabetes,0.7880542567584415
CDKN2B,Diabetes Mellitus,0.7880542567584415
CDKN2B,Biliary Tract Cancer,0.7880542567584415
CDKN2B,Nervous System Neoplasms,0.7880542567584415
CDKN2B,Atypical meningioma,0.7880542567584415
CDKN2B,Periodontitis Juvenile,0.7880542567584415
CDKN2B,Small cell carcinoma of lung,0.7880542567584415
CDKN2B,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
CDKN2B,Pleomorphic Xanthoastrocytoma,0.7880542567584415
CDKN2B,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
CDKN2B,Follicular adenoma,0.7880542567584415
CDKN2B,Myelodysplasia,0.7880542567584415
CDKN2B,Blastic plasmacytoid dendritic cell neoplasm,0.7880542567584415
CDKN2B,Oral infection,0.7880542567584415
CDKN2B,Poisoning,0.7880542567584415
CDKN2B,Myeloid Leukemia Chronic,0.7880542567584415
CDKN2B,Myeloid Leukemia,0.7880542567584415
CDKN2B,Aortic Aneurysm,0.7880542567584415
CDKN2B,Refractory anemia with excess blasts in transformation (clinical),0.7880542567584415
CDKN2B,Aneurysmal disease,0.7880542567584415
CDKN2B,Primary cutaneous B-cell lymphoma,0.7880542567584415
CDKN2B,Malignant Glioma,0.7880542567584415
CDKN2B,Ulcer,0.7880542567584415
CDKN2B,Laryngeal Diseases,0.7908231553833205
CDKN2B,Metastatic melanoma,0.7940665326856218
CDKN2B,Nerve Sheath Tumors,0.7967714690735718
CDKN2B,Experimental Organism Basal Cell Carcinoma,0.8009048756462318
CDKN2B,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.8009048756462318
CDKN2B,Chronic Periodontitis,0.8019075543217649
CDKN2B,Xerosis,0.8019075543217649
CDKN2B,Allergic disposition,0.8019075543217649
CDKN2B,Hereditary Malignant Neoplasm,0.8019075543217649
CDKN2B,Hairy Cell Leukemia,0.8019075543217649
CDKN2B,Thrombocytopenia,0.8019075543217649
CDKN2B,Myocardial Infarction,0.8019075543217649
CDKN2B,Dry skin,0.8019075543217649
CDKN2B,Multiple Endocrine Neoplasia Type 1,0.8019075543217649
CDKN2B,Chronic Lymphocytic Leukemia,0.8019075543217649
CDKN2B,Arteriopathic disease,0.8019075543217649
CDKN2B,neurofibroma,0.8019075543217649
CDKN2B,Human papilloma virus infection,0.8019075543217649
CDKN2B,Aortic Diseases,0.8019075543217649
CDKN2B,Stomach Neoplasms,0.8044379824544406
CDKN2B,Recurrent Childhood Acute Lymphoblastic Leukemia,0.8067197998685076
CDKN2B,ovarian neoplasm,0.8067197998685076
CDKN2B,Adenocarcinoma of lung (disorder),0.8098851543361193
CDKN2B,Neurofibromatoses,0.8098851543361193
CDKN2B,Lymphoma T-Cell Cutaneous,0.8098851543361193
CDKN2B,Hereditary Leiomyomatosis and Renal Cell Cancer,0.8098851543361193
CDKN2B,Blast Phase,0.8114747041691183
CDKN2B,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
CDKN2B,Myeloproliferative disease,0.8138488881521341
CDKN2B,Plasma cell dyscrasia,0.8138488881521341
CDKN2B,Liver diseases,0.8140222479282434
CDKN2B,Adult Acute Lymphocytic Leukemia,0.8145035474981049
CDKN2B,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
CDKN2B,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
CDKN2B,Childhood Rhabdomyosarcoma,0.8168901801930506
CDKN2B,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
CDKN2B,Hyperkeratosis,0.8190761496232595
CDKN2B,Mammary Tumorigenesis,0.8190761496232595
CDKN2B,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CDKN2B,African Trypanosomiasis,0.8190761496232595
CDKN2B,Malignant neoplasm of tongue,0.8232134984476662
CDKN2B,Mouth Neoplasms,0.8232134984476662
CDKN2B,Liver Cirrhosis,0.8232134984476662
CDKN2B,Infant Acute Lymphoblastic Leukemia,0.8232134984476662
CDKN2B,Immune thrombocytopenic purpura,0.8232134984476662
CDKN2B,Thyroid Gland Follicular Adenoma,0.8232134984476662
CDKN2B,polyps,0.8232134984476662
CDKN2B,Therapy-related myelodysplastic syndrome,0.8232134984476662
CDKN2B,Hereditary Melanoma,0.8232134984476662
CDKN2B,Low Tension Glaucoma,0.8270909867833504
CDKN2B,Malignant Peripheral Nerve Sheath Tumor,0.8272008757995397
CDKN2B,Actinic keratosis,0.8272008757995397
CDKN2B,Hematopoetic Myelodysplasia,0.8272008757995397
CDKN2B,Meningioma benign no ICD-O subtype,0.8272008757995397
CDKN2B,Pituitary Adenoma,0.834094492023826
CDKN2B,Glioblastoma Multiforme,0.8342163953428735
CDKN2B,Carcinoma Transitional Cell,0.8368219249856942
CDKN2B,Cholangiocarcinoma,0.8402911822757345
CDKN2B,Glaucoma Primary Open Angle,0.8402911822757345
CDKN2B,Acute respiratory failure,0.8402911822757345
CDKN2B,Papilloma,0.8402911822757345
CDKN2B,Aneurysm,0.8402911822757345
CDKN2B,Sezary Syndrome,0.8402911822757345
CDKN2B,Liposarcoma Dedifferentiated,0.8402911822757345
CDKN2B,Adult Acute Myeloblastic Leukemia,0.841396342333011
CDKN2B,Hepatitis B,0.841396342333011
CDKN2B,Hypertensive disease,0.8474481237156937
CDKN2B,Familial multiple trichoepitheliomata,0.8523465762428218
CDKN2B,Medulloblastoma,0.8548862007194026
CDKN2B,Cirrhosis,0.8554819098734854
CDKN2B,Leukemia Myelomonocytic Chronic,0.8576420926340393
CDKN2B,Neoplasm Residual,0.8578473133580928
CDKN2B,Follicular thyroid carcinoma,0.8584283190330553
CDKN2B,Kartagener Syndrome,0.8608860081595284
CDKN2B,Plasmacytoma,0.8608860081595284
CDKN2B,Squamous cell carcinoma of esophagus,0.8610447277138289
CDKN2B,Cerebrovascular accident,0.8648405521677974
CDKN2B,Parathyroid Neoplasms,0.8648405521677974
CDKN2B,Anaplastic Oligodendroglioma,0.8690346447728063
CDKN2B,Medullary carcinoma of thyroid,0.8757755363384367
CDKN2B,Primary Myelofibrosis,0.876210765330195
CDKN2B,Hyperplasia,0.876210765330195
CDKN2B,Hepatitis Chronic,0.8769418330148872
CDKN2B,Precursor cell lymphoblastic lymphoma,0.8769418330148872
CDKN2B,Rheumatic Fever,0.8769418330148872
CDKN2B,Carcinoma Papillary,0.887080330932516
CDKN2B,Coronary Artery Disease,0.887595340546704
CDKN2B,Leukoplakia Oral,0.887595340546704
CDKN2B,Malignant Pleural Mesothelioma,0.8935933996254593
CDKN2B,nervous system disorder,0.8959157818691486
CDKN2B,Hepatitis Alcoholic,0.8959157818691486
CDKN2B,mixed gliomas,0.8959157818691486
CDKN2B,Meningioma,0.8973454964837912
CDKN2B,Mycosis Fungoides,0.8989612563669234
CDKN2B,Lymphoid leukemia,0.9083161862856644
CDKN2B,Coronary heart disease,0.9119978323790848
CDKN2B,Chordoma,0.9189398569397552
CDKN2B,Anaplastic astrocytoma,0.9262273158806068
CDKN2B,Uveal melanoma,0.929235785949896
CDKN2B,Pituitary Diseases,0.93156380601526
CDKN2B,Kidney Failure Acute,0.9373358316580888
CDKN2B,Skin Neoplasms,0.9434459508692176
CDKN2B,Ependymoma,0.9564633032157428
CDKN2B,Endometriosis,0.960644037248553
CDKN2B,Cutaneous Melanoma,0.9639249377588224
CDKN2B,Ischemic stroke,0.9896536639644284
CDKN2B,Adrenocortical Adenoma,0.4532988396145482
CDKN2B,Insulinoma,0.4532988396145482
CDKN2B,Adrenocortical Carcinoma,0.4532988396145482
CDKN2B,Multiple Endocrine Neoplasia,0.4532988396145482
CDKN2B,Parathyroid Hyperplasia,0.4532988396145482
CDKN2B,Glucagonoma,0.4532988396145482
CDKN2B,Angiofibroma,0.4904280964420943
CDKN2B,Zollinger-Ellison Syndrome,0.5957016454669307
CDKN2B,Subcutaneous Lipoma,0.6734982286750932
CDKN2B,Thymoma,0.7765582368651238
CDKN2B,Prolactinoma,0.7765582368651238
CDKN2B,Parathyroid Adenoma,0.7765582368651238
CDKN2B,Peptic Ulcer,0.7765582368651238
CDKN2B,Esophagitis,0.7765582368651238
CDKN2B,Melanoma,0.7765582368651238
CDKN2B,Hyperinsulinemic Hypoglycemia,0.7765582368651238
CDKN2B,Hyperparathyroidism,0.7765582368651238
CDKN2B,Hypercalcemia,0.7765582368651238
CDKN2B,Myelodysplastic Syndrome,0.7765582368651238
CDKN2B,Pituitary Adenoma,0.7765582368651238
CDKN2B,Atypical Mole Melanoma Syndrome,0.7765582368651238
CDKN2B,Stomach Neoplasms,0.7765582368651238
CDKN2B,Lymphoma,0.7765582368651238
CDKN2B,Lymphoblastic Leukemia,0.7765582368651238
CDKN2B,Coronary Arteriosclerosis,0.7797212851906329
CDKN2B,Thyroid Gland Follicular Adenoma,0.7860378120955526
CDKN2B,Retinal Diseases,0.8115918568696846
CDKN2B,Cholestasis,0.8115918568696846
CDKN2B,Malignant Neoplasm,0.8115918568696846
CDKN2B,Nasopharyngeal Neoplasms,0.8115918568696846
CDKN2B,Mammary Neoplasms,0.8165359516083085
CDKN2B,Nevus,0.8457525389282121
CDKN2B,Pancreatic Neoplasm,0.861756360478846
CDKN2B,Coronary Artery Disease,0.861756360478846
CDKN2B,Glaucoma,0.8903630091389316
CDKN2B,Diabetes Mellitus,0.919442421650838
CDKN2B,Lung Adenocarcinoma,0.9350723667380212
CDKN2B,Glioma,0.9748811500794422
CDKN2B,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
CDKN2B,Familial atypical multiple mole melanoma syndrome ORPHA:404560,0.5867963421058087
CDKN2B,Melanoma and neural system tumor syndrome ORPHA:252206,0.5867963421058087
CDKN2B,Familial melanoma ORPHA:618,0.6873535151929783
CDKN2B,Diaphyseal medullary stenosis-bone malignancy syndrome ORPHA:85182,0.8922466888454011
CDKN2B,KLHL9-related early-onset distal myopathy ORPHA:399081,0.8922466888454011
CDKN2B,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2B,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2B,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2B,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CDKN2B,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CDKN2B,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
CDKN2B,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2B,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
CDKN2B,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
CDKN2B,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
CDKN2B,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
CDKN2B,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
CDKN2B,Human adenovirus 1 fiber,0.8999095837312036
CDKN2B,Human adenovirus 5 fiber,0.8999095837312036
CDKN2B,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
CDKN2B,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
CDKN2B,Horsepox virus HSPV011a,0.8999095837312036
CDKN2B,Cowpox virus CPXV213 protein (gene: CPXV213 CDS),0.8999095837312036
CDKN2B,Cowpox virus CPXV027 protein (gene: CPXV027 CDS),0.8999095837312036
CDKN2B,Vaccinia virus hypothetical protein,0.8999095837312036
CDKN2B,Ectromelia virus ERPV ankyrin and nfkb inhibitor,0.8999095837312036
CDKN2B,Vaccinia virus Ankara 72.4k ankyrin repeat protein f1,0.8999095837312036
CDKN2B,Cowpox virus CPXV011 protein (gene: CPXV011 CDS),0.8999095837312036
CDKN2B,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.8999095837312036
CDKN2B,Horsepox virus HSPV022 (ankyrin-like protein,0.8999095837312036
CDKN2B,Provisional),0.8999095837312036
CDKN2B,Monkeypox virus ankyrin-like protein,0.8999095837312036
CDKN2B,Horsepox virus HSPV033c (ankyrin repeats),0.8999095837312036
CDKN2B,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.8999095837312036
CDKN2B,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
CDKN2B,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
CDKN2B,Variola virus hypothetical protein (gene: D6L),0.8999095837312036
CDKN2B,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
CDKN2B,Vaccinia virus ankyrin-like protein (gene: C9L),0.8999095837312036
CDKN2B,Horsepox virus HSPV201a (ankyrin repeats),0.8999095837312036
CDKN2B,Yaba-like disease virus 147R protein (gene: 147R),0.9018002218631122
CDKN2B,Cowpox virus CPXV041 protein (gene: CPXV041 CDS),0.9057542447893764
CDKN2B,Horsepox virus HSPV035 (ankyrin repeats),0.9057542447893764
CDKN2B,Horsepox virus HSPV004 (ankyrin repeats),0.9057542447893764
CDKN2B,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: C1L),0.9057542447893764
CDKN2B,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
CDKN2B,Vaccinia virus ankyrin-like protein (gene: K1L),0.9057542447893764
CDKN2B,Horsepox virus HSPV196 (ankyrin-like protein,0.9057542447893764
CDKN2B,Provisional),0.9057542447893764
CDKN2B,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
CDKN2B,Variola virus hypothetical protein (gene: B19R),0.9057542447893764
CDKN2B,Vaccinia virus Ankara CP77 Host range protein f1,0.9057542447893764
CDKN2B,Vaccinia virus Ankara Host range protein,0.9057542447893764
CDKN2B,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.9057542447893764
CDKN2B,Variola virus hypothetical protein (gene: B21R),0.9057542447893764
CDKN2B,Ectromelia virus ERPV ankyrin,0.9057542447893764
CDKN2B,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
CDKN2B,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.9057542447893764
CDKN2B,Vaccinia virus ankyrin-like protein (gene: B18R),0.9057542447893764
CDKN2B,Variola virus hypothetical protein (gene: D7L),0.9057542447893764
CDKN2B,Horsepox virus HSPV033b (Ankyrin repeats),0.9058994261255549
CDKN2B,Variola virus hypothetical protein (gene: G3R),0.9058994261255549
CDKN2B,Orf virus ORF126 ankyrin repeat protein,0.9071659214187592
CDKN2B,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9115856929326512
CDKN2B,Monkeypox virus Zaire-96-I-16 B17R (gene: B17R),0.915880438522078
CDKN2B,Horsepox virus HSPV020b (ankyrin repeats),0.915880438522078
CDKN2B,Vaccinia virus Ankara CP77 host range protein f3,0.915880438522078
CDKN2B,Horsepox virus HSPV005b (ankyrin repeats),0.915880438522078
CDKN2B,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.9176018655958595
CDKN2B,Horsepox virus HSPV005c (Ankyrin repeats),0.9176018655958595
CDKN2B,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L),0.9224878266317492
CDKN2B,Cowpox virus CPXV019 protein (gene: CPXV019 CDS),0.9237501457186692
CDKN2B,Yaba-like disease virus 8L protein (gene: 8L),0.9237501457186692
CDKN2B,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
CDKN2B,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.9237501457186692
CDKN2B,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.9237501457186692
CDKN2B,Vaccinia virus Ankara CP77 host range protein f4,0.9237501457186692
CDKN2B,Vaccinia virus Ankara 67.9k ankyrin repeat protein,0.928070054828895
CDKN2B,Cowpox virus CPXV008 protein (gene: CPXV008 CDS),0.9287050575620676
CDKN2B,Horsepox virus HSPV011b (ankyrin repeats),0.9287050575620676
CDKN2B,Horsepox virus HSPV014b (ankyrin repeats),0.9287050575620676
CDKN2B,Horsepox virus HSPV014c (ankyrin repeats),0.9287050575620676
CDKN2B,Vaccinia virus ankyin-like protein (gene: M1L),0.9318782091866168
CDKN2B,Yaba-like disease virus 146R protein (gene: 146R),0.9364561700418303
CDKN2B,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.9366403811337995
CDKN2B,Variola virus hypothetical protein (gene: B6R),0.9383505321091749
CDKN2B,Vaccinia virus ankyrin-like protein,0.9383505321091749
CDKN2B,Orf virus ORF129 ankyrin repeat protein,0.9386073090182748
CDKN2B,Cowpox virus CPXV017 protein (gene: CPXV017 CDS),0.9397923093369096
CDKN2B,Variola virus ankyin-like protein (gene: O1L),0.9397923093369096
CDKN2B,Horsepox virus HSPV194 (ankyrin repeats),0.9397923093369096
CDKN2B,Cowpox virus CPXV006 protein (gene: CPXV006 CDS),0.9397923093369096
CDKN2B,Horsepox virus HSPV012 (ankyrin-like protein,0.9397923093369096
CDKN2B,Provisional),0.9397923093369096
CDKN2B,Cowpox virus CPXV220 protein (gene: CPXV220 CDS),0.9563208507960556
CDKN2D,Malignant neoplasm of breast,0.4084380369379369
CDKN2D,Carcinoma of bladder,0.4084380369379369
CDKN2D,Breast Carcinoma,0.7333611688795861
CDKN2D,Malignant neoplasm of ovary,0.7333611688795861
CDKN2D,Ovarian Carcinoma,0.7333611688795861
CDKN2D,Melanoma astrocytoma syndrome,0.7765852775619541
CDKN2D,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CDKN2D,Atrial Premature Complexes,0.7765852775619541
CDKN2D,Leukemogenesis,0.7765852775619541
CDKN2D,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CDKN2D,Gastrinoma,0.7765852775619541
CDKN2D,Pancreatic Neoplasm,0.7765852775619541
CDKN2D,Nevus,0.7765852775619541
CDKN2D,Glioma,0.7880542567584415
CDKN2D,Malignant neoplasm of lung,0.7880542567584415
CDKN2D,Abnormality of the lymphatic system,0.7880542567584415
CDKN2D,Refractory anemias,0.7880542567584415
CDKN2D,Promyelocytic leukemia,0.7880542567584415
CDKN2D,Osteosarcoma,0.7880542567584415
CDKN2D,Acute Promyelocytic Leukemia,0.7880542567584415
CDKN2D,Epithelial ovarian cancer,0.7880542567584415
CDKN2D,Leukemia T-Cell,0.7880542567584415
CDKN2D,Parathyroid Adenoma,0.7880542567584415
CDKN2D,Primary malignant neoplasm of lung,0.7880542567584415
CDKN2D,insulinoma,0.7880542567584415
CDKN2D,Carcinoma of lung,0.7880542567584415
CDKN2D,Neuroblastoma,0.7880542567584415
CDKN2D,Central neuroblastoma,0.7880542567584415
CDKN2D,melanoma,0.7880542567584415
CDKN2D,Familial Atypical Mole Melanoma Syndrome,0.7880542567584415
CDKN2D,Melanocytic nevus,0.7880542567584415
CDKN2D,Malignant neoplasm of stomach,0.7880542567584415
CDKN2D,Ganglioglioma,0.7880542567584415
CDKN2D,Infection caused by Helicobacter pylori,0.7880542567584415
CDKN2D,Sarcoma,0.7880542567584415
CDKN2D,Abnormality of the hair,0.7880542567584415
CDKN2D,Abnormality of the hair shaft,0.7880542567584415
CDKN2D,Lymphatic Diseases,0.7880542567584415
CDKN2D,Retinoblastoma,0.7880542567584415
CDKN2D,Freckles,0.7880542567584415
CDKN2D,Rat Adrenal Gland Pheochromocytoma,0.7880542567584415
CDKN2D,Autoimmune Diseases,0.7880542567584415
CDKN2D,Rheumatoid Arthritis,0.7880542567584415
CDKN2D,Carcinoid Tumor,0.7880542567584415
CDKN2D,Sjogren's Syndrome,0.7880542567584415
CDKN2D,Xerosis,0.8019075543217649
CDKN2D,Congenital deafness,0.8019075543217649
CDKN2D,Multiple Sclerosis,0.8019075543217649
CDKN2D,Dry skin,0.8019075543217649
CDKN2D,Embryonal Carcinoma,0.8019075543217649
CDKN2D,Degenerative polyarthritis,0.8019075543217649
CDKN2D,Hereditary Diffuse Gastric Cancer,0.8019075543217649
CDKN2D,Encephalomyelitis,0.8019075543217649
CDKN2D,Human T-cell lymphotrophic virus type I [HTLV-I],0.8019075543217649
CDKN2D,Stomach Neoplasms,0.8044379824544406
CDKN2D,stage neuroblastoma,0.8098851543361193
CDKN2D,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
CDKN2D,gastritis h pylori,0.8168901801930506
CDKN2D,Gallbladder Carcinoma,0.8232134984476662
CDKN2D,Psoriasis vulgaris,0.8272008757995397
CDKN2D,Amyotrophic Lateral Sclerosis,0.8402911822757345
CDKN2D,Thymoma,0.8402911822757345
CDKN2D,Celiac Disease,0.8402911822757345
CDKN2D,Medulloblastoma,0.8548862007194026
CDKN2D,Parkinson Disease,0.8772392350816924
CDKN2D,Secondary malignant neoplasm of lymph node,0.900167961295542
CDKN2D,Dwarfism,0.9098977259629772
CDKN2D,Cutaneous Melanoma,0.9639249377588224
CDKN2D,Stomach Neoplasms,0.7765582368651238
CDKN2D,Gastric Cancer,0.861756360478846
CDKN2D,CCDC115-CDG ORPHA:468684,0.1991445465001551
CDKN2D,8p11.2 deletion syndrome ORPHA:251066,0.3832844616405875
CDKN2D,Brachydactyly type B2 ORPHA:140908,0.3832844616405875
CDKN2D,Hermansky-Pudlak syndrome type 7 ORPHA:231531,0.3832844616405875
CDKN2D,Polymicrogyria with optic nerve hypoplasia ORPHA:250972,0.3832844616405875
CDKN2D,Stapes ankylosis with broad thumbs and toes ORPHA:140917,0.3832844616405875
CDKN2D,Tarsal-carpal coalition syndrome ORPHA:1412,0.3832844616405875
CDKN2D,Early-onset Lafora body disease ORPHA:324290,0.5867963421058087
CDKN2D,Obesity due to CEP19 deficiency ORPHA:397615,0.7929682744768703
CDKN2D,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2D,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2D,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2D,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
CDKN2D,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CDKN2D,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CDKN2D,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CDKN2D,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2D,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CDKN2D,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
CDKN2D,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
CDKN2D,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
CDKN2D,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
CDKN2D,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
CDKN2D,Human adenovirus 1 fiber,0.8999095837312036
CDKN2D,Human adenovirus 5 fiber,0.8999095837312036
CDKN2D,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
CDKN2D,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
CDKN2D,Horsepox virus HSPV011a,0.8999095837312036
CDKN2D,Cowpox virus CPXV213 protein (gene: CPXV213 CDS),0.8999095837312036
CDKN2D,Cowpox virus CPXV027 protein (gene: CPXV027 CDS),0.8999095837312036
CDKN2D,Titi monkey adenovirus ECC-2011 fiber,0.8999095837312036
CDKN2D,Vaccinia virus hypothetical protein,0.8999095837312036
CDKN2D,Ectromelia virus ERPV ankyrin and nfkb inhibitor,0.8999095837312036
CDKN2D,Vaccinia virus Ankara 72.4k ankyrin repeat protein f1,0.8999095837312036
CDKN2D,Cowpox virus CPXV011 protein (gene: CPXV011 CDS),0.8999095837312036
CDKN2D,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.8999095837312036
CDKN2D,Horsepox virus HSPV022 (ankyrin-like protein,0.8999095837312036
CDKN2D,Provisional),0.8999095837312036
CDKN2D,Human mastadenovirus E fiber (gene: L5),0.8999095837312036
CDKN2D,Human adenovirus E4 fiber protein,0.8999095837312036
CDKN2D,Monkeypox virus ankyrin-like protein,0.8999095837312036
CDKN2D,Horsepox virus HSPV033c (ankyrin repeats),0.8999095837312036
CDKN2D,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.8999095837312036
CDKN2D,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
CDKN2D,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
CDKN2D,Variola virus hypothetical protein (gene: D6L),0.8999095837312036
CDKN2D,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
CDKN2D,Horsepox virus HSPV201a (ankyrin repeats),0.8999095837312036
CDKN2D,Yaba-like disease virus 147R protein (gene: 147R),0.9018002218631122
CDKN2D,Cowpox virus CPXV041 protein (gene: CPXV041 CDS),0.9057542447893764
CDKN2D,Horsepox virus HSPV035 (ankyrin repeats),0.9057542447893764
CDKN2D,Horsepox virus HSPV004 (ankyrin repeats),0.9057542447893764
CDKN2D,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
CDKN2D,Vaccinia virus ankyrin-like protein (gene: K1L),0.9057542447893764
CDKN2D,Horsepox virus HSPV196 (ankyrin-like protein,0.9057542447893764
CDKN2D,Provisional),0.9057542447893764
CDKN2D,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
CDKN2D,Variola virus hypothetical protein (gene: B19R),0.9057542447893764
CDKN2D,Vaccinia virus Ankara CP77 Host range protein f1,0.9057542447893764
CDKN2D,Vaccinia virus Ankara Host range protein,0.9057542447893764
CDKN2D,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.9057542447893764
CDKN2D,Variola virus hypothetical protein (gene: B21R),0.9057542447893764
CDKN2D,Ectromelia virus ERPV ankyrin,0.9057542447893764
CDKN2D,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
CDKN2D,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.9057542447893764
CDKN2D,Vaccinia virus ankyrin-like protein (gene: B18R),0.9057542447893764
CDKN2D,Variola virus hypothetical protein (gene: D7L),0.9058994261255549
CDKN2D,Variola virus hypothetical protein (gene: G3R),0.9058994261255549
CDKN2D,Orf virus ORF126 ankyrin repeat protein,0.9071659214187592
CDKN2D,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9115856929326512
CDKN2D,Monkeypox virus Zaire-96-I-16 B17R (gene: B17R),0.915880438522078
CDKN2D,Horsepox virus HSPV020b (ankyrin repeats),0.915880438522078
CDKN2D,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.9176018655958595
CDKN2D,Horsepox virus HSPV005c (Ankyrin repeats),0.9176018655958595
CDKN2D,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L),0.9224878266317492
CDKN2D,Cowpox virus CPXV019 protein (gene: CPXV019 CDS),0.9237501457186692
CDKN2D,Yaba-like disease virus 8L protein (gene: 8L),0.9237501457186692
CDKN2D,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
CDKN2D,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.9237501457186692
CDKN2D,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.9237501457186692
CDKN2D,Vaccinia virus Ankara CP77 host range protein f4,0.9237501457186692
CDKN2D,Vaccinia virus Ankara 67.9k ankyrin repeat protein,0.928070054828895
CDKN2D,Cowpox virus CPXV008 protein (gene: CPXV008 CDS),0.9287050575620676
CDKN2D,Horsepox virus HSPV011b (ankyrin repeats),0.9287050575620676
CDKN2D,Horsepox virus HSPV014b (ankyrin repeats),0.9287050575620676
CDKN2D,Horsepox virus HSPV014c (ankyrin repeats),0.9287050575620676
CDKN2D,Vaccinia virus ankyin-like protein (gene: M1L),0.9287050575620676
CDKN2D,Yaba-like disease virus 146R protein (gene: 146R),0.9318782091866168
CDKN2D,Vaccinia virus Ankara CP77 host range protein f2,0.9364561700418303
CDKN2D,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.9366403811337995
CDKN2D,Variola virus hypothetical protein (gene: B6R),0.9383505321091749
CDKN2D,Vaccinia virus ankyrin-like protein,0.9383505321091749
CDKN2D,Orf virus ORF129 ankyrin repeat protein,0.9386073090182748
CDKN2D,Cowpox virus CPXV017 protein (gene: CPXV017 CDS),0.9397923093369096
CDKN2D,Variola virus ankyin-like protein (gene: O1L),0.9397923093369096
CDKN2D,Horsepox virus HSPV194 (ankyrin repeats),0.9397923093369096
CDKN2D,Cowpox virus CPXV006 protein (gene: CPXV006 CDS),0.9397923093369096
CDKN2D,Horsepox virus HSPV012 (ankyrin-like protein,0.9397923093369096
CDKN2D,Provisional),0.9397923093369096
CDKN2D,Cowpox virus CPXV220 protein (gene: CPXV220 CDS),0.9563208507960556
CDX2,Malignant neoplasm of breast,0.4084380369379369
CDX2,Adenomatous Polyposis Coli,0.5196624042573144
CDX2,Breast Carcinoma,0.7333611688795861
CDX2,Carcinogenesis,0.7333611688795861
CDX2,Malignant neoplasm of ovary,0.7333611688795861
CDX2,leukemia,0.7333611688795861
CDX2,Ovarian Carcinoma,0.7333611688795861
CDX2,Adenocarcinoma,0.750391252594775
CDX2,Malignant neoplasm of pancreas,0.7688485284765829
CDX2,Colorectal Carcinoma,0.7765852775619541
CDX2,Pancreatic carcinoma,0.7765852775619541
CDX2,Colon Carcinoma,0.7765852775619541
CDX2,Leukemia Myelocytic Acute,0.7765852775619541
CDX2,Metaplasia,0.7765852775619541
CDX2,Malignant tumor of colon,0.7765852775619541
CDX2,Esophageal carcinoma,0.7765852775619541
CDX2,Leukemogenesis,0.7765852775619541
CDX2,Endometrial Neoplasms,0.7765852775619541
CDX2,Non-Small Cell Lung Carcinoma,0.7765852775619541
CDX2,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CDX2,Colorectal Neoplasms,0.7765852775619541
CDX2,Pancreatic Neoplasm,0.7765852775619541
CDX2,Pancreatic intraepithelial neoplasia,0.7765852775619541
CDX2,Adenoma,0.7765852775619541
CDX2,Intestinal Cancer,0.7765852775619541
CDX2,Endometrial Carcinoma,0.7765852775619541
CDX2,Esophageal Neoplasms,0.7765852775619541
CDX2,Malignant neoplasm of lung,0.7880542567584415
CDX2,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
CDX2,Malignant neoplasm of prostate,0.7880542567584415
CDX2,Juvenile polyp,0.7880542567584415
CDX2,Liver carcinoma,0.7880542567584415
CDX2,Malignant neoplasm of esophagus,0.7880542567584415
CDX2,Cholelithiasis,0.7880542567584415
CDX2,Colorectal Cancer,0.7880542567584415
CDX2,Epithelial ovarian cancer,0.7880542567584415
CDX2,Intestinal Polyposis,0.7880542567584415
CDX2,Glioblastoma,0.7880542567584415
CDX2,Prostate carcinoma,0.7880542567584415
CDX2,Primary malignant neoplasm of lung,0.7880542567584415
CDX2,Neoplasm Metastasis,0.7880542567584415
CDX2,Carcinoma of lung,0.7880542567584415
CDX2,Ductal Carcinoma,0.7880542567584415
CDX2,Monocyte count procedure,0.7880542567584415
CDX2,Monocyte count result,0.7880542567584415
CDX2,Malignant Neoplasms,0.7880542567584415
CDX2,melanoma,0.7880542567584415
CDX2,Intestinal Neoplasms,0.7880542567584415
CDX2,Adenocarcinoma of pancreas,0.7880542567584415
CDX2,Lung Neoplasms,0.7880542567584415
CDX2,Adenoviral infections,0.7880542567584415
CDX2,Peutz-Jeghers Syndrome,0.7880542567584415
CDX2,Neoplasms,0.7880542567584415
CDX2,Bile Reflux,0.7880542567584415
CDX2,Malignant neoplasm of stomach,0.7880542567584415
CDX2,Mucinous Adenocarcinoma,0.7880542567584415
CDX2,Congenital contractural arachnodactyly,0.7880542567584415
CDX2,Esophagitis,0.7880542567584415
CDX2,Benign Prostatic Hyperplasia,0.7880542567584415
CDX2,Invasive Ductal Breast Carcinoma,0.7880542567584415
CDX2,Esophageal dysplasia,0.7880542567584415
CDX2,Intramucosal Adenocarcinoma,0.7880542567584415
CDX2,Pancreatitis Chronic,0.7880542567584415
CDX2,Malignant neoplasm of large intestine,0.7880542567584415
CDX2,Large cell neuroendocrine carcinoma,0.7880542567584415
CDX2,Infection caused by Helicobacter pylori,0.7880542567584415
CDX2,Tumor Progression,0.7880542567584415
CDX2,Adenocarcinoma of colon,0.7880542567584415
CDX2,Rectal Neoplasms,0.7880542567584415
CDX2,Bladder Adenocarcinoma,0.7880542567584415
CDX2,Acute leukemia,0.7880542567584415
CDX2,Congenital chromosomal disease,0.7880542567584415
CDX2,Intestinal Polyps,0.7880542567584415
CDX2,Acute lymphocytic leukemia,0.7880542567584415
CDX2,Stomach Carcinoma,0.7880542567584415
CDX2,Intestinal metaplasia of gastric mucosa,0.7880542567584415
CDX2,Adenocarcinoma intestinal type,0.7880542567584415
CDX2,Hamartomatous polyp,0.7880542567584415
CDX2,Squamous cell carcinoma,0.7880542567584415
CDX2,invasive cancer,0.7880542567584415
CDX2,Gastritis Atrophic,0.7880542567584415
CDX2,Barrett Epithelium,0.7880542567584415
CDX2,Carcinoma,0.7880542567584415
CDX2,Periodontitis Juvenile,0.7880542567584415
CDX2,Small cell carcinoma of lung,0.7880542567584415
CDX2,Huntington Disease,0.7880542567584415
CDX2,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
CDX2,Cystadenocarcinoma Mucinous,0.7880542567584415
CDX2,Gastrointestinal carcinoma,0.7880542567584415
CDX2,Crohn Disease,0.7880542567584415
CDX2,Metastatic Neoplasm,0.7880542567584415
CDX2,Pancreatic Diseases,0.7880542567584415
CDX2,Myeloid Leukemia Chronic,0.7880542567584415
CDX2,Adenosquamous carcinoma,0.7880542567584415
CDX2,Metastatic melanoma,0.7940665326856218
CDX2,Experimental Organism Basal Cell Carcinoma,0.8009048756462318
CDX2,ALPHA-THALASSEMIA/MENTAL RETARDATION SYNDROME NONDELETION TYPE X-LINKED,0.8019075543217649
CDX2,Gastrointestinal inflammation,0.8019075543217649
CDX2,Multiple Sclerosis,0.8019075543217649
CDX2,Psoriasis,0.8019075543217649
CDX2,Stage III Colon Cancer AJCC v7,0.8019075543217649
CDX2,Adenocarcinoma of large intestine,0.8019075543217649
CDX2,Malignant neoplasm of gallbladder,0.8019075543217649
CDX2,Stage III Colon Cancer,0.8019075543217649
CDX2,Cognitive changes,0.8019075543217649
CDX2,Liver neoplasms,0.8019075543217649
CDX2,Enterocolitis,0.8019075543217649
CDX2,Precancerous Conditions,0.8026504676141903
CDX2,Stomach Neoplasms,0.8044379824544406
CDX2,Adenomatous Polyps,0.8067197998685076
CDX2,Carcinoma Small Cell,0.8098851543361193
CDX2,Adenocarcinoma of lung (disorder),0.8098851543361193
CDX2,Herpes Simplex Infections,0.8098851543361193
CDX2,Mucinous neoplasm,0.8098851543361193
CDX2,Premenopausal breast cancer,0.8098851543361193
CDX2,Hamartoma,0.8145035474981049
CDX2,HIV Infections,0.8145035474981049
CDX2,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
CDX2,Stage II Colon Cancer AJCC v7,0.8168901801930506
CDX2,Poorly differentiated carcinoma,0.8168901801930506
CDX2,Adenocarcinoma Tubular,0.8168901801930506
CDX2,Ulcerative Colitis,0.8190761496232595
CDX2,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
CDX2,Stage II Colon Cancer,0.8190761496232595
CDX2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CDX2,Gastro-esophageal reflux disease with esophagitis,0.8190761496232595
CDX2,Juvenile polyposis syndrome,0.8190761496232595
CDX2,Osteopenia,0.8212681436603975
CDX2,Colonic Neoplasms,0.8212681436603975
CDX2,Secondary malignant neoplasm of lung,0.8232134984476662
CDX2,Gastric Adenocarcinoma,0.8232134984476662
CDX2,Secondary malignant neoplasm of pancreas,0.8232134984476662
CDX2,Anastomosis,0.8232134984476662
CDX2,Gallbladder Carcinoma,0.8232134984476662
CDX2,polyps,0.8232134984476662
CDX2,Hirschsprung Disease,0.8232134984476662
CDX2,Hereditary pyropoikilocytosis,0.8272008757995397
CDX2,Tuberculosis,0.8368219249856942
CDX2,Gastroesophageal reflux disease,0.8368219249856942
CDX2,Cholangiocarcinoma,0.8402911822757345
CDX2,Colorectal cancer metastatic,0.8402911822757345
CDX2,Peptic Esophagitis,0.8402911822757345
CDX2,Colonic Polyps,0.843190898187174
CDX2,Medullary carcinoma,0.8523465762428218
CDX2,Turcot syndrome (disorder),0.8554819098734854
CDX2,Neoplasm Residual,0.8578473133580928
CDX2,Rectal Carcinoma,0.8584283190330553
CDX2,Hyperplastic Polyp,0.8584283190330553
CDX2,Tuberculosis Pulmonary,0.8610447277138289
CDX2,HER2 gene amplification,0.8648405521677974
CDX2,Chronic Obstructive Airway Disease,0.8648405521677974
CDX2,Papillary thyroid carcinoma,0.8757755363384367
CDX2,Adenocarcinoma Of Esophagus,0.8769418330148872
CDX2,Multiple polyps,0.8769418330148872
CDX2,Hereditary Nonpolyposis Colorectal Cancer,0.8790903385143003
CDX2,Inflammatory Bowel Diseases,0.8815127642200768
CDX2,Pain,0.887595340546704
CDX2,Neuroendocrine Tumors,0.887595340546704
CDX2,Hyperactive behavior,0.8878860377518915
CDX2,Barrett Esophagus,0.8980854850210683
CDX2,Obesity,0.8989612563669234
CDX2,Secondary malignant neoplasm of lymph node,0.900167961295542
CDX2,Osteoarthritis Knee,0.9262273158806068
CDX2,Ductal Breast Carcinoma,0.9307095582633488
CDX2,Malignant neoplasm of skin,0.93413028051677
CDX2,Gastritis,0.9399783595775548
CDX2,Osteoporosis,0.9639249377588224
CDX2,Colonic Neoplasms,0.8210988731657684
CDX2,Familial expansile osteolysis ORPHA:85195,0.1991445465001551
CDX2,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1991445465001551
CDX2,Acrocapitofemoral dysplasia ORPHA:63446,0.7929682744768703
CDX2,Guttmacher syndrome ORPHA:2957,0.7929682744768703
CDX2,Hand-foot-genital syndrome ORPHA:2438,0.7929682744768703
CDX2,17q12 microdeletion syndrome ORPHA:261265,0.7929682744768703
CDX2,Partial pancreatic agenesis ORPHA:2805,0.8922466888454011
CDX2,Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963,0.8922466888454011
CDX2,Brachydactyly-syndactyly Zhao type ORPHA:93409,0.8922466888454011
CDX2,Congenital chloride diarrhea ORPHA:53689,0.8922466888454011
CDX2,Congenital sucrase-isomaltase deficiency ORPHA:35122,0.8922466888454011
CDX2,Microtia ORPHA:83463,0.8922466888454011
CDX2,NON RARE IN EUROPE: Brachydactyly type D ORPHA:93385,0.8922466888454011
CDX2,Syndactyly type 5 ORPHA:93406,0.8922466888454011
CDX2,Synpolydactyly type 1 ORPHA:295195,0.8922466888454011
CDX2,VACTERL/VATER association ORPHA:887,0.8922466888454011
CDX2,Zygodactyly type 3 ORPHA:295191,0.8922466888454011
CDX2,MODY ORPHA:552,0.8922466888454011
CDX2,Enteric anendocrinosis ORPHA:83620,0.8922466888454011
CDX2,Hypoplastic pancreas-intestinal atresia-hypoplastic gallbladder syndrome ORPHA:293864,0.8922466888454011
CDX2,Papiine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.8999095837312036
CEBPB,Malignant neoplasm of breast,0.4084380369379369
CEBPB,Breast Carcinoma,0.7333611688795861
CEBPB,Carcinogenesis,0.7333611688795861
CEBPB,B-Cell Lymphomas,0.7333611688795861
CEBPB,leukemia,0.7333611688795861
CEBPB,Parathyroid hyperplasia,0.7495999465637118
CEBPB,Malignant neoplasm of pancreas,0.7688485284765829
CEBPB,Hepatoblastoma,0.7765852775619541
CEBPB,Colorectal Carcinoma,0.7765852775619541
CEBPB,Pancreatic carcinoma,0.7765852775619541
CEBPB,Colon Carcinoma,0.7765852775619541
CEBPB,Leukemia Myelocytic Acute,0.7765852775619541
CEBPB,Malignant tumor of colon,0.7765852775619541
CEBPB,Esophageal carcinoma,0.7765852775619541
CEBPB,Lymphoma,0.7765852775619541
CEBPB,Carcinoma breast stage IV,0.7765852775619541
CEBPB,Adenoma,0.7765852775619541
CEBPB,Thyroid Neoplasm,0.7765852775619541
CEBPB,Esophageal Neoplasms,0.7765852775619541
CEBPB,Mammary Neoplasms,0.7880542567584415
CEBPB,Glioma,0.7880542567584415
CEBPB,Malignant neoplasm of lung,0.7880542567584415
CEBPB,Malignant neoplasm of prostate,0.7880542567584415
CEBPB,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
CEBPB,Hyperparathyroidism Secondary,0.7880542567584415
CEBPB,Refractory anemias,0.7880542567584415
CEBPB,Promyelocytic leukemia,0.7880542567584415
CEBPB,Liver carcinoma,0.7880542567584415
CEBPB,Malignant neoplasm of esophagus,0.7880542567584415
CEBPB,Acute Promyelocytic Leukemia,0.7880542567584415
CEBPB,Colorectal Cancer,0.7880542567584415
CEBPB,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
CEBPB,Glioblastoma,0.7880542567584415
CEBPB,Prostate carcinoma,0.7880542567584415
CEBPB,Primary malignant neoplasm of lung,0.7880542567584415
CEBPB,Neoplasm Metastasis,0.7880542567584415
CEBPB,Prostatic Neoplasms,0.7880542567584415
CEBPB,Carcinoma of lung,0.7880542567584415
CEBPB,Squamous cell carcinoma of the head and neck,0.7880542567584415
CEBPB,Malignant neoplasm of liver,0.7880542567584415
CEBPB,Serum total cholesterol measurement,0.7880542567584415
CEBPB,melanoma,0.7880542567584415
CEBPB,Ewings sarcoma,0.7880542567584415
CEBPB,Lung Neoplasms,0.7880542567584415
CEBPB,Adenovirus Infections,0.7880542567584415
CEBPB,Neoplasms,0.7880542567584415
CEBPB,Malignant neoplasm of stomach,0.7880542567584415
CEBPB,High density lipoprotein measurement,0.7880542567584415
CEBPB,Bile duct carcinoma,0.7880542567584415
CEBPB,Giant Cell Tumor of Bone,0.7880542567584415
CEBPB,Adult Fibrosarcoma,0.7880542567584415
CEBPB,Malignant neoplasm of large intestine,0.7880542567584415
CEBPB,Dementia,0.7880542567584415
CEBPB,Lupus Erythematosus Systemic,0.7880542567584415
CEBPB,Paget Disease,0.7880542567584415
CEBPB,Renal Cell Carcinoma,0.7880542567584415
CEBPB,Presenile dementia,0.7880542567584415
CEBPB,Alzheimer's Disease,0.7880542567584415
CEBPB,Stomach Carcinoma,0.7880542567584415
CEBPB,Osteitis Deformans,0.7880542567584415
CEBPB,Hepatitis C,0.7880542567584415
CEBPB,Cardiovascular Diseases,0.7880542567584415
CEBPB,Congenital neutropenia,0.7880542567584415
CEBPB,Glaucoma,0.7880542567584415
CEBPB,Adult Anaplastic Large Cell Lymphoma,0.7880542567584415
CEBPB,Squamous cell carcinoma,0.7880542567584415
CEBPB,Rheumatoid Arthritis,0.7880542567584415
CEBPB,Severe congenital neutropenia,0.7880542567584415
CEBPB,Diabetes,0.7880542567584415
CEBPB,Diabetes Mellitus,0.7880542567584415
CEBPB,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
CEBPB,Metastatic Neoplasm,0.7880542567584415
CEBPB,Virus Diseases,0.7880542567584415
CEBPB,Myeloid Leukemia,0.7880542567584415
CEBPB,Cleidocranial Dysplasia,0.7880542567584415
CEBPB,Anaplastic Large Cell Lymphoma ALK-Positive,0.7908231553833205
CEBPB,Allergic disposition,0.8019075543217649
CEBPB,Leukoencephalopathy Progressive Multifocal,0.8019075543217649
CEBPB,Anaplastic large B-cell lymphoma,0.8019075543217649
CEBPB,Fibrosarcoma,0.8019075543217649
CEBPB,Chronic Lymphocytic Leukemia,0.8019075543217649
CEBPB,Embryonal Carcinoma,0.8019075543217649
CEBPB,Degenerative polyarthritis,0.8019075543217649
CEBPB,Liver neoplasms,0.8019075543217649
CEBPB,Kidney Diseases,0.8019075543217649
CEBPB,Brain Injuries Focal,0.8067197998685076
CEBPB,Injuries Acute Brain,0.8067197998685076
CEBPB,Brain Injuries,0.8067197998685076
CEBPB,Brain Lacerations,0.8067197998685076
CEBPB,Adenocarcinoma of lung (disorder),0.8098851543361193
CEBPB,HIV Infections,0.8145035474981049
CEBPB,Sterility Postpartum,0.8145035474981049
CEBPB,Subfertility Female,0.8145035474981049
CEBPB,Female sterility,0.8145035474981049
CEBPB,Delirium Dementia Amnestic Cognitive Disorders,0.8168901801930506
CEBPB,Gastrointestinal Carcinoid Tumor,0.8190761496232595
CEBPB,Dengue Fever,0.8190761496232595
CEBPB,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CEBPB,Connective Tissue Diseases,0.8212681436603975
CEBPB,Female infertility,0.8232134984476662
CEBPB,Epstein-Barr Virus Infections,0.8232134984476662
CEBPB,Infection,0.8272008757995397
CEBPB,Vitamin D Deficiency,0.834094492023826
CEBPB,Tuberculosis,0.8368219249856942
CEBPB,Steatohepatitis,0.8402911822757345
CEBPB,Neurocognitive Disorders,0.8402911822757345
CEBPB,Erythroblastosis,0.8554819098734854
CEBPB,Squamous cell carcinoma of esophagus,0.8610447277138289
CEBPB,Fatty Liver,0.8628363180844141
CEBPB,Low density lipoprotein cholesterol measurement,0.8648405521677974
CEBPB,Papillary thyroid carcinoma,0.8757755363384367
CEBPB,Parkinson Disease,0.8772392350816924
CEBPB,Pulmonary Fibrosis,0.8911256045597441
CEBPB,nervous system disorder,0.8959157818691486
CEBPB,Brain Ischemia,0.8980854850210683
CEBPB,Obesity,0.8989612563669234
CEBPB,Cerebral Ischemia,0.9083161862856644
CEBPB,Hamman-Rich syndrome,0.9262273158806068
CEBPB,Fibroid Tumor,0.9373358316580888
CEBPB,Arthritis,0.9431511078237256
CEBPB,Hepatitis C Chronic,0.9432051631882106
CEBPB,Kaposi Sarcoma,0.9435654233359168
CEBPB,Uterine Fibroids,0.9557184806547836
CEBPB,Liver Carcinoma,0.7765582368651238
CEBPB,Fatty Liver,0.8321692755697452
CEBPB,Subfertility,0.8356859041719433
CEBPB,Cerebral Ischemia,0.9069867032339078
CEBPB,Alveolitis,0.9398381935810408
CEBPB,Pulmonary Fibrosis,0.9832345076528324
CEBPB,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
CEBPB,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
CEBPB,Heme oxygenase-1 deficiency ORPHA:562509,0.1040670578681756
CEBPB,Thrombomodulin-related bleeding disorder ORPHA:436169,0.1040670578681756
CEBPB,CLN10 disease ORPHA:228337,0.1991445465001551
CEBPB,Clear cell renal carcinoma ORPHA:319276,0.3832844616405875
CEBPB,Pediatric systemic lupus erythematosus ORPHA:93552,0.3832844616405875
CEBPB,Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480,0.7929682744768703
CEBPB,FTH1-related iron overload ORPHA:247790,0.7929682744768703
CEBPB,Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369,0.7929682744768703
CEBPB,Recurrent Neisseria infections due to factor D deficiency ORPHA:169467,0.7929682744768703
CEBPB,Monkeypox virus ankyrin-like protein,0.8999095837312036
CENPA,Malignant neoplasm of breast,0.4084380369379369
CENPA,Breast Carcinoma,0.7333611688795861
CENPA,Carcinogenesis,0.7333611688795861
CENPA,Adenocarcinoma,0.750391252594775
CENPA,Colorectal Carcinoma,0.7765852775619541
CENPA,Colorectal Neoplasms,0.7765852775619541
CENPA,Liver carcinoma,0.7880542567584415
CENPA,Colorectal Cancer,0.7880542567584415
CENPA,Epithelial ovarian cancer,0.7880542567584415
CENPA,Triple Negative Breast Neoplasms,0.7880542567584415
CENPA,Adenocarcinoma of lung (disorder),0.8098851543361193
CENPA,aggressive cancer,0.8168901801930506
CENPA,Scleroderma,0.8212681436603975
CENPA,Systemic Scleroderma,0.8402911822757345
CENPA,Liver Carcinoma,0.7765582368651238
CENPA,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
CENPA,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
CENPA,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
CENPA,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
CENPA,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
CENPA,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
CENPA,Currarino syndrome ORPHA:1552,0.0155394890951578
CENPA,Filippi syndrome ORPHA:3255,0.0155394890951578
CENPA,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
CENPA,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
CENPA,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
CENPA,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
CENPA,Stromme syndrome ORPHA:506307,0.0155394890951578
CENPA,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
CENPA,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
CENPA,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
CENPA,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
CENPA,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
CENPA,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
CENPA,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
CENPA,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
CENPA,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
CENPA,Small cell lung cancer ORPHA:70573,0.0429491792829903
CENPA,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.1040670578681756
CENPA,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1040670578681756
CENPA,Hyper-IgM syndrome type 5 ORPHA:101092,0.1040670578681756
CENPA,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.1040670578681756
CENPA,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.1040670578681756
CENPA,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.1040670578681756
CENPA,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.1040670578681756
CENPA,Hydrolethalus ORPHA:2189,0.1054066549396977
CENPA,Dedifferentiated liposarcoma ORPHA:99970,0.1068643725150898
CENPA,Well-differentiated liposarcoma ORPHA:99971,0.1068643725150898
CENPA,46XX gonadal dysgenesis ORPHA:243,0.1419890644363008
CENPA,46XY complete gonadal dysgenesis ORPHA:242,0.1479888965090844
CENPA,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.1991445465001551
CENPA,Autosomal recessive cutis laxa type 2B ORPHA:357064,0.1991445465001551
CENPA,Denys-Drash syndrome ORPHA:220,0.1991445465001551
CENPA,Frasier syndrome ORPHA:347,0.1991445465001551
CENPA,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.1991445465001551
CENPA,Hereditary coproporphyria ORPHA:79273,0.1991445465001551
CENPA,Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664,0.1991445465001551
CENPA,Meacham syndrome ORPHA:3097,0.1991445465001551
CENPA,PYCR1-related De Barsy syndrome ORPHA:293633,0.1991445465001551
CENPA,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.1991445465001551
CENPA,Li-Fraumeni syndrome ORPHA:524,0.3891940933600213
CENPA,Acquired partial lipodystrophy ORPHA:79087,0.5867963421058087
CENPA,Athabaskan brainstem dysgenesis syndrome ORPHA:69739,0.5867963421058087
CENPA,Baller-Gerold syndrome ORPHA:1225,0.5867963421058087
CENPA,Bosley-Salih-Alorainy syndrome ORPHA:69737,0.5867963421058087
CENPA,Progressive myoclonic epilepsy type 9 ORPHA:457265,0.5867963421058087
CENPA,RAPADILINO syndrome ORPHA:3021,0.5867963421058087
CENPA,Rothmund-Thomson syndrome type 2 ORPHA:221016,0.5867963421058087
CENPA,Amish nemaline myopathy ORPHA:98902,0.7929682744768703
CENPA,Spondyloepimetaphyseal dysplasia with multiple dislocations ORPHA:93360,0.7929682744768703
CENPA,Familial isolated congenital asplenia ORPHA:101351,0.7929682744768703
CENPA,SPONASTRIME dysplasia ORPHA:93357,0.8922466888454011
CENPA,Influenza B virus (B/Memphis/12/97) HA protein,0.8999095837312036
CENPA,Cowpox virus Ati or CPXV158 protein (gene: ati),0.8999095837312036
CENPA,Human adenovirus 41 E2A DBP,0.8999095837312036
CENPA,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
CENPA,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
CENPA,Variola virus hypothetical protein (gene: A28L),0.8999095837312036
CENPA,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.8999095837312036
CENPA,BK polyomavirus large T antigen,0.8999095837312036
CENPA,Influenza A virus (A/Korea/426/1968(H2N2)) nonstructural protein 1 (gene: NS1),0.8999095837312036
CENPA,Human papillomavirus 138 replication protein (gene: E1),0.8999095837312036
CENPA,JC polyomavirus hypothetical protein,0.9057542447893764
CENPA,Human papillomavirus 17 early protein (gene: E1),0.9057542447893764
CEP41,Biparietal narrowing,0.7880542567584415
CEP41,Decreased width of the skull,0.7880542567584415
CEP41,Ewings sarcoma,0.7880542567584415
CEP41,Joubert syndrome with ocular defect,0.7880542567584415
CEP41,Feeding difficulties in infancy,0.7880542567584415
CEP41,Nystagmus,0.7880542567584415
CEP41,Cognitive delay,0.7880542567584415
CEP41,Defective or absent horizontal voluntary eye movements,0.7880542567584415
CEP41,Global developmental delay,0.7880542567584415
CEP41,Mental and motor retardation,0.7880542567584415
CEP41,Oculomotor apraxia,0.7908231553833205
CEP41,Gait abnormality,0.8019075543217649
CEP41,Long face,0.8019075543217649
CEP41,Episodic tachypnea,0.8019075543217649
CEP41,Molar tooth sign on MRI,0.8067197998685076
CEP41,Apnea,0.8145035474981049
CEP41,Retinal Dystrophies,0.8190761496232595
CEP41,Congenital hypoplasia of penis,0.8232134984476662
CEP41,Feeding difficulties,0.8272008757995397
CEP41,Mental deficiency,0.8402911822757345
CEP41,Generalized hypotonia,0.843190898187174
CEP41,Cerebellar vermis hypoplasia,0.8610447277138289
CEP41,Dull intelligence,0.8757755363384367
CEP41,Low intelligence,0.8757755363384367
CEP41,Familial aplasia of the vermis,0.8769418330148872
CEP41,Poor school performance,0.8913141512402477
CEP41,Cystic Kidney Diseases,0.8959157818691486
CEP41,Cerebellar Ataxia,0.906476206143938
CEP41,Muscle hypotonia,0.9124568647908072
CEP41,Mental Retardation,0.922229272318747
CEP41,Congenital ocular coloboma (disorder),0.9432051631882106
CEP41,Intellectual Disability,0.9478210444156088
CEP41,Autism Spectrum Disorders,0.9639249377588224
CEP41,Polydactyly,0.9685329573219852
CEP41,Ciliopathies,0.98328107300087
CEP41,Retinal Dystrophy,0.7765582368651238
CEP41,Oculovestibuloauditory Syndrome,0.7765582368651238
CEP41,Oculomotor Apraxia,0.7765582368651238
CEP41,Joubert Syndrome With Ocular Defect,0.7765582368651238
CEP41,Nystagmus,0.7765582368651238
CEP41,Developmental Delay,0.7765582368651238
CEP41,Polymicrogyria,0.7765582368651238
CEP41,Disorder Of Eye,0.7765582368651238
CEP41,Schizophrenia,0.7860378120955526
CEP41,Fundus Coloboma,0.8115918568696846
CEP41,Retinal Coloboma,0.8115918568696846
CEP41,Oral Cleft,0.8115918568696846
CEP41,Dextrocardia,0.8115918568696846
CEP41,Penis Agenesis,0.8115918568696846
CEP41,Joubert Syndrome,0.8201196687803188
CEP41,Mental Retardation,0.8337953215113012
CEP41,Cerebellar Vermis Agenesis,0.861756360478846
CEP41,Autism Spectrum Disorder,0.8662301945830305
CEP41,Polydactyly Of Toes,0.8903630091389316
CEP41,Strabismus,0.8908485337686392
CEP41,Congenital Cerebral Hernia,0.924275664330454
CEP41,Scoliosis,0.924275664330454
CEP41,Congenital Coloboma Of Iris,0.9318760199717074
CEP41,Hydrocephalus,0.9574431947800732
CEP41,Polydactyly,0.9578111936867284
CEP41,Situs Inversus,0.9658957825498884
CEP41,Ciliopathies,0.9658957825498884
CEP41,Agenesis Of Corpus Callosum,0.980894832851993
CEP41,Ptosis,0.9832345076528324
CEP41,Hirschsprung Disease,0.9832345076528324
CEP41,Joubert syndrome with ocular defect ORPHA:220493,0.606625035400596
CEP41,Joubert syndrome ORPHA:475,0.8922466888454011
CEP41,Meckel syndrome ORPHA:564,0.8977183736895791
CERS5,Malignant neoplasm of breast,0.4084380369379369
CERS5,Breast Carcinoma,0.7333611688795861
CERS5,Colon Carcinoma,0.7765852775619541
CERS5,Malignant tumor of colon,0.7765852775619541
CERS5,Systolic Pressure,0.8098851543361193
CERS5,Hypertension,0.7765582368651238
CERS5,Navajo neurohepatopathy ORPHA:255229,0.7929682744768703
CERS5,Human immunodeficiency virus envelope glycoprotein (gene: env),0.8999095837312036
CERS5,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
CERS5,Yaba monkey tumor virus 72L,0.9359472799230178
CERS5,Junin mammarenavirus L protein,0.9397923093369096
CERS5,Lassa mammarenavirus L protein,0.9397923093369096
CERS5,Guanarito mammarenavirus L protein,0.9450424991150602
CETN3,Carcinoma of bladder,0.4084380369379369
CETN3,Bladder Neoplasm,0.4084380369379369
CETN3,Malignant neoplasm of urinary bladder,0.5071083164302358
CETN3,Glioma,0.7880542567584415
CETN3,Astrocytoma,0.7880542567584415
CETN3,Neoplasms,0.7880542567584415
CETN3,Meningioma benign no ICD-O subtype,0.8272008757995397
CETN3,Pituitary Neoplasms,0.8368219249856942
CETN3,Meningioma,0.8973454964837912
CETN3,Alazami syndrome ORPHA:319671,0.5867963421058087
CETN3,Brachydactyly-short stature-retinitis pigmentosa syndrome ORPHA:166035,0.7929682744768703
CETN3,Hypomyelination with brain stem and spinal cord involvement and leg spasticity ORPHA:363412,0.7929682744768703
CETN3,Medium chain acyl-CoA dehydrogenase deficiency ORPHA:42,0.8922466888454011
CETN3,Oral-facial-digital syndrome with short stature and brachymesophalangy ORPHA:508501,0.8922466888454011
CETN3,Parkinson-dementia complex of Guam ORPHA:90020,0.8922466888454011
CETN3,Cerebrofaciothoracic dysplasia ORPHA:1394,0.8922466888454011
CHKA,Malignant neoplasm of breast,0.4084380369379369
CHKA,Breast Carcinoma,0.7333611688795861
CHKA,Carcinogenesis,0.7333611688795861
CHKA,Malignant neoplasm of ovary,0.7333611688795861
CHKA,Ovarian Carcinoma,0.7333611688795861
CHKA,Malignant neoplasm of pancreas,0.7688485284765829
CHKA,Colorectal Carcinoma,0.7765852775619541
CHKA,Pancreatic carcinoma,0.7765852775619541
CHKA,Colon Carcinoma,0.7765852775619541
CHKA,Malignant tumor of colon,0.7765852775619541
CHKA,Lymphoma,0.7765852775619541
CHKA,Leukemogenesis,0.7765852775619541
CHKA,Non-Small Cell Lung Carcinoma,0.7765852775619541
CHKA,Prostatic Intraepithelial Neoplasias,0.7765852775619541
CHKA,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CHKA,Colorectal Neoplasms,0.7765852775619541
CHKA,Pancreatic Neoplasm,0.7765852775619541
CHKA,Mammary Neoplasms,0.7880542567584415
CHKA,Glioma,0.7880542567584415
CHKA,Malignant neoplasm of lung,0.7880542567584415
CHKA,Malignant neoplasm of prostate,0.7880542567584415
CHKA,Refractory anemias,0.7880542567584415
CHKA,stage non-small cell lung cancer,0.7880542567584415
CHKA,Liver carcinoma,0.7880542567584415
CHKA,Colorectal Cancer,0.7880542567584415
CHKA,Epithelial ovarian cancer,0.7880542567584415
CHKA,T-Cell Lymphoma,0.7880542567584415
CHKA,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
CHKA,Prostate carcinoma,0.7880542567584415
CHKA,Primary malignant neoplasm of lung,0.7880542567584415
CHKA,Neoplasm Metastasis,0.7880542567584415
CHKA,Prostatic Neoplasms,0.7880542567584415
CHKA,Carcinoma of lung,0.7880542567584415
CHKA,Malignant neoplasm of liver,0.7880542567584415
CHKA,Neuroblastoma,0.7880542567584415
CHKA,Central neuroblastoma,0.7880542567584415
CHKA,Hematologic Neoplasms,0.7880542567584415
CHKA,Adenovirus Infections,0.7880542567584415
CHKA,Tumor Progression,0.7880542567584415
CHKA,Status Dysraphicus,0.7880542567584415
CHKA,Rheumatoid Arthritis,0.7880542567584415
CHKA,Aortic Valve Insufficiency,0.7880542567584415
CHKA,Rachischisis,0.7880542567584415
CHKA,Congenital muscular dystrophy (disorder),0.8019075543217649
CHKA,Colonic Neoplasms,0.8212681436603975
CHKA,Spina Bifida,0.8272008757995397
CHKA,Other specified transient cerebral ischemias,0.8402911822757345
CHKA,Hepatitis B,0.841396342333011
CHKA,Transient Ischemic Attack,0.8816060628973529
CHKA,Status Dysraphicus,0.7765582368651238
CHKA,Rachischisis,0.7765582368651238
CHKA,Spina Bifida,0.8974842552599366
CHM,Breast Carcinoma,0.7333611688795861
CHM,Retinal pigment epithelial abnormality,0.7765852775619541
CHM,Abnormality of retinal pigmentation,0.7765852775619541
CHM,Progressive visual loss,0.7765852775619541
CHM,Decreased visual acuity progressive,0.7765852775619541
CHM,Hermanski-Pudlak Syndrome,0.7880542567584415
CHM,Neuroblastoma,0.7880542567584415
CHM,Central neuroblastoma,0.7880542567584415
CHM,Malignant Neoplasms,0.7880542567584415
CHM,Choroideremia,0.7880542567584415
CHM,Retinal Diseases,0.7880542567584415
CHM,Difficulties with night vision,0.7880542567584415
CHM,Central blindness,0.7880542567584415
CHM,Chorioretinal degeneration,0.7880542567584415
CHM,Night Blindness,0.7880542567584415
CHM,Choroidal and/or chorioretinal disorder,0.7880542567584415
CHM,Low Vision,0.7880542567584415
CHM,Dementia,0.7880542567584415
CHM,Presenile dementia,0.7880542567584415
CHM,Alzheimer's Disease,0.7880542567584415
CHM,Canine Osteosarcoma,0.7880542567584415
CHM,Visual Impairment,0.7880542567584415
CHM,Solid Neoplasm,0.7880542567584415
CHM,Chorioretinal atrophy,0.7880542567584415
CHM,Electroretinogram abnormal,0.7908231553833205
CHM,Primary malignant neoplasm,0.7908231553833205
CHM,Alcoholic Intoxication Chronic,0.8019075543217649
CHM,Essential Tremor,0.8098851543361193
CHM,Graft-vs-Host Disease,0.8190761496232595
CHM,Alcohol Use Disorder,0.8272008757995397
CHM,Degenerative disorder,0.8363138748299018
CHM,Retinitis Pigmentosa,0.8402911822757345
CHM,Parkinsonian Disorders,0.8486035047899471
CHM,Opiate Addiction,0.8554819098734854
CHM,Visual field constriction,0.8610447277138289
CHM,Parkinson Disease,0.8772392350816924
CHM,Autosomal dominant retinitis pigmentosa,0.8774809019744603
CHM,Restless Legs Syndrome,0.8851456306720444
CHM,Myopia,0.9506863447189738
CHM,Mental Retardation X-Linked,0.951016614400691
CHM,Disorder of eye,0.9578035687879456
CHM,Retinal Dystrophy,0.7765582368651238
CHM,Choroideremia,0.7765582368651238
CHM,Nyctalopia,0.7765582368651238
CHM,Chorioretinal Atrophy,0.7765582368651238
CHM,Disorder Of Eye,0.7765582368651238
CHM,Retinitis Pigmentosa,0.861756360478846
CHM,Myopia,0.9832345076528324
CHM,X-linked intellectual disability Cabezas type ORPHA:85293,0.5867963421058087
CHM,Autosomal recessive spastic paraplegia type 71 ORPHA:401840,0.7929682744768703
CHM,COG6-CGD ORPHA:464443,0.7929682744768703
CHM,Christianson syndrome ORPHA:85278,0.7929682744768703
CHM,Craniolenticulosutural dysplasia ORPHA:50814,0.7929682744768703
CHM,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome ORPHA:363523,0.7929682744768703
CHM,Hypomyelination-congenital cataract syndrome ORPHA:85163,0.7929682744768703
CHM,MEGDEL syndrome ORPHA:352328,0.7929682744768703
CHM,Autosomal recessive spastic paraplegia type 69 ORPHA:401830,0.8922466888454011
CHM,Carney complex ORPHA:1359,0.8922466888454011
CHM,Choroideremia ORPHA:180,0.8922466888454011
CHM,Familial atrial myxoma ORPHA:615,0.8922466888454011
CHM,Hyperparathyroidism-jaw tumor syndrome ORPHA:99880,0.8922466888454011
CHM,Parathyroid carcinoma ORPHA:143,0.8922466888454011
CHM,Reticulate acropigmentation of Kitamura ORPHA:178307,0.8922466888454011
CHM,Cataract-intellectual disability-hypogonadism syndrome ORPHA:1387,0.8922466888454011
CHM,Autosomal recessive spastic paraplegia type 53 ORPHA:319199,0.8922466888454011
CHM,Neonatal epileptic encephalopathy due to glutaminase deficiency ORPHA:557064,0.8922466888454011
CHM,Progressive spondyloepimetaphyseal dysplasia-short stature-short fourth metatarsals-intellectual disability syndrome ORPHA:457395,0.8922466888454011
CHM,Pyruvate dehydrogenase phosphatase deficiency ORPHA:79246,0.8922466888454011
CHM,Spastic ataxia-dysarthria due to glutaminase deficiency ORPHA:557056,0.8922466888454011
CHM,Micro syndrome ORPHA:2510,0.8922466888454011
CHM,Hereditary sensory and autonomic neuropathy type 1 ORPHA:36386,0.8922466888454011
CHN2,Mammary Neoplasms,0.7880542567584415
CHN2,Malignant neoplasm of liver,0.7880542567584415
CHN2,Neuroblastoma,0.7880542567584415
CHN2,Central neuroblastoma,0.7880542567584415
CHN2,melanoma,0.7880542567584415
CHN2,Hepatosplenic T-cell lymphoma,0.7880542567584415
CHN2,Nonproliferative diabetic retinopathy,0.7880542567584415
CHN2,Liver neoplasms,0.8019075543217649
CHN2,Precancerous Conditions,0.8026504676141903
CHN2,Acquired CJD,0.8145035474981049
CHN2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CHN2,Diabetic Retinopathy,0.8402911822757345
CHN2,Condition Preneoplastic,0.8648405521677974
CHN2,Psychotic Disorders,0.939985154445373
CHN2,Diabetic Nephropathy,0.7765582368651238
CHN2,Reactive Psychosis,0.7765582368651238
CHN2,Psychosis,0.7765582368651238
CHN2,Leukemia,0.7765582368651238
CHN2,Alzheimer Disease,0.8457525389282121
CHN2,Liver Cancer,0.924275664330454
CHN2,Liver Neoplasms,0.9543024119762946
CHN2,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.1040670578681756
CHN2,Gamma-aminobutyric acid transaminase deficiency ORPHA:2066,0.7929682744768703
CHN2,L-Arginine:glycine amidinotransferase deficiency ORPHA:35704,0.8922466888454011
CHST4,Adenocarcinoma,0.750391252594775
CHST4,Mucinous Adenocarcinoma,0.7880542567584415
CHST4,Transitional cell carcinoma of bladder,0.7880542567584415
CHST4,Multiple Endocrine Neoplasia Type 1,0.8019075543217649
CIB2,Malignant neoplasm of breast,0.4084380369379369
CIB2,Carcinoma of bladder,0.4084380369379369
CIB2,Bladder Neoplasm,0.4084380369379369
CIB2,Malignant neoplasm of urinary bladder,0.5071083164302358
CIB2,Breast Carcinoma,0.7333611688795861
CIB2,Hydatidiform Mole Partial,0.7333611688795861
CIB2,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CIB2,Carcinogenesis,0.7333611688795861
CIB2,Malignant neoplasm of ovary,0.7333611688795861
CIB2,B-Cell Lymphomas,0.7333611688795861
CIB2,Ovarian Carcinoma,0.7333611688795861
CIB2,Hepatoblastoma,0.7765852775619541
CIB2,Beckwith-Wiedemann Syndrome,0.7765852775619541
CIB2,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
CIB2,MYELODYSPLASTIC SYNDROME,0.7765852775619541
CIB2,Non-Small Cell Lung Carcinoma,0.7765852775619541
CIB2,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CIB2,Complete hydatidiform mole,0.7765852775619541
CIB2,Adenoma,0.7765852775619541
CIB2,Nevus,0.7765852775619541
CIB2,Malignant neoplasm of lung,0.7880542567584415
CIB2,Malignant neoplasm of prostate,0.7880542567584415
CIB2,Low Grade Lymphoma (neoplasm),0.7880542567584415
CIB2,Liver carcinoma,0.7880542567584415
CIB2,Epithelial ovarian cancer,0.7880542567584415
CIB2,Rhabdomyosarcoma,0.7880542567584415
CIB2,HYDATIDIFORM MOLE RECURRENT 1,0.7880542567584415
CIB2,Leukemia T-Cell,0.7880542567584415
CIB2,Prostate carcinoma,0.7880542567584415
CIB2,Nephroblastoma,0.7880542567584415
CIB2,Primary malignant neoplasm of lung,0.7880542567584415
CIB2,Neoplasm Metastasis,0.7880542567584415
CIB2,Carcinoma of lung,0.7880542567584415
CIB2,Hydatidiform Mole,0.7880542567584415
CIB2,Glucocorticoid Receptor Deficiency,0.7880542567584415
CIB2,Difficulties with night vision,0.7880542567584415
CIB2,Renal glomerular disease,0.7880542567584415
CIB2,Melanocytic nevus,0.7880542567584415
CIB2,Pigmentary iris degeneration,0.7880542567584415
CIB2,Profound sensorineural hearing impairment,0.7880542567584415
CIB2,Night Blindness,0.7880542567584415
CIB2,Aplasia/Hypoplasia of the cerebellum,0.7880542567584415
CIB2,Nasopharyngeal carcinoma,0.7880542567584415
CIB2,Infection caused by Helicobacter pylori,0.7880542567584415
CIB2,Tumor Progression,0.7880542567584415
CIB2,Sarcoma,0.7880542567584415
CIB2,Benign melanocytic nevus,0.7880542567584415
CIB2,Lymphoma Follicular,0.7880542567584415
CIB2,Acute lymphocytic leukemia,0.7880542567584415
CIB2,Abnormal vision,0.7880542567584415
CIB2,Abnormality of cochlea,0.7880542567584415
CIB2,Cognitive delay,0.7880542567584415
CIB2,Usher syndrome type 1A,0.7880542567584415
CIB2,Vestibular dysfunction,0.7880542567584415
CIB2,Vestibular hypofunction,0.7880542567584415
CIB2,Squamous cell carcinoma,0.7880542567584415
CIB2,Diabetes,0.7880542567584415
CIB2,Diabetes Mellitus,0.7880542567584415
CIB2,Global developmental delay,0.7880542567584415
CIB2,Mental and motor retardation,0.7880542567584415
CIB2,Usher Syndrome Type I,0.7880542567584415
CIB2,Electroretinogram abnormal,0.7908231553833205
CIB2,IGA Glomerulonephritis,0.8019075543217649
CIB2,Hyperinsulinism,0.8019075543217649
CIB2,Retinal blind spot,0.8019075543217649
CIB2,Scotoma,0.8019075543217649
CIB2,Glomerulosclerosis (disorder),0.8019075543217649
CIB2,Schizophrenia,0.8067197998685076
CIB2,Mucosa-Associated Lymphoid Tissue Lymphoma,0.8190761496232595
CIB2,Lip and Oral Cavity Carcinoma,0.8190761496232595
CIB2,No development of motor milestones,0.8212681436603975
CIB2,Usher Syndrome,0.8212681436603975
CIB2,Motor delay,0.8232134984476662
CIB2,Hemianopsia,0.8232134984476662
CIB2,High-grade hypermetropia,0.8270909867833504
CIB2,Embryonal Rhabdomyosarcoma,0.8368219249856942
CIB2,Nonsyndromic Deafness,0.8368219249856942
CIB2,Retinitis Pigmentosa,0.8402911822757345
CIB2,Mental deficiency,0.8402911822757345
CIB2,Oral Cavity Carcinoma,0.8402911822757345
CIB2,Familial (FPAH),0.8648405521677974
CIB2,Chronic Obstructive Airway Disease,0.8648405521677974
CIB2,Dull intelligence,0.8757755363384367
CIB2,Low intelligence,0.8757755363384367
CIB2,Cataract,0.8769418330148872
CIB2,Choriocarcinoma,0.8769418330148872
CIB2,Poor school performance,0.8913141512402477
CIB2,Malignant neoplasm of mouth,0.8946938397586319
CIB2,Cerebellar Ataxia,0.906476206143938
CIB2,Lens Opacities,0.9117936912777788
CIB2,Mental Retardation,0.922229272318747
CIB2,Intellectual Disability,0.9478210444156088
CIB2,Sensorineural Hearing Loss (disorder),0.9520060723130308
CIB2,Asthma,0.9672478180546946
CIB2,Nyctalopia,0.7765582368651238
CIB2,Developmental Delay,0.7765582368651238
CIB2,Disorder Of Eye,0.7765582368651238
CIB2,Schizophrenia,0.7860378120955526
CIB2,Subcortical Cerebral Atrophy,0.8115918568696846
CIB2,Non-Syndromic Sensorineural Deafness,0.8115918568696846
CIB2,Hearing Loss,0.8115918568696846
CIB2,Motor Delay,0.8210988731657684
CIB2,Usher Syndrome,0.8337953215113012
CIB2,Hallucinations,0.8337953215113012
CIB2,Mental Retardation,0.8337953215113012
CIB2,Deafness,0.8457525389282121
CIB2,Hemianopsia,0.8476516371290275
CIB2,Anxiety Disorder,0.8507213163251659
CIB2,Cerebral Cortical Atrophy,0.861756360478846
CIB2,Rod-cone Dystrophy,0.8903301324869451
CIB2,Mental Depression,0.8903630091389316
CIB2,Nonsyndromic Deafness,0.9398381935810408
CIB2,Cataract,0.974502015052702
CIB2,Usher syndrome type 1 ORPHA:231169,0.2661730864557679
CIB2,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.5867963421058087
CIB2,Classic Bartter syndrome ORPHA:93605,0.5867963421058087
CIB2,Intellectual disability-developmental delay-contractures syndrome ORPHA:3454,0.5867963421058087
CIB2,Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893,0.7929682744768703
CIB2,X-linked Emery-Dreifuss muscular dystrophy ORPHA:98863,0.7929682744768703
CKB,Malignant neoplasm of breast,0.4084380369379369
CKB,Breast Carcinoma,0.7333611688795861
CKB,Carcinogenesis,0.7333611688795861
CKB,Malignant neoplasm of ovary,0.7333611688795861
CKB,leukemia,0.7333611688795861
CKB,Ovarian Carcinoma,0.7333611688795861
CKB,Adenocarcinoma,0.750391252594775
CKB,Colorectal Carcinoma,0.7765852775619541
CKB,Colon Carcinoma,0.7765852775619541
CKB,Malignant tumor of colon,0.7765852775619541
CKB,Cervix carcinoma,0.7765852775619541
CKB,Malignant tumor of cervix,0.7768809924982332
CKB,Colorectal Cancer,0.7880542567584415
CKB,Epithelial ovarian cancer,0.7880542567584415
CKB,cervical cancer,0.7880542567584415
CKB,Neoplasm Metastasis,0.7880542567584415
CKB,Malignant neoplasm of stomach,0.7880542567584415
CKB,Tumor Progression,0.7880542567584415
CKB,Hematological Disease,0.7880542567584415
CKB,Alzheimer's Disease,0.7880542567584415
CKB,Stomach Carcinoma,0.7880542567584415
CKB,Hepatitis C,0.7880542567584415
CKB,Uveitis,0.7880542567584415
CKB,Small cell carcinoma of lung,0.7880542567584415
CKB,Huntington Disease,0.7880542567584415
CKB,Secondary malignant neoplasm of liver,0.7908231553833205
CKB,Regurgitation,0.8019075543217649
CKB,Pick Disease of the Brain,0.8019075543217649
CKB,Myocardial Infarction,0.8019075543217649
CKB,Hereditary Diffuse Gastric Cancer,0.8019075543217649
CKB,Precancerous Conditions,0.8026504676141903
CKB,Acute Coronary Syndrome,0.8037546774788534
CKB,Stomach Neoplasms,0.8044379824544406
CKB,Schizophrenia,0.8067197998685076
CKB,Adenocarcinoma Tubular,0.8168901801930506
CKB,Colonic Neoplasms,0.8212681436603975
CKB,Hypoglycemia,0.8232134984476662
CKB,polyps,0.8232134984476662
CKB,Left Ventricular Hypertrophy,0.8402911822757345
CKB,Carcinoma Cribriform,0.8648405521677974
CKB,Carcinoma Granular Cell,0.8648405521677974
CKB,Adenocarcinoma Basal Cell,0.8648405521677974
CKB,Adenocarcinoma Oxyphilic,0.8745234584149799
CKB,Cardiomyopathy Dilated,0.9564633032157428
CKB,Stomach Neoplasms,0.7765582368651238
CKB,Schizophrenia,0.7860378120955526
CKB,Left Ventricular Hypertrophy,0.8115918568696846
CKB,Lung Carcinoma,0.8139950454942313
CKB,Myocardial Infarction,0.861756360478846
CKB,Gastric Cancer,0.861756360478846
CKB,Coronary Syndrome,0.8903301324869451
CKB,Carcinoma,0.9069867032339078
CKB,Adenocarcinoma,0.9350723667380212
CKB,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
CKB,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
CKB,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.1068643725150898
CKB,Benign hereditary chorea ORPHA:1429,0.1991445465001551
CKB,Coloboma of choroid and retina ORPHA:98942,0.3977968344535308
CKB,Coloboma of iris ORPHA:98944,0.3977968344535308
CKB,Achondroplasia ORPHA:15,0.5867963421058087
CKB,Autosomal dominant spastic paraplegia type 31 ORPHA:101011,0.5867963421058087
CKB,Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120,0.5867963421058087
CKB,Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164,0.5867963421058087
CKB,Classic Bartter syndrome ORPHA:93605,0.5867963421058087
CKB,Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262,0.5867963421058087
CKB,Hypochondroplasia ORPHA:429,0.5867963421058087
CKB,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144,0.5867963421058087
CKB,Muenke syndrome ORPHA:53271,0.5867963421058087
CKB,Progressive myoclonic epilepsy type 8 ORPHA:424027,0.5867963421058087
CKB,Right sided atrial isomerism ORPHA:97548,0.5867963421058087
CKB,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165,0.5867963421058087
CKB,Thanatophoric dysplasia type 1 ORPHA:1860,0.5867963421058087
CKB,Thanatophoric dysplasia type 2 ORPHA:93274,0.5867963421058087
CKB,X-linked creatine transporter deficiency ORPHA:52503,0.5867963421058087
CKB,Paroxysmal non-kinesigenic dyskinesia ORPHA:98810,0.5867963421058087
CKB,Brain-lung-thyroid syndrome ORPHA:209905,0.8922466888454011
CKB,Distal arthrogryposis type 5D ORPHA:329457,0.8922466888454011
CKB,Oculoauricular syndrome Schorderet type ORPHA:157962,0.8922466888454011
CKB,Coloboma of eye lens ORPHA:98943,0.8922466888454011
CKB,Coloboma of eyelid ORPHA:98946,0.8922466888454011
CKB,Coloboma of macula ORPHA:98945,0.8922466888454011
CKB,Coloboma of optic disc ORPHA:98947,0.8922466888454011
CLDN2,Malignant neoplasm of breast,0.4084380369379369
CLDN2,Breast Carcinoma,0.7333611688795861
CLDN2,Carcinogenesis,0.7333611688795861
CLDN2,Adenocarcinoma,0.750391252594775
CLDN2,Hepatoblastoma,0.7765852775619541
CLDN2,Colorectal Carcinoma,0.7765852775619541
CLDN2,Colon Carcinoma,0.7765852775619541
CLDN2,Metaplasia,0.7765852775619541
CLDN2,Malignant tumor of colon,0.7765852775619541
CLDN2,Non-Small Cell Lung Carcinoma,0.7765852775619541
CLDN2,Colorectal Neoplasms,0.7765852775619541
CLDN2,Carcinoma breast stage IV,0.7765852775619541
CLDN2,Adenoma,0.7765852775619541
CLDN2,Mammary Neoplasms,0.7880542567584415
CLDN2,Malignant neoplasm of lung,0.7880542567584415
CLDN2,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
CLDN2,Pancreatitis Alcoholic,0.7880542567584415
CLDN2,Cholelithiasis,0.7880542567584415
CLDN2,Colorectal Cancer,0.7880542567584415
CLDN2,Primary malignant neoplasm of lung,0.7880542567584415
CLDN2,Neoplasm Metastasis,0.7880542567584415
CLDN2,Carcinoma Endometrioid,0.7880542567584415
CLDN2,Carcinoma of lung,0.7880542567584415
CLDN2,Malignant Neoplasms,0.7880542567584415
CLDN2,Malignant neoplasm of stomach,0.7880542567584415
CLDN2,Diarrhea,0.7880542567584415
CLDN2,Pancreatitis Chronic,0.7880542567584415
CLDN2,Tumor Progression,0.7880542567584415
CLDN2,Salmonella infections,0.7880542567584415
CLDN2,Cholecystolithiasis,0.7880542567584415
CLDN2,Secondary malignant neoplasm of skin,0.7880542567584415
CLDN2,Squamous cell carcinoma,0.7880542567584415
CLDN2,Carcinoid Tumor,0.7880542567584415
CLDN2,Crohn Disease,0.7880542567584415
CLDN2,Bacterial Infections,0.7908231553833205
CLDN2,Secondary malignant neoplasm of liver,0.7908231553833205
CLDN2,Primary malignant neoplasm,0.7908231553833205
CLDN2,Cholecystitis,0.7908231553833205
CLDN2,Adenocarcinoma of lung (disorder),0.8098851543361193
CLDN2,Cholesterol gallstones,0.8145035474981049
CLDN2,Pancreatitis,0.8168901801930506
CLDN2,Ulcerative Colitis,0.8190761496232595
CLDN2,Secondary malignant neoplasm of lung,0.8232134984476662
CLDN2,Inflammatory Bowel Diseases,0.8815127642200768
CLDN2,Necrotizing enterocolitis in fetus OR newborn,0.8980854850210683
CLDN2,Secondary malignant neoplasm of lymph node,0.900167961295542
CLDN2,Colitis,0.9738491767258852
CLDN2,Pancreatitis,0.8115918568696846
CLDN2,Obstructive Azoospermia,0.8115918568696846
CLDN2,Isolated neonatal sclerosing cholangitis ORPHA:480556,0.1991445465001551
CLDN2,HNF1B-related autosomal dominant tubulointerstitial kidney disease ORPHA:93111,0.3832844616405875
CLDN2,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119,0.3832844616405875
CLDN2,Chromophobe renal cell carcinoma ORPHA:319303,0.3832844616405875
CLDN2,Hyperinsulinism due to HNF1A deficiency ORPHA:324575,0.3832844616405875
CLDN2,Hyperinsulinism due to HNF4A deficiency ORPHA:263455,0.3832844616405875
CLDN2,Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528,0.5867963421058087
CLDN2,Bilateral multicystic dysplastic kidney ORPHA:97364,0.5867963421058087
CLDN2,Medullary sponge kidney ORPHA:1309,0.5867963421058087
CLDN2,Renal dysplasia bilateral ORPHA:93173,0.5867963421058087
CLDN2,Renal dysplasia unilateral ORPHA:93172,0.5867963421058087
CLDN2,Unilateral multicystic dysplastic kidney ORPHA:97363,0.5867963421058087
CLDN2,Rotor syndrome ORPHA:3111,0.7929682744768703
CLDN2,Acrocapitofemoral dysplasia ORPHA:63446,0.7929682744768703
CLDN2,Aromatic L-amino acid decarboxylase deficiency ORPHA:35708,0.7929682744768703
CLDN2,CIDEC-related familial partial lipodystrophy ORPHA:435651,0.7929682744768703
CLDN2,Dubin-Johnson syndrome ORPHA:234,0.7929682744768703
CLDN2,Progressive familial intrahepatic cholestasis type 5 ORPHA:480476,0.7929682744768703
CLDN2,X-linked Charcot-Marie-Tooth disease type 1 ORPHA:101075,0.7929682744768703
CLDN2,X-linked progressive cerebellar ataxia ORPHA:1175,0.7929682744768703
CLDN2,17q12 microdeletion syndrome ORPHA:261265,0.7929682744768703
CLDN2,Brachytelephalangic chondrodysplasia punctata ORPHA:79345,0.8922466888454011
CLDN2,Hereditary fructose intolerance ORPHA:469,0.8922466888454011
CLDN2,Hereditary hypercarotenemia and vitamin A deficiency ORPHA:199285,0.8922466888454011
CLDN2,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.8922466888454011
CLDN9,Malignant neoplasm of prostate,0.7880542567584415
CLDN9,Prostatic Neoplasms,0.7880542567584415
CLDN9,Prostate Cancer,0.7765582368651238
CLDN9,Prostatic Neoplasms,0.7765582368651238
CLDN9,Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305,0.7929682744768703
CLGN,Multiple malignancy,0.7880542567584415
CLGN,Seminoma,0.7880542567584415
CLGN,Hyperphenylalaninemia due to DNAJC12 deficiency ORPHA:508523,0.7929682744768703
CLGN,46XY partial gonadal dysgenesis ORPHA:251510,0.8668760866668862
CLGN,WAGR syndrome ORPHA:893,0.8922466888454011
CLGN,Combined pituitary hormone deficiencies genetic forms ORPHA:95494,0.8922466888454011
CLIC3,Malignant neoplasm of breast,0.4084380369379369
CLIC3,Carcinoma of bladder,0.4084380369379369
CLIC3,Bladder Neoplasm,0.4084380369379369
CLIC3,Malignant neoplasm of urinary bladder,0.5071083164302358
CLIC3,Breast Carcinoma,0.7333611688795861
CLIC3,Malignant neoplasm of ovary,0.7333611688795861
CLIC3,Ovarian Carcinoma,0.7333611688795861
CLIC3,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
CLIC3,Neoplasm Metastasis,0.7880542567584415
CLIC3,Eclampsia,0.7880542567584415
CLIC3,Mucoepidermoid Carcinoma,0.7880542567584415
CLIC3,Tumor Progression,0.7880542567584415
CLIC3,Secondary malignant neoplasm of lymph node,0.900167961295542
CLIC3,Idiopathic juvenile osteoporosis ORPHA:85193,0.7929682744768703
CLIC3,Annular epidermolytic ichthyosis ORPHA:281139,0.8922466888454011
CLIC3,Autosomal dominant epidermolytic ichthyosis ORPHA:312,0.8922466888454011
CLIC3,Congenital reticular ichthyosiform erythroderma ORPHA:281190,0.8922466888454011
CLIC3,Hypoparathyroidism-sensorineural deafness-renal disease syndrome ORPHA:2237,0.8922466888454011
CLK3,Carcinoma of bladder,0.4084380369379369
CLK3,Cleft upper lip,0.7880542567584415
CLK3,Bladder Carcinoma,0.9231137872214272
CLK3,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
CLK3,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
CLK3,Birt-Hogg-Dube syndrome ORPHA:122,0.1991445465001551
CLK3,Familial spontaneous pneumothorax ORPHA:2903,0.1991445465001551
CLK3,Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228,0.1991445465001551
CLK3,CAMOS syndrome ORPHA:83472,0.1991445465001551
CLK3,Coats plus syndrome ORPHA:313838,0.1991445465001551
CLK3,CLN3 disease ORPHA:228346,0.3832844616405875
CLK3,Grange syndrome ORPHA:79094,0.3832844616405875
CLK3,Glycogen storage disease due to liver phosphorylase kinase deficiency ORPHA:264580,0.3832844616405875
CLK3,Hermansky-Pudlak syndrome with pulmonary fibrosis ORPHA:231500,0.3832844616405875
CLK3,Familial focal epilepsy with variable foci ORPHA:98820,0.3832844616405875
CLK3,Pityriasis rubra pilaris ORPHA:2897,0.5867963421058087
CLK3,Combined malonic and methylmalonic acidemia ORPHA:289504,0.8922466888454011
CLK3,Renal-hepatic-pancreatic dysplasia ORPHA:294415,0.8922466888454011
CLK3,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
CLK3,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
CLK3,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
CLK3,Provisional),0.8999095837312036
CLK3,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CLK3,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CLK3,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CLK3,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
CLK3,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
CLK3,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
CLK3,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CLK3,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
CLK3,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
CLK3,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
CLK3,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
CLK3,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CLK3,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
CLSTN3,Colorectal Cancer,0.7880542567584415
CLSTN3,Amyloidosis,0.8672189956534445
CLSTN3,Schizophrenia,0.7860378120955526
CLSTN3,Colorectal Cancer,0.9832345076528324
CLSTN3,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
CLSTN3,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
CLSTN3,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
CLSTN3,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.1040670578681756
CLSTN3,Gorlin syndrome ORPHA:377,0.5867963421058087
CLSTN3,SYNGAP1-related developmental and epileptic encephalopathy ORPHA:544254,0.7929682744768703
CLSTN3,Dopamine beta-hydroxylase deficiency ORPHA:230,0.8922466888454011
CLU,Malignant neoplasm of breast,0.4084380369379369
CLU,Carcinoma of bladder,0.4084380369379369
CLU,Bladder Neoplasm,0.4084380369379369
CLU,Malignant neoplasm of urinary bladder,0.5071083164302358
CLU,Adenomatous Polyposis Coli,0.5196624042573144
CLU,Breast Carcinoma,0.7333611688795861
CLU,Diffuse Large B-Cell Lymphoma,0.7333611688795861
CLU,Carcinogenesis,0.7333611688795861
CLU,Malignant neoplasm of ovary,0.7333611688795861
CLU,B-Cell Lymphomas,0.7333611688795861
CLU,Ovarian Carcinoma,0.7333611688795861
CLU,Adenocarcinoma,0.750391252594775
CLU,Malignant neoplasm of pancreas,0.7688485284765829
CLU,Colorectal Carcinoma,0.7765852775619541
CLU,Pancreatic carcinoma,0.7765852775619541
CLU,Dementia familial Danish,0.7765852775619541
CLU,Colon Carcinoma,0.7765852775619541
CLU,androgen independent prostate cancer,0.7765852775619541
CLU,Malignant tumor of colon,0.7765852775619541
CLU,Lymphoma,0.7765852775619541
CLU,Endometrial Neoplasms,0.7765852775619541
CLU,Cervix carcinoma,0.7765852775619541
CLU,Non-Small Cell Lung Carcinoma,0.7765852775619541
CLU,Hypercholesterolemia,0.7765852775619541
CLU,HIV Encephalopathy,0.7765852775619541
CLU,Prostatic Intraepithelial Neoplasias,0.7765852775619541
CLU,Colorectal Neoplasms,0.7765852775619541
CLU,HIV encephalitis,0.7765852775619541
CLU,Adenoma,0.7765852775619541
CLU,Thyroid Neoplasm,0.7765852775619541
CLU,Endometrial Carcinoma,0.7765852775619541
CLU,Vascular Diseases,0.7765852775619541
CLU,Malignant tumor of cervix,0.7768809924982332
CLU,Mammary Neoplasms,0.7880542567584415
CLU,Glioma,0.7880542567584415
CLU,Malignant neoplasm of lung,0.7880542567584415
CLU,Malignant neoplasm of prostate,0.7880542567584415
CLU,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
CLU,Mastocytosis Systemic,0.7880542567584415
CLU,Liver carcinoma,0.7880542567584415
CLU,Malignant Meningioma,0.7880542567584415
CLU,Osteosarcoma,0.7880542567584415
CLU,Thyroid carcinoma,0.7880542567584415
CLU,Colorectal Cancer,0.7880542567584415
CLU,Epithelial ovarian cancer,0.7880542567584415
CLU,Multiple malignancy,0.7880542567584415
CLU,Hepatocarcinogenesis,0.7880542567584415
CLU,Glioblastoma,0.7880542567584415
CLU,Osteosarcoma of bone,0.7880542567584415
CLU,Hemangioblastoma,0.7880542567584415
CLU,Prostate carcinoma,0.7880542567584415
CLU,Astrocytoma,0.7880542567584415
CLU,Primary malignant neoplasm of lung,0.7880542567584415
CLU,cervical cancer,0.7880542567584415
CLU,Neoplasm Metastasis,0.7880542567584415
CLU,Prion Diseases,0.7880542567584415
CLU,Epithelioma,0.7880542567584415
CLU,Exfoliation Syndrome,0.7880542567584415
CLU,Malignant neoplasm of testis,0.7880542567584415
CLU,Hepatitis D Infection,0.7880542567584415
CLU,Carcinoma Endometrioid,0.7880542567584415
CLU,Prostatic Neoplasms,0.7880542567584415
CLU,Carcinoma of lung,0.7880542567584415
CLU,Malignant neoplasm of thyroid,0.7880542567584415
CLU,Squamous cell carcinoma of the head and neck,0.7880542567584415
CLU,Triple Negative Breast Neoplasms,0.7880542567584415
CLU,Neuroblastoma,0.7880542567584415
CLU,Central neuroblastoma,0.7880542567584415
CLU,Immunologic Deficiency Syndromes,0.7880542567584415
CLU,Malignant Neoplasms,0.7880542567584415
CLU,melanoma,0.7880542567584415
CLU,Lung Neoplasms,0.7880542567584415
CLU,Metastatic Prostate Carcinoma,0.7880542567584415
CLU,Neoplasms,0.7880542567584415
CLU,Libman-Sacks Disease,0.7880542567584415
CLU,PERIODONTITIS LOCALIZED AGGRESSIVE,0.7880542567584415
CLU,Malignant neoplasm of stomach,0.7880542567584415
CLU,AURAL ATRESIA CONGENITAL,0.7880542567584415
CLU,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
CLU,Membranous glomerulonephritis,0.7880542567584415
CLU,Myxoid cyst,0.7880542567584415
CLU,Hemolytic-Uremic Syndrome,0.7880542567584415
CLU,Skin Carcinogenesis,0.7880542567584415
CLU,Papillary serous cystadenocarcinoma,0.7880542567584415
CLU,Hodgkin Disease,0.7880542567584415
CLU,Benign Prostatic Hyperplasia,0.7880542567584415
CLU,Brain Neoplasms,0.7880542567584415
CLU,Sensory denervation disorder,0.7880542567584415
CLU,Pancreatitis Chronic,0.7880542567584415
CLU,Nasopharyngeal carcinoma,0.7880542567584415
CLU,Asthenozoospermia,0.7880542567584415
CLU,Malignant Testicular Germ Cell Tumor,0.7880542567584415
CLU,Dementia,0.7880542567584415
CLU,Tumor Progression,0.7880542567584415
CLU,Endometrial Diseases,0.7880542567584415
CLU,Sarcoma,0.7880542567584415
CLU,Lupus Erythematosus Systemic,0.7880542567584415
CLU,Fuchs Endothelial Dystrophy,0.7880542567584415
CLU,Renal Cell Carcinoma,0.7880542567584415
CLU,Seminoma,0.7880542567584415
CLU,Presenile dementia,0.7880542567584415
CLU,Arteriosclerosis,0.7880542567584415
CLU,Atherosclerosis,0.7880542567584415
CLU,Alzheimer's Disease,0.7880542567584415
CLU,Periodontitis,0.7880542567584415
CLU,Stomach Carcinoma,0.7880542567584415
CLU,Juvenile psoriatic arthritis,0.7880542567584415
CLU,Hepatitis C,0.7880542567584415
CLU,Glaucoma,0.7880542567584415
CLU,Cystadenoma Mucinous,0.7880542567584415
CLU,Squamous cell carcinoma,0.7880542567584415
CLU,Infiltrating Cervical Carcinoma,0.7880542567584415
CLU,Rheumatoid Arthritis,0.7880542567584415
CLU,Juvenile-Onset Still Disease,0.7880542567584415
CLU,Diabetes,0.7880542567584415
CLU,Desmoplastic melanoma,0.7880542567584415
CLU,Diabetes Mellitus,0.7880542567584415
CLU,Carcinoid Tumor,0.7880542567584415
CLU,Aortic Valve Insufficiency,0.7880542567584415
CLU,Adenoma of large intestine,0.7880542567584415
CLU,Diffuse Intrinsic Pontine Glioma,0.7880542567584415
CLU,Retinal Degeneration,0.7880542567584415
CLU,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.7880542567584415
CLU,PACHYONYCHIA CONGENITA 3,0.7880542567584415
CLU,Thinking and speaking disturbances,0.7880542567584415
CLU,Hormone refractory prostate cancer,0.7880542567584415
CLU,Acute malaria,0.7880542567584415
CLU,Fish-Eye Disease,0.7880542567584415
CLU,Pathologic Neovascularization,0.7880542567584415
CLU,Cholestasis,0.7880542567584415
CLU,Pancreatic Diseases,0.7880542567584415
CLU,Polyneuropathy,0.7880542567584415
CLU,Secondary malignant neoplasm of liver,0.7908231553833205
CLU,Primary malignant neoplasm,0.7908231553833205
CLU,CADASIL Syndrome,0.7908231553833205
CLU,Metastatic melanoma,0.7940665326856218
CLU,Juvenile arthritis,0.8009048756462318
CLU,Hemangioma,0.8009048756462318
CLU,Plaque Amyloid,0.8009048756462318
CLU,Endometrial Endometrioid Adenocarcinoma,0.8009048756462318
CLU,Chronic Periodontitis,0.8019075543217649
CLU,Adult-Onset Still Disease,0.8019075543217649
CLU,Pre-Eclampsia,0.8019075543217649
CLU,Cerebral atrophy,0.8019075543217649
CLU,Multiple Sclerosis,0.8019075543217649
CLU,Oligospermia,0.8019075543217649
CLU,Fleck corneal dystrophy,0.8019075543217649
CLU,Kidney Failure Chronic,0.8019075543217649
CLU,Fibrosarcoma,0.8019075543217649
CLU,Synovitis,0.8019075543217649
CLU,Degenerative polyarthritis,0.8019075543217649
CLU,Encephalomyelitis,0.8019075543217649
CLU,Senile Plaques,0.8019075543217649
CLU,Liver neoplasms,0.8019075543217649
CLU,Kidney Diseases,0.8019075543217649
CLU,Gingival Diseases,0.8026798872257774
CLU,Acute Coronary Syndrome,0.8037546774788534
CLU,ovarian neoplasm,0.8067197998685076
CLU,Schizophrenia,0.8067197998685076
CLU,Adenocarcinoma of lung (disorder),0.8098851543361193
CLU,Convulsions,0.8098851543361193
CLU,Liver diseases,0.8140222479282434
CLU,Absence Seizures,0.8168901801930506
CLU,Prostatic Hypertrophy,0.8168901801930506
CLU,Ulcerative Colitis,0.8190761496232595
CLU,Generalized seizures,0.8190761496232595
CLU,Impaired cognition,0.8190761496232595
CLU,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
CLU,Seizures Focal,0.8190761496232595
CLU,Colonic Neoplasms,0.8212681436603975
CLU,Inflammation,0.8212681436603975
CLU,Trigeminal Neuralgia,0.8212681436603975
CLU,Nephrotic Syndrome,0.8232134984476662
CLU,Secondary malignant neoplasm of lung,0.8232134984476662
CLU,Liver Cirrhosis,0.8232134984476662
CLU,Testicular Neoplasms,0.8232134984476662
CLU,Angle Closure Glaucoma,0.8232134984476662
CLU,Metastatic Carcinoma,0.8232134984476662
CLU,Alzheimer's Disease Focal Onset,0.8232134984476662
CLU,Acute Confusional Senile Dementia,0.8232134984476662
CLU,Prostatic Hyperplasia,0.8232134984476662
CLU,Amyotrophic Lateral Sclerosis Sporadic,0.8270909867833504
CLU,Periodontal Diseases,0.8270909867833504
CLU,Neurodegenerative Disorders,0.8272008757995397
CLU,Fibrosis Liver,0.8272008757995397
CLU,Osteoarthrosis Deformans,0.834094492023826
CLU,Anti-Basement Membrane Glomerulonephritis,0.834094492023826
CLU,Glioblastoma Multiforme,0.8342163953428735
CLU,Recurrent tumor,0.8368219249856942
CLU,Traditional Serrated Adenoma,0.8402911822757345
CLU,AMYOTROPHIC LATERAL SCLEROSIS 1,0.8402911822757345
CLU,Glaucoma Primary Open Angle,0.8402911822757345
CLU,Alzheimer Disease Late Onset,0.8402911822757345
CLU,Mixed cryoglobulinemia,0.8402911822757345
CLU,Retinitis Pigmentosa,0.8402911822757345
CLU,Mild cognitive disorder,0.8402911822757345
CLU,Primary Carcinoma,0.8402911822757345
CLU,Papilloma,0.8402911822757345
CLU,Single Seizure,0.8402911822757345
CLU,Seizures Auditory,0.8402911822757345
CLU,Seizures Clonic,0.8402911822757345
CLU,Seizures Sensory,0.8402911822757345
CLU,Seizures Somatosensory,0.8402911822757345
CLU,Vertiginous seizure,0.8402911822757345
CLU,Atonic Absence Seizures,0.8402911822757345
CLU,Generalized Absence Seizures,0.8402911822757345
CLU,Gustatory seizure,0.8402911822757345
CLU,Jacksonian Seizure,0.8402911822757345
CLU,Non-epileptic convulsion,0.8402911822757345
CLU,Nonepileptic Seizures,0.8402911822757345
CLU,Olfactory seizure,0.8402911822757345
CLU,Down Syndrome,0.8420665668584452
CLU,Epileptic Seizures,0.843190898187174
CLU,Tonic Seizures,0.8474481237156937
CLU,Hypertensive disease,0.8474481237156937
CLU,Drug-Induced Liver Disease,0.8523465762428218
CLU,Chronic graft-versus-host disease,0.8523465762428218
CLU,Hepatitis Toxic,0.8548862007194026
CLU,Chemical and Drug Induced Liver Injury,0.8548862007194026
CLU,Chemically-Induced Liver Toxicity,0.8548862007194026
CLU,Drug-Induced Acute Liver Injury,0.8548862007194026
CLU,Cirrhosis,0.8554819098734854
CLU,Convulsive Seizures,0.8578473133580928
CLU,Cystadenoma,0.8578473133580928
CLU,Hepatitis Drug-Induced,0.8578473133580928
CLU,Squamous cell carcinoma of esophagus,0.8610447277138289
CLU,NEUROTICISM,0.8610447277138289
CLU,Epileptic drop attack,0.8648405521677974
CLU,Tonic - clonic seizures,0.8648405521677974
CLU,Alzheimer Disease Early Onset,0.8648405521677974
CLU,Complex partial seizures,0.8648405521677974
CLU,Atrophic,0.8648405521677974
CLU,Von Hippel-Lindau Syndrome,0.8648405521677974
CLU,Amyloidosis,0.8672189956534445
CLU,Mental Depression,0.8769418330148872
CLU,Proteinuria,0.8769418330148872
CLU,Parkinson Disease,0.8772392350816924
CLU,Familial Alzheimer Disease (FAD),0.8786853464107758
CLU,Thyroid Nodule,0.8815127642200768
CLU,Hepatolenticular Degeneration,0.8867509400747969
CLU,Carcinoma Papillary,0.887080330932516
CLU,nervous system disorder,0.8959157818691486
CLU,Brain Ischemia,0.8980854850210683
CLU,Secondary malignant neoplasm of lymph node,0.900167961295542
CLU,Visual seizure,0.900167961295542
CLU,Depressive disorder,0.9103315000053974
CLU,Pulmonary Hypertension,0.9103315000053974
CLU,Coronary heart disease,0.9119978323790848
CLU,Adverse reaction to drug,0.9119978323790848
CLU,Drug toxicity,0.9119978323790848
CLU,Lesion of brain,0.914995991166204
CLU,Myoclonic Seizures,0.914995991166204
CLU,Acute Kidney Insufficiency,0.9193385822373632
CLU,Acute kidney injury,0.9258401930327972
CLU,Pituitary Diseases,0.93156380601526
CLU,Ischemia of kidney,0.9349647051157376
CLU,Kidney Failure Acute,0.9373358316580888
CLU,Refractory cancer,0.9377696084218796
CLU,Skin Neoplasms,0.9434459508692176
CLU,Seizures,0.9478210444156088
CLU,Malaria,0.9512505437112568
CLU,Epilepsy,0.963331724428282
CLU,Ureteral obstruction,0.963331724428282
CLU,Renal fibrosis,0.98964300672626
CLU,Prostate Cancer,0.7765582368651238
CLU,Melanoma,0.7765582368651238
CLU,Nonbacterial Verrucal Endocardiosis,0.7765582368651238
CLU,Prostatic Neoplasms,0.7765582368651238
CLU,Juvenile Arthritis,0.7765582368651238
CLU,Polyarthritis Rheumatoid Factor Positive,0.7765582368651238
CLU,Seronegative Polyarthritis,0.7765582368651238
CLU,Still Disease,0.7765582368651238
CLU,Schizophrenia,0.7860378120955526
CLU,Kidney Disease,0.8210988731657684
CLU,Lateral Sclerosis,0.8444537302152433
CLU,Alzheimer Disease,0.8457525389282121
CLU,Hypotonic Seizures,0.8601151608808731
CLU,Seizure,0.861756360478846
CLU,Osteoarthrosis Deformans,0.861756360478846
CLU,Senile Dementia,0.861756360478846
CLU,Jacksonian Seizure,0.861756360478846
CLU,Cognitive Disorder,0.861756360478846
CLU,Clonic Seizures,0.8903301324869451
CLU,Arthritis,0.9046917974656596
CLU,Lupus Erythematosus,0.9145387439550552
CLU,Impaired Cognition,0.9231137872214272
CLU,Acute Kidney Insufficiency,0.9578111936867284
CLU,Kidney Failure,0.9658957825498884
CLU,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.1040670578681756
CLU,46XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752,0.3832844616405875
CLU,CLCN4-related X-linked intellectual disability syndrome ORPHA:485350,0.5867963421058087
CLU,Microphthalmia with limb anomalies ORPHA:1106,0.5867963421058087
CLU,Autosomal recessive extra-oral halitosis ORPHA:562538,0.7929682744768703
CLU,Autosomal dominant spastic paraplegia type 17 ORPHA:100998,0.8922466888454011
CLU,Severe neurodegenerative syndrome with lipodystrophy ORPHA:363400,0.8922466888454011
COQ10A,Liver Cirrhosis Experimental,0.8014900279306119
COQ10A,Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159,0.5867963421058087
COQ10A,Telethonin-related  limb-girdle muscular dystrophy R7 ORPHA:34514,0.5867963421058087
COQ10A,Familial steroid-resistant nephrotic syndrome with sensorineural deafness ORPHA:280406,0.7929682744768703
COQ10A,Glycogen storage disease due to muscle beta-enolase deficiency ORPHA:99849,0.8922466888454011
COQ7,Low Vision,0.7880542567584415
COQ7,Serum creatinine raised,0.7880542567584415
COQ7,Cognitive delay,0.7880542567584415
COQ7,Visual Impairment,0.7880542567584415
COQ7,COENZYME Q10 DEFICIENCY,0.7880542567584415
COQ7,Global developmental delay,0.7880542567584415
COQ7,Polyneuropathy,0.7880542567584415
COQ7,Mental and motor retardation,0.7880542567584415
COQ7,Congenital deafness,0.8019075543217649
COQ7,Peripheral demyelination,0.8019075543217649
COQ7,Steroid resistant nephrotic syndrome of childhood,0.8019075543217649
COQ7,Steroid-resistant nephrotic syndrome,0.8067197998685076
COQ7,Hearing Loss Partial,0.8098851543361193
COQ7,Deafness,0.8190761496232595
COQ7,No development of motor milestones,0.8212681436603975
COQ7,Motor delay,0.8232134984476662
COQ7,Postnatal growth retardation,0.8270909867833504
COQ7,Feeding difficulties,0.8272008757995397
COQ7,Neurodegenerative Disorders,0.8272008757995397
COQ7,hearing impairment,0.834094492023826
COQ7,Small for gestational age (disorder),0.8402911822757345
COQ7,Low Birth Weights,0.8402911822757345
COQ7,Peripheral Neuropathy,0.8402911822757345
COQ7,RENAL ADYSPLASIA,0.8402911822757345
COQ7,Generalized hypotonia,0.843190898187174
COQ7,Renal dysplasia,0.8554819098734854
COQ7,Maternal oligohydramnios,0.8648405521677974
COQ7,Oligohydramnios,0.8774809019744603
COQ7,Pain,0.887595340546704
COQ7,Mitochondrial Diseases,0.8989612563669234
COQ7,Infant Small for Gestational Age,0.9083161862856644
COQ7,Intrauterine retardation,0.9111864999692114
COQ7,Muscle hypotonia,0.9124568647908072
COQ7,Fetal Growth Retardation,0.9307095582633488
COQ7,Respiratory distress,0.9393256300017014
COQ7,Muscle Weakness,0.9512505437112568
COQ7,Congenital hypoplasia of lung,0.9557184806547836
COQ7,Flexion contractures of joints,0.9614320311453906
COQ7,Flexion contracture,0.9621920228183704
COQ7,Contracture of joint,0.9639249377588224
COQ7,Contracture,0.9769594699984444
COQ7,Dyspnea,0.9858417751377604
COQ7,Coenzyme Q10 Deficiency,0.7765582368651238
COQ7,Hypertension,0.7765582368651238
COQ7,Developmental Delay,0.7765582368651238
COQ7,Left Ventricular Hypertrophy,0.8115918568696846
COQ7,Motor Delay,0.8210988731657684
COQ7,Renal Dysplasia,0.8903630091389316
COQ7,Polyneuropathy,0.9436990979382386
COQ7,Pulmonary Hypoplasia,0.9658957825498884
COQ7,Human T-lymphotropic virus 3 envelope (gene: env),0.8999095837312036
COQ7,Human T-cell lymphotropic virus type 2b env,0.8999095837312036
COQ7,Human T-lymphotropic virus 4 envelope glycoprotein (gene: env),0.8999095837312036
COQ7,Human T-lymphotropic virus 2 p21E envelope protein,0.8999095837312036
COQ7,Japanese encephalitis virus hypothetical protein,0.8999095837312036
COQ7,Human T-cell leukemia virus type I gp46 SU (gene: env),0.8999095837312036
COQ7,Human T-lymphotropic virus 2 hypothetical protein (env propeptide),0.8999095837312036
COQ7,Ntaya virus full_polyprotein 1..3427,0.8999095837312036
COQ7,Cowpox virus Ati or CPXV158 protein (gene: ati),0.8999095837312036
COQ7,Ilheus virus full_polyprotein 1..3424,0.8999095837312036
COQ7,West Nile virus SA381/00 non-structural protein 5,0.8999095837312036
COQ7,West Nile virus lineage 1 RNA-dependent RNA polymerase NS5 (gene: flavivirus polyprotein),0.8999095837312036
COQ7,West Nile virus lineage 2 RNA-dependent RNA polymerase NS5 (gene: flavivirus polyprotein),0.8999095837312036
COQ7,Murray Valley encephalitis virus NS5,0.8999095837312036
COQ7,West Nile virus H442 non-structural protein 5,0.8999095837312036
COQ7,West Nile virus SPU116/89 non-structural protein 5,0.8999095837312036
COQ7,West Nile virus SA93/01 non-structural protein 5,0.8999095837312036
COQ7,Zika virus RNA-dependent RNA polymerase NS5 (gene: flavivirus polyprotein),0.8999095837312036
COQ7,Yellow fever virus RNA-dependent RNA polymerase,0.8999095837312036
COQ7,Langat virus nonstructural protein NS5,0.8999095837312036
COQ7,Dengue virus 3 RNA-dependent RNA polymerase NS5 (gene: flavivirus polyprotein),0.8999095837312036
COQ7,Dengue virus 1 RNA-dependent RNA polymerase NS5 (gene: flavivirus polyprotein),0.8999095837312036
COQ7,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
COQ7,Dengue virus 2 RNA-dependent RNA polymerase NS5 (gene: flavivirus polyprotein),0.8999095837312036
COQ7,Kyasanur Forest disease virus NS5,0.8999095837312036
COQ7,Powassan virus RNA-dependent RNA polymerase,0.8999095837312036
COQ7,Wesselsbron virus full_polyprotein 1..3405,0.8999095837312036
COQ7,Louping ill virus RNA-dependent RNA polymerase,0.8999095837312036
COQ7,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
COQ7,Variola virus hypothetical protein (gene: A28L),0.8999095837312036
COQ7,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.8999095837312036
COQ7,Influenza A virus (A/California/04/2009(H1N1)) matrix protein 2 (gene: M2),0.8999095837312036
COQ7,Yaba monkey tumor virus anti-apoptotic membrane protein,0.8999095837312036
COQ7,Karshi virus (Royal Farm virus) full_polyprotein 1..3416,0.8999095837312036
COQ7,Omsk hemorrhagic fever virus full_polyprotein 1..3414,0.8999095837312036
COQ7,Monkeypox virus cowpox A-type inclusion protein,0.8999095837312036
COQ7,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
COQ7,Nipah henipavirus P phosphoprotein,0.8999095837312036
COQ7,Variola virus double-strand RNA-binding protein (gene: E3L),0.9057542447893764
CORO1A,Malignant neoplasm of breast,0.4084380369379369
CORO1A,Breast Carcinoma,0.7333611688795861
CORO1A,Hydatidiform Mole Partial,0.7333611688795861
CORO1A,Carcinogenesis,0.7333611688795861
CORO1A,Malignant neoplasm of ovary,0.7333611688795861
CORO1A,Cerebellar malformation,0.7333611688795861
CORO1A,leukemia,0.7333611688795861
CORO1A,Ovarian Carcinoma,0.7333611688795861
CORO1A,Epidermodysplasia Verruciformis,0.7765852775619541
CORO1A,Colorectal Carcinoma,0.7765852775619541
CORO1A,Colon Carcinoma,0.7765852775619541
CORO1A,Malignant tumor of colon,0.7765852775619541
CORO1A,Lymphoma,0.7765852775619541
CORO1A,Complete hydatidiform mole,0.7765852775619541
CORO1A,Mammary Neoplasms,0.7880542567584415
CORO1A,Liver carcinoma,0.7880542567584415
CORO1A,Triploidy syndrome,0.7880542567584415
CORO1A,Colorectal Cancer,0.7880542567584415
CORO1A,Lymphopenia,0.7880542567584415
CORO1A,HYDATIDIFORM MOLE RECURRENT 1,0.7880542567584415
CORO1A,Nephroblastoma,0.7880542567584415
CORO1A,insulinoma,0.7880542567584415
CORO1A,Neoplasm Metastasis,0.7880542567584415
CORO1A,Primary immune deficiency disorder,0.7880542567584415
CORO1A,Hydatidiform Mole,0.7880542567584415
CORO1A,Immunologic Deficiency Syndromes,0.7880542567584415
CORO1A,Malignant Neoplasms,0.7880542567584415
CORO1A,Neoplasms,0.7880542567584415
CORO1A,Severe Combined Immunodeficiency,0.7880542567584415
CORO1A,Malignant neoplasm of large intestine,0.7880542567584415
CORO1A,Lupus Erythematosus Systemic,0.7880542567584415
CORO1A,Lymphoma Follicular,0.7880542567584415
CORO1A,Gestational Trophoblastic Neoplasms,0.7880542567584415
CORO1A,Cognitive delay,0.7880542567584415
CORO1A,Squamous cell carcinoma,0.7880542567584415
CORO1A,Carcinoma,0.7880542567584415
CORO1A,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
CORO1A,Global developmental delay,0.7880542567584415
CORO1A,Virus Diseases,0.7880542567584415
CORO1A,Mental and motor retardation,0.7880542567584415
CORO1A,Primary malignant neoplasm,0.7908231553833205
CORO1A,Carcinoma Spindle-Cell,0.7950434752274518
CORO1A,Undifferentiated carcinoma,0.8019075543217649
CORO1A,Lupus Erythematosus,0.8067197998685076
CORO1A,ovarian neoplasm,0.8067197998685076
CORO1A,Lupus Erythematosus Discoid,0.8098851543361193
CORO1A,Adult Acute Lymphocytic Leukemia,0.8145035474981049
CORO1A,Carcinomatosis,0.8190761496232595
CORO1A,Lupus Vulgaris,0.8232134984476662
CORO1A,Tuberculosis,0.8368219249856942
CORO1A,Mammary Carcinoma Animal,0.8402911822757345
CORO1A,Animal Mammary Neoplasms,0.8402911822757345
CORO1A,Anaplastic carcinoma,0.8402911822757345
CORO1A,Muscular Dystrophy Duchenne,0.8815127642200768
CORO1A,Hydrocephalus,0.8851456306720444
CORO1A,Hyperactive behavior,0.8878860377518915
CORO1A,Recurrent respiratory infections,0.9083161862856644
CORO1A,Attention deficit hyperactivity disorder,0.9770263358372888
CORO1A,Omenn Syndrome,0.7765582368651238
CORO1A,Immunologic Deficiency Syndromes,0.7765582368651238
CORO1A,Severe Combined Immunodeficiency Disease,0.7765582368651238
CORO1A,Lymphopenia,0.7765582368651238
CORO1A,Developmental Delay,0.7765582368651238
CORO1A,Immunodeficiency,0.8115918568696846
CORO1A,Anaplastic Carcinoma,0.8115918568696846
CORO1A,Carcinoma,0.9069867032339078
CORO1A,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
CORO1A,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
CORO1A,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
CORO1A,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.1040670578681756
CORO1A,LIPE-related familial partial lipodystrophy ORPHA:435660,0.1040670578681756
CORO1A,Aicardi-Goutieres syndrome ORPHA:51,0.1294848460749822
CORO1A,Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549,0.1991445465001551
CORO1A,Coats plus syndrome ORPHA:313838,0.1991445465001551
CORO1A,Autosomal recessive malignant osteopetrosis ORPHA:667,0.2120485863056726
CORO1A,Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566,0.3832844616405875
CORO1A,Combined immunodeficiency-enteropathy spectrum ORPHA:436252,0.3832844616405875
CORO1A,Congenital non-communicating hydrocephalus ORPHA:269510,0.3832844616405875
CORO1A,Grange syndrome ORPHA:79094,0.3832844616405875
CORO1A,Hermansky-Pudlak syndrome type 7 ORPHA:231531,0.3832844616405875
CORO1A,Multiple intestinal atresia ORPHA:2300,0.3832844616405875
CORO1A,Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606,0.3832844616405875
CORO1A,Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301,0.3832844616405875
CORO1A,Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003,0.3832844616405875
CORO1A,Spinocerebellar ataxia type 40 ORPHA:423275,0.3832844616405875
CORO1A,Familial focal epilepsy with variable foci ORPHA:98820,0.3832844616405875
CORO1A,Autosomal dominant severe congenital neutropenia ORPHA:486,0.3891940933600213
CORO1A,Epidermodysplasia verruciformis ORPHA:302,0.3891940933600213
CORO1A,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499,0.5867963421058087
CORO1A,Neutrophil immunodeficiency syndrome ORPHA:183707,0.5867963421058087
CORO1A,WHIM syndrome ORPHA:51636,0.5867963421058087
CORO1A,Cystic leukoencephalopathy without megalencephaly ORPHA:85136,0.5867963421058087
CORO1A,Familial hemophagocytic lymphohistiocytosis ORPHA:540,0.5959529547720634
CORO1A,Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942,0.7929682744768703
CORO1A,Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943,0.7929682744768703
CORO1A,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046,0.7929682744768703
CORO1A,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585,0.7929682744768703
CORO1A,BENTA disease ORPHA:464336,0.7929682744768703
CORO1A,Charcot-Marie-Tooth disease type 1B ORPHA:101082,0.7929682744768703
CORO1A,Combined immunodeficiency due to OX40 deficiency ORPHA:431149,0.7929682744768703
CORO1A,Hyperinsulinism due to UCP2 deficiency ORPHA:276556,0.7929682744768703
CORO1A,Persistent polyclonal B-cell lymphocytosis ORPHA:300324,0.7929682744768703
CORO1A,Severe combined immunodeficiency due to CARD11 deficiency ORPHA:357237,0.7929682744768703
CORO1A,T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078,0.7929682744768703
CORO1A,X-linked severe congenital neutropenia ORPHA:86788,0.7929682744768703
CORO1A,X-linked thrombocytopenia with normal platelets ORPHA:852,0.7929682744768703
CORO1A,Acute basophilic leukemia ORPHA:86849,0.7929682744768703
CORO1A,Recurrent infection due to specific granule deficiency ORPHA:169142,0.7929682744768703
CORO1A,Complete hydatidiform mole ORPHA:254688,0.795266832401002
CORO1A,Autosomal agammaglobulinemia ORPHA:33110,0.8029813443753846
CORO1A,Common variable immunodeficiency ORPHA:1572,0.8564946241562607
CORO1A,Combined immunodeficiency due to CD27 deficiency ORPHA:238505,0.8922466888454011
CORO1A,Combined immunodeficiency due to IL21R deficiency ORPHA:357329,0.8922466888454011
CORO1A,Combined immunodeficiency due to ZAP70 deficiency ORPHA:911,0.8922466888454011
CORO1A,DOCK2 deficiency ORPHA:447737,0.8922466888454011
CORO1A,Hyperzincemia and hypercalprotectinemia ORPHA:251523,0.8922466888454011
CORO1A,Leukocyte adhesion deficiency type I ORPHA:99842,0.8922466888454011
CORO1A,Leukocyte adhesion deficiency type III ORPHA:99844,0.8922466888454011
CORO1A,NON RARE IN EUROPE: Psoriatic arthritis ORPHA:40050,0.8922466888454011
CORO1A,Pancytopenia due to IKZF1 mutations ORPHA:317473,0.8922466888454011
CORO1A,Pyogenic arthritis-pyoderma gangrenosum-acne syndrome ORPHA:69126,0.8922466888454011
CORO1A,Severe combined immunodeficiency due to LCK deficiency ORPHA:280142,0.8922466888454011
CORO1A,T-B+ severe combined immunodeficiency due to gamma chain deficiency ORPHA:276,0.8922466888454011
CORO1A,Stevens-Johnson syndrome ORPHA:36426,0.8922466888454011
CORO1A,Wiskott-Aldrich syndrome ORPHA:906,0.8922466888454011
CORO1A,Immunodeficiency by defective expression of MHC class II ORPHA:572,0.8922466888454011
CORO1A,Narcolepsy type 2 ORPHA:83465,0.8922466888454011
CORO1A,Narcolepsy type 1 ORPHA:2073,0.8922466888454011
CORO1A,Primary biliary cholangitis ORPHA:186,0.8922466888454011
CORO1A,Precursor B-cell acute lymphoblastic leukemia ORPHA:99860,0.8922466888454011
COX19,Cytochrome-c Oxidase Deficiency,0.8486035047899471
COX19,TMEM199-CDG ORPHA:466703,0.3832844616405875
COX19,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome ORPHA:467176,0.8922466888454011
CRADD,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CRADD,Osteosarcoma,0.7880542567584415
CRADD,Osteosarcoma of bone,0.7880542567584415
CRADD,Agyria,0.7880542567584415
CRADD,Lissencephaly,0.7880542567584415
CRADD,Renal Cell Carcinoma,0.7880542567584415
CRADD,Alzheimer's Disease,0.7880542567584415
CRADD,Macrocephaly,0.7880542567584415
CRADD,Papillary Renal Cell Carcinoma,0.7880542567584415
CRADD,Increased head circumference,0.7880542567584415
CRADD,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
CRADD,Chromophobe Renal Cell Carcinoma,0.8019075543217649
CRADD,Delayed speech and language development,0.8168901801930506
CRADD,Sarcomatoid Renal Cell Carcinoma,0.8190761496232595
CRADD,Collecting Duct Carcinoma of the Kidney,0.8272008757995397
CRADD,Hip circumference,0.8363138748299018
CRADD,Speech impairment,0.8402911822757345
CRADD,Mental deficiency,0.8402911822757345
CRADD,Language Delay,0.8402911822757345
CRADD,Speech Delay,0.8474481237156937
CRADD,Dull intelligence,0.8757755363384367
CRADD,Low intelligence,0.8757755363384367
CRADD,Body mass index,0.8867509400747969
CRADD,Finding of body mass index,0.8867509400747969
CRADD,Poor school performance,0.8913141512402477
CRADD,Septicemia,0.917543617287358
CRADD,Sepsis,0.9189398569397552
CRADD,Mental Retardation,0.922229272318747
CRADD,Body Height,0.9390727893210336
CRADD,Intellectual Disability,0.9478210444156088
CRADD,Non-Syndromic Intellectual Disability,0.6734982286750932
CRADD,Stereotyped Behavior,0.7765582368651238
CRADD,Dyskinetic Syndrome,0.7765582368651238
CRADD,Lissencephaly,0.7765582368651238
CRADD,Salaam Seizures,0.7765582368651238
CRADD,Cortical Dysplasia,0.7765582368651238
CRADD,Developmental Delay,0.7765582368651238
CRADD,Macrocephaly,0.7765582368651238
CRADD,Polymicrogyria,0.7765582368651238
CRADD,Hypoplasia Of Corpus Callosum,0.7949861636679444
CRADD,Central Visual Impairment,0.8115918568696846
CRADD,Dyssomnia,0.8201196687803188
CRADD,Pachygyria,0.8210988731657684
CRADD,Motor Delay,0.8210988731657684
CRADD,Mental Retardation,0.8337953215113012
CRADD,Cerebral Atrophy,0.8339308890552987
CRADD,Chromophobe Carcinoma,0.8356859041719433
CRADD,Alzheimer Disease,0.8457525389282121
CRADD,Absence Of Septum Pellucidum,0.8476516371290275
CRADD,Papillary Renal Carcinoma,0.8476516371290275
CRADD,Sleep Disorders,0.8601151608808731
CRADD,Seizure,0.861756360478846
CRADD,Knee Osteoarthritis,0.861756360478846
CRADD,Renal Carcinoma,0.8727045307126416
CRADD,Microcephaly,0.8903630091389316
CRADD,Mental Depression,0.8903630091389316
CRADD,Osteoarthritis Of Hip,0.8903630091389316
CRADD,Arthritis,0.9046917974656596
CRADD,Autism,0.911896615143974
CRADD,Carnitine-acylcarnitine translocase deficiency ORPHA:159,0.5867963421058087
CRADD,Biotinidase deficiency ORPHA:79241,0.7929682744768703
CRADD,Autosomal recessive non-syndromic intellectual disability ORPHA:88616,0.8922466888454011
CTCF,Malignant neoplasm of breast,0.4084380369379369
CTCF,Carcinoma of bladder,0.4084380369379369
CTCF,Bladder Neoplasm,0.4084380369379369
CTCF,Malignant neoplasm of urinary bladder,0.5071083164302358
CTCF,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
CTCF,Breast Carcinoma,0.7333611688795861
CTCF,Carcinogenesis,0.7333611688795861
CTCF,Malignant neoplasm of ovary,0.7333611688795861
CTCF,B-Cell Lymphomas,0.7333611688795861
CTCF,Superinfection,0.7333611688795861
CTCF,leukemia,0.7333611688795861
CTCF,Ovarian Carcinoma,0.7333611688795861
CTCF,Beckwith-Wiedemann Syndrome,0.7765852775619541
CTCF,Colorectal Carcinoma,0.7765852775619541
CTCF,Colon Carcinoma,0.7765852775619541
CTCF,Malignant tumor of colon,0.7765852775619541
CTCF,Lymphoma,0.7765852775619541
CTCF,Leukemogenesis,0.7765852775619541
CTCF,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
CTCF,Russell-Silver syndrome,0.7765852775619541
CTCF,Tooth problem,0.7765852775619541
CTCF,Endometrial Carcinoma,0.7765852775619541
CTCF,Mammary Neoplasms,0.7880542567584415
CTCF,Glioma,0.7880542567584415
CTCF,Abnormality of the dentition,0.7880542567584415
CTCF,Malignant neoplasm of lung,0.7880542567584415
CTCF,Malignant neoplasm of prostate,0.7880542567584415
CTCF,Myotonic Dystrophy,0.7880542567584415
CTCF,Liver carcinoma,0.7880542567584415
CTCF,Invasive carcinoma of breast,0.7880542567584415
CTCF,Malignant Head and Neck Neoplasm,0.7880542567584415
CTCF,Osteosarcoma,0.7880542567584415
CTCF,Acute Promyelocytic Leukemia,0.7880542567584415
CTCF,Colorectal Cancer,0.7880542567584415
CTCF,Epithelial ovarian cancer,0.7880542567584415
CTCF,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
CTCF,Glioblastoma,0.7880542567584415
CTCF,Osteosarcoma of bone,0.7880542567584415
CTCF,Prostate carcinoma,0.7880542567584415
CTCF,Nephroblastoma,0.7880542567584415
CTCF,Primary malignant neoplasm of lung,0.7880542567584415
CTCF,Neoplasm Metastasis,0.7880542567584415
CTCF,Malignant neoplasm of testis,0.7880542567584415
CTCF,Prostatic Neoplasms,0.7880542567584415
CTCF,Carcinoma of lung,0.7880542567584415
CTCF,Malignant neoplasm of liver,0.7880542567584415
CTCF,Ductal Carcinoma,0.7880542567584415
CTCF,Lung Neoplasms,0.7880542567584415
CTCF,Lobular carcinoma in situ of breast,0.7880542567584415
CTCF,Metastatic Prostate Carcinoma,0.7880542567584415
CTCF,Neoplasms,0.7880542567584415
CTCF,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
CTCF,MYELOPROLIFERATIVE SYNDROME TRANSIENT,0.7880542567584415
CTCF,Mental disorders,0.7880542567584415
CTCF,Myxoid cyst,0.7880542567584415
CTCF,Abnormal behavior,0.7880542567584415
CTCF,Benign Prostatic Hyperplasia,0.7880542567584415
CTCF,Invasive Ductal Breast Carcinoma,0.7880542567584415
CTCF,Asthenozoospermia,0.7880542567584415
CTCF,Williams Syndrome,0.7880542567584415
CTCF,Infection caused by Helicobacter pylori,0.7880542567584415
CTCF,Tumor Progression,0.7880542567584415
CTCF,ECTRODACTYLY ECTODERMAL DYSPLASIA AND CLEFT LIP/PALATE SYNDROME 1,0.7880542567584415
CTCF,Leukemia Megakaryoblastic of Down Syndrome,0.7880542567584415
CTCF,MYOTONIC DYSTROPHY 1,0.7880542567584415
CTCF,Retinoblastoma,0.7880542567584415
CTCF,Acute lymphocytic leukemia,0.7880542567584415
CTCF,Cognitive delay,0.7880542567584415
CTCF,Strawberry nevus of skin,0.7880542567584415
CTCF,Squamous cell carcinoma,0.7880542567584415
CTCF,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
CTCF,Global developmental delay,0.7880542567584415
CTCF,Metastatic Neoplasm,0.7880542567584415
CTCF,Myeloid Leukemia,0.7880542567584415
CTCF,Mental and motor retardation,0.7880542567584415
CTCF,Metastasis from malignant tumor of prostate,0.7908231553833205
CTCF,Teratozoospermia,0.7908231553833205
CTCF,Oligospermia,0.8019075543217649
CTCF,Opitz GBBB Syndrome X-Linked,0.8019075543217649
CTCF,Granulomatous Slack Skin,0.8019075543217649
CTCF,Muscular Dystrophy Facioscapulohumeral,0.8019075543217649
CTCF,Thin lips,0.8067197998685076
CTCF,ovarian neoplasm,0.8067197998685076
CTCF,Schizophrenia,0.8067197998685076
CTCF,Lymphoma T-Cell Cutaneous,0.8098851543361193
CTCF,Herpes Simplex Infections,0.8098851543361193
CTCF,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
CTCF,Cornelia De Lange Syndrome,0.8168901801930506
CTCF,Early infantile epileptic encephalopathy with suppression bursts,0.8190761496232595
CTCF,Gastrointestinal Carcinoid Tumor,0.8190761496232595
CTCF,Microcephaly,0.8232134984476662
CTCF,Infection,0.8272008757995397
CTCF,Feeding difficulties,0.8272008757995397
CTCF,Congenital Abnormality,0.8402911822757345
CTCF,Strabismus,0.8402911822757345
CTCF,Fragile X Syndrome,0.8402911822757345
CTCF,Mental deficiency,0.8402911822757345
CTCF,Cryptorchidism,0.8402911822757345
CTCF,Sleeplessness,0.8402911822757345
CTCF,Generalized hypotonia,0.843190898187174
CTCF,Sporadic Breast Carcinoma,0.8474481237156937
CTCF,Friedreich Ataxia,0.8584283190330553
CTCF,Metabolic Syndrome X,0.8610447277138289
CTCF,Dull intelligence,0.8757755363384367
CTCF,Low intelligence,0.8757755363384367
CTCF,Malignant neoplasm of endometrium,0.8769418330148872
CTCF,Uterine Corpus Cancer,0.8771562273432176
CTCF,FRIEDREICH ATAXIA 1,0.8806784681730055
CTCF,Short stature,0.8815127642200768
CTCF,Poor school performance,0.8913141512402477
CTCF,Spinocerebellar Ataxia Type 7,0.8942113186235617
CTCF,Dwarfism,0.9098977259629772
CTCF,Hyperopia,0.914995991166204
CTCF,Influenza,0.9193385822373632
CTCF,Mental Retardation,0.922229272318747
CTCF,Kaposi Sarcoma,0.9435654233359168
CTCF,Intellectual Disability,0.9478210444156088
CTCF,Germ cell tumor,0.9564633032157428
CTCF,Small head,0.9822381479823692
CTCF,Prostatic Neoplasms,0.7765582368651238
CTCF,Neurodevelopmental Disorders,0.7765582368651238
CTCF,Nephroblastoma,0.7765582368651238
CTCF,Leukemia Megakaryoblastic Of Down Syndrome,0.7765582368651238
CTCF,Developmental Delay,0.7765582368651238
CTCF,Lymphoma,0.7765582368651238
CTCF,Lymphoblastic Leukemia,0.7765582368651238
CTCF,Schizophrenia,0.7860378120955526
CTCF,Granulomatous Slack Skin,0.8115918568696846
CTCF,Mammary Neoplasms,0.8165359516083085
CTCF,Movement Disorders,0.829560580336605
CTCF,Mental Retardation,0.8337953215113012
CTCF,Cryptorchidism,0.861756360478846
CTCF,Microcephaly,0.8903630091389316
CTCF,Strabismus,0.8908485337686392
CTCF,Autism,0.911896615143974
CTCF,Dwarfism,0.9510372690456612
CTCF,Multiple Congenital Anomalies,0.963385108667098
CTCF,Dysmorphic Features,0.9726139569926774
CTCF,Hyperopia,0.9801375145248504
CTCF,Precursor T-cell acute lymphoblastic leukemia ORPHA:99861,0.3832844616405875
CTCF,Oculofaciocardiodental syndrome ORPHA:2712,0.3832844616405875
CTCF,15q24 microdeletion syndrome ORPHA:94065,0.5867963421058087
CTCF,SIN3A-related intellectual disability syndrome due to a point mutation ORPHA:500166,0.5867963421058087
CTCF,Acute myeloid leukemia with t(6,0.5867963421058087
CTCF,9)(p23,0.5867963421058087
CTCF,q34) ORPHA:402014,0.6467006456772204
CTCF,Neuroendocrine tumor of stomach ORPHA:100075,0.7929682744768703
CTCF,Coffin-Siris syndrome ORPHA:1465,0.7929682744768703
CTCF,16p13.2 microdeletion syndrome ORPHA:500055,0.795266832401002
CTCF,PRUNE1-related neurological syndrome ORPHA:544469,0.8922466888454011
CTCF,Cardiofaciocutaneous syndrome ORPHA:1340,0.8922466888454011
CTCF,Human papillomavirus type 6 E5B (gene: E5B),0.8999095837312036
CTIF,Malignant neoplasm of breast,0.4084380369379369
CTIF,Red Blood Cell Count measurement,0.7880542567584415
CTIF,Rheumatoid Arthritis,0.7880542567584415
CTIF,Schizophrenia,0.8067197998685076
CTIF,Parkinson Disease,0.8772392350816924
CTIF,Calcification of coronary artery,0.9377696084218796
CTIF,Schizophrenia,0.7860378120955526
CTIF,Breast Cancer,0.8903630091389316
CTIF,Rheumatoid Arthritis,0.9251646147729308
CTIF,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
CTIF,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
CTIF,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
CTIF,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
CTIF,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.1040670578681756
CTIF,Monosomy 22q13.3 ORPHA:48652,0.1040670578681756
CTIF,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.1040670578681756
CTIF,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.1040670578681756
CTIF,Bilateral perisylvian polymicrogyria ORPHA:98889,0.1068643725150898
CTIF,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069,0.1991445465001551
CTIF,Classic Hodgkin lymphoma nodular sclerosis type ORPHA:98843,0.1991445465001551
CTIF,Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851,0.1991445465001551
CTIF,Lethal congenital contracture syndrome type 3 ORPHA:137783,0.1991445465001551
CTIF,Synaptic congenital myasthenic syndromes ORPHA:98915,0.1991445465001551
CTIF,19p13.3 microduplication syndrome ORPHA:447980,0.3832844616405875
CTIF,Congenital insensitivity to pain with severe intellectual disability ORPHA:453510,0.3832844616405875
CTIF,Malan overgrowth syndrome ORPHA:420179,0.3832844616405875
CTIF,Marshall-Smith syndrome ORPHA:561,0.3832844616405875
CTIF,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126,0.3832844616405875
CTIF,Perry syndrome ORPHA:178509,0.3832844616405875
CTIF,Shprintzen-Goldberg syndrome ORPHA:2462,0.3832844616405875
CTIF,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3832844616405875
CTIF,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3891940933600213
CTIF,CLCN4-related X-linked intellectual disability syndrome ORPHA:485350,0.5867963421058087
CTIF,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.5867963421058087
CTIF,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.5867963421058087
CTIF,Atrophoderma vermiculata ORPHA:79100,0.7929682744768703
CTIF,Congenital muscular dystrophy with integrin alpha-7 deficiency ORPHA:34520,0.7929682744768703
CTIF,Lethal osteosclerotic bone dysplasia ORPHA:1832,0.7929682744768703
CTIF,Distal hereditary motor neuropathy type 7 ORPHA:139589,0.8922466888454011
CTIF,Miller-Dieker syndrome ORPHA:531,0.8922466888454011
CTIF,Potocki-Shaffer syndrome ORPHA:52022,0.8922466888454011
CYP2U1,Lower limb hyperreflexia,0.7765852775619541
CYP2U1,Hypoplasia of corpus callosum,0.7880542567584415
CYP2U1,Toe-walking gait,0.7880542567584415
CYP2U1,Cognitive delay,0.7880542567584415
CYP2U1,Global developmental delay,0.7880542567584415
CYP2U1,Mental and motor retardation,0.7880542567584415
CYP2U1,Nerve Degeneration,0.8009048756462318
CYP2U1,Spastic Paraplegia,0.8067197998685076
CYP2U1,No development of motor milestones,0.8212681436603975
CYP2U1,Motor delay,0.8232134984476662
CYP2U1,Neurodegenerative Disorders,0.8272008757995397
CYP2U1,Spastic gait,0.834094492023826
CYP2U1,Disorder of macula of retina,0.8368219249856942
CYP2U1,Gait Unsteady,0.8584283190330553
CYP2U1,Ataxias Hereditary,0.9265708351135048
CYP2U1,Henoch-Schoenlein Purpura,0.9325666311629114
CYP2U1,Intellectual Disability,0.9478210444156088
CYP2U1,Leukodystrophy,0.954882372756482
CYP2U1,Spastic Paraplegia Hereditary,0.9561991866282916
CYP2U1,Babinski Reflex,0.9672478180546946
CYP2U1,Developmental Delay,0.7765582368651238
CYP2U1,Hypoplasia Of Corpus Callosum,0.7949861636679444
CYP2U1,Spastic Paraplegia,0.8182883735985873
CYP2U1,Motor Delay,0.8210988731657684
CYP2U1,Mental Retardation,0.8337953215113012
CYP2U1,Impaired Cognition,0.9231137872214272
CYP2U1,Peripheral Axonal Neuropathy,0.9259420053407031
CYP2U1,Chondrodysplasia-disorder of sex development syndrome ORPHA:1422,0.8922466888454011
CYP2U1,Lafora disease ORPHA:501,0.8922466888454011
CYP2U1,Autosomal recessive spastic paraplegia type 56 ORPHA:320411,0.8922466888454011
CYTH3,Pregnancy Complications,0.8402911822757345
CYTH3,Heart Failure,0.9024492468099392
CYTH3,Cold-induced sweating syndrome ORPHA:157820,0.1068643725150898
CYTH3,19p13.3 microduplication syndrome ORPHA:447980,0.3832844616405875
CYTH3,Malan overgrowth syndrome ORPHA:420179,0.3832844616405875
CYTH3,Marshall-Smith syndrome ORPHA:561,0.3832844616405875
CYTH3,Potocki-Shaffer syndrome ORPHA:52022,0.8922466888454011
DAZAP2,Multiple Myeloma,0.7880542567584415
DAZAP2,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
DAZAP2,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
DAZAP2,Beta-propeller protein-associated neurodegeneration ORPHA:329284,0.1991445465001551
DAZAP2,CCDC115-CDG ORPHA:468684,0.1991445465001551
DAZAP2,Hermansky-Pudlak syndrome type 8 ORPHA:231537,0.3832844616405875
DAZAP2,TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261,0.3832844616405875
DAZAP2,Variant ABeta2M amyloidosis ORPHA:314652,0.3832844616405875
DAZAP2,ABri amyloidosis ORPHA:97345,0.5867963421058087
DAZAP2,ADan amyloidosis ORPHA:97346,0.5867963421058087
DAZAP2,CEDNIK syndrome ORPHA:66631,0.5867963421058087
DAZAP2,Charcot-Marie-Tooth disease type 1C ORPHA:101083,0.5867963421058087
DAZAP2,Hereditary myopathy with lactic acidosis due to ISCU deficiency ORPHA:43115,0.5867963421058087
DAZAP2,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592,0.5867963421058087
DAZAP2,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies ORPHA:397758,0.5867963421058087
DAZAP2,Acatalasemia ORPHA:926,0.7929682744768703
DAZAP2,CLN2 disease ORPHA:228349,0.7929682744768703
DAZAP2,Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324,0.7929682744768703
DAZAP2,RNF13-related severe early-onset epileptic encephalopathy ORPHA:544503,0.7929682744768703
DAZAP2,X-linked centronuclear myopathy ORPHA:596,0.7929682744768703
DAZAP2,Methylmalonic acidemia with homocystinuria type cblF ORPHA:79284,0.8922466888454011
DDX17,Malignant neoplasm of breast,0.4084380369379369
DDX17,Breast Carcinoma,0.7333611688795861
DDX17,Carcinogenesis,0.7333611688795861
DDX17,Colon Carcinoma,0.7765852775619541
DDX17,Malignant tumor of colon,0.7765852775619541
DDX17,Non-Small Cell Lung Carcinoma,0.7765852775619541
DDX17,Mammary Neoplasms,0.7880542567584415
DDX17,Monosomy,0.7880542567584415
DDX17,Colonic Neoplasms,0.8212681436603975
DDX17,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
DDX17,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
DDX17,Distal monosomy 1q ORPHA:36367,0.1040670578681756
DDX17,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964,0.3832844616405875
DDX17,Dyschromatosis symmetrica hereditaria ORPHA:41,0.3832844616405875
DDX17,Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220,0.3832844616405875
DDX17,Huntington disease ORPHA:399,0.3832844616405875
DDX17,Isolated focal cortical dysplasia type IIb ORPHA:269008,0.3832844616405875
DDX17,Uveal melanoma ORPHA:39044,0.3977968344535308
DDX17,Adult hepatocellular carcinoma ORPHA:210159,0.4491081214880772
DDX17,Juvenile Huntington disease ORPHA:248111,0.5867963421058087
DDX17,NEK9-related lethal skeletal dysplasia ORPHA:464366,0.5867963421058087
DDX17,Nevus comedonicus syndrome ORPHA:64754,0.5867963421058087
DDX17,Gorlin syndrome ORPHA:377,0.5867963421058087
DDX17,B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome ORPHA:567502,0.7929682744768703
DDX17,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome ORPHA:508542,0.7929682744768703
DDX17,Multiple endocrine neoplasia type 4 ORPHA:276152,0.7929682744768703
DDX17,Myhre syndrome ORPHA:2588,0.7929682744768703
DDX17,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency ORPHA:353284,0.7929682744768703
DDX17,Sotos syndrome ORPHA:821,0.7929682744768703
DDX17,Systemic mastocytosis with associated hematologic neoplasm ORPHA:98849,0.795266832401002
DDX17,5q35 microduplication syndrome ORPHA:228415,0.8922466888454011
DDX17,Beckwith-Wiedemann syndrome due to NSD1 mutation ORPHA:238613,0.8922466888454011
DDX17,DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion ORPHA:268261,0.8922466888454011
DDX17,Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome ORPHA:404476,0.8922466888454011
DDX17,Gynandroblastoma ORPHA:99914,0.8922466888454011
DDX17,Intellectual disability syndrome due to a DYRK1A point mutation ORPHA:464311,0.8922466888454011
DDX17,Malignant Sertoli-Leydig cell tumor of the ovary ORPHA:99916,0.8922466888454011
DDX17,Pleuropulmonary blastoma familial tumor susceptibility syndrome ORPHA:284343,0.8922466888454011
DDX17,Short stature-pituitary and cerebellar defects-small sella turcica syndrome ORPHA:85442,0.8922466888454011
DDX17,Kabuki syndrome ORPHA:2322,0.8922466888454011
DDX17,Immunodeficiency due to MASP-2 deficiency ORPHA:331187,0.8922466888454011
DDX17,White-Sutton syndrome ORPHA:468678,0.8922466888454011
DDX17,Yaba-like disease virus 88L protein (gene: 88L),0.8999095837312036
DDX17,Monkeypox virus bifunctional ATPase/nucleoside triphosphate phosphohydrolase-I,0.8999095837312036
DDX17,Monkeypox virus Zaire-96-I-16 E11L (gene: E11L),0.8999095837312036
DDX17,Variola virus hypothetical protein (gene: N1L),0.8999095837312036
DDX17,Orf virus ORF069 early transcription factor VETFs,0.8999095837312036
DDX17,Cercopithecine alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
DDX17,Variola virus RNA helicase NPH-II (gene: K8R),0.8999095837312036
DDX17,Yaba monkey tumor virus RNA helicase NPH-II,0.8999095837312036
DDX17,Vaccinia virus RNA helicase NPH-II (gene: I8R),0.8999095837312036
DDX17,Yaba monkey tumor virus 110R,0.8999095837312036
DDX17,Orf virus ORF095 DNA helicase,0.8999095837312036
DDX17,Cowpox virus CPXV087 protein (gene: CPXV087 CDS),0.8999095837312036
DDX17,Molluscum contagiosum virus subtype 1 MC050R,0.8999095837312036
DDX17,Molluscum contagiosum virus subtype 1 MC100R (gene: MC100L),0.8999095837312036
DDX17,Yaba-like disease virus 49R protein (gene: 49R),0.8999095837312036
DDX17,Vaccinia virus Ankara NTP-dependent RNA helicase NPH-II,0.8999095837312036
DDX17,Orf virus ORF036 RNA helicase NPH-II,0.8999095837312036
DEAF1,Adenocarcinoma,0.750391252594775
DEAF1,Colorectal Carcinoma,0.7765852775619541
DEAF1,Serum cholesterol raised,0.7765852775619541
DEAF1,Hypercholesterolemia,0.7765852775619541
DEAF1,Colorectal Cancer,0.7880542567584415
DEAF1,Nonverbal,0.7880542567584415
DEAF1,Frontal bossing,0.7880542567584415
DEAF1,Dyskinetic syndrome,0.7880542567584415
DEAF1,Absent speech,0.7880542567584415
DEAF1,Hoarseness,0.7880542567584415
DEAF1,Corticospinal tract hypoplasia,0.7880542567584415
DEAF1,Mental disorders,0.7880542567584415
DEAF1,Abnormal behavior,0.7880542567584415
DEAF1,Agitation,0.7880542567584415
DEAF1,Aplasia/Hypoplasia of the corpus callosum,0.7880542567584415
DEAF1,Hypertrophy of lower jaw,0.7880542567584415
DEAF1,mandibular excess (physical finding),0.7880542567584415
DEAF1,Mandibular hyperplasia,0.7880542567584415
DEAF1,Conductive hearing loss,0.7880542567584415
DEAF1,Increased size of the mandible,0.7880542567584415
DEAF1,Recurrent infections,0.7880542567584415
DEAF1,Horizontal eyebrow,0.7880542567584415
DEAF1,Class III malocclusion,0.7880542567584415
DEAF1,Tented mouth,0.7880542567584415
DEAF1,Tented upper lip,0.7880542567584415
DEAF1,Tented upper lip vermilion,0.7880542567584415
DEAF1,Decreased corneal diameter,0.7880542567584415
DEAF1,Feeding difficulties in infancy,0.7880542567584415
DEAF1,Microcornea,0.7880542567584415
DEAF1,Large face,0.7880542567584415
DEAF1,Anteverted nostril,0.7880542567584415
DEAF1,Small midface,0.7880542567584415
DEAF1,Decreased projection of midface,0.7880542567584415
DEAF1,Hypotrophic midface,0.7880542567584415
DEAF1,Midface retrusion,0.7880542567584415
DEAF1,Depression and Suicide,0.7880542567584415
DEAF1,Cognitive delay,0.7880542567584415
DEAF1,Delayed eruption of primary teeth,0.7880542567584415
DEAF1,Serum triglycerides raised,0.7880542567584415
DEAF1,Diabetes,0.7880542567584415
DEAF1,Diabetes Mellitus,0.7880542567584415
DEAF1,Hyperacusis,0.7880542567584415
DEAF1,Hyperglycemia,0.7880542567584415
DEAF1,Global developmental delay,0.7880542567584415
DEAF1,Mental Retardation Psychosocial,0.7880542567584415
DEAF1,Mental and motor retardation,0.7880542567584415
DEAF1,Sunken eyes,0.8019075543217649
DEAF1,Acquired flat foot,0.8019075543217649
DEAF1,Enophthalmos,0.8019075543217649
DEAF1,Gait abnormality,0.8019075543217649
DEAF1,Profound Mental Retardation,0.8019075543217649
DEAF1,Self-harm,0.8019075543217649
DEAF1,Self-Injurious Behavior,0.8019075543217649
DEAF1,Flatfoot,0.8019075543217649
DEAF1,Extrapyramidal sign,0.8019075543217649
DEAF1,Taurodontism,0.8019075543217649
DEAF1,Involuntary Movements,0.8019075543217649
DEAF1,Large elongated pulp chamber,0.8019075543217649
DEAF1,Autistic Disorder,0.8019075543217649
DEAF1,Curvature of little finger,0.8019075543217649
DEAF1,Poor eye contact,0.8019075543217649
DEAF1,Clinodactyly of the 5th finger,0.8019075543217649
DEAF1,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
DEAF1,Smith-Magenis syndrome,0.8145035474981049
DEAF1,Delayed speech and language development,0.8168901801930506
DEAF1,Upward slant of palpebral fissure,0.8168901801930506
DEAF1,PANIC DISORDER 1,0.8168901801930506
DEAF1,Impaired pain sensation,0.8190761496232595
DEAF1,Reduced fetal movement,0.8212681436603975
DEAF1,Broad flat nasal bridge,0.8213459222602666
DEAF1,Nasal bridge wide,0.8232134984476662
DEAF1,Gastroesophageal reflux disease,0.8368219249856942
DEAF1,Decreased tendon reflex,0.8391186563955684
DEAF1,Speech Disorders,0.8402911822757345
DEAF1,Panic Disorder,0.8402911822757345
DEAF1,Strabismus,0.8402911822757345
DEAF1,Speech impairment,0.8402911822757345
DEAF1,Curvature of spine,0.8402911822757345
DEAF1,Dilated ventricles (finding),0.8402911822757345
DEAF1,Mental deficiency,0.8402911822757345
DEAF1,Abnormal form of the vertebral bodies,0.8402911822757345
DEAF1,Language Delay,0.8402911822757345
DEAF1,Acquired scoliosis,0.8402911822757345
DEAF1,Sleep disturbances,0.8402911822757345
DEAF1,Generalized hypotonia,0.843190898187174
DEAF1,Failure to thrive in infancy,0.843190898187174
DEAF1,Speech Delay,0.8474481237156937
DEAF1,Memory impairment,0.8474481237156937
DEAF1,Concave bridge of nose,0.8578473133580928
DEAF1,Depressed nasal root/bridge,0.8578473133580928
DEAF1,Depressed nasal bridge,0.8584283190330553
DEAF1,Retrusion of lower jaw,0.8648405521677974
DEAF1,Decreased projection of lower jaw,0.8648405521677974
DEAF1,Decreased projection of mandible,0.8648405521677974
DEAF1,Hypoplastic mandible condyle,0.8648405521677974
DEAF1,Aplasia/Hypoplasia of the mandible,0.8648405521677974
DEAF1,Micrognathism,0.8648405521677974
DEAF1,Dull intelligence,0.8757755363384367
DEAF1,Low intelligence,0.8757755363384367
DEAF1,Mental Depression,0.8769418330148872
DEAF1,Chronic ear infection,0.8769418330148872
DEAF1,Synophrys,0.8774809019744603
DEAF1,Syndactyly of the toes,0.8806784681730055
DEAF1,Open mouth (finding),0.8806784681730055
DEAF1,Short stature,0.8815127642200768
DEAF1,Abnormality of cardiovascular system morphology,0.882453254162044
DEAF1,Orbital separation excessive,0.8851456306720444
DEAF1,Chronic otitis media,0.8867509400747969
DEAF1,Poor school performance,0.8913141512402477
DEAF1,Acid reflux,0.8962930275917275
DEAF1,Obesity,0.8989612563669234
DEAF1,Neurodevelopmental Disorders,0.9015731019095328
DEAF1,Stereotyped Behavior,0.9039108388826153
DEAF1,Thick lower lip vermilion,0.9039108388826153
DEAF1,Full lower lip,0.9039108388826153
DEAF1,Mood Disorders,0.9093740881835894
DEAF1,Congenital Heart Defects,0.9098977259629772
DEAF1,Depressive disorder,0.9103315000053974
DEAF1,Muscle hypotonia,0.9124568647908072
DEAF1,Short philtrum,0.9146732238562176
DEAF1,Status Epilepticus,0.914995991166204
DEAF1,Anxiety disease,0.9154499654632742
DEAF1,Heartburn,0.9214835359141188
DEAF1,Mental Retardation,0.922229272318747
DEAF1,Stereotypic Movement Disorder,0.9258401930327972
DEAF1,Broad forehead,0.929814249105729
DEAF1,Mood swings,0.9366917377729386
DEAF1,Small nose,0.937361082398064
DEAF1,Short nose,0.9390727893210336
DEAF1,Physical aggression,0.9432051631882106
DEAF1,Aggressive reaction,0.9446671211493156
DEAF1,Unipolar Depression,0.9455834988784428
DEAF1,Aggressive behavior,0.9459312971127588
DEAF1,Anxiety Disorders,0.946564927793026
DEAF1,Intellectual Disability,0.9478210444156088
DEAF1,Myopia,0.9506863447189738
DEAF1,Wide skull shape,0.9534337109847604
DEAF1,Broad cranium shape,0.9534337109847604
DEAF1,Brachycephaly,0.957487573707278
DEAF1,Epilepsy,0.963331724428282
DEAF1,Electroencephalogram abnormal,0.9646935500290964
DEAF1,Major Depressive Disorder,0.9658628445524134
DEAF1,Anxiety,0.9708740267329932
DEAF1,Attention deficit hyperactivity disorder,0.9770263358372888
DEAF1,Dyschezia,0.9822381479823692
DEAF1,Brachydactyly,0.9896536639644284
DEAF1,Constipation,0.9896536639644284
DEAF1,Genetic Diseases Inborn,0.9926099929361648
DEAF1,Non-Syndromic Intellectual Disability,0.6734982286750932
DEAF1,Stereotyped Behavior,0.7765582368651238
DEAF1,Dyskinetic Syndrome,0.7765582368651238
DEAF1,Smith-Magenis Syndrome,0.7765582368651238
DEAF1,Pica,0.7765582368651238
DEAF1,Repetitive Compulsive Behavior,0.7765582368651238
DEAF1,Retinal Detachment,0.7765582368651238
DEAF1,Developmental Delay,0.7765582368651238
DEAF1,Macrocephaly,0.7765582368651238
DEAF1,Microcornea,0.7765582368651238
DEAF1,Precocious Puberty,0.7765582368651238
DEAF1,Hypercholesterolemia,0.8115918568696846
DEAF1,Otitis Media,0.8115918568696846
DEAF1,Frontal Bossing,0.8115918568696846
DEAF1,Malocclusion,0.8115918568696846
DEAF1,Hearing Loss,0.8115918568696846
DEAF1,Dyssomnia,0.8201196687803188
DEAF1,Mental Retardation,0.8337953215113012
DEAF1,Developmental Dysplasia Of The Hip,0.8356859041719433
DEAF1,Taurodontism,0.8457525389282121
DEAF1,Anxiety Disorder,0.8507213163251659
DEAF1,Sleep Disorders,0.8601151608808731
DEAF1,Autism Spectrum Disorder,0.8662301945830305
DEAF1,Hypothyroidism,0.8879896755141929
DEAF1,Microcephaly,0.8903630091389316
DEAF1,Mental Depression,0.8903630091389316
DEAF1,Strabismus,0.8908485337686392
DEAF1,Speech Disorders,0.9069867032339078
DEAF1,Mood Swings,0.9069867032339078
DEAF1,Autism,0.911896615143974
DEAF1,Scoliosis,0.924275664330454
DEAF1,Micrognathism,0.9398381935810408
DEAF1,Camptodactyly Of Fingers,0.943322675973118
DEAF1,Dwarfism,0.9510372690456612
DEAF1,Status Epilepticus,0.9543024119762946
DEAF1,Developmental Regression,0.9658957825498884
DEAF1,Synophrys,0.9658957825498884
DEAF1,Dysmorphic Features,0.9726139569926774
DEAF1,Attention Deficit Hyperactivity Disorder,0.980894832851993
DEAF1,Myopia,0.9832345076528324
DEAF1,Obesity,0.9832345076528324
DEAF1,Brachycephaly,0.986561188259959
DEAF1,Gastroesophageal Reflux Disease,0.9870402800551054
DEAF1,Syndactyly Of The Toes,0.9870402800551054
DEAF1,Brachydactyly,0.9887104428514284
DEAF1,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
DEAF1,Smith-Magenis syndrome ORPHA:819,0.1117946631214258
DEAF1,Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620,0.3832844616405875
DEAF1,Autosomal dominant non-syndromic intellectual disability ORPHA:178469,0.7929682744768703
DEAF1,MPI-CDG ORPHA:79319,0.8922466888454011
DEGS1,Osteopetrosis,0.7765852775619541
DEGS1,Esophageal carcinoma,0.7765852775619541
DEGS1,Malignant neoplasm of prostate,0.7880542567584415
DEGS1,Neoplasm Metastasis,0.7880542567584415
DEGS1,Prostatic Neoplasms,0.7880542567584415
DEGS1,Diabetes,0.7880542567584415
DEGS1,Diabetes Mellitus,0.7880542567584415
DEGS1,Polyneuropathy,0.7880542567584415
DEGS1,Obesity,0.8989612563669234
DEGS1,Spastic Quadriplegia,0.7765582368651238
DEGS1,Prostate Cancer,0.7765582368651238
DEGS1,Prostatic Neoplasms,0.7765582368651238
DEGS1,Nystagmus,0.7765582368651238
DEGS1,Developmental Delay,0.7765582368651238
DEGS1,Leukodystrophy,0.8115918568696846
DEGS1,Brainstem Atrophy,0.8115918568696846
DEGS1,Cerebellar Atrophy,0.8337953215113012
DEGS1,Scoliosis,0.924275664330454
DEGS1,Dysarthria,0.988987376043163
DEPDC7,Liver Cirrhosis Experimental,0.8014900279306119
DEPDC7,Mental Depression,0.8769418330148872
DEPDC7,Parkinson Disease,0.8772392350816924
DEPDC7,Depressive Symptoms,0.905201167721829
DEPDC7,Depressive disorder,0.9103315000053974
DEPDC7,GNE myopathy ORPHA:602,0.3832844616405875
DEPDC7,Sialuria ORPHA:3166,0.3832844616405875
DEPDC7,Glutaric acidemia type 3 ORPHA:35706,0.8922466888454011
DGAT1,Serum cholesterol raised,0.7765852775619541
DGAT1,Hypercholesterolemia,0.7765852775619541
DGAT1,Malignant neoplasm of prostate,0.7880542567584415
DGAT1,Prostate carcinoma,0.7880542567584415
DGAT1,Diarrhea,0.7880542567584415
DGAT1,Arteriosclerosis,0.7880542567584415
DGAT1,Atherosclerosis,0.7880542567584415
DGAT1,Hepatitis C,0.7880542567584415
DGAT1,Diarrheal disorder,0.7880542567584415
DGAT1,Sore to touch,0.7880542567584415
DGAT1,Kidney Failure Chronic,0.8019075543217649
DGAT1,Decreased albumin,0.8098851543361193
DGAT1,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
DGAT1,Nephrotic Syndrome,0.8232134984476662
DGAT1,Vomiting,0.8270909867833504
DGAT1,Steatohepatitis,0.8402911822757345
DGAT1,Hypoalbuminemia,0.8402911822757345
DGAT1,Alopecia,0.8523465762428218
DGAT1,Fatty Liver,0.8628363180844141
DGAT1,Heart failure,0.8867509400747969
DGAT1,Congestive heart failure,0.8976039441125321
DGAT1,Obesity,0.8989612563669234
DGAT1,Metabolic Diseases,0.9564633032157428
DGAT1,Hyperlipidemia,0.9676817033456722
DGAT1,Protein-losing Enteropathy,0.7765582368651238
DGAT1,Hypercholesterolemia,0.8115918568696846
DGAT1,Hyperlipidemia,0.861756360478846
DGAT1,Hypoalbuminemia,0.8903630091389316
DGAT1,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.1040670578681756
DGAT1,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.1054066549396977
DGAT1,D-2-hydroxyglutaric aciduria ORPHA:79315,0.1054066549396977
DGAT1,Neutral lipid storage myopathy ORPHA:98908,0.1991445465001551
DGAT1,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.1991445465001551
DGAT1,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.1991445465001551
DGAT1,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3832844616405875
DGAT1,D-glyceric aciduria ORPHA:941,0.3832844616405875
DGAT1,5-oxoprolinase deficiency ORPHA:33572,0.5867963421058087
DGAT1,Embryonal rhabdomyosarcoma ORPHA:99757,0.7929682744768703
DGAT1,Familial renal glucosuria ORPHA:69076,0.8922466888454011
DHRS3,Thyroid Neoplasm,0.7765852775619541
DHRS3,Neoplasm Metastasis,0.7880542567584415
DHRS3,Neuroblastoma,0.7880542567584415
DHRS3,Central neuroblastoma,0.7880542567584415
DHRS3,ADULT SYNDROME,0.7880542567584415
DHRS3,Rudiger syndrome 1,0.7880542567584415
DHRS3,Liver Cirrhosis Experimental,0.8014900279306119
DHRS3,Craniosynostosis,0.8486035047899471
DHRS3,Papillary thyroid carcinoma,0.8757755363384367
DHRS3,Obesity,0.8989612563669234
DHRS3,46XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752,0.3832844616405875
DHRS3,HELLP syndrome ORPHA:244242,0.8922466888454011
DHRS3,Atypical hemolytic uremic syndrome with complement gene abnormality ORPHA:544472,0.8922466888454011
DHRS3,Ectromelia virus ERPV hydroxysteroid dehydrogenase,0.8999095837312036
DHRS3,Cowpox virus CPXV182 protein (gene: CPXV182 CDS),0.8999095837312036
DHRS3,Vaccinia virus hydroxysteroid dehydrogenase (gene: A44L),0.8999095837312036
DHRS3,Horsepox virus HSPV166 (Rossmann-fold NAD(P)(+)-binding proteins),0.8999095837312036
DHRS3,Vaccinia virus Ankara 3 beta-hydroxysteroid dehydrogenase,0.8999095837312036
DHRS3,Molluscum contagiosum virus subtype 1 MC152R (gene: MC152R),0.8999095837312036
DHRS3,Yaba-like disease virus 133L protein (gene: 133L),0.8999095837312036
DHRS3,Monkeypox virus bifunctional hydroxysteroid dehydrogenase/deletion attenuates intradermal lesion in VAC-mouse model,0.8999095837312036
DHRS3,Monkeypox virus Zaire-96-I-16 A45L (gene: A45L),0.8999095837312036
DHRS9,Carcinoma of bladder,0.4084380369379369
DHRS9,Bladder Neoplasm,0.4084380369379369
DHRS9,Malignant neoplasm of urinary bladder,0.5071083164302358
DHRS9,androgen independent prostate cancer,0.7765852775619541
DHRS9,Malignant neoplasm of prostate,0.7880542567584415
DHRS9,Prostate carcinoma,0.7880542567584415
DHRS9,Prostatic Diseases,0.7880542567584415
DHRS9,Glaucoma,0.7880542567584415
DHRS9,Alcoholic Intoxication Chronic,0.8019075543217649
DHRS9,Infection,0.8272008757995397
DHRS9,Epilepsy,0.963331724428282
DHRS9,Thrombomodulin-related bleeding disorder ORPHA:436169,0.1040670578681756
DHRS9,Metaphyseal anadysplasia ORPHA:1040,0.3832844616405875
DHRS9,Exfoliative ichthyosis ORPHA:289586,0.5867963421058087
DHRS9,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581,0.5867963421058087
DHRS9,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569,0.5867963421058087
DHRS9,Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635,0.5867963421058087
DHRS9,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787,0.5867963421058087
DHRS9,Haim-Munk syndrome ORPHA:2342,0.5867963421058087
DHRS9,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898,0.5867963421058087
DHRS9,Papillon-Lefevre ORPHA:678,0.5867963421058087
DHRS9,Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115,0.7929682744768703
DHRS9,GM2 gangliosidosis AB variant ORPHA:309246,0.8922466888454011
DHRS9,Osteopetrosis with renal tubular acidosis ORPHA:2785,0.8922466888454011
DHRS9,Acral peeling skin syndrome ORPHA:263534,0.8922466888454011
DHRS9,Ectromelia virus ERPV hydroxysteroid dehydrogenase,0.8999095837312036
DHRS9,Cowpox virus CPXV182 protein (gene: CPXV182 CDS),0.8999095837312036
DHRS9,Vaccinia virus hydroxysteroid dehydrogenase (gene: A44L),0.8999095837312036
DHRS9,Horsepox virus HSPV166 (Rossmann-fold NAD(P)(+)-binding proteins),0.8999095837312036
DHRS9,Vaccinia virus Ankara 3 beta-hydroxysteroid dehydrogenase,0.8999095837312036
DHRS9,Molluscum contagiosum virus subtype 1 MC152R (gene: MC152R),0.8999095837312036
DHRS9,Yaba-like disease virus 133L protein (gene: 133L),0.8999095837312036
DHRS9,Monkeypox virus bifunctional hydroxysteroid dehydrogenase/deletion attenuates intradermal lesion in VAC-mouse model,0.8999095837312036
DHRS9,Monkeypox virus Zaire-96-I-16 A45L (gene: A45L),0.8999095837312036
DIDO1,Colorectal Carcinoma,0.7765852775619541
DIDO1,MYELODYSPLASTIC SYNDROME,0.7765852775619541
DIDO1,Myelodysplastic-Myeloproliferative Diseases,0.7880542567584415
DIDO1,Colorectal Cancer,0.7880542567584415
DIDO1,melanoma,0.7880542567584415
DIDO1,Adenoma of large intestine,0.7880542567584415
DIDO1,Myocardial Infarction,0.8019075543217649
DIDO1,Myocardial Infarction,0.861756360478846
DIDO1,Esophagus Neoplasm,0.9832345076528324
DIDO1,X-linked intellectual disability Siderius type ORPHA:85287,0.1991445465001551
DIDO1,CAMOS syndrome ORPHA:83472,0.1991445465001551
DIDO1,Precursor T-cell acute lymphoblastic leukemia ORPHA:99861,0.3832844616405875
DIDO1,Dyschromatosis symmetrica hereditaria ORPHA:41,0.3832844616405875
DIDO1,Oculofaciocardiodental syndrome ORPHA:2712,0.3832844616405875
DIDO1,QRICH1-related intellectual disability-chondrodysplasia syndrome ORPHA:580940,0.3832844616405875
DIDO1,Chronic myelomonocytic leukemia ORPHA:98823,0.3891940933600213
DIDO1,Adult hepatocellular carcinoma ORPHA:210159,0.4491081214880772
DIDO1,15q24 microdeletion syndrome ORPHA:94065,0.5867963421058087
DIDO1,Autosomal dominant Charcot-Marie-Tooth disease type 2Z ORPHA:466768,0.5867963421058087
DIDO1,Floating-Harbor syndrome ORPHA:2044,0.5867963421058087
DIDO1,Pancreatic agenesis-holoprosencephaly syndrome ORPHA:556955,0.5867963421058087
DIDO1,SIN3A-related intellectual disability syndrome due to a point mutation ORPHA:500166,0.5867963421058087
DIDO1,Spondylocarpotarsal synostosis ORPHA:3275,0.5867963421058087
DIDO1,Juvenile amyotrophic lateral sclerosis ORPHA:300605,0.5959529547720634
DIDO1,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder ORPHA:500180,0.7929682744768703
DIDO1,Kleefstra syndrome due to 9q34 microdeletion ORPHA:96147,0.7929682744768703
DIDO1,Microcephalic osteodysplastic primordial dwarfism type II ORPHA:2637,0.7929682744768703
DIDO1,Perlman syndrome ORPHA:2849,0.7929682744768703
DIDO1,Systemic mastocytosis with associated hematologic neoplasm ORPHA:98849,0.795266832401002
DIDO1,ADNP syndrome ORPHA:404448,0.8922466888454011
DIDO1,Blepharophimosis-intellectual disability syndrome MKB type ORPHA:293707,0.8922466888454011
DIDO1,FG syndrome type 1 ORPHA:93932,0.8922466888454011
DIDO1,Short stature-pituitary and cerebellar defects-small sella turcica syndrome ORPHA:85442,0.8922466888454011
DIDO1,Kabuki syndrome ORPHA:2322,0.8922466888454011
DIDO1,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DIDO1,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DIDO1,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DIDO1,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DIDO1,Human papillomavirus 122 transforming protein E7 (gene: E7),0.8999095837312036
DIDO1,Human papillomavirus 111 E7 protein (gene: E7),0.8999095837312036
DIDO1,Human papillomavirus 94 E2 protein (gene: E2),0.8999095837312036
DIDO1,Human papillomavirus 113 E7 protein (gene: E7),0.8999095837312036
DIDO1,Vaccinia virus Ankara soluble TNF receptor II precursor f1,0.8999095837312036
DIDO1,Human gammaherpesvirus 8 K4.1 (gene: K4.1),0.8999095837312036
DIDO1,Human mastadenovirus D membrane glycoprotein E3 gp19K (gene: E3),0.8999095837312036
DIDO1,Human adenovirus 56 19K protein (gene: E3),0.8999095837312036
DIDO1,Orf virus ORF020 dsRNA-binding PKR inhibitor,0.8999095837312036
DIDO1,Human papillomavirus type 27 early protein (gene: E2),0.8999095837312036
DIDO1,Variola virus semaphorin-like protein (gene: A44R),0.8999095837312036
DIDO1,Variola virus hypothetical protein (gene: J7R),0.8999095837312036
DIDO1,Human papillomavirus type XS2 E2 (gene: E2),0.8999095837312036
DIDO1,Banna virus strain JKT-6423 vp12,0.8999095837312036
DIDO1,Human papillomavirus type 72b E2 protein (gene: E2),0.8999095837312036
DIDO1,Monkeypox virus secreted epidermal growth factor-like protein,0.8999095837312036
DIDO1,Monkeypox virus Zaire-96-I-16 epidermal growth factor-like protein (EGF-like protein) (gene: D3R),0.8999095837312036
DIDO1,Human papillomavirus type 78 regulatory protein E2 (gene: E2),0.8999095837312036
DIDO1,Vaccinia virus Ankara vaccinia virus growth factor (VGF),0.8999095837312036
DIDO1,Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146),0.8999095837312036
DIDO1,Human papillomavirus 3 envelope protein (gene: E2),0.8999095837312036
DIDO1,Kyasanur Forest disease virus NS2B,0.8999095837312036
DIDO1,Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147),0.8999095837312036
DIDO1,Variola virus epidermal growth factor-like protein (EGF-like protein) (gene: D1L),0.8999095837312036
DIDO1,Hepatitis C virus genotype 3 E1 protein,0.8999095837312036
DIDO1,Human papillomavirus type 62 putative regulatory protein E2 (gene: E2),0.8999095837312036
DIDO1,Hepatitis C virus genotype 4 E1 protein,0.8999095837312036
DIDO1,Vaccinia virus epidermal growth factor-like protein (EGF-like protein) (gene: C11R),0.8999095837312036
DIDO1,Monkeypox virus bifunctional DNA-dependent RNA polymerase subunit rpo30/intermediate-gene transcription factor VITF1,0.8999095837312036
DIDO1,Monkeypox virus Zaire-96-I-16 RNA polymerase subunit (gene: F4L),0.8999095837312036
DIDO1,Horsepox virus HSPV016 (Epidermal growth factor-like protein,0.8999095837312036
DIDO1,Provisional),0.8999095837312036
DIDO1,Vaccinia virus semaphorin-like protein,0.8999095837312036
DIDO1,Vaccinia virus Ankara Semaphorin-like protein f2,0.8999095837312036
DIDO1,Human papillomavirus type 68a E2 protein,0.8999095837312036
DIDO1,Human papillomavirus type 34 early protein (gene: E2),0.8999095837312036
DIDO1,Adult diarrheal rotavirus strain J19 NSP1,0.8999095837312036
DIDO1,Norovirus Hu/GII/BG1C0282/2011/BGD protein p48 (gene: POL),0.8999095837312036
DIDO1,Human papillomavirus 117 E2,0.8999095837312036
DIDO1,Human group 1 coronavirus associated with pneumonia ORF 1a,0.8999095837312036
DIDO1,Human betaherpesvirus 5 deoxyuridine triphosphatase (gene: UL72),0.8999095837312036
DIDO1,Norovirus Hu/Norwalk/10313/2010/VNM protein p48 (gene: POL),0.8999095837312036
DIDO1,Norovirus Hu/Norwalk/10378/2010/VNM protein p48 (gene: POL),0.8999095837312036
DIDO1,Norovirus Hu/GII/20469/2010/VNM protein p48 (gene: POL),0.8999095837312036
DIDO1,Human papillomavirus type 53 early protein (gene: E2),0.8999095837312036
DIDO1,Norovirus Hu/GII.4/NIHIC17.9/2013/USA protein p48 (gene: POL),0.8999095837312036
DIDO1,Norovirus Hu/Norwalk/10328/2010/VNM protein p48 (gene: POL),0.8999095837312036
DIDO1,Human papillomavirus type 68b E2 protein (gene: E2),0.8999095837312036
DIDO1,Yaba monkey tumor virus RNA polymerase subunit,0.8999095837312036
DIDO1,Enterovirus B genome polyportein,0.8999095837312036
DIDO1,Enterovirus B73 full_polyprotein 1..2188,0.8999095837312036
DIDO1,Cercopithecine betaherpesvirus 5 chemokine vCXCL7 (gene: UL146D),0.8999095837312036
DIDO1,Human papillomavirus type 87 putative E2 protein (gene: e2),0.8999095837312036
DIDO1,Enterovirus B106 full_polyprotein 1..2192,0.8999095837312036
DIDO1,Human papillomavirus type 102 E2 protein,0.8999095837312036
DIDO1,Human betacoronavirus 2c Jordan-N3/2012 ORF4a protein (gene: ORF4a),0.9018002218631122
DIDO1,Human papillomavirus type 30 early protein (gene: E2),0.903486026792944
DIDO1,Echovirus E5 full_polyprotein 1..2196,0.9057542447893764
DIDO1,Human papillomavirus type 68 E2 (gene: E2),0.9057542447893764
DIDO1,Echovirus E9 full_polyprotein 1..2203,0.9057542447893764
DIDO1,Human betacoronavirus 2c England-Qatar/2012 ORF4a,0.9057542447893764
DIDO1,Betacoronavirus England 1 NS3B protein (gene: ns3b),0.9057542447893764
DIDO1,Human papillomavirus type 84 putative regulatory protein E2 (gene: E2),0.9057542447893764
DIDO1,Human papillomavirus type 10 envelope protein (gene: E2),0.9057542447893764
DIDO1,Human papillomavirus type 114 E2 protein (gene: E2),0.9057542447893764
DIDO1,Human papillomavirus 15 early protein (gene: E2),0.9057542447893764
DIDO1,Human betacoronavirus 2c EMC/2012 ORF4a (gene: orf4a),0.9057542447893764
DIDO1,Middle East respiratory syndrome-related coronavirus NS4A protein (gene: orf4a),0.9237501457186692
DIDO1,Monkeypox virus double-stranded RNA binding protein,0.9237501457186692
DIDO1,Monkeypox virus Zaire-96-I-16 double-strand RNA-binding protein (gene: F3L),0.9287050575620676
DIDO1,Coxsackievirus A20 full_polyprotein 1..2208,0.9287050575620676
DIDO1,Human poliovirus 3 polyprotein,0.9318782091866168
DIDO1,Human poliovirus 1 enterovirus precursor polypeptide,0.9359472799230178
DIDO1,Coxsackievirus B4 full_polyprotein 1..2183,0.9366403811337995
DIS3L,Medulloblastoma,0.8548862007194026
DIS3L,Succinic semialdehyde dehydrogenase deficiency ORPHA:22,0.1991445465001551
DIS3L,Classic maple syrup urine disease ORPHA:268145,0.8922466888454011
DIS3L,Intermittent maple syrup urine disease ORPHA:268173,0.8922466888454011
DIS3L,Thiamine-responsive maple syrup urine disease ORPHA:268184,0.8922466888454011
DIS3L,Intermediate maple syrup urine disease ORPHA:268162,0.8922466888454011
DISP2,Lung Diseases Interstitial,0.969655257819091
DISP2,Lung Diseases,0.8903630091389316
DISP2,Benign paroxysmal torticollis of infancy ORPHA:71518,0.8922466888454011
DISP2,Cerebellar ataxia Cayman type ORPHA:94122,0.8922466888454011
DISP2,Familial paroxysmal ataxia ORPHA:97,0.8922466888454011
DISP2,GNB5-related intellectual disability-cardiac arrhythmia syndrome ORPHA:542306,0.8922466888454011
DISP2,NON RARE IN EUROPE: Non rare obesity ORPHA:521399,0.8922466888454011
DISP2,Spinocerebellar ataxia type 6 ORPHA:98758,0.8922466888454011
DISP2,Autosomal dominant nocturnal frontal lobe epilepsy ORPHA:98784,0.8922466888454011
DIXDC1,Carcinogenesis,0.7333611688795861
DIXDC1,Colon Carcinoma,0.7765852775619541
DIXDC1,Malignant tumor of colon,0.7765852775619541
DIXDC1,Malignant neoplasm of lung,0.7880542567584415
DIXDC1,Liver carcinoma,0.7880542567584415
DIXDC1,Primary malignant neoplasm of lung,0.7880542567584415
DIXDC1,Neoplasm Metastasis,0.7880542567584415
DIXDC1,Carcinoma of lung,0.7880542567584415
DIXDC1,Abnormal behavior,0.7880542567584415
DIXDC1,Manic Disorder,0.7880542567584415
DIXDC1,Manic,0.7880542567584415
DIXDC1,Depression Bipolar,0.8019075543217649
DIXDC1,Autistic Disorder,0.8019075543217649
DIXDC1,Adenocarcinoma of large intestine,0.8019075543217649
DIXDC1,Schizophrenia,0.8067197998685076
DIXDC1,Anxiety States Neurotic,0.8402911822757345
DIXDC1,Depression Neurotic,0.8402911822757345
DIXDC1,Melancholia,0.8402911822757345
DIXDC1,Depressive Syndrome,0.8402911822757345
DIXDC1,Sporadic Breast Carcinoma,0.8474481237156937
DIXDC1,Endogenous depression,0.8523465762428218
DIXDC1,Anxiety neurosis (finding),0.8610447277138289
DIXDC1,Mental Depression,0.8769418330148872
DIXDC1,Bipolar Disorder,0.900167961295542
DIXDC1,Depressive disorder,0.9103315000053974
DIXDC1,Unipolar Depression,0.9455834988784428
DIXDC1,Anxiety Disorders,0.946564927793026
DIXDC1,Manic Disorder,0.7765582368651238
DIXDC1,Schizophrenia,0.7860378120955526
DIXDC1,Anxiety Disorder,0.8507213163251659
DIXDC1,Melancholia,0.861756360478846
DIXDC1,Mental Depression,0.8903630091389316
DIXDC1,Autism,0.911896615143974
DIXDC1,Bipolar Disorder,0.943322675973118
DIXDC1,Persistent hyperplastic primary vitreous ORPHA:91495,0.3832844616405875
DIXDC1,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3891940933600213
DIXDC1,1p31p32 microdeletion syndrome ORPHA:401986,0.5867963421058087
DIXDC1,Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946,0.5867963421058087
DIXDC1,Autosomal recessive spastic paraplegia type 67 ORPHA:401820,0.5867963421058087
DIXDC1,Atrial septal defect ostium primum type ORPHA:99106,0.7929682744768703
DIXDC1,Autosomal dominant striatal neurodegeneration ORPHA:228169,0.7929682744768703
DIXDC1,Infantile-onset ascending hereditary spastic paralysis ORPHA:293168,0.7929682744768703
DIXDC1,Cenani-Lenz syndrome ORPHA:3258,0.7929682744768703
DIXDC1,Short rib-polydactyly syndrome Majewski type ORPHA:93269,0.7929682744768703
DIXDC1,Inherited congenital spastic tetraplegia ORPHA:210141,0.7929682744768703
DIXDC1,Male infertility due to globozoospermia ORPHA:171709,0.795266832401002
DIXDC1,Bilateral striopallidodentate calcinosis ORPHA:1980,0.8105918570729571
DIXDC1,Jeune syndrome ORPHA:474,0.8105918570729571
DIXDC1,15q14 microdeletion syndrome ORPHA:261190,0.8922466888454011
DIXDC1,Alpha-B crystallin-related late-onset myopathy ORPHA:399058,0.8922466888454011
DIXDC1,Anterior maxillary protrusion-strabismus-intellectual disability syndrome ORPHA:562559,0.8922466888454011
DIXDC1,Distal monosomy 12p ORPHA:280325,0.8922466888454011
DIXDC1,Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553,0.8922466888454011
DIXDC1,Short rib-polydactyly syndrome Saldino-Noonan type ORPHA:93270,0.8922466888454011
DIXDC1,Congenital ptosis ORPHA:91411,0.8922466888454011
DIXDC1,Isolated brachycephaly ORPHA:35099,0.8922466888454011
DIXDC1,Isolated plagiocephaly ORPHA:35098,0.8922466888454011
DIXDC1,Short rib-polydactyly syndrome Verma-Naumoff type ORPHA:93271,0.8922466888454011
DIXDC1,Hereditary hyperekplexia ORPHA:3197,0.8922466888454011
DIXDC1,Joubert syndrome with oculorenal defect ORPHA:2318,0.8922466888454011
DIXDC1,Bardet-Biedl syndrome ORPHA:110,0.8922466888454011
DIXDC1,Joubert syndrome with renal defect ORPHA:220497,0.8922466888454011
DIXDC1,Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome ORPHA:1154,0.8922466888454011
DIXDC1,BVES-related limb-girdle muscular dystrophy ORPHA:476084,0.8922466888454011
DIXDC1,Becker muscular dystrophy ORPHA:98895,0.8922466888454011
DIXDC1,Gordon syndrome ORPHA:376,0.8922466888454011
DIXDC1,Lissencephaly syndrome Norman-Roberts type ORPHA:89844,0.8922466888454011
DIXDC1,Marden-Walker syndrome ORPHA:2461,0.8922466888454011
DIXDC1,Spinocerebellar ataxia type 27 ORPHA:98764,0.8922466888454011
DIXDC1,Spondyloepimetaphyseal dysplasia-short limb-abnormal calcification syndrome ORPHA:93358,0.8922466888454011
DIXDC1,Symptomatic form of muscular dystrophy of Duchenne and Becker in female carriers ORPHA:206546,0.8922466888454011
DIXDC1,Hereditary mixed polyposis syndrome ORPHA:157794,0.8922466888454011
DIXDC1,Juvenile primary lateral sclerosis ORPHA:247604,0.8922466888454011
DIXDC1,Severe early-childhood-onset retinal dystrophy ORPHA:364055,0.8922466888454011
DIXDC1,Stargardt disease ORPHA:827,0.8922466888454011
DOCK4,Carcinogenesis,0.7333611688795861
DOCK4,Malignant neoplasm of ovary,0.7333611688795861
DOCK4,Ovarian Carcinoma,0.7333611688795861
DOCK4,Leukemia Myelocytic Acute,0.7765852775619541
DOCK4,MYELODYSPLASTIC SYNDROME,0.7765852775619541
DOCK4,Osteosarcoma,0.7880542567584415
DOCK4,Osteosarcoma of bone,0.7880542567584415
DOCK4,Neoplasm Metastasis,0.7880542567584415
DOCK4,C-reactive protein measurement,0.7880542567584415
DOCK4,Neuroblastoma,0.7880542567584415
DOCK4,Central neuroblastoma,0.7880542567584415
DOCK4,response to fenofibrate,0.7880542567584415
DOCK4,Pancytopenia,0.7880542567584415
DOCK4,Dyslexia,0.7880542567584415
DOCK4,Autistic Disorder,0.8019075543217649
DOCK4,Schizophrenia,0.8067197998685076
DOCK4,Adenocarcinoma of lung (disorder),0.8098851543361193
DOCK4,Schizophrenia,0.7860378120955526
DOCK4,Mental Depression,0.8903630091389316
DOCK4,Autism,0.911896615143974
DOCK4,Diabetes Mellitus,0.919442421650838
DOCK4,Bipolar Disorder,0.943322675973118
DOCK4,Acromelic frontonasal dysplasia ORPHA:1827,0.1040670578681756
DOCK4,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3891940933600213
DOCK4,Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946,0.5867963421058087
DOCK4,Charcot-Marie-Tooth disease type 4H ORPHA:99954,0.5867963421058087
DOCK4,Polyendocrine-polyneuropathy syndrome ORPHA:453533,0.5867963421058087
DOCK4,Tangier disease ORPHA:31150,0.5867963421058087
DOCK4,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670,0.7929682744768703
DOCK4,Young-onset Parkinson disease ORPHA:2828,0.8668760866668862
DOCK4,Charcot-Marie-Tooth disease type 4B2 ORPHA:99956,0.8922466888454011
DOCK4,Episodic ataxia type 6 ORPHA:209967,0.8922466888454011
DOCK4,Familial lipoprotein lipase deficiency ORPHA:309015,0.8922466888454011
DOCK4,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
DOCK4,Human immunodeficiency virus 1 Nef (gene: nef),0.8999095837312036
DOCK4,Human alphaherpesvirus 2 envelope glycoprotein E (gene: US8),0.9450424991150602
DRAP1,melanoma,0.7880542567584415
DRAP1,Melanoma,0.7765582368651238
DRAP1,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
DRAP1,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
DRAP1,Focal dermal hypoplasia ORPHA:2092,0.1040670578681756
DRAP1,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.1040670578681756
DRAP1,CADDS ORPHA:369942,0.1991445465001551
DRAP1,Autosomal recessive cerebellar ataxia due to STUB1 deficiency ORPHA:412057,0.5867963421058087
DRAP1,Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026,0.5867963421058087
DRAP1,Familial hypocalciuric hypercalcemia type 3 ORPHA:101050,0.5867963421058087
DRAP1,Hyperbiliverdinemia ORPHA:276405,0.5867963421058087
DRAP1,NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362,0.5867963421058087
DRAP1,Spondylometaphyseal dysplasia Sedaghatian type ORPHA:93317,0.7929682744768703
DRAP1,Acromegaly ORPHA:963,0.7929682744768703
DRAP1,X-linked Emery-Dreifuss muscular dystrophy ORPHA:98863,0.7929682744768703
DUSP14,Monocyte count procedure,0.7880542567584415
DUSP14,Monocyte count result,0.7880542567584415
DUSP14,melanoma,0.7880542567584415
DUSP14,Encephalomyelitis,0.8019075543217649
DUSP14,Tuberculosis,0.8368219249856942
DUSP14,Cold-induced sweating syndrome ORPHA:157820,0.1068643725150898
DUSP14,Microcephaly-congenital cataract-psoriasiform dermatitis syndrome ORPHA:488168,0.8922466888454011
DUSP14,Hutchinson-Gilford progeria syndrome ORPHA:740,0.8922466888454011
DUSP14,Restrictive dermopathy ORPHA:1662,0.8922466888454011
DUSP14,Orf virus ORF057 putative protein-tyrosine phosphatase,0.8999095837312036
DUSP14,Molluscum contagiosum virus subtype 1 MC082L (gene: MC082L),0.8999095837312036
DYRK1B,Malignant neoplasm of breast,0.4084380369379369
DYRK1B,Breast Carcinoma,0.7333611688795861
DYRK1B,Carcinogenesis,0.7333611688795861
DYRK1B,Malignant neoplasm of ovary,0.7333611688795861
DYRK1B,Ovarian Carcinoma,0.7333611688795861
DYRK1B,Adenocarcinoma,0.750391252594775
DYRK1B,Malignant neoplasm of pancreas,0.7688485284765829
DYRK1B,Pancreatic carcinoma,0.7765852775619541
DYRK1B,Colon Carcinoma,0.7765852775619541
DYRK1B,Malignant tumor of colon,0.7765852775619541
DYRK1B,Serum cholesterol raised,0.7765852775619541
DYRK1B,Non-Small Cell Lung Carcinoma,0.7765852775619541
DYRK1B,Hypercholesterolemia,0.7765852775619541
DYRK1B,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
DYRK1B,Malignant neoplasm of lung,0.7880542567584415
DYRK1B,Malignant neoplasm of prostate,0.7880542567584415
DYRK1B,Osteosarcoma,0.7880542567584415
DYRK1B,Rhabdomyosarcoma,0.7880542567584415
DYRK1B,Osteosarcoma of bone,0.7880542567584415
DYRK1B,Prostate carcinoma,0.7880542567584415
DYRK1B,Primary malignant neoplasm of lung,0.7880542567584415
DYRK1B,Carcinoma of lung,0.7880542567584415
DYRK1B,Adenocarcinoma of pancreas,0.7880542567584415
DYRK1B,Increase in blood pressure,0.7880542567584415
DYRK1B,Solid Neoplasm,0.7880542567584415
DYRK1B,Metastatic melanoma,0.7940665326856218
DYRK1B,ovarian neoplasm,0.8067197998685076
DYRK1B,Hereditary hemochromatosis,0.8138488881521341
DYRK1B,Obesity Abdominal,0.8368219249856942
DYRK1B,Hypertensive disease,0.8474481237156937
DYRK1B,Metabolic Syndrome X,0.8610447277138289
DYRK1B,Ovarian Neoplasm,0.7765582368651238
DYRK1B,Coronary Stenosis,0.7765582368651238
DYRK1B,Hypertension,0.7765582368651238
DYRK1B,Ovarian Cancer,0.7797212851906329
DYRK1B,Hypercholesterolemia,0.8115918568696846
DYRK1B,Myocardial Infarction,0.861756360478846
DYRK1B,Metastatic Melanoma,0.8903301324869451
DYRK1B,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
DYRK1B,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
DYRK1B,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
DYRK1B,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
DYRK1B,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.1040670578681756
DYRK1B,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.1040670578681756
DYRK1B,Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738,0.3832844616405875
DYRK1B,Arnold-Chiari malformation type II ORPHA:1136,0.5867963421058087
DYRK1B,Telethonin-related  limb-girdle muscular dystrophy R7 ORPHA:34514,0.5867963421058087
DYRK1B,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
DYRK1B,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
DYRK1B,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
DYRK1B,Provisional),0.8999095837312036
DYRK1B,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DYRK1B,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DYRK1B,Human gammaherpesvirus 8 ORF72,0.8999095837312036
DYRK1B,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DYRK1B,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
DYRK1B,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
DYRK1B,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
DYRK1B,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
DYRK1B,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
DYRK1B,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
DYRK1B,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
DYRK1B,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
DYRK1B,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
DYRK1B,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
DYRK1B,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DYRK1B,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
DYRK1B,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
DYRK1B,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
DYRK1B,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
DYRK1B,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
DYRK1B,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
DYRK1B,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
DYRK1B,Monkeypox virus ser/thr kinase,0.8999095837312036
DYRK1B,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
DYRK1B,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
DYRK1B,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
DYRK1B,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
DYRK1B,Orf virus ORF020 dsRNA-binding PKR inhibitor,0.8999095837312036
DYRK1B,Banna virus strain JKT-6423 vp12,0.8999095837312036
DYRK1B,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.8999095837312036
DYRK1B,Yaba monkey tumor virus 142R,0.8999095837312036
DYRK1B,Adult diarrheal rotavirus strain J19 NSP1,0.8999095837312036
DYRK1B,Human immunodeficiency virus 1 integrase (gene: gag-pol),0.8999095837312036
DYRK1B,Monkeypox virus ankyrin-like protein,0.8999095837312036
DYRK1B,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.9057542447893764
DYRK1B,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
EBAG9,Malignant neoplasm of breast,0.4084380369379369
EBAG9,Bladder Neoplasm,0.4084380369379369
EBAG9,Breast Carcinoma,0.7333611688795861
EBAG9,Carcinogenesis,0.7333611688795861
EBAG9,Malignant neoplasm of ovary,0.7333611688795861
EBAG9,leukemia,0.7333611688795861
EBAG9,Ovarian Carcinoma,0.7333611688795861
EBAG9,Adenocarcinoma,0.750391252594775
EBAG9,Malignant neoplasm of pancreas,0.7688485284765829
EBAG9,Pancreatic carcinoma,0.7765852775619541
EBAG9,Endometrial Neoplasms,0.7765852775619541
EBAG9,Pancreatic Neoplasm,0.7765852775619541
EBAG9,Cholangitis,0.7765852775619541
EBAG9,Endometrial Carcinoma,0.7765852775619541
EBAG9,Mammary Neoplasms,0.7880542567584415
EBAG9,Glioma,0.7880542567584415
EBAG9,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
EBAG9,Malignant neoplasm of prostate,0.7880542567584415
EBAG9,Liver carcinoma,0.7880542567584415
EBAG9,Invasive carcinoma of breast,0.7880542567584415
EBAG9,Epithelial ovarian cancer,0.7880542567584415
EBAG9,Tumor Promotion,0.7880542567584415
EBAG9,Prostate carcinoma,0.7880542567584415
EBAG9,Neoplasm Metastasis,0.7880542567584415
EBAG9,Prostatic Neoplasms,0.7880542567584415
EBAG9,Carcinoma of lung,0.7880542567584415
EBAG9,Mesothelioma,0.7880542567584415
EBAG9,Ductal Carcinoma,0.7880542567584415
EBAG9,Eclampsia,0.7880542567584415
EBAG9,Gall Bladder Diseases,0.7880542567584415
EBAG9,Malignant neoplasm of stomach,0.7880542567584415
EBAG9,Hodgkin Disease,0.7880542567584415
EBAG9,Tumor Progression,0.7880542567584415
EBAG9,Renal Cell Carcinoma,0.7880542567584415
EBAG9,Stomach Carcinoma,0.7880542567584415
EBAG9,Squamous cell carcinoma,0.7880542567584415
EBAG9,Rheumatoid Arthritis,0.7880542567584415
EBAG9,Diabetes Mellitus,0.7880542567584415
EBAG9,Intrahepatic Cholangiocarcinoma,0.7880542567584415
EBAG9,Pre-Eclampsia,0.8019075543217649
EBAG9,ovarian neoplasm,0.8067197998685076
EBAG9,Graft-vs-Host Disease,0.8190761496232595
EBAG9,Extrahepatic Cholangiocarcinoma,0.8190761496232595
EBAG9,Endometrial adenocarcinoma,0.8190761496232595
EBAG9,Primary biliary cirrhosis,0.8212681436603975
EBAG9,Gastric Adenocarcinoma,0.8232134984476662
EBAG9,Epstein-Barr Virus Infections,0.8232134984476662
EBAG9,Cholangiocarcinoma,0.8402911822757345
EBAG9,Anemia,0.8584283190330553
EBAG9,Anaplasia,0.8648405521677974
EBAG9,Endometriosis,0.960644037248553
EBAG9,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency ORPHA:308425,0.7929682744768703
EBAG9,3-methylglutaconic aciduria type 1 ORPHA:67046,0.8922466888454011
EBAG9,Dilated cardiomyopathy with ataxia ORPHA:66634,0.8922466888454011
ECI2,leukemia,0.7333611688795861
ECI2,MYELODYSPLASTIC SYNDROME,0.7765852775619541
ECI2,Myeloid Leukemia,0.7880542567584415
ECI2,Paroxysmal nocturnal hemoglobinuria,0.8019075543217649
ECI2,Diabetes Autoimmune,0.8019075543217649
ECI2,Acquired aplastic anemia,0.8402911822757345
ECI2,Aplastic Anemia,0.9710463782716944
ECI2,Beta-ketothiolase deficiency ORPHA:134,0.8922466888454011
ECI2,Guanidinoacetate methyltransferase deficiency ORPHA:382,0.8922466888454011
EHD1,melanoma,0.7880542567584415
EHD1,Multiple Sclerosis,0.8019075543217649
EHD1,Autistic Disorder,0.8019075543217649
EHD1,Schizophrenia,0.8067197998685076
EHD1,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
EHD1,Obesity,0.8989612563669234
EHD1,Cardiomyopathies,0.9557184806547836
EHD1,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
EHD1,Incontinentia pigmenti ORPHA:464,0.0414176838632111
EHD1,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
EHD1,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
EHD1,Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813,0.1054066549396977
EHD1,Camurati-Engelmann disease ORPHA:1328,0.1991445465001551
EHD1,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.1991445465001551
EHD1,Infantile inflammatory bowel disease with neurological involvement ORPHA:565788,0.1991445465001551
EHD1,MYH9-related disease ORPHA:182050,0.1991445465001551
EHD1,Stormorken-Sjaastad-Langslet syndrome ORPHA:3204,0.1991445465001551
EHD1,Ependymoma ORPHA:251636,0.3832844616405875
EHD1,RELA fusion-positive ependymoma ORPHA:530792,0.3832844616405875
EHD1,Autosomal recessive spastic paraplegia type 48 ORPHA:306511,0.5867963421058087
EHD1,Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428,0.5867963421058087
EHD1,Becker nevus syndrome ORPHA:64755,0.7929682744768703
EHD1,Developmental malformations-deafness-dystonia syndrome ORPHA:79107,0.7929682744768703
EIF1AY,Immune System Diseases,0.8402911822757345
EIF1AY,Azoospermia,0.8648405521677974
EIF1AY,45X/46XY mixed gonadal dysgenesis ORPHA:1772,0.8922466888454011
EIF1AY,Partial chromosome Y deletion ORPHA:1646,0.8922466888454011
EIF4A3,Reticulocyte count (procedure),0.5071083164302358
EIF4A3,Cervix carcinoma,0.7765852775619541
EIF4A3,Pancreatic Neoplasm,0.7765852775619541
EIF4A3,Liver carcinoma,0.7880542567584415
EIF4A3,Hyperplasia of nose,0.7880542567584415
EIF4A3,Hypertrophy of nose,0.7880542567584415
EIF4A3,Large nose,0.7880542567584415
EIF4A3,Malignant neoplasm of stomach,0.7880542567584415
EIF4A3,Congenital hypoplasia,0.7880542567584415
EIF4A3,Protruding ear,0.7880542567584415
EIF4A3,Stomach Carcinoma,0.7880542567584415
EIF4A3,Prominent ear,0.7880542567584415
EIF4A3,Cognitive delay,0.7880542567584415
EIF4A3,Limb Deformities Congenital,0.7880542567584415
EIF4A3,Global developmental delay,0.7880542567584415
EIF4A3,Mental and motor retardation,0.7880542567584415
EIF4A3,Abnormality of the voice,0.7908231553833205
EIF4A3,Microretrognathia,0.8019075543217649
EIF4A3,Proximal placement of thumb,0.8019075543217649
EIF4A3,Curvature of little finger,0.8019075543217649
EIF4A3,Clinodactyly of the 5th finger,0.8019075543217649
EIF4A3,Stomach Neoplasms,0.8044379824544406
EIF4A3,Radial ray hypoplasia,0.8138488881521341
EIF4A3,Congenital hypoplasia of radius,0.8145035474981049
EIF4A3,Pierre Robin Syndrome,0.8145035474981049
EIF4A3,Limb defects,0.8232134984476662
EIF4A3,Feeding difficulties,0.8272008757995397
EIF4A3,Congenital Abnormality,0.8402911822757345
EIF4A3,Hypoplasia of thumb,0.8402911822757345
EIF4A3,Short phalanx of finger,0.8402911822757345
EIF4A3,Cleft uvula,0.8402911822757345
EIF4A3,Microstomia,0.8554819098734854
EIF4A3,Low set ears,0.8700543109506378
EIF4A3,Short metacarpal,0.8774809019744603
EIF4A3,Short stature,0.8815127642200768
EIF4A3,Byzanthine arch palate,0.9119978323790848
EIF4A3,Intellectual Disability,0.9478210444156088
EIF4A3,Congenital clubfoot,0.951016614400691
EIF4A3,Congenital Hypoplasia Of Radius,0.7765582368651238
EIF4A3,Developmental Delay,0.7765582368651238
EIF4A3,Pierre-Robin Syndrome,0.8115918568696846
EIF4A3,Mesomelia,0.8115918568696846
EIF4A3,Mental Retardation,0.8337953215113012
EIF4A3,Hypoplasia Of Thumb,0.861756360478846
EIF4A3,Microtia,0.8974842552599366
EIF4A3,Camptodactyly Of Fingers,0.943322675973118
EIF4A3,Dwarfism,0.9510372690456612
EIF4A3,Microstomia,0.9543024119762946
EIF4A3,High Palate,0.9578111936867284
EIF4A3,Congenital Clubfoot,0.9832345076528324
EIF4A3,Amish lethal microcephaly ORPHA:99742,0.7929682744768703
EIF4A3,Pontocerebellar hypoplasia type 10 ORPHA:411493,0.7929682744768703
EIF4A3,Progressive polyneuropathy with bilateral striatal necrosis ORPHA:217396,0.7929682744768703
EIF4A3,Purine nucleoside phosphorylase deficiency ORPHA:760,0.7929682744768703
EIF4A3,Richieri Costa-Pereira syndrome ORPHA:3102,0.7929682744768703
EIF4A3,Pontocerebellar hypoplasia type 2 ORPHA:2524,0.8029813443753846
EIF4A3,Dyskeratosis congenita ORPHA:1775,0.8668760866668862
EIF4A3,Cerebrocostomandibular syndrome ORPHA:1393,0.8922466888454011
EIF4A3,Fabry disease ORPHA:324,0.8922466888454011
EIF4A3,Mandibulofacial dysostosis-microcephaly syndrome ORPHA:79113,0.8922466888454011
EIF4A3,Congenital dyserythropoietic anemia type II ORPHA:98873,0.8922466888454011
EIF4A3,Glycogen storage disease due to phosphoglycerate kinase 1 deficiency ORPHA:713,0.8922466888454011
EIF4A3,Spondyloepimetaphyseal dysplasia Genevieve type ORPHA:168454,0.8922466888454011
EIF4A3,Treacher-Collins syndrome ORPHA:861,0.8922466888454011
EIF4A3,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
EIF4A3,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
EIF4A3,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
EIF4A3,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
EIF4A3,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
EIF4A3,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
EIF4A3,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
EIF4A3,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
EIF4A3,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
EIF4A3,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
EIF4A3,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
EIF4A3,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
EIF4A3,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
EIF4A3,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
EIF4A3,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.8999095837312036
EIF4A3,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
EIF4A3,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
EIF4A3,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
EIF4A3,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
EIF4A3,Yaba-like disease virus 142R protein (gene: 142R),0.8999095837312036
EIF4A3,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
EIF4A3,Monkeypox virus ser/thr kinase,0.8999095837312036
EIF4A3,Cowpox virus CPXV123 protein (gene: CPXV123 CDS),0.8999095837312036
EIF4A3,Yaba-like disease virus 88L protein (gene: 88L),0.8999095837312036
EIF4A3,Monkeypox virus early gene transcription factor VETF 70 kDa small subunit,0.8999095837312036
EIF4A3,Monkeypox virus Zaire-96-I-16 E6R (gene: E6R),0.8999095837312036
EIF4A3,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
EIF4A3,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
EIF4A3,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
EIF4A3,Dengue virus 3 nonstructural protein NS3 (gene: flavivirus polyprotein),0.8999095837312036
EIF4A3,Monkeypox virus bifunctional ATPase/nucleoside triphosphate phosphohydrolase-I,0.8999095837312036
EIF4A3,Monkeypox virus Zaire-96-I-16 E11L (gene: E11L),0.8999095837312036
EIF4A3,Variola virus hypothetical protein (gene: B1R),0.8999095837312036
EIF4A3,Vaccinia virus Ankara serine/threonine-protein kinase-like,0.8999095837312036
EIF4A3,Variola virus hypothetical protein (gene: N1L),0.8999095837312036
EIF4A3,Orf virus ORF069 early transcription factor VETFs,0.8999095837312036
EIF4A3,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
EIF4A3,Human betaherpesvirus 7 DNA replication origin-binding helicase (gene: U73),0.8999095837312036
EIF4A3,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.8999095837312036
EIF4A3,Human adenovirus 21a 100 kDa hexon-assembly associated protein (gene: L4),0.8999095837312036
EIF4A3,Macacine alphaherpesvirus 1 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
EIF4A3,Vaccinia virus ser/thr kinase (gene: B1R),0.8999095837312036
EIF4A3,Vaccinia virus Ankara Serine/threonine-protein kinase,0.8999095837312036
EIF4A3,Monkeypox virus ser/thr protein kinase-like protein,0.8999095837312036
EIF4A3,Human adenovirus 68 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
EIF4A3,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.8999095837312036
EIF4A3,Human mastadenovirus B hexon assembly protein 100K (gene: L4),0.8999095837312036
EIF4A3,Human adenovirus B3 L4 100-kDa protein (gene: L4),0.8999095837312036
EIF4A3,GB virus C (Pegivirus C HPgV) NS3 proteinase/ATPase/helicase,0.8999095837312036
EIF4A3,Yaba monkey tumor virus 142R,0.8999095837312036
EIF4A3,Monkeypox virus Zaire-96-I-16 B11R (gene: B11R),0.8999095837312036
EIF4A3,Cercopithecine alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
EIF4A3,Variola virus RNA helicase NPH-II (gene: K8R),0.8999095837312036
EIF4A3,Yaba monkey tumor virus RNA helicase NPH-II,0.8999095837312036
EIF4A3,Vaccinia virus RNA helicase NPH-II (gene: I8R),0.8999095837312036
EIF4A3,Yaba monkey tumor virus 110R,0.8999095837312036
EIF4A3,Orf virus ORF095 DNA helicase,0.8999095837312036
EIF4A3,Horsepox virus HSPV112 (DEAD-like helicases superfamily),0.8999095837312036
EIF4A3,Cowpox virus CPXV087 protein (gene: CPXV087 CDS),0.8999095837312036
EIF4A3,Human adenovirus 7 100K,0.8999095837312036
EIF4A3,Variola virus hypothetical protein (gene: A18R),0.8999095837312036
EIF4A3,Molluscum contagiosum virus subtype 1 MC050R,0.8999095837312036
EIF4A3,Molluscum contagiosum virus subtype 1 MC100R (gene: MC100L),0.8999095837312036
EIF4A3,Yaba-like disease virus 49R protein (gene: 49R),0.8999095837312036
EIF4A3,Human betaherpesvirus 6 U73 origin binding protein (gene: U73),0.8999095837312036
EIF4A3,Human betaherpesvirus 6A DNA replication origin-binding helicase (gene: U73),0.8999095837312036
EIF4A3,Dengue virus 1 nonstructural protein NS3 (gene: flavivirus polyprotein),0.8999095837312036
EIF4A3,Monkeypox virus Zaire-96-I-16 A19R (gene: A19R),0.8999095837312036
EIF4A3,Variola virus hypothetical protein (gene: F6R),0.8999095837312036
EIF4A3,Horsepox virus HSPV189 (Serine/threonine protein kinase),0.8999095837312036
EIF4A3,Human alphaherpesvirus 3 DNA replication origin-binding helicase (gene: ORF51),0.8999095837312036
EIF4A3,Vaccinia virus Ankara NTP-dependent RNA helicase NPH-II,0.8999095837312036
EIF4A3,Vaccinia virus Ankara transcription termination factor,0.8999095837312036
EIF4A3,Vaccinia virus 70kDa small subunit of early gene transcription factor VETF (gene: D6R),0.8999095837312036
EIF4A3,Orf virus ORF072 transcription termination factor NPH-I,0.8999095837312036
EIF4A3,Yaba monkey tumor virus 88L,0.8999095837312036
EIF4A3,Ectromelia virus ERPV viral early transcription factor small subunit,0.8999095837312036
EIF4A3,Papiine alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
EIF4A3,Vaccinia virus Ankara Early transcription factor 70 kDa subunit,0.8999095837312036
EIF4A3,Vaccinia virus DNA helicase (gene: A18R),0.8999095837312036
EIF4A3,Vaccinia virus Ankara early gene termination factor/Nucleoside triphosphatase I,0.8999095837312036
EIF4A3,Horsepox virus HSPV117,0.8999095837312036
EIF4A3,Monkeypox virus DNA helicase,0.8999095837312036
EIF4A3,Yaba monkey tumor virus 84R,0.8999095837312036
EIF4A3,Ectromelia virus ERPV DNA helicase,0.8999095837312036
EIF4A3,Orf virus ORF130 putative serine/threonine protein kinase,0.8999095837312036
EIF4A3,Orf virus ORF036 RNA helicase NPH-II,0.8999095837312036
EIF4A3,Cowpox virus CPXV128 protein (gene: CPXV128 CDS),0.8999095837312036
EIF4A3,Vaccinia virus ATPase nucleoside triphosphate phosphohydrolase-I NPH-I (gene: D11L),0.8999095837312036
EIF4A3,Molluscum contagiosum virus subtype 1 MC095R (gene: MC095R),0.8999095837312036
EIF4A3,Vaccinia virus ser/thr protein kinase-like protein (gene: B12R),0.8999095837312036
EIF4A3,Human betaherpesvirus 6B origin binding protein (gene: U73),0.8999095837312036
EIF4A3,Yaba-like disease virus 110R protein (gene: 110R),0.8999095837312036
EIF4A3,Molluscum contagiosum virus subtype 1 MC123R (gene: MC123R),0.8999095837312036
EIF4A3,Cowpox virus CPXV151 protein (gene: CPXV151 CDS),0.8999095837312036
EIF4A3,Human alphaherpesvirus 1 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
EIF4A3,Ectromelia virus ERPV helicase NPH-I,0.8999095837312036
EIF4A3,Horsepox virus HSPV139 (DEAD-like helicases superfamily),0.8999095837312036
EIF4A3,Human alphaherpesvirus 2 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
EIF4A3,Human herpesvirus 3 strain Dumas helicase,0.9057542447893764
EIF4A3,Hepatitis C virus subtype 2k/1b full_polyprotein 1..3010,0.9057542447893764
EIF4A3,Monkeypox virus bifunctional DNA/RNA-helicase/DExH-NPH-II,0.9057542447893764
EIF4A3,Monkeypox virus Zaire-96-I-16 RNA helicase NPH-II (gene: I8R),0.9057542447893764
EIF4A3,Horsepox virus HSPV078 (RNA helicase NPH-II),0.9057542447893764
EIF4A3,Ectromelia virus ERPV RNA helicase,0.9057542447893764
EMG1,Fatty acid measurement,0.7765852775619541
EMG1,Hyperplasia of nose,0.7880542567584415
EMG1,Hypertrophy of nose,0.7880542567584415
EMG1,Large nose,0.7880542567584415
EMG1,Nephroblastoma,0.7880542567584415
EMG1,Sloping forehead,0.7880542567584415
EMG1,Ewings sarcoma,0.7880542567584415
EMG1,Abnormal joint morphology,0.7880542567584415
EMG1,Feeding difficulties in infancy,0.7880542567584415
EMG1,Neural Tube Defects,0.7880542567584415
EMG1,Curvature of little finger,0.8019075543217649
EMG1,Severe postnatal growth retardation,0.8019075543217649
EMG1,Clinodactyly of the 5th finger,0.8019075543217649
EMG1,HIV Infections,0.8145035474981049
EMG1,Scleroderma,0.8212681436603975
EMG1,Small for gestational age (disorder),0.8402911822757345
EMG1,Low Birth Weights,0.8402911822757345
EMG1,Systemic Scleroderma,0.8402911822757345
EMG1,Vertical Talus,0.8402911822757345
EMG1,Cryptorchidism,0.8402911822757345
EMG1,HIV Coinfection,0.843190898187174
EMG1,Flexion contracture of proximal interphalangeal joint,0.8578473133580928
EMG1,Retrusion of lower jaw,0.8648405521677974
EMG1,Decreased projection of lower jaw,0.8648405521677974
EMG1,Decreased projection of mandible,0.8648405521677974
EMG1,Hypoplastic mandible condyle,0.8648405521677974
EMG1,Aplasia/Hypoplasia of the mandible,0.8648405521677974
EMG1,Joint stiffness,0.8648405521677974
EMG1,Micrognathism,0.8648405521677974
EMG1,Severe global developmental delay,0.8648405521677974
EMG1,Amyloidosis,0.8672189956534445
EMG1,Arthropathy,0.8769418330148872
EMG1,Short stature,0.8815127642200768
EMG1,Severe psychomotor retardation,0.8815127642200768
EMG1,Death in infancy,0.9390727893210336
EMG1,Death in early childhood,0.9393256300017014
EMG1,Small head,0.9822381479823692
EMG1,Oral Cleft,0.8115918568696846
EMG1,Vertical Talus,0.861756360478846
EMG1,Cryptorchidism,0.861756360478846
EMG1,Microcephaly,0.8903630091389316
EMG1,Micrognathism,0.9398381935810408
EMG1,Camptodactyly Of Fingers,0.943322675973118
EMG1,Dwarfism,0.9510372690456612
EMG1,TMEM199-CDG ORPHA:466703,0.3832844616405875
EMG1,Schnyder corneal dystrophy ORPHA:98967,0.5867963421058087
EMG1,Bowen-Conradi syndrome ORPHA:1270,0.8922466888454011
EMG1,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect ORPHA:466784,0.8922466888454011
EMG1,RFT1-CDG ORPHA:244310,0.8922466888454011
EMG1,Severe neonatal lactic acidosis due to NFS1-ISD11 complex deficiency ORPHA:397593,0.8922466888454011
ENOX2,Malignant neoplasm of breast,0.4084380369379369
ENOX2,Cervix carcinoma,0.7765852775619541
ENOX2,Malignant tumor of cervix,0.7768809924982332
ENOX2,Rhabdomyosarcoma,0.7880542567584415
ENOX2,cervical cancer,0.7880542567584415
ENOX2,Malignant Neoplasms,0.7880542567584415
ENOX2,Neoplasms,0.7880542567584415
ENOX2,Malignant neoplasm of stomach,0.7880542567584415
ENOX2,Malignant mesothelioma,0.7880542567584415
ENOX2,Stomach Carcinoma,0.7880542567584415
ENOX2,Benign Neoplasm,0.887595340546704
ENOX2,Intellectual Disability,0.9478210444156088
ENOX2,Malignant Neoplasm,0.8115918568696846
ENOX2,Malignant Mesothelioma,0.8877197959767673
ENOX2,Benign Neoplasm,0.9087218501169084
ENOX2,Neoplasms,0.980894832851993
ENTPD2,Malignant neoplasm of pancreas,0.7688485284765829
ENTPD2,Pancreatic carcinoma,0.7765852775619541
ENTPD2,Liver carcinoma,0.7880542567584415
ENTPD2,Biliary cirrhosis,0.7880542567584415
ENTPD2,melanoma,0.7880542567584415
ENTPD2,Biliary Cirrhosis Secondary,0.7880542567584415
ENTPD2,Pancreatitis Chronic,0.7880542567584415
ENTPD2,Tumor Progression,0.7880542567584415
ENTPD2,Cytomegalovirus Infections,0.7880542567584415
ENTPD2,Liver neoplasms,0.8019075543217649
ENTPD2,Primary biliary cirrhosis,0.8212681436603975
ENTPD2,Hypertensive disease,0.8474481237156937
ENTPD2,Biliary Cholangitis,0.7765582368651238
ENTPD2,Biliary Cirrhosis,0.7765582368651238
ENTPD2,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
ENTPD2,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.1040670578681756
ENTPD2,Apparent mineralocorticoid excess ORPHA:320,0.1991445465001551
ENTPD2,NON RARE IN EUROPE: Hypodontia ORPHA:2227,0.4621817429362311
ENTPD2,Systemic primary carnitine deficiency ORPHA:158,0.5867963421058087
ENTPD2,Autosomal recessive spastic paraplegia type 35 ORPHA:171629,0.7929682744768703
ENTPD2,Fatty acid hydroxylase-associated neurodegeneration ORPHA:329308,0.7929682744768703
ENTPD2,Naxos disease ORPHA:34217,0.7929682744768703
ENTPD2,Marie Unna hereditary hypotrichosis ORPHA:444,0.8922466888454011
ERI1,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
ERI1,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
ERI1,Platelet distribution width measurement,0.7880542567584415
ERI1,Platelet distribution width result,0.7880542567584415
ERI1,Narcolepsy,0.8067197998685076
ERI1,Developmental Delay,0.7765582368651238
ERI1,Narcolepsy,0.8260230451542778
ERI1,Renal Aplasia,0.8827958376161968
ERI1,Hypomyelination-congenital cataract syndrome ORPHA:85163,0.7929682744768703
ERI1,Temtamy preaxial brachydactyly syndrome ORPHA:363417,0.7929682744768703
ERI1,Cutis marmorata telangiectatica congenita ORPHA:1556,0.8922466888454011
ERI1,Greenberg dysplasia ORPHA:1426,0.8922466888454011
ERI1,Hermansky-Pudlak syndrome with neutropenia ORPHA:183678,0.8922466888454011
ERI1,Regressive spondylometaphyseal dysplasia ORPHA:448267,0.8922466888454011
ERI1,Reynolds syndrome ORPHA:779,0.8922466888454011
ERI1,Xeroderma pigmentosum variant ORPHA:90342,0.8922466888454011
ERI1,Fetal encasement syndrome ORPHA:465824,0.8922466888454011
ERI1,Alport syndrome-intellectual disability-midface hypoplasia-elliptocytosis syndrome ORPHA:86818,0.8922466888454011
ERI1,Hermansky-Pudlak syndrome without pulmonary fibrosis ORPHA:231512,0.8922466888454011
ERI1,Human alphaherpesvirus 1 DNA polymerase catalytic subunit (gene: UL30),0.8999095837312036
ESAM,Neoplasm Metastasis,0.7880542567584415
ESAM,Pneumonitis,0.8019075543217649
ESAM,Schizophrenia,0.8067197998685076
ESAM,Pneumonia,0.834094492023826
ESAM,Chronic Obstructive Airway Disease,0.8648405521677974
ESAM,Disseminated Malignant Neoplasm,0.8867509400747969
ESAM,Schizophrenia,0.7860378120955526
ESAM,Hemochromatosis type 5 ORPHA:447792,0.3832844616405875
ESAM,Polymicrogyria with optic nerve hypoplasia ORPHA:250972,0.3832844616405875
ESAM,Diencephalic-mesencephalic junction dysplasia ORPHA:319192,0.5867963421058087
ESAM,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735,0.7929682744768703
ESAM,Von Willebrand disease type 1 ORPHA:166078,0.8922466888454011
ESAM,Von Willebrand disease type 2A ORPHA:166084,0.8922466888454011
ESAM,Von Willebrand disease type 2B ORPHA:166087,0.8922466888454011
ESAM,Von Willebrand disease type 2M ORPHA:166090,0.8922466888454011
ESAM,Von Willebrand disease type 2N ORPHA:166093,0.8922466888454011
ESAM,Von Willebrand disease type 3 ORPHA:166096,0.8922466888454011
ESAM,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
ESAM,Variola virus hypothetical protein (gene: B20R),0.8999095837312036
ESAM,Ectromelia virus ERPV IFN alpha/beta receptor,0.8999095837312036
ESAM,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.8999095837312036
ESAM,Human gammaherpesvirus 4 BARF1 protein (gene: BARF1),0.8999095837312036
ESAM,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
ESAM,Cowpox virus CPXV209 protein (gene: CPXV209 CDS),0.8999095837312036
ESAM,Human herpesvirus 4 type 2 BARF1,0.8999095837312036
ESAM,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
ESAM,Human adenovirus 56 CR1 beta protein (gene: E3),0.8999095837312036
ESAM,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
ESAM,Vaccinia virus Ankara soluble and cell surface interferon-alpha/beta receptor,0.8999095837312036
ESAM,Ectromelia virus ERPV IL-1 beta receptor,0.8999095837312036
ESAM,Human gammaherpesvirus 8 K14,0.8999095837312036
ESAM,Monkeypox virus IFN-alpha/beta-receptor-like secreted glycoprotein,0.8999095837312036
ESAM,Monkeypox virus Zaire-96-I-16 B16R (gene: B16R),0.8999095837312036
ESAM,Vaccinia virus IFN-alpha/beta-receptor-like secreted glycoprotein (gene: B19R),0.8999095837312036
ESAM,Horsepox virus HSPV195 (immunoglobulin like protein),0.8999095837312036
ESAM,Human betaherpesvirus 5 membrane protein UL6 (gene: UL6),0.8999095837312036
ESAM,Human betaherpesvirus 5 envelope glycoprotein UL4 (gene: UL4),0.8999095837312036
ESAM,Cowpox virus CPXV212 protein (gene: CPXV212 CDS),0.8999095837312036
ESAM,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
ESAM,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.8999095837312036
ESAM,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
ESAM,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
ESAM,Variola virus hypothetical protein (gene: J9R),0.8999095837312036
ESAM,Human mastadenovirus A E3 CR1-beta1,0.8999095837312036
ESAM,Horsepox virus HSPV192 (IL-beta-binding protein,0.8999095837312036
ESAM,Provisional),0.8999095837312036
ESAM,Human adenovirus 64 E3 48.9 kDa protein,0.9057542447893764
ESAM,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
ESAM,Human adenovirus 23 CR1 b protein (gene: E3),0.9057542447893764
ESAM,Human adenovirus D37 48.9 kDa (gene: E3),0.9057542447893764
ESAM,Human adenovirus 61 E3 CR1 beta,0.9057542447893764
ESAM,Molluscum contagiosum virus subtype 1 MC162R (gene: MC162R),0.9057542447893764
ESAM,Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A),0.9058994261255549
ESAM,Vaccinia virus hemagglutinin (gene: A56R),0.915880438522078
ESAM,Cercopithecine betaherpesvirus 5 membrane protein RL11M (gene: RL11M),0.915880438522078
ESAM,Human adenovirus 41 E3 31.6K,0.9176018655958595
ESAM,Human adenovirus 71 E3 CR1-beta (gene: E3),0.9187390604217726
ESAM,Human adenovirus 43 CR1-beta protein (gene: E3),0.9197295331382644
ESAM,Human adenovirus 18 CR1-beta protein (gene: E3),0.9237501457186692
ESAM,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9237501457186692
ESAM,Human adenovirus D8 45.5kDa protein (gene: E3),0.9237501457186692
ESAM,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.9237501457186692
ESAM,Human adenovirus 65 E3 CR1-b,0.9287050575620676
ESAM,Yaba monkey tumor virus Ig domain OX-2-like protein,0.9287050575620676
ESAM,Cercopithecine betaherpesvirus 5 membrane protein RL11Q (gene: RL11Q),0.9359472799230178
ESAM,Monkeypox virus bifunctional IL-1-beta-inhibitor,0.9364561700418303
ESAM,Human mastadenovirus A E3 CR1-alpha1,0.9397923093369096
ESAM,Human adenovirus 19 CR1-beta (gene: E3),0.9397923093369096
ESAM,Human adenovirus 63 CR1 beta protein (gene: E3),0.9626366082099888
ESAM,Human adenovirus 67 E3 CR1-b,0.9687349764960514
ESAM,Human adenovirus 58 CR1-beta (gene: E3),0.9738234079697116
ESAM,Human mastadenovirus D membrane glycoprotein E3 CR1-beta (gene: E3),0.9738234079697116
EVI5L,Age at menarche,0.9214835359141188
EVI5L,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
EVI5L,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
EVI5L,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
EVI5L,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
EVI5L,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
EVI5L,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
EVI5L,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
EVI5L,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
EVI5L,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
EVI5L,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
EVI5L,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.1040670578681756
EVI5L,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.1040670578681756
EVI5L,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.1040670578681756
EVI5L,BAP1-related tumor predisposition syndrome ORPHA:289539,0.1040670578681756
EVI5L,Cerebellar-facial-dental syndrome ORPHA:444072,0.1040670578681756
EVI5L,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.1040670578681756
EVI5L,Kufor-Rakeb syndrome ORPHA:306674,0.1040670578681756
EVI5L,LIPE-related familial partial lipodystrophy ORPHA:435660,0.1040670578681756
EVI5L,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.1040670578681756
EVI5L,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.1040670578681756
EVI5L,Steinert myotonic dystrophy ORPHA:273,0.1040670578681756
EVI5L,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.1040670578681756
EVI5L,Smith-Magenis syndrome ORPHA:819,0.1117946631214258
EVI5L,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069,0.1991445465001551
EVI5L,CLN4B disease ORPHA:228343,0.1991445465001551
EVI5L,Charcot-Marie-Tooth disease type 4F ORPHA:99952,0.1991445465001551
EVI5L,Lethal congenital contracture syndrome type 3 ORPHA:137783,0.1991445465001551
EVI5L,Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406,0.1991445465001551
EVI5L,Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620,0.3832844616405875
EVI5L,Perry syndrome ORPHA:178509,0.3832844616405875
EVI5L,Mazabraud syndrome ORPHA:57782,0.5867963421058087
EVI5L,McCune-Albright syndrome ORPHA:562,0.5867963421058087
EVI5L,Monostotic fibrous dysplasia ORPHA:93277,0.5867963421058087
EVI5L,Polyostotic fibrous dysplasia ORPHA:93276,0.5867963421058087
EVI5L,Progressive osseous heteroplasia ORPHA:2762,0.5867963421058087
EVI5L,Pseudohypoparathyroidism type 1A ORPHA:79443,0.5867963421058087
EVI5L,Pseudohypoparathyroidism type 1C ORPHA:79444,0.5867963421058087
EVI5L,Pseudopseudohypoparathyroidism ORPHA:79445,0.5867963421058087
EVI5L,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613,0.7929682744768703
EVI5L,Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817,0.7929682744768703
EVI5L,Neurofibromatosis-Noonan syndrome ORPHA:638,0.7929682744768703
EXOC3L4,Platelet Count measurement,0.7880542567584415
EXOC3L4,Biliary cirrhosis,0.7880542567584415
EXOC3L4,Serum gamma-glutamyl transferase measurement,0.7880542567584415
EXOC3L4,Platelet mean volume determination (procedure),0.7880542567584415
EXOC3L4,Platelet hematocrit measurement,0.7880542567584415
EXOC3L4,Primary biliary cirrhosis,0.8212681436603975
EXOC3L4,HNF1B-related autosomal dominant tubulointerstitial kidney disease ORPHA:93111,0.3832844616405875
EXOC3L4,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119,0.3832844616405875
EXOC3L4,Chromophobe renal cell carcinoma ORPHA:319303,0.3832844616405875
EXOC3L4,Hyperinsulinism due to HNF1A deficiency ORPHA:324575,0.3832844616405875
EXOC3L4,Hyperinsulinism due to HNF4A deficiency ORPHA:263455,0.3832844616405875
EXOC3L4,Phosphoenolpyruvate carboxykinase deficiency ORPHA:2880,0.7929682744768703
EXOC3L4,NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406,0.8105918570729571
EXOC3L4,Hyaluronidase deficiency ORPHA:67041,0.8922466888454011
FAM83F,Malignant neoplasm of breast,0.4084380369379369
FAM83F,Squamous cell carcinoma of esophagus,0.8610447277138289
FAM83F,Prostate Cancer,0.7765582368651238
FAM83F,Breast Cancer,0.8903630091389316
FAM83F,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.1991445465001551
FAM83F,Autosomal recessive cerebral atrophy ORPHA:363969,0.1991445465001551
FAM83F,Congenital intrauterine infection-like syndrome ORPHA:1229,0.1991445465001551
FAM83F,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.1991445465001551
FAM83F,Generalized pseudohypoaldosteronism type 1 ORPHA:171876,0.3832844616405875
FAM83F,Liddle syndrome ORPHA:526,0.3832844616405875
FAM83F,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3832844616405875
FAM83F,Syndromic congenital sodium diarrhea ORPHA:563708,0.3832844616405875
FAM83F,Idiopathic bronchiectasis ORPHA:60033,0.5867963421058087
FAM83F,Mullerian aplasia and hyperandrogenism ORPHA:247768,0.5867963421058087
FAM83F,SERKAL syndrome ORPHA:139466,0.5867963421058087
FAM83F,Congenital bilateral absence of vas deferens ORPHA:48,0.5867963421058087
FAM83F,NON RARE IN EUROPE: Recurrent acute pancreatitis ORPHA:64740,0.5867963421058087
FAM83F,Familial thyroid dyshormonogenesis ORPHA:95716,0.5959529547720634
FAM83F,Epidermolysis bullosa simplex due to exophilin 5 deficiency ORPHA:412189,0.7929682744768703
FAM83F,Glucose-galactose malabsorption ORPHA:35710,0.7929682744768703
FAM83F,Neonatal severe primary hyperparathyroidism ORPHA:417,0.7929682744768703
FAM83F,Genetic transient congenital hypothyroidism ORPHA:226316,0.8922466888454011
FAM83F,Pulmonary alveolar microlithiasis ORPHA:60025,0.8922466888454011
FAM83F,Maternal riboflavin deficiency ORPHA:411712,0.8922466888454011
FAM83F,Osteosclerotic metaphyseal dysplasia ORPHA:500548,0.8922466888454011
FAM83F,Monkeypox virus Zaire-96-I-16 phospholipase-D-like protein (gene: C4L),0.8999095837312036
FAM83F,Monkeypox virus phospholipase-D-like protein,0.8999095837312036
FAM83F,Horsepox virus HSPV038 (phospholipase-D-like protein,0.8999095837312036
FAM83F,Provisional),0.8999095837312036
FAM83F,Vaccinia virus Ankara DNA nicking-joining enzyme,0.8999095837312036
FAM83F,Cowpox virus CPXV044 (gene: CPXV044 CDS),0.8999095837312036
FAM83F,Ectromelia virus ERPV nicking/joining enzyme,0.8999095837312036
FAM83F,Vaccinia virus phospholipase-D-like protein (gene: K4L),0.8999095837312036
FAM83F,Orf virus ORF011 putative EEV envelope phospholipase,0.8999095837312036
FAM83F,Variola virus palmytilated EEV membrane glycoprotein (gene: C17L),0.8999095837312036
FAM83F,Vaccinia virus palmytilated EEV membrane glycoprotein (gene: F13L),0.8999095837312036
FAM83F,Monkeypox virus Zaire-96-I-16 palmytilated EEV membrane glycoprotein (gene: C19L),0.8999095837312036
FAM83F,Cowpox virus CPXV061 protein (gene: CPXV061 CDS),0.8999095837312036
FAM83F,Horsepox virus HSPV053 (palmytilated EEV membrane glycoprotein),0.8999095837312036
FAM83F,Ectromelia virus ERPV EEV phospholipase,0.8999095837312036
FANK1,X-linked hypophosphatemia ORPHA:89936,0.8922466888454011
FANK1,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
FANK1,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
FANK1,Provisional),0.8999095837312036
FANK1,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
FANK1,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
FANK1,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
FANK1,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
FANK1,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
FANK1,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
FANK1,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
FANK1,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
FANK1,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
FANK1,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
FANK1,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
FANK1,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
FANK1,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
FANK1,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
FANK1,Monkeypox virus ser/thr kinase,0.8999095837312036
FANK1,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
FANK1,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
FANK1,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
FANK1,Human rhinovirus A20 2C,0.8999095837312036
FANK1,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
FANK1,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
FANK1,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
FANK1,Human rhinovirus A88 2C (P2-C),0.8999095837312036
FANK1,Human adenovirus 1 fiber,0.8999095837312036
FANK1,Human adenovirus 5 fiber,0.8999095837312036
FANK1,Human rhinovirus QCE 2C,0.8999095837312036
FANK1,Monkeypox virus cowpox A-type inclusion protein,0.8999095837312036
FANK1,Human adenovirus 28 fiber,0.8999095837312036
FANK1,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
FANK1,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
FANK1,Horsepox virus HSPV011a,0.8999095837312036
FANK1,Human adenovirus 22 fiber protein (gene: L5),0.8999095837312036
FANK1,Cowpox virus CPXV213 protein (gene: CPXV213 CDS),0.8999095837312036
FANK1,Cowpox virus CPXV027 protein (gene: CPXV027 CDS),0.8999095837312036
FANK1,Echovirus E19 2C,0.8999095837312036
FANK1,Titi monkey adenovirus ECC-2011 fiber,0.8999095837312036
FANK1,Vaccinia virus hypothetical protein,0.8999095837312036
FANK1,Ectromelia virus ERPV ankyrin and nfkb inhibitor,0.8999095837312036
FANK1,Vaccinia virus Ankara 72.4k ankyrin repeat protein f1,0.8999095837312036
FANK1,Cowpox virus CPXV011 protein (gene: CPXV011 CDS),0.8999095837312036
FANK1,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.8999095837312036
FANK1,Human rhinovirus A89 2C,0.8999095837312036
FANK1,Horsepox virus HSPV022 (ankyrin-like protein,0.8999095837312036
FANK1,Human mastadenovirus E fiber (gene: L5),0.8999095837312036
FANK1,Human adenovirus E4 fiber protein,0.8999095837312036
FANK1,Monkeypox virus ankyrin-like protein,0.8999095837312036
FANK1,Enterovirus C109 2C,0.8999095837312036
FANK1,Human adenovirus Chiba_E086/2012 fiber (gene: L5),0.8999095837312036
FANK1,Horsepox virus HSPV033c (ankyrin repeats),0.8999095837312036
FANK1,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.8999095837312036
FANK1,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
FANK1,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
FANK1,Variola virus hypothetical protein (gene: D6L),0.8999095837312036
FANK1,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
FANK1,Vaccinia virus ankyrin-like protein (gene: C9L),0.8999095837312036
FANK1,Horsepox virus HSPV201a (ankyrin repeats),0.9018002218631122
FANK1,Yaba-like disease virus 147R protein (gene: 147R),0.9057542447893764
FANK1,Cowpox virus CPXV041 protein (gene: CPXV041 CDS),0.9057542447893764
FANK1,Horsepox virus HSPV035 (ankyrin repeats),0.9057542447893764
FANK1,Horsepox virus HSPV004 (ankyrin repeats),0.9057542447893764
FANK1,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: C1L),0.9057542447893764
FANK1,Rhinovirus A P2-C polypeptide,0.9057542447893764
FANK1,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
FANK1,Vaccinia virus ankyrin-like protein (gene: K1L),0.9057542447893764
FANK1,Vaccinia virus Ankara putative monoglyceride lipase f2,0.9057542447893764
FANK1,Horsepox virus HSPV196 (ankyrin-like protein,0.9057542447893764
FANK1,Provisional),0.9057542447893764
FANK1,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
FANK1,Variola virus hypothetical protein (gene: B19R),0.9057542447893764
FANK1,Coxsackievirus A18 2C protein,0.9057542447893764
FANK1,Vaccinia virus Ankara CP77 Host range protein f1,0.9057542447893764
FANK1,Vaccinia virus Ankara Host range protein,0.9057542447893764
FANK1,Human rhinovirus A7 2C,0.9057542447893764
FANK1,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.9057542447893764
FANK1,Variola virus hypothetical protein (gene: B21R),0.9057542447893764
FANK1,Ectromelia virus ERPV ankyrin,0.9057542447893764
FANK1,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
FANK1,Human adenovirus 71 fiber (gene: L5),0.9057542447893764
FANK1,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.9057542447893764
FANK1,Vaccinia virus ankyrin-like protein (gene: B18R),0.9057542447893764
FANK1,Human adenovirus 19 fiber (gene: L5),0.9057542447893764
FANK1,Human adenovirus 58 fiber (gene: L5),0.9057542447893764
FANK1,Human adenovirus D10 fiber (gene: L5),0.9057542447893764
FANK1,Human adenovirus 65 L5 fiber,0.9057542447893764
FANK1,Human mastadenovirus D fiber (gene: L5),0.9057542447893764
FANK1,Human adenovirus 56 fiber protein (gene: L5),0.9057542447893764
FANK1,Human adenovirus 64 L5 fiber protein,0.9057542447893764
FANK1,Human adenovirus D37 fiber (gene: L5),0.9057542447893764
FANK1,Horsepox virus HSPV033b (Ankyrin repeats),0.9057542447893764
FANK1,Human adenovirus D8 fiber (gene: L5),0.9058994261255549
FANK1,Human adenovirus 54 fiber,0.9058994261255549
FANK1,Variola virus hypothetical protein (gene: G3R),0.9058994261255549
FANK1,Orf virus ORF126 ankyrin repeat protein,0.9058994261255549
FANK1,Human mastadenovirus D fiber,0.9065231464138438
FANK1,Human adenovirus 17 fiber,0.9071659214187592
FANK1,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9115856929326512
FANK1,Human adenovirus 63 fiber protein (gene: L5),0.9118403763180049
FANK1,Monkeypox virus Zaire-96-I-16 B17R (gene: B17R),0.915880438522078
FANK1,Horsepox virus HSPV020b (ankyrin repeats),0.915880438522078
FANK1,Human adenovirus 49 fiber,0.915880438522078
FANK1,Vaccinia virus Ankara CP77 host range protein f3,0.915880438522078
FANK1,Human adenovirus 23 fibre protein (gene: L5),0.915880438522078
FANK1,Human adenovirus 67 L5 fiber,0.915880438522078
FANK1,Horsepox virus HSPV005b (ankyrin repeats),0.9176018655958595
FANK1,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.9176018655958595
FANK1,Horsepox virus HSPV005c (Ankyrin repeats),0.9176642913406818
FANK1,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L),0.9224878266317492
FANK1,Cowpox virus CPXV019 protein (gene: CPXV019 CDS),0.9237501457186692
FANK1,Human adenovirus 46 fiber,0.9237501457186692
FANK1,Yaba-like disease virus 8L protein (gene: 8L),0.9237501457186692
FANK1,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
FANK1,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.9237501457186692
FANK1,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.9237501457186692
FANK1,Vaccinia virus Ankara CP77 host range protein f4,0.928070054828895
FANK1,Vaccinia virus Ankara 67.9k ankyrin repeat protein,0.9287050575620676
FANK1,Cowpox virus CPXV008 protein (gene: CPXV008 CDS),0.9287050575620676
FANK1,Horsepox virus HSPV011b (ankyrin repeats),0.9287050575620676
FANK1,Horsepox virus HSPV014b (ankyrin repeats),0.9287050575620676
FANK1,Horsepox virus HSPV014c (ankyrin repeats),0.9287050575620676
FANK1,Vaccinia virus ankyin-like protein (gene: M1L),0.9318782091866168
FANK1,Yaba-like disease virus 146R protein (gene: 146R),0.9364561700418303
FANK1,Vaccinia virus Ankara CP77 host range protein f2,0.9366403811337995
FANK1,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.9383505321091749
FANK1,Variola virus hypothetical protein (gene: B6R),0.9383505321091749
FANK1,Vaccinia virus ankyrin-like protein,0.9386073090182748
FANK1,Orf virus ORF129 ankyrin repeat protein,0.9397923093369096
FANK1,Cowpox virus CPXV017 protein (gene: CPXV017 CDS),0.9397923093369096
FANK1,Variola virus ankyin-like protein (gene: O1L),0.9397923093369096
FANK1,Horsepox virus HSPV194 (ankyrin repeats),0.9397923093369096
FANK1,Cowpox virus CPXV006 protein (gene: CPXV006 CDS),0.9397923093369096
FANK1,Horsepox virus HSPV012 (ankyrin-like protein,0.9397923093369096
FANK1,Provisional),0.9563208507960556
FARP2,Esophageal carcinoma,0.7765852775619541
FARP2,Esophageal Neoplasms,0.7765852775619541
FARP2,Liver carcinoma,0.7880542567584415
FARP2,Malignant neoplasm of esophagus,0.7880542567584415
FARP2,Prostate carcinoma,0.7880542567584415
FARP2,Squamous cell carcinoma of the head and neck,0.7880542567584415
FARP2,Seasonal Affective Disorder,0.7880542567584415
FARP2,Chromosome 2q37 deletion syndrome,0.7880542567584415
FARP2,Hepatitis E,0.7880542567584415
FARP2,Fibrinogen assay,0.7880542567584415
FARP2,Nasopharyngeal Neoplasms,0.7880542567584415
FARP2,Vitiligo,0.8019075543217649
FARP2,Autistic Disorder,0.8019075543217649
FARP2,Chronic Lymphocytic Leukemia,0.8019075543217649
FARP2,Phenylketonurias,0.8145035474981049
FARP2,Leigh Disease,0.8402911822757345
FARP2,Diphtheria,0.8867509400747969
FARP2,Prostate Cancer,0.7765582368651238
FARP2,Lymphocytic Leukemia,0.7765582368651238
FARP2,Vitiligo,0.7765582368651238
FARP2,Nasopharyngeal Carcinoma,0.8115918568696846
FARP2,Autism,0.911896615143974
FARP2,GNE myopathy ORPHA:602,0.3832844616405875
FARP2,Sialuria ORPHA:3166,0.3832844616405875
FARP2,Dent disease type 1 ORPHA:93622,0.5867963421058087
FARP2,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.8999095837312036
FARP2,Dugbe virus L protein,0.8999095837312036
FARP2,Human papillomavirus 94 E2 protein (gene: E2),0.8999095837312036
FARP2,Human papillomavirus 117 E2,0.8999095837312036
FARP2,Human papillomavirus type 90 putative regulatory protein E2 (gene: E2),0.9057542447893764
FBXO44,Malignant neoplasm of prostate,0.7880542567584415
FBXO44,Prostatic Neoplasms,0.7880542567584415
FBXO44,Sclerocystic Ovaries,0.7880542567584415
FBXO44,Polycystic Ovary Syndrome,0.9174808175273056
FBXO44,Prostate Cancer,0.7765582368651238
FBXO44,Prostatic Neoplasms,0.7765582368651238
FBXO44,Sclerocystic Ovaries,0.7765582368651238
FBXO44,Polycystic Ovary Syndrome,0.7765582368651238
FBXO44,Amelocerebrohypohidrotic syndrome ORPHA:1946,0.8922466888454011
FCHSD1,Nodular fasciitis ORPHA:477742,0.5867963421058087
FCHSD1,COFS syndrome ORPHA:1466,0.8922466888454011
FCHSD1,Human T-lymphotropic virus 3 envelope (gene: env),0.8999095837312036
FCHSD1,Human T-cell lymphotropic virus type 2b env,0.8999095837312036
FCHSD1,Human T-lymphotropic virus 4 envelope glycoprotein (gene: env),0.8999095837312036
FCHSD1,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
FCHSD1,Human T-lymphotropic virus 2 hypothetical protein (env propeptide),0.8999095837312036
FCHSD1,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
FCHSD1,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.8999095837312036
FCHSD1,Lake Victoria marburgvirus - DRC1999 glycoprotein (gene: GP),0.8999095837312036
FCHSD1,Ravn virus - Ravn Kenya 1987 glycoprotein (gene: GP),0.8999095837312036
FCHSD1,Marburg marburgvirus glycoprotein (gene: GP),0.8999095837312036
FGD3,Malignant neoplasm of breast,0.4084380369379369
FGD3,Breast Carcinoma,0.7333611688795861
FGD3,Thyroid carcinoma,0.7880542567584415
FGD3,Skeletal dysplasia,0.8815127642200768
FGD3,Osteochondrodysplasias,0.9117936912777788
FGD3,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
FGD3,Gamma-glutamyl transpeptidase deficiency ORPHA:33573,0.1991445465001551
FGD3,Coats plus syndrome ORPHA:313838,0.1991445465001551
FGD3,Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566,0.3832844616405875
FGD3,Congenital non-communicating hydrocephalus ORPHA:269510,0.3832844616405875
FGD3,Fructose-16-bisphosphatase deficiency ORPHA:348,0.3832844616405875
FGD3,Grange syndrome ORPHA:79094,0.3832844616405875
FGD3,Gray platelet syndrome ORPHA:721,0.3832844616405875
FGD3,Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606,0.3832844616405875
FGD3,Osteogenesis imperfecta type 5 ORPHA:216828,0.3832844616405875
FGD3,Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003,0.3832844616405875
FGD3,Spinocerebellar ataxia type 40 ORPHA:423275,0.3832844616405875
FGD3,Epidermodysplasia verruciformis ORPHA:302,0.3891940933600213
FGD3,WHIM syndrome ORPHA:51636,0.5867963421058087
FGD3,Familial hemophagocytic lymphohistiocytosis ORPHA:540,0.5959529547720634
FGD3,Aland Islands eye disease ORPHA:178333,0.7929682744768703
FGD3,Hyperinsulinism due to UCP2 deficiency ORPHA:276556,0.7929682744768703
FGD3,Odonto-onycho-dermal dysplasia ORPHA:2721,0.7929682744768703
FGD3,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.7929682744768703
FGD3,Serrated polyposis syndrome ORPHA:157798,0.7929682744768703
FGD3,X-linked severe congenital neutropenia ORPHA:86788,0.7929682744768703
FGD3,X-linked thrombocytopenia with normal platelets ORPHA:852,0.7929682744768703
FGD3,Acute basophilic leukemia ORPHA:86849,0.7929682744768703
FGD3,Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305,0.7929682744768703
FGD3,Nephrogenic diabetes insipidus ORPHA:223,0.7929682744768703
FGD3,Blau syndrome ORPHA:90340,0.8922466888454011
FGD3,Combined immunodeficiency due to DOCK8 deficiency ORPHA:217390,0.8922466888454011
FGD3,X-linked Charcot-Marie-Tooth disease type 6 ORPHA:352675,0.8922466888454011
FGD3,NON RARE IN EUROPE: Ulcerative colitis ORPHA:771,0.8922466888454011
FGD3,NON RARE IN EUROPE: Multiple sclerosis ORPHA:802,0.8922466888454011
FGD3,Female infertility due to oocyte meiotic arrest ORPHA:488191,0.8922466888454011
FGFBP1,Malignant neoplasm of breast,0.4084380369379369
FGFBP1,Breast Carcinoma,0.7333611688795861
FGFBP1,Carcinogenesis,0.7333611688795861
FGFBP1,Colorectal Carcinoma,0.7765852775619541
FGFBP1,Pancreatic intraepithelial neoplasia,0.7765852775619541
FGFBP1,Invasive carcinoma of breast,0.7880542567584415
FGFBP1,Colorectal Cancer,0.7880542567584415
FGFBP1,Adenocarcinoma of pancreas,0.7880542567584415
FGFBP1,Invasive Carcinoma,0.7880542567584415
FGFBP1,Squamous cell carcinoma,0.7880542567584415
FGFBP1,Adenomatous polyp of colon,0.8019075543217649
FGFBP1,Kidney Diseases,0.8019075543217649
FGFBP1,Precancerous Conditions,0.8026504676141903
FGFBP1,Hypertensive disease,0.8474481237156937
FGFBP1,Van der Woude syndrome ORPHA:888,0.1991445465001551
FGFBP1,EEM syndrome ORPHA:1897,0.1991445465001551
FGFBP1,Hypotrichosis with juvenile macular degeneration ORPHA:1573,0.1991445465001551
FGFBP1,Gelatinous drop-like corneal dystrophy ORPHA:98957,0.3832844616405875
FGFBP1,Bifid uvula ORPHA:99771,0.3832844616405875
FGFBP1,Cleft hard palate ORPHA:101023,0.3832844616405875
FGFBP1,Cleft velum ORPHA:99772,0.3832844616405875
FGFBP1,Submucosal cleft palate ORPHA:155878,0.3832844616405875
FGFBP1,Cleft lip and alveolus ORPHA:141291,0.3891940933600213
FGFBP1,Isolated cleft lip ORPHA:199302,0.3891940933600213
FGFBP1,Localized junctional epidermolysis bullosa ORPHA:251393,0.5867963421058087
FGFBP1,Bartsocas-Papas syndrome ORPHA:1234,0.5867963421058087
FGFBP1,CHAND syndrome ORPHA:1401,0.5867963421058087
FGFBP1,Neuropathy with hearing impairment ORPHA:139512,0.5867963421058087
FGFBP1,Sebocystomatosis ORPHA:841,0.5867963421058087
FGFBP1,Hypocalcified amelogenesis imperfecta ORPHA:100032,0.5959529547720634
FGFBP1,Intermediate generalized junctional epidermolysis bullosa ORPHA:79402,0.7929682744768703
FGFBP1,Pachyonychia congenita ORPHA:2309,0.7929682744768703
FGFBP1,Self-improving collodion baby ORPHA:281122,0.7929682744768703
FGFBP1,Acral self-healing collodion baby ORPHA:281127,0.7929682744768703
FGFBP1,Bathing suit ichthyosis ORPHA:100976,0.7929682744768703
FGFBP1,Epithelial recurrent erosion dystrophy ORPHA:293381,0.7929682744768703
FGFBP1,Harlequin ichthyosis ORPHA:457,0.7929682744768703
FGFBP1,Hereditary hypotrichosis with recurrent skin vesicles ORPHA:217407,0.7929682744768703
FGFBP1,Keratoderma hereditarium mutilans ORPHA:494,0.7929682744768703
FGFBP1,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698,0.7929682744768703
FGFBP1,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.7929682744768703
FGFBP1,Metaphyseal chondrodysplasia Spahr type ORPHA:2501,0.7929682744768703
FGFBP1,Netherton syndrome ORPHA:634,0.7929682744768703
FGFBP1,Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286,0.7929682744768703
FGFBP1,Spondyloepimetaphyseal dysplasia Missouri type ORPHA:93356,0.7929682744768703
FGFBP1,Xanthinuria type I ORPHA:93601,0.7929682744768703
FGFBP1,Bladder exstrophy ORPHA:93930,0.7929682744768703
FGFBP1,Junctional epidermolysis bullosa with pyloric atresia ORPHA:79403,0.7929682744768703
FGFBP1,Palmoplantar keratoderma-deafness syndrome ORPHA:2202,0.7929682744768703
FGFBP1,Uncombable hair syndrome ORPHA:1410,0.7929682744768703
FGFBP1,Erythrokeratodermia variabilis ORPHA:317,0.7929682744768703
FGFBP1,Idiopathic juvenile osteoporosis ORPHA:85193,0.7929682744768703
FGFBP1,Hypoplastic amelogenesis imperfecta ORPHA:100031,0.8105918570729571
FGFBP1,Autosomal dominant generalized epidermolysis bullosa simplex intermediate form ORPHA:79399,0.8922466888454011
FGFBP1,Autosomal dominant generalized epidermolysis bullosa simplex severe form ORPHA:79396,0.8922466888454011
FGFBP1,Epidermolysis bullosa simplex with mottled pigmentation ORPHA:79397,0.8922466888454011
FGFBP1,KID syndrome ORPHA:477,0.8922466888454011
FGFBP1,Localized epidermolysis bullosa simplex ORPHA:79400,0.8922466888454011
FGFBP1,Severe generalized junctional epidermolysis bullosa ORPHA:79404,0.8922466888454011
FGFBP1,AA amyloidosis ORPHA:85445,0.8922466888454011
FGFBP1,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering ORPHA:402003,0.8922466888454011
FGFBP1,Autosomal recessive generalized epidermolysis bullosa simplex ORPHA:89838,0.8922466888454011
FGFBP1,Bamforth-Lazarus syndrome ORPHA:1226,0.8922466888454011
FGFBP1,Dermatopathia pigmentosa reticularis ORPHA:86920,0.8922466888454011
FGFBP1,Ectodermal dysplasia-skin fragility syndrome ORPHA:158668,0.8922466888454011
FGFBP1,Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681,0.8922466888454011
FGFBP1,Epidermolytic palmoplantar keratoderma ORPHA:2199,0.8922466888454011
FGFBP1,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement ORPHA:31043,0.8922466888454011
FGFBP1,Laryngo-onycho-cutaneous syndrome ORPHA:2407,0.8922466888454011
FGFBP1,Monilethrix ORPHA:573,0.8922466888454011
FGFBP1,Naegeli-Franceschetti-Jadassohn syndrome ORPHA:69087,0.8922466888454011
FGFBP1,Palmoplantar keratoderma Nagashima type ORPHA:140966,0.8922466888454011
FGFBP1,Peeling skin syndrome type B ORPHA:263553,0.8922466888454011
FGFBP1,Acrodermatitis continua of Hallopeau ORPHA:163931,0.8922466888454011
FGFBP1,Autosomal recessive infantile hypercalcemia ORPHA:300547,0.8922466888454011
FGFBP1,Generalized pustular psoriasis ORPHA:247353,0.8922466888454011
FGFBP1,Hypotrichosis simplex of the scalp ORPHA:90368,0.8922466888454011
FGFBP1,Isolated focal non-epidermolytic palmoplantar keratoderma ORPHA:448264,0.8922466888454011
FGFBP1,Meesmann corneal dystrophy ORPHA:98954,0.8922466888454011
FGFBP1,Pure hair and nail ectodermal dysplasia ORPHA:69084,0.8922466888454011
FGFBP1,Pustulosis palmaris et plantaris ORPHA:163927,0.8922466888454011
FGFBP1,Athyreosis ORPHA:95713,0.8922466888454011
FGFBP1,Congenital non-bullous ichthyosiform erythroderma ORPHA:79394,0.8922466888454011
FGFBP1,White sponge nevus ORPHA:171723,0.8922466888454011
FGFBP1,ADULT syndrome ORPHA:978,0.8922466888454011
FGFBP1,Ankyloblepharon-ectodermal defects-cleft lip/palate syndrome ORPHA:1071,0.8922466888454011
FGFBP1,EEC syndrome ORPHA:1896,0.8922466888454011
FGFBP1,Kindler epidermolysis bullosa ORPHA:2908,0.8922466888454011
FGFBP1,Limb-mammary syndrome ORPHA:69085,0.8922466888454011
FGFBP1,Partial corpus callosum agenesis-cerebellar vermis hypoplasia with posterior fossa cysts syndrome ORPHA:401959,0.8922466888454011
FGFBP1,Severe combined immunodeficiency due to FOXN1 deficiency ORPHA:169095,0.8922466888454011
FRY,Malignant neoplasm of breast,0.4084380369379369
FRY,Breast Carcinoma,0.7333611688795861
FRY,Carcinogenesis,0.7333611688795861
FRY,Ovarian Carcinoma,0.7333611688795861
FRY,Colorectal Cancer,0.7880542567584415
FRY,Epithelial ovarian cancer,0.7880542567584415
FRY,Prostate carcinoma,0.7880542567584415
FRY,Carcinoma of lung,0.7880542567584415
FRY,Mental Retardation Psychosocial,0.7880542567584415
FRY,Liver Cirrhosis Experimental,0.8014900279306119
FRY,Profound Mental Retardation,0.8019075543217649
FRY,Narcolepsy,0.8067197998685076
FRY,Adenocarcinoma of lung (disorder),0.8098851543361193
FRY,Systolic Pressure,0.8098851543361193
FRY,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
FRY,Endometrioid carcinoma ovary,0.8402911822757345
FRY,Ovarian Serous Adenocarcinoma,0.8402911822757345
FRY,Mental deficiency,0.8402911822757345
FRY,Calcification of coronary artery,0.9377696084218796
FRY,Intellectual Disability,0.9478210444156088
FRY,Squamous cell carcinoma of lung,0.9564633032157428
FRY,Ovarian Neoplasm,0.7765582368651238
FRY,Ovarian Endometrioid Carcinoma,0.7765582368651238
FRY,Prostate Cancer,0.7765582368651238
FRY,Ovarian Serous Adenocarcinoma,0.7765582368651238
FRY,Lung Carcinoma,0.8139950454942313
FRY,Colonic Neoplasms,0.8210988731657684
FRY,Narcolepsy,0.8260230451542778
FRY,Mental Retardation,0.8337953215113012
FRY,Lung Cancer,0.8706864397989688
FRY,Diabetes Mellitus,0.919442421650838
FRY,Lung Adenocarcinoma,0.9350723667380212
FRY,Breast Carcinoma,0.9398381935810408
FRY,Colorectal Neoplasms,0.9510372690456612
FRY,Colorectal Cancer,0.9832345076528324
FRY,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
FRY,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.1040670578681756
FRY,Distal monosomy 1q ORPHA:36367,0.1040670578681756
FRY,2q37 microdeletion syndrome ORPHA:1001,0.1991445465001551
FRY,SHORT syndrome ORPHA:3163,0.3832844616405875
FRY,Autosomal recessive ataxia Beauce type ORPHA:88644,0.5867963421058087
FRY,Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332,0.5867963421058087
FRY,Charcot-Marie-Tooth disease type 4H ORPHA:99954,0.5867963421058087
FRY,Diencephalic-mesencephalic junction dysplasia ORPHA:319192,0.5867963421058087
FRY,Pseudohypoaldosteronism type 2D ORPHA:300525,0.5867963421058087
FRY,Tangier disease ORPHA:31150,0.5867963421058087
FRY,Spinocerebellar ataxia type 1 ORPHA:98755,0.7929682744768703
FRY,Angelman syndrome due to imprinting defect in 15q11-q13 ORPHA:411515,0.7929682744768703
FRY,Antenatal Bartter syndrome ORPHA:93604,0.7929682744768703
FRY,Familial short QT syndrome ORPHA:51083,0.795266832401002
FRY,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome ORPHA:496689,0.8922466888454011
FRY,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome ORPHA:496686,0.8922466888454011
FRY,Malonic aciduria ORPHA:943,0.8922466888454011
FRY,Multifocal pattern dystrophy simulating fundus flavimaculatus ORPHA:99003,0.8922466888454011
FRY,Adult-onset foveomacular vitelliform dystrophy ORPHA:99000,0.8922466888454011
FRY,Fundus albipunctatus ORPHA:227796,0.8922466888454011
FRY,Acute myeloid leukemia with t(8,0.8922466888454011
FSTL3,Malignant neoplasm of breast,0.4084380369379369
FSTL3,Breast Carcinoma,0.7333611688795861
FSTL3,Mammary Neoplasms,0.7880542567584415
FSTL3,Invasive carcinoma of breast,0.7880542567584415
FSTL3,Eclampsia,0.7880542567584415
FSTL3,Rheumatism,0.7880542567584415
FSTL3,Diminished ovarian reserve,0.7880542567584415
FSTL3,Liver neoplasms,0.8019075543217649
FSTL3,Steatohepatitis,0.8402911822757345
FSTL3,Fatty Liver,0.8628363180844141
FSTL3,Heart failure,0.8867509400747969
FSTL3,Congestive heart failure,0.8976039441125321
FSTL3,Obesity,0.8989612563669234
FSTL3,Cardiac fibrosis,0.929814249105729
FSTL3,Renal Insufficiency,0.946564927793026
FSTL3,Crisponi syndrome ORPHA:1545,0.0155394890951578
FSTL3,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
FSTL3,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.1040670578681756
FSTL3,Cold-induced sweating syndrome ORPHA:157820,0.1068643725150898
FSTL3,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.1991445465001551
FSTL3,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.1991445465001551
FSTL3,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.1991445465001551
FSTL3,Familial cortical myoclonus ORPHA:319189,0.1991445465001551
FSTL3,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900,0.1991445465001551
FSTL3,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.1991445465001551
FSTL3,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.1991445465001551
FSTL3,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.1991445465001551
FSTL3,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.1991445465001551
FSTL3,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.1991445465001551
FSTL3,Early-onset posterior polar cataract ORPHA:98993,0.2475924359068358
FSTL3,Giant cell glioblastoma ORPHA:251579,0.2844858212863536
FSTL3,Gliosarcoma ORPHA:251576,0.2844858212863536
FSTL3,Atypical Werner syndrome ORPHA:79474,0.3832844616405875
FSTL3,Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855,0.3832844616405875
FSTL3,Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365,0.3832844616405875
FSTL3,Charcot-Marie-Tooth disease type 2B1 ORPHA:98856,0.3832844616405875
FSTL3,Congenital insensitivity to pain with severe intellectual disability ORPHA:453510,0.3832844616405875
FSTL3,Congenital muscular dystrophy due to LMNA mutation ORPHA:157973,0.3832844616405875
FSTL3,Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284,0.3832844616405875
FSTL3,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229,0.3832844616405875
FSTL3,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751,0.3832844616405875
FSTL3,Familial partial lipodystrophy Dunnigan type ORPHA:2348,0.3832844616405875
FSTL3,Familial partial lipodystrophy Kobberling type ORPHA:79084,0.3832844616405875
FSTL3,Heart-hand syndrome Slovenian type ORPHA:168796,0.3832844616405875
FSTL3,LMNA-related cardiocutaneous progeria syndrome ORPHA:363618,0.3832844616405875
FSTL3,Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153,0.3832844616405875
FSTL3,Cap myopathy ORPHA:171881,0.3832844616405875
FSTL3,Congenital short bowel syndrome ORPHA:2301,0.3832844616405875
FSTL3,Thyroid ectopia ORPHA:95712,0.3832844616405875
FSTL3,Autosomal dominant omodysplasia ORPHA:93328,0.5867963421058087
FSTL3,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476,0.5867963421058087
FSTL3,Hereditary combined deficiency of vitamin K-dependent clotting factors ORPHA:98434,0.5867963421058087
FSTL3,Congenital generalized lipodystrophy ORPHA:528,0.8105918570729571
FXR2,Autistic Disorder,0.8019075543217649
FXR2,Fragile X Syndrome,0.8402911822757345
FXR2,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
FXR2,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
FXR2,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
FXR2,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.1040670578681756
FXR2,Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717,0.1991445465001551
FXR2,Early-onset posterior polar cataract ORPHA:98993,0.2475924359068358
FXR2,Perry syndrome ORPHA:178509,0.3832844616405875
FXR2,POMGNT1-related  limb-girdle muscular dystrophy R15 ORPHA:206564,0.7929682744768703
FXR2,Congenital muscular dystrophy without intellectual disability ORPHA:370980,0.795266832401002
FXR2,Autosomal dominant Charcot-Marie-Tooth disease type 2A2 ORPHA:99947,0.8922466888454011
FXR2,Hereditary motor and sensory neuropathy type 5 ORPHA:64751,0.8922466888454011
FXR2,Multiple symmetric lipomatosis ORPHA:2398,0.8922466888454011
FXR2,Severe early-onset axonal neuropathy due to MFN2 deficiency ORPHA:90118,0.8922466888454011
FXR2,Congenital muscular dystrophy with cerebellar involvement ORPHA:370959,0.8922466888454011
FXR2,Human papillomavirus 94 E2 protein (gene: E2),0.8999095837312036
FXR2,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) hemagglutinin (gene: HA),0.8999095837312036
FXR2,Human papillomavirus type 27 early protein (gene: E2),0.8999095837312036
FXR2,Human papillomavirus type 6 E5B (gene: E5B),0.8999095837312036
FXR2,Human papillomavirus type 163 E7 (gene: E7),0.8999095837312036
FXR2,Human papillomavirus type 69 E2,0.8999095837312036
GALNT6,Malignant neoplasm of breast,0.4084380369379369
GALNT6,Breast Carcinoma,0.7333611688795861
GALNT6,Carcinogenesis,0.7333611688795861
GALNT6,Malignant neoplasm of ovary,0.7333611688795861
GALNT6,Ovarian Carcinoma,0.7333611688795861
GALNT6,Colorectal Carcinoma,0.7765852775619541
GALNT6,Mammary Neoplasms,0.7880542567584415
GALNT6,Epithelial ovarian cancer,0.7880542567584415
GAS2L1,Leukemia Myelocytic Acute,0.7765852775619541
GAS2L1,Acute Myeloid Leukemia M1,0.7880542567584415
GAS2L1,Acute Myeloid Leukemia (AML-M2),0.7880542567584415
GAS2L1,Schizophrenia,0.8067197998685076
GAS2L1,Leukemia,0.7765582368651238
GAS2L1,Myeloid Leukemia,0.8356859041719433
GAS2L1,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
GAS2L1,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
GAS2L1,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
GAS2L1,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
GAS2L1,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.1040670578681756
GAS2L1,CLN10 disease ORPHA:228337,0.1991445465001551
GAS2L1,Classic Hodgkin lymphoma nodular sclerosis type ORPHA:98843,0.1991445465001551
GAS2L1,Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851,0.1991445465001551
GAS2L1,19p13.3 microduplication syndrome ORPHA:447980,0.3832844616405875
GAS2L1,ACys amyloidosis ORPHA:100008,0.3832844616405875
GAS2L1,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E ORPHA:93114,0.3832844616405875
GAS2L1,Malan overgrowth syndrome ORPHA:420179,0.3832844616405875
GAS2L1,Marshall-Smith syndrome ORPHA:561,0.3832844616405875
GAS2L1,5-oxoprolinase deficiency ORPHA:33572,0.5867963421058087
GAS2L1,Microduplication Xp11.22p11.23 syndrome ORPHA:217377,0.5867963421058087
GAS2L1,Severe intellectual disability-progressive postnatal microcephaly-midline stereotypic hand movements syndrome ORPHA:397933,0.5867963421058087
GAS2L1,Paroxysmal non-kinesigenic dyskinesia ORPHA:98810,0.5867963421058087
GAS2L1,Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.606625035400596
GAS2L1,Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817,0.7929682744768703
GAS2L1,Lethal osteosclerotic bone dysplasia ORPHA:1832,0.7929682744768703
GAS2L1,Deafness-lymphedema-leukemia syndrome ORPHA:3226,0.8922466888454011
GAS2L1,Monocytopenia with susceptibility to infections ORPHA:228423,0.8922466888454011
GAS2L1,Microcephaly-corpus callosum and cerebellar vermis hypoplasia-facial dysmorphism-intellectual disability syndrom ORPHA:500159,0.8922466888454011
GCNT3,Malignant neoplasm of pancreas,0.7688485284765829
GCNT3,Colorectal Carcinoma,0.7765852775619541
GCNT3,Pancreatic carcinoma,0.7765852775619541
GCNT3,Colon Carcinoma,0.7765852775619541
GCNT3,Malignant tumor of colon,0.7765852775619541
GCNT3,Colorectal Neoplasms,0.7765852775619541
GCNT3,Liver carcinoma,0.7880542567584415
GCNT3,Colorectal Cancer,0.7880542567584415
GCNT3,Neoplasm Metastasis,0.7880542567584415
GCNT3,Colonic Neoplasms,0.8212681436603975
GCNT3,Autosomal recessive cerebral atrophy ORPHA:363969,0.1991445465001551
GCNT3,Familial expansile osteolysis ORPHA:85195,0.1991445465001551
GCNT3,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1991445465001551
GCNT3,HNF1B-related autosomal dominant tubulointerstitial kidney disease ORPHA:93111,0.3832844616405875
GCNT3,Chromophobe renal cell carcinoma ORPHA:319303,0.3832844616405875
GCNT3,Hyperinsulinism due to HNF1A deficiency ORPHA:324575,0.3832844616405875
GCNT3,Hyperinsulinism due to HNF4A deficiency ORPHA:263455,0.3832844616405875
GCNT3,Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528,0.5867963421058087
GCNT3,Bilateral multicystic dysplastic kidney ORPHA:97364,0.5867963421058087
GCNT3,Medullary sponge kidney ORPHA:1309,0.5867963421058087
GCNT3,Renal dysplasia bilateral ORPHA:93173,0.5867963421058087
GCNT3,Renal dysplasia unilateral ORPHA:93172,0.5867963421058087
GCNT3,Unilateral multicystic dysplastic kidney ORPHA:97363,0.5867963421058087
GCNT3,Congenital bilateral absence of vas deferens ORPHA:48,0.5867963421058087
GCNT3,NON RARE IN EUROPE: Recurrent acute pancreatitis ORPHA:64740,0.5867963421058087
GCNT3,Familial thyroid dyshormonogenesis ORPHA:95716,0.5959529547720634
GCNT3,Hypoplastic amelogenesis imperfecta ORPHA:100031,0.8105918570729571
GCNT3,Autism spectrum disorder-epilepsy-arthrogryposis syndrome ORPHA:370943,0.8922466888454011
GCNT3,Genetic transient congenital hypothyroidism ORPHA:226316,0.8922466888454011
GCNT3,Cystinuria type A ORPHA:93612,0.8922466888454011
GCNT3,Hereditary chronic pancreatitis ORPHA:676,0.8922466888454011
GCNT3,Tropical pancreatitis ORPHA:103918,0.8922466888454011
GCNT3,Iminoglycinuria ORPHA:42062,0.8922466888454011
GDF11,Colorectal Carcinoma,0.7765852775619541
GDF11,Congenital exomphalos,0.7765852775619541
GDF11,Colorectal Neoplasms,0.7765852775619541
GDF11,Congenital omphalocele,0.7880542567584415
GDF11,Colorectal Cancer,0.7880542567584415
GDF11,Triple Negative Breast Neoplasms,0.7880542567584415
GDF11,Neoplasms,0.7880542567584415
GDF11,Alzheimer's Disease,0.7880542567584415
GDF11,Currarino triad,0.7880542567584415
GDF11,Agenesis,0.8402911822757345
GDF11,Secondary malignant neoplasm of lymph node,0.900167961295542
GDF11,DOORS syndrome ORPHA:79500,0.5867963421058087
GDF11,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587,0.5867963421058087
GDF11,Progressive myoclonic epilepsy with dystonia ORPHA:352596,0.5867963421058087
GDF11,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727,0.5867963421058087
GDF15,Malignant neoplasm of breast,0.4084380369379369
GDF15,Carcinoma of bladder,0.4084380369379369
GDF15,Bladder Neoplasm,0.4084380369379369
GDF15,Malignant neoplasm of urinary bladder,0.5071083164302358
GDF15,Breast Carcinoma,0.7333611688795861
GDF15,Carcinogenesis,0.7333611688795861
GDF15,Malignant neoplasm of ovary,0.7333611688795861
GDF15,Ovarian Carcinoma,0.7333611688795861
GDF15,Malignant neoplasm of pancreas,0.7688485284765829
GDF15,Mitochondrial Respiratory Chain Deficiencies,0.7765852775619541
GDF15,Colorectal Carcinoma,0.7765852775619541
GDF15,Pancreatic carcinoma,0.7765852775619541
GDF15,Colon Carcinoma,0.7765852775619541
GDF15,Sideroblastic anemia,0.7765852775619541
GDF15,Metaplasia,0.7765852775619541
GDF15,Malignant tumor of colon,0.7765852775619541
GDF15,Cervix carcinoma,0.7765852775619541
GDF15,Non-Small Cell Lung Carcinoma,0.7765852775619541
GDF15,Refractory anemia without ringed sideroblasts without excess blasts,0.7765852775619541
GDF15,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
GDF15,Colorectal Neoplasms,0.7765852775619541
GDF15,Pancreatic Neoplasm,0.7765852775619541
GDF15,Adenoma,0.7765852775619541
GDF15,Intestinal Cancer,0.7765852775619541
GDF15,Thyroid Neoplasm,0.7765852775619541
GDF15,Malignant tumor of cervix,0.7768809924982332
GDF15,Mammary Neoplasms,0.7880542567584415
GDF15,Glioma,0.7880542567584415
GDF15,Malignant neoplasm of lung,0.7880542567584415
GDF15,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
GDF15,Malignant neoplasm of prostate,0.7880542567584415
GDF15,Refractory anemias,0.7880542567584415
GDF15,Biliary Tract Neoplasm,0.7880542567584415
GDF15,Pulmonary Thromboembolisms,0.7880542567584415
GDF15,Liver carcinoma,0.7880542567584415
GDF15,Malignant Head and Neck Neoplasm,0.7880542567584415
GDF15,Mycoses,0.7880542567584415
GDF15,Thyroid carcinoma,0.7880542567584415
GDF15,Ataxia Telangiectasia,0.7880542567584415
GDF15,Colorectal Cancer,0.7880542567584415
GDF15,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
GDF15,Glioblastoma,0.7880542567584415
GDF15,Prostate carcinoma,0.7880542567584415
GDF15,Primary malignant neoplasm of lung,0.7880542567584415
GDF15,cervical cancer,0.7880542567584415
GDF15,Neoplasm Metastasis,0.7880542567584415
GDF15,Prostatic Neoplasms,0.7880542567584415
GDF15,Carcinoma of lung,0.7880542567584415
GDF15,Malignant neoplasm of thyroid,0.7880542567584415
GDF15,Squamous cell carcinoma of the head and neck,0.7880542567584415
GDF15,Malignant neoplasm of liver,0.7880542567584415
GDF15,Van der Woude syndrome,0.7880542567584415
GDF15,melanoma,0.7880542567584415
GDF15,Intestinal Neoplasms,0.7880542567584415
GDF15,Multiple Myeloma,0.7880542567584415
GDF15,Lung Neoplasms,0.7880542567584415
GDF15,Pregnancy in Diabetics,0.7880542567584415
GDF15,Metastatic Prostate Carcinoma,0.7880542567584415
GDF15,Malignant neoplasm of stomach,0.7880542567584415
GDF15,Viral hepatitis,0.7880542567584415
GDF15,Skin Pigmentation Disorder,0.7880542567584415
GDF15,Benign Prostatic Hyperplasia,0.7880542567584415
GDF15,Well Differentiated Oligodendroglioma,0.7880542567584415
GDF15,Brain Neoplasms,0.7880542567584415
GDF15,oligodendroglioma,0.7880542567584415
GDF15,Dementia,0.7880542567584415
GDF15,Stromal Neoplasm,0.7880542567584415
GDF15,Tumor Progression,0.7880542567584415
GDF15,Low Grade Prostatic Intraepithelial Neoplasia,0.7880542567584415
GDF15,Prostatic Diseases,0.7880542567584415
GDF15,Prostatic Adenoma,0.7880542567584415
GDF15,Coronary Arteriosclerosis,0.7880542567584415
GDF15,Presenile dementia,0.7880542567584415
GDF15,Arteriosclerosis,0.7880542567584415
GDF15,Atherosclerosis,0.7880542567584415
GDF15,Alzheimer's Disease,0.7880542567584415
GDF15,Intestinal Polyps,0.7880542567584415
GDF15,Pulmonary Embolism,0.7880542567584415
GDF15,Stomach Carcinoma,0.7880542567584415
GDF15,Anorexia,0.7880542567584415
GDF15,Hepatitis C,0.7880542567584415
GDF15,Acute myocardial infarction,0.7880542567584415
GDF15,Cardiovascular Diseases,0.7880542567584415
GDF15,Squamous cell carcinoma,0.7880542567584415
GDF15,Polycythemia Vera,0.7880542567584415
GDF15,Mitochondrial Myopathies,0.7880542567584415
GDF15,Rheumatoid Arthritis,0.7880542567584415
GDF15,Diabetes,0.7880542567584415
GDF15,Diabetes Mellitus,0.7880542567584415
GDF15,Huntington Disease,0.7880542567584415
GDF15,Anaplastic thyroid carcinoma,0.7880542567584415
GDF15,Hormone refractory prostate cancer,0.7880542567584415
GDF15,Follicular adenoma,0.7880542567584415
GDF15,Metastatic Neoplasm,0.7880542567584415
GDF15,Central nervous system lesion,0.7880542567584415
GDF15,Mouth Diseases,0.7880542567584415
GDF15,Virus Diseases,0.7880542567584415
GDF15,Malignant Glioma,0.7880542567584415
GDF15,Metastasis from malignant tumor of prostate,0.7908231553833205
GDF15,Refractory anemia with ringed sideroblasts,0.7908231553833205
GDF15,Metastatic melanoma,0.7940665326856218
GDF15,Chronic myeloproliferative disorder,0.7945683314244791
GDF15,Thrombocythemia Essential,0.8009048756462318
GDF15,Bile duct proliferation,0.8019075543217649
GDF15,Vitiligo,0.8019075543217649
GDF15,Pneumonitis,0.8019075543217649
GDF15,Myocardial Infarction,0.8019075543217649
GDF15,Degenerative polyarthritis,0.8019075543217649
GDF15,Liver neoplasms,0.8019075543217649
GDF15,Precancerous Conditions,0.8026504676141903
GDF15,Acute Coronary Syndrome,0.8037546774788534
GDF15,Stomach Neoplasms,0.8044379824544406
GDF15,Adenomatous Polyps,0.8067197998685076
GDF15,ovarian neoplasm,0.8067197998685076
GDF15,Adenocarcinoma of lung (disorder),0.8098851543361193
GDF15,Gastrointestinal Neoplasms,0.8145035474981049
GDF15,Superficial ulcer,0.8168901801930506
GDF15,Impaired cognition,0.8190761496232595
GDF15,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
GDF15,Liver Cirrhosis,0.8232134984476662
GDF15,Hemochromatosis,0.8232134984476662
GDF15,Iron Overload,0.8272008757995397
GDF15,Pneumonia,0.834094492023826
GDF15,Recurrent tumor,0.8368219249856942
GDF15,Pregnancy Complications,0.8402911822757345
GDF15,Systemic Scleroderma,0.8402911822757345
GDF15,Idiopathic pulmonary hypertension,0.8402911822757345
GDF15,Mild cognitive disorder,0.8402911822757345
GDF15,Left Ventricular Hypertrophy,0.8402911822757345
GDF15,Cachexia,0.8402911822757345
GDF15,Endothelial dysfunction,0.8402911822757345
GDF15,Parkinsonian Disorders,0.8486035047899471
GDF15,Cirrhosis,0.8554819098734854
GDF15,Anemia,0.8584283190330553
GDF15,Weight Gain,0.8584283190330553
GDF15,Follicular thyroid carcinoma,0.8584283190330553
GDF15,Cerebrovascular accident,0.8648405521677974
GDF15,Myocardial Ischemia,0.8648405521677974
GDF15,Atrial Fibrillation,0.8648405521677974
GDF15,Chronic Obstructive Airway Disease,0.8648405521677974
GDF15,Premature Birth,0.8648405521677974
GDF15,Adenocarcinoma Of Esophagus,0.8769418330148872
GDF15,Parkinson Disease,0.8772392350816924
GDF15,Adult Liver Carcinoma,0.8806784681730055
GDF15,Lewy Body Disease,0.8851456306720444
GDF15,Heart failure,0.8867509400747969
GDF15,Coronary Artery Disease,0.887595340546704
GDF15,Pulmonary Fibrosis,0.8911256045597441
GDF15,Congestive heart failure,0.8976039441125321
GDF15,Barrett Esophagus,0.8980854850210683
GDF15,Obesity,0.8989612563669234
GDF15,Mitochondrial Diseases,0.8989612563669234
GDF15,High-Grade Prostatic Intraepithelial Neoplasia,0.9024758035783405
GDF15,Thalassemia,0.9117936912777788
GDF15,Anemia Sickle Cell,0.9252532782268056
GDF15,Idiopathic pulmonary arterial hypertension,0.9262273158806068
GDF15,VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding),0.9262273158806068
GDF15,Neoplasms Intracranial,0.9307095582633488
GDF15,Heart Decompensation,0.9387505562433404
GDF15,Diabetic Nephropathy,0.9390727893210336
GDF15,Heart Failure Right-Sided,0.942246125102556
GDF15,Hepatitis C Chronic,0.9432051631882106
GDF15,Myocardial Failure,0.9432051631882106
GDF15,Secondary malignant neoplasm of bone,0.946564927793026
GDF15,Essential Hypertension,0.9557184806547836
GDF15,Left-Sided Heart Failure,0.9561991866282916
GDF15,beta^+^ Thalassemia,0.9564633032157428
GDF15,early pregnancy,0.9571401094099016
GDF15,beta Thalassemia,0.9598257094806012
GDF15,Ischemic stroke,0.9896536639644284
GDF15,Sideroblastic Anemia,0.7765582368651238
GDF15,Prostate Cancer,0.7765582368651238
GDF15,Melanoma,0.7765582368651238
GDF15,Prostatic Neoplasms,0.7765582368651238
GDF15,Gastrointestinal Neoplasms,0.7765582368651238
GDF15,Liver Carcinoma,0.7765582368651238
GDF15,Mouth Diseases,0.7765582368651238
GDF15,Coronary Arteriosclerosis,0.7797212851906329
GDF15,Left Ventricular Hypertrophy,0.8115918568696846
GDF15,Myocardial Infarction,0.861756360478846
GDF15,Coronary Artery Disease,0.861756360478846
GDF15,Heart Failure,0.9024492468099392
GDF15,Congestive Heart Failure,0.9543024119762946
GDF15,Myocardial Ischemia,0.9578111936867284
GDF15,Congenital bile acid synthesis defect type 1 ORPHA:79301,0.5867963421058087
GDF15,Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030,0.5867963421058087
GDF15,Pseudohypoaldosteronism type 2B ORPHA:88939,0.5867963421058087
GDF15,Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298,0.5867963421058087
GDF15,Xanthinuria type II ORPHA:93602,0.5867963421058087
GDF15,Aromatase deficiency ORPHA:91,0.8922466888454011
GDF15,Aromatase excess syndrome ORPHA:178345,0.8922466888454011
GDF15,Erythrocyte galactose epimerase deficiency ORPHA:308473,0.8922466888454011
GDF15,Generalized galactose epimerase deficiency ORPHA:308487,0.8922466888454011
GDF15,Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria ORPHA:99646,0.8922466888454011
GDF15,REN-related autosomal dominant tubulointerstitial kidney disease ORPHA:217330,0.8922466888454011
GDF15,Congenital sialidosis type 2 ORPHA:93400,0.8922466888454011
GDF15,Juvenile sialidosis type 2 ORPHA:93399,0.8922466888454011
GDF15,Sialidosis type 1 ORPHA:812,0.8922466888454011
GGTLC1,Carcinogenesis,0.7333611688795861
GGTLC1,Cholestatic liver disease,0.7765852775619541
GGTLC1,Amyloidosis Familial,0.7880542567584415
GGTLC1,Liver carcinoma,0.7880542567584415
GGTLC1,Cholelithiasis,0.7880542567584415
GGTLC1,Prostate carcinoma,0.7880542567584415
GGTLC1,Neoplasm Metastasis,0.7880542567584415
GGTLC1,Ewings sarcoma,0.7880542567584415
GGTLC1,Neoplasms,0.7880542567584415
GGTLC1,Infection by Wuchereria bancrofti,0.7880542567584415
GGTLC1,Malignant neoplasm of stomach,0.7880542567584415
GGTLC1,Arthrogryposis renal dysfunction cholestasis syndrome,0.7880542567584415
GGTLC1,Elephantiasis,0.7880542567584415
GGTLC1,Viral hepatitis type G,0.7880542567584415
GGTLC1,Lupus Erythematosus Systemic,0.7880542567584415
GGTLC1,heavy drinking,0.7880542567584415
GGTLC1,Benign recurrent intrahepatic cholestasis,0.7880542567584415
GGTLC1,Stomach Carcinoma,0.7880542567584415
GGTLC1,Hepatitis C,0.7880542567584415
GGTLC1,Eosinophilia Tropical,0.7880542567584415
GGTLC1,Diabetes,0.7880542567584415
GGTLC1,Diabetes Mellitus,0.7880542567584415
GGTLC1,Pulmonary Pathology,0.7880542567584415
GGTLC1,Cholestasis,0.7880542567584415
GGTLC1,Plaque Amyloid,0.8009048756462318
GGTLC1,Filarial Elephantiases,0.8009048756462318
GGTLC1,Viremia,0.8019075543217649
GGTLC1,Leukopenia,0.8019075543217649
GGTLC1,Nonalcoholic Steatohepatitis,0.8067197998685076
GGTLC1,Liver diseases,0.8140222479282434
GGTLC1,Progressive intrahepatic cholestasis (disorder),0.8190761496232595
GGTLC1,Fibrosis Liver,0.8272008757995397
GGTLC1,Cholestasis in newborn,0.8402911822757345
GGTLC1,Steatohepatitis,0.8402911822757345
GGTLC1,Cholestasis of pregnancy,0.843190898187174
GGTLC1,Hypertensive disease,0.8474481237156937
GGTLC1,Keratoconus,0.8584283190330553
GGTLC1,Hypophosphatemia,0.8610447277138289
GGTLC1,Fatty Liver,0.8628363180844141
GGTLC1,Pruritus,0.8911256045597441
GGTLC1,Hypertension Portal,0.9377481698983606
GGTLC1,Melanoma B16,0.9621920228183704
GGTLC1,Asthma,0.9672478180546946
GGTLC1,Infant acute respiratory distress syndrome ORPHA:70587,0.5867963421058087
GGTLC1,Brain-lung-thyroid syndrome ORPHA:209905,0.8922466888454011
GGTLC1,Chronic respiratory distress with surfactant metabolism deficiency ORPHA:217566,0.8922466888454011
GGTLC1,Interstitial lung disease due to SP-C deficiency ORPHA:440392,0.8922466888454011
GGTLC1,Neonatal acute respiratory distress due to SP-B deficiency ORPHA:217563,0.8922466888454011
GNG8,T-Cell Lymphoma,0.7880542567584415
GNG8,Lymphoma T-Cell Cutaneous,0.8098851543361193
GNG8,Liver diseases,0.8140222479282434
GNG8,Liver Dysfunction,0.8402911822757345
GNG8,Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma,0.8648405521677974
GNG8,Mycosis Fungoides,0.8989612563669234
GNG8,Hereditary sensory and autonomic neuropathy type 4 ORPHA:642,0.5867963421058087
GPRIN1,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
GPRIN1,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
GPRIN1,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
GPRIN1,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.1040670578681756
GPRIN1,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.1040670578681756
GPRIN1,MASA syndrome ORPHA:2466,0.1040670578681756
GPRIN1,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.1040670578681756
GPRIN1,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.1040670578681756
GPRIN1,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.1991445465001551
GPRIN1,Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664,0.1991445465001551
GPRIN1,Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406,0.1991445465001551
GPRIN1,Familial congenital mirror movements ORPHA:238722,0.2120485863056726
GPRIN1,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570,0.3832844616405875
GPRIN1,Ichthyosis-prematurity syndrome ORPHA:88621,0.3832844616405875
GPRIN1,Coloboma of choroid and retina ORPHA:98942,0.3977968344535308
GPRIN1,Coloboma of iris ORPHA:98944,0.3977968344535308
GPRIN1,Aarskog-Scott syndrome ORPHA:915,0.5867963421058087
GPRIN1,Autosomal recessive spastic paraplegia type 26 ORPHA:101006,0.5867963421058087
GPRIN1,Myoclonus-dystonia syndrome ORPHA:36899,0.606625035400596
GPRIN1,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613,0.7929682744768703
GPRIN1,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome ORPHA:231720,0.7929682744768703
GTF3C6,Autosomal recessive spastic paraplegia type 77 ORPHA:466722,0.8922466888454011
GTF3C6,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy ORPHA:495844,0.8922466888454011
GTF3C6,Combined oxidative phosphorylation defect type 14 ORPHA:319519,0.8922466888454011
GTF3C6,Keratosis linearis-ichthyosis congenita-sclerosing keratoderma syndrome ORPHA:281201,0.8922466888454011
GTF3C6,McKusick-Kaufman syndrome ORPHA:2473,0.8922466888454011
GTF3C6,Multiple mitochondrial dysfunctions syndrome type 1 ORPHA:401869,0.8922466888454011
GTF3C6,TMEM70-related mitochondrial encephalo-cardio-myopathy ORPHA:1194,0.8922466888454011
HENMT1,Neuroblastoma,0.7880542567584415
HENMT1,Central neuroblastoma,0.7880542567584415
HENMT1,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
HERC1,Reticulocyte count (procedure),0.5071083164302358
HERC1,Tall stature,0.7765852775619541
HERC1,Triangular face,0.7765852775619541
HERC1,Long foot,0.7880542567584415
HERC1,Frontal bossing,0.7880542567584415
HERC1,Joint laxity,0.7880542567584415
HERC1,Large hand,0.7880542567584415
HERC1,Large auricle,0.7880542567584415
HERC1,Large pinnae,0.7880542567584415
HERC1,Macrotia,0.7880542567584415
HERC1,Hypertrophy of lower jaw,0.7880542567584415
HERC1,mandibular excess (physical finding),0.7880542567584415
HERC1,Mandibular hyperplasia,0.7880542567584415
HERC1,Increased size of the mandible,0.7880542567584415
HERC1,Bulging forehead,0.7880542567584415
HERC1,Prominent forehead,0.7880542567584415
HERC1,Class III malocclusion,0.7880542567584415
HERC1,Macrocephaly,0.7880542567584415
HERC1,Cognitive delay,0.7880542567584415
HERC1,Sparse eyebrow,0.7880542567584415
HERC1,Increased head circumference,0.7880542567584415
HERC1,Macroencephaly,0.7880542567584415
HERC1,Global developmental delay,0.7880542567584415
HERC1,Prominent eyes,0.7880542567584415
HERC1,Protruding eyes,0.7880542567584415
HERC1,Mental and motor retardation,0.7880542567584415
HERC1,Prominent globes,0.7880542567584415
HERC1,Exophthalmos,0.7908231553833205
HERC1,Angelman Syndrome,0.8019075543217649
HERC1,Acquired flat foot,0.8019075543217649
HERC1,Flatfoot,0.8019075543217649
HERC1,Long face,0.8019075543217649
HERC1,Arachnodactyly,0.8019075543217649
HERC1,Posteriorly rotated ear,0.8026798872257774
HERC1,Big calvaria,0.8098851543361193
HERC1,Increased size of skull,0.8098851543361193
HERC1,Upward slant of palpebral fissure,0.8168901801930506
HERC1,Downward slant of palpebral fissure,0.8168901801930506
HERC1,Convex nasal bridge,0.8232134984476662
HERC1,Prominent nasal bridge,0.8232134984476662
HERC1,Curvature of spine,0.8402911822757345
HERC1,Dilated ventricles (finding),0.8402911822757345
HERC1,Mental deficiency,0.8402911822757345
HERC1,Acquired scoliosis,0.8402911822757345
HERC1,Generalized hypotonia,0.843190898187174
HERC1,Hypotrophic malar bone,0.8490659121857849
HERC1,Malar flattening,0.8490659121857849
HERC1,Low set ears,0.8700543109506378
HERC1,Dull intelligence,0.8757755363384367
HERC1,Low intelligence,0.8757755363384367
HERC1,Cerebellar atrophy,0.8815127642200768
HERC1,Orbital separation excessive,0.8851456306720444
HERC1,Poor school performance,0.8913141512402477
HERC1,Age related macular degeneration,0.8980854850210683
HERC1,Lordosis,0.9083161862856644
HERC1,Byzanthine arch palate,0.9119978323790848
HERC1,Gait Ataxia,0.9119978323790848
HERC1,Hyperkyphosis,0.9154499654632742
HERC1,Severe mental retardation (I.Q. 20-34),0.917543617287358
HERC1,Mental Retardation,0.922229272318747
HERC1,Kyphosis deformity of spine,0.9288355565549664
HERC1,Calcification of coronary artery,0.9377696084218796
HERC1,Intellectual Disability,0.9478210444156088
HERC1,Developmental Delay,0.7765582368651238
HERC1,Macrocephaly,0.7765582368651238
HERC1,Frontal Bossing,0.8115918568696846
HERC1,Macrotia,0.8115918568696846
HERC1,Malocclusion,0.8115918568696846
HERC1,Proptosis,0.8115918568696846
HERC1,Atrial Fibrillation,0.8115918568696846
HERC1,Paroxysmal Atrial Fibrillation,0.8115918568696846
HERC1,Mental Retardation,0.8337953215113012
HERC1,Arachnodactyly,0.861756360478846
HERC1,Posteriorly Rotated Ear,0.8903301324869451
HERC1,Scoliosis,0.924275664330454
HERC1,High Palate,0.9578111936867284
HERC1,Chronic Obstructive Pulmonary Disease,0.966063509695942
HERC1,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
HERC1,2q37 microdeletion syndrome ORPHA:1001,0.1991445465001551
HERC1,SHORT syndrome ORPHA:3163,0.3832844616405875
HERC1,Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220,0.3832844616405875
HERC1,Huntington disease ORPHA:399,0.3832844616405875
HERC1,Autosomal recessive ataxia Beauce type ORPHA:88644,0.5867963421058087
HERC1,Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332,0.5867963421058087
HERC1,Juvenile Huntington disease ORPHA:248111,0.5867963421058087
HERC1,Polyendocrine-polyneuropathy syndrome ORPHA:453533,0.5867963421058087
HERC1,Pseudohypoaldosteronism type 2D ORPHA:300525,0.5867963421058087
HERC1,Acute promyelocytic leukemia ORPHA:520,0.7150309491065155
HERC1,APC-related attenuated familial adenomatous polyposis ORPHA:247806,0.7929682744768703
HERC1,Autosomal recessive spastic paraplegia type 15 ORPHA:100996,0.7929682744768703
HERC1,Autosomal recessive spastic paraplegia type 54 ORPHA:320380,0.7929682744768703
HERC1,Familial adenomatous polyposis due to 5q22.2 microdeletion ORPHA:261584,0.7929682744768703
HERC1,Gardner syndrome ORPHA:79665,0.7929682744768703
HERC1,Gastric adenocarcinoma and proximal polyposis of the stomach ORPHA:314022,0.7929682744768703
HERC1,Griscelli syndrome type 1 ORPHA:79476,0.7929682744768703
HERC1,Microcephalic osteodysplastic primordial dwarfism type II ORPHA:2637,0.7929682744768703
HERC1,Microcephalic primordial dwarfism Dauber type ORPHA:319675,0.7929682744768703
HERC1,Myhre syndrome ORPHA:2588,0.7929682744768703
HERC1,Neuroectodermal melanolysosomal disease ORPHA:33445,0.7929682744768703
HERC1,Nicolaides-Baraitser syndrome ORPHA:3051,0.7929682744768703
HERC1,Perlman syndrome ORPHA:2849,0.7929682744768703
HERC1,Rubinstein-Taybi syndrome due to EP300 haploinsufficiency ORPHA:353284,0.7929682744768703
HERC1,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome ORPHA:521390,0.7929682744768703
HERC1,Turcot syndrome with polyposis ORPHA:99818,0.7929682744768703
HERC1,Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065,0.7929682744768703
HERC1,Angelman syndrome due to imprinting defect in 15q11-q13 ORPHA:411515,0.7929682744768703
HERC1,Sotos syndrome ORPHA:821,0.7929682744768703
HERC1,Acute myeloid leukemia with t(8,0.8922466888454011
HERC1,16)(p11,0.8922466888454011
HERC1,p13) translocation ORPHA:370026,0.8922466888454011
HERC1,5q35 microduplication syndrome ORPHA:228415,0.8922466888454011
HERC1,Acute myeloid leukaemia with myelodysplasia-related features ORPHA:86845,0.8922466888454011
HERC1,Amyotrophic lateral sclerosis type 4 ORPHA:357043,0.8922466888454011
HERC1,Ataxia-telangiectasia ORPHA:100,0.8922466888454011
HERC1,Ataxia-telangiectasia variant ORPHA:370109,0.8922466888454011
HERC1,Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome ORPHA:457193,0.8922466888454011
HERC1,Autosomal recessive Charcot-Marie-Tooth disease type 2X ORPHA:466775,0.8922466888454011
HERC1,Autosomal recessive spastic paraplegia type 11 ORPHA:2822,0.8922466888454011
HERC1,Beckwith-Wiedemann syndrome due to NSD1 mutation ORPHA:238613,0.8922466888454011
HERC1,Cohen syndrome ORPHA:193,0.8922466888454011
HERC1,DYRK1A-related intellectual disability syndrome due to 21q22.13q22.2 microdeletion ORPHA:268261,0.8922466888454011
HERC1,Developmental delay-facial dysmorphism syndrome due to MED13L deficiency ORPHA:369891,0.8922466888454011
HERC1,Dyggve-Melchior-Clausen disease ORPHA:239,0.8922466888454011
HERC1,Fleck corneal dystrophy ORPHA:98970,0.8922466888454011
HERC1,Germinoma of the central nervous system ORPHA:91352,0.8922466888454011
HERC1,Global developmental delay-lung cysts-overgrowth-Wilms tumor syndrome ORPHA:404476,0.8922466888454011
HERC1,Gynandroblastoma ORPHA:99914,0.8922466888454011
HERC1,Intellectual disability syndrome due to a DYRK1A point mutation ORPHA:464311,0.8922466888454011
HERC1,Intellectual disability-hyperkinetic movement-truncal ataxia syndrome ORPHA:369847,0.8922466888454011
HERC1,Isolated generalized anhidrosis with normal sweat glands ORPHA:468666,0.8922466888454011
HERC1,Malignant Sertoli-Leydig cell tumor of the ovary ORPHA:99916,0.8922466888454011
HERC1,Mucolipidosis type II ORPHA:576,0.8922466888454011
HERC1,Mucolipidosis type III alpha/beta ORPHA:423461,0.8922466888454011
HERC1,Pleuropulmonary blastoma familial tumor susceptibility syndrome ORPHA:284343,0.8922466888454011
HERC1,Refractory anemia ORPHA:98826,0.8922466888454011
HERC1,Refractory anemia with excess blasts ORPHA:86839,0.8922466888454011
HERC1,Spinocerebellar ataxia type 15/16 ORPHA:98769,0.8922466888454011
HERC1,Spinocerebellar ataxia type 29 ORPHA:208513,0.8922466888454011
HERC1,TRAPPC11-related  limb-girdle muscular dystrophy R18 ORPHA:369840,0.8922466888454011
HERC1,X-linked dystonia-parkinsonism ORPHA:53351,0.8922466888454011
HERC1,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome ORPHA:480907,0.8922466888454011
HERC1,Acquired idiopathic sideroblastic anemia ORPHA:75564,0.8922466888454011
HERC1,Autosomal recessive spastic paraplegia type 23 ORPHA:101003,0.8922466888454011
HERC1,Moebius syndrome ORPHA:570,0.8922466888454011
HERC1,Progressive cerebello-cerebral atrophy ORPHA:247198,0.8922466888454011
HERC1,Tessier number 7 facial cleft ORPHA:141276,0.8922466888454011
HERC1,17q21.31 microdeletion syndrome ORPHA:363958,0.8922466888454011
HERC1,2q23.1 microdeletion syndrome ORPHA:228402,0.8922466888454011
HERC1,6q25 microdeletion syndrome ORPHA:251056,0.8922466888454011
HERC1,Acute myeloid leukemia with 11q23 abnormalities ORPHA:98831,0.8922466888454011
HERC1,Acute undifferentiated leukemia ORPHA:98835,0.8922466888454011
HERC1,Autosomal recessive spastic paraplegia type 28 ORPHA:101008,0.8922466888454011
HERC1,Blepharophimosis-intellectual disability syndrome SBBYS type ORPHA:3047,0.8922466888454011
HERC1,Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome ORPHA:466921,0.8922466888454011
HERC1,Classic hairy cell leukemia ORPHA:58017,0.8922466888454011
HERC1,Classic multiminicore myopathy ORPHA:324604,0.8922466888454011
HERC1,Developmental delay with autism spectrum disorder and gait instability ORPHA:329195,0.8922466888454011
HERC1,Distal nebulin myopathy ORPHA:399103,0.8922466888454011
HERC1,Early-onset myopathy with fatal cardiomyopathy ORPHA:289377,0.8922466888454011
HERC1,Genitopatellar syndrome ORPHA:85201,0.8922466888454011
HERC1,Hereditary myopathy with early respiratory failure ORPHA:178464,0.8922466888454011
HERC1,Intermediate epidermolysis bullosa simplex with cardiomyopathy ORPHA:508529,0.8922466888454011
HERC1,Johanson-Blizzard syndrome ORPHA:2315,0.8922466888454011
HERC1,Koolen-De Vries syndrome due to a point mutation ORPHA:363965,0.8922466888454011
HERC1,Langerhans cell histiocytosis ORPHA:389,0.8922466888454011
HERC1,Megalencephaly-severe kyphoscoliosis-overgrowth syndrome ORPHA:457359,0.8922466888454011
HERC1,Methylcobalamin deficiency type cblG ORPHA:2170,0.8922466888454011
HERC1,Posterior-predominant lissencephaly-broad flat pons and medulla-midline crossing defects syndrome ORPHA:572013,0.8922466888454011
HERC1,Pseudohypoaldosteronism type 2C ORPHA:88940,0.8922466888454011
HERC1,Short stature-delayed bone age due to thyroid hormone metabolism deficiency ORPHA:171706,0.8922466888454011
HERC1,Short stature-optic atrophy-Pelger-Huet anomaly syndrome ORPHA:391677,0.8922466888454011
HERC1,Spinocerebellar ataxia type 11 ORPHA:98767,0.8922466888454011
HERC1,Syringocystadenoma papilliferum ORPHA:840,0.8922466888454011
HERC1,TBCK-related intellectual disability syndrome ORPHA:488632,0.8922466888454011
HERC1,Tibial muscular dystrophy ORPHA:609,0.8922466888454011
HERC1,Titin-related  limb-girdle muscular dystrophy R10 ORPHA:140922,0.8922466888454011
HERC1,Trichorhinophalangeal syndrome type 1 and 3 ORPHA:77258,0.8922466888454011
HERC1,Vici syndrome ORPHA:1493,0.8922466888454011
HERC1,Wiedemann-Steiner syndrome ORPHA:319182,0.8922466888454011
HERC1,Acute myeloid leukemia with t(9,0.8922466888454011
HERC1,11)(p22,0.8922466888454011
HERC1,q23) ORPHA:402017,0.8922466888454011
HERC1,Cushing disease ORPHA:96253,0.8922466888454011
HERC1,Hemimegalencephaly ORPHA:99802,0.8922466888454011
HERC1,Kleefstra syndrome due to a point mutation ORPHA:261652,0.8922466888454011
HERC1,Mixed phenotype acute leukemia ORPHA:530995,0.8922466888454011
HERPUD1,Carcinoma of bladder,0.4084380369379369
HERPUD1,Bladder Neoplasm,0.4084380369379369
HERPUD1,Carcinogenesis,0.7333611688795861
HERPUD1,leukemia,0.7333611688795861
HERPUD1,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
HERPUD1,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
HERPUD1,Glioma,0.7880542567584415
HERPUD1,Malignant neoplasm of prostate,0.7880542567584415
HERPUD1,Ataxia Telangiectasia,0.7880542567584415
HERPUD1,Leukemia T-Cell,0.7880542567584415
HERPUD1,Prostate carcinoma,0.7880542567584415
HERPUD1,Neoplasm Metastasis,0.7880542567584415
HERPUD1,Prostatic Neoplasms,0.7880542567584415
HERPUD1,Hyperhomocysteinemia,0.7880542567584415
HERPUD1,Burkitt Lymphoma,0.7880542567584415
HERPUD1,Hodgkin Disease,0.7880542567584415
HERPUD1,Congenital chromosomal disease,0.7880542567584415
HERPUD1,Acute lymphocytic leukemia,0.7880542567584415
HERPUD1,Classical Hodgkin's Lymphoma,0.7880542567584415
HERPUD1,Myeloid Leukemia Chronic,0.7880542567584415
HERPUD1,Alcoholic Intoxication Chronic,0.8019075543217649
HERPUD1,Reactive systemic amyloidosis,0.8098851543361193
HERPUD1,HIV Infections,0.8145035474981049
HERPUD1,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
HERPUD1,Triglycerides measurement,0.8232134984476662
HERPUD1,Carcinoma Transitional Cell,0.8368219249856942
HERPUD1,Philadelphia chromosome-positive acute lymphoblastic leukemia,0.887595340546704
HERPUD1,Prostate Cancer,0.7765582368651238
HERPUD1,Prostatic Neoplasms,0.7765582368651238
HERPUD1,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.5867963421058087
HERPUD1,Juvenile-onset diabetes mellitus-central and peripheral neurodegeneration syndrome ORPHA:445062,0.8922466888454011
HERPUD1,Human betaherpesvirus 6 U31 large tegument protein (gene: U31),0.8999095837312036
HERPUD1,Human betaherpesvirus 6A large tegument protein (gene: U31),0.8999095837312036
HERPUD1,Human betaherpesvirus 6B large tegument protein (gene: U31),0.8999095837312036
HERPUD1,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.8999095837312036
HERPUD1,Dugbe virus L protein,0.8999095837312036
HERPUD1,Human betaherpesvirus 7 large tegument protein (gene: U31),0.8999095837312036
HERPUD1,Human betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
HERPUD1,Influenza B virus nonstructural protein 1 (gene: NS1),0.8999095837312036
HERPUD1,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
HERPUD1,SARS coronavirus Tor2 replicase 1AB,0.8999095837312036
HERPUD1,SARS coronavirus P2 full_polyprotein 1..7073,0.8999095837312036
HERPUD1,SARS coronavirus nsp3-pp1a/pp1ab (gene: orf1ab),0.8999095837312036
HERPUD1,Influenza B virus (B/Memphis/12/97) NS protein,0.8999095837312036
HERPUD1,Human immunodeficiency virus envelope glycoprotein (gene: env),0.8999095837312036
HERPUD1,SARS coronavirus excised_polyprotein 1..4369 (gene: orf1ab),0.9057542447893764
HERPUD1,SARS coronavirus P2 full_polyprotein 1..4382,0.9057542447893764
HEXIM1,Malignant neoplasm of breast,0.4084380369379369
HEXIM1,Breast Carcinoma,0.7333611688795861
HEXIM1,Carcinogenesis,0.7333611688795861
HEXIM1,leukemia,0.7333611688795861
HEXIM1,Leukemia Myelocytic Acute,0.7765852775619541
HEXIM1,Right Ventricular Hypertrophy,0.7765852775619541
HEXIM1,Leukemogenesis,0.7765852775619541
HEXIM1,Malignant neoplasm of prostate,0.7880542567584415
HEXIM1,Liver carcinoma,0.7880542567584415
HEXIM1,Prostate carcinoma,0.7880542567584415
HEXIM1,Neuroblastoma,0.7880542567584415
HEXIM1,Central neuroblastoma,0.7880542567584415
HEXIM1,melanoma,0.7880542567584415
HEXIM1,Tumor Progression,0.7880542567584415
HEXIM1,Adenocarcinoma of prostate,0.7880542567584415
HEXIM1,Myeloid Leukemia,0.7880542567584415
HEXIM1,Secondary malignant neoplasm of liver,0.7908231553833205
HEXIM1,Liver Cirrhosis Experimental,0.8014900279306119
HEXIM1,Left Ventricular Hypertrophy,0.8402911822757345
HEXIM1,Aneurysm,0.8402911822757345
HEXIM1,Hypertensive disease,0.8474481237156937
HEXIM1,Idiopathic pulmonary arterial hypertension,0.9262273158806068
HEXIM1,Muscle degeneration,0.9450328871666054
HEXIM1,Myopathy,0.9557184806547836
HEXIM1,Acute Erythroblastic Leukemia,0.9639249377588224
HEXIM1,Drug Dependence,0.9816840072553962
HEXIM1,Salivirus NG-J1 3D,0.8999095837312036
HEXIM1,Influenza B virus (B/Memphis/12/97) HA protein,0.8999095837312036
HEXIM1,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
HEXIM1,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.8999095837312036
HEXIM1,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
HIP1R,Diffuse Large B-Cell Lymphoma,0.7333611688795861
HIP1R,MAJOR AFFECTIVE DISORDER 8,0.8019075543217649
HIP1R,MAJOR AFFECTIVE DISORDER 9,0.8019075543217649
HIP1R,MAJOR AFFECTIVE DISORDER 7,0.8019075543217649
HIP1R,Chronic Lymphocytic Leukemia,0.8019075543217649
HIP1R,Essential Tremor,0.8098851543361193
HIP1R,MAJOR AFFECTIVE DISORDER 4,0.8101097852323003
HIP1R,MAJOR AFFECTIVE DISORDER 6,0.8101097852323003
HIP1R,MAJOR AFFECTIVE DISORDER 1,0.8145035474981049
HIP1R,MAJOR AFFECTIVE DISORDER 2,0.8402911822757345
HIP1R,Parkinson Disease,0.8772392350816924
HIP1R,Bipolar Disorder,0.900167961295542
HIP1R,Trisomy,0.9029289778792944
HIP1R,Protein Deficiency,0.9119978323790848
HIP1R,Schizophrenia,0.7860378120955526
HIP1R,Atrial Fibrillation,0.8115918568696846
HIP1R,Paroxysmal Atrial Fibrillation,0.8115918568696846
HIP1R,Bipolar Disorder,0.943322675973118
HIP1R,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.1040670578681756
HIP1R,Cowpox virus Ati or CPXV158 protein (gene: ati),0.8999095837312036
HIP1R,Sagiyama virus full_polyprotein 1..1253 (gene: C-E3-E2-6K-E1),0.8999095837312036
HIP1R,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
HIP1R,Nipah henipavirus P phosphoprotein,0.8999095837312036
HOTAIR,Malignant neoplasm of breast,0.4084380369379369
HOTAIR,Carcinoma of bladder,0.4084380369379369
HOTAIR,Bladder Neoplasm,0.4084380369379369
HOTAIR,Malignant neoplasm of urinary bladder,0.5071083164302358
HOTAIR,Breast Carcinoma,0.7333611688795861
HOTAIR,Carcinogenesis,0.7333611688795861
HOTAIR,Malignant neoplasm of ovary,0.7333611688795861
HOTAIR,Ovarian Carcinoma,0.7333611688795861
HOTAIR,Malignant neoplasm of pancreas,0.7688485284765829
HOTAIR,Colorectal Carcinoma,0.7765852775619541
HOTAIR,Pancreatic carcinoma,0.7765852775619541
HOTAIR,Laryngeal Squamous Cell Carcinoma,0.7765852775619541
HOTAIR,Gastrointestinal Stromal Tumors,0.7765852775619541
HOTAIR,Colon Carcinoma,0.7765852775619541
HOTAIR,Leukemia Myelocytic Acute,0.7765852775619541
HOTAIR,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
HOTAIR,Malignant tumor of colon,0.7765852775619541
HOTAIR,Esophageal carcinoma,0.7765852775619541
HOTAIR,Cervix carcinoma,0.7765852775619541
HOTAIR,Non-Small Cell Lung Carcinoma,0.7765852775619541
HOTAIR,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
HOTAIR,Pancreatic Neoplasm,0.7765852775619541
HOTAIR,Carcinoma breast stage IV,0.7765852775619541
HOTAIR,Endometrial Carcinoma,0.7765852775619541
HOTAIR,Esophageal Neoplasms,0.7765852775619541
HOTAIR,Malignant tumor of cervix,0.7768809924982332
HOTAIR,Mammary Neoplasms,0.7880542567584415
HOTAIR,Glioma,0.7880542567584415
HOTAIR,Malignant neoplasm of lung,0.7880542567584415
HOTAIR,Malignant neoplasm of prostate,0.7880542567584415
HOTAIR,Liver carcinoma,0.7880542567584415
HOTAIR,Malignant neoplasm of esophagus,0.7880542567584415
HOTAIR,Osteosarcoma,0.7880542567584415
HOTAIR,Colorectal Cancer,0.7880542567584415
HOTAIR,Epithelial ovarian cancer,0.7880542567584415
HOTAIR,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
HOTAIR,Hepatocarcinogenesis,0.7880542567584415
HOTAIR,Glioblastoma,0.7880542567584415
HOTAIR,Osteosarcoma of bone,0.7880542567584415
HOTAIR,Prostate carcinoma,0.7880542567584415
HOTAIR,Astrocytoma,0.7880542567584415
HOTAIR,Primary malignant neoplasm of lung,0.7880542567584415
HOTAIR,cervical cancer,0.7880542567584415
HOTAIR,Neoplasm Metastasis,0.7880542567584415
HOTAIR,Carcinoma of lung,0.7880542567584415
HOTAIR,Squamous cell carcinoma of the head and neck,0.7880542567584415
HOTAIR,Triple Negative Breast Neoplasms,0.7880542567584415
HOTAIR,Malignant neoplasm of liver,0.7880542567584415
HOTAIR,Cancer of Digestive System,0.7880542567584415
HOTAIR,Ductal Carcinoma,0.7880542567584415
HOTAIR,Immunologic Deficiency Syndromes,0.7880542567584415
HOTAIR,Malignant Neoplasms,0.7880542567584415
HOTAIR,melanoma,0.7880542567584415
HOTAIR,Gastrointestinal Diseases,0.7880542567584415
HOTAIR,Malignant neoplasm of stomach,0.7880542567584415
HOTAIR,Transitional cell carcinoma of bladder,0.7880542567584415
HOTAIR,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
HOTAIR,Benign Prostatic Hyperplasia,0.7880542567584415
HOTAIR,Malignant neoplasm of large intestine,0.7880542567584415
HOTAIR,Nasopharyngeal carcinoma,0.7880542567584415
HOTAIR,Tumor Progression,0.7880542567584415
HOTAIR,Lupus Erythematosus Systemic,0.7880542567584415
HOTAIR,Childhood Glioblastoma,0.7880542567584415
HOTAIR,Renal Cell Carcinoma,0.7880542567584415
HOTAIR,Adult Glioblastoma,0.7880542567584415
HOTAIR,Tumor Initiation,0.7880542567584415
HOTAIR,Digestive System Disorders,0.7880542567584415
HOTAIR,Stomach Carcinoma,0.7880542567584415
HOTAIR,Stage IV Colorectal Cancer,0.7880542567584415
HOTAIR,Stage IV Colorectal Cancer AJCC v7,0.7880542567584415
HOTAIR,Squamous cell carcinoma,0.7880542567584415
HOTAIR,Rheumatoid Arthritis,0.7880542567584415
HOTAIR,Carcinoma,0.7880542567584415
HOTAIR,Small cell carcinoma of lung,0.7880542567584415
HOTAIR,Hormone refractory prostate cancer,0.7880542567584415
HOTAIR,Metastatic Neoplasm,0.7880542567584415
HOTAIR,Myeloid Leukemia Chronic,0.7880542567584415
HOTAIR,Secondary malignant neoplasm of liver,0.7908231553833205
HOTAIR,Primary malignant neoplasm,0.7908231553833205
HOTAIR,Leukocyte adhesion deficiency type 1,0.8009048756462318
HOTAIR,Gastrointestinal Stromal Sarcoma,0.8019075543217649
HOTAIR,Primary Sj??gren's syndrome,0.8019075543217649
HOTAIR,Malignant neoplasm of gallbladder,0.8019075543217649
HOTAIR,Hereditary Diffuse Gastric Cancer,0.8019075543217649
HOTAIR,Childhood Osteosarcoma,0.8019075543217649
HOTAIR,Stomach Neoplasms,0.8044379824544406
HOTAIR,Adenocarcinoma of lung (disorder),0.8098851543361193
HOTAIR,Aortic valve calcification,0.8190761496232595
HOTAIR,Gastric Cardia Adenocarcinoma,0.8212681436603975
HOTAIR,Gastric Adenocarcinoma,0.8232134984476662
HOTAIR,Gallbladder Carcinoma,0.8232134984476662
HOTAIR,Multiple tumors,0.8272008757995397
HOTAIR,Glioblastoma Multiforme,0.8342163953428735
HOTAIR,Recurrent tumor,0.8368219249856942
HOTAIR,Lymphatic Metastasis,0.8368219249856942
HOTAIR,Carcinoma Transitional Cell,0.8368219249856942
HOTAIR,Neoplasm Recurrence Local,0.8402911822757345
HOTAIR,Malignant Squamous Cell Neoplasm,0.8402911822757345
HOTAIR,Aortic Aneurysm Thoracic,0.8402911822757345
HOTAIR,Inflammatory Breast Carcinoma,0.841396342333011
HOTAIR,Hepatitis B,0.841396342333011
HOTAIR,Squamous cell carcinoma of esophagus,0.8610447277138289
HOTAIR,Renal carcinoma,0.8648405521677974
HOTAIR,Giant Cell Arteritis,0.8648405521677974
HOTAIR,Parkinson Disease,0.8772392350816924
HOTAIR,Heart Diseases,0.8989612563669234
HOTAIR,Secondary malignant neoplasm of lymph node,0.900167961295542
HOTAIR,Malignancy,0.906476206143938
HOTAIR,Urothelial Carcinoma,0.9441119274323576
HOTAIR,Liver Carcinoma,0.7765582368651238
HOTAIR,Stomach Neoplasms,0.7765582368651238
HOTAIR,Cervical Cancer,0.861756360478846
HOTAIR,Gastric Cancer,0.861756360478846
HOTAIR,Uterine Cervix Neoplasm,0.861756360478846
HOXB13,Malignant neoplasm of breast,0.4084380369379369
HOXB13,Carcinoma of bladder,0.4084380369379369
HOXB13,Bladder Neoplasm,0.4084380369379369
HOXB13,Malignant neoplasm of urinary bladder,0.5071083164302358
HOXB13,Breast Carcinoma,0.7333611688795861
HOXB13,Carcinogenesis,0.7333611688795861
HOXB13,Malignant neoplasm of ovary,0.7333611688795861
HOXB13,leukemia,0.7333611688795861
HOXB13,Ovarian Carcinoma,0.7333611688795861
HOXB13,Adenocarcinoma,0.750391252594775
HOXB13,Colorectal Carcinoma,0.7765852775619541
HOXB13,Colon Carcinoma,0.7765852775619541
HOXB13,Malignant tumor of colon,0.7765852775619541
HOXB13,Endometrial Neoplasms,0.7765852775619541
HOXB13,Prostatic Intraepithelial Neoplasias,0.7765852775619541
HOXB13,Colorectal Neoplasms,0.7765852775619541
HOXB13,Endometrial Carcinoma,0.7765852775619541
HOXB13,Mammary Neoplasms,0.7880542567584415
HOXB13,Malignant neoplasm of prostate,0.7880542567584415
HOXB13,Colorectal Cancer,0.7880542567584415
HOXB13,Prostate carcinoma,0.7880542567584415
HOXB13,Prostatic Neoplasms,0.7880542567584415
HOXB13,melanoma,0.7880542567584415
HOXB13,Renal Cell Carcinoma,0.7880542567584415
HOXB13,Neoplastic Syndromes Hereditary,0.7880542567584415
HOXB13,Myxopapillary ependymoma,0.7880542567584415
HOXB13,Solid Neoplasm,0.7880542567584415
HOXB13,Aortic Valve Insufficiency,0.7880542567584415
HOXB13,Prostate cancer familial,0.7880542567584415
HOXB13,Phyllodes Tumor,0.8019075543217649
HOXB13,ovarian neoplasm,0.8067197998685076
HOXB13,Breast cancer recurrent,0.8145035474981049
HOXB13,Early-Stage Breast Carcinoma,0.8168901801930506
HOXB13,Neoplasm Invasiveness,0.8232134984476662
HOXB13,Recurrent tumor,0.8368219249856942
HOXB13,Squamous cell carcinoma of esophagus,0.8610447277138289
HOXB13,Malignant neoplasm of endometrium,0.8769418330148872
HOXB13,Uterine Corpus Cancer,0.8771562273432176
HOXB13,Mammary Neoplasms Human,0.8815127642200768
HOXB13,Secondary malignant neoplasm of lymph node,0.900167961295542
HOXB13,Prostate Cancer,0.7765582368651238
HOXB13,Melanoma,0.7765582368651238
HOXB13,Prostatic Neoplasms,0.7765582368651238
HOXB13,Prostate Cancer Hereditary,0.7765582368651238
HOXB13,Hereditary Cancer Syndrome,0.7765582368651238
HOXB13,Ovarian Cancer,0.7797212851906329
HOXB13,Mammary Neoplasms,0.8165359516083085
HOXB13,Colonic Neoplasms,0.8210988731657684
HOXB13,Marfan Syndrome,0.8477374749042494
HOXB13,Breast Cancer,0.8903630091389316
HOXB13,Breast Carcinoma,0.9398381935810408
HOXB13,Familial prostate cancer ORPHA:1331,0.2844858212863536
HOXB13,Guttmacher syndrome ORPHA:2957,0.7929682744768703
HOXB13,Hand-foot-genital syndrome ORPHA:2438,0.7929682744768703
HOXB13,Brachydactyly-syndactyly Zhao type ORPHA:93409,0.8922466888454011
HOXB13,Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390,0.8922466888454011
HOXB13,NON RARE IN EUROPE: Brachydactyly type D ORPHA:93385,0.8922466888454011
HOXB13,Syndactyly type 5 ORPHA:93406,0.8922466888454011
HOXB13,Synpolydactyly type 1 ORPHA:295195,0.8922466888454011
HOXB13,VACTERL/VATER association ORPHA:887,0.8922466888454011
HOXB13,Zygodactyly type 3 ORPHA:295191,0.8922466888454011
HS6ST1,Sparse body hair,0.7880542567584415
HS6ST1,Cartilage-hair hypoplasia,0.7880542567584415
HS6ST1,Reduced bone mineral density,0.7880542567584415
HS6ST1,Diabetes,0.7880542567584415
HS6ST1,Diabetes Mellitus,0.7880542567584415
HS6ST1,Abnormality of the voice,0.7908231553833205
HS6ST1,Abnormality of body height,0.7908231553833205
HS6ST1,Increased female libido,0.7908231553833205
HS6ST1,Generalized osteopenia,0.8009048756462318
HS6ST1,Eunuchoid habitus,0.8009048756462318
HS6ST1,Hypothalamic gonadotropin-releasing hormone deficiency,0.8019075543217649
HS6ST1,Absence of pubertal development,0.8019075543217649
HS6ST1,Wide spaced nipples,0.8019075543217649
HS6ST1,Erectile abnormalities,0.8019075543217649
HS6ST1,Female hypogonadism syndrome,0.8019075543217649
HS6ST1,Kallmann Syndrome,0.8067197998685076
HS6ST1,Absence of secondary sex characteristics,0.8138488881521341
HS6ST1,Anterior hypopituitarism,0.8145035474981049
HS6ST1,Osteopenia,0.8212681436603975
HS6ST1,Congenital hypoplasia of penis,0.8232134984476662
HS6ST1,Decreased testosterone in males,0.8270909867833504
HS6ST1,Testicular hypogonadism,0.8272008757995397
HS6ST1,Congenital hypoplasia of breast,0.8272008757995397
HS6ST1,Infantile uterus,0.8272008757995397
HS6ST1,Sense of smell impaired,0.8368219249856942
HS6ST1,Anosmia,0.8368219249856942
HS6ST1,Secondary physiologic amenorrhea,0.8402911822757345
HS6ST1,Cryptorchidism,0.8402911822757345
HS6ST1,Congenital hypoplasia of ovary,0.8402911822757345
HS6ST1,Hypoplastic ovary,0.8402911822757345
HS6ST1,Decreased fertility,0.8402911822757345
HS6ST1,Small testicle,0.8584283190330553
HS6ST1,Delayed bone age,0.8769418330148872
HS6ST1,Hypogonadotropic hypogonadism,0.8769418330148872
HS6ST1,Idiopathic hypogonadotropic hypogonadism,0.8769418330148872
HS6ST1,Depressive disorder,0.9103315000053974
HS6ST1,Primary physiologic amenorrhea,0.914995991166204
HS6ST1,Anxiety disease,0.9154499654632742
HS6ST1,Gynecomastia,0.917543617287358
HS6ST1,Non-obstructive azoospermia,0.9193385822373632
HS6ST1,Cyst,0.929235785949896
HS6ST1,Idiopathic Pulmonary Fibrosis,0.9393256300017014
HS6ST1,Hypogonadism Isolated Hypogonadotropic,0.9505280654948344
HS6ST1,Erectile dysfunction,0.951016614400691
HS6ST1,Delayed Puberty,0.957487573707278
HS6ST1,Osteoporosis,0.9639249377588224
HS6ST1,Anxiety,0.9708740267329932
HS6ST1,Nystagmus,0.7765582368651238
HS6ST1,Schizophrenia,0.7860378120955526
HS6ST1,Secondary Physiologic Amenorrhea,0.7860378120955526
HS6ST1,Osteopenia,0.8115918568696846
HS6ST1,Normosmic Congenital Hypogonadotropic Hypogonadism,0.8115918568696846
HS6ST1,Hypogonadotropic Hypogonadism With Or Without Anosmia,0.8115918568696846
HS6ST1,Hearing Loss,0.8115918568696846
HS6ST1,Diabetes,0.8115918568696846
HS6ST1,Congenital Camptodactyly,0.8115918568696846
HS6ST1,Penis Agenesis,0.8115918568696846
HS6ST1,Female Hypogonadism Syndrome,0.8115918568696846
HS6ST1,Skeletal Dysplasia,0.8182883735985873
HS6ST1,Osteochondrodysplasia,0.8210988731657684
HS6ST1,Kallmann Syndrome,0.8210988731657684
HS6ST1,Mirror Movements,0.8356859041719433
HS6ST1,Testicular Hypogonadism,0.8457525389282121
HS6ST1,Anxiety Disorder,0.8507213163251659
HS6ST1,Breast Hypoplasia,0.8611702959552964
HS6ST1,Paraplegia,0.8611702959552964
HS6ST1,Cryptorchidism,0.861756360478846
HS6ST1,Hypoplasia Of The Ovary,0.861756360478846
HS6ST1,Congenital Sensorineural Hearing Loss,0.8706864397989688
HS6ST1,Osteoporosis,0.8903301324869451
HS6ST1,Hypopituitarism,0.8903630091389316
HS6ST1,Mental Depression,0.8903630091389316
HS6ST1,Erectile Dysfunction,0.9046917974656596
HS6ST1,Diabetes Mellitus,0.919442421650838
HS6ST1,Non-obstructive Azoospermia,0.919442421650838
HS6ST1,Gynecomastia,0.951883341147811
HS6ST1,Renal Agenesis,0.9574431947800732
HS6ST1,Physiologic Amenorrhea,0.9726837163662044
HS6ST1,Hypogonadotropic Hypogonadism,0.980894832851993
HS6ST1,Ptosis,0.9832345076528324
HS6ST1,Ichthyosis,0.9832345076528324
HS6ST1,Obesity,0.9832345076528324
HS6ST1,Dysarthria,0.988987376043163
HS6ST1,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
HS6ST1,Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253,0.1040670578681756
HS6ST1,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.1040670578681756
HS6ST1,NAD(P)HX dehydratase deficiency ORPHA:555402,0.1991445465001551
HS6ST1,Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717,0.1991445465001551
HS6ST1,Crouzon disease ORPHA:207,0.3832844616405875
HS6ST1,Familial multinodular goiter ORPHA:276399,0.3832844616405875
HS6ST1,Hyperprolinemia type 2 ORPHA:79101,0.5867963421058087
HS6ST1,Normosmic congenital hypogonadotropic hypogonadism ORPHA:432,0.8922466888454011
HS6ST1,Kallmann syndrome ORPHA:478,0.8922466888454011
HTR7P1,Mucopolysaccharidosis type 6 rapidly progressing ORPHA:276212,0.1991445465001551
HTR7P1,Mucopolysaccharidosis type 6 slowly progressing ORPHA:276223,0.1991445465001551
IER3,Malignant neoplasm of breast,0.4084380369379369
IER3,Breast Carcinoma,0.7333611688795861
IER3,Carcinogenesis,0.7333611688795861
IER3,leukemia,0.7333611688795861
IER3,Malignant neoplasm of pancreas,0.7688485284765829
IER3,Colorectal Carcinoma,0.7765852775619541
IER3,Pancreatic carcinoma,0.7765852775619541
IER3,MYELODYSPLASTIC SYNDROME,0.7765852775619541
IER3,Cervix carcinoma,0.7765852775619541
IER3,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
IER3,Pancreatic Neoplasm,0.7765852775619541
IER3,Malignant tumor of cervix,0.7768809924982332
IER3,Glioma,0.7880542567584415
IER3,Osteosarcoma,0.7880542567584415
IER3,Acute Promyelocytic Leukemia,0.7880542567584415
IER3,Colorectal Cancer,0.7880542567584415
IER3,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
IER3,Osteosarcoma of bone,0.7880542567584415
IER3,cervical cancer,0.7880542567584415
IER3,Malignant neoplasm of liver,0.7880542567584415
IER3,Malignant neoplasm of stomach,0.7880542567584415
IER3,Mental disorders,0.7880542567584415
IER3,Abnormal behavior,0.7880542567584415
IER3,Severe Combined Immunodeficiency,0.7880542567584415
IER3,Lupus Erythematosus Systemic,0.7880542567584415
IER3,Stomach Carcinoma,0.7880542567584415
IER3,Autoimmune Diseases,0.7880542567584415
IER3,Squamous cell carcinoma,0.7880542567584415
IER3,Huntington Disease,0.7880542567584415
IER3,Virus Diseases,0.7880542567584415
IER3,Dermatitis Irritant,0.8019075543217649
IER3,Lupus Erythematosus,0.8067197998685076
IER3,Lupus Erythematosus Discoid,0.8098851543361193
IER3,Pancreatitis,0.8168901801930506
IER3,Arteriovenous fistula,0.8168901801930506
IER3,Gastric Adenocarcinoma,0.8232134984476662
IER3,Lupus Vulgaris,0.8232134984476662
IER3,Infection,0.8272008757995397
IER3,Sezary Syndrome,0.8402911822757345
IER3,Hypertensive disease,0.8474481237156937
IER3,Leishmaniasis Cutaneous,0.8554819098734854
IER3,Arsenic Poisoning Inorganic,0.8769418330148872
IER3,Nervous System Organic Arsenic Poisoning,0.8769418330148872
IER3,Arsenic Encephalopathy,0.8769418330148872
IER3,Arsenic Induced Polyneuropathy,0.8769418330148872
IER3,Arsenic Poisoning,0.8769418330148872
IER3,Pseudohyperkalemia Cardiff,0.9578035687879456
IER3,Colitis,0.9738491767258852
IER3,Dermatologic disorders,0.9912501168001682
IER3,Hypertension,0.7765582368651238
IER3,Dermatitis,0.861756360478846
IER3,Arsenic Encephalopathy,0.8932724875174971
IER3,Dermatologic Disorders,0.9259420053407031
IER3,Crisponi syndrome ORPHA:1545,0.0155394890951578
IER3,Quebec platelet disorder ORPHA:220436,0.3832844616405875
IER3,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.3832844616405875
IER3,Thyroid ectopia ORPHA:95712,0.3832844616405875
IER3,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,0.3891940933600213
IER3,B4GALT1-CDG ORPHA:79332,0.5867963421058087
IER3,Niemann-Pick disease type C adult neurologic onset ORPHA:216986,0.5867963421058087
IER3,Niemann-Pick disease type C juvenile neurologic onset ORPHA:216981,0.5867963421058087
IER3,Niemann-Pick disease type C late infantile neurologic onset ORPHA:216978,0.5867963421058087
IER3,Niemann-Pick disease type C severe early infantile neurologic onset ORPHA:216975,0.5867963421058087
IER3,Niemann-Pick disease type C severe perinatal form ORPHA:216972,0.5867963421058087
IER3,FTH1-related iron overload ORPHA:247790,0.7929682744768703
IER3,Hypoplastic amelogenesis imperfecta ORPHA:100031,0.8105918570729571
IFI30,Malignant neoplasm of breast,0.4084380369379369
IFI30,Breast Carcinoma,0.7333611688795861
IFI30,Leukemia Myelocytic Acute,0.7765852775619541
IFI30,Carcinoma breast stage IV,0.7765852775619541
IFI30,Acute Myeloid Leukemia M1,0.7880542567584415
IFI30,melanoma,0.7880542567584415
IFI30,Hemophilia B,0.7880542567584415
IFI30,Acute Myeloid Leukemia (AML-M2),0.7880542567584415
IFI30,Cardiovascular Diseases,0.7880542567584415
IFI30,Diabetes,0.7880542567584415
IFI30,Diabetes Mellitus,0.7880542567584415
IFI30,Hyperglycemia,0.7880542567584415
IFI30,Tumor Immunity,0.7880542567584415
IFI30,Experimental Organism Basal Cell Carcinoma,0.8009048756462318
IFI30,Multiple Sclerosis,0.8019075543217649
IFI30,Neuromyelitis Optica,0.8402911822757345
IFI30,Metabolic Syndrome X,0.8610447277138289
IFI30,Obesity,0.8989612563669234
IFI30,Dermatitis Allergic Contact,0.9431511078237256
IFI30,Leukemia,0.7765582368651238
IFI30,Myeloid Leukemia,0.8356859041719433
IFI30,Dermatitis,0.861756360478846
IFI30,Multiple Sclerosis,0.980894832851993
IFI30,CLN11 disease ORPHA:314629,0.1040670578681756
IFI30,Heme oxygenase-1 deficiency ORPHA:562509,0.1040670578681756
IFI30,Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813,0.1054066549396977
IFI30,Aicardi-Goutieres syndrome ORPHA:51,0.1294848460749822
IFI30,Alpha-mannosidosis adult form ORPHA:309288,0.1991445465001551
IFI30,Alpha-mannosidosis infantile form ORPHA:309282,0.1991445465001551
IFI30,Autosomal dominant dopa-responsive dystonia ORPHA:98808,0.1991445465001551
IFI30,Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713,0.1991445465001551
IFI30,GTP cyclohydrolase I deficiency ORPHA:2102,0.1991445465001551
IFI30,Gamma-glutamyl transpeptidase deficiency ORPHA:33573,0.1991445465001551
IFI30,Waldenstrom macroglobulinemia ORPHA:33226,0.1991445465001551
IFI30,Dehydrated hereditary stomatocytosis ORPHA:3202,0.2047219337649946
IFI30,Takayasu arteritis ORPHA:3287,0.2047219337649946
IFI30,Autosomal recessive malignant osteopetrosis ORPHA:667,0.2120485863056726
IFI30,CLN3 disease ORPHA:228346,0.3832844616405875
IFI30,Combined immunodeficiency-enteropathy spectrum ORPHA:436252,0.3832844616405875
IFI30,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.3832844616405875
IFI30,Fructose-16-bisphosphatase deficiency ORPHA:348,0.3832844616405875
IFI30,Multiple intestinal atresia ORPHA:2300,0.3832844616405875
IFI30,Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198,0.3832844616405875
IFI30,Metaphyseal anadysplasia ORPHA:1040,0.3832844616405875
IFI30,Dysosteosclerosis ORPHA:1782,0.3832844616405875
IFI30,Pediatric systemic lupus erythematosus ORPHA:93552,0.3832844616405875
IFI30,Autosomal dominant severe congenital neutropenia ORPHA:486,0.3891940933600213
IFI30,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,0.3891940933600213
IFI30,Herpes simplex virus encephalitis ORPHA:1930,0.3977968344535308
IFI30,Exfoliative ichthyosis ORPHA:289586,0.5867963421058087
IFI30,Immunodeficiency by defective expression of MHC class I ORPHA:34592,0.5867963421058087
IFI30,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.5867963421058087
IFI30,Charcot-Marie-Tooth disease type 1C ORPHA:101083,0.5867963421058087
IFI30,Galactose mutarotase deficiency ORPHA:570422,0.5867963421058087
IFI30,Galactosialidosis ORPHA:351,0.5867963421058087
IFI30,Genetic hyperferritinemia without iron overload ORPHA:254704,0.5867963421058087
IFI30,Haim-Munk syndrome ORPHA:2342,0.5867963421058087
IFI30,Hereditary hyperferritinemia-cataract syndrome ORPHA:163,0.5867963421058087
IFI30,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.5867963421058087
IFI30,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428,0.5867963421058087
IFI30,L-ferritin deficiency ORPHA:440731,0.5867963421058087
IFI30,Mucopolysaccharidosis type 7 ORPHA:584,0.5867963421058087
IFI30,Neuroferritinopathy ORPHA:157846,0.5867963421058087
IFI30,Papillon-Lefevre ORPHA:678,0.5867963421058087
IFI30,Cystic leukoencephalopathy without megalencephaly ORPHA:85136,0.5867963421058087
IFI30,Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298,0.5867963421058087
IFI30,Chronic mucocutaneous candidiasis ORPHA:1334,0.606625035400596
IFI30,Acatalasemia ORPHA:926,0.7929682744768703
IFI30,Alpha-1-antitrypsin deficiency ORPHA:60,0.7929682744768703
IFI30,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319589,0.7929682744768703
IFI30,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency ORPHA:319574,0.7929682744768703
IFI30,Fowler vasculopaty ORPHA:221126,0.7929682744768703
IFI30,Fucosidosis ORPHA:349,0.7929682744768703
IFI30,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation ORPHA:178396,0.7929682744768703
IFI30,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR2 deficiency ORPHA:319547,0.7929682744768703
IFI30,Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634,0.7929682744768703
IFI30,Recurrent Neisseria infections due to factor D deficiency ORPHA:169467,0.7929682744768703
IFI30,Sterile multifocal osteomyelitis with periostitis and pustulosis ORPHA:210115,0.7929682744768703
IFI30,Transaldolase deficiency ORPHA:101028,0.7929682744768703
IFI30,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632,0.7929682744768703
IFI30,Alpha-N-acetylgalactosaminidase deficiency type 1 ORPHA:79279,0.8922466888454011
IFI30,Alpha-N-acetylgalactosaminidase deficiency type 2 ORPHA:79280,0.8922466888454011
IFI30,Alpha-N-acetylgalactosaminidase deficiency type 3 ORPHA:79281,0.8922466888454011
IFI30,Cholesteryl ester storage disease ORPHA:75234,0.8922466888454011
IFI30,GM2 gangliosidosis AB variant ORPHA:309246,0.8922466888454011
IFI30,Hyper-IgM syndrome type 3 ORPHA:101090,0.8922466888454011
IFI30,SLC39A8-CDG ORPHA:468699,0.8922466888454011
IFI30,Spondyloenchondrodysplasia ORPHA:1855,0.8922466888454011
IFI30,Wolman disease ORPHA:75233,0.8922466888454011
IFI30,Diffuse cutaneous systemic sclerosis ORPHA:220393,0.8922466888454011
IFI30,CLN1 disease ORPHA:228329,0.8922466888454011
IFI44,androgen independent prostate cancer,0.7765852775619541
IFI44,Nonspecific interstitial pneumonia,0.7765852775619541
IFI44,Malignant neoplasm of prostate,0.7880542567584415
IFI44,Prostate carcinoma,0.7880542567584415
IFI44,Benign Prostatic Hyperplasia,0.7880542567584415
IFI44,Lupus Erythematosus Systemic,0.7880542567584415
IFI44,Seminoma,0.7880542567584415
IFI44,Hepatitis C,0.7880542567584415
IFI44,Rheumatoid Arthritis,0.7880542567584415
IFI44,Human anaplasmosis due to Anaplasma phagocytophilum,0.8067197998685076
IFI44,Testicular Neoplasms,0.8232134984476662
IFI44,Prostatic Hyperplasia,0.8232134984476662
IFI44,Spinal Muscular Atrophy,0.8402911822757345
IFI44,liposarcoma,0.8806784681730055
IFI44,Influenza,0.9193385822373632
IFI44,Abortion Tubal,0.9446671211493156
IFI44,Spontaneous abortion,0.963331724428282
IFI44,Miscarriage,0.9658957825498884
IFI44,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
IFI44,Variant ABeta2M amyloidosis ORPHA:314652,0.3832844616405875
IFI44,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487,0.5867963421058087
IFI44,Autosomal dominant Kenny-Caffey syndrome ORPHA:93325,0.5867963421058087
IFI44,Familial normophosphatemic tumoral calcinosis ORPHA:306658,0.5867963421058087
IFI44,Generalized glucocorticoid resistance syndrome ORPHA:786,0.5867963421058087
IFI44,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428,0.5867963421058087
IFI44,MIRAGE syndrome ORPHA:494433,0.5867963421058087
IFI44,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595,0.5867963421058087
IFI44,Osteocraniostenosis ORPHA:2763,0.5867963421058087
IFI44,Proteasome-associated autoinflammatory syndrome ORPHA:324977,0.5867963421058087
IFI44,Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311,0.5867963421058087
IFI44,USP18 deficiency ORPHA:481665,0.5867963421058087
IFI44,Familial Chilblain lupus ORPHA:481662,0.5867963421058087
IFI44,Singleton-Merten dysplasia ORPHA:85191,0.7929682744768703
IFI44,1p21.3 microdeletion syndrome ORPHA:293948,0.7929682744768703
IFI44,Dihydropyrimidine dehydrogenase deficiency ORPHA:1675,0.7929682744768703
IFI44,STING-associated vasculopathy with onset in infancy ORPHA:425120,0.7929682744768703
IFI44,Ataxia-pancytopenia syndrome ORPHA:2585,0.8922466888454011
IGSF8,Glioma,0.7880542567584415
IGSF8,Malignant neoplasm of prostate,0.7880542567584415
IGSF8,Glioblastoma,0.7880542567584415
IGSF8,Prostate carcinoma,0.7880542567584415
IGSF8,Neoplasm Metastasis,0.7880542567584415
IGSF8,Prostatic Neoplasms,0.7880542567584415
IGSF8,melanoma,0.7880542567584415
IGSF8,Hepatitis C,0.7880542567584415
IGSF8,Metastatic melanoma,0.7940665326856218
IGSF8,Secondary malignant neoplasm of lung,0.8232134984476662
IGSF8,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
IGSF8,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.1040670578681756
IGSF8,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.1040670578681756
IGSF8,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.1040670578681756
IGSF8,Focal dermal hypoplasia ORPHA:2092,0.1040670578681756
IGSF8,Kufor-Rakeb syndrome ORPHA:306674,0.1040670578681756
IGSF8,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.1040670578681756
IGSF8,Leukonychia totalis ORPHA:2387,0.1991445465001551
IGSF8,NAD(P)HX dehydratase deficiency ORPHA:555402,0.1991445465001551
IGSF8,Early myoclonic encephalopathy ORPHA:1935,0.1991445465001551
IGSF8,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.2386105733903937
IGSF8,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848,0.7929682744768703
IGSF8,CLN13 disease ORPHA:352709,0.8922466888454011
IGSF8,Infantile cerebellar-retinal degeneration ORPHA:313850,0.8922466888454011
IGSF8,Human T-lymphotropic virus 3 envelope (gene: env),0.8999095837312036
IGSF8,Human T-cell lymphotropic virus type 2b env,0.8999095837312036
IGSF8,Human T-lymphotropic virus 4 envelope glycoprotein (gene: env),0.8999095837312036
IGSF8,Human T-lymphotropic virus 2 p21E envelope protein,0.8999095837312036
IGSF8,Japanese encephalitis virus hypothetical protein,0.8999095837312036
IGSF8,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
IGSF8,Human T-cell leukemia virus type I gp46 SU (gene: env),0.8999095837312036
IGSF8,Molluscum contagiosum virus subtype 1 MC069R (gene: MC069R),0.8999095837312036
IGSF8,Influenza B virus (B/Memphis/12/97) HA protein,0.8999095837312036
IGSF8,Ntaya virus full_polyprotein 1..3427,0.8999095837312036
IGSF8,Ilheus virus full_polyprotein 1..3424,0.8999095837312036
IGSF8,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
IGSF8,Adeno-associated virus 3B capsid protein VP1,0.8999095837312036
IGSF8,Vaccinia virus IMV membrane protein (gene: L1R),0.8999095837312036
IGSF8,Vaccinia virus Ankara myristylated IMV virion protein,0.8999095837312036
IGSF8,Variola virus hypothetical protein (gene: M1R),0.8999095837312036
IGSF8,Cowpox virus CPXV099 protein (gene: CPXV099 CDS),0.8999095837312036
IGSF8,Monkeypox virus myristylprotein,0.8999095837312036
IGSF8,Monkeypox virus Zaire-96-I-16 M1R (gene: M1R),0.8999095837312036
IGSF8,Ectromelia virus ERPV IMV myristylated membrane protein,0.8999095837312036
IGSF8,Horsepox virus HSPV089 (Lipid membrane protein),0.8999095837312036
IGSF8,Cowpox virus CPXV123 protein (gene: CPXV123 CDS),0.8999095837312036
IGSF8,Yaba monkey tumor virus 60R,0.8999095837312036
IGSF8,Yaba-like disease virus 60R protein (gene: 60R),0.8999095837312036
IGSF8,Monkeypox virus early gene transcription factor VETF 70 kDa small subunit,0.8999095837312036
IGSF8,Monkeypox virus Zaire-96-I-16 E6R (gene: E6R),0.8999095837312036
IGSF8,Reston ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
IGSF8,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Human orthopneumovirus fusion protein (gene: F),0.8999095837312036
IGSF8,Dengue virus 2 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
IGSF8,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
IGSF8,Human immunodeficiency virus 1 Gag-Pol (gene: gag-pol),0.8999095837312036
IGSF8,Influenza A virus (A/California/04/2009(H1N1)) HA1 (gene: HA),0.8999095837312036
IGSF8,Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147),0.8999095837312036
IGSF8,Hepatitis B virus pre-capsid protein (gene: C),0.8999095837312036
IGSF8,Bundibugyo ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
IGSF8,Human immunodeficiency virus 1 Pr55(Gag) (gene: gag),0.8999095837312036
IGSF8,Influenza A virus (A/Northern Territory/60/1968(H3N2)) HA2 (gene: HA),0.8999095837312036
IGSF8,HBV genotype D HBeAg (gene: PreC/C),0.8999095837312036
IGSF8,Human gammaherpesvirus 8 K4.1 (gene: K4.1),0.8999095837312036
IGSF8,Influenza A virus (A/Korea/426/1968(H2N2)) HA1 (gene: HA),0.8999095837312036
IGSF8,Influenza A virus (A/New York/392/2004(H3N2)) HA1 (gene: HA),0.8999095837312036
IGSF8,HBV genotype H PC/C protein (gene: PC/C),0.8999095837312036
IGSF8,HBV genotype B preC/C protein (gene: preC/C),0.8999095837312036
IGSF8,HBV genotype C core protein (gene: C),0.8999095837312036
IGSF8,HBV genotype C HBeAg (gene: PreC/C),0.8999095837312036
IGSF8,Variola virus S-S bond formation pathway protein (gene: C13L),0.8999095837312036
IGSF8,Human immunodeficiency virus gag protein (gene: gag),0.8999095837312036
IGSF8,HBV recombinant C/G HBeAg (gene: preC/C),0.8999095837312036
IGSF8,Hepatitis B virus capsid protein (gene: C),0.8999095837312036
IGSF8,HBV recombinant B/C HBc protein (gene: C),0.8999095837312036
IGSF8,Wesselsbron virus full_polyprotein 1..3405,0.8999095837312036
IGSF8,HBV genotype C preC/C protein (gene: preC/C),0.8999095837312036
IGSF8,Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
IGSF8,Dengue virus 3 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
IGSF8,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.8999095837312036
IGSF8,Influenza A virus (A/New York/599/1996(H3N2)) HA1 (gene: HA),0.8999095837312036
IGSF8,Adeno-associated virus - 4 capsid,0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2011/GII/Yuzawa/Gira2HS VP1 (gene: VP1),0.8999095837312036
IGSF8,HBV genotype C HBc protein (gene: C),0.8999095837312036
IGSF8,Yaba-like disease virus 141R protein (gene: 141R),0.8999095837312036
IGSF8,Human gammaherpesvirus 4 BARF1 protein (gene: BARF1),0.8999095837312036
IGSF8,Molluscum contagiosum virus subtype 1 MC161R (gene: MC161R),0.8999095837312036
IGSF8,Human immunodeficiency virus 1 Envelope surface glycoprotein gp160 precursor (gene: env),0.8999095837312036
IGSF8,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
IGSF8,Influenza A virus (A/Korea/426/1968(H2N2)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Influenza A virus (A/Hong Kong/1073/99(H9N2)) Hemagglutinin (gene: ha),0.8999095837312036
IGSF8,Human immunodeficiency virus 2 full_polyprotein 1..521 (gene: gag-pol),0.8999095837312036
IGSF8,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
IGSF8,HBV genotype B C protein (gene: C),0.8999095837312036
IGSF8,Influenza A virus (A/Northern Territory/60/1968(H3N2)) HA1 (gene: HA),0.8999095837312036
IGSF8,West Nile virus SA93/01 envelope protein,0.8999095837312036
IGSF8,West Nile virus SPU116/89 envelope protein,0.8999095837312036
IGSF8,Human alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.8999095837312036
IGSF8,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
IGSF8,Influenza A virus (A/New York/599/1996(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Human betaherpesvirus 6B G-protein coupled receptor (gene: U12),0.8999095837312036
IGSF8,West Nile virus lineage 1 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
IGSF8,HBV genotype C C protein (gene: C),0.8999095837312036
IGSF8,Influenza A virus (A/New York/392/2004(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,West Nile virus SA381/00 envelope protein,0.8999095837312036
IGSF8,Norovirus GII.17 VP1 (gene: VP1),0.8999095837312036
IGSF8,Human herpesvirus 4 type 2 BARF1,0.8999095837312036
IGSF8,Influenza A virus (A/New York/602/1996(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Murray Valley encephalitis virus envelope protein E,0.8999095837312036
IGSF8,Rio Bravo virus envelope protein,0.8999095837312036
IGSF8,West Nile virus H442 envelope protein,0.8999095837312036
IGSF8,Ebola virus - Mayinga Zaire 1976 virion spike glycoprotein precursor (gene: GP),0.8999095837312036
IGSF8,Zaire ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
IGSF8,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) haemagglutinin (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII.3/HK71/1978/CHN capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human T-lymphotropic virus 2 Gag-Pro-Pol,0.8999095837312036
IGSF8,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
IGSF8,Human adenovirus 56 CR1 beta protein (gene: E3),0.8999095837312036
IGSF8,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) HA2 (gene: HA),0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2000/GII.P12_GII.12/Saitama/KU16 VP1 (gene: VP1),0.8999095837312036
IGSF8,Influenza A virus (A/Northern Territory/60/1968(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2001/GII.P12_GII.12/Saitama/T15 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2001/GII.P12_GII.12/Saitama/T18 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2002/GII.P16_GII.17/Saitama/T87 VP1 (gene: VP1),0.8999095837312036
IGSF8,Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147),0.8999095837312036
IGSF8,Human T-cell leukemia virus type I p21 TM (gene: env),0.8999095837312036
IGSF8,Vaccinia virus IL-beta-binding protein (gene: VACWR-B15R),0.8999095837312036
IGSF8,Norovirus Hu/GII/10002/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
IGSF8,Norovirus Hu/GII.12/CGMH39/2010/TW VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.12/CGMH40/2010/TW VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.12/CGMH41/2010/TW VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.12/CGMH42/2010/TW VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.12/HS210/2010/USA capsid protein VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.g-GII.12/Gunnedah/NSW895P/2010/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.g-GII.12/Wahroonga/NSW004P/2009/AU VP1,0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2007/GII.P7_GII.14/Fukuoka/KK282 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.12/HS206/2010/USA VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/CHDC4871/1977/US VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/CHDC5191/1974/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/10003/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/10012/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10034/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10054/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10062/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10075/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10078/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10079/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10110/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10114/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10129/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10136/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10145/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10158/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10160/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10163/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10169/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10177/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10179/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10182/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10194/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10203/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10204/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10222/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10238/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10255/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10296/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20010/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20014/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20019/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20067/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20069/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20092/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20093/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20118/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20122/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20128/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20135/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20139/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20140/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20142/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Macacine alphaherpesvirus 1 envelope glycoprotein D (gene: US6),0.8999095837312036
IGSF8,Sudan ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
IGSF8,Sudan ebolavirus - Nakisamata structural glycoprotein (gene: GP),0.8999095837312036
IGSF8,Influenza A virus (A/Korea/426/1968(H2N2)) HA2 (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII.12/CGMH38/2010/TW VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.14/8610/Saga/2008/JPN capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/HS191/2004/USA VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/HS66/2001/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Japanese encephalitis virus prodexcised_polyprotein 1..794,0.8999095837312036
IGSF8,Dengue virus full_polyprotein 1..3387,0.8999095837312036
IGSF8,Ectromelia virus ERPV IL-1 beta receptor,0.8999095837312036
IGSF8,Human immunodeficiency virus 1 Envelope surface glycoprotein gp120 (gene: env),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/CHDC2094/1974/US VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/MD-2004/2004/US VP1,0.8999095837312036
IGSF8,Human immunodeficiency virus pol protein (gene: pol),0.8999095837312036
IGSF8,Human calicivirus NLV/GII/Langen1061/2002/DE major structural protein,0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2007/GII.P7_GII.14/Sendai/YG99 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Ohio/7I/2012/USA major capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10328/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human gammaherpesvirus 8 K14,0.8999095837312036
IGSF8,West Nile virus lineage 1 excised_polyprotein 1..787 (gene: flavivirus polyprotein),0.8999095837312036
IGSF8,Papiine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.8999095837312036
IGSF8,Saint Louis encephalitis virus full_polyprotein 1..3430,0.8999095837312036
IGSF8,Influenza A virus (A/California/07/2009(H1N1)) HA1 (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH19/2009/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Randwick/NSW882J/2011/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII/Seoul1367/KOR/2010 major capsid protein,0.8999095837312036
IGSF8,Dengue virus 4 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
IGSF8,Influenza A virus (A/Shanghai/02/2013(H7N9)) HA2 (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Jannali/NSW774M/2011/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Ohio/7G/2012/USA major capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Seoul/1071/2010/KOR major capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII/Seoul1055/KOR/2010 major capsid protein,0.8999095837312036
IGSF8,Cercopithecine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.8999095837312036
IGSF8,Human adenovirus 28 fiber,0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH01/2006/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/JB-15/KOR/2008 capsid protein,0.8999095837312036
IGSF8,Human metapneumovirus fusion glycoprotein precursor (gene: F),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC1.13/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC1.16/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/Seoul1072/KOR/2010 major capsid protein,0.8999095837312036
IGSF8,Human betaherpesvirus 5 membrane protein UL6 (gene: UL6),0.8999095837312036
IGSF8,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) HA1 (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII/BG1C0004/2010/BGD capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10235/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human adenovirus 22 fiber protein (gene: L5),0.8999095837312036
IGSF8,Human immunodeficiency virus envelope glycoprotein (gene: env),0.8999095837312036
IGSF8,Norovirus Hu/GII/10037/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/BG1C0066/2011/BGD capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/BG1C0282/2011/BGD capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10199/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20008/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20066/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Ectromelia virus ERPV hemagglutinin,0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH20/2009/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/20477/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10176/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human adenovirus 31 fiber protein (gene: FIber),0.8999095837312036
IGSF8,Norovirus Hu/GII/BG1C0204/2011/BGD capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/BG1C0270/2011/BGD capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/BG1C0317/2011/BGD capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20094/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Murray Valley encephalitis virus prodexcised_polyprotein 1..793,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10137/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10223/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20044/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human betaherpesvirus 5 envelope glycoprotein UL4 (gene: UL4),0.8999095837312036
IGSF8,Human alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10074/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10162/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10173/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20016/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20035/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20047/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
IGSF8,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.8999095837312036
IGSF8,Human immunodeficiency virus 1 Pol (gene: gag-pol),0.8999095837312036
IGSF8,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
IGSF8,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2001/GII.P22_GII.5/Saitama/T49 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2010/GII.P4_GII.4/Shimada/ASC96 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CBNU2/2007/KR capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Berowra/NSW767L/2012/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC11.3/2013/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10247/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Influenza A virus (A/Shanghai/02/2013(H7N9)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH13/2007/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/CHDC4108/1987/US VP1,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10051/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10116/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10183/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10236/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human calicivirus Hu/NLV/GII/MD145-12/1987/US capsid protein,0.8999095837312036
IGSF8,Human mastadenovirus A fiber,0.8999095837312036
IGSF8,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/108 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus GII/Hu/TW/2012/GII.Pe_GII.4_Sydney2012/Taipei/109 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH23/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH26/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/CHDC3967/1988/US VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/GZ2010-L87/Guangzhou/CHN/2011 major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Human adenovirus 12 fiber protein,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10368/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human mastadenovirus E fiber (gene: L5),0.8999095837312036
IGSF8,Human adenovirus E4 fiber protein,0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH21/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH24/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH25/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH27/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Caringbah/NSW409G/2011/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/HS292/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC13/2011/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC18.1/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC27.1/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC28.4/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/New Orleans/2010/USA VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/SGU-110421/KOR/2011 VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII/20469/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/BG1C0241-33/2011/BGD capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/Seoul1282/KOR/2010 major capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII/Seoul1488/KOR/2011 major capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10325/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10386/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human adenovirus Chiba_E086/2012 fiber (gene: L5),0.8999095837312036
IGSF8,Norovirus GII/Hu/JP/2002/GII.P5_GII.5/Saitama/T52 VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH05/2006/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH08/2006/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH16/2007/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Doonside/NSW536I/2011/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/GZ2010-L26/Guangzhou/CHN/2010 major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Jiangsu1/2011/CHN major capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC2.2/2010/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC2.3/2010/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC27.2/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII/Shanghai/SH2/2008/CHN VP1,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10285/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10313/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/10378/2010/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/Shanghai/SH5/2009/CHN VP1,0.8999095837312036
IGSF8,Variola virus hypothetical protein (gene: J9R),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH11/2006/TW major viral capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH14/2007/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH15/2007/TW major viral capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/20199/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/HS288/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC17.1/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC17.5/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC17.6/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC17.8/2013/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC17.9/2013/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC28.5/2012/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/NIHIC35/2013/USA capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Ohio/684/USA VP1,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Rockdale/NSW006D/2009/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20123/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Human mastadenovirus A E3 CR1-beta1,0.8999095837312036
IGSF8,Horsepox virus HSPV192 (IL-beta-binding protein,0.8999095837312036
IGSF8,Provisional),0.8999095837312036
IGSF8,Modoc virus envelope protein,0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH10/2006/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH22/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Miranda/NSW850K/2011/AU VP1,0.8999095837312036
IGSF8,Norovirus Hu/Norwalk/20033/2009/VNM capsid protein VP1 (gene: VP1),0.8999095837312036
IGSF8,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) HA2 (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH18/2008/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Norovirus Hu/GII-4/CGMH28/2010/TW major viral capsid protein (gene: VP1),0.8999095837312036
IGSF8,Human adenovirus 43 fiber protein (pIV) (gene: L5),0.8999095837312036
IGSF8,Influenza A virus (A/California/04/2009(H1N1)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Influenza A virus (A/California/07/2009(H1N1)) hemagglutinin (gene: HA),0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Guangzhou/GZ2010-L88/CHN/2011 major viral capsid protein,0.8999095837312036
IGSF8,Norovirus Hu/GII.4/Guangzhou/GZ2010-L91/CHN/2011 major viral capsid protein,0.9028576823827708
IGSF8,Human gammaherpesvirus 8 K6 (gene: K6),0.9056300531913352
IGSF8,Human T-lymphotropic virus 2 full_polyprotein 1..982,0.9057542447893764
IGSF8,West Nile virus lineage 2 excised_polyprotein 1..2273 (gene: flavivirus polyprotein),0.9057542447893764
IGSF8,Reston ebolavirus - Reston virion spike glycoprotein precursor (gene: GP),0.9057542447893764
IGSF8,Molluscum contagiosum virus subtype 1 MC013L (gene: MC013L),0.9057542447893764
IGSF8,Vaccinia virus Ankara CD47-like protein,0.9057542447893764
IGSF8,West Nile virus lineage 2 envelope protein E (gene: flavivirus polyprotein),0.9057542447893764
IGSF8,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
IGSF8,Orf virus ORF132 vascular endothelial growth factor-like protein,0.9057542447893764
IGSF8,Human adenovirus 36 fiber,0.9057542447893764
IGSF8,SARS coronavirus P2 spike glycoprotein precursor,0.9057542447893764
IGSF8,SARS coronavirus E2 glycoprotein precursor (gene: S),0.9057542447893764
IGSF8,SARS coronavirus Tor2 spike glycoprotein,0.9057542447893764
IGSF8,Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R),0.9057542447893764
IGSF8,Human papillomavirus 173 E1,0.9057542447893764
IGSF8,Human adenovirus D37 48.9 kDa (gene: E3),0.9057542447893764
IGSF8,Human adenovirus 71 fiber (gene: L5),0.9057542447893764
IGSF8,Influenza A virus (A/New York/599/1996(H3N2)) HA2 (gene: HA),0.9057542447893764
IGSF8,Influenza A virus (A/New York/602/1996(H3N2)) HA2 (gene: HA),0.9057542447893764
IGSF8,Human adenovirus 19 fiber (gene: L5),0.9057542447893764
IGSF8,Human adenovirus 58 fiber (gene: L5),0.9057542447893764
IGSF8,Human adenovirus D10 fiber (gene: L5),0.9057542447893764
IGSF8,Human adenovirus 61 E3 CR1 beta,0.9057542447893764
IGSF8,Molluscum contagiosum virus subtype 1 MC162R (gene: MC162R),0.9057542447893764
IGSF8,Human adenovirus 65 L5 fiber,0.9057542447893764
IGSF8,Human mastadenovirus D fiber (gene: L5),0.9057542447893764
IGSF8,Human adenovirus 56 fiber protein (gene: L5),0.9057542447893764
IGSF8,Human adenovirus 64 L5 fiber protein,0.9057542447893764
IGSF8,Human adenovirus D37 fiber (gene: L5),0.9057542447893764
IGSF8,Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A),0.9057542447893764
IGSF8,Influenza A virus (A/New York/392/2004(H3N2)) HA2 (gene: HA),0.9057542447893764
IGSF8,Human adenovirus D8 fiber (gene: L5),0.9057542447893764
IGSF8,Human adenovirus 54 fiber,0.9058994261255549
IGSF8,Human mastadenovirus D fiber,0.9058994261255549
IGSF8,Human adenovirus 17 fiber,0.9058994261255549
IGSF8,Vaccinia virus hemagglutinin (gene: A56R),0.9065231464138438
IGSF8,Human adenovirus 63 fiber protein (gene: L5),0.9118403763180049
IGSF8,Human adenovirus 49 fiber,0.915880438522078
IGSF8,Cercopithecine betaherpesvirus 5 membrane protein RL11M (gene: RL11M),0.915880438522078
IGSF8,Human adenovirus 23 fibre protein (gene: L5),0.915880438522078
IGSF8,Human adenovirus 67 L5 fiber,0.915880438522078
IGSF8,Human adenovirus 41 E3 31.6K,0.9176642913406818
IGSF8,Human adenovirus 46 fiber,0.9197295331382644
IGSF8,Human adenovirus 18 CR1-beta protein (gene: E3),0.9237501457186692
IGSF8,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9237501457186692
IGSF8,Human adenovirus D8 45.5kDa protein (gene: E3),0.9237501457186692
IGSF8,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.9237501457186692
IGSF8,Human betaherpesvirus 5 membrane glycoprotein UL11 (gene: UL11),0.9287050575620676
IGSF8,Yaba monkey tumor virus Ig domain OX-2-like protein,0.9287050575620676
IGSF8,Vaccinia virus Ankara Haemagglutinin,0.9287050575620676
IGSF8,Human gammaherpesvirus 4 probable membrane glycoprotein (gene: BILF2),0.9287050575620676
IGSF8,Human herpesvirus 4 type 2 BILF2,0.9287050575620676
IGSF8,Cercopithecine betaherpesvirus 5 membrane protein RL11Q (gene: RL11Q),0.9318782091866168
IGSF8,West Nile virus lineage 2 excised_polyprotein 1..791 (gene: flavivirus polyprotein),0.9318782091866168
IGSF8,Influenza A virus (A/California/04/2009(H1N1)) HA2 (gene: HA),0.9318782091866168
IGSF8,Influenza A virus (A/California/07/2009(H1N1)) HA2 (gene: HA),0.9364561700418303
IGSF8,Human mastadenovirus A E3 CR1-alpha1,0.9366403811337995
IGSF8,Human betaherpesvirus 5 membrane glycoprotein UL7 (gene: UL7),0.978882862740732
IPO8,Endometrial Carcinoma,0.7765852775619541
IPO8,Malignant neoplasm of lung,0.7880542567584415
IPO8,Primary malignant neoplasm of lung,0.7880542567584415
IPO8,Carcinoma of lung,0.7880542567584415
IPO8,Degenerative polyarthritis,0.8019075543217649
IPO8,Schizophrenia,0.8067197998685076
IPO8,Inflammatory Bowel Diseases,0.8815127642200768
IPO8,Bipolar Disorder,0.900167961295542
IPO8,Schizoaffective Disorder,0.9441119274323576
IPO8,Schizophrenia,0.7860378120955526
IPO8,Schizoaffective Disorder,0.9015263516356564
IPO8,Bipolar Disorder,0.943322675973118
IPO8,NEK9-related lethal skeletal dysplasia ORPHA:464366,0.5867963421058087
IPO8,Nevus comedonicus syndrome ORPHA:64754,0.5867963421058087
IPO8,Pancreatic agenesis-holoprosencephaly syndrome ORPHA:556955,0.5867963421058087
IPO8,X-linked intellectual disability Cabezas type ORPHA:85293,0.5867963421058087
IPO8,Juvenile amyotrophic lateral sclerosis ORPHA:300605,0.5959529547720634
IPO8,Juvenile myelomonocytic leukemia ORPHA:86834,0.6196505963261838
IPO8,Endometrial stromal sarcoma ORPHA:213711,0.8922466888454011
IPO8,Hereditary late-onset Parkinson disease ORPHA:411602,0.8922466888454011
IPO8,Endocrine-cerebro-osteodysplasia syndrome ORPHA:199332,0.8922466888454011
IPO8,Rhizomelic chondrodysplasia punctata type 3 ORPHA:309803,0.8922466888454011
IPO8,Primary mediastinal large B-cell lymphoma ORPHA:98838,0.8922466888454011
IPO8,Syndromic diarrhea ORPHA:84064,0.8922466888454011
IQCJ-SCHIP1,Adenomatous Polyposis Coli,0.5196624042573144
IQCJ-SCHIP1,Total iron binding capacity function,0.7880542567584415
IQCJ-SCHIP1,Iron binding capacity total measurement,0.7880542567584415
IQCJ-SCHIP1,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
IQCJ-SCHIP1,Chromophobe Renal Cell Carcinoma,0.8019075543217649
IQCJ-SCHIP1,Triglycerides measurement,0.8232134984476662
IQCJ-SCHIP1,Waist Circumference,0.9241582777301016
IQCJ-SCHIP1,Smoking Behaviors,0.9564633032157428
IQCJ-SCHIP1,Oral Ulcer,0.7765582368651238
IQCJ-SCHIP1,Asthma,0.9832345076528324
IQSEC1,Malignant neoplasm of breast,0.4084380369379369
IQSEC1,Breast Carcinoma,0.7333611688795861
IQSEC1,Adenocarcinoma,0.750391252594775
IQSEC1,Malignant neoplasm of pancreas,0.7688485284765829
IQSEC1,Pancreatic carcinoma,0.7765852775619541
IQSEC1,Mammary Neoplasms,0.7880542567584415
IQSEC1,Malignant neoplasm of lung,0.7880542567584415
IQSEC1,Liver carcinoma,0.7880542567584415
IQSEC1,Malignant Head and Neck Neoplasm,0.7880542567584415
IQSEC1,Neoplasm Metastasis,0.7880542567584415
IQSEC1,Ductal Carcinoma,0.7880542567584415
IQSEC1,Lung Neoplasms,0.7880542567584415
IQSEC1,Secondary malignant neoplasm of liver,0.7908231553833205
IQSEC1,Liver neoplasms,0.8019075543217649
IQSEC1,Adenocarcinoma of lung (disorder),0.8098851543361193
IQSEC1,Brain Aneurysm,0.8145035474981049
IQSEC1,Head and Neck Carcinoma,0.8648405521677974
IQSEC1,Non-Syndromic Intellectual Disability,0.6734982286750932
IQSEC1,Developmental Delay,0.7765582368651238
IQSEC1,Mental Retardation,0.8337953215113012
IQSEC1,Lung Cancer,0.8706864397989688
IQSEC1,Intracranial Aneurysm,0.8759421888249375
IQSEC1,Lung Neoplasms,0.8903301324869451
IQSEC1,Dwarfism,0.9510372690456612
IQSEC1,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
IQSEC1,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
IQSEC1,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
IQSEC1,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
IQSEC1,Distal monosomy 1q ORPHA:36367,0.1040670578681756
IQSEC1,2q37 microdeletion syndrome ORPHA:1001,0.1991445465001551
IQSEC1,Birt-Hogg-Dube syndrome ORPHA:122,0.1991445465001551
IQSEC1,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144,0.1991445465001551
IQSEC1,Familial spontaneous pneumothorax ORPHA:2903,0.1991445465001551
IQSEC1,Mucopolysaccharidosis type 2 attenuated form ORPHA:217093,0.1991445465001551
IQSEC1,Mucopolysaccharidosis type 2 severe form ORPHA:217085,0.1991445465001551
IQSEC1,Progressive myoclonic epilepsy type 3 ORPHA:263516,0.3832844616405875
IQSEC1,Huntington disease ORPHA:399,0.3832844616405875
IQSEC1,COG1-CDG ORPHA:263508,0.5867963421058087
IQSEC1,External auditory canal aplasia/hypoplasia ORPHA:141074,0.5867963421058087
IQSEC1,Primary intraosseous venous malformation ORPHA:140436,0.5867963421058087
IQSEC1,Ramon syndrome ORPHA:3019,0.5867963421058087
IQSEC1,Spinocerebellar ataxia type 13 ORPHA:98768,0.5867963421058087
IQSEC1,Familial advanced sleep-phase syndrome ORPHA:164736,0.7929682744768703
IQSEC1,Autosomal recessive non-syndromic intellectual disability ORPHA:88616,0.8922466888454011
IQSEC1,Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome ORPHA:329224,0.8922466888454011
IQSEC1,RERE-related neurodevelopmental syndrome ORPHA:494344,0.8922466888454011
IQSEC1,Rett syndrome ORPHA:778,0.8922466888454011
IQSEC1,Rubinstein-Taybi syndrome due to 16p13.3 microdeletion ORPHA:353281,0.8922466888454011
IQSEC1,Rubinstein-Taybi syndrome due to CREBBP mutations ORPHA:353277,0.8922466888454011
IQSEC1,Severe neonatal-onset encephalopathy with microcephaly ORPHA:209370,0.8922466888454011
IQSEC1,Trisomy Xq28 ORPHA:1762,0.8922466888454011
IQSEC1,X-linked intellectual disability-psychosis-macroorchidism syndrome ORPHA:3077,0.8922466888454011
IQSEC1,Porphyria due to ALA dehydratase deficiency ORPHA:100924,0.8922466888454011
ISG15,Malignant neoplasm of breast,0.4084380369379369
ISG15,Carcinoma of bladder,0.4084380369379369
ISG15,Bladder Neoplasm,0.4084380369379369
ISG15,Malignant neoplasm of urinary bladder,0.5071083164302358
ISG15,Breast Carcinoma,0.7333611688795861
ISG15,Carcinogenesis,0.7333611688795861
ISG15,Malignant neoplasm of pancreas,0.7688485284765829
ISG15,Pancreatic carcinoma,0.7765852775619541
ISG15,Esophageal carcinoma,0.7765852775619541
ISG15,Non-Small Cell Lung Carcinoma,0.7765852775619541
ISG15,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
ISG15,Esophageal Neoplasms,0.7765852775619541
ISG15,Mammary Neoplasms,0.7880542567584415
ISG15,Refractory anemias,0.7880542567584415
ISG15,Promyelocytic leukemia,0.7880542567584415
ISG15,Liver carcinoma,0.7880542567584415
ISG15,Malignant neoplasm of esophagus,0.7880542567584415
ISG15,Acute Promyelocytic Leukemia,0.7880542567584415
ISG15,Ataxia Telangiectasia,0.7880542567584415
ISG15,Neoplasm Metastasis,0.7880542567584415
ISG15,Triple Negative Breast Neoplasms,0.7880542567584415
ISG15,Immunologic Deficiency Syndromes,0.7880542567584415
ISG15,melanoma,0.7880542567584415
ISG15,Lung Neoplasms,0.7880542567584415
ISG15,Hemorrhagic Fever Crimean,0.7880542567584415
ISG15,Malignant neoplasm of stomach,0.7880542567584415
ISG15,Vesicular Stomatitis,0.7880542567584415
ISG15,Recurrent mycobacterial infections,0.7880542567584415
ISG15,Nasopharyngeal carcinoma,0.7880542567584415
ISG15,Hepatitis E,0.7880542567584415
ISG15,Sindbis virus infection,0.7880542567584415
ISG15,Lupus Erythematosus Systemic,0.7880542567584415
ISG15,Fungal keratitis,0.7880542567584415
ISG15,Stomach Carcinoma,0.7880542567584415
ISG15,Inflammatory cardiomyopathy,0.7880542567584415
ISG15,Autoimmune Diseases,0.7880542567584415
ISG15,Hepatitis C,0.7880542567584415
ISG15,Usher Syndrome Type III,0.7880542567584415
ISG15,Rheumatoid Arthritis,0.7880542567584415
ISG15,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.7880542567584415
ISG15,Tumor Immunity,0.7880542567584415
ISG15,Virus Diseases,0.7880542567584415
ISG15,Infection by Candida albicans,0.7880542567584415
ISG15,Bacterial Infections,0.7908231553833205
ISG15,Psoriasis,0.8019075543217649
ISG15,Listeriosis,0.8019075543217649
ISG15,Liver neoplasms,0.8019075543217649
ISG15,ovarian neoplasm,0.8067197998685076
ISG15,Hepatitis C Virus Infection,0.8138488881521341
ISG15,Myocarditis,0.8190761496232595
ISG15,Lip and Oral Cavity Carcinoma,0.8190761496232595
ISG15,Malignant neoplasm of tongue,0.8232134984476662
ISG15,Adult type dermatomyositis,0.8272008757995397
ISG15,Tuberculosis,0.8368219249856942
ISG15,Congenital Abnormality,0.8402911822757345
ISG15,Mycobacterium Infections,0.8402911822757345
ISG15,Hepatitis B,0.841396342333011
ISG15,Dermatomyositis,0.8648405521677974
ISG15,Respiratory Syncytial Virus Infections,0.8648405521677974
ISG15,Cystitis,0.8648405521677974
ISG15,Heart failure,0.8867509400747969
ISG15,Malignant neoplasm of mouth,0.8946938397586319
ISG15,Congestive heart failure,0.8976039441125321
ISG15,Influenza,0.9193385822373632
ISG15,Hepatitis C Chronic,0.9432051631882106
ISG15,Malignant neoplasm of larynx,0.9571401094099016
ISG15,Immunologic Deficiency Syndromes,0.7765582368651238
ISG15,Liver Carcinoma,0.7765582368651238
ISG15,Psychosis,0.7765582368651238
ISG15,Involutional Depression,0.8115918568696846
ISG15,Involutional Paraphrenia,0.8115918568696846
ISG15,Mental Depression,0.8903630091389316
ISG15,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
ISG15,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
ISG15,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.1040670578681756
ISG15,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,0.3891940933600213
ISG15,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487,0.5867963421058087
ISG15,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect ORPHA:521411,0.5867963421058087
ISG15,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595,0.5867963421058087
ISG15,Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311,0.5867963421058087
ISG15,USP18 deficiency ORPHA:481665,0.5867963421058087
ISG15,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
ISG15,Human adenovirus 11+34 encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ISG15,Human adenovirus 34 maturation protein IVa2 (gene: IVa2),0.8999095837312036
ISG15,Human adenovirus 35 IVa2,0.8999095837312036
ISG15,Human betaherpesvirus 6 U31 large tegument protein (gene: U31),0.8999095837312036
ISG15,Human betaherpesvirus 6A large tegument protein (gene: U31),0.8999095837312036
ISG15,Human betaherpesvirus 6B large tegument protein (gene: U31),0.8999095837312036
ISG15,Human mastadenovirus B encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ISG15,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.8999095837312036
ISG15,Dugbe virus L protein,0.8999095837312036
ISG15,Human betaherpesvirus 7 large tegument protein (gene: U31),0.8999095837312036
ISG15,SARS coronavirus endoRNAse (gene: orf1ab),0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp1 protein (gene: orf1ab),0.8999095837312036
ISG15,Human betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
ISG15,Human adenovirus 14 IVa2 protein (gene: IVa2),0.8999095837312036
ISG15,Human adenovirus 55 pIVa2 50.9 kDa protein,0.8999095837312036
ISG15,Human adenovirus 66 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ISG15,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
ISG15,Human mastadenovirus E encapsidation protein IVa2 (gene: IVa2),0.8999095837312036
ISG15,Human adenovirus E4 protein IVa2,0.8999095837312036
ISG15,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
ISG15,SARS coronavirus RNA-dependent RNA polymerase (gene: orf1ab),0.8999095837312036
ISG15,Horsepox virus HSPV197 (Hypothetical protein),0.8999095837312036
ISG15,Influenza B virus nonstructural protein 1 (gene: NS1),0.8999095837312036
ISG15,Human adenovirus 3+7 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ISG15,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
ISG15,Human herpesvirus 3 strain Dumas ring-finger protein,0.8999095837312036
ISG15,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.8999095837312036
ISG15,SARS coronavirus 2-O-ribose methyltransferase (2-o-MT) (gene: orf1ab),0.8999095837312036
ISG15,Vaccinia virus Ankara viral core cysteine proteinase,0.8999095837312036
ISG15,Reston ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
ISG15,Yaba-like disease virus 140R protein (gene: 140R),0.8999095837312036
ISG15,Macacine alphaherpesvirus 1 large tegument protein (gene: UL36),0.8999095837312036
ISG15,SARS coronavirus nsp9-pp1a/pp1ab (gene: orf1ab),0.8999095837312036
ISG15,Human adenovirus 11a IVa2,0.8999095837312036
ISG15,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
ISG15,Variola virus hypothetical protein (gene: K7L),0.8999095837312036
ISG15,Monkeypox virus viral core cysteine proteinase,0.8999095837312036
ISG15,Monkeypox virus Zaire-96-I-16 I7L (gene: I7L),0.8999095837312036
ISG15,SARS coronavirus nsp13-pp1ab (ZD NTPase/HEL,0.8999095837312036
ISG15,RNA (gene: orf1ab),0.8999095837312036
ISG15,Yaba monkey tumor virus 48L,0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp12 protein (gene: orf1ab),0.8999095837312036
ISG15,Bundibugyo ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
ISG15,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.8999095837312036
ISG15,Vaccinia virus viral core cysteine proteinase (gene: I7L),0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp5 protein (gene: orf1ab),0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp16 protein (gene: orf1ab),0.8999095837312036
ISG15,SARS coronavirus nsp4-pp1a/pp1ab (gene: orf1ab),0.8999095837312036
ISG15,Rotavirus A NSP4,0.8999095837312036
ISG15,Horsepox virus HSPV077 (Vaccinia virus I7 processing peptidase),0.8999095837312036
ISG15,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
ISG15,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp4 protein (gene: orf1ab),0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp10 protein (gene: orf1ab),0.8999095837312036
ISG15,SARS coronavirus formerly known as growth-factor-like protein (gene: orf1ab),0.8999095837312036
ISG15,Human gammaherpesvirus 8 K4.1 (gene: K4.1),0.8999095837312036
ISG15,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp9 protein (gene: orf1ab),0.8999095837312036
ISG15,SARS coronavirus 3C-like proteinase (gene: orf1ab),0.8999095837312036
ISG15,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.8999095837312036
ISG15,Yaba-like disease virus 19L protein (gene: 19L),0.8999095837312036
ISG15,SARS coronavirus leader protein (gene: orf1ab),0.8999095837312036
ISG15,Human parainfluenza virus 1 strain Washington/1964 phosphoprotein (gene: P),0.8999095837312036
ISG15,Human respirovirus 1 phosphoprotein (gene: P),0.8999095837312036
ISG15,Macacine alphaherpesvirus 1 DNA replication origin-binding helicase (gene: UL9),0.8999095837312036
ISG15,Human adenovirus 16 maturation protein IVA2 (gene: IVa2),0.8999095837312036
ISG15,Reston ebolavirus polymerase complex protein (gene: VP35),0.8999095837312036
ISG15,Human alphaherpesvirus 2 multifunctional expression regulator (gene: UL54),0.8999095837312036
ISG15,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.8999095837312036
ISG15,Ectromelia virus ERPV kelch-like protein,0.8999095837312036
ISG15,Vaccinia virus Kelch-like protein (gene: F3L),0.8999095837312036
ISG15,Vaccinia virus Ankara Kelch-like protein,0.8999095837312036
ISG15,Vaccinia virus kelch-like protein (gene: A55R),0.8999095837312036
ISG15,SARS coronavirus Tor2 replicase 1AB,0.8999095837312036
ISG15,Cercopithecine alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.8999095837312036
ISG15,SARS coronavirus P2 full_polyprotein 1..7073,0.8999095837312036
ISG15,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.8999095837312036
ISG15,Yaba-like disease virus 141R protein (gene: 141R),0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp13 protein (gene: orf1ab),0.8999095837312036
ISG15,Yaba monkey tumor virus kelch-like protein,0.8999095837312036
ISG15,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
ISG15,Variola virus hypothetical protein (gene: A28L),0.8999095837312036
ISG15,Horsepox virus HSPV043 (Kelch-like protein,0.8999095837312036
ISG15,Provisional),0.8999095837312036
ISG15,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
ISG15,SARS coronavirus nsp3-pp1a/pp1ab (gene: orf1ab),0.8999095837312036
ISG15,Human betaherpesvirus 6B G-protein coupled receptor (gene: U12),0.8999095837312036
ISG15,Macacine alphaherpesvirus 1 tegument protein VP22 (gene: UL49),0.8999095837312036
ISG15,Papiine alphaherpesvirus 2 large tegument protein (gene: UL36),0.8999095837312036
ISG15,Horsepox virus HSPV029 (kelch-like protein,0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp8 protein (gene: orf1ab),0.8999095837312036
ISG15,Human parechovirus 6 capsid protein VP0,0.8999095837312036
ISG15,Influenza B virus (B/Memphis/12/97) NS protein,0.8999095837312036
ISG15,Variola virus hypothetical protein (gene: B22R),0.8999095837312036
ISG15,Cowpox virus CPXV035 protein (gene: CPXV035 CDS),0.8999095837312036
ISG15,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
ISG15,Ebola virus - Mayinga Zaire 1976 virion spike glycoprotein precursor (gene: GP),0.8999095837312036
ISG15,Zaire ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
ISG15,Vaccinia virus kelch-like protein (gene: C2L),0.8999095837312036
ISG15,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
ISG15,Reston ebolavirus - Reston VP35 (gene: VP35),0.8999095837312036
ISG15,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp15 protein (gene: orf1ab),0.8999095837312036
ISG15,SARS coronavirus nsp7-pp1a/pp1ab (gene: orf1ab),0.8999095837312036
ISG15,Human immunodeficiency virus pol protein (gene: pol),0.8999095837312036
ISG15,Human gammaherpesvirus 8 K14,0.8999095837312036
ISG15,Human rhinovirus QCE 3C,0.8999095837312036
ISG15,Orf virus ORF035 virion core protease,0.8999095837312036
ISG15,Monkeypox virus cowpox A-type inclusion protein,0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp3 protein (gene: orf1ab),0.8999095837312036
ISG15,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
ISG15,Human gammaherpesvirus 4 large tegument protein (gene: BPLF1),0.8999095837312036
ISG15,Human herpesvirus 4 type 2 BPLF1,0.8999095837312036
ISG15,Human herpesvirus 3 strain Dumas Tegument protein VP22 (gene: ORF9),0.8999095837312036
ISG15,Human alphaherpesvirus 3 tegument protein VP22 (gene: ORF9),0.8999095837312036
ISG15,Variola virus hypothetical protein (gene: A35L),0.8999095837312036
ISG15,Middle East respiratory syndrome-related coronavirus nsp7 protein (gene: orf1ab),0.8999095837312036
ISG15,Human immunodeficiency virus envelope glycoprotein (gene: env),0.8999095837312036
ISG15,SARS coronavirus nsp8-pp1a/pp1ab (gene: orf1ab),0.8999095837312036
ISG15,Ectromelia virus ERPV hemagglutinin,0.8999095837312036
ISG15,Aichi virus 1 3D,0.8999095837312036
ISG15,Cercopithecine alphaherpesvirus 2 large tegument protein (gene: UL36),0.8999095837312036
ISG15,Cowpox virus CPXV086 protein (gene: CPXV086 CDS),0.8999095837312036
ISG15,Human betacoronavirus 2c EMC/2012 ORF1ab (gene: orf1ab),0.8999095837312036
ISG15,Yaba-like disease virus 48L protein (gene: 48L),0.8999095837312036
ISG15,Human group 1 coronavirus associated with pneumonia ORF 1a,0.8999095837312036
ISG15,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
ISG15,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.8999095837312036
ISG15,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
ISG15,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
ISG15,Human alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.8999095837312036
ISG15,Variola virus hypothetical protein (gene: J9R),0.8999095837312036
ISG15,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
ISG15,Human mastadenovirus A E3 CR1-beta1,0.9028576823827708
ISG15,Human alphaherpesvirus 1 tegument protein VP22 (gene: UL49),0.9057542447893764
ISG15,Human gammaherpesvirus 8 ORF64 (gene: ORF64),0.9057542447893764
ISG15,Molluscum contagiosum virus subtype 1 MC049L (gene: MC049L),0.9057542447893764
ISG15,Molluscum contagiosum virus subtype 1 MC013L (gene: MC013L),0.9057542447893764
ISG15,SARS coronavirus excised_polyprotein 1..4369 (gene: orf1ab),0.9057542447893764
ISG15,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
ISG15,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
ISG15,SARS coronavirus P2 full_polyprotein 1..4382,0.9057542447893764
ISG15,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
ISG15,Human adenovirus 61 E3 CR1 beta,0.9057542447893764
ISG15,Human herpesvirus 3 strain Dumas Large tegument protein deneddylase (gene: ORF22),0.9057542447893764
ISG15,Human alphaherpesvirus 3 large tegument protein (gene: ORF22),0.9057542447893764
ISG15,Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A),0.9057542447893764
ISG15,Human betacoronavirus 2c Jordan-N3/2012 ORF1ab protein (gene: ORF1ab),0.9057542447893764
ISG15,Orf virus ORF071 NPH-PPH downregulator,0.9058994261255549
ISG15,Betacoronavirus England 1 ORF1b protein (gene: orf1ab),0.915880438522078
ISG15,Human betacoronavirus 2c England-Qatar/2012 ORF1ab,0.9176018655958595
ISG15,Vaccinia virus hemagglutinin (gene: A56R),0.9176018655958595
ISG15,Human adenovirus 41 E3 31.6K,0.9187390604217726
ISG15,Human betacoronavirus 2c Jordan-N3/2012 ORF1a protein (gene: ORF1ab),0.9197295331382644
ISG15,Molluscum contagiosum virus subtype 1 MC099R (gene: MC099R),0.9224878266317492
ISG15,Human betacoronavirus 2c EMC/2012 ORF1a (gene: orf1ab),0.9224878266317492
ISG15,Human adenovirus 18 CR1-beta protein (gene: E3),0.9237501457186692
ISG15,Human betacoronavirus 2c England-Qatar/2012 ORF1a,0.9237501457186692
ISG15,Betacoronavirus England 1 ORF1a protein (gene: orf1ab),0.928070054828895
ISG15,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9287050575620676
ISG15,Human alphaherpesvirus 1 large tegument protein (gene: UL36),0.9287050575620676
ISG15,Papiine alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.9287050575620676
ISG15,Human group 1 coronavirus associated with pneumonia ORF 1ab,0.9287050575620676
ISG15,Vaccinia virus Ankara Haemagglutinin,0.9325850920715436
ISG15,Human coronavirus 229E full_polyprotein 1..4085,0.945571760415642
ITM2B,Malignant neoplasm of breast,0.4084380369379369
ITM2B,Breast Carcinoma,0.7333611688795861
ITM2B,B-Cell Lymphomas,0.7333611688795861
ITM2B,Dementia familial Danish,0.7765852775619541
ITM2B,Lymphoma,0.7765852775619541
ITM2B,Mammary Neoplasms,0.7880542567584415
ITM2B,Amyloidosis Familial,0.7880542567584415
ITM2B,Neurofibrillary degeneration (morphologic abnormality),0.7880542567584415
ITM2B,T-Cell Lymphoma,0.7880542567584415
ITM2B,Prion Diseases,0.7880542567584415
ITM2B,Prostatic Neoplasms,0.7880542567584415
ITM2B,Neuroblastoma,0.7880542567584415
ITM2B,Muscle Hypertonia,0.7880542567584415
ITM2B,Central neuroblastoma,0.7880542567584415
ITM2B,Retinal Diseases,0.7880542567584415
ITM2B,Posterior polar cataract,0.7880542567584415
ITM2B,AURAL ATRESIA CONGENITAL,0.7880542567584415
ITM2B,Myxoid cyst,0.7880542567584415
ITM2B,Pallor of optic disc,0.7880542567584415
ITM2B,Dementia familial British,0.7880542567584415
ITM2B,Dementia,0.7880542567584415
ITM2B,Photophobia,0.7880542567584415
ITM2B,Presenile dementia,0.7880542567584415
ITM2B,Alzheimer's Disease,0.7880542567584415
ITM2B,Cerebral Amyloid Angiopathy,0.7880542567584415
ITM2B,Cerebral Amyloid Angiopathy Hereditary,0.7880542567584415
ITM2B,Coinfection,0.7880542567584415
ITM2B,Familial Dementia,0.7880542567584415
ITM2B,Photodysphoria,0.7880542567584415
ITM2B,Amyloid angiopathy,0.7908231553833205
ITM2B,Plaque Amyloid,0.8009048756462318
ITM2B,Congenital deafness,0.8019075543217649
ITM2B,Progressive neurologic deterioration,0.8019075543217649
ITM2B,Senile Plaques,0.8019075543217649
ITM2B,Hearing Loss Partial,0.8098851543361193
ITM2B,Deafness,0.8190761496232595
ITM2B,Terminal tremor,0.8190761496232595
ITM2B,Impaired cognition,0.8190761496232595
ITM2B,Tremor,0.8190761496232595
ITM2B,Retinal Dystrophies,0.8190761496232595
ITM2B,Fibrillation,0.8190761496232595
ITM2B,Neurodegenerative Disorders,0.8272008757995397
ITM2B,Lipoma,0.8272008757995397
ITM2B,hearing impairment,0.834094492023826
ITM2B,Ataxia,0.8402911822757345
ITM2B,Hypertensive disease,0.8474481237156937
ITM2B,Memory impairment,0.8474481237156937
ITM2B,Action Tremor,0.8642802827048847
ITM2B,Muscle Rigidity,0.8648405521677974
ITM2B,Amyloidosis,0.8672189956534445
ITM2B,Memory Loss,0.8769418330148872
ITM2B,Cerebellar Ataxia,0.906476206143938
ITM2B,Psychotic Disorders,0.939985154445373
ITM2B,Muscle Spasticity,0.9564633032157428
ITM2B,Stroke,0.7765582368651238
ITM2B,Retinal Dystrophy,0.7765582368651238
ITM2B,Cerebral Amyloid Angiopathy,0.7765582368651238
ITM2B,Ischemic Stroke,0.7765582368651238
ITM2B,Psychosis,0.7765582368651238
ITM2B,Hypertension,0.7765582368651238
ITM2B,Dementia,0.861756360478846
ITM2B,Spastic Tetraparesis,0.861756360478846
ITM2B,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.1040670578681756
ITM2B,Mucopolysaccharidosis type 2 attenuated form ORPHA:217093,0.1991445465001551
ITM2B,Mucopolysaccharidosis type 2 severe form ORPHA:217085,0.1991445465001551
ITM2B,46XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752,0.3832844616405875
ITM2B,Duane retraction syndrome with congenital deafness ORPHA:529574,0.3832844616405875
ITM2B,Hemochromatosis type 4 ORPHA:139491,0.3832844616405875
ITM2B,Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774,0.3832844616405875
ITM2B,ABri amyloidosis ORPHA:97345,0.5867963421058087
ITM2B,ADan amyloidosis ORPHA:97346,0.5867963421058087
ITM2B,Atypical Gaucher disease due to saposin C deficiency ORPHA:309252,0.5867963421058087
ITM2B,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581,0.5867963421058087
ITM2B,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569,0.5867963421058087
ITM2B,Ayme-Gripp syndrome ORPHA:1272,0.5867963421058087
ITM2B,Encephalopathy due to prosaposin deficiency ORPHA:139406,0.5867963421058087
ITM2B,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854,0.5867963421058087
ITM2B,Hereditary myopathy with lactic acidosis due to ISCU deficiency ORPHA:43115,0.5867963421058087
ITM2B,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898,0.5867963421058087
ITM2B,Mitochondrial DNA depletion syndrome myopathic form ORPHA:254875,0.5867963421058087
ITM2B,NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907,0.5867963421058087
ITM2B,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies ORPHA:397758,0.5867963421058087
ITM2B,Infantile Krabbe disease ORPHA:206436,0.5867963421058087
ITM2B,Adult Krabbe disease ORPHA:206448,0.7929682744768703
ITM2B,Cerebrotendinous xanthomatosis ORPHA:909,0.7929682744768703
ITM2B,Farber disease ORPHA:333,0.7929682744768703
ITM2B,Late-infantile/juvenile Krabbe disease ORPHA:206443,0.7929682744768703
ITM2B,RNF13-related severe early-onset epileptic encephalopathy ORPHA:544503,0.7929682744768703
ITM2B,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome ORPHA:2590,0.7929682744768703
ITM2B,Antenatal Bartter syndrome ORPHA:93604,0.7929682744768703
ITM2B,AGel amyloidosis ORPHA:85448,0.8922466888454011
ITM2B,Familial multiple nevi flammei ORPHA:624,0.8922466888454011
ITM2B,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105,0.8922466888454011
ITM2B,Marfan syndrome type 2 ORPHA:284973,0.8922466888454011
ITM2B,Methylmalonic acidemia with homocystinuria type cblF ORPHA:79284,0.8922466888454011
ITM2B,Sanfilippo syndrome type C ORPHA:79271,0.8922466888454011
ITM2B,Sturge-Weber syndrome ORPHA:3205,0.8922466888454011
ITM2B,X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328,0.8922466888454011
ITM2B,Semantic dementia ORPHA:100069,0.8922466888454011
ITM2B,Glycogen storage disease due to LAMP-2 deficiency ORPHA:34587,0.8922466888454011
ITM2B,X-linked intellectual disability Hedera type ORPHA:93952,0.8922466888454011
ITM2B,X-linked parkinsonism-spasticity syndrome ORPHA:363654,0.8922466888454011
ITPRIP,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
ITPRIP,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
ITPRIP,Camurati-Engelmann disease ORPHA:1328,0.1991445465001551
ITPRIP,Infantile inflammatory bowel disease with neurological involvement ORPHA:565788,0.1991445465001551
ITPRIP,Mucopolysaccharidosis type 6 rapidly progressing ORPHA:276212,0.1991445465001551
ITPRIP,Mucopolysaccharidosis type 6 slowly progressing ORPHA:276223,0.1991445465001551
ITPRIP,Musculocontractural Ehlers-Danlos syndrome ORPHA:2953,0.1991445465001551
ITPRIP,Polydactyly of a biphalangeal thumb ORPHA:93339,0.3832844616405875
ITPRIP,Squamous cell carcinoma of salivary glands ORPHA:500481,0.3832844616405875
ITPRIP,Squamous cell carcinoma of the hypopharynx ORPHA:494547,0.3832844616405875
ITPRIP,Squamous cell carcinoma of the larynx ORPHA:494550,0.3832844616405875
ITPRIP,Squamous cell carcinoma of the lip ORPHA:502366,0.3832844616405875
ITPRIP,Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464,0.3832844616405875
ITPRIP,Squamous cell carcinoma of the oral cavity ORPHA:502363,0.3832844616405875
ITPRIP,Squamous cell carcinoma of the oropharynx ORPHA:500478,0.3832844616405875
ITPRIP,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454,0.5867963421058087
ITPRIP,Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366,0.5867963421058087
ITPRIP,Temtamy preaxial brachydactyly syndrome ORPHA:363417,0.7929682744768703
ITPRIP,Loeys-Dietz syndrome ORPHA:60030,0.7929682744768703
ITPRIP,Combined immunodeficiency due to Moesin deficiency ORPHA:504530,0.8922466888454011
ITPRIP,Paternal uniparental disomy of chromosome 6 ORPHA:96191,0.8922466888454011
KAT5,Malignant neoplasm of breast,0.4084380369379369
KAT5,Carcinoma of bladder,0.4084380369379369
KAT5,Bladder Neoplasm,0.4084380369379369
KAT5,Malignant neoplasm of urinary bladder,0.5071083164302358
KAT5,Breast Carcinoma,0.7333611688795861
KAT5,Carcinogenesis,0.7333611688795861
KAT5,leukemia,0.7333611688795861
KAT5,Ovarian Carcinoma,0.7333611688795861
KAT5,Allergic bronchitis,0.7765852775619541
KAT5,Colorectal Carcinoma,0.7765852775619541
KAT5,Colon Carcinoma,0.7765852775619541
KAT5,Leukemia Myelocytic Acute,0.7765852775619541
KAT5,Malignant tumor of colon,0.7765852775619541
KAT5,Lymphoma,0.7765852775619541
KAT5,Leukemogenesis,0.7765852775619541
KAT5,Non-Small Cell Lung Carcinoma,0.7765852775619541
KAT5,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
KAT5,Uric acid measurement (procedure),0.7765852775619541
KAT5,Carcinoma breast stage IV,0.7765852775619541
KAT5,Mammary Neoplasms,0.7880542567584415
KAT5,Glioma,0.7880542567584415
KAT5,Malignant neoplasm of lung,0.7880542567584415
KAT5,Malignant neoplasm of prostate,0.7880542567584415
KAT5,Promyelocytic leukemia,0.7880542567584415
KAT5,Liver carcinoma,0.7880542567584415
KAT5,Thyroid carcinoma,0.7880542567584415
KAT5,Colorectal Cancer,0.7880542567584415
KAT5,Epithelial ovarian cancer,0.7880542567584415
KAT5,Tumor Promotion,0.7880542567584415
KAT5,Glioblastoma,0.7880542567584415
KAT5,Prostate carcinoma,0.7880542567584415
KAT5,Primary malignant neoplasm of lung,0.7880542567584415
KAT5,Neoplasm Metastasis,0.7880542567584415
KAT5,Carcinoma of lung,0.7880542567584415
KAT5,Malignant neoplasm of thyroid,0.7880542567584415
KAT5,melanoma,0.7880542567584415
KAT5,Neoplasms,0.7880542567584415
KAT5,Benign Prostatic Hyperplasia,0.7880542567584415
KAT5,Tumor Progression,0.7880542567584415
KAT5,Salmonella infections,0.7880542567584415
KAT5,Arteriosclerosis,0.7880542567584415
KAT5,Atherosclerosis,0.7880542567584415
KAT5,Alzheimer's Disease,0.7880542567584415
KAT5,Autoimmune Diseases,0.7880542567584415
KAT5,Fanconi Anemia,0.7880542567584415
KAT5,invasive cancer,0.7880542567584415
KAT5,Rheumatoid Arthritis,0.7880542567584415
KAT5,Other specified iron deficiency anemias,0.7880542567584415
KAT5,Crohn Disease,0.7880542567584415
KAT5,Bacterial Infections,0.7908231553833205
KAT5,Metastatic melanoma,0.7940665326856218
KAT5,Leukoencephalopathy Progressive Multifocal,0.8019075543217649
KAT5,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8019075543217649
KAT5,Liver neoplasms,0.8019075543217649
KAT5,Adult T Acute Lymphoblastic Leukemia,0.8067197998685076
KAT5,Schizophrenia,0.8067197998685076
KAT5,Acute GVH disease,0.8101097852323003
KAT5,Dysplastic Nevus,0.8138488881521341
KAT5,Bronchial Hyperreactivity,0.8190761496232595
KAT5,Graft-vs-Host Disease,0.8190761496232595
KAT5,Neurodegenerative Disorders,0.8272008757995397
KAT5,Celiac Disease,0.8402911822757345
KAT5,Sleep disturbances,0.8402911822757345
KAT5,Hepatitis B,0.841396342333011
KAT5,Memory impairment,0.8474481237156937
KAT5,Sleep Disorders,0.8486035047899471
KAT5,Papillary thyroid carcinoma,0.8757755363384367
KAT5,Allergic asthma,0.887595340546704
KAT5,Pulmonary Fibrosis,0.8911256045597441
KAT5,Arthritis Psoriatic,0.8946938397586319
KAT5,nervous system disorder,0.8959157818691486
KAT5,Obesity,0.8989612563669234
KAT5,Bipolar Disorder,0.900167961295542
KAT5,Spinocerebellar Ataxia Type 1,0.906476206143938
KAT5,Cerebral Ischemia,0.9083161862856644
KAT5,Septicemia,0.917543617287358
KAT5,Epileptic encephalopathy,0.917543617287358
KAT5,Sepsis,0.9189398569397552
KAT5,Bacteremia,0.9214835359141188
KAT5,Intellectual Disability,0.9478210444156088
KAT5,Cerebral Infarction,0.9564633032157428
KAT5,Metabolic Diseases,0.9564633032157428
KAT5,Asthma,0.9672478180546946
KAT5,Gout,0.7765582368651238
KAT5,Gouty Arthritis,0.7765582368651238
KAT5,Yunis-Varon syndrome ORPHA:3472,0.5867963421058087
KAT5,Human gammaherpesvirus 4 EBNA-2 nuclear protein (gene: BYRF1),0.9057542447893764
KAT5,Human herpesvirus 4 type 2 EBNA-2,0.9057542447893764
KAT7,Malignant neoplasm of breast,0.4084380369379369
KAT7,Carcinoma of bladder,0.4084380369379369
KAT7,Bladder Neoplasm,0.4084380369379369
KAT7,Malignant neoplasm of urinary bladder,0.5071083164302358
KAT7,Breast Carcinoma,0.7333611688795861
KAT7,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
KAT7,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
KAT7,Mammary Neoplasms,0.7880542567584415
KAT7,Mean Corpuscular Volume (result),0.7880542567584415
KAT7,Aortic Valve Insufficiency,0.7880542567584415
KAT7,Central Serous Chorioretinopathy,0.7908231553833205
KAT7,Androgen-Insensitivity Syndrome,0.9039108388826153
KAT7,Kidney Failure Acute,0.9373358316580888
KAT7,RIDDLE syndrome ORPHA:420741,0.8922466888454011
KAT7,Familial primary hypomagnesemia with normocalciuria and normocalcemia ORPHA:34527,0.8922466888454011
KATNB1,Cortical gyral simplification,0.7765852775619541
KATNB1,Ataxia Telangiectasia,0.7880542567584415
KATNB1,Agyria,0.7880542567584415
KATNB1,Sloping forehead,0.7880542567584415
KATNB1,Lissencephaly,0.7880542567584415
KATNB1,Malformations of Cortical Development,0.7880542567584415
KATNB1,Microlissencephaly,0.7880542567584415
KATNB1,Invasive Ductal Breast Carcinoma,0.7880542567584415
KATNB1,Hypoplasia of corpus callosum,0.7880542567584415
KATNB1,Cognitive delay,0.7880542567584415
KATNB1,Partial or complete agenesis of corpus callosum,0.7880542567584415
KATNB1,Anaplastic thyroid carcinoma,0.7880542567584415
KATNB1,Partial agenesis of corpus callosum,0.7880542567584415
KATNB1,Global developmental delay,0.7880542567584415
KATNB1,Mental and motor retardation,0.7880542567584415
KATNB1,Oligospermia,0.8019075543217649
KATNB1,Impaired cognition,0.8190761496232595
KATNB1,Microcephaly,0.8232134984476662
KATNB1,Congenital Abnormality,0.8402911822757345
KATNB1,Pachygyria,0.8402911822757345
KATNB1,Dilated ventricles (finding),0.8402911822757345
KATNB1,Polymicrogyria,0.8584283190330553
KATNB1,Holoprosencephaly,0.8648405521677974
KATNB1,Mental impairment,0.876210765330195
KATNB1,Small head,0.9822381479823692
KATNB1,Microlissencephaly,0.7765582368651238
KATNB1,Partial Agenesis Of Corpus Callosum,0.7765582368651238
KATNB1,Developmental Delay,0.7765582368651238
KATNB1,Polymicrogyria,0.7765582368651238
KATNB1,Hypoplasia Of Corpus Callosum,0.7949861636679444
KATNB1,Pachygyria,0.8210988731657684
KATNB1,Microcephaly,0.8903630091389316
KATNB1,Neuronal Heterotopia,0.8932724875174971
KATNB1,Impaired Cognition,0.9231137872214272
KATNB1,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
KATNB1,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
KATNB1,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
KATNB1,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.1040670578681756
KATNB1,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.1040670578681756
KATNB1,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.1040670578681756
KATNB1,BAP1-related tumor predisposition syndrome ORPHA:289539,0.1040670578681756
KATNB1,Kufor-Rakeb syndrome ORPHA:306674,0.1040670578681756
KATNB1,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.1040670578681756
KATNB1,Intellectual disability-epilepsy-extrapyramidal syndrome ORPHA:468620,0.3832844616405875
KATNB1,Arnold-Chiari malformation type II ORPHA:1136,0.5867963421058087
KATNB1,Microlissencephaly ORPHA:1083,0.7929682744768703
KATNB1,Hereditary isolated aplastic anemia ORPHA:397692,0.7929682744768703
KCNE3,Serum total cholesterol measurement,0.7880542567584415
KCNE3,ST segment elevation (finding),0.7880542567584415
KCNE3,Episodic flaccid weakness,0.7880542567584415
KCNE3,Episodic hypokalemia,0.7880542567584415
KCNE3,Hyperkalemic periodic paralysis,0.7880542567584415
KCNE3,Neuroleptic Malignant Syndrome,0.7880542567584415
KCNE3,Periodic hypokalemic paresis,0.7880542567584415
KCNE3,Exercise-induced muscle fatigue,0.7880542567584415
KCNE3,Hypokalemic periodic paralysis type 1,0.7880542567584415
KCNE3,Alzheimer's Disease,0.7880542567584415
KCNE3,Thyrotoxic periodic paralysis,0.7880542567584415
KCNE3,Hypokalemic periodic paralysis,0.7880542567584415
KCNE3,Lone atrial fibrillation,0.7880542567584415
KCNE3,Paramyotonia Congenita (disorder),0.7880542567584415
KCNE3,Familial Periodic Paralysis,0.7880542567584415
KCNE3,periodic paralysis (finding),0.7880542567584415
KCNE3,Brugada Syndrome (disorder),0.7880542567584415
KCNE3,Channelopathies,0.7908231553833205
KCNE3,Increased intramyocellular lipid droplets,0.8019075543217649
KCNE3,Mildly elevated creatine phosphokinase,0.8098851543361193
KCNE3,Long QT Syndrome,0.8138488881521341
KCNE3,Hyperglycemia Postprandial,0.8138488881521341
KCNE3,Electromyogram abnormal,0.8190761496232595
KCNE3,Triglycerides measurement,0.8232134984476662
KCNE3,Ventricular Fibrillation,0.8232134984476662
KCNE3,Neurodegenerative Disorders,0.8272008757995397
KCNE3,Syncope,0.8402911822757345
KCNE3,Cardiac Arrest,0.8402911822757345
KCNE3,Low density lipoprotein cholesterol measurement,0.8648405521677974
KCNE3,Atrial Fibrillation,0.8648405521677974
KCNE3,Familial M??ni??re disease,0.8769418330148872
KCNE3,Adrenocortical Adenoma,0.4532988396145482
KCNE3,Long QT Syndrome,0.7765582368651238
KCNE3,Hypokalemic Periodic Paralysis,0.7765582368651238
KCNE3,Periodic Hypokalemic Paresis,0.7765582368651238
KCNE3,Trifascicular Block,0.8115918568696846
KCNE3,Paroxysmal Ventricular Tachycardia,0.8115918568696846
KCNE3,Sick Sinus Syndrome,0.8165359516083085
KCNE3,Supraventricular Tachycardia,0.8165359516083085
KCNE3,Brugada Syndrome,0.8201196687803188
KCNE3,Bundle Branch Block,0.861756360478846
KCNE3,Ventricular Fibrillation,0.8662301945830305
KCNE3,Atrioventricular Block,0.8903301324869451
KCNE3,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.1040670578681756
KCNE3,Fructose-16-bisphosphatase deficiency ORPHA:348,0.3832844616405875
KCNE3,Hemochromatosis type 4 ORPHA:139491,0.3832844616405875
KCNE3,Galactose mutarotase deficiency ORPHA:570422,0.5867963421058087
KCNE3,Haim-Munk syndrome ORPHA:2342,0.5867963421058087
KCNE3,Papillon-Lefevre ORPHA:678,0.5867963421058087
KCNE3,Adult Krabbe disease ORPHA:206448,0.7929682744768703
KCNE3,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity ORPHA:314373,0.7929682744768703
KCNE3,Farber disease ORPHA:333,0.7929682744768703
KCNE3,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency ORPHA:314376,0.7929682744768703
KCNE3,Late-infantile/juvenile Krabbe disease ORPHA:206443,0.7929682744768703
KCNE3,Spinal muscular atrophy-progressive myoclonic epilepsy syndrome ORPHA:2590,0.7929682744768703
KCNE3,ALys amyloidosis ORPHA:93561,0.8922466888454011
KCNE3,Brain dopamine-serotonin vesicular transport disease ORPHA:352649,0.8922466888454011
KCNE3,Hypohidrosis-electrolyte imbalance-lacrimal gland dysfunction-ichthyosis-xerostomia syndrome ORPHA:528105,0.8922466888454011
KCNE3,Lysinuric protein intolerance ORPHA:470,0.8922466888454011
KCNE3,Jervell and Lange-Nielsen syndrome ORPHA:90647,0.8922466888454011
KCNE3,Primary hypomagnesemia with secondary hypocalcemia ORPHA:30924,0.8922466888454011
KCNE3,Hypokalemic periodic paralysis ORPHA:681,0.8922466888454011
KCNE3,Brugada syndrome ORPHA:130,0.9157590847454716
KCNK7,Nephrogenic diabetes insipidus ORPHA:223,0.7929682744768703
KCNK7,Palmoplantar keratoderma-hereditary motor and sensory neuropathy syndrome ORPHA:538574,0.7929682744768703
KCNK7,Annular epidermolytic ichthyosis ORPHA:281139,0.8922466888454011
KCNK7,Autosomal dominant epidermolytic ichthyosis ORPHA:312,0.8922466888454011
KCNK7,Congenital reticular ichthyosiform erythroderma ORPHA:281190,0.8922466888454011
KCNK7,Monkeypox virus cowpox A-type inclusion protein,0.8999095837312036
KCNQ1OT1,Carcinogenesis,0.7333611688795861
KCNQ1OT1,Malignant neoplasm of pancreas,0.7688485284765829
KCNQ1OT1,Hepatoblastoma,0.7765852775619541
KCNQ1OT1,Beckwith-Wiedemann Syndrome,0.7765852775619541
KCNQ1OT1,Adrenocortical cytomegaly,0.7765852775619541
KCNQ1OT1,Overgrowth of external genitalia,0.7765852775619541
KCNQ1OT1,Pancreatic hyperplasia,0.7765852775619541
KCNQ1OT1,Colorectal Carcinoma,0.7765852775619541
KCNQ1OT1,Nephrolithiasis,0.7765852775619541
KCNQ1OT1,HEMIHYPERPLASIA ISOLATED,0.7765852775619541
KCNQ1OT1,MENTAL RETARDATION X-LINKED SNYDER-ROBINSON TYPE,0.7765852775619541
KCNQ1OT1,Advanced bone age,0.7765852775619541
KCNQ1OT1,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
KCNQ1OT1,Asymmetric overgrowth,0.7765852775619541
KCNQ1OT1,Posterior helix pit,0.7765852775619541
KCNQ1OT1,Esophageal carcinoma,0.7765852775619541
KCNQ1OT1,Neonatal hypoglycemia,0.7765852775619541
KCNQ1OT1,Russell-Silver syndrome,0.7765852775619541
KCNQ1OT1,Colorectal Neoplasms,0.7765852775619541
KCNQ1OT1,Tooth problem,0.7765852775619541
KCNQ1OT1,Renal cortical cysts,0.7765852775619541
KCNQ1OT1,Transient neonatal diabetes mellitus,0.7765852775619541
KCNQ1OT1,Congenital hemihypertrophy,0.7765852775619541
KCNQ1OT1,Esophageal Neoplasms,0.7765852775619541
KCNQ1OT1,Abnormality of the dentition,0.7880542567584415
KCNQ1OT1,Congenital omphalocele,0.7880542567584415
KCNQ1OT1,Liver carcinoma,0.7880542567584415
KCNQ1OT1,Overgrowth Syndrome,0.7880542567584415
KCNQ1OT1,Malignant neoplasm of esophagus,0.7880542567584415
KCNQ1OT1,Colorectal Cancer,0.7880542567584415
KCNQ1OT1,Hepatocarcinogenesis,0.7880542567584415
KCNQ1OT1,Diastasis recti,0.7880542567584415
KCNQ1OT1,Nephroblastoma,0.7880542567584415
KCNQ1OT1,Embryonal Neoplasm,0.7880542567584415
KCNQ1OT1,ANOPHTHALMIA AND PULMONARY HYPOPLASIA,0.7880542567584415
KCNQ1OT1,Neoplasm Metastasis,0.7880542567584415
KCNQ1OT1,Enlarged kidney,0.7880542567584415
KCNQ1OT1,Fetal overgrowth,0.7880542567584415
KCNQ1OT1,Generalized overgrowth,0.7880542567584415
KCNQ1OT1,Overgrowth,0.7880542567584415
KCNQ1OT1,Neuroblastoma,0.7880542567584415
KCNQ1OT1,Central neuroblastoma,0.7880542567584415
KCNQ1OT1,Port-Wine Stain,0.7880542567584415
KCNQ1OT1,Pelizaeus-Merzbacher Disease,0.7880542567584415
KCNQ1OT1,Malignant neoplasm of stomach,0.7880542567584415
KCNQ1OT1,Gonadoblastoma,0.7880542567584415
KCNQ1OT1,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
KCNQ1OT1,Large late-closing fontanelle,0.7880542567584415
KCNQ1OT1,Wide bregma sutures,0.7880542567584415
KCNQ1OT1,Large bregma sutures,0.7880542567584415
KCNQ1OT1,Large fontanelle,0.7880542567584415
KCNQ1OT1,Asymmetry of the thorax,0.7880542567584415
KCNQ1OT1,Prominent metopic ridge,0.7880542567584415
KCNQ1OT1,Klippel-Trenaunay-Weber Syndrome,0.7880542567584415
KCNQ1OT1,Increased calcium level in kidney,0.7880542567584415
KCNQ1OT1,Prominent back of the head,0.7880542567584415
KCNQ1OT1,Prominent occiput,0.7880542567584415
KCNQ1OT1,Coronary Arteriosclerosis,0.7880542567584415
KCNQ1OT1,Congenital chromosomal disease,0.7880542567584415
KCNQ1OT1,Small midface,0.7880542567584415
KCNQ1OT1,Decreased projection of midface,0.7880542567584415
KCNQ1OT1,Hypotrophic midface,0.7880542567584415
KCNQ1OT1,Midface retrusion,0.7880542567584415
KCNQ1OT1,Acute myocardial infarction,0.7880542567584415
KCNQ1OT1,Neural Tube Defects,0.7880542567584415
KCNQ1OT1,Diabetes,0.7880542567584415
KCNQ1OT1,Diabetes Mellitus,0.7880542567584415
KCNQ1OT1,Tumors of Adrenal Cortex,0.7880542567584415
KCNQ1OT1,Prominent eyes,0.7880542567584415
KCNQ1OT1,Protruding eyes,0.7880542567584415
KCNQ1OT1,Prominent globes,0.7880542567584415
KCNQ1OT1,Exophthalmos,0.7908231553833205
KCNQ1OT1,Nephrocalcinosis,0.8009048756462318
KCNQ1OT1,Angelman Syndrome,0.8019075543217649
KCNQ1OT1,Myocardial Infarction,0.8019075543217649
KCNQ1OT1,Liver neoplasms,0.8019075543217649
KCNQ1OT1,Kidney Diseases,0.8019075543217649
KCNQ1OT1,Adenocarcinoma of lung (disorder),0.8098851543361193
KCNQ1OT1,Dandy-Walker Syndrome,0.8190761496232595
KCNQ1OT1,Adrenocortical carcinoma,0.8232134984476662
KCNQ1OT1,Congenital Abnormality,0.8402911822757345
KCNQ1OT1,Macroglossia,0.8402911822757345
KCNQ1OT1,Curvature of spine,0.8402911822757345
KCNQ1OT1,Cryptorchidism,0.8402911822757345
KCNQ1OT1,Acquired scoliosis,0.8402911822757345
KCNQ1OT1,Facial asymmetry,0.8402911822757345
KCNQ1OT1,Inflammatory Breast Carcinoma,0.841396342333011
KCNQ1OT1,Vesico-Ureteral Reflux,0.8576420926340393
KCNQ1OT1,Myocardial Ischemia,0.8648405521677974
KCNQ1OT1,Congenital defects,0.8648405521677974
KCNQ1OT1,Hepatomegaly,0.887595340546704
KCNQ1OT1,Thickened facial skin with coarse facial features,0.9103315000053974
KCNQ1OT1,Coarse facial features,0.9117936912777788
KCNQ1OT1,Cardiomegaly,0.9184153253162451
KCNQ1OT1,Trichohepatoenteric Syndrome,0.94939825643792
KCNQ1OT1,Cardiomyopathies,0.9557184806547836
KCNQ1OT1,Mild Mental Retardation,0.9685329573219852
KCNQ1OT1,Adrenocortical Carcinoma,0.4532988396145482
KCNQ1OT1,Beckwith-Wiedemann Syndrome,0.4904280964420943
KCNQ1OT1,Gonadoblastoma,0.6734982286750932
KCNQ1OT1,Nephrolithiasis,0.7765582368651238
KCNQ1OT1,Congenital Hemihypertrophy,0.7765582368651238
KCNQ1OT1,Hepatoblastoma,0.7765582368651238
KCNQ1OT1,Long QT Syndrome,0.7765582368651238
KCNQ1OT1,Congenital Long QT Syndrome,0.7765582368651238
KCNQ1OT1,Nephroblastoma,0.7765582368651238
KCNQ1OT1,Phakomatosis Pigmentovascularis,0.7765582368651238
KCNQ1OT1,Hypoglycemia,0.7765582368651238
KCNQ1OT1,Congenital Omphalocele,0.8115918568696846
KCNQ1OT1,Proptosis,0.8115918568696846
KCNQ1OT1,Nephrocalcinosis,0.8115918568696846
KCNQ1OT1,Meningomyelocele,0.8115918568696846
KCNQ1OT1,Mental Retardation,0.8337953215113012
KCNQ1OT1,Vesicoureteral Reflux,0.8611702959552964
KCNQ1OT1,Cryptorchidism,0.861756360478846
KCNQ1OT1,Macroglossia,0.8879896755141929
KCNQ1OT1,Cardiomyopathy,0.9145387439550552
KCNQ1OT1,Diabetes Mellitus,0.919442421650838
KCNQ1OT1,Scoliosis,0.924275664330454
KCNQ1OT1,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117,0.7929682744768703
KCNQ1OT1,Isolated hemihyperplasia ORPHA:2128,0.7929682744768703
KCTD12,Carcinogenesis,0.7333611688795861
KCTD12,Gastrointestinal Stromal Tumors,0.7765852775619541
KCTD12,Schizophrenia,0.8067197998685076
KCTD12,Bipolar Disorder,0.900167961295542
KCTD12,Mood Disorders,0.9093740881835894
KCTD12,Schizophrenia,0.7860378120955526
KCTD12,Bipolar Disorder,0.943322675973118
KCTD12,Mood Disorder,0.9726139569926774
KCTD12,Acromelic frontonasal dysplasia ORPHA:1827,0.1040670578681756
KCTD12,Distal monosomy 1q ORPHA:36367,0.1040670578681756
KCTD12,Thrombomodulin-related bleeding disorder ORPHA:436169,0.1040670578681756
KCTD12,Duane retraction syndrome with congenital deafness ORPHA:529574,0.3832844616405875
KCTD12,Hemochromatosis type 5 ORPHA:447792,0.3832844616405875
KCTD12,Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774,0.3832844616405875
KCTD12,Uveal melanoma ORPHA:39044,0.3977968344535308
KCTD12,Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635,0.5867963421058087
KCTD12,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787,0.5867963421058087
KCTD12,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670,0.7929682744768703
KCTD12,Familial multiple nevi flammei ORPHA:624,0.8922466888454011
KCTD12,Sturge-Weber syndrome ORPHA:3205,0.8922466888454011
KCTD12,Wagner disease ORPHA:898,0.8922466888454011
KCTD12,Paternal uniparental disomy of chromosome 6 ORPHA:96191,0.8922466888454011
KCTD12,Horsepox virus HSPV197 (Hypothetical protein),0.8999095837312036
KCTD12,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.8999095837312036
KCTD12,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.8999095837312036
KCTD12,Horsepox virus HSPV008,0.8999095837312036
KCTD12,Ectromelia virus ERPV kelch-like protein,0.8999095837312036
KCTD12,Vaccinia virus Kelch-like protein (gene: F3L),0.8999095837312036
KCTD12,Vaccinia virus Ankara Kelch-like protein,0.8999095837312036
KCTD12,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.8999095837312036
KCTD12,Horsepox virus HSPV043 (Kelch-like protein,0.8999095837312036
KEAP1,Malignant neoplasm of breast,0.4084380369379369
KEAP1,Breast Carcinoma,0.7333611688795861
KEAP1,Carcinogenesis,0.7333611688795861
KEAP1,Malignant neoplasm of ovary,0.7333611688795861
KEAP1,Ovarian Carcinoma,0.7333611688795861
KEAP1,Adenocarcinoma,0.750391252594775
KEAP1,Malignant neoplasm of pancreas,0.7688485284765829
KEAP1,Hepatoblastoma,0.7765852775619541
KEAP1,Colorectal Carcinoma,0.7765852775619541
KEAP1,Pancreatic carcinoma,0.7765852775619541
KEAP1,Colon Carcinoma,0.7765852775619541
KEAP1,Leukemia Myelocytic Acute,0.7765852775619541
KEAP1,Right Ventricular Hypertrophy,0.7765852775619541
KEAP1,Malignant tumor of colon,0.7765852775619541
KEAP1,Cervix carcinoma,0.7765852775619541
KEAP1,Non-Small Cell Lung Carcinoma,0.7765852775619541
KEAP1,Cholera Infantum,0.7765852775619541
KEAP1,Vascular Diseases,0.7765852775619541
KEAP1,Malignant tumor of cervix,0.7768809924982332
KEAP1,Glioma,0.7880542567584415
KEAP1,Malignant neoplasm of lung,0.7880542567584415
KEAP1,Malignant neoplasm of prostate,0.7880542567584415
KEAP1,Liver carcinoma,0.7880542567584415
KEAP1,Invasive carcinoma of breast,0.7880542567584415
KEAP1,Malignant Head and Neck Neoplasm,0.7880542567584415
KEAP1,Colorectal Cancer,0.7880542567584415
KEAP1,Epithelial ovarian cancer,0.7880542567584415
KEAP1,Tumor Promotion,0.7880542567584415
KEAP1,Disease Exacerbation,0.7880542567584415
KEAP1,Primary malignant neoplasm of lung,0.7880542567584415
KEAP1,cervical cancer,0.7880542567584415
KEAP1,Neoplasm Metastasis,0.7880542567584415
KEAP1,Functional Gastrointestinal Disorders,0.7880542567584415
KEAP1,Prostatic Neoplasms,0.7880542567584415
KEAP1,Carcinoma of lung,0.7880542567584415
KEAP1,Triple Negative Breast Neoplasms,0.7880542567584415
KEAP1,Van der Woude syndrome,0.7880542567584415
KEAP1,Immunologic Deficiency Syndromes,0.7880542567584415
KEAP1,melanoma,0.7880542567584415
KEAP1,Lung Neoplasms,0.7880542567584415
KEAP1,Gastrointestinal Diseases,0.7880542567584415
KEAP1,Keratoma,0.7880542567584415
KEAP1,Keratosis Blennorrhagica,0.7880542567584415
KEAP1,Malignant neoplasm of stomach,0.7880542567584415
KEAP1,Euthyroid Goiter,0.7880542567584415
KEAP1,Malignant neoplasm of large intestine,0.7880542567584415
KEAP1,Tumor Progression,0.7880542567584415
KEAP1,Renal Cell Carcinoma,0.7880542567584415
KEAP1,Seminoma,0.7880542567584415
KEAP1,Keratosis,0.7880542567584415
KEAP1,Chemical Carcinogenesis,0.7880542567584415
KEAP1,Alzheimer's Disease,0.7880542567584415
KEAP1,Stomach Carcinoma,0.7880542567584415
KEAP1,Osteitis Deformans,0.7880542567584415
KEAP1,Cardiovascular Diseases,0.7880542567584415
KEAP1,Age-related cataract,0.7880542567584415
KEAP1,gallbladder neoplasm,0.7880542567584415
KEAP1,Squamous cell carcinoma,0.7880542567584415
KEAP1,Diabetes Mellitus,0.7880542567584415
KEAP1,Papillary Renal Cell Carcinoma,0.7880542567584415
KEAP1,Biliary Tract Cancer,0.7880542567584415
KEAP1,Ankylosing spondylitis,0.7880542567584415
KEAP1,Huntington Disease,0.7880542567584415
KEAP1,Pleuropulmonary blastoma,0.7880542567584415
KEAP1,Crohn Disease,0.7880542567584415
KEAP1,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
KEAP1,Malignant Glioma,0.7880542567584415
KEAP1,Vascular inflammations,0.7908231553833205
KEAP1,Chromophobe Renal Cell Carcinoma,0.8019075543217649
KEAP1,Cervical Squamous Cell Carcinoma,0.8019075543217649
KEAP1,Psoriasis,0.8019075543217649
KEAP1,Kidney Failure Chronic,0.8019075543217649
KEAP1,Malignant neoplasm of gallbladder,0.8019075543217649
KEAP1,Lung diseases,0.8019075543217649
KEAP1,Kidney Diseases,0.8019075543217649
KEAP1,Nonalcoholic Steatohepatitis,0.8067197998685076
KEAP1,ovarian neoplasm,0.8067197998685076
KEAP1,Adenocarcinoma of lung (disorder),0.8098851543361193
KEAP1,Basal cell nevus,0.8098851543361193
KEAP1,Tongue Neoplasms,0.8168901801930506
KEAP1,Ulcerative Colitis,0.8190761496232595
KEAP1,Hyperkeratosis,0.8190761496232595
KEAP1,Sarcomatoid Renal Cell Carcinoma,0.8190761496232595
KEAP1,Liver Cirrhosis,0.8232134984476662
KEAP1,Gallbladder Carcinoma,0.8232134984476662
KEAP1,Multinodular goiter,0.8232134984476662
KEAP1,Neurodegenerative Disorders,0.8272008757995397
KEAP1,Collecting Duct Carcinoma of the Kidney,0.8272008757995397
KEAP1,Cholangitis Sclerosing,0.8337767145465158
KEAP1,Motor neuron atrophy,0.8363138748299018
KEAP1,Diabetic Retinopathy,0.8402911822757345
KEAP1,Amyotrophic Lateral Sclerosis,0.8402911822757345
KEAP1,Other ureteric obstruction,0.8402911822757345
KEAP1,Cervical Intraepithelial Neoplasia,0.8402911822757345
KEAP1,Squamous cell carcinoma of esophagus,0.8610447277138289
KEAP1,Exanthema,0.8619324281003841
KEAP1,Cataract,0.8769418330148872
KEAP1,Respiratory Distress Syndrome Adult,0.8769418330148872
KEAP1,Polyp of large intestine,0.8774809019744603
KEAP1,Addictive Behavior,0.9015731019095328
KEAP1,Septicemia,0.917543617287358
KEAP1,Sepsis,0.9189398569397552
KEAP1,Chronic Kidney Diseases,0.9393256300017014
KEAP1,Hepatitis,0.939985154445373
KEAP1,Basal cell carcinoma,0.9431511078237256
KEAP1,Squamous cell carcinoma of lung,0.9564633032157428
KEAP1,Drug abuse,0.9658628445524134
KEAP1,Chronic kidney disease stage 5,0.9694882155560866
KEAP1,Pulmonary Emphysema,0.9920086799398428
KEAP1,Functional Gastrointestinal Disorders,0.7765582368651238
KEAP1,Gastrointestinal Diseases,0.7765582368651238
KEAP1,Biliary Cholangitis,0.7765582368651238
KEAP1,Ovarian Neoplasm,0.7765582368651238
KEAP1,Prostate Cancer,0.7765582368651238
KEAP1,Keratoma,0.7765582368651238
KEAP1,Keratosis,0.7765582368651238
KEAP1,Keratosis Blennorrhagica,0.7765582368651238
KEAP1,Prostatic Neoplasms,0.7765582368651238
KEAP1,Alveolar Rhabdomyosarcoma,0.7765582368651238
KEAP1,Pilomatrixoma,0.7765582368651238
KEAP1,Biliary Cirrhosis,0.7765582368651238
KEAP1,Seminoma,0.7765582368651238
KEAP1,Medulloepithelioma,0.7765582368651238
KEAP1,Gallbladder Cancer,0.7765582368651238
KEAP1,Cholestasis,0.8115918568696846
KEAP1,Neoplasm Of Gallbladder,0.8115918568696846
KEAP1,Polyp Of Large Intestine,0.8115918568696846
KEAP1,Lung Carcinoma,0.8139950454942313
KEAP1,Chromophobe Carcinoma,0.8356859041719433
KEAP1,Papillary Renal Carcinoma,0.8476516371290275
KEAP1,Thyroid Carcinoma,0.8611702959552964
KEAP1,Ulcerative Colitis,0.861756360478846
KEAP1,Renal Carcinoma,0.8727045307126416
KEAP1,Hypothyroidism,0.8879896755141929
KEAP1,Cholangitis,0.8885757656973042
KEAP1,Ankylosing Spondylitis,0.8903301324869451
KEAP1,Crohn Disease,0.8903630091389316
KEAP1,Breast Cancer,0.8903630091389316
KEAP1,Carcinoma,0.9069867032339078
KEAP1,Lung Adenocarcinoma,0.9350723667380212
KEAP1,Psoriasis,0.974502015052702
KEAP1,Familial multinodular goiter ORPHA:276399,0.3832844616405875
KEAP1,Horsepox virus HSPV197 (Hypothetical protein),0.8999095837312036
KEAP1,Yaba-like disease virus 140R protein (gene: 140R),0.8999095837312036
KEAP1,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.8999095837312036
KEAP1,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.8999095837312036
KEAP1,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.8999095837312036
KEAP1,Horsepox virus HSPV008,0.8999095837312036
KEAP1,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.8999095837312036
KEAP1,Yaba-like disease virus 19L protein (gene: 19L),0.8999095837312036
KEAP1,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.8999095837312036
KEAP1,Ectromelia virus ERPV kelch-like protein,0.8999095837312036
KEAP1,Vaccinia virus Kelch-like protein (gene: F3L),0.8999095837312036
KEAP1,Vaccinia virus Ankara Kelch-like protein,0.8999095837312036
KEAP1,Vaccinia virus kelch-like protein (gene: A55R),0.8999095837312036
KEAP1,Variola virus hypothetical protein (gene: J7R),0.8999095837312036
KEAP1,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.8999095837312036
KEAP1,Monkeypox virus Zaire-96-I-16 B1R (gene: B1R),0.8999095837312036
KEAP1,Yaba monkey tumor virus kelch-like protein,0.8999095837312036
KEAP1,Horsepox virus HSPV043 (Kelch-like protein,0.8999095837312036
KEAP1,Provisional),0.8999095837312036
KEAP1,Horsepox virus HSPV029 (kelch-like protein,0.8999095837312036
KEAP1,Cowpox virus CPXV035 protein (gene: CPXV035 CDS),0.8999095837312036
KEAP1,Variola virus hypothetical protein (gene: B24R),0.8999095837312036
KEAP1,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.8999095837312036
KEAP1,Vaccinia virus kelch-like protein (gene: C2L),0.8999095837312036
KEAP1,Monkeypox virus Zaire-96-I-16 D17L (gene: D17L),0.8999095837312036
KEAP1,Horsepox virus HSPV176 (kelch-like protein,0.8999095837312036
KEAP1,Variola virus hypothetical protein (gene: J8R),0.8999095837312036
KEAP1,Variola virus hypothetical protein (gene: D13L),0.8999095837312036
KEAP1,Vaccinia virus Ankara 18.9k Kelch-like protein,0.8999095837312036
KEAP1,Horsepox virus HSPV187 (kelch-like protein,0.8999095837312036
KEAP1,Monkeypox virus Zaire-96-I-16 D16L (gene: D16L),0.8999095837312036
KEAP1,Cowpox virus CPXV204 protein (gene: CPXV204 CDS),0.9057542447893764
KEAP1,Variola virus hypothetical protein (gene: C7L),0.9057542447893764
KIAA0513,Schizophrenia,0.8067197998685076
KIAA0513,Amyotrophic Lateral Sclerosis,0.8402911822757345
KIAA0513,Leukemia,0.7765582368651238
KIAA0513,Amyotrophic Lateral Sclerosis,0.9543024119762946
KIAA0513,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
KIAA0513,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
KIAA0513,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
KIAA0513,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.1040670578681756
KIAA0513,Birt-Hogg-Dube syndrome ORPHA:122,0.1991445465001551
KIAA0513,Familial spontaneous pneumothorax ORPHA:2903,0.1991445465001551
KIAA0513,Mucopolysaccharidosis type 2 attenuated form ORPHA:217093,0.1991445465001551
KIAA0513,Mucopolysaccharidosis type 2 severe form ORPHA:217085,0.1991445465001551
KIAA0513,8p11.2 deletion syndrome ORPHA:251066,0.3832844616405875
KIAA0513,Infantile Krabbe disease ORPHA:206436,0.5867963421058087
KIAA0513,Gamma-aminobutyric acid transaminase deficiency ORPHA:2066,0.7929682744768703
KIAA0513,Spinocerebellar ataxia type 1 ORPHA:98755,0.7929682744768703
KIAA0513,Kyphoscoliosis-lateral tongue atrophy-hereditary spastic paraplegia syndrome ORPHA:496689,0.8922466888454011
KIAA0513,Kyphosis-lateral tongue atrophy-myofibrillar myopathy syndrome ORPHA:496686,0.8922466888454011
KIAA0513,Rett syndrome ORPHA:778,0.8922466888454011
KIAA0513,Severe neonatal-onset encephalopathy with microcephaly ORPHA:209370,0.8922466888454011
KIAA0513,Trisomy Xq28 ORPHA:1762,0.8922466888454011
KIAA0513,X-linked intellectual disability-psychosis-macroorchidism syndrome ORPHA:3077,0.8922466888454011
KIF20A,Malignant neoplasm of breast,0.4084380369379369
KIF20A,Breast Carcinoma,0.7333611688795861
KIF20A,Carcinogenesis,0.7333611688795861
KIF20A,Malignant neoplasm of pancreas,0.7688485284765829
KIF20A,Pancreatic carcinoma,0.7765852775619541
KIF20A,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
KIF20A,Pancreatic Neoplasm,0.7765852775619541
KIF20A,melanoma,0.7880542567584415
KIF20A,Melanocytic nevus,0.7880542567584415
KIF20A,Other restrictive cardiomyopathy,0.7880542567584415
KIF20A,Malignant neoplasm of stomach,0.7880542567584415
KIF20A,Histiocytoid Cardiomyopathy,0.7880542567584415
KIF20A,Stomach Carcinoma,0.7880542567584415
KIF20A,Restrictive cardiomyopathy,0.8019075543217649
KIF20A,Stomach Neoplasms,0.8044379824544406
KIF20A,Liver Carcinoma,0.7765582368651238
KIF20A,Restrictive Cardiomyopathy,0.8115918568696846
KIF20A,Cardiomyopathy,0.9145387439550552
KIF20A,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
KIF20A,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
KIF20A,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
KIF20A,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
KIF20A,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
KIF20A,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
KIF20A,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
KIF20A,Currarino syndrome ORPHA:1552,0.0155394890951578
KIF20A,Filippi syndrome ORPHA:3255,0.0155394890951578
KIF20A,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
KIF20A,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
KIF20A,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
KIF20A,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
KIF20A,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
KIF20A,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
KIF20A,Stromme syndrome ORPHA:506307,0.0155394890951578
KIF20A,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
KIF20A,Citrullinemia type II ORPHA:247585,0.0414176838632111
KIF20A,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
KIF20A,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
KIF20A,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
KIF20A,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
KIF20A,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
KIF20A,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
KIF20A,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
KIF20A,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
KIF20A,Small cell lung cancer ORPHA:70573,0.0429491792829903
KIF20A,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1040670578681756
KIF20A,Hyper-IgM syndrome type 5 ORPHA:101092,0.1040670578681756
KIF20A,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.1040670578681756
KIF20A,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.1040670578681756
KIF20A,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.1040670578681756
KIF20A,Hydrolethalus ORPHA:2189,0.1054066549396977
KIF20A,Dedifferentiated liposarcoma ORPHA:99970,0.1068643725150898
KIF20A,Well-differentiated liposarcoma ORPHA:99971,0.1068643725150898
KIF20A,46XX gonadal dysgenesis ORPHA:243,0.1419890644363008
KIF20A,46XY complete gonadal dysgenesis ORPHA:242,0.1479888965090844
KIF20A,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.1991445465001551
KIF20A,Autosomal recessive cutis laxa type 2B ORPHA:357064,0.1991445465001551
KIF20A,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.1991445465001551
KIF20A,Denys-Drash syndrome ORPHA:220,0.1991445465001551
KIF20A,Frasier syndrome ORPHA:347,0.1991445465001551
KIF20A,Jawad syndrome ORPHA:313795,0.1991445465001551
KIF20A,Meacham syndrome ORPHA:3097,0.1991445465001551
KIF20A,PYCR1-related De Barsy syndrome ORPHA:293633,0.1991445465001551
KIF20A,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.1991445465001551
KIF20A,Familial congenital mirror movements ORPHA:238722,0.2120485863056726
KIF20A,Familial prostate cancer ORPHA:1331,0.2844858212863536
KIF20A,Autosomal recessive spastic paraplegia type 62 ORPHA:401785,0.3832844616405875
KIF20A,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993,0.3832844616405875
KIF20A,Li-Fraumeni syndrome ORPHA:524,0.3891940933600213
KIF20A,Nephroblastoma ORPHA:654,0.4491081214880772
KIF20A,Neu-Laxova syndrome ORPHA:2671,0.5867963421058087
KIF20A,Acquired partial lipodystrophy ORPHA:79087,0.5867963421058087
KIF20A,Autosomal dominant spastic paraplegia type 13 ORPHA:100994,0.5867963421058087
KIF20A,Baller-Gerold syndrome ORPHA:1225,0.5867963421058087
KIF20A,Chudley-McCullough syndrome ORPHA:314597,0.5867963421058087
KIF20A,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288,0.5867963421058087
KIF20A,Progressive myoclonic epilepsy type 9 ORPHA:457265,0.5867963421058087
KIF20A,RAPADILINO syndrome ORPHA:3021,0.5867963421058087
KIF20A,Rothmund-Thomson syndrome type 2 ORPHA:221016,0.5867963421058087
KIF20A,Combined immunodeficiency with granulomatosis ORPHA:157949,0.7929682744768703
KIF20A,Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206,0.7929682744768703
KIF20A,3-phosphoglycerate dehydrogenase deficiency infantile/juvenile form ORPHA:79351,0.7929682744768703
KIF20A,ALDH18A1-related De Barsy syndrome ORPHA:35664,0.7929682744768703
KIF20A,Adrenocortical carcinoma ORPHA:1501,0.7929682744768703
KIF20A,Autosomal dominant spastic paraplegia type 9A ORPHA:447753,0.7929682744768703
KIF20A,Autosomal dominant spastic paraplegia type 9B ORPHA:447757,0.7929682744768703
KIF20A,Autosomal recessive spastic paraplegia type 9B ORPHA:447760,0.7929682744768703
KIF20A,Choroid plexus carcinoma ORPHA:251899,0.7929682744768703
KIF20A,Familial clubfoot due to 5q31 microdeletion ORPHA:293144,0.7929682744768703
KIF20A,Familial clubfoot due to PITX1 point mutation ORPHA:293150,0.7929682744768703
KIF20A,Guttmacher syndrome ORPHA:2957,0.7929682744768703
KIF20A,Hand-foot-genital syndrome ORPHA:2438,0.7929682744768703
KIF20A,Macrocephaly-intellectual disability-left ventricular non compaction syndrome ORPHA:466791,0.7929682744768703
KIF20A,Mirror-image polydactyly ORPHA:498494,0.7929682744768703
KIF20A,Papilloma of choroid plexus ORPHA:2807,0.7929682744768703
KIF20A,STT3A-CDG ORPHA:370921,0.7929682744768703
KIF20A,Brachydactyly-elbow wrist dysplasia syndrome ORPHA:1275,0.7929682744768703
KIF20A,Geroderma osteodysplastica ORPHA:2078,0.7929682744768703
KIF20A,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.8029813443753846
KIF20A,46XY partial gonadal dysgenesis ORPHA:251510,0.8668760866668862
KIF20A,Atrial septal defect-atrioventricular conduction defects syndrome ORPHA:1479,0.8922466888454011
KIF20A,Branchio-oculo-facial syndrome ORPHA:1297,0.8922466888454011
KIF20A,CAD-CDG ORPHA:448010,0.8922466888454011
KIF20A,Frontonasal dysplasia-severe microphthalmia-severe facial clefting syndrome ORPHA:306542,0.8922466888454011
KIF20A,Genetic steroid-resistant nephrotic syndrome ORPHA:656,0.9267491058512334
KIFC2,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
KIFC2,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
KIFC2,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
KIFC2,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
KIFC2,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
KIFC2,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
KIFC2,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
KIFC2,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
KIFC2,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
KIFC2,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
KIFC2,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
KIFC2,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
KIFC2,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.1040670578681756
KIFC2,Albers Schonberg osteopetrosis ORPHA:53,0.1040670578681756
KIFC2,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.1040670578681756
KIFC2,Cerebellar-facial-dental syndrome ORPHA:444072,0.1040670578681756
KIFC2,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.1040670578681756
KIFC2,Kufor-Rakeb syndrome ORPHA:306674,0.1040670578681756
KIFC2,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.1040670578681756
KIFC2,Smith-Magenis syndrome ORPHA:819,0.1117946631214258
KIFC2,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433,0.1991445465001551
KIFC2,CLN4B disease ORPHA:228343,0.1991445465001551
KIFC2,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160,0.1991445465001551
KIFC2,Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257,0.1991445465001551
KIFC2,Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215,0.1991445465001551
KIFC2,Hurler syndrome ORPHA:93473,0.1991445465001551
KIFC2,Hurler-Scheie syndrome ORPHA:93476,0.1991445465001551
KIFC2,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401,0.1991445465001551
KIFC2,POMT1-related  limb-girdle muscular dystrophy R11 ORPHA:86812,0.1991445465001551
KIFC2,Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361,0.1991445465001551
KIFC2,Scheie syndrome ORPHA:93474,0.1991445465001551
KIFC2,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569,0.1991445465001551
KIFC2,Early myoclonic encephalopathy ORPHA:1935,0.1991445465001551
KIFC2,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.1991445465001551
KIFC2,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.2386105733903937
KIFC2,17p11.2 microduplication syndrome ORPHA:1713,0.3832844616405875
KIFC2,Distal 16p11.2 microdeletion syndrome ORPHA:261222,0.3832844616405875
KIFC2,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316,0.3832844616405875
KIFC2,PMP22-RAI1 contiguous gene duplication syndrome ORPHA:477817,0.3832844616405875
KIFC2,Proximal 16p11.2 microdeletion syndrome ORPHA:261197,0.3832844616405875
KIFC2,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency ORPHA:329249,0.3832844616405875
KIFC2,Wolf-Hirschhorn syndrome ORPHA:280,0.4100904865085126
KIFC2,Spinocerebellar ataxia type 13 ORPHA:98768,0.5867963421058087
KLF4,Malignant neoplasm of breast,0.4084380369379369
KLF4,Carcinoma of bladder,0.4084380369379369
KLF4,Bladder Neoplasm,0.4084380369379369
KLF4,Malignant neoplasm of urinary bladder,0.5071083164302358
KLF4,Adenomatous Polyposis Coli,0.5196624042573144
KLF4,Breast Carcinoma,0.7333611688795861
KLF4,Carcinogenesis,0.7333611688795861
KLF4,Malignant neoplasm of ovary,0.7333611688795861
KLF4,B-Cell Lymphomas,0.7333611688795861
KLF4,leukemia,0.7333611688795861
KLF4,Ovarian Carcinoma,0.7333611688795861
KLF4,Malignant neoplasm of pancreas,0.7688485284765829
KLF4,Colorectal Carcinoma,0.7765852775619541
KLF4,Pancreatic carcinoma,0.7765852775619541
KLF4,Colon Carcinoma,0.7765852775619541
KLF4,Leukemia Myelocytic Acute,0.7765852775619541
KLF4,Right Ventricular Hypertrophy,0.7765852775619541
KLF4,Malignant tumor of colon,0.7765852775619541
KLF4,Atrial Premature Complexes,0.7765852775619541
KLF4,Esophageal carcinoma,0.7765852775619541
KLF4,Lymphoma,0.7765852775619541
KLF4,Leukemogenesis,0.7765852775619541
KLF4,Cervix carcinoma,0.7765852775619541
KLF4,Non-Small Cell Lung Carcinoma,0.7765852775619541
KLF4,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
KLF4,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
KLF4,Colorectal Neoplasms,0.7765852775619541
KLF4,Pancreatic Neoplasm,0.7765852775619541
KLF4,Pancreatic intraepithelial neoplasia,0.7765852775619541
KLF4,Adenoma,0.7765852775619541
KLF4,Vascular Diseases,0.7765852775619541
KLF4,Esophageal Neoplasms,0.7765852775619541
KLF4,Malignant tumor of cervix,0.7768809924982332
KLF4,Mammary Neoplasms,0.7880542567584415
KLF4,Glioma,0.7880542567584415
KLF4,Malignant neoplasm of lung,0.7880542567584415
KLF4,Malignant neoplasm of gastrointestinal tract,0.7880542567584415
KLF4,Malignant neoplasm of prostate,0.7880542567584415
KLF4,Liver carcinoma,0.7880542567584415
KLF4,Malignant Meningioma,0.7880542567584415
KLF4,Malignant neoplasm of esophagus,0.7880542567584415
KLF4,Osteosarcoma,0.7880542567584415
KLF4,Colorectal Cancer,0.7880542567584415
KLF4,Leukemia T-Cell,0.7880542567584415
KLF4,Tumor Promotion,0.7880542567584415
KLF4,Glioblastoma,0.7880542567584415
KLF4,Osteosarcoma of bone,0.7880542567584415
KLF4,Prostate carcinoma,0.7880542567584415
KLF4,Astrocytoma,0.7880542567584415
KLF4,Pulmonary Edema,0.7880542567584415
KLF4,Primary malignant neoplasm of lung,0.7880542567584415
KLF4,cervical cancer,0.7880542567584415
KLF4,Neoplasm Metastasis,0.7880542567584415
KLF4,Carcinoma of lung,0.7880542567584415
KLF4,Squamous cell carcinoma of the head and neck,0.7880542567584415
KLF4,Triple Negative Breast Neoplasms,0.7880542567584415
KLF4,Neuroblastoma,0.7880542567584415
KLF4,Central neuroblastoma,0.7880542567584415
KLF4,Familial lichen amyloidosis,0.7880542567584415
KLF4,Cancer of Digestive System,0.7880542567584415
KLF4,Ductal Carcinoma,0.7880542567584415
KLF4,Hematologic Neoplasms,0.7880542567584415
KLF4,melanoma,0.7880542567584415
KLF4,Intestinal Neoplasms,0.7880542567584415
KLF4,Multiple Myeloma,0.7880542567584415
KLF4,Lung Neoplasms,0.7880542567584415
KLF4,Metastatic malignant neoplasm to brain,0.7880542567584415
KLF4,Metastatic Prostate Carcinoma,0.7880542567584415
KLF4,Neoplasms,0.7880542567584415
KLF4,Squamous cell carcinoma of mouth,0.7880542567584415
KLF4,Malignant neoplasm of stomach,0.7880542567584415
KLF4,Burkitt Lymphoma,0.7880542567584415
KLF4,Skin Carcinogenesis,0.7880542567584415
KLF4,Intratubular malignant germ cells,0.7880542567584415
KLF4,Hodgkin Disease,0.7880542567584415
KLF4,Benign Prostatic Hyperplasia,0.7880542567584415
KLF4,Severe Combined Immunodeficiency,0.7880542567584415
KLF4,Cleft palate with cleft lip,0.7880542567584415
KLF4,Malignant neoplasm of large intestine,0.7880542567584415
KLF4,Nasopharyngeal carcinoma,0.7880542567584415
KLF4,Tumor Progression,0.7880542567584415
KLF4,Adenocarcinoma of colon,0.7880542567584415
KLF4,Maladaptive behavior associated with physical illness,0.7880542567584415
KLF4,Sarcoma,0.7880542567584415
KLF4,Renal Cell Carcinoma,0.7880542567584415
KLF4,Seminoma,0.7880542567584415
KLF4,Tumor Initiation,0.7880542567584415
KLF4,Arteriosclerosis,0.7880542567584415
KLF4,Atherosclerosis,0.7880542567584415
KLF4,Congenital chromosomal disease,0.7880542567584415
KLF4,Acute lymphocytic leukemia,0.7880542567584415
KLF4,Stomach Carcinoma,0.7880542567584415
KLF4,Juvenile psoriatic arthritis,0.7880542567584415
KLF4,Acute myocardial infarction,0.7880542567584415
KLF4,Cells in urine,0.7880542567584415
KLF4,Squamous cell carcinoma,0.7880542567584415
KLF4,Polycythemia Vera,0.7880542567584415
KLF4,Thrombus,0.7880542567584415
KLF4,Carcinoma Pancreatic Ductal,0.7880542567584415
KLF4,Carcinoma in situ of uterine cervix,0.7880542567584415
KLF4,Juvenile-Onset Still Disease,0.7880542567584415
KLF4,Germinoma,0.7880542567584415
KLF4,Barrett Epithelium,0.7880542567584415
KLF4,Adenoma of large intestine,0.7880542567584415
KLF4,Cervix Intraepithelial Neoplasia Grade 3 AJCC v7,0.7880542567584415
KLF4,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
KLF4,Anaplastic thyroid carcinoma,0.7880542567584415
KLF4,Secretory meningioma,0.7880542567584415
KLF4,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
KLF4,Metastatic Neoplasm,0.7880542567584415
KLF4,Myeloid Leukemia Chronic,0.7880542567584415
KLF4,Myeloid Leukemia,0.7880542567584415
KLF4,Aortic Aneurysm,0.7880542567584415
KLF4,Central Serous Chorioretinopathy,0.7908231553833205
KLF4,Vascular inflammations,0.7908231553833205
KLF4,Metastasis from malignant tumor of prostate,0.7908231553833205
KLF4,Juvenile arthritis,0.8009048756462318
KLF4,Experimental Organism Basal Cell Carcinoma,0.8009048756462318
KLF4,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.8009048756462318
KLF4,Cavernous Hemangioma of Brain,0.8019075543217649
KLF4,SMITH-MCCORT DYSPLASIA 1,0.8019075543217649
KLF4,Pneumonitis,0.8019075543217649
KLF4,Cervical Squamous Cell Carcinoma,0.8019075543217649
KLF4,Myocardial Infarction,0.8019075543217649
KLF4,Hepatic methionine adenosyltransferase deficiency,0.8019075543217649
KLF4,Childhood Osteosarcoma,0.8019075543217649
KLF4,Stomach Neoplasms,0.8044379824544406
KLF4,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
KLF4,Breast adenocarcinoma,0.8138488881521341
KLF4,Keratoconjunctivitis Sicca,0.8145035474981049
KLF4,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
KLF4,Multiple Sclerosis Relapsing-Remitting,0.8190761496232595
KLF4,Mammary Tumorigenesis,0.8190761496232595
KLF4,Lip and Oral Cavity Carcinoma,0.8190761496232595
KLF4,Colonic Neoplasms,0.8212681436603975
KLF4,Stickler syndrome type 1,0.8212681436603975
KLF4,Thrombotic Microangiopathies,0.8212681436603975
KLF4,Gastric Adenocarcinoma,0.8232134984476662
KLF4,Neurodegenerative Disorders,0.8272008757995397
KLF4,Pneumonia,0.834094492023826
KLF4,Congenital Abnormality,0.8402911822757345
KLF4,Subarachnoid Hemorrhage,0.8402911822757345
KLF4,Immune System Diseases,0.8402911822757345
KLF4,Patent ductus arteriosus,0.8402911822757345
KLF4,Aortic aneurysm without mention of rupture NOS,0.8402911822757345
KLF4,Thrombosis,0.8402911822757345
KLF4,Aneurysm,0.8402911822757345
KLF4,Hypertensive disease,0.8474481237156937
KLF4,Medulloblastoma,0.8548862007194026
KLF4,Rectal Carcinoma,0.8584283190330553
KLF4,Hyperplastic Polyp,0.8584283190330553
KLF4,Squamous cell carcinoma of esophagus,0.8610447277138289
KLF4,Renal carcinoma,0.8648405521677974
KLF4,Anaplasia,0.8648405521677974
KLF4,Myocardial Ischemia,0.8648405521677974
KLF4,Malignant neoplasm of kidney,0.8818220091065441
KLF4,Malignant neoplasm of mouth,0.8946938397586319
KLF4,Meningioma,0.8973454964837912
KLF4,Barrett Esophagus,0.8980854850210683
KLF4,Obesity,0.8989612563669234
KLF4,Squamous cell carcinoma of skin,0.8989612563669234
KLF4,Secondary malignant neoplasm of lymph node,0.900167961295542
KLF4,Congenital Heart Defects,0.9098977259629772
KLF4,Idiopathic pulmonary arterial hypertension,0.9262273158806068
KLF4,Malignant neoplasm of skin,0.93413028051677
KLF4,Secondary malignant neoplasm of bone,0.946564927793026
KLF4,Teratoma,0.9505280654948344
KLF4,Aortic Aneurysm Abdominal,0.9578035687879456
KLF4,Juvenile Arthritis,0.7765582368651238
KLF4,Polyarthritis Rheumatoid Factor Positive,0.7765582368651238
KLF4,Seronegative Polyarthritis,0.7765582368651238
KLF4,Still Disease,0.7765582368651238
KLF4,Meningioma,0.8611702959552964
KLF4,Arthritis,0.9046917974656596
KLF4,Myocardial Ischemia,0.9578111936867284
KLF4,Congenital Heart Defects,0.963385108667098
KLF4,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
KLF4,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
KLF4,Heme oxygenase-1 deficiency ORPHA:562509,0.1040670578681756
KLF4,Thrombomodulin-related bleeding disorder ORPHA:436169,0.1040670578681756
KLF4,ACys amyloidosis ORPHA:100008,0.3832844616405875
KLF4,Charcot-Marie-Tooth disease type 4D ORPHA:99950,0.3832844616405875
KLF4,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.3832844616405875
KLF4,Duane retraction syndrome with congenital deafness ORPHA:529574,0.3832844616405875
KLF4,Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774,0.3832844616405875
KLF4,Cryptogenic multifocal ulcerous stenosing enteritis ORPHA:468635,0.5867963421058087
KLF4,Cytosolic phospholipase-A2 alpha deficiency associated bleeding disorder ORPHA:477787,0.5867963421058087
KLF4,Epithelial basement membrane dystrophy ORPHA:98956,0.7929682744768703
KLF4,Glycogen storage disease due to liver glycogen phosphorylase deficiency ORPHA:369,0.7929682744768703
KLF4,Granular corneal dystrophy type I ORPHA:98962,0.7929682744768703
KLF4,Granular corneal dystrophy type II ORPHA:98963,0.7929682744768703
KLF4,Lattice corneal dystrophy type I ORPHA:98964,0.7929682744768703
KLF4,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138,0.7929682744768703
KLF4,RIN2 syndrome ORPHA:217335,0.7929682744768703
KLF4,Reis-Bucklers corneal dystrophy ORPHA:98961,0.7929682744768703
KLF4,Thiel-Behnke corneal dystrophy ORPHA:98960,0.7929682744768703
KLF4,Congenital generalized lipodystrophy ORPHA:528,0.8105918570729571
KLF4,AGel amyloidosis ORPHA:85448,0.8922466888454011
KLF4,Carnitine palmitoyl transferase 1A deficiency ORPHA:156,0.8922466888454011
KLF4,Inherited acute myeloid leukemia ORPHA:319465,0.8922466888454011
KLF4,Human papillomavirus type 6 E5B (gene: E5B),0.8999095837312036
KLHL29,Red Blood Cell Count measurement,0.7880542567584415
KLHL29,Platelet hematocrit measurement,0.7880542567584415
KLHL29,Hemoglobin measurement,0.7880542567584415
KLHL29,Hematocrit procedure,0.8402911822757345
KLHL29,Hypertensive disease,0.8474481237156937
KLHL29,Coronary heart disease,0.9119978323790848
KLHL29,Hypertension,0.7765582368651238
KLHL29,Epilepsy,0.8611702959552964
KLHL29,Coronary Heart Disease,0.861756360478846
KLHL29,Mental Depression,0.8903630091389316
KLHL29,Mood Disorder,0.9726139569926774
KLHL29,Juvenile nephronophthisis ORPHA:93592,0.6335420546867965
KLHL29,Horsepox virus HSPV197 (Hypothetical protein),0.8999095837312036
KLHL29,Yaba-like disease virus 140R protein (gene: 140R),0.8999095837312036
KLHL29,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.8999095837312036
KLHL29,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.8999095837312036
KLHL29,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.8999095837312036
KLHL29,Horsepox virus HSPV008,0.8999095837312036
KLHL29,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.8999095837312036
KLHL29,Yaba-like disease virus 19L protein (gene: 19L),0.8999095837312036
KLHL29,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.8999095837312036
KLHL29,Ectromelia virus ERPV kelch-like protein,0.8999095837312036
KLHL29,Vaccinia virus Kelch-like protein (gene: F3L),0.8999095837312036
KLHL29,Vaccinia virus Ankara Kelch-like protein,0.8999095837312036
KLHL29,Vaccinia virus kelch-like protein (gene: A55R),0.8999095837312036
KLHL29,Variola virus hypothetical protein (gene: J7R),0.8999095837312036
KLHL29,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.8999095837312036
KLHL29,Monkeypox virus Zaire-96-I-16 B1R (gene: B1R),0.8999095837312036
KLHL29,Yaba monkey tumor virus kelch-like protein,0.8999095837312036
KLHL29,Horsepox virus HSPV043 (Kelch-like protein,0.8999095837312036
KLHL29,Provisional),0.8999095837312036
KLHL29,Horsepox virus HSPV029 (kelch-like protein,0.8999095837312036
KLHL29,Cowpox virus CPXV035 protein (gene: CPXV035 CDS),0.8999095837312036
KLHL29,Variola virus hypothetical protein (gene: B24R),0.8999095837312036
KLHL29,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.8999095837312036
KLHL29,Vaccinia virus kelch-like protein (gene: C2L),0.8999095837312036
KLHL29,Monkeypox virus Zaire-96-I-16 D17L (gene: D17L),0.8999095837312036
KLHL29,Horsepox virus HSPV176 (kelch-like protein,0.8999095837312036
KLHL29,Variola virus hypothetical protein (gene: J8R),0.8999095837312036
KLHL29,Variola virus hypothetical protein (gene: D13L),0.8999095837312036
KLHL29,Vaccinia virus Ankara 18.9k Kelch-like protein,0.8999095837312036
KLHL29,Horsepox virus HSPV187 (kelch-like protein,0.8999095837312036
KLHL29,Monkeypox virus Zaire-96-I-16 D16L (gene: D16L),0.8999095837312036
KLHL29,Cowpox virus CPXV204 protein (gene: CPXV204 CDS),0.9057542447893764
KLK8,Malignant neoplasm of breast,0.4084380369379369
KLK8,Breast Carcinoma,0.7333611688795861
KLK8,Carcinogenesis,0.7333611688795861
KLK8,Malignant neoplasm of ovary,0.7333611688795861
KLK8,Ovarian Carcinoma,0.7333611688795861
KLK8,Adenocarcinoma,0.750391252594775
KLK8,Colorectal Carcinoma,0.7765852775619541
KLK8,Cervix carcinoma,0.7765852775619541
KLK8,Non-Small Cell Lung Carcinoma,0.7765852775619541
KLK8,Endometrial Carcinoma,0.7765852775619541
KLK8,Malignant tumor of cervix,0.7768809924982332
KLK8,Malignant neoplasm of lung,0.7880542567584415
KLK8,Colorectal Cancer,0.7880542567584415
KLK8,Epithelial ovarian cancer,0.7880542567584415
KLK8,Primary malignant neoplasm of lung,0.7880542567584415
KLK8,cervical cancer,0.7880542567584415
KLK8,Neoplasm Metastasis,0.7880542567584415
KLK8,Carcinoma of lung,0.7880542567584415
KLK8,Squamous cell carcinoma of the head and neck,0.7880542567584415
KLK8,Lung Neoplasms,0.7880542567584415
KLK8,Mental disorders,0.7880542567584415
KLK8,Abnormal behavior,0.7880542567584415
KLK8,Malignant neoplasm of large intestine,0.7880542567584415
KLK8,Viral Encephalitis,0.7880542567584415
KLK8,Psoriasis,0.8019075543217649
KLK8,Luminal A Breast Carcinoma,0.8019075543217649
KLK8,Encephalomyelitis,0.8019075543217649
KLK8,ovarian neoplasm,0.8067197998685076
KLK8,Schizophrenia,0.8067197998685076
KLK8,Hyperkeratosis,0.8190761496232595
KLK8,Inflammatory dermatosis,0.8554819098734854
KLK8,Mental Depression,0.8769418330148872
KLK8,Dermatitis,0.8815127642200768
KLK8,Bipolar Disorder,0.900167961295542
KLK8,Depressive disorder,0.9103315000053974
KLK8,Bipolar Disorder,0.943322675973118
KLK8,Van der Woude syndrome ORPHA:888,0.1991445465001551
KLK8,EEM syndrome ORPHA:1897,0.1991445465001551
KLK8,Hypotrichosis with juvenile macular degeneration ORPHA:1573,0.1991445465001551
KLK8,Bifid uvula ORPHA:99771,0.3832844616405875
KLK8,Cleft hard palate ORPHA:101023,0.3832844616405875
KLK8,Cleft velum ORPHA:99772,0.3832844616405875
KLK8,Submucosal cleft palate ORPHA:155878,0.3832844616405875
KLK8,Cleft lip and alveolus ORPHA:141291,0.3891940933600213
KLK8,Isolated cleft lip ORPHA:199302,0.3891940933600213
KLK8,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034,0.5867963421058087
KLK8,Neuropathy with hearing impairment ORPHA:139512,0.5867963421058087
KLK8,Sebocystomatosis ORPHA:841,0.5867963421058087
KLK8,Tricho-dento-osseous syndrome ORPHA:3352,0.5867963421058087
KLK8,Pachyonychia congenita ORPHA:2309,0.7929682744768703
KLK8,Self-improving collodion baby ORPHA:281122,0.7929682744768703
KLK8,Acral self-healing collodion baby ORPHA:281127,0.7929682744768703
KLK8,Bathing suit ichthyosis ORPHA:100976,0.7929682744768703
KLK8,Epithelial recurrent erosion dystrophy ORPHA:293381,0.7929682744768703
KLK8,Hereditary hypotrichosis with recurrent skin vesicles ORPHA:217407,0.7929682744768703
KLK8,Keratoderma hereditarium mutilans ORPHA:494,0.7929682744768703
KLK8,Knuckle pads-leukonychia-sensorineural deafness-palmoplantar hyperkeratosis syndrome ORPHA:2698,0.7929682744768703
KLK8,Late-onset junctional epidermolysis bullosa ORPHA:79406,0.7929682744768703
KLK8,Netherton syndrome ORPHA:634,0.7929682744768703
KLK8,Porokeratotic eccrine ostial and dermal duct nevus ORPHA:166286,0.7929682744768703
KLK8,Bladder exstrophy ORPHA:93930,0.7929682744768703
KLK8,Palmoplantar keratoderma-deafness syndrome ORPHA:2202,0.7929682744768703
KLK8,Severe dermatitis-multiple allergies-metabolic wasting syndrome ORPHA:369992,0.7929682744768703
KLK8,Uncombable hair syndrome ORPHA:1410,0.7929682744768703
KLK8,Erythrokeratodermia variabilis ORPHA:317,0.7929682744768703
KLK8,Autosomal dominant generalized epidermolysis bullosa simplex intermediate form ORPHA:79399,0.8922466888454011
KLK8,Autosomal dominant generalized epidermolysis bullosa simplex severe form ORPHA:79396,0.8922466888454011
KLK8,Epidermolysis bullosa simplex with mottled pigmentation ORPHA:79397,0.8922466888454011
KLK8,KID syndrome ORPHA:477,0.8922466888454011
KLK8,Localized epidermolysis bullosa simplex ORPHA:79400,0.8922466888454011
KLK8,Autosomal dominant focal non-epidermolytic palmoplantar keratoderma with plantar blistering ORPHA:402003,0.8922466888454011
KLK8,Autosomal recessive generalized epidermolysis bullosa simplex ORPHA:89838,0.8922466888454011
KLK8,Dermatopathia pigmentosa reticularis ORPHA:86920,0.8922466888454011
KLK8,Epidermolysis bullosa simplex with circinate migratory erythema ORPHA:158681,0.8922466888454011
KLK8,Epidermolytic palmoplantar keratoderma ORPHA:2199,0.8922466888454011
KLK8,Naegeli-Franceschetti-Jadassohn syndrome ORPHA:69087,0.8922466888454011
KLK8,Peeling skin syndrome type B ORPHA:263553,0.8922466888454011
KLK8,Acrodermatitis continua of Hallopeau ORPHA:163931,0.8922466888454011
KLK8,Generalized pustular psoriasis ORPHA:247353,0.8922466888454011
KLK8,Hypotrichosis simplex of the scalp ORPHA:90368,0.8922466888454011
KLK8,Isolated focal non-epidermolytic palmoplantar keratoderma ORPHA:448264,0.8922466888454011
KLK8,Meesmann corneal dystrophy ORPHA:98954,0.8922466888454011
KLK8,Pure hair and nail ectodermal dysplasia ORPHA:69084,0.8922466888454011
KLK8,Pustulosis palmaris et plantaris ORPHA:163927,0.8922466888454011
KLK8,Congenital non-bullous ichthyosiform erythroderma ORPHA:79394,0.8922466888454011
KLK8,DITRA ORPHA:404546,0.8922466888454011
KLK8,Diffuse palmoplantar keratoderma with painful fissures ORPHA:369999,0.8922466888454011
KLK8,Focal palmoplantar keratoderma with joint keratoses ORPHA:370002,0.8922466888454011
KLK8,Hereditary palmoplantar keratoderma Gamborg-Nielsen type ORPHA:86923,0.8922466888454011
KLK8,Mal de Meleda ORPHA:87503,0.8922466888454011
KLK8,Postural orthostatic tachycardia syndrome due to NET deficiency ORPHA:443236,0.8922466888454011
KLK8,Ichthyosis-short stature-brachydactyly-microspherophakia syndrome ORPHA:363992,0.8922466888454011
KLK8,Striate palmoplantar keratoderma ORPHA:50942,0.8922466888454011
KLK8,Lamellar ichthyosis ORPHA:313,0.8922466888454011
KLK8,HMO Astrovirus A non-structural protein,0.915880438522078
LCMT2,Autosomal dominant hypophosphatemic rickets ORPHA:89937,0.8922466888454011
LCMT2,Horsepox virus HSPV197 (Hypothetical protein),0.8999095837312036
LCMT2,Yaba-like disease virus 140R protein (gene: 140R),0.8999095837312036
LCMT2,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.8999095837312036
LCMT2,Ectromelia virus ERPV kelch-like protein,0.8999095837312036
LIPG,Malignant neoplasm of breast,0.4084380369379369
LIPG,Breast Carcinoma,0.7333611688795861
LIPG,Hypercholesterolemia,0.7765852775619541
LIPG,Vascular Diseases,0.7765852775619541
LIPG,Serum total cholesterol measurement,0.7880542567584415
LIPG,High density lipoprotein measurement,0.7880542567584415
LIPG,Hemolytic-Uremic Syndrome,0.7880542567584415
LIPG,Coronary Arteriosclerosis,0.7880542567584415
LIPG,Retinoblastoma,0.7880542567584415
LIPG,Arteriosclerosis,0.7880542567584415
LIPG,Atherosclerosis,0.7880542567584415
LIPG,Acute myocardial infarction,0.7880542567584415
LIPG,Cardiovascular Diseases,0.7880542567584415
LIPG,Diabetes Mellitus,0.7880542567584415
LIPG,Cholesteryl Ester Transfer Protein Deficiency,0.8009048756462318
LIPG,Myocardial Infarction,0.8019075543217649
LIPG,Autistic Disorder,0.8019075543217649
LIPG,Dyslipidemias,0.8138488881521341
LIPG,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
LIPG,Diabetic Retinopathy,0.8402911822757345
LIPG,Proliferative retinopathy,0.8402911822757345
LIPG,Phospholipid measurement,0.843190898187174
LIPG,Hypertensive disease,0.8474481237156937
LIPG,Deep Vein Thrombosis,0.8584283190330553
LIPG,Metabolic Syndrome X,0.8610447277138289
LIPG,Allergic asthma,0.887595340546704
LIPG,Coronary Artery Disease,0.887595340546704
LIPG,Obesity,0.8989612563669234
LIPG,Depressive Symptoms,0.905201167721829
LIPG,Coronary heart disease,0.9119978323790848
LIPG,Uveal melanoma,0.929235785949896
LIPG,Overweight,0.929814249105729
LIPG,Germ cell tumor,0.9564633032157428
LIPG,Alzheimer Disease,0.8457525389282121
LIPG,Autism,0.911896615143974
LMF2,Malignant neoplasm of breast,0.4084380369379369
LMF2,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
LMF2,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
LMF2,Mean corpuscular hemoglobin concentration determination,0.7880542567584415
LMF2,Alzheimer's Disease,0.7880542567584415
LMF2,Breast Cancer,0.8903630091389316
LMF2,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
LMF2,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
LMF2,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
LMF2,Crisponi syndrome ORPHA:1545,0.0155394890951578
LMF2,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
LMF2,Barth syndrome ORPHA:111,0.0414176838632111
LMF2,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
LMF2,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
LMF2,Incontinentia pigmenti ORPHA:464,0.0414176838632111
LMF2,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
LMF2,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
LMF2,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
LMF2,Albers Schonberg osteopetrosis ORPHA:53,0.1040670578681756
LMF2,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.1040670578681756
LMF2,BAP1-related tumor predisposition syndrome ORPHA:289539,0.1040670578681756
LMF2,CLN11 disease ORPHA:314629,0.1040670578681756
LMF2,Focal dermal hypoplasia ORPHA:2092,0.1040670578681756
LMF2,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.1040670578681756
LMF2,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.1040670578681756
LMF2,D-2-hydroxyglutaric aciduria ORPHA:79315,0.1054066549396977
LMF2,Adrenomyeloneuropathy ORPHA:139399,0.1991445465001551
LMF2,Alpha-mannosidosis adult form ORPHA:309288,0.1991445465001551
LMF2,Alpha-mannosidosis infantile form ORPHA:309282,0.1991445465001551
LMF2,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433,0.1991445465001551
LMF2,CLN10 disease ORPHA:228337,0.1991445465001551
LMF2,Combined oxidative phosphorylation defect type 27 ORPHA:477774,0.1991445465001551
LMF2,Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257,0.1991445465001551
LMF2,Hurler syndrome ORPHA:93473,0.1991445465001551
LMF2,Hurler-Scheie syndrome ORPHA:93476,0.1991445465001551
LMF2,Leukonychia totalis ORPHA:2387,0.1991445465001551
LMF2,MYH9-related disease ORPHA:182050,0.1991445465001551
LMF2,Mucolipidosis type IV ORPHA:578,0.1991445465001551
LMF2,NAD(P)HX dehydratase deficiency ORPHA:555402,0.1991445465001551
LMF2,Neutral lipid storage myopathy ORPHA:98908,0.1991445465001551
LMF2,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401,0.1991445465001551
LMF2,Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361,0.1991445465001551
LMF2,Scheie syndrome ORPHA:93474,0.1991445465001551
LMF2,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.1991445465001551
LMF2,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.1991445465001551
LMF2,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.1991445465001551
LMF2,CADDS ORPHA:369942,0.1991445465001551
LMF2,Cerebellar ataxia-hypogonadism syndrome ORPHA:1173,0.1991445465001551
LMF2,Early myoclonic encephalopathy ORPHA:1935,0.1991445465001551
LMF2,Charcot-Marie-Tooth disease type 2B2 ORPHA:101101,0.3832844616405875
LMF2,Metachromatic leukodystrophy adult form ORPHA:309271,0.3832844616405875
LMF2,Metachromatic leukodystrophy juvenile form ORPHA:309263,0.3832844616405875
LMF2,Metachromatic leukodystrophy late infantile form ORPHA:309256,0.3832844616405875
LMF2,Ataxia-oculomotor apraxia type 4 ORPHA:459033,0.3832844616405875
LMF2,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3832844616405875
LMF2,Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284,0.3832844616405875
LMF2,D-glyceric aciduria ORPHA:941,0.3832844616405875
LMF2,Intellectual disability-strabismus syndrome ORPHA:363528,0.3832844616405875
LMF2,MOGS-CDG ORPHA:79330,0.3832844616405875
LMF2,Mucopolysaccharidosis type 4A ORPHA:309297,0.3832844616405875
LMF2,NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751,0.3832844616405875
LMF2,Spondylo-ocular syndrome ORPHA:85194,0.3832844616405875
LMF2,TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642,0.3832844616405875
LMF2,Van den Ende-Gupta syndrome ORPHA:2460,0.3832844616405875
LMF2,3C syndrome ORPHA:7,0.3832844616405875
LMF2,Desbuquois syndrome ORPHA:1425,0.3832844616405875
LMF2,Ependymoma ORPHA:251636,0.3832844616405875
LMF2,RELA fusion-positive ependymoma ORPHA:530792,0.3832844616405875
LMF2,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.3832844616405875
LMF2,Prolactinoma ORPHA:2965,0.3832844616405875
LMF2,Rare isolated myopia ORPHA:98619,0.3832844616405875
LMF2,Chronic myelomonocytic leukemia ORPHA:98823,0.3891940933600213
LMF2,Alpers-Huttenlocher syndrome ORPHA:726,0.5867963421058087
LMF2,Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180,0.5867963421058087
LMF2,Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964,0.5867963421058087
LMF2,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect ORPHA:521411,0.5867963421058087
LMF2,Autosomal recessive spastic paraplegia type 39 ORPHA:139480,0.5867963421058087
LMF2,Autosomal recessive spastic paraplegia type 48 ORPHA:306511,0.5867963421058087
LMF2,Laurence-Moon syndrome ORPHA:2377,0.5867963421058087
LMF2,Lethal brain and heart developmental defects ORPHA:580933,0.5867963421058087
LMF2,Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845,0.5867963421058087
LMF2,MAN1B1-CDG ORPHA:397941,0.5867963421058087
LMF2,Neuralgic amyotrophy ORPHA:2901,0.5867963421058087
LMF2,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome ORPHA:529665,0.5867963421058087
LMF2,Polyglucosan body myopathy type 1 ORPHA:397937,0.5867963421058087
LMF2,Recessive mitochondrial ataxia syndrome ORPHA:94125,0.5867963421058087
LMF2,Sanfilippo syndrome type B ORPHA:79270,0.5867963421058087
LMF2,Spinocerebellar ataxia with epilepsy ORPHA:254881,0.5867963421058087
LMF2,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363,0.5867963421058087
LMF2,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173,0.5867963421058087
LMF2,Autosomal recessive progressive external ophthalmoplegia ORPHA:254886,0.5867963421058087
LMF2,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome ORPHA:70595,0.5867963421058087
LMF2,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome ORPHA:466794,0.7929682744768703
LMF2,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:75496,0.7929682744768703
LMF2,FLNA-related X-linked myxomatous valvular dysplasia ORPHA:555877,0.7929682744768703
LMF2,Familial LCAT deficiency ORPHA:79293,0.7929682744768703
LMF2,Fish-eye disease ORPHA:79292,0.7929682744768703
LMF2,GMPPB-related  limb-girdle muscular dystrophy R19 ORPHA:363623,0.7929682744768703
LMF2,Glycogen storage disease due to acid maltase deficiency infantile onset ORPHA:308552,0.7929682744768703
LMF2,Glycogen storage disease due to acid maltase deficiency late-onset ORPHA:420429,0.7929682744768703
LMF2,Larsen-like syndrome B3GAT3 type ORPHA:284139,0.7929682744768703
LMF2,Leukocyte adhesion deficiency type II ORPHA:99843,0.7929682744768703
LMF2,Melnick-Needles syndrome ORPHA:2484,0.7929682744768703
LMF2,Neuronal intestinal pseudoobstruction ORPHA:99811,0.7929682744768703
LMF2,Otopalatodigital syndrome type 1 ORPHA:90650,0.7929682744768703
LMF2,Otopalatodigital syndrome type 2 ORPHA:90652,0.7929682744768703
LMF2,Pontocerebellar hypoplasia type 8 ORPHA:324569,0.7929682744768703
LMF2,Sanfilippo syndrome type A ORPHA:79269,0.7929682744768703
LMF2,Terminal osseous dysplasia-pigmentary defects syndrome ORPHA:88630,0.7929682744768703
LMF2,X-linked Ehlers-Danlos syndrome ORPHA:75497,0.7929682744768703
LMF2,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome ORPHA:482606,0.7929682744768703
LMF2,Alveolar soft tissue sarcoma ORPHA:163699,0.7929682744768703
LMF2,Fibrolamellar hepatocellular carcinoma ORPHA:401920,0.7929682744768703
LMF2,ALG12-CDG ORPHA:79324,0.8922466888454011
LMF2,Argininosuccinic aciduria ORPHA:23,0.8922466888454011
LMF2,Autosomal recessive spastic paraplegia type 76 ORPHA:488594,0.8922466888454011
LMF2,Childhood-onset basal ganglia degeneration syndrome ORPHA:497906,0.8922466888454011
LMF2,Cutis laxa with severe pulmonary gastrointestinal and urinary anomalies ORPHA:221145,0.8922466888454011
LMF2,Fetal Gaucher disease ORPHA:85212,0.8922466888454011
LMF2,Gaucher disease type 2 ORPHA:77260,0.8922466888454011
LMF2,Gaucher disease type 3 ORPHA:77261,0.8922466888454011
LMF2,Gaucher disease-ophthalmoplegia-cardiovascular calcification syndrome ORPHA:2072,0.8922466888454011
LMF2,Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625,0.8922466888454011
LMF2,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome ORPHA:369837,0.8922466888454011
LMF2,NON RARE IN EUROPE: Parkinson disease ORPHA:319705,0.8922466888454011
LMF2,Niemann-Pick disease type A ORPHA:77292,0.8922466888454011
LMF2,Niemann-Pick disease type B ORPHA:77293,0.8922466888454011
LMF2,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:157965,0.8922466888454011
LMF2,Null pituitary adenoma ORPHA:314790,0.8922466888454011
LMF2,Pituitary gigantism ORPHA:99725,0.8922466888454011
LMF2,Silent pituitary adenoma ORPHA:314786,0.8922466888454011
LMTK3,Malignant neoplasm of breast,0.4084380369379369
LMTK3,Breast Carcinoma,0.7333611688795861
LMTK3,Colorectal Carcinoma,0.7765852775619541
LMTK3,Thyroid Neoplasm,0.7765852775619541
LMTK3,Malignant neoplasm of prostate,0.7880542567584415
LMTK3,Thyroid carcinoma,0.7880542567584415
LMTK3,Colorectal Cancer,0.7880542567584415
LMTK3,Prostate carcinoma,0.7880542567584415
LMTK3,Malignant neoplasm of thyroid,0.7880542567584415
LMTK3,Malignant neoplasm of stomach,0.7880542567584415
LMTK3,Tumor Progression,0.7880542567584415
LMTK3,Stomach Carcinoma,0.7880542567584415
LMTK3,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
LMTK3,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
LMTK3,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
LMTK3,Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253,0.1040670578681756
LMTK3,Bilateral generalized polymicrogyria ORPHA:208447,0.1991445465001551
LMTK3,Usher syndrome type 1 ORPHA:231169,0.2661730864557679
LMTK3,Crouzon disease ORPHA:207,0.3832844616405875
LMTK3,Fuhrmann syndrome ORPHA:2854,0.5867963421058087
LMTK3,Phocomelia Schinzel type ORPHA:2879,0.5867963421058087
LMTK3,Spinocerebellar ataxia type 13 ORPHA:98768,0.5867963421058087
LMTK3,Isolated split hand-split foot malformation ORPHA:2440,0.606625035400596
LMTK3,SYNGAP1-related developmental and epileptic encephalopathy ORPHA:544254,0.7929682744768703
LMTK3,Spinocerebellar ataxia type 14 ORPHA:98763,0.7929682744768703
LMTK3,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
LMTK3,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
LMTK3,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
LMTK3,Provisional),0.8999095837312036
LMTK3,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
LMTK3,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
LMTK3,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
LMTK3,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
LMTK3,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
LMTK3,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
LMTK3,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
LMTK3,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
LMTK3,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
LMTK3,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
LMTK3,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
LMTK3,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
LMTK3,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
LMTK3,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
LMTK3,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
LMTK3,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
LMTK3,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
LMTK3,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
LMTK3,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
LMTK3,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
LMTK3,Yaba-like disease virus 142R protein (gene: 142R),0.8999095837312036
LMTK3,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
LMTK3,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
LMTK3,Monkeypox virus ser/thr kinase,0.8999095837312036
LMTK3,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
LMTK3,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
LMTK3,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
LMTK3,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
LMTK3,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
LMTK3,Orf virus ORF020 dsRNA-binding PKR inhibitor,0.8999095837312036
LMTK3,Vaccinia virus ser/thr kinase (gene: B1R),0.8999095837312036
LMTK3,Vaccinia virus Ankara Serine/threonine-protein kinase,0.8999095837312036
LMTK3,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.8999095837312036
LMTK3,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.8999095837312036
LMTK3,Yaba monkey tumor virus 142R,0.8999095837312036
LMTK3,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
LMTK3,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
LMTK3,Papiine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.8999095837312036
LMTK3,Human immunodeficiency virus pol protein (gene: pol),0.8999095837312036
LMTK3,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
LMTK3,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
LMTK3,Orf virus ORF130 putative serine/threonine protein kinase,0.8999095837312036
LMTK3,Human immunodeficiency virus 1 integrase (gene: gag-pol),0.8999095837312036
LMTK3,Human immunodeficiency virus 1 Pol (gene: gag-pol),0.8999095837312036
LMTK3,Monkeypox virus ankyrin-like protein,0.8999095837312036
LMTK3,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.8999095837312036
LMTK3,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
LMTK3,Human alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.9057542447893764
LMTK3,Ectromelia virus ERPV profilin-like protein,0.9057542447893764
LMTK3,Macaque simian foamy virus Pol (gene: pol),0.9057542447893764
LMTK3,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
LMTK3,African green monkey simian foamy virus Pol precursor (gene: pol),0.9057542447893764
LMTK3,Ectromelia virus ERPV ankyrin,0.9057542447893764
LMTK3,Variola virus hypothetical protein (gene: A47R),0.9057542447893764
LMTK3,Monkeypox virus profilin-like protein,0.9057542447893764
LMTK3,Monkeypox virus Zaire-96-I-16 A42R (gene: A42R),0.9057542447893764
LMTK3,Horsepox virus HSPV164 (Profilin),0.9057542447893764
LMTK3,Vaccinia virus profilin-like protein (gene: A42R),0.9057542447893764
LMTK3,Vaccinia virus Ankara Profilin-1-like,0.9057542447893764
LMTK3,Cowpox virus CPXV179 protein (gene: CPXV179 CDS),0.9057542447893764
LMTK3,Variola virus hypothetical protein (gene: G3R),0.9237501457186692
LMTK3,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
LMTK3,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.9364561700418303
LMTK3,Variola virus hypothetical protein (gene: B6R),0.9496696866493144
LMTK3,Simian foamy virus full_polyprotein 1..1146 (gene: pol),0.9687349764960514
LPAR6,Malignant neoplasm of breast,0.4084380369379369
LPAR6,Carcinoma of bladder,0.4084380369379369
LPAR6,Bladder Neoplasm,0.4084380369379369
LPAR6,Malignant neoplasm of urinary bladder,0.5071083164302358
LPAR6,Breast Carcinoma,0.7333611688795861
LPAR6,Carcinogenesis,0.7333611688795861
LPAR6,Reduced tensile strength of hair,0.7333611688795861
LPAR6,Fractured hair,0.7333611688795861
LPAR6,Fragile hair,0.7333611688795861
LPAR6,Brittle hair,0.7495999465637118
LPAR6,Liver carcinoma,0.7880542567584415
LPAR6,Hypopigmentation of hair,0.7880542567584415
LPAR6,Sparse body hair,0.7880542567584415
LPAR6,Metastatic malignant neoplasm to brain,0.7880542567584415
LPAR6,Woolly hair congenital,0.7880542567584415
LPAR6,Total Hypotrichosis Mari type,0.7880542567584415
LPAR6,Fine hair,0.7880542567584415
LPAR6,Hypotrichosis of the scalp,0.7880542567584415
LPAR6,Fair hair,0.7880542567584415
LPAR6,Rough hair texture,0.7880542567584415
LPAR6,Coarse hair,0.7880542567584415
LPAR6,Blonde hair,0.7880542567584415
LPAR6,Sparse eyelashes,0.7880542567584415
LPAR6,Hair Diseases,0.7880542567584415
LPAR6,Crohn Disease,0.7880542567584415
LPAR6,HYPERCHOLESTEROLEMIA AUTOSOMAL RECESSIVE,0.7880542567584415
LPAR6,Wooly hair,0.7880542567584415
LPAR6,Afro-textured hair,0.7880542567584415
LPAR6,Kinky hair texture,0.7880542567584415
LPAR6,Nappy hair texture,0.7880542567584415
LPAR6,Sparse and thin eyebrow,0.7967714690735718
LPAR6,Hypotrichosis,0.8019075543217649
LPAR6,Hypotrichosis simplex,0.8019075543217649
LPAR6,Lung diseases,0.8019075543217649
LPAR6,Ulcerative Colitis,0.8190761496232595
LPAR6,Slow-growing hair,0.8190761496232595
LPAR6,Alopecia,0.8523465762428218
LPAR6,Woolly Hair,0.7765582368651238
LPAR6,Hypotrichosis Simplex,0.7765582368651238
LPAR6,Hypotrichosis,0.8115918568696846
LPAR6,Strabismus,0.8908485337686392
LPAR6,Alopecia,0.9367173114041438
LPAR6,Cataract,0.974502015052702
LPAR6,SHORT syndrome ORPHA:3163,0.3832844616405875
LPAR6,ABri amyloidosis ORPHA:97345,0.5867963421058087
LPAR6,ADan amyloidosis ORPHA:97346,0.5867963421058087
LPAR6,Ayme-Gripp syndrome ORPHA:1272,0.5867963421058087
LPAR6,Retinal dystrophy with inner retinal dysfunction and ganglion cell anomalies ORPHA:397758,0.5867963421058087
LPAR6,Adult Krabbe disease ORPHA:206448,0.7929682744768703
LPAR6,Late-infantile/juvenile Krabbe disease ORPHA:206443,0.7929682744768703
LPAR6,Angelman syndrome due to imprinting defect in 15q11-q13 ORPHA:411515,0.7929682744768703
LPAR6,Squamous cell carcinoma of the esophagus ORPHA:99977,0.795266832401002
LPAR6,Bietti crystalline dystrophy ORPHA:41751,0.8922466888454011
LPAR6,Enamel-renal syndrome ORPHA:1031,0.8922466888454011
LPAR6,Vitamin B12-responsive methylmalonic acidemia type cblA ORPHA:79310,0.8922466888454011
LPAR6,Moyamoya disease ORPHA:2573,0.8922466888454011
LPAR6,Hypotrichosis simplex ORPHA:55654,0.8922466888454011
LPAR6,Woolly hair ORPHA:170,0.8922466888454011
LPCAT3,Fatty acid measurement,0.7765852775619541
LPCAT3,Liver carcinoma,0.7880542567584415
LPCAT3,Arteriosclerosis,0.7880542567584415
LPCAT3,Atherosclerosis,0.7880542567584415
LPCAT3,Hyperglycemia,0.7880542567584415
LPCAT3,Red cell distribution width determination,0.8019075543217649
LPCAT3,RDW - Red blood cell distribution width result,0.8019075543217649
LPCAT3,Essential Hypertension,0.9557184806547836
LPCAT3,Mucopolysaccharidosis type 7 ORPHA:584,0.5867963421058087
LPCAT3,Biotinidase deficiency ORPHA:79241,0.7929682744768703
LPCAT3,Fucosidosis ORPHA:349,0.7929682744768703
LPCAT3,Carnitine palmitoyl transferase II deficiency myopathic form ORPHA:228302,0.8922466888454011
LPCAT3,Carnitine palmitoyl transferase II deficiency neonatal form ORPHA:228308,0.8922466888454011
LPCAT3,Carnitine palmitoyl transferase II deficiency severe infantile form ORPHA:228305,0.8922466888454011
LYST,Paresthesia,0.7765852775619541
LYST,Lymphoma,0.7765852775619541
LYST,Amblyopia,0.7765852775619541
LYST,Hemophagocytic Syndrome,0.7765852775619541
LYST,Hypopigmentation of hair,0.7880542567584415
LYST,Chediak-Higashi Syndrome,0.7880542567584415
LYST,Exfoliation Syndrome,0.7880542567584415
LYST,Hermanski-Pudlak Syndrome,0.7880542567584415
LYST,Decreased nerve conduction velocity,0.7880542567584415
LYST,Immunologic Deficiency Syndromes,0.7880542567584415
LYST,Lymphadenopathy,0.7880542567584415
LYST,Body fluid retention,0.7880542567584415
LYST,Pigmentary iris degeneration,0.7880542567584415
LYST,Recurrent cutaneous abscess formation,0.7880542567584415
LYST,aspirin sensitivity,0.7880542567584415
LYST,Cohen syndrome,0.7880542567584415
LYST,Hypothalamic Dysfunction Syndromes,0.7880542567584415
LYST,White hair,0.7880542567584415
LYST,Low Vision,0.7880542567584415
LYST,Recurrent infections,0.7880542567584415
LYST,Lupus Erythematosus Systemic,0.7880542567584415
LYST,Photophobia,0.7880542567584415
LYST,Periodontitis,0.7880542567584415
LYST,Recurrent bacterial skin infections,0.7880542567584415
LYST,Nystagmus,0.7880542567584415
LYST,Infantile nystagmus,0.7880542567584415
LYST,Cognitive delay,0.7880542567584415
LYST,Foot-drop,0.7880542567584415
LYST,Visual Impairment,0.7880542567584415
LYST,Foot dorsiflexor weakness,0.7880542567584415
LYST,Lymphohistiocytosis Hemophagocytic,0.7880542567584415
LYST,Epistaxis,0.7880542567584415
LYST,Frequent nosebleeds,0.7880542567584415
LYST,Global developmental delay,0.7880542567584415
LYST,Edema,0.7880542567584415
LYST,Cranial nerve palsies,0.7880542567584415
LYST,Photodysphoria,0.7880542567584415
LYST,Mental and motor retardation,0.7880542567584415
LYST,Gingivitis,0.7880542567584415
LYST,Onychomycosis,0.7880542567584415
LYST,Nerve Degeneration,0.8009048756462318
LYST,Piebaldism,0.8009048756462318
LYST,Allergic disposition,0.8019075543217649
LYST,Generalized hypopigmentation,0.8019075543217649
LYST,Gait abnormality,0.8019075543217649
LYST,Gingival Hemorrhage,0.8019075543217649
LYST,Platelet Storage Pool Deficiency,0.8019075543217649
LYST,Neuro-degenerative disease,0.8019075543217649
LYST,Decreased platelet count,0.8019075543217649
LYST,Reduced visual acuity,0.8019075543217649
LYST,Leukopenia,0.8019075543217649
LYST,Thrombocytopenia,0.8019075543217649
LYST,Gingival Diseases,0.8026798872257774
LYST,Spastic Paraplegia,0.8067197998685076
LYST,Neutrophil count decreased,0.8101097852323003
LYST,Hypopigmentation disorder,0.8138488881521341
LYST,Fever,0.8168901801930506
LYST,Albinism Ocular,0.8190761496232595
LYST,Tremor,0.8190761496232595
LYST,Albinism Oculocutaneous,0.8212681436603975
LYST,Skin Ulcer,0.8232134984476662
LYST,Periodontal Diseases,0.8270909867833504
LYST,Neurodegenerative Disorders,0.8272008757995397
LYST,Abnormality of coagulation,0.8368219249856942
LYST,Decreased tendon reflex,0.8391186563955684
LYST,Splenomegaly,0.8402911822757345
LYST,Strabismus,0.8402911822757345
LYST,Peripheral Neuropathy,0.8402911822757345
LYST,Mental deficiency,0.8402911822757345
LYST,Icterus,0.8402911822757345
LYST,Albinism,0.8578473133580928
LYST,Anemia,0.8584283190330553
LYST,Atrial Fibrillation,0.8648405521677974
LYST,Hemoglobin low,0.8648405521677974
LYST,Hemorrhagic Disorders,0.8690346447728063
LYST,Dull intelligence,0.8757755363384367
LYST,Low intelligence,0.8757755363384367
LYST,Eosinophilia,0.8769418330148872
LYST,Parkinson Disease,0.8772392350816924
LYST,Absent tendon reflex,0.8867509400747969
LYST,Hepatomegaly,0.887595340546704
LYST,Reflex Deep Tendon Absent,0.8911256045597441
LYST,Absent reflex,0.8911256045597441
LYST,Poor school performance,0.8913141512402477
LYST,Recurrent respiratory infections,0.9083161862856644
LYST,Increased tendency to bruise,0.914995991166204
LYST,Neuropathy,0.914995991166204
LYST,Eosinophilic disorder,0.9193385822373632
LYST,Mental Retardation,0.922229272318747
LYST,Blood Coagulation Disorders,0.9307095582633488
LYST,Chronic Kidney Diseases,0.9393256300017014
LYST,Intellectual Disability,0.9478210444156088
LYST,Seizures,0.9478210444156088
LYST,Trichohepatoenteric Syndrome,0.94939825643792
LYST,Nasal Polyps,0.9614320311453906
LYST,Epilepsy,0.963331724428282
LYST,Gingivitis,0.7765582368651238
LYST,Melanocytic Nevus,0.7765582368651238
LYST,Hypopigmentation Disorder,0.7765582368651238
LYST,Immunologic Deficiency Syndromes,0.7765582368651238
LYST,Nystagmus,0.7765582368651238
LYST,Cranial Nerve Paralysis,0.7765582368651238
LYST,Developmental Delay,0.7765582368651238
LYST,Lymphoma,0.7765582368651238
LYST,Periodontitis,0.7765582368651238
LYST,Leukopenia,0.8091514409416879
LYST,Albinism,0.8115918568696846
LYST,Ocular Albinism,0.8115918568696846
LYST,Spastic Paraplegia,0.8182883735985873
LYST,Parkinson Disease,0.8182883735985873
LYST,Movement Disorders,0.829560580336605
LYST,Cerebellar Atrophy,0.8337953215113012
LYST,Mental Retardation,0.8337953215113012
LYST,Neutropenia,0.8476516371290275
LYST,Strabismus,0.8908485337686392
LYST,Lupus Erythematosus,0.9145387439550552
LYST,Anemia,0.9369188149054885
LYST,Nervous System Diseases,0.9492120794677584
LYST,Developmental Regression,0.9658957825498884
LYST,Atrial Septal Defect,0.9832345076528324
LYST,2q37 microdeletion syndrome ORPHA:1001,0.1991445465001551
LYST,Cleidocranial dysplasia ORPHA:1452,0.3832844616405875
LYST,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504,0.3832844616405875
LYST,SHORT syndrome ORPHA:3163,0.3832844616405875
LYST,TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261,0.3832844616405875
LYST,Autosomal recessive ataxia Beauce type ORPHA:88644,0.5867963421058087
LYST,Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332,0.5867963421058087
LYST,Early-onset Lafora body disease ORPHA:324290,0.5867963421058087
LYST,External auditory canal aplasia/hypoplasia ORPHA:141074,0.5867963421058087
LYST,Generalized glucocorticoid resistance syndrome ORPHA:786,0.5867963421058087
LYST,Familial platelet disorder with associated myeloid malignancy ORPHA:71290,0.5867963421058087
LYST,Acute promyelocytic leukemia ORPHA:520,0.7150309491065155
LYST,1p21.3 microdeletion syndrome ORPHA:293948,0.7929682744768703
LYST,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957,0.7929682744768703
LYST,Coffin-Lowry syndrome ORPHA:192,0.7929682744768703
LYST,Complex lethal osteochondrodysplasia ORPHA:457378,0.7929682744768703
LYST,Dihydropyrimidine dehydrogenase deficiency ORPHA:1675,0.7929682744768703
LYST,GM3 synthase deficiency ORPHA:370933,0.7929682744768703
LYST,Microcephalic primordial dwarfism Dauber type ORPHA:319675,0.7929682744768703
LYST,Nicolaides-Baraitser syndrome ORPHA:3051,0.7929682744768703
LYST,Spinocerebellar ataxia type 1 ORPHA:98755,0.7929682744768703
LYST,Symptomatic form of Coffin-Lowry syndrome in female carriers ORPHA:276630,0.7929682744768703
LYST,Squamous cell carcinoma of the esophagus ORPHA:99977,0.795266832401002
LYST,Acute myeloid leukaemia with myelodysplasia-related features ORPHA:86845,0.8922466888454011
LYST,Attenuated Chediak-Higashi syndrome ORPHA:352723,0.8922466888454011
LYST,Autosomal dominant vitreoretinochoroidopathy ORPHA:3086,0.8922466888454011
LYST,Autosomal recessive bestrophinopathy ORPHA:139455,0.8922466888454011
LYST,Bannayan-Riley-Ruvalcaba syndrome ORPHA:109,0.8922466888454011
LYST,Best vitelliform macular dystrophy ORPHA:1243,0.8922466888454011
LYST,Bietti crystalline dystrophy ORPHA:41751,0.8922466888454011
LYST,Calpain-3-related  limb-girdle muscular dystrophy R1 ORPHA:267,0.8922466888454011
LYST,Chediak-Higashi syndrome ORPHA:167,0.8922466888454011
LYST,Corpus callosum agenesis-neuronopathy syndrome ORPHA:1496,0.8922466888454011
LYST,Familial cylindromatosis ORPHA:211,0.8922466888454011
LYST,Familial multiple trichoepithelioma ORPHA:867,0.8922466888454011
LYST,Lhermitte-Duclos disease ORPHA:65285,0.8922466888454011
LYST,MRCS syndrome ORPHA:263347,0.8922466888454011
LYST,PDE4D haploinsufficiency syndrome ORPHA:439822,0.8922466888454011
LYST,Polycythemia vera ORPHA:729,0.8922466888454011
LYST,Proteus-like syndrome ORPHA:2969,0.8922466888454011
LYST,Refractory anemia ORPHA:98826,0.8922466888454011
LYST,Refractory anemia with excess blasts ORPHA:86839,0.8922466888454011
LYST,Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome ORPHA:137608,0.8922466888454011
LYST,Spinocerebellar ataxia type 15/16 ORPHA:98769,0.8922466888454011
LYST,Spinocerebellar ataxia type 29 ORPHA:208513,0.8922466888454011
LYST,Spinocerebellar ataxia type 7 ORPHA:94147,0.8922466888454011
LYST,Acrodysostosis ORPHA:950,0.8922466888454011
LYST,Acrodysostosis with multiple hormone resistance ORPHA:280651,0.8922466888454011
LYST,Activated PI3K-delta syndrome ORPHA:397596,0.8922466888454011
LYST,Primary myelofibrosis ORPHA:824,0.8922466888454011
LYST,Gingival fibromatosis-hypertrichosis syndrome ORPHA:2026,0.8922466888454011
LYST,Mowat-Wilson syndrome due to a ZEB2 point mutation ORPHA:261552,0.8922466888454011
LYST,Mowat-Wilson syndrome due to monosomy 2q22 ORPHA:261537,0.8922466888454011
LYST,Budd-Chiari syndrome ORPHA:131,0.8922466888454011
LYST,Thyroid hypoplasia ORPHA:95720,0.8922466888454011
LYST,Achromatopsia ORPHA:49382,0.8922466888454011
LYST,Variola virus semaphorin-like protein (gene: A44R),0.8999095837312036
MAFB,leukemia,0.7333611688795861
MAFB,Leukemia Myelocytic Acute,0.7765852775619541
MAFB,Lymphoma,0.7765852775619541
MAFB,Triangular face,0.7765852775619541
MAFB,Liver carcinoma,0.7880542567584415
MAFB,Leukemia Plasma Cell,0.7880542567584415
MAFB,Duane Retraction Syndrome,0.7880542567584415
MAFB,Multiple Myeloma,0.7880542567584415
MAFB,Cleft palate isolated,0.7880542567584415
MAFB,Oculomotor Nerve Paralysis,0.7880542567584415
MAFB,Increase in blood pressure,0.7880542567584415
MAFB,Nasopharyngeal carcinoma,0.7880542567584415
MAFB,Cleft Palate,0.7880542567584415
MAFB,Abnormal vertebral segmentation and fusion,0.7880542567584415
MAFB,Anteverted nostril,0.7880542567584415
MAFB,Ulnar deviation of hand,0.7880542567584415
MAFB,Cleft upper lip,0.7880542567584415
MAFB,Prominent eyes,0.7880542567584415
MAFB,Protruding eyes,0.7880542567584415
MAFB,Prominent globes,0.7880542567584415
MAFB,Exophthalmos,0.7908231553833205
MAFB,Generalized osteopenia,0.8009048756462318
MAFB,Sunken eyes,0.8019075543217649
MAFB,Enophthalmos,0.8019075543217649
MAFB,Gait abnormality,0.8019075543217649
MAFB,Limitation of joint mobility,0.8019075543217649
MAFB,Short palpebral fissure,0.8019075543217649
MAFB,Kidney Diseases,0.8019075543217649
MAFB,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
MAFB,Dyslipidemias,0.8138488881521341
MAFB,Cardiac Lymphoma,0.8145035474981049
MAFB,Electromyogram abnormal,0.8190761496232595
MAFB,Arthralgia,0.8190761496232595
MAFB,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
MAFB,Slender long bone,0.8190761496232595
MAFB,Osteopenia,0.8212681436603975
MAFB,Retrusion of upper jaw bones,0.8232134984476662
MAFB,Decreased projection of maxilla,0.8232134984476662
MAFB,Deficiency of upper jaw bones,0.8232134984476662
MAFB,Hypoplasia of the maxilla,0.8232134984476662
MAFB,Hypotrophic maxilla,0.8232134984476662
MAFB,Maxillary retrognathia,0.8232134984476662
MAFB,Milroy Disease,0.834094492023826
MAFB,Strabismus,0.8402911822757345
MAFB,Osteogenesis Imperfecta,0.8402911822757345
MAFB,Cachexia,0.8402911822757345
MAFB,Kidney damage,0.843190898187174
MAFB,Hypertensive disease,0.8474481237156937
MAFB,Flexion contracture of proximal interphalangeal joint,0.8578473133580928
MAFB,Retrusion of lower jaw,0.8648405521677974
MAFB,Decreased projection of lower jaw,0.8648405521677974
MAFB,Decreased projection of mandible,0.8648405521677974
MAFB,Hypoplastic mandible condyle,0.8648405521677974
MAFB,Aplasia/Hypoplasia of the mandible,0.8648405521677974
MAFB,Micrognathism,0.8648405521677974
MAFB,Proteinuria,0.8769418330148872
MAFB,Low posterior hairline,0.8851456306720444
MAFB,Blepharophimosis,0.9189398569397552
MAFB,Renal failure in adulthood,0.929814249105729
MAFB,Renal Insufficiency,0.946564927793026
MAFB,Intellectual Disability,0.9478210444156088
MAFB,Sensorineural Hearing Loss (disorder),0.9520060723130308
MAFB,Uranostaphyloschisis,0.9534337109847604
MAFB,Congenital pes cavus,0.957487573707278
MAFB,Kidney Failure,0.9894341523578486
MAFB,Congenital Hypoplasia Of Radius,0.7765582368651238
MAFB,Plagiocephaly,0.7765582368651238
MAFB,Hypoplasia Of The Maxilla,0.7765582368651238
MAFB,Nystagmus,0.7765582368651238
MAFB,Hypertension,0.7765582368651238
MAFB,Aniridia,0.7765582368651238
MAFB,Developmental Delay,0.7765582368651238
MAFB,Microcornea,0.7765582368651238
MAFB,Duane Retraction Syndrome,0.7765582368651238
MAFB,Fundus Coloboma,0.8115918568696846
MAFB,Osteopenia,0.8115918568696846
MAFB,Retinal Coloboma,0.8115918568696846
MAFB,Oculomotor Nerve Palsy,0.8115918568696846
MAFB,Proptosis,0.8115918568696846
MAFB,Hearing Loss,0.8115918568696846
MAFB,Congenital Camptodactyly,0.8115918568696846
MAFB,Stenosis Of External Auditory Canal,0.8115918568696846
MAFB,Kidney Disease,0.8210988731657684
MAFB,Blepharospasm,0.8210988731657684
MAFB,Hypoplasia Of Optic Disc,0.829560580336605
MAFB,Neck Webbing,0.8337953215113012
MAFB,Ectopic Kidney,0.861756360478846
MAFB,Microcephaly,0.8903630091389316
MAFB,Strabismus,0.8908485337686392
MAFB,Spina Bifida Occulta,0.9166047043368432
MAFB,Congenital Coloboma Of Iris,0.9318760199717074
MAFB,Micrognathism,0.9398381935810408
MAFB,Blepharophimosis,0.9543024119762946
MAFB,Polydactyly,0.9578111936867284
MAFB,Renal Insufficiency,0.9726837163662044
MAFB,Ptosis,0.9832345076528324
MAFB,Congenital Clubfoot,0.9832345076528324
MAFB,Brachydactyly,0.9887104428514284
MAFB,Congenital brain dysgenesis due to glutamine synthetase deficiency ORPHA:71278,0.1040670578681756
MAFB,Thrombomodulin-related bleeding disorder ORPHA:436169,0.1040670578681756
MAFB,ACys amyloidosis ORPHA:100008,0.3832844616405875
MAFB,Charcot-Marie-Tooth disease type 4D ORPHA:99950,0.3832844616405875
MAFB,Duane retraction syndrome with congenital deafness ORPHA:529574,0.3832844616405875
MAFB,Multicentric carpo-tarsal osteolysis with or without nephropathy ORPHA:2774,0.3832844616405875
MAFB,Atypical Gaucher disease due to saposin C deficiency ORPHA:309252,0.5867963421058087
MAFB,Ayme-Gripp syndrome ORPHA:1272,0.5867963421058087
MAFB,Beckwith-Wiedemann syndrome due to CDKN1C mutation ORPHA:231120,0.5867963421058087
MAFB,Charcot-Marie-Tooth disease type 4H ORPHA:99954,0.5867963421058087
MAFB,Encephalopathy due to prosaposin deficiency ORPHA:139406,0.5867963421058087
MAFB,Intrauterine growth restriction-short stature-early adult-onset diabetes syndrome ORPHA:436144,0.5867963421058087
MAFB,Tangier disease ORPHA:31150,0.5867963421058087
MAFB,Acute myeloid leukemia with CEBPA somatic mutations ORPHA:319480,0.7929682744768703
MAFB,Cerebrotendinous xanthomatosis ORPHA:909,0.7929682744768703
MAFB,Duane retraction syndrome ORPHA:233,0.7929682744768703
MAFB,C1 inhibitor deficiency ORPHA:459353,0.8922466888454011
MAFB,Hereditary angioedema type 1 ORPHA:100050,0.8922466888454011
MAFB,Hereditary angioedema type 2 ORPHA:100051,0.8922466888454011
MAFB,NON RARE IN EUROPE: Berger disease ORPHA:34145,0.8922466888454011
MAFB,Sanfilippo syndrome type C ORPHA:79271,0.8922466888454011
MAFB,Inherited acute myeloid leukemia ORPHA:319465,0.8922466888454011
MAFB,Semantic dementia ORPHA:100069,0.8922466888454011
MAFB,Japanese encephalitis virus hypothetical protein,0.8999095837312036
MAFB,Salivirus NG-J1 3D,0.8999095837312036
MAFB,Human enteric coronavirus 4408 spike protein (gene: S),0.8999095837312036
MAFB,Human enteric coronavirus strain 4408 spike protein,0.8999095837312036
MAFB,Rotavirus A NSP4,0.8999095837312036
MAFB,Human parainfluenza virus 1 strain Washington/1964 phosphoprotein (gene: P),0.8999095837312036
MAFB,Human respirovirus 1 phosphoprotein (gene: P),0.8999095837312036
MAFB,Sagiyama virus full_polyprotein 1..1253 (gene: C-E3-E2-6K-E1),0.8999095837312036
MAFB,Variola virus hypothetical protein (gene: A28L),0.8999095837312036
MAFB,Japanese encephalitis virus anchored core protein C,0.8999095837312036
MAFB,Japanese encephalitis virus prodexcised_polyprotein 1..794,0.8999095837312036
MAFB,West Nile virus lineage 1 capsid protein C (gene: flavivirus polyprotein),0.8999095837312036
MAP3K14,Malignant neoplasm of breast,0.4084380369379369
MAP3K14,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
MAP3K14,Breast Carcinoma,0.7333611688795861
MAP3K14,Diffuse Large B-Cell Lymphoma,0.7333611688795861
MAP3K14,Carcinogenesis,0.7333611688795861
MAP3K14,B-Cell Lymphomas,0.7333611688795861
MAP3K14,Lymphoma,0.7765852775619541
MAP3K14,Glioma,0.7880542567584415
MAP3K14,Myotonic Dystrophy,0.7880542567584415
MAP3K14,Liver carcinoma,0.7880542567584415
MAP3K14,Lymphopenia,0.7880542567584415
MAP3K14,Glioblastoma,0.7880542567584415
MAP3K14,Primary immune deficiency disorder,0.7880542567584415
MAP3K14,Prostatic Neoplasms,0.7880542567584415
MAP3K14,Biliary cirrhosis,0.7880542567584415
MAP3K14,melanoma,0.7880542567584415
MAP3K14,Peutz-Jeghers Syndrome,0.7880542567584415
MAP3K14,Ovarian Mucinous Adenocarcinoma,0.7880542567584415
MAP3K14,vascular ischemia,0.7880542567584415
MAP3K14,Neoplastic Syndromes Hereditary,0.7880542567584415
MAP3K14,Classical Hodgkin's Lymphoma,0.7880542567584415
MAP3K14,Sjogren's Syndrome,0.7880542567584415
MAP3K14,Anaplastic thyroid carcinoma,0.7880542567584415
MAP3K14,Neurofibromatosis Type 3 mixed central and peripheral,0.7880542567584415
MAP3K14,Virus Diseases,0.7880542567584415
MAP3K14,Pick Disease of the Brain,0.8019075543217649
MAP3K14,Embryonal Carcinoma,0.8019075543217649
MAP3K14,Schizophrenia,0.8067197998685076
MAP3K14,Herpes Simplex Infections,0.8098851543361193
MAP3K14,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
MAP3K14,Primary biliary cirrhosis,0.8212681436603975
MAP3K14,Tuberculosis,0.8368219249856942
MAP3K14,Down Syndrome,0.8420665668584452
MAP3K14,Medullary carcinoma of thyroid,0.8757755363384367
MAP3K14,Heart failure,0.8867509400747969
MAP3K14,Congestive heart failure,0.8976039441125321
MAP3K14,Frontotemporal dementia,0.9024758035783405
MAP3K14,Sicca Syndrome,0.9039108388826153
MAP3K14,Ovarian Adenocarcinoma,0.7765582368651238
MAP3K14,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.1991445465001551
MAP3K14,NIK deficiency ORPHA:447731,0.1991445465001551
MAP3K14,Odonto-onycho-dermal dysplasia ORPHA:2721,0.7929682744768703
MAP3K14,Schopf-Schulz-Passarge syndrome ORPHA:50944,0.7929682744768703
MAP3K14,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
MAP3K14,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
MAP3K14,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
MAP3K14,Provisional),0.8999095837312036
MAP3K14,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAP3K14,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAP3K14,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAP3K14,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAP3K14,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
MAP3K14,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
MAP3K14,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
MAP3K14,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
MAP3K14,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
MAP3K14,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
MAP3K14,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
MAP3K14,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
MAP3K14,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAP3K14,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAP3K14,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAP3K14,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAP3K14,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAP3K14,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAP3K14,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
MAP3K14,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
MAP3K14,Yaba-like disease virus 142R protein (gene: 142R),0.8999095837312036
MAP3K14,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
MAP3K14,Monkeypox virus ser/thr kinase,0.8999095837312036
MAP3K14,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
MAP3K14,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
MAP3K14,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
MAP3K14,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
MAP3K14,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.8999095837312036
MAP3K14,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.8999095837312036
MAP3K14,Papiine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.9237501457186692
MAPKAPK2,Carcinoma of bladder,0.4084380369379369
MAPKAPK2,Bladder Neoplasm,0.4084380369379369
MAPKAPK2,Malignant neoplasm of urinary bladder,0.5071083164302358
MAPKAPK2,Carcinogenesis,0.7333611688795861
MAPKAPK2,Malignant neoplasm of pancreas,0.7688485284765829
MAPKAPK2,Pancreatic carcinoma,0.7765852775619541
MAPKAPK2,Gastrointestinal Stromal Tumors,0.7765852775619541
MAPKAPK2,Non-Small Cell Lung Carcinoma,0.7765852775619541
MAPKAPK2,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
MAPKAPK2,Mammary Neoplasms,0.7880542567584415
MAPKAPK2,Glioma,0.7880542567584415
MAPKAPK2,Malignant neoplasm of lung,0.7880542567584415
MAPKAPK2,Malignant neoplasm of prostate,0.7880542567584415
MAPKAPK2,Invasive carcinoma of breast,0.7880542567584415
MAPKAPK2,Malignant Head and Neck Neoplasm,0.7880542567584415
MAPKAPK2,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
MAPKAPK2,Glioblastoma,0.7880542567584415
MAPKAPK2,Prostate carcinoma,0.7880542567584415
MAPKAPK2,Primary malignant neoplasm of lung,0.7880542567584415
MAPKAPK2,Prostatic Neoplasms,0.7880542567584415
MAPKAPK2,Carcinoma of lung,0.7880542567584415
MAPKAPK2,Malignant neoplasm of liver,0.7880542567584415
MAPKAPK2,Van der Woude syndrome,0.7880542567584415
MAPKAPK2,Multiple Myeloma,0.7880542567584415
MAPKAPK2,Nasopharyngeal carcinoma,0.7880542567584415
MAPKAPK2,Alzheimer's Disease,0.7880542567584415
MAPKAPK2,Pemphigus Vulgaris,0.8019075543217649
MAPKAPK2,Psoriasis,0.8019075543217649
MAPKAPK2,Epstein-Barr Virus Infections,0.8232134984476662
MAPKAPK2,Clostridium,0.8554819098734854
MAPKAPK2,difficile (disorder),0.882453254162044
MAPKAPK2,Inflammatory disorder,0.8867509400747969
MAPKAPK2,Heart failure,0.8911256045597441
MAPKAPK2,Pulmonary Fibrosis,0.8976039441125321
MAPKAPK2,Oral Ulcer,0.7765582368651238
MAPKAPK2,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
MAPKAPK2,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.1991445465001551
MAPKAPK2,Early-onset posterior subcapsular cataract ORPHA:441447,0.220389120533256
MAPKAPK2,Desbuquois syndrome ORPHA:1425,0.3832844616405875
MAPKAPK2,Chronic myelomonocytic leukemia ORPHA:98823,0.3891940933600213
MAPKAPK2,Schneckenbecken dysplasia ORPHA:3144,0.5867963421058087
MAPKAPK2,Dejerine-Sottas syndrome ORPHA:64748,0.8922466888454011
MAPKAPK2,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
MAPKAPK2,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
MAPKAPK2,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
MAPKAPK2,Provisional),0.8999095837312036
MAPKAPK2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAPKAPK2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAPKAPK2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAPKAPK2,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAPKAPK2,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
MAPKAPK2,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
MAPKAPK2,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
MAPKAPK2,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
MAPKAPK2,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
MAPKAPK2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
MAPKAPK2,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
MAPKAPK2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
MAPKAPK2,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
MAPKAPK2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAPKAPK2,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MAPKAPK2,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAPKAPK2,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.8999095837312036
MAPKAPK2,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAPKAPK2,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
MAPKAPK2,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
MAPKAPK2,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
MAPKAPK2,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
MAPKAPK2,Monkeypox virus ser/thr kinase,0.8999095837312036
MAPKAPK2,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
MAPKAPK2,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
MAPKAPK2,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
MAPKAPK2,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
MAPKAPK2,Variola virus hypothetical protein (gene: B1R),0.8999095837312036
MAPKAPK2,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
MAPKAPK2,Cowpox virus CPXV206 protein (gene: CPXV206 CDS),0.8999095837312036
MAPKAPK2,Vaccinia virus ser/thr kinase (gene: B1R),0.8999095837312036
MAPKAPK2,Vaccinia virus Ankara Serine/threonine-protein kinase,0.8999095837312036
MAPKAPK2,Horsepox virus HSPV179 (Serine/Threonine protein kinase Vaccinia Related Kinase),0.8999095837312036
MAPRE2,Adenomatous Polyposis Coli,0.5196624042573144
MAPRE2,Carcinogenesis,0.7333611688795861
MAPRE2,leukemia,0.7333611688795861
MAPRE2,Malignant neoplasm of pancreas,0.7688485284765829
MAPRE2,Pancreatic carcinoma,0.7765852775619541
MAPRE2,Rotting teeth,0.7880542567584415
MAPRE2,Liver carcinoma,0.7880542567584415
MAPRE2,Dental caries,0.7880542567584415
MAPRE2,Colorectal Cancer,0.7880542567584415
MAPRE2,Body fluid retention,0.7880542567584415
MAPRE2,Diffusely thickened skin,0.7880542567584415
MAPRE2,Thick skin,0.7880542567584415
MAPRE2,Hypoplasia of corpus callosum,0.7880542567584415
MAPRE2,Broad neck,0.7880542567584415
MAPRE2,Decreased corneal diameter,0.7880542567584415
MAPRE2,Microcornea,0.7880542567584415
MAPRE2,Squamous cell carcinoma,0.7880542567584415
MAPRE2,Edema,0.7880542567584415
MAPRE2,Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,0.8009048756462318
MAPRE2,Short palpebral fissure,0.8019075543217649
MAPRE2,Posteriorly rotated ear,0.8026798872257774
MAPRE2,Delayed speech and language development,0.8168901801930506
MAPRE2,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
MAPRE2,Upward slant of palpebral fissure,0.8168901801930506
MAPRE2,Downward slant of palpebral fissure,0.8168901801930506
MAPRE2,No development of motor milestones,0.8212681436603975
MAPRE2,Hypoplasia of scrotum,0.8212681436603975
MAPRE2,Motor delay,0.8232134984476662
MAPRE2,Abnormally small eyeball,0.8402911822757345
MAPRE2,Decreased size of eyeball,0.8402911822757345
MAPRE2,Irregular hyperpigmentation,0.8402911822757345
MAPRE2,Speech impairment,0.8402911822757345
MAPRE2,Cryptorchidism,0.8402911822757345
MAPRE2,Language Delay,0.8402911822757345
MAPRE2,Generalized hypotonia,0.843190898187174
MAPRE2,Speech Delay,0.8474481237156937
MAPRE2,Microstomia,0.8554819098734854
MAPRE2,Retrusion of lower jaw,0.8648405521677974
MAPRE2,Decreased projection of lower jaw,0.8648405521677974
MAPRE2,Decreased projection of mandible,0.8648405521677974
MAPRE2,Hypoplastic mandible condyle,0.8648405521677974
MAPRE2,Aplasia/Hypoplasia of the mandible,0.8648405521677974
MAPRE2,Micrognathism,0.8648405521677974
MAPRE2,Low set ears,0.8700543109506378
MAPRE2,Flat face,0.882453254162044
MAPRE2,Congenital Epicanthus,0.8867509400747969
MAPRE2,Congenital small ears,0.8959157818691486
MAPRE2,Microphthalmos,0.9154499654632742
MAPRE2,Penile hypospadias,0.9393256300017014
MAPRE2,Intellectual Disability,0.9478210444156088
MAPRE2,Seizures,0.9478210444156088
MAPRE2,Hypospadias,0.94939825643792
MAPRE2,Uranostaphyloschisis,0.9534337109847604
MAPRE2,Short neck,0.954882372756482
MAPRE2,Epilepsy,0.963331724428282
MAPRE2,Developmental Delay,0.7765582368651238
MAPRE2,Microcornea,0.7765582368651238
MAPRE2,Hypoplasia Of Corpus Callosum,0.7949861636679444
MAPRE2,Retinal Diseases,0.8115918568696846
MAPRE2,Motor Delay,0.8210988731657684
MAPRE2,Mental Retardation,0.8337953215113012
MAPRE2,Cryptorchidism,0.861756360478846
MAPRE2,Posteriorly Rotated Ear,0.8903301324869451
MAPRE2,Microcephaly,0.8903630091389316
MAPRE2,Microtia,0.8974842552599366
MAPRE2,Micrognathism,0.9398381935810408
MAPRE2,Microphthalmos,0.941216656523771
MAPRE2,Dwarfism,0.9510372690456612
MAPRE2,Congestive Heart Failure,0.9543024119762946
MAPRE2,Neuroblastoma,0.9543024119762946
MAPRE2,Microstomia,0.9543024119762946
MAPRE2,Hypospadias,0.974502015052702
MAPRE2,Congenital Epicanthus,0.974502015052702
MAPRE2,Congenital Exomphalos,0.980894832851993
MAPRE2,Intellectual disability-developmental delay-contractures syndrome ORPHA:3454,0.5867963421058087
MAPRE2,Multiple benign circumferential skin creases on limbs ORPHA:2505,0.7929682744768703
MAPRE2,Fried syndrome ORPHA:85335,0.8922466888454011
MAPRE2,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568,0.8922466888454011
MAPRE2,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329,0.8922466888454011
MAPRE2,Prader-Willi syndrome due to translocation ORPHA:177907,0.8922466888454011
MARVELD3,Adenocarcinoma,0.750391252594775
MARVELD3,Malignant neoplasm of pancreas,0.7688485284765829
MARVELD3,Pancreatic carcinoma,0.7765852775619541
MARVELD3,Malignant neoplasm of lung,0.7880542567584415
MARVELD3,Primary malignant neoplasm of lung,0.7880542567584415
MARVELD3,Carcinoma of lung,0.7880542567584415
MARVELD3,Calcification of coronary artery,0.9377696084218796
MARVELD3,Apparent mineralocorticoid excess ORPHA:320,0.1991445465001551
MARVELD3,Autosomal dominant popliteal pterygium syndrome ORPHA:1300,0.1991445465001551
MARVELD3,Autosomal recessive cerebral atrophy ORPHA:363969,0.1991445465001551
MARVELD3,Congenital intrauterine infection-like syndrome ORPHA:1229,0.1991445465001551
MARVELD3,Congenital tufting enteropathy ORPHA:92050,0.1991445465001551
MARVELD3,EEM syndrome ORPHA:1897,0.1991445465001551
MARVELD3,Hypotrichosis with juvenile macular degeneration ORPHA:1573,0.1991445465001551
MARVELD3,Isolated neonatal sclerosing cholangitis ORPHA:480556,0.1991445465001551
MARVELD3,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.1991445465001551
MARVELD3,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.1991445465001551
MARVELD3,Nail and teeth abnormalities-marginal palmoplantar keratoderma-oral hyperpigmentation syndrome ORPHA:423454,0.1991445465001551
MARVELD3,Generalized pseudohypoaldosteronism type 1 ORPHA:171876,0.3832844616405875
MARVELD3,Liddle syndrome ORPHA:526,0.3832844616405875
MARVELD3,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119,0.3832844616405875
MARVELD3,Congenital hereditary endothelial dystrophy type I ORPHA:98975,0.3832844616405875
MARVELD3,Familial hyperprolactinemia ORPHA:397685,0.3832844616405875
MARVELD3,RFVT3-related riboflavin transporter deficiency ORPHA:572550,0.3832844616405875
MARVELD3,Syndromic congenital sodium diarrhea ORPHA:563708,0.3832844616405875
MARVELD3,Blepharo-cheilo-odontic syndrome ORPHA:1997,0.3832844616405875
MARVELD3,Cholangiocarcinoma ORPHA:70567,0.5867963421058087
MARVELD3,Idiopathic bronchiectasis ORPHA:60033,0.5867963421058087
MARVELD3,Low isolated anorectal malformation ORPHA:171215,0.5867963421058087
MARVELD3,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744,0.5867963421058087
MARVELD3,Congenital bilateral absence of vas deferens ORPHA:48,0.5867963421058087
MARVELD3,Microvillus inclusion disease ORPHA:2290,0.5867963421058087
MARVELD3,Progressive familial intrahepatic cholestasis type 1 ORPHA:79306,0.5867963421058087
MARVELD3,NON RARE IN EUROPE: Recurrent acute pancreatitis ORPHA:64740,0.5867963421058087
MARVELD3,Familial thyroid dyshormonogenesis ORPHA:95716,0.5959529547720634
MARVELD3,Epidermolysis bullosa simplex due to exophilin 5 deficiency ORPHA:412189,0.7929682744768703
MARVELD3,Xanthinuria type I ORPHA:93601,0.7929682744768703
MARVELD3,Neonatal severe primary hyperparathyroidism ORPHA:417,0.7929682744768703
MARVELD3,Carnitine palmitoyl transferase II deficiency myopathic form ORPHA:228302,0.8922466888454011
MARVELD3,Carnitine palmitoyl transferase II deficiency neonatal form ORPHA:228308,0.8922466888454011
MARVELD3,Carnitine palmitoyl transferase II deficiency severe infantile form ORPHA:228305,0.8922466888454011
MBNL2,Myotonic Dystrophy,0.7880542567584415
MBNL2,MYOTONIC DYSTROPHY 1,0.7880542567584415
MBNL2,Infant Premature,0.7880542567584415
MBNL2,HUNTINGTON DISEASE-LIKE 2,0.7880542567584415
MBNL2,Diabetes Mellitus,0.7880542567584415
MBNL2,Alcoholic Intoxication Chronic,0.8019075543217649
MBNL2,Tetralogy of Fallot,0.8769418330148872
MBNL2,Myopathy,0.9557184806547836
MBNL2,GNE myopathy ORPHA:602,0.3832844616405875
MBNL2,Sialuria ORPHA:3166,0.3832844616405875
MBNL2,1p31p32 microdeletion syndrome ORPHA:401986,0.5867963421058087
MBNL2,Charcot-Marie-Tooth disease type 4C ORPHA:99949,0.5867963421058087
MBNL2,Familial Alzheimer-like prion disease ORPHA:280397,0.7929682744768703
MBNL2,Fatal familial insomnia ORPHA:466,0.7929682744768703
MBNL2,Gerstmann-Straussler-Scheinker syndrome ORPHA:356,0.7929682744768703
MBNL2,Huntington disease-like 1 ORPHA:157941,0.7929682744768703
MBNL2,Inherited Creutzfeldt-Jakob disease ORPHA:282166,0.7929682744768703
MBNL2,Kuru ORPHA:454745,0.7929682744768703
MBNL2,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138,0.7929682744768703
MBNL2,PrP systemic amyloidosis ORPHA:397606,0.7929682744768703
MBNL2,Sporadic fatal insomnia ORPHA:586130,0.7929682744768703
MBNL2,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation ORPHA:438216,0.8922466888454011
MBNL2,Recessive X-linked ichthyosis ORPHA:461,0.8922466888454011
MBNL2,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion ORPHA:314655,0.8922466888454011
MBNL2,Syndromic recessive X-linked ichthyosis ORPHA:281090,0.8922466888454011
MBNL2,Acrodysostosis ORPHA:950,0.8922466888454011
MBNL2,Acrodysostosis with multiple hormone resistance ORPHA:280651,0.8922466888454011
MBNL2,HELLP syndrome ORPHA:244242,0.8922466888454011
MBNL2,X-linked myotubular myopathy-abnormal genitalia syndrome ORPHA:456328,0.8922466888454011
MBNL2,Obesity due to leptin receptor gene deficiency ORPHA:179494,0.8922466888454011
MBNL2,Autosomal dominant Emery-Dreifuss muscular dystrophy ORPHA:98853,0.8922466888454011
MDC1,Malignant neoplasm of breast,0.4084380369379369
MDC1,Carcinoma of bladder,0.4084380369379369
MDC1,Bladder Neoplasm,0.4084380369379369
MDC1,Malignant neoplasm of urinary bladder,0.5071083164302358
MDC1,Breast Carcinoma,0.7333611688795861
MDC1,Carcinogenesis,0.7333611688795861
MDC1,Malignant neoplasm of ovary,0.7333611688795861
MDC1,Ovarian Carcinoma,0.7333611688795861
MDC1,Esophageal carcinoma,0.7765852775619541
MDC1,Cervix carcinoma,0.7765852775619541
MDC1,Esophageal Neoplasms,0.7765852775619541
MDC1,Malignant tumor of cervix,0.7768809924982332
MDC1,Malignant neoplasm of lung,0.7880542567584415
MDC1,Malignant neoplasm of prostate,0.7880542567584415
MDC1,Malignant neoplasm of esophagus,0.7880542567584415
MDC1,Prostate carcinoma,0.7880542567584415
MDC1,Primary malignant neoplasm of lung,0.7880542567584415
MDC1,cervical cancer,0.7880542567584415
MDC1,Neoplasm Metastasis,0.7880542567584415
MDC1,Carcinoma of lung,0.7880542567584415
MDC1,Malignant neoplasm of nasopharynx,0.7880542567584415
MDC1,Malignant neoplasm of stomach,0.7880542567584415
MDC1,Cancer of Nasopharynx,0.7880542567584415
MDC1,Nasopharyngeal carcinoma,0.7880542567584415
MDC1,Tumor Progression,0.7880542567584415
MDC1,Stomach Carcinoma,0.7880542567584415
MDC1,Rheumatoid Arthritis,0.7880542567584415
MDC1,Aortic Valve Insufficiency,0.7880542567584415
MDC1,Body mass index,0.8867509400747969
MDC1,Finding of body mass index,0.8867509400747969
MDC1,Rheumatoid Arthritis,0.9251646147729308
MDC1,X-linked intellectual disability Siderius type ORPHA:85287,0.1991445465001551
MDC1,Precursor T-cell acute lymphoblastic leukemia ORPHA:99861,0.3832844616405875
MDC1,Oculofaciocardiodental syndrome ORPHA:2712,0.3832844616405875
MDC1,15q24 microdeletion syndrome ORPHA:94065,0.5867963421058087
MDC1,Autosomal dominant Charcot-Marie-Tooth disease type 2Z ORPHA:466768,0.5867963421058087
MDC1,Floating-Harbor syndrome ORPHA:2044,0.5867963421058087
MDC1,Methylmalonic acidemia with homocystinuria type cblX ORPHA:369962,0.5867963421058087
MDC1,SIN3A-related intellectual disability syndrome due to a point mutation ORPHA:500166,0.5867963421058087
MDC1,Juvenile amyotrophic lateral sclerosis ORPHA:300605,0.5959529547720634
MDC1,Coffin-Siris syndrome ORPHA:1465,0.6467006456772204
MDC1,NUT midline carcinoma ORPHA:443167,0.7929682744768703
MDC1,Familial infantile bilateral striatal necrosis ORPHA:225154,0.7929682744768703
MDC1,Familial isolated hyperparathyroidism ORPHA:99879,0.7929682744768703
MDC1,Osteopathia striata-cranial sclerosis syndrome ORPHA:2780,0.8922466888454011
MDC1,SMARCA4-deficient sarcoma of thorax ORPHA:466962,0.8922466888454011
MDC1,Small cell carcinoma of the ovary ORPHA:370396,0.8922466888454011
MDC1,Lujan-Fryns syndrome ORPHA:776,0.8922466888454011
MDC1,Clear cell sarcoma of kidney ORPHA:457246,0.8922466888454011
MDC1,Macrocephaly-intellectual disability-neurodevelopmental disorder-small thorax syndrome ORPHA:457485,0.8922466888454011
MED26,Schizophrenia,0.7860378120955526
MED26,Hermansky-Pudlak syndrome type 8 ORPHA:231537,0.3832844616405875
MED26,Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431,0.5867963421058087
MEF2B,Diffuse Large B-Cell Lymphoma,0.7333611688795861
MEF2B,Carcinogenesis,0.7333611688795861
MEF2B,Leukemogenesis,0.7765852775619541
MEF2B,Lymphoma Non-Hodgkin,0.7880542567584415
MEF2B,Serum total cholesterol measurement,0.7880542567584415
MEF2B,Hodgkin Disease,0.7880542567584415
MEF2B,Lymphoma Follicular,0.7880542567584415
MEF2B,Multiple Sclerosis,0.8019075543217649
MEF2B,Ataxia,0.8402911822757345
MEF2B,Low density lipoprotein cholesterol measurement,0.8648405521677974
MEF2B,Cerebellar Ataxia,0.906476206143938
MEF2B,Polydactyly of a biphalangeal thumb ORPHA:93339,0.3832844616405875
MEF2B,Human parechovirus 5 full_polyprotein 1..2185,0.9057542447893764
MERTK,Malignant neoplasm of breast,0.4084380369379369
MERTK,Breast Carcinoma,0.7333611688795861
MERTK,leukemia,0.7333611688795861
MERTK,Leukemia Myelocytic Acute,0.7765852775619541
MERTK,Retinal pigment epithelial abnormality,0.7765852775619541
MERTK,Abnormality of retinal pigmentation,0.7765852775619541
MERTK,Lymphoma,0.7765852775619541
MERTK,Progressive visual loss,0.7765852775619541
MERTK,Leukemogenesis,0.7765852775619541
MERTK,Non-Small Cell Lung Carcinoma,0.7765852775619541
MERTK,Decreased visual acuity progressive,0.7765852775619541
MERTK,Glioma,0.7880542567584415
MERTK,Middle East Respiratory Syndrome,0.7880542567584415
MERTK,Malignant neoplasm of lung,0.7880542567584415
MERTK,Malignant neoplasm of prostate,0.7880542567584415
MERTK,IMMUNE SUPPRESSION,0.7880542567584415
MERTK,Pulmonary Thromboembolisms,0.7880542567584415
MERTK,Thromboembolism,0.7880542567584415
MERTK,Rhabdomyosarcoma,0.7880542567584415
MERTK,Lymphopenia,0.7880542567584415
MERTK,Multiple malignancy,0.7880542567584415
MERTK,Glioblastoma,0.7880542567584415
MERTK,Prostate carcinoma,0.7880542567584415
MERTK,Primary malignant neoplasm of lung,0.7880542567584415
MERTK,Neoplasm Metastasis,0.7880542567584415
MERTK,Carcinoma of lung,0.7880542567584415
MERTK,Squamous cell carcinoma of the head and neck,0.7880542567584415
MERTK,Malignant Neoplasms,0.7880542567584415
MERTK,melanoma,0.7880542567584415
MERTK,Retinal Diseases,0.7880542567584415
MERTK,Difficulties with night vision,0.7880542567584415
MERTK,Night Blindness,0.7880542567584415
MERTK,Pallor of optic disc,0.7880542567584415
MERTK,Brain Neoplasms,0.7880542567584415
MERTK,Conductive hearing loss,0.7880542567584415
MERTK,Tumor Progression,0.7880542567584415
MERTK,Lupus Erythematosus Systemic,0.7880542567584415
MERTK,Hematological Disease,0.7880542567584415
MERTK,Photophobia,0.7880542567584415
MERTK,Photoreceptor degeneration,0.7880542567584415
MERTK,Arteriosclerosis,0.7880542567584415
MERTK,Atherosclerosis,0.7880542567584415
MERTK,Acute lymphocytic leukemia,0.7880542567584415
MERTK,Nystagmus,0.7880542567584415
MERTK,Pulmonary Embolism,0.7880542567584415
MERTK,Anteverted nostril,0.7880542567584415
MERTK,Autoimmune Diseases,0.7880542567584415
MERTK,Hepatitis C,0.7880542567584415
MERTK,Glaucoma,0.7880542567584415
MERTK,Thrombus,0.7880542567584415
MERTK,Abnormality of the retinal vasculature,0.7880542567584415
MERTK,Demyelinating Diseases,0.7880542567584415
MERTK,Carcinoma,0.7880542567584415
MERTK,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
MERTK,Photodysphoria,0.7880542567584415
MERTK,Virus Diseases,0.7880542567584415
MERTK,Optic Atrophy,0.7880542567584415
MERTK,Atrophoderma maculatum,0.7880542567584415
MERTK,Electroretinogram abnormal,0.7908231553833205
MERTK,Primary malignant neoplasm,0.7908231553833205
MERTK,Carcinoma Spindle-Cell,0.7950434752274518
MERTK,Undifferentiated carcinoma,0.8019075543217649
MERTK,IGA Glomerulonephritis,0.8019075543217649
MERTK,Hyperinsulinism,0.8019075543217649
MERTK,Allergic disposition,0.8019075543217649
MERTK,Benign neoplasm of aortic body and other paraganglia,0.8019075543217649
MERTK,Malignant Adrenal Medulla Neoplasm,0.8019075543217649
MERTK,Malignant neoplasm of aortic body and other paraganglia,0.8019075543217649
MERTK,Multiple Sclerosis,0.8019075543217649
MERTK,Leukopenia,0.8019075543217649
MERTK,Myocardial Infarction,0.8019075543217649
MERTK,Benign neoplasm of adrenal gland,0.8019075543217649
MERTK,Blindness Legal,0.8019075543217649
MERTK,Lupus Erythematosus,0.8067197998685076
MERTK,Blindness,0.8098851543361193
MERTK,Lupus Erythematosus Discoid,0.8098851543361193
MERTK,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
MERTK,Liver diseases,0.8140222479282434
MERTK,Congenital anomaly of testis,0.8168901801930506
MERTK,Progressive night blindness,0.8168901801930506
MERTK,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
MERTK,Carcinomatosis,0.8190761496232595
MERTK,Peritonitis,0.8190761496232595
MERTK,Retinal Dystrophies,0.8190761496232595
MERTK,Broad flat nasal bridge,0.8213459222602666
MERTK,Liver Cirrhosis,0.8232134984476662
MERTK,Nasal bridge wide,0.8232134984476662
MERTK,Congenital hypoplasia of penis,0.8232134984476662
MERTK,Severe Acute Respiratory Syndrome,0.8232134984476662
MERTK,Fibrosis Liver,0.8272008757995397
MERTK,Atypical scarring of skin,0.8272008757995397
MERTK,Glioblastoma Multiforme,0.8342163953428735
MERTK,Retinitis Pigmentosa,0.8402911822757345
MERTK,Anaplastic carcinoma,0.8402911822757345
MERTK,Mental deficiency,0.8402911822757345
MERTK,Thrombosis,0.8402911822757345
MERTK,Hypogonadism,0.8402911822757345
MERTK,Carotid Atherosclerosis,0.8497448945325101
MERTK,Amaurosis congenita of Leber type 1,0.8578473133580928
MERTK,Autosomal recessive retinitis pigmentosa,0.8578473133580928
MERTK,Keratoconus,0.8584283190330553
MERTK,Childhood Leukemia,0.8610447277138289
MERTK,Dull intelligence,0.8757755363384367
MERTK,Low intelligence,0.8757755363384367
MERTK,Cataract,0.8769418330148872
MERTK,Encephalitis St. Louis,0.8769418330148872
MERTK,Poor school performance,0.8913141512402477
MERTK,Age related macular degeneration,0.8980854850210683
MERTK,Obesity,0.8989612563669234
MERTK,Ophthalmoplegia,0.900167961295542
MERTK,Lymphoid leukemia,0.9083161862856644
MERTK,Lens Opacities,0.9117936912777788
MERTK,Paraganglioma,0.9119978323790848
MERTK,Mental Retardation,0.922229272318747
MERTK,Intellectual Disability,0.9478210444156088
MERTK,Sensorineural Hearing Loss (disorder),0.9520060723130308
MERTK,Genetic Diseases Inborn,0.9926099929361648
MERTK,Carcinoma Of The Head And Neck,0.4532988396145482
MERTK,Retinal Dystrophy,0.7765582368651238
MERTK,Liver Cirrhosis,0.7765582368651238
MERTK,Nystagmus,0.7765582368651238
MERTK,Nyctalopia,0.7765582368651238
MERTK,Pulmonary Thromboembolism,0.7765582368651238
MERTK,Leukemia,0.7765582368651238
MERTK,Disorder Of Eye,0.7765582368651238
MERTK,Optic Atrophy,0.8115918568696846
MERTK,Hereditary Paraganglioma-Pheochromocytoma Syndromes,0.8115918568696846
MERTK,Hearing Loss,0.8115918568696846
MERTK,Anetoderma,0.8115918568696846
MERTK,Anaplastic Carcinoma,0.8115918568696846
MERTK,Mental Retardation,0.8337953215113012
MERTK,Leber Congenital Amaurosis,0.8611702959552964
MERTK,Retinitis Pigmentosa,0.861756360478846
MERTK,Hyperinsulinism,0.861756360478846
MERTK,Renal Carcinoma,0.8727045307126416
MERTK,Keratoconus,0.8879896755141929
MERTK,Rod-cone Dystrophy,0.8903301324869451
MERTK,Glaucoma,0.8903630091389316
MERTK,Glomerulonephritis,0.9005327950701606
MERTK,Carcinoma,0.9069867032339078
MERTK,Diabetes Mellitus,0.919442421650838
MERTK,Hypogonadism,0.9259420053407031
MERTK,Cataract,0.974502015052702
MERTK,Multiple Sclerosis,0.980894832851993
MERTK,Congenital Hypoplasia Of Penis,0.9832345076528324
MERTK,Obesity,0.9832345076528324
MERTK,Retinitis pigmentosa ORPHA:791,0.8922466888454011
MERTK,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MERTK,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MERTK,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MERTK,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
MERTK,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
MERTK,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
MERTK,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MERTK,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
MERTK,Variola virus hypothetical protein (gene: B20R),0.8999095837312036
MERTK,Ectromelia virus ERPV IFN alpha/beta receptor,0.8999095837312036
MERTK,Human gammaherpesvirus 4 BARF1 protein (gene: BARF1),0.8999095837312036
MERTK,Human immunodeficiency virus 1 Envelope surface glycoprotein gp160 precursor (gene: env),0.8999095837312036
MERTK,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
MERTK,Cowpox virus CPXV209 protein (gene: CPXV209 CDS),0.8999095837312036
MERTK,Human herpesvirus 4 type 2 BARF1,0.8999095837312036
MERTK,Human adenovirus 56 CR1 beta protein (gene: E3),0.8999095837312036
MERTK,Vaccinia virus IL-beta-binding protein (gene: VACWR-B15R),0.8999095837312036
MERTK,Vaccinia virus Ankara soluble and cell surface interferon-alpha/beta receptor,0.8999095837312036
MERTK,Monkeypox virus IFN-alpha/beta-receptor-like secreted glycoprotein,0.8999095837312036
MERTK,Monkeypox virus Zaire-96-I-16 B16R (gene: B16R),0.8999095837312036
MERTK,Vaccinia virus IFN-alpha/beta-receptor-like secreted glycoprotein (gene: B19R),0.8999095837312036
MERTK,Horsepox virus HSPV195 (immunoglobulin like protein),0.8999095837312036
MERTK,Cowpox virus CPXV212 protein (gene: CPXV212 CDS),0.8999095837312036
MERTK,Vaccinia virus Ankara Interleukin-1 beta receptor,0.8999095837312036
MERTK,Horsepox virus HSPV192 (IL-beta-binding protein,0.8999095837312036
MERTK,Provisional),0.8999095837312036
MERTK,Human adenovirus 64 E3 48.9 kDa protein,0.9057542447893764
MERTK,Human adenovirus 23 CR1 b protein (gene: E3),0.9237501457186692
MERTK,Human adenovirus 65 E3 CR1-b,0.9397923093369096
METTL18,Ischemic stroke,0.9896536639644284
METTL18,Lipoyl transferase 2 deficiency ORPHA:447795,0.3832844616405875
METTL18,Lipoyl transferase 1 deficiency ORPHA:401862,0.5867963421058087
METTL18,Aspartylglucosaminuria ORPHA:93,0.7929682744768703
METTL18,Methylmalonic acidemia due to methylmalonyl-CoA epimerase deficiency ORPHA:308425,0.7929682744768703
METTL18,PRUNE1-related neurological syndrome ORPHA:544469,0.7929682744768703
METTL18,Pontocerebellar hypoplasia type 10 ORPHA:411493,0.7929682744768703
METTL18,Pontocerebellar hypoplasia type 2 ORPHA:2524,0.8029813443753846
METTL18,ALG6-CDG ORPHA:79320,0.8922466888454011
METTL18,Cernunnos-XLF deficiency ORPHA:169079,0.8922466888454011
METTL18,Primary dystonia DYT6 type ORPHA:98806,0.8922466888454011
METTL18,Catel-Manzke syndrome ORPHA:1388,0.8922466888454011
METTL18,Combined oxidative phosphorylation defect type 30 ORPHA:478042,0.8922466888454011
METTL18,SLC35A1-CDG ORPHA:238459,0.8922466888454011
METTL18,Severe growth deficiency-strabismus-extensive dermal melanocytosis-intellectual disability syndrome ORPHA:488627,0.8922466888454011
METTL18,LIG4 syndrome ORPHA:99812,0.8922466888454011
METTL18,Microcephalic primordial dwarfism-insulin resistance syndrome ORPHA:436182,0.8922466888454011
MICA,Malignant neoplasm of breast,0.4084380369379369
MICA,Adenomatous Polyposis Coli,0.5196624042573144
MICA,Breast Carcinoma,0.7333611688795861
MICA,Thromboangiitis Obliterans,0.7333611688795861
MICA,Malignant neoplasm of ovary,0.7333611688795861
MICA,leukemia,0.7333611688795861
MICA,Ovarian Carcinoma,0.7333611688795861
MICA,Adenocarcinoma,0.750391252594775
MICA,Malignant neoplasm of pancreas,0.7688485284765829
MICA,Colorectal Carcinoma,0.7765852775619541
MICA,Pancreatic carcinoma,0.7765852775619541
MICA,Colon Carcinoma,0.7765852775619541
MICA,Malignant tumor of colon,0.7765852775619541
MICA,Leukemogenesis,0.7765852775619541
MICA,Cervix carcinoma,0.7765852775619541
MICA,Non-Small Cell Lung Carcinoma,0.7765852775619541
MICA,Hypercholesterolemia,0.7765852775619541
MICA,Carcinoma breast stage IV,0.7765852775619541
MICA,Thyroid Neoplasm,0.7765852775619541
MICA,Malignant tumor of cervix,0.7768809924982332
MICA,Platelet distribution width measurement,0.7880542567584415
MICA,Platelet distribution width result,0.7880542567584415
MICA,Glioma,0.7880542567584415
MICA,Malignant neoplasm of lung,0.7880542567584415
MICA,Malignant neoplasm of prostate,0.7880542567584415
MICA,stage non-small cell lung cancer,0.7880542567584415
MICA,Liver carcinoma,0.7880542567584415
MICA,Pyothorax-Associated Lymphoma,0.7880542567584415
MICA,Malignant Head and Neck Neoplasm,0.7880542567584415
MICA,Osteosarcoma,0.7880542567584415
MICA,Thyroid carcinoma,0.7880542567584415
MICA,Triploidy syndrome,0.7880542567584415
MICA,Cholelithiasis,0.7880542567584415
MICA,Colorectal Cancer,0.7880542567584415
MICA,Epithelial ovarian cancer,0.7880542567584415
MICA,Spondylarthritis,0.7880542567584415
MICA,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
MICA,Osteosarcoma of bone,0.7880542567584415
MICA,Prostate carcinoma,0.7880542567584415
MICA,Primary malignant neoplasm of lung,0.7880542567584415
MICA,cervical cancer,0.7880542567584415
MICA,Neoplasm Metastasis,0.7880542567584415
MICA,Epithelioma,0.7880542567584415
MICA,Carcinoma of lung,0.7880542567584415
MICA,Malignant neoplasm of thyroid,0.7880542567584415
MICA,Squamous cell carcinoma of the head and neck,0.7880542567584415
MICA,Malignant neoplasm of liver,0.7880542567584415
MICA,Neuroblastoma,0.7880542567584415
MICA,Central neuroblastoma,0.7880542567584415
MICA,Serum total cholesterol measurement,0.7880542567584415
MICA,Immunologic Deficiency Syndromes,0.7880542567584415
MICA,Hematologic Neoplasms,0.7880542567584415
MICA,melanoma,0.7880542567584415
MICA,Multiple Myeloma,0.7880542567584415
MICA,Neoplasms,0.7880542567584415
MICA,Malignant neoplasm of stomach,0.7880542567584415
MICA,Burkitt Lymphoma,0.7880542567584415
MICA,Vesicular Stomatitis,0.7880542567584415
MICA,Skin Carcinogenesis,0.7880542567584415
MICA,Viral hepatitis,0.7880542567584415
MICA,Congenital contractural arachnodactyly,0.7880542567584415
MICA,Hodgkin Disease,0.7880542567584415
MICA,Melanoma recurrent,0.7880542567584415
MICA,Nasopharyngeal carcinoma,0.7880542567584415
MICA,Hepatitis B Virus-Related Hepatocellular Carcinoma,0.7880542567584415
MICA,Tumor Progression,0.7880542567584415
MICA,Lupus Erythematosus Systemic,0.7880542567584415
MICA,Renal Cell Carcinoma,0.7880542567584415
MICA,Takayasu Arteritis,0.7880542567584415
MICA,Arteriosclerosis,0.7880542567584415
MICA,Atherosclerosis,0.7880542567584415
MICA,Hypersensitive syndrome,0.7880542567584415
MICA,Stomach Carcinoma,0.7880542567584415
MICA,Ocular Toxoplasmosis,0.7880542567584415
MICA,Hepatitis C,0.7880542567584415
MICA,Squamous cell carcinoma,0.7880542567584415
MICA,Rheumatoid Arthritis,0.7880542567584415
MICA,Diabetes,0.7880542567584415
MICA,Gastrointestinal symptom,0.7880542567584415
MICA,Maxillary Sinus Squamous Cell Carcinoma,0.7880542567584415
MICA,Diabetes Mellitus,0.7880542567584415
MICA,Ankylosing spondylitis,0.7880542567584415
MICA,Ductal Carcinoma In Situ with Microinvasion,0.7880542567584415
MICA,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.7880542567584415
MICA,Autoimmune Primary Adrenal Insufficiency,0.7880542567584415
MICA,Crohn Disease,0.7880542567584415
MICA,Vasculitis,0.7880542567584415
MICA,Cytomegalovirus Infections,0.7880542567584415
MICA,Virus Diseases,0.7880542567584415
MICA,Myeloid Leukemia Chronic,0.7880542567584415
MICA,Leprosy Paucibacillary,0.7880542567584415
MICA,Thymus Hyperplasia,0.7880542567584415
MICA,Malignant Glioma,0.7880542567584415
MICA,Experimental Organism Basal Cell Carcinoma,0.8009048756462318
MICA,Chronic Chagas' disease,0.8009048756462318
MICA,Leukemia Large Granular Lymphocytic,0.8019075543217649
MICA,Multiple Sclerosis,0.8019075543217649
MICA,Psoriasis,0.8019075543217649
MICA,Myocardial Infarction,0.8019075543217649
MICA,Kidney Failure Chronic,0.8019075543217649
MICA,Addison Disease,0.8019075543217649
MICA,Diabetes Autoimmune,0.8019075543217649
MICA,Liver neoplasms,0.8019075543217649
MICA,T-Cell Large Granular Lymphocyte Leukemia,0.8019075543217649
MICA,Adenocarcinoma of lung (disorder),0.8098851543361193
MICA,Acute GVH disease,0.8101097852323003
MICA,Addison's disease due to autoimmunity,0.8138488881521341
MICA,Liver diseases,0.8140222479282434
MICA,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
MICA,Coronary Aneurysm,0.8145035474981049
MICA,Ulcerative Colitis,0.8190761496232595
MICA,Acute colitis,0.8190761496232595
MICA,Latent autoimmune diabetes mellitus in adult,0.8190761496232595
MICA,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
MICA,Intestinal Diseases,0.8190761496232595
MICA,Primary sclerosing cholangitis,0.8212681436603975
MICA,Hypersensitivity,0.8232134984476662
MICA,Psoriasis vulgaris,0.8272008757995397
MICA,Glioblastoma Multiforme,0.8342163953428735
MICA,Lymphatic Metastasis,0.8368219249856942
MICA,Malignant Squamous Cell Neoplasm,0.8402911822757345
MICA,Thymoma,0.8402911822757345
MICA,Acute anterior uveitis,0.8402911822757345
MICA,Oral Submucous Fibrosis,0.8402911822757345
MICA,Celiac Disease,0.8402911822757345
MICA,Toxoplasmosis,0.8402911822757345
MICA,Hepatitis B,0.841396342333011
MICA,Chronic graft-versus-host disease,0.8523465762428218
MICA,Rous Sarcoma,0.8610447277138289
MICA,Bronchiectasis,0.8610447277138289
MICA,Respiratory Syncytial Virus Infections,0.8648405521677974
MICA,Familial Mediterranean Fever,0.8648405521677974
MICA,Azoospermia,0.8648405521677974
MICA,Giant Cell Arteritis,0.8648405521677974
MICA,Hepatitis B Chronic,0.8745234584149799
MICA,Familial M??ni??re disease,0.8769418330148872
MICA,Inflammatory Bowel Diseases,0.8815127642200768
MICA,Arthritis Psoriatic,0.8946938397586319
MICA,Heart Diseases,0.8989612563669234
MICA,Leprosy,0.9001392794088324
MICA,Secondary malignant neoplasm of lymph node,0.900167961295542
MICA,HIV-1 infection,0.9119978323790848
MICA,Skin carcinoma,0.9214835359141188
MICA,Hamman-Rich syndrome,0.9262273158806068
MICA,Malignant neoplasm of skin,0.93413028051677
MICA,Body Height,0.9390727893210336
MICA,Idiopathic Pulmonary Fibrosis,0.9393256300017014
MICA,Hepatitis,0.939985154445373
MICA,Pleural effusion disorder,0.9431511078237256
MICA,Hepatitis C Chronic,0.9432051631882106
MICA,Behcet Syndrome,0.9446671211493156
MICA,Hepatitis A,0.9459312971127588
MICA,Merkel cell carcinoma,0.9459312971127588
MICA,Muscle Weakness,0.9512505437112568
MICA,Chronic kidney disease stage 5,0.9694882155560866
MICA,Liver Carcinoma,0.7765582368651238
MICA,Coronary Aneurysm,0.8115918568696846
MICA,Oral Submucous Fibrosis,0.8115918568696846
MICA,Behcet Syndrome,0.8611702959552964
MICA,Psoriatic Arthritis,0.8706864397989688
MICA,Ankylosing Spondylitis,0.8903301324869451
MICA,Diabetes Mellitus,0.919442421650838
MICA,Rheumatoid Arthritis,0.9251646147729308
MICA,NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498,0.7929682744768703
MICA,Sporadic porphyria cutanea tarda ORPHA:443057,0.7929682744768703
MICA,Symptomatic form of hemochromatosis type 1 ORPHA:465508,0.7929682744768703
MICA,Yaba-like disease virus 2L protein (gene: 2L),0.8999095837312036
MICA,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
MICA,Yaba monkey tumor virus MHC-like TNF binding protein,0.8999095837312036
MICA,Human mastadenovirus D membrane glycoprotein E3 gp19K (gene: E3),0.8999095837312036
MICA,Human adenovirus 56 19K protein (gene: E3),0.8999095837312036
MICA,Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
MICA,Human gammaherpesvirus 4 BARF1 protein (gene: BARF1),0.8999095837312036
MICA,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
MICA,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
MICA,Human herpesvirus 4 type 2 BARF1,0.8999095837312036
MICA,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
MICA,Human betaherpesvirus 5 membrane glycoprotein UL16 (gene: UL16),0.8999095837312036
MICA,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
MICA,Human adenovirus 65 E3 gp19K,0.8999095837312036
MICA,Human adenovirus 67 E3 gp19K,0.8999095837312036
MICA,Human mastadenovirus D E3 gp19K,0.8999095837312036
MICA,Human adenovirus 19 gp19K (gene: E3),0.8999095837312036
MICA,Cowpox virus CPXV203 protein (gene: CPXV203 CDS),0.8999095837312036
MICA,Human adenovirus 46 156R,0.8999095837312036
MICA,Human adenovirus 54 17.6 kDa protein,0.8999095837312036
MICA,Human adenovirus 23 gp 19K protein (gene: E3),0.8999095837312036
MICA,Human alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
MICA,Human adenovirus 1 E3 gp19K,0.8999095837312036
MICA,Human adenovirus 5 E3 gp19K,0.8999095837312036
MICA,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
MICA,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
MICA,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
MICA,Human mastadenovirus C membrane glycoprotein E3 gp19K (gene: E3A),0.8999095837312036
MICA,Human adenovirus 2 E3 gp19K,0.8999095837312036
MICA,Human adenovirus 6 E3gp19k (gene: E3),0.8999095837312036
MICA,Human adenovirus 58 18.4 kDa protein (gene: E3),0.8999095837312036
MICA,Human adenovirus 28 E3 gp19K-like protein (gene: E3),0.8999095837312036
MICA,Human adenovirus 36 E3 18.4K,0.8999095837312036
MICA,Human adenovirus 43 gp19K-like protein (gene: E3),0.8999095837312036
MICA,Human adenovirus 71 E3 immune modulating protein (gene: E3),0.8999095837312036
MICA,Human adenovirus 64 E3 18.6 kDa protein,0.9057542447893764
MICA,Human adenovirus D37 18.6 kDa (gene: E3),0.9057542447893764
MICA,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
MICA,Human adenovirus D10 19KDa protein (gene: E3),0.9057542447893764
MICA,Human adenovirus 61 E3 CR1 beta,0.9057542447893764
MICA,Molluscum contagiosum virus subtype 1 MC033L (gene: MC033L),0.9057542447893764
MICA,Vaccinia virus hemagglutinin (gene: A56R),0.9058994261255549
MICA,Yaba-like disease virus 123R protein (gene: 123R),0.9103786566415374
MICA,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.9237501457186692
MICA,Vaccinia virus Ankara Haemagglutinin,0.9287050575620676
MICA,Yaba monkey tumor virus IEV and EEV membrane glycoprotein,0.9397923093369096
MICA,Human betaherpesvirus 5 membrane glycoprotein UL18 (gene: UL18),0.9687349764960514
MICAL2,Prostatic Intraepithelial Neoplasias,0.7765852775619541
MICAL2,Malignant neoplasm of prostate,0.7880542567584415
MICAL2,Prostate carcinoma,0.7880542567584415
MICAL2,Neoplasm Metastasis,0.7880542567584415
MICAL2,Prostatic Neoplasms,0.7880542567584415
MICAL2,Malignant neoplasm of stomach,0.7880542567584415
MICAL2,Tumor Progression,0.7880542567584415
MICAL2,Narcolepsy,0.8067197998685076
MICAL2,RESTING HEART RATE,0.8610447277138289
MICAL2,Cerebrovascular accident,0.8648405521677974
MICAL2,Stroke,0.7765582368651238
MICAL2,Narcolepsy,0.8260230451542778
MICAL2,Alzheimer Disease,0.8457525389282121
MICAL2,Charcot-Marie-Tooth disease type 4D ORPHA:99950,0.3832844616405875
MICAL2,Charcot-Marie-Tooth disease type 4C ORPHA:99949,0.5867963421058087
MICAL2,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854,0.5867963421058087
MICAL2,Mitochondrial DNA depletion syndrome myopathic form ORPHA:254875,0.5867963421058087
MICAL2,NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907,0.5867963421058087
MICAL2,Peeling skin-leukonychia-acral punctate keratoses-cheilitis-knuckle pads syndrome ORPHA:444138,0.7929682744768703
MICAL2,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome ORPHA:85167,0.8922466888454011
MIDN,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
MIDN,Early-onset posterior subcapsular cataract ORPHA:441447,0.220389120533256
MIDN,Desbuquois syndrome ORPHA:1425,0.3832844616405875
MIDN,Acute megakaryoblastic leukemia without Down syndrome ORPHA:329469,0.7929682744768703
MIDN,Fibrolamellar hepatocellular carcinoma ORPHA:401920,0.7929682744768703
MIDN,NUT midline carcinoma ORPHA:443167,0.7929682744768703
MIDN,RERE-related neurodevelopmental syndrome ORPHA:494344,0.8922466888454011
MIDN,Leber plus disease ORPHA:99718,0.8922466888454011
MIDN,Human betaherpesvirus 6 U31 large tegument protein (gene: U31),0.8999095837312036
MIDN,Human betaherpesvirus 6A large tegument protein (gene: U31),0.8999095837312036
MIDN,Human betaherpesvirus 6B large tegument protein (gene: U31),0.8999095837312036
MIDN,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.8999095837312036
MIDN,Dugbe virus L protein,0.8999095837312036
MIDN,Human betaherpesvirus 7 large tegument protein (gene: U31),0.8999095837312036
MIDN,Rotavirus A NSP4,0.8999095837312036
MIDN,Monkeypox virus Zaire-96-I-16 B1R (gene: B1R),0.8999095837312036
MIDN,Variola virus hypothetical protein (gene: B24R),0.8999095837312036
MLLT11,Malignant neoplasm of breast,0.4084380369379369
MLLT11,Breast Carcinoma,0.7333611688795861
MLLT11,Malignant neoplasm of ovary,0.7333611688795861
MLLT11,Ovarian Carcinoma,0.7333611688795861
MLLT11,Colorectal Carcinoma,0.7765852775619541
MLLT11,Leukemia Myelocytic Acute,0.7765852775619541
MLLT11,MYELODYSPLASTIC SYNDROME,0.7765852775619541
MLLT11,Leukemogenesis,0.7765852775619541
MLLT11,Mammary Neoplasms,0.7880542567584415
MLLT11,Colorectal Cancer,0.7880542567584415
MLLT11,Epithelial ovarian cancer,0.7880542567584415
MLLT11,Adult Myelodysplastic Syndrome,0.7880542567584415
MLLT11,Neoplasm Metastasis,0.7880542567584415
MLLT11,Acute myelomonocytic leukemia,0.7880542567584415
MLLT11,Malignant Neoplasms,0.7880542567584415
MLLT11,Hematologic Neoplasms,0.7880542567584415
MLLT11,Juvenile Myelomonocytic Leukemia,0.7880542567584415
MLLT11,Metastatic malignant neoplasm to brain,0.7880542567584415
MLLT11,Malignant neoplasm of large intestine,0.7880542567584415
MLLT11,Tumor Progression,0.7880542567584415
MLLT11,Acute leukemia,0.7880542567584415
MLLT11,Infant Premature,0.7880542567584415
MLLT11,Congenital chromosomal disease,0.7880542567584415
MLLT11,Solid Neoplasm,0.7880542567584415
MLLT11,Adult Solid Neoplasm,0.7880542567584415
MLLT11,Secondary malignant neoplasm of liver,0.7908231553833205
MLLT11,Childhood Acute Myeloid Leukemia,0.8009048756462318
MLLT11,Childhood Solid Neoplasm,0.8019075543217649
MLLT11,Secondary malignant neoplasm of lung,0.8232134984476662
MLLT11,MIXED LINEAGE LEUKEMIA,0.8232134984476662
MLLT11,Adult Acute Myeloblastic Leukemia,0.841396342333011
MLLT11,Hyperactive behavior,0.8878860377518915
MLLT11,Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379,0.3832844616405875
MLLT11,Progressive myoclonic epilepsy type 3 ORPHA:263516,0.3832844616405875
MLLT11,Intellectual disability-developmental delay-contractures syndrome ORPHA:3454,0.5867963421058087
MLLT11,Multiple benign circumferential skin creases on limbs ORPHA:2505,0.7929682744768703
MLLT11,Lissencephaly due to TUBA1A mutation ORPHA:171680,0.8922466888454011
MMP24,Glioblastoma,0.7880542567584415
MMP24,Neoplasm Metastasis,0.7880542567584415
MMP24,Brain Neoplasms,0.7880542567584415
MMP24,Tumor Progression,0.7880542567584415
MMP24,Alzheimer's Disease,0.7880542567584415
MMP24,Diabetes,0.7880542567584415
MMP24,Diabetes Mellitus,0.7880542567584415
MMP24,Multiple Sclerosis,0.8019075543217649
MMP24,Kidney Failure Chronic,0.8019075543217649
MMP24,Impaired cognition,0.8190761496232595
MMP24,Protein C antigen measurement,0.8648405521677974
MMP24,Protein C measurement,0.8648405521677974
MMP24,Amyloidosis,0.8672189956534445
MMP24,Pain,0.887595340546704
MMP24,Diabetic Nephropathy,0.9390727893210336
MMP24,Body Height,0.9390727893210336
MMP24,Hyperalgesia Thermal,0.9441119274323576
MMP24,Hyperalgesia,0.9514640836642632
MMP24,Chronic kidney disease stage 5,0.9694882155560866
MMP24,Kidney Failure,0.9894341523578486
MRAP2,Adrenocortical carcinoma,0.8232134984476662
MRAP2,Aplasia Cutis Congenita,0.8911256045597441
MRAP2,Obesity,0.8989612563669234
MRAP2,Obesity Morbid,0.946564927793026
MRAP2,Agenesis of corpus callosum,0.9701053690483854
MRAP2,Prader-Willi Syndrome,0.7860378120955526
MRAP2,Obesity,0.9832345076528324
MRPL19,Malignant neoplasm of breast,0.4084380369379369
MRPL19,Breast Carcinoma,0.7333611688795861
MRPL19,Endometrial Carcinoma,0.7765852775619541
MRPL19,Mammary Neoplasms,0.7880542567584415
MRPL19,Dyslexia,0.7880542567584415
MRPL19,Mammary Neoplasms Human,0.8815127642200768
MRPL19,Leukemia,0.7765582368651238
MRPL19,Mammary Neoplasms,0.8165359516083085
MRPL19,Marfan Syndrome,0.8477374749042494
MRPL19,Breast Cancer,0.8903630091389316
MRPL19,Breast Carcinoma,0.9398381935810408
MRPL19,Hereditary coproporphyria ORPHA:79273,0.1991445465001551
MRPL19,Combined oxidative phosphorylation defect type 24 ORPHA:444458,0.7929682744768703
MRPL19,Congenital bile acid synthesis defect type 4 ORPHA:79095,0.7929682744768703
MRPL19,Exercise-induced hyperinsulinism ORPHA:165991,0.7929682744768703
MRPL19,Ketoacidosis due to monocarboxylate transporter-1 deficiency ORPHA:438075,0.7929682744768703
MRPL19,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ORPHA:478049,0.7929682744768703
MRPL19,Metabolic myopathy due to lactate transporter defect ORPHA:171690,0.7929682744768703
MRPL19,Peters plus syndrome ORPHA:709,0.7929682744768703
MRPL19,Spinocerebellar ataxia type 10 ORPHA:98761,0.7929682744768703
MRPL19,2p21 microdeletion syndrome without cystinuria ORPHA:369881,0.7929682744768703
MRPL19,3-methylcrotonyl-CoA carboxylase deficiency ORPHA:6,0.8922466888454011
MRPL19,Autosomal erythropoietic protoporphyria ORPHA:79278,0.8922466888454011
MRPL19,BRESEK syndrome ORPHA:85284,0.8922466888454011
MRPL19,Beta-ketothiolase deficiency ORPHA:134,0.8922466888454011
MRPL19,Brain calcification Rajab type ORPHA:178506,0.8922466888454011
MRPL19,Combined oxidative phosphorylation defect type 11 ORPHA:324535,0.8922466888454011
MRPL19,Combined oxidative phosphorylation defect type 9 ORPHA:319509,0.8922466888454011
MRPL19,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome ORPHA:521432,0.8922466888454011
MRPL19,EVEN-plus syndrome ORPHA:496751,0.8922466888454011
MRPL19,Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome ORPHA:505237,0.8922466888454011
MRPL19,FASTKD2-related infantile mitochondrial encephalomyopathy ORPHA:166105,0.8922466888454011
MRPL19,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 ORPHA:137681,0.8922466888454011
MRPL19,Ichthyosis follicularis-alopecia-photophobia syndrome ORPHA:2273,0.8922466888454011
MRPL19,Lathosterolosis ORPHA:46059,0.8922466888454011
MRPL19,Medium chain acyl-CoA dehydrogenase deficiency ORPHA:42,0.8922466888454011
MRPL19,Methylcobalamin deficiency type cblE ORPHA:2169,0.8922466888454011
MRPL19,Microcephaly-capillary malformation syndrome ORPHA:294016,0.8922466888454011
MRPL19,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome ORPHA:280679,0.8922466888454011
MRPL19,Progressive encephalopathy with leukodystrophy due to DECR deficiency ORPHA:431361,0.8922466888454011
MRPL19,Pyridoxal phosphate-responsive seizures ORPHA:79096,0.8922466888454011
MRPL19,Thiamine-responsive megaloblastic anemia syndrome ORPHA:49827,0.8922466888454011
MRPL19,WARS2-related combined oxidative phosphorylation defect ORPHA:572798,0.8922466888454011
MRPL19,Classic maple syrup urine disease ORPHA:268145,0.8922466888454011
MRPL19,Intermittent maple syrup urine disease ORPHA:268173,0.8922466888454011
MRPL19,Thiamine-responsive maple syrup urine disease ORPHA:268184,0.8922466888454011
MRPL19,Infantile Refsum disease ORPHA:772,0.8922466888454011
MRPL19,Neonatal adrenoleukodystrophy ORPHA:44,0.8922466888454011
MRPL19,Zellweger syndrome ORPHA:912,0.8922466888454011
MRPL19,Propionic acidemia ORPHA:35,0.8922466888454011
MRPL19,Cataract-growth hormone deficiency-sensory neuropathy-sensorineural hearing loss-skeletal dysplasia syndrome ORPHA:436174,0.8922466888454011
MRPL19,Combined oxidative phosphorylation defect type 26 ORPHA:477684,0.8922466888454011
MRPL19,Combined oxidative phosphorylation defect type 39 ORPHA:565624,0.8922466888454011
MRPL19,Congenital lactic acidosis Saguenay-Lac-Saint-Jean type ORPHA:70472,0.8922466888454011
MRPL19,Early-onset spastic ataxia-myoclonic epilepsy-neuropathy syndrome ORPHA:313772,0.8922466888454011
MRPL19,Endosteal sclerosis-cerebellar hypoplasia syndrome ORPHA:85186,0.8922466888454011
MRPL19,Fumaric aciduria ORPHA:24,0.8922466888454011
MRPL19,Glycogen storage disease due to glycogen debranching enzyme deficiency ORPHA:366,0.8922466888454011
MRPL19,Hereditary leiomyomatosis and renal cell cancer ORPHA:523,0.8922466888454011
MRPL19,Hyperinsulinism-hyperammonemia syndrome ORPHA:35878,0.8922466888454011
MRPL19,Hypermethioninemia encephalopathy due to adenosine kinase deficiency ORPHA:289290,0.8922466888454011
MRPL19,Hypotonia with lactic acidemia and hyperammonemia ORPHA:137908,0.8922466888454011
MRPL19,Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome ORPHA:314051,0.8922466888454011
MRPL19,Mitochondrial DNA depletion syndrome encephalomyopathic form with methylmalonic aciduria ORPHA:1933,0.8922466888454011
MRPL19,Pyruvate dehydrogenase E2 deficiency ORPHA:79244,0.8922466888454011
MRPL19,Pyruvate dehydrogenase E3 deficiency ORPHA:2394,0.8922466888454011
MRPL19,Pyruvate dehydrogenase E3-binding protein deficiency ORPHA:255182,0.8922466888454011
MRPL19,Spinocerebellar ataxia type 28 ORPHA:101109,0.8922466888454011
MRPL19,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type B ORPHA:308393,0.8922466888454011
MRPL19,TRIM32-related  limb-girdle muscular dystrophy R8 ORPHA:1878,0.8922466888454011
MRPL19,Vitamin B12-unresponsive methylmalonic acidemia type mut- ORPHA:79312,0.8922466888454011
MRPL19,Vitamin B12-unresponsive methylmalonic acidemia type mut0 ORPHA:289916,0.8922466888454011
MRPL19,Adult-onset chronic progressive external ophthalmoplegia with mitochondrial myopathy ORPHA:329336,0.8922466888454011
MRPL19,Shwachman-Diamond syndrome ORPHA:811,0.8922466888454011
MRPL54,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.1040670578681756
MRPL54,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.1040670578681756
MRPL54,Marinesco-Sjogren syndrome ORPHA:559,0.1054066549396977
MRPL54,CCDC115-CDG ORPHA:468684,0.1991445465001551
MRPL54,3C syndrome ORPHA:7,0.3832844616405875
MRPL54,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect ORPHA:521411,0.5867963421058087
MRPL54,Carnitine-acylcarnitine translocase deficiency ORPHA:159,0.5867963421058087
MRPL54,Familial hypocalciuric hypercalcemia type 3 ORPHA:101050,0.5867963421058087
MRPL54,Hyperbiliverdinemia ORPHA:276405,0.5867963421058087
MRPL54,Ethylmalonic encephalopathy ORPHA:51188,0.7929682744768703
MRPL54,Glutaryl-CoA dehydrogenase deficiency ORPHA:25,0.7929682744768703
MRPL54,MPDU1-CDG ORPHA:79323,0.7929682744768703
MRPL54,Prolidase deficiency ORPHA:742,0.7929682744768703
MRPL54,Spondylometaphyseal dysplasia Sedaghatian type ORPHA:93317,0.7929682744768703
MRPL54,Acromegaly ORPHA:963,0.7929682744768703
MRPL54,3-methylglutaconic aciduria type 8 ORPHA:505208,0.8922466888454011
MRPL54,Adenine phosphoribosyltransferase deficiency ORPHA:976,0.8922466888454011
MRPL54,Autosomal recessive spastic paraplegia type 77 ORPHA:466722,0.8922466888454011
MRPL54,Combined oxidative phosphorylation defect type 14 ORPHA:319519,0.8922466888454011
MRPL54,HSD10 disease atypical type ORPHA:85295,0.8922466888454011
MRPL54,HSD10 disease infantile type ORPHA:391428,0.8922466888454011
MRPL54,HSD10 disease neonatal type ORPHA:391457,0.8922466888454011
MRPL54,Hepatoerythropoietic porphyria ORPHA:95159,0.8922466888454011
MRPL54,ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement ORPHA:457375,0.8922466888454011
MRPL54,Autosomal recessive severe congenital neutropenia due to JAGN1 deficiency ORPHA:423384,0.8922466888454011
MRPL54,Combined oxidative phosphorylation defect type 29 ORPHA:478029,0.8922466888454011
MRPL54,DPM3-CDG ORPHA:263494,0.8922466888454011
MRPL54,Hamel cerebro-palato-cardiac syndrome ORPHA:93946,0.8922466888454011
MRPL54,Kostmann syndrome ORPHA:99749,0.8922466888454011
MRPL54,Lethal intrauterine growth restriction-cortical malformation-congenital contractures syndrome ORPHA:2570,0.8922466888454011
MRPL54,Pentosuria ORPHA:2843,0.8922466888454011
MRPL54,Primary immunodeficiency syndrome due to LAMTOR2 deficiency ORPHA:90023,0.8922466888454011
MRPL54,SSR4-CDG ORPHA:370927,0.8922466888454011
MRPL54,SURF1-related Charcot-Marie-Tooth disease type 4 ORPHA:391351,0.8922466888454011
MRPL54,X-linked intellectual disability Golabi-Ito-Hall type ORPHA:93947,0.8922466888454011
MRPL54,X-linked intellectual disability Porteous type ORPHA:93945,0.8922466888454011
MRPL54,X-linked intellectual disability Sutherland-Haan type ORPHA:93950,0.8922466888454011
MRPL54,Isolated succinate-CoQ reductase deficiency ORPHA:3208,0.8922466888454011
MRPL54,Leigh syndrome with cardiomyopathy ORPHA:70474,0.8922466888454011
MTHFS,Neuroblastoma,0.7880542567584415
MTHFS,Central neuroblastoma,0.7880542567584415
MTHFS,Cleft palate isolated,0.7880542567584415
MTHFS,Cleft Palate,0.7880542567584415
MTHFS,Cleft upper lip,0.7880542567584415
MTHFS,Dysautonomia,0.7765582368651238
MTHFS,Salaam Seizures,0.7765582368651238
MTHFS,Developmental Delay,0.7765582368651238
MTHFS,Cerebellar Atrophy,0.8337953215113012
MTHFS,Hypotonic Seizures,0.8601151608808731
MTHFS,Epilepsy,0.8611702959552964
MTHFS,Seizure,0.861756360478846
MTHFS,Dyscognitive Seizures,0.861756360478846
MTHFS,Microcephaly,0.8903630091389316
MTHFS,Esotropia,0.8903630091389316
MTHFS,Dwarfism,0.9510372690456612
MTHFS,Autosomal dominant dopa-responsive dystonia ORPHA:98808,0.1991445465001551
MTHFS,GTP cyclohydrolase I deficiency ORPHA:2102,0.1991445465001551
MTHFS,Carnitine-acylcarnitine translocase deficiency ORPHA:159,0.5867963421058087
MTHFS,Cystic leukoencephalopathy without megalencephaly ORPHA:85136,0.5867963421058087
MTHFS,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency ORPHA:404493,0.7929682744768703
MTHFS,Tyrosinemia type 1 ORPHA:882,0.7929682744768703
MTHFS,Early-onset generalized limb-onset dystonia ORPHA:256,0.8922466888454011
MTHFS,Multiple mitochondrial dysfunctions syndrome type 4 ORPHA:457406,0.8922466888454011
MTMR1,Myotonic Dystrophy,0.7880542567584415
MTMR1,Congenital Myotonic Dystrophy,0.7880542567584415
MTMR1,Dystrophia myotonica 2,0.8769418330148872
MTMR1,Intellectual Disability,0.9478210444156088
MTMR1,Arthrogryposis,0.9896536639644284
MTMR1,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454,0.5867963421058087
MTMR1,Cardiofaciocutaneous syndrome ORPHA:1340,0.795266832401002
MYZAP,High density lipoprotein measurement,0.7880542567584415
MYZAP,Juvenile psoriatic arthritis,0.7880542567584415
MYZAP,Juvenile-Onset Still Disease,0.7880542567584415
MYZAP,Juvenile arthritis,0.8009048756462318
MYZAP,Cardiomyopathy Dilated,0.9564633032157428
MYZAP,Juvenile Arthritis,0.7765582368651238
MYZAP,Polyarthritis Rheumatoid Factor Positive,0.7765582368651238
MYZAP,Seronegative Polyarthritis,0.7765582368651238
MYZAP,Still Disease,0.7765582368651238
MYZAP,Atrial Fibrillation,0.8115918568696846
MYZAP,Coronary Heart Disease,0.861756360478846
MYZAP,Arthritis,0.9046917974656596
MYZAP,Cardiomyopathy,0.9145387439550552
MYZAP,Hemochromatosis type 5 ORPHA:447792,0.3832844616405875
N4BP1,drug response,0.7880542567584415
N4BP1,Rheumatoid Arthritis,0.7880542567584415
N4BP1,Rheumatoid Arthritis,0.9251646147729308
N4BP1,Dyschromatosis symmetrica hereditaria ORPHA:41,0.3832844616405875
N4BP1,Desbuquois syndrome ORPHA:1425,0.3832844616405875
N4BP1,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977,0.5867963421058087
N4BP1,Autosomal recessive spastic paraplegia type 45 ORPHA:320396,0.8922466888454011
N4BP1,Polyvalvular heart disease syndrome ORPHA:228410,0.8922466888454011
NAE1,Oropharyngeal disorders,0.7880542567584415
NAE1,Alzheimer's Disease,0.7880542567584415
NAE1,Down Syndrome,0.8420665668584452
NAE1,Amyloidosis,0.8672189956534445
NAE1,Vocal cord and pharyngeal distal myopathy ORPHA:600,0.3832844616405875
NAE1,Charcot-Marie-Tooth disease type 4B1 ORPHA:99955,0.5867963421058087
NAE1,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:330050,0.5867963421058087
NAE1,Autosomal recessive spastic paraplegia type 61 ORPHA:401780,0.7929682744768703
NAE1,Brachydactyly-short stature-retinitis pigmentosa syndrome ORPHA:166035,0.7929682744768703
NAE1,Combined oxidative phosphorylation defect type 24 ORPHA:444458,0.7929682744768703
NAE1,Hypomyelination with brain stem and spinal cord involvement and leg spasticity ORPHA:363412,0.7929682744768703
NAE1,Spinocerebellar ataxia type 10 ORPHA:98761,0.7929682744768703
NAE1,Succinyl-CoA:3-oxoacid CoA transferase deficiency ORPHA:832,0.7929682744768703
NAE1,2p21 microdeletion syndrome without cystinuria ORPHA:369881,0.7929682744768703
NAE1,Autosomal thrombocytopenia with normal platelets ORPHA:168629,0.795266832401002
NAE1,Autosomal dominant optic atrophy classic form ORPHA:98673,0.8922466888454011
NAE1,Acute infantile liver failure-multisystemic involvement syndrome ORPHA:370088,0.8922466888454011
NAE1,Combined oxidative phosphorylation defect type 13 ORPHA:319514,0.8922466888454011
NAE1,Combined oxidative phosphorylation defect type 9 ORPHA:319509,0.8922466888454011
NAE1,Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency ORPHA:284435,0.8922466888454011
NAE1,Moyamoya angiopathy-short stature-facial dysmorphism-hypergonadotropic hypogonadism syndrome ORPHA:280679,0.8922466888454011
NAE1,Multiple mitochondrial dysfunctions syndrome type 6 ORPHA:569290,0.8922466888454011
NAE1,Parkinson-dementia complex of Guam ORPHA:90020,0.8922466888454011
NAE1,Dystonia 16 ORPHA:210571,0.8922466888454011
NAE1,Glomuvenous malformation ORPHA:83454,0.8922466888454011
NAE1,MFF-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:485421,0.8922466888454011
NAE1,Pontocerebellar hypoplasia type 6 ORPHA:166073,0.8922466888454011
NAE1,Retinitis pigmentosa-juvenile cataract-short stature-intellectual disability syndrome ORPHA:436245,0.8922466888454011
NAE1,Rhizomelic chondrodysplasia punctata type 2 ORPHA:309796,0.8922466888454011
NAE1,X-linked myopathy with excessive autophagy ORPHA:25980,0.8922466888454011
NAE1,Pontocerebellar hypoplasia type 1 ORPHA:2254,0.8922466888454011
NDC80,Malignant neoplasm of breast,0.4084380369379369
NDC80,Breast Carcinoma,0.7333611688795861
NDC80,Carcinogenesis,0.7333611688795861
NDC80,Malignant neoplasm of ovary,0.7333611688795861
NDC80,leukemia,0.7333611688795861
NDC80,Ovarian Carcinoma,0.7333611688795861
NDC80,Colon Carcinoma,0.7765852775619541
NDC80,Cervix carcinoma,0.7765852775619541
NDC80,Non-Small Cell Lung Carcinoma,0.7765852775619541
NDC80,Endometrial Carcinoma,0.7765852775619541
NDC80,Malignant tumor of cervix,0.7768809924982332
NDC80,Mammary Neoplasms,0.7880542567584415
NDC80,Glioma,0.7880542567584415
NDC80,Malignant neoplasm of lung,0.7880542567584415
NDC80,Liver carcinoma,0.7880542567584415
NDC80,Osteosarcoma,0.7880542567584415
NDC80,Epithelial ovarian cancer,0.7880542567584415
NDC80,Osteosarcoma of bone,0.7880542567584415
NDC80,Primary malignant neoplasm of lung,0.7880542567584415
NDC80,cervical cancer,0.7880542567584415
NDC80,Malignant neoplasm of testis,0.7880542567584415
NDC80,Carcinoma of lung,0.7880542567584415
NDC80,Malignant neoplasm of liver,0.7880542567584415
NDC80,Primary Malignant Liver Neoplasm,0.7880542567584415
NDC80,Neoplasms,0.7880542567584415
NDC80,Mucinous Adenocarcinoma,0.7880542567584415
NDC80,MYELOPROLIFERATIVE SYNDROME TRANSIENT,0.7880542567584415
NDC80,Well Differentiated Oligodendroglioma,0.7880542567584415
NDC80,oligodendroglioma,0.7880542567584415
NDC80,Hemangioma,0.8009048756462318
NDC80,Cervical Adenocarcinoma,0.8019075543217649
NDC80,Childhood Osteosarcoma,0.8019075543217649
NDC80,Benign neoplasm of breast,0.8098851543361193
NDC80,Endometrial adenocarcinoma,0.8190761496232595
NDC80,Malignant neoplasm of endometrium,0.8769418330148872
NDC80,Uterine Corpus Cancer,0.8771562273432176
NDC80,Adenocarcinoma Endometrioid,0.8774809019744603
NDC80,Malignant Pleural Mesothelioma,0.8935933996254593
NDC80,Overweight,0.929814249105729
NDC80,Liver Carcinoma,0.7765582368651238
NDC80,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
NDC80,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
NDC80,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
NDC80,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
NDC80,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
NDC80,Filippi syndrome ORPHA:3255,0.0155394890951578
NDC80,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
NDC80,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
NDC80,Stromme syndrome ORPHA:506307,0.0155394890951578
NDC80,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
NDC80,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
NDC80,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.1040670578681756
NDC80,Combined immunodeficiency due to GINS1 deficiency ORPHA:505227,0.1040670578681756
NDC80,Denys-Drash syndrome ORPHA:220,0.1991445465001551
NDC80,Frasier syndrome ORPHA:347,0.1991445465001551
NDC80,Meacham syndrome ORPHA:3097,0.1991445465001551
NDC80,Familial prostate cancer ORPHA:1331,0.2844858212863536
NDC80,Li-Fraumeni syndrome ORPHA:524,0.3891940933600213
NDC80,Nephroblastoma ORPHA:654,0.4491081214880772
NDC80,Primary peritoneal carcinoma ORPHA:168829,0.5867963421058087
NDC80,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.5867963421058087
NDC80,Muir-Torre syndrome ORPHA:587,0.5867963421058087
NDC80,Osteosarcoma ORPHA:668,0.5867963421058087
NDC80,Familial pancreatic carcinoma ORPHA:1333,0.6599133692748571
NDC80,Fanconi anemia ORPHA:84,0.7593059616185558
NDC80,Bloom syndrome ORPHA:125,0.7929682744768703
NDC80,DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470,0.7929682744768703
NDC80,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462,0.7929682744768703
NDC80,Spinocerebellar ataxia with axonal neuropathy type 1 ORPHA:94124,0.7929682744768703
NDC80,VACTERL with hydrocephalus ORPHA:3412,0.7929682744768703
NDC80,Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139,0.7929682744768703
NDC80,ICF syndrome ORPHA:2268,0.795266832401002
NDC80,Seckel syndrome ORPHA:808,0.8211968342881582
NDC80,Hereditary breast cancer ORPHA:227535,0.8329982337461243
NDC80,Autosomal recessive primary microcephaly ORPHA:2512,0.8922466888454011
NDC80,Hereditary site-specific ovarian cancer syndrome ORPHA:213524,0.8922466888454011
NDC80,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome ORPHA:314404,0.8922466888454011
NDC80,Hereditary fibrosing poikiloderma-tendon contractures-myopathy-pulmonary fibrosis syndrome ORPHA:221043,0.8922466888454011
NDC80,Hereditary sensory neuropathy-deafness-dementia syndrome ORPHA:456318,0.8922466888454011
NDC80,Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894,0.8922466888454011
NDC80,Roberts syndrome ORPHA:3103,0.8922466888454011
NDC80,Xeroderma pigmentosum variant ORPHA:90342,0.8922466888454011
NDC80,Weaver syndrome ORPHA:3447,0.8922466888454011
NDC80,Facioscapulohumeral dystrophy ORPHA:269,0.8922466888454011
NDC80,Hereditary breast and ovarian cancer syndrome ORPHA:145,0.8922466888454011
NDC80,Pleomorphic salivary gland adenoma ORPHA:454821,0.8922466888454011
NDRG1,Malignant neoplasm of breast,0.4084380369379369
NDRG1,Bladder Neoplasm,0.4084380369379369
NDRG1,Breast Carcinoma,0.7333611688795861
NDRG1,Carcinogenesis,0.7333611688795861
NDRG1,Adenocarcinoma,0.750391252594775
NDRG1,Malignant neoplasm of pancreas,0.7688485284765829
NDRG1,Colorectal Carcinoma,0.7765852775619541
NDRG1,Pancreatic carcinoma,0.7765852775619541
NDRG1,Colon Carcinoma,0.7765852775619541
NDRG1,Leukemia Myelocytic Acute,0.7765852775619541
NDRG1,Malignant tumor of colon,0.7765852775619541
NDRG1,Endometrial Neoplasms,0.7765852775619541
NDRG1,Cervix carcinoma,0.7765852775619541
NDRG1,Non-Small Cell Lung Carcinoma,0.7765852775619541
NDRG1,Prostatic Intraepithelial Neoplasias,0.7765852775619541
NDRG1,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
NDRG1,Colorectal Neoplasms,0.7765852775619541
NDRG1,Pancreatic Neoplasm,0.7765852775619541
NDRG1,Endometrial Carcinoma,0.7765852775619541
NDRG1,Mammary Neoplasms,0.7880542567584415
NDRG1,Glioma,0.7880542567584415
NDRG1,Malignant neoplasm of lung,0.7880542567584415
NDRG1,Malignant neoplasm of prostate,0.7880542567584415
NDRG1,Liver carcinoma,0.7880542567584415
NDRG1,Osteosarcoma,0.7880542567584415
NDRG1,Acute Promyelocytic Leukemia,0.7880542567584415
NDRG1,Colorectal Cancer,0.7880542567584415
NDRG1,Multiple malignancy,0.7880542567584415
NDRG1,Hepatocarcinogenesis,0.7880542567584415
NDRG1,Glioblastoma,0.7880542567584415
NDRG1,Osteosarcoma of bone,0.7880542567584415
NDRG1,Hemangioblastoma,0.7880542567584415
NDRG1,Prostate carcinoma,0.7880542567584415
NDRG1,Astrocytoma,0.7880542567584415
NDRG1,Primary malignant neoplasm of lung,0.7880542567584415
NDRG1,Neoplasm Metastasis,0.7880542567584415
NDRG1,Neuroepithelioma,0.7880542567584415
NDRG1,Prostatic Neoplasms,0.7880542567584415
NDRG1,Carcinoma of lung,0.7880542567584415
NDRG1,Squamous cell carcinoma of the head and neck,0.7880542567584415
NDRG1,Malignant neoplasm of liver,0.7880542567584415
NDRG1,Neuroblastoma,0.7880542567584415
NDRG1,Decreased nerve conduction velocity,0.7880542567584415
NDRG1,Central neuroblastoma,0.7880542567584415
NDRG1,Malignant Neoplasms,0.7880542567584415
NDRG1,melanoma,0.7880542567584415
NDRG1,Multiple Myeloma,0.7880542567584415
NDRG1,Metastatic Prostate Carcinoma,0.7880542567584415
NDRG1,Neoplasms,0.7880542567584415
NDRG1,Abnormal visual evoked potential,0.7880542567584415
NDRG1,Secondary malignant neoplasm of prostate,0.7880542567584415
NDRG1,Malignant neoplasm of stomach,0.7880542567584415
NDRG1,Brain Neoplasms,0.7880542567584415
NDRG1,Nasopharyngeal carcinoma,0.7880542567584415
NDRG1,Tumor Progression,0.7880542567584415
NDRG1,Abnormal auditory evoked potential,0.7880542567584415
NDRG1,Oropharyngeal Neoplasms,0.7880542567584415
NDRG1,Renal Cell Carcinoma,0.7880542567584415
NDRG1,Neuroectodermal Tumor Primitive,0.7880542567584415
NDRG1,Segmental peripheral demyelination/remyelination,0.7880542567584415
NDRG1,Axonal loss,0.7880542567584415
NDRG1,Stomach Carcinoma,0.7880542567584415
NDRG1,Squamous cell carcinoma,0.7880542567584415
NDRG1,Solid Neoplasm,0.7880542567584415
NDRG1,Demyelinating Diseases,0.7880542567584415
NDRG1,Carcinoma Pancreatic Ductal,0.7880542567584415
NDRG1,Peripheral demyelinating neuropathy,0.7880542567584415
NDRG1,Papillary Renal Cell Carcinoma,0.7880542567584415
NDRG1,Aortic Valve Insufficiency,0.7880542567584415
NDRG1,Adenoma of large intestine,0.7880542567584415
NDRG1,Small cell carcinoma of lung,0.7880542567584415
NDRG1,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
NDRG1,Dejerine-Sottas Disease (disorder),0.7880542567584415
NDRG1,Metastatic Neoplasm,0.7880542567584415
NDRG1,Hereditary motor and sensory neuropathy types I-IV,0.7880542567584415
NDRG1,Hypertrophic neuropathy of infancy,0.7880542567584415
NDRG1,Peroneal muscular atrophy (axonal type) (hypertrophic type),0.7880542567584415
NDRG1,Secondary malignant neoplasm of liver,0.7908231553833205
NDRG1,Malignant neoplasm of colon stage IV,0.7908231553833205
NDRG1,Metastasis from malignant tumor of prostate,0.7908231553833205
NDRG1,Primary malignant neoplasm,0.7908231553833205
NDRG1,Smooth Muscle Tumor,0.7908231553833205
NDRG1,Liver Cirrhosis Experimental,0.8014900279306119
NDRG1,Oropharyngeal Carcinoma,0.8019075543217649
NDRG1,Chromophobe Renal Cell Carcinoma,0.8019075543217649
NDRG1,Gait abnormality,0.8019075543217649
NDRG1,Congenital deafness,0.8019075543217649
NDRG1,Roussy-Levy Syndrome (disorder),0.8019075543217649
NDRG1,Multiple Sclerosis,0.8019075543217649
NDRG1,Childhood Osteosarcoma,0.8019075543217649
NDRG1,Liver neoplasms,0.8019075543217649
NDRG1,Onion bulb formation,0.8019075543217649
NDRG1,Adenocarcinoma of lung (disorder),0.8098851543361193
NDRG1,Hearing Loss Partial,0.8098851543361193
NDRG1,Childhood Cerebral Astrocytoma,0.8098851543361193
NDRG1,Intracranial Astrocytoma,0.8098851543361193
NDRG1,Hereditary hemochromatosis,0.8138488881521341
NDRG1,Cerebral Astrocytoma,0.8138488881521341
NDRG1,Protoplasmic astrocytoma,0.8168901801930506
NDRG1,Deafness,0.8190761496232595
NDRG1,Lip and Oral Cavity Carcinoma,0.8190761496232595
NDRG1,Sarcomatoid Renal Cell Carcinoma,0.8190761496232595
NDRG1,Grade I Astrocytoma,0.8190761496232595
NDRG1,Colonic Neoplasms,0.8212681436603975
NDRG1,Fibrillary Astrocytoma,0.8212681436603975
NDRG1,Hereditary Motor and Sensory Neuropathies,0.8212681436603975
NDRG1,Mixed oligoastrocytoma,0.8212681436603975
NDRG1,Mouth Neoplasms,0.8232134984476662
NDRG1,Collecting Duct Carcinoma of the Kidney,0.8272008757995397
NDRG1,Juvenile Pilocytic Astrocytoma,0.8272008757995397
NDRG1,hearing impairment,0.834094492023826
NDRG1,Glioblastoma Multiforme,0.8342163953428735
NDRG1,Subependymal Giant Cell Astrocytoma,0.8368219249856942
NDRG1,Decreased tendon reflex,0.8391186563955684
NDRG1,Malignant neoplasm of stomach stage IV,0.8402911822757345
NDRG1,CATARACT ANTERIOR POLAR,0.8402911822757345
NDRG1,Gemistocytic astrocytoma,0.8402911822757345
NDRG1,Peripheral Neuropathy,0.8402911822757345
NDRG1,Inherited neuropathies,0.8402911822757345
NDRG1,Hand deformities,0.843190898187174
NDRG1,Squamous cell carcinoma of esophagus,0.8610447277138289
NDRG1,Paresis,0.8642802827048847
NDRG1,Renal carcinoma,0.8648405521677974
NDRG1,Malignant neoplasm of endometrium,0.8769418330148872
NDRG1,Uterine Corpus Cancer,0.8771562273432176
NDRG1,Kidney Neoplasm,0.8774809019744603
NDRG1,Mammary Neoplasms Human,0.8815127642200768
NDRG1,Diffuse Astrocytoma,0.8815127642200768
NDRG1,Malignant neoplasm of kidney,0.8818220091065441
NDRG1,Absent tendon reflex,0.8867509400747969
NDRG1,Reflex Deep Tendon Absent,0.8911256045597441
NDRG1,Absent reflex,0.8911256045597441
NDRG1,Malignant neoplasm of mouth,0.8946938397586319
NDRG1,Secondary malignant neoplasm of lymph node,0.900167961295542
NDRG1,Distal amyotrophy,0.9024758035783405
NDRG1,Giant Cell Glioblastoma,0.9039108388826153
NDRG1,Distal sensory impairment,0.906476206143938
NDRG1,Sensory neuropathy,0.9098977259629772
NDRG1,Distal muscle weakness,0.9146732238562176
NDRG1,Neuropathy,0.914995991166204
NDRG1,Distal limb muscle weakness due to peripheral neuropathy,0.9154499654632742
NDRG1,Anoxia,0.9184153253162451
NDRG1,Anaplastic astrocytoma,0.9262273158806068
NDRG1,Secondary Neoplasm,0.9432051631882106
NDRG1,Intellectual Disability,0.9478210444156088
NDRG1,Muscle Weakness,0.9512505437112568
NDRG1,Pilocytic Astrocytoma,0.9540608878641196
NDRG1,Charcot-Marie-Tooth Disease,0.963331724428282
NDRG1,Tumor Angiogenesis,0.9656926709728724
NDRG1,Substance Use Disorders,0.9658628445524134
NDRG1,Drug abuse,0.9658628445524134
NDRG1,Malignant neoplasm of brain,0.9769594699984444
NDRG1,Carcinoma Of The Head And Neck,0.4532988396145482
NDRG1,Oropharyngeal Carcinoma,0.6734982286750932
NDRG1,Prostate Cancer,0.7765582368651238
NDRG1,Melanoma,0.7765582368651238
NDRG1,Hemangioblastoma,0.7765582368651238
NDRG1,Prostatic Neoplasms,0.7765582368651238
NDRG1,Pancreatic Ductal Carcinoma,0.8115918568696846
NDRG1,Intracranial Astrocytoma,0.8115918568696846
NDRG1,Grade I Astrocytoma,0.8115918568696846
NDRG1,Oligoastrocytoma,0.8115918568696846
NDRG1,Fibrillary Astrocytoma,0.8115918568696846
NDRG1,Protoplasmic Astrocytoma,0.8115918568696846
NDRG1,Gemistocytic Astrocytoma,0.8115918568696846
NDRG1,Lung Carcinoma,0.8139950454942313
NDRG1,Mammary Neoplasms,0.8165359516083085
NDRG1,Anaplastic Astrocytoma,0.8201196687803188
NDRG1,Chromophobe Carcinoma,0.8356859041719433
NDRG1,Papillary Renal Carcinoma,0.8476516371290275
NDRG1,Marfan Syndrome,0.8477374749042494
NDRG1,Astrocytoma,0.861756360478846
NDRG1,Kidney Cancer,0.861756360478846
NDRG1,Renal Carcinoma,0.8727045307126416
NDRG1,Kidney Neoplasm,0.8759421888249375
NDRG1,Mouth Neoplasms,0.8903301324869451
NDRG1,Breast Cancer,0.8903630091389316
NDRG1,Charcot-Marie-Tooth Disease,0.9087218501169084
NDRG1,Liver Cancer,0.924275664330454
NDRG1,Breast Carcinoma,0.9398381935810408
NDRG1,Giant Cell Glioblastoma,0.9398381935810408
NDRG1,Liver Neoplasms,0.9543024119762946
NDRG1,Distal Amyotrophy,0.963385108667098
NDRG1,Glioblastoma,0.9832345076528324
NDRG1,Charcot-Marie-Tooth disease type 4D ORPHA:99950,0.3832844616405875
NDRG1,Mitochondrial DNA depletion syndrome myopathic form ORPHA:254875,0.5867963421058087
NDRG1,Familial Alzheimer-like prion disease ORPHA:280397,0.7929682744768703
NDRG1,Fatal familial insomnia ORPHA:466,0.7929682744768703
NDRG1,Gerstmann-Straussler-Scheinker syndrome ORPHA:356,0.7929682744768703
NDRG1,Huntington disease-like 1 ORPHA:157941,0.7929682744768703
NDRG1,Inherited Creutzfeldt-Jakob disease ORPHA:282166,0.7929682744768703
NDRG1,Kuru ORPHA:454745,0.7929682744768703
NDRG1,PrP systemic amyloidosis ORPHA:397606,0.7929682744768703
NDRG1,Sporadic fatal insomnia ORPHA:586130,0.7929682744768703
NDRG1,Keratolytic winter erythema ORPHA:50943,0.8922466888454011
NDRG1,Autosomal dominant secondary polycythemia ORPHA:247511,0.8922466888454011
NDRG1,Vaccinia virus Ankara putative monoglyceride lipase f2,0.9057542447893764
NES,Malignant neoplasm of breast,0.4084380369379369
NES,Adenomatous Polyposis Coli,0.5196624042573144
NES,Breast Carcinoma,0.7333611688795861
NES,Carcinogenesis,0.7333611688795861
NES,Malignant neoplasm of ovary,0.7333611688795861
NES,B-Cell Lymphomas,0.7333611688795861
NES,Ovarian Carcinoma,0.7333611688795861
NES,Adenocarcinoma,0.750391252594775
NES,Malignant neoplasm of pancreas,0.7688485284765829
NES,Pancreatic carcinoma,0.7765852775619541
NES,Gastrointestinal Stromal Tumors,0.7765852775619541
NES,Atrial Premature Complexes,0.7765852775619541
NES,Cervix carcinoma,0.7765852775619541
NES,Non-Small Cell Lung Carcinoma,0.7765852775619541
NES,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
NES,Colorectal Neoplasms,0.7765852775619541
NES,Pancreatic Neoplasm,0.7765852775619541
NES,Carcinoma breast stage IV,0.7765852775619541
NES,Pancreatic intraepithelial neoplasia,0.7765852775619541
NES,Adenoma,0.7765852775619541
NES,Thyroid Neoplasm,0.7765852775619541
NES,Endometrial Carcinoma,0.7765852775619541
NES,Malignant tumor of cervix,0.7768809924982332
NES,Glioma,0.7880542567584415
NES,Malignant neoplasm of lung,0.7880542567584415
NES,Malignant neoplasm of prostate,0.7880542567584415
NES,Liver carcinoma,0.7880542567584415
NES,Osteosarcoma,0.7880542567584415
NES,Ataxia Telangiectasia,0.7880542567584415
NES,Rhabdomyosarcoma,0.7880542567584415
NES,Leukemia Plasma Cell,0.7880542567584415
NES,Glioblastoma,0.7880542567584415
NES,Osteosarcoma of bone,0.7880542567584415
NES,Hemangioblastoma,0.7880542567584415
NES,Astrocytoma,0.7880542567584415
NES,Nephroblastoma,0.7880542567584415
NES,Primary malignant neoplasm of lung,0.7880542567584415
NES,cervical cancer,0.7880542567584415
NES,Neoplasm Metastasis,0.7880542567584415
NES,Prostatic Neoplasms,0.7880542567584415
NES,Monoclonal Gammopathy of Undetermined Significance,0.7880542567584415
NES,Carcinoma of lung,0.7880542567584415
NES,Cockayne Syndrome Type I,0.7880542567584415
NES,Triple Negative Breast Neoplasms,0.7880542567584415
NES,Neuroblastoma,0.7880542567584415
NES,Central neuroblastoma,0.7880542567584415
NES,Immunologic Deficiency Syndromes,0.7880542567584415
NES,Malignant Neoplasms,0.7880542567584415
NES,melanoma,0.7880542567584415
NES,Increased drug resistance,0.7880542567584415
NES,Multiple Myeloma,0.7880542567584415
NES,Lung Neoplasms,0.7880542567584415
NES,Retinal Diseases,0.7880542567584415
NES,Metastatic malignant neoplasm to brain,0.7880542567584415
NES,Neoplasms,0.7880542567584415
NES,Membranous glomerulonephritis,0.7880542567584415
NES,Well Differentiated Oligodendroglioma,0.7880542567584415
NES,Brain Neoplasms,0.7880542567584415
NES,Nasopharyngeal carcinoma,0.7880542567584415
NES,oligodendroglioma,0.7880542567584415
NES,Large cell neuroendocrine carcinoma,0.7880542567584415
NES,Dementia,0.7880542567584415
NES,Tumor Progression,0.7880542567584415
NES,Pericytic Neoplasm,0.7880542567584415
NES,Sarcoma,0.7880542567584415
NES,Childhood Glioblastoma,0.7880542567584415
NES,Acquired Immunodeficiency Syndrome,0.7880542567584415
NES,Photophobia,0.7880542567584415
NES,Adult Glioblastoma,0.7880542567584415
NES,Coronary Arteriosclerosis,0.7880542567584415
NES,Arteriosclerosis,0.7880542567584415
NES,Atherosclerosis,0.7880542567584415
NES,Alzheimer's Disease,0.7880542567584415
NES,Epilepsy Tonic-Clonic Familial,0.7880542567584415
NES,Epilepsy Tonic-Clonic Symptomatic,0.7880542567584415
NES,Cryptogenic Tonic-Clonic Epilepsy,0.7880542567584415
NES,Secondary pulmonary hypertension,0.7880542567584415
NES,Acute myocardial infarction,0.7880542567584415
NES,Squamous cell carcinoma,0.7880542567584415
NES,Infiltrating Cervical Carcinoma,0.7880542567584415
NES,Solid Neoplasm,0.7880542567584415
NES,Nervous System Neoplasms,0.7880542567584415
NES,Uterine Corpus Carcinosarcoma,0.7880542567584415
NES,Nephrosis,0.7880542567584415
NES,Hyperglycemia,0.7880542567584415
NES,Small cell carcinoma of lung,0.7880542567584415
NES,Intrahepatic Cholangiocarcinoma,0.7880542567584415
NES,Metastatic Neoplasm,0.7880542567584415
NES,Tonic-Clonic Epilepsy,0.7880542567584415
NES,Myeloid Leukemia Chronic,0.7880542567584415
NES,Malignant Glioma,0.7880542567584415
NES,Secondary malignant neoplasm of liver,0.7908231553833205
NES,Primary malignant neoplasm,0.7908231553833205
NES,Chronic myeloproliferative disorder,0.7945683314244791
NES,Nerve Sheath Tumors,0.7967714690735718
NES,Cortical Dysplasia,0.8019075543217649
NES,Myocardial Infarction,0.8019075543217649
NES,Focal glomerulosclerosis,0.8019075543217649
NES,Fibrosarcoma,0.8019075543217649
NES,Carotid artery occlusion,0.8019075543217649
NES,neurofibroma,0.8019075543217649
NES,Kidney Diseases,0.8019075543217649
NES,Uterine Carcinosarcoma,0.8019075543217649
NES,Indian childhood cirrhosis,0.8067197998685076
NES,Schizophrenia,0.8067197998685076
NES,Neurofibromatoses,0.8098851543361193
NES,Herpes Simplex Infections,0.8098851543361193
NES,Vascular anomaly,0.8098851543361193
NES,Mixed Oligodendroglioma-Astrocytoma,0.8098851543361193
NES,Congenital Hyperinsulinism,0.8138488881521341
NES,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
NES,Secondary malignant neoplasm of lung,0.8232134984476662
NES,Microcephaly,0.8232134984476662
NES,Malignant Peripheral Nerve Sheath Tumor,0.8272008757995397
NES,Abscess,0.8272008757995397
NES,Pituitary Adenoma,0.834094492023826
NES,Glioblastoma Multiforme,0.8342163953428735
NES,Motor neuron atrophy,0.8363138748299018
NES,Recurrent tumor,0.8368219249856942
NES,Pituitary Neoplasms,0.8368219249856942
NES,Gastroesophageal reflux disease,0.8368219249856942
NES,Amyotrophic Lateral Sclerosis,0.8402911822757345
NES,Cervical Intraepithelial Neoplasia,0.8402911822757345
NES,Sleep Apnea Central,0.8402911822757345
NES,Medulloblastoma,0.8548862007194026
NES,Exanthema,0.8619324281003841
NES,Anaplasia,0.8648405521677974
NES,Cerebrovascular accident,0.8648405521677974
NES,Migraine Disorders,0.8648405521677974
NES,Neurologic Symptoms,0.8690346447728063
NES,Brain Infarction,0.876210765330195
NES,Uterine Cancer,0.8774809019744603
NES,tumor vasculature,0.8806784681730055
NES,Dentatorubral-Pallidoluysian Atrophy,0.8815127642200768
NES,Hydrocephalus,0.8851456306720444
NES,Heart failure,0.8867509400747969
NES,Neurilemmoma,0.887595340546704
NES,Coronary Artery Disease,0.887595340546704
NES,Congestive heart failure,0.8976039441125321
NES,Barrett Esophagus,0.8980854850210683
NES,Brain Ischemia,0.8980854850210683
NES,Central Nervous System Neoplasms,0.8989612563669234
NES,Secondary malignant neoplasm of lymph node,0.900167961295542
NES,Encephalitis,0.900167961295542
NES,Glioblastoma IDH-Wildtype,0.906476206143938
NES,synovial sarcoma,0.9119978323790848
NES,Coronary heart disease,0.9119978323790848
NES,Creutzfeldt-Jakob disease,0.9193385822373632
NES,Kidney Failure Acute,0.9373358316580888
NES,Fibroid Tumor,0.9373358316580888
NES,Seizures,0.9478210444156088
NES,Uterine Fibroids,0.9557184806547836
NES,Interstitial lung fibrosis,0.9564633032157428
NES,Epilepsy,0.963331724428282
NES,Tumor Angiogenesis,0.9656926709728724
NES,Tuberous Sclerosis,0.9884235744717738
NES,Cryptogenic Tonic-Clonic Epilepsy,0.7765582368651238
NES,Tonic-Clonic Epilepsy,0.7765582368651238
NES,Nephrosis,0.7860378120955526
NES,Epilepsy,0.8611702959552964
NES,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.1040670578681756
NES,MASA syndrome ORPHA:2466,0.1040670578681756
NES,Monosomy 22q13.3 ORPHA:48652,0.1040670578681756
NES,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.1040670578681756
NES,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.1040670578681756
NES,Frank-Ter Haar syndrome ORPHA:137834,0.1991445465001551
NES,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570,0.3832844616405875
NES,Dermatofibrosarcoma protuberans ORPHA:31112,0.3832844616405875
NES,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3832844616405875
NES,Persistent hyperplastic primary vitreous ORPHA:91495,0.3832844616405875
NES,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.5867963421058087
NES,Classic Bartter syndrome ORPHA:93605,0.5867963421058087
NES,Lateral meningocele syndrome ORPHA:2789,0.5867963421058087
NES,Pierson syndrome ORPHA:2670,0.5867963421058087
NES,3M syndrome ORPHA:2616,0.5867963421058087
NES,Autosomal dominant otospondylomegaepiphyseal dysplasia ORPHA:166100,0.5867963421058087
NES,Autosomal recessive Robinow syndrome ORPHA:1507,0.5867963421058087
NES,Carpenter syndrome ORPHA:65759,0.5867963421058087
NES,Hyperostosis corticalis generalisata ORPHA:3416,0.5867963421058087
NES,46XX ovotesticular disorder of sex development ORPHA:2138,0.5867963421058087
NES,Acrocallosal syndrome ORPHA:36,0.5867963421058087
NES,Congenital fibrosis of extraocular muscles ORPHA:45358,0.5867963421058087
NES,Ollier disease ORPHA:296,0.5867963421058087
NES,Silver-Russell syndrome due to a point mutation ORPHA:397590,0.5959529547720634
NES,Familial exudative vitreoretinopathy ORPHA:891,0.6196505963261838
NES,Colobomatous microphthalmia ORPHA:98938,0.6467006456772204
NES,Tetralogy of Fallot ORPHA:3303,0.7007232363756918
NES,Early-onset nuclear cataract ORPHA:98991,0.7895126437786436
NES,46XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563,0.7929682744768703
NES,Brachydactyly type B1 ORPHA:572385,0.7929682744768703
NES,Congenital muscular dystrophy with integrin alpha-7 deficiency ORPHA:34520,0.7929682744768703
NES,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.7929682744768703
NES,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735,0.7929682744768703
NES,Keipert syndrome ORPHA:2662,0.7929682744768703
NES,Kuskokwim syndrome ORPHA:1149,0.7929682744768703
NES,Legius syndrome ORPHA:137605,0.7929682744768703
NES,Muscle filaminopathy ORPHA:171445,0.7929682744768703
NES,Polymicrogyria due to TUBB2B mutation ORPHA:300573,0.7929682744768703
NES,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.7929682744768703
NES,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386,0.7929682744768703
NES,Familial avascular necrosis of femoral head ORPHA:86820,0.7929682744768703
NES,Hypoplastic left heart syndrome ORPHA:2248,0.7929682744768703
NES,Roussy-Levy syndrome ORPHA:3115,0.7929682744768703
NES,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117,0.7929682744768703
NES,Butterfly-shaped pigment dystrophy ORPHA:99001,0.7929682744768703
NES,Duane retraction syndrome ORPHA:233,0.7929682744768703
NES,Isolated hemihyperplasia ORPHA:2128,0.7929682744768703
NES,Retinopathy of prematurity ORPHA:90050,0.7929682744768703
NES,Familial bicuspid aortic valve ORPHA:402075,0.795266832401002
NES,Familial progressive cardiac conduction defect ORPHA:871,0.795266832401002
NES,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.8029813443753846
NES,Skeletal Ewing sarcoma ORPHA:319,0.8029813443753846
NES,Atrial septal defect ostium secundum type ORPHA:99103,0.8105918570729571
NES,Bilateral striopallidodentate calcinosis ORPHA:1980,0.8105918570729571
NES,Familial porencephaly ORPHA:99810,0.8922466888454011
NES,Simpson-Golabi-Behmel syndrome ORPHA:373,0.8922466888454011
NES,Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010,0.8922466888454011
NES,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.8922466888454011
NES,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome ORPHA:352654,0.8922466888454011
NES,Familial schizencephaly ORPHA:481986,0.8922466888454011
NES,Glycogen storage disease due to muscle phosphofructokinase deficiency ORPHA:371,0.8922466888454011
NES,HANAC syndrome ORPHA:73229,0.8922466888454011
NES,Oculodentodigital dysplasia ORPHA:2710,0.8922466888454011
NES,Optic atrophy-intellectual disability syndrome ORPHA:401777,0.8922466888454011
NES,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.8922466888454011
NES,Retinal arterial tortuosity ORPHA:75326,0.8922466888454011
NES,Stuve-Wiedemann syndrome ORPHA:3206,0.8922466888454011
NES,Steel syndrome ORPHA:438117,0.8922466888454011
NES,Syndactyly type 3 ORPHA:93404,0.8922466888454011
NES,Tubulinopathy-associated dysgyria ORPHA:467166,0.8922466888454011
NES,Cerebrofacioarticular syndrome ORPHA:314679,0.8922466888454011
NES,Congenital ptosis ORPHA:91411,0.8922466888454011
NES,Fibrochondrogenesis ORPHA:2021,0.8922466888454011
NES,Non-seminomatous germ cell tumor of testis ORPHA:363494,0.8922466888454011
NES,Pfeiffer syndrome type 1 ORPHA:93258,0.8922466888454011
NES,Postaxial polydactyly type B ORPHA:93335,0.8922466888454011
NES,Sclerosteosis ORPHA:3152,0.8922466888454011
NES,Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144,0.8922466888454011
NES,Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140,0.8922466888454011
NES,Spondylometaphyseal dysplasia 'corner fracture' type ORPHA:93315,0.8922466888454011
NES,NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293,0.8922466888454011
NES,Isolated brachycephaly ORPHA:35099,0.8922466888454011
NES,Isolated plagiocephaly ORPHA:35098,0.8922466888454011
NES,46XX testicular disorder of sex development ORPHA:393,0.8922466888454011
NES,Hirschsprung disease ORPHA:388,0.8922466888454011
NES,Osteogenesis imperfecta type 4 ORPHA:216820,0.8922466888454011
NES,Lobar holoprosencephaly ORPHA:93924,0.8922466888454011
NES,Midline interhemispheric variant of holoprosencephaly ORPHA:93926,0.8922466888454011
NES,Septopreoptic holoprosencephaly ORPHA:280195,0.8922466888454011
NES,Microform holoprosencephaly ORPHA:280200,0.8922466888454011
NES,Kallmann syndrome ORPHA:478,0.8922466888454011
NES,Familial isolated dilated cardiomyopathy ORPHA:154,0.8922466888454011
NES,Achondrogenesis type 2 ORPHA:93296,0.8922466888454011
NES,Acute inflammatory demyelinating polyradiculoneuropathy ORPHA:98916,0.8922466888454011
NES,Autosomal dominant myopia-midfacial retrusion-sensorineural hearing loss-rhizomelic dysplasia syndrome ORPHA:440354,0.8922466888454011
NES,Autosomal dominant rhegmatogenous retinal detachment ORPHA:209867,0.8922466888454011
NES,Autosomal recessive omodysplasia ORPHA:93329,0.8922466888454011
NES,BNAR syndrome ORPHA:217266,0.8922466888454011
NES,Blomstrand lethal chondrodysplasia ORPHA:50945,0.8922466888454011
NES,Brachydactyly-arterial hypertension syndrome ORPHA:1276,0.8922466888454011
NES,Butyrylcholinesterase deficiency ORPHA:132,0.8922466888454011
NES,Charcot-Marie-Tooth disease type 1A ORPHA:101081,0.8922466888454011
NES,Charcot-Marie-Tooth disease type 1E ORPHA:90658,0.8922466888454011
NES,Congenital alveolar capillary dysplasia ORPHA:210122,0.8922466888454011
NES,Congenital factor X deficiency ORPHA:328,0.8922466888454011
NES,Craniodiaphyseal dysplasia ORPHA:1513,0.8922466888454011
NES,Curry-Jones syndrome ORPHA:1553,0.8922466888454011
NES,Dysbetalipoproteinemia ORPHA:412,0.8922466888454011
NES,Dysspondyloenchondromatosis ORPHA:85198,0.8922466888454011
NES,Eiken syndrome ORPHA:79106,0.8922466888454011
NES,Familial sick sinus syndrome ORPHA:166282,0.8922466888454011
NES,Gamma-sarcoglycan-related  limb-girdle muscular dystrophy R5 ORPHA:353,0.8922466888454011
NES,Hartsfield syndrome ORPHA:2117,0.8922466888454011
NES,Hereditary neuropathy with liability to pressure palsies ORPHA:640,0.8922466888454011
NES,Hypochondrogenesis ORPHA:93297,0.8922466888454011
NES,Kagami-Ogata syndrome due to maternal 14q32.2 hypermethylation ORPHA:254534,0.8922466888454011
NES,Kagami-Ogata syndrome due to maternal 14q32.2 microdeletion ORPHA:254528,0.8922466888454011
NES,Kagami-Ogata syndrome due to paternal uniparental disomy of chromosome 14 ORPHA:96334,0.8922466888454011
NES,Kniest dysplasia ORPHA:485,0.8922466888454011
NES,Legg-Calve-Perthes disease ORPHA:2380,0.8922466888454011
NES,Lipoprotein glomerulopathy ORPHA:329481,0.8922466888454011
NES,Marshall syndrome ORPHA:560,0.8922466888454011
NES,Metaphyseal chondrodysplasia Jansen type ORPHA:33067,0.8922466888454011
NES,Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis ORPHA:93279,0.8922466888454011
NES,Multiple epiphyseal dysplasia Beighton type ORPHA:166011,0.8922466888454011
NES,Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement ORPHA:168953,0.8922466888454011
NES,Oculotrichoanal syndrome ORPHA:2717,0.8922466888454011
NES,Osteoglosphonic dysplasia ORPHA:2645,0.8922466888454011
NES,Platyspondylic dysplasia Torrance type ORPHA:85166,0.8922466888454011
NES,Primary failure of tooth eruption ORPHA:412206,0.8922466888454011
NES,Sea-blue histiocytosis ORPHA:158029,0.8922466888454011
NES,Severe intellectual disability-corpus callosum agenesis-facial dysmorphism-cerebellar ataxia syndrome ORPHA:466688,0.8922466888454011
NES,Sorsby pseudoinflammatory fundus dystrophy ORPHA:59181,0.8922466888454011
NES,Spondyloepimetaphyseal dysplasia congenita Strudwick type ORPHA:93346,0.8922466888454011
NES,Spondyloepiphyseal dysplasia congenita ORPHA:94068,0.8922466888454011
NES,Spondyloepiphyseal dysplasia with metatarsal shortening ORPHA:137678,0.8922466888454011
NES,Spondyloepiphyseal dysplasia Stanescu type ORPHA:459051,0.8922466888454011
NES,Spondylometaphyseal dysplasia Schmidt type ORPHA:93316,0.8922466888454011
NES,Spondyloperipheral dysplasia-short ulna syndrome ORPHA:1856,0.8922466888454011
NES,Stickler syndrome type 1 ORPHA:90653,0.8922466888454011
NES,Stickler syndrome type 2 ORPHA:90654,0.8922466888454011
NES,Temple syndrome due to maternal uniparental disomy of chromosome 14 ORPHA:96184,0.8922466888454011
NES,Temple syndrome due to paternal 14q32.2 hypomethylation ORPHA:254531,0.8922466888454011
NES,Temple syndrome due to paternal 14q32.2 microdeletion ORPHA:254525,0.8922466888454011
NES,Agnathia-holoprosencephaly-situs inversus syndrome ORPHA:990,0.8922466888454011
NES,Congenital communicating hydrocephalus ORPHA:269505,0.8922466888454011
NES,Infantile myofibromatosis ORPHA:2591,0.8922466888454011
NES,Isolated trigonocephaly ORPHA:3366,0.8922466888454011
NES,Townes-Brocks syndrome ORPHA:857,0.8922466888454011
NES,Waardenburg syndrome type 2 ORPHA:895,0.8922466888454011
NES,Left ventricular noncompaction ORPHA:54260,0.896422440954666
NES,Alobar holoprosencephaly ORPHA:93925,0.9016687655325558
NES,Semilobar holoprosencephaly ORPHA:220386,0.9025296114347576
NEURL3,Leukemia,0.7765582368651238
NEURL3,Familial expansile osteolysis ORPHA:85195,0.1991445465001551
NEURL3,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1991445465001551
NEURL3,Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528,0.5867963421058087
NEURL3,Familial primary hypomagnesemia with hypercalciuria and nephrocalcinosis without severe ocular involvement ORPHA:31043,0.8922466888454011
NME6,Colon Carcinoma,0.7765852775619541
NME6,Malignant tumor of colon,0.7765852775619541
NME6,Stomach Carcinoma,0.7880542567584415
NME6,Crohn Disease,0.7880542567584415
NME6,TMEM199-CDG ORPHA:466703,0.3832844616405875
NME6,Combined oxidative phosphorylation defect type 15 ORPHA:319524,0.7929682744768703
NME6,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders ORPHA:505248,0.8922466888454011
NME6,Human adenovirus 21 DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus 21a DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus 16 DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus 68 DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus 7d2 DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus 50 DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus 66 DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human mastadenovirus B DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus B3 E2B DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus 3+7 DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human mastadenovirus E DNA polymerase (gene: E2B),0.8999095837312036
NME6,Human adenovirus E4 DNA polymerase,0.8999095837312036
NMI,Malignant neoplasm of breast,0.4084380369379369
NMI,Breast Carcinoma,0.7333611688795861
NMI,Carcinogenesis,0.7333611688795861
NMI,Malignant neoplasm of ovary,0.7333611688795861
NMI,Ovarian Carcinoma,0.7333611688795861
NMI,Adenocarcinoma,0.750391252594775
NMI,Mammary Neoplasms,0.7880542567584415
NMI,Glioma,0.7880542567584415
NMI,Glioblastoma,0.7880542567584415
NMI,Neoplasm Metastasis,0.7880542567584415
NMI,Malignant Neoplasms,0.7880542567584415
NMI,melanoma,0.7880542567584415
NMI,Neoplasms,0.7880542567584415
NMI,Malignant neoplasm of stomach,0.7880542567584415
NMI,Stomach Carcinoma,0.7880542567584415
NMI,Metastatic Neoplasm,0.7880542567584415
NMI,Primary malignant neoplasm,0.7908231553833205
NMI,malignant neoplasm of breast staging,0.8009048756462318
NMI,Liver Cirrhosis Experimental,0.8014900279306119
NMI,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.1040670578681756
NMI,Aicardi-Goutieres syndrome ORPHA:51,0.1294848460749822
NMI,Autosomal dominant dopa-responsive dystonia ORPHA:98808,0.1991445465001551
NMI,Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713,0.1991445465001551
NMI,GTP cyclohydrolase I deficiency ORPHA:2102,0.1991445465001551
NMI,Waldenstrom macroglobulinemia ORPHA:33226,0.1991445465001551
NMI,Dehydrated hereditary stomatocytosis ORPHA:3202,0.2047219337649946
NMI,Takayasu arteritis ORPHA:3287,0.2047219337649946
NMI,Cleidocranial dysplasia ORPHA:1452,0.3832844616405875
NMI,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.3832844616405875
NMI,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504,0.3832844616405875
NMI,Variant ABeta2M amyloidosis ORPHA:314652,0.3832844616405875
NMI,Autosomal dominant severe congenital neutropenia ORPHA:486,0.3891940933600213
NMI,Herpes simplex virus encephalitis ORPHA:1930,0.3977968344535308
NMI,Exfoliative ichthyosis ORPHA:289586,0.5867963421058087
NMI,Immunodeficiency by defective expression of MHC class I ORPHA:34592,0.5867963421058087
NMI,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487,0.5867963421058087
NMI,Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517,0.5867963421058087
NMI,Autosomal dominant Kenny-Caffey syndrome ORPHA:93325,0.5867963421058087
NMI,B4GALT1-CDG ORPHA:79332,0.5867963421058087
NMI,Congenital isolated ACTH deficiency ORPHA:199296,0.5867963421058087
NMI,Familial normophosphatemic tumoral calcinosis ORPHA:306658,0.5867963421058087
NMI,Galactose mutarotase deficiency ORPHA:570422,0.5867963421058087
NMI,Generalized glucocorticoid resistance syndrome ORPHA:786,0.5867963421058087
NMI,Haim-Munk syndrome ORPHA:2342,0.5867963421058087
NMI,Hereditary pediatric Behcet-like disease ORPHA:476102,0.5867963421058087
NMI,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.5867963421058087
NMI,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977,0.5867963421058087
NMI,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592,0.5867963421058087
NMI,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428,0.5867963421058087
NMI,MIRAGE syndrome ORPHA:494433,0.5867963421058087
NMI,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595,0.5867963421058087
NMI,Neutral lipid storage disease with ichthyosis ORPHA:98907,0.5867963421058087
NMI,Neutrophil immunodeficiency syndrome ORPHA:183707,0.5867963421058087
NMI,Orofaciodigital syndrome type 5 ORPHA:2919,0.5867963421058087
NMI,Osteocraniostenosis ORPHA:2763,0.5867963421058087
NMI,Papillon-Lefevre ORPHA:678,0.5867963421058087
NMI,Proteasome-associated autoinflammatory syndrome ORPHA:324977,0.5867963421058087
NMI,Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311,0.5867963421058087
NMI,USP18 deficiency ORPHA:481665,0.5867963421058087
NMI,Familial Chilblain lupus ORPHA:481662,0.5867963421058087
NMI,Familial cerebral cavernous malformation ORPHA:221061,0.5867963421058087
NMI,Familial platelet disorder with associated myeloid malignancy ORPHA:71290,0.5867963421058087
NMI,Singleton-Merten dysplasia ORPHA:85191,0.7929682744768703
NMI,Acatalasemia ORPHA:926,0.7929682744768703
NMI,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency ORPHA:404493,0.7929682744768703
NMI,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957,0.7929682744768703
NMI,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815,0.7929682744768703
NMI,Griscelli syndrome type 2 ORPHA:79477,0.7929682744768703
NMI,NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498,0.7929682744768703
NMI,Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634,0.7929682744768703
NMI,STING-associated vasculopathy with onset in infancy ORPHA:425120,0.7929682744768703
NMI,Sporadic porphyria cutanea tarda ORPHA:443057,0.7929682744768703
NMI,Symptomatic form of hemochromatosis type 1 ORPHA:465508,0.7929682744768703
NMI,Short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia ORPHA:632,0.7929682744768703
NMI,Ataxia-pancytopenia syndrome ORPHA:2585,0.8922466888454011
NMI,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency ORPHA:35120,0.8922466888454011
NMI,SLC39A8-CDG ORPHA:468699,0.8922466888454011
NMI,Acral peeling skin syndrome ORPHA:263534,0.8922466888454011
NMI,Vogt-Koyanagi-Harada disease ORPHA:3437,0.8922466888454011
NMI,Congenital generalized hypercontractile muscle stiffness syndrome ORPHA:476406,0.8922466888454011
NMI,Hepatic veno-occlusive disease-immunodeficiency syndrome ORPHA:79124,0.8922466888454011
NMI,Human adenovirus 21a 100 kDa hexon-assembly associated protein (gene: L4),0.8999095837312036
NMI,Human adenovirus 68 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
NMI,Human adenovirus 66 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
NMI,Human adenovirus 7 100K,0.8999095837312036
NMI,Human adenovirus 16 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
NMI,Human adenovirus 7d2 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
NMI,Cercopithecine betaherpesvirus 5 tegument protein UL37 (gene: UL47),0.8999095837312036
NOL3,Malignant neoplasm of breast,0.4084380369379369
NOL3,Breast Carcinoma,0.7333611688795861
NOL3,Carcinogenesis,0.7333611688795861
NOL3,Malignant neoplasm of ovary,0.7333611688795861
NOL3,Malignant neoplasm of pancreas,0.7688485284765829
NOL3,Mitochondrial Respiratory Chain Deficiencies,0.7765852775619541
NOL3,Colorectal Carcinoma,0.7765852775619541
NOL3,Pancreatic carcinoma,0.7765852775619541
NOL3,Leukemia Myelocytic Acute,0.7765852775619541
NOL3,Lymphoma,0.7765852775619541
NOL3,Mammary Neoplasms,0.7880542567584415
NOL3,Liver carcinoma,0.7880542567584415
NOL3,Colorectal Cancer,0.7880542567584415
NOL3,T-Cell Lymphoma,0.7880542567584415
NOL3,Neuroblastoma,0.7880542567584415
NOL3,Central neuroblastoma,0.7880542567584415
NOL3,Ductal Carcinoma,0.7880542567584415
NOL3,Spasmodic movement,0.7880542567584415
NOL3,Involuntary jerking movements,0.7880542567584415
NOL3,High density lipoprotein measurement,0.7880542567584415
NOL3,Hodgkin Disease,0.7880542567584415
NOL3,Renal Cell Carcinoma,0.7880542567584415
NOL3,Myoclonus,0.7880542567584415
NOL3,AIDS related complex,0.7880542567584415
NOL3,Electron Transport Chain Deficiencies Mitochondrial,0.7880542567584415
NOL3,Stomach Carcinoma,0.7880542567584415
NOL3,Oxidative Phosphorylation Deficiencies,0.7880542567584415
NOL3,Falls,0.7880542567584415
NOL3,Wiskott-Aldrich Syndrome,0.8019075543217649
NOL3,Lip and Oral Cavity Carcinoma,0.8190761496232595
NOL3,Colonic Neoplasms,0.8212681436603975
NOL3,Pain,0.887595340546704
NOL3,Mitochondrial Diseases,0.8989612563669234
NOL3,Cerebellar Ataxia,0.906476206143938
NOL3,Chagas Disease,0.9193385822373632
NOL3,Hypertrophic Cardiomyopathy,0.9459312971127588
NOL3,Cardiomyopathy Dilated,0.9564633032157428
NOL3,Asthma,0.9672478180546946
NOL3,Mitochondrial Electron Transport Chain Deficiencies,0.7765582368651238
NOL3,Mitochondrial Respiratory Chain Deficiencies,0.7765582368651238
NOL3,Oxidative Phosphorylation Deficiency,0.7765582368651238
NOL3,Mitochondrial Diseases,0.924275664330454
NOL3,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
NOL3,Familial cortical myoclonus ORPHA:319189,0.1991445465001551
NOL3,Alopecia universalis ORPHA:701,0.3832844616405875
NOL3,Atrichia with papular lesions ORPHA:86819,0.3832844616405875
NOL3,Dyschromatosis universalis hereditaria ORPHA:241,0.3832844616405875
NOL3,Familial pseudohyperkalemia ORPHA:90044,0.3832844616405875
NOL3,Muscular dystrophy Selcen type ORPHA:199340,0.3832844616405875
NOL3,Congenital bile acid synthesis defect type 1 ORPHA:79301,0.5867963421058087
NOL3,Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594,0.5867963421058087
NOL3,Hemolytic anemia due to adenylate kinase deficiency ORPHA:86817,0.7929682744768703
NOL3,Adenylosuccinate synthetase-like 1-related distal myopathy ORPHA:482601,0.8922466888454011
NOL3,Glycogen storage disease due to muscle phosphorylase kinase deficiency ORPHA:715,0.8922466888454011
NOS1AP,Malignant neoplasm of breast,0.4084380369379369
NOS1AP,Breast Carcinoma,0.7333611688795861
NOS1AP,Chronic heart failure,0.7880542567584415
NOS1AP,Serum total cholesterol measurement,0.7880542567584415
NOS1AP,Monocyte count procedure,0.7880542567584415
NOS1AP,Monocyte count result,0.7880542567584415
NOS1AP,High density lipoprotein measurement,0.7880542567584415
NOS1AP,Mental disorders,0.7880542567584415
NOS1AP,Abnormal behavior,0.7880542567584415
NOS1AP,Coronary Arteriosclerosis,0.7880542567584415
NOS1AP,Arteriosclerosis,0.7880542567584415
NOS1AP,Atherosclerosis,0.7880542567584415
NOS1AP,Electrocardiogram,0.7880542567584415
NOS1AP,Diabetes,0.7880542567584415
NOS1AP,Vascular occlusion,0.7880542567584415
NOS1AP,Diabetes Mellitus,0.7880542567584415
NOS1AP,Brugada Syndrome (disorder),0.7880542567584415
NOS1AP,Diabetic peripheral neuropathy,0.8019075543217649
NOS1AP,Severe depression,0.8019075543217649
NOS1AP,Skin Erosion,0.8019075543217649
NOS1AP,Schizophrenia,0.8067197998685076
NOS1AP,Long QT Syndrome,0.8138488881521341
NOS1AP,Romano-Ward Syndrome,0.8145035474981049
NOS1AP,Congenital long QT syndrome,0.8190761496232595
NOS1AP,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
NOS1AP,Triglycerides measurement,0.8232134984476662
NOS1AP,Cardiac Arrest,0.8402911822757345
NOS1AP,cardiac event,0.8523465762428218
NOS1AP,Sudden Cardiac Death,0.8554819098734854
NOS1AP,Low density lipoprotein cholesterol measurement,0.8648405521677974
NOS1AP,Ventricular arrhythmia,0.8745234584149799
NOS1AP,Mental Depression,0.8769418330148872
NOS1AP,Heart failure,0.8867509400747969
NOS1AP,Coronary Artery Disease,0.887595340546704
NOS1AP,Congestive heart failure,0.8976039441125321
NOS1AP,Bipolar Disorder,0.900167961295542
NOS1AP,Depressive disorder,0.9103315000053974
NOS1AP,Coronary heart disease,0.9119978323790848
NOS1AP,Sciatic Neuropathy,0.929235785949896
NOS1AP,Post-Traumatic Stress Disorder,0.9446671211493156
NOS1AP,Hypertrophic Cardiomyopathy,0.9459312971127588
NOS1AP,Dysautonomia,0.7765582368651238
NOS1AP,Schizophrenia,0.7860378120955526
NOS1AP,Romano-Ward Syndrome,0.8115918568696846
NOS1AP,Torsades De Pointes,0.8115918568696846
NOS1AP,Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403,0.3832844616405875
NOS1AP,Spinocerebellar ataxia type 5 ORPHA:98766,0.3832844616405875
NOS1AP,9q33.3q34.11 microdeletion syndrome ORPHA:495818,0.3832844616405875
NOS1AP,Persistent hyperplastic primary vitreous ORPHA:91495,0.3832844616405875
NOS1AP,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.5867963421058087
NOS1AP,Achondroplasia ORPHA:15,0.5867963421058087
NOS1AP,Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335,0.5867963421058087
NOS1AP,Autosomal dominant spastic paraplegia type 31 ORPHA:101011,0.5867963421058087
NOS1AP,Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164,0.5867963421058087
NOS1AP,Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262,0.5867963421058087
NOS1AP,Hypochondroplasia ORPHA:429,0.5867963421058087
NOS1AP,Muenke syndrome ORPHA:53271,0.5867963421058087
NOS1AP,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.5867963421058087
NOS1AP,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165,0.5867963421058087
NOS1AP,Thanatophoric dysplasia type 1 ORPHA:1860,0.5867963421058087
NOS1AP,Thanatophoric dysplasia type 2 ORPHA:93274,0.5867963421058087
NOS1AP,Wilson disease ORPHA:905,0.5867963421058087
NOS1AP,Atypical juvenile parkinsonism ORPHA:391411,0.5867963421058087
NOS1AP,NON RARE IN EUROPE: Aldosterone-producing adenoma ORPHA:85142,0.8029813443753846
NOS1AP,Pontocerebellar hypoplasia type 3 ORPHA:97249,0.8922466888454011
NOS1AP,Hypoplastic tibiae-postaxial polydactyly syndrome ORPHA:3332,0.8922466888454011
NOS1AP,Polydactyly of a triphalangeal thumb ORPHA:93336,0.8922466888454011
NOS1AP,Radial hemimelia ORPHA:93321,0.8922466888454011
NOS1AP,Syndactyly type 4 ORPHA:93405,0.8922466888454011
NOS1AP,Triphalangeal thumb-polysyndactyly syndrome ORPHA:2950,0.8922466888454011
NOS1AP,Usher syndrome type 2 ORPHA:231178,0.8922466888454011
NOS1AP,2q32q33 microdeletion syndrome ORPHA:251019,0.8922466888454011
NOS1AP,SATB2-associated syndrome due to a chromosomal rearrangement ORPHA:251028,0.8922466888454011
NOS1AP,SATB2-associated syndrome due to a pathogenic variant ORPHA:576283,0.8922466888454011
NOS1AP,CHARGE syndrome ORPHA:138,0.8922466888454011
NOS1AP,Renal hypoplasia bilateral ORPHA:97362,0.8922466888454011
NOS1AP,Romano-Ward syndrome ORPHA:101016,0.9091525520868836
NOXA1,Adenocarcinoma,0.750391252594775
NOXA1,Colon Carcinoma,0.7765852775619541
NOXA1,Malignant tumor of colon,0.7765852775619541
NOXA1,Vascular Diseases,0.7765852775619541
NOXA1,Arteriosclerosis,0.7880542567584415
NOXA1,Atherosclerosis,0.7880542567584415
NOXA1,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
NOXA1,D-2-hydroxyglutaric aciduria ORPHA:79315,0.1054066549396977
NOXA1,CLN10 disease ORPHA:228337,0.1991445465001551
NOXA1,Hurler syndrome ORPHA:93473,0.1991445465001551
NOXA1,Hurler-Scheie syndrome ORPHA:93476,0.1991445465001551
NOXA1,Scheie syndrome ORPHA:93474,0.1991445465001551
NOXA1,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.1991445465001551
NOXA1,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.2386105733903937
NOXA1,5-oxoprolinase deficiency ORPHA:33572,0.5867963421058087
NOXA1,Glycogen storage disease due to acid maltase deficiency infantile onset ORPHA:308552,0.7929682744768703
NOXA1,Glycogen storage disease due to acid maltase deficiency late-onset ORPHA:420429,0.7929682744768703
NOXA1,Congenital sodium diarrhea ORPHA:103908,0.8922466888454011
NOXA1,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
NOXA1,Human immunodeficiency virus 1 Nef (gene: nef),0.8999095837312036
NOXA1,Variola virus hypothetical protein (gene: J7R),0.8999095837312036
NOXA1,Human immunodeficiency virus 2 nef protein,0.8999095837312036
NOXA1,Human gammaherpesvirus 4 EBNA-2 nuclear protein (gene: BYRF1),0.9057542447893764
NOXA1,Human herpesvirus 4 type 2 EBNA-2,0.9057542447893764
NSA2,Biliary cirrhosis,0.7880542567584415
NSA2,Biliary Cirrhosis Secondary,0.7880542567584415
NSA2,Diabetes,0.7880542567584415
NSA2,Diabetes Mellitus,0.7880542567584415
NSA2,Hyperglycemia,0.7880542567584415
NSA2,Kidney Diseases,0.8019075543217649
NSA2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
NSA2,Primary biliary cirrhosis,0.8212681436603975
NSA2,Diabetic Nephropathy,0.9390727893210336
NSA2,Biliary Cholangitis,0.7765582368651238
NSA2,Biliary Cirrhosis,0.7765582368651238
NSA2,Alazami syndrome ORPHA:319671,0.5867963421058087
NSA2,Brachydactyly-short stature-retinitis pigmentosa syndrome ORPHA:166035,0.7929682744768703
NSA2,Hypomyelination with brain stem and spinal cord involvement and leg spasticity ORPHA:363412,0.7929682744768703
NSA2,Autosomal dominant aplasia and myelodysplasia ORPHA:314399,0.8922466888454011
NSA2,Multiple mitochondrial dysfunctions syndrome type 6 ORPHA:569290,0.8922466888454011
NSA2,Corpus callosum agenesis-intellectual disability-coloboma-micrognathia syndrome ORPHA:52055,0.8922466888454011
NSA2,Pelizaeus-Merzbacher-like disease due to AIMP1 mutation ORPHA:280293,0.8922466888454011
NSA2,Blackfan-Diamond anemia ORPHA:124,0.8922466888454011
NUAK1,Malignant neoplasm of breast,0.4084380369379369
NUAK1,Breast Carcinoma,0.7333611688795861
NUAK1,Malignant neoplasm of pancreas,0.7688485284765829
NUAK1,Colorectal Carcinoma,0.7765852775619541
NUAK1,Pancreatic carcinoma,0.7765852775619541
NUAK1,Colon Carcinoma,0.7765852775619541
NUAK1,Malignant tumor of colon,0.7765852775619541
NUAK1,Lymphoma,0.7765852775619541
NUAK1,Non-Small Cell Lung Carcinoma,0.7765852775619541
NUAK1,Liver carcinoma,0.7880542567584415
NUAK1,Malignant Head and Neck Neoplasm,0.7880542567584415
NUAK1,Colorectal Cancer,0.7880542567584415
NUAK1,T-Cell Lymphoma,0.7880542567584415
NUAK1,Neoplasm Metastasis,0.7880542567584415
NUAK1,Squamous cell carcinoma of the head and neck,0.7880542567584415
NUAK1,Malignant Neoplasms,0.7880542567584415
NUAK1,melanoma,0.7880542567584415
NUAK1,Multiple Myeloma,0.7880542567584415
NUAK1,Malignant neoplasm of stomach,0.7880542567584415
NUAK1,Burkitt Lymphoma,0.7880542567584415
NUAK1,Tumor Progression,0.7880542567584415
NUAK1,Stomach Carcinoma,0.7880542567584415
NUAK1,Metastatic Neoplasm,0.7880542567584415
NUAK1,Primary malignant neoplasm,0.7908231553833205
NUAK1,Metastatic melanoma,0.7940665326856218
NUAK1,Secondary malignant neoplasm of lung,0.8232134984476662
NUAK1,Neoplasm Invasiveness,0.8232134984476662
NUAK1,Plasmacytoma,0.8608860081595284
NUAK1,Secondary malignant neoplasm of lymph node,0.900167961295542
NUAK1,Diabetic Nephropathy,0.9390727893210336
NUAK1,Multiple Myeloma,0.963385108667098
NUAK1,Attention Deficit Hyperactivity Disorder,0.980894832851993
NUAK1,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
NUAK1,Monosomy 22q13.3 ORPHA:48652,0.1040670578681756
NUAK1,Frank-Ter Haar syndrome ORPHA:137834,0.1991445465001551
NUAK1,Benign hereditary chorea ORPHA:1429,0.1991445465001551
NUAK1,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867,0.3832844616405875
NUAK1,Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580,0.3832844616405875
NUAK1,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126,0.3832844616405875
NUAK1,Non-immune hydrops fetalis ORPHA:363999,0.3832844616405875
NUAK1,Dermatofibrosarcoma protuberans ORPHA:31112,0.3832844616405875
NUAK1,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3832844616405875
NUAK1,Persistent hyperplastic primary vitreous ORPHA:91495,0.3832844616405875
NUAK1,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.5867963421058087
NUAK1,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.5867963421058087
NUAK1,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.5867963421058087
NUAK1,Isolated biliary atresia ORPHA:30391,0.5867963421058087
NUAK1,Microphthalmia with limb anomalies ORPHA:1106,0.5867963421058087
NUAK1,Multiple epiphyseal dysplasia type 5 ORPHA:93311,0.5867963421058087
NUAK1,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.5867963421058087
NUAK1,Spondyloepimetaphyseal dysplasia matrilin-3 type ORPHA:156728,0.5867963421058087
NUAK1,Wolfram-like syndrome ORPHA:411590,0.5867963421058087
NUAK1,Autosomal recessive Robinow syndrome ORPHA:1507,0.5867963421058087
NUAK1,Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359,0.5867963421058087
NUAK1,Silver-Russell syndrome due to a point mutation ORPHA:397590,0.5959529547720634
NUAK1,Colobomatous microphthalmia ORPHA:98938,0.6467006456772204
NUAK1,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.6873535151929783
NUAK1,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.6873535151929783
NUAK1,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.7007232363756918
NUAK1,Tetralogy of Fallot ORPHA:3303,0.7007232363756918
NUAK1,Early-onset nuclear cataract ORPHA:98991,0.7895126437786436
NUAK1,Bruck syndrome ORPHA:2771,0.7929682744768703
NUAK1,20p12.3 microdeletion syndrome ORPHA:261295,0.7929682744768703
NUAK1,ABeta amyloidosis Arctic type ORPHA:324723,0.7929682744768703
NUAK1,ABeta amyloidosis Dutch type ORPHA:100006,0.7929682744768703
NUAK1,ABeta amyloidosis Iowa type ORPHA:324708,0.7929682744768703
NUAK1,ABeta amyloidosis Italian type ORPHA:324713,0.7929682744768703
NUAK1,ABetaA21G amyloidosis ORPHA:324718,0.7929682744768703
NUAK1,ABetaL34V amyloidosis ORPHA:324703,0.7929682744768703
NUAK1,Atrial septal defect ostium primum type ORPHA:99106,0.7929682744768703
NUAK1,Campomelic dysplasia ORPHA:140,0.7929682744768703
NUAK1,Craniosynostosis Boston type ORPHA:1541,0.7929682744768703
NUAK1,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.7929682744768703
NUAK1,Isolated Pierre Robin syndrome ORPHA:718,0.7929682744768703
NUAK1,Kuskokwim syndrome ORPHA:1149,0.7929682744768703
NUAK1,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.7929682744768703
NUAK1,Lymphedema-posterior choanal atresia syndrome ORPHA:99141,0.7929682744768703
NUAK1,Muscle filaminopathy ORPHA:171445,0.7929682744768703
NUAK1,Myopathic Ehlers-Danlos syndrome ORPHA:536516,0.7929682744768703
NUAK1,Nance-Horan syndrome ORPHA:627,0.7929682744768703
NUAK1,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.7929682744768703
NUAK1,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.7929682744768703
NUAK1,Scalp-ear-nipple syndrome ORPHA:2036,0.7929682744768703
NUAK1,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386,0.7929682744768703
NUAK1,Craniometaphyseal dysplasia ORPHA:1522,0.7929682744768703
NUAK1,Hypoplastic left heart syndrome ORPHA:2248,0.7929682744768703
NUAK1,Beckwith-Wiedemann syndrome due to imprinting defect of 11p15 ORPHA:231117,0.7929682744768703
NUAK1,Butterfly-shaped pigment dystrophy ORPHA:99001,0.7929682744768703
NUAK1,Duane retraction syndrome ORPHA:233,0.7929682744768703
NUAK1,Isolated hemihyperplasia ORPHA:2128,0.7929682744768703
NUAK1,Saethre-Chotzen syndrome ORPHA:794,0.7929682744768703
NUAK1,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.795266832401002
NUAK1,Familial progressive cardiac conduction defect ORPHA:871,0.795266832401002
NUAK1,Peters anomaly ORPHA:708,0.8029813443753846
NUAK1,Atrial septal defect ostium secundum type ORPHA:99103,0.8105918570729571
NUAK1,Bilateral striopallidodentate calcinosis ORPHA:1980,0.8105918570729571
NUAK1,Renal agenesis unilateral ORPHA:93100,0.8211968342881582
NUAK1,Walker-Warburg syndrome ORPHA:899,0.8778481542696168
NUAK1,Familial porencephaly ORPHA:99810,0.8922466888454011
NUAK1,X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018,0.8922466888454011
NUAK1,15q14 microdeletion syndrome ORPHA:261190,0.8922466888454011
NUAK1,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.8922466888454011
NUAK1,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.8922466888454011
NUAK1,Autosomal dominant palmoplantar keratoderma and congenital alopecia ORPHA:1010,0.8922466888454011
NUAK1,Autosomal dominant slowed nerve conduction velocity ORPHA:140481,0.8922466888454011
NUAK1,COL4A1-related familial vascular leukoencephalopathy ORPHA:36383,0.8922466888454011
NUAK1,Cerebral autosomal recessive arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:199354,0.8922466888454011
NUAK1,Dicarboxylic aminoaciduria ORPHA:2195,0.8922466888454011
NUAK1,Familial generalized lentiginosis ORPHA:231040,0.8922466888454011
NUAK1,Familial progressive hyper- and hypopigmentation ORPHA:280628,0.8922466888454011
NUAK1,Familial progressive hyperpigmentation ORPHA:79146,0.8922466888454011
NUAK1,Familial schizencephaly ORPHA:481986,0.8922466888454011
NUAK1,Growth delay due to insulin-like growth factor I resistance ORPHA:73273,0.8922466888454011
NUAK1,HANAC syndrome ORPHA:73229,0.8922466888454011
NUAK1,HTRA1-related autosomal dominant cerebral small vessel disease ORPHA:482077,0.8922466888454011
NUAK1,Helicoid peripapillary chorioretinal degeneration ORPHA:86813,0.8922466888454011
NUAK1,Hot water reflex epilepsy ORPHA:166412,0.8922466888454011
NUAK1,Microphthalmia with brain and digit anomalies ORPHA:139471,0.8922466888454011
NUAK1,Oculodentodigital dysplasia ORPHA:2710,0.8922466888454011
NUAK1,Optic atrophy-intellectual disability syndrome ORPHA:401777,0.8922466888454011
NUAK1,Pigmentation defects-palmoplantar keratoderma-skin carcinoma syndrome ORPHA:447961,0.8922466888454011
NUAK1,Pontine autosomal dominant microangiopathy with leukoencephalopathy ORPHA:477749,0.8922466888454011
NUAK1,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012,0.8922466888454011
NUAK1,Retinal arterial tortuosity ORPHA:75326,0.8922466888454011
NUAK1,SIX2-related frontonasal dysplasia ORPHA:488437,0.8922466888454011
NUAK1,Short rib-polydactyly syndrome Saldino-Noonan type ORPHA:93270,0.8922466888454011
NUAK1,Stuve-Wiedemann syndrome ORPHA:3206,0.8922466888454011
NUAK1,Steel syndrome ORPHA:438117,0.8922466888454011
NUAK1,Syndactyly type 3 ORPHA:93404,0.8922466888454011
NUAK1,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.8922466888454011
NUAK1,X-linked Alport syndrome ORPHA:88917,0.8922466888454011
NUAK1,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome ORPHA:500188,0.8922466888454011
NUAK1,Cerebrofacioarticular syndrome ORPHA:314679,0.8922466888454011
NUAK1,Congenital diaphragmatic hernia ORPHA:2140,0.8922466888454011
NUAK1,Malignant peripheral nerve sheath tumor ORPHA:3148,0.8922466888454011
NUAK1,Non-seminomatous germ cell tumor of testis ORPHA:363494,0.8922466888454011
NUAK1,Pfeiffer syndrome type 1 ORPHA:93258,0.8922466888454011
NUAK1,Phakomatosis cesioflammea ORPHA:79483,0.8922466888454011
NUAK1,Sclerosteosis ORPHA:3152,0.8922466888454011
NUAK1,Silver-Russell syndrome due to 11p15 microduplication ORPHA:231144,0.8922466888454011
NUAK1,Silver-Russell syndrome due to an imprinting defect of 11p15 ORPHA:231140,0.8922466888454011
NUAK1,Tetraamelia-multiple malformations syndrome ORPHA:3301,0.8922466888454011
NUAK1,X-linked hypohidrotic ectodermal dysplasia ORPHA:181,0.8922466888454011
NUAK1,Brachydactyly type A2 ORPHA:93396,0.8922466888454011
NUAK1,Isolated aniridia ORPHA:250923,0.8922466888454011
NUAK1,NON RARE IN EUROPE: Infantile capillary hemangioma ORPHA:464293,0.8922466888454011
NUAK1,Epithelioid hemangioendothelioma ORPHA:157791,0.8922466888454011
NUAK1,Hirschsprung disease ORPHA:388,0.8922466888454011
NUAK1,Lobar holoprosencephaly ORPHA:93924,0.8922466888454011
NUAK1,Midline interhemispheric variant of holoprosencephaly ORPHA:93926,0.8922466888454011
NUAK1,Septopreoptic holoprosencephaly ORPHA:280195,0.8922466888454011
NUAK1,Microform holoprosencephaly ORPHA:280200,0.8922466888454011
NUAK1,Allan-Herndon-Dudley syndrome ORPHA:59,0.8922466888454011
NUAK1,Beta-sarcoglycan-related  limb-girdle muscular dystrophy R4 ORPHA:119,0.8922466888454011
NUAK1,CHST3-related skeletal dysplasia ORPHA:263463,0.8922466888454011
NUAK1,Charcot-Marie-Tooth disease type 2R ORPHA:397968,0.8922466888454011
NUAK1,Childhood-onset benign chorea with striatal involvement ORPHA:494541,0.8922466888454011
NUAK1,Diaphanospondylodysostosis ORPHA:66637,0.8922466888454011
NUAK1,Epidermolysis bullosa simplex due to BP230 deficiency ORPHA:412181,0.8922466888454011
NUAK1,Female restricted epilepsy with intellectual disability ORPHA:101039,0.8922466888454011
NUAK1,GAPO syndrome ORPHA:2067,0.8922466888454011
NUAK1,Goldberg-Shprintzen megacolon syndrome ORPHA:66629,0.8922466888454011
NUAK1,Greig cephalopolysyndactyly syndrome ORPHA:380,0.8922466888454011
NUAK1,Hereditary sensory and autonomic neuropathy type 6 ORPHA:314381,0.8922466888454011
NUAK1,Infantile-onset generalized dyskinesia with orofacial involvement ORPHA:494526,0.8922466888454011
NUAK1,Ischiovertebral syndrome ORPHA:85200,0.8922466888454011
NUAK1,Malignant epithelial tumor of salivary glands ORPHA:276145,0.8922466888454011
NUAK1,Metopic ridging-ptosis-facial dysmorphism syndrome ORPHA:502430,0.8922466888454011
NUAK1,Oculocutaneous albinism type 3 ORPHA:79433,0.8922466888454011
NUAK1,Pallister-Hall syndrome ORPHA:672,0.8922466888454011
NUAK1,Polysyndactyly ORPHA:93338,0.8922466888454011
NUAK1,Sensorineural deafness with dilated cardiomyopathy ORPHA:217622,0.8922466888454011
NUAK1,Tibial hemimelia ORPHA:93322,0.8922466888454011
NUAK1,X-linked intellectual disability Najm type ORPHA:163937,0.8922466888454011
NUAK1,X-linked osteoporosis with fractures ORPHA:391330,0.8922466888454011
NUAK1,Congenital cataract microcornea with corneal opacity ORPHA:289499,0.8922466888454011
NUAK1,Posterior hypospadias ORPHA:95706,0.8922466888454011
NUAK1,Rolandic epilepsy-speech dyspraxia syndrome ORPHA:163721,0.8922466888454011
NUAK1,Renal agenesis bilateral ORPHA:1848,0.8922466888454011
NUAK1,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
NUAK1,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
NUAK1,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
NUAK1,Provisional),0.8999095837312036
NUAK1,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
NUAK1,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
NUAK1,Human gammaherpesvirus 8 ORF72,0.8999095837312036
NUAK1,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
NUAK1,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
NUAK1,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
NUAK1,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
NUAK1,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
NUAK1,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
NUAK1,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
NUAK1,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
NUAK1,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
NUAK1,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
NUAK1,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
NUAK1,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
NUAK1,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
NUAK1,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
NUAK1,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
NUAK1,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
NUAK1,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
NUAK1,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
NUAK1,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
NUAK1,Monkeypox virus ser/thr kinase,0.8999095837312036
NUAK1,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
NUAK1,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
NUAK1,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
NUAK1,Cowpox virus CPXV196 protein (gene: CPXV196 CDS),0.8999095837312036
NUAK1,Yaba monkey tumor virus 142R,0.8999095837312036
NUAK1,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
NUAK1,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
NUAK1,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
NUAK1,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
NUAK1,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
NUAK1,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.8999095837312036
NUAK1,Monkeypox virus ankyrin-like protein,0.8999095837312036
NUAK1,Horsepox virus HSPV033c (ankyrin repeats),0.8999095837312036
NUAK1,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
NUAK1,Variola virus hypothetical protein (gene: D6L),0.8999095837312036
NUAK1,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
NUAK1,Yaba-like disease virus 147R protein (gene: 147R),0.9057542447893764
NUAK1,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
NUAK1,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
NUAK1,Variola virus hypothetical protein (gene: B19R),0.9057542447893764
NUAK1,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.9057542447893764
NUAK1,Ectromelia virus ERPV ankyrin,0.9057542447893764
NUAK1,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
NUAK1,Vaccinia virus ankyrin-like protein (gene: B18R),0.9058994261255549
NUAK1,Orf virus ORF126 ankyrin repeat protein,0.915880438522078
NUAK1,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.915880438522078
NUAK1,Horsepox virus HSPV005c (Ankyrin repeats),0.9237501457186692
NUAK1,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
NUAK1,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.9287050575620676
NUAK1,Horsepox virus HSPV014c (ankyrin repeats),0.9287050575620676
NUAK1,Vaccinia virus ankyin-like protein (gene: M1L),0.9318782091866168
NUAK1,Cowpox virus CPXV211 protein (gene: CPXV211 CDS),0.9383505321091749
NUAK1,Orf virus ORF129 ankyrin repeat protein,0.9386073090182748
NUAK1,Variola virus ankyin-like protein (gene: O1L),0.9397923093369096
NUAK1,Horsepox virus HSPV012 (ankyrin-like protein,0.9397923093369096
NUAK1,Provisional),0.9397923093369096
NUMBL,Glioma,0.7880542567584415
NUMBL,Neoplasm Metastasis,0.7880542567584415
NUMBL,Carcinoma of lung,0.7880542567584415
NUMBL,Neuroblastoma,0.7880542567584415
NUMBL,Central neuroblastoma,0.7880542567584415
NUMBL,Schizophrenia,0.8067197998685076
NUMBL,Progressive cGVHD,0.8610447277138289
NUMBL,Prostate Cancer,0.7765582368651238
NUMBL,Schizophrenia,0.7860378120955526
NUMBL,Lung Carcinoma,0.8139950454942313
NUMBL,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
NUMBL,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
NUMBL,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
NUMBL,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
NUMBL,Steinert myotonic dystrophy ORPHA:273,0.1040670578681756
NUMBL,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069,0.1991445465001551
NUMBL,Van den Ende-Gupta syndrome ORPHA:2460,0.3832844616405875
NUMBL,Dentatorubral pallidoluysian atrophy ORPHA:101,0.5867963421058087
NUMBL,POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559,0.5867963421058087
NUMBL,Isolated scaphocephaly ORPHA:35093,0.5867963421058087
NUMBL,46XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563,0.7929682744768703
NUP50,Leukemia,0.7765582368651238
NUP50,Precursor T-cell acute lymphoblastic leukemia ORPHA:99861,0.3832844616405875
NUP50,Pancreatic agenesis-holoprosencephaly syndrome ORPHA:556955,0.5867963421058087
NUP50,Acute myeloid leukemia with t(6,0.5867963421058087
NUP50,9)(p23,0.7929682744768703
NUP50,q34) ORPHA:402014,0.795266832401002
NUP50,Spinocerebellar ataxia with axonal neuropathy type 1 ORPHA:94124,0.8922466888454011
NUP50,Extraskeletal Ewing sarcoma ORPHA:370334,0.8922466888454011
NUP50,Atypical pantothenate kinase-associated neurodegeneration ORPHA:216873,0.8922466888454011
NUP50,CTCF-related neurodevelopmental disorder ORPHA:363611,0.8922466888454011
NUP50,Classic pantothenate kinase-associated neurodegeneration ORPHA:216866,0.8922466888454011
NUP50,Greenberg dysplasia ORPHA:1426,0.8922466888454011
NUP50,Hereditary neuroendocrine tumor of small intestine ORPHA:456333,0.8922466888454011
NUP50,Infantile-onset periodic fever-panniculitis-dermatosis syndrome ORPHA:500062,0.8922466888454011
NUP50,Regressive spondylometaphyseal dysplasia ORPHA:448267,0.8922466888454011
NUP50,Reynolds syndrome ORPHA:779,0.8922466888454011
NXF1,Esophageal carcinoma,0.7765852775619541
NXF1,Lymphoma,0.7765852775619541
NXF1,Cervix carcinoma,0.7765852775619541
NXF1,Malignant tumor of cervix,0.7768809924982332
NXF1,Malignant neoplasm of lung,0.7880542567584415
NXF1,Skin lesion,0.7880542567584415
NXF1,Primary malignant neoplasm of lung,0.7880542567584415
NXF1,cervical cancer,0.7880542567584415
NXF1,Neoplasm Metastasis,0.7880542567584415
NXF1,Bloom Syndrome,0.7880542567584415
NXF1,Primary immune deficiency disorder,0.7880542567584415
NXF1,Carcinoma of lung,0.7880542567584415
NXF1,Hermanski-Pudlak Syndrome,0.7880542567584415
NXF1,Squamous cell carcinoma of the head and neck,0.7880542567584415
NXF1,Mesothelioma,0.7880542567584415
NXF1,melanoma,0.7880542567584415
NXF1,Eclampsia,0.7880542567584415
NXF1,Lung Neoplasms,0.7880542567584415
NXF1,Cowpox,0.7880542567584415
NXF1,Hodgkin Disease,0.7880542567584415
NXF1,Bare Lymphocyte Syndrome Type I,0.7880542567584415
NXF1,Renal Cell Carcinoma,0.7880542567584415
NXF1,Infant Premature,0.7880542567584415
NXF1,Granulomatosis with polyangiitis,0.7880542567584415
NXF1,Alzheimer's Disease,0.7880542567584415
NXF1,Marek Disease,0.7880542567584415
NXF1,Autoimmune Diseases,0.7880542567584415
NXF1,Hepatitis C,0.7880542567584415
NXF1,Rheumatoid Arthritis,0.7880542567584415
NXF1,Ankylosing spondylitis,0.7880542567584415
NXF1,Reiter Syndrome,0.7880542567584415
NXF1,Sjogren's Syndrome,0.7880542567584415
NXF1,Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis,0.7880542567584415
NXF1,Idiopathic bronchiectasis,0.7880542567584415
NXF1,Vasculitis,0.7880542567584415
NXF1,Cholestasis,0.7880542567584415
NXF1,Virus Diseases,0.7880542567584415
NXF1,Bacterial Infections,0.7908231553833205
NXF1,Juvenile arthritis,0.8009048756462318
NXF1,Autoimmune liver disease,0.8009048756462318
NXF1,Multiple Sclerosis,0.8019075543217649
NXF1,Psoriasis,0.8019075543217649
NXF1,Lung diseases,0.8019075543217649
NXF1,Bare lymphocyte syndrome 2,0.8067197998685076
NXF1,Herpes Simplex Infections,0.8098851543361193
NXF1,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
NXF1,Erythema Nodosum,0.8145035474981049
NXF1,Ulcerative Colitis,0.8190761496232595
NXF1,Dengue Fever,0.8190761496232595
NXF1,Cervical high grade squamous intraepithelial lesion,0.8190761496232595
NXF1,Juvenile rheumatoid arthritis,0.8212681436603975
NXF1,Tuberculosis,0.8368219249856942
NXF1,Hepatitis B,0.841396342333011
NXF1,Varicella zoster,0.8554819098734854
NXF1,Bronchiectasis,0.8610447277138289
NXF1,Dermatitis Atopic,0.8867509400747969
NXF1,Secondary malignant neoplasm of lymph node,0.900167961295542
NXF1,Eczema,0.909484944705772
NXF1,Malnutrition,0.9184153253162451
NXF1,Sarcoidosis,0.929235785949896
NXF1,Behcet Syndrome,0.9446671211493156
NXF1,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
NXF1,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
NXF1,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
NXF1,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
NXF1,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.1040670578681756
NXF1,Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635,0.1991445465001551
NXF1,Methylmalonic acidemia with homocystinuria type cblJ ORPHA:369955,0.1991445465001551
NXF1,Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228,0.1991445465001551
NXF1,CAMOS syndrome ORPHA:83472,0.1991445465001551
NXF1,Classic galactosemia ORPHA:79239,0.3832844616405875
NXF1,Craniosynostosis-dental anomalies ORPHA:284149,0.3832844616405875
NXF1,Grange syndrome ORPHA:79094,0.3832844616405875
NXF1,QRICH1-related intellectual disability-chondrodysplasia syndrome ORPHA:580940,0.3832844616405875
NXF1,Glycogen storage disease due to liver phosphorylase kinase deficiency ORPHA:264580,0.3832844616405875
NXF1,Chronic myelomonocytic leukemia ORPHA:98823,0.3891940933600213
NXF1,Primary intraosseous venous malformation ORPHA:140436,0.5867963421058087
NXF1,Ramon syndrome ORPHA:3019,0.5867963421058087
NXF1,Autosomal dominant multiple pterygium syndrome ORPHA:65743,0.7929682744768703
NXF1,CLN2 disease ORPHA:228349,0.7929682744768703
NXF1,Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324,0.7929682744768703
NXF1,Myxoid/round cell liposarcoma ORPHA:99967,0.8922466888454011
NXF1,Parvovirus NIH-CQV putative capsid protein (gene: cap),0.8999095837312036
NXPH4,Uric acid measurement (procedure),0.7765852775619541
NXPH4,Autosomal dominant compelling helio ophthalmic outburst syndrome,0.8009048756462318
NXPH4,Gout,0.7765582368651238
NXPH4,Gouty Arthritis,0.7765582368651238
NXPH4,Achoo Syndrome,0.8115918568696846
NXPH4,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
NXPH4,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
NXPH4,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
NXPH4,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
NXPH4,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.1991445465001551
NXPH4,Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664,0.1991445465001551
NXPH4,Isolated split hand-split foot malformation ORPHA:2440,0.606625035400596
NXPH4,Anterior segment developmental anomaly ORPHA:88632,0.7929682744768703
NXPH4,Congenital primary aphakia ORPHA:83461,0.7929682744768703
NXPH4,Non-acquired combined pituitary hormone deficiency-sensorineural hearing loss-spine abnormalities syndrome ORPHA:231720,0.7929682744768703
NXPH4,Idiopathic juvenile osteoporosis ORPHA:85193,0.7929682744768703
NXPH4,Short stature-auditory canal atresia-mandibular hypoplasia-skeletal anomalies syndrome ORPHA:397623,0.8922466888454011
OASL,C-reactive protein measurement,0.7880542567584415
OASL,Serum gamma-glutamyl transferase measurement,0.7880542567584415
OASL,Lupus Erythematosus Systemic,0.7880542567584415
OASL,Hepatitis C,0.7880542567584415
OASL,Respiratory syncytial virus (RSV) infection in conditions classified elsewhere and of unspecified site,0.7880542567584415
OASL,Tick-Borne Encephalitis,0.8067197998685076
OASL,Aspartate aminotransferase measurement,0.8145035474981049
OASL,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
OASL,Inflammation,0.8212681436603975
OASL,Systemic Scleroderma,0.8402911822757345
OASL,Influenza,0.9193385822373632
OASL,Diabetes Mellitus,0.919442421650838
OASL,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
OASL,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
OASL,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.1040670578681756
OASL,Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813,0.1054066549396977
OASL,Aicardi-Goutieres syndrome ORPHA:51,0.1294848460749822
OASL,Autosomal dominant dopa-responsive dystonia ORPHA:98808,0.1991445465001551
OASL,Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713,0.1991445465001551
OASL,GTP cyclohydrolase I deficiency ORPHA:2102,0.1991445465001551
OASL,Waldenstrom macroglobulinemia ORPHA:33226,0.1991445465001551
OASL,Takayasu arteritis ORPHA:3287,0.2047219337649946
OASL,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.3832844616405875
OASL,Metaphyseal anadysplasia ORPHA:1040,0.3832844616405875
OASL,Herpes simplex virus encephalitis ORPHA:1930,0.3977968344535308
OASL,Exfoliative ichthyosis ORPHA:289586,0.5867963421058087
OASL,Immunodeficiency by defective expression of MHC class I ORPHA:34592,0.5867963421058087
OASL,Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome ORPHA:391487,0.5867963421058087
OASL,Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517,0.5867963421058087
OASL,Charcot-Marie-Tooth disease type 1C ORPHA:101083,0.5867963421058087
OASL,Familial normophosphatemic tumoral calcinosis ORPHA:306658,0.5867963421058087
OASL,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.5867963421058087
OASL,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977,0.5867963421058087
OASL,Infantile-onset pulmonary alveolar proteinosis-hypogammaglobulinemia ORPHA:572428,0.5867963421058087
OASL,MIRAGE syndrome ORPHA:494433,0.5867963421058087
OASL,Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency ORPHA:319595,0.5867963421058087
OASL,Susceptibility to viral and mycobacterial infections due to STAT1 deficiency ORPHA:391311,0.5867963421058087
OASL,USP18 deficiency ORPHA:481665,0.5867963421058087
OASL,Singleton-Merten dysplasia ORPHA:85191,0.7929682744768703
OASL,Birdshot chorioretinopathy ORPHA:179,0.7929682744768703
OASL,Congenital muscular dystrophy-respiratory failure-skin abnormalities-joint hyperlaxity syndrome ORPHA:486815,0.7929682744768703
OASL,Nasopharyngeal carcinoma ORPHA:150,0.8922466888454011
OASL,Autosomal recessive hypohidrotic ectodermal dysplasia ORPHA:248,0.8922466888454011
OASL,Human betaherpesvirus 6 U31 large tegument protein (gene: U31),0.8999095837312036
OASL,Human betaherpesvirus 6A large tegument protein (gene: U31),0.8999095837312036
OASL,Human betaherpesvirus 6B large tegument protein (gene: U31),0.8999095837312036
OASL,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.8999095837312036
OASL,Dugbe virus L protein,0.8999095837312036
OASL,Human betaherpesvirus 7 large tegument protein (gene: U31),0.8999095837312036
OASL,Human betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
OASL,Vaccinia virus Ankara viral core cysteine proteinase,0.8999095837312036
OASL,Variola virus hypothetical protein (gene: K7L),0.8999095837312036
OASL,Monkeypox virus viral core cysteine proteinase,0.8999095837312036
OASL,Monkeypox virus Zaire-96-I-16 I7L (gene: I7L),0.8999095837312036
OASL,Yaba monkey tumor virus 48L,0.8999095837312036
OASL,Vaccinia virus viral core cysteine proteinase (gene: I7L),0.8999095837312036
OASL,Horsepox virus HSPV077 (Vaccinia virus I7 processing peptidase),0.8999095837312036
OASL,Cercopithecine betaherpesvirus 5 large tegument protein (gene: UL48),0.8999095837312036
OASL,SARS coronavirus Tor2 replicase 1AB,0.8999095837312036
OASL,SARS coronavirus P2 full_polyprotein 1..7073,0.8999095837312036
OASL,SARS coronavirus nsp3-pp1a/pp1ab (gene: orf1ab),0.8999095837312036
OASL,SARS coronavirus excised_polyprotein 1..4369 (gene: orf1ab),0.9057542447893764
OASL,SARS coronavirus P2 full_polyprotein 1..4382,0.9057542447893764
OIP5,Malignant neoplasm of breast,0.4084380369379369
OIP5,Carcinoma of bladder,0.4084380369379369
OIP5,Bladder Neoplasm,0.4084380369379369
OIP5,Malignant neoplasm of urinary bladder,0.5071083164302358
OIP5,Breast Carcinoma,0.7333611688795861
OIP5,Carcinogenesis,0.7333611688795861
OIP5,Esophageal carcinoma,0.7765852775619541
OIP5,Esophageal Neoplasms,0.7765852775619541
OIP5,Malignant neoplasm of lung,0.7880542567584415
OIP5,Liver carcinoma,0.7880542567584415
OIP5,Malignant neoplasm of esophagus,0.7880542567584415
OIP5,Glioblastoma,0.7880542567584415
OIP5,Malignant Neoplasms,0.7880542567584415
OIP5,Malignant neoplasm of stomach,0.7880542567584415
OIP5,Stomach Carcinoma,0.7880542567584415
OIP5,Squamous cell carcinoma,0.7880542567584415
OIP5,Primary malignant neoplasm,0.7908231553833205
OIP5,Obesity,0.8989612563669234
OIP5,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
OIP5,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
OIP5,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
OIP5,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
OIP5,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
OIP5,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
OIP5,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
OIP5,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
OIP5,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
OIP5,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
OIP5,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.1040670578681756
OIP5,Hyper-IgM syndrome type 5 ORPHA:101092,0.1040670578681756
OIP5,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.1040670578681756
OIP5,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.1040670578681756
OIP5,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.1040670578681756
OIP5,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.1991445465001551
OIP5,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.1991445465001551
OIP5,Hereditary coproporphyria ORPHA:79273,0.1991445465001551
OIP5,Lipoyl transferase 2 deficiency ORPHA:447795,0.3832844616405875
OIP5,Acute intermittent porphyria ORPHA:79276,0.5867963421058087
OIP5,Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030,0.5867963421058087
OIP5,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.5867963421058087
OIP5,ALG8-CDG ORPHA:79325,0.7929682744768703
OIP5,Amish nemaline myopathy ORPHA:98902,0.7929682744768703
OIP5,Combined oxidative phosphorylation defect type 24 ORPHA:444458,0.7929682744768703
OIP5,Spondyloepimetaphyseal dysplasia with multiple dislocations ORPHA:93360,0.7929682744768703
OIP5,Autosomal recessive Kenny-Caffey syndrome ORPHA:93324,0.8922466888454011
OIP5,Brody myopathy ORPHA:53347,0.8922466888454011
OIP5,Cutis marmorata telangiectatica congenita ORPHA:1556,0.8922466888454011
OIP5,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome ORPHA:254898,0.8922466888454011
OIP5,Early-onset progressive encephalopathy-spastic ataxia-distal spinal muscular atrophy syndrome ORPHA:496756,0.8922466888454011
OIP5,Reticular dysgenesis ORPHA:33355,0.8922466888454011
OIP5,Sanjad-Sakati syndrome ORPHA:2323,0.8922466888454011
OIP5,Anaplastic oligodendroglioma ORPHA:251630,0.8922466888454011
OIP5,Oligodendroglioma ORPHA:251627,0.8922466888454011
OIP5,Adenylosuccinate lyase deficiency ORPHA:46,0.8922466888454011
OIP5,Combined oxidative phosphorylation defect type 2 ORPHA:254920,0.8922466888454011
OIP5,Mohr-Tranebjaerg syndrome ORPHA:52368,0.8922466888454011
OIP5,Multiple system atrophy cerebellar type ORPHA:227510,0.8922466888454011
OIP5,Multiple system atrophy parkinsonian type ORPHA:98933,0.8922466888454011
OMA1,Carcinoma of bladder,0.4084380369379369
OMA1,Malignant neoplasm of urinary bladder,0.5071083164302358
OMA1,Colorectal Cancer,0.7880542567584415
OMA1,Duane Retraction Syndrome,0.7880542567584415
OMA1,Autistic Disorder,0.8019075543217649
OMA1,Impaired cognition,0.8190761496232595
OMA1,Cognition Disorders,0.8270909867833504
OMA1,Familial multiple trichoepitheliomata,0.8523465762428218
OMA1,Colorectal Cancer,0.9832345076528324
OMA1,Alacrimia-choreoathetosis-liver dysfunction syndrome ORPHA:404454,0.3832844616405875
OMA1,Lipoyl transferase 1 deficiency ORPHA:401862,0.5867963421058087
OMA1,Orofaciodigital syndrome type 5 ORPHA:2919,0.5867963421058087
OMA1,6q terminal deletion syndrome ORPHA:75857,0.7929682744768703
OMA1,3-methylglutaconic aciduria type 1 ORPHA:67046,0.8922466888454011
OMA1,ALG6-CDG ORPHA:79320,0.8922466888454011
OMA1,COG2-CDG ORPHA:435934,0.8922466888454011
OMA1,Intermediate maple syrup urine disease ORPHA:268162,0.8922466888454011
OMA1,Cowden syndrome ORPHA:201,0.8953775799945711
OSBPL7,Diabetes Mellitus,0.919442421650838
OSBPL7,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
P4HA2,Malignant neoplasm of breast,0.4084380369379369
P4HA2,Breast Carcinoma,0.7333611688795861
P4HA2,Mammary Neoplasms,0.7880542567584415
P4HA2,Liver carcinoma,0.7880542567584415
P4HA2,Neoplasm Metastasis,0.7880542567584415
P4HA2,Triple Negative Breast Neoplasms,0.7880542567584415
P4HA2,Eosinophil count procedure,0.7880542567584415
P4HA2,Eosinophil count result,0.7880542567584415
P4HA2,Squamous cell carcinoma of mouth,0.7880542567584415
P4HA2,Temporal Arteritis,0.7880542567584415
P4HA2,Crohn Disease,0.7880542567584415
P4HA2,Degenerative polyarthritis,0.8019075543217649
P4HA2,Liver neoplasms,0.8019075543217649
P4HA2,Blood basophil count (lab test),0.8190761496232595
P4HA2,Secondary malignant neoplasm of lung,0.8232134984476662
P4HA2,Hepatitis B,0.841396342333011
P4HA2,Severe myopia,0.9432051631882106
P4HA2,Temporal Arteritis,0.7765582368651238
P4HA2,Hypertension,0.7765582368651238
P4HA2,Crohn Disease,0.8903630091389316
P4HA2,Myopia,0.9832345076528324
P4HA2,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.1040670578681756
P4HA2,Familial cortical myoclonus ORPHA:319189,0.1991445465001551
P4HA2,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900,0.1991445465001551
P4HA2,Atypical Werner syndrome ORPHA:79474,0.3832844616405875
P4HA2,Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855,0.3832844616405875
P4HA2,Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365,0.3832844616405875
P4HA2,Charcot-Marie-Tooth disease type 2B1 ORPHA:98856,0.3832844616405875
P4HA2,Congenital muscular dystrophy due to LMNA mutation ORPHA:157973,0.3832844616405875
P4HA2,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229,0.3832844616405875
P4HA2,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751,0.3832844616405875
P4HA2,Familial partial lipodystrophy Dunnigan type ORPHA:2348,0.3832844616405875
P4HA2,Familial partial lipodystrophy Kobberling type ORPHA:79084,0.3832844616405875
P4HA2,Heart-hand syndrome Slovenian type ORPHA:168796,0.3832844616405875
P4HA2,LMNA-related cardiocutaneous progeria syndrome ORPHA:363618,0.3832844616405875
P4HA2,Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153,0.3832844616405875
P4HA2,Thyroid ectopia ORPHA:95712,0.3832844616405875
P4HA2,Multiple osteochondromas ORPHA:321,0.5867963421058087
P4HA2,Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289,0.5867963421058087
P4HA2,Colobomatous macrophthalmia-microcornea syndrome ORPHA:468672,0.5867963421058087
P4HA2,Multiple epiphyseal dysplasia type 5 ORPHA:93311,0.5867963421058087
P4HA2,Multiple myeloma ORPHA:29073,0.5867963421058087
P4HA2,Pseudohypoaldosteronism type 2B ORPHA:88939,0.5867963421058087
P4HA2,Spondyloepimetaphyseal dysplasia matrilin-3 type ORPHA:156728,0.5867963421058087
P4HA2,Xanthinuria type II ORPHA:93602,0.5867963421058087
P4HA2,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.5867963421058087
P4HA2,Bruck syndrome ORPHA:2771,0.7929682744768703
P4HA2,Acromesomelic dysplasia Hunter-Thompson type ORPHA:968,0.7929682744768703
P4HA2,Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442,0.7929682744768703
P4HA2,Arnold-Chiari malformation type I ORPHA:268882,0.7929682744768703
P4HA2,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135,0.7929682744768703
P4HA2,Chondrosarcoma ORPHA:55880,0.7929682744768703
P4HA2,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.7929682744768703
P4HA2,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.7929682744768703
P4HA2,Facial dysmorphism-lens dislocation-anterior segment abnormalities-spontaneous filtering blebs syndrome ORPHA:412022,0.7929682744768703
P4HA2,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179,0.7929682744768703
P4HA2,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274,0.7929682744768703
P4HA2,Familial primary localized cutaneous amyloidosis ORPHA:353220,0.7929682744768703
P4HA2,Papillary renal cell carcinoma ORPHA:319298,0.7929682744768703
P4HA2,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.795266832401002
P4HA2,Aromatase deficiency ORPHA:91,0.8922466888454011
P4HA2,Aromatase excess syndrome ORPHA:178345,0.8922466888454011
P4HA2,Fibronectin glomerulopathy ORPHA:84090,0.8922466888454011
P4HA2,Hereditary papillary renal cell carcinoma ORPHA:47044,0.8922466888454011
P4HA2,Interstitial lung disease-nephrotic syndrome-epidermolysis bullosa syndrome ORPHA:306504,0.8922466888454011
P4HA2,Isolated hyperchlorhidrosis ORPHA:542657,0.8922466888454011
P4HA2,Lipoid proteinosis ORPHA:530,0.8922466888454011
P4HA2,Multiple paragangliomas associated with polycythemia ORPHA:324299,0.8922466888454011
P4HA2,Osteofibrous dysplasia ORPHA:488265,0.8922466888454011
P4HA2,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.8922466888454011
P4HA2,Ulnar-mammary syndrome ORPHA:3138,0.8922466888454011
P4HA2,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.8922466888454011
P4HA2,Juvenile Paget disease ORPHA:2801,0.8922466888454011
P4HA2,Radio-ulnar synostosis-amegakaryocytic thrombocytopenia syndrome ORPHA:71289,0.8922466888454011
P4HA2,Auriculocondylar syndrome ORPHA:137888,0.8922466888454011
P4HA2,Brachydactyly type A2 ORPHA:93396,0.8922466888454011
P4HA2,Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067,0.8922466888454011
P4HA2,Partial atrioventricular septal defect ORPHA:1330,0.8922466888454011
P4HA2,Giant cell arteritis ORPHA:397,0.8922466888454011
P4HA2,Adenocarcinoma of ovary ORPHA:213504,0.8922466888454011
P4HA2,Autosomal recessive brachyolmia ORPHA:448242,0.8922466888454011
P4HA2,Hypodontia-dysplasia of nails syndrome ORPHA:2228,0.8922466888454011
P4HA2,Lethal hydranencephaly-diaphragmatic hernia syndrome ORPHA:480528,0.8922466888454011
P4HA2,PPARG-related familial partial lipodystrophy ORPHA:79083,0.8922466888454011
P4HA2,Primary CD59 deficiency ORPHA:169464,0.8922466888454011
P4HA2,Spondyloepimetaphyseal dysplasia PAPSS2 type ORPHA:93282,0.8922466888454011
P4HA2,Trehalase deficiency ORPHA:103909,0.8922466888454011
P4HA2,Acute myeloid leukemia with inv(3)(q21q26.2) or t(3,0.8922466888454011
P4HA2,3)(q21,0.8922466888454011
P4HA2,q26.2) ORPHA:402020,0.8922466888454011
PACSIN2,leukemia,0.7333611688795861
PACSIN2,Platelet distribution width measurement,0.7880542567584415
PACSIN2,Platelet distribution width result,0.7880542567584415
PACSIN2,Platelet Count measurement,0.7880542567584415
PACSIN2,Platelet mean volume determination (procedure),0.7880542567584415
PACSIN2,Juvenile psoriatic arthritis,0.7880542567584415
PACSIN2,Juvenile-Onset Still Disease,0.7880542567584415
PACSIN2,Juvenile arthritis,0.8009048756462318
PACSIN2,Diabetic Nephropathy,0.9390727893210336
PACSIN2,Juvenile Arthritis,0.7765582368651238
PACSIN2,Polyarthritis Rheumatoid Factor Positive,0.7765582368651238
PACSIN2,Seronegative Polyarthritis,0.7765582368651238
PACSIN2,Still Disease,0.7765582368651238
PACSIN2,Arthritis,0.9046917974656596
PACSIN2,MYH9-related disease ORPHA:182050,0.1991445465001551
PACSIN2,Cowpox virus Ati or CPXV158 protein (gene: ati),0.8999095837312036
PACSIN2,Macacine alphaherpesvirus 1 large tegument protein (gene: UL36),0.8999095837312036
PACSIN2,Papiine alphaherpesvirus 2 large tegument protein (gene: UL36),0.8999095837312036
PACSIN2,Marburg marburgvirus glycoprotein (gene: GP),0.8999095837312036
PACSIN2,Marburg virus - Musoke Kenya 1980 glycoprotein (gene: GP),0.9057542447893764
PAN2,Adenocarcinoma,0.750391252594775
PAN2,Colorectal Carcinoma,0.7765852775619541
PAN2,Colorectal Cancer,0.7880542567584415
PAN2,Cholestasis,0.7880542567584415
PAN2,Drug-Induced Liver Disease,0.8523465762428218
PAN2,Hepatitis Toxic,0.8548862007194026
PAN2,Chemical and Drug Induced Liver Injury,0.8548862007194026
PAN2,Chemically-Induced Liver Toxicity,0.8548862007194026
PAN2,Drug-Induced Acute Liver Injury,0.8548862007194026
PAN2,Hepatitis Drug-Induced,0.8578473133580928
PAN2,Cholestasis,0.8115918568696846
PAN2,Colorectal Cancer,0.9832345076528324
PAN2,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
PAN2,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
PAN2,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.1040670578681756
PAN2,Methylmalonic acidemia with homocystinuria type cblJ ORPHA:369955,0.1991445465001551
PAN2,Succinic semialdehyde dehydrogenase deficiency ORPHA:22,0.1991445465001551
PAN2,X-linked intellectual disability Siderius type ORPHA:85287,0.1991445465001551
PAN2,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964,0.3832844616405875
PAN2,Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220,0.3832844616405875
PAN2,Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159,0.5867963421058087
PAN2,NEK9-related lethal skeletal dysplasia ORPHA:464366,0.5867963421058087
PAN2,Nevus comedonicus syndrome ORPHA:64754,0.5867963421058087
PAN2,6q terminal deletion syndrome ORPHA:75857,0.7929682744768703
PAN2,COG7-CDG ORPHA:79333,0.7929682744768703
PAN2,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
PAN2,Yaba-like disease virus 141R protein (gene: 141R),0.8999095837312036
PAN2,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
PAN2,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
PAN2,Ectromelia virus ERPV hemagglutinin,0.8999095837312036
PAN2,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
PAN2,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.8999095837312036
PAN2,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
PAN2,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
PAN2,Yaba monkey tumor virus DNA polymerase,0.8999095837312036
PAN2,Ectromelia virus ERPV DNA polymerase,0.8999095837312036
PAN2,Variola virus hypothetical protein (gene: J9R),0.8999095837312036
PAN2,Vaccinia virus DNA polymerase (gene: E9L),0.8999095837312036
PAN2,Horsepox virus HSPV066 (DNA polymerase,0.8999095837312036
PAN2,Provisional),0.9057542447893764
PAN2,Vaccinia virus Ankara DNA polymerase,0.9057542447893764
PAN2,Variola virus DNA polymerase (gene: E9L),0.9057542447893764
PAN2,Cowpox virus CPXV075 protein (gene: CPXV075 CDS),0.9057542447893764
PAN2,Horsepox virus HSPV177 (Immunoglobulin like),0.9058994261255549
PAN2,Vaccinia virus hemagglutinin (gene: A56R),0.9197295331382644
PAN2,Human adenovirus 18 CR1-beta protein (gene: E3),0.9237501457186692
PAN2,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9287050575620676
PDLIM7,Malignant neoplasm of breast,0.4084380369379369
PDLIM7,Breast Carcinoma,0.7333611688795861
PDLIM7,Diffuse Large B-Cell Lymphoma,0.7333611688795861
PDLIM7,Carcinogenesis,0.7333611688795861
PDLIM7,B-Cell Lymphomas,0.7333611688795861
PDLIM7,Superinfection,0.7333611688795861
PDLIM7,leukemia,0.7333611688795861
PDLIM7,Adenocarcinoma,0.750391252594775
PDLIM7,Reticulosarcoma,0.7765852775619541
PDLIM7,Epidermodysplasia Verruciformis,0.7765852775619541
PDLIM7,Asymptomatic human immunodeficiency virus infection,0.7765852775619541
PDLIM7,Colorectal Carcinoma,0.7765852775619541
PDLIM7,Colon Carcinoma,0.7765852775619541
PDLIM7,Malignant tumor of colon,0.7765852775619541
PDLIM7,Lymphoma,0.7765852775619541
PDLIM7,Leukemogenesis,0.7765852775619541
PDLIM7,Cervix carcinoma,0.7765852775619541
PDLIM7,Non-Small Cell Lung Carcinoma,0.7765852775619541
PDLIM7,Lymphoma Extranodal NK-T-Cell,0.7765852775619541
PDLIM7,Hemophagocytic Syndrome,0.7765852775619541
PDLIM7,Malignant tumor of cervix,0.7768809924982332
PDLIM7,Malignant neoplasm of prostate,0.7880542567584415
PDLIM7,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
PDLIM7,Skin lesion,0.7880542567584415
PDLIM7,Lymphoma Non-Hodgkin,0.7880542567584415
PDLIM7,Liver carcinoma,0.7880542567584415
PDLIM7,Pyothorax-Associated Lymphoma,0.7880542567584415
PDLIM7,Malignant Head and Neck Neoplasm,0.7880542567584415
PDLIM7,Osteosarcoma,0.7880542567584415
PDLIM7,Thyroid carcinoma,0.7880542567584415
PDLIM7,Ataxia Telangiectasia,0.7880542567584415
PDLIM7,Rhabdomyosarcoma,0.7880542567584415
PDLIM7,T-Cell Lymphoma,0.7880542567584415
PDLIM7,Osteosarcoma of bone,0.7880542567584415
PDLIM7,Prostate carcinoma,0.7880542567584415
PDLIM7,cervical cancer,0.7880542567584415
PDLIM7,Neoplasm Metastasis,0.7880542567584415
PDLIM7,Epithelioma,0.7880542567584415
PDLIM7,Immunologic Deficiency Syndromes,0.7880542567584415
PDLIM7,Malignant Neoplasms,0.7880542567584415
PDLIM7,Hematologic Neoplasms,0.7880542567584415
PDLIM7,Malignant neoplasm of nasopharynx,0.7880542567584415
PDLIM7,Increased drug resistance,0.7880542567584415
PDLIM7,Lymphoid hyperplasia,0.7880542567584415
PDLIM7,Nasal and nasal-type NK/T-cell lymphoma,0.7880542567584415
PDLIM7,Malignant neoplasm of stomach,0.7880542567584415
PDLIM7,Burkitt Lymphoma,0.7880542567584415
PDLIM7,African Burkitt's lymphoma,0.7880542567584415
PDLIM7,Mental disorders,0.7880542567584415
PDLIM7,Cancer of Nasopharynx,0.7880542567584415
PDLIM7,Oropharyngeal disorders,0.7880542567584415
PDLIM7,Malignant mesothelioma,0.7880542567584415
PDLIM7,Hodgkin Disease,0.7880542567584415
PDLIM7,Lymphocytosis,0.7880542567584415
PDLIM7,Severe Combined Immunodeficiency,0.7880542567584415
PDLIM7,Nasopharyngeal carcinoma,0.7880542567584415
PDLIM7,Tumor Progression,0.7880542567584415
PDLIM7,Persistent Polyclonal B-Cell Lymphocytosis,0.7880542567584415
PDLIM7,Lupus Erythematosus Systemic,0.7880542567584415
PDLIM7,Acquired Immunodeficiency Syndrome,0.7880542567584415
PDLIM7,Chemical Carcinogenesis,0.7880542567584415
PDLIM7,Primary Effusion Lymphoma,0.7880542567584415
PDLIM7,Familial dilated cardiomyopathy,0.7880542567584415
PDLIM7,Congenital chromosomal disease,0.7880542567584415
PDLIM7,AIDS related complex,0.7880542567584415
PDLIM7,Adenolymphoma,0.7880542567584415
PDLIM7,Stomach Carcinoma,0.7880542567584415
PDLIM7,Lymphoepithelial carcinoma,0.7880542567584415
PDLIM7,Autoimmune Diseases,0.7880542567584415
PDLIM7,Hepatitis C,0.7880542567584415
PDLIM7,Primary Cutaneous Follicle Center Lymphoma,0.7880542567584415
PDLIM7,Squamous cell carcinoma,0.7880542567584415
PDLIM7,Classical Hodgkin's Lymphoma,0.7880542567584415
PDLIM7,Rheumatoid Arthritis,0.7880542567584415
PDLIM7,Skin callus,0.7880542567584415
PDLIM7,AIDS-Related Non-Hodgkin Lymphoma,0.7880542567584415
PDLIM7,Gastritis Atrophic,0.7880542567584415
PDLIM7,Coinfection,0.7880542567584415
PDLIM7,Ankylosing spondylitis,0.7880542567584415
PDLIM7,Lyme Disease,0.7880542567584415
PDLIM7,Nevi and Melanomas,0.7880542567584415
PDLIM7,Lymphohistiocytosis Hemophagocytic,0.7880542567584415
PDLIM7,Central nervous system lymphoma,0.7880542567584415
PDLIM7,Intrahepatic Cholangiocarcinoma,0.7880542567584415
PDLIM7,Hyperkeratosis lenticularis perstans,0.7880542567584415
PDLIM7,Post-transplant lymphoproliferative disorder,0.7880542567584415
PDLIM7,Rheumatism,0.7880542567584415
PDLIM7,Virus Diseases,0.7880542567584415
PDLIM7,Gingivitis,0.7880542567584415
PDLIM7,Primary central nervous system lymphoma,0.7880542567584415
PDLIM7,Pulpitis,0.7880542567584415
PDLIM7,Melanoma Amelanotic,0.7908231553833205
PDLIM7,Nasal Type Extranodal NK/T-Cell Lymphoma,0.7908231553833205
PDLIM7,Undifferentiated carcinoma,0.8019075543217649
PDLIM7,Otitis Media with Effusion,0.8019075543217649
PDLIM7,Adult Hodgkin Lymphoma,0.8019075543217649
PDLIM7,Multiple Sclerosis,0.8019075543217649
PDLIM7,Chronic Lymphocytic Leukemia,0.8019075543217649
PDLIM7,Degenerative polyarthritis,0.8019075543217649
PDLIM7,Liver neoplasms,0.8019075543217649
PDLIM7,Lymphomatoid Papulosis,0.8019075543217649
PDLIM7,Precancerous Conditions,0.8026504676141903
PDLIM7,Pharyngeal Carcinoma,0.8067197998685076
PDLIM7,Herpes Simplex Infections,0.8098851543361193
PDLIM7,Lymphoma AIDS-Related,0.8138488881521341
PDLIM7,HIV Infections,0.8145035474981049
PDLIM7,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
PDLIM7,Collagen Diseases,0.8145035474981049
PDLIM7,Opportunistic Infections,0.8190761496232595
PDLIM7,Epstein-Barr Virus Infections,0.8232134984476662
PDLIM7,MIXED LINEAGE LEUKEMIA,0.8232134984476662
PDLIM7,Aggressive Non-Hodgkin Lymphoma,0.8272008757995397
PDLIM7,Immunoblastic Large-Cell Lymphoma,0.8272008757995397
PDLIM7,Infectious Mononucleosis,0.834094492023826
PDLIM7,Recurrent tumor,0.8368219249856942
PDLIM7,Papilloma,0.8402911822757345
PDLIM7,Nodular Sclerosis Classical Hodgkin Lymphoma,0.8402911822757345
PDLIM7,Intervertebral Disc Degeneration,0.841396342333011
PDLIM7,Lymphoproliferative Disorders,0.8508164886128737
PDLIM7,Angioimmunoblastic Lymphadenopathy,0.8578473133580928
PDLIM7,Squamous cell carcinoma of esophagus,0.8610447277138289
PDLIM7,Hantavirus Infections,0.8648405521677974
PDLIM7,Peripheral T-Cell Lymphoma,0.876210765330195
PDLIM7,Dermatitis Atopic,0.8867509400747969
PDLIM7,Hyperactive behavior,0.8878860377518915
PDLIM7,Arthritis Psoriatic,0.8946938397586319
PDLIM7,Secondary malignant neoplasm of lymph node,0.900167961295542
PDLIM7,Niemann-Pick Disease Type C,0.9024758035783405
PDLIM7,Eczema,0.909484944705772
PDLIM7,Intraepithelial Neoplasia,0.9262273158806068
PDLIM7,Myasthenia Gravis,0.9390727893210336
PDLIM7,Graves Disease,0.94939825643792
PDLIM7,Tumor Angiogenesis,0.9656926709728724
PDLIM7,Breast Cancer,0.8903630091389316
PDLIM7,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
PDLIM7,Crisponi syndrome ORPHA:1545,0.0155394890951578
PDLIM7,CLN11 disease ORPHA:314629,0.1040670578681756
PDLIM7,Adrenomyeloneuropathy ORPHA:139399,0.1991445465001551
PDLIM7,Classic Hodgkin lymphoma nodular sclerosis type ORPHA:98843,0.1991445465001551
PDLIM7,Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851,0.1991445465001551
PDLIM7,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900,0.1991445465001551
PDLIM7,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.1991445465001551
PDLIM7,Musculocontractural Ehlers-Danlos syndrome ORPHA:2953,0.1991445465001551
PDLIM7,Hemochromatosis type 5 ORPHA:447792,0.3832844616405875
PDLIM7,Cap myopathy ORPHA:171881,0.3832844616405875
PDLIM7,Congenital short bowel syndrome ORPHA:2301,0.3832844616405875
PDLIM7,Autosomal dominant omodysplasia ORPHA:93328,0.5867963421058087
PDLIM7,Proximal symphalangism ORPHA:3250,0.5867963421058087
PDLIM7,Truncus arteriosus ORPHA:3384,0.5867963421058087
PDLIM7,Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.606625035400596
PDLIM7,Amish nemaline myopathy ORPHA:98902,0.7929682744768703
PDLIM7,Becker nevus syndrome ORPHA:64755,0.7929682744768703
PDLIM7,Developmental malformations-deafness-dystonia syndrome ORPHA:79107,0.7929682744768703
PDLIM7,FLNA-related X-linked myxomatous valvular dysplasia ORPHA:555877,0.7929682744768703
PDLIM7,Melnick-Needles syndrome ORPHA:2484,0.7929682744768703
PDLIM7,Neuronal intestinal pseudoobstruction ORPHA:99811,0.7929682744768703
PDLIM7,Otopalatodigital syndrome type 1 ORPHA:90650,0.7929682744768703
PDLIM7,Otopalatodigital syndrome type 2 ORPHA:90652,0.7929682744768703
PDLIM7,Terminal osseous dysplasia-pigmentary defects syndrome ORPHA:88630,0.7929682744768703
PDLIM7,X-linked Ehlers-Danlos syndrome ORPHA:75497,0.7929682744768703
PDLIM7,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome ORPHA:482606,0.7929682744768703
PDLIM7,X-linked Emery-Dreifuss muscular dystrophy ORPHA:98863,0.7929682744768703
PDLIM7,Deafness-lymphedema-leukemia syndrome ORPHA:3226,0.8922466888454011
PDLIM7,Glycogen storage disease due to muscle and heart glycogen synthase deficiency ORPHA:137625,0.8922466888454011
PDLIM7,Monocytopenia with susceptibility to infections ORPHA:228423,0.8922466888454011
PDLIM7,SLC39A13-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:157965,0.8922466888454011
PDLIM7,Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752,0.8922466888454011
PDLIM7,Human papillomavirus type 6 E5B (gene: E5B),0.8999095837312036
PDLIM7,Yaba monkey tumor virus 66R,0.8999095837312036
PDLIM7,Yaba-like disease virus 66R protein (gene: 66R),0.8999095837312036
PDLIM7,Yaba-like disease virus 147R protein (gene: 147R),0.8999095837312036
PDLIM7,Molluscum contagiosum virus subtype 1 MC034L (gene: MC034L),0.8999095837312036
PDLIM7,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.9057542447893764
PDLIM7,Ectromelia virus ERPV ankyrin,0.9057542447893764
PDLIM7,Horsepox virus HSPV005c (Ankyrin repeats),0.915880438522078
PDZK1IP1,Malignant neoplasm of breast,0.4084380369379369
PDZK1IP1,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
PDZK1IP1,Breast Carcinoma,0.7333611688795861
PDZK1IP1,Carcinogenesis,0.7333611688795861
PDZK1IP1,Ovarian Carcinoma,0.7333611688795861
PDZK1IP1,Adenoma,0.7765852775619541
PDZK1IP1,Mammary Neoplasms,0.7880542567584415
PDZK1IP1,Malignant neoplasm of prostate,0.7880542567584415
PDZK1IP1,Thyroid carcinoma,0.7880542567584415
PDZK1IP1,Dental caries,0.7880542567584415
PDZK1IP1,Prostatic Neoplasms,0.7880542567584415
PDZK1IP1,Malignant neoplasm of thyroid,0.7880542567584415
PDZK1IP1,Mesothelioma,0.7880542567584415
PDZK1IP1,Malignant Neoplasms,0.7880542567584415
PDZK1IP1,Hematologic Neoplasms,0.7880542567584415
PDZK1IP1,melanoma,0.7880542567584415
PDZK1IP1,Multiple Myeloma,0.7880542567584415
PDZK1IP1,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
PDZK1IP1,Tumor Progression,0.7880542567584415
PDZK1IP1,Uterine Cervical Neoplasm,0.7880542567584415
PDZK1IP1,Solid Neoplasm,0.7880542567584415
PDZK1IP1,Primary malignant neoplasm,0.7908231553833205
PDZK1IP1,Adenomatous polyp of colon,0.8019075543217649
PDZK1IP1,Precancerous Conditions,0.8026504676141903
PDZK1IP1,Ulcerative Colitis,0.8190761496232595
PDZK1IP1,Caries (morphologic abnormality),0.8648405521677974
PDZK1IP1,Dermatitis Atopic,0.8867509400747969
PDZK1IP1,Eczema,0.909484944705772
PDZK1IP1,Dermatologic disorders,0.9912501168001682
PDZK1IP1,Prostate Cancer,0.7765582368651238
PDZK1IP1,Prostatic Neoplasms,0.7765582368651238
PDZK1IP1,Bilateral frontoparietal polymicrogyria ORPHA:101070,0.1040670578681756
PDZK1IP1,Alkaptonuria ORPHA:56,0.1991445465001551
PDZK1IP1,46XY disorder of sex development due to 17-beta-hydroxysteroid dehydrogenase 3 deficiency ORPHA:752,0.3832844616405875
PDZK1IP1,Hemochromatosis type 4 ORPHA:139491,0.3832844616405875
PDZK1IP1,Autosomal recessive extra-oral halitosis ORPHA:562538,0.7929682744768703
PDZK1IP1,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857,0.7929682744768703
PDZK1IP1,Cranio-osteoarthropathy ORPHA:1525,0.7929682744768703
PDZK1IP1,Isolated congenital digital clubbing ORPHA:217059,0.7929682744768703
PDZK1IP1,Dominant hypophosphatemia with nephrolithiasis or osteoporosis ORPHA:244305,0.7929682744768703
PDZK1IP1,McLeod neuroacanthocytosis syndrome ORPHA:59306,0.8922466888454011
PGS1,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
PGS1,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
PGS1,Serum total cholesterol measurement,0.7880542567584415
PGS1,High density lipoprotein measurement,0.7880542567584415
PGS1,Leukemia,0.7765582368651238
PGS1,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
PGS1,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
PGS1,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
PGS1,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
PGS1,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.1040670578681756
PGS1,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.1040670578681756
PGS1,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.1040670578681756
PGS1,Combined oxidative phosphorylation defect type 27 ORPHA:477774,0.1991445465001551
PGS1,Polydactyly of a biphalangeal thumb ORPHA:93339,0.3832844616405875
PGS1,Primary intraosseous venous malformation ORPHA:140436,0.5867963421058087
PGS1,Ramon syndrome ORPHA:3019,0.5867963421058087
PHF14,Carcinogenesis,0.7333611688795861
PHF14,Cerebrovascular accident,0.8648405521677974
PHF14,Stroke,0.7765582368651238
PHF14,Alzheimer Disease,0.8457525389282121
PHF14,Asthma,0.9832345076528324
PHF14,Vocal cord and pharyngeal distal myopathy ORPHA:600,0.3832844616405875
PHF14,X-linked intellectual disability-short stature-overweight syndrome ORPHA:457240,0.5867963421058087
PHF14,Nijmegen breakage syndrome-like disorder ORPHA:240760,0.8922466888454011
PHF14,Human papillomavirus 122 transforming protein E7 (gene: E7),0.8999095837312036
PHF14,Human papillomavirus 111 E7 protein (gene: E7),0.8999095837312036
PIGB,Developmental Delay,0.7765582368651238
PIGB,Mental Retardation,0.8337953215113012
PIGB,Alacrimia-choreoathetosis-liver dysfunction syndrome ORPHA:404454,0.3832844616405875
PIGB,TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261,0.3832844616405875
PIGB,Squamous cell carcinoma of salivary glands ORPHA:500481,0.3832844616405875
PIGB,Squamous cell carcinoma of the hypopharynx ORPHA:494547,0.3832844616405875
PIGB,Squamous cell carcinoma of the larynx ORPHA:494550,0.3832844616405875
PIGB,Squamous cell carcinoma of the lip ORPHA:502366,0.3832844616405875
PIGB,Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464,0.3832844616405875
PIGB,Squamous cell carcinoma of the oral cavity ORPHA:502363,0.3832844616405875
PIGB,Squamous cell carcinoma of the oropharynx ORPHA:500478,0.3832844616405875
PIGB,Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517,0.5867963421058087
PIGB,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592,0.5867963421058087
PIGB,Lipoyl transferase 1 deficiency ORPHA:401862,0.5867963421058087
PIGB,Orofaciodigital syndrome type 5 ORPHA:2919,0.5867963421058087
PIGB,Familial cerebral cavernous malformation ORPHA:221061,0.5867963421058087
PIGB,Combined oxidative phosphorylation defect type 15 ORPHA:319524,0.7929682744768703
PIGB,Obesity due to CEP19 deficiency ORPHA:397615,0.7929682744768703
PIGB,Severe combined immunodeficiency due to DCLRE1C deficiency ORPHA:275,0.7929682744768703
PIGB,Prenatal-onset spinal muscular atrophy with congenital bone fractures ORPHA:486811,0.8922466888454011
PIGB,Severe intellectual disability and progressive spastic paraplegia ORPHA:280763,0.8922466888454011
PITPNM1,Malignant neoplasm of breast,0.4084380369379369
PITPNM1,Breast Carcinoma,0.7333611688795861
PITPNM1,Neoplasm Metastasis,0.7880542567584415
PITPNM1,Retinal Degeneration,0.7880542567584415
PITPNM1,Schizophrenia,0.8067197998685076
PITPNM1,Secondary malignant neoplasm of lung,0.8232134984476662
PITPNM1,Schizophrenia,0.7860378120955526
PITPNM1,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
PITPNM1,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
PITPNM1,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.1040670578681756
PITPNM1,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.1040670578681756
PITPNM1,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.1040670578681756
PITPNM1,Kufor-Rakeb syndrome ORPHA:306674,0.1040670578681756
PITPNM1,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.1040670578681756
PITPNM1,CLN4B disease ORPHA:228343,0.1991445465001551
PITPNM1,Leukonychia totalis ORPHA:2387,0.1991445465001551
PITPNM1,Cerebellar ataxia-hypogonadism syndrome ORPHA:1173,0.1991445465001551
PITPNM1,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.2386105733903937
PITPNM1,Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738,0.3832844616405875
PITPNM1,Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180,0.5867963421058087
PITPNM1,Autosomal recessive spastic paraplegia type 39 ORPHA:139480,0.5867963421058087
PITPNM1,Laurence-Moon syndrome ORPHA:2377,0.5867963421058087
PITPNM1,Neuralgic amyotrophy ORPHA:2901,0.5867963421058087
PITPNM1,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363,0.5867963421058087
PITPNM1,Autosomal dominant Charcot-Marie-Tooth disease type 2M ORPHA:228179,0.7929682744768703
PITPNM1,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B ORPHA:100044,0.7929682744768703
PITPNM1,Fetal akinesia-cerebral and retinal hemorrhage syndrome ORPHA:363409,0.7929682744768703
PITPNM1,Intellectual disability-craniofacial dysmorphism-cryptorchidism syndrome ORPHA:329224,0.8922466888454011
PLA2G10,Malignant neoplasm of breast,0.4084380369379369
PLA2G10,Adenomatous Polyposis Coli,0.5196624042573144
PLA2G10,Breast Carcinoma,0.7333611688795861
PLA2G10,Carcinogenesis,0.7333611688795861
PLA2G10,Adenocarcinoma,0.750391252594775
PLA2G10,Allergic bronchitis,0.7765852775619541
PLA2G10,Colorectal Carcinoma,0.7765852775619541
PLA2G10,Colon Carcinoma,0.7765852775619541
PLA2G10,androgen independent prostate cancer,0.7765852775619541
PLA2G10,Malignant tumor of colon,0.7765852775619541
PLA2G10,Non-Small Cell Lung Carcinoma,0.7765852775619541
PLA2G10,Adenoma,0.7765852775619541
PLA2G10,Cholangitis,0.7765852775619541
PLA2G10,Malignant neoplasm of lung,0.7880542567584415
PLA2G10,Malignant neoplasm of prostate,0.7880542567584415
PLA2G10,Liver carcinoma,0.7880542567584415
PLA2G10,Invasive carcinoma of breast,0.7880542567584415
PLA2G10,Cholelithiasis,0.7880542567584415
PLA2G10,Colorectal Cancer,0.7880542567584415
PLA2G10,Lymphopenia,0.7880542567584415
PLA2G10,Intestinal Polyposis,0.7880542567584415
PLA2G10,Prostate carcinoma,0.7880542567584415
PLA2G10,Astrocytoma,0.7880542567584415
PLA2G10,Primary malignant neoplasm of lung,0.7880542567584415
PLA2G10,Prostatic Neoplasms,0.7880542567584415
PLA2G10,Carcinoma of lung,0.7880542567584415
PLA2G10,Lung Neoplasms,0.7880542567584415
PLA2G10,Adenovirus Infections,0.7880542567584415
PLA2G10,Adenocarcinoma of colon,0.7880542567584415
PLA2G10,Coronary Arteriosclerosis,0.7880542567584415
PLA2G10,Arteriosclerosis,0.7880542567584415
PLA2G10,Atherosclerosis,0.7880542567584415
PLA2G10,Coprophilia (disorder),0.7880542567584415
PLA2G10,Cholecystolithiasis,0.7880542567584415
PLA2G10,Cardiovascular Diseases,0.7880542567584415
PLA2G10,Rheumatoid Arthritis,0.7880542567584415
PLA2G10,Crohn Disease,0.7880542567584415
PLA2G10,Childhood Astrocytoma,0.7880542567584415
PLA2G10,Myeloid Leukemia,0.7880542567584415
PLA2G10,Pleurisy,0.8019075543217649
PLA2G10,Psoriasis,0.8019075543217649
PLA2G10,Kidney Failure Chronic,0.8019075543217649
PLA2G10,Liver neoplasms,0.8019075543217649
PLA2G10,Tangier Disease,0.8067197998685076
PLA2G10,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
PLA2G10,polyps,0.8232134984476662
PLA2G10,Retinitis Pigmentosa,0.8402911822757345
PLA2G10,Endothelial dysfunction,0.8402911822757345
PLA2G10,Craniosynostosis,0.8486035047899471
PLA2G10,Chronic Obstructive Airway Disease,0.8648405521677974
PLA2G10,Coronary Artery Disease,0.887595340546704
PLA2G10,nervous system disorder,0.8959157818691486
PLA2G10,Bipolar Disorder,0.900167961295542
PLA2G10,Depressive disorder,0.9103315000053974
PLA2G10,Coronary heart disease,0.9119978323790848
PLA2G10,Arthritis,0.9431511078237256
PLA2G10,Aortic Aneurysm Abdominal,0.9578035687879456
PLA2G10,Nasal Polyps,0.9614320311453906
PLA2G10,Asthma,0.9672478180546946
PLA2G10,Chronic kidney disease stage 5,0.9694882155560866
PLA2G10,Colitis,0.9738491767258852
PLEKHM1,Ovarian Carcinoma,0.7333611688795861
PLEKHM1,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
PLEKHM1,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
PLEKHM1,Osteopetrosis,0.7765852775619541
PLEKHM1,Epithelial ovarian cancer,0.7880542567584415
PLEKHM1,Erlenmeyer flask deformity of the femurs,0.7880542567584415
PLEKHM1,Generalized osteopenia,0.8009048756462318
PLEKHM1,Ovarian Serous Adenocarcinoma,0.8402911822757345
PLEKHM1,Osteosclerosis,0.8402911822757345
PLEKHM1,Osteopetrosis,0.4532988396145482
PLEKHM1,Ovarian Neoplasm,0.7765582368651238
PLEKHM1,Ovarian Serous Adenocarcinoma,0.7765582368651238
PLEKHM1,Osteomyelitis,0.7765582368651238
PLEKHM1,Osteopenia,0.8115918568696846
PLEKHM1,Anodontia,0.829560580336605
PLEKHM1,Mental Depression,0.8903630091389316
PLEKHM1,Alopecia,0.9367173114041438
PLEKHM1,Anemia,0.9369188149054885
PLEKHM1,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
PLEKHM1,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
PLEKHM1,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
PLEKHM1,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
PLEKHM1,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
PLEKHM1,Birt-Hogg-Dube syndrome ORPHA:122,0.1991445465001551
PLEKHM1,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144,0.1991445465001551
PLEKHM1,Familial spontaneous pneumothorax ORPHA:2903,0.1991445465001551
PLEKHM1,Mucolipidosis type IV ORPHA:578,0.1991445465001551
PLEKHM1,NIK deficiency ORPHA:447731,0.1991445465001551
PLEKHM1,CLN3 disease ORPHA:228346,0.3832844616405875
PLEKHM1,Clear cell renal carcinoma ORPHA:319276,0.3832844616405875
PLEKHM1,Combined immunodeficiency-enteropathy spectrum ORPHA:436252,0.3832844616405875
PLEKHM1,Mucopolysaccharidosis type 4A ORPHA:309297,0.3832844616405875
PLEKHM1,Multiple intestinal atresia ORPHA:2300,0.3832844616405875
PLEKHM1,Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198,0.3832844616405875
PLEKHM1,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ORPHA:480864,0.3832844616405875
PLEKHM1,Desbuquois syndrome ORPHA:1425,0.3832844616405875
PLEKHM1,Hermansky-Pudlak syndrome with pulmonary fibrosis ORPHA:231500,0.3832844616405875
PLEKHM1,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499,0.5867963421058087
PLEKHM1,Combined immunodeficiency due to STIM1 deficiency ORPHA:317430,0.5867963421058087
PLEKHM1,Early-onset Lafora body disease ORPHA:324290,0.5867963421058087
PLEKHM1,Autosomal recessive progressive external ophthalmoplegia ORPHA:254886,0.5867963421058087
PLEKHM1,Nodular fasciitis ORPHA:477742,0.5867963421058087
PLEKHM1,Chronic mucocutaneous candidiasis ORPHA:1334,0.606625035400596
PLEKHM1,Autosomal recessive spastic paraplegia type 15 ORPHA:100996,0.7929682744768703
PLEKHM1,Oculocerebrofacial syndrome Kaufman type ORPHA:2707,0.8922466888454011
PLIN3,Cervix carcinoma,0.7765852775619541
PLIN3,Liver carcinoma,0.7880542567584415
PLIN3,Carcinoma of lung,0.7880542567584415
PLIN3,Hepatitis C,0.7880542567584415
PLIN3,Liver Cirrhosis Experimental,0.8014900279306119
PLIN3,Liver neoplasms,0.8019075543217649
PLIN3,Obesity,0.8989612563669234
PLIN3,Lung Carcinoma,0.8139950454942313
PLIN3,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
PLIN3,CLN11 disease ORPHA:314629,0.1040670578681756
PLIN3,Musculocontractural Ehlers-Danlos syndrome ORPHA:2953,0.1991445465001551
PLIN3,Quebec platelet disorder ORPHA:220436,0.3832844616405875
PLIN3,Cap myopathy ORPHA:171881,0.3832844616405875
PLIN3,Rare isolated myopia ORPHA:98619,0.3832844616405875
PLIN3,Niemann-Pick disease type C adult neurologic onset ORPHA:216986,0.5867963421058087
PLIN3,Niemann-Pick disease type C juvenile neurologic onset ORPHA:216981,0.5867963421058087
PLIN3,Niemann-Pick disease type C late infantile neurologic onset ORPHA:216978,0.5867963421058087
PLIN3,Niemann-Pick disease type C severe early infantile neurologic onset ORPHA:216975,0.5867963421058087
PLIN3,Niemann-Pick disease type C severe perinatal form ORPHA:216972,0.5867963421058087
PLIN3,Proximal symphalangism ORPHA:3250,0.5867963421058087
PLIN3,Ethylmalonic encephalopathy ORPHA:51188,0.7929682744768703
PLIN3,Martinique crinkled retinal pigment epitheliopathy ORPHA:466718,0.8922466888454011
PLIN3,Spondylometaphyseal dysplasia-cone-rod dystrophy syndrome ORPHA:85167,0.8922466888454011
PLIN3,Familial porphyria cutanea tarda ORPHA:443062,0.8922466888454011
PLK4,Malignant neoplasm of breast,0.4084380369379369
PLK4,Breast Carcinoma,0.7333611688795861
PLK4,leukemia,0.7333611688795861
PLK4,Colorectal Carcinoma,0.7765852775619541
PLK4,Colon Carcinoma,0.7765852775619541
PLK4,Cortical gyral simplification,0.7765852775619541
PLK4,MYELODYSPLASTIC SYNDROME,0.7765852775619541
PLK4,Retinal pigment epithelial abnormality,0.7765852775619541
PLK4,Abnormality of retinal pigmentation,0.7765852775619541
PLK4,Malignant tumor of colon,0.7765852775619541
PLK4,Lymphoma,0.7765852775619541
PLK4,Malignant neoplasm of prostate,0.7880542567584415
PLK4,Liver carcinoma,0.7880542567584415
PLK4,Rhabdoid Tumor,0.7880542567584415
PLK4,Colorectal Cancer,0.7880542567584415
PLK4,Hepatocarcinogenesis,0.7880542567584415
PLK4,Prostate carcinoma,0.7880542567584415
PLK4,Embryonal Neoplasm,0.7880542567584415
PLK4,Neoplasm Metastasis,0.7880542567584415
PLK4,Biparietal narrowing,0.7880542567584415
PLK4,Decreased width of the skull,0.7880542567584415
PLK4,Muscle Hypertonia,0.7880542567584415
PLK4,Sloping forehead,0.7880542567584415
PLK4,Malignant Neoplasms,0.7880542567584415
PLK4,Hematologic Neoplasms,0.7880542567584415
PLK4,Abnormality of the eyelashes,0.7880542567584415
PLK4,Sparse scalp hair,0.7880542567584415
PLK4,Microlissencephaly,0.7880542567584415
PLK4,Eye Diseases Hereditary,0.7880542567584415
PLK4,Aplasia/Hypoplasia of the cerebellum,0.7880542567584415
PLK4,Low Vision,0.7880542567584415
PLK4,Supratentorial atrophy,0.7880542567584415
PLK4,Seckel syndrome,0.7880542567584415
PLK4,Tumor Progression,0.7880542567584415
PLK4,Decreased corneal diameter,0.7880542567584415
PLK4,Microcornea,0.7880542567584415
PLK4,Acute lymphocytic leukemia,0.7880542567584415
PLK4,Nystagmus,0.7880542567584415
PLK4,Protruding ear,0.7880542567584415
PLK4,Anteverted nostril,0.7880542567584415
PLK4,Prominent ear,0.7880542567584415
PLK4,Cognitive delay,0.7880542567584415
PLK4,Glaucoma,0.7880542567584415
PLK4,Absent earlobe,0.7880542567584415
PLK4,Visual Impairment,0.7880542567584415
PLK4,Malformations of Cortical Development Group II,0.7880542567584415
PLK4,Degenerative brain disorder,0.7880542567584415
PLK4,Congenital absence of germinal epithelium of testes,0.7880542567584415
PLK4,Pointed chin,0.7880542567584415
PLK4,Global developmental delay,0.7880542567584415
PLK4,Optic Atrophy,0.7880542567584415
PLK4,Mental and motor retardation,0.7880542567584415
PLK4,Primary malignant neoplasm,0.7908231553833205
PLK4,PITUITARY DWARFISM I,0.8009048756462318
PLK4,Mild global developmental delay,0.8019075543217649
PLK4,Psychomotor retardation mild,0.8019075543217649
PLK4,Cerebral atrophy,0.8019075543217649
PLK4,Curvature of little finger,0.8019075543217649
PLK4,Clinodactyly of the 5th finger,0.8019075543217649
PLK4,Prematurely aged appearance,0.8019075543217649
PLK4,Primary microcephaly,0.8067197998685076
PLK4,Abnormality of the skull,0.8098851543361193
PLK4,Costello syndrome (disorder),0.8145035474981049
PLK4,Downward slant of palpebral fissure,0.8168901801930506
PLK4,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
PLK4,Reduced number of teeth,0.8190761496232595
PLK4,Impaired cognition,0.8190761496232595
PLK4,Severe Congenital Microcephaly,0.8212681436603975
PLK4,Broad flat nasal bridge,0.8213459222602666
PLK4,Nasal bridge wide,0.8232134984476662
PLK4,Microcephaly,0.8232134984476662
PLK4,Sandal gap,0.8232134984476662
PLK4,Tooth agenesis,0.8232134984476662
PLK4,Cone-shaped epiphysis,0.8272008757995397
PLK4,Abnormally small eyeball,0.8402911822757345
PLK4,Decreased size of eyeball,0.8402911822757345
PLK4,Strabismus,0.8402911822757345
PLK4,Curvature of spine,0.8402911822757345
PLK4,Defective tooth enamel,0.8402911822757345
PLK4,Dystrophic tooth enamel,0.8402911822757345
PLK4,Mental deficiency,0.8402911822757345
PLK4,Cachexia,0.8402911822757345
PLK4,Acquired scoliosis,0.8402911822757345
PLK4,Abnormality of dental enamel,0.8402911822757345
PLK4,Craniosynostosis,0.8486035047899471
PLK4,Convex nasal ridge,0.8578473133580928
PLK4,Retrusion of lower jaw,0.8648405521677974
PLK4,Decreased projection of lower jaw,0.8648405521677974
PLK4,Decreased projection of mandible,0.8648405521677974
PLK4,Hypoplastic mandible condyle,0.8648405521677974
PLK4,Azoospermia,0.8648405521677974
PLK4,Aplasia/Hypoplasia of the mandible,0.8648405521677974
PLK4,Micrognathism,0.8648405521677974
PLK4,Dull intelligence,0.8757755363384367
PLK4,Low intelligence,0.8757755363384367
PLK4,Mental impairment,0.876210765330195
PLK4,Cataract,0.8769418330148872
PLK4,Delayed bone age,0.8769418330148872
PLK4,Thin face,0.8769418330148872
PLK4,Narrow face,0.8769418330148872
PLK4,Cerebellar atrophy,0.8815127642200768
PLK4,Short stature,0.8815127642200768
PLK4,Cerebellar degeneration,0.8838621755797691
PLK4,Poor school performance,0.8913141512402477
PLK4,Infant Small for Gestational Age,0.9083161862856644
PLK4,Dwarfism,0.9098977259629772
PLK4,Intrauterine retardation,0.9111864999692114
PLK4,Lens Opacities,0.9117936912777788
PLK4,Hip Dislocation Congenital,0.914995991166204
PLK4,Microphthalmos,0.9154499654632742
PLK4,Mental Retardation,0.922229272318747
PLK4,Infratentorial atrophy,0.9265708351135048
PLK4,Fetal Growth Retardation,0.9307095582633488
PLK4,Joint hyperflexibility,0.9473064300361868
PLK4,Intellectual Disability,0.9478210444156088
PLK4,Seizures,0.9478210444156088
PLK4,Epilepsy,0.963331724428282
PLK4,Small head,0.9822381479823692
PLK4,Microcephaly With Chorioretinopathy,0.4532988396145482
PLK4,Microlissencephaly,0.7765582368651238
PLK4,Eye Diseases,0.7765582368651238
PLK4,Nystagmus,0.7765582368651238
PLK4,Developmental Delay,0.7765582368651238
PLK4,Microcornea,0.7765582368651238
PLK4,Optic Atrophy,0.8115918568696846
PLK4,Congenital Microcephaly,0.8115918568696846
PLK4,Malformation Of Cortical Development,0.8115918568696846
PLK4,Seckel Syndrome,0.8115918568696846
PLK4,Craniosynostosis,0.8115918568696846
PLK4,Cerebellar Atrophy,0.8337953215113012
PLK4,Mental Retardation,0.8337953215113012
PLK4,Cerebral Atrophy,0.8339308890552987
PLK4,Cerebral Cortical Atrophy,0.861756360478846
PLK4,Microcephaly,0.8903630091389316
PLK4,Glaucoma,0.8903630091389316
PLK4,Strabismus,0.8908485337686392
PLK4,Impaired Cognition,0.9231137872214272
PLK4,Scoliosis,0.924275664330454
PLK4,Micrognathism,0.9398381935810408
PLK4,Microphthalmos,0.941216656523771
PLK4,Camptodactyly Of Fingers,0.943322675973118
PLK4,Dwarfism,0.9510372690456612
PLK4,Cataract,0.974502015052702
PLK4,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
PLK4,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
PLK4,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
PLK4,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
PLK4,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
PLK4,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
PLK4,Filippi syndrome ORPHA:3255,0.0155394890951578
PLK4,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
PLK4,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
PLK4,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
PLK4,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
PLK4,Stromme syndrome ORPHA:506307,0.0155394890951578
PLK4,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
PLK4,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
PLK4,Lethal fetal cerebrorenogenitourinary agenesis/hypoplasia syndrome ORPHA:439897,0.0414176838632111
PLK4,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
PLK4,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
PLK4,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
PLK4,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
PLK4,Small cell lung cancer ORPHA:70573,0.0429491792829903
PLK4,Chronic atrial and intestinal dysrhythmia syndrome ORPHA:435988,0.1040670578681756
PLK4,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.1040670578681756
PLK4,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.1040670578681756
PLK4,Dedifferentiated liposarcoma ORPHA:99970,0.1068643725150898
PLK4,Well-differentiated liposarcoma ORPHA:99971,0.1068643725150898
PLK4,46XX gonadal dysgenesis ORPHA:243,0.1419890644363008
PLK4,46XY complete gonadal dysgenesis ORPHA:242,0.1479888965090844
PLK4,Combined immunodeficiency due to partial RAG1 deficiency ORPHA:231154,0.1991445465001551
PLK4,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.1991445465001551
PLK4,Jawad syndrome ORPHA:313795,0.1991445465001551
PLK4,Linear nevus sebaceus syndrome ORPHA:2612,0.2047219337649946
PLK4,Familial prostate cancer ORPHA:1331,0.2844858212863536
PLK4,Palatal anomalies-widely spaced teeth-facial dysmorphism-developmental delay syndrome ORPHA:477993,0.3832844616405875
PLK4,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430,0.3832844616405875
PLK4,Nephroblastoma ORPHA:654,0.4491081214880772
PLK4,1q44 microdeletion syndrome ORPHA:238769,0.5867963421058087
PLK4,Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026,0.5867963421058087
PLK4,Chudley-McCullough syndrome ORPHA:314597,0.5867963421058087
PLK4,Primary peritoneal carcinoma ORPHA:168829,0.5867963421058087
PLK4,NON RARE IN EUROPE: Lactase non-persistence in adulthood ORPHA:319681,0.5867963421058087
PLK4,Autosomal recessive chorioretinopathy-microcephaly syndrome ORPHA:2518,0.5867963421058087
PLK4,Muir-Torre syndrome ORPHA:587,0.5867963421058087
PLK4,Osteosarcoma ORPHA:668,0.5867963421058087
PLK4,Familial pancreatic carcinoma ORPHA:1333,0.6599133692748571
PLK4,Fanconi anemia ORPHA:84,0.7593059616185558
PLK4,Combined immunodeficiency with granulomatosis ORPHA:157949,0.7929682744768703
PLK4,Severe combined immunodeficiency due to complete RAG1/2 deficiency ORPHA:331206,0.7929682744768703
PLK4,Bloom syndrome ORPHA:125,0.7929682744768703
PLK4,DNA2-related mitochondrial DNA deletion syndrome ORPHA:352470,0.7929682744768703
PLK4,Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations ORPHA:319462,0.7929682744768703
PLK4,Spinocerebellar ataxia with axonal neuropathy type 1 ORPHA:94124,0.7929682744768703
PLK4,VACTERL with hydrocephalus ORPHA:3412,0.7929682744768703
PLK4,RAS-associated autoimmune leukoproliferative disease ORPHA:268114,0.7929682744768703
PLK4,ICF syndrome ORPHA:2268,0.795266832401002
PLK4,Seckel syndrome ORPHA:808,0.8211968342881582
PLK4,Hereditary breast cancer ORPHA:227535,0.8329982337461243
PLK4,Autosomal recessive primary microcephaly ORPHA:2512,0.8922466888454011
PLK4,Hereditary site-specific ovarian cancer syndrome ORPHA:213524,0.8922466888454011
PLK4,Autosomal dominant cerebellar ataxia-deafness-narcolepsy syndrome ORPHA:314404,0.8922466888454011
PLK4,Hereditary sensory neuropathy-deafness-dementia syndrome ORPHA:456318,0.8922466888454011
PLK4,Microcephaly-complex motor and sensory axonal neuropathy syndrome ORPHA:423894,0.8922466888454011
PLK4,Acute myeloblastic leukemia without maturation ORPHA:98833,0.8922466888454011
PLK4,Constitutional mismatch repair deficiency syndrome ORPHA:252202,0.8922466888454011
PLK4,Weaver syndrome ORPHA:3447,0.8922466888454011
PLK4,Hypothyroidism due to deficient transcription factors involved in pituitary development or function ORPHA:226307,0.8922466888454011
PLK4,Hereditary breast and ovarian cancer syndrome ORPHA:145,0.8922466888454011
PLK4,Borjeson-Forssman-Lehmann syndrome ORPHA:127,0.8922466888454011
PLK4,X-linked intellectual disability Van Esch type ORPHA:163976,0.8922466888454011
PLK4,X-linked reticulate pigmentary disorder ORPHA:85453,0.8922466888454011
PLK4,Xeroderma pigmentosum-Cockayne syndrome complex ORPHA:220295,0.8922466888454011
PLK4,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
PLK4,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
PLK4,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
PLK4,Human gammaherpesvirus 8 ORF72,0.8999095837312036
PLK4,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
PLK4,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
PLK4,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
PLK4,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
PLK4,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
PLK4,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
PLK4,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
PLK4,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
PLK4,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
PLK4,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
PLK4,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
PLK4,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
PLK4,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
PLK4,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
PLK4,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
PLK4,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
PLK4,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
PLK4,Horsepox virus HSPV011a,0.8999095837312036
PLK4,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.8999095837312036
PLK4,Monkeypox virus ankyrin-like protein,0.8999095837312036
PLK4,Horsepox virus HSPV033c (ankyrin repeats),0.8999095837312036
PLK4,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
PLK4,Horsepox virus HSPV201a (ankyrin repeats),0.8999095837312036
PLK4,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9058994261255549
PNMA1,Encephalomyelitis,0.8019075543217649
PNMA1,CNS disorder,0.8168901801930506
PNMA1,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
PNMA1,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
PNMA1,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.1040670578681756
PNMA1,Mazabraud syndrome ORPHA:57782,0.5867963421058087
PNMA1,McCune-Albright syndrome ORPHA:562,0.5867963421058087
PNMA1,Monostotic fibrous dysplasia ORPHA:93277,0.5867963421058087
PNMA1,Polyostotic fibrous dysplasia ORPHA:93276,0.5867963421058087
PNMA1,Progressive osseous heteroplasia ORPHA:2762,0.5867963421058087
PNMA1,Pseudohypoparathyroidism type 1A ORPHA:79443,0.5867963421058087
PNMA1,Pseudohypoparathyroidism type 1C ORPHA:79444,0.5867963421058087
PNMA1,Pseudopseudohypoparathyroidism ORPHA:79445,0.5867963421058087
PNMA1,Global developmental delay-neuro-ophthalmological abnormalities-seizures-intellectual disability syndrome ORPHA:488613,0.7929682744768703
PNMA1,Lissencephaly due to TUBA1A mutation ORPHA:171680,0.8922466888454011
PNMA1,FRAXF syndrome ORPHA:100974,0.8922466888454011
PNPT1,Malignant neoplasm of pancreas,0.7688485284765829
PNPT1,Mitochondrial Respiratory Chain Deficiencies,0.7765852775619541
PNPT1,Pancreatic carcinoma,0.7765852775619541
PNPT1,Liver carcinoma,0.7880542567584415
PNPT1,Choreoathetoid movements,0.7880542567584415
PNPT1,Nonverbal,0.7880542567584415
PNPT1,Dyskinetic syndrome,0.7880542567584415
PNPT1,Absent speech,0.7880542567584415
PNPT1,Neuroblastoma,0.7880542567584415
PNPT1,Decreased nerve conduction velocity,0.7880542567584415
PNPT1,Central neuroblastoma,0.7880542567584415
PNPT1,Choreoathetosis,0.7880542567584415
PNPT1,melanoma,0.7880542567584415
PNPT1,Myxoid cyst,0.7880542567584415
PNPT1,Adenocarcinoma of colon,0.7880542567584415
PNPT1,Adenocarcinoma of prostate,0.7880542567584415
PNPT1,Congenital deafness,0.8019075543217649
PNPT1,Hearing Loss Partial,0.8098851543361193
PNPT1,Deafness,0.8190761496232595
PNPT1,hearing impairment,0.834094492023826
PNPT1,Nonsyndromic Deafness,0.8368219249856942
PNPT1,Decreased tendon reflex,0.8391186563955684
PNPT1,Dystonia,0.8402911822757345
PNPT1,Dystonic disease,0.8402911822757345
PNPT1,Leigh Disease,0.8402911822757345
PNPT1,Growth retardation,0.8610447277138289
PNPT1,Poor growth,0.8610447277138289
PNPT1,Growth delay,0.8610447277138289
PNPT1,Severe muscular hypotonia,0.8642802827048847
PNPT1,Very poor growth,0.8648405521677974
PNPT1,Chronic Obstructive Airway Disease,0.8648405521677974
PNPT1,Mitochondrial Diseases,0.8989612563669234
PNPT1,Growth failure,0.9066109052713736
PNPT1,Muscle degeneration,0.9450328871666054
PNPT1,Intellectual Disability,0.9478210444156088
PNPT1,Skeletal muscle atrophy,0.9902977519938704
PNPT1,Neurogenic muscle atrophy especially in the lower limbs,0.9902977519938704
PNPT1,Neurogenic Muscular Atrophy,0.992026975660552
PNPT1,Orofacial Dyskinesia,0.7765582368651238
PNPT1,Dyskinetic Syndrome,0.7765582368651238
PNPT1,Liver Carcinoma,0.7765582368651238
PNPT1,Nystagmus,0.7765582368651238
PNPT1,Combined Oxidative Phosphorylation Deficiency,0.7765582368651238
PNPT1,Developmental Delay,0.7765582368651238
PNPT1,Choreoathetosis,0.7765582368651238
PNPT1,Non-Syndromic Sensorineural Deafness,0.8115918568696846
PNPT1,Leukodystrophy,0.8115918568696846
PNPT1,Hearing Loss,0.8115918568696846
PNPT1,Encephalopathy,0.8210988731657684
PNPT1,Mental Retardation,0.8337953215113012
PNPT1,Hip Contracture,0.8457525389282121
PNPT1,Deafness,0.8457525389282121
PNPT1,Sensory Neuropathy,0.8879896755141929
PNPT1,Hypothyroidism,0.8879896755141929
PNPT1,Cataract,0.974502015052702
PNPT1,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.5867963421058087
PNPT1,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome ORPHA:254343,0.8922466888454011
PNPT1,Combined oxidative phosphorylation defect type 13 ORPHA:319514,0.8922466888454011
PNPT1,Hepatoencephalopathy due to combined oxidative phosphorylation defect type 1 ORPHA:137681,0.8922466888454011
PNPT1,QRSL1-related combined oxidative phosphorylation defect ORPHA:570491,0.8922466888454011
PPFIA3,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
PPFIA3,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
PPFIA3,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
PPFIA3,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
PPFIA3,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
PPFIA3,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
PPFIA3,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
PPFIA3,Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253,0.1040670578681756
PPFIA3,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.1040670578681756
PPFIA3,MASA syndrome ORPHA:2466,0.1040670578681756
PPFIA3,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.1040670578681756
PPFIA3,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.1040670578681756
PPFIA3,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.1068643725150898
PPFIA3,Bilateral generalized polymicrogyria ORPHA:208447,0.1991445465001551
PPFIA3,Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215,0.1991445465001551
PPFIA3,Hereditary sensory and autonomic neuropathy type 8 ORPHA:478664,0.1991445465001551
PPFIA3,Familial infantile myoclonic epilepsy ORPHA:352582,0.1991445465001551
PPFIA3,Spastic paraplegia-optic atrophy-neuropathy syndrome ORPHA:320406,0.1991445465001551
PPFIA3,Familial congenital mirror movements ORPHA:238722,0.2120485863056726
PPFIA3,Dyschromatosis universalis hereditaria ORPHA:241,0.3832844616405875
PPFIA3,Familial pseudohyperkalemia ORPHA:90044,0.3832844616405875
PPFIA3,Interstitial lung disease due to ABCA3 deficiency ORPHA:440402,0.3832844616405875
PPFIA3,Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403,0.3832844616405875
PPFIA3,Spinocerebellar ataxia type 5 ORPHA:98766,0.3832844616405875
PPFIA3,Coloboma of choroid and retina ORPHA:98942,0.3977968344535308
PPFIA3,Coloboma of iris ORPHA:98944,0.3977968344535308
PPFIA3,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency ORPHA:276580,0.5867963421058087
PPFIA3,Autosomal recessive dopa-responsive dystonia ORPHA:101150,0.5867963421058087
PPFIA3,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency ORPHA:79644,0.5867963421058087
PPFIA3,Autosomal recessive spastic paraplegia type 26 ORPHA:101006,0.5867963421058087
PPFIA3,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency ORPHA:276603,0.5867963421058087
PPFIA3,Familial gastric type 1 neuroendocrine tumor ORPHA:464756,0.5867963421058087
PPFIA3,Intermediate DEND syndrome ORPHA:99989,0.5867963421058087
PPFIA3,Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540,0.5867963421058087
PPFIA3,Autosomal dominant otospondylomegaepiphyseal dysplasia ORPHA:166100,0.5867963421058087
PPFIA3,Isolated split hand-split foot malformation ORPHA:2440,0.606625035400596
PPFIA3,Hemolytic anemia due to glucophosphate isomerase deficiency ORPHA:712,0.8922466888454011
PPFIA3,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
PPIF,Malignant neoplasm of breast,0.4084380369379369
PPIF,Breast Carcinoma,0.7333611688795861
PPIF,Malignant neoplasm of pancreas,0.7688485284765829
PPIF,Pancreatic carcinoma,0.7765852775619541
PPIF,Mammary Neoplasms,0.7880542567584415
PPIF,Glioma,0.7880542567584415
PPIF,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
PPIF,Malignant neoplasm of liver,0.7880542567584415
PPIF,Familial dilated cardiomyopathy,0.7880542567584415
PPIF,Alzheimer's Disease,0.7880542567584415
PPIF,Cardiovascular Diseases,0.7880542567584415
PPIF,Mitochondrial Myopathies,0.7880542567584415
PPIF,Diabetes,0.7880542567584415
PPIF,Diabetes Mellitus,0.7880542567584415
PPIF,Hyperglycemia,0.7880542567584415
PPIF,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
PPIF,Ulcer,0.7880542567584415
PPIF,Impaired cognition,0.8190761496232595
PPIF,Intestinal Diseases,0.8190761496232595
PPIF,Neurodegenerative Disorders,0.8272008757995397
PPIF,Tuberculosis,0.8368219249856942
PPIF,Amyotrophic Lateral Sclerosis,0.8402911822757345
PPIF,Glaucoma Primary Open Angle,0.8402911822757345
PPIF,Adrenoleukodystrophy,0.8402911822757345
PPIF,Amyloidosis,0.8672189956534445
PPIF,Parkinson Disease,0.8772392350816924
PPIF,Muscular Dystrophy Duchenne,0.8815127642200768
PPIF,Muscle degeneration,0.9450328871666054
PPIF,Muscular Dystrophy,0.9540608878641196
PPIF,Myopathy,0.9557184806547836
PPIF,Intestinal Diseases,0.7765582368651238
PPIF,Purine nucleoside phosphorylase deficiency ORPHA:760,0.7929682744768703
PPIF,Tyrosinemia type 1 ORPHA:882,0.7929682744768703
PPIF,Fabry disease ORPHA:324,0.8922466888454011
PPIF,Human immunodeficiency virus 1 capsid (gene: gag),0.8999095837312036
PPIF,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
PPIF,Human immunodeficiency virus 1 Gag-Pol (gene: gag-pol),0.8999095837312036
PPIF,Human immunodeficiency virus 1 Pr55(Gag) (gene: gag),0.8999095837312036
PPIF,Human immunodeficiency virus gag protein (gene: gag),0.8999095837312036
PPIF,Human immunodeficiency virus 2 full_polyprotein 1..521 (gene: gag-pol),0.8999095837312036
PPP1R13L,Malignant neoplasm of breast,0.4084380369379369
PPP1R13L,Breast Carcinoma,0.7333611688795861
PPP1R13L,Carcinogenesis,0.7333611688795861
PPP1R13L,Malignant neoplasm of ovary,0.7333611688795861
PPP1R13L,leukemia,0.7333611688795861
PPP1R13L,Ovarian Carcinoma,0.7333611688795861
PPP1R13L,Colon Carcinoma,0.7765852775619541
PPP1R13L,Leukemia Myelocytic Acute,0.7765852775619541
PPP1R13L,Malignant tumor of colon,0.7765852775619541
PPP1R13L,Leukemogenesis,0.7765852775619541
PPP1R13L,Cervix carcinoma,0.7765852775619541
PPP1R13L,Non-Small Cell Lung Carcinoma,0.7765852775619541
PPP1R13L,Adenoma,0.7765852775619541
PPP1R13L,Thyroid Neoplasm,0.7765852775619541
PPP1R13L,Malignant tumor of cervix,0.7768809924982332
PPP1R13L,Glioma,0.7880542567584415
PPP1R13L,Malignant neoplasm of lung,0.7880542567584415
PPP1R13L,Malignant neoplasm of prostate,0.7880542567584415
PPP1R13L,Liver carcinoma,0.7880542567584415
PPP1R13L,Thyroid carcinoma,0.7880542567584415
PPP1R13L,Glioblastoma,0.7880542567584415
PPP1R13L,Prostate carcinoma,0.7880542567584415
PPP1R13L,Astrocytoma,0.7880542567584415
PPP1R13L,Primary malignant neoplasm of lung,0.7880542567584415
PPP1R13L,cervical cancer,0.7880542567584415
PPP1R13L,Neoplasm Metastasis,0.7880542567584415
PPP1R13L,Malignant neoplasm of testis,0.7880542567584415
PPP1R13L,Carcinoma of lung,0.7880542567584415
PPP1R13L,Malignant neoplasm of thyroid,0.7880542567584415
PPP1R13L,Malignant Neoplasms,0.7880542567584415
PPP1R13L,melanoma,0.7880542567584415
PPP1R13L,Multiple Myeloma,0.7880542567584415
PPP1R13L,Neoplasms,0.7880542567584415
PPP1R13L,Melanocytic nevus,0.7880542567584415
PPP1R13L,Epithelial tumor of ovary,0.7880542567584415
PPP1R13L,Malignant Testicular Germ Cell Tumor,0.7880542567584415
PPP1R13L,Tumor Progression,0.7880542567584415
PPP1R13L,Aneurysm Ruptured,0.7880542567584415
PPP1R13L,Acute leukemia,0.7880542567584415
PPP1R13L,Acute lymphocytic leukemia,0.7880542567584415
PPP1R13L,Virus Diseases,0.7880542567584415
PPP1R13L,Primary malignant neoplasm,0.7908231553833205
PPP1R13L,Experimental Organism Basal Cell Carcinoma,0.8009048756462318
PPP1R13L,Hairy Cell Leukemia,0.8019075543217649
PPP1R13L,Melanocytic nevus of skin,0.8019075543217649
PPP1R13L,Chronic Lymphocytic Leukemia,0.8019075543217649
PPP1R13L,Hereditary hemochromatosis,0.8138488881521341
PPP1R13L,Liver Cirrhosis,0.8232134984476662
PPP1R13L,Glioblastoma Multiforme,0.8342163953428735
PPP1R13L,Arrhythmogenic Right Ventricular Dysplasia,0.8402911822757345
PPP1R13L,Hepatitis B,0.841396342333011
PPP1R13L,Cirrhosis,0.8554819098734854
PPP1R13L,Rectal Carcinoma,0.8584283190330553
PPP1R13L,Childhood Leukemia,0.8610447277138289
PPP1R13L,Cerebral Aneurysm,0.8642802827048847
PPP1R13L,Medullary carcinoma of thyroid,0.8757755363384367
PPP1R13L,Papillary thyroid carcinoma,0.8757755363384367
PPP1R13L,Adenocarcinoma Clear Cell,0.946564927793026
PPP1R13L,Cardiomyopathies,0.9557184806547836
PPP1R13L,Leukemia,0.7765582368651238
PPP1R13L,LEOPARD Syndrome,0.8115918568696846
PPP1R13L,Cardiomyopathy,0.9145387439550552
PPP1R13L,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
PPP1R13L,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
PPP1R13L,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
PPP1R13L,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
PPP1R13L,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.1991445465001551
PPP1R13L,Cleft lip/palate ORPHA:199306,0.2567797333165013
PPP1R13L,Cleft lip and alveolus ORPHA:141291,0.3891940933600213
PPP1R13L,Isolated cleft lip ORPHA:199302,0.3891940933600213
PPP1R13L,Localized junctional epidermolysis bullosa ORPHA:251393,0.5867963421058087
PPP1R13L,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.5867963421058087
PPP1R13L,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034,0.5867963421058087
PPP1R13L,Sebocystomatosis ORPHA:841,0.5867963421058087
PPP1R13L,Tricho-dento-osseous syndrome ORPHA:3352,0.5867963421058087
PPP1R13L,Self-improving collodion baby ORPHA:281122,0.7929682744768703
PPP1R13L,Acral self-healing collodion baby ORPHA:281127,0.7929682744768703
PPP1R13L,Bathing suit ichthyosis ORPHA:100976,0.7929682744768703
PPP1R13L,MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949,0.7929682744768703
PPP1R13L,Monilethrix ORPHA:573,0.8922466888454011
PPP1R13L,Progressive symmetric erythrokeratodermia ORPHA:316,0.8922466888454011
PPP1R13L,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
PPP1R13L,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
PPP1R13L,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
PPP1R13L,Banna virus strain JKT-6423 vp12,0.8999095837312036
PPP1R13L,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
PPP1R13L,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
PPP1R13L,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
PPP1R13L,Human adenovirus 1 fiber,0.8999095837312036
PPP1R13L,Human adenovirus 5 fiber,0.8999095837312036
PPP1R13L,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
PPP1R13L,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
PPP1R13L,Cowpox virus CPXV213 protein (gene: CPXV213 CDS),0.8999095837312036
PPP1R13L,Cowpox virus CPXV027 protein (gene: CPXV027 CDS),0.8999095837312036
PPP1R13L,Titi monkey adenovirus ECC-2011 fiber,0.8999095837312036
PPP1R13L,Vaccinia virus hypothetical protein,0.8999095837312036
PPP1R13L,Vaccinia virus Ankara 72.4k ankyrin repeat protein f1,0.8999095837312036
PPP1R13L,Cowpox virus CPXV011 protein (gene: CPXV011 CDS),0.8999095837312036
PPP1R13L,Horsepox virus HSPV022 (ankyrin-like protein,0.8999095837312036
PPP1R13L,Provisional),0.8999095837312036
PPP1R13L,Monkeypox virus ankyrin-like protein,0.8999095837312036
PPP1R13L,Monkeypox virus Zaire-96-I-16 J3L (gene: J3L),0.8999095837312036
PPP1R13L,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
PPP1R13L,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
PPP1R13L,Variola virus hypothetical protein (gene: D6L),0.8999095837312036
PPP1R13L,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
PPP1R13L,Vaccinia virus ankyrin-like protein (gene: C9L),0.8999095837312036
PPP1R13L,Horsepox virus HSPV201a (ankyrin repeats),0.8999095837312036
PPP1R13L,Yaba-like disease virus 147R protein (gene: 147R),0.9057542447893764
PPP1R13L,Horsepox virus HSPV004 (ankyrin repeats),0.9057542447893764
PPP1R13L,Yaba monkey tumor virus ankyrin-like protein,0.9057542447893764
PPP1R13L,Horsepox virus HSPV196 (ankyrin-like protein,0.9057542447893764
PPP1R13L,Provisional),0.9057542447893764
PPP1R13L,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
PPP1R13L,Variola virus hypothetical protein (gene: B19R),0.9057542447893764
PPP1R13L,Vaccinia virus Ankara CP77 Host range protein f1,0.9057542447893764
PPP1R13L,Cowpox virus CPXV039 (gene: CPXV039 CDS),0.9057542447893764
PPP1R13L,Variola virus hypothetical protein (gene: B21R),0.9057542447893764
PPP1R13L,Ectromelia virus ERPV ankyrin,0.9057542447893764
PPP1R13L,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
PPP1R13L,Cowpox virus VHR1 or CPXV025 protein (gene: VHR1),0.9057542447893764
PPP1R13L,Vaccinia virus ankyrin-like protein (gene: B18R),0.9058994261255549
PPP1R13L,Horsepox virus HSPV033b (Ankyrin repeats),0.9071659214187592
PPP1R13L,Orf virus ORF126 ankyrin repeat protein,0.915880438522078
PPP1R13L,Monkeypox virus Zaire-96-I-16 B17R (gene: B17R),0.915880438522078
PPP1R13L,Vaccinia virus Ankara CP77 host range protein f3,0.9176018655958595
PPP1R13L,Horsepox virus HSPV005b (ankyrin repeats),0.9176018655958595
PPP1R13L,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D9L),0.9224878266317492
PPP1R13L,Cowpox virus CPXV019 protein (gene: CPXV019 CDS),0.9237501457186692
PPP1R13L,Yaba-like disease virus 8L protein (gene: 8L),0.9237501457186692
PPP1R13L,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
PPP1R13L,Cowpox virus CPXV016 protein (gene: CPXV016 CDS),0.9237501457186692
PPP1R13L,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.9237501457186692
PPP1R13L,Vaccinia virus Ankara 67.9k ankyrin repeat protein,0.9287050575620676
PPP1R13L,Cowpox virus CPXV008 protein (gene: CPXV008 CDS),0.9364561700418303
PPP1R13L,Vaccinia virus ankyin-like protein (gene: M1L),0.9366403811337995
PPP1R13L,Variola virus hypothetical protein (gene: B6R),0.9383505321091749
PPP1R13L,Vaccinia virus ankyrin-like protein,0.9397923093369096
PREPL,Nephrolithiasis,0.7765852775619541
PREPL,Frontal bossing,0.7880542567584415
PREPL,Myasthenic Syndrome,0.7880542567584415
PREPL,Increased appetite (finding),0.7880542567584415
PREPL,Hyperphagia,0.7880542567584415
PREPL,Tented mouth,0.7880542567584415
PREPL,Tented upper lip,0.7880542567584415
PREPL,Tented upper lip vermilion,0.7880542567584415
PREPL,Cognitive delay,0.7880542567584415
PREPL,Cystinuria,0.7880542567584415
PREPL,Lambert-Eaton Myasthenic Syndrome,0.7880542567584415
PREPL,Global developmental delay,0.7880542567584415
PREPL,Mental and motor retardation,0.7880542567584415
PREPL,Mitochondrial respiratory chain defects,0.7880542567584415
PREPL,Myasthenic Syndromes Congenital Slow Channel,0.7908231553833205
PREPL,Moderate mental retardation (I.Q. 35-49),0.8009048756462318
PREPL,Congenital Myasthenic Syndromes Presynaptic,0.8019075543217649
PREPL,Congenital Myasthenic Syndromes Postsynaptic,0.8019075543217649
PREPL,Myasthenias,0.8019075543217649
PREPL,Isolated somatotropin deficiency,0.8101097852323003
PREPL,No development of motor milestones,0.8212681436603975
PREPL,Reduced fetal movement,0.8212681436603975
PREPL,Motor delay,0.8232134984476662
PREPL,Somatotropin deficiency,0.8270909867833504
PREPL,Feeding difficulties,0.8272008757995397
PREPL,Turridolichocephaly,0.8368219249856942
PREPL,Narrow cranium shape,0.8368219249856942
PREPL,Narrow head shape,0.8368219249856942
PREPL,Narrow skull shape,0.8368219249856942
PREPL,Long narrow head,0.8402911822757345
PREPL,Hypogonadism,0.8402911822757345
PREPL,Generalized hypotonia,0.843190898187174
PREPL,Myasthenic Syndromes Congenital,0.8486035047899471
PREPL,Concave bridge of nose,0.8578473133580928
PREPL,Depressed nasal root/bridge,0.8578473133580928
PREPL,Depressed nasal bridge,0.8584283190330553
PREPL,Hypocalcemia,0.8584283190330553
PREPL,Growth retardation,0.8610447277138289
PREPL,Poor growth,0.8610447277138289
PREPL,Growth delay,0.8610447277138289
PREPL,Very poor growth,0.8648405521677974
PREPL,Long eyelashes,0.8648405521677974
PREPL,Hypernasal voice,0.876210765330195
PREPL,Nasal voice,0.876210765330195
PREPL,Short stature,0.8815127642200768
PREPL,Congenital Epicanthus,0.8867509400747969
PREPL,Failure to Thrive,0.8959157818691486
PREPL,Fatigue,0.9029289778792944
PREPL,Growth failure,0.9066109052713736
PREPL,Muscle hypotonia,0.9124568647908072
PREPL,Acidosis Lactic,0.942246125102556
PREPL,Intellectual Disability,0.9478210444156088
PREPL,Seizures,0.9478210444156088
PREPL,Retrognathia,0.9514640836642632
PREPL,Epilepsy,0.963331724428282
PREPL,Lactic acidemia,0.9692578766570316
PREPL,Low-set posteriorly rotated ears,0.9692578766570316
PREPL,Blepharoptosis,0.9770263358372888
PREPL,Undergrowth,0.9884235744717738
PREPL,Failure to gain weight,0.9896536639644284
PREPL,Pediatric failure to thrive,0.9896536639644284
PREPL,Nephrolithiasis,0.7765582368651238
PREPL,Cystinuria,0.7765582368651238
PREPL,Hypoglycemia,0.7765582368651238
PREPL,Somatotropin Deficiency,0.7765582368651238
PREPL,Developmental Delay,0.7765582368651238
PREPL,Isolated Somatotropin Deficiency,0.7860378120955526
PREPL,Frontal Bossing,0.8115918568696846
PREPL,Motor Delay,0.8210988731657684
PREPL,Mental Retardation,0.8337953215113012
PREPL,Myasthenic Syndrome,0.8476516371290275
PREPL,Premature Menopause,0.8903630091389316
PREPL,Hypogonadism,0.9259420053407031
PREPL,Dolichocephaly,0.9398381935810408
PREPL,Dwarfism,0.9510372690456612
PREPL,Congenital Epicanthus,0.974502015052702
PREPL,Ptosis,0.9832345076528324
PREPL,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.1040670578681756
PREPL,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.1068643725150898
PREPL,Succinic semialdehyde dehydrogenase deficiency ORPHA:22,0.1991445465001551
PREPL,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3891940933600213
PREPL,Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946,0.5867963421058087
PREPL,Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335,0.5867963421058087
PREPL,Autosomal dominant spastic paraplegia type 31 ORPHA:101011,0.5867963421058087
PREPL,Autosomal recessive spastic paraplegia type 67 ORPHA:401820,0.5867963421058087
PREPL,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:330050,0.5867963421058087
PREPL,DOORS syndrome ORPHA:79500,0.5867963421058087
PREPL,Focal epilepsy-intellectual disability-cerebro-cerebellar malformation ORPHA:352587,0.5867963421058087
PREPL,Progressive myoclonic epilepsy with dystonia ORPHA:352596,0.5867963421058087
PREPL,Rolandic epilepsy-paroxysmal exercise-induced dystonia-writer's cramp syndrome ORPHA:163727,0.5867963421058087
PREPL,Atypical juvenile parkinsonism ORPHA:391411,0.5867963421058087
PREPL,Autosomal dominant non-syndromic intellectual disability ORPHA:178469,0.7929682744768703
PREPL,APC-related attenuated familial adenomatous polyposis ORPHA:247806,0.7929682744768703
PREPL,Autosomal dominant Charcot-Marie-Tooth disease type 2K ORPHA:99944,0.7929682744768703
PREPL,Autosomal dominant keratitis ORPHA:2334,0.7929682744768703
PREPL,Autosomal dominant striatal neurodegeneration ORPHA:228169,0.7929682744768703
PREPL,Autosomal recessive Charcot-Marie-Tooth disease with hoarseness ORPHA:101097,0.7929682744768703
PREPL,Autosomal recessive intermediate Charcot-Marie-Tooth disease type A ORPHA:217055,0.7929682744768703
PREPL,Autosomal recessive spastic paraplegia type 54 ORPHA:320380,0.7929682744768703
PREPL,COG6-CGD ORPHA:464443,0.7929682744768703
PREPL,Charcot-Marie-Tooth disease type 2H ORPHA:101102,0.7929682744768703
PREPL,Charcot-Marie-Tooth disease type 4A ORPHA:99948,0.7929682744768703
PREPL,Christianson syndrome ORPHA:85278,0.7929682744768703
PREPL,Familial adenomatous polyposis due to 5q22.2 microdeletion ORPHA:261584,0.7929682744768703
PREPL,Foveal hypoplasia-presenile cataract syndrome ORPHA:2253,0.7929682744768703
PREPL,Gardner syndrome ORPHA:79665,0.7929682744768703
PREPL,Gastric adenocarcinoma and proximal polyposis of the stomach ORPHA:314022,0.7929682744768703
PREPL,Hyperphenylalaninemia due to DNAJC12 deficiency ORPHA:508523,0.7929682744768703
PREPL,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome ORPHA:363523,0.7929682744768703
PREPL,Infantile-onset ascending hereditary spastic paralysis ORPHA:293168,0.7929682744768703
PREPL,Isolated optic nerve hypoplasia/aplasia ORPHA:137902,0.7929682744768703
PREPL,Lissencephaly due to LIS1 mutation ORPHA:95232,0.7929682744768703
PREPL,Morning glory disc anomaly ORPHA:35737,0.7929682744768703
PREPL,Mulibrey nanism ORPHA:2576,0.7929682744768703
PREPL,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome ORPHA:521390,0.7929682744768703
PREPL,Succinyl-CoA:3-oxoacid CoA transferase deficiency ORPHA:832,0.7929682744768703
PREPL,Turcot syndrome with polyposis ORPHA:99818,0.7929682744768703
PREPL,2p21 microdeletion syndrome without cystinuria ORPHA:369881,0.7929682744768703
PREPL,Aniridia-cerebellar ataxia-intellectual disability syndrome ORPHA:1065,0.7929682744768703
PREPL,Cenani-Lenz syndrome ORPHA:3258,0.7929682744768703
PREPL,Congenital neutropenia-myelofibrosis-nephromegaly syndrome ORPHA:369852,0.7929682744768703
PREPL,Short rib-polydactyly syndrome Majewski type ORPHA:93269,0.7929682744768703
PREPL,Inherited congenital spastic tetraplegia ORPHA:210141,0.7929682744768703
PREPL,Male infertility due to globozoospermia ORPHA:171709,0.795266832401002
PREPL,NON RARE IN EUROPE: Aldosterone-producing adenoma ORPHA:85142,0.8029813443753846
PREPL,Jeune syndrome ORPHA:474,0.8105918570729571
PREPL,Young-onset Parkinson disease ORPHA:2828,0.8668760866668862
PREPL,17q11 microdeletion syndrome ORPHA:97685,0.8922466888454011
PREPL,17q11.2 microduplication syndrome ORPHA:139474,0.8922466888454011
PREPL,Anterior maxillary protrusion-strabismus-intellectual disability syndrome ORPHA:562559,0.8922466888454011
PREPL,Carney complex ORPHA:1359,0.8922466888454011
PREPL,Familial atrial myxoma ORPHA:615,0.8922466888454011
PREPL,Glycogen storage disease due to muscle phosphofructokinase deficiency ORPHA:371,0.8922466888454011
PREPL,Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion ORPHA:363700,0.8922466888454011
PREPL,PURA-related severe neonatal hypotonia-seizures-encephalopathy syndrome due to a point mutation ORPHA:438216,0.8922466888454011
PREPL,Progressive encephalopathy with leukodystrophy due to DECR deficiency ORPHA:431361,0.8922466888454011
PREPL,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome ORPHA:505242,0.8922466888454011
PREPL,Severe neonatal hypotonia-seizures-encephalopathy syndrome due to 5q31.3 microdeletion ORPHA:314655,0.8922466888454011
PREPL,Sudden infant death-dysgenesis of the testes syndrome ORPHA:168593,0.8922466888454011
PREPL,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C ORPHA:308400,0.8922466888454011
PREPL,X-linked external auditory canal atresia-dilated internal auditory canal-facial dysmorphism syndrome ORPHA:500188,0.8922466888454011
PREPL,17p13.3 microduplication syndrome ORPHA:217385,0.8922466888454011
PREPL,Desmoid tumor ORPHA:873,0.8922466888454011
PREPL,Short rib-polydactyly syndrome Beemer-Langer type ORPHA:93268,0.8922466888454011
PREPL,Atypical hypotonia-cystinuria syndrome ORPHA:238523,0.8922466888454011
PREPL,Isolated aniridia ORPHA:250923,0.8922466888454011
PREPL,2p21 microdeletion syndrome ORPHA:163693,0.8922466888454011
PREPL,Hereditary sensory and autonomic neuropathy type 2 ORPHA:970,0.8922466888454011
PREPL,Short rib-polydactyly syndrome Verma-Naumoff type ORPHA:93271,0.8922466888454011
PREPL,Hereditary hyperekplexia ORPHA:3197,0.8922466888454011
PREPL,Bardet-Biedl syndrome ORPHA:110,0.8922466888454011
PREPL,Epileptic encephalopathy with global cerebral demyelination ORPHA:353217,0.8922466888454011
PREPL,Familial encephalopathy with neuroserpin inclusion bodies ORPHA:85110,0.8922466888454011
PREPL,Metachondromatosis ORPHA:2499,0.8922466888454011
PREPL,Short rib-polydactyly syndrome type 5 ORPHA:498497,0.8922466888454011
PREPL,Angelman syndrome due to maternal 15q11q13 deletion ORPHA:98794,0.8922466888454011
PREPL,Hypomyelination with atrophy of basal ganglia and cerebellum ORPHA:139441,0.8922466888454011
PREPL,Hypotonia-cystinuria syndrome ORPHA:163690,0.8922466888454011
PREPL,Subcortical band heterotopia ORPHA:99796,0.8922466888454011
PREPL,Catecholaminergic polymorphic ventricular tachycardia ORPHA:3286,0.8922466888454011
PREPL,Pilomyxoid astrocytoma ORPHA:251615,0.8922466888454011
PREPL,X-linked non-syndromic intellectual disability ORPHA:777,0.9308133040426916
PREPL,Non-specific early-onset epileptic encephalopathy ORPHA:442835,0.9381787052130178
PRRT2,Malignant neoplasm of breast,0.4084380369379369
PRRT2,Breast Carcinoma,0.7333611688795861
PRRT2,Diffuse Large B-Cell Lymphoma,0.7333611688795861
PRRT2,Carcinogenesis,0.7333611688795861
PRRT2,Thromboangiitis Obliterans,0.7333611688795861
PRRT2,Malignant neoplasm of ovary,0.7333611688795861
PRRT2,leukemia,0.7333611688795861
PRRT2,Ovarian Carcinoma,0.7333611688795861
PRRT2,Malignant neoplasm of pancreas,0.7688485284765829
PRRT2,Colorectal Carcinoma,0.7765852775619541
PRRT2,Pancreatic carcinoma,0.7765852775619541
PRRT2,Gastrointestinal Stromal Tumors,0.7765852775619541
PRRT2,Colon Carcinoma,0.7765852775619541
PRRT2,Leukemia Myelocytic Acute,0.7765852775619541
PRRT2,Paresthesia,0.7765852775619541
PRRT2,androgen independent prostate cancer,0.7765852775619541
PRRT2,Malignant tumor of colon,0.7765852775619541
PRRT2,Cervix carcinoma,0.7765852775619541
PRRT2,Non-Small Cell Lung Carcinoma,0.7765852775619541
PRRT2,Segmental dystonia,0.7765852775619541
PRRT2,Myelomonocytic leukemia,0.7765852775619541
PRRT2,Carcinoma breast stage IV,0.7765852775619541
PRRT2,Laryngeal dystonia,0.7765852775619541
PRRT2,Rhabdoid Tumor of the Kidney,0.7765852775619541
PRRT2,Vascular Diseases,0.7765852775619541
PRRT2,Malignant tumor of cervix,0.7768809924982332
PRRT2,Mammary Neoplasms,0.7880542567584415
PRRT2,Glioma,0.7880542567584415
PRRT2,Malignant neoplasm of lung,0.7880542567584415
PRRT2,Malignant neoplasm of prostate,0.7880542567584415
PRRT2,Myotonic Dystrophy,0.7880542567584415
PRRT2,Hyperparathyroidism Secondary,0.7880542567584415
PRRT2,Lymphoma Non-Hodgkin,0.7880542567584415
PRRT2,Liver carcinoma,0.7880542567584415
PRRT2,Myeloid and Lymphoid Neoplasms with FGFR1 Rearrangement,0.7880542567584415
PRRT2,Thyroid carcinoma,0.7880542567584415
PRRT2,Acute Promyelocytic Leukemia,0.7880542567584415
PRRT2,Colorectal Cancer,0.7880542567584415
PRRT2,Choreoathetoid movements,0.7880542567584415
PRRT2,Glioblastoma,0.7880542567584415
PRRT2,Prostate carcinoma,0.7880542567584415
PRRT2,Astrocytoma,0.7880542567584415
PRRT2,Sudden infant death syndrome,0.7880542567584415
PRRT2,Dyskinetic syndrome,0.7880542567584415
PRRT2,Pulmonary Edema,0.7880542567584415
PRRT2,Primary malignant neoplasm of lung,0.7880542567584415
PRRT2,CATARACT MARNER TYPE,0.7880542567584415
PRRT2,cervical cancer,0.7880542567584415
PRRT2,Neoplasm Metastasis,0.7880542567584415
PRRT2,Abnormality of vision,0.7880542567584415
PRRT2,Bloom Syndrome,0.7880542567584415
PRRT2,Carcinoma of lung,0.7880542567584415
PRRT2,Malignant neoplasm of thyroid,0.7880542567584415
PRRT2,Mesothelioma,0.7880542567584415
PRRT2,Neuroblastoma,0.7880542567584415
PRRT2,Muscle Hypertonia,0.7880542567584415
PRRT2,Central neuroblastoma,0.7880542567584415
PRRT2,Choreoathetosis,0.7880542567584415
PRRT2,Interstitial Cystitis,0.7880542567584415
PRRT2,Malignant Neoplasms,0.7880542567584415
PRRT2,melanoma,0.7880542567584415
PRRT2,Ewings sarcoma,0.7880542567584415
PRRT2,Intestinal Neoplasms,0.7880542567584415
PRRT2,Multiple Myeloma,0.7880542567584415
PRRT2,Spasmodic movement,0.7880542567584415
PRRT2,Involuntary jerking movements,0.7880542567584415
PRRT2,Afebrile seizure,0.7880542567584415
PRRT2,Benign neonatal epilepsy,0.7880542567584415
PRRT2,Burning sensation,0.7880542567584415
PRRT2,Involuntary dystonic or choreiform movements,0.7880542567584415
PRRT2,Malignant neoplasm of stomach,0.7880542567584415
PRRT2,Burkitt Lymphoma,0.7880542567584415
PRRT2,Invasive Ductal Breast Carcinoma,0.7880542567584415
PRRT2,AL-RAQAD SYNDROME,0.7880542567584415
PRRT2,Hemiplegic migraine,0.7880542567584415
PRRT2,Lupus Erythematosus Systemic,0.7880542567584415
PRRT2,Renal Cell Carcinoma,0.7880542567584415
PRRT2,MYOTONIC DYSTROPHY 1,0.7880542567584415
PRRT2,Myoclonus,0.7880542567584415
PRRT2,Alzheimer's Disease,0.7880542567584415
PRRT2,Acute lymphocytic leukemia,0.7880542567584415
PRRT2,Nystagmus,0.7880542567584415
PRRT2,Stomach Carcinoma,0.7880542567584415
PRRT2,Dyskinesias Paroxysmal,0.7880542567584415
PRRT2,Generalized Epilepsy with Febrile Seizures Plus,0.7880542567584415
PRRT2,Autoimmune Diseases,0.7880542567584415
PRRT2,Axenfeld-Rieger syndrome,0.7880542567584415
PRRT2,Hyperactive deep tendon reflexes,0.7880542567584415
PRRT2,Infrequent generalized seizures,0.7880542567584415
PRRT2,Squamous cell carcinoma,0.7880542567584415
PRRT2,Rheumatoid Arthritis,0.7880542567584415
PRRT2,Peripheral demyelinating neuropathy,0.7880542567584415
PRRT2,Disorder of face,0.7880542567584415
PRRT2,Abnormality of the face,0.7880542567584415
PRRT2,Adenocarcinoma of prostate,0.7880542567584415
PRRT2,Hyperglycemia,0.7880542567584415
PRRT2,Familial benign neonatal epilepsy,0.7880542567584415
PRRT2,Familial Hemiplegic Migraine,0.7880542567584415
PRRT2,Lingual-Facial-Buccal Dyskinesia,0.7880542567584415
PRRT2,Malignant melanoma of choroid,0.7880542567584415
PRRT2,Tumor Immunity,0.7880542567584415
PRRT2,Hemiplegia/hemiparesis,0.7880542567584415
PRRT2,Dysesthesia,0.7880542567584415
PRRT2,Cholestasis,0.7880542567584415
PRRT2,Mental Retardation Psychosocial,0.7880542567584415
PRRT2,Human immunodeficiency virus II infection,0.7880542567584415
PRRT2,Immunosuppression,0.7880542567584415
PRRT2,Primary malignant neoplasm,0.7908231553833205
PRRT2,Myoclonic dystonia,0.7908231553833205
PRRT2,Metastatic melanoma,0.7940665326856218
PRRT2,Large cell carcinoma of lung,0.7967714690735718
PRRT2,Cavernous Hemangioma of Brain,0.8019075543217649
PRRT2,Sunken eyes,0.8019075543217649
PRRT2,Enophthalmos,0.8019075543217649
PRRT2,Profound Mental Retardation,0.8019075543217649
PRRT2,Dystonia Paroxysmal,0.8019075543217649
PRRT2,Disturbance of consciousness,0.8019075543217649
PRRT2,Dystonia Musculorum Deformans,0.8019075543217649
PRRT2,Multiple Sclerosis,0.8019075543217649
PRRT2,Febrile Convulsions,0.8019075543217649
PRRT2,Episodic Ataxia,0.8019075543217649
PRRT2,Paroxysmal nonkinesigenic dyskinesia,0.8019075543217649
PRRT2,Chronic Lymphocytic Leukemia,0.8019075543217649
PRRT2,Glomerulosclerosis (disorder),0.8019075543217649
PRRT2,West Syndrome,0.8019075543217649
PRRT2,Dystonia Primary,0.8019075543217649
PRRT2,MOHR-TRANEBJAERG SYNDROME,0.8067197998685076
PRRT2,Convulsions,0.8098851543361193
PRRT2,HIV Infections,0.8145035474981049
PRRT2,Torticollis,0.8145035474981049
PRRT2,Absence Seizures,0.8168901801930506
PRRT2,Generalized seizures,0.8190761496232595
PRRT2,Lip and Oral Cavity Carcinoma,0.8190761496232595
PRRT2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
PRRT2,Epilepsy Rolandic,0.8190761496232595
PRRT2,Seizures Focal,0.8190761496232595
PRRT2,Scleroderma,0.8212681436603975
PRRT2,Colonic Neoplasms,0.8212681436603975
PRRT2,Hepatic Fibrosis Congenital,0.8212681436603975
PRRT2,Infantile Severe Myoclonic Epilepsy,0.8212681436603975
PRRT2,Pemphigus,0.8212681436603975
PRRT2,Secondary malignant neoplasm of lung,0.8232134984476662
PRRT2,Dystonia Disorders,0.8232134984476662
PRRT2,Severe Acute Respiratory Syndrome,0.8232134984476662
PRRT2,Diabetic Retinopathy,0.8402911822757345
PRRT2,airway disease,0.8402911822757345
PRRT2,Dystonia,0.8402911822757345
PRRT2,Systemic Scleroderma,0.8402911822757345
PRRT2,Intermittent migraine headaches,0.8402911822757345
PRRT2,Peripheral Neuropathy,0.8402911822757345
PRRT2,Mental deficiency,0.8402911822757345
PRRT2,ATRICHIA WITH PAPULAR LESIONS,0.843190898187174
PRRT2,NONAKA MYOPATHY,0.8578473133580928
PRRT2,Follicular thyroid carcinoma,0.8584283190330553
PRRT2,Squamous cell carcinoma of esophagus,0.8610447277138289
PRRT2,Migraine Disorders,0.8648405521677974
PRRT2,Amyloidosis,0.8672189956534445
PRRT2,Familial Alzheimer Disease (FAD),0.8786853464107758
PRRT2,Inflammatory Bowel Diseases,0.8815127642200768
PRRT2,Hypertrophic disorder of skin unspecified,0.8815127642200768
PRRT2,Migraine with Aura,0.8851456306720444
PRRT2,Heart failure,0.8867509400747969
PRRT2,Hyperactive behavior,0.8878860377518915
PRRT2,Pulmonary Fibrosis,0.8911256045597441
PRRT2,Malignant neoplasm of mouth,0.8946938397586319
PRRT2,nervous system disorder,0.8959157818691486
PRRT2,Chorea,0.8959157818691486
PRRT2,Congestive heart failure,0.8976039441125321
PRRT2,Inflammatory pain,0.900167961295542
PRRT2,Cerebellar Ataxia,0.906476206143938
PRRT2,Paroxysmal kinesigenic choreoathetosis,0.9083161862856644
PRRT2,Muscle hypotonia,0.9124568647908072
PRRT2,Leishmaniasis Visceral,0.9154499654632742
PRRT2,Epileptic encephalopathy,0.917543617287358
PRRT2,Polycystic Kidney Autosomal Dominant,0.9193385822373632
PRRT2,Mental Retardation,0.922229272318747
PRRT2,Encephalopathies,0.9265708351135048
PRRT2,Ataxias Hereditary,0.9265708351135048
PRRT2,Uveal melanoma,0.929235785949896
PRRT2,Movement Disorders,0.929235785949896
PRRT2,Developmental Disabilities,0.929814249105729
PRRT2,Arthritis,0.9431511078237256
PRRT2,Intellectual Disability,0.9478210444156088
PRRT2,Seizures,0.9478210444156088
PRRT2,Congenital anomaly of face,0.9561991866282916
PRRT2,Endometriosis,0.960644037248553
PRRT2,Epilepsy,0.963331724428282
PRRT2,Autism Spectrum Disorders,0.9639249377588224
PRRT2,Asthma,0.9672478180546946
PRRT2,Cystic Fibrosis,0.9874278479946328
PRRT2,Paroxysmal Nonkinesigenic Dyskinesia,0.4532988396145482
PRRT2,Stereotyped Behavior,0.7765582368651238
PRRT2,Dyskinesia,0.7765582368651238
PRRT2,Orofacial Dyskinesia,0.7765582368651238
PRRT2,Focal Seizures,0.7765582368651238
PRRT2,Dyskinetic Syndrome,0.7765582368651238
PRRT2,Benign Epilepsy,0.7765582368651238
PRRT2,Nystagmus,0.7765582368651238
PRRT2,Choreoathetosis,0.7765582368651238
PRRT2,Trismus,0.8082616889285628
PRRT2,Writer`s Cramp,0.8115918568696846
PRRT2,Hearing Loss,0.8115918568696846
PRRT2,Dystonia,0.8115918568696846
PRRT2,Hemiplegia/hemiparesis,0.8115918568696846
PRRT2,Movement Disorders,0.829560580336605
PRRT2,Hallucinations,0.8337953215113012
PRRT2,Mental Retardation,0.8337953215113012
PRRT2,Anxiety Disorder,0.8507213163251659
PRRT2,Epilepsy,0.8611702959552964
PRRT2,Seizure,0.861756360478846
PRRT2,Retinitis Pigmentosa,0.861756360478846
PRRT2,Dysphasia,0.8903630091389316
PRRT2,Speech Disorders,0.9069867032339078
PRRT2,Migraine,0.9658957825498884
PRRT2,Specific Learning Disorder,0.9832345076528324
PRRT2,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
PRRT2,Interstitial lung disease due to ABCA3 deficiency ORPHA:440402,0.3832844616405875
PRRT2,Infant acute respiratory distress syndrome ORPHA:70587,0.5867963421058087
PRRT2,Paroxysmal non-kinesigenic dyskinesia ORPHA:98810,0.5867963421058087
PRRT2,Early infantile epileptic encephalopathy ORPHA:1934,0.7593059616185558
PRRT2,Distal hereditary motor neuropathy type 7 ORPHA:139589,0.8922466888454011
PRRT2,Horizontal gaze palsy with progressive scoliosis ORPHA:2744,0.8922466888454011
PRRT2,Infantile convulsions and choreoathetosis ORPHA:31709,0.8922466888454011
PRRT2,Myoclonic-astatic epilepsy ORPHA:1942,0.8922466888454011
PRRT2,Presynaptic congenital myasthenic syndromes ORPHA:98914,0.8922466888454011
PRRT2,Autosomal dominant spastic paraplegia type 73 ORPHA:444099,0.8922466888454011
PRRT2,Paroxysmal kinesigenic dyskinesia ORPHA:98809,0.8922466888454011
PRRT2,Familial or sporadic hemiplegic migraine ORPHA:569,0.8922466888454011
PRRT2,Benign familial infantile epilepsy ORPHA:306,0.8922466888454011
PRSS16,Carcinogenesis,0.7333611688795861
PRSS16,Infantile Colic,0.7880542567584415
PRSS16,Autoimmune Diseases,0.7880542567584415
PRSS16,Schizophrenia,0.8067197998685076
PRSS16,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
PRSS16,Colitis,0.9738491767258852
PRSS16,Schizophrenia,0.7860378120955526
PRSS16,Currarino syndrome ORPHA:1552,0.0155394890951578
PSIP1,Malignant neoplasm of breast,0.4084380369379369
PSIP1,Carcinoma of bladder,0.4084380369379369
PSIP1,Bladder Neoplasm,0.4084380369379369
PSIP1,Malignant neoplasm of urinary bladder,0.5071083164302358
PSIP1,Breast Carcinoma,0.7333611688795861
PSIP1,Diffuse Large B-Cell Lymphoma,0.7333611688795861
PSIP1,Carcinogenesis,0.7333611688795861
PSIP1,Malignant neoplasm of ovary,0.7333611688795861
PSIP1,leukemia,0.7333611688795861
PSIP1,Ovarian Carcinoma,0.7333611688795861
PSIP1,Malignant neoplasm of pancreas,0.7688485284765829
PSIP1,Osteopetrosis,0.7765852775619541
PSIP1,Pancreatic carcinoma,0.7765852775619541
PSIP1,Colon Carcinoma,0.7765852775619541
PSIP1,Leukemia Myelocytic Acute,0.7765852775619541
PSIP1,MYELODYSPLASTIC SYNDROME,0.7765852775619541
PSIP1,Leukemogenesis,0.7765852775619541
PSIP1,Non-Small Cell Lung Carcinoma,0.7765852775619541
PSIP1,Mammary Neoplasms,0.7880542567584415
PSIP1,Glioma,0.7880542567584415
PSIP1,Chronic Fatigue Syndrome,0.7880542567584415
PSIP1,Malignant neoplasm of prostate,0.7880542567584415
PSIP1,Ki-1+ Anaplastic Large Cell Lymphoma,0.7880542567584415
PSIP1,Epithelial ovarian cancer,0.7880542567584415
PSIP1,T-Cell Lymphoma,0.7880542567584415
PSIP1,Prostate carcinoma,0.7880542567584415
PSIP1,Neoplasm Metastasis,0.7880542567584415
PSIP1,Acute Myeloid Leukemia M1,0.7880542567584415
PSIP1,Neuroblastoma,0.7880542567584415
PSIP1,Central neuroblastoma,0.7880542567584415
PSIP1,Immunologic Deficiency Syndromes,0.7880542567584415
PSIP1,melanoma,0.7880542567584415
PSIP1,Malignant neoplasm of stomach,0.7880542567584415
PSIP1,Congenital contractural arachnodactyly,0.7880542567584415
PSIP1,Malignant mesothelioma,0.7880542567584415
PSIP1,Hodgkin Disease,0.7880542567584415
PSIP1,Pancreatitis Chronic,0.7880542567584415
PSIP1,Photoreceptor degeneration,0.7880542567584415
PSIP1,Acute leukemia,0.7880542567584415
PSIP1,Retinoblastoma,0.7880542567584415
PSIP1,Primary Effusion Lymphoma,0.7880542567584415
PSIP1,Neuroectodermal Tumor Primitive,0.7880542567584415
PSIP1,Alzheimer's Disease,0.7880542567584415
PSIP1,TNF receptor-associated periodic fever syndrome (TRAPS),0.7880542567584415
PSIP1,Stomach Carcinoma,0.7880542567584415
PSIP1,Autoimmune Diseases,0.7880542567584415
PSIP1,Acute Myeloid Leukemia (AML-M2),0.7880542567584415
PSIP1,Hyperlipidemia Familial Combined,0.7880542567584415
PSIP1,Squamous cell carcinoma,0.7880542567584415
PSIP1,Diabetes,0.7880542567584415
PSIP1,Diabetes Mellitus,0.7880542567584415
PSIP1,Abnormality of the skeletal system,0.7880542567584415
PSIP1,Ankylosing spondylitis,0.7880542567584415
PSIP1,Huntington Disease,0.7880542567584415
PSIP1,Hormone refractory prostate cancer,0.7880542567584415
PSIP1,Cytomegalovirus Infections,0.7880542567584415
PSIP1,Myeloid Leukemia Chronic,0.7880542567584415
PSIP1,Myeloid Leukemia,0.7880542567584415
PSIP1,Adenosquamous carcinoma,0.7880542567584415
PSIP1,Childhood Acute Myeloid Leukemia,0.8009048756462318
PSIP1,Leukemia Large Granular Lymphocytic,0.8019075543217649
PSIP1,Alveolitis,0.8019075543217649
PSIP1,Fibrosarcoma,0.8019075543217649
PSIP1,Chronic Lymphocytic Leukemia,0.8019075543217649
PSIP1,Blepharitis,0.8067197998685076
PSIP1,Eating Disorders,0.8101097852323003
PSIP1,Myeloproliferative disease,0.8138488881521341
PSIP1,Liver diseases,0.8140222479282434
PSIP1,HIV Infections,0.8145035474981049
PSIP1,Primary infection NOS,0.8168901801930506
PSIP1,MIXED LINEAGE LEUKEMIA,0.8232134984476662
PSIP1,Infection,0.8272008757995397
PSIP1,Psoriasis vulgaris,0.8272008757995397
PSIP1,Amyotrophic Lateral Sclerosis,0.8402911822757345
PSIP1,Epiretinal Membrane,0.8402911822757345
PSIP1,Rhinitis,0.8402911822757345
PSIP1,Alopecia,0.8523465762428218
PSIP1,Medulloblastoma,0.8548862007194026
PSIP1,Neoplasm Residual,0.8578473133580928
PSIP1,Squamous cell carcinoma of esophagus,0.8610447277138289
PSIP1,Progressive sensorineural hearing impairment,0.8648405521677974
PSIP1,Amyloidosis,0.8672189956534445
PSIP1,Alopecia Areata,0.8690346447728063
PSIP1,Dermatitis Atopic,0.8867509400747969
PSIP1,Neurilemmoma,0.887595340546704
PSIP1,Eczema,0.909484944705772
PSIP1,Allergic rhinitis (disorder),0.922577745415874
PSIP1,Limb ischemia,0.929235785949896
PSIP1,Carcinoma of larynx,0.9377696084218796
PSIP1,Unipolar Depression,0.9455834988784428
PSIP1,Malaria,0.9512505437112568
PSIP1,Major Depressive Disorder,0.9658628445524134
PSIP1,Asthma,0.9672478180546946
PSIP1,Leukemia,0.7765582368651238
PSIP1,Myeloid Leukemia,0.8356859041719433
PSIP1,Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379,0.3832844616405875
PSIP1,Neuroendocrine tumor of stomach ORPHA:100075,0.5867963421058087
PSIP1,Acute myeloblastic leukemia with maturation ORPHA:98834,0.5867963421058087
PSIP1,B-cell immunodeficiency-limb anomaly-urogenital malformation syndrome ORPHA:567502,0.7929682744768703
PSIP1,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome ORPHA:504476,0.7929682744768703
PSIP1,Monosomy 9q22.3 ORPHA:77301,0.7929682744768703
PSIP1,Schilbach-Rott syndrome ORPHA:2353,0.7929682744768703
PSIP1,Succinyl-CoA:3-oxoacid CoA transferase deficiency ORPHA:832,0.7929682744768703
PSIP1,NON RARE IN EUROPE: Primary ovarian failure ORPHA:619,0.8922466888454011
PSIP1,Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency ORPHA:284435,0.8922466888454011
PSIP1,Human immunodeficiency virus 1 capsid (gene: gag),0.8999095837312036
PSIP1,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
PSIP1,Human immunodeficiency virus 1 Gag-Pol (gene: gag-pol),0.8999095837312036
PSIP1,Human immunodeficiency virus 1 p66 subunit (gene: gag-pol),0.8999095837312036
PSIP1,Human immunodeficiency virus 1 reverse transcriptase p51 subunit (gene: gag-pol),0.8999095837312036
PSIP1,Human T-lymphotropic virus 2 Gag-Pro-Pol,0.8999095837312036
PSIP1,Human immunodeficiency virus pol protein (gene: pol),0.8999095837312036
PSIP1,Human immunodeficiency virus 1 integrase (gene: gag-pol),0.8999095837312036
PSIP1,Human immunodeficiency virus 1 Pol (gene: gag-pol),0.8999095837312036
PSIP1,Human immunodeficiency virus 1 aspartic peptidase (gene: gag-pol),0.8999095837312036
PSIP1,Human T-lymphotropic virus 2 full_polyprotein 1..982,0.9056300531913352
PSIP1,African green monkey simian foamy virus Pol precursor (gene: pol),0.9057542447893764
PSIP1,Human T-cell leukemia virus type I p15NC-p14PR-p95RT/IN (gene: gag-pro-pol),0.9224369592826992
PSIP1,Human T-cell leukemia virus type I Pr gag-pro-pol (gene: gag-pro-pol),0.9224878266317492
PSIP1,Human T-lymphotropic virus 4 polymerase (gene: pol),0.9237501457186692
PSIP1,Human T-lymphotropic virus 3 polymerase (gene: pol),0.9397923093369096
PSTK,Hypertensive disease,0.8474481237156937
PSTK,Hypertension,0.7765582368651238
PSTK,Neonatal severe cardiopulmonary failure due to mitochondrial methylation defect ORPHA:466784,0.8922466888454011
PSTK,Lipoic acid synthetase deficiency ORPHA:401859,0.8922466888454011
PSTK,POGLUT1-related  limb-girdle muscular dystrophy R21 ORPHA:480682,0.8922466888454011
PTGES3,Malignant neoplasm of breast,0.4084380369379369
PTGES3,Reticulocyte count (procedure),0.5071083164302358
PTGES3,Breast Carcinoma,0.7333611688795861
PTGES3,Carcinogenesis,0.7333611688795861
PTGES3,Adenocarcinoma,0.750391252594775
PTGES3,Non-Small Cell Lung Carcinoma,0.7765852775619541
PTGES3,Mammary Neoplasms,0.7880542567584415
PTGES3,Malignant neoplasm of prostate,0.7880542567584415
PTGES3,Prostate carcinoma,0.7880542567584415
PTGES3,Neoplasm Metastasis,0.7880542567584415
PTGES3,Isodicentric Chromosome 15 Syndrome,0.7880542567584415
PTGES3,Malignant neoplasm of stomach,0.7880542567584415
PTGES3,Retinoblastoma,0.7880542567584415
PTGES3,Invasive Carcinoma,0.7880542567584415
PTGES3,Alzheimer's Disease,0.7880542567584415
PTGES3,Periodontitis,0.7880542567584415
PTGES3,Stomach Carcinoma,0.7880542567584415
PTGES3,Lyme Disease,0.7880542567584415
PTGES3,Developmental reading disorder,0.7880542567584415
PTGES3,Fibrosarcoma,0.8019075543217649
PTGES3,Schizophrenia,0.8067197998685076
PTGES3,Tremor,0.8190761496232595
PTGES3,Amyloidosis,0.8672189956534445
PTGES3,Pervasive Development Disorder,0.8806784681730055
PTGES3,Autism Spectrum Disorders,0.9639249377588224
PTGES3,Linear nevus sebaceus syndrome ORPHA:2612,0.2047219337649946
PTGES3,Autosomal recessive spastic paraplegia type 61 ORPHA:401780,0.7929682744768703
PTGES3,Spinocerebellar ataxia type 10 ORPHA:98761,0.7929682744768703
PTGES3,Distal 17p13.3 microdeletion syndrome ORPHA:261257,0.8922466888454011
PTGES3,Microcephaly-capillary malformation syndrome ORPHA:294016,0.8922466888454011
PTGES3,Mitochondrial non-syndromic sensorineural deafness ORPHA:90641,0.8922466888454011
PTGES3,Hypoxanthine guanine phosphoribosyltransferase partial deficiency ORPHA:79233,0.8922466888454011
PTGES3,Lesch-Nyhan syndrome ORPHA:510,0.8922466888454011
PTGES3,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to 9q21.3 microdeletion ORPHA:352665,0.8922466888454011
PTGES3,Neurodevelopmental disorder-craniofacial dysmorphism-cardiac defect-skeletal anomalies syndrome due to a point mutation ORPHA:453504,0.8922466888454011
PTGES3,Proximal myotonic myopathy ORPHA:606,0.8922466888454011
PTGES3,Spinocerebellar ataxia type 38 ORPHA:423296,0.8922466888454011
PTGES3,Thrombocytopenia-absent radius syndrome ORPHA:3320,0.8922466888454011
PTGES3,Frontotemporal dementia with motor neuron disease ORPHA:275872,0.8922466888454011
PTGES3,Amyotrophic lateral sclerosis ORPHA:803,0.937224824246693
PTGES3,Dengue virus 2 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
PTGES3,Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147),0.8999095837312036
PTGES3,Human gammaherpesvirus 8 K4.1 (gene: K4.1),0.8999095837312036
PTGES3,Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
PTGES3,Human betaherpesvirus 5 chemokine vCXCL1 (gene: UL146),0.8999095837312036
PTGES3,Human betaherpesvirus 5 chemokine vCXCL2 (gene: UL147),0.8999095837312036
PTGES3,Molluscum contagiosum virus subtype 1 MC148R (gene: MC148R),0.9057542447893764
PTGES3,Cercopithecine betaherpesvirus 5 chemokine vCXCL10 (gene: UL146G),0.9237501457186692
PTPRU,Malignant neoplasm of breast,0.4084380369379369
PTPRU,Breast Carcinoma,0.7333611688795861
PTPRU,Carcinogenesis,0.7333611688795861
PTPRU,Malignant neoplasm of ovary,0.7333611688795861
PTPRU,leukemia,0.7333611688795861
PTPRU,Ovarian Carcinoma,0.7333611688795861
PTPRU,Leukemia Myelocytic Acute,0.7765852775619541
PTPRU,Colorectal Neoplasms,0.7765852775619541
PTPRU,Carcinoma breast stage IV,0.7765852775619541
PTPRU,Glioma,0.7880542567584415
PTPRU,Malignant neoplasm of lung,0.7880542567584415
PTPRU,Malignant neoplasm of prostate,0.7880542567584415
PTPRU,Osteosarcoma,0.7880542567584415
PTPRU,Colorectal Cancer,0.7880542567584415
PTPRU,Osteosarcoma of bone,0.7880542567584415
PTPRU,Prostate carcinoma,0.7880542567584415
PTPRU,Astrocytoma,0.7880542567584415
PTPRU,Primary malignant neoplasm of lung,0.7880542567584415
PTPRU,Neoplasm Metastasis,0.7880542567584415
PTPRU,Carcinoma of lung,0.7880542567584415
PTPRU,Turner Syndrome Male,0.7880542567584415
PTPRU,Malignant Neoplasms,0.7880542567584415
PTPRU,melanoma,0.7880542567584415
PTPRU,Adenocarcinoma of pancreas,0.7880542567584415
PTPRU,Lung Neoplasms,0.7880542567584415
PTPRU,Neoplasms,0.7880542567584415
PTPRU,Membranous glomerulonephritis,0.7880542567584415
PTPRU,Renal Cell Carcinoma,0.7880542567584415
PTPRU,Congenital chromosomal disease,0.7880542567584415
PTPRU,Fanconi Anemia,0.7880542567584415
PTPRU,Diabetes in children,0.7880542567584415
PTPRU,Polycythemia Vera,0.7880542567584415
PTPRU,Diabetes,0.7880542567584415
PTPRU,Diabetes Mellitus,0.7880542567584415
PTPRU,Nephrosis,0.7880542567584415
PTPRU,Hyperglycemia,0.7880542567584415
PTPRU,Primary malignant neoplasm,0.7908231553833205
PTPRU,Noonan Syndrome,0.8019075543217649
PTPRU,Multiple Sclerosis,0.8019075543217649
PTPRU,Focal glomerulosclerosis,0.8019075543217649
PTPRU,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8019075543217649
PTPRU,Adenocarcinoma of lung (disorder),0.8098851543361193
PTPRU,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
PTPRU,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
PTPRU,Neuroectodermal Tumors,0.8232134984476662
PTPRU,Stage IV Skin Melanoma,0.8270909867833504
PTPRU,Glioblastoma Multiforme,0.8342163953428735
PTPRU,Hypertensive disease,0.8474481237156937
PTPRU,Renal carcinoma,0.8648405521677974
PTPRU,Kidney Neoplasm,0.8774809019744603
PTPRU,Inflammatory Bowel Diseases,0.8815127642200768
PTPRU,Malignant neoplasm of kidney,0.8818220091065441
PTPRU,Obesity,0.8989612563669234
PTPRU,Clear-cell metastatic renal cell carcinoma,0.8989612563669234
PTPRU,Pheochromocytoma,0.9557184806547836
PTPRU,Colorectal Cancer,0.9832345076528324
PTPRU,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
PTPRU,Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253,0.1040670578681756
PTPRU,Monosomy 22q13.3 ORPHA:48652,0.1040670578681756
PTPRU,Saldino-Mainzer syndrome ORPHA:140969,0.1991445465001551
PTPRU,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.1991445465001551
PTPRU,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.1991445465001551
PTPRU,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.1991445465001551
PTPRU,Familial cortical myoclonus ORPHA:319189,0.1991445465001551
PTPRU,Frank-Ter Haar syndrome ORPHA:137834,0.1991445465001551
PTPRU,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.1991445465001551
PTPRU,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.1991445465001551
PTPRU,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.1991445465001551
PTPRU,Pyruvate carboxylase deficiency benign type ORPHA:353320,0.1991445465001551
PTPRU,Pyruvate carboxylase deficiency infantile type ORPHA:353308,0.1991445465001551
PTPRU,Pyruvate carboxylase deficiency severe neonatal type ORPHA:353314,0.1991445465001551
PTPRU,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.1991445465001551
PTPRU,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.1991445465001551
PTPRU,Benign hereditary chorea ORPHA:1429,0.1991445465001551
PTPRU,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.1991445465001551
PTPRU,Familial hypercholanemia ORPHA:238475,0.2047219337649946
PTPRU,Early-onset posterior polar cataract ORPHA:98993,0.2475924359068358
PTPRU,Cleft lip/palate ORPHA:199306,0.2567797333165013
PTPRU,Alopecia universalis ORPHA:701,0.3832844616405875
PTPRU,Atrichia with papular lesions ORPHA:86819,0.3832844616405875
PTPRU,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867,0.3832844616405875
PTPRU,Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580,0.3832844616405875
PTPRU,Congenital insensitivity to pain with severe intellectual disability ORPHA:453510,0.3832844616405875
PTPRU,Dyschromatosis universalis hereditaria ORPHA:241,0.3832844616405875
PTPRU,Familial pseudohyperkalemia ORPHA:90044,0.3832844616405875
PTPRU,Hereditary folate malabsorption ORPHA:90045,0.3832844616405875
PTPRU,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.3832844616405875
PTPRU,Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403,0.3832844616405875
PTPRU,Spinocerebellar ataxia type 5 ORPHA:98766,0.3832844616405875
PTPRU,Crouzon disease ORPHA:207,0.3832844616405875
PTPRU,Alopecia-intellectual disability syndrome ORPHA:2850,0.3832844616405875
PTPRU,Coloboma of choroid and retina ORPHA:98942,0.3977968344535308
PTPRU,Coloboma of iris ORPHA:98944,0.3977968344535308
PTPRU,NON RARE IN EUROPE: Hypodontia ORPHA:2227,0.4621817429362311
PTPRU,Lethal acantholytic erosive disorder ORPHA:158687,0.5867963421058087
PTPRU,Achondroplasia ORPHA:15,0.5867963421058087
PTPRU,Acute neonatal citrullinemia type I ORPHA:247546,0.5867963421058087
PTPRU,Adult-onset citrullinemia type I ORPHA:247573,0.5867963421058087
PTPRU,Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164,0.5867963421058087
PTPRU,Carvajal syndrome ORPHA:65282,0.5867963421058087
PTPRU,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.5867963421058087
PTPRU,Classic Bartter syndrome ORPHA:93605,0.5867963421058087
PTPRU,Congenital hereditary endothelial dystrophy type II ORPHA:293603,0.5867963421058087
PTPRU,Corneal dystrophy-perceptive deafness syndrome ORPHA:1490,0.5867963421058087
PTPRU,Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262,0.5867963421058087
PTPRU,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.5867963421058087
PTPRU,Hyperprolinemia type 2 ORPHA:79101,0.5867963421058087
PTPRU,Hypochondroplasia ORPHA:429,0.5867963421058087
PTPRU,Hypomaturation-hypoplastic amelogenesis imperfecta with taurodontism ORPHA:100034,0.5867963421058087
PTPRU,Isolated biliary atresia ORPHA:30391,0.5867963421058087
PTPRU,Isolated congenital breast hypoplasia/aplasia ORPHA:180188,0.5867963421058087
PTPRU,Lateral meningocele syndrome ORPHA:2789,0.5867963421058087
PTPRU,Muenke syndrome ORPHA:53271,0.5867963421058087
PTPRU,POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559,0.5867963421058087
PTPRU,Pierson syndrome ORPHA:2670,0.5867963421058087
PTPRU,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165,0.5867963421058087
PTPRU,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.5867963421058087
PTPRU,Thanatophoric dysplasia type 1 ORPHA:1860,0.5867963421058087
PTPRU,Thanatophoric dysplasia type 2 ORPHA:93274,0.5867963421058087
PTPRU,Tricho-dento-osseous syndrome ORPHA:3352,0.5867963421058087
PTPRU,Wilson disease ORPHA:905,0.5867963421058087
PTPRU,Wolfram-like syndrome ORPHA:411590,0.5867963421058087
PTPRU,X-linked creatine transporter deficiency ORPHA:52503,0.5867963421058087
PTPRU,3M syndrome ORPHA:2616,0.5867963421058087
PTPRU,Autosomal recessive Robinow syndrome ORPHA:1507,0.5867963421058087
PTPRU,Carpenter syndrome ORPHA:65759,0.5867963421058087
PTPRU,Hyperostosis corticalis generalisata ORPHA:3416,0.5867963421058087
PTPRU,46XX ovotesticular disorder of sex development ORPHA:2138,0.5867963421058087
PTPRU,Acrocallosal syndrome ORPHA:36,0.5867963421058087
PTPRU,Aplasia cutis congenita ORPHA:1114,0.5959529547720634
PTPRU,Familial exudative vitreoretinopathy ORPHA:891,0.6196505963261838
PTPRU,Juvenile nephronophthisis ORPHA:93592,0.6335420546867965
PTPRU,Colobomatous microphthalmia ORPHA:98938,0.6467006456772204
PTPRU,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.6873535151929783
PTPRU,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.6873535151929783
PTPRU,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.7007232363756918
PTPRU,Tetralogy of Fallot ORPHA:3303,0.7007232363756918
PTPRU,Early-onset nuclear cataract ORPHA:98991,0.7895126437786436
PTPRU,Acrokeratosis verruciformis of Hopf ORPHA:79151,0.7929682744768703
PTPRU,Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16 ORPHA:280333,0.7929682744768703
PTPRU,Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937,0.7929682744768703
PTPRU,Autosomal dominant brachyolmia ORPHA:93304,0.7929682744768703
PTPRU,Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216,0.7929682744768703
PTPRU,Autosomal dominant osteopetrosis type 1 ORPHA:2783,0.7929682744768703
PTPRU,Autosomal spastic paraplegia type 58 ORPHA:397946,0.7929682744768703
PTPRU,Brachydactyly type B1 ORPHA:572385,0.7929682744768703
PTPRU,Campomelic dysplasia ORPHA:140,0.7929682744768703
PTPRU,Craniosynostosis Boston type ORPHA:1541,0.7929682744768703
PTPRU,Darier disease ORPHA:218,0.7929682744768703
PTPRU,Dent disease type 2 ORPHA:93623,0.7929682744768703
PTPRU,Endosteal hyperostosis Worth type ORPHA:2790,0.7929682744768703
PTPRU,Familial congenital nasolacrimal duct obstruction ORPHA:451612,0.7929682744768703
PTPRU,Familial digital arthropathy-brachydactyly ORPHA:85169,0.7929682744768703
PTPRU,Familial hypocalciuric hypercalcemia type 2 ORPHA:101049,0.7929682744768703
PTPRU,Isolated Pierre Robin syndrome ORPHA:718,0.7929682744768703
PTPRU,Keipert syndrome ORPHA:2662,0.7929682744768703
PTPRU,LAMA5-related multisystemic syndrome ORPHA:521450,0.7929682744768703
PTPRU,LRP5-related primary osteoporosis ORPHA:498481,0.7929682744768703
PTPRU,Lethal occipital encephalocele-skeletal dysplasia syndrome ORPHA:293925,0.7929682744768703
PTPRU,Metatropic dysplasia ORPHA:2635,0.7929682744768703
PTPRU,Muscle-eye-brain disease with bilateral multicystic leucodystrophy ORPHA:370997,0.7929682744768703
PTPRU,Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382,0.7929682744768703
PTPRU,Oculocerebrorenal syndrome of Lowe ORPHA:534,0.7929682744768703
PTPRU,Osteoporosis-pseudoglioma syndrome ORPHA:2788,0.7929682744768703
PTPRU,Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377,0.7929682744768703
PTPRU,Parastremmatic dwarfism ORPHA:2646,0.7929682744768703
PTPRU,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.7929682744768703
PTPRU,Phakomatosis cesiomarmorata ORPHA:79484,0.7929682744768703
PTPRU,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673,0.7929682744768703
PTPRU,Scalp-ear-nipple syndrome ORPHA:2036,0.7929682744768703
PTPRU,Scapuloperoneal spinal muscular atrophy ORPHA:431255,0.7929682744768703
PTPRU,Spondyloepiphyseal dysplasia Maroteaux type ORPHA:263482,0.7929682744768703
PTPRU,Spondylometaphyseal dysplasia Kozlowski type ORPHA:93314,0.7929682744768703
PTPRU,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type A ORPHA:308386,0.7929682744768703
PTPRU,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.7929682744768703
PTPRU,Familial avascular necrosis of femoral head ORPHA:86820,0.7929682744768703
PTPRU,Butterfly-shaped pigment dystrophy ORPHA:99001,0.7929682744768703
PTPRU,Retinopathy of prematurity ORPHA:90050,0.7929682744768703
PTPRU,Saethre-Chotzen syndrome ORPHA:794,0.7929682744768703
PTPRU,Atypical glycine encephalopathy ORPHA:289863,0.795266832401002
PTPRU,Familial progressive cardiac conduction defect ORPHA:871,0.795266832401002
PTPRU,Infantile glycine encephalopathy ORPHA:289860,0.795266832401002
PTPRU,Peters anomaly ORPHA:708,0.8029813443753846
PTPRU,Renal agenesis unilateral ORPHA:93100,0.8211968342881582
PTPRU,Oligodontia ORPHA:99798,0.8778481542696168
PTPRU,Walker-Warburg syndrome ORPHA:899,0.8778481542696168
PTPRU,Total early-onset cataract ORPHA:98994,0.8922466888454011
PTPRU,Simpson-Golabi-Behmel syndrome ORPHA:373,0.8922466888454011
PTPRU,X-linked Alport syndrome-diffuse leiomyomatosis ORPHA:1018,0.8922466888454011
PTPRU,22q11.2 duplication syndrome ORPHA:1727,0.8922466888454011
PTPRU,Autosomal dominant Charcot-Marie-Tooth disease type 2L ORPHA:99945,0.8922466888454011
PTPRU,Autosomal dominant distal axonal motor neuropathy-myofibrillar myopathy syndrome ORPHA:476093,0.8922466888454011
PTPRU,Craniofacial dysplasia-osteopenia syndrome ORPHA:314555,0.8922466888454011
PTPRU,Desmosterolosis ORPHA:35107,0.8922466888454011
PTPRU,Fraser syndrome ORPHA:2052,0.8922466888454011
PTPRU,Frontonasal dysplasia-alopecia-genital anomalies syndrome ORPHA:228390,0.8922466888454011
PTPRU,Helicoid peripapillary chorioretinal degeneration ORPHA:86813,0.8922466888454011
PTPRU,SIX2-related frontonasal dysplasia ORPHA:488437,0.8922466888454011
PTPRU,Ulnar-mammary syndrome ORPHA:3138,0.8922466888454011
PTPRU,Uveal coloboma-cleft lip and palate-intellectual disability ORPHA:1473,0.8922466888454011
PTPRU,X-linked Alport syndrome ORPHA:88917,0.8922466888454011
PTPRU,Axenfeld anomaly ORPHA:98978,0.8922466888454011
PTPRU,Axenfeld-Rieger syndrome ORPHA:782,0.8922466888454011
PTPRU,Lacrimoauriculodentodigital syndrome ORPHA:2363,0.8922466888454011
PTPRU,Rieger anomaly ORPHA:91483,0.8922466888454011
PTPRU,X-linked hypohidrotic ectodermal dysplasia ORPHA:181,0.8922466888454011
PTPRU,BOR syndrome ORPHA:107,0.8922466888454011
PTPRU,Complete atrioventricular septal defect with ventricular hypoplasia ORPHA:99067,0.8922466888454011
PTPRU,Complete atrioventricular septal defect-tetralogy of Fallot ORPHA:99068,0.8922466888454011
PTPRU,Partial atrioventricular septal defect ORPHA:1330,0.8922466888454011
PTPRU,Coloboma of eye lens ORPHA:98943,0.8922466888454011
PTPRU,Coloboma of eyelid ORPHA:98946,0.8922466888454011
PTPRU,Coloboma of macula ORPHA:98945,0.8922466888454011
PTPRU,Coloboma of optic disc ORPHA:98947,0.8922466888454011
PTPRU,Split hand-split foot-deafness syndrome ORPHA:71271,0.8922466888454011
PTPRU,Branchiootic syndrome ORPHA:52429,0.8922466888454011
PTPRU,Enlarged parietal foramina ORPHA:60015,0.8922466888454011
PTPRU,Matthew-Wood syndrome ORPHA:2470,0.8922466888454011
PTPRU,X-linked non-syndromic sensorineural deafness type DFN ORPHA:90625,0.8922466888454011
PTPRU,Human gammaherpesvirus 4 BARF1 protein (gene: BARF1),0.8999095837312036
PTPRU,Human herpesvirus 4 type 2 BARF1,0.8999095837312036
PTPRU,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
PTPRU,Monkeypox virus soluble interferon-gamma receptor-like protein,0.8999095837312036
PTPRU,Monkeypox virus Zaire-96-I-16 B9R (gene: B9R),0.8999095837312036
PTPRU,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
PTPRU,Horsepox virus HSPV185 (Interferon gamma receptor IFNGR1),0.8999095837312036
PTPRU,Ectromelia virus ERPV interferon gamma receptor,0.9057542447893764
PTPRU,Human adenovirus 41 E3 31.6K,0.915880438522078
PTPRU,Human adenovirus 18 CR1-beta protein (gene: E3),0.9197295331382644
RAB11FIP3,Malignant neoplasm of breast,0.4084380369379369
RAB11FIP3,Breast Carcinoma,0.7333611688795861
RAB11FIP3,Cervix carcinoma,0.7765852775619541
RAB11FIP3,Platelet distribution width measurement,0.7880542567584415
RAB11FIP3,Platelet distribution width result,0.7880542567584415
RAB11FIP3,Neoplasm Metastasis,0.7880542567584415
RAB11FIP3,Platelet Count measurement,0.7880542567584415
RAB11FIP3,Chondrosarcoma,0.7880542567584415
RAB11FIP3,Neural Tube Defects,0.7880542567584415
RAB11FIP3,Coinfection,0.7880542567584415
RAB11FIP3,Acrania,0.8190761496232595
RAB11FIP3,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
RAB11FIP3,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
RAB11FIP3,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
RAB11FIP3,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
RAB11FIP3,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
RAB11FIP3,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
RAB11FIP3,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
RAB11FIP3,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
RAB11FIP3,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
RAB11FIP3,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
RAB11FIP3,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.1040670578681756
RAB11FIP3,Cerebellar-facial-dental syndrome ORPHA:444072,0.1040670578681756
RAB11FIP3,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.1040670578681756
RAB11FIP3,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.1040670578681756
RAB11FIP3,Steinert myotonic dystrophy ORPHA:273,0.1040670578681756
RAB11FIP3,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.1040670578681756
RAB11FIP3,Saldino-Mainzer syndrome ORPHA:140969,0.1991445465001551
RAB11FIP3,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069,0.1991445465001551
RAB11FIP3,Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899,0.1991445465001551
RAB11FIP3,Charcot-Marie-Tooth disease type 4F ORPHA:99952,0.1991445465001551
RAB11FIP3,Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215,0.1991445465001551
RAB11FIP3,Knobloch syndrome ORPHA:1571,0.1991445465001551
RAB11FIP3,Lethal congenital contracture syndrome type 3 ORPHA:137783,0.1991445465001551
RAB11FIP3,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.1991445465001551
RAB11FIP3,Synaptic congenital myasthenic syndromes ORPHA:98915,0.1991445465001551
RAB11FIP3,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E ORPHA:93114,0.3832844616405875
RAB11FIP3,Interstitial lung disease due to ABCA3 deficiency ORPHA:440402,0.3832844616405875
RAB11FIP3,Perry syndrome ORPHA:178509,0.3832844616405875
RAB11FIP3,Congenital muscular dystrophy with intellectual disability ORPHA:370968,0.3977968344535308
RAB11FIP3,Dentatorubral pallidoluysian atrophy ORPHA:101,0.5867963421058087
RAB11FIP3,Mazabraud syndrome ORPHA:57782,0.5867963421058087
RAB11FIP3,McCune-Albright syndrome ORPHA:562,0.5867963421058087
RAB11FIP3,Monostotic fibrous dysplasia ORPHA:93277,0.5867963421058087
RAB11FIP3,Polyostotic fibrous dysplasia ORPHA:93276,0.5867963421058087
RAB11FIP3,Progressive osseous heteroplasia ORPHA:2762,0.5867963421058087
RAB11FIP3,Pseudohypoparathyroidism type 1A ORPHA:79443,0.5867963421058087
RAB11FIP3,Pseudohypoparathyroidism type 1C ORPHA:79444,0.5867963421058087
RAB11FIP3,Pseudopseudohypoparathyroidism ORPHA:79445,0.5867963421058087
RAB11FIP3,Acute megakaryoblastic leukemia without Down syndrome ORPHA:329469,0.7929682744768703
RAB11FIP3,Neurofibromatosis-Noonan syndrome ORPHA:638,0.7929682744768703
RAB11FIP3,Pseudohypoparathyroidism type 1B ORPHA:94089,0.8922466888454011
RAB36,Leukemia,0.7765582368651238
RAB36,Orofaciodigital syndrome type 3 ORPHA:2752,0.8922466888454011
RAB36,Langat virus envelope membrane-associated glycoprotein,0.8999095837312036
RAB36,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
RAB36,Louping ill virus envelope protein,0.9057542447893764
RAB42,Mucopolysaccharidosis type 6 rapidly progressing ORPHA:276212,0.1991445465001551
RAB42,Mucopolysaccharidosis type 6 slowly progressing ORPHA:276223,0.1991445465001551
RAB9A,Hypercholesterolemia,0.7765852775619541
RAB9A,Mycoplasma Infections,0.7880542567584415
RAB9A,Lipoidosis,0.7880542567584415
RAB9A,Streptococcal Infections,0.8098851543361193
RAB9A,Pneumonia,0.834094492023826
RAB9A,Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714,0.5867963421058087
RAB9A,Hyperbiliverdinemia ORPHA:276405,0.5867963421058087
RAB9A,Aspartylglucosaminuria ORPHA:93,0.7929682744768703
RAB9A,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to TUD deficiency ORPHA:404493,0.7929682744768703
RAB9A,X-linked intellectual disability Nascimento type ORPHA:163956,0.8922466888454011
RAB9A,Human betaherpesvirus 5 regulatory protein IE2 (gene: UL122),0.8999095837312036
RAB9A,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
RALGPS1,Bladder Neoplasm,0.4084380369379369
RALGPS1,Malignant neoplasm of urinary bladder,0.5071083164302358
RALGPS1,Schizophrenia,0.7860378120955526
RALGPS1,Bladder Neoplasm,0.8115918568696846
RALGPS1,Urinary Bladder Cancer,0.8115918568696846
RALGPS1,Succinic semialdehyde dehydrogenase deficiency ORPHA:22,0.1991445465001551
RALGPS1,Usher syndrome type 1 ORPHA:231169,0.2661730864557679
RALGPS1,Gamma-aminobutyric acid transaminase deficiency ORPHA:2066,0.7929682744768703
RALGPS1,Monosomy 9q22.3 ORPHA:77301,0.7929682744768703
RALGPS1,Schilbach-Rott syndrome ORPHA:2353,0.7929682744768703
RALGPS1,AXIN2-related attenuated familial adenomatous polyposis ORPHA:401911,0.8922466888454011
RALGPS1,Autosomal dominant focal dystonia DYT25 type ORPHA:329466,0.8922466888454011
RALGPS1,Hyperprolinemia type 1 ORPHA:419,0.8922466888454011
RALGPS1,Oligodontia-cancer predisposition syndrome ORPHA:300576,0.8922466888454011
RALGPS1,Isolated anencephaly ORPHA:563609,0.8922466888454011
RALGPS1,Isolated exencephaly ORPHA:563612,0.8922466888454011
RALGPS1,ANK3-related intellectual disability-sleep disturbance syndrome ORPHA:356996,0.8922466888454011
RALGPS1,Autism spectrum disorder due to AUTS2 deficiency ORPHA:352490,0.8922466888454011
RASA4,Juvenile Myelomonocytic Leukemia,0.7880542567584415
RASA4,Monosomy,0.7880542567584415
RASA4,Colorectal cancer metastatic,0.8402911822757345
RASA4,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
RASA4,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
RASA4,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome ORPHA:352662,0.3832844616405875
RASA4,Craniosynostosis-dental anomalies ORPHA:284149,0.3832844616405875
RASA4,Glycogen storage disease due to muscle glycogen phosphorylase deficiency ORPHA:368,0.3832844616405875
RASA4,XYLT1-CDG ORPHA:370930,0.5867963421058087
RASA4,Autosomal recessive centronuclear myopathy ORPHA:169186,0.7929682744768703
RASA4,Primary sclerosing cholangitis ORPHA:171,0.7929682744768703
RASA4,NON RARE IN EUROPE: Berger disease ORPHA:34145,0.8922466888454011
RASA4,Benign Samaritan congenital myopathy ORPHA:324581,0.8922466888454011
RASA4,Central core disease ORPHA:597,0.8922466888454011
RASA4,Congenital multicore myopathy with external ophthalmoplegia ORPHA:98905,0.8922466888454011
RASA4,Congenital myopathy with myasthenic-like onset ORPHA:424107,0.8922466888454011
RASA4,Exercise-induced malignant hyperthermia ORPHA:466650,0.8922466888454011
RASA4,King-Denborough syndrome ORPHA:99741,0.8922466888454011
RASA4,Moderate multiminicore disease with hand involvement ORPHA:178145,0.8922466888454011
RASGRP2,Prolonged bleeding time,0.7880542567584415
RASGRP2,Leukocyte Adhesion Deficiency Type III,0.7880542567584415
RASGRP2,Epistaxis,0.7880542567584415
RASGRP2,Frequent nosebleeds,0.7880542567584415
RASGRP2,Leukocyte adhesion deficiency type 1,0.8009048756462318
RASGRP2,Thrombocytopenia,0.8019075543217649
RASGRP2,Blood Platelet Disorders,0.8272008757995397
RASGRP2,Bleeding Disorder,0.7765582368651238
RASGRP2,Platelet-type Bleeding Disorder,0.8115918568696846
RASGRP2,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
RASGRP2,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
RASGRP2,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.1040670578681756
RASGRP2,LIPE-related familial partial lipodystrophy ORPHA:435660,0.1040670578681756
RASGRP2,Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549,0.1991445465001551
RASGRP2,8p11.2 deletion syndrome ORPHA:251066,0.3832844616405875
RASGRP2,Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566,0.3832844616405875
RASGRP2,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome ORPHA:352662,0.3832844616405875
RASGRP2,Glycogen storage disease due to muscle glycogen phosphorylase deficiency ORPHA:368,0.3832844616405875
RASGRP2,Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606,0.3832844616405875
RASGRP2,Osteogenesis imperfecta type 5 ORPHA:216828,0.3832844616405875
RASGRP2,Polydactyly of a biphalangeal thumb ORPHA:93339,0.3832844616405875
RASGRP2,Polymicrogyria with optic nerve hypoplasia ORPHA:250972,0.3832844616405875
RASGRP2,Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301,0.3832844616405875
RASGRP2,Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003,0.3832844616405875
RASGRP2,Hereditary sensory and autonomic neuropathy type 4 ORPHA:642,0.5867963421058087
RASGRP2,Laron syndrome with immunodeficiency ORPHA:220465,0.5867963421058087
RASGRP2,Obesity due to pro-opiomelanocortin deficiency ORPHA:71526,0.5867963421058087
RASGRP2,XYLT1-CDG ORPHA:370930,0.5867963421058087
RASGRP2,NON RARE IN EUROPE: Vitiligo ORPHA:3435,0.5867963421058087
RASGRP2,Aland Islands eye disease ORPHA:178333,0.7929682744768703
RASGRP2,T-B+ severe combined immunodeficiency due to JAK3 deficiency ORPHA:35078,0.7929682744768703
RASGRP2,Familial medullary thyroid carcinoma ORPHA:99361,0.7929682744768703
RASGRP2,Complete hydatidiform mole ORPHA:254688,0.795266832401002
RASGRP2,Hereditary central diabetes insipidus ORPHA:30925,0.8922466888454011
RASGRP2,Short stature due to growth hormone qualitative anomaly ORPHA:629,0.8922466888454011
RASGRP2,TSH-secreting pituitary adenoma ORPHA:91347,0.8922466888454011
RASGRP2,Isolated growth hormone deficiency type II ORPHA:231679,0.8922466888454011
RASGRP2,Partial hydatidiform mole ORPHA:254693,0.8922466888454011
RASGRP2,Hereditary elliptocytosis ORPHA:288,0.8922466888454011
RASGRP2,Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16 ORPHA:98791,0.8922466888454011
RASGRP2,Hb Bart's hydrops fetalis ORPHA:163596,0.8922466888454011
RASGRP2,Hemoglobin H disease ORPHA:93616,0.8922466888454011
RASGRP2,Acute myeloid leukemia with minimal differentiation ORPHA:98832,0.8922466888454011
RASGRP2,Isolated growth hormone deficiency type IA ORPHA:231662,0.8922466888454011
RASGRP2,Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16,0.8922466888454011
RASL10A,Glioma,0.7880542567584415
RASL10A,Glioblastoma,0.7880542567584415
RASL10A,Platelet mean volume determination (procedure),0.7880542567584415
RASL10A,Neuroepithelial Perineurial and Schwann Cell Neoplasm,0.7880542567584415
RASL10A,Malignant Glioma,0.7880542567584415
RASL10A,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
RASL10A,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
RASL10A,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
RBM7,Non-Small Cell Lung Carcinoma,0.7765852775619541
RBM7,Lung Carcinoma,0.8139950454942313
RBM7,Squamous cell carcinoma of salivary glands ORPHA:500481,0.3832844616405875
RBM7,Squamous cell carcinoma of the hypopharynx ORPHA:494547,0.3832844616405875
RBM7,Squamous cell carcinoma of the larynx ORPHA:494550,0.3832844616405875
RBM7,Squamous cell carcinoma of the lip ORPHA:502366,0.3832844616405875
RBM7,Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464,0.3832844616405875
RBM7,Squamous cell carcinoma of the oral cavity ORPHA:502363,0.3832844616405875
RBM7,Squamous cell carcinoma of the oropharynx ORPHA:500478,0.3832844616405875
RBM7,DNAJB6-related  limb-girdle muscular dystrophy D1 ORPHA:34516,0.7929682744768703
RBM7,Prenatal-onset spinal muscular atrophy with congenital bone fractures ORPHA:486811,0.8922466888454011
RBM7,Infantile cerebral and cerebellar atrophy with postnatal progressive microcephaly ORPHA:402364,0.8922466888454011
RBM7,Human adenovirus 21a 100 kDa hexon-assembly associated protein (gene: L4),0.8999095837312036
RBM7,Human adenovirus 68 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
RBM7,Human mastadenovirus B hexon assembly protein 100K (gene: L4),0.8999095837312036
RBM7,Human adenovirus B3 L4 100-kDa protein (gene: L4),0.8999095837312036
RBM7,Human adenovirus 66 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
RBM7,Cercopithecine betaherpesvirus 5 tegument protein UL37 (gene: UL47),0.8999095837312036
RBM7,Human papillomavirus type 43 E2 protein (gene: E2),0.8999095837312036
RBX1,Carcinoma of bladder,0.4084380369379369
RBX1,Bladder Neoplasm,0.4084380369379369
RBX1,Malignant neoplasm of urinary bladder,0.5071083164302358
RBX1,Breast Carcinoma,0.7333611688795861
RBX1,Carcinogenesis,0.7333611688795861
RBX1,Malignant neoplasm of ovary,0.7333611688795861
RBX1,Ovarian Carcinoma,0.7333611688795861
RBX1,Esophageal carcinoma,0.7765852775619541
RBX1,Vascular Diseases,0.7765852775619541
RBX1,Esophageal Neoplasms,0.7765852775619541
RBX1,Liver carcinoma,0.7880542567584415
RBX1,Malignant neoplasm of esophagus,0.7880542567584415
RBX1,Malignant Head and Neck Neoplasm,0.7880542567584415
RBX1,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
RBX1,Neoplasm Metastasis,0.7880542567584415
RBX1,Squamous cell carcinoma of the head and neck,0.7880542567584415
RBX1,Malignant neoplasm of liver,0.7880542567584415
RBX1,Neoplasms,0.7880542567584415
RBX1,Malignant neoplasm of stomach,0.7880542567584415
RBX1,Transitional cell carcinoma of bladder,0.7880542567584415
RBX1,GLOMUVENOUS MALFORMATIONS,0.7880542567584415
RBX1,Tumor Progression,0.7880542567584415
RBX1,Renal Cell Carcinoma,0.7880542567584415
RBX1,Stomach Carcinoma,0.7880542567584415
RBX1,Crohn Disease,0.7880542567584415
RBX1,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
RBX1,Toxic Epidermal Necrolysis,0.8019075543217649
RBX1,Stomach Neoplasms,0.8044379824544406
RBX1,Drug-Induced Stevens Johnson Syndrome,0.8190761496232595
RBX1,Mycoplasma-Induced Stevens-Johnson Syndrome,0.8190761496232595
RBX1,Stevens-Johnson Syndrome Toxic Epidermal Necrolysis Spectrum,0.8212681436603975
RBX1,Carcinoma Transitional Cell,0.8368219249856942
RBX1,Stevens-Johnson Syndrome,0.8610447277138289
RBX1,Von Hippel-Lindau Syndrome,0.8648405521677974
RBX1,Clear-cell metastatic renal cell carcinoma,0.8989612563669234
RBX1,Polycythemia,0.8989612563669234
RBX1,Anxiety Disorder,0.8507213163251659
RBX1,Stevens-Johnson Syndrome,0.8611702959552964
RBX1,DNAJB6-related  limb-girdle muscular dystrophy D1 ORPHA:34516,0.7929682744768703
RBX1,C11ORF73-related autosomal recessive hypomyelinating leukodystrophy ORPHA:495844,0.8922466888454011
RBX1,Multiple mitochondrial dysfunctions syndrome type 4 ORPHA:457406,0.8922466888454011
RBX1,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
RBX1,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
RBX1,Human herpesvirus 3 strain Dumas ring-finger protein,0.8999095837312036
RBX1,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.8999095837312036
RBX1,Parainfluenza virus 5 V protein (gene: V/P),0.8999095837312036
RBX1,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
RBX1,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
RBX1,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
RBX1,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
RBX1,Monkeypox virus ankyrin-like protein,0.8999095837312036
RBX1,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
RBX1,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
RBX1,Ectromelia virus ERPV ankyrin,0.9057542447893764
RBX1,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
RBX1,Yaba-like disease virus 34L protein (gene: 34L),0.9057542447893764
RBX1,Orf virus ORF126 ankyrin repeat protein,0.9058994261255549
RBX1,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
RBX1,Variola virus hypothetical protein (gene: B6R),0.9364561700418303
RCCD1,Non-Small Cell Lung Carcinoma,0.7765852775619541
RCCD1,Mammary Neoplasms,0.8165359516083085
RCCD1,Marfan Syndrome,0.8477374749042494
RCCD1,Breast Cancer,0.8903630091389316
RCCD1,Breast Carcinoma,0.9398381935810408
RCCD1,Combined oxidative phosphorylation defect type 23 ORPHA:444013,0.5867963421058087
RDH13,Liver Cirrhosis Experimental,0.8014900279306119
RDH13,Drug-Induced Liver Disease,0.8523465762428218
RDH13,Hepatitis Toxic,0.8548862007194026
RDH13,Chemical and Drug Induced Liver Injury,0.8548862007194026
RDH13,Chemically-Induced Liver Toxicity,0.8548862007194026
RDH13,Drug-Induced Acute Liver Injury,0.8548862007194026
RDH13,Hepatitis Drug-Induced,0.8578473133580928
RDH13,Necrosis,0.8648405521677974
RDH13,Pityriasis rubra pilaris ORPHA:2897,0.5867963421058087
RDH13,Autosomal dominant optic atrophy and cataract ORPHA:67036,0.8922466888454011
RDH13,3-methylglutaconic aciduria type 3 ORPHA:67047,0.8922466888454011
RDH13,Ectromelia virus ERPV hydroxysteroid dehydrogenase,0.8999095837312036
RDH13,Cowpox virus CPXV182 protein (gene: CPXV182 CDS),0.8999095837312036
RDH13,Vaccinia virus hydroxysteroid dehydrogenase (gene: A44L),0.8999095837312036
RDH13,Horsepox virus HSPV166 (Rossmann-fold NAD(P)(+)-binding proteins),0.8999095837312036
RDH13,Vaccinia virus Ankara 3 beta-hydroxysteroid dehydrogenase,0.8999095837312036
RDH13,Molluscum contagiosum virus subtype 1 MC152R (gene: MC152R),0.8999095837312036
RDH13,Yaba-like disease virus 133L protein (gene: 133L),0.8999095837312036
REC8,Malignant neoplasm of prostate,0.7880542567584415
REC8,Thyroid carcinoma,0.7880542567584415
REC8,Prostatic Neoplasms,0.7880542567584415
REC8,Malignant neoplasm of thyroid,0.7880542567584415
REC8,melanoma,0.7880542567584415
REC8,Congenital absence of germinal epithelium of testes,0.7880542567584415
REC8,Gastrointestinal Stromal Sarcoma,0.8019075543217649
REC8,Dysmorphic features,0.8648405521677974
REC8,Mental Retardation,0.922229272318747
REC8,Intellectual Disability,0.9478210444156088
REC8,Prostate Cancer,0.7765582368651238
REC8,Melanoma,0.7765582368651238
REC8,Prostatic Neoplasms,0.7765582368651238
REC8,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
REC8,Methylmalonic acidemia with homocystinuria type cblJ ORPHA:369955,0.1991445465001551
REEP6,Colon Carcinoma,0.7765852775619541
REEP6,Retinal pigment epithelial abnormality,0.7765852775619541
REEP6,Abnormality of retinal pigmentation,0.7765852775619541
REEP6,Malignant tumor of colon,0.7765852775619541
REEP6,Difficulties with night vision,0.7880542567584415
REEP6,Night Blindness,0.7880542567584415
REEP6,Conductive hearing loss,0.7880542567584415
REEP6,Photophobia,0.7880542567584415
REEP6,Nystagmus,0.7880542567584415
REEP6,Anteverted nostril,0.7880542567584415
REEP6,Glaucoma,0.7880542567584415
REEP6,Abnormality of the retinal vasculature,0.7880542567584415
REEP6,Crohn Disease,0.7880542567584415
REEP6,Photodysphoria,0.7880542567584415
REEP6,Optic Atrophy,0.7880542567584415
REEP6,Electroretinogram abnormal,0.7908231553833205
REEP6,Hyperinsulinism,0.8019075543217649
REEP6,Reduced visual acuity,0.8019075543217649
REEP6,Posterior subcapsular cataract,0.8019075543217649
REEP6,Blindness Legal,0.8019075543217649
REEP6,Blindness,0.8098851543361193
REEP6,Congenital anomaly of testis,0.8168901801930506
REEP6,Progressive night blindness,0.8168901801930506
REEP6,Ulcerative Colitis,0.8190761496232595
REEP6,Broad flat nasal bridge,0.8213459222602666
REEP6,Nasal bridge wide,0.8232134984476662
REEP6,Congenital hypoplasia of penis,0.8232134984476662
REEP6,Atypical scarring of skin,0.8272008757995397
REEP6,Retinitis Pigmentosa,0.8402911822757345
REEP6,Mental deficiency,0.8402911822757345
REEP6,Hypogonadism,0.8402911822757345
REEP6,Keratoconus,0.8584283190330553
REEP6,Dull intelligence,0.8757755363384367
REEP6,Low intelligence,0.8757755363384367
REEP6,Cataract,0.8769418330148872
REEP6,Inflammatory Bowel Diseases,0.8815127642200768
REEP6,Poor school performance,0.8913141512402477
REEP6,Obesity,0.8989612563669234
REEP6,Ophthalmoplegia,0.900167961295542
REEP6,Lens Opacities,0.9117936912777788
REEP6,Mental Retardation,0.922229272318747
REEP6,Intellectual Disability,0.9478210444156088
REEP6,Sensorineural Hearing Loss (disorder),0.9520060723130308
REEP6,Nystagmus,0.7765582368651238
REEP6,Nyctalopia,0.7765582368651238
REEP6,Capsular Cataract,0.8115918568696846
REEP6,Optic Atrophy,0.8115918568696846
REEP6,Hearing Loss,0.8115918568696846
REEP6,Mental Retardation,0.8337953215113012
REEP6,Retinitis Pigmentosa,0.861756360478846
REEP6,Hyperinsulinism,0.861756360478846
REEP6,Keratoconus,0.8879896755141929
REEP6,Rod-cone Dystrophy,0.8903301324869451
REEP6,Glaucoma,0.8903630091389316
REEP6,Diabetes Mellitus,0.919442421650838
REEP6,Hypogonadism,0.9259420053407031
REEP6,Cataract,0.974502015052702
REEP6,Congenital Hypoplasia Of Penis,0.9832345076528324
REEP6,Obesity,0.9832345076528324
REEP6,Pyruvate carboxylase deficiency benign type ORPHA:353320,0.1991445465001551
REEP6,Pyruvate carboxylase deficiency infantile type ORPHA:353308,0.1991445465001551
REEP6,Pyruvate carboxylase deficiency severe neonatal type ORPHA:353314,0.1991445465001551
REEP6,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3832844616405875
REEP6,Congenital factor XII deficiency ORPHA:330,0.5867963421058087
REEP6,F12-related hereditary angioedema with normal C1Inh ORPHA:100054,0.5867963421058087
REEP6,Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927,0.5867963421058087
REEP6,Hyperprolinemia type 2 ORPHA:79101,0.5867963421058087
REEP6,Ollier disease ORPHA:296,0.5867963421058087
REEP6,Congenital bile acid synthesis defect type 4 ORPHA:79095,0.7929682744768703
REEP6,Essential fructosuria ORPHA:2056,0.7929682744768703
REEP6,Hyperimmunoglobulinemia D with periodic fever ORPHA:343,0.7929682744768703
REEP6,Mevalonic aciduria ORPHA:29,0.7929682744768703
REEP6,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib ORPHA:79259,0.8922466888454011
REEP6,Guanidinoacetate methyltransferase deficiency ORPHA:382,0.8922466888454011
REEP6,Isolated sedoheptulokinase deficiency ORPHA:440713,0.8922466888454011
REEP6,Neurological conditions associated with aminoacylase 1 deficiency ORPHA:137754,0.8922466888454011
REEP6,Maffucci syndrome ORPHA:163634,0.8922466888454011
REEP6,Retinitis pigmentosa ORPHA:791,0.8922466888454011
REEP6,Autosomal dominant mitochondrial myopathy with exercise intolerance ORPHA:457050,0.8922466888454011
REEP6,Lower motor neuron syndrome with late-adult onset ORPHA:276435,0.8922466888454011
REEP6,Pterin-4 alpha-carbinolamine dehydratase deficiency ORPHA:1578,0.8922466888454011
REEP6,Congenital cataract-hypertrophic cardiomyopathy-mitochondrial myopathy syndrome ORPHA:1369,0.8922466888454011
RGS11,Ankylosing spondylitis,0.7880542567584415
RGS11,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
RGS11,Lethal congenital contracture syndrome type 3 ORPHA:137783,0.1991445465001551
RGS11,Interstitial lung disease due to ABCA3 deficiency ORPHA:440402,0.3832844616405875
RGS11,Hypomyelination neuropathy-arthrogryposis syndrome ORPHA:2680,0.3832844616405875
RGS11,Paroxysmal non-kinesigenic dyskinesia ORPHA:98810,0.5867963421058087
RGS11,Permanent neonatal diabetes mellitus ORPHA:99885,0.5959529547720634
RGS11,CLN13 disease ORPHA:352709,0.8922466888454011
RGS11,Familial dyskinesia and facial myokymia ORPHA:324588,0.8922466888454011
RGS11,Familial benign flecked retina ORPHA:363989,0.8922466888454011
RGS11,Microphthalmia-retinitis pigmentosa-foveoschisis-optic disc drusen syndrome ORPHA:251279,0.8922466888454011
RGS11,Transient neonatal diabetes mellitus ORPHA:99886,0.8922466888454011
RHEBL1,Leukemia Myelocytic Acute,0.7765852775619541
RHEBL1,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
RHEBL1,Childhood Acute Myeloid Leukemia,0.8009048756462318
RHEBL1,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.3832844616405875
RHEBL1,Amish lethal microcephaly ORPHA:99742,0.7929682744768703
RHEBL1,Progressive polyneuropathy with bilateral striatal necrosis ORPHA:217396,0.7929682744768703
RHEBL1,Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139,0.7929682744768703
RHEBL1,Langat virus envelope membrane-associated glycoprotein,0.8999095837312036
RHEBL1,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
RHPN1,Sclerocystic Ovaries,0.7880542567584415
RHPN1,Polycystic Ovary Syndrome,0.9174808175273056
RHPN1,Sclerocystic Ovaries,0.7765582368651238
RHPN1,Polycystic Ovary Syndrome,0.7765582368651238
RHPN1,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160,0.1991445465001551
RHPN1,Autosomal dominant spondylocostal dysostosis ORPHA:1797,0.8922466888454011
RHPN2,Colorectal Carcinoma,0.7765852775619541
RHPN2,Colorectal Neoplasms,0.7765852775619541
RHPN2,Glioma,0.7880542567584415
RHPN2,Colorectal Cancer,0.7880542567584415
RHPN2,Glioblastoma,0.7880542567584415
RHPN2,Nasopharyngeal Neoplasms,0.7880542567584415
RHPN2,Malignant Glioma,0.7880542567584415
RHPN2,Adenocarcinoma of large intestine,0.8019075543217649
RHPN2,Nasopharyngeal Carcinoma,0.8115918568696846
RHPN2,Colorectal Adenoma,0.8115918568696846
RHPN2,Colonic Neoplasms,0.8210988731657684
RHPN2,Colorectal Neoplasms,0.9510372690456612
RHPN2,Colorectal Cancer,0.9832345076528324
RHPN2,Currarino syndrome ORPHA:1552,0.0155394890951578
RHPN2,Apparent mineralocorticoid excess ORPHA:320,0.1991445465001551
RHPN2,Congenital intrauterine infection-like syndrome ORPHA:1229,0.1991445465001551
RHPN2,Congenital tufting enteropathy ORPHA:92050,0.1991445465001551
RHPN2,Isolated neonatal sclerosing cholangitis ORPHA:480556,0.1991445465001551
RHPN2,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.1991445465001551
RHPN2,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.1991445465001551
RHPN2,Hereditary folate malabsorption ORPHA:90045,0.3832844616405875
RHPN2,Bartsocas-Papas syndrome ORPHA:1234,0.5867963421058087
RHPN2,CHAND syndrome ORPHA:1401,0.5867963421058087
RHPN2,Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540,0.5867963421058087
RHPN2,Wilson disease ORPHA:905,0.5867963421058087
RHPN2,Xanthinuria type II ORPHA:93602,0.5867963421058087
RHPN2,Microvillus inclusion disease ORPHA:2290,0.5867963421058087
RHPN2,Familial steroid-resistant nephrotic syndrome with adrenal insufficiency ORPHA:506334,0.7929682744768703
RHPN2,Neurodegenerative syndrome due to cerebral folate transport deficiency ORPHA:217382,0.7929682744768703
RHPN2,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.7929682744768703
RHPN2,17q12 microdeletion syndrome ORPHA:261265,0.7929682744768703
RHPN2,Oligodontia ORPHA:99798,0.8778481542696168
RHPN2,Hereditary hypercarotenemia and vitamin A deficiency ORPHA:199285,0.8922466888454011
RHPN2,Hypoplastic tibiae-postaxial polydactyly syndrome ORPHA:3332,0.8922466888454011
RHPN2,Polydactyly of a triphalangeal thumb ORPHA:93336,0.8922466888454011
RHPN2,Radial hemimelia ORPHA:93321,0.8922466888454011
RHPN2,Syndactyly type 4 ORPHA:93405,0.8922466888454011
RHPN2,Triphalangeal thumb-polysyndactyly syndrome ORPHA:2950,0.8922466888454011
RHPN2,Senior-Boichis syndrome ORPHA:84081,0.8922466888454011
RHPN2,Molluscum contagiosum virus subtype 1 MC034L (gene: MC034L),0.8999095837312036
RIMS3,Rat Adrenal Gland Pheochromocytoma,0.7880542567584415
RIMS3,Autistic Disorder,0.8019075543217649
RIMS3,Schizophrenia,0.8067197998685076
RIMS3,Schizophrenia,0.7860378120955526
RIMS3,Distal 22q11.2 microdeletion syndrome ORPHA:261330,0.3832844616405875
RIMS3,Primary dystonia DYT4 type ORPHA:98805,0.5867963421058087
RIMS3,Cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome ORPHA:1171,0.7929682744768703
RIMS3,Rapid-onset dystonia-parkinsonism ORPHA:71517,0.7929682744768703
RIMS3,Ventriculomegaly-cystic kidney disease ORPHA:443988,0.8922466888454011
RIOK3,Reticulocyte count (procedure),0.5071083164302358
RIOK3,Pancreatic Neoplasm,0.7765852775619541
RIOK3,Neoplasm Metastasis,0.7880542567584415
RIOK3,Adenocarcinoma of pancreas,0.7880542567584415
RIOK3,Virus Diseases,0.7880542567584415
RIOK3,Secondary malignant neoplasm of lung,0.8232134984476662
RIOK3,Measles,0.8938510789776706
RIOK3,Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714,0.5867963421058087
RIOK3,Neutral lipid storage disease with ichthyosis ORPHA:98907,0.5867963421058087
RIOK3,Spinocerebellar ataxia type 18 ORPHA:98771,0.7929682744768703
RIOK3,X-linked centronuclear myopathy ORPHA:596,0.7929682744768703
RIOK3,Noonan syndrome-like disorder with loose anagen hair ORPHA:2701,0.8922466888454011
RIOK3,Autosomal recessive spastic paraplegia type 45 ORPHA:320396,0.8922466888454011
RIOK3,Hemolytic anemia due to pyrimidine 5' nucleotidase deficiency ORPHA:35120,0.8922466888454011
RIOK3,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
RIOK3,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
RIOK3,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
RIOK3,Human gammaherpesvirus 8 ORF72,0.8999095837312036
RIOK3,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
RIOK3,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
RIOK3,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
RIOK3,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
RIOK3,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
RIOK3,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
RIOK3,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
RIOK3,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
RIOK3,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
RIOK3,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
RIOK3,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
RIOK3,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
RIOK3,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
RIOK3,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
RIOK3,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
RIOK3,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
RNF24,HIV Infections,0.8145035474981049
RNF24,Drug-Induced Liver Disease,0.8523465762428218
RNF24,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
RNF24,Obesity due to CEP19 deficiency ORPHA:397615,0.7929682744768703
RNF24,Atypical pantothenate kinase-associated neurodegeneration ORPHA:216873,0.8922466888454011
RNF24,Classic pantothenate kinase-associated neurodegeneration ORPHA:216866,0.8922466888454011
RNF24,Autosomal dominant macrothrombocytopenia ORPHA:140957,0.8922466888454011
RNF41,Malignant neoplasm of breast,0.4084380369379369
RNF41,Breast Carcinoma,0.7333611688795861
RNF41,Colorectal Carcinoma,0.7765852775619541
RNF41,Mammary Neoplasms,0.7880542567584415
RNF41,Glioma,0.7880542567584415
RNF41,Malignant neoplasm of prostate,0.7880542567584415
RNF41,Colorectal Cancer,0.7880542567584415
RNF41,Glioblastoma,0.7880542567584415
RNF41,Prostate carcinoma,0.7880542567584415
RNF41,Neoplasm Metastasis,0.7880542567584415
RNF41,Mental disorders,0.7880542567584415
RNF41,Vesicular Stomatitis,0.7880542567584415
RNF41,Malignant neoplasm of large intestine,0.7880542567584415
RNF41,Tumor Progression,0.7880542567584415
RNF41,Childhood Glioblastoma,0.7880542567584415
RNF41,Adult Glioblastoma,0.7880542567584415
RNF41,Tumor Initiation,0.7880542567584415
RNF41,Chronic Lymphocytic Leukemia,0.8019075543217649
RNF41,Mammary Tumorigenesis,0.8190761496232595
RNF41,Parkinson Disease,0.8772392350816924
RNF41,Bipolar Disorder,0.900167961295542
RNF41,Unipolar Depression,0.9455834988784428
RNF41,Anxiety Disorders,0.946564927793026
RNF41,Seizures,0.9478210444156088
RNF41,Major Depressive Disorder,0.9658628445524134
RNF41,Anxiety,0.9708740267329932
RNF41,Mental Depression,0.8903630091389316
RNF41,Bipolar Disorder,0.943322675973118
RNF41,Human herpesvirus 3 strain Dumas ring-finger protein,0.8999095837312036
RNF41,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.8999095837312036
RPUSD1,Crisponi syndrome ORPHA:1545,0.0155394890951578
RPUSD1,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
RPUSD1,Incontinentia pigmenti ORPHA:464,0.0414176838632111
RPUSD1,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
RPUSD1,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
RPUSD1,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
RPUSD1,Focal dermal hypoplasia ORPHA:2092,0.1040670578681756
RPUSD1,Adrenomyeloneuropathy ORPHA:139399,0.1991445465001551
RPUSD1,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.1991445465001551
RPUSD1,CADDS ORPHA:369942,0.1991445465001551
RPUSD1,Early myoclonic encephalopathy ORPHA:1935,0.1991445465001551
RPUSD1,Galactokinase deficiency ORPHA:79237,0.3832844616405875
RPUSD1,Ichthyosis-prematurity syndrome ORPHA:88621,0.3832844616405875
RPUSD1,Intellectual disability-strabismus syndrome ORPHA:363528,0.3832844616405875
RPUSD1,Lipoyl transferase 2 deficiency ORPHA:447795,0.3832844616405875
RPUSD1,MOGS-CDG ORPHA:79330,0.3832844616405875
RPUSD1,Spondylo-ocular syndrome ORPHA:85194,0.3832844616405875
RPUSD1,TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642,0.3832844616405875
RPUSD1,Testicular regression syndrome ORPHA:983,0.3832844616405875
RPUSD1,3C syndrome ORPHA:7,0.3832844616405875
RPUSD1,Rare isolated myopia ORPHA:98619,0.3832844616405875
RPUSD1,Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815,0.5867963421058087
RPUSD1,Autosomal recessive axonal Charcot-Marie-Tooth disease due to copper metabolism defect ORPHA:521411,0.5867963421058087
RPUSD1,Autosomal recessive cerebellar ataxia due to STUB1 deficiency ORPHA:412057,0.5867963421058087
RPUSD1,Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026,0.5867963421058087
RPUSD1,Combined oxidative phosphorylation defect type 23 ORPHA:444013,0.5867963421058087
RPUSD1,Congenital factor XII deficiency ORPHA:330,0.5867963421058087
RPUSD1,F12-related hereditary angioedema with normal C1Inh ORPHA:100054,0.5867963421058087
RPUSD1,Familial atypical multiple mole melanoma syndrome ORPHA:404560,0.5867963421058087
RPUSD1,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694,0.5867963421058087
RPUSD1,Lethal brain and heart developmental defects ORPHA:580933,0.5867963421058087
RPUSD1,Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845,0.5867963421058087
RPUSD1,Melanoma and neural system tumor syndrome ORPHA:252206,0.5867963421058087
RPUSD1,NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362,0.5867963421058087
RPUSD1,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome ORPHA:529665,0.5867963421058087
RPUSD1,Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790,0.5867963421058087
RPUSD1,RFVT2-related riboflavin transporter deficiency ORPHA:572543,0.5867963421058087
RPUSD1,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome ORPHA:363444,0.5867963421058087
RPUSD1,Transketolase deficiency ORPHA:488618,0.5867963421058087
RPUSD1,Familial melanoma ORPHA:618,0.6873535151929783
RPUSD1,8q24.3 microdeletion syndrome ORPHA:508488,0.7929682744768703
RPUSD1,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome ORPHA:466794,0.7929682744768703
RPUSD1,Auditory neuropathy-optic atrophy syndrome ORPHA:542585,0.7929682744768703
RPUSD1,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency ORPHA:308410,0.7929682744768703
RPUSD1,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:75496,0.7929682744768703
RPUSD1,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ORPHA:330054,0.7929682744768703
RPUSD1,DDX41-related hematologic malignancy predisposition syndrome ORPHA:488647,0.7929682744768703
RPUSD1,Disseminated superficial actinic porokeratosis ORPHA:79152,0.7929682744768703
RPUSD1,GMPPB-related  limb-girdle muscular dystrophy R19 ORPHA:363623,0.7929682744768703
RPUSD1,Glycogen storage disease due to aldolase A deficiency ORPHA:57,0.7929682744768703
RPUSD1,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome ORPHA:508498,0.7929682744768703
RPUSD1,Larsen-like syndrome B3GAT3 type ORPHA:284139,0.7929682744768703
RPUSD1,Leukocyte adhesion deficiency type II ORPHA:99843,0.7929682744768703
RPUSD1,Macrocephaly-developmental delay syndrome ORPHA:397612,0.7929682744768703
RPUSD1,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome ORPHA:363649,0.7929682744768703
RPUSD1,Methylmalonic aciduria due to transcobalamin receptor defect ORPHA:280183,0.7929682744768703
RPUSD1,NTHL1-related attenuated familial adenomatous polyposis ORPHA:454840,0.7929682744768703
RPUSD1,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470,0.7929682744768703
RPUSD1,PYCR2-related microcephaly-progressive leukoencephalopathy ORPHA:481152,0.7929682744768703
RPUSD1,Pontocerebellar hypoplasia type 8 ORPHA:324569,0.7929682744768703
RPUSD1,Spinocerebellar ataxia type 4 ORPHA:98765,0.7929682744768703
RPUSD1,Insulinoma ORPHA:97279,0.7929682744768703
RPUSD1,MEDNIK syndrome ORPHA:171851,0.7929682744768703
RPUSD1,Microlissencephaly ORPHA:1083,0.7929682744768703
RPUSD1,Hereditary isolated aplastic anemia ORPHA:397692,0.7929682744768703
RPUSD1,Schwannomatosis ORPHA:93921,0.795266832401002
RPUSD1,ALG12-CDG ORPHA:79324,0.8922466888454011
RPUSD1,Adenine phosphoribosyltransferase deficiency ORPHA:976,0.8922466888454011
RPUSD1,Autosomal recessive spondylometaphyseal dysplasia Megarbane type ORPHA:401979,0.8922466888454011
RPUSD1,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:536467,0.8922466888454011
RPUSD1,Congenital muscular dystrophy with intellectual disability and severe epilepsy ORPHA:329178,0.8922466888454011
RPUSD1,Costello syndrome ORPHA:3071,0.8922466888454011
RPUSD1,Phakomatosis pigmentokeratotica ORPHA:2874,0.8922466888454011
RPUSD1,TARP syndrome ORPHA:2886,0.8922466888454011
RPUSD1,Woolly hair nevus ORPHA:79414,0.8922466888454011
RPUSD1,Null pituitary adenoma ORPHA:314790,0.8922466888454011
RPUSD1,Pituitary gigantism ORPHA:99725,0.8922466888454011
RPUSD1,Silent pituitary adenoma ORPHA:314786,0.8922466888454011
RPUSD1,Baraitser-Winter cerebrofrontofacial syndrome ORPHA:2995,0.8922466888454011
RPUSD1,Acrofacial dysostosis Rodriguez type ORPHA:1788,0.8922466888454011
RPUSD1,COASY protein-associated neurodegeneration ORPHA:397725,0.8922466888454011
RPUSD1,DL-2-hydroxyglutaric aciduria ORPHA:356978,0.8922466888454011
RPUSD1,FADD-related immunodeficiency ORPHA:306550,0.8922466888454011
RPUSD1,Nager syndrome ORPHA:245,0.8922466888454011
RPUSD1,Ogden syndrome ORPHA:276432,0.8922466888454011
RPUSD1,Pontocerebellar hypoplasia type 4 ORPHA:166063,0.8922466888454011
RPUSD1,Oculootodental syndrome ORPHA:99806,0.8922466888454011
RRP9,Malignant neoplasm of breast,0.4084380369379369
RRP9,Disease Exacerbation,0.7880542567584415
RRP9,Malignant neoplasm of stomach,0.7880542567584415
RRP9,Hereditary Diffuse Gastric Cancer,0.8019075543217649
RRP9,Stomach Neoplasms,0.8044379824544406
RRP9,Stomach Neoplasms,0.7765582368651238
RRP9,Gastric Cancer,0.861756360478846
RRP9,Breast Cancer,0.8903630091389316
RRP9,Focal dermal hypoplasia ORPHA:2092,0.1040670578681756
RRP9,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.3832844616405875
RRP9,Lipoyl transferase 2 deficiency ORPHA:447795,0.3832844616405875
RRP9,Testicular regression syndrome ORPHA:983,0.3832844616405875
RRP9,Acute intermittent porphyria ORPHA:79276,0.5867963421058087
RRP9,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694,0.5867963421058087
RRP9,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome ORPHA:502423,0.5867963421058087
RRP9,Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790,0.5867963421058087
RRP9,RFVT2-related riboflavin transporter deficiency ORPHA:572543,0.5867963421058087
RRP9,Schnyder corneal dystrophy ORPHA:98967,0.5867963421058087
RRP9,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome ORPHA:363444,0.5867963421058087
RRP9,Transketolase deficiency ORPHA:488618,0.5867963421058087
RRP9,Familial melanoma ORPHA:618,0.6873535151929783
RRP9,8q24.3 microdeletion syndrome ORPHA:508488,0.7929682744768703
RRP9,Auditory neuropathy-optic atrophy syndrome ORPHA:542585,0.7929682744768703
RRP9,B4GALT7-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:75496,0.7929682744768703
RRP9,Bjornstad syndrome ORPHA:123,0.7929682744768703
RRP9,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ORPHA:330054,0.7929682744768703
RRP9,DDX41-related hematologic malignancy predisposition syndrome ORPHA:488647,0.7929682744768703
RRP9,Disseminated superficial actinic porokeratosis ORPHA:79152,0.7929682744768703
RRP9,GRACILE syndrome ORPHA:53693,0.7929682744768703
RRP9,Glutaryl-CoA dehydrogenase deficiency ORPHA:25,0.7929682744768703
RRP9,Hyperimmunoglobulinemia D with periodic fever ORPHA:343,0.7929682744768703
RRP9,Intellectual disability-cardiac anomalies-short stature-joint laxity syndrome ORPHA:508498,0.7929682744768703
RRP9,Leydig cell hypoplasia due to LHB deficiency ORPHA:325448,0.7929682744768703
RRP9,MPDU1-CDG ORPHA:79323,0.7929682744768703
RRP9,Macrocephaly-developmental delay syndrome ORPHA:397612,0.7929682744768703
RRP9,Methylmalonic aciduria due to transcobalamin receptor defect ORPHA:280183,0.7929682744768703
RRP9,Mevalonic aciduria ORPHA:29,0.7929682744768703
RRP9,NTHL1-related attenuated familial adenomatous polyposis ORPHA:454840,0.7929682744768703
RRP9,Optic atrophy-ataxia-peripheral neuropathy-global developmental delay syndrome ORPHA:543470,0.7929682744768703
RRP9,Renal tubulopathy-encephalopathy-liver failure syndrome ORPHA:254902,0.7929682744768703
RRP9,Richieri Costa-Pereira syndrome ORPHA:3102,0.7929682744768703
RRP9,S-adenosylhomocysteine hydrolase deficiency ORPHA:88618,0.7929682744768703
RRP9,Spinocerebellar ataxia type 4 ORPHA:98765,0.7929682744768703
RRP9,Lymphomatoid papulosis ORPHA:98842,0.7929682744768703
RRP9,Primary cutaneous anaplastic large cell lymphoma ORPHA:300865,0.7929682744768703
RRP9,Dyskeratosis congenita ORPHA:1775,0.8668760866668862
RRP9,3-methylglutaconic aciduria type 8 ORPHA:505208,0.8922466888454011
RRP9,ALG1-CDG ORPHA:79327,0.8922466888454011
RRP9,Autosomal recessive cerebelloparenchymal disorder type 3 ORPHA:1170,0.8922466888454011
RRP9,Autosomal recessive spondylometaphyseal dysplasia Megarbane type ORPHA:401979,0.8922466888454011
RRP9,Cerebrocostomandibular syndrome ORPHA:1393,0.8922466888454011
RRP9,Combined oxidative phosphorylation defect type 17 ORPHA:369913,0.8922466888454011
RRP9,DK1-CDG ORPHA:91131,0.8922466888454011
RRP9,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome ORPHA:404437,0.8922466888454011
RRP9,HSD10 disease atypical type ORPHA:85295,0.8922466888454011
RRP9,HSD10 disease infantile type ORPHA:391428,0.8922466888454011
RRP9,HSD10 disease neonatal type ORPHA:391457,0.8922466888454011
RRP9,ITPA-related lethal infantile neurological disorder with cataract and cardiac involvement ORPHA:457375,0.8922466888454011
RRP9,Lenz-Majewski hyperostotic dwarfism ORPHA:2658,0.8922466888454011
RRP9,MUTYH-related attenuated familial adenomatous polyposis ORPHA:247798,0.8922466888454011
RRP9,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome ORPHA:423306,0.8922466888454011
RRP9,Pontocerebellar hypoplasia type 7 ORPHA:284339,0.8922466888454011
RRP9,Spinal muscular atrophy with respiratory distress type 2 ORPHA:404521,0.8922466888454011
RRP9,Spinocerebellar ataxia type 36 ORPHA:276198,0.8922466888454011
RRP9,Mitochondrial myopathy and sideroblastic anemia ORPHA:2598,0.8922466888454011
RRP9,Triple A syndrome ORPHA:869,0.8922466888454011
RRP9,Hyperphosphatasia-intellectual disability syndrome ORPHA:247262,0.8922466888454011
RRP9,Hoyeraal-Hreidarsson syndrome ORPHA:3322,0.8922466888454011
RRP9,Perrault syndrome ORPHA:2855,0.8922466888454011
RRP9,ALG3-CDG ORPHA:79321,0.8922466888454011
RRP9,Acyl-CoA dehydrogenase 9 deficiency ORPHA:99901,0.8922466888454011
RRP9,Atypical teratoid rhabdoid tumor ORPHA:99966,0.8922466888454011
RRP9,Autosomal dominant Charcot-Marie-Tooth disease type 2U ORPHA:397735,0.8922466888454011
RRP9,Autosomal recessive spastic ataxia with leukoencephalopathy ORPHA:314603,0.8922466888454011
RRP9,Autosomal recessive spastic paraplegia type 70 ORPHA:401835,0.8922466888454011
RRP9,Burkitt lymphoma ORPHA:543,0.8922466888454011
RRP9,CHILD syndrome ORPHA:139,0.8922466888454011
RRP9,CK syndrome ORPHA:251383,0.8922466888454011
RRP9,Combined oxidative phosphorylation defect type 25 ORPHA:447954,0.8922466888454011
RRP9,Combined oxidative phosphorylation defect type 4 ORPHA:254925,0.8922466888454011
RRP9,DDOST-CDG ORPHA:300536,0.8922466888454011
RRP9,DPAGT1-CDG ORPHA:86309,0.8922466888454011
RRP9,Distal hereditary motor neuropathy Jerash type ORPHA:139552,0.8922466888454011
RRP9,Glutathione synthetase deficiency with 5-oxoprolinuria ORPHA:289846,0.8922466888454011
RRP9,Glutathione synthetase deficiency without 5-oxoprolinuria ORPHA:289849,0.8922466888454011
RRP9,Lethal ataxia with deafness and optic atrophy ORPHA:1187,0.8922466888454011
RRP9,MEND syndrome ORPHA:401973,0.8922466888454011
RRP9,MEPAN syndrome ORPHA:508093,0.8922466888454011
RRP9,NAD(P)HX epimerase deficiency ORPHA:555407,0.8922466888454011
RRP9,Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency ORPHA:440427,0.8922466888454011
RRP9,Severe phosphoribosylpyrophosphate synthetase superactivity ORPHA:411543,0.8922466888454011
RRP9,X-linked Charcot-Marie-Tooth disease type 5 ORPHA:99014,0.8922466888454011
RRP9,X-linked dominant chondrodysplasia punctata ORPHA:35173,0.8922466888454011
RRP9,X-linked intellectual disability-limb spasticity-retinal dystrophy-diabetes insipidus syndrome ORPHA:423479,0.8922466888454011
RRP9,Autosomal recessive sideroblastic anemia ORPHA:260305,0.8922466888454011
RRP9,Pyruvate dehydrogenase E1-alpha deficiency ORPHA:79243,0.8922466888454011
RRP9,Autosomal recessive isolated optic atrophy ORPHA:98676,0.8922466888454011
RRP9,Congenital or early infantile CACH syndrome ORPHA:157713,0.8922466888454011
RRP9,Cree leukoencephalopathy ORPHA:99854,0.8922466888454011
RRP9,Juvenile or adult CACH syndrome ORPHA:157719,0.8922466888454011
RRP9,Late infantile CACH syndrome ORPHA:157716,0.8922466888454011
RRP9,Ovarioleukodystrophy ORPHA:99853,0.8922466888454011
RWDD2B,Familial steroid-resistant nephrotic syndrome with sensorineural deafness ORPHA:280406,0.7929682744768703
RWDD2B,Pyridoxal phosphate-responsive seizures ORPHA:79096,0.8922466888454011
S1PR2,Malignant neoplasm of breast,0.4084380369379369
S1PR2,Reticulocyte count (procedure),0.5071083164302358
S1PR2,Breast Carcinoma,0.7333611688795861
S1PR2,Diffuse Large B-Cell Lymphoma,0.7333611688795861
S1PR2,Vascular Diseases,0.7765852775619541
S1PR2,Glioma,0.7880542567584415
S1PR2,Lymphoma Non-Hodgkin,0.7880542567584415
S1PR2,Nephroblastoma,0.7880542567584415
S1PR2,Pulmonary Edema,0.7880542567584415
S1PR2,Neoplasm Metastasis,0.7880542567584415
S1PR2,Congenital contractural arachnodactyly,0.7880542567584415
S1PR2,Coronary Arteriosclerosis,0.7880542567584415
S1PR2,Autoimmune Diseases,0.7880542567584415
S1PR2,Limb Deformities Congenital,0.7880542567584415
S1PR2,Rheumatoid Arthritis,0.7880542567584415
S1PR2,Vascular inflammations,0.7908231553833205
S1PR2,Multiple Sclerosis,0.8019075543217649
S1PR2,Chronic Lymphocytic Leukemia,0.8019075543217649
S1PR2,Neoplasm Invasiveness,0.8232134984476662
S1PR2,DEAFNESS AUTOSOMAL RECESSIVE (disorder),0.8270909867833504
S1PR2,Fibrosis Liver,0.8272008757995397
S1PR2,Congenital Abnormality,0.8402911822757345
S1PR2,Cholangiocarcinoma,0.8402911822757345
S1PR2,Diabetes Mellitus Experimental,0.8642802827048847
S1PR2,Streptozotocin Diabetes,0.8642802827048847
S1PR2,Alloxan Diabetes,0.8642802827048847
S1PR2,Myocardial Ischemia,0.8648405521677974
S1PR2,Chronic Obstructive Airway Disease,0.8648405521677974
S1PR2,Sensorineural hearing loss bilateral,0.8942113186235617
S1PR2,Heart Diseases,0.8989612563669234
S1PR2,Hematopoietic Neoplasms,0.946564927793026
S1PR2,Sensorineural Hearing Loss (disorder),0.9520060723130308
S1PR2,Endometriosis,0.960644037248553
S1PR2,Non-Syndromic Sensorineural Deafness,0.8115918568696846
S1PR2,Hearing Loss,0.8115918568696846
S1PR2,Deafness,0.8457525389282121
S1PR2,Heart Diseases,0.861756360478846
S1PR2,Cardiovascular Diseases,0.924275664330454
S1PR2,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.5867963421058087
SAT2,Malignant neoplasm of breast,0.4084380369379369
SAT2,Breast Carcinoma,0.7333611688795861
SAT2,Carcinogenesis,0.7333611688795861
SAT2,Thromboangiitis Obliterans,0.7333611688795861
SAT2,Adenocarcinoma,0.750391252594775
SAT2,Malignant neoplasm of pancreas,0.7688485284765829
SAT2,Colorectal Carcinoma,0.7765852775619541
SAT2,Pancreatic carcinoma,0.7765852775619541
SAT2,Prostatic Intraepithelial Neoplasias,0.7765852775619541
SAT2,Colorectal Neoplasms,0.7765852775619541
SAT2,Adenoma,0.7765852775619541
SAT2,Mammary Neoplasms,0.7880542567584415
SAT2,Liver carcinoma,0.7880542567584415
SAT2,Colorectal Cancer,0.7880542567584415
SAT2,Hepatocarcinogenesis,0.7880542567584415
SAT2,Nephroblastoma,0.7880542567584415
SAT2,Epithelioma,0.7880542567584415
SAT2,melanoma,0.7880542567584415
SAT2,Intestinal Neoplasms,0.7880542567584415
SAT2,Malignant neoplasm of stomach,0.7880542567584415
SAT2,Infection caused by Helicobacter pylori,0.7880542567584415
SAT2,Stomach Carcinoma,0.7880542567584415
SAT2,Gastritis Atrophic,0.7880542567584415
SAT2,Adenocarcinoma of prostate,0.7880542567584415
SAT2,Precancerous Conditions,0.8026504676141903
SAT2,Infection,0.8272008757995397
SAT2,Atypical Lipoma,0.8272008757995397
SAT2,Glioblastoma Multiforme,0.8342163953428735
SAT2,Fibroadenoma,0.8769418330148872
SAT2,Prolidase deficiency ORPHA:742,0.7929682744768703
SBF1P1,Leukemia,0.7765582368651238
SCAF11,Malignant neoplasm of breast,0.4084380369379369
SCAF11,Carcinoma of bladder,0.4084380369379369
SCAF11,Bladder Neoplasm,0.4084380369379369
SCAF11,Malignant neoplasm of urinary bladder,0.5071083164302358
SCAF11,Breast Carcinoma,0.7333611688795861
SCAF11,Malignant neoplasm of ovary,0.7333611688795861
SCAF11,Ovarian Carcinoma,0.7333611688795861
SCAF11,Malignant neoplasm of pancreas,0.7688485284765829
SCAF11,Pancreatic carcinoma,0.7765852775619541
SCAF11,Colon Carcinoma,0.7765852775619541
SCAF11,Malignant tumor of colon,0.7765852775619541
SCAF11,Cervix carcinoma,0.7765852775619541
SCAF11,Non-Small Cell Lung Carcinoma,0.7765852775619541
SCAF11,Malignant tumor of cervix,0.7768809924982332
SCAF11,Mammary Neoplasms,0.7880542567584415
SCAF11,Glioma,0.7880542567584415
SCAF11,Liver carcinoma,0.7880542567584415
SCAF11,Hepatocarcinogenesis,0.7880542567584415
SCAF11,cervical cancer,0.7880542567584415
SCAF11,Neoplasm Metastasis,0.7880542567584415
SCAF11,Squamous cell carcinoma of the head and neck,0.7880542567584415
SCAF11,Malignant neoplasm of stomach,0.7880542567584415
SCAF11,Malignant mesothelioma,0.7880542567584415
SCAF11,Mowat-Wilson syndrome,0.7880542567584415
SCAF11,Tumor Progression,0.7880542567584415
SCAF11,Renal Cell Carcinoma,0.7880542567584415
SCAF11,Stomach Carcinoma,0.7880542567584415
SCAF11,Squamous cell carcinoma,0.7880542567584415
SCAF11,Carcinoma Spindle-Cell,0.7950434752274518
SCAF11,Phyllodes Tumor,0.8019075543217649
SCAF11,Pneumonitis,0.8019075543217649
SCAF11,Liver neoplasms,0.8019075543217649
SCAF11,Adrenocortical carcinoma,0.8232134984476662
SCAF11,Hirschsprung Disease,0.8232134984476662
SCAF11,Pneumonia,0.834094492023826
SCAF11,Spinal Muscular Atrophy,0.8402911822757345
SCAF11,Congenital Abnormality,0.8402911822757345
SCAF11,Carcinomatosis of peritoneal cavity,0.8584283190330553
SCAF11,Coronary Artery Disease,0.887595340546704
SCAF11,Squamous cell carcinoma of tongue,0.9119978323790848
SCAF11,Severe mental retardation (I.Q. 20-34),0.917543617287358
SCAF11,Motor Neuron Disease,0.9614320311453906
SCAF11,Coronary Artery Disease,0.861756360478846
SCAF11,Alacrimia-choreoathetosis-liver dysfunction syndrome ORPHA:404454,0.3832844616405875
SCAF11,TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261,0.3832844616405875
SCAF11,X-linked intellectual disability-short stature-overweight syndrome ORPHA:457240,0.5867963421058087
SCAF11,Familial cerebral cavernous malformation ORPHA:221061,0.5867963421058087
SCAF11,Familial platelet disorder with associated myeloid malignancy ORPHA:71290,0.5867963421058087
SCAF11,Acute promyelocytic leukemia ORPHA:520,0.7150309491065155
SCAF11,Joubert syndrome with Jeune asphyxiating thoracic dystrophy ORPHA:397715,0.7929682744768703
SCAF11,12q15q21.1 microdeletion syndrome ORPHA:289513,0.7929682744768703
SCAF11,Coffin-Lowry syndrome ORPHA:192,0.7929682744768703
SCAF11,Congenital progressive bone marrow failure-B-cell immunodeficiency-skeletal dysplasia syndrome ORPHA:508542,0.7929682744768703
SCAF11,Microcephalic primordial dwarfism Dauber type ORPHA:319675,0.7929682744768703
SCAF11,Severe combined immunodeficiency due to DCLRE1C deficiency ORPHA:275,0.7929682744768703
SCAF11,Symptomatic form of Coffin-Lowry syndrome in female carriers ORPHA:276630,0.7929682744768703
SCAF11,Xq25 microduplication syndrome ORPHA:521258,0.7929682744768703
SCAF11,Extraskeletal Ewing sarcoma ORPHA:370334,0.795266832401002
SCAF11,5p13 microduplication syndrome ORPHA:329802,0.8922466888454011
SCAF11,ALG13-CDG ORPHA:324422,0.8922466888454011
SCAF11,Amyotrophic lateral sclerosis type 4 ORPHA:357043,0.8922466888454011
SCAF11,Autism spectrum disorder-epilepsy-arthrogryposis syndrome ORPHA:370943,0.8922466888454011
SCAF11,Autoimmune hemolytic anemia-autoimmune thrombocytopenia-primary immunodeficiency syndrome ORPHA:444463,0.8922466888454011
SCAF11,Autosomal dominant intellectual disability-craniofacial anomalies-cardiac defects syndrome ORPHA:457193,0.8922466888454011
SCAF11,Autosomal recessive Charcot-Marie-Tooth disease type 2X ORPHA:466775,0.8922466888454011
SCAF11,Autosomal recessive spastic paraplegia type 11 ORPHA:2822,0.8922466888454011
SCAF11,Brain malformations-musculoskeletal abnormalities-facial dysmorphism-intellectual disability syndrome ORPHA:500150,0.8922466888454011
SCAF11,Cohen syndrome ORPHA:193,0.8922466888454011
SCAF11,Combined immunodeficiency due to MALT1 deficiency ORPHA:397964,0.8922466888454011
SCAF11,Developmental delay-facial dysmorphism syndrome due to MED13L deficiency ORPHA:369891,0.8922466888454011
SCAF11,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to 10p11.21p12.31 microdeletion ORPHA:284169,0.8922466888454011
SCAF11,Facial dysmorphism-developmental delay-behavioral abnormalities syndrome due to WAC point mutation ORPHA:466950,0.8922466888454011
SCAF11,Fleck corneal dystrophy ORPHA:98970,0.8922466888454011
SCAF11,Fragile X syndrome ORPHA:908,0.8922466888454011
SCAF11,Fragile X-associated tremor/ataxia syndrome ORPHA:93256,0.8922466888454011
SCAF11,Germinoma of the central nervous system ORPHA:91352,0.8922466888454011
SCAF11,Hermansky-Pudlak syndrome with neutropenia ORPHA:183678,0.8922466888454011
SCAF11,Hyperparathyroidism-jaw tumor syndrome ORPHA:99880,0.8922466888454011
SCAF11,Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome ORPHA:2250,0.8922466888454011
SCAF11,Infantile-onset periodic fever-panniculitis-dermatosis syndrome ORPHA:500062,0.8922466888454011
SCAF11,Intellectual disability-autism-speech apraxia-craniofacial dysmorphism syndrome ORPHA:529965,0.8922466888454011
SCAF11,Intellectual disability-hyperkinetic movement-truncal ataxia syndrome ORPHA:369847,0.8922466888454011
SCAF11,Isolated generalized anhidrosis with normal sweat glands ORPHA:468666,0.8922466888454011
SCAF11,Mucolipidosis type II ORPHA:576,0.8922466888454011
SCAF11,Mucolipidosis type III alpha/beta ORPHA:423461,0.8922466888454011
SCAF11,Parathyroid carcinoma ORPHA:143,0.8922466888454011
SCAF11,Primary ciliary dyskinesia-retinitis pigmentosa syndrome ORPHA:247522,0.8922466888454011
SCAF11,Reticulate acropigmentation of Kitamura ORPHA:178307,0.8922466888454011
SCAF11,STAG1-related intellectual disability-facial dysmorphism-gastroesophageal reflux syndrome ORPHA:502434,0.8922466888454011
SCAF11,Spinocerebellar ataxia type 7 ORPHA:94147,0.8922466888454011
SCAF11,Symptomatic form of fragile X syndrome in female carrier ORPHA:449291,0.8922466888454011
SCAF11,TRAPPC11-related  limb-girdle muscular dystrophy R18 ORPHA:369840,0.8922466888454011
SCAF11,X-linked dystonia-parkinsonism ORPHA:53351,0.8922466888454011
SCAF11,X-linked intellectual disability-global development delay-facial dysmorphism-sacral caudal remnant syndrome ORPHA:480907,0.8922466888454011
SCAF11,Xq27.3q28 duplication syndrome ORPHA:261483,0.8922466888454011
SCAF11,Acquired idiopathic sideroblastic anemia ORPHA:75564,0.8922466888454011
SCAF11,Progressive cerebello-cerebral atrophy ORPHA:247198,0.8922466888454011
SCAF11,Renal-hepatic-pancreatic dysplasia ORPHA:294415,0.8922466888454011
SCAF11,46XX ovarian dysgenesis-short stature syndrome ORPHA:444048,0.8922466888454011
SCAF11,Achondrogenesis type 1A ORPHA:93299,0.8922466888454011
SCAF11,Autosomal dominant spastic paraplegia type 42 ORPHA:171863,0.8922466888454011
SCAF11,Autosomal recessive spastic paraplegia type 59 ORPHA:401795,0.8922466888454011
SCAF11,COG5-CDG ORPHA:263487,0.8922466888454011
SCAF11,Congenital cataract-hearing loss-severe developmental delay syndrome ORPHA:300313,0.8922466888454011
SCAF11,Intellectual disability-coarse face-macrocephaly-cerebellar hypotrophy syndrome ORPHA:397709,0.8922466888454011
SCAF11,Menkes disease ORPHA:565,0.8922466888454011
SCAF11,Mitochondrial DNA depletion syndrome encephalomyopathic form with variable craniofacial anomalies ORPHA:369897,0.8922466888454011
SCAF11,NPHP3-related Meckel-like syndrome ORPHA:3032,0.8922466888454011
SCAF11,Occipital horn syndrome ORPHA:198,0.8922466888454011
SCAF11,Odontochondrodysplasia ORPHA:166272,0.8922466888454011
SCAF11,Orofaciodigital syndrome type 1 ORPHA:2750,0.8922466888454011
SCAF11,Wrinkly skin syndrome ORPHA:2834,0.8922466888454011
SCAF11,X-linked distal spinal muscular atrophy type 3 ORPHA:139557,0.8922466888454011
SCAF11,Dentin dysplasia type I ORPHA:99789,0.8922466888454011
SCAF11,Hereditary gingival fibromatosis ORPHA:2024,0.8922466888454011
SEC16A,Malignant neoplasm of breast,0.4084380369379369
SEC16A,Spondylarthritis,0.7880542567584415
SEC16A,Eosinophil count procedure,0.7880542567584415
SEC16A,Eosinophil count result,0.7880542567584415
SEC16A,Parkinson Disease,0.8772392350816924
SEC16A,Squamous cell carcinoma of skin,0.8989612563669234
SEC16A,Skin Carcinoma,0.861756360478846
SEC16A,Carcinoma,0.9069867032339078
SEC16A,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
SEC16A,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
SEC16A,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
SEC16A,Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635,0.1991445465001551
SEC16A,Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257,0.1991445465001551
SEC16A,MYH9-related disease ORPHA:182050,0.1991445465001551
SEC16A,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401,0.1991445465001551
SEC16A,Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361,0.1991445465001551
SEC16A,X-linked intellectual disability Siderius type ORPHA:85287,0.1991445465001551
SEC16A,CAMOS syndrome ORPHA:83472,0.1991445465001551
SEC16A,17p11.2 microduplication syndrome ORPHA:1713,0.3832844616405875
SEC16A,Dyschromatosis symmetrica hereditaria ORPHA:41,0.3832844616405875
SEC16A,PMP22-RAI1 contiguous gene duplication syndrome ORPHA:477817,0.3832844616405875
SEC16A,Isolated focal cortical dysplasia type IIb ORPHA:269008,0.3832844616405875
SEC16A,Adult hepatocellular carcinoma ORPHA:210159,0.4491081214880772
SEC16A,Idiopathic pulmonary fibrosis ORPHA:2032,0.5047266821728011
SEC16A,Autosomal dominant Charcot-Marie-Tooth disease type 2Z ORPHA:466768,0.5867963421058087
SEC16A,Floating-Harbor syndrome ORPHA:2044,0.5867963421058087
SEC16A,Juvenile Huntington disease ORPHA:248111,0.5867963421058087
SEC16A,Methylmalonic acidemia with homocystinuria type cblX ORPHA:369962,0.5867963421058087
SEC16A,Isolated focal cortical dysplasia type IIa ORPHA:269001,0.5867963421058087
SEC16A,Schneckenbecken dysplasia ORPHA:3144,0.5867963421058087
SEC16A,Spondylocarpotarsal synostosis ORPHA:3275,0.5867963421058087
SEC16A,22q11.2 deletion syndrome ORPHA:567,0.6599133692748571
SEC16A,COG7-CDG ORPHA:79333,0.7929682744768703
SEC16A,Infantile-onset X-linked spinal muscular atrophy ORPHA:1145,0.7929682744768703
SEC16A,Kleefstra syndrome due to 9q34 microdeletion ORPHA:96147,0.7929682744768703
SEC16A,Opsismodysplasia ORPHA:2746,0.7929682744768703
SEC16A,Syndromic X-linked intellectual disability due to JARID1C mutation ORPHA:85279,0.7929682744768703
SEC16A,Chronic myeloid leukemia ORPHA:521,0.7929682744768703
SEC16A,Familial advanced sleep-phase syndrome ORPHA:164736,0.7929682744768703
SEC16A,Familial infantile bilateral striatal necrosis ORPHA:225154,0.7929682744768703
SEC16A,Autosomal dominant Charcot-Marie-Tooth disease type 2DD ORPHA:521414,0.8922466888454011
SEC16A,Blepharophimosis-intellectual disability syndrome MKB type ORPHA:293707,0.8922466888454011
SEC16A,DIAPH1-related sensorineural hearing loss-thrombocytopenia syndrome ORPHA:494444,0.8922466888454011
SEC16A,FG syndrome type 1 ORPHA:93932,0.8922466888454011
SEC16A,Jalili syndrome ORPHA:1873,0.8922466888454011
SEC16A,Progressive microcephaly-seizures-cortical blindness-developmental delay syndrome ORPHA:477814,0.8922466888454011
SEC16A,16q24.3 microdeletion syndrome ORPHA:261250,0.8922466888454011
SEC16A,KBG syndrome ORPHA:2332,0.8922466888454011
SEC16A,Progressive autosomal recessive ataxia-deafness syndrome ORPHA:448251,0.8922466888454011
SEC16A,Papiine alphaherpesvirus 2 helicase-primase helicase subunit (gene: UL5),0.8999095837312036
SEC23A,Reduced tensile strength of hair,0.7333611688795861
SEC23A,Fractured hair,0.7333611688795861
SEC23A,Fragile hair,0.7333611688795861
SEC23A,Brittle hair,0.7495999465637118
SEC23A,Rotting teeth,0.7880542567584415
SEC23A,Dental caries,0.7880542567584415
SEC23A,Early tooth exfoliation,0.7880542567584415
SEC23A,Premature tooth loss,0.7880542567584415
SEC23A,Prostate carcinoma,0.7880542567584415
SEC23A,Frontal bossing,0.7880542567584415
SEC23A,Joint laxity,0.7880542567584415
SEC23A,Hyperplasia of supraorbital margins,0.7880542567584415
SEC23A,Hyperplasia of supraorbital ridge,0.7880542567584415
SEC23A,Hypertrophy of supraorbital margins,0.7880542567584415
SEC23A,Hypertrophy of supraorbital ridge,0.7880542567584415
SEC23A,Prominent supraorbital ridges,0.7880542567584415
SEC23A,Large late-closing fontanelle,0.7880542567584415
SEC23A,Wide bregma sutures,0.7880542567584415
SEC23A,Large bregma sutures,0.7880542567584415
SEC23A,Large fontanelle,0.7880542567584415
SEC23A,Vitamin D measurement,0.7880542567584415
SEC23A,Narrow iliac wings,0.7880542567584415
SEC23A,Narrow thorax,0.7880542567584415
SEC23A,Anteverted nostril,0.7880542567584415
SEC23A,Small midface,0.7880542567584415
SEC23A,Decreased projection of midface,0.7880542567584415
SEC23A,Hypotrophic midface,0.7880542567584415
SEC23A,Midface retrusion,0.7880542567584415
SEC23A,Strawberry nevus of skin,0.7880542567584415
SEC23A,Rough hair texture,0.7880542567584415
SEC23A,Coarse hair,0.7880542567584415
SEC23A,Hypoplasia of teeth,0.7880542567584415
SEC23A,Increased head circumference,0.7880542567584415
SEC23A,Decreased calcification of skull,0.7908231553833205
SEC23A,Defect of skull ossification,0.7908231553833205
SEC23A,Delayed closure of the soft spot on the skull,0.7908231553833205
SEC23A,Late closure of anterior fontanel,0.7908231553833205
SEC23A,Acquired flat foot,0.8019075543217649
SEC23A,Flatfoot,0.8019075543217649
SEC23A,Degenerative polyarthritis,0.8019075543217649
SEC23A,Thin lips,0.8067197998685076
SEC23A,Big calvaria,0.8098851543361193
SEC23A,Increased size of skull,0.8098851543361193
SEC23A,Decreased width of tooth,0.8168901801930506
SEC23A,Microdontia (disorder),0.8190761496232595
SEC23A,Broad flat nasal bridge,0.8213459222602666
SEC23A,Decreased size of teeth,0.8232134984476662
SEC23A,Nasal bridge wide,0.8232134984476662
SEC23A,Retrusion of upper jaw bones,0.8232134984476662
SEC23A,Decreased projection of maxilla,0.8232134984476662
SEC23A,Deficiency of upper jaw bones,0.8232134984476662
SEC23A,Hypoplasia of the maxilla,0.8232134984476662
SEC23A,Hypotrophic maxilla,0.8232134984476662
SEC23A,Late tooth eruption,0.8232134984476662
SEC23A,Maxillary retrognathia,0.8232134984476662
SEC23A,Convex nasal bridge,0.8232134984476662
SEC23A,Prominent nasal bridge,0.8232134984476662
SEC23A,Osteoarthrosis Deformans,0.834094492023826
SEC23A,Curvature of spine,0.8402911822757345
SEC23A,Sparse hair,0.8402911822757345
SEC23A,Thin sparse hair,0.8402911822757345
SEC23A,Cryptorchidism,0.8402911822757345
SEC23A,Acquired scoliosis,0.8402911822757345
SEC23A,Melanoderma (disorder),0.8402911822757345
SEC23A,Hypotrophic malar bone,0.8490659121857849
SEC23A,Malar flattening,0.8490659121857849
SEC23A,Hyperpigmentation,0.8578473133580928
SEC23A,Wide anterior fontanel,0.8648405521677974
SEC23A,Cataract,0.8769418330148872
SEC23A,Smooth philtrum,0.8774809019744603
SEC23A,Short stature,0.8815127642200768
SEC23A,Wide nose,0.882453254162044
SEC23A,Orbital separation excessive,0.8851456306720444
SEC23A,Abnormal skeletal development,0.9039108388826153
SEC23A,Osteochondrodysplasias,0.9117936912777788
SEC23A,Macrostomia,0.9393256300017014
SEC23A,Long philtrum,0.9459312971127588
SEC23A,Bilateral cataracts (disorder),0.9459312971127588
SEC23A,Thin upper lip vermilion,0.9557184806547836
SEC23A,Hypoplasia Of The Maxilla,0.7765582368651238
SEC23A,Macrocephaly,0.7765582368651238
SEC23A,Hypoplasia Of Teeth,0.7765582368651238
SEC23A,Frontal Bossing,0.8115918568696846
SEC23A,Defect Of Skull Ossification,0.8115918568696846
SEC23A,Strawberry Nevus Of Skin,0.8165359516083085
SEC23A,Skeletal Dysplasia,0.8182883735985873
SEC23A,Osteochondrodysplasia,0.8210988731657684
SEC23A,Osteoarthrosis Deformans,0.861756360478846
SEC23A,Cryptorchidism,0.861756360478846
SEC23A,Microdontia,0.861756360478846
SEC23A,Arthritis,0.9046917974656596
SEC23A,Scoliosis,0.924275664330454
SEC23A,Dwarfism,0.9510372690456612
SEC23A,High Palate,0.9578111936867284
SEC23A,Macrostomia,0.9832345076528324
SEC23A,Mucopolysaccharidosis type 6 rapidly progressing ORPHA:276212,0.1991445465001551
SEC23A,Mucopolysaccharidosis type 6 slowly progressing ORPHA:276223,0.1991445465001551
SEC23A,X-linked intellectual disability Cabezas type ORPHA:85293,0.5867963421058087
SEC23A,Adult polyglucosan body disease ORPHA:206583,0.7929682744768703
SEC23A,COG6-CGD ORPHA:464443,0.7929682744768703
SEC23A,Craniolenticulosutural dysplasia ORPHA:50814,0.7929682744768703
SEC23A,Glycogen storage disease due to glycogen branching enzyme deficiency adult neuromuscular form ORPHA:308712,0.7929682744768703
SEC23A,Glycogen storage disease due to glycogen branching enzyme deficiency childhood combined hepatic and myopathic form ORPHA:308684,0.7929682744768703
SEC23A,Glycogen storage disease due to glycogen branching enzyme deficiency childhood neuromuscular form ORPHA:308698,0.7929682744768703
SEC23A,Glycogen storage disease due to glycogen branching enzyme deficiency congenital neuromuscular form ORPHA:308670,0.7929682744768703
SEC23A,Glycogen storage disease due to glycogen branching enzyme deficiency fatal perinatal neuromuscular form ORPHA:308655,0.7929682744768703
SEC23A,Glycogen storage disease due to glycogen branching enzyme deficiency non progressive hepatic form ORPHA:308638,0.7929682744768703
SEC23A,Glycogen storage disease due to glycogen branching enzyme deficiency progressive hepatic form ORPHA:308621,0.7929682744768703
SEC23A,Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome ORPHA:363523,0.7929682744768703
SEC23A,Hypomyelination-congenital cataract syndrome ORPHA:85163,0.7929682744768703
SEC23A,Kyphoscoliotic Ehlers-Danlos syndrome due to FKBP22 deficiency ORPHA:300179,0.7929682744768703
SEC23A,Peters plus syndrome ORPHA:709,0.7929682744768703
SEC23A,Pulmonary venoocclusive disease ORPHA:31837,0.7929682744768703
SEC23A,BRESEK syndrome ORPHA:85284,0.8922466888454011
SEC23A,Chondrodysplasia with joint dislocations gPAPP type ORPHA:280586,0.8922466888454011
SEC23A,Choroideremia ORPHA:180,0.8922466888454011
SEC23A,Hypopigmentation-punctate palmoplantar keratoderma syndrome ORPHA:324561,0.8922466888454011
SEC23A,Ichthyosis follicularis-alopecia-photophobia syndrome ORPHA:2273,0.8922466888454011
SEC23A,Scott syndrome ORPHA:806,0.8922466888454011
SEC23A,Combined deficiency of factor V and factor VIII ORPHA:35909,0.8922466888454011
SEC23A,PGM1-CDG ORPHA:319646,0.8922466888454011
SEC23A,PGM3-CDG ORPHA:443811,0.8922466888454011
SEC23A,Pulmonary capillary hemangiomatosis ORPHA:199241,0.8922466888454011
SEC23A,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
SEC23A,Cercopithecine betaherpesvirus 5 chemokine vCXCL2 (gene: UL147),0.8999095837312036
SEC23A,Human T-lymphotropic virus 2 Gag-Pro-Pol,0.8999095837312036
SEC23A,Human immunodeficiency virus pol protein (gene: pol),0.8999095837312036
SEC23A,Human immunodeficiency virus 1 integrase (gene: gag-pol),0.8999095837312036
SEC23A,Human immunodeficiency virus 1 Pol (gene: gag-pol),0.8999095837312036
SEC23A,Monkeypox virus ankyrin-like protein,0.8999095837312036
SEC23A,Macaque simian foamy virus Pol (gene: pol),0.9057542447893764
SEMA6C,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
SEMA6C,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
SEMA6C,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
SEMA6C,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
SEMA6C,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
SEMA6C,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
SEMA6C,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
SEMA6C,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
SEMA6C,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
SEMA6C,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.1040670578681756
SEMA6C,Steinert myotonic dystrophy ORPHA:273,0.1040670578681756
SEMA6C,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.1040670578681756
SEMA6C,AHDC1-related intellectual disability-obstructive sleep apnea-mild dysmorphism syndrome ORPHA:412069,0.1991445465001551
SEMA6C,Charcot-Marie-Tooth disease type 4F ORPHA:99952,0.1991445465001551
SEMA6C,Knobloch syndrome ORPHA:1571,0.1991445465001551
SEMA6C,Lethal congenital contracture syndrome type 3 ORPHA:137783,0.1991445465001551
SEMA6C,Synaptic congenital myasthenic syndromes ORPHA:98915,0.1991445465001551
SEMA6C,Congenital insensitivity to pain with severe intellectual disability ORPHA:453510,0.3832844616405875
SEMA6C,Telethonin-related  limb-girdle muscular dystrophy R7 ORPHA:34514,0.5867963421058087
SEMA6C,Autosomal dominant otospondylomegaepiphyseal dysplasia ORPHA:166100,0.5867963421058087
SEMA6C,Gorlin syndrome ORPHA:377,0.5867963421058087
SEMA6C,Acetazolamide-responsive myotonia ORPHA:99736,0.7929682744768703
SEMA6C,Congenital muscular dystrophy with integrin alpha-7 deficiency ORPHA:34520,0.7929682744768703
SEMA6C,Hyperkalemic periodic paralysis ORPHA:682,0.7929682744768703
SEMA6C,Myotonia fluctuans ORPHA:99734,0.7929682744768703
SEMA6C,Myotonia permanens ORPHA:99735,0.7929682744768703
SEMA6C,Paramyotonia congenita of Von Eulenburg ORPHA:684,0.7929682744768703
SEMA6C,IMAGe syndrome ORPHA:85173,0.7929682744768703
SEMA6C,Autosomal recessive centronuclear myopathy ORPHA:169186,0.7929682744768703
SEMA6C,AXIN2-related attenuated familial adenomatous polyposis ORPHA:401911,0.8922466888454011
SEMA6C,Glycogen storage disease due to phosphoglycerate mutase deficiency ORPHA:97234,0.8922466888454011
SEMA6C,Oligodontia-cancer predisposition syndrome ORPHA:300576,0.8922466888454011
SEMA6C,Atrial standstill ORPHA:1344,0.8922466888454011
SEMA6C,Fibrochondrogenesis ORPHA:2021,0.8922466888454011
SEMA6C,Isolated anencephaly ORPHA:563609,0.8922466888454011
SEMA6C,Isolated exencephaly ORPHA:563612,0.8922466888454011
SEMA6C,Postsynaptic congenital myasthenic syndromes ORPHA:98913,0.8922466888454011
SEMA6C,Acromesomelic dysplasia Maroteaux type ORPHA:40,0.8922466888454011
SEMA6C,Familial mitral valve prolapse ORPHA:741,0.8922466888454011
SEMA6C,Tall stature-scoliosis-macrodactyly of the great toes syndrome ORPHA:329191,0.8922466888454011
SEMA6C,Vaccinia virus Ankara Semaphorin-like protein f1,0.8999095837312036
SEMA6C,Cowpox virus CPXV176 protein (gene: CPXV176 CDS),0.8999095837312036
SEMA6C,Horsepox virus HSPV161 (semaphorin-like protein,0.8999095837312036
SERPINA6,Malignant neoplasm of ovary,0.7333611688795861
SERPINA6,leukemia,0.7333611688795861
SERPINA6,Ovarian Carcinoma,0.7333611688795861
SERPINA6,Hepatoblastoma,0.7765852775619541
SERPINA6,Endometrial Carcinoma,0.7765852775619541
SERPINA6,Chronic Fatigue Syndrome,0.7880542567584415
SERPINA6,Lymphoma Non-Hodgkin,0.7880542567584415
SERPINA6,Adrenocorticotropic hormone (ACTH) deficiency (disorder),0.7880542567584415
SERPINA6,Liver carcinoma,0.7880542567584415
SERPINA6,Increase in blood pressure,0.7880542567584415
SERPINA6,Hematological Disease,0.7880542567584415
SERPINA6,Granulomatosis with polyangiitis,0.7880542567584415
SERPINA6,dowling-degos disease,0.7880542567584415
SERPINA6,Pauci-immune Glomerulonephritis associated with Granulomatosis with Polyangiitis,0.7880542567584415
SERPINA6,Widespread Chronic Pain,0.7880542567584415
SERPINA6,Liver Cirrhosis Experimental,0.8014900279306119
SERPINA6,Hyperinsulinism,0.8019075543217649
SERPINA6,Liver neoplasms,0.8019075543217649
SERPINA6,Liver Cirrhosis,0.8232134984476662
SERPINA6,Fibrosis Liver,0.8272008757995397
SERPINA6,Hypotension,0.834094492023826
SERPINA6,Steatohepatitis,0.8402911822757345
SERPINA6,Chronic pain,0.843190898187174
SERPINA6,Hypertensive disease,0.8474481237156937
SERPINA6,Drug-Induced Liver Disease,0.8523465762428218
SERPINA6,Hepatitis Toxic,0.8548862007194026
SERPINA6,Chemical and Drug Induced Liver Injury,0.8548862007194026
SERPINA6,Chemically-Induced Liver Toxicity,0.8548862007194026
SERPINA6,Drug-Induced Acute Liver Injury,0.8548862007194026
SERPINA6,Hepatitis Drug-Induced,0.8578473133580928
SERPINA6,Metabolic Syndrome X,0.8610447277138289
SERPINA6,Fatty Liver,0.8628363180844141
SERPINA6,Anaplasia,0.8648405521677974
SERPINA6,Mental Depression,0.8769418330148872
SERPINA6,Pain,0.887595340546704
SERPINA6,Obesity,0.8989612563669234
SERPINA6,Fatigue,0.9029289778792944
SERPINA6,Lymphoid leukemia,0.9083161862856644
SERPINA6,Depressive disorder,0.9103315000053974
SERPINA6,Abnormality of metabolism/homeostasis,0.914995991166204
SERPINA6,Hyperthyroidism,0.9557184806547836
SERPINA6,Liver Cirrhosis,0.7765582368651238
SERPINA6,Hypertension,0.7765582368651238
SERPINA6,Fatty Liver,0.8321692755697452
SERPINA6,Liver Fibrosis,0.8903301324869451
SERPINA6,Mental Depression,0.8903630091389316
SERPINA6,Alkaptonuria ORPHA:56,0.1991445465001551
SERPINA6,Isolated neonatal sclerosing cholangitis ORPHA:480556,0.1991445465001551
SERPINA6,Familial hypercholanemia ORPHA:238475,0.2047219337649946
SERPINA6,HNF1B-related autosomal dominant tubulointerstitial kidney disease ORPHA:93111,0.3832844616405875
SERPINA6,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119,0.3832844616405875
SERPINA6,Chromophobe renal cell carcinoma ORPHA:319303,0.3832844616405875
SERPINA6,Familial hyperprolactinemia ORPHA:397685,0.3832844616405875
SERPINA6,Hyperinsulinism due to HNF1A deficiency ORPHA:324575,0.3832844616405875
SERPINA6,Hyperinsulinism due to HNF4A deficiency ORPHA:263455,0.3832844616405875
SERPINA6,Alopecia-intellectual disability syndrome ORPHA:2850,0.3832844616405875
SERPINA6,Autosomal dominant primary hypomagnesemia with hypocalciuria ORPHA:34528,0.5867963421058087
SERPINA6,Bilateral multicystic dysplastic kidney ORPHA:97364,0.5867963421058087
SERPINA6,Medullary sponge kidney ORPHA:1309,0.5867963421058087
SERPINA6,Renal dysplasia bilateral ORPHA:93173,0.5867963421058087
SERPINA6,Renal dysplasia unilateral ORPHA:93172,0.5867963421058087
SERPINA6,Unilateral multicystic dysplastic kidney ORPHA:97363,0.5867963421058087
SERPINA6,Rotor syndrome ORPHA:3111,0.7929682744768703
SERPINA6,Aromatic L-amino acid decarboxylase deficiency ORPHA:35708,0.7929682744768703
SERPINA6,Dubin-Johnson syndrome ORPHA:234,0.7929682744768703
SERPINA6,Progressive familial intrahepatic cholestasis type 5 ORPHA:480476,0.7929682744768703
SERPINA6,X-linked Charcot-Marie-Tooth disease type 1 ORPHA:101075,0.7929682744768703
SERPINA6,X-linked progressive cerebellar ataxia ORPHA:1175,0.7929682744768703
SERPINA6,Phosphoenolpyruvate carboxykinase deficiency ORPHA:2880,0.7929682744768703
SERPINA6,Early-onset anterior polar cataract ORPHA:98988,0.795266832401002
SERPINA6,NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406,0.8105918570729571
SERPINA6,Atypical hemolytic uremic syndrome with anti-factor H antibodies ORPHA:93581,0.8922466888454011
SERPINA6,C3 glomerulopathy ORPHA:329918,0.8922466888454011
SERPINA6,Familial afibrinogenemia ORPHA:98880,0.8922466888454011
SERPINA6,Familial dysfibrinogenemia ORPHA:98881,0.8922466888454011
SERPINA6,Familial hypodysfibrinogenemia ORPHA:248408,0.8922466888454011
SERPINA6,Familial hypofibrinogenemia ORPHA:101041,0.8922466888454011
SERPINA6,3-hydroxy-3-methylglutaryl-CoA synthase deficiency ORPHA:35701,0.8922466888454011
SERPINA6,46XY disorder of sex development due to 5-alpha-reductase 2 deficiency ORPHA:753,0.8922466888454011
SERPINA6,AApoAII amyloidosis ORPHA:238269,0.8922466888454011
SERPINA6,AFib amyloidosis ORPHA:93562,0.8922466888454011
SERPINA6,Brachytelephalangic chondrodysplasia punctata ORPHA:79345,0.8922466888454011
SERPINA6,Brain demyelination due to methionine adenosyltransferase deficiency ORPHA:168598,0.8922466888454011
SERPINA6,Caroli disease ORPHA:53035,0.8922466888454011
SERPINA6,Congenital analbuminemia ORPHA:86816,0.8922466888454011
SERPINA6,Congenital bile acid synthesis defect type 2 ORPHA:79303,0.8922466888454011
SERPINA6,Congenital factor II deficiency ORPHA:325,0.8922466888454011
SERPINA6,Congenital factor XI deficiency ORPHA:329,0.8922466888454011
SERPINA6,Congenital high-molecular-weight kininogen deficiency ORPHA:483,0.8922466888454011
SERPINA6,Corticosteroid-binding globulin deficiency ORPHA:199247,0.8922466888454011
SERPINA6,Dihydropyrimidinuria ORPHA:38874,0.8922466888454011
SERPINA6,Familial apolipoprotein A5 deficiency ORPHA:530849,0.8922466888454011
SERPINA6,Fanconi-Bickel syndrome ORPHA:2088,0.8922466888454011
SERPINA6,Hawkinsinuria ORPHA:2118,0.8922466888454011
SERPINA6,Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766,0.8922466888454011
SERPINA6,Hereditary thrombophilia due to congenital antithrombin deficiency ORPHA:82,0.8922466888454011
SERPINA6,Hyaluronidase deficiency ORPHA:67041,0.8922466888454011
SERPINA6,Hypertryptophanemia ORPHA:2224,0.8922466888454011
SERPINA6,IRIDA syndrome ORPHA:209981,0.8922466888454011
SERPINA6,NON RARE IN EUROPE: Congenital isolated thyroxine-binding globulin deficiency ORPHA:209893,0.8922466888454011
SERPINA6,NON RARE IN EUROPE: Familial dysalbuminemic hyperthyroxinemia ORPHA:276271,0.8922466888454011
SERPINA6,Severe hereditary thrombophilia due to congenital protein C deficiency ORPHA:745,0.8922466888454011
SERPINA6,Thrombocythemia with distal limb defects ORPHA:329319,0.8922466888454011
SERPINA6,Tyrosinemia type 2 ORPHA:28378,0.8922466888454011
SERPINA6,Tyrosinemia type 3 ORPHA:69723,0.8922466888454011
SERPINA6,Urocanic aciduria ORPHA:210128,0.8922466888454011
SERPINA6,46XY disorder of sex development due to testicular 1720-desmolase deficiency ORPHA:443087,0.8922466888454011
SERPINA6,Cerebral sinovenous thrombosis ORPHA:329217,0.8922466888454011
SERPINA6,Cholesterol-ester transfer protein deficiency ORPHA:79506,0.8922466888454011
SERPINA6,NON RARE IN EUROPE: Hyperlipoproteinemia type 4 ORPHA:413,0.8922466888454011
SERPINA6,Immunodeficiency due to a late component of complement deficiency ORPHA:169150,0.8922466888454011
SERPINA6,Homozygous familial hypercholesterolemia ORPHA:391665,0.8922466888454011
SERPINA6,Intrahepatic cholestasis of pregnancy ORPHA:69665,0.8922466888454011
SERPINA6,Primary Fanconi renotubular syndrome ORPHA:3337,0.8922466888454011
SERPINA6,NON RARE IN EUROPE: Non rare thrombophilia ORPHA:64738,0.8922466888454011
SERPINA6,8p23.1 microdeletion syndrome ORPHA:251071,0.8922466888454011
SERPINA6,AApoAI amyloidosis ORPHA:93560,0.8922466888454011
SERPINA6,ATTRV122I amyloidosis ORPHA:85451,0.8922466888454011
SERPINA6,ATTRV30M amyloidosis ORPHA:85447,0.8922466888454011
SERPINA6,Abetalipoproteinemia ORPHA:14,0.8922466888454011
SERPINA6,Aceruloplasminemia ORPHA:48818,0.8922466888454011
SERPINA6,Classic phenylketonuria ORPHA:79254,0.8922466888454011
SERPINA6,Congenital alpha2-antiplasmin deficiency ORPHA:79,0.8922466888454011
SERPINA6,Congenital deficiency in alpha-fetoprotein ORPHA:168612,0.8922466888454011
SERPINA6,Congenital factor VII deficiency ORPHA:327,0.8922466888454011
SERPINA6,Formiminoglutamic aciduria ORPHA:51208,0.8922466888454011
SERPINA6,GCGR-related hyperglucagonemia ORPHA:438274,0.8922466888454011
SERPINA6,Hereditary persistence of alpha-fetoprotein ORPHA:168615,0.8922466888454011
SERPINA6,Maternal phenylketonuria ORPHA:2209,0.8922466888454011
SERPINA6,Mild hyperphenylalaninemia ORPHA:79651,0.8922466888454011
SERPINA6,Mild phenylketonuria ORPHA:79253,0.8922466888454011
SERPINA6,Progressive retinal dystrophy due to retinol transport defect ORPHA:352718,0.8922466888454011
SERPINA6,Short stature due to primary acid-labile subunit deficiency ORPHA:140941,0.8922466888454011
SERPINA6,Tetrahydrobiopterin-responsive hyperphenylalaninemia/phenylketonuria ORPHA:293284,0.8922466888454011
SERPINA6,Generalized arterial calcification of infancy ORPHA:51608,0.8922466888454011
SERPINA6,NON RARE IN EUROPE: Non-alcoholic fatty liver disease ORPHA:33271,0.8922466888454011
SERPINA6,Pseudoxanthoma elasticum ORPHA:758,0.8922466888454011
SERPINA6,Familial papillary or follicular thyroid carcinoma ORPHA:319487,0.8922466888454011
SERPINA6,NON RARE IN EUROPE: Familial hypobetalipoproteinemia ORPHA:426,0.8922466888454011
SERPINH1,Malignant neoplasm of breast,0.4084380369379369
SERPINH1,Breast Carcinoma,0.7333611688795861
SERPINH1,Relative macrocephaly,0.7765852775619541
SERPINH1,Laryngeal Squamous Cell Carcinoma,0.7765852775619541
SERPINH1,Nephrolithiasis,0.7765852775619541
SERPINH1,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
SERPINH1,Triangular face,0.7765852775619541
SERPINH1,Nonspecific interstitial pneumonia,0.7765852775619541
SERPINH1,Glioma,0.7880542567584415
SERPINH1,Skin lesion,0.7880542567584415
SERPINH1,Dental caries,0.7880542567584415
SERPINH1,Leukemia T-Cell,0.7880542567584415
SERPINH1,Mycosis fungoides/Sezary syndrome NOS,0.7880542567584415
SERPINH1,Neuroblastoma,0.7880542567584415
SERPINH1,Central neuroblastoma,0.7880542567584415
SERPINH1,Neoplasms,0.7880542567584415
SERPINH1,Chronic lung disease,0.7880542567584415
SERPINH1,Malignant neoplasm of stomach,0.7880542567584415
SERPINH1,Joint laxity,0.7880542567584415
SERPINH1,Conjunctival scar,0.7880542567584415
SERPINH1,Hypercalcemia,0.7880542567584415
SERPINH1,Bulging forehead,0.7880542567584415
SERPINH1,Prominent forehead,0.7880542567584415
SERPINH1,Tumor Progression,0.7880542567584415
SERPINH1,Collagen-vascular disease,0.7880542567584415
SERPINH1,Coronary artery atheroma,0.7880542567584415
SERPINH1,Ocular Cicatricial Pemphigoid,0.7880542567584415
SERPINH1,Coronary Arteriosclerosis,0.7880542567584415
SERPINH1,Narrow thorax,0.7880542567584415
SERPINH1,Stomach Carcinoma,0.7880542567584415
SERPINH1,Small midface,0.7880542567584415
SERPINH1,Decreased projection of midface,0.7880542567584415
SERPINH1,Hypotrophic midface,0.7880542567584415
SERPINH1,Midface retrusion,0.7880542567584415
SERPINH1,Autoimmune Diseases,0.7880542567584415
SERPINH1,Cardiovascular Diseases,0.7880542567584415
SERPINH1,Pemphigoid Benign Mucous Membrane,0.7880542567584415
SERPINH1,Generalized joint laxity,0.7880542567584415
SERPINH1,Osteogenesis imperfecta type III (disorder),0.7880542567584415
SERPINH1,Rheumatoid Arthritis,0.7880542567584415
SERPINH1,Broad ribs,0.7880542567584415
SERPINH1,Shallow orbits,0.7908231553833205
SERPINH1,Endocarditis,0.7908231553833205
SERPINH1,Epidermolysis Bullosa Acquisita,0.7908231553833205
SERPINH1,Plaque Amyloid,0.8009048756462318
SERPINH1,Generalized osteopenia,0.8009048756462318
SERPINH1,Liver Cirrhosis Experimental,0.8014900279306119
SERPINH1,Collapse of vertebra,0.8019075543217649
SERPINH1,Compression fracture of vertebral column,0.8019075543217649
SERPINH1,Cervical Squamous Cell Carcinoma,0.8019075543217649
SERPINH1,Physical Activity Measurement,0.8019075543217649
SERPINH1,Dentinogenesis Imperfecta,0.8019075543217649
SERPINH1,Senile Plaques,0.8019075543217649
SERPINH1,Diabetic foot ulcer,0.8019075543217649
SERPINH1,Thin rib,0.8067197998685076
SERPINH1,Knee joint valgus deformity,0.8067197998685076
SERPINH1,Platyspondyly,0.8168901801930506
SERPINH1,High pitched voice,0.8168901801930506
SERPINH1,Ulcerative Colitis,0.8190761496232595
SERPINH1,Dengue Fever,0.8190761496232595
SERPINH1,Scleroderma,0.8212681436603975
SERPINH1,Osteopenia,0.8212681436603975
SERPINH1,Liver Cirrhosis,0.8232134984476662
SERPINH1,Infective endocarditis,0.8232134984476662
SERPINH1,Right Middle Cerebral Artery Infarction,0.8232134984476662
SERPINH1,Embolic Infarction Middle Cerebral Artery,0.8232134984476662
SERPINH1,Thrombotic Infarction Middle Cerebral Artery,0.8232134984476662
SERPINH1,Left Middle Cerebral Artery Infarction,0.8232134984476662
SERPINH1,Middle Cerebral Artery Embolus,0.8232134984476662
SERPINH1,Middle Cerebral Artery Syndrome,0.8232134984476662
SERPINH1,Middle Cerebral Artery Thrombosis,0.8232134984476662
SERPINH1,Fibrosis Liver,0.8272008757995397
SERPINH1,Bacterial Endocarditis,0.8272008757995397
SERPINH1,Hip circumference,0.8363138748299018
SERPINH1,Micromelia,0.8363138748299018
SERPINH1,Tropical Spastic Paraparesis,0.8368219249856942
SERPINH1,Systemic Scleroderma,0.8402911822757345
SERPINH1,Curvature of spine,0.8402911822757345
SERPINH1,Osteogenesis Imperfecta,0.8402911822757345
SERPINH1,Cervical Intraepithelial Neoplasia,0.8402911822757345
SERPINH1,Blue sclera,0.8402911822757345
SERPINH1,Acquired scoliosis,0.8402911822757345
SERPINH1,Pyloric Stenosis,0.8402911822757345
SERPINH1,Generalized hypotonia,0.843190898187174
SERPINH1,Diabetic Foot,0.843190898187174
SERPINH1,Hypotrophic malar bone,0.8490659121857849
SERPINH1,Malar flattening,0.8490659121857849
SERPINH1,Squamous cell carcinoma of esophagus,0.8610447277138289
SERPINH1,Retrusion of lower jaw,0.8648405521677974
SERPINH1,Decreased projection of lower jaw,0.8648405521677974
SERPINH1,Decreased projection of mandible,0.8648405521677974
SERPINH1,Hypoplastic mandible condyle,0.8648405521677974
SERPINH1,Aplasia/Hypoplasia of the mandible,0.8648405521677974
SERPINH1,Micrognathism,0.8648405521677974
SERPINH1,Hepatitis B Chronic,0.8745234584149799
SERPINH1,Hernia Inguinal,0.8769418330148872
SERPINH1,Narrow forehead,0.8769418330148872
SERPINH1,Respiratory Distress Syndrome Adult,0.8769418330148872
SERPINH1,Short stature,0.8815127642200768
SERPINH1,Body mass index,0.8867509400747969
SERPINH1,Finding of body mass index,0.8867509400747969
SERPINH1,High forehead,0.8867509400747969
SERPINH1,Middle Cerebral Artery Occlusion,0.887595340546704
SERPINH1,Coronary Artery Disease,0.887595340546704
SERPINH1,Hereditary gingival fibromatosis,0.8980854850210683
SERPINH1,Influenza,0.9193385822373632
SERPINH1,Complete atrioventricular block,0.929814249105729
SERPINH1,Fibroid Tumor,0.9373358316580888
SERPINH1,Body Height,0.9390727893210336
SERPINH1,Ischemia,0.9393256300017014
SERPINH1,Kaposi Sarcoma,0.9435654233359168
SERPINH1,Infarction Middle Cerebral Artery,0.9514640836642632
SERPINH1,Uterine Fibroids,0.9557184806547836
SERPINH1,Pheochromocytoma,0.9557184806547836
SERPINH1,Hamartoma Syndrome Multiple,0.963331724428282
SERPINH1,Nephrolithiasis,0.7765582368651238
SERPINH1,Dentinogenesis Imperfecta,0.7765582368651238
SERPINH1,Liver Cirrhosis,0.7765582368651238
SERPINH1,Macrocephaly,0.7765582368651238
SERPINH1,Osteopenia,0.8115918568696846
SERPINH1,Osteogenesis Imperfecta,0.8115918568696846
SERPINH1,Cerebral Infraction,0.8457525389282121
SERPINH1,Cerebral Thrombosis,0.8566038214826551
SERPINH1,Coronary Artery Disease,0.861756360478846
SERPINH1,Micromelia,0.861756360478846
SERPINH1,Liver Fibrosis,0.8903301324869451
SERPINH1,Respiratory Distress Syndrome,0.8903630091389316
SERPINH1,Lung Diseases,0.8903630091389316
SERPINH1,Scoliosis,0.924275664330454
SERPINH1,Micrognathism,0.9398381935810408
SERPINH1,Dwarfism,0.9510372690456612
SERPINH1,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
SERPINH1,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.1040670578681756
SERPINH1,Cold-induced sweating syndrome ORPHA:157820,0.1068643725150898
SERPINH1,Knobloch syndrome ORPHA:1571,0.1991445465001551
SERPINH1,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900,0.1991445465001551
SERPINH1,Musculocontractural Ehlers-Danlos syndrome ORPHA:2953,0.1991445465001551
SERPINH1,Early-onset posterior polar cataract ORPHA:98993,0.2475924359068358
SERPINH1,Giant cell glioblastoma ORPHA:251579,0.2844858212863536
SERPINH1,Gliosarcoma ORPHA:251576,0.2844858212863536
SERPINH1,Atypical Werner syndrome ORPHA:79474,0.3832844616405875
SERPINH1,Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855,0.3832844616405875
SERPINH1,Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365,0.3832844616405875
SERPINH1,Charcot-Marie-Tooth disease type 2B1 ORPHA:98856,0.3832844616405875
SERPINH1,Congenital muscular dystrophy due to LMNA mutation ORPHA:157973,0.3832844616405875
SERPINH1,Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284,0.3832844616405875
SERPINH1,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229,0.3832844616405875
SERPINH1,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751,0.3832844616405875
SERPINH1,Familial partial lipodystrophy Dunnigan type ORPHA:2348,0.3832844616405875
SERPINH1,Familial partial lipodystrophy Kobberling type ORPHA:79084,0.3832844616405875
SERPINH1,Heart-hand syndrome Slovenian type ORPHA:168796,0.3832844616405875
SERPINH1,LMNA-related cardiocutaneous progeria syndrome ORPHA:363618,0.3832844616405875
SERPINH1,Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153,0.3832844616405875
SERPINH1,Muscular dystrophy Selcen type ORPHA:199340,0.3832844616405875
SERPINH1,Quebec platelet disorder ORPHA:220436,0.3832844616405875
SERPINH1,Van den Ende-Gupta syndrome ORPHA:2460,0.3832844616405875
SERPINH1,Congenital short bowel syndrome ORPHA:2301,0.3832844616405875
SERPINH1,Dermatofibrosarcoma protuberans ORPHA:31112,0.3832844616405875
SERPINH1,Thyroid ectopia ORPHA:95712,0.3832844616405875
SERPINH1,Multiple osteochondromas ORPHA:321,0.5867963421058087
SERPINH1,Aarskog-Scott syndrome ORPHA:915,0.5867963421058087
SERPINH1,Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289,0.5867963421058087
SERPINH1,Autosomal dominant omodysplasia ORPHA:93328,0.5867963421058087
SERPINH1,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476,0.5867963421058087
SERPINH1,Multiple epiphyseal dysplasia type 5 ORPHA:93311,0.5867963421058087
SERPINH1,Multiple myeloma ORPHA:29073,0.5867963421058087
SERPINH1,Pseudohypoaldosteronism type 2B ORPHA:88939,0.5867963421058087
SERPINH1,Seizures-scoliosis-macrocephaly syndrome ORPHA:466926,0.5867963421058087
SERPINH1,Spondyloepimetaphyseal dysplasia matrilin-3 type ORPHA:156728,0.5867963421058087
SERPINH1,3M syndrome ORPHA:2616,0.5867963421058087
SERPINH1,Autosomal recessive Robinow syndrome ORPHA:1507,0.5867963421058087
SERPINH1,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.5867963421058087
SERPINH1,Hereditary combined deficiency of vitamin K-dependent clotting factors ORPHA:98434,0.5867963421058087
SERPINH1,Hyperostosis corticalis generalisata ORPHA:3416,0.5867963421058087
SERPINH1,Truncus arteriosus ORPHA:3384,0.5867963421058087
SERPINH1,Acrocallosal syndrome ORPHA:36,0.5867963421058087
SERPINH1,Isolated scaphocephaly ORPHA:35093,0.5867963421058087
SERPINH1,Myxofibrosarcoma ORPHA:79105,0.5867963421058087
SERPINH1,Silver-Russell syndrome due to a point mutation ORPHA:397590,0.5959529547720634
SERPINH1,Familial exudative vitreoretinopathy ORPHA:891,0.6196505963261838
SERPINH1,Tetralogy of Fallot ORPHA:3303,0.7007232363756918
SERPINH1,Early-onset nuclear cataract ORPHA:98991,0.7895126437786436
SERPINH1,Bruck syndrome ORPHA:2771,0.7929682744768703
SERPINH1,20p12.3 microdeletion syndrome ORPHA:261295,0.7929682744768703
SERPINH1,46XY gonadal dysgenesis-motor and sensory neuropathy syndrome ORPHA:168563,0.7929682744768703
SERPINH1,Arnold-Chiari malformation type I ORPHA:268882,0.7929682744768703
SERPINH1,Autosomal dominant Charcot-Marie-Tooth disease type 2C ORPHA:99937,0.7929682744768703
SERPINH1,Autosomal dominant brachyolmia ORPHA:93304,0.7929682744768703
SERPINH1,Autosomal dominant congenital benign spinal muscular atrophy ORPHA:1216,0.7929682744768703
SERPINH1,Autosomal dominant osteopetrosis type 1 ORPHA:2783,0.7929682744768703
SERPINH1,Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333,0.7929682744768703
SERPINH1,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354,0.7929682744768703
SERPINH1,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361,0.7929682744768703
SERPINH1,Brachydactyly type B1 ORPHA:572385,0.7929682744768703
SERPINH1,Chondrosarcoma ORPHA:55880,0.7929682744768703
SERPINH1,Cobblestone lissencephaly without muscular or ocular involvement ORPHA:352682,0.7929682744768703
SERPINH1,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.7929682744768703
SERPINH1,Craniofrontonasal dysplasia ORPHA:1520,0.7929682744768703
SERPINH1,Craniosynostosis Boston type ORPHA:1541,0.7929682744768703
SERPINH1,Distal myopathy with posterior leg and anterior hand involvement ORPHA:63273,0.7929682744768703
SERPINH1,Endosteal hyperostosis Worth type ORPHA:2790,0.7929682744768703
SERPINH1,Familial digital arthropathy-brachydactyly ORPHA:85169,0.7929682744768703
SERPINH1,Kuskokwim syndrome ORPHA:1149,0.7929682744768703
SERPINH1,LRP5-related primary osteoporosis ORPHA:498481,0.7929682744768703
SERPINH1,Metatropic dysplasia ORPHA:2635,0.7929682744768703
SERPINH1,Multiple epiphyseal dysplasia Al-Gazali type ORPHA:166024,0.7929682744768703
SERPINH1,Muscle filaminopathy ORPHA:171445,0.7929682744768703
SERPINH1,Osteoporosis-pseudoglioma syndrome ORPHA:2788,0.7929682744768703
SERPINH1,Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377,0.7929682744768703
SERPINH1,Parastremmatic dwarfism ORPHA:2646,0.7929682744768703
SERPINH1,Parietal foramina with clavicular hypoplasia ORPHA:251290,0.7929682744768703
SERPINH1,Postaxial polydactyly-anterior pituitary anomalies-facial dysmorphism syndrome ORPHA:420584,0.7929682744768703
SERPINH1,Scapuloperoneal spinal muscular atrophy ORPHA:431255,0.7929682744768703
SERPINH1,Spondyloepiphyseal dysplasia Maroteaux type ORPHA:263482,0.7929682744768703
SERPINH1,Spondylometaphyseal dysplasia Kozlowski type ORPHA:93314,0.7929682744768703
SERPINH1,Familial avascular necrosis of femoral head ORPHA:86820,0.7929682744768703
SERPINH1,Hypoplastic left heart syndrome ORPHA:2248,0.7929682744768703
SERPINH1,Familial bicuspid aortic valve ORPHA:402075,0.795266832401002
SERPINH1,Familial isolated restrictive cardiomyopathy ORPHA:75249,0.8029813443753846
SERPINH1,Osteogenesis imperfecta type 2 ORPHA:216804,0.8029813443753846
SERPINH1,Peters anomaly ORPHA:708,0.8029813443753846
SERPINH1,Skeletal Ewing sarcoma ORPHA:319,0.8029813443753846
SERPINH1,Atrial septal defect ostium secundum type ORPHA:99103,0.8105918570729571
SERPINH1,Autosomal dominant polycystic kidney disease ORPHA:730,0.8105918570729571
SERPINH1,Osteogenesis imperfecta type 3 ORPHA:216812,0.8211968342881582
SERPINH1,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.8922466888454011
SERPINH1,Caffey disease ORPHA:1310,0.8922466888454011
SERPINH1,Congenital contractural arachnodactyly ORPHA:115,0.8922466888454011
SERPINH1,Dyssegmental dysplasia Silverman-Handmaker type ORPHA:1865,0.8922466888454011
SERPINH1,Dystonia-parkinsonism-hypermanganesemia syndrome ORPHA:521406,0.8922466888454011
SERPINH1,Fibronectin glomerulopathy ORPHA:84090,0.8922466888454011
SERPINH1,Glutaric acidemia type 3 ORPHA:35706,0.8922466888454011
SERPINH1,Microphthalmia with brain and digit anomalies ORPHA:139471,0.8922466888454011
SERPINH1,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.8922466888454011
SERPINH1,Pancreatic hypoplasia-diabetes-congenital heart disease syndrome ORPHA:2255,0.8922466888454011
SERPINH1,Schwartz-Jampel syndrome ORPHA:800,0.8922466888454011
SERPINH1,Vein of Galen aneurysmal malformation ORPHA:1053,0.8922466888454011
SERPINH1,Woolly hair-palmoplantar keratoderma syndrome ORPHA:420686,0.8922466888454011
SERPINH1,Axenfeld anomaly ORPHA:98978,0.8922466888454011
SERPINH1,Axenfeld-Rieger syndrome ORPHA:782,0.8922466888454011
SERPINH1,Cole-Carpenter syndrome ORPHA:2050,0.8922466888454011
SERPINH1,Hereditary sensory and autonomic neuropathy type 5 ORPHA:64752,0.8922466888454011
SERPINH1,Postaxial polydactyly type B ORPHA:93335,0.8922466888454011
SERPINH1,Rieger anomaly ORPHA:91483,0.8922466888454011
SERPINH1,Spondylometaphyseal dysplasia 'corner fracture' type ORPHA:93315,0.8922466888454011
SERPINH1,BOR syndrome ORPHA:107,0.8922466888454011
SERPINH1,Milroy disease ORPHA:79452,0.8922466888454011
SERPINH1,Autosomal dominant Robinow syndrome ORPHA:3107,0.8922466888454011
SERPINH1,Osteogenesis imperfecta type 4 ORPHA:216820,0.8922466888454011
SERPINH1,Classical Ehlers-Danlos syndrome ORPHA:287,0.8922466888454011
SERPINH1,Multicentric osteolysis-nodulosis-arthropathy spectrum ORPHA:371428,0.8922466888454011
SERPINH1,Ablepharon macrostomia syndrome ORPHA:920,0.8922466888454011
SERPINH1,Arterial tortuosity syndrome ORPHA:3342,0.8922466888454011
SERPINH1,Barber-Say syndrome ORPHA:1231,0.8922466888454011
SERPINH1,Focal facial dermal dysplasia type III ORPHA:1807,0.8922466888454011
SERPINH1,High bone mass osteogenesis imperfecta ORPHA:314029,0.8922466888454011
SERPINH1,Lymphedema-distichiasis syndrome ORPHA:33001,0.8922466888454011
SERPINH1,Ring dermoid of cornea ORPHA:91481,0.8922466888454011
SERPINH1,NON RARE IN EUROPE: Ventricular septal defect ORPHA:1480,0.8922466888454011
SERPINH1,Cowpox virus SPI3 or CPXV042 protein (gene: SPI3),0.8999095837312036
SERTAD2,Carcinogenesis,0.7333611688795861
SERTAD2,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
SERTAD2,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
SERTAD2,Colorectal Carcinoma,0.7765852775619541
SERTAD2,Liver carcinoma,0.7880542567584415
SERTAD2,Mean Corpuscular Volume (result),0.7880542567584415
SERTAD2,Aggressive systemic mastocytosis ORPHA:98850,0.8029813443753846
SGSM2,Insulin measurement,0.7880542567584415
SGSM2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
SGSM2,Obesity,0.8989612563669234
SGSM2,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
SGSM2,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
SGSM2,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
SGSM2,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
SGSM2,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
SGSM2,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
SGSM2,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
SGSM2,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
SGSM2,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
SGSM2,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
SGSM2,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
SGSM2,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
SGSM2,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
SGSM2,Cerebellar-facial-dental syndrome ORPHA:444072,0.1040670578681756
SGSM2,DNAJB2-related Charcot-Marie-Tooth disease type 2 ORPHA:443950,0.1040670578681756
SGSM2,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.1040670578681756
SGSM2,Young adult-onset distal hereditary motor neuropathy ORPHA:314485,0.1040670578681756
SGSM2,Bilateral perisylvian polymicrogyria ORPHA:98889,0.1068643725150898
SGSM2,Saldino-Mainzer syndrome ORPHA:140969,0.1991445465001551
SGSM2,Birt-Hogg-Dube syndrome ORPHA:122,0.1991445465001551
SGSM2,Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899,0.1991445465001551
SGSM2,Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635,0.1991445465001551
SGSM2,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144,0.1991445465001551
SGSM2,Familial spontaneous pneumothorax ORPHA:2903,0.1991445465001551
SGSM2,Hurler syndrome ORPHA:93473,0.1991445465001551
SGSM2,Hurler-Scheie syndrome ORPHA:93476,0.1991445465001551
SGSM2,Methylmalonic acidemia with homocystinuria type cblJ ORPHA:369955,0.1991445465001551
SGSM2,POMT1-related  limb-girdle muscular dystrophy R11 ORPHA:86812,0.1991445465001551
SGSM2,Scheie syndrome ORPHA:93474,0.1991445465001551
SGSM2,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569,0.1991445465001551
SGSM2,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.1991445465001551
SGSM2,Synaptic congenital myasthenic syndromes ORPHA:98915,0.1991445465001551
SGSM2,17p11.2 microduplication syndrome ORPHA:1713,0.3832844616405875
SGSM2,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964,0.3832844616405875
SGSM2,Distal 16p11.2 microdeletion syndrome ORPHA:261222,0.3832844616405875
SGSM2,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316,0.3832844616405875
SGSM2,PMP22-RAI1 contiguous gene duplication syndrome ORPHA:477817,0.3832844616405875
SGSM2,Proximal 16p11.2 microdeletion syndrome ORPHA:261197,0.3832844616405875
SGSM2,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency ORPHA:329249,0.3832844616405875
SGSM2,Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220,0.3832844616405875
SGSM2,Isolated focal cortical dysplasia type IIb ORPHA:269008,0.3832844616405875
SGSM2,Congenital muscular dystrophy with intellectual disability ORPHA:370968,0.3977968344535308
SGSM2,Uveal melanoma ORPHA:39044,0.3977968344535308
SGSM2,Adult hepatocellular carcinoma ORPHA:210159,0.4491081214880772
SGSM2,COG1-CDG ORPHA:263508,0.5867963421058087
SGSM2,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome ORPHA:459061,0.5867963421058087
SGSM2,Isolated focal cortical dysplasia type IIa ORPHA:269001,0.5867963421058087
SGSM2,Primary lateral sclerosis ORPHA:35689,0.7929682744768703
SGSM2,SYNGAP1-related developmental and epileptic encephalopathy ORPHA:544254,0.7929682744768703
SGSM2,Spastic paraplegia type 7 ORPHA:99013,0.7929682744768703
SGSM2,Familial advanced sleep-phase syndrome ORPHA:164736,0.7929682744768703
SGSM2,Pseudohypoparathyroidism type 1B ORPHA:94089,0.8922466888454011
SH2B2,Malignant neoplasm of prostate,0.7880542567584415
SH2B2,Prostate carcinoma,0.7880542567584415
SH2B2,Hyperhomocysteinemia,0.7880542567584415
SH2B2,Lupus Erythematosus Systemic,0.7880542567584415
SH2B2,Chondrosarcoma,0.7880542567584415
SH2B2,Autoimmune Diseases,0.7880542567584415
SH2B2,Antiphospholipid Syndrome,0.7880542567584415
SH2B2,Autoimmune Primary Adrenal Insufficiency,0.7880542567584415
SH2B2,Cryopyrin-Associated Periodic Syndromes,0.8019075543217649
SH2B2,Systemic Inflammatory Response Syndrome,0.8019075543217649
SH2B2,Addison Disease,0.8019075543217649
SH2B2,Thrombophilia,0.8232134984476662
SH2B2,Respiratory Distress Syndrome Adult,0.8769418330148872
SH2B2,Pain,0.887595340546704
SH2B2,Blood Coagulation Disorders,0.9307095582633488
SH2B2,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
SH2B2,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
SH2B2,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
SH2B2,Polydactyly of a biphalangeal thumb ORPHA:93339,0.3832844616405875
SH2B2,Native American myopathy ORPHA:168572,0.8922466888454011
SH2B2,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
SH2B2,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
SH2B2,Provisional),0.8999095837312036
SH2B2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
SH2B2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
SH2B2,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
SH2B2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
SH2B2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
SH2B2,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
SH2B2,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
SH2B2,Monkeypox virus ser/thr kinase,0.8999095837312036
SH2B2,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
SH2B2,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
SH2B2,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
SH2B2,Nipah henipavirus P phosphoprotein,0.8999095837312036
SH2B2,Monkeypox virus ankyrin-like protein,0.8999095837312036
SH2B2,Enterovirus B genome polyportein,0.8999095837312036
SH2B2,Enterovirus B73 full_polyprotein 1..2188,0.8999095837312036
SH2B2,Enterovirus B106 full_polyprotein 1..2192,0.903486026792944
SH2B2,Echovirus E5 full_polyprotein 1..2196,0.9057542447893764
SH2B2,Echovirus E9 full_polyprotein 1..2203,0.9359472799230178
SH2B2,Echovirus E30 full_polyprotein 1..2194,0.9364561700418303
SH2B2,Coxsackievirus B6 full_polyprotein 1..2184,0.9366403811337995
SH2B3,Malignant neoplasm of breast,0.4084380369379369
SH2B3,Reticulocyte count (procedure),0.5071083164302358
SH2B3,Breast Carcinoma,0.7333611688795861
SH2B3,Malignant neoplasm of ovary,0.7333611688795861
SH2B3,leukemia,0.7333611688795861
SH2B3,Ovarian Carcinoma,0.7333611688795861
SH2B3,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
SH2B3,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
SH2B3,Colorectal Carcinoma,0.7765852775619541
SH2B3,Acrocyanosis,0.7765852775619541
SH2B3,Leukemia Myelocytic Acute,0.7765852775619541
SH2B3,Paresthesia,0.7765852775619541
SH2B3,MYELODYSPLASTIC SYNDROME,0.7765852775619541
SH2B3,Arterial thrombosis,0.7765852775619541
SH2B3,Leukemogenesis,0.7765852775619541
SH2B3,Endometrial Neoplasms,0.7765852775619541
SH2B3,Uric acid measurement (procedure),0.7765852775619541
SH2B3,Endometrial Carcinoma,0.7765852775619541
SH2B3,Malignant neoplasm of lung,0.7880542567584415
SH2B3,Colorectal Cancer,0.7880542567584415
SH2B3,Primary malignant neoplasm of lung,0.7880542567584415
SH2B3,Carcinoma of lung,0.7880542567584415
SH2B3,Red Blood Cell Count measurement,0.7880542567584415
SH2B3,Platelet Count measurement,0.7880542567584415
SH2B3,Serum total cholesterol measurement,0.7880542567584415
SH2B3,Biliary cirrhosis,0.7880542567584415
SH2B3,Monocyte count procedure,0.7880542567584415
SH2B3,Monocyte count result,0.7880542567584415
SH2B3,Hematologic Neoplasms,0.7880542567584415
SH2B3,Juvenile Myelomonocytic Leukemia,0.7880542567584415
SH2B3,Eosinophil count procedure,0.7880542567584415
SH2B3,Eosinophil count result,0.7880542567584415
SH2B3,Libman-Sacks Disease,0.7880542567584415
SH2B3,Beta-2-microglobulin measurement,0.7880542567584415
SH2B3,Hematocrit increased,0.7880542567584415
SH2B3,Processing speed,0.7880542567584415
SH2B3,MYELOPROLIFERATIVE SYNDROME TRANSIENT,0.7880542567584415
SH2B3,Hemoglobin increased,0.7880542567584415
SH2B3,Increased megakaryocyte count,0.7880542567584415
SH2B3,Increase in blood pressure,0.7880542567584415
SH2B3,Mean corpuscular hemoglobin concentration determination,0.7880542567584415
SH2B3,Prolonged bleeding time,0.7880542567584415
SH2B3,Lupus Erythematosus Systemic,0.7880542567584415
SH2B3,Hematological Disease,0.7880542567584415
SH2B3,Thrombocytosis Autosomal Dominant,0.7880542567584415
SH2B3,Coronary Arteriosclerosis,0.7880542567584415
SH2B3,Alzheimer's Disease,0.7880542567584415
SH2B3,Platelet hematocrit measurement,0.7880542567584415
SH2B3,Acute lymphocytic leukemia,0.7880542567584415
SH2B3,Abnormal platelet morphology,0.7880542567584415
SH2B3,Amaurosis Fugax,0.7880542567584415
SH2B3,Impaired platelet aggregation,0.7880542567584415
SH2B3,Autoimmune Diseases,0.7880542567584415
SH2B3,Cardiovascular Diseases,0.7880542567584415
SH2B3,Polycythemia Vera,0.7880542567584415
SH2B3,Solid Neoplasm,0.7880542567584415
SH2B3,Rheumatoid Arthritis,0.7880542567584415
SH2B3,Antiphospholipid Syndrome,0.7880542567584415
SH2B3,Diabetes,0.7880542567584415
SH2B3,Diabetes Mellitus,0.7880542567584415
SH2B3,Fibrinogen assay,0.7880542567584415
SH2B3,Abnormality of the skeletal system,0.7880542567584415
SH2B3,Ankylosing spondylitis,0.7880542567584415
SH2B3,Acute Cerebrovascular Accidents,0.7880542567584415
SH2B3,Increased number of platelets,0.7880542567584415
SH2B3,Crohn Disease,0.7880542567584415
SH2B3,Global developmental delay,0.7880542567584415
SH2B3,Thrombocytosis,0.7880542567584415
SH2B3,Myeloid Leukemia Chronic,0.7880542567584415
SH2B3,Hemoglobin measurement,0.7880542567584415
SH2B3,Bacterial Infections,0.7908231553833205
SH2B3,Vascular inflammations,0.7908231553833205
SH2B3,Chronic myeloproliferative disorder,0.7945683314244791
SH2B3,Juvenile arthritis,0.8009048756462318
SH2B3,Thrombocythemia Essential,0.8009048756462318
SH2B3,Vitiligo,0.8019075543217649
SH2B3,Psoriasis,0.8019075543217649
SH2B3,Myocardial Infarction,0.8019075543217649
SH2B3,Neutrophil count (procedure),0.8019075543217649
SH2B3,Diabetes Autoimmune,0.8019075543217649
SH2B3,Familial erythrocytosis,0.8019075543217649
SH2B3,Systolic Pressure,0.8098851543361193
SH2B3,Blast Phase,0.8114747041691183
SH2B3,Myeloproliferative disease,0.8138488881521341
SH2B3,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
SH2B3,Brain hemorrhage,0.8168901801930506
SH2B3,Ulcerative Colitis,0.8190761496232595
SH2B3,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
SH2B3,Blood basophil count (lab test),0.8190761496232595
SH2B3,Primary sclerosing cholangitis,0.8212681436603975
SH2B3,Granulocyte count,0.8212681436603975
SH2B3,Inflammation,0.8212681436603975
SH2B3,Headache,0.8270909867833504
SH2B3,Cholangitis Sclerosing,0.8337767145465158
SH2B3,Venous Thrombosis,0.8363138748299018
SH2B3,Splenomegaly,0.8402911822757345
SH2B3,Amyotrophic Lateral Sclerosis,0.8402911822757345
SH2B3,Immune System Diseases,0.8402911822757345
SH2B3,Transient Cerebral Ischemia,0.8402911822757345
SH2B3,Celiac Disease,0.8402911822757345
SH2B3,Hematocrit procedure,0.8402911822757345
SH2B3,Hypertensive disease,0.8474481237156937
SH2B3,Dyspnea on exertion,0.8554819098734854
SH2B3,Dizziness,0.8642802827048847
SH2B3,Low density lipoprotein cholesterol measurement,0.8648405521677974
SH2B3,Cerebrovascular accident,0.8648405521677974
SH2B3,Vertigo,0.8648405521677974
SH2B3,Primary Myelofibrosis,0.876210765330195
SH2B3,Tetralogy of Fallot,0.8769418330148872
SH2B3,Malignant neoplasm of endometrium,0.8769418330148872
SH2B3,Eosinophilia,0.8769418330148872
SH2B3,Uterine Corpus Cancer,0.8771562273432176
SH2B3,Inflammatory Bowel Diseases,0.8815127642200768
SH2B3,Cerebral Hemorrhage,0.882453254162044
SH2B3,Coronary Artery Disease,0.887595340546704
SH2B3,nervous system disorder,0.8959157818691486
SH2B3,Systemic arterial pressure,0.900167961295542
SH2B3,Blood Pressure,0.900167961295542
SH2B3,Blood pressure finding,0.900167961295542
SH2B3,Chest Pain,0.900167961295542
SH2B3,Fatigue,0.9029289778792944
SH2B3,Coronary heart disease,0.9119978323790848
SH2B3,Eosinophilic disorder,0.9193385822373632
SH2B3,Myelofibrosis,0.9325666311629114
SH2B3,White Blood Cell Count procedure,0.9431511078237256
SH2B3,Lymphocyte Count measurement,0.9473064300361868
SH2B3,Graves Disease,0.94939825643792
SH2B3,Diastolic blood pressure,0.9505280654948344
SH2B3,Hepatitis Autoimmune,0.9571401094099016
SH2B3,Thyroid Diseases,0.9639249377588224
SH2B3,Hypothyroidism,0.9816840072553962
SH2B3,Developmental delay (disorder),0.9874278479946328
SH2B3,Gout,0.7765582368651238
SH2B3,Gouty Arthritis,0.7765582368651238
SH2B3,Stroke,0.7765582368651238
SH2B3,Hematologic Neoplasms,0.7765582368651238
SH2B3,Ovarian Neoplasm,0.7765582368651238
SH2B3,Ovarian Endometrioid Carcinoma,0.7765582368651238
SH2B3,Sclerosing Cholangitis,0.7765582368651238
SH2B3,Prostate Cancer,0.7765582368651238
SH2B3,Ovarian Serous Adenocarcinoma,0.7765582368651238
SH2B3,Nonbacterial Verrucal Endocardiosis,0.7765582368651238
SH2B3,Myelomonocytic Leukemia,0.7765582368651238
SH2B3,Lymphocytic Leukemia,0.7765582368651238
SH2B3,Polycythemia Vera,0.7765582368651238
SH2B3,Vascular Diseases,0.7765582368651238
SH2B3,Myelodysplastic Syndrome,0.7765582368651238
SH2B3,Vitiligo,0.7765582368651238
SH2B3,Ischemic Stroke,0.7765582368651238
SH2B3,Hypertension,0.7765582368651238
SH2B3,Thrombocythemia,0.7765582368651238
SH2B3,Myelofibrosis,0.7765582368651238
SH2B3,Leukemia,0.7765582368651238
SH2B3,Erythrocytosis,0.7765582368651238
SH2B3,Lymphoblastic Leukemia,0.7765582368651238
SH2B3,Coronary Arteriosclerosis,0.7797212851906329
SH2B3,Endometrial Neoplasms,0.7860378120955526
SH2B3,Autoimmune Hepatitis,0.8115918568696846
SH2B3,Myelodysplasia,0.8115918568696846
SH2B3,Endometrial Carcinoma,0.8115918568696846
SH2B3,Lung Carcinoma,0.8139950454942313
SH2B3,Colonic Neoplasms,0.8210988731657684
SH2B3,Thrombocytosis,0.8457525389282121
SH2B3,Myeloproliferative Disorder,0.861756360478846
SH2B3,Myocardial Infarction,0.861756360478846
SH2B3,Inflammatory Bowel Disease,0.861756360478846
SH2B3,Blood Coagulation Disorders,0.861756360478846
SH2B3,Brittle Diabetes Mellitus,0.861756360478846
SH2B3,Coronary Artery Disease,0.861756360478846
SH2B3,Ulcerative Colitis,0.861756360478846
SH2B3,Coronary Heart Disease,0.861756360478846
SH2B3,Autoimmune Diabetes,0.861756360478846
SH2B3,Hypothyroidism,0.8879896755141929
SH2B3,Cholangitis,0.8885757656973042
SH2B3,Transient Ischemic Attack,0.8903301324869451
SH2B3,Ankylosing Spondylitis,0.8903301324869451
SH2B3,Immune System Diseases,0.8903301324869451
SH2B3,Crohn Disease,0.8903630091389316
SH2B3,Lupus Erythematosus,0.9145387439550552
SH2B3,Diabetes Mellitus,0.919442421650838
SH2B3,Cardiovascular Diseases,0.924275664330454
SH2B3,Celiac Disease,0.9246807042779188
SH2B3,Lung Adenocarcinoma,0.9350723667380212
SH2B3,Breast Carcinoma,0.9398381935810408
SH2B3,Colorectal Neoplasms,0.9510372690456612
SH2B3,Psoriasis,0.974502015052702
SH2B3,Tetralogy Of Fallot,0.9832345076528324
SH2B3,Autoimmune Diseases,0.9832345076528324
SH2B3,Colorectal Cancer,0.9832345076528324
SH2B3,Camurati-Engelmann disease ORPHA:1328,0.1991445465001551
SH2B3,Infantile inflammatory bowel disease with neurological involvement ORPHA:565788,0.1991445465001551
SH2B3,Mucopolysaccharidosis type 6 rapidly progressing ORPHA:276212,0.1991445465001551
SH2B3,Mucopolysaccharidosis type 6 slowly progressing ORPHA:276223,0.1991445465001551
SH2B3,Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366,0.5867963421058087
SH2B3,Nodular fasciitis ORPHA:477742,0.5867963421058087
SH2B3,Fetal and neonatal alloimmune thrombocytopenia ORPHA:853,0.606625035400596
SH2B3,Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942,0.7929682744768703
SH2B3,Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943,0.7929682744768703
SH2B3,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046,0.7929682744768703
SH2B3,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585,0.7929682744768703
SH2B3,Charcot-Marie-Tooth disease type 1B ORPHA:101082,0.7929682744768703
SH2B3,Essential thrombocythemia ORPHA:3318,0.8105918570729571
SH2B3,Bleeding diathesis due to thromboxane synthesis deficiency ORPHA:220443,0.8922466888454011
SH2B3,Combined immunodeficiency due to Moesin deficiency ORPHA:504530,0.8922466888454011
SH2B3,Infantile systemic hyalinosis ORPHA:2176,0.8922466888454011
SH2B3,Juvenile hyaline fibromatosis ORPHA:2028,0.8922466888454011
SH2B3,Autosomal dominant macrothrombocytopenia ORPHA:140957,0.8922466888454011
SH2D3C,Malignant neoplasm of breast,0.4084380369379369
SH2D3C,Breast Carcinoma,0.7333611688795861
SH2D3C,Mammary Neoplasms,0.7880542567584415
SH2D3C,Neuroblastoma,0.7880542567584415
SH2D3C,Central neuroblastoma,0.7880542567584415
SH2D3C,Diarrhea,0.7880542567584415
SH2D3C,Rotavirus Infections,0.8642802827048847
SH2D3C,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
SH2D3C,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
SH2D3C,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
SH2D3C,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
SH2D3C,LIPE-related familial partial lipodystrophy ORPHA:435660,0.1040670578681756
SH2D3C,Acute encephalopathy with biphasic seizures and late reduced diffusion ORPHA:363549,0.1991445465001551
SH2D3C,Bleeding disorder due to CalDAG-GEFI deficiency ORPHA:420566,0.3832844616405875
SH2D3C,Congenital non-communicating hydrocephalus ORPHA:269510,0.3832844616405875
SH2D3C,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome ORPHA:352662,0.3832844616405875
SH2D3C,Glycogen storage disease due to muscle glycogen phosphorylase deficiency ORPHA:368,0.3832844616405875
SH2D3C,Nephrogenic syndrome of inappropriate antidiuresis ORPHA:93606,0.3832844616405875
SH2D3C,Polymicrogyria with optic nerve hypoplasia ORPHA:250972,0.3832844616405875
SH2D3C,Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301,0.3832844616405875
SH2D3C,Severe combined immunodeficiency due to CORO1A deficiency ORPHA:228003,0.3832844616405875
SH2D3C,Spinocerebellar ataxia type 40 ORPHA:423275,0.3832844616405875
SH2D3C,Diencephalic-mesencephalic junction dysplasia ORPHA:319192,0.5867963421058087
SH2D3C,Hereditary sensory and autonomic neuropathy type 4 ORPHA:642,0.5867963421058087
SH2D3C,Laron syndrome with immunodeficiency ORPHA:220465,0.5867963421058087
SH2D3C,Obesity due to pro-opiomelanocortin deficiency ORPHA:71526,0.5867963421058087
SH2D3C,WHIM syndrome ORPHA:51636,0.5867963421058087
SH2D3C,XYLT1-CDG ORPHA:370930,0.5867963421058087
SH2D3C,NON RARE IN EUROPE: Vitiligo ORPHA:3435,0.5867963421058087
SH2D3C,Autosomal dominant Charcot-Marie-Tooth disease type 2I ORPHA:99942,0.7929682744768703
SH2D3C,Autosomal dominant Charcot-Marie-Tooth disease type 2J ORPHA:99943,0.7929682744768703
SH2D3C,Autosomal dominant intermediate Charcot-Marie-Tooth disease type D ORPHA:100046,0.7929682744768703
SH2D3C,Autosomal dominant intermediate Charcot-Marie-Tooth disease with neuropathic pain ORPHA:324585,0.7929682744768703
SH2D3C,Charcot-Marie-Tooth disease type 1B ORPHA:101082,0.7929682744768703
SH2D3C,Antenatal Bartter syndrome ORPHA:93604,0.7929682744768703
SH2D3C,Familial medullary thyroid carcinoma ORPHA:99361,0.7929682744768703
SH2D3C,Autosomal agammaglobulinemia ORPHA:33110,0.8029813443753846
SH2D3C,TSH-secreting pituitary adenoma ORPHA:91347,0.8922466888454011
SH2D3C,Hereditary elliptocytosis ORPHA:288,0.8922466888454011
SH2D3C,Precursor B-cell acute lymphoblastic leukemia ORPHA:99860,0.8922466888454011
SH3PXD2A,Cervix carcinoma,0.7765852775619541
SH3PXD2A,Malignant tumor of cervix,0.7768809924982332
SH3PXD2A,cervical cancer,0.7880542567584415
SH3PXD2A,Neoplasm Metastasis,0.7880542567584415
SH3PXD2A,Eclampsia,0.7880542567584415
SH3PXD2A,Congenital chromosomal disease,0.7880542567584415
SH3PXD2A,Adenocarcinoma of prostate,0.7880542567584415
SH3PXD2A,Acute Cerebrovascular Accidents,0.7880542567584415
SH3PXD2A,Neurofibrosarcoma,0.7880542567584415
SH3PXD2A,Schizophrenia,0.8067197998685076
SH3PXD2A,Adenocarcinoma of lung (disorder),0.8098851543361193
SH3PXD2A,familial atrial fibrillation,0.8168901801930506
SH3PXD2A,Persistent atrial fibrillation,0.8168901801930506
SH3PXD2A,Malignant Peripheral Nerve Sheath Tumor,0.8272008757995397
SH3PXD2A,Alzheimer Disease Late Onset,0.8402911822757345
SH3PXD2A,Cerebrovascular accident,0.8648405521677974
SH3PXD2A,Atrial Fibrillation,0.8648405521677974
SH3PXD2A,Paroxysmal atrial fibrillation,0.8815127642200768
SH3PXD2A,Stroke,0.7765582368651238
SH3PXD2A,Neurofibrosarcoma,0.7765582368651238
SH3PXD2A,Schizophrenia,0.7860378120955526
SH3PXD2A,Atrial Fibrillation,0.8115918568696846
SH3PXD2A,Paroxysmal Atrial Fibrillation,0.8115918568696846
SH3PXD2A,Rheumatoid Arthritis,0.9251646147729308
SH3PXD2A,Asthma,0.9832345076528324
SH3PXD2A,GNE myopathy ORPHA:602,0.3832844616405875
SH3PXD2A,Sialuria ORPHA:3166,0.3832844616405875
SH3PXD2A,Shprintzen-Goldberg syndrome ORPHA:2462,0.3832844616405875
SH3PXD2A,Atrophoderma vermiculata ORPHA:79100,0.7929682744768703
SH3PXD2A,Craniometaphyseal dysplasia ORPHA:1522,0.7929682744768703
SH3PXD2A,Duchenne muscular dystrophy ORPHA:98896,0.8922466888454011
SH3PXD2A,Familial calcium pyrophosphate deposition ORPHA:1416,0.8922466888454011
SH3PXD2A,Malignant peripheral nerve sheath tumor ORPHA:3148,0.8922466888454011
SH3PXD2A,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome ORPHA:83473,0.8922466888454011
SH3PXD2A,Acrofacial dysostosis Weyers type ORPHA:952,0.8922466888454011
SH3PXD2A,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
SH3PXD2A,Human immunodeficiency virus 1 Nef (gene: nef),0.8999095837312036
SH3PXD2A,Human immunodeficiency virus 2 nef protein,0.8999095837312036
SH3PXD2A,Human T-cell leukemia virus type I p15NC-p14PR-p95RT/IN (gene: gag-pro-pol),0.9224369592826992
SH3PXD2A,Human T-cell leukemia virus type I Pr gag-pro-pol (gene: gag-pro-pol),0.9224878266317492
SHF,Neoplasm Metastasis,0.7880542567584415
SHF,Neuroblastoma,0.7880542567584415
SHF,Central neuroblastoma,0.7880542567584415
SHF,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
SHF,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
SHF,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
SHF,Provisional),0.8999095837312036
SHF,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
SHF,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
SHF,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
SHF,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
SHF,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
SHF,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
SHF,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
SHF,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
SHF,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
SHF,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
SHF,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
SHF,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
SHF,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
SHF,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
SHF,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
SHF,Monkeypox virus ser/thr kinase,0.8999095837312036
SHF,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
SHF,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
SHF,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
SHF,Cowpox virus CPXV168 protein (gene: CPXV168 CDS),0.8999095837312036
SHF,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
SHF,Nipah henipavirus P phosphoprotein,0.8999095837312036
SHF,Monkeypox virus bifunctional EEV membrane phosphoglycoprotein/associates with A36R,0.8999095837312036
SHF,Monkeypox virus Zaire-96-I-16 A35R (gene: A35R),0.8999095837312036
SHF,Monkeypox virus ankyrin-like protein,0.9057542447893764
SIRPB1,Reticulosarcoma,0.7765852775619541
SIRPB1,Schizophrenia,0.8067197998685076
SIRPB1,Impulsive character (finding),0.8402911822757345
SIRPB1,Schizophrenia,0.7860378120955526
SIRPB1,Cleidocranial dysplasia ORPHA:1452,0.3832844616405875
SIRPB1,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504,0.3832844616405875
SIRPB1,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ORPHA:480864,0.3832844616405875
SIRPB1,Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366,0.5867963421058087
SIRPB1,1p21.3 microdeletion syndrome ORPHA:293948,0.7929682744768703
SIRPB1,Cherubism ORPHA:184,0.7929682744768703
SIRPB1,Dihydropyrimidine dehydrogenase deficiency ORPHA:1675,0.7929682744768703
SIRPB1,Essential thrombocythemia ORPHA:3318,0.8105918570729571
SIRPB1,Attenuated Chediak-Higashi syndrome ORPHA:352723,0.8922466888454011
SIRPB1,Autosomal dominant deafness-onychodystrophy syndrome ORPHA:79499,0.8922466888454011
SIRPB1,Autosomal dominant vitreoretinochoroidopathy ORPHA:3086,0.8922466888454011
SIRPB1,Autosomal recessive bestrophinopathy ORPHA:139455,0.8922466888454011
SIRPB1,Best vitelliform macular dystrophy ORPHA:1243,0.8922466888454011
SIRPB1,Chediak-Higashi syndrome ORPHA:167,0.8922466888454011
SIRPB1,Corpus callosum agenesis-neuronopathy syndrome ORPHA:1496,0.8922466888454011
SIRPB1,Diaphragmatic hernia-short bowel-asplenia syndrome ORPHA:527468,0.8922466888454011
SIRPB1,Histidinemia ORPHA:2157,0.8922466888454011
SIRPB1,MRCS syndrome ORPHA:263347,0.8922466888454011
SIRPB1,Polycythemia vera ORPHA:729,0.8922466888454011
SIRPB1,Susceptibility to localized juvenile periodontitis ORPHA:447740,0.8922466888454011
SIRPB1,Intermittent hydrarthrosis ORPHA:329967,0.8922466888454011
SIRPB1,Jervell and Lange-Nielsen syndrome ORPHA:90647,0.8922466888454011
SIRPB1,Primary myelofibrosis ORPHA:824,0.8922466888454011
SIRPB1,Hereditary clear cell renal cell carcinoma ORPHA:422526,0.8922466888454011
SIRPB1,Atypical chronic myeloid leukemia ORPHA:98824,0.8922466888454011
SIRPB1,Autosomal recessive severe congenital neutropenia due to CSF3R deficiency ORPHA:420702,0.8922466888454011
SIRPB1,Autosomal recessive severe congenital neutropenia due to CXCR2 deficiency ORPHA:420699,0.8922466888454011
SIRPB1,Beta-mannosidosis ORPHA:118,0.8922466888454011
SIRPB1,CEBPE-associated autoinflammation-immunodeficiency-neutrophil dysfunction syndrome ORPHA:566067,0.8922466888454011
SIRPB1,CINCA syndrome ORPHA:1451,0.8922466888454011
SIRPB1,Childhood encephalopathy due to thiamine pyrophosphokinase deficiency ORPHA:293955,0.8922466888454011
SIRPB1,Chronic neutrophilic leukemia ORPHA:86829,0.8922466888454011
SIRPB1,Cyclic neutropenia ORPHA:2686,0.8922466888454011
SIRPB1,Familial Mediterranean fever ORPHA:342,0.8922466888454011
SIRPB1,Familial cold urticaria ORPHA:47045,0.8922466888454011
SIRPB1,Ghosal hematodiaphyseal dysplasia ORPHA:1802,0.8922466888454011
SIRPB1,Hereditary neutrophilia ORPHA:279943,0.8922466888454011
SIRPB1,Muckle-Wells syndrome ORPHA:575,0.8922466888454011
SIRPB1,Myeloperoxidase deficiency ORPHA:2587,0.8922466888454011
SIRPB1,NLRC4-related familial cold autoinflammatory syndrome ORPHA:576349,0.8922466888454011
SIRPB1,NLRP12-associated hereditary periodic fever syndrome ORPHA:247868,0.8922466888454011
SIRPB1,Periodic fever-infantile enterocolitis-autoinflammatory syndrome ORPHA:436166,0.8922466888454011
SIRPB1,Properdin deficiency ORPHA:2966,0.8922466888454011
SIRPB1,Sweet syndrome ORPHA:3243,0.8922466888454011
SIRPB1,Tuberculosis ORPHA:3389,0.8922466888454011
SIRPB1,Vibratory urticaria ORPHA:493342,0.8922466888454011
SIRPB1,Microcephaly-polymicrogyria-corpus callosum agenesis syndrome ORPHA:171703,0.8922466888454011
SIRPB1,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
SIRPB1,Molluscum contagiosum virus subtype 1 MC069R (gene: MC069R),0.8999095837312036
SIRPB1,Ntaya virus full_polyprotein 1..3427,0.8999095837312036
SIRPB1,Ilheus virus full_polyprotein 1..3424,0.8999095837312036
SIRPB1,Adeno-associated virus 3B capsid protein VP1,0.8999095837312036
SIRPB1,Vaccinia virus IMV membrane protein (gene: L1R),0.8999095837312036
SIRPB1,Vaccinia virus Ankara myristylated IMV virion protein,0.8999095837312036
SIRPB1,Variola virus hypothetical protein (gene: M1R),0.8999095837312036
SIRPB1,Cowpox virus CPXV099 protein (gene: CPXV099 CDS),0.8999095837312036
SIRPB1,Monkeypox virus myristylprotein,0.8999095837312036
SIRPB1,Monkeypox virus Zaire-96-I-16 M1R (gene: M1R),0.8999095837312036
SIRPB1,Ectromelia virus ERPV IMV myristylated membrane protein,0.8999095837312036
SIRPB1,Horsepox virus HSPV089 (Lipid membrane protein),0.8999095837312036
SIRPB1,Yaba monkey tumor virus 60R,0.8999095837312036
SIRPB1,Yaba-like disease virus 60R protein (gene: 60R),0.8999095837312036
SIRPB1,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) hemagglutinin (gene: HA),0.8999095837312036
SIRPB1,Yaba-like disease virus 2L protein (gene: 2L),0.8999095837312036
SIRPB1,Human orthopneumovirus fusion protein (gene: F),0.8999095837312036
SIRPB1,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
SIRPB1,Hepatitis B virus pre-capsid protein (gene: C),0.8999095837312036
SIRPB1,Influenza A virus (A/Northern Territory/60/1968(H3N2)) HA2 (gene: HA),0.8999095837312036
SIRPB1,HBV genotype D HBeAg (gene: PreC/C),0.8999095837312036
SIRPB1,Yaba monkey tumor virus MHC-like TNF binding protein,0.8999095837312036
SIRPB1,Influenza A virus (A/Korea/426/1968(H2N2)) HA1 (gene: HA),0.8999095837312036
SIRPB1,Influenza A virus (A/New York/392/2004(H3N2)) HA1 (gene: HA),0.8999095837312036
SIRPB1,HBV genotype H PC/C protein (gene: PC/C),0.8999095837312036
SIRPB1,HBV genotype B preC/C protein (gene: preC/C),0.8999095837312036
SIRPB1,HBV genotype C core protein (gene: C),0.8999095837312036
SIRPB1,HBV genotype C HBeAg (gene: PreC/C),0.8999095837312036
SIRPB1,HBV recombinant C/G HBeAg (gene: preC/C),0.8999095837312036
SIRPB1,Hepatitis B virus capsid protein (gene: C),0.8999095837312036
SIRPB1,HBV recombinant B/C HBc protein (gene: C),0.8999095837312036
SIRPB1,HBV genotype C preC/C protein (gene: preC/C),0.8999095837312036
SIRPB1,Macacine alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
SIRPB1,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.8999095837312036
SIRPB1,Influenza A virus (A/New York/599/1996(H3N2)) HA1 (gene: HA),0.8999095837312036
SIRPB1,HBV genotype C HBc protein (gene: C),0.8999095837312036
SIRPB1,Human gammaherpesvirus 4 BARF1 protein (gene: BARF1),0.8999095837312036
SIRPB1,Influenza A virus (A/Korea/426/1968(H2N2)) hemagglutinin (gene: HA),0.8999095837312036
SIRPB1,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
SIRPB1,Adeno-associated virus - 2 major coat protein VP3,0.8999095837312036
SIRPB1,Adeno-associated virus - 2 major coat protein VP2,0.8999095837312036
SIRPB1,HBV genotype B C protein (gene: C),0.8999095837312036
SIRPB1,Influenza A virus (A/Northern Territory/60/1968(H3N2)) HA1 (gene: HA),0.8999095837312036
SIRPB1,West Nile virus SA93/01 envelope protein,0.8999095837312036
SIRPB1,West Nile virus SPU116/89 envelope protein,0.8999095837312036
SIRPB1,Human alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.8999095837312036
SIRPB1,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
SIRPB1,Influenza A virus (A/New York/599/1996(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
SIRPB1,West Nile virus lineage 1 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
SIRPB1,HBV genotype C C protein (gene: C),0.8999095837312036
SIRPB1,Adeno-associated virus - 2 major coat protein VP1,0.8999095837312036
SIRPB1,Adeno-associated virus - 3 capsid protein,0.8999095837312036
SIRPB1,Influenza A virus (A/New York/392/2004(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
SIRPB1,West Nile virus SA381/00 envelope protein,0.8999095837312036
SIRPB1,Human herpesvirus 4 type 2 BARF1,0.8999095837312036
SIRPB1,Influenza A virus (A/New York/602/1996(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
SIRPB1,Murray Valley encephalitis virus envelope protein E,0.8999095837312036
SIRPB1,West Nile virus H442 envelope protein,0.8999095837312036
SIRPB1,Influenza A virus (A/Puerto Rico/8/1934(H1N1)) haemagglutinin (gene: HA),0.8999095837312036
SIRPB1,Human betaherpesvirus 7 membrane glycoprotein UL119 (gene: U85),0.8999095837312036
SIRPB1,Influenza A virus (A/Northern Territory/60/1968(H3N2)) hemagglutinin (gene: HA),0.8999095837312036
SIRPB1,Influenza A virus (A/Shanghai/02/2013(H7N9)) neuraminidase (gene: NA),0.8999095837312036
SIRPB1,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
SIRPB1,Adeno-associated virus - 6 capsid protein VP1,0.8999095837312036
SIRPB1,Orf virus ORF047 putative myristylated IMV envelope protein,0.8999095837312036
SIRPB1,Rotavirus C outer capsid protein (gene: VP7),0.8999095837312036
SIRPB1,Macacine alphaherpesvirus 1 envelope glycoprotein D (gene: US6),0.8999095837312036
SIRPB1,Dengue virus full_polyprotein 1..3387,0.8999095837312036
SIRPB1,Rotavirus A VP7 (gene: VP7),0.8999095837312036
SIRPB1,West Nile virus lineage 1 excised_polyprotein 1..787 (gene: flavivirus polyprotein),0.8999095837312036
SIRPB1,Papiine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.8999095837312036
SIRPB1,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
SIRPB1,Dengue virus 4 envelope protein E (gene: flavivirus polyprotein),0.8999095837312036
SIRPB1,Cercopithecine alphaherpesvirus 2 envelope glycoprotein D (gene: US6),0.8999095837312036
SIRPB1,Influenza A virus (A/New York/602/1996(H3N2)) HA1 (gene: HA),0.8999095837312036
SIRPB1,Human betaherpesvirus 5 membrane protein UL6 (gene: UL6),0.8999095837312036
SIRPB1,Influenza A virus (A/Hong Kong/1073/99(H9N2)) neuraminidase (gene: na),0.8999095837312036
SIRPB1,Monkeypox virus Zaire-96-I-16 E8L (gene: E8L),0.8999095837312036
SIRPB1,Influenza A virus (A/Northern Territory/60/1968(H3N2)) neuraminidase (gene: NA),0.8999095837312036
SIRPB1,Monkeypox virus IMV membrane protein,0.8999095837312036
SIRPB1,Ectromelia virus ERPV hemagglutinin,0.8999095837312036
SIRPB1,Vaccinia virus IMV membrane protein (gene: D8L),0.8999095837312036
SIRPB1,Influenza A virus (A/New York/392/2004(H3N2)) neuraminidase (gene: NA),0.8999095837312036
SIRPB1,Influenza A virus (A/New York/599/1996(H3N2)) neuraminidase (gene: NA),0.8999095837312036
SIRPB1,Influenza A virus (A/New York/602/1996(H3N2)) neuraminidase (gene: NA),0.8999095837312036
SIRPB1,Murray Valley encephalitis virus prodexcised_polyprotein 1..793,0.8999095837312036
SIRPB1,Human betaherpesvirus 5 envelope glycoprotein UL4 (gene: UL4),0.8999095837312036
SIRPB1,Human alphaherpesvirus 1 envelope glycoprotein C (gene: UL44),0.8999095837312036
SIRPB1,Influenza A virus (A/Korea/426/1968(H2N2)) neuraminidase (gene: NA),0.8999095837312036
SIRPB1,Horsepox virus HSPV114 (Eukaryotic-type carbonic anhydrase),0.8999095837312036
SIRPB1,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
SIRPB1,Cowpox virus CPXV194 protein (gene: CPXV194 CDS),0.8999095837312036
SIRPB1,Human betaherpesvirus 6 U85 OX-2 homologue (gene: U85),0.8999095837312036
SIRPB1,Human betaherpesvirus 6A membrane glycoprotein UL119 (gene: U85),0.8999095837312036
SIRPB1,Cowpox virus CPXV125 protein (gene: CPV125 CDS),0.8999095837312036
SIRPB1,Ectromelia virus ERPV carbonic anhydrase,0.8999095837312036
SIRPB1,Vaccinia virus Ankara IMV chondroitin-binding membrane protein,0.8999095837312036
SIRPB1,Variola virus hypothetical protein (gene: J9R),0.8999095837312036
SIRPB1,Human mastadenovirus A E3 CR1-beta1,0.8999095837312036
SIRPB1,Variola virus hypothetical protein (gene: F8L),0.8999095837312036
SIRPB1,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
SIRPB1,Human adenovirus 61 E3 CR1 beta,0.9057542447893764
SIRPB1,Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A),0.9057542447893764
SIRPB1,Vaccinia virus hemagglutinin (gene: A56R),0.9058994261255549
SIRPB1,Human adenovirus 41 E3 31.6K,0.915880438522078
SIRPB1,Human adenovirus 18 CR1-beta protein (gene: E3),0.9197295331382644
SIRPB1,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9237501457186692
SIRPB1,Molluscum contagiosum virus subtype 1 MC080R (gene: MC080R),0.9237501457186692
SIRPB1,Vaccinia virus Ankara Haemagglutinin,0.9287050575620676
SLC16A3,Malignant neoplasm of breast,0.4084380369379369
SLC16A3,Carcinoma of bladder,0.4084380369379369
SLC16A3,Bladder Neoplasm,0.4084380369379369
SLC16A3,Malignant neoplasm of urinary bladder,0.5071083164302358
SLC16A3,Breast Carcinoma,0.7333611688795861
SLC16A3,Adenocarcinoma,0.750391252594775
SLC16A3,Malignant neoplasm of pancreas,0.7688485284765829
SLC16A3,Pancreatic carcinoma,0.7765852775619541
SLC16A3,Cervix carcinoma,0.7765852775619541
SLC16A3,Carcinoma breast stage IV,0.7765852775619541
SLC16A3,Glioma,0.7880542567584415
SLC16A3,Malignant neoplasm of prostate,0.7880542567584415
SLC16A3,Liver carcinoma,0.7880542567584415
SLC16A3,Rhabdomyosarcoma,0.7880542567584415
SLC16A3,Glioblastoma,0.7880542567584415
SLC16A3,Prostate carcinoma,0.7880542567584415
SLC16A3,Astrocytoma,0.7880542567584415
SLC16A3,Neoplasm Metastasis,0.7880542567584415
SLC16A3,Van der Woude syndrome,0.7880542567584415
SLC16A3,Multiple Myeloma,0.7880542567584415
SLC16A3,Neoplasms,0.7880542567584415
SLC16A3,Tumor Progression,0.7880542567584415
SLC16A3,Adenocarcinoma of colon,0.7880542567584415
SLC16A3,Renal Cell Carcinoma,0.7880542567584415
SLC16A3,Tumor Initiation,0.7880542567584415
SLC16A3,Arteriosclerosis,0.7880542567584415
SLC16A3,Atherosclerosis,0.7880542567584415
SLC16A3,Squamous cell carcinoma,0.7880542567584415
SLC16A3,Rheumatoid Arthritis,0.7880542567584415
SLC16A3,Small cell carcinoma of lung,0.7880542567584415
SLC16A3,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
SLC16A3,Luminal A Breast Carcinoma,0.8019075543217649
SLC16A3,Degenerative polyarthritis,0.8019075543217649
SLC16A3,West Nile viral infection,0.8101097852323003
SLC16A3,Patent ductus arteriosus,0.8402911822757345
SLC16A3,Renal carcinoma,0.8648405521677974
SLC16A3,Malignant neoplasm of kidney,0.8818220091065441
SLC16A3,Disseminated Malignant Neoplasm,0.8867509400747969
SLC16A3,Malignant Pleural Mesothelioma,0.8935933996254593
SLC16A3,Addictive Behavior,0.9015731019095328
SLC16A3,Arthritis,0.9431511078237256
SLC16A3,Stomach Neoplasms,0.7765582368651238
SLC16A3,Mammary Neoplasms,0.8165359516083085
SLC16A3,Marfan Syndrome,0.8477374749042494
SLC16A3,Gastric Cancer,0.861756360478846
SLC16A3,Breast Cancer,0.8903630091389316
SLC16A3,Breast Carcinoma,0.9398381935810408
SLC16A3,Crisponi syndrome ORPHA:1545,0.0155394890951578
SLC16A3,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
SLC16A3,Mucopolysaccharidosis type 4A ORPHA:309297,0.3832844616405875
SLC16A3,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.3832844616405875
SLC16A3,B4GALT1-CDG ORPHA:79332,0.5867963421058087
SLC16A3,Niemann-Pick disease type C adult neurologic onset ORPHA:216986,0.5867963421058087
SLC16A3,Niemann-Pick disease type C juvenile neurologic onset ORPHA:216981,0.5867963421058087
SLC16A3,Niemann-Pick disease type C late infantile neurologic onset ORPHA:216978,0.5867963421058087
SLC16A3,Niemann-Pick disease type C severe early infantile neurologic onset ORPHA:216975,0.5867963421058087
SLC16A3,Niemann-Pick disease type C severe perinatal form ORPHA:216972,0.5867963421058087
SLC16A3,Epithelial basement membrane dystrophy ORPHA:98956,0.7929682744768703
SLC16A3,Granular corneal dystrophy type I ORPHA:98962,0.7929682744768703
SLC16A3,Granular corneal dystrophy type II ORPHA:98963,0.7929682744768703
SLC16A3,Lattice corneal dystrophy type I ORPHA:98964,0.7929682744768703
SLC16A3,NON RARE IN EUROPE: Hemochromatosis type 1 ORPHA:139498,0.7929682744768703
SLC16A3,Reis-Bucklers corneal dystrophy ORPHA:98961,0.7929682744768703
SLC16A3,Sporadic porphyria cutanea tarda ORPHA:443057,0.7929682744768703
SLC16A3,Symptomatic form of hemochromatosis type 1 ORPHA:465508,0.7929682744768703
SLC16A3,Thiel-Behnke corneal dystrophy ORPHA:98960,0.7929682744768703
SLC19A2,Malignant neoplasm of breast,0.4084380369379369
SLC19A2,Breast Carcinoma,0.7333611688795861
SLC19A2,Paresthesia,0.7765852775619541
SLC19A2,Sideroblastic anemia,0.7765852775619541
SLC19A2,Anemia Megaloblastic,0.7880542567584415
SLC19A2,Hoarseness,0.7880542567584415
SLC19A2,Cone-Rod Dystrophies,0.7880542567584415
SLC19A2,Pallor,0.7880542567584415
SLC19A2,Diarrhea,0.7880542567584415
SLC19A2,Wernicke-Korsakoff Syndrome,0.7880542567584415
SLC19A2,Thiamine Deficiency,0.7880542567584415
SLC19A2,Nystagmus,0.7880542567584415
SLC19A2,Abnormal vision,0.7880542567584415
SLC19A2,Anorexia,0.7880542567584415
SLC19A2,Neural Tube Defects,0.7880542567584415
SLC19A2,Diabetes,0.7880542567584415
SLC19A2,Diabetes Mellitus,0.7880542567584415
SLC19A2,Cone dystrophy,0.7880542567584415
SLC19A2,Retinal Degeneration,0.7880542567584415
SLC19A2,Myeloid Leukemia Chronic,0.7880542567584415
SLC19A2,Optic Atrophy,0.7880542567584415
SLC19A2,Vitamin B 12 Deficiency,0.7880542567584415
SLC19A2,Liver Cirrhosis Experimental,0.8014900279306119
SLC19A2,Decreased platelet count,0.8019075543217649
SLC19A2,Thrombocytopenia,0.8019075543217649
SLC19A2,Kidney Failure Chronic,0.8019075543217649
SLC19A2,Activated Protein C Resistance,0.8190761496232595
SLC19A2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
SLC19A2,Headache,0.8270909867833504
SLC19A2,Neonatal diabetes mellitus,0.8368219249856942
SLC19A2,Retinitis Pigmentosa,0.8402911822757345
SLC19A2,Abnormal urinary amino-acid findings,0.8486035047899471
SLC19A2,Aminoaciduria,0.8584283190330553
SLC19A2,Skin Abnormalities,0.8690346447728063
SLC19A2,Short stature,0.8815127642200768
SLC19A2,Mitochondrial Diseases,0.8989612563669234
SLC19A2,Cytopenia,0.9001392794088324
SLC19A2,Congenital anemia,0.9015731019095328
SLC19A2,Abnormal heart beat,0.9366917377729386
SLC19A2,ECG abnormality,0.9366917377729386
SLC19A2,Cardiac conduction abnormality,0.9387505562433404
SLC19A2,Electrocardiogram abnormal,0.9390727893210336
SLC19A2,Electrocardiographic changes,0.9393256300017014
SLC19A2,Lethargy,0.9446671211493156
SLC19A2,Sensorineural Hearing Loss (disorder),0.9520060723130308
SLC19A2,Cardiac Arrhythmia,0.9586815140144712
SLC19A2,Atrial Septal Defects,0.9768262648503316
SLC19A2,Dermatologic disorders,0.9912501168001682
SLC19A2,Ventricular Septal Defects,0.9920086799398428
SLC19A2,Sideroblastic Anemia,0.7765582368651238
SLC19A2,Stroke,0.7765582368651238
SLC19A2,Retinal Dystrophy,0.7765582368651238
SLC19A2,Nystagmus,0.7765582368651238
SLC19A2,Anorexia,0.8091514409416879
SLC19A2,Cone-rod Dystrophy,0.8115918568696846
SLC19A2,Optic Atrophy,0.8115918568696846
SLC19A2,Hearing Loss,0.8115918568696846
SLC19A2,Diabetes Mellitus,0.919442421650838
SLC19A2,Anemia,0.9369188149054885
SLC19A2,Dwarfism,0.9510372690456612
SLC19A2,Congestive Heart Failure,0.9543024119762946
SLC19A2,Atrial Septal Defect,0.9832345076528324
SLC19A2,Ventricular Septal Defect,0.998271416892984
SLC19A2,Citrullinemia type II ORPHA:247585,0.0414176838632111
SLC19A2,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
SLC19A2,Dent disease type 1 ORPHA:93622,0.5867963421058087
SLC19A2,Thiamine-responsive megaloblastic anemia syndrome ORPHA:49827,0.8922466888454011
SLC23A2,Malignant neoplasm of breast,0.4084380369379369
SLC23A2,Breast Carcinoma,0.7333611688795861
SLC23A2,Lymphoma,0.7765852775619541
SLC23A2,Adenoma,0.7765852775619541
SLC23A2,Lymphoma Non-Hodgkin,0.7880542567584415
SLC23A2,Malignant Head and Neck Neoplasm,0.7880542567584415
SLC23A2,Neuroblastoma,0.7880542567584415
SLC23A2,Central neuroblastoma,0.7880542567584415
SLC23A2,Malignant neoplasm of stomach,0.7880542567584415
SLC23A2,Stomach Carcinoma,0.7880542567584415
SLC23A2,Cardiovascular Diseases,0.7880542567584415
SLC23A2,Cholestasis,0.7880542567584415
SLC23A2,Hyperinsulinism,0.8019075543217649
SLC23A2,Chronic Periodontitis,0.8019075543217649
SLC23A2,Autistic Disorder,0.8019075543217649
SLC23A2,Chronic Lymphocytic Leukemia,0.8019075543217649
SLC23A2,Acute Coronary Syndrome,0.8037546774788534
SLC23A2,Liver diseases,0.8140222479282434
SLC23A2,Spinal Muscular Atrophy,0.8402911822757345
SLC23A2,Cholangiocarcinoma,0.8402911822757345
SLC23A2,Adult Cholangiocarcinoma,0.8648405521677974
SLC23A2,Premature Birth,0.8648405521677974
SLC23A2,SVEINSSON CHORIORETINAL ATROPHY,0.8690346447728063
SLC23A2,Choriocarcinoma,0.8769418330148872
SLC23A2,Obesity,0.8989612563669234
SLC23A2,Cystic Fibrosis,0.9874278479946328
SLC23A2,Cholestasis,0.8115918568696846
SLC23A2,Autism,0.911896615143974
SLC23A2,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.5867963421058087
SLC25A25,NAD(P)HX dehydratase deficiency ORPHA:555402,0.1991445465001551
SLC25A27,Neuroblastoma,0.7880542567584415
SLC25A27,Central neuroblastoma,0.7880542567584415
SLC25A27,Alzheimer's Disease,0.7880542567584415
SLC25A27,Multiple Sclerosis,0.8019075543217649
SLC25A27,Degenerative polyarthritis,0.8019075543217649
SLC25A27,Schizophrenia,0.8067197998685076
SLC25A27,Alzheimer Disease Late Onset,0.8402911822757345
SLC25A27,Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency,0.8402911822757345
SLC25A27,Schizophrenia,0.7860378120955526
SLC25A27,Hashimoto Disease,0.8115918568696846
SLC25A27,Autoimmune Thyroiditis,0.8662301945830305
SLC25A27,Graves Disease,0.8903630091389316
SLC25A27,Benign hereditary chorea ORPHA:1429,0.1991445465001551
SLC25A27,Synaptic congenital myasthenic syndromes ORPHA:98915,0.1991445465001551
SLC25A27,Primary pigmented nodular adrenocortical disease ORPHA:189439,0.3891940933600213
SLC25A27,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.5867963421058087
SLC25A27,1p31p32 microdeletion syndrome ORPHA:401986,0.5867963421058087
SLC25A27,Microphthalmia with limb anomalies ORPHA:1106,0.5867963421058087
SLC25A27,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.5867963421058087
SLC25A27,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.5867963421058087
SLC25A27,Autosomal dominant striatal neurodegeneration ORPHA:228169,0.7929682744768703
SLC25A27,Inherited congenital spastic tetraplegia ORPHA:210141,0.7929682744768703
SLC25A27,Episodic ataxia type 6 ORPHA:209967,0.8922466888454011
SLC25A27,PLIN1-related familial partial lipodystrophy ORPHA:280356,0.8922466888454011
SLC25A27,Oculocutaneous albinism type 4 ORPHA:79435,0.8922466888454011
SLC25A27,Sjogren-Larsson syndrome ORPHA:816,0.8922466888454011
SLC25A44,Carcinoma testes,0.8272008757995397
SLC25A44,Testicular Germ Cell Tumor,0.8648405521677974
SLC25A44,Leukemia,0.7765582368651238
SLC25A44,Testicular Neoplasms,0.8201196687803188
SLC25A44,Testicular Germ Cell Tumor,0.8903301324869451
SLC25A44,Hermansky-Pudlak syndrome type 8 ORPHA:231537,0.3832844616405875
SLC25A44,Autosomal dominant optic atrophy and cataract ORPHA:67036,0.8922466888454011
SLC25A44,3-methylglutaconic aciduria type 3 ORPHA:67047,0.8922466888454011
SLC46A1,leukemia,0.7333611688795861
SLC46A1,Colorectal Carcinoma,0.7765852775619541
SLC46A1,Non-Small Cell Lung Carcinoma,0.7765852775619541
SLC46A1,Malignant neoplasm of lung,0.7880542567584415
SLC46A1,Colorectal Cancer,0.7880542567584415
SLC46A1,Epithelial ovarian cancer,0.7880542567584415
SLC46A1,Basal ganglia calcification,0.7880542567584415
SLC46A1,Dyskinetic syndrome,0.7880542567584415
SLC46A1,Primary malignant neoplasm of lung,0.7880542567584415
SLC46A1,Carcinoma of lung,0.7880542567584415
SLC46A1,Anemia Megaloblastic,0.7880542567584415
SLC46A1,Mesothelioma,0.7880542567584415
SLC46A1,Hyperhomocysteinemia,0.7880542567584415
SLC46A1,Pallor,0.7880542567584415
SLC46A1,Diarrhea,0.7880542567584415
SLC46A1,Abnormal behavior,0.7880542567584415
SLC46A1,Folic Acid Deficiency,0.7880542567584415
SLC46A1,Severe Combined Immunodeficiency,0.7880542567584415
SLC46A1,Hemifacial microsomia,0.7880542567584415
SLC46A1,Recurrent infections,0.7880542567584415
SLC46A1,Red and sore lips,0.7880542567584415
SLC46A1,Feeding difficulties in infancy,0.7880542567584415
SLC46A1,Infant Premature,0.7880542567584415
SLC46A1,Pancytopenia,0.7880542567584415
SLC46A1,Anorexia,0.7880542567584415
SLC46A1,Cheilitis,0.7880542567584415
SLC46A1,Cognitive delay,0.7880542567584415
SLC46A1,Solid Neoplasm,0.7880542567584415
SLC46A1,Global developmental delay,0.7880542567584415
SLC46A1,Behavioral Symptoms,0.7880542567584415
SLC46A1,Mental and motor retardation,0.7880542567584415
SLC46A1,Liver Cirrhosis Experimental,0.8014900279306119
SLC46A1,Alcoholic Intoxication Chronic,0.8019075543217649
SLC46A1,Decreased platelet count,0.8019075543217649
SLC46A1,Leukopenia,0.8019075543217649
SLC46A1,Thrombocytopenia,0.8019075543217649
SLC46A1,Athetosis,0.8019075543217649
SLC46A1,Kidney Failure Chronic,0.8019075543217649
SLC46A1,Neutrophil count decreased,0.8101097852323003
SLC46A1,Inborn Errors of Metabolism,0.8138488881521341
SLC46A1,Oral Ulcer,0.8190761496232595
SLC46A1,Hemochromatosis,0.8232134984476662
SLC46A1,Hypogammaglobulinemia,0.8232134984476662
SLC46A1,Irritation - emotion,0.8270909867833504
SLC46A1,Gastroesophageal reflux disease,0.8368219249856942
SLC46A1,Malabsorption Syndrome,0.8402911822757345
SLC46A1,Peripheral Neuropathy,0.8402911822757345
SLC46A1,Mental deficiency,0.8402911822757345
SLC46A1,Generalized hypotonia,0.843190898187174
SLC46A1,Anemia,0.8584283190330553
SLC46A1,Decreased antibody level in blood,0.8584283190330553
SLC46A1,Dull intelligence,0.8757755363384367
SLC46A1,Low intelligence,0.8757755363384367
SLC46A1,Iron deficiency,0.8769418330148872
SLC46A1,HEMOCHROMATOSIS TYPE 1,0.8806784681730055
SLC46A1,Poor school performance,0.8913141512402477
SLC46A1,Acid reflux,0.8962930275917275
SLC46A1,Cerebellar Ataxia,0.906476206143938
SLC46A1,Neuropathy,0.914995991166204
SLC46A1,Heartburn,0.9214835359141188
SLC46A1,Mental Retardation,0.922229272318747
SLC46A1,Movement Disorders,0.929235785949896
SLC46A1,Malabsorption,0.9432051631882106
SLC46A1,Intellectual Disability,0.9478210444156088
SLC46A1,Seizures,0.9478210444156088
SLC46A1,Nausea and vomiting,0.9586815140144712
SLC46A1,Epilepsy,0.963331724428282
SLC46A1,Cystic Fibrosis,0.9874278479946328
SLC46A1,Undergrowth,0.9884235744717738
SLC46A1,Failure to gain weight,0.9896536639644284
SLC46A1,Pediatric failure to thrive,0.9896536639644284
SLC46A1,Hyperhomocysteinemia,0.7311975666200533
SLC46A1,Oral Ulcer,0.7765582368651238
SLC46A1,Dyskinetic Syndrome,0.7765582368651238
SLC46A1,Glossitis,0.7765582368651238
SLC46A1,Immunologic Deficiency Syndromes,0.7765582368651238
SLC46A1,Eosinophilia,0.7765582368651238
SLC46A1,Cheilitis,0.7765582368651238
SLC46A1,Developmental Delay,0.7765582368651238
SLC46A1,Leukopenia,0.8091514409416879
SLC46A1,Anorexia,0.8091514409416879
SLC46A1,Mental Retardation,0.8337953215113012
SLC46A1,Neutropenia,0.8476516371290275
SLC46A1,Pancytopenia,0.861756360478846
SLC46A1,Anemia,0.9369188149054885
SLC46A1,Nervous System Diseases,0.9492120794677584
SLC46A1,Malabsorption Syndrome,0.9850811241696034
SLC46A1,Gastroesophageal Reflux Disease,0.9870402800551054
SLC46A1,Hereditary folate malabsorption ORPHA:90045,0.3832844616405875
SLC46A1,Systemic primary carnitine deficiency ORPHA:158,0.5867963421058087
SLC46A1,Isolated sulfite oxidase deficiency ORPHA:99731,0.8922466888454011
SMYD5,Malignant neoplasm of breast,0.4084380369379369
SMYD5,Breast Carcinoma,0.7333611688795861
SMYD5,Carcinogenesis,0.7333611688795861
SMYD5,leukemia,0.7333611688795861
SMYD5,Leukemia Myelocytic Acute,0.7765852775619541
SMYD5,Non-Small Cell Lung Carcinoma,0.7765852775619541
SMYD5,Monocytic leukemia,0.7880542567584415
SMYD5,Liver carcinoma,0.7880542567584415
SMYD5,Acute Promyelocytic Leukemia,0.7880542567584415
SMYD5,Neuroblastoma,0.7880542567584415
SMYD5,Central neuroblastoma,0.7880542567584415
SMYD5,M5b Acute differentiated monocytic leukemia,0.7880542567584415
SMYD5,Focal dermal hypoplasia ORPHA:2092,0.1040670578681756
SMYD5,Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717,0.1991445465001551
SMYD5,Hyperuricemia-pulmonary hypertension-renal failure-alkalosis syndrome ORPHA:363694,0.5867963421058087
SMYD5,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome ORPHA:502423,0.5867963421058087
SMYD5,Bjornstad syndrome ORPHA:123,0.7929682744768703
SMYD5,GRACILE syndrome ORPHA:53693,0.7929682744768703
SMYD5,POMGNT1-related  limb-girdle muscular dystrophy R15 ORPHA:206564,0.7929682744768703
SMYD5,Renal tubulopathy-encephalopathy-liver failure syndrome ORPHA:254902,0.7929682744768703
SMYD5,Schwannomatosis ORPHA:93921,0.795266832401002
SMYD5,Spinal muscular atrophy with respiratory distress type 2 ORPHA:404521,0.8922466888454011
SMYD5,Triple A syndrome ORPHA:869,0.8922466888454011
SMYD5,Perrault syndrome ORPHA:2855,0.8922466888454011
SMYD5,Infantile Refsum disease ORPHA:772,0.8922466888454011
SMYD5,Neonatal adrenoleukodystrophy ORPHA:44,0.8922466888454011
SMYD5,Zellweger syndrome ORPHA:912,0.8922466888454011
SMYD5,Intellectual disability-macrocephaly-hypotonia-behavioral abnormalities syndrome ORPHA:457279,0.8922466888454011
SNAPC5,Melanoma,0.7765582368651238
SNPH,Malignant Neoplasms,0.7880542567584415
SNPH,Primary malignant neoplasm,0.7908231553833205
SNPH,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
SNPH,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
SNPH,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
SNPH,LIPE-related familial partial lipodystrophy ORPHA:435660,0.1040670578681756
SNPH,8p11.2 deletion syndrome ORPHA:251066,0.3832844616405875
SNPH,Brachydactyly type B2 ORPHA:140908,0.3832844616405875
SNPH,Progressive myoclonic epilepsy type 3 ORPHA:263516,0.3832844616405875
SNPH,Stapes ankylosis with broad thumbs and toes ORPHA:140917,0.3832844616405875
SNPH,Tarsal-carpal coalition syndrome ORPHA:1412,0.3832844616405875
SNPH,Fuhrmann syndrome ORPHA:2854,0.5867963421058087
SNPH,Phocomelia Schinzel type ORPHA:2879,0.5867963421058087
SNPH,NON RARE IN EUROPE: Vitiligo ORPHA:3435,0.5867963421058087
SNPH,Autosomal recessive centronuclear myopathy ORPHA:169186,0.7929682744768703
SNPH,Megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome ORPHA:83473,0.8922466888454011
SNPH,Multiple synostoses syndrome ORPHA:3237,0.8922466888454011
SNRNP35,Cholera,0.9459312971127588
SNRNP35,Hermansky-Pudlak syndrome type 8 ORPHA:231537,0.3832844616405875
SNRNP35,TMEM199-CDG ORPHA:466703,0.3832844616405875
SNRNP35,CEDNIK syndrome ORPHA:66631,0.5867963421058087
SNRNP35,Familial steroid-resistant nephrotic syndrome with sensorineural deafness ORPHA:280406,0.7929682744768703
SNUPN,Mycoses,0.7880542567584415
SNUPN,Combined oxidative phosphorylation defect type 15 ORPHA:319524,0.7929682744768703
SNUPN,Navajo neurohepatopathy ORPHA:255229,0.7929682744768703
SNX18,Drug-Induced Liver Disease,0.8523465762428218
SNX18,Hepatitis Toxic,0.8548862007194026
SNX18,Chemical and Drug Induced Liver Injury,0.8548862007194026
SNX18,Chemically-Induced Liver Toxicity,0.8548862007194026
SNX18,Drug-Induced Acute Liver Injury,0.8548862007194026
SNX18,Hepatitis Drug-Induced,0.8578473133580928
SNX18,Acromelic frontonasal dysplasia ORPHA:1827,0.1040670578681756
SNX18,BICD2-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:363454,0.5867963421058087
SNX18,Autosomal dominant intermediate Charcot-Marie-Tooth disease type F ORPHA:352670,0.7929682744768703
SNX18,Loeys-Dietz syndrome ORPHA:60030,0.7929682744768703
SNX18,Charcot-Marie-Tooth disease type 2T ORPHA:495274,0.8922466888454011
SNX18,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization ORPHA:69063,0.8922466888454011
SNX18,MME-related autosomal dominant Charcot Marie Tooth disease type 2 ORPHA:497757,0.8922466888454011
SNX18,Spinocerebellar ataxia type 43 ORPHA:497764,0.8922466888454011
SNX18,Alagille syndrome due to a NOTCH2 point mutation ORPHA:261629,0.8922466888454011
SNX18,Hajdu-Cheney syndrome ORPHA:955,0.8922466888454011
SNX18,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
SNX18,Human immunodeficiency virus 1 Nef (gene: nef),0.8999095837312036
SNX29,Fatty acid measurement,0.7765852775619541
SNX29,Narcolepsy,0.8067197998685076
SNX29,Schizophrenia,0.8067197998685076
SNX29,Body mass index,0.8867509400747969
SNX29,Finding of body mass index,0.8867509400747969
SNX29,Intelligence,0.9093740881835894
SNX29,Smoking Behaviors,0.9564633032157428
SNX29,Schizophrenia,0.7860378120955526
SNX29,Narcolepsy,0.8260230451542778
SNX29,Mental Depression,0.8903630091389316
SNX29,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
SNX29,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
SNX29,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
SNX29,Autosomal recessive ataxia Beauce type ORPHA:88644,0.5867963421058087
SNX29,Autosomal recessive cerebellar ataxia-epilepsy-intellectual disability syndrome due to RUBCN deficiency ORPHA:404499,0.5867963421058087
SNX29,Autosomal recessive myogenic arthrogryposis multiplex congenita ORPHA:319332,0.5867963421058087
SNX29,External auditory canal aplasia/hypoplasia ORPHA:141074,0.5867963421058087
SNX29,XYLT1-CDG ORPHA:370930,0.5867963421058087
SNX29,Autosomal recessive spastic paraplegia type 15 ORPHA:100996,0.7929682744768703
SNX29,GM3 synthase deficiency ORPHA:370933,0.7929682744768703
SNX29,Griscelli syndrome type 1 ORPHA:79476,0.7929682744768703
SNX29,Neuroectodermal melanolysosomal disease ORPHA:33445,0.7929682744768703
SNX29,Nicolaides-Baraitser syndrome ORPHA:3051,0.7929682744768703
SNX29,Estrogen resistance syndrome ORPHA:785,0.8922466888454011
SNX29,Oculocerebrofacial syndrome Kaufman type ORPHA:2707,0.8922466888454011
SNX29,Moyamoya disease ORPHA:2573,0.8922466888454011
SPAG7,Platelet mean volume determination (procedure),0.7880542567584415
SPAG9,Malignant neoplasm of breast,0.4084380369379369
SPAG9,Carcinoma of bladder,0.4084380369379369
SPAG9,Bladder Neoplasm,0.4084380369379369
SPAG9,Malignant neoplasm of urinary bladder,0.5071083164302358
SPAG9,Breast Carcinoma,0.7333611688795861
SPAG9,Carcinogenesis,0.7333611688795861
SPAG9,leukemia,0.7333611688795861
SPAG9,Ovarian Carcinoma,0.7333611688795861
SPAG9,Colorectal Carcinoma,0.7765852775619541
SPAG9,Colon Carcinoma,0.7765852775619541
SPAG9,TARSAL-CARPAL COALITION SYNDROME,0.7765852775619541
SPAG9,Malignant tumor of colon,0.7765852775619541
SPAG9,Lymphoma,0.7765852775619541
SPAG9,Cervix carcinoma,0.7765852775619541
SPAG9,Non-Small Cell Lung Carcinoma,0.7765852775619541
SPAG9,Thyroid Neoplasm,0.7765852775619541
SPAG9,Malignant tumor of cervix,0.7768809924982332
SPAG9,Mammary Neoplasms,0.7880542567584415
SPAG9,Malignant neoplasm of lung,0.7880542567584415
SPAG9,Malignant neoplasm of prostate,0.7880542567584415
SPAG9,Liver carcinoma,0.7880542567584415
SPAG9,Thyroid carcinoma,0.7880542567584415
SPAG9,Colorectal Cancer,0.7880542567584415
SPAG9,Epithelial ovarian cancer,0.7880542567584415
SPAG9,Prostate carcinoma,0.7880542567584415
SPAG9,Astrocytoma,0.7880542567584415
SPAG9,Primary malignant neoplasm of lung,0.7880542567584415
SPAG9,cervical cancer,0.7880542567584415
SPAG9,Neoplasm Metastasis,0.7880542567584415
SPAG9,Malignant neoplasm of testis,0.7880542567584415
SPAG9,Carcinoma of lung,0.7880542567584415
SPAG9,Malignant neoplasm of thyroid,0.7880542567584415
SPAG9,Triple Negative Breast Neoplasms,0.7880542567584415
SPAG9,Malignant Neoplasms,0.7880542567584415
SPAG9,Neoplasms,0.7880542567584415
SPAG9,Burkitt Lymphoma,0.7880542567584415
SPAG9,Cleft palate isolated,0.7880542567584415
SPAG9,Transitional cell carcinoma of bladder,0.7880542567584415
SPAG9,African Burkitt's lymphoma,0.7880542567584415
SPAG9,Tumor Progression,0.7880542567584415
SPAG9,Renal Cell Carcinoma,0.7880542567584415
SPAG9,Acquired Immunodeficiency Syndrome,0.7880542567584415
SPAG9,Alzheimer's Disease,0.7880542567584415
SPAG9,Acute lymphocytic leukemia,0.7880542567584415
SPAG9,Squamous cell carcinoma,0.7880542567584415
SPAG9,Uterine Cervical Neoplasm,0.7880542567584415
SPAG9,Malignant hyperpyrexia due to anesthesia,0.7880542567584415
SPAG9,Childhood Acute Lymphoblastic Leukemia,0.7880542567584415
SPAG9,Follicular adenoma,0.7880542567584415
SPAG9,Myeloid Leukemia Chronic,0.7880542567584415
SPAG9,Thyroid Gland Follicular Adenoma,0.8232134984476662
SPAG9,Systemic Scleroderma,0.8402911822757345
SPAG9,Renal carcinoma,0.8648405521677974
SPAG9,Malignant neoplasm of kidney,0.8818220091065441
SPAG9,Cerebral Palsy,0.9193385822373632
SPAG9,Acromelic frontonasal dysplasia ORPHA:1827,0.1040670578681756
SPAG9,GNE myopathy ORPHA:602,0.3832844616405875
SPAG9,Sialuria ORPHA:3166,0.3832844616405875
SPAG9,Non-specific syndromic intellectual disability ORPHA:528084,0.5867963421058087
SPAG9,Autosomal dominant Charcot-Marie-Tooth disease type 2A1 ORPHA:99946,0.5867963421058087
SPAG9,Autosomal recessive spastic paraplegia type 67 ORPHA:401820,0.5867963421058087
SPAG9,Dent disease type 1 ORPHA:93622,0.5867963421058087
SPAG9,Polyendocrine-polyneuropathy syndrome ORPHA:453533,0.5867963421058087
SPAG9,Atypical juvenile parkinsonism ORPHA:391411,0.5867963421058087
SPAG9,APC-related attenuated familial adenomatous polyposis ORPHA:247806,0.7929682744768703
SPAG9,Familial adenomatous polyposis due to 5q22.2 microdeletion ORPHA:261584,0.7929682744768703
SPAG9,Gardner syndrome ORPHA:79665,0.7929682744768703
SPAG9,Gastric adenocarcinoma and proximal polyposis of the stomach ORPHA:314022,0.7929682744768703
SPAG9,Griscelli syndrome type 1 ORPHA:79476,0.7929682744768703
SPAG9,Infantile-onset ascending hereditary spastic paralysis ORPHA:293168,0.7929682744768703
SPAG9,Lissencephaly due to LIS1 mutation ORPHA:95232,0.7929682744768703
SPAG9,Neuroectodermal melanolysosomal disease ORPHA:33445,0.7929682744768703
SPAG9,Spastic paraplegia-intellectual disability-nystagmus-obesity syndrome ORPHA:521390,0.7929682744768703
SPAG9,Turcot syndrome with polyposis ORPHA:99818,0.7929682744768703
SPAG9,Cenani-Lenz syndrome ORPHA:3258,0.7929682744768703
SPAG9,Congenital neutropenia-myelofibrosis-nephromegaly syndrome ORPHA:369852,0.7929682744768703
SPAG9,Congenitally uncorrected transposition of the great arteries ORPHA:860,0.7929682744768703
SPAG9,17q11 microdeletion syndrome ORPHA:97685,0.8922466888454011
SPAG9,17q11.2 microduplication syndrome ORPHA:139474,0.8922466888454011
SPAG9,Autosomal dominant Charcot-Marie-Tooth disease type 2O ORPHA:284232,0.8922466888454011
SPAG9,Charcot-Marie-Tooth disease type 4B2 ORPHA:99956,0.8922466888454011
SPAG9,DYNC1H1-related autosomal dominant childhood-onset proximal spinal muscular atrophy ORPHA:209341,0.8922466888454011
SPAG9,Distal monosomy 12p ORPHA:280325,0.8922466888454011
SPAG9,Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion ORPHA:363700,0.8922466888454011
SPAG9,Autosomal recessive spastic paraplegia type 23 ORPHA:101003,0.8922466888454011
SPAG9,Desmoid tumor ORPHA:873,0.8922466888454011
SPAG9,Moebius syndrome ORPHA:570,0.8922466888454011
SPAG9,Tessier number 7 facial cleft ORPHA:141276,0.8922466888454011
SPAG9,Hereditary sensory and autonomic neuropathy type 2 ORPHA:970,0.8922466888454011
SPAG9,Hereditary late-onset Parkinson disease ORPHA:411602,0.8922466888454011
SPAG9,Cognitive impairment-coarse facies-heart defects-obesity-pulmonary involvement-short stature-skeletal dysplasia syndrome ORPHA:444077,0.8922466888454011
SPAG9,PEHO-like syndrome ORPHA:99807,0.8922466888454011
SPAG9,Craniopharyngioma ORPHA:54595,0.8922466888454011
SPAG9,Freeman-Sheldon syndrome ORPHA:2053,0.8922466888454011
SPIN1,Carcinogenesis,0.7333611688795861
SPIN1,Malignant neoplasm of ovary,0.7333611688795861
SPIN1,Ovarian Carcinoma,0.7333611688795861
SPIN1,Triple Negative Breast Neoplasms,0.7880542567584415
SPIN1,Seasonal Affective Disorder,0.7880542567584415
SPIN1,Squamous cell carcinoma,0.7880542567584415
SPIN1,Herpes Simplex Infections,0.8098851543361193
SPIN1,Lipomatosis Multiple,0.8190761496232595
SPIN1,Lipoma,0.8272008757995397
SPIN1,Hepatitis B,0.841396342333011
SPIN1,liposarcoma,0.8806784681730055
SPIN1,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.1040670578681756
SPIN1,Non-specific syndromic intellectual disability ORPHA:528084,0.5867963421058087
SPIN1,Autosomal recessive spastic paraplegia type 67 ORPHA:401820,0.5867963421058087
SPIN1,Charcot-Marie-Tooth disease type 4B1 ORPHA:99955,0.5867963421058087
SPIN1,Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359,0.5867963421058087
SPIN1,Juvenile myelomonocytic leukemia ORPHA:86834,0.6196505963261838
SPIN1,Differentiated thyroid carcinoma ORPHA:146,0.7929682744768703
SPIN1,Autosomal recessive spastic paraplegia type 61 ORPHA:401780,0.7929682744768703
SPIN1,Lissencephaly due to LIS1 mutation ORPHA:95232,0.7929682744768703
SPIN1,Mulibrey nanism ORPHA:2576,0.7929682744768703
SPIN1,Peters plus syndrome ORPHA:709,0.7929682744768703
SPIN1,Congenital neutropenia-myelofibrosis-nephromegaly syndrome ORPHA:369852,0.7929682744768703
SPIN1,Male infertility due to globozoospermia ORPHA:171709,0.795266832401002
SPIN1,Chondrodysplasia with joint dislocations gPAPP type ORPHA:280586,0.8922466888454011
SPIN1,Lathosterolosis ORPHA:46059,0.8922466888454011
SPIN1,Microcystic stromal tumor ORPHA:569248,0.8922466888454011
SPIN1,Pilomatrixoma ORPHA:91414,0.8922466888454011
SPIN1,Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome ORPHA:505242,0.8922466888454011
SPIN1,Reticular dystrophy of the retinal pigment epithelium ORPHA:99002,0.8922466888454011
SPIN1,Severe intellectual disability-progressive spastic diplegia syndrome ORPHA:404473,0.8922466888454011
SPIN1,Sudden infant death-dysgenesis of the testes syndrome ORPHA:168593,0.8922466888454011
SPIN1,17p13.3 microduplication syndrome ORPHA:217385,0.8922466888454011
SPIN1,Miller-Dieker syndrome ORPHA:531,0.8922466888454011
SPIN1,Joubert syndrome with oculorenal defect ORPHA:2318,0.8922466888454011
SPIN1,Periventricular nodular heterotopia ORPHA:98892,0.8922466888454011
SPIN1,Congenital muscular dystrophy Fukuyama type ORPHA:272,0.8922466888454011
SPIN1,Familial benign chronic pemphigus ORPHA:2841,0.8922466888454011
SPIN1,Fukutin-related  limb-girdle muscular dystrophy R13 ORPHA:206554,0.8922466888454011
SPIN1,Encephalocraniocutaneous lipomatosis ORPHA:2396,0.8922466888454011
SPOCK2,Glioma,0.7880542567584415
SPOCK2,Ankylosing spondylitis,0.7880542567584415
SPOCK2,Bronchopulmonary Dysplasia,0.9446671211493156
SPOCK2,Bronchopulmonary Dysplasia,0.7765582368651238
SPOCK2,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.1040670578681756
SPOCK2,Distal monosomy 1q ORPHA:36367,0.1040670578681756
SPOCK2,2q37 microdeletion syndrome ORPHA:1001,0.1991445465001551
SPOCK2,Mucopolysaccharidosis type 2 attenuated form ORPHA:217093,0.1991445465001551
SPOCK2,Mucopolysaccharidosis type 2 severe form ORPHA:217085,0.1991445465001551
SPOCK2,Corneal intraepithelial dyskeratosis-palmoplantar hyperkeratosis-laryngeal dyskeratosis syndrome ORPHA:352662,0.3832844616405875
SPOCK2,Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379,0.3832844616405875
SPOCK2,Glycogen storage disease due to muscle glycogen phosphorylase deficiency ORPHA:368,0.3832844616405875
SPOCK2,Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301,0.3832844616405875
SPOCK2,Fuhrmann syndrome ORPHA:2854,0.5867963421058087
SPOCK2,Phocomelia Schinzel type ORPHA:2879,0.5867963421058087
SPOCK2,Pseudohypoaldosteronism type 2D ORPHA:300525,0.5867963421058087
SPOCK2,Multiple endocrine neoplasia type 4 ORPHA:276152,0.7929682744768703
SPOCK2,Dopamine beta-hydroxylase deficiency ORPHA:230,0.8922466888454011
SPOCK2,PDE4D haploinsufficiency syndrome ORPHA:439822,0.8922466888454011
SPOCK2,Imerslund-Grasbeck syndrome ORPHA:35858,0.8922466888454011
SPOCK2,Isolated congenital anosmia ORPHA:88620,0.8922466888454011
SPON2,Colorectal Carcinoma,0.7765852775619541
SPON2,Colon Carcinoma,0.7765852775619541
SPON2,Malignant tumor of colon,0.7765852775619541
SPON2,Malignant neoplasm of prostate,0.7880542567584415
SPON2,Liver carcinoma,0.7880542567584415
SPON2,Colorectal Cancer,0.7880542567584415
SPON2,Prostatic Neoplasms,0.7880542567584415
SPON2,Malignant neoplasm of large intestine,0.7880542567584415
SPON2,Tumor Progression,0.7880542567584415
SPON2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
SPON2,Metabolic Diseases,0.9564633032157428
SPON2,Prostate Cancer,0.7765582368651238
SPON2,Prostatic Neoplasms,0.7765582368651238
SPON2,Charcot-Marie-Tooth disease type 2T ORPHA:495274,0.8922466888454011
SPON2,Congenital membranous nephropathy due to fetomaternal anti-neutral endopeptidase alloimmunization ORPHA:69063,0.8922466888454011
SPON2,MME-related autosomal dominant Charcot Marie Tooth disease type 2 ORPHA:497757,0.8922466888454011
SPON2,Renin-angiotensin-aldosterone system-blocker-induced angioedema ORPHA:100057,0.8922466888454011
SPON2,Spinocerebellar ataxia type 43 ORPHA:497764,0.8922466888454011
SPRY2,Malignant neoplasm of breast,0.4084380369379369
SPRY2,Breast Carcinoma,0.7333611688795861
SPRY2,Carcinogenesis,0.7333611688795861
SPRY2,B-Cell Lymphomas,0.7333611688795861
SPRY2,Colon Carcinoma,0.7765852775619541
SPRY2,Malignant tumor of colon,0.7765852775619541
SPRY2,Lymphoma,0.7765852775619541
SPRY2,Non-Small Cell Lung Carcinoma,0.7765852775619541
SPRY2,Glioma,0.7880542567584415
SPRY2,Malignant neoplasm of lung,0.7880542567584415
SPRY2,Malignant neoplasm of prostate,0.7880542567584415
SPRY2,Lymphoma Non-Hodgkin,0.7880542567584415
SPRY2,Liver carcinoma,0.7880542567584415
SPRY2,Osteosarcoma,0.7880542567584415
SPRY2,Thyroid carcinoma,0.7880542567584415
SPRY2,Epithelial ovarian cancer,0.7880542567584415
SPRY2,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
SPRY2,Hepatocarcinogenesis,0.7880542567584415
SPRY2,Osteosarcoma of bone,0.7880542567584415
SPRY2,Prostate carcinoma,0.7880542567584415
SPRY2,Primary malignant neoplasm of lung,0.7880542567584415
SPRY2,Prostatic Neoplasms,0.7880542567584415
SPRY2,Carcinoma of lung,0.7880542567584415
SPRY2,Malignant neoplasm of thyroid,0.7880542567584415
SPRY2,Malignant neoplasm of liver,0.7880542567584415
SPRY2,Neuroblastoma,0.7880542567584415
SPRY2,melanoma,0.7880542567584415
SPRY2,Adenocarcinoma of pancreas,0.7880542567584415
SPRY2,Lung Neoplasms,0.7880542567584415
SPRY2,Cartilage-hair hypoplasia,0.7880542567584415
SPRY2,Cleft palate isolated,0.7880542567584415
SPRY2,Benign Prostatic Hyperplasia,0.7880542567584415
SPRY2,Seminoma,0.7880542567584415
SPRY2,Cleft Palate,0.7880542567584415
SPRY2,Cardiovascular Diseases,0.7880542567584415
SPRY2,Rheumatoid Arthritis,0.7880542567584415
SPRY2,Cleft upper lip,0.7880542567584415
SPRY2,Lymphoma Diffuse,0.7880542567584415
SPRY2,Secondary malignant neoplasm of liver,0.7908231553833205
SPRY2,IGA Glomerulonephritis,0.8019075543217649
SPRY2,Esophageal Achalasia,0.8019075543217649
SPRY2,Lung diseases,0.8019075543217649
SPRY2,Fibrosarcoma,0.8019075543217649
SPRY2,Degenerative polyarthritis,0.8019075543217649
SPRY2,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
SPRY2,Liver Cirrhosis,0.8232134984476662
SPRY2,Fibrosis Liver,0.8272008757995397
SPRY2,Glioblastoma Multiforme,0.8342163953428735
SPRY2,Yolk Sac Tumor,0.8402911822757345
SPRY2,Cirrhosis,0.8554819098734854
SPRY2,Papillary thyroid carcinoma,0.8757755363384367
SPRY2,Arthritis,0.9431511078237256
SPRY2,Hematopoietic Neoplasms,0.946564927793026
SPRY2,Craniofacial Abnormalities,0.9856761890270216
SPRY2,Lung Cancer,0.8706864397989688
SPRY2,Lung Neoplasms,0.8903301324869451
SPRY2,Lung Diseases,0.8903630091389316
SPRY2,Glomerulonephritis,0.9005327950701606
SPRY2,20p12.3 microdeletion syndrome ORPHA:261295,0.7929682744768703
SPRY2,Legius syndrome ORPHA:137605,0.7929682744768703
SPRY2,Roussy-Levy syndrome ORPHA:3115,0.7929682744768703
SPRY2,Skeletal Ewing sarcoma ORPHA:319,0.8029813443753846
SPSB3,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
SPSB3,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
SPSB3,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
SPSB3,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
SPSB3,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
SPSB3,Barth syndrome ORPHA:111,0.0414176838632111
SPSB3,Incontinentia pigmenti ORPHA:464,0.0414176838632111
SPSB3,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
SPSB3,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
SPSB3,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
SPSB3,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
SPSB3,LIPE-related familial partial lipodystrophy ORPHA:435660,0.1040670578681756
SPSB3,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.1040670578681756
SPSB3,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.1054066549396977
SPSB3,D-2-hydroxyglutaric aciduria ORPHA:79315,0.1054066549396977
SPSB3,Marinesco-Sjogren syndrome ORPHA:559,0.1054066549396977
SPSB3,Beta-propeller protein-associated neurodegeneration ORPHA:329284,0.1991445465001551
SPSB3,CCDC115-CDG ORPHA:468684,0.1991445465001551
SPSB3,Leukonychia totalis ORPHA:2387,0.1991445465001551
SPSB3,Neutral lipid storage myopathy ORPHA:98908,0.1991445465001551
SPSB3,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.1991445465001551
SPSB3,Metachromatic leukodystrophy adult form ORPHA:309271,0.3832844616405875
SPSB3,Metachromatic leukodystrophy juvenile form ORPHA:309263,0.3832844616405875
SPSB3,Metachromatic leukodystrophy late infantile form ORPHA:309256,0.3832844616405875
SPSB3,Classic galactosemia ORPHA:79239,0.3832844616405875
SPSB3,D-glyceric aciduria ORPHA:941,0.3832844616405875
SPSB3,Mucolipidosis type III gamma ORPHA:423470,0.3832844616405875
SPSB3,NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751,0.3832844616405875
SPSB3,Prolactinoma ORPHA:2965,0.3832844616405875
SPSB3,Arnold-Chiari malformation type II ORPHA:1136,0.5867963421058087
SPSB3,Polyglucosan body myopathy type 1 ORPHA:397937,0.5867963421058087
SPSB3,Acromegaly ORPHA:963,0.7929682744768703
SPSB3,Tubular aggregate myopathy ORPHA:2593,0.7929682744768703
SRSF8,Hereditary myopathy with lactic acidosis due to ISCU deficiency ORPHA:43115,0.5867963421058087
SRSF8,Cercopithecine betaherpesvirus 5 tegument protein UL37 (gene: UL47),0.8999095837312036
ST3GAL5,Thromboangiitis Obliterans,0.7333611688795861
ST3GAL5,Malignant neoplasm of ovary,0.7333611688795861
ST3GAL5,Ovarian Carcinoma,0.7333611688795861
ST3GAL5,Lower limb hyperreflexia,0.7765852775619541
ST3GAL5,Leukemia Myelocytic Acute,0.7765852775619541
ST3GAL5,Liver carcinoma,0.7880542567584415
ST3GAL5,Epithelial ovarian cancer,0.7880542567584415
ST3GAL5,Choreoathetoid movements,0.7880542567584415
ST3GAL5,Nonverbal,0.7880542567584415
ST3GAL5,Absent speech,0.7880542567584415
ST3GAL5,Choreoathetosis,0.7880542567584415
ST3GAL5,Spasmodic movement,0.7880542567584415
ST3GAL5,Involuntary jerking movements,0.7880542567584415
ST3GAL5,Feeding difficulties in infancy,0.7880542567584415
ST3GAL5,Myoclonus,0.7880542567584415
ST3GAL5,Abnormal vision,0.7880542567584415
ST3GAL5,Cognitive delay,0.7880542567584415
ST3GAL5,Rheumatoid Arthritis,0.7880542567584415
ST3GAL5,Global developmental delay,0.7880542567584415
ST3GAL5,Optic Atrophy,0.7880542567584415
ST3GAL5,Mental and motor retardation,0.7880542567584415
ST3GAL5,Global brain atrophy,0.7908231553833205
ST3GAL5,Pick Disease of the Brain,0.8019075543217649
ST3GAL5,Degenerative polyarthritis,0.8019075543217649
ST3GAL5,Vomiting,0.8270909867833504
ST3GAL5,Irritation - emotion,0.8270909867833504
ST3GAL5,Cortical visual impairment,0.8402911822757345
ST3GAL5,Generalized hypotonia,0.843190898187174
ST3GAL5,Blindness Cortical,0.843190898187174
ST3GAL5,Hypermelanotic macule,0.8523465762428218
ST3GAL5,Central visual impairment,0.8584283190330553
ST3GAL5,Tonic - clonic seizures,0.8648405521677974
ST3GAL5,Status Epilepticus,0.914995991166204
ST3GAL5,Epileptic encephalopathy,0.917543617287358
ST3GAL5,Thyroid associated opthalmopathies,0.9258401930327972
ST3GAL5,Arthritis,0.9431511078237256
ST3GAL5,Intellectual Disability,0.9478210444156088
ST3GAL5,Congenital Disorders of Glycosylation,0.9540608878641196
ST3GAL5,Epilepsy,0.963331724428282
ST3GAL5,Psychomotor regression progressive,0.9692578766570316
ST3GAL5,Loss of developmental milestones,0.9692578766570316
ST3GAL5,Mental deterioration in childhood,0.9692578766570316
ST3GAL5,Neurodevelopmental regression,0.9692578766570316
ST3GAL5,Psychomotor regression,0.9692578766570316
ST3GAL5,Psychomotor regression beginning in infancy,0.9692578766570316
ST3GAL5,Psychomotor regression in infants,0.9707275133033936
ST3GAL5,Developmental regression,0.9707275133033936
ST3GAL5,Undergrowth,0.9884235744717738
ST3GAL5,Failure to gain weight,0.9896536639644284
ST3GAL5,Pediatric failure to thrive,0.9896536639644284
ST3GAL5,Paroxysmal Nonkinesigenic Dyskinesia,0.4532988396145482
ST3GAL5,Stereotyped Behavior,0.7765582368651238
ST3GAL5,Dyskinetic Syndrome,0.7765582368651238
ST3GAL5,Nystagmus,0.7765582368651238
ST3GAL5,Developmental Delay,0.7765582368651238
ST3GAL5,Choreoathetosis,0.7765582368651238
ST3GAL5,Optic Atrophy,0.8115918568696846
ST3GAL5,Hearing Loss,0.8115918568696846
ST3GAL5,Central Visual Impairment,0.8115918568696846
ST3GAL5,Mental Retardation,0.8337953215113012
ST3GAL5,Cerebral Cortical Atrophy,0.861756360478846
ST3GAL5,Seizure,0.861756360478846
ST3GAL5,Cerebral Palsy,0.8903301324869451
ST3GAL5,Microcephaly,0.8903630091389316
ST3GAL5,Status Epilepticus,0.9543024119762946
ST3GAL5,Developmental Regression,0.9658957825498884
ST3GAL5,Mucopolysaccharidosis type 2 attenuated form ORPHA:217093,0.1991445465001551
ST3GAL5,Mucopolysaccharidosis type 2 severe form ORPHA:217085,0.1991445465001551
ST3GAL5,Progressive myoclonic epilepsy type 3 ORPHA:263516,0.3832844616405875
ST3GAL5,Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome ORPHA:447997,0.5867963421058087
ST3GAL5,GM3 synthase deficiency ORPHA:370933,0.7929682744768703
STARD3,Malignant neoplasm of breast,0.4084380369379369
STARD3,Breast Carcinoma,0.7333611688795861
STARD3,Carcinogenesis,0.7333611688795861
STARD3,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
STARD3,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
STARD3,Mammary Neoplasms,0.7880542567584415
STARD3,Malignant neoplasm of prostate,0.7880542567584415
STARD3,Prostate carcinoma,0.7880542567584415
STARD3,Prostatic Neoplasms,0.7880542567584415
STARD3,Malignant neoplasm of stomach,0.7880542567584415
STARD3,High density lipoprotein measurement,0.7880542567584415
STARD3,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
STARD3,Stomach Carcinoma,0.7880542567584415
STARD3,cocaine use,0.8019075543217649
STARD3,Asthma,0.9672478180546946
STARD3,Prostate Cancer,0.7765582368651238
STARD3,Prostatic Neoplasms,0.7765582368651238
STARD3,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
STARD3,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
STARD3,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
STARD3,Barth syndrome ORPHA:111,0.0414176838632111
STARD3,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
STARD3,Incontinentia pigmenti ORPHA:464,0.0414176838632111
STARD3,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
STARD3,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
STARD3,Albers Schonberg osteopetrosis ORPHA:53,0.1040670578681756
STARD3,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.1040670578681756
STARD3,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.1040670578681756
STARD3,Alpha-mannosidosis adult form ORPHA:309288,0.1991445465001551
STARD3,Alpha-mannosidosis infantile form ORPHA:309282,0.1991445465001551
STARD3,Gamma-glutamyl transpeptidase deficiency ORPHA:33573,0.1991445465001551
STARD3,Leukonychia totalis ORPHA:2387,0.1991445465001551
STARD3,Mucolipidosis type IV ORPHA:578,0.1991445465001551
STARD3,Cerebellar ataxia-hypogonadism syndrome ORPHA:1173,0.1991445465001551
STARD3,Charcot-Marie-Tooth disease type 2B2 ORPHA:101101,0.3832844616405875
STARD3,Metachromatic leukodystrophy adult form ORPHA:309271,0.3832844616405875
STARD3,Metachromatic leukodystrophy juvenile form ORPHA:309263,0.3832844616405875
STARD3,Metachromatic leukodystrophy late infantile form ORPHA:309256,0.3832844616405875
STARD3,Ataxia-oculomotor apraxia type 4 ORPHA:459033,0.3832844616405875
STARD3,D-glyceric aciduria ORPHA:941,0.3832844616405875
STARD3,NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751,0.3832844616405875
STARD3,3C syndrome ORPHA:7,0.3832844616405875
STARD3,Prolactinoma ORPHA:2965,0.3832844616405875
STARD3,Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180,0.5867963421058087
STARD3,Autosomal recessive spastic paraplegia type 39 ORPHA:139480,0.5867963421058087
STARD3,Laurence-Moon syndrome ORPHA:2377,0.5867963421058087
STARD3,Polyglucosan body myopathy type 1 ORPHA:397937,0.5867963421058087
STARD3,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363,0.5867963421058087
STARD3,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173,0.5867963421058087
STARD3,Yunis-Varon syndrome ORPHA:3472,0.5867963421058087
STARD3,Infantile nephropathic cystinosis ORPHA:411629,0.7929682744768703
STARD3,Juvenile nephropathic cystinosis ORPHA:411634,0.7929682744768703
STARD3,Ocular cystinosis ORPHA:411641,0.7929682744768703
STARD3,Sanfilippo syndrome type A ORPHA:79269,0.7929682744768703
STARD3,Alveolar soft tissue sarcoma ORPHA:163699,0.7929682744768703
STARD3,H syndrome ORPHA:168569,0.8922466888454011
STK11IP,Adenocarcinoma,0.750391252594775
STK11IP,Peutz-Jeghers Syndrome,0.7880542567584415
STK11IP,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
STK11IP,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
STK11IP,Barth syndrome ORPHA:111,0.0414176838632111
STK11IP,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
STK11IP,Albers Schonberg osteopetrosis ORPHA:53,0.1040670578681756
STK11IP,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160,0.1991445465001551
STK11IP,Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635,0.1991445465001551
STK11IP,Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228,0.1991445465001551
STK11IP,Cerebellar ataxia-hypogonadism syndrome ORPHA:1173,0.1991445465001551
STK11IP,Early-onset autosomal dominant Alzheimer disease ORPHA:1020,0.2386105733903937
STK11IP,Charcot-Marie-Tooth disease type 2B2 ORPHA:101101,0.3832844616405875
STK11IP,Ataxia-oculomotor apraxia type 4 ORPHA:459033,0.3832844616405875
STK11IP,MOGS-CDG ORPHA:79330,0.3832844616405875
STK11IP,Mucopolysaccharidosis type 4A ORPHA:309297,0.3832844616405875
STK11IP,3C syndrome ORPHA:7,0.3832844616405875
STK11IP,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.3832844616405875
STK11IP,Prolactinoma ORPHA:2965,0.3832844616405875
STK11IP,Alpers-Huttenlocher syndrome ORPHA:726,0.5867963421058087
STK11IP,Ataxia-hypogonadism-choroidal dystrophy syndrome ORPHA:1180,0.5867963421058087
STK11IP,Autosomal recessive spastic paraplegia type 39 ORPHA:139480,0.5867963421058087
STK11IP,Autosomal recessive spastic paraplegia type 48 ORPHA:306511,0.5867963421058087
STK11IP,Laurence-Moon syndrome ORPHA:2377,0.5867963421058087
STK11IP,Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845,0.5867963421058087
STK11IP,MAN1B1-CDG ORPHA:397941,0.5867963421058087
STK11IP,Recessive mitochondrial ataxia syndrome ORPHA:94125,0.5867963421058087
STK11IP,Spinocerebellar ataxia with epilepsy ORPHA:254881,0.5867963421058087
STK11IP,Trichomegaly-retina pigmentary degeneration-dwarfism syndrome ORPHA:3363,0.5867963421058087
STK11IP,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173,0.5867963421058087
STK11IP,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome ORPHA:70595,0.5867963421058087
STK11IP,Yunis-Varon syndrome ORPHA:3472,0.5867963421058087
STK11IP,COG7-CDG ORPHA:79333,0.7929682744768703
STK11IP,Charcot-Marie-Tooth disease type 2S ORPHA:443073,0.7929682744768703
STK11IP,Porphyria variegata ORPHA:79473,0.7929682744768703
STK11IP,Spinal muscular atrophy with respiratory distress type 1 ORPHA:98920,0.7929682744768703
STK17B,Malignant neoplasm of breast,0.4084380369379369
STK17B,Breast Carcinoma,0.7333611688795861
STK17B,Colorectal Carcinoma,0.7765852775619541
STK17B,Mammary Neoplasms,0.7880542567584415
STK17B,IMMUNE SUPPRESSION,0.7880542567584415
STK17B,Thyroid carcinoma,0.7880542567584415
STK17B,Colorectal Cancer,0.7880542567584415
STK17B,Autoimmune Diseases,0.7880542567584415
STK17B,Multiple Sclerosis,0.8019075543217649
STK17B,Lymphoma T-Cell Cutaneous,0.8098851543361193
STK17B,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
STK17B,Papillary thyroid carcinoma,0.8757755363384367
STK17B,Idiopathic Pulmonary Fibrosis,0.9393256300017014
STK17B,Alacrimia-choreoathetosis-liver dysfunction syndrome ORPHA:404454,0.3832844616405875
STK17B,Cleidocranial dysplasia ORPHA:1452,0.3832844616405875
STK17B,Complement hyperactivation-angiopathic thrombosis-protein-losing enteropathy syndrome ORPHA:566175,0.3832844616405875
STK17B,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504,0.3832844616405875
STK17B,TOR1AIP1-related limb-girdle muscular dystrophy ORPHA:424261,0.3832844616405875
STK17B,Variant ABeta2M amyloidosis ORPHA:314652,0.3832844616405875
STK17B,Squamous cell carcinoma of salivary glands ORPHA:500481,0.3832844616405875
STK17B,Squamous cell carcinoma of the hypopharynx ORPHA:494547,0.3832844616405875
STK17B,Squamous cell carcinoma of the larynx ORPHA:494550,0.3832844616405875
STK17B,Squamous cell carcinoma of the lip ORPHA:502366,0.3832844616405875
STK17B,Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464,0.3832844616405875
STK17B,Squamous cell carcinoma of the oral cavity ORPHA:502363,0.3832844616405875
STK17B,Squamous cell carcinoma of the oropharynx ORPHA:500478,0.3832844616405875
STK17B,Autoimmune lymphoproliferative syndrome with recurrent viral infections ORPHA:275517,0.5867963421058087
STK17B,Autosomal dominant Kenny-Caffey syndrome ORPHA:93325,0.5867963421058087
STK17B,Familial normophosphatemic tumoral calcinosis ORPHA:306658,0.5867963421058087
STK17B,Generalized glucocorticoid resistance syndrome ORPHA:786,0.5867963421058087
STK17B,Hereditary pediatric Behcet-like disease ORPHA:476102,0.5867963421058087
STK17B,Immunodeficiency due to interleukin-1 receptor-associated kinase-4 deficiency ORPHA:70592,0.5867963421058087
STK17B,MIRAGE syndrome ORPHA:494433,0.5867963421058087
STK17B,Orofaciodigital syndrome type 5 ORPHA:2919,0.5867963421058087
STK17B,Osteocraniostenosis ORPHA:2763,0.5867963421058087
STK17B,Familial cerebral cavernous malformation ORPHA:221061,0.5867963421058087
STK17B,Familial platelet disorder with associated myeloid malignancy ORPHA:71290,0.5867963421058087
STK17B,Acute promyelocytic leukemia ORPHA:520,0.7150309491065155
STK17B,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial JAK1 deficiency ORPHA:574957,0.7929682744768703
STK17B,Coffin-Lowry syndrome ORPHA:192,0.7929682744768703
STK17B,Griscelli syndrome type 2 ORPHA:79477,0.7929682744768703
STK17B,Severe combined immunodeficiency due to DCLRE1C deficiency ORPHA:275,0.7929682744768703
STK17B,Symptomatic form of Coffin-Lowry syndrome in female carriers ORPHA:276630,0.7929682744768703
STK17B,X-linked centronuclear myopathy ORPHA:596,0.7929682744768703
STK17B,Loeys-Dietz syndrome ORPHA:60030,0.7929682744768703
STK17B,Squamous cell carcinoma of the esophagus ORPHA:99977,0.795266832401002
STK17B,Aggressive systemic mastocytosis ORPHA:98850,0.8029813443753846
STK17B,Essential thrombocythemia ORPHA:3318,0.8105918570729571
STK17B,Omenn syndrome ORPHA:39041,0.8447648476081987
STK17B,Bannayan-Riley-Ruvalcaba syndrome ORPHA:109,0.8922466888454011
STK17B,Combined immunodeficiency due to MALT1 deficiency ORPHA:397964,0.8922466888454011
STK17B,Familial cylindromatosis ORPHA:211,0.8922466888454011
STK17B,Familial multiple trichoepithelioma ORPHA:867,0.8922466888454011
STK17B,Hydranencephaly ORPHA:2177,0.8922466888454011
STK17B,Hyposmia-nasal and ocular hypoplasia-hypogonadotropic hypogonadism syndrome ORPHA:2250,0.8922466888454011
STK17B,Infantile systemic hyalinosis ORPHA:2176,0.8922466888454011
STK17B,Juvenile hyaline fibromatosis ORPHA:2028,0.8922466888454011
STK17B,Lhermitte-Duclos disease ORPHA:65285,0.8922466888454011
STK17B,NDE1-related microhydranencephaly ORPHA:443162,0.8922466888454011
STK17B,Proteus-like syndrome ORPHA:2969,0.8922466888454011
STK17B,Segmental outgrowth-lipomatosis-arteriovenous malformation-epidermal nevus syndrome ORPHA:137608,0.8922466888454011
STK17B,X-linked Charcot-Marie-Tooth disease type 6 ORPHA:352675,0.8922466888454011
STK17B,Vogt-Koyanagi-Harada disease ORPHA:3437,0.8922466888454011
STK17B,Activated PI3K-delta syndrome ORPHA:397596,0.8922466888454011
STK17B,High grade B-cell lymphoma with MYC and/ or BCL2 and/or BCL6 rearrangement ORPHA:480541,0.8922466888454011
STK17B,Combined immunodeficiency due to STK4 deficiency ORPHA:314689,0.8922466888454011
STK17B,Distal monosomy 15q ORPHA:1596,0.8922466888454011
STK17B,Intellectual disability-severe speech delay-mild dysmorphism syndrome ORPHA:391372,0.8922466888454011
STK17B,Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome ORPHA:487796,0.8922466888454011
STK17B,T-B+ severe combined immunodeficiency due to IL-7Ralpha deficiency ORPHA:169154,0.8922466888454011
STK17B,MALT lymphoma ORPHA:52417,0.8922466888454011
STK17B,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
STK17B,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
STK17B,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
STK17B,Human gammaherpesvirus 8 ORF72,0.8999095837312036
STK17B,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
STK17B,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
STK17B,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
STK17B,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
STK17B,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
STK17B,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
STK17B,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
STK17B,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
STK17B,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
STK17B,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
STK17B,Human orthopneumovirus fusion protein (gene: F),0.8999095837312036
STK17B,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
STK17B,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
STK17B,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
STK17B,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
STK17B,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
STK17B,Monkeypox virus ankyrin-like protein,0.8999095837312036
STK17B,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
STK17B,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
STK17B,Human Respiratory syncytial virus 9320 F,0.9057542447893764
STK17B,Respiratory syncytial virus Fusion protein (F) (gene: F),0.9057542447893764
STK17B,Respiratory syncytial virus type A fusion protein (gene: F),0.9057542447893764
STK17B,Orf virus ORF126 ankyrin repeat protein,0.9058994261255549
SUGT1,Heart failure,0.8867509400747969
SUGT1,Congestive heart failure,0.8976039441125321
SUGT1,MEGDEL syndrome ORPHA:352328,0.7929682744768703
SUGT1,ALG9-CDG ORPHA:79328,0.8922466888454011
SUGT1,Autosomal recessive spastic ataxia-optic atrophy-dysarthria syndrome ORPHA:254343,0.8922466888454011
SUGT1,Diaphyseal medullary stenosis-bone malignancy syndrome ORPHA:85182,0.8922466888454011
SUGT1,Atypical hypotonia-cystinuria syndrome ORPHA:238523,0.8922466888454011
SUGT1,2p21 microdeletion syndrome ORPHA:163693,0.8922466888454011
SUGT1,Giant axonal neuropathy ORPHA:643,0.8922466888454011
SUGT1,Neurodegeneration due to 3-hydroxyisobutyryl-CoA hydrolase deficiency ORPHA:88639,0.8922466888454011
SUGT1,NON RARE IN EUROPE: Barrett esophagus ORPHA:1232,0.8922466888454011
SUGT1,Preeclampsia ORPHA:275555,0.8922466888454011
SUGT1,Vaccinia virus cowpox A-type inclusion protein,0.8999095837312036
SYNCRIP,leukemia,0.7333611688795861
SYNCRIP,Colon Carcinoma,0.7765852775619541
SYNCRIP,Malignant tumor of colon,0.7765852775619541
SYNCRIP,Myeloid Leukemia,0.7880542567584415
SYNCRIP,Spinal Muscular Atrophy,0.8402911822757345
SYNCRIP,Septicemia,0.917543617287358
SYNCRIP,Sepsis,0.9189398569397552
SYNCRIP,Intellectual Disability,0.9478210444156088
SYNCRIP,Leukemia,0.7765582368651238
SYNCRIP,Linear nevus sebaceus syndrome ORPHA:2612,0.2047219337649946
SYNCRIP,Familial multinodular goiter ORPHA:276399,0.3832844616405875
SYNCRIP,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430,0.3832844616405875
SYNCRIP,1q44 microdeletion syndrome ORPHA:238769,0.5867963421058087
SYNCRIP,Charcot-Marie-Tooth disease type 4B1 ORPHA:99955,0.5867963421058087
SYNCRIP,Acute myeloblastic leukemia with maturation ORPHA:98834,0.5867963421058087
SYNCRIP,Juvenile myelomonocytic leukemia ORPHA:86834,0.6196505963261838
SYNCRIP,Familial pancreatic carcinoma ORPHA:1333,0.6599133692748571
SYNCRIP,Differentiated thyroid carcinoma ORPHA:146,0.7929682744768703
SYNCRIP,Cerebellar ataxia with neuropathy and bilateral vestibular areflexia syndrome ORPHA:504476,0.7929682744768703
SYNCRIP,RAS-associated autoimmune leukoproliferative disease ORPHA:268114,0.7929682744768703
SYNCRIP,Autosomal dominant aplasia and myelodysplasia ORPHA:314399,0.8922466888454011
SYNCRIP,EVEN-plus syndrome ORPHA:496751,0.8922466888454011
SYNCRIP,Early-onset seizures-distal limb anomalies-facial dysmorphism-global developmental delay syndrome ORPHA:505237,0.8922466888454011
SYNCRIP,Gabriele-de Vries syndrome ORPHA:506358,0.8922466888454011
SYNCRIP,Pseudohypoaldosteronism type 2E ORPHA:300530,0.8922466888454011
SYNCRIP,Acute myeloblastic leukemia without maturation ORPHA:98833,0.8922466888454011
SYNCRIP,Dubowitz syndrome ORPHA:235,0.8922466888454011
SYNCRIP,Human immunodeficiency virus 1 capsid (gene: gag),0.8999095837312036
SYNCRIP,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
SYNCRIP,Influenza B virus (B/Memphis/12/97) HA protein,0.8999095837312036
SYNCRIP,Human papillomavirus 94 E2 protein (gene: E2),0.8999095837312036
SYNCRIP,Human immunodeficiency virus 1 Gag-Pol (gene: gag-pol),0.8999095837312036
SYNCRIP,Human immunodeficiency virus 1 Pr55(Gag) (gene: gag),0.8999095837312036
SYNCRIP,Human adenovirus 21a 100 kDa hexon-assembly associated protein (gene: L4),0.8999095837312036
SYNCRIP,Human immunodeficiency virus gag protein (gene: gag),0.8999095837312036
SYNCRIP,Human papillomavirus type 27 early protein (gene: E2),0.8999095837312036
SYNCRIP,Human adenovirus 68 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
SYNCRIP,Human papillomavirus type XS2 E2 (gene: E2),0.8999095837312036
SYNCRIP,Human mastadenovirus B hexon assembly protein 100K (gene: L4),0.8999095837312036
SYNCRIP,Human adenovirus B3 L4 100-kDa protein (gene: L4),0.8999095837312036
SYNCRIP,Molluscum contagiosum virus subtype 1 MC161R (gene: MC161R),0.8999095837312036
SYNCRIP,Human immunodeficiency virus 1 Envelope surface glycoprotein gp160 precursor (gene: env),0.8999095837312036
SYNCRIP,Human immunodeficiency virus 2 full_polyprotein 1..521 (gene: gag-pol),0.8999095837312036
SYNCRIP,Human adenovirus 66 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
SYNCRIP,Human papillomavirus type 72b E2 protein (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus type 78 regulatory protein E2 (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus 3 envelope protein (gene: E2),0.8999095837312036
SYNCRIP,Human adenovirus 7 100K,0.8999095837312036
SYNCRIP,BK polyomavirus large T antigen,0.8999095837312036
SYNCRIP,Human herpesvirus 4 type 2 EBNA-1,0.8999095837312036
SYNCRIP,Human papillomavirus type 62 putative regulatory protein E2 (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus type 68a E2 protein,0.8999095837312036
SYNCRIP,Human papillomavirus type 34 early protein (gene: E2),0.8999095837312036
SYNCRIP,Human adenovirus 16 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
SYNCRIP,Human adenovirus 7d2 100 kDa hexon assembly-associated protein (gene: L4),0.8999095837312036
SYNCRIP,Human papillomavirus 179 E2 protein (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus E2 (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus type 53 early protein (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus type 68b E2 protein (gene: E2),0.8999095837312036
SYNCRIP,Variola virus sulfhydryl oxidase (gene: E10R),0.8999095837312036
SYNCRIP,Cercopithecine betaherpesvirus 5 tegument protein UL37 (gene: UL47),0.8999095837312036
SYNCRIP,Human papillomavirus type 13 E2 (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus type 43 E2 protein (gene: E2),0.8999095837312036
SYNCRIP,Human papillomavirus 173 E2,0.8999095837312036
SYNCRIP,Human papillomavirus type 102 E2 protein,0.8999095837312036
SYNCRIP,Human papillomavirus type 30 early protein (gene: E2),0.9018002218631122
SYNCRIP,Human papillomavirus type 68 E2 (gene: E2),0.9057542447893764
SYNCRIP,Human papillomavirus type 90 putative regulatory protein E2 (gene: E2),0.9057542447893764
SYNCRIP,Human papillomavirus type 10 envelope protein (gene: E2),0.9057542447893764
SYNCRIP,Human papillomavirus type 114 E2 protein (gene: E2),0.9057542447893764
SYNCRIP,Human papillomavirus type 119 regulatory protein E2 (gene: E2),0.9057542447893764
SYNCRIP,Human papillomavirus type 67 E2,0.9058994261255549
SYNCRIP,Human papillomavirus 125 putative E2 protein (gene: E2),0.9103786566415374
SYNCRIP,Titi monkey adenovirus ECC-2011 100K,0.915880438522078
SYNCRIP,Trichodysplasia spinulosa-associated polyomavirus large T antigen (gene: T),0.9176018655958595
SYNCRIP,Human papillomavirus type 112 E2 protein (gene: E2),0.9176018655958595
SYNCRIP,Human papillomavirus type 128 E2 (gene: E2),0.9224878266317492
SYNCRIP,Human papillomavirus type 83 transactivator (gene: E2),0.9224878266317492
SYNCRIP,Human papillomavirus type 57 E2,0.9237501457186692
SYNCRIP,Human papillomavirus type 52 early protein (gene: E2),0.9237501457186692
SYNCRIP,Human papillomavirus type 27b E2 protein (gene: E2),0.9287050575620676
SYNCRIP,Human papillomavirus type 106 E2 protein,0.9287050575620676
SYNCRIP,Influenza A virus (A/California/04/2009(H1N1)) HA2 (gene: HA),0.9318782091866168
SYNCRIP,Influenza A virus (A/California/07/2009(H1N1)) HA2 (gene: HA),0.9318782091866168
SYNCRIP,Alphapapillomavirus 3 regulatory protein E2 (gene: E2),0.9325850920715436
SYNCRIP,Human papillomavirus type 40 early protein (gene: E2),0.9397923093369096
SYNCRIP,Human papillomavirus type 81 E2 protein (gene: E2),0.9397923093369096
SYNCRIP,Human papillomavirus type 7 early protein (gene: E2),0.9397923093369096
SYNCRIP,Alphapapillomavirus 4 early protein E2 (gene: E2),0.9397923093369096
SYNCRIP,Human papillomavirus type 2 E2 protein (gene: E2),0.9397923093369096
SYNCRIP,Human papillomavirus type 32 early protein (gene: E2),0.9446489750009684
SYNGR3,PRKAR1B-related neurodegenerative dementia with intermediate filaments ORPHA:412066,0.0155394890951578
SYNGR3,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
SYNGR3,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
SYNGR3,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.1040670578681756
SYNGR3,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.1040670578681756
SYNGR3,MASA syndrome ORPHA:2466,0.1040670578681756
SYNGR3,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.1040670578681756
SYNGR3,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.1040670578681756
SYNGR3,Congenital microcephaly-severe encephalopathy-progressive cerebral atrophy syndrome ORPHA:391376,0.1991445465001551
SYNGR3,Familial gastric type 1 neuroendocrine tumor ORPHA:464756,0.5867963421058087
SYNGR3,Primary dystonia DYT4 type ORPHA:98805,0.5867963421058087
SYNGR3,Idiopathic central precocious puberty ORPHA:169615,0.5867963421058087
SYNPO,Malignant neoplasm of breast,0.4084380369379369
SYNPO,Breast Carcinoma,0.7333611688795861
SYNPO,Epidermodysplasia Verruciformis,0.7765852775619541
SYNPO,Malignant neoplasm of prostate,0.7880542567584415
SYNPO,Nephroblastoma,0.7880542567584415
SYNPO,Focal Segmental Glomerulosclerosis Not Otherwise Specified,0.7880542567584415
SYNPO,Renal glomerular disease,0.7880542567584415
SYNPO,Membranous glomerulonephritis,0.7880542567584415
SYNPO,Primary Focal Segmental Glomerulosclerosis,0.7880542567584415
SYNPO,hypertensive nephropathy,0.7880542567584415
SYNPO,IGA Glomerulonephritis,0.8019075543217649
SYNPO,Nephrosclerosis,0.8019075543217649
SYNPO,Pre-Eclampsia,0.8019075543217649
SYNPO,Focal glomerulosclerosis,0.8019075543217649
SYNPO,Kidney Diseases,0.8019075543217649
SYNPO,Schizophrenia,0.8067197998685076
SYNPO,AIDS-Associated Nephropathy,0.8190761496232595
SYNPO,Nephrotic Syndrome,0.8232134984476662
SYNPO,Glomerulosclerosis,0.7765582368651238
SYNPO,Focal Segmental Glomerulosclerosis,0.7765582368651238
SYNPO,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
SYNPO,Bilateral perisylvian polymicrogyria ORPHA:98889,0.1068643725150898
SYNPO,Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899,0.1991445465001551
SYNPO,19p13.3 microduplication syndrome ORPHA:447980,0.3832844616405875
SYNPO,Malan overgrowth syndrome ORPHA:420179,0.3832844616405875
SYNPO,Marshall-Smith syndrome ORPHA:561,0.3832844616405875
SYNPO,Non-immune hydrops fetalis ORPHA:363999,0.3832844616405875
SYNPO,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.5867963421058087
SYNPO,NON RARE IN EUROPE: Benign familial hematuria ORPHA:97562,0.5867963421058087
SYNPO,Hypotrichosis-lymphedema-telangiectasia-renal defect syndrome ORPHA:69735,0.7929682744768703
SYNPO,RIN2 syndrome ORPHA:217335,0.7929682744768703
SYNPO,Craniometaphyseal dysplasia ORPHA:1522,0.7929682744768703
SYNPO,Distal hereditary motor neuropathy type 2 ORPHA:139525,0.795266832401002
SYNPO,Alpha-B crystallin-related late-onset myopathy ORPHA:399058,0.8922466888454011
SYNPO,Fatal infantile hypertonic myofibrillar myopathy ORPHA:280553,0.8922466888454011
SYNPO,Multiple paragangliomas associated with polycythemia ORPHA:324299,0.8922466888454011
SYNPO,Recessive X-linked ichthyosis ORPHA:461,0.8922466888454011
SYNPO,Syndromic recessive X-linked ichthyosis ORPHA:281090,0.8922466888454011
SYNPO,Acromicric dysplasia ORPHA:969,0.8922466888454011
SYNPO,Duchenne muscular dystrophy ORPHA:98896,0.8922466888454011
SYNPO,Familial calcium pyrophosphate deposition ORPHA:1416,0.8922466888454011
SYNPO,Autosomal dominant secondary polycythemia ORPHA:247511,0.8922466888454011
SYNPO,Autosomal dominant Alport syndrome ORPHA:88918,0.8922466888454011
SYNPO,Autosomal recessive Alport syndrome ORPHA:88919,0.8922466888454011
SYNPO,De novo thrombotic microangiopathy after kidney transplantation ORPHA:244275,0.8922466888454011
SYNPO,Complement component 3 deficiency ORPHA:280133,0.8922466888454011
SYNPO,Familial GPIHBP1 deficiency ORPHA:535458,0.8922466888454011
SYNPO,Familial drusen ORPHA:75376,0.8922466888454011
SYNPO,Familial retinal arterial macroaneurysm ORPHA:284247,0.8922466888454011
SYNPO,Hereditary arterial and articular multiple calcification syndrome ORPHA:289601,0.8922466888454011
SYNPO,Immunodeficiency with factor I anomaly ORPHA:200418,0.8922466888454011
SYNPO,LIMS2-related limb-girdle muscular dystrophy ORPHA:466801,0.8922466888454011
SYNPO,Geleophysic dysplasia ORPHA:2623,0.8922466888454011
SYNPO,Familial cerebral saccular aneurysm ORPHA:231160,0.8922466888454011
SYNPO,NON RARE IN EUROPE: Age-related macular degeneration ORPHA:279,0.8922466888454011
SYT7,Glioblastoma,0.7880542567584415
SYT7,Childhood Glioblastoma,0.7880542567584415
SYT7,Adult Glioblastoma,0.7880542567584415
SYT7,Intelligence,0.9093740881835894
SYT7,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
SYT7,Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253,0.1040670578681756
SYT7,Monosomy 22q13.3 ORPHA:48652,0.1040670578681756
SYT7,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.1068643725150898
SYT7,Apparent mineralocorticoid excess ORPHA:320,0.1991445465001551
SYT7,Bilateral generalized polymicrogyria ORPHA:208447,0.1991445465001551
SYT7,Lethal congenital contracture syndrome type 2 ORPHA:137776,0.1991445465001551
SYT7,MYO5B-related progressive familial intrahepatic cholestasis ORPHA:480491,0.1991445465001551
SYT7,Pyruvate carboxylase deficiency benign type ORPHA:353320,0.1991445465001551
SYT7,Pyruvate carboxylase deficiency infantile type ORPHA:353308,0.1991445465001551
SYT7,Pyruvate carboxylase deficiency severe neonatal type ORPHA:353314,0.1991445465001551
SYT7,Benign hereditary chorea ORPHA:1429,0.1991445465001551
SYT7,Familial infantile myoclonic epilepsy ORPHA:352582,0.1991445465001551
SYT7,Familial hypercholanemia ORPHA:238475,0.2047219337649946
SYT7,Usher syndrome type 1 ORPHA:231169,0.2661730864557679
SYT7,Alopecia universalis ORPHA:701,0.3832844616405875
SYT7,Atrichia with papular lesions ORPHA:86819,0.3832844616405875
SYT7,Hereditary folate malabsorption ORPHA:90045,0.3832844616405875
SYT7,Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403,0.3832844616405875
SYT7,Spinocerebellar ataxia type 5 ORPHA:98766,0.3832844616405875
SYT7,9q33.3q34.11 microdeletion syndrome ORPHA:495818,0.3832844616405875
SYT7,Alopecia-intellectual disability syndrome ORPHA:2850,0.3832844616405875
SYT7,Persistent hyperplastic primary vitreous ORPHA:91495,0.3832844616405875
SYT7,NON RARE IN EUROPE: Hypodontia ORPHA:2227,0.4621817429362311
SYT7,Autosomal recessive non-syndromic sensorineural deafness type DFNB ORPHA:90636,0.5867963421058087
SYT7,Achondroplasia ORPHA:15,0.5867963421058087
SYT7,Acute neonatal citrullinemia type I ORPHA:247546,0.5867963421058087
SYT7,Adult-onset citrullinemia type I ORPHA:247573,0.5867963421058087
SYT7,Autosomal dominant adult-onset proximal spinal muscular atrophy ORPHA:209335,0.5867963421058087
SYT7,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency ORPHA:276580,0.5867963421058087
SYT7,Autosomal dominant spastic paraplegia type 31 ORPHA:101011,0.5867963421058087
SYT7,Autosomal recessive dopa-responsive dystonia ORPHA:101150,0.5867963421058087
SYT7,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency ORPHA:79644,0.5867963421058087
SYT7,Camptodactyly-tall stature-scoliosis-hearing loss syndrome ORPHA:85164,0.5867963421058087
SYT7,Carvajal syndrome ORPHA:65282,0.5867963421058087
SYT7,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.5867963421058087
SYT7,Cholangiocarcinoma ORPHA:70567,0.5867963421058087
SYT7,Crouzon syndrome-acanthosis nigricans syndrome ORPHA:93262,0.5867963421058087
SYT7,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency ORPHA:276603,0.5867963421058087
SYT7,Erythrokeratodermia-cardiomyopathy syndrome ORPHA:476096,0.5867963421058087
SYT7,Hypochondroplasia ORPHA:429,0.5867963421058087
SYT7,Intermediate DEND syndrome ORPHA:99989,0.5867963421058087
SYT7,Isolated congenital breast hypoplasia/aplasia ORPHA:180188,0.5867963421058087
SYT7,Lateral meningocele syndrome ORPHA:2789,0.5867963421058087
SYT7,Low isolated anorectal malformation ORPHA:171215,0.5867963421058087
SYT7,Microphthalmia with limb anomalies ORPHA:1106,0.5867963421058087
SYT7,Muenke syndrome ORPHA:53271,0.5867963421058087
SYT7,Peripheral neuropathy-myopathy-hoarseness-hearing loss syndrome ORPHA:397744,0.5867963421058087
SYT7,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta ORPHA:566243,0.5867963421058087
SYT7,Severe achondroplasia-developmental delay-acanthosis nigricans syndrome ORPHA:85165,0.5867963421058087
SYT7,Skin fragility-woolly hair-palmoplantar keratoderma syndrome ORPHA:293165,0.5867963421058087
SYT7,Thanatophoric dysplasia type 1 ORPHA:1860,0.5867963421058087
SYT7,Thanatophoric dysplasia type 2 ORPHA:93274,0.5867963421058087
SYT7,Wilson disease ORPHA:905,0.5867963421058087
SYT7,X-linked recessive ocular albinism ORPHA:54,0.5867963421058087
SYT7,46XX ovotesticular disorder of sex development ORPHA:2138,0.5867963421058087
SYT7,Ollier disease ORPHA:296,0.5867963421058087
SYT7,Permanent neonatal diabetes mellitus ORPHA:99885,0.5959529547720634
SYT7,Familial isolated arrhythmogenic ventricular dysplasia biventricular form ORPHA:293899,0.6873535151929783
SYT7,Familial isolated arrhythmogenic ventricular dysplasia left dominant form ORPHA:293888,0.6873535151929783
SYT7,Familial isolated arrhythmogenic ventricular dysplasia right dominant form ORPHA:293910,0.7007232363756918
SYT7,DEND syndrome ORPHA:79134,0.7929682744768703
SYT7,Apert syndrome ORPHA:87,0.7929682744768703
SYT7,Campomelic dysplasia ORPHA:140,0.7929682744768703
SYT7,Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome ORPHA:1555,0.7929682744768703
SYT7,FGFR2-related bent bone dysplasia ORPHA:313855,0.7929682744768703
SYT7,Familial congenital nasolacrimal duct obstruction ORPHA:451612,0.7929682744768703
SYT7,Familial scaphocephaly syndrome McGillivray type ORPHA:168624,0.7929682744768703
SYT7,Hyperphenylalaninemia due to DNAJC12 deficiency ORPHA:508523,0.7929682744768703
SYT7,Isolated Pierre Robin syndrome ORPHA:718,0.7929682744768703
SYT7,Jackson-Weiss syndrome ORPHA:1540,0.7929682744768703
SYT7,Pfeiffer syndrome type 2 ORPHA:93259,0.7929682744768703
SYT7,Pfeiffer syndrome type 3 ORPHA:93260,0.7929682744768703
SYT7,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673,0.7929682744768703
SYT7,Autosomal dominant hypocalcemia ORPHA:428,0.7929682744768703
SYT7,Saethre-Chotzen syndrome ORPHA:794,0.7929682744768703
SYT7,Atypical glycine encephalopathy ORPHA:289863,0.795266832401002
SYT7,Early-onset anterior polar cataract ORPHA:98988,0.795266832401002
SYT7,Infantile glycine encephalopathy ORPHA:289860,0.795266832401002
SYT7,NON RARE IN EUROPE: Aldosterone-producing adenoma ORPHA:85142,0.8029813443753846
SYT7,Renal agenesis unilateral ORPHA:93100,0.8211968342881582
SYT7,Dicarboxylic aminoaciduria ORPHA:2195,0.8922466888454011
SYT7,Familial dyskinesia and facial myokymia ORPHA:324588,0.8922466888454011
SYT7,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome ORPHA:397618,0.8922466888454011
SYT7,Hot water reflex epilepsy ORPHA:166412,0.8922466888454011
SYT7,Monoamine oxidase A deficiency ORPHA:3057,0.8922466888454011
SYT7,OBSOLETE: Alpha-1-antichymotrypsin deficiency ORPHA:93594,0.8922466888454011
SYT7,Pontocerebellar hypoplasia type 3 ORPHA:97249,0.8922466888454011
SYT7,Progressive sensorineural hearing loss-hypertrophic cardiomyopathy syndrome ORPHA:228012,0.8922466888454011
SYT7,Sulfite oxidase deficiency due to molybdenum cofactor deficiency type C ORPHA:308400,0.8922466888454011
SYT7,Thrombocythemia with distal limb defects ORPHA:329319,0.8922466888454011
SYT7,Lacrimoauriculodentodigital syndrome ORPHA:2363,0.8922466888454011
SYT7,Complete atrioventricular septal defect-tetralogy of Fallot ORPHA:99068,0.8922466888454011
SYT7,Multiple endocrine neoplasia type 2A ORPHA:247698,0.8922466888454011
SYT7,Multiple endocrine neoplasia type 2B ORPHA:247709,0.8922466888454011
SYTL3,Chediak-Higashi Syndrome,0.7880542567584415
SYTL3,Lipoprotein (a) measurement,0.7880542567584415
SYTL3,airway disease,0.8402911822757345
SYTL3,Vascular Diseases,0.7765582368651238
SYTL3,Cleidocranial dysplasia ORPHA:1452,0.3832844616405875
SYTL3,Metaphyseal dysplasia-maxillary hypoplasia-brachydacty syndrome ORPHA:2504,0.3832844616405875
TADA1,Infant Premature,0.7880542567584415
TADA1,Rheumatoid Arthritis,0.7880542567584415
TADA1,Post MI,0.7880542567584415
TADA1,Degenerative polyarthritis,0.8019075543217649
TADA1,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
TADA1,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
TADA1,PRUNE1-related neurological syndrome ORPHA:544469,0.7929682744768703
TADA1,COG2-CDG ORPHA:435934,0.8922466888454011
TADA1,Methylcobalamin deficiency type cblE ORPHA:2169,0.8922466888454011
TADA1,Anaplastic oligodendroglioma ORPHA:251630,0.8922466888454011
TADA1,Oligodendroglioma ORPHA:251627,0.8922466888454011
TAOK2,Adenocarcinoma,0.750391252594775
TAOK2,Leukemia Myelocytic Acute,0.7765852775619541
TAOK2,Liver carcinoma,0.7880542567584415
TAOK2,Malignant neoplasm of stomach,0.7880542567584415
TAOK2,Dementia,0.7880542567584415
TAOK2,Acute leukemia,0.7880542567584415
TAOK2,Presenile dementia,0.7880542567584415
TAOK2,Alzheimer's Disease,0.7880542567584415
TAOK2,Stomach Carcinoma,0.7880542567584415
TAOK2,Small cell carcinoma of lung,0.7880542567584415
TAOK2,Senile Plaques,0.8019075543217649
TAOK2,Schizophrenia,0.8067197998685076
TAOK2,Carcinoma Small Cell,0.8098851543361193
TAOK2,Adenocarcinoma of lung (disorder),0.8098851543361193
TAOK2,Klinefelter Syndrome,0.8190761496232595
TAOK2,Klinefelter's syndrome - male with more than two X chromosomes,0.8368219249856942
TAOK2,Pervasive Development Disorder,0.8806784681730055
TAOK2,Autism Spectrum Disorders,0.9639249377588224
TAOK2,Psychosis,0.7765582368651238
TAOK2,Schizophrenia,0.7860378120955526
TAOK2,Otospondylomegaepiphyseal dysplasia ORPHA:1427,0.0144185025972157
TAOK2,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
TAOK2,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
TAOK2,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
TAOK2,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
TAOK2,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
TAOK2,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
TAOK2,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
TAOK2,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
TAOK2,Oculocutaneous albinism type 2 ORPHA:79432,0.0414176838632111
TAOK2,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
TAOK2,NON RARE IN EUROPE: Metabolic syndrome ORPHA:411969,0.0429491792829903
TAOK2,ATP13A2-related juvenile neuronal ceroid lipofuscinosis ORPHA:314632,0.1040670578681756
TAOK2,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.1040670578681756
TAOK2,Autosomal recessive spastic paraplegia type 78 ORPHA:513436,0.1040670578681756
TAOK2,Cerebellar-facial-dental syndrome ORPHA:444072,0.1040670578681756
TAOK2,Kufor-Rakeb syndrome ORPHA:306674,0.1040670578681756
TAOK2,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.1040670578681756
TAOK2,Steinert myotonic dystrophy ORPHA:273,0.1040670578681756
TAOK2,Smith-Magenis syndrome ORPHA:819,0.1117946631214258
TAOK2,Saldino-Mainzer syndrome ORPHA:140969,0.1991445465001551
TAOK2,Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899,0.1991445465001551
TAOK2,CLN4B disease ORPHA:228343,0.1991445465001551
TAOK2,Charcot-Marie-Tooth disease type 4F ORPHA:99952,0.1991445465001551
TAOK2,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160,0.1991445465001551
TAOK2,Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257,0.1991445465001551
TAOK2,Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215,0.1991445465001551
TAOK2,Knobloch syndrome ORPHA:1571,0.1991445465001551
TAOK2,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401,0.1991445465001551
TAOK2,POMT1-related  limb-girdle muscular dystrophy R11 ORPHA:86812,0.1991445465001551
TAOK2,Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361,0.1991445465001551
TAOK2,Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717,0.1991445465001551
TAOK2,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569,0.1991445465001551
TAOK2,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.1991445465001551
TAOK2,17p11.2 microduplication syndrome ORPHA:1713,0.3832844616405875
TAOK2,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E ORPHA:93114,0.3832844616405875
TAOK2,Distal 16p11.2 microdeletion syndrome ORPHA:261222,0.3832844616405875
TAOK2,Distal 22q11.2 microdeletion syndrome ORPHA:261330,0.3832844616405875
TAOK2,PMP22-RAI1 contiguous gene duplication syndrome ORPHA:477817,0.3832844616405875
TAOK2,Perry syndrome ORPHA:178509,0.3832844616405875
TAOK2,Proximal 16p11.2 microdeletion syndrome ORPHA:261197,0.3832844616405875
TAOK2,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency ORPHA:329249,0.3832844616405875
TAOK2,Crouzon disease ORPHA:207,0.3832844616405875
TAOK2,Familial multinodular goiter ORPHA:276399,0.3832844616405875
TAOK2,Isolated focal cortical dysplasia type IIb ORPHA:269008,0.3832844616405875
TAOK2,Congenital muscular dystrophy with intellectual disability ORPHA:370968,0.3977968344535308
TAOK2,Wolf-Hirschhorn syndrome ORPHA:280,0.4100904865085126
TAOK2,Adult hepatocellular carcinoma ORPHA:210159,0.4491081214880772
TAOK2,Idiopathic pulmonary fibrosis ORPHA:2032,0.5047266821728011
TAOK2,Familial lambdoid synostosis ORPHA:3267,0.5867963421058087
TAOK2,Frontorhiny ORPHA:391474,0.5867963421058087
TAOK2,Isolated cloverleaf skull syndrome ORPHA:2343,0.5867963421058087
TAOK2,Juvenile Huntington disease ORPHA:248111,0.5867963421058087
TAOK2,MAN1B1-CDG ORPHA:397941,0.5867963421058087
TAOK2,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract ORPHA:500545,0.5867963421058087
TAOK2,Autosomal recessive progressive external ophthalmoplegia ORPHA:254886,0.5867963421058087
TAOK2,Isolated focal cortical dysplasia type IIa ORPHA:269001,0.5867963421058087
TAOK2,Schneckenbecken dysplasia ORPHA:3144,0.5867963421058087
TAOK2,22q11.2 deletion syndrome ORPHA:567,0.6599133692748571
TAOK2,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder ORPHA:500180,0.7929682744768703
TAOK2,Opsismodysplasia ORPHA:2746,0.7929682744768703
TAOK2,Syndromic X-linked intellectual disability due to JARID1C mutation ORPHA:85279,0.7929682744768703
TAOK2,Acute megakaryoblastic leukemia without Down syndrome ORPHA:329469,0.7929682744768703
TAOK2,Neurofibromatosis-Noonan syndrome ORPHA:638,0.7929682744768703
TAOK2,Chronic myeloid leukemia ORPHA:521,0.7929682744768703
TAOK2,Congenital muscular dystrophy without intellectual disability ORPHA:370980,0.795266832401002
TAOK2,Autosomal dominant Charcot-Marie-Tooth disease type 2A2 ORPHA:99947,0.8922466888454011
TAOK2,Hereditary motor and sensory neuropathy type 5 ORPHA:64751,0.8922466888454011
TAOK2,Jalili syndrome ORPHA:1873,0.8922466888454011
TAOK2,Multiple symmetric lipomatosis ORPHA:2398,0.8922466888454011
TAOK2,Ocular albinism ORPHA:284804,0.8922466888454011
TAOK2,Severe early-onset axonal neuropathy due to MFN2 deficiency ORPHA:90118,0.8922466888454011
TAOK2,Oxoglutaric aciduria ORPHA:31,0.8922466888454011
TAOK2,Proteus syndrome ORPHA:744,0.8922466888454011
TAOK2,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
TAOK2,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
TAOK2,Provisional),0.8999095837312036
TAOK2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TAOK2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TAOK2,Human gammaherpesvirus 8 ORF72,0.8999095837312036
TAOK2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TAOK2,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
TAOK2,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
TAOK2,Cowpox virus CPXV057 protein (gene: CPXV057 CDS),0.8999095837312036
TAOK2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
TAOK2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
TAOK2,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
TAOK2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TAOK2,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TBC1D8,Malignant neoplasm of ovary,0.7333611688795861
TBC1D8,Ovarian Carcinoma,0.7333611688795861
TBC1D8,Eosinophil count procedure,0.7880542567584415
TBC1D8,Eosinophil count result,0.7880542567584415
TBC1D8,Brain Neoplasms,0.7880542567584415
TBC1D8,Renal Cell Carcinoma,0.7880542567584415
TBC1D8,Alzheimer's Disease,0.7880542567584415
TBC1D8,Conventional (Clear Cell) Renal Cell Carcinoma,0.7880542567584415
TBC1D8,Neutrophil count (procedure),0.8019075543217649
TBC1D8,Ovarian adenocarcinoma,0.8067197998685076
TBC1D8,Granulocyte count,0.8212681436603975
TBC1D8,Hyperlipoproteinemia Type IIa,0.8402911822757345
TBC1D8,Osteoporosis,0.9639249377588224
TBC1D8,Osteoporosis,0.8903301324869451
TBC1D8,Impaired Cognition,0.9231137872214272
TBC1D8,Charcot-Marie-Tooth disease type 4H ORPHA:99954,0.5867963421058087
TBPL1,Malignant neoplasm of breast,0.4084380369379369
TBPL1,Carcinoma of bladder,0.4084380369379369
TBPL1,Bladder Neoplasm,0.4084380369379369
TBPL1,Malignant neoplasm of urinary bladder,0.5071083164302358
TBPL1,Breast Carcinoma,0.7333611688795861
TBPL1,Carcinogenesis,0.7333611688795861
TBPL1,leukemia,0.7333611688795861
TBPL1,Beckwith-Wiedemann Syndrome,0.7765852775619541
TBPL1,Colorectal Carcinoma,0.7765852775619541
TBPL1,Colon Carcinoma,0.7765852775619541
TBPL1,Malignant tumor of colon,0.7765852775619541
TBPL1,Lymphoma,0.7765852775619541
TBPL1,Non-Small Cell Lung Carcinoma,0.7765852775619541
TBPL1,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
TBPL1,Mammary Neoplasms,0.7880542567584415
TBPL1,Malignant neoplasm of prostate,0.7880542567584415
TBPL1,Promyelocytic leukemia,0.7880542567584415
TBPL1,Liver carcinoma,0.7880542567584415
TBPL1,Colorectal Cancer,0.7880542567584415
TBPL1,Chronic heart failure,0.7880542567584415
TBPL1,Leukemia T-Cell,0.7880542567584415
TBPL1,Hepatocarcinogenesis,0.7880542567584415
TBPL1,Glioblastoma,0.7880542567584415
TBPL1,Prostate carcinoma,0.7880542567584415
TBPL1,CATARACT MARNER TYPE,0.7880542567584415
TBPL1,Neoplasm Metastasis,0.7880542567584415
TBPL1,Isodicentric Chromosome 15 Syndrome,0.7880542567584415
TBPL1,Prostatic Neoplasms,0.7880542567584415
TBPL1,Monoclonal Gammopathy of Undetermined Significance,0.7880542567584415
TBPL1,Focal Segmental Glomerulosclerosis Not Otherwise Specified,0.7880542567584415
TBPL1,Neuroblastoma,0.7880542567584415
TBPL1,Central neuroblastoma,0.7880542567584415
TBPL1,Interstitial Cystitis,0.7880542567584415
TBPL1,Immunologic Deficiency Syndromes,0.7880542567584415
TBPL1,Multiple Myeloma,0.7880542567584415
TBPL1,Pelizaeus-Merzbacher Disease,0.7880542567584415
TBPL1,Renal glomerular disease,0.7880542567584415
TBPL1,Malignant neoplasm of stomach,0.7880542567584415
TBPL1,Noninfiltrating Intraductal Carcinoma,0.7880542567584415
TBPL1,Familial Nonmedullary Thyroid Gland Carcinoma,0.7880542567584415
TBPL1,Lubs X-linked mental retardation syndrome,0.7880542567584415
TBPL1,Renal Cell Carcinoma,0.7880542567584415
TBPL1,Acute leukemia,0.7880542567584415
TBPL1,Invasive Carcinoma,0.7880542567584415
TBPL1,Stomach Carcinoma,0.7880542567584415
TBPL1,Fanconi Anemia,0.7880542567584415
TBPL1,Cardiovascular Diseases,0.7880542567584415
TBPL1,Squamous cell carcinoma,0.7880542567584415
TBPL1,Mitochondrial Myopathies,0.7880542567584415
TBPL1,Mucolipidosis Type IV,0.7880542567584415
TBPL1,Crohn Disease,0.7880542567584415
TBPL1,Channelopathies,0.7908231553833205
TBPL1,Nijmegen Breakage Syndrome,0.8019075543217649
TBPL1,Cockayne Syndrome Type II,0.8019075543217649
TBPL1,Focal glomerulosclerosis,0.8019075543217649
TBPL1,FANCONI ANEMIA COMPLEMENTATION GROUP A (disorder),0.8019075543217649
TBPL1,Skin Erosion,0.8019075543217649
TBPL1,Kidney Diseases,0.8019075543217649
TBPL1,Tooth Attrition,0.8019075543217649
TBPL1,Schizophrenia,0.8067197998685076
TBPL1,Liver diseases,0.8140222479282434
TBPL1,Pancreatitis,0.8168901801930506
TBPL1,Polycystic Kidney Diseases,0.8168901801930506
TBPL1,Ulcerative Colitis,0.8190761496232595
TBPL1,Chronic interstitial cystitis,0.8190761496232595
TBPL1,Desmoplastic,0.8190761496232595
TBPL1,precancerous lesions,0.8232134984476662
TBPL1,Iron Overload,0.8272008757995397
TBPL1,Glioblastoma Multiforme,0.8342163953428735
TBPL1,Degenerative disorder,0.8363138748299018
TBPL1,Premature aging syndrome,0.8402911822757345
TBPL1,Ataxia,0.8402911822757345
TBPL1,Inflammatory dermatosis,0.8554819098734854
TBPL1,Common Migraine,0.8648405521677974
TBPL1,Migraine Disorders,0.8648405521677974
TBPL1,Inflammatory Bowel Diseases,0.8815127642200768
TBPL1,Dermatitis,0.8815127642200768
TBPL1,Heart failure,0.8867509400747969
TBPL1,Pain,0.887595340546704
TBPL1,Congestive heart failure,0.8976039441125321
TBPL1,Cerebellar Ataxia,0.906476206143938
TBPL1,Hypertriglyceridemia,0.9154499654632742
TBPL1,Polycystic Kidney Autosomal Dominant,0.9193385822373632
TBPL1,Coughing,0.9262273158806068
TBPL1,Malignant neoplasm of skin,0.93413028051677
TBPL1,Skin Neoplasms,0.9434459508692176
TBPL1,Ataxia Spinocerebellar,0.94939825643792
TBPL1,Nicotine Dependence,0.9557184806547836
TBPL1,Asthma,0.9672478180546946
TBPL1,Hemolytic anemia due to diphosphoglycerate mutase deficiency ORPHA:714,0.5867963421058087
TBPL1,DNAJB6-related  limb-girdle muscular dystrophy D1 ORPHA:34516,0.7929682744768703
TBPL1,Spinocerebellar ataxia type 18 ORPHA:98771,0.7929682744768703
TBPL1,Multiple mitochondrial dysfunctions syndrome type 5 ORPHA:569274,0.8922466888454011
TBPL1,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
TBX19,Neonatal hypoglycemia,0.7765852775619541
TBX19,Small adrenal gland,0.7765852775619541
TBX19,Adrenal hypoplasia,0.7765852775619541
TBX19,Adrenocorticotropic hormone (ACTH) deficiency (disorder),0.7880542567584415
TBX19,Prolonged neonatal jaundice,0.7880542567584415
TBX19,Adrenocorticotropin deficient adrenal insufficiency,0.7880542567584415
TBX19,Neonatal Jaundice,0.7880542567584415
TBX19,X-linked Adrenal Hypoplasia,0.7880542567584415
TBX19,Hypoglycemic seizures,0.7880542567584415
TBX19,Decreased circulating cortisol level,0.7880542567584415
TBX19,Hypocortisolemia,0.7880542567584415
TBX19,Alcoholic Intoxication Chronic,0.8019075543217649
TBX19,Alcohol abuse,0.8019075543217649
TBX19,Fasting Hypoglycemia,0.8168901801930506
TBX19,Alcohol Use Disorder,0.8272008757995397
TBX19,Hypotension,0.834094492023826
TBX19,Hyponatremia,0.8402911822757345
TBX19,Common Variable Immunodeficiency,0.8402911822757345
TBX19,Endocrine System Diseases,0.8584283190330553
TBX19,Pituitary-dependent Cushing's disease,0.8648405521677974
TBX19,Mental Depression,0.8769418330148872
TBX19,Fatigue,0.9029289778792944
TBX19,Depressive disorder,0.9103315000053974
TBX19,Adrenocorticotropin Deficient Adrenal Insufficiency,0.7765582368651238
TBX19,Adrenocorticotropic Hormone Deficiency,0.7765582368651238
TBX19,Hypoglycemia,0.7765582368651238
TBX19,Hypoglycemic Seizures,0.8115918568696846
TBX19,Mental Depression,0.8903630091389316
TBX19,Congenital isolated ACTH deficiency ORPHA:199296,0.5867963421058087
TCAP,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
TCAP,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
TCAP,Increased connective tissue,0.7880542567584415
TCAP,Familial dilated cardiomyopathy,0.7880542567584415
TCAP,Areflexia of lower limbs,0.7880542567584415
TCAP,Distal lower limb muscle weakness,0.7880542567584415
TCAP,Lower limb atrophy,0.7880542567584415
TCAP,Lower limb muscle hypotrophy,0.7880542567584415
TCAP,Proximal muscle weakness in lower limbs,0.7880542567584415
TCAP,Foot-drop,0.7880542567584415
TCAP,Foot dorsiflexor weakness,0.7880542567584415
TCAP,Distal lower limb amyotrophy,0.7880542567584415
TCAP,Autosomal recessive childhood type muscular dystrophy resembling Duchenne or Becker muscular dystrophy,0.7880542567584415
TCAP,Benign scapuloperoneal muscular dystrophy with early contractures [Emery-Dreifuss],0.7880542567584415
TCAP,Congenital muscular dystrophy with specific morphological abnormalities of the muscle fiber,0.7880542567584415
TCAP,Severe [Duchenne] muscular dystrophy,0.7880542567584415
TCAP,Ocular muscular dystrophy,0.7880542567584415
TCAP,Rimmed vacuoles on biopsy,0.7880542567584415
TCAP,Difficulty running,0.7880542567584415
TCAP,Calf muscle hypertrophy,0.8009048756462318
TCAP,Difficulty walking up stairs,0.8019075543217649
TCAP,Muscular Dystrophy Facioscapulohumeral,0.8019075543217649
TCAP,Congenital muscular dystrophy (disorder),0.8019075543217649
TCAP,X-Linked Emery-Dreifuss Muscular Dystrophy,0.8168901801930506
TCAP,Increased variability in muscle fiber diameter,0.8168901801930506
TCAP,Muscular Dystrophy Oculopharyngeal,0.8402911822757345
TCAP,Becker Muscular Dystrophy,0.8402911822757345
TCAP,Distal Muscular Dystrophies,0.8402911822757345
TCAP,Lower limb muscle weakness,0.843190898187174
TCAP,Difficulty walking,0.8769418330148872
TCAP,Muscle biopsy shows dystrophic changes,0.8774809019744603
TCAP,Cardiomyopathy Hypertrophic Familial,0.8959157818691486
TCAP,Conduction disorder of the heart,0.906476206143938
TCAP,Muscular Dystrophies Limb-Girdle,0.9262273158806068
TCAP,Neuromuscular Diseases,0.9377481698983606
TCAP,Hypertrophic Cardiomyopathy,0.9459312971127588
TCAP,Muscular Dystrophy,0.9540608878641196
TCAP,Myopathy,0.9557184806547836
TCAP,Cardiomyopathies,0.9557184806547836
TCAP,Cardiomyopathy Dilated,0.9564633032157428
TCAP,Charcot-Marie-Tooth Disease,0.963331724428282
TCAP,Elevated creatine kinase,0.97164261098259
TCAP,Creatine phosphokinase serum increased,0.9736199434973628
TCAP,Arthrogryposis,0.9896536639644284
TCAP,Lipoatrophy,0.7765582368651238
TCAP,Lipodystrophy,0.8115918568696846
TCAP,Hearing Loss,0.8115918568696846
TCAP,Distal Lower Limb Amyotrophy,0.8210988731657684
TCAP,Dilated Cardiomyopathy,0.861756360478846
TCAP,Cardiomyopathy,0.9145387439550552
TCAP,Muscular Dystrophy,0.9318760199717074
TCAP,Hypertrophic Cardiomyopathy,0.9726837163662044
TCAP,Palmoplantar Keratoderma,0.9832345076528324
TCAP,Myopathy,0.986561188259959
TCAP,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
TCAP,Glycogen storage disease due to muscle glycogen phosphorylase deficiency ORPHA:368,0.3832844616405875
TCAP,Telethonin-related  limb-girdle muscular dystrophy R7 ORPHA:34514,0.5867963421058087
TCAP,Acetazolamide-responsive myotonia ORPHA:99736,0.7929682744768703
TCAP,Hyperkalemic periodic paralysis ORPHA:682,0.7929682744768703
TCAP,Myotonia fluctuans ORPHA:99734,0.7929682744768703
TCAP,Myotonia permanens ORPHA:99735,0.7929682744768703
TCAP,Paramyotonia congenita of Von Eulenburg ORPHA:684,0.7929682744768703
TCAP,Brody myopathy ORPHA:53347,0.8922466888454011
TCAP,Glycogen storage disease due to muscle beta-enolase deficiency ORPHA:99849,0.8922466888454011
TCAP,Glycogen storage disease due to phosphoglycerate mutase deficiency ORPHA:97234,0.8922466888454011
TCAP,Atrial standstill ORPHA:1344,0.8922466888454011
TCAP,Lafora disease ORPHA:501,0.8922466888454011
TCAP,Fetal akinesia deformation sequence ORPHA:994,0.8922466888454011
TCAP,Familial isolated dilated cardiomyopathy ORPHA:154,0.8922466888454011
TCAP,Congenital myopathy with excess of thin filaments ORPHA:98904,0.8922466888454011
TCAP,Distal myopathy Tateyama type ORPHA:488650,0.8922466888454011
TCAP,Ebstein malformation of the tricuspid valve ORPHA:1880,0.8922466888454011
TCAP,Hyaline body myopathy ORPHA:53698,0.8922466888454011
TCAP,Isolated asymptomatic elevation of creatine phosphokinase ORPHA:206599,0.8922466888454011
TCAP,Klippel-Feil anomaly-myopathy-facial dysmorphism syndrome ORPHA:447974,0.8922466888454011
TCAP,Laing early-onset distal myopathy ORPHA:59135,0.8922466888454011
TCAP,MYH7-related late-onset scapuloperoneal muscular dystrophy ORPHA:437572,0.8922466888454011
TCAP,Progressive scapulohumeroperoneal distal myopathy ORPHA:447977,0.8922466888454011
TCAP,Rippling muscle disease ORPHA:97238,0.8922466888454011
TCAP,Thomsen and Becker disease ORPHA:614,0.8922466888454011
TCAP,Vacuolar myopathy with sarcoplasmic reticulum protein aggregates ORPHA:88635,0.8922466888454011
TCAP,Zebra body myopathy ORPHA:97240,0.8922466888454011
TCAP,Rigid spine syndrome ORPHA:97244,0.8922466888454011
TCAP,Childhood-onset nemaline myopathy ORPHA:171439,0.8922466888454011
TCAP,Intermediate nemaline myopathy ORPHA:171433,0.8922466888454011
TCAP,Sheldon-Hall syndrome ORPHA:1147,0.8922466888454011
TCAP,Congenital fiber-type disproportion myopathy ORPHA:2020,0.8922466888454011
TCAP,Distal arthrogryposis type 1 ORPHA:1146,0.8922466888454011
TCAP,NON RARE IN EUROPE: Familial isolated hypertrophic cardiomyopathy ORPHA:155,0.9075572232275184
TCAP,Cowpox virus CPXV209 protein (gene: CPXV209 CDS),0.8999095837312036
TCAP,Vaccinia virus Ankara Interleukin-1 beta receptor,0.8999095837312036
TCAP,Variola virus hypothetical protein (gene: J9R),0.8999095837312036
TCAP,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
TCAP,Vaccinia virus hemagglutinin (gene: A56R),0.9058994261255549
TCERG1,Huntington Disease,0.7880542567584415
TCERG1,Narcolepsy,0.8067197998685076
TCERG1,Neurodegenerative Disorders,0.8272008757995397
TCERG1,Narcolepsy,0.8260230451542778
TCERG1,Precursor T-cell acute lymphoblastic leukemia ORPHA:99861,0.3832844616405875
TCERG1,Oculofaciocardiodental syndrome ORPHA:2712,0.3832844616405875
TCERG1,Vocal cord and pharyngeal distal myopathy ORPHA:600,0.3832844616405875
TCERG1,Non-specific syndromic intellectual disability ORPHA:528084,0.5867963421058087
TCERG1,1q44 microdeletion syndrome ORPHA:238769,0.5867963421058087
TCERG1,DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect ORPHA:330050,0.5867963421058087
TCERG1,X-linked intellectual disability-short stature-overweight syndrome ORPHA:457240,0.5867963421058087
TCERG1,Acute myeloid leukemia with t(6,0.5867963421058087
TCERG1,9)(p23,0.5867963421058087
TCERG1,q34) ORPHA:402014,0.5867963421058087
TCERG1,Neuroendocrine tumor of stomach ORPHA:100075,0.5867963421058087
TCERG1,Acute myeloblastic leukemia with maturation ORPHA:98834,0.606625035400596
TCERG1,Autosomal recessive chorioretinopathy-microcephaly syndrome ORPHA:2518,0.6467006456772204
TCERG1,Joubert syndrome with ocular defect ORPHA:220493,0.7929682744768703
TCERG1,Coffin-Siris syndrome ORPHA:1465,0.7929682744768703
TCERG1,Differentiated thyroid carcinoma ORPHA:146,0.7929682744768703
TCERG1,16p13.2 microdeletion syndrome ORPHA:500055,0.7929682744768703
TCERG1,Autosomal recessive spastic paraplegia type 71 ORPHA:401840,0.7929682744768703
TCERG1,Microcephalic osteodysplastic primordial dwarfism type II ORPHA:2637,0.7929682744768703
TCERG1,Desmoplastic small round cell tumor ORPHA:83469,0.795266832401002
TCERG1,Familial isolated hyperparathyroidism ORPHA:99879,0.8922466888454011
TCERG1,Autosomal thrombocytopenia with normal platelets ORPHA:168629,0.8922466888454011
TCERG1,NON RARE IN EUROPE: Primary ovarian failure ORPHA:619,0.8922466888454011
TCERG1,ANE syndrome ORPHA:157954,0.8922466888454011
TCERG1,Absence of fingerprints-congenital milia syndrome ORPHA:1658,0.8922466888454011
TCERG1,Acute infantile liver failure-multisystemic involvement syndrome ORPHA:370088,0.8922466888454011
TCERG1,HNRNPDL-related  limb-girdle muscular dystrophy D3 ORPHA:55596,0.8922466888454011
TCERG1,Huriez syndrome ORPHA:384,0.8922466888454011
TCERG1,Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency ORPHA:404440,0.8922466888454011
TCERG1,Isolated congenital adermatoglyphia ORPHA:289465,0.8922466888454011
TCERG1,Werner syndrome ORPHA:902,0.8922466888454011
TCERG1,Woodhouse-Sakati syndrome ORPHA:3464,0.8922466888454011
TCERG1,17q24.2 microdeletion syndrome ORPHA:529962,0.8922466888454011
TCERG1,Nijmegen breakage syndrome-like disorder ORPHA:240760,0.8922466888454011
TCERG1,Proximal spinal muscular atrophy type 1 ORPHA:83330,0.8922466888454011
TCERG1,Proximal spinal muscular atrophy type 2 ORPHA:83418,0.8922466888454011
TCERG1,Proximal spinal muscular atrophy type 3 ORPHA:83419,0.8922466888454011
TCERG1,Cornelia de Lange syndrome ORPHA:199,0.8922466888454011
TCERG1,Extraskeletal myxoid chondrosarcoma ORPHA:209916,0.8922466888454011
TCERG1,Infantile nephronophthisis ORPHA:93591,0.8922466888454011
TCERG1,Hypomyelinating leukodystrophy-ataxia-hypodontia-hypomyelination syndrome ORPHA:137639,0.8922466888454011
TCERG1,Hypomyelination-cerebellar atrophy-hypoplasia of the corpus callosum syndrome ORPHA:447893,0.8922466888454011
TCERG1,Odontoleukodystrophy ORPHA:77295,0.8922466888454011
TCERG1,Rothmund-Thomson syndrome type 1 ORPHA:221008,0.8922466888454011
TCERG1,Tremor-ataxia-central hypomyelination syndrome ORPHA:447896,0.8922466888454011
TCERG1,Wiedemann-Rautenstrauch syndrome ORPHA:3455,0.8922466888454011
TCERG1,Human immunodeficiency virus 2 full_polyprotein 1..1550 (gene: gag-pol),0.8999095837312036
TCERG1,Rio Bravo virus anchored core protein C,0.8999095837312036
TCERG1,Human adenovirus 41 E2A DBP,0.8999095837312036
TCERG1,Rio Bravo virus core protein C,0.8999095837312036
TCERG1,Modoc virus capsid protein,0.8999095837312036
TCERG1,Tai Forest ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
TCERG1,Ectromelia virus ERPV hydroxysteroid dehydrogenase,0.8999095837312036
TCERG1,Reston ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
TCERG1,Bundibugyo ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
TCERG1,Human adenovirus Chiba_E086/2012 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Variola virus hypothetical protein (gene: I1L),0.8999095837312036
TCERG1,Cercopithecine alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.8999095837312036
TCERG1,Human adenovirus 5 DBP,0.8999095837312036
TCERG1,Human adenovirus 66 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 7 DBP,0.8999095837312036
TCERG1,Sagiyama virus full_polyprotein 1..1253 (gene: C-E3-E2-6K-E1),0.8999095837312036
TCERG1,Human mastadenovirus C single-stranded DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human mastadenovirus E single-stranded DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 2 DBP,0.8999095837312036
TCERG1,Human adenovirus 6 DBP 59 kDa protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 7d2 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus E4 E2A DNA binding protein,0.8999095837312036
TCERG1,Human immunodeficiency virus 1 Envelope surface glycoprotein gp160 precursor (gene: env),0.8999095837312036
TCERG1,Human papillomavirus type 72b E1 protein (gene: E1),0.8999095837312036
TCERG1,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.8999095837312036
TCERG1,Human papillomavirus type 150 putative E1 product (gene: E1),0.8999095837312036
TCERG1,Human adenovirus 16 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 23 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 3+7 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 46 DBP,0.8999095837312036
TCERG1,Human adenovirus B3 E2A DNA binding protein DBP (gene: E2A),0.8999095837312036
TCERG1,Cowpox virus CPXV110 protein (gene: CPXV110 CDS),0.8999095837312036
TCERG1,Human adenovirus 58 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Rhinovirus C 3D,0.8999095837312036
TCERG1,Macacine alphaherpesvirus 1 tegument protein VP22 (gene: UL49),0.8999095837312036
TCERG1,Papiine alphaherpesvirus 2 large tegument protein (gene: UL36),0.8999095837312036
TCERG1,Human adenovirus 21 DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 22 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 43 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 50 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 54 DNA binding protein,0.8999095837312036
TCERG1,Human adenovirus 71 ssDNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus D8 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human papillomavirus type 103 E1,0.8999095837312036
TCERG1,Human adenovirus 1 DBP,0.8999095837312036
TCERG1,Human adenovirus 49 DNA Binding Protein,0.8999095837312036
TCERG1,Human adenovirus 21a DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 36 DBP,0.8999095837312036
TCERG1,Human adenovirus 19 DNA binding (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 56 DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 65 E2A DNA binding protein,0.8999095837312036
TCERG1,Human adenovirus D10 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 63 DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 64 E2A DNA binding protein,0.8999095837312036
TCERG1,Human adenovirus 68 DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus D37 DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human mastadenovirus B single-stranded DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 67 E2A DNA binding protein,0.8999095837312036
TCERG1,Human mastadenovirus D single-stranded DNA-binding protein (gene: E2A),0.8999095837312036
TCERG1,Human adenovirus 28 single-stranded DNA binding protein (gene: E2A),0.8999095837312036
TCERG1,Sudan ebolavirus spike glycoprotein (gene: GP),0.8999095837312036
TCERG1,Sudan ebolavirus - Nakisamata structural glycoprotein (gene: GP),0.8999095837312036
TCERG1,Monkeypox virus cowpox A-type inclusion protein,0.8999095837312036
TCERG1,Human enterovirus 79 3D,0.8999095837312036
TCERG1,Human herpesvirus 3 strain Dumas Tegument protein VP22 (gene: ORF9),0.8999095837312036
TCERG1,Human alphaherpesvirus 3 tegument protein VP22 (gene: ORF9),0.8999095837312036
TCERG1,Echovirus E29 3D,0.8999095837312036
TCERG1,Echovirus E16 3D,0.8999095837312036
TCERG1,Coxsackievirus B5 polyprotein region 11 (gene: 1A),0.8999095837312036
TCERG1,Influenza A virus (A/Hong Kong/1073/99(H9N2)) matrix protein 1 (gene: M1),0.8999095837312036
TCERG1,Influenza A virus (A/goose/Guangdong/1/1996(H5N1)) matrix protein 1 (gene: M1),0.8999095837312036
TCERG1,Influenza A virus (A/California/07/2009(H1N1)) matrix protein 1 (gene: M1),0.8999095837312036
TCERG1,Influenza A virus (A/California/04/2009(H1N1)) matrix protein 1 (gene: M1),0.8999095837312036
TCERG1,Human alphaherpesvirus 2 tegument protein VP22 (gene: UL49),0.8999095837312036
TCERG1,Echovirus E32 3D,0.8999095837312036
TCERG1,Human alphaherpesvirus 1 tegument protein VP22 (gene: UL49),0.8999095837312036
TCERG1,Echovirus 9 strain Barty polymerase,0.8999095837312036
TCERG1,Echovirus E6 3D,0.8999095837312036
TCERG1,Echovirus E21 3D,0.9028576823827708
TCFL5,Colon Carcinoma,0.7765852775619541
TCFL5,Adenoma,0.7765852775619541
TCFL5,Liver carcinoma,0.7880542567584415
TCFL5,Multiple malignancy,0.7880542567584415
TCFL5,Glioblastoma,0.7880542567584415
TCFL5,Seminoma,0.7880542567584415
TCFL5,Acute lymphocytic leukemia,0.7880542567584415
TCFL5,Myocardial Infarction,0.8019075543217649
TCFL5,Peritonitis,0.8190761496232595
TCFL5,Cerebrovascular accident,0.8648405521677974
TCFL5,Premature Menopause,0.9707275133033936
TCFL5,Ovarian Failure Premature,0.9816840072553962
TCFL5,Cystic Fibrosis,0.9874278479946328
TCIRG1,Osteopetrosis,0.7765852775619541
TCIRG1,Compression of optic nerve,0.7765852775619541
TCIRG1,Rotting teeth,0.7880542567584415
TCIRG1,Mycoses,0.7880542567584415
TCIRG1,Dental caries,0.7880542567584415
TCIRG1,Frontal bossing,0.7880542567584415
TCIRG1,Pathological fracture,0.7880542567584415
TCIRG1,Pallor,0.7880542567584415
TCIRG1,Lymphadenopathy,0.7880542567584415
TCIRG1,Abnormal visual evoked potential,0.7880542567584415
TCIRG1,Opsoclonus,0.7880542567584415
TCIRG1,Abnormality of hair consistency,0.7880542567584415
TCIRG1,Abnormality of hair curl pattern,0.7880542567584415
TCIRG1,Abnormality of hair texture,0.7880542567584415
TCIRG1,Abnormality of hair volume,0.7880542567584415
TCIRG1,Low Vision,0.7880542567584415
TCIRG1,Osteoporosis with pseudoglioma,0.7880542567584415
TCIRG1,Varying degree of multiple fractures,0.7880542567584415
TCIRG1,Frequent fractures,0.7880542567584415
TCIRG1,Increased fracture rate,0.7880542567584415
TCIRG1,Fractures Multiple,0.7880542567584415
TCIRG1,Facial paralysis,0.7880542567584415
TCIRG1,Bowing of the long bones,0.7880542567584415
TCIRG1,Nystagmus,0.7880542567584415
TCIRG1,Pancytopenia,0.7880542567584415
TCIRG1,Narrow thorax,0.7880542567584415
TCIRG1,Reduced bone mineral density,0.7880542567584415
TCIRG1,Abnormality of temperature regulation,0.7880542567584415
TCIRG1,Alkaline phosphatase raised,0.7880542567584415
TCIRG1,Congenital neutropenia,0.7880542567584415
TCIRG1,Infantile malignant osteopetrosis,0.7880542567584415
TCIRG1,Visual Impairment,0.7880542567584415
TCIRG1,Severe congenital neutropenia,0.7880542567584415
TCIRG1,Increased head circumference,0.7880542567584415
TCIRG1,Body Temperature Changes,0.7880542567584415
TCIRG1,Chronic rhinitis,0.7880542567584415
TCIRG1,Optic Atrophy,0.7880542567584415
TCIRG1,Bone pain,0.7880542567584415
TCIRG1,Precocious exfoliation of primary tooth,0.7880542567584415
TCIRG1,Ophthalmoparesis,0.8009048756462318
TCIRG1,Congenital deafness,0.8019075543217649
TCIRG1,Tetany,0.8019075543217649
TCIRG1,Blindness Legal,0.8019075543217649
TCIRG1,Blindness,0.8098851543361193
TCIRG1,Abnormality of the skull,0.8098851543361193
TCIRG1,Hearing Loss Partial,0.8098851543361193
TCIRG1,Big calvaria,0.8098851543361193
TCIRG1,Increased size of skull,0.8098851543361193
TCIRG1,Flared metaphysis,0.8098851543361193
TCIRG1,Infection of bone,0.8145035474981049
TCIRG1,Deafness,0.8190761496232595
TCIRG1,Tremor,0.8190761496232595
TCIRG1,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
TCIRG1,Late tooth eruption,0.8232134984476662
TCIRG1,Hip joint varus deformity - observation,0.8270909867833504
TCIRG1,hearing impairment,0.834094492023826
TCIRG1,Splenomegaly,0.8402911822757345
TCIRG1,Infection by Cryptococcus neoformans,0.8402911822757345
TCIRG1,Idiopathic pulmonary hypertension,0.8402911822757345
TCIRG1,Otitis Media,0.8402911822757345
TCIRG1,Craniosynostosis,0.8486035047899471
TCIRG1,Bone Diseases,0.8578473133580928
TCIRG1,Abnormality of the ribs,0.8578473133580928
TCIRG1,Anemia,0.8584283190330553
TCIRG1,Growth retardation,0.8610447277138289
TCIRG1,Poor growth,0.8610447277138289
TCIRG1,Growth delay,0.8610447277138289
TCIRG1,Very poor growth,0.8648405521677974
TCIRG1,Abnormality of epiphysis morphology,0.8648405521677974
TCIRG1,Hemoglobin low,0.8648405521677974
TCIRG1,Osteomyelitis,0.8769418330148872
TCIRG1,Skin blisters,0.882453254162044
TCIRG1,Abnormal blistering of the skin,0.882453254162044
TCIRG1,Hydrocephalus,0.8851456306720444
TCIRG1,Skin bullae,0.8851456306720444
TCIRG1,Hepatomegaly,0.887595340546704
TCIRG1,Encephalitis,0.900167961295542
TCIRG1,Growth failure,0.9066109052713736
TCIRG1,Recurrent respiratory infections,0.9083161862856644
TCIRG1,Abnormality of the metaphysis,0.9083161862856644
TCIRG1,Sepsis,0.9189398569397552
TCIRG1,Facial muscle weakness of muscles innervated by CN VII,0.9189398569397552
TCIRG1,Bell Palsy,0.9258401930327972
TCIRG1,Facial Paresis,0.9258401930327972
TCIRG1,Idiopathic pulmonary arterial hypertension,0.9262273158806068
TCIRG1,Seizures,0.9478210444156088
TCIRG1,Congenital clubfoot,0.951016614400691
TCIRG1,Epilepsy,0.963331724428282
TCIRG1,Undergrowth,0.9884235744717738
TCIRG1,Failure to gain weight,0.9896536639644284
TCIRG1,Pediatric failure to thrive,0.9896536639644284
TCIRG1,Osteopetrosis,0.4532988396145482
TCIRG1,Oral Ulcer,0.7765582368651238
TCIRG1,Gingivitis,0.7765582368651238
TCIRG1,Opsoclonus,0.7765582368651238
TCIRG1,Pharyngitis,0.7765582368651238
TCIRG1,Myelodysplastic Syndrome,0.7765582368651238
TCIRG1,Monocytosis,0.7765582368651238
TCIRG1,Pyoderma Gangrenosum,0.7765582368651238
TCIRG1,Osteomyelitis,0.7765582368651238
TCIRG1,Eosinophilia,0.7765582368651238
TCIRG1,Nystagmus,0.7765582368651238
TCIRG1,Lymphopenia,0.7765582368651238
TCIRG1,Cranial Nerve Paralysis,0.7765582368651238
TCIRG1,Macrocephaly,0.7765582368651238
TCIRG1,Leukemia,0.7765582368651238
TCIRG1,Lymphoblastic Leukemia,0.7765582368651238
TCIRG1,Periodontitis,0.7765582368651238
TCIRG1,Congenital Neutropenia,0.8082616889285628
TCIRG1,Osteopenia,0.8115918568696846
TCIRG1,Otitis Media,0.8115918568696846
TCIRG1,Frontal Bossing,0.8115918568696846
TCIRG1,Optic Atrophy,0.8115918568696846
TCIRG1,Aplastic Anemia,0.8115918568696846
TCIRG1,Myelodysplasia,0.8115918568696846
TCIRG1,Craniosynostosis,0.8115918568696846
TCIRG1,Neutropenia,0.8476516371290275
TCIRG1,Aphthous Ulcer,0.861756360478846
TCIRG1,Pancytopenia,0.861756360478846
TCIRG1,Pulmonary Arterial Hypertension,0.8903630091389316
TCIRG1,Rhinitis,0.9046917974656596
TCIRG1,Hemangioma,0.9251646147729308
TCIRG1,Anemia,0.9369188149054885
TCIRG1,Hydrocephalus,0.9574431947800732
TCIRG1,Facial Paralysis,0.9832345076528324
TCIRG1,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
TCIRG1,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
TCIRG1,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
TCIRG1,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
TCIRG1,Incontinentia pigmenti ORPHA:464,0.0414176838632111
TCIRG1,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
TCIRG1,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
TCIRG1,Tumor necrosis factor receptor 1 associated periodic syndrome ORPHA:32960,0.0414176838632111
TCIRG1,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
TCIRG1,Intermediate osteopetrosis ORPHA:210110,0.0414176838632111
TCIRG1,CLN11 disease ORPHA:314629,0.1040670578681756
TCIRG1,Heme oxygenase-1 deficiency ORPHA:562509,0.1040670578681756
TCIRG1,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.1040670578681756
TCIRG1,Congenital chronic diarrhea with protein-losing enteropathy ORPHA:329242,0.1054066549396977
TCIRG1,Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813,0.1054066549396977
TCIRG1,Marinesco-Sjogren syndrome ORPHA:559,0.1054066549396977
TCIRG1,Adrenomyeloneuropathy ORPHA:139399,0.1991445465001551
TCIRG1,Alpha-mannosidosis adult form ORPHA:309288,0.1991445465001551
TCIRG1,Alpha-mannosidosis infantile form ORPHA:309282,0.1991445465001551
TCIRG1,Bacterial susceptibility due to TLR signaling pathway deficiency ORPHA:183713,0.1991445465001551
TCIRG1,Beta-propeller protein-associated neurodegeneration ORPHA:329284,0.1991445465001551
TCIRG1,Camurati-Engelmann disease ORPHA:1328,0.1991445465001551
TCIRG1,Combined oxidative phosphorylation defect type 27 ORPHA:477774,0.1991445465001551
TCIRG1,Deficiency in anterior pituitary function-variable immunodeficiency syndrome ORPHA:293978,0.1991445465001551
TCIRG1,Gamma-glutamyl transpeptidase deficiency ORPHA:33573,0.1991445465001551
TCIRG1,Infantile inflammatory bowel disease with neurological involvement ORPHA:565788,0.1991445465001551
TCIRG1,MYH9-related disease ORPHA:182050,0.1991445465001551
TCIRG1,Mucolipidosis type IV ORPHA:578,0.1991445465001551
TCIRG1,NIK deficiency ORPHA:447731,0.1991445465001551
TCIRG1,Neutral lipid storage myopathy ORPHA:98908,0.1991445465001551
TCIRG1,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.1991445465001551
TCIRG1,Waldenstrom macroglobulinemia ORPHA:33226,0.1991445465001551
TCIRG1,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.1991445465001551
TCIRG1,Stormorken-Sjaastad-Langslet syndrome ORPHA:3204,0.1991445465001551
TCIRG1,Dehydrated hereditary stomatocytosis ORPHA:3202,0.2047219337649946
TCIRG1,Takayasu arteritis ORPHA:3287,0.2047219337649946
TCIRG1,Autosomal recessive malignant osteopetrosis ORPHA:667,0.2120485863056726
TCIRG1,Metachromatic leukodystrophy adult form ORPHA:309271,0.3832844616405875
TCIRG1,Metachromatic leukodystrophy juvenile form ORPHA:309263,0.3832844616405875
TCIRG1,Metachromatic leukodystrophy late infantile form ORPHA:309256,0.3832844616405875
TCIRG1,CLN3 disease ORPHA:228346,0.3832844616405875
TCIRG1,Clear cell renal carcinoma ORPHA:319276,0.3832844616405875
TCIRG1,Combined immunodeficiency-enteropathy spectrum ORPHA:436252,0.3832844616405875
TCIRG1,D-glyceric aciduria ORPHA:941,0.3832844616405875
TCIRG1,Gray platelet syndrome ORPHA:721,0.3832844616405875
TCIRG1,Mucolipidosis type III gamma ORPHA:423470,0.3832844616405875
TCIRG1,Mucopolysaccharidosis type 4A ORPHA:309297,0.3832844616405875
TCIRG1,Multiple intestinal atresia ORPHA:2300,0.3832844616405875
TCIRG1,NON RARE IN EUROPE: Pseudoarylsulfatase A deficiency ORPHA:751,0.3832844616405875
TCIRG1,Palmoplantar keratoderma-esophageal carcinoma syndrome ORPHA:2198,0.3832844616405875
TCIRG1,Ependymoma ORPHA:251636,0.3832844616405875
TCIRG1,RELA fusion-positive ependymoma ORPHA:530792,0.3832844616405875
TCIRG1,Solitary fibrous tumor/hemangiopericytoma ORPHA:2126,0.3832844616405875
TCIRG1,Dysosteosclerosis ORPHA:1782,0.3832844616405875
TCIRG1,Pediatric systemic lupus erythematosus ORPHA:93552,0.3832844616405875
TCIRG1,Autosomal dominant severe congenital neutropenia ORPHA:486,0.3891940933600213
TCIRG1,Epidermodysplasia verruciformis ORPHA:302,0.3891940933600213
TCIRG1,Systemic-onset juvenile idiopathic arthritis ORPHA:85414,0.3891940933600213
TCIRG1,Herpes simplex virus encephalitis ORPHA:1930,0.3977968344535308
TCIRG1,Immunodeficiency by defective expression of MHC class I ORPHA:34592,0.5867963421058087
TCIRG1,Autosomal dominant Kenny-Caffey syndrome ORPHA:93325,0.5867963421058087
TCIRG1,Autosomal recessive spastic paraplegia type 48 ORPHA:306511,0.5867963421058087
TCIRG1,B4GALT1-CDG ORPHA:79332,0.5867963421058087
TCIRG1,Cathepsin A-related arteriopathy-strokes-leukoencephalopathy ORPHA:575553,0.5867963421058087
TCIRG1,Combined immunodeficiency due to ORAI1 deficiency ORPHA:317428,0.5867963421058087
TCIRG1,Congenital isolated ACTH deficiency ORPHA:199296,0.5867963421058087
TCIRG1,Galactosialidosis ORPHA:351,0.5867963421058087
TCIRG1,Genetic hyperferritinemia without iron overload ORPHA:254704,0.5867963421058087
TCIRG1,Growth retardation-mild developmental delay-chronic hepatitis syndrome ORPHA:391366,0.5867963421058087
TCIRG1,Hereditary hyperferritinemia-cataract syndrome ORPHA:163,0.5867963421058087
TCIRG1,Hereditary pediatric Behcet-like disease ORPHA:476102,0.5867963421058087
TCIRG1,Hypocalcemic vitamin D-resistant rickets ORPHA:93160,0.5867963421058087
TCIRG1,Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome ORPHA:529977,0.5867963421058087
TCIRG1,L-ferritin deficiency ORPHA:440731,0.5867963421058087
TCIRG1,Mucopolysaccharidosis type 7 ORPHA:584,0.5867963421058087
TCIRG1,Neuroferritinopathy ORPHA:157846,0.5867963421058087
TCIRG1,Osteocraniostenosis ORPHA:2763,0.5867963421058087
TCIRG1,Polyglucosan body myopathy type 1 ORPHA:397937,0.5867963421058087
TCIRG1,Proteasome-associated autoinflammatory syndrome ORPHA:324977,0.5867963421058087
TCIRG1,Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis ORPHA:329173,0.5867963421058087
TCIRG1,Familial Chilblain lupus ORPHA:481662,0.5867963421058087
TCIRG1,Mitochondrial neurogastrointestinal encephalomyopathy ORPHA:298,0.5867963421058087
TCIRG1,Chronic mucocutaneous candidiasis ORPHA:1334,0.606625035400596
TCIRG1,Birdshot chorioretinopathy ORPHA:179,0.7929682744768703
TCIRG1,CLN2 disease ORPHA:228349,0.7929682744768703
TCIRG1,Childhood-onset autosomal recessive slowly progressive spinocerebellar ataxia ORPHA:284324,0.7929682744768703
TCIRG1,Embryonal rhabdomyosarcoma ORPHA:99757,0.7929682744768703
TCIRG1,Fowler vasculopaty ORPHA:221126,0.7929682744768703
TCIRG1,Overgrowth-macrocephaly-facial dysmorphism syndrome ORPHA:137634,0.7929682744768703
TCIRG1,STING-associated vasculopathy with onset in infancy ORPHA:425120,0.7929682744768703
TCIRG1,Sanfilippo syndrome type A ORPHA:79269,0.7929682744768703
TCIRG1,Transaldolase deficiency ORPHA:101028,0.7929682744768703
TCIRG1,Recurrent infection due to specific granule deficiency ORPHA:169142,0.7929682744768703
TCIRG1,Alpha-N-acetylgalactosaminidase deficiency type 1 ORPHA:79279,0.8922466888454011
TCIRG1,Alpha-N-acetylgalactosaminidase deficiency type 2 ORPHA:79280,0.8922466888454011
TCIRG1,Alpha-N-acetylgalactosaminidase deficiency type 3 ORPHA:79281,0.8922466888454011
TCIRG1,Carnitine palmitoyl transferase 1A deficiency ORPHA:156,0.8922466888454011
TCIRG1,H syndrome ORPHA:168569,0.8922466888454011
TCIRG1,Marfan syndrome type 2 ORPHA:284973,0.8922466888454011
TCIRG1,Martinique crinkled retinal pigment epitheliopathy ORPHA:466718,0.8922466888454011
TCIRG1,Predisposition to invasive fungal disease due to CARD9 deficiency ORPHA:457088,0.8922466888454011
TCIRG1,Monkeypox virus ankyrin-like protein,0.8999095837312036
TESK2,Reticulocyte count (procedure),0.5071083164302358
TESK2,Platelet distribution width measurement,0.7880542567584415
TESK2,Platelet distribution width result,0.7880542567584415
TESK2,Infiltrating duct carcinoma of female breast,0.7880542567584415
TESK2,Platelet Count measurement,0.7880542567584415
TESK2,Platelet mean volume determination (procedure),0.7880542567584415
TESK2,Platelet hematocrit measurement,0.7880542567584415
TESK2,Alcoholic Intoxication Chronic,0.8019075543217649
TESK2,Infiltrating Duct Carcinoma Of Female Breast,0.7765582368651238
TESK2,Chronic Obstructive Pulmonary Disease,0.966063509695942
TESK2,Human betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
TESK2,Vaccinia virus Ankara Serine/threonine-protein kinase 2,0.8999095837312036
TESK2,Horsepox virus HSPV050 (Ser/Thr kinase,0.8999095837312036
TESK2,Provisional),0.8999095837312036
TESK2,Human alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TESK2,Macacine alphaherpesvirus 1 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TESK2,Human gammaherpesvirus 8 ORF72,0.8999095837312036
TESK2,Human alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TESK2,Macacine alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
TESK2,Human alphaherpesvirus 3 tegument serine/threonine protein kinase (gene: ORF47),0.8999095837312036
TESK2,Human betaherpesvirus 6 U69 ganciclovir kinase phosphotransferase (gene: U69),0.8999095837312036
TESK2,Human betaherpesvirus 6A tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
TESK2,Human betaherpesvirus 7 tegument serine/threonine protein kinase (gene: U69),0.8999095837312036
TESK2,Human alphaherpesvirus 3 serine/threonine protein kinase US3 (gene: ORF66),0.8999095837312036
TESK2,Monkeypox virus Zaire-96-I-16 Ser/Thr kinase (gene: C16L),0.8999095837312036
TESK2,Human herpesvirus 3 strain Dumas serine-threonine protein kinase,0.8999095837312036
TESK2,Ectromelia virus ERPV serine/threonine kinase,0.8999095837312036
TESK2,Papiine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TESK2,Cercopithecine alphaherpesvirus 2 serine/threonine protein kinase US3 (gene: US3),0.8999095837312036
TESK2,Papiine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
TESK2,Monkeypox virus Zaire-96-I-16 B3R (gene: B3R),0.8999095837312036
TESK2,Human alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
TESK2,Cercopithecine alphaherpesvirus 2 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
TESK2,Human alphaherpesvirus 1 tegument serine/threonine protein kinase (gene: UL13),0.8999095837312036
TESK2,Human gammaherpesvirus 8 ORF36 (gene: ORF36),0.8999095837312036
TESK2,Vaccinia virus Ser/Thr kinase (gene: F10L),0.8999095837312036
TESK2,Human betaherpesvirus 6B Phosphotransferase (gene: U69),0.8999095837312036
TESK2,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
TESK2,Monkeypox virus ser/thr kinase,0.8999095837312036
TESK2,Variola virus Ser/Thr kinase (gene: C14L),0.8999095837312036
TESK2,Cercopithecine betaherpesvirus 5 tegument serine/threonine protein kinase (gene: UL97),0.8999095837312036
TESK2,Human gammaherpesvirus 4 BGLF4 protein (gene: BGLF4),0.8999095837312036
TESK2,Human herpesvirus 4 type 2 BGLF4,0.8999095837312036
TESK2,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
TESK2,Molluscum contagiosum virus subtype 1 MC017L (gene: MC017L),0.8999095837312036
TESK2,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
TESK2,Horsepox virus HSPV011a,0.8999095837312036
TLCD1,Currarino syndrome ORPHA:1552,0.0155394890951578
TLCD1,Citrullinemia type II ORPHA:247585,0.0414176838632111
TLCD1,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
TLCD1,Autosomal recessive cutis laxa type 2B ORPHA:357064,0.1991445465001551
TLCD1,PYCR1-related De Barsy syndrome ORPHA:293633,0.1991445465001551
TLCD1,Congenital hereditary endothelial dystrophy type II ORPHA:293603,0.5867963421058087
TLCD1,Corneal dystrophy-perceptive deafness syndrome ORPHA:1490,0.5867963421058087
TLCD1,Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594,0.5867963421058087
TLCD1,Familial atypical multiple mole melanoma syndrome ORPHA:404560,0.5867963421058087
TLCD1,Melanoma and neural system tumor syndrome ORPHA:252206,0.5867963421058087
TLCD1,Xanthinuria type II ORPHA:93602,0.5867963421058087
TLCD1,Familial clubfoot due to 5q31 microdeletion ORPHA:293144,0.7929682744768703
TLCD1,Familial clubfoot due to PITX1 point mutation ORPHA:293150,0.7929682744768703
TLCD1,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ORPHA:478049,0.7929682744768703
TLCD1,Leydig cell hypoplasia due to LHB deficiency ORPHA:325448,0.7929682744768703
TLCD1,Mirror-image polydactyly ORPHA:498494,0.7929682744768703
TLCD1,Brachydactyly-elbow wrist dysplasia syndrome ORPHA:1275,0.7929682744768703
TLCD1,3-methylcrotonyl-CoA carboxylase deficiency ORPHA:6,0.8922466888454011
TLCD1,Branchio-oculo-facial syndrome ORPHA:1297,0.8922466888454011
TLCD1,Congenital cataract-severe neonatal hepatopathy-global developmental delay syndrome ORPHA:521432,0.8922466888454011
TLCD1,DK1-CDG ORPHA:91131,0.8922466888454011
TLCD1,Erythrocyte galactose epimerase deficiency ORPHA:308473,0.8922466888454011
TLCD1,Generalized galactose epimerase deficiency ORPHA:308487,0.8922466888454011
TLCD1,Neurological conditions associated with aminoacylase 1 deficiency ORPHA:137754,0.8922466888454011
TLCD1,PMM2-CDG ORPHA:79318,0.8922466888454011
TLCD1,SRD5A3-CDG ORPHA:324737,0.8922466888454011
TLCD1,Vitamin B12-responsive methylmalonic acidemia type cblB ORPHA:79311,0.8922466888454011
TLCD1,Congenital myasthenic syndromes with glycosylation defect ORPHA:353327,0.8922466888454011
TMCC2,Reticulocyte count (procedure),0.5071083164302358
TMCC2,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
TMCC2,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
TMCC2,Platelet distribution width measurement,0.7880542567584415
TMCC2,Platelet distribution width result,0.7880542567584415
TMCC2,Platelet Count measurement,0.7880542567584415
TMCC2,Mean corpuscular hemoglobin concentration determination,0.7880542567584415
TMCC2,Platelet mean volume determination (procedure),0.7880542567584415
TMCC2,Mean Corpuscular Volume (result),0.7880542567584415
TMCC2,Autosomal dominant spastic paraplegia type 12 ORPHA:100993,0.0144185025972157
TMCC2,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
TMCC2,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
TMCC2,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
TMCC2,8p11.2 deletion syndrome ORPHA:251066,0.3832844616405875
TMCC2,Distal 22q11.2 microdeletion syndrome ORPHA:261330,0.3832844616405875
TMCC2,Polymicrogyria with optic nerve hypoplasia ORPHA:250972,0.3832844616405875
TMCC2,CLCN4-related X-linked intellectual disability syndrome ORPHA:485350,0.5867963421058087
TMCC2,NON RARE IN EUROPE: Vitiligo ORPHA:3435,0.5867963421058087
TMCC2,Young-onset Parkinson disease ORPHA:2828,0.8668760866668862
TMED1,Malignant neoplasm of breast,0.4084380369379369
TMED1,Malignant neoplasm of lung,0.7880542567584415
TMED1,Mycoses,0.7880542567584415
TMED1,Primary malignant neoplasm of lung,0.7880542567584415
TMED1,Carcinoma of lung,0.7880542567584415
TMED1,Adenocarcinoma of pancreas,0.7880542567584415
TMED1,Pancreatitis Chronic,0.7880542567584415
TMED1,Coronary Arteriosclerosis,0.7880542567584415
TMED1,Arteriosclerosis,0.7880542567584415
TMED1,Atherosclerosis,0.7880542567584415
TMED1,Autoimmune Diseases,0.7880542567584415
TMED1,Cardiovascular Diseases,0.7880542567584415
TMED1,Crohn Disease,0.7880542567584415
TMED1,HIV Infections,0.8145035474981049
TMED1,Osteopenia,0.8212681436603975
TMED1,Coronary Artery Disease,0.887595340546704
TMED1,Coronary heart disease,0.9119978323790848
TMED1,Carcinoma Lewis Lung,0.9432051631882106
TMED1,Asthma,0.9672478180546946
TMED1,Breast Cancer,0.8903630091389316
TMED1,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
TMED1,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.1040670578681756
TMED1,CADDS ORPHA:369942,0.1991445465001551
TMED1,Congenital adrenal hyperplasia due to cytochrome P450 oxidoreductase deficiency ORPHA:95699,0.3832844616405875
TMED1,Galactokinase deficiency ORPHA:79237,0.3832844616405875
TMED1,Rare isolated myopia ORPHA:98619,0.3832844616405875
TMED1,Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964,0.5867963421058087
TMED1,Familial hypocalciuric hypercalcemia type 3 ORPHA:101050,0.5867963421058087
TMED1,Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927,0.5867963421058087
TMED1,Hyperbiliverdinemia ORPHA:276405,0.5867963421058087
TMED1,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome ORPHA:529665,0.5867963421058087
TMED1,Sanfilippo syndrome type B ORPHA:79270,0.5867963421058087
TMED1,THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome ORPHA:363444,0.5867963421058087
TMED1,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency ORPHA:308410,0.7929682744768703
TMED1,Biotinidase deficiency ORPHA:79241,0.7929682744768703
TMED1,Glycogen storage disease due to aldolase A deficiency ORPHA:57,0.7929682744768703
TMED1,Infantile nephropathic cystinosis ORPHA:411629,0.7929682744768703
TMED1,Juvenile nephropathic cystinosis ORPHA:411634,0.7929682744768703
TMED1,MPDU1-CDG ORPHA:79323,0.7929682744768703
TMED1,Ocular cystinosis ORPHA:411641,0.7929682744768703
TMED1,Pontocerebellar hypoplasia type 8 ORPHA:324569,0.7929682744768703
TMED1,Prolidase deficiency ORPHA:742,0.7929682744768703
TMED1,Spondylometaphyseal dysplasia Sedaghatian type ORPHA:93317,0.7929682744768703
TMED1,Hepatoerythropoietic porphyria ORPHA:95159,0.8922466888454011
TMED1,Intellectual disability-seizures-hypophosphatasia-ophthalmic-skeletal anomalies syndrome ORPHA:369837,0.8922466888454011
TMED1,Severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome ORPHA:369939,0.8922466888454011
TMEM129,Carcinoma of bladder,0.4084380369379369
TMEM129,Bladder Neoplasm,0.4084380369379369
TMEM129,Malignant neoplasm of urinary bladder,0.5071083164302358
TMEM129,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
TMEM129,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
TMEM129,Short chain acyl-CoA dehydrogenase deficiency ORPHA:26792,0.1040670578681756
TMEM129,D-2-hydroxyglutaric aciduria ORPHA:79315,0.1054066549396977
TMEM129,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433,0.1991445465001551
TMEM129,Classic Hodgkin lymphoma nodular sclerosis type ORPHA:98843,0.1991445465001551
TMEM129,NAD(P)HX dehydratase deficiency ORPHA:555402,0.1991445465001551
TMEM129,Very long chain acyl-CoA dehydrogenase deficiency ORPHA:26793,0.1991445465001551
TMEM129,Spondylo-ocular syndrome ORPHA:85194,0.3832844616405875
TMEM129,Autosomal dominant Charcot-Marie-Tooth disease type 2V ORPHA:447964,0.5867963421058087
TMEM129,Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815,0.5867963421058087
TMEM129,Autosomal recessive cerebellar ataxia due to STUB1 deficiency ORPHA:412057,0.5867963421058087
TMEM129,Neurodevelopmental delay-seizures-ophthalmic anomalies-osteopenia-cerebellar atrophy syndrome ORPHA:529665,0.5867963421058087
TMEM129,Sanfilippo syndrome type B ORPHA:79270,0.5867963421058087
TMEM129,Isovaleric acidemia ORPHA:33,0.8922466888454011
TMEM169,Early-onset parkinsonism-intellectual disability syndrome ORPHA:2379,0.3832844616405875
TMEM169,Progressive myoclonic epilepsy type 3 ORPHA:263516,0.3832844616405875
TMEM169,Idiopathic central precocious puberty ORPHA:169615,0.5867963421058087
TMEM170B,Distal monosomy 1q ORPHA:36367,0.1040670578681756
TMEM170B,Polyendocrine-polyneuropathy syndrome ORPHA:453533,0.5867963421058087
TMEM170B,Angiocentric glioma ORPHA:251671,0.5867963421058087
TMEM170B,Complex lethal osteochondrodysplasia ORPHA:457378,0.7929682744768703
TMEM170B,Fried syndrome ORPHA:85335,0.8922466888454011
TMEM170B,X-linked intellectual disability-Dandy-Walker malformation-basal ganglia disease-seizures syndrome ORPHA:1568,0.8922466888454011
TMEM170B,X-linked intellectual disability-hypotonia-facial dysmorphism-aggressive behavior syndrome ORPHA:85329,0.8922466888454011
TMEM170B,Bilateral parasagittal parieto-occipital polymicrogyria ORPHA:208441,0.8922466888454011
TMEM170B,Charcot-Marie-Tooth disease type 4J ORPHA:139515,0.8922466888454011
TMEM45B,Carcinogenesis,0.7333611688795861
TMEM45B,Malignant neoplasm of lung,0.7880542567584415
TMEM45B,Osteosarcoma,0.7880542567584415
TMEM45B,Osteosarcoma of bone,0.7880542567584415
TMEM45B,Primary malignant neoplasm of lung,0.7880542567584415
TMEM45B,Carcinoma of lung,0.7880542567584415
TMEM45B,Neoplasms,0.7880542567584415
TMEM45B,Childhood Osteosarcoma,0.8019075543217649
TMEM45B,Alkaptonuria ORPHA:56,0.1991445465001551
TMEM45B,Autosomal recessive cerebral atrophy ORPHA:363969,0.1991445465001551
TMEM45B,Familial expansile osteolysis ORPHA:85195,0.1991445465001551
TMEM45B,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1991445465001551
TMEM45B,Familial hyperprolactinemia ORPHA:397685,0.3832844616405875
TMEM45B,Fructose-16-bisphosphatase deficiency ORPHA:348,0.3832844616405875
TMEM45B,NON RARE IN EUROPE: Recurrent acute pancreatitis ORPHA:64740,0.5867963421058087
TMEM45B,Familial thyroid dyshormonogenesis ORPHA:95716,0.5959529547720634
TMEM45B,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to complete RORgamma receptor deficiency ORPHA:477857,0.7929682744768703
TMEM45B,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity ORPHA:314373,0.7929682744768703
TMEM45B,Cranio-osteoarthropathy ORPHA:1525,0.7929682744768703
TMEM45B,Glucose-galactose malabsorption ORPHA:35710,0.7929682744768703
TMEM45B,Ichthyosis-hypotrichosis syndrome ORPHA:91132,0.7929682744768703
TMEM45B,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency ORPHA:314376,0.7929682744768703
TMEM45B,Isolated congenital digital clubbing ORPHA:217059,0.7929682744768703
TMEM45B,Serrated polyposis syndrome ORPHA:157798,0.7929682744768703
TMEM45B,Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971,0.8922466888454011
TMEM45B,Familial hyperphosphatemic tumoral calcinosis/Hyperphosphatemic hyperostosis syndrome ORPHA:306661,0.8922466888454011
TMEM45B,Autosomal dominant hypohidrotic ectodermal dysplasia ORPHA:1810,0.8922466888454011
TNFRSF10B,Malignant neoplasm of breast,0.4084380369379369
TNFRSF10B,Carcinoma of bladder,0.4084380369379369
TNFRSF10B,Bladder Neoplasm,0.4084380369379369
TNFRSF10B,Malignant neoplasm of urinary bladder,0.5071083164302358
TNFRSF10B,Adenomatous Polyposis Coli,0.5196624042573144
TNFRSF10B,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
TNFRSF10B,Breast Carcinoma,0.7333611688795861
TNFRSF10B,Diffuse Large B-Cell Lymphoma,0.7333611688795861
TNFRSF10B,Carcinogenesis,0.7333611688795861
TNFRSF10B,Malignant neoplasm of ovary,0.7333611688795861
TNFRSF10B,B-Cell Lymphomas,0.7333611688795861
TNFRSF10B,leukemia,0.7333611688795861
TNFRSF10B,Ovarian Carcinoma,0.7333611688795861
TNFRSF10B,Adenocarcinoma,0.750391252594775
TNFRSF10B,Malignant neoplasm of pancreas,0.7688485284765829
TNFRSF10B,Colorectal Carcinoma,0.7765852775619541
TNFRSF10B,Pancreatic carcinoma,0.7765852775619541
TNFRSF10B,Laryngeal Squamous Cell Carcinoma,0.7765852775619541
TNFRSF10B,Colon Carcinoma,0.7765852775619541
TNFRSF10B,Leukemia Myelocytic Acute,0.7765852775619541
TNFRSF10B,Malignant tumor of colon,0.7765852775619541
TNFRSF10B,Esophageal carcinoma,0.7765852775619541
TNFRSF10B,Lymphoma,0.7765852775619541
TNFRSF10B,Cervix carcinoma,0.7765852775619541
TNFRSF10B,Non-Small Cell Lung Carcinoma,0.7765852775619541
TNFRSF10B,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
TNFRSF10B,Pancreatic Ductal Adenocarcinoma,0.7765852775619541
TNFRSF10B,Colorectal Neoplasms,0.7765852775619541
TNFRSF10B,Pancreatic Neoplasm,0.7765852775619541
TNFRSF10B,Cholestatic liver disease,0.7765852775619541
TNFRSF10B,Esophageal Neoplasms,0.7765852775619541
TNFRSF10B,Malignant tumor of cervix,0.7768809924982332
TNFRSF10B,Mammary Neoplasms,0.7880542567584415
TNFRSF10B,Glioma,0.7880542567584415
TNFRSF10B,Malignant neoplasm of lung,0.7880542567584415
TNFRSF10B,Malignant neoplasm of prostate,0.7880542567584415
TNFRSF10B,Lymphoma Non-Hodgkin,0.7880542567584415
TNFRSF10B,Liver carcinoma,0.7880542567584415
TNFRSF10B,Malignant neoplasm of esophagus,0.7880542567584415
TNFRSF10B,Malignant Head and Neck Neoplasm,0.7880542567584415
TNFRSF10B,Osteosarcoma,0.7880542567584415
TNFRSF10B,Colorectal Cancer,0.7880542567584415
TNFRSF10B,Epithelial ovarian cancer,0.7880542567584415
TNFRSF10B,Rhabdomyosarcoma,0.7880542567584415
TNFRSF10B,Glioblastoma,0.7880542567584415
TNFRSF10B,Osteosarcoma of bone,0.7880542567584415
TNFRSF10B,Prostate carcinoma,0.7880542567584415
TNFRSF10B,Primary malignant neoplasm of lung,0.7880542567584415
TNFRSF10B,cervical cancer,0.7880542567584415
TNFRSF10B,Neoplasm Metastasis,0.7880542567584415
TNFRSF10B,Epithelioma,0.7880542567584415
TNFRSF10B,Malignant neoplasm of testis,0.7880542567584415
TNFRSF10B,Carcinoma of lung,0.7880542567584415
TNFRSF10B,Squamous cell carcinoma of the head and neck,0.7880542567584415
TNFRSF10B,Triple Negative Breast Neoplasms,0.7880542567584415
TNFRSF10B,Mesothelioma,0.7880542567584415
TNFRSF10B,Hematologic Neoplasms,0.7880542567584415
TNFRSF10B,melanoma,0.7880542567584415
TNFRSF10B,Ewings sarcoma,0.7880542567584415
TNFRSF10B,Multiple Myeloma,0.7880542567584415
TNFRSF10B,Lung Neoplasms,0.7880542567584415
TNFRSF10B,Adenovirus Infections,0.7880542567584415
TNFRSF10B,Neoplasms,0.7880542567584415
TNFRSF10B,Squamous cell carcinoma of mouth,0.7880542567584415
TNFRSF10B,Malignant neoplasm of stomach,0.7880542567584415
TNFRSF10B,Transitional cell carcinoma of bladder,0.7880542567584415
TNFRSF10B,Brain Neoplasms,0.7880542567584415
TNFRSF10B,Squamous cell carcinoma of lip,0.7880542567584415
TNFRSF10B,Pancreatitis Chronic,0.7880542567584415
TNFRSF10B,Malignant Testicular Germ Cell Tumor,0.7880542567584415
TNFRSF10B,Sarcoma,0.7880542567584415
TNFRSF10B,Lupus Erythematosus Systemic,0.7880542567584415
TNFRSF10B,Renal Cell Carcinoma,0.7880542567584415
TNFRSF10B,Primary Effusion Lymphoma,0.7880542567584415
TNFRSF10B,Stomach Carcinoma,0.7880542567584415
TNFRSF10B,Squamous cell carcinoma,0.7880542567584415
TNFRSF10B,Solid Neoplasm,0.7880542567584415
TNFRSF10B,Rheumatoid Arthritis,0.7880542567584415
TNFRSF10B,Adenoma of large intestine,0.7880542567584415
TNFRSF10B,Small cell carcinoma of lung,0.7880542567584415
TNFRSF10B,Virus Diseases,0.7880542567584415
TNFRSF10B,Secondary malignant neoplasm of liver,0.7908231553833205
TNFRSF10B,Multiple Sclerosis,0.8019075543217649
TNFRSF10B,Psoriasis,0.8019075543217649
TNFRSF10B,Chronic Lymphocytic Leukemia,0.8019075543217649
TNFRSF10B,Embryonal Carcinoma,0.8019075543217649
TNFRSF10B,Liver neoplasms,0.8019075543217649
TNFRSF10B,Nonalcoholic Steatohepatitis,0.8067197998685076
TNFRSF10B,Precursor T-Cell Lymphoblastic Leukemia-Lymphoma,0.8138488881521341
TNFRSF10B,Early-Stage Breast Carcinoma,0.8168901801930506
TNFRSF10B,Dengue Fever,0.8190761496232595
TNFRSF10B,Squamous cell carcinoma of the hypopharynx,0.8190761496232595
TNFRSF10B,Colonic Neoplasms,0.8212681436603975
TNFRSF10B,Infection,0.8272008757995397
TNFRSF10B,Glioblastoma Multiforme,0.8342163953428735
TNFRSF10B,Amyotrophic Lateral Sclerosis,0.8402911822757345
TNFRSF10B,Patent ductus arteriosus,0.8402911822757345
TNFRSF10B,Malignant Squamous Cell Neoplasm,0.8402911822757345
TNFRSF10B,Sezary Syndrome,0.8402911822757345
TNFRSF10B,Colorectal cancer metastatic,0.8402911822757345
TNFRSF10B,Liver Neoplasms Experimental,0.8648405521677974
TNFRSF10B,Experimental Hepatoma,0.8648405521677974
TNFRSF10B,Hepatoma Novikoff,0.8648405521677974
TNFRSF10B,Hepatoma Morris,0.8711129600224142
TNFRSF10B,Hepatitis Chronic,0.8769418330148872
TNFRSF10B,tumor vasculature,0.8806784681730055
TNFRSF10B,Squamous cell carcinoma of oropharynx,0.887595340546704
TNFRSF10B,Secondary malignant neoplasm of lymph node,0.900167961295542
TNFRSF10B,Anoxia,0.9184153253162451
TNFRSF10B,Carcinoma Of The Head And Neck,0.4532988396145482
TNFRSF10B,Oropharyngeal Carcinoma,0.6734982286750932
TNFRSF10B,Oral Cavity Carcinoma,0.7765582368651238
TNFRSF10B,Pancreatic Neoplasm,0.861756360478846
TNFRSF10B,Pancreatic Cancer,0.8903301324869451
TNFRSF10B,Carcinoma,0.9069867032339078
TNFRSF10B,Musculocontractural Ehlers-Danlos syndrome ORPHA:2953,0.1991445465001551
TNFRSF10B,Squamous cell carcinoma of salivary glands ORPHA:500481,0.3832844616405875
TNFRSF10B,Squamous cell carcinoma of the hypopharynx ORPHA:494547,0.3832844616405875
TNFRSF10B,Squamous cell carcinoma of the larynx ORPHA:494550,0.3832844616405875
TNFRSF10B,Squamous cell carcinoma of the lip ORPHA:502366,0.3832844616405875
TNFRSF10B,Squamous cell carcinoma of the nasal cavity and paranasal sinuses ORPHA:500464,0.3832844616405875
TNFRSF10B,Squamous cell carcinoma of the oral cavity ORPHA:502363,0.3832844616405875
TNFRSF10B,Squamous cell carcinoma of the oropharynx ORPHA:500478,0.3832844616405875
TNFRSF10B,Bilateral microtia-deafness-cleft palate syndrome ORPHA:140963,0.8922466888454011
TNFRSF10B,Microtia ORPHA:83463,0.8922466888454011
TNFRSF10B,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
TNFRSF10B,Human adenovirus 52 E3 CR1-beta1 (gene: E3),0.8999095837312036
TNFRSF10B,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
TNFRSF10B,Human betaherpesvirus 5 membrane glycoprotein UL141 (gene: UL141),0.8999095837312036
TNFRSF10B,Cercopithecine betaherpesvirus 5 membrane glycoprotein UL141 (gene: UL141),0.8999095837312036
TNFRSF10B,Monkeypox virus bifunctional hemagglutinin/type-I membrane glycoprotein,0.8999095837312036
TNFRSF10B,Monkeypox virus Zaire-96-I-16 B2R (gene: B2R),0.8999095837312036
TNFRSF10B,Variola virus hypothetical protein (gene: J9R),0.8999095837312036
TNFRSF10B,Human mastadenovirus A E3 CR1-beta1,0.8999095837312036
TNFRSF10B,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
TNFRSF10B,Human adenovirus 61 E3 CR1 beta,0.9057542447893764
TNFRSF10B,Human mastadenovirus F membrane glycoprotein E3 CR1-beta (gene: E3A),0.9057542447893764
TNFRSF10B,Vaccinia virus hemagglutinin (gene: A56R),0.9058994261255549
TNFRSF10B,Human adenovirus 41 E3 31.6K,0.915880438522078
TNFRSF10B,Human adenovirus 18 CR1-beta protein (gene: E3),0.9197295331382644
TNFRSF10B,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9237501457186692
TNFRSF10B,Vaccinia virus Ankara Haemagglutinin,0.9287050575620676
TNFRSF11A,Malignant neoplasm of breast,0.4084380369379369
TNFRSF11A,Breast Carcinoma,0.7333611688795861
TNFRSF11A,Carcinogenesis,0.7333611688795861
TNFRSF11A,leukemia,0.7333611688795861
TNFRSF11A,Osteopetrosis,0.7765852775619541
TNFRSF11A,Compression of optic nerve,0.7765852775619541
TNFRSF11A,Leukemia Myelocytic Acute,0.7765852775619541
TNFRSF11A,Retinal pigment epithelial abnormality,0.7765852775619541
TNFRSF11A,Abnormality of retinal pigmentation,0.7765852775619541
TNFRSF11A,Esophageal carcinoma,0.7765852775619541
TNFRSF11A,Progressive visual loss,0.7765852775619541
TNFRSF11A,Non-Small Cell Lung Carcinoma,0.7765852775619541
TNFRSF11A,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
TNFRSF11A,Decreased visual acuity progressive,0.7765852775619541
TNFRSF11A,Tooth problem,0.7765852775619541
TNFRSF11A,Endometrial Carcinoma,0.7765852775619541
TNFRSF11A,Esophageal Neoplasms,0.7765852775619541
TNFRSF11A,Mammary Neoplasms,0.7880542567584415
TNFRSF11A,Glioma,0.7880542567584415
TNFRSF11A,Abnormality of the dentition,0.7880542567584415
TNFRSF11A,Malignant neoplasm of lung,0.7880542567584415
TNFRSF11A,Malignant neoplasm of prostate,0.7880542567584415
TNFRSF11A,Refractory anemias,0.7880542567584415
TNFRSF11A,Liver carcinoma,0.7880542567584415
TNFRSF11A,Invasive carcinoma of breast,0.7880542567584415
TNFRSF11A,Malignant neoplasm of esophagus,0.7880542567584415
TNFRSF11A,Osteosarcoma,0.7880542567584415
TNFRSF11A,Spondylarthritis,0.7880542567584415
TNFRSF11A,Early tooth exfoliation,0.7880542567584415
TNFRSF11A,Premature tooth loss,0.7880542567584415
TNFRSF11A,Glioblastoma,0.7880542567584415
TNFRSF11A,Osteosarcoma of bone,0.7880542567584415
TNFRSF11A,Prostate carcinoma,0.7880542567584415
TNFRSF11A,Astrocytoma,0.7880542567584415
TNFRSF11A,Primary malignant neoplasm of lung,0.7880542567584415
TNFRSF11A,Neoplasm Metastasis,0.7880542567584415
TNFRSF11A,Prostatic Neoplasms,0.7880542567584415
TNFRSF11A,Carcinoma of lung,0.7880542567584415
TNFRSF11A,melanoma,0.7880542567584415
TNFRSF11A,Pathological fracture,0.7880542567584415
TNFRSF11A,Multiple Myeloma,0.7880542567584415
TNFRSF11A,Metastatic Prostate Carcinoma,0.7880542567584415
TNFRSF11A,Renal glomerular disease,0.7880542567584415
TNFRSF11A,Hyperphosphatasemia with bone disease,0.7880542567584415
TNFRSF11A,Abnormal trabecular bone morphology,0.7880542567584415
TNFRSF11A,Neoplasm of skeletal system,0.7880542567584415
TNFRSF11A,Increase in blood pressure,0.7880542567584415
TNFRSF11A,Giant Cell Tumor of Bone,0.7880542567584415
TNFRSF11A,Conductive hearing loss,0.7880542567584415
TNFRSF11A,Tumor Progression,0.7880542567584415
TNFRSF11A,Thick skull bones,0.7880542567584415
TNFRSF11A,Cranial hyperostosis,0.7880542567584415
TNFRSF11A,Enlargement of skull bones,0.7880542567584415
TNFRSF11A,Excessive growth of skull bones,0.7880542567584415
TNFRSF11A,Hypertrophy of cranial bones,0.7880542567584415
TNFRSF11A,Sarcoma,0.7880542567584415
TNFRSF11A,Paget Disease,0.7880542567584415
TNFRSF11A,Varying degree of multiple fractures,0.7880542567584415
TNFRSF11A,Frequent fractures,0.7880542567584415
TNFRSF11A,Increased fracture rate,0.7880542567584415
TNFRSF11A,Fractures Multiple,0.7880542567584415
TNFRSF11A,Recurrent pulmonary infections,0.7880542567584415
TNFRSF11A,Multiple pulmonary infections,0.7880542567584415
TNFRSF11A,Hydroxyprolinuria,0.7880542567584415
TNFRSF11A,Coronary Arteriosclerosis,0.7880542567584415
TNFRSF11A,Arteriosclerosis,0.7880542567584415
TNFRSF11A,Atherosclerosis,0.7880542567584415
TNFRSF11A,Periodontitis,0.7880542567584415
TNFRSF11A,Recurrent pneumonia,0.7880542567584415
TNFRSF11A,Bowing of the long bones,0.7880542567584415
TNFRSF11A,Hemophilia B,0.7880542567584415
TNFRSF11A,Secondary Sj??gren's syndrome,0.7880542567584415
TNFRSF11A,Hereditary Autoinflammatory Diseases,0.7880542567584415
TNFRSF11A,Nystagmus,0.7880542567584415
TNFRSF11A,Chondrosarcoma,0.7880542567584415
TNFRSF11A,Osteitis Deformans,0.7880542567584415
TNFRSF11A,Cognitive delay,0.7880542567584415
TNFRSF11A,Autoimmune Diseases,0.7880542567584415
TNFRSF11A,Alkaline phosphatase raised,0.7880542567584415
TNFRSF11A,Acute myocardial infarction,0.7880542567584415
TNFRSF11A,Cardiovascular Diseases,0.7880542567584415
TNFRSF11A,Thin bony cortex,0.7880542567584415
TNFRSF11A,Squamous cell carcinoma,0.7880542567584415
TNFRSF11A,Solid Neoplasm,0.7880542567584415
TNFRSF11A,Rheumatoid Arthritis,0.7880542567584415
TNFRSF11A,Increased head circumference,0.7880542567584415
TNFRSF11A,PACHYONYCHIA CONGENITA 3,0.7880542567584415
TNFRSF11A,Global developmental delay,0.7880542567584415
TNFRSF11A,Optic Atrophy,0.7880542567584415
TNFRSF11A,Mental and motor retardation,0.7880542567584415
TNFRSF11A,Osteoporosis Postmenopausal,0.7880542567584415
TNFRSF11A,Bone pain,0.7880542567584415
TNFRSF11A,Rough bone trabeculation,0.7908231553833205
TNFRSF11A,Juvenile arthritis,0.8009048756462318
TNFRSF11A,Chronic multifocal osteomyelitis,0.8009048756462318
TNFRSF11A,Congenital deafness,0.8019075543217649
TNFRSF11A,Vitiligo,0.8019075543217649
TNFRSF11A,Chronic Lymphocytic Leukemia,0.8019075543217649
TNFRSF11A,Infectious disease of lung,0.8019075543217649
TNFRSF11A,Degenerative polyarthritis,0.8019075543217649
TNFRSF11A,Temporomandibular Joint Disorders,0.8019075543217649
TNFRSF11A,Abnormality of the clavicle,0.8019075543217649
TNFRSF11A,Acute Coronary Syndrome,0.8037546774788534
TNFRSF11A,Angina Unstable,0.8067197998685076
TNFRSF11A,Hearing Loss Partial,0.8098851543361193
TNFRSF11A,Big calvaria,0.8098851543361193
TNFRSF11A,Increased size of skull,0.8098851543361193
TNFRSF11A,Breast adenocarcinoma,0.8138488881521341
TNFRSF11A,Agammaglobulinemia,0.8138488881521341
TNFRSF11A,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
TNFRSF11A,Autoinflammatory disorder,0.8145035474981049
TNFRSF11A,Stable angina,0.8168901801930506
TNFRSF11A,Congenital pectus carinatum,0.8168901801930506
TNFRSF11A,Congenital malformation syndrome,0.8168901801930506
TNFRSF11A,aggressive cancer,0.8168901801930506
TNFRSF11A,Ulcerative Colitis,0.8190761496232595
TNFRSF11A,Myocarditis,0.8190761496232595
TNFRSF11A,Deafness,0.8190761496232595
TNFRSF11A,Gastrointestinal Carcinoid Tumor,0.8190761496232595
TNFRSF11A,Mammary Tumorigenesis,0.8190761496232595
TNFRSF11A,Arthralgia,0.8190761496232595
TNFRSF11A,Osteopenia,0.8212681436603975
TNFRSF11A,Juvenile rheumatoid arthritis,0.8212681436603975
TNFRSF11A,Secondary malignant neoplasm of lung,0.8232134984476662
TNFRSF11A,bone destruction,0.8232134984476662
TNFRSF11A,Hypersensitivity,0.8232134984476662
TNFRSF11A,Hypogammaglobulinemia,0.8232134984476662
TNFRSF11A,Pneumonia,0.834094492023826
TNFRSF11A,hearing impairment,0.834094492023826
TNFRSF11A,Lytic lesion,0.8402911822757345
TNFRSF11A,Left Ventricular Hypertrophy,0.8402911822757345
TNFRSF11A,Non-small cell lung cancer metastatic,0.8402911822757345
TNFRSF11A,Osteogenesis Imperfecta,0.8402911822757345
TNFRSF11A,Hypertensive disease,0.8474481237156937
TNFRSF11A,Bone Diseases,0.8578473133580928
TNFRSF11A,Anemia,0.8584283190330553
TNFRSF11A,Squamous cell carcinoma of esophagus,0.8610447277138289
TNFRSF11A,Bone Diseases Developmental,0.8648405521677974
TNFRSF11A,Early Rheumatoid Arthritis,0.8648405521677974
TNFRSF11A,Atrial Fibrillation,0.8648405521677974
TNFRSF11A,Hemoglobin low,0.8648405521677974
TNFRSF11A,Malignant neoplasm of endometrium,0.8769418330148872
TNFRSF11A,Uterine Corpus Cancer,0.8771562273432176
TNFRSF11A,Short stature,0.8815127642200768
TNFRSF11A,Inflammatory disorder,0.882453254162044
TNFRSF11A,Coronary Artery Disease,0.887595340546704
TNFRSF11A,Cooley's anemia,0.887595340546704
TNFRSF11A,Hyperactive behavior,0.8878860377518915
TNFRSF11A,Hyperuricemia,0.8942113186235617
TNFRSF11A,Bone neoplasms,0.8959157818691486
TNFRSF11A,Obesity,0.8989612563669234
TNFRSF11A,Congenital Heart Defects,0.9098977259629772
TNFRSF11A,Coronary heart disease,0.9119978323790848
TNFRSF11A,Influenza,0.9193385822373632
TNFRSF11A,Hemophilia A,0.9193385822373632
TNFRSF11A,Myasthenia Gravis,0.9390727893210336
TNFRSF11A,Arthritis,0.9431511078237256
TNFRSF11A,Secondary malignant neoplasm of bone,0.946564927793026
TNFRSF11A,Malaria,0.9512505437112568
TNFRSF11A,Osteoporosis,0.9639249377588224
TNFRSF11A,Osteopetrosis,0.4532988396145482
TNFRSF11A,Melanocytic Nevus,0.7765582368651238
TNFRSF11A,Lymphocytic Leukemia,0.7765582368651238
TNFRSF11A,Brain Stem Compression,0.7765582368651238
TNFRSF11A,Hypocalcemic Seizures,0.7765582368651238
TNFRSF11A,Vitiligo,0.7765582368651238
TNFRSF11A,Nystagmus,0.7765582368651238
TNFRSF11A,Hypertension,0.7765582368651238
TNFRSF11A,Cranial Nerve Paralysis,0.7765582368651238
TNFRSF11A,Developmental Delay,0.7765582368651238
TNFRSF11A,Macrocephaly,0.7765582368651238
TNFRSF11A,Paget Disease,0.7765582368651238
TNFRSF11A,Optic Atrophy,0.8115918568696846
TNFRSF11A,Proptosis,0.8115918568696846
TNFRSF11A,Hearing Loss,0.8115918568696846
TNFRSF11A,Motor Delay,0.8210988731657684
TNFRSF11A,Hyperuricemia,0.8897718769742773
TNFRSF11A,Osteoporosis,0.8903301324869451
TNFRSF11A,Osteosarcoma,0.8903301324869451
TNFRSF11A,Congenital Pectus Carinatum,0.9024492468099392
TNFRSF11A,Myasthenia Gravis,0.924275664330454
TNFRSF11A,Anemia,0.9369188149054885
TNFRSF11A,Dwarfism,0.9510372690456612
TNFRSF11A,Hydrocephalus,0.9574431947800732
TNFRSF11A,Eczema,0.9658957825498884
TNFRSF11A,Asthma,0.9832345076528324
TNFRSF11A,Familial expansile osteolysis ORPHA:85195,0.1991445465001551
TNFRSF11A,Osteopetrosis-hypogammaglobulinemia syndrome ORPHA:178389,0.1991445465001551
TNFRSF11A,Dysosteosclerosis ORPHA:1782,0.3832844616405875
TNFRSF11A,NON RARE IN EUROPE: Paget disease of bone ORPHA:280110,0.7929682744768703
TNFRSF11A,Juvenile Paget disease ORPHA:2801,0.8922466888454011
TNFRSF11A,Adult-onset myasthenia gravis ORPHA:391490,0.8922466888454011
TNFRSF11A,Vaccinia virus Ankara soluble TNF receptor II precursor f1,0.8999095837312036
TNFRSF11A,Monkeypox virus Zaire-96-I-16 Tumor necrosis Factor-receptor like protein (gene: K1R),0.8999095837312036
TNFRSF11A,Cowpox virus CrmC or CPXV191 protein (gene: CrmC),0.8999095837312036
TNFRSF11A,Vaccinia virus secreted TNF-receptor-like protein (gene: A53R),0.8999095837312036
TNFRSF11A,Horsepox virus HSPV175 (Tumor necrosis factor receptor superfamily (TNFRSF)),0.8999095837312036
TNFRSF11A,Cercopithecine betaherpesvirus 5 membrane glycoprotein UL144 (gene: UL144),0.8999095837312036
TNFRSF11A,Vaccinia virus Ankara TNF receptor domain/CrmC,0.8999095837312036
TNFRSF11A,Variola virus hypothetical protein (gene: G4R),0.8999095837312036
TNFRSF11A,Horsepox virus HSPV003 (Tumor necrosis factor receptor superfamily members),0.8999095837312036
TNFRSF11A,Human betaherpesvirus 5 membrane glycoprotein UL144 (gene: UL144),0.8999095837312036
TNFRSF11A,Monkeypox virus Zaire-96-I-16 J2L (gene: J2L),0.9056300531913352
TNFRSF11A,Cowpox virus CrmB or CPXV005 protein (gene: crmB),0.9057542447893764
TNFRSF11A,Monkeypox virus TNF-alpha-receptor-like protein,0.9057542447893764
TNFSF9,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
TNFSF9,B-Cell Lymphomas,0.7333611688795861
TNFSF9,Ovarian Carcinoma,0.7333611688795861
TNFSF9,Adenocarcinoma,0.750391252594775
TNFSF9,Colorectal Carcinoma,0.7765852775619541
TNFSF9,Colon Carcinoma,0.7765852775619541
TNFSF9,Leukemia Myelocytic Acute,0.7765852775619541
TNFSF9,Malignant tumor of colon,0.7765852775619541
TNFSF9,Lymphoma,0.7765852775619541
TNFSF9,Cervix carcinoma,0.7765852775619541
TNFSF9,Colorectal Neoplasms,0.7765852775619541
TNFSF9,Malignant tumor of cervix,0.7768809924982332
TNFSF9,Malignant neoplasm of prostate,0.7880542567584415
TNFSF9,IMMUNE SUPPRESSION,0.7880542567584415
TNFSF9,Liver carcinoma,0.7880542567584415
TNFSF9,Colorectal Cancer,0.7880542567584415
TNFSF9,Epithelial ovarian cancer,0.7880542567584415
TNFSF9,Prostate carcinoma,0.7880542567584415
TNFSF9,cervical cancer,0.7880542567584415
TNFSF9,Neuroblastoma,0.7880542567584415
TNFSF9,Lymphocytic infiltration,0.7880542567584415
TNFSF9,Central neuroblastoma,0.7880542567584415
TNFSF9,Malignant Neoplasms,0.7880542567584415
TNFSF9,Malignant neoplasm of stomach,0.7880542567584415
TNFSF9,Burkitt Lymphoma,0.7880542567584415
TNFSF9,Mycobacterium avium infection,0.7880542567584415
TNFSF9,Stromal Neoplasm,0.7880542567584415
TNFSF9,Takayasu Arteritis,0.7880542567584415
TNFSF9,Arteriosclerosis,0.7880542567584415
TNFSF9,Atherosclerosis,0.7880542567584415
TNFSF9,Autoimmune Diseases,0.7880542567584415
TNFSF9,Single tumor,0.7880542567584415
TNFSF9,Rheumatoid Arthritis,0.7880542567584415
TNFSF9,Crohn Disease,0.7880542567584415
TNFSF9,Tumor Immunity,0.7880542567584415
TNFSF9,Mycobacterium avium-intracellulare Infection,0.7880542567584415
TNFSF9,Primary malignant neoplasm,0.7908231553833205
TNFSF9,Multiple Sclerosis,0.8019075543217649
TNFSF9,Chronic Lymphocytic Leukemia,0.8019075543217649
TNFSF9,Hereditary Diffuse Gastric Cancer,0.8019075543217649
TNFSF9,Stomach Neoplasms,0.8044379824544406
TNFSF9,HIV Infections,0.8145035474981049
TNFSF9,Primary biliary cirrhosis,0.8212681436603975
TNFSF9,Contact hypersensitivity,0.8942113186235617
TNFSF9,Contact Dermatitis,0.917543617287358
TNFSF9,Influenza,0.9193385822373632
TNFSF9,Stomach Neoplasms,0.7765582368651238
TNFSF9,Gastric Cancer,0.861756360478846
TNFSF9,Dermatitis,0.861756360478846
TNFSF9,Crisponi syndrome ORPHA:1545,0.0155394890951578
TNFSF9,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.3832844616405875
TNFSF9,Athabaskan brainstem dysgenesis syndrome ORPHA:69739,0.5867963421058087
TNFSF9,Bosley-Salih-Alorainy syndrome ORPHA:69737,0.5867963421058087
TNFSF9,Familial atypical multiple mole melanoma syndrome ORPHA:404560,0.5867963421058087
TNFSF9,Melanoma and neural system tumor syndrome ORPHA:252206,0.5867963421058087
TNKS1BP1,Malignant Neoplasms,0.7880542567584415
TNKS1BP1,Primary malignant neoplasm,0.7908231553833205
TNKS1BP1,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
TNKS1BP1,Congenital thrombotic thrombocytopenic purpura ORPHA:93583,0.0414176838632111
TNKS1BP1,Antley-Bixler syndrome ORPHA:83,0.0414176838632111
TNKS1BP1,Cleft lip/palate-ectodermal dysplasia syndrome ORPHA:3253,0.1040670578681756
TNKS1BP1,Monosomy 22q13.3 ORPHA:48652,0.1040670578681756
TNKS1BP1,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.1040670578681756
TNKS1BP1,Steinert myotonic dystrophy ORPHA:273,0.1040670578681756
TNKS1BP1,Bilateral perisylvian polymicrogyria ORPHA:98889,0.1068643725150898
TNKS1BP1,Saldino-Mainzer syndrome ORPHA:140969,0.1991445465001551
TNKS1BP1,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.1991445465001551
TNKS1BP1,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.1991445465001551
TNKS1BP1,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.1991445465001551
TNKS1BP1,Epidermolysis bullosa simplex with muscular dystrophy ORPHA:257,0.1991445465001551
TNKS1BP1,Familial cortical myoclonus ORPHA:319189,0.1991445465001551
TNKS1BP1,Frank-Ter Haar syndrome ORPHA:137834,0.1991445465001551
TNKS1BP1,Knobloch syndrome ORPHA:1571,0.1991445465001551
TNKS1BP1,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.1991445465001551
TNKS1BP1,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.1991445465001551
TNKS1BP1,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.1991445465001551
TNKS1BP1,PLEC-related intermediate epidermolysis bullosa simplex without extracutaneous involvement ORPHA:79401,0.1991445465001551
TNKS1BP1,Plectin-related  limb-girdle muscular dystrophy R17 ORPHA:254361,0.1991445465001551
TNKS1BP1,Pyruvate carboxylase deficiency benign type ORPHA:353320,0.1991445465001551
TNKS1BP1,Pyruvate carboxylase deficiency infantile type ORPHA:353308,0.1991445465001551
TNKS1BP1,Pyruvate carboxylase deficiency severe neonatal type ORPHA:353314,0.1991445465001551
TNKS1BP1,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.1991445465001551
TNKS1BP1,Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717,0.1991445465001551
TNKS1BP1,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.1991445465001551
TNKS1BP1,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.1991445465001551
TNKS1BP1,Progressive myoclonic epilepsy type 5 ORPHA:402082,0.1991445465001551
TNKS1BP1,Familial hypercholanemia ORPHA:238475,0.2047219337649946
TNKS1BP1,Early-onset posterior subcapsular cataract ORPHA:441447,0.220389120533256
TNKS1BP1,Early-onset posterior polar cataract ORPHA:98993,0.2475924359068358
TNKS1BP1,Giant cell glioblastoma ORPHA:251579,0.2844858212863536
TNKS1BP1,Gliosarcoma ORPHA:251576,0.2844858212863536
TNKS1BP1,Alopecia universalis ORPHA:701,0.3832844616405875
TNKS1BP1,Atrichia with papular lesions ORPHA:86819,0.3832844616405875
TNKS1BP1,Atypical Werner syndrome ORPHA:79474,0.3832844616405875
TNKS1BP1,Autosomal dominant intermediate Charcot-Marie-Tooth disease type E ORPHA:93114,0.3832844616405875
TNKS1BP1,Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855,0.3832844616405875
TNKS1BP1,Autosomal recessive intermediate Charcot-Marie-Tooth disease type C ORPHA:369867,0.3832844616405875
TNKS1BP1,Autosomal recessive lower motor neuron disease with childhood onset ORPHA:206580,0.3832844616405875
TNKS1BP1,Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365,0.3832844616405875
TNKS1BP1,Charcot-Marie-Tooth disease type 2B1 ORPHA:98856,0.3832844616405875
TNKS1BP1,Congenital muscular dystrophy due to LMNA mutation ORPHA:157973,0.3832844616405875
TNKS1BP1,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229,0.3832844616405875
TNKS1BP1,Dyschromatosis universalis hereditaria ORPHA:241,0.3832844616405875
TNKS1BP1,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751,0.3832844616405875
TNKS1BP1,Familial partial lipodystrophy Dunnigan type ORPHA:2348,0.3832844616405875
TNKS1BP1,Familial partial lipodystrophy Kobberling type ORPHA:79084,0.3832844616405875
TNKS1BP1,Familial pseudohyperkalemia ORPHA:90044,0.3832844616405875
TNKS1BP1,Heart-hand syndrome Slovenian type ORPHA:168796,0.3832844616405875
TNKS1BP1,LMNA-related cardiocutaneous progeria syndrome ORPHA:363618,0.3832844616405875
TNKS1BP1,Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153,0.3832844616405875
TNKS1BP1,Muscular dystrophy Selcen type ORPHA:199340,0.3832844616405875
TNKS1BP1,Non-immune hydrops fetalis ORPHA:363999,0.3832844616405875
TNKS1BP1,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.3832844616405875
TNKS1BP1,Spectrin-associated autosomal recessive cerebellar ataxia ORPHA:352403,0.3832844616405875
TNKS1BP1,Spinocerebellar ataxia type 5 ORPHA:98766,0.3832844616405875
TNKS1BP1,Van den Ende-Gupta syndrome ORPHA:2460,0.3832844616405875
TNKS1BP1,Crouzon disease ORPHA:207,0.3832844616405875
TNKS1BP1,Dermatofibrosarcoma protuberans ORPHA:31112,0.3832844616405875
TNKS1BP1,Shprintzen-Goldberg syndrome ORPHA:2462,0.3832844616405875
TNKS1BP1,Alopecia-intellectual disability syndrome ORPHA:2850,0.3832844616405875
TNKS1BP1,Idiopathic pulmonary fibrosis ORPHA:2032,0.5047266821728011
TNKS1BP1,Lethal acantholytic erosive disorder ORPHA:158687,0.5867963421058087
TNKS1BP1,Multiple osteochondromas ORPHA:321,0.5867963421058087
TNKS1BP1,Aarskog-Scott syndrome ORPHA:915,0.5867963421058087
TNKS1BP1,Acute neonatal citrullinemia type I ORPHA:247546,0.5867963421058087
TNKS1BP1,Adult-onset citrullinemia type I ORPHA:247573,0.5867963421058087
TNKS1BP1,Alagille syndrome due to 20p12 microdeletion ORPHA:261600,0.5867963421058087
TNKS1BP1,Alagille syndrome due to a JAG1 point mutation ORPHA:261619,0.5867963421058087
TNKS1BP1,Cerebral autosomal dominant arteriopathy-subcortical infarcts-leukoencephalopathy ORPHA:136,0.5867963421058087
TNKS1BP1,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476,0.5867963421058087
TNKS1BP1,Congenital hereditary endothelial dystrophy type II ORPHA:293603,0.5867963421058087
TNKS1BP1,Corneal dystrophy-perceptive deafness syndrome ORPHA:1490,0.5867963421058087
TNKS1BP1,Dentatorubral pallidoluysian atrophy ORPHA:101,0.5867963421058087
TNKS1BP1,Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594,0.5867963421058087
TNKS1BP1,Hyperprolinemia type 2 ORPHA:79101,0.5867963421058087
TNKS1BP1,Isolated biliary atresia ORPHA:30391,0.5867963421058087
TNKS1BP1,Isolated congenital breast hypoplasia/aplasia ORPHA:180188,0.5867963421058087
TNKS1BP1,Lateral meningocele syndrome ORPHA:2789,0.5867963421058087
TNKS1BP1,Multiple myeloma ORPHA:29073,0.5867963421058087
TNKS1BP1,POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559,0.5867963421058087
TNKS1BP1,Pierson syndrome ORPHA:2670,0.5867963421058087
TNKS1BP1,Seizures-scoliosis-macrocephaly syndrome ORPHA:466926,0.5867963421058087
TNKS1BP1,Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298,0.5867963421058087
TNKS1BP1,Wolfram-like syndrome ORPHA:411590,0.5867963421058087
TNKS1BP1,X-linked creatine transporter deficiency ORPHA:52503,0.5867963421058087
TNKS1BP1,3M syndrome ORPHA:2616,0.5867963421058087
TNKS1BP1,Autosomal recessive generalized dystrophic epidermolysis bullosa severe form ORPHA:79408,0.5867963421058087
TNKS1BP1,Carpenter syndrome ORPHA:65759,0.5867963421058087
TNKS1BP1,Hyperostosis corticalis generalisata ORPHA:3416,0.5867963421058087
TNKS1BP1,Spondylocarpotarsal synostosis ORPHA:3275,0.5867963421058087
TNKS1BP1,Spondyloepimetaphyseal dysplasia with joint laxity ORPHA:93359,0.5867963421058087
TNKS1BP1,Acrocallosal syndrome ORPHA:36,0.5867963421058087
TNKS1BP1,Hereditary diffuse gastric cancer ORPHA:26106,0.5867963421058087
TNKS1BP1,Isolated scaphocephaly ORPHA:35093,0.5867963421058087
TNKS1BP1,Myxofibrosarcoma ORPHA:79105,0.5867963421058087
TNKS1BP1,Aplasia cutis congenita ORPHA:1114,0.5959529547720634
TNKS1BP1,Familial exudative vitreoretinopathy ORPHA:891,0.6196505963261838
TNKS1BP1,Juvenile nephronophthisis ORPHA:93592,0.6335420546867965
TNKS1BP1,Acrokeratosis verruciformis of Hopf ORPHA:79151,0.7929682744768703
TNKS1BP1,Alpha-dystroglycan-related  limb-girdle muscular dystrophy R16 ORPHA:280333,0.7929682744768703
TNKS1BP1,Atelosteogenesis type I ORPHA:1190,0.7929682744768703
TNKS1BP1,Atelosteogenesis type III ORPHA:56305,0.7929682744768703
TNKS1BP1,Autosomal dominant osteopetrosis type 1 ORPHA:2783,0.7929682744768703
TNKS1BP1,Autosomal spastic paraplegia type 58 ORPHA:397946,0.7929682744768703
TNKS1BP1,Boomerang dysplasia ORPHA:1263,0.7929682744768703
TNKS1BP1,Craniofrontonasal dysplasia ORPHA:1520,0.7929682744768703
TNKS1BP1,Darier disease ORPHA:218,0.7929682744768703
TNKS1BP1,Dent disease type 2 ORPHA:93623,0.7929682744768703
TNKS1BP1,Endosteal hyperostosis Worth type ORPHA:2790,0.7929682744768703
TNKS1BP1,Familial congenital nasolacrimal duct obstruction ORPHA:451612,0.7929682744768703
TNKS1BP1,Familial hypocalciuric hypercalcemia type 2 ORPHA:101049,0.7929682744768703
TNKS1BP1,LAMA5-related multisystemic syndrome ORPHA:521450,0.7929682744768703
TNKS1BP1,LRP5-related primary osteoporosis ORPHA:498481,0.7929682744768703
TNKS1BP1,Larsen syndrome ORPHA:503,0.7929682744768703
TNKS1BP1,MUC1-related autosomal dominant tubulointerstitial kidney disease ORPHA:88949,0.7929682744768703
TNKS1BP1,Multiple epiphyseal dysplasia Al-Gazali type ORPHA:166024,0.7929682744768703
TNKS1BP1,Muscle-eye-brain disease with bilateral multicystic leucodystrophy ORPHA:370997,0.7929682744768703
TNKS1BP1,Naxos disease ORPHA:34217,0.7929682744768703
TNKS1BP1,Oculocerebrorenal syndrome of Lowe ORPHA:534,0.7929682744768703
TNKS1BP1,Osteoporosis-pseudoglioma syndrome ORPHA:2788,0.7929682744768703
TNKS1BP1,Osteosclerosis-developmental delay-craniosynostosis syndrome ORPHA:178377,0.7929682744768703
TNKS1BP1,POMGNT1-related  limb-girdle muscular dystrophy R15 ORPHA:206564,0.7929682744768703
TNKS1BP1,Phakomatosis cesiomarmorata ORPHA:79484,0.7929682744768703
TNKS1BP1,Postnatal microcephaly-infantile hypotonia-spastic diplegia-dysarthria-intellectual disability syndrome ORPHA:477673,0.7929682744768703
TNKS1BP1,Autosomal dominant non-syndromic sensorineural deafness type DFNA ORPHA:90635,0.7929682744768703
TNKS1BP1,Autosomal dominant hypocalcemia ORPHA:428,0.7929682744768703
TNKS1BP1,Retinopathy of prematurity ORPHA:90050,0.7929682744768703
TNKS1BP1,Familial bicuspid aortic valve ORPHA:402075,0.795266832401002
TNKS1BP1,Autosomal dominant polycystic kidney disease ORPHA:730,0.8105918570729571
TNKS1BP1,Osteogenesis imperfecta type 3 ORPHA:216812,0.8211968342881582
TNKS1BP1,Walker-Warburg syndrome ORPHA:899,0.8778481542696168
TNKS1BP1,Total early-onset cataract ORPHA:98994,0.8922466888454011
TNKS1BP1,22q11.2 duplication syndrome ORPHA:1727,0.8922466888454011
TNKS1BP1,Autosomal dominant Charcot-Marie-Tooth disease type 2DD ORPHA:521414,0.8922466888454011
TNKS1BP1,Autosomal dominant neovascular inflammatory vitreoretinopathy ORPHA:329211,0.8922466888454011
TNKS1BP1,Craniofacial dysplasia-osteopenia syndrome ORPHA:314555,0.8922466888454011
TNKS1BP1,Desmosterolosis ORPHA:35107,0.8922466888454011
TNKS1BP1,Dyssegmental dysplasia Silverman-Handmaker type ORPHA:1865,0.8922466888454011
TNKS1BP1,Dystonia-parkinsonism-hypermanganesemia syndrome ORPHA:521406,0.8922466888454011
TNKS1BP1,Microcystic stromal tumor ORPHA:569248,0.8922466888454011
TNKS1BP1,Pilomatrixoma ORPHA:91414,0.8922466888454011
TNKS1BP1,Schwartz-Jampel syndrome ORPHA:800,0.8922466888454011
TNKS1BP1,Severe intellectual disability-progressive spastic diplegia syndrome ORPHA:404473,0.8922466888454011
TNKS1BP1,Vein of Galen aneurysmal malformation ORPHA:1053,0.8922466888454011
TNKS1BP1,Isolated polycystic liver disease ORPHA:2924,0.8922466888454011
TNKS1BP1,Milroy disease ORPHA:79452,0.8922466888454011
TNKS1BP1,Autosomal dominant Robinow syndrome ORPHA:3107,0.8922466888454011
TNKS1BP1,Familial multiple meningioma ORPHA:263662,0.8922466888454011
TNKS1BP1,Autosomal recessive spastic paraplegia type 18 ORPHA:209951,0.8922466888454011
TNKS1BP1,Recessive intellectual disability-motor dysfunction-multiple joint contractures syndrome ORPHA:280384,0.8922466888454011
TNKS1BP1,Cervical spina bifida aperta ORPHA:268392,0.8922466888454011
TNKS1BP1,Cervical spina bifida cystica ORPHA:268762,0.8922466888454011
TNKS1BP1,Cervicothoracic spina bifida aperta ORPHA:268397,0.8922466888454011
TNKS1BP1,Cervicothoracic spina bifida cystica ORPHA:268766,0.8922466888454011
TNKS1BP1,Lumbosacral spina bifida aperta ORPHA:268388,0.8922466888454011
TNKS1BP1,Lumbosacral spina bifida cystica ORPHA:268758,0.8922466888454011
TNKS1BP1,Muscle-eye-brain disease ORPHA:588,0.8922466888454011
TNKS1BP1,Thoracolumbosacral spina bifida aperta ORPHA:268384,0.8922466888454011
TNKS1BP1,Thoracolumbosacral spina bifida cystica ORPHA:268752,0.8922466888454011
TNKS1BP1,Total spina bifida aperta ORPHA:268377,0.8922466888454011
TNKS1BP1,Total spina bifida cystica ORPHA:268748,0.8922466888454011
TNKS1BP1,Upper thoracic spina bifida aperta ORPHA:268740,0.8922466888454011
TNKS1BP1,Upper thoracic spina bifida cystica ORPHA:268770,0.8922466888454011
TOE1,Spasmodic movement,0.7880542567584415
TOE1,Involuntary jerking movements,0.7880542567584415
TOE1,Large auricle,0.7880542567584415
TOE1,Large pinnae,0.7880542567584415
TOE1,Macrotia,0.7880542567584415
TOE1,Thick upper lip vermilion,0.7880542567584415
TOE1,Supratentorial atrophy,0.7880542567584415
TOE1,Hypoplasia of corpus callosum,0.7880542567584415
TOE1,Myoclonus,0.7880542567584415
TOE1,Nystagmus,0.7880542567584415
TOE1,Cognitive delay,0.7880542567584415
TOE1,Degenerative brain disorder,0.7880542567584415
TOE1,Hypoplasia of the pons,0.7880542567584415
TOE1,Defective or absent horizontal voluntary eye movements,0.7880542567584415
TOE1,Pontoneocerebellar hypoplasia,0.7880542567584415
TOE1,Global developmental delay,0.7880542567584415
TOE1,Progressive microcephaly,0.7880542567584415
TOE1,Congenital pontocerebellar hypoplasia,0.7880542567584415
TOE1,Optic Atrophy,0.7880542567584415
TOE1,Mental and motor retardation,0.7880542567584415
TOE1,Oculomotor apraxia,0.7908231553833205
TOE1,Disorders of Sex Development,0.8019075543217649
TOE1,Cerebral atrophy,0.8019075543217649
TOE1,Spastic Paraplegia,0.8067197998685076
TOE1,Apnea,0.8145035474981049
TOE1,Broad flat nasal bridge,0.8213459222602666
TOE1,Nasal bridge wide,0.8232134984476662
TOE1,Congenital hypoplasia of penis,0.8232134984476662
TOE1,Cerebellar Hypoplasia,0.8402911822757345
TOE1,Generalized hypotonia,0.843190898187174
TOE1,Concave bridge of nose,0.8578473133580928
TOE1,Depressed nasal root/bridge,0.8578473133580928
TOE1,Depressed nasal bridge,0.8584283190330553
TOE1,Retrusion of lower jaw,0.8648405521677974
TOE1,Decreased projection of lower jaw,0.8648405521677974
TOE1,Decreased projection of mandible,0.8648405521677974
TOE1,Hypoplastic mandible condyle,0.8648405521677974
TOE1,Aplasia/Hypoplasia of the mandible,0.8648405521677974
TOE1,Micrognathism,0.8648405521677974
TOE1,Ambiguous Genitalia,0.8648405521677974
TOE1,Congenital Epicanthus,0.8867509400747969
TOE1,Intellectual Disability,0.9478210444156088
TOE1,Seizures,0.9478210444156088
TOE1,Epilepsy,0.963331724428282
TOE1,Hyperreflexia,0.998046372175909
TOE1,Oculovestibuloauditory Syndrome,0.7765582368651238
TOE1,Oculomotor Apraxia,0.7765582368651238
TOE1,Hereditary Cancer Syndrome,0.7765582368651238
TOE1,Nystagmus,0.7765582368651238
TOE1,Developmental Delay,0.7765582368651238
TOE1,Hypoplasia Of Corpus Callosum,0.7949861636679444
TOE1,Macrotia,0.8115918568696846
TOE1,Hypertrophy Of Clitoris,0.8115918568696846
TOE1,Pontoneocerebellar Hypoplasia,0.8115918568696846
TOE1,Optic Atrophy,0.8115918568696846
TOE1,Penis Agenesis,0.8115918568696846
TOE1,Spastic Paraplegia,0.8182883735985873
TOE1,Mental Retardation,0.8337953215113012
TOE1,Cerebral Atrophy,0.8339308890552987
TOE1,Cerebellar Hypoplasia,0.8601151608808731
TOE1,Ambiguous Genitalia,0.8611702959552964
TOE1,Cryptorchidism,0.861756360478846
TOE1,Gonadal Dysgenesis,0.861756360478846
TOE1,Microcephaly,0.8903630091389316
TOE1,Micrognathism,0.9398381935810408
TOE1,High Palate,0.9578111936867284
TOE1,Congenital Epicanthus,0.974502015052702
TOE1,Combined immunodeficiency due to CD70 deficiency ORPHA:538958,0.3832844616405875
TOE1,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome ORPHA:502423,0.5867963421058087
TOE1,Schnyder corneal dystrophy ORPHA:98967,0.5867963421058087
TOE1,Amish lethal microcephaly ORPHA:99742,0.7929682744768703
TOE1,Pontocerebellar hypoplasia type 10 ORPHA:411493,0.7929682744768703
TOE1,Progressive polyneuropathy with bilateral striatal necrosis ORPHA:217396,0.7929682744768703
TOE1,Purine nucleoside phosphorylase deficiency ORPHA:760,0.7929682744768703
TOE1,Severe combined immunodeficiency due to adenosine deaminase deficiency ORPHA:277,0.7929682744768703
TOE1,Combined immunodeficiency with faciooculoskeletal anomalies ORPHA:221139,0.7929682744768703
TOE1,Pontocerebellar hypoplasia type 2 ORPHA:2524,0.8029813443753846
TOE1,Dyskeratosis congenita ORPHA:1775,0.8668760866668862
TOE1,Bowen-Conradi syndrome ORPHA:1270,0.8922466888454011
TOE1,Cernunnos-XLF deficiency ORPHA:169079,0.8922466888454011
TOE1,Deafness-encephaloneuropathy-obesity-valvulopathy syndrome ORPHA:254898,0.8922466888454011
TOE1,Early-onset generalized limb-onset dystonia ORPHA:256,0.8922466888454011
TOE1,Lenz-Majewski hyperostotic dwarfism ORPHA:2658,0.8922466888454011
TOE1,MUTYH-related attenuated familial adenomatous polyposis ORPHA:247798,0.8922466888454011
TOE1,Pontocerebellar hypoplasia type 7 ORPHA:284339,0.8922466888454011
TOE1,RFT1-CDG ORPHA:244310,0.8922466888454011
TOE1,Ribose-5-P isomerase deficiency ORPHA:440706,0.8922466888454011
TOE1,Spinocerebellar ataxia type 17 ORPHA:98759,0.8922466888454011
TOE1,Hypocalcemic vitamin D-dependent rickets ORPHA:289157,0.8922466888454011
TOE1,Mitochondrial myopathy and sideroblastic anemia ORPHA:2598,0.8922466888454011
TOE1,Immunodeficiency by defective expression of MHC class II ORPHA:572,0.8922466888454011
TOE1,Hyperphosphatasia-intellectual disability syndrome ORPHA:247262,0.8922466888454011
TOE1,Hoyeraal-Hreidarsson syndrome ORPHA:3322,0.8922466888454011
TOE1,Arthrogryposis-renal dysfunction-cholestasis syndrome ORPHA:2697,0.8922466888454011
TOE1,Arthrogryposis-anterior horn cell disease syndrome ORPHA:53696,0.8922466888454011
TOE1,Autosomal recessive cerebellar ataxia due to CWF19L1 deficiency ORPHA:453521,0.8922466888454011
TOE1,Lethal congenital contracture syndrome type 1 ORPHA:1486,0.8922466888454011
TOE1,Severe intellectual disability-short stature-behavioral abnormalities-facial dysmorphism syndrome ORPHA:391307,0.8922466888454011
TOE1,Xeroderma pigmentosum ORPHA:910,0.8922466888454011
TP53I3,Malignant neoplasm of breast,0.4084380369379369
TP53I3,Breast Carcinoma,0.7333611688795861
TP53I3,Colorectal Carcinoma,0.7765852775619541
TP53I3,Non-Small Cell Lung Carcinoma,0.7765852775619541
TP53I3,Malignant neoplasm of prostate,0.7880542567584415
TP53I3,Colorectal Cancer,0.7880542567584415
TP53I3,Prostate carcinoma,0.7880542567584415
TP53I3,Squamous cell carcinoma of the head and neck,0.7880542567584415
TP53I3,melanoma,0.7880542567584415
TP53I3,Ewings sarcoma,0.7880542567584415
TP53I3,Coinfection,0.7880542567584415
TP53I3,Carcinoma,0.7880542567584415
TP53I3,Carcinoma Spindle-Cell,0.7950434752274518
TP53I3,Undifferentiated carcinoma,0.8019075543217649
TP53I3,Adenoma of lung,0.8019075543217649
TP53I3,Carcinomatosis,0.8190761496232595
TP53I3,Mammary Carcinoma Animal,0.8402911822757345
TP53I3,Animal Mammary Neoplasms,0.8402911822757345
TP53I3,Anaplastic carcinoma,0.8402911822757345
TP53I3,Anaplastic Carcinoma,0.8115918568696846
TP53I3,Breast Cancer,0.8903630091389316
TP53I3,Carcinoma,0.9069867032339078
TP53I3,Hereditary thrombocytopenia with early-onset myelofibrosis ORPHA:480851,0.1991445465001551
TP53I3,Quebec platelet disorder ORPHA:220436,0.3832844616405875
TP53I3,Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289,0.5867963421058087
TP53I3,Metaphyseal chondromatosis with D-2-hydroxyglutaric aciduria ORPHA:99646,0.8922466888454011
TPPP,Bladder Neoplasm,0.4084380369379369
TPPP,Superinfection,0.7333611688795861
TPPP,leukemia,0.7333611688795861
TPPP,Reticulosarcoma,0.7765852775619541
TPPP,Asymptomatic human immunodeficiency virus infection,0.7765852775619541
TPPP,Colon Carcinoma,0.7765852775619541
TPPP,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
TPPP,HIV Encephalopathy,0.7765852775619541
TPPP,HIV encephalitis,0.7765852775619541
TPPP,Chronic Fatigue Syndrome,0.7880542567584415
TPPP,Prion Diseases,0.7880542567584415
TPPP,Hepatitis D Infection,0.7880542567584415
TPPP,Immunologic Deficiency Syndromes,0.7880542567584415
TPPP,Lymphadenopathy,0.7880542567584415
TPPP,Renal Cell Carcinoma,0.7880542567584415
TPPP,Acquired Immunodeficiency Syndrome,0.7880542567584415
TPPP,Infant Premature,0.7880542567584415
TPPP,Alzheimer's Disease,0.7880542567584415
TPPP,Ketosis,0.7880542567584415
TPPP,Sjogren's Syndrome,0.7880542567584415
TPPP,Huntington Disease,0.7880542567584415
TPPP,Virus Diseases,0.7880542567584415
TPPP,Acute HIV infection,0.7880542567584415
TPPP,Viremia,0.8019075543217649
TPPP,Primary HIV infection,0.8019075543217649
TPPP,Leukoencephalopathy Progressive Multifocal,0.8019075543217649
TPPP,Lung diseases,0.8019075543217649
TPPP,Borna Disease,0.8067197998685076
TPPP,HIV Infections,0.8145035474981049
TPPP,Primary infection NOS,0.8168901801930506
TPPP,CNS disorder,0.8168901801930506
TPPP,Welts,0.8168901801930506
TPPP,Neurodegenerative Disorders,0.8272008757995397
TPPP,Common acute lymphoblastic leukemia,0.834094492023826
TPPP,Tuberculosis,0.8368219249856942
TPPP,Amyotrophic Lateral Sclerosis,0.8402911822757345
TPPP,Cerebellar Diseases,0.8402911822757345
TPPP,Mycobacterium Infections,0.8402911822757345
TPPP,Hepatitis B,0.841396342333011
TPPP,Memory impairment,0.8474481237156937
TPPP,Hippocampal sclerosis,0.8584283190330553
TPPP,Tuberculosis Pulmonary,0.8610447277138289
TPPP,Cerebrovascular accident,0.8648405521677974
TPPP,Amyloidosis,0.8672189956534445
TPPP,Neurologic Symptoms,0.8690346447728063
TPPP,Adenocarcinoma Of Esophagus,0.8769418330148872
TPPP,Parkinson Disease,0.8772392350816924
TPPP,Parasitemia,0.882453254162044
TPPP,Lewy Body Disease,0.8851456306720444
TPPP,Shy-Drager Syndrome,0.8989612563669234
TPPP,Mood Disorders,0.9093740881835894
TPPP,Influenza,0.9193385822373632
TPPP,Psychotic Disorders,0.939985154445373
TPPP,Unipolar Depression,0.9455834988784428
TPPP,Urticaria,0.9473064300361868
TPPP,Malaria,0.9512505437112568
TPPP,Major Depressive Disorder,0.9658628445524134
TPPP,Esophageal Cancer,0.8165359516083085
TPPP,Barrett Esophagus,0.8457525389282121
TPPP,Mental Depression,0.8903630091389316
TPPP,Resistance to thyroid hormone due to a mutation in thyroid hormone receptor alpha ORPHA:566231,0.0155394890951578
TPPP,1p36 deletion syndrome ORPHA:1606,0.0184072076199886
TPPP,Succinic semialdehyde dehydrogenase deficiency ORPHA:22,0.1991445465001551
TPPP,Infant acute respiratory distress syndrome ORPHA:70587,0.5867963421058087
TPPP,Early infantile epileptic encephalopathy ORPHA:1934,0.7593059616185558
TPPP,Autosomal dominant focal dystonia DYT25 type ORPHA:329466,0.8922466888454011
TPPP,Chronic respiratory distress with surfactant metabolism deficiency ORPHA:217566,0.8922466888454011
TPPP,Hyperprolinemia type 1 ORPHA:419,0.8922466888454011
TPPP,Interstitial lung disease due to SP-C deficiency ORPHA:440392,0.8922466888454011
TPPP,Peripheral demyelinating neuropathy-central dysmyelinating leukodystrophy-Waardenburg syndrome-Hirschsprung disease ORPHA:163746,0.8922466888454011
TRAM2,Vascular Diseases,0.7765582368651238
TRAM2,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
TRAM2,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900,0.1991445465001551
TRAM2,MYH9-related disease ORPHA:182050,0.1991445465001551
TRAM2,Mucopolysaccharidosis type 6 rapidly progressing ORPHA:276212,0.1991445465001551
TRAM2,Mucopolysaccharidosis type 6 slowly progressing ORPHA:276223,0.1991445465001551
TRAM2,Musculocontractural Ehlers-Danlos syndrome ORPHA:2953,0.1991445465001551
TRAM2,Giant cell glioblastoma ORPHA:251579,0.2844858212863536
TRAM2,Gliosarcoma ORPHA:251576,0.2844858212863536
TRAM2,Autosomal recessive spastic paraplegia type 62 ORPHA:401785,0.3832844616405875
TRAM2,Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284,0.3832844616405875
TRAM2,Cap myopathy ORPHA:171881,0.3832844616405875
TRAM2,Congenital short bowel syndrome ORPHA:2301,0.3832844616405875
TRAM2,Chronic myelomonocytic leukemia ORPHA:98823,0.3891940933600213
TRAM2,Multiple osteochondromas ORPHA:321,0.5867963421058087
TRAM2,Aneurysm-osteoarthritis syndrome ORPHA:284984,0.5867963421058087
TRAM2,Pseudohypoaldosteronism type 2B ORPHA:88939,0.5867963421058087
TRAM2,Seizures-scoliosis-macrocephaly syndrome ORPHA:466926,0.5867963421058087
TRAM2,Hereditary combined deficiency of vitamin K-dependent clotting factors ORPHA:98434,0.5867963421058087
TRAM2,Proximal symphalangism ORPHA:3250,0.5867963421058087
TRAM2,Schneckenbecken dysplasia ORPHA:3144,0.5867963421058087
TRAM2,Spondylocarpotarsal synostosis ORPHA:3275,0.5867963421058087
TRAM2,Myxofibrosarcoma ORPHA:79105,0.5867963421058087
TRAM2,Acromesomelic dysplasia Hunter-Thompson type ORPHA:968,0.7929682744768703
TRAM2,Adult polyglucosan body disease ORPHA:206583,0.7929682744768703
TRAM2,Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442,0.7929682744768703
TRAM2,Congenital plasminogen activator inhibitor type 1 deficiency ORPHA:465,0.7929682744768703
TRAM2,Glycogen storage disease due to glycogen branching enzyme deficiency adult neuromuscular form ORPHA:308712,0.7929682744768703
TRAM2,Glycogen storage disease due to glycogen branching enzyme deficiency childhood combined hepatic and myopathic form ORPHA:308684,0.7929682744768703
TRAM2,Glycogen storage disease due to glycogen branching enzyme deficiency childhood neuromuscular form ORPHA:308698,0.7929682744768703
TRAM2,Glycogen storage disease due to glycogen branching enzyme deficiency congenital neuromuscular form ORPHA:308670,0.7929682744768703
TRAM2,Glycogen storage disease due to glycogen branching enzyme deficiency fatal perinatal neuromuscular form ORPHA:308655,0.7929682744768703
TRAM2,Glycogen storage disease due to glycogen branching enzyme deficiency non progressive hepatic form ORPHA:308638,0.7929682744768703
TRAM2,Glycogen storage disease due to glycogen branching enzyme deficiency progressive hepatic form ORPHA:308621,0.7929682744768703
TRAM2,Osteogenesis imperfecta type 2 ORPHA:216804,0.8029813443753846
TRAM2,Autosomal dominant polycystic kidney disease ORPHA:730,0.8105918570729571
TRAM2,Scott syndrome ORPHA:806,0.8922466888454011
TRAM2,Cole-Carpenter syndrome ORPHA:2050,0.8922466888454011
TRAM2,Neurogenic arthrogryposis multiplex congenita ORPHA:1143,0.8922466888454011
TRAM2,Frontometaphyseal dysplasia ORPHA:1826,0.8922466888454011
TREX1,Lower limb hyperreflexia,0.7765852775619541
TREX1,Acrocyanosis,0.7765852775619541
TREX1,Progressive visual loss,0.7765852775619541
TREX1,Decreased visual acuity progressive,0.7765852775619541
TREX1,Glioma,0.7880542567584415
TREX1,Mycoses,0.7880542567584415
TREX1,Ataxia Telangiectasia,0.7880542567584415
TREX1,Basal ganglia calcification,0.7880542567584415
TREX1,Neoplasm Metastasis,0.7880542567584415
TREX1,Prolonged neonatal jaundice,0.7880542567584415
TREX1,melanoma,0.7880542567584415
TREX1,Retinal Diseases,0.7880542567584415
TREX1,Libman-Sacks Disease,0.7880542567584415
TREX1,Chilblain lupus 1,0.7880542567584415
TREX1,Focal white matter lesions,0.7880542567584415
TREX1,Abnormal behavior,0.7880542567584415
TREX1,Retinal Hemorrhage,0.7880542567584415
TREX1,Aicardi-Goutieres Syndrome 2,0.7880542567584415
TREX1,Pain in limb,0.7880542567584415
TREX1,Progressive brain disease,0.7880542567584415
TREX1,Low Vision,0.7880542567584415
TREX1,Neonatal Jaundice,0.7880542567584415
TREX1,Supratentorial atrophy,0.7880542567584415
TREX1,Dementia,0.7880542567584415
TREX1,Polyposis Gastric,0.7880542567584415
TREX1,Progressive encephalopathy,0.7880542567584415
TREX1,Pseudo-TORCH syndrome,0.7880542567584415
TREX1,Lupus Erythematosus Systemic,0.7880542567584415
TREX1,Feeding difficulties in infancy,0.7880542567584415
TREX1,Nystagmus,0.7880542567584415
TREX1,Raynaud Disease,0.7880542567584415
TREX1,Cognitive delay,0.7880542567584415
TREX1,Autoimmune Diseases,0.7880542567584415
TREX1,Macular retinal edema,0.7880542567584415
TREX1,Visual Impairment,0.7880542567584415
TREX1,Rheumatoid Arthritis,0.7880542567584415
TREX1,Abnormality of the retinal vasculature,0.7880542567584415
TREX1,Degenerative brain disorder,0.7880542567584415
TREX1,Vasculitis of the skin,0.7880542567584415
TREX1,Chronic inflammatory disorder,0.7880542567584415
TREX1,Global developmental delay,0.7880542567584415
TREX1,Behavioral Symptoms,0.7880542567584415
TREX1,Progressive microcephaly,0.7880542567584415
TREX1,Hemiplegia/hemiparesis,0.7880542567584415
TREX1,AICARDI-GOUTIERES SYNDROME,0.7880542567584415
TREX1,Morphological abnormality of the pyramidal tract,0.7880542567584415
TREX1,Pyramidal tract disease,0.7880542567584415
TREX1,Virus Diseases,0.7880542567584415
TREX1,Mental and motor retardation,0.7880542567584415
TREX1,Malignant Glioma,0.7880542567584415
TREX1,Lupus Erythematosus Cutaneous,0.7908231553833205
TREX1,Abnormality of the periventricular white matter,0.7908231553833205
TREX1,AICARDI-GOUTIERES SYNDROME 1,0.8009048756462318
TREX1,Porencephalic cyst,0.8009048756462318
TREX1,Arhinencephaly,0.8019075543217649
TREX1,Coloboma of eyelid,0.8019075543217649
TREX1,Raynaud Phenomenon,0.8019075543217649
TREX1,Profound Mental Retardation,0.8019075543217649
TREX1,Decreased platelet count,0.8019075543217649
TREX1,Cerebral atrophy,0.8019075543217649
TREX1,Extrapyramidal sign,0.8019075543217649
TREX1,Thrombocytopenia,0.8019075543217649
TREX1,Spider Veins,0.8019075543217649
TREX1,Petechiae,0.8019075543217649
TREX1,Degenerative polyarthritis,0.8019075543217649
TREX1,Kidney Diseases,0.8019075543217649
TREX1,Congenital infectious disease,0.8019075543217649
TREX1,ESR raised,0.8019075543217649
TREX1,Poor head control,0.8019075543217649
TREX1,Lupus Erythematosus,0.8067197998685076
TREX1,Respiratory Tract Infections,0.8067197998685076
TREX1,Lupus Erythematosus Discoid,0.8098851543361193
TREX1,HIV Infections,0.8145035474981049
TREX1,Fever,0.8168901801930506
TREX1,Arthralgia,0.8190761496232595
TREX1,Inflammation,0.8212681436603975
TREX1,Lupus Vulgaris,0.8232134984476662
TREX1,Skin Ulcer,0.8232134984476662
TREX1,Muscular hypotonia of the trunk,0.8270909867833504
TREX1,Retroviridae Infections,0.8272008757995397
TREX1,Dermatomyositis Childhood Type,0.8402911822757345
TREX1,Strabismus,0.8402911822757345
TREX1,Immune System Diseases,0.8402911822757345
TREX1,Dystonia,0.8402911822757345
TREX1,Systemic Scleroderma,0.8402911822757345
TREX1,Intermittent migraine headaches,0.8402911822757345
TREX1,Dystonic disease,0.8402911822757345
TREX1,High urine occult blood,0.8402911822757345
TREX1,Apraxias,0.8402911822757345
TREX1,Liver Dysfunction,0.8402911822757345
TREX1,Telangiectasis,0.8402911822757345
TREX1,Hematuria,0.8578473133580928
TREX1,Mental deterioration,0.8610447277138289
TREX1,Cerebrovascular accident,0.8648405521677974
TREX1,Subclinical abnormal liver function tests,0.8648405521677974
TREX1,Transaminases increased,0.8648405521677974
TREX1,Elevated liver enzymes,0.8648405521677974
TREX1,Increased liver function tests,0.8648405521677974
TREX1,Liver enzymes abnormal,0.8648405521677974
TREX1,Liver function tests abnormal finding,0.8648405521677974
TREX1,Migraine Disorders,0.8648405521677974
TREX1,Elevated hepatic transaminases,0.8648405521677974
TREX1,Chlamydia Infections,0.8648405521677974
TREX1,Extrapyramidal Disorders,0.8648405521677974
TREX1,Hepatosplenomegaly,0.8648405521677974
TREX1,Hemiparesis,0.876210765330195
TREX1,Profound intellectual disabilities,0.876210765330195
TREX1,Proteinuria,0.8769418330148872
TREX1,Inclusion Body Myopathy Sporadic,0.8769418330148872
TREX1,Inflammatory disorder,0.882453254162044
TREX1,Leukoencephalopathies,0.9154499654632742
TREX1,Epileptic encephalopathy,0.917543617287358
TREX1,Influenza,0.9193385822373632
TREX1,Encephalopathies,0.9265708351135048
TREX1,Intellectual Disability,0.9478210444156088
TREX1,Seizures,0.9478210444156088
TREX1,Leukodystrophy,0.954882372756482
TREX1,Muscle Spasticity,0.9564633032157428
TREX1,Epilepsy,0.963331724428282
TREX1,Brain Diseases,0.9740616963450036
TREX1,Dysarthria,0.9972800266537104
TREX1,Stroke,0.7765582368651238
TREX1,Spastic Quadriplegia,0.7765582368651238
TREX1,Nonbacterial Verrucal Endocardiosis,0.7765582368651238
TREX1,Macular Edema,0.7765582368651238
TREX1,Gastric Polyposis,0.7765582368651238
TREX1,Lymphocytic Leukemia,0.7765582368651238
TREX1,Chilblain Lesions,0.7765582368651238
TREX1,Pseudo-TORCH Syndrome,0.7765582368651238
TREX1,Degeneration Of The Striatum,0.7765582368651238
TREX1,Enchondroma,0.7765582368651238
TREX1,Aicardi Goutieres Syndrome,0.7765582368651238
TREX1,Plagiocephaly,0.7765582368651238
TREX1,Lipoatrophy,0.7765582368651238
TREX1,Nystagmus,0.7765582368651238
TREX1,Psychosis,0.7765582368651238
TREX1,Developmental Delay,0.7765582368651238
TREX1,Alloimmune Thrombocytopenia,0.7765582368651238
TREX1,Renal Glomerular Disease,0.7765582368651238
TREX1,Hypoplasia Of Corpus Callosum,0.7949861636679444
TREX1,Leukopenia,0.8091514409416879
TREX1,Retinal Diseases,0.8115918568696846
TREX1,Micronodular Cirrhosis,0.8115918568696846
TREX1,Panniculitis,0.8115918568696846
TREX1,Vasculitis,0.8115918568696846
TREX1,Lipodystrophy,0.8115918568696846
TREX1,Leukodystrophy,0.8115918568696846
TREX1,Raynaud Phenomenon,0.8115918568696846
TREX1,Hemiplegia/hemiparesis,0.8115918568696846
TREX1,Penis Agenesis,0.8115918568696846
TREX1,Acquired Porencephaly,0.8115918568696846
TREX1,Porencephalic Cyst,0.8165359516083085
TREX1,Kidney Disease,0.8210988731657684
TREX1,Cutis Marmorata,0.831108575640545
TREX1,Pleuritis,0.8337953215113012
TREX1,Mental Retardation,0.8337953215113012
TREX1,Cerebral Atrophy,0.8339308890552987
TREX1,Systemic Lupus Erythematosus,0.8356859041719433
TREX1,Pericarditis,0.8457525389282121
TREX1,Apraxia,0.8457525389282121
TREX1,Arrhinencephaly,0.8476516371290275
TREX1,Autoinflammatory Disease,0.8476516371290275
TREX1,Cerebellar Hypoplasia,0.8601151608808731
TREX1,Demyelinating Neuropathy,0.861756360478846
TREX1,Glaucoma Congenital,0.861756360478846
TREX1,Dementia,0.861756360478846
TREX1,Hypothyroidism,0.8879896755141929
TREX1,Microcephaly,0.8903630091389316
TREX1,Myositis,0.8903630091389316
TREX1,Glaucoma,0.8903630091389316
TREX1,Strabismus,0.8908485337686392
TREX1,Brain Atrophy,0.9024492468099392
TREX1,Arthritis,0.9046917974656596
TREX1,Lupus Erythematosus,0.9145387439550552
TREX1,Diabetes Mellitus,0.919442421650838
TREX1,Scoliosis,0.924275664330454
TREX1,Anemia,0.9369188149054885
TREX1,Dwarfism,0.9510372690456612
TREX1,Leukoencephalopathy,0.9540785594585928
TREX1,Aortic Aneurysm,0.9543024119762946
TREX1,Nephritis,0.957165873648102
TREX1,Developmental Regression,0.9658957825498884
TREX1,Migraine,0.9658957825498884
TREX1,Hypertrophic Cardiomyopathy,0.9726837163662044
TREX1,Ptosis,0.9832345076528324
TREX1,Dysarthria,0.988987376043163
TREX1,Epileptic Encephalopathy,0.9969015583346668
TREX1,Predisposition to severe viral infection due to IRF7 deficiency ORPHA:574918,0.0155394890951578
TREX1,Retinal vasculopathy with cerebral leukoencephalopathy and systemic manifestations ORPHA:247691,0.0155394890951578
TREX1,Mendelian susceptibility to mycobacterial diseases due to complete ISG15 deficiency ORPHA:319563,0.1040670578681756
TREX1,Hypohidrotic ectodermal dysplasia with immunodeficiency ORPHA:98813,0.1054066549396977
TREX1,Marinesco-Sjogren syndrome ORPHA:559,0.1054066549396977
TREX1,Aicardi-Goutieres syndrome ORPHA:51,0.1294848460749822
TREX1,Stormorken-Sjaastad-Langslet syndrome ORPHA:3204,0.1991445465001551
TREX1,Revesz syndrome ORPHA:3088,0.3832844616405875
TREX1,Herpes simplex virus encephalitis ORPHA:1930,0.3977968344535308
TREX1,Proteasome-associated autoinflammatory syndrome ORPHA:324977,0.5867963421058087
TREX1,Familial Chilblain lupus ORPHA:481662,0.5867963421058087
TREX1,Systemic lupus erythematosus ORPHA:536,0.8922466888454011
TRIM13,Malignant neoplasm of breast,0.4084380369379369
TRIM13,Breast Carcinoma,0.7333611688795861
TRIM13,Carcinogenesis,0.7333611688795861
TRIM13,Malignant neoplasm of ovary,0.7333611688795861
TRIM13,B-Cell Lymphomas,0.7333611688795861
TRIM13,leukemia,0.7333611688795861
TRIM13,Ovarian Carcinoma,0.7333611688795861
TRIM13,Colorectal Carcinoma,0.7765852775619541
TRIM13,Leukemia Myelocytic Acute,0.7765852775619541
TRIM13,Lymphoma,0.7765852775619541
TRIM13,Cholestatic liver disease,0.7765852775619541
TRIM13,Adenoma,0.7765852775619541
TRIM13,Glioma,0.7880542567584415
TRIM13,Malignant neoplasm of prostate,0.7880542567584415
TRIM13,Lymphoma Non-Hodgkin,0.7880542567584415
TRIM13,Liver carcinoma,0.7880542567584415
TRIM13,Osteosarcoma,0.7880542567584415
TRIM13,Ataxia Telangiectasia,0.7880542567584415
TRIM13,Colorectal Cancer,0.7880542567584415
TRIM13,Tumor Promotion,0.7880542567584415
TRIM13,Glioblastoma,0.7880542567584415
TRIM13,Osteosarcoma of bone,0.7880542567584415
TRIM13,Prostate carcinoma,0.7880542567584415
TRIM13,Astrocytoma,0.7880542567584415
TRIM13,Parathyroid Adenoma,0.7880542567584415
TRIM13,Immunologic Deficiency Syndromes,0.7880542567584415
TRIM13,Malignant Neoplasms,0.7880542567584415
TRIM13,Hematologic Neoplasms,0.7880542567584415
TRIM13,melanoma,0.7880542567584415
TRIM13,Multiple Myeloma,0.7880542567584415
TRIM13,Adenoviral infections,0.7880542567584415
TRIM13,Brain Neoplasms,0.7880542567584415
TRIM13,Sarcoma,0.7880542567584415
TRIM13,Tumor Initiation,0.7880542567584415
TRIM13,Alzheimer's Disease,0.7880542567584415
TRIM13,Acute lymphocytic leukemia,0.7880542567584415
TRIM13,Solid Neoplasm,0.7880542567584415
TRIM13,X-linked agammaglobulinemia with growth hormone deficiency,0.7880542567584415
TRIM13,Hypoparathyroidism - autosomal dominant,0.7880542567584415
TRIM13,Adult Lymphoma,0.7880542567584415
TRIM13,Acute Cerebrovascular Accidents,0.7880542567584415
TRIM13,Autosomal dominant hypocalcemia,0.7880542567584415
TRIM13,Childhood Lymphoma,0.7880542567584415
TRIM13,Cholestasis,0.7880542567584415
TRIM13,Virus Diseases,0.7880542567584415
TRIM13,Carney Complex Type 1,0.7880542567584415
TRIM13,Primary malignant neoplasm,0.7908231553833205
TRIM13,Leukopenia,0.8019075543217649
TRIM13,Chronic Lymphocytic Leukemia,0.8019075543217649
TRIM13,Liver neoplasms,0.8019075543217649
TRIM13,Precursor B-cell lymphoblastic leukemia,0.8168901801930506
TRIM13,Precursor Cell Lymphoblastic Leukemia Lymphoma,0.8190761496232595
TRIM13,Secondary malignant neoplasm of lung,0.8232134984476662
TRIM13,Genitourinary Cancer,0.8402911822757345
TRIM13,Icterus,0.8402911822757345
TRIM13,MYELOPROLIFERATIVE DISORDER CHRONIC WITH EOSINOPHILIA,0.8402911822757345
TRIM13,Hypoparathyroidism,0.8402911822757345
TRIM13,Restenosis,0.8508164886128737
TRIM13,Childhood Leukemia,0.8610447277138289
TRIM13,Obesity,0.8989612563669234
TRIM13,Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor,0.8989612563669234
TRIM13,Neutropenia,0.9387505562433404
TRIM13,Cardiomyopathy Dilated,0.9564633032157428
TRIM13,Hypothyroidism,0.9816840072553962
TRIM13,MEGDEL syndrome ORPHA:352328,0.7929682744768703
TRIM13,Dyggve-Melchior-Clausen disease ORPHA:239,0.8922466888454011
TRIM13,Smith-McCort dysplasia ORPHA:178355,0.8922466888454011
TRIM13,Macrocephaly-intellectual disability-autism syndrome ORPHA:210548,0.8922466888454011
TRIM13,Human herpesvirus 3 strain Dumas ring-finger protein,0.8999095837312036
TRIM13,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.8999095837312036
TRIM15,Colon Carcinoma,0.7765852775619541
TRIM15,Malignant tumor of colon,0.7765852775619541
TRIM15,Rheumatoid Arthritis,0.7880542567584415
TRIM15,Vitiligo,0.8019075543217649
TRIM15,Psoriasis,0.8019075543217649
TRIM15,Vitiligo,0.7765582368651238
TRIM15,Ulcerative Colitis,0.861756360478846
TRIM15,Rheumatoid Arthritis,0.9251646147729308
TRIM15,Alkaptonuria ORPHA:56,0.1991445465001551
TRIM15,HNF1B-related autosomal dominant tubulointerstitial kidney disease ORPHA:93111,0.3832844616405875
TRIM15,Autosomal dominant preaxial polydactyly-upperback hypertrichosis syndrome ORPHA:476119,0.3832844616405875
TRIM15,Chromophobe renal cell carcinoma ORPHA:319303,0.3832844616405875
TRIM15,Hyperinsulinism due to HNF1A deficiency ORPHA:324575,0.3832844616405875
TRIM15,Hyperinsulinism due to HNF4A deficiency ORPHA:263455,0.3832844616405875
TRIM15,Bilateral multicystic dysplastic kidney ORPHA:97364,0.5867963421058087
TRIM15,Medullary sponge kidney ORPHA:1309,0.5867963421058087
TRIM15,Renal dysplasia bilateral ORPHA:93173,0.5867963421058087
TRIM15,Renal dysplasia unilateral ORPHA:93172,0.5867963421058087
TRIM15,Unilateral multicystic dysplastic kidney ORPHA:97363,0.5867963421058087
TRIM15,Acrocapitofemoral dysplasia ORPHA:63446,0.7929682744768703
TRIM15,Aromatic L-amino acid decarboxylase deficiency ORPHA:35708,0.7929682744768703
TRIM15,CIDEC-related familial partial lipodystrophy ORPHA:435651,0.7929682744768703
TRIM15,Progressive familial intrahepatic cholestasis type 5 ORPHA:480476,0.7929682744768703
TRIM15,X-linked Charcot-Marie-Tooth disease type 1 ORPHA:101075,0.7929682744768703
TRIM15,X-linked progressive cerebellar ataxia ORPHA:1175,0.7929682744768703
TRIM15,Phosphoenolpyruvate carboxykinase deficiency ORPHA:2880,0.7929682744768703
TRIM15,Early-onset anterior polar cataract ORPHA:98988,0.795266832401002
TRIM15,NON RARE IN EUROPE: Heterozygous familial hypercholesterolemia ORPHA:406,0.8105918570729571
TRIM15,Congenital chloride diarrhea ORPHA:53689,0.8922466888454011
TRIM15,Congenital sucrase-isomaltase deficiency ORPHA:35122,0.8922466888454011
TRIM15,Hemolytic anemia due to red cell pyruvate kinase deficiency ORPHA:766,0.8922466888454011
TRIM15,Marie Unna hereditary hypotrichosis ORPHA:444,0.8922466888454011
TRIM15,Homozygous familial hypercholesterolemia ORPHA:391665,0.8922466888454011
TRIM15,Cirrhosis-dystonia-polycythemia-hypermanganesemia syndrome ORPHA:309854,0.8922466888454011
TRIM15,Hartnup disease ORPHA:2116,0.8922466888454011
TRIM15,Human herpesvirus 3 strain Dumas ring-finger protein,0.8999095837312036
TRIM15,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.8999095837312036
TRIM15,Human alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
TRIM15,Papiine alphaherpesvirus 2 envelope glycoprotein C (gene: UL44),0.8999095837312036
TRIM47,Carcinogenesis,0.7333611688795861
TRIM47,Non-Small Cell Lung Carcinoma,0.7765852775619541
TRIM47,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
TRIM47,Familial cortical myoclonus ORPHA:319189,0.1991445465001551
TRIM47,Epidermolysis bullosa simplex with pyloric atresia ORPHA:158684,0.1991445465001551
TRIM47,Muscular dystrophy Selcen type ORPHA:199340,0.3832844616405875
TRIM47,Congenital bile acid synthesis defect type 1 ORPHA:79301,0.5867963421058087
TRIM47,Hyperammonemia due to N-acetylglutamate synthase deficiency ORPHA:927,0.5867963421058087
TRIP10,Malignant neoplasm of breast,0.4084380369379369
TRIP10,Breast Carcinoma,0.7333611688795861
TRIP10,Carcinogenesis,0.7333611688795861
TRIP10,Malignant neoplasm of ovary,0.7333611688795861
TRIP10,Ovarian Carcinoma,0.7333611688795861
TRIP10,Cervix carcinoma,0.7765852775619541
TRIP10,Adenoma,0.7765852775619541
TRIP10,Malignant tumor of cervix,0.7768809924982332
TRIP10,Mammary Neoplasms,0.7880542567584415
TRIP10,Malignant neoplasm of prostate,0.7880542567584415
TRIP10,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
TRIP10,Prostate carcinoma,0.7880542567584415
TRIP10,cervical cancer,0.7880542567584415
TRIP10,Neoplasm Metastasis,0.7880542567584415
TRIP10,Triple Negative Breast Neoplasms,0.7880542567584415
TRIP10,Malignant neoplasm of liver,0.7880542567584415
TRIP10,Bile duct carcinoma,0.7880542567584415
TRIP10,Brain Neoplasms,0.7880542567584415
TRIP10,Huntington Disease,0.7880542567584415
TRIP10,Chronic Lymphocytic Leukemia,0.8019075543217649
TRIP10,Secondary malignant neoplasm of lung,0.8232134984476662
TRIP10,Streptococcal pneumonia,0.8368219249856942
TRIP10,Cholangiocarcinoma,0.8402911822757345
TRIP10,Lobar Pneumonia,0.9098977259629772
TRIP10,Mucocutaneous Lymph Node Syndrome,0.914995991166204
TRIP10,Autosomal dominant Charcot-Marie-Tooth disease type 2F ORPHA:99940,0.0414176838632111
TRIP10,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.1040670578681756
TRIP10,Early-onset posterior subcapsular cataract ORPHA:441447,0.220389120533256
TRIP10,Early-onset posterior polar cataract ORPHA:98993,0.2475924359068358
TRIP10,Giant cell glioblastoma ORPHA:251579,0.2844858212863536
TRIP10,Gliosarcoma ORPHA:251576,0.2844858212863536
TRIP10,Atypical Werner syndrome ORPHA:79474,0.3832844616405875
TRIP10,Autosomal recessive Emery-Dreifuss muscular dystrophy ORPHA:98855,0.3832844616405875
TRIP10,Autosomal semi-dominant severe lipodystrophic laminopathy ORPHA:280365,0.3832844616405875
TRIP10,Charcot-Marie-Tooth disease type 2B1 ORPHA:98856,0.3832844616405875
TRIP10,Congenital muscular dystrophy due to LMNA mutation ORPHA:157973,0.3832844616405875
TRIP10,Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome ORPHA:2229,0.3832844616405875
TRIP10,Familial dilated cardiomyopathy with conduction defect due to LMNA mutation ORPHA:300751,0.3832844616405875
TRIP10,Familial partial lipodystrophy Dunnigan type ORPHA:2348,0.3832844616405875
TRIP10,Familial partial lipodystrophy Kobberling type ORPHA:79084,0.3832844616405875
TRIP10,Heart-hand syndrome Slovenian type ORPHA:168796,0.3832844616405875
TRIP10,LMNA-related cardiocutaneous progeria syndrome ORPHA:363618,0.3832844616405875
TRIP10,Mandibuloacral dysplasia with type A lipodystrophy ORPHA:90153,0.3832844616405875
TRIP10,Muscular dystrophy Selcen type ORPHA:199340,0.3832844616405875
TRIP10,Progressive familial intrahepatic cholestasis type 4 ORPHA:480483,0.3832844616405875
TRIP10,Quebec platelet disorder ORPHA:220436,0.3832844616405875
TRIP10,Cap myopathy ORPHA:171881,0.3832844616405875
TRIP10,Thyroid ectopia ORPHA:95712,0.3832844616405875
TRIP10,Congenital hereditary endothelial dystrophy type II ORPHA:293603,0.5867963421058087
TRIP10,Corneal dystrophy-perceptive deafness syndrome ORPHA:1490,0.5867963421058087
TRIP10,Dopa-responsive dystonia due to sepiapterin reductase deficiency ORPHA:70594,0.5867963421058087
TRIP10,Severe congenital hypochromic anemia with ringed sideroblasts ORPHA:300298,0.5867963421058087
TRIP10,Craniofrontonasal dysplasia ORPHA:1520,0.7929682744768703
TRIP10,Male infertility due to large-headed multiflagellar polyploid spermatozoa ORPHA:137893,0.7929682744768703
TRIP10,Lipoid proteinosis ORPHA:530,0.8922466888454011
TRIP10,NON RARE IN EUROPE: Primary adult open-angle glaucoma ORPHA:353225,0.8922466888454011
TRIP10,Human immunodeficiency virus nef protein (gene: nef),0.8999095837312036
TRIP10,Variola virus hypothetical protein (gene: B20R),0.8999095837312036
TRIP10,Ectromelia virus ERPV IFN alpha/beta receptor,0.8999095837312036
TRIP10,Vaccinia virus Ankara 150k A-type inclusion protein (ATI) f1,0.8999095837312036
TRIP10,Pichinde mammarenavirus N protein,0.8999095837312036
TRIP10,Hendra henipavirus phosphoprotein P (gene: P/V/C),0.8999095837312036
TRIP10,Nipah henipavirus P phosphoprotein,0.8999095837312036
TRIP10,Human gammaherpesvirus 4 EBNA-2 nuclear protein (gene: BYRF1),0.9057542447893764
TRIP10,Human herpesvirus 4 type 2 EBNA-2,0.9057542447893764
TRIP10,Cercopithecine betaherpesvirus 5 membrane glycoprotein US2 (gene: US2),0.9287050575620676
TRIP10,Mumps virus phoshoprotein (gene: V/P),0.9597398910543528
TRIP10,Mumps virus genotype G phosphoprotein (gene: P),0.9626366082099888
TSC22D2,Moyamoya Disease,0.8611702959552964
TSC22D2,Acromelic frontonasal dysplasia ORPHA:1827,0.1040670578681756
TSC22D2,Spinocerebellar ataxia type 2 ORPHA:98756,0.8922466888454011
TSPAN5,drug response,0.7880542567584415
TSPAN5,Rheumatoid Arthritis,0.9251646147729308
TSPAN5,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
TSPAN5,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
TSPAN5,Intellectual disability-developmental delay-contractures syndrome ORPHA:3454,0.5867963421058087
TSPAN5,Proximal symphalangism ORPHA:3250,0.5867963421058087
TSPAN5,Multiple synostoses syndrome ORPHA:3237,0.8922466888454011
TSPAN5,Congenital ichthyosis-intellectual disability-spastic quadriplegia syndrome ORPHA:352333,0.8922466888454011
TSPAN5,Spinocerebellar ataxia type 34 ORPHA:1955,0.8922466888454011
TUBB3,Malignant neoplasm of breast,0.4084380369379369
TUBB3,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
TUBB3,Breast Carcinoma,0.7333611688795861
TUBB3,Malignant neoplasm of ovary,0.7333611688795861
TUBB3,Ovarian Carcinoma,0.7333611688795861
TUBB3,Adenocarcinoma,0.750391252594775
TUBB3,Colorectal Carcinoma,0.7765852775619541
TUBB3,Non-Small Cell Lung Carcinoma,0.7765852775619541
TUBB3,Segmental dystonia,0.7765852775619541
TUBB3,Amblyopia,0.7765852775619541
TUBB3,Carcinoma breast stage IV,0.7765852775619541
TUBB3,Laryngeal dystonia,0.7765852775619541
TUBB3,Mammary Neoplasms,0.7880542567584415
TUBB3,Malignant neoplasm of prostate,0.7880542567584415
TUBB3,Colorectal Cancer,0.7880542567584415
TUBB3,Glioblastoma,0.7880542567584415
TUBB3,Prostate carcinoma,0.7880542567584415
TUBB3,Agyria,0.7880542567584415
TUBB3,Neoplasm Metastasis,0.7880542567584415
TUBB3,Prostatic Neoplasms,0.7880542567584415
TUBB3,Neuroblastoma,0.7880542567584415
TUBB3,Hoarseness,0.7880542567584415
TUBB3,Central neuroblastoma,0.7880542567584415
TUBB3,Malignant Neoplasms,0.7880542567584415
TUBB3,Lung Neoplasms,0.7880542567584415
TUBB3,Extraskeletal Myxoid Chondrosarcoma,0.7880542567584415
TUBB3,Metastatic malignant neoplasm to brain,0.7880542567584415
TUBB3,Lissencephaly,0.7880542567584415
TUBB3,Malformations of Cortical Development,0.7880542567584415
TUBB3,Well Differentiated Oligodendroglioma,0.7880542567584415
TUBB3,oligodendroglioma,0.7880542567584415
TUBB3,Tumor Progression,0.7880542567584415
TUBB3,Congenital Fibrosis of the Extraocular Muscles,0.7880542567584415
TUBB3,Hypoplasia of corpus callosum,0.7880542567584415
TUBB3,Nystagmus,0.7880542567584415
TUBB3,Chondrosarcoma,0.7880542567584415
TUBB3,Cognitive delay,0.7880542567584415
TUBB3,Mixed sensory-motor polyneuropathy,0.7880542567584415
TUBB3,Squamous cell carcinoma,0.7880542567584415
TUBB3,Solid Neoplasm,0.7880542567584415
TUBB3,Malformations of Cortical Development Group II,0.7880542567584415
TUBB3,Global developmental delay,0.7880542567584415
TUBB3,Vocal Cord Paralysis,0.7880542567584415
TUBB3,Mental and motor retardation,0.7880542567584415
TUBB3,Mobius Syndrome,0.7880542567584415
TUBB3,Moderate mental retardation (I.Q. 35-49),0.8009048756462318
TUBB3,Oropharyngeal Carcinoma,0.8019075543217649
TUBB3,Cortical Dysplasia,0.8019075543217649
TUBB3,Kallmann Syndrome,0.8067197998685076
TUBB3,ovarian neoplasm,0.8067197998685076
TUBB3,Malignant transformation,0.8168901801930506
TUBB3,Klinefelter Syndrome,0.8190761496232595
TUBB3,Exotropia,0.8190761496232595
TUBB3,Dysphonia,0.8190761496232595
TUBB3,Desmoplastic,0.8190761496232595
TUBB3,Hypoglycemia,0.8232134984476662
TUBB3,Dystonia Disorders,0.8232134984476662
TUBB3,Vomiting,0.8270909867833504
TUBB3,Muscular hypotonia of the trunk,0.8270909867833504
TUBB3,Malignant neoplasm of oropharynx,0.8272008757995397
TUBB3,Hypoplasia of the brainstem,0.834094492023826
TUBB3,Glioblastoma Multiforme,0.8342163953428735
TUBB3,Cerebellar Hypoplasia,0.8402911822757345
TUBB3,Congenital Abnormality,0.8402911822757345
TUBB3,Strabismus,0.8402911822757345
TUBB3,Dystonia,0.8402911822757345
TUBB3,Ptosis,0.8402911822757345
TUBB3,Macular dystrophy corneal type 1,0.8402911822757345
TUBB3,Malonic aciduria,0.8402911822757345
TUBB3,Medulloblastoma,0.8548862007194026
TUBB3,Polymicrogyria,0.8584283190330553
TUBB3,Hypogonadotropic hypogonadism,0.8769418330148872
TUBB3,Mammary Neoplasms Human,0.8815127642200768
TUBB3,Secondary malignant neoplasm of lymph node,0.900167961295542
TUBB3,Epileptic encephalopathy,0.917543617287358
TUBB3,Rash and Dermatitis Adverse Event Associated with Chemoradiation,0.9366917377729386
TUBB3,Refractory cancer,0.9377696084218796
TUBB3,Cerebrovascular Disorders,0.9387505562433404
TUBB3,Intellectual Disability,0.9478210444156088
TUBB3,Muscle Spasticity,0.9564633032157428
TUBB3,Charcot-Marie-Tooth Disease,0.963331724428282
TUBB3,Agenesis of corpus callosum,0.9701053690483854
TUBB3,Blepharoptosis,0.9770263358372888
TUBB3,Small head,0.9822381479823692
TUBB3,Stereotyped Behavior,0.7765582368651238
TUBB3,Spastic Quadriplegia,0.7765582368651238
TUBB3,Oculovestibuloauditory Syndrome,0.7765582368651238
TUBB3,Ovarian Neoplasm,0.7765582368651238
TUBB3,Focal Seizures,0.7765582368651238
TUBB3,Oculomotor Apraxia,0.7765582368651238
TUBB3,Hypoplasia Of The Olfactory Bulb,0.7765582368651238
TUBB3,Dysgenesis Of The Hippocampus,0.7765582368651238
TUBB3,Dysautonomia,0.7765582368651238
TUBB3,Lissencephaly,0.7765582368651238
TUBB3,Cubitus Valgus,0.7765582368651238
TUBB3,Partial Agenesis Of Corpus Callosum,0.7765582368651238
TUBB3,Cortical Dysplasia With Other Brain Malformations,0.7765582368651238
TUBB3,Plagiocephaly,0.7765582368651238
TUBB3,Nystagmus,0.7765582368651238
TUBB3,Cortical Dysplasia,0.7765582368651238
TUBB3,Developmental Delay,0.7765582368651238
TUBB3,Macrocephaly,0.7765582368651238
TUBB3,Polymicrogyria,0.7765582368651238
TUBB3,Spastic Ataxia,0.7765582368651238
TUBB3,Ovarian Cancer,0.7797212851906329
TUBB3,Hypoplasia Of Corpus Callosum,0.7949861636679444
TUBB3,Cobblestone Lissencephaly,0.8082616889285628
TUBB3,Congenital Microcephaly,0.8115918568696846
TUBB3,Malformation Of Cortical Development,0.8115918568696846
TUBB3,Social Communication Disorder,0.8115918568696846
TUBB3,Mammary Neoplasms,0.8165359516083085
TUBB3,Exotropia,0.8201196687803188
TUBB3,Spastic Diplegia,0.8337953215113012
TUBB3,Mental Retardation,0.8337953215113012
TUBB3,Marfan Syndrome,0.8477374749042494
TUBB3,Cerebellar Hypoplasia,0.8601151608808731
TUBB3,Hypoplasia Of The Optic Nerve,0.8903301324869451
TUBB3,Microcephaly,0.8903630091389316
TUBB3,Esotropia,0.8903630091389316
TUBB3,Breast Cancer,0.8903630091389316
TUBB3,Strabismus,0.8908485337686392
TUBB3,Mood Swings,0.9069867032339078
TUBB3,Acquired Kyphoscoliosis,0.9145387439550552
TUBB3,Congenital Kyphoscoliosis,0.9147194468246628
TUBB3,Micrognathism,0.9398381935810408
TUBB3,Breast Carcinoma,0.9398381935810408
TUBB3,Sensorineural Hearing Loss,0.9543024119762946
TUBB3,Hydrocephalus,0.9574431947800732
TUBB3,High Palate,0.9578111936867284
TUBB3,Multiple Congenital Anomalies,0.963385108667098
TUBB3,Congenital Epicanthus,0.974502015052702
TUBB3,Agenesis Of Corpus Callosum,0.980894832851993
TUBB3,Ptosis,0.9832345076528324
TUBB3,Dysarthria,0.988987376043163
TUBB3,Classic glucose transporter type 1 deficiency syndrome ORPHA:71277,0.0155394890951578
TUBB3,Hereditary cryohydrocytosis with reduced stomatin ORPHA:168577,0.0155394890951578
TUBB3,Paroxysmal dystonic choreathetosis with episodic ataxia and spasticity ORPHA:53583,0.0155394890951578
TUBB3,Spinocerebellar ataxia type 21 ORPHA:98773,0.0155394890951578
TUBB3,Paroxysmal exertion-induced dyskinesia ORPHA:98811,0.0155394890951578
TUBB3,Autosomal recessive spondylocostal dysostosis ORPHA:2311,0.0473879273649914
TUBB3,Hydrocephalus with stenosis of the aqueduct of Sylvius ORPHA:2182,0.1040670578681756
TUBB3,MASA syndrome ORPHA:2466,0.1040670578681756
TUBB3,X-linked complicated corpus callosum dysgenesis ORPHA:1497,0.1040670578681756
TUBB3,X-linked complicated spastic paraplegia type 1 ORPHA:306617,0.1040670578681756
TUBB3,Cold-induced sweating syndrome ORPHA:157820,0.1068643725150898
TUBB3,Distal hereditary motor neuropathy type 5 ORPHA:139536,0.1068643725150898
TUBB3,Familial congenital mirror movements ORPHA:238722,0.2120485863056726
TUBB3,Cortical dysgenesis with pontocerebellar hypoplasia due to TUBB3 mutation ORPHA:300570,0.3832844616405875
TUBB3,9q33.3q34.11 microdeletion syndrome ORPHA:495818,0.3832844616405875
TUBB3,Coloboma of choroid and retina ORPHA:98942,0.3977968344535308
TUBB3,Coloboma of iris ORPHA:98944,0.3977968344535308
TUBB3,Aarskog-Scott syndrome ORPHA:915,0.5867963421058087
TUBB3,Autosomal recessive dopa-responsive dystonia ORPHA:101150,0.5867963421058087
TUBB3,Autosomal recessive spastic paraplegia type 26 ORPHA:101006,0.5867963421058087
TUBB3,Multiple epiphyseal dysplasia type 5 ORPHA:93311,0.5867963421058087
TUBB3,POMT2-related  limb-girdle muscular dystrophy R14 ORPHA:206559,0.5867963421058087
TUBB3,Progressive myoclonic epilepsy type 8 ORPHA:424027,0.5867963421058087
TUBB3,Spondyloepimetaphyseal dysplasia matrilin-3 type ORPHA:156728,0.5867963421058087
TUBB3,46XX ovotesticular disorder of sex development ORPHA:2138,0.5867963421058087
TUBB3,Congenital fibrosis of extraocular muscles ORPHA:45358,0.5867963421058087
TUBB3,Myoclonus-dystonia syndrome ORPHA:36899,0.606625035400596
TUBB3,Colobomatous microphthalmia ORPHA:98938,0.6467006456772204
TUBB3,Arnold-Chiari malformation type I ORPHA:268882,0.7929682744768703
TUBB3,Blepharophimosis-ptosis-epicanthus inversus syndrome plus ORPHA:572333,0.7929682744768703
TUBB3,Blepharophimosis-ptosis-epicanthus inversus syndrome type 1 ORPHA:572354,0.7929682744768703
TUBB3,Blepharophimosis-ptosis-epicanthus inversus syndrome type 2 ORPHA:572361,0.7929682744768703
TUBB3,Multiple epiphyseal dysplasia Al-Gazali type ORPHA:166024,0.7929682744768703
TUBB3,Polymicrogyria due to TUBB2B mutation ORPHA:300573,0.7929682744768703
TUBB3,Autosomal spastic paraplegia type 72 ORPHA:401849,0.8922466888454011
TUBB3,Classic homocystinuria ORPHA:394,0.8922466888454011
TUBB3,Early-onset progressive neurodegeneration-blindness-ataxia-spasticity syndrome ORPHA:352654,0.8922466888454011
TUBB3,Neurofibromatosis type 2 ORPHA:637,0.8922466888454011
TUBB3,Tubulinopathy-associated dysgyria ORPHA:467166,0.8922466888454011
TUBB3,Tetraamelia-multiple malformations syndrome ORPHA:3301,0.8922466888454011
TUBB3,46XX testicular disorder of sex development ORPHA:393,0.8922466888454011
TUBB3,Infantile hypotonia-oculomotor anomalies-hyperkinetic movements-developmental delay syndrome ORPHA:522077,0.8922466888454011
TUBB3,X-linked adrenal hypoplasia congenita ORPHA:95702,0.8922466888454011
TUBB3,Yaba monkey tumor virus ankyrin repeat protein,0.8999095837312036
TUBB3,Yaba-like disease virus 11L protein (gene: 11L),0.8999095837312036
TUBB3,Monkeypox virus Zaire-96-I-16 B5R (gene: B5R),0.8999095837312036
TUBB3,Horsepox virus HSPV020e (ankyrin repeats),0.8999095837312036
TUBB3,Orf virus ORF008 ankyrin repeat protein,0.8999095837312036
TUBB3,Horsepox virus HSPV181 (ankyrin repeats),0.8999095837312036
TUBB3,Orf virus ORF123 ankyrin repeat protein,0.8999095837312036
TUBB3,Vaccinia virus hypothetical protein,0.8999095837312036
TUBB3,Vaccinia virus Ankara 72.4k ankyrin repeat protein f2,0.8999095837312036
TUBB3,Monkeypox virus ankyrin-like protein,0.8999095837312036
TUBB3,Horsepox virus HSPV033c (ankyrin repeats),0.8999095837312036
TUBB3,Horsepox virus HSPV011c (ankyrin repeats),0.8999095837312036
TUBB3,Vaccinia virus Ankara 78.7k Ankyrin repeat protein f1,0.8999095837312036
TUBB3,Vaccinia virus ankyrin-like protein (gene: B4R),0.8999095837312036
TUBB3,Vaccinia virus ankyrin-like protein (gene: C9L),0.8999095837312036
TUBB3,Horsepox virus HSPV201a (ankyrin repeats),0.8999095837312036
TUBB3,Cowpox virus CPXV198 protein (gene: CPXV198 CDS),0.9057542447893764
TUBB3,Ectromelia virus ERPV ankyrin,0.9057542447893764
TUBB3,Orf virus ORF128 ankyrin repeat protein,0.9057542447893764
TUBB3,Horsepox virus HSPV033b (Ankyrin repeats),0.9057542447893764
TUBB3,Orf virus ORF126 ankyrin repeat protein,0.9058994261255549
TUBB3,Vaccinia virus Ankara 54.4k ankyrin repeat protein f1,0.9058994261255549
TUBB3,Horsepox virus HSPV005b (ankyrin repeats),0.915880438522078
TUBB3,Monkeypox virus Zaire-96-I-16 ankyin-like protein (gene: O1L),0.915880438522078
TUBB3,Yaba-like disease virus 8L protein (gene: 8L),0.9224878266317492
TUBB3,Vaccinia virus Ankara 65.4k Ankyrin repeat protein,0.9237501457186692
TUBB3,Vaccinia virus Ankara 54.4k ankyrin repeat protein f2,0.9237501457186692
TUBB3,Variola virus hypothetical protein (gene: B6R),0.9364561700418303
TUBB3,Monkeypox virus Zaire-96-I-16 ankyrin-like protein (gene: D7L),0.9563208507960556
TUBGCP3,Malignant lymphoma lymphocytic intermediate differentiation diffuse,0.7333611688795861
TUBGCP3,Carcinogenesis,0.7333611688795861
TUBGCP3,Glioblastoma,0.7880542567584415
TUBGCP3,Astrocytoma,0.7880542567584415
TUBGCP3,Mucinous Adenocarcinoma,0.7880542567584415
TUBGCP3,Liver neoplasms,0.8019075543217649
TUBGCP3,Primary microcephaly,0.8067197998685076
TUBGCP3,Microcephaly,0.8903630091389316
TUBGCP5,Autistic Disorder,0.8019075543217649
TUBGCP5,Speech Disorders,0.8402911822757345
TUBGCP5,Obsessive compulsive behavior,0.8648405521677974
TUBGCP5,Prader-Willi Syndrome,0.8648405521677974
TUBGCP5,Joubert syndrome ORPHA:475,0.8922466888454011
TUBGCP5,ALG9-CDG ORPHA:79328,0.8922466888454011
TUBGCP5,Holocarboxylase synthetase deficiency ORPHA:79242,0.8922466888454011
TUBGCP6,Cortical gyral simplification,0.7765852775619541
TUBGCP6,Retinal pigment epithelial abnormality,0.7765852775619541
TUBGCP6,Abnormality of retinal pigmentation,0.7765852775619541
TUBGCP6,Biparietal narrowing,0.7880542567584415
TUBGCP6,Decreased width of the skull,0.7880542567584415
TUBGCP6,Muscle Hypertonia,0.7880542567584415
TUBGCP6,Sloping forehead,0.7880542567584415
TUBGCP6,Abnormality of the eyelashes,0.7880542567584415
TUBGCP6,Retinal Diseases,0.7880542567584415
TUBGCP6,Pallor of optic disc,0.7880542567584415
TUBGCP6,Aplasia/Hypoplasia of the cerebellum,0.7880542567584415
TUBGCP6,Low Vision,0.7880542567584415
TUBGCP6,Abnormal pigmentation,0.7880542567584415
TUBGCP6,Supratentorial atrophy,0.7880542567584415
TUBGCP6,Seckel syndrome,0.7880542567584415
TUBGCP6,Nystagmus,0.7880542567584415
TUBGCP6,Protruding ear,0.7880542567584415
TUBGCP6,Anteverted nostril,0.7880542567584415
TUBGCP6,Prominent ear,0.7880542567584415
TUBGCP6,Cognitive delay,0.7880542567584415
TUBGCP6,Visual Impairment,0.7880542567584415
TUBGCP6,Malformations of Cortical Development Group II,0.7880542567584415
TUBGCP6,Degenerative brain disorder,0.7880542567584415
TUBGCP6,Pointed chin,0.7880542567584415
TUBGCP6,Global developmental delay,0.7880542567584415
TUBGCP6,Optic Atrophy,0.7880542567584415
TUBGCP6,Mental and motor retardation,0.7880542567584415
TUBGCP6,Chorioretinal dysplasia,0.7880542567584415
TUBGCP6,Cerebral atrophy,0.8019075543217649
TUBGCP6,Primary microcephaly,0.8067197998685076
TUBGCP6,Retinal Dystrophies,0.8190761496232595
TUBGCP6,Broad flat nasal bridge,0.8213459222602666
TUBGCP6,Nasal bridge wide,0.8232134984476662
TUBGCP6,Microcephaly,0.8232134984476662
TUBGCP6,Cerebellar Hypoplasia,0.8402911822757345
TUBGCP6,Congenital Abnormality,0.8402911822757345
TUBGCP6,Abnormally small eyeball,0.8402911822757345
TUBGCP6,Decreased size of eyeball,0.8402911822757345
TUBGCP6,Strabismus,0.8402911822757345
TUBGCP6,Curvature of spine,0.8402911822757345
TUBGCP6,Pachygyria,0.8402911822757345
TUBGCP6,Mental deficiency,0.8402911822757345
TUBGCP6,Acquired scoliosis,0.8402911822757345
TUBGCP6,Dull intelligence,0.8757755363384367
TUBGCP6,Low intelligence,0.8757755363384367
TUBGCP6,Cataract,0.8769418330148872
TUBGCP6,Short stature,0.8815127642200768
TUBGCP6,Poor school performance,0.8913141512402477
TUBGCP6,Infant Small for Gestational Age,0.9083161862856644
TUBGCP6,Intrauterine retardation,0.9111864999692114
TUBGCP6,Lens Opacities,0.9117936912777788
TUBGCP6,Microphthalmos,0.9154499654632742
TUBGCP6,Mental Retardation,0.922229272318747
TUBGCP6,Retinal Detachment,0.929814249105729
TUBGCP6,Fetal Growth Retardation,0.9307095582633488
TUBGCP6,Intellectual Disability,0.9478210444156088
TUBGCP6,Seizures,0.9478210444156088
TUBGCP6,Epilepsy,0.963331724428282
TUBGCP6,Small head,0.9822381479823692
TUBGCP6,Microcephaly With Chorioretinopathy,0.4532988396145482
TUBGCP6,Retinal Dystrophy,0.7765582368651238
TUBGCP6,Nystagmus,0.7765582368651238
TUBGCP6,Retinal Detachment,0.7765582368651238
TUBGCP6,Developmental Delay,0.7765582368651238
TUBGCP6,Leukemia,0.7765582368651238
TUBGCP6,Optic Atrophy,0.8115918568696846
TUBGCP6,Malformation Of Cortical Development,0.8115918568696846
TUBGCP6,Pachygyria,0.8210988731657684
TUBGCP6,Mental Retardation,0.8337953215113012
TUBGCP6,Cerebral Atrophy,0.8339308890552987
TUBGCP6,Cerebellar Hypoplasia,0.8601151608808731
TUBGCP6,Cerebral Cortical Atrophy,0.861756360478846
TUBGCP6,Microcephaly,0.8903630091389316
TUBGCP6,Strabismus,0.8908485337686392
TUBGCP6,Scoliosis,0.924275664330454
TUBGCP6,Microphthalmos,0.941216656523771
TUBGCP6,Dwarfism,0.9510372690456612
TUBGCP6,Cataract,0.974502015052702
TUBGCP6,Autosomal dominant centronuclear myopathy ORPHA:169189,0.0036432528126817
TUBGCP6,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
TUBGCP6,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
TUBGCP6,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
TUBGCP6,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
TUBGCP6,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
TUBGCP6,Autosomal dominant polycystic kidney disease type 1 with tuberous sclerosis ORPHA:88924,0.0414176838632111
TUBGCP6,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
TUBGCP6,Barth syndrome ORPHA:111,0.0414176838632111
TUBGCP6,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
TUBGCP6,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
TUBGCP6,Megaconial congenital muscular dystrophy ORPHA:280671,0.0414176838632111
TUBGCP6,Proximal myopathy with focal depletion of mitochondria ORPHA:521305,0.0414176838632111
TUBGCP6,Lymphangioleiomyomatosis ORPHA:538,0.0414176838632111
TUBGCP6,Tuberous sclerosis complex ORPHA:805,0.0414176838632111
TUBGCP6,Albers Schonberg osteopetrosis ORPHA:53,0.1040670578681756
TUBGCP6,Autosomal dominant spastic ataxia type 1 ORPHA:251282,0.1040670578681756
TUBGCP6,Cerebellar-facial-dental syndrome ORPHA:444072,0.1040670578681756
TUBGCP6,LIPE-related familial partial lipodystrophy ORPHA:435660,0.1040670578681756
TUBGCP6,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.1040670578681756
TUBGCP6,D-2-hydroxyglutaric aciduria ORPHA:79315,0.1054066549396977
TUBGCP6,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433,0.1991445465001551
TUBGCP6,Birt-Hogg-Dube syndrome ORPHA:122,0.1991445465001551
TUBGCP6,Combined oxidative phosphorylation defect type 27 ORPHA:477774,0.1991445465001551
TUBGCP6,Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635,0.1991445465001551
TUBGCP6,Early-onset progressive encephalopathy-hearing loss-pons hypoplasia-brain atrophy syndrome ORPHA:500144,0.1991445465001551
TUBGCP6,Familial spontaneous pneumothorax ORPHA:2903,0.1991445465001551
TUBGCP6,Hurler syndrome ORPHA:93473,0.1991445465001551
TUBGCP6,Hurler-Scheie syndrome ORPHA:93476,0.1991445465001551
TUBGCP6,Methylmalonic acidemia with homocystinuria type cblJ ORPHA:369955,0.1991445465001551
TUBGCP6,Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228,0.1991445465001551
TUBGCP6,POMT1-related  limb-girdle muscular dystrophy R11 ORPHA:86812,0.1991445465001551
TUBGCP6,Scheie syndrome ORPHA:93474,0.1991445465001551
TUBGCP6,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569,0.1991445465001551
TUBGCP6,CAMOS syndrome ORPHA:83472,0.1991445465001551
TUBGCP6,Cerebellar ataxia-hypogonadism syndrome ORPHA:1173,0.1991445465001551
TUBGCP6,Coats plus syndrome ORPHA:313838,0.1991445465001551
TUBGCP6,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964,0.3832844616405875
TUBGCP6,Classic galactosemia ORPHA:79239,0.3832844616405875
TUBGCP6,Craniosynostosis-dental anomalies ORPHA:284149,0.3832844616405875
TUBGCP6,Distal 16p11.2 microdeletion syndrome ORPHA:261222,0.3832844616405875
TUBGCP6,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316,0.3832844616405875
TUBGCP6,Proximal 16p11.2 microdeletion syndrome ORPHA:261197,0.3832844616405875
TUBGCP6,Severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency ORPHA:329249,0.3832844616405875
TUBGCP6,Deafness-enamel hypoplasia-nail defects syndrome ORPHA:3220,0.3832844616405875
TUBGCP6,Glycogen storage disease due to liver phosphorylase kinase deficiency ORPHA:264580,0.3832844616405875
TUBGCP6,Hermansky-Pudlak syndrome with pulmonary fibrosis ORPHA:231500,0.3832844616405875
TUBGCP6,Isolated focal cortical dysplasia type IIb ORPHA:269008,0.3832844616405875
TUBGCP6,Uveal melanoma ORPHA:39044,0.3977968344535308
TUBGCP6,Alpers-Huttenlocher syndrome ORPHA:726,0.5867963421058087
TUBGCP6,COG1-CDG ORPHA:263508,0.5867963421058087
TUBGCP6,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome ORPHA:459061,0.5867963421058087
TUBGCP6,Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159,0.5867963421058087
TUBGCP6,NEK9-related lethal skeletal dysplasia ORPHA:464366,0.5867963421058087
TUBGCP6,Nevus comedonicus syndrome ORPHA:64754,0.5867963421058087
TUBGCP6,Recessive mitochondrial ataxia syndrome ORPHA:94125,0.5867963421058087
TUBGCP6,Spinocerebellar ataxia with epilepsy ORPHA:254881,0.5867963421058087
TUBGCP6,Autosomal recessive progressive external ophthalmoplegia ORPHA:254886,0.5867963421058087
TUBGCP6,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome ORPHA:70595,0.5867963421058087
TUBGCP6,Autosomal recessive chorioretinopathy-microcephaly syndrome ORPHA:2518,0.5867963421058087
TUBGCP6,Autosomal dominant Charcot-Marie-Tooth disease type 2M ORPHA:228179,0.7929682744768703
TUBGCP6,Autosomal dominant intermediate Charcot-Marie-Tooth disease type B ORPHA:100044,0.7929682744768703
TUBGCP6,Autosomal dominant multiple pterygium syndrome ORPHA:65743,0.7929682744768703
TUBGCP6,Charcot-Marie-Tooth disease type 2S ORPHA:443073,0.7929682744768703
TUBGCP6,Familial LCAT deficiency ORPHA:79293,0.7929682744768703
TUBGCP6,Fetal akinesia-cerebral and retinal hemorrhage syndrome ORPHA:363409,0.7929682744768703
TUBGCP6,Fish-eye disease ORPHA:79292,0.7929682744768703
TUBGCP6,Kleefstra syndrome due to 9q34 microdeletion ORPHA:96147,0.7929682744768703
TUBGCP6,Perlman syndrome ORPHA:2849,0.7929682744768703
TUBGCP6,Primary lateral sclerosis ORPHA:35689,0.7929682744768703
TUBGCP6,Short stature-brachydactyly-obesity-global developmental delay syndrome ORPHA:464288,0.7929682744768703
TUBGCP6,Spastic paraplegia type 7 ORPHA:99013,0.7929682744768703
TUBGCP6,Spinal muscular atrophy with respiratory distress type 1 ORPHA:98920,0.7929682744768703
TUBGCP6,Congenital dyserythropoietic anemia type I ORPHA:98869,0.7929682744768703
TUBGCP6,Primary sclerosing cholangitis ORPHA:171,0.7929682744768703
TUBGCP6,Hereditary diffuse leukoencephalopathy with axonal spheroids and pigmented glia ORPHA:313808,0.8922466888454011
TUBGCP6,Acute infantile liver failure due to synthesis defect of mtDNA-encoded proteins ORPHA:217371,0.8922466888454011
TUBGCP6,Mitochondrial myopathy with reversible cytochrome C oxidase deficiency ORPHA:254864,0.8922466888454011
TUBGCP6,Orf virus ORF057 putative protein-tyrosine phosphatase,0.8999095837312036
TXNIP,Malignant neoplasm of breast,0.4084380369379369
TXNIP,Carcinoma of bladder,0.4084380369379369
TXNIP,Bladder Neoplasm,0.4084380369379369
TXNIP,Malignant neoplasm of urinary bladder,0.5071083164302358
TXNIP,Breast Carcinoma,0.7333611688795861
TXNIP,Diffuse Large B-Cell Lymphoma,0.7333611688795861
TXNIP,Carcinogenesis,0.7333611688795861
TXNIP,leukemia,0.7333611688795861
TXNIP,Malignant neoplasm of pancreas,0.7688485284765829
TXNIP,Pancreatic carcinoma,0.7765852775619541
TXNIP,Leukemia Myelocytic Acute,0.7765852775619541
TXNIP,Malignant neoplasm of body of stomach,0.7765852775619541
TXNIP,Malignant tumor of greater curve of stomach,0.7765852775619541
TXNIP,Malignant tumor of lesser curve of stomach,0.7765852775619541
TXNIP,Adult T-Cell Lymphoma/Leukemia,0.7765852775619541
TXNIP,Pancreatic Neoplasm,0.7765852775619541
TXNIP,Carcinoma breast stage IV,0.7765852775619541
TXNIP,Thyroid Neoplasm,0.7765852775619541
TXNIP,Vascular Diseases,0.7765852775619541
TXNIP,Malignant neoplasm of lung,0.7880542567584415
TXNIP,Malignant neoplasm of prostate,0.7880542567584415
TXNIP,Promyelocytic leukemia,0.7880542567584415
TXNIP,Liver carcinoma,0.7880542567584415
TXNIP,Thyroid carcinoma,0.7880542567584415
TXNIP,Acute Promyelocytic Leukemia,0.7880542567584415
TXNIP,Ataxia Telangiectasia,0.7880542567584415
TXNIP,Leukemia T-Cell,0.7880542567584415
TXNIP,Hepatocarcinogenesis,0.7880542567584415
TXNIP,Prostate carcinoma,0.7880542567584415
TXNIP,Disease Exacerbation,0.7880542567584415
TXNIP,Primary malignant neoplasm of lung,0.7880542567584415
TXNIP,Neoplasm Metastasis,0.7880542567584415
TXNIP,Prostatic Neoplasms,0.7880542567584415
TXNIP,Carcinoma of lung,0.7880542567584415
TXNIP,Cockayne Syndrome Type I,0.7880542567584415
TXNIP,Malignant neoplasm of thyroid,0.7880542567584415
TXNIP,Squamous cell carcinoma of the head and neck,0.7880542567584415
TXNIP,Triple Negative Breast Neoplasms,0.7880542567584415
TXNIP,Nodular glomerulosclerosis,0.7880542567584415
TXNIP,Malignant Neoplasms,0.7880542567584415
TXNIP,melanoma,0.7880542567584415
TXNIP,Multiple Myeloma,0.7880542567584415
TXNIP,Retinal Diseases,0.7880542567584415
TXNIP,Pregnancy in Diabetics,0.7880542567584415
TXNIP,Neoplasms,0.7880542567584415
TXNIP,Lymphoid hyperplasia,0.7880542567584415
TXNIP,Malignant neoplasm of stomach,0.7880542567584415
TXNIP,Myxoid cyst,0.7880542567584415
TXNIP,Adult Hepatocellular Carcinoma,0.7880542567584415
TXNIP,Malignant mesothelioma,0.7880542567584415
TXNIP,Benign Prostatic Hyperplasia,0.7880542567584415
TXNIP,Brain Neoplasms,0.7880542567584415
TXNIP,ACTH-Secreting Pituitary Adenoma,0.7880542567584415
TXNIP,Renal Cell Carcinoma,0.7880542567584415
TXNIP,Insulin resistance in diabetes,0.7880542567584415
TXNIP,Coronary Arteriosclerosis,0.7880542567584415
TXNIP,Stomach Carcinoma,0.7880542567584415
TXNIP,Hyperlipidemia Familial Combined,0.7880542567584415
TXNIP,Glaucoma,0.7880542567584415
TXNIP,obsolete Combined hyperlipidemia,0.7880542567584415
TXNIP,Rheumatoid Arthritis,0.7880542567584415
TXNIP,Diabetes,0.7880542567584415
TXNIP,Diabetes Mellitus,0.7880542567584415
TXNIP,Hyperglycemia,0.7880542567584415
TXNIP,Wolfram Syndrome,0.7880542567584415
TXNIP,Primary malignant neoplasm,0.7908231553833205
TXNIP,Hyperinsulinism,0.8019075543217649
TXNIP,Stomach Neoplasms,0.8044379824544406
TXNIP,Schizophrenia,0.8067197998685076
TXNIP,Dyslipidemias,0.8138488881521341
TXNIP,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
TXNIP,Ulcerative Colitis,0.8190761496232595
TXNIP,Diabetes Mellitus Non-Insulin-Dependent,0.8190761496232595
TXNIP,Inflammation,0.8212681436603975
TXNIP,Hypoglycemia,0.8232134984476662
TXNIP,Neurodegenerative Disorders,0.8272008757995397
TXNIP,Diabetic Retinopathy,0.8402911822757345
TXNIP,Steatohepatitis,0.8402911822757345
TXNIP,Endothelial dysfunction,0.8402911822757345
TXNIP,Hypertensive disease,0.8474481237156937
TXNIP,Adrenal Cushing's syndrome,0.8578473133580928
TXNIP,Fatty Liver,0.8628363180844141
TXNIP,Diabetic Cardiomyopathies,0.8642802827048847
TXNIP,Myocardial Ischemia,0.8648405521677974
TXNIP,Cushing Syndrome,0.882453254162044
TXNIP,Gestational Diabetes,0.882453254162044
TXNIP,Cytopenia,0.9001392794088324
TXNIP,Congenital anemia,0.9015731019095328
TXNIP,Hypertriglyceridemia,0.9154499654632742
TXNIP,Anoxia,0.9184153253162451
TXNIP,Diabetic Nephropathy,0.9390727893210336
TXNIP,Hepatitis,0.939985154445373
TXNIP,Acidosis Lactic,0.942246125102556
TXNIP,Endometriosis,0.960644037248553
TXNIP,Differentiated Thyroid Gland Carcinoma,0.9639249377588224
TXNIP,Tumor Angiogenesis,0.9656926709728724
TXNIP,Asthma,0.9672478180546946
TXNIP,Hyperlipidemia,0.9676817033456722
TXNIP,Impaired glucose tolerance,0.9734506818882446
TXNIP,Endometrioma,0.992026975660552
TXNIP,Non-alcoholic Fatty Liver Disease,0.9924277189223056
TXNIP,Diabetic Nephropathy,0.7765582368651238
TXNIP,Glomerulosclerosis,0.7765582368651238
TXNIP,Diffuse Lymphoma,0.7765582368651238
TXNIP,Rheumatoid Arthritis,0.9251646147729308
TXNIP,Endometriosis,0.9726139569926774
TXNIP,Endometrioma,0.9832345076528324
TXNIP,Multiple endocrine neoplasia type 4 ORPHA:276152,0.7929682744768703
UBAP2L,Colorectal Carcinoma,0.7765852775619541
UBAP2L,Liver carcinoma,0.7880542567584415
UBAP2L,Colorectal Cancer,0.7880542567584415
UBAP2L,Neoplasm Metastasis,0.7880542567584415
UBAP2L,Malignant Neoplasms,0.7880542567584415
UBAP2L,Neoplasms,0.7880542567584415
UBAP2L,Metastatic Neoplasm,0.7880542567584415
UBAP2L,X-linked intellectual disability Siderius type ORPHA:85287,0.1991445465001551
UBAP2L,Precursor T-cell acute lymphoblastic leukemia ORPHA:99861,0.3832844616405875
UBAP2L,Oculofaciocardiodental syndrome ORPHA:2712,0.3832844616405875
UBAP2L,QRICH1-related intellectual disability-chondrodysplasia syndrome ORPHA:580940,0.3832844616405875
UBAP2L,Autosomal dominant Charcot-Marie-Tooth disease type 2Z ORPHA:466768,0.5867963421058087
UBAP2L,Floating-Harbor syndrome ORPHA:2044,0.5867963421058087
UBAP2L,Methylmalonic acidemia with homocystinuria type cblX ORPHA:369962,0.5867963421058087
UBAP2L,Mitochondrial myopathy-cerebellar ataxia-pigmentary retinopathy syndrome ORPHA:502423,0.5867963421058087
UBAP2L,Pancreatic agenesis-holoprosencephaly syndrome ORPHA:556955,0.5867963421058087
UBAP2L,Myxofibrosarcoma ORPHA:79105,0.5867963421058087
UBAP2L,Juvenile amyotrophic lateral sclerosis ORPHA:300605,0.5959529547720634
UBAP2L,Coffin-Siris syndrome ORPHA:1465,0.6467006456772204
UBAP2L,Adult-onset cervical dystonia DYT23 type ORPHA:420492,0.7929682744768703
UBAP2L,Infantile-onset X-linked spinal muscular atrophy ORPHA:1145,0.7929682744768703
UBAP2L,Macrocephaly-intellectual disability-left ventricular non compaction syndrome ORPHA:466791,0.7929682744768703
UBAP2L,Desmoplastic small round cell tumor ORPHA:83469,0.7929682744768703
UBAP2L,Familial infantile bilateral striatal necrosis ORPHA:225154,0.7929682744768703
UBAP2L,Familial isolated hyperparathyroidism ORPHA:99879,0.7929682744768703
UBAP2L,Autosomal recessive non-syndromic intellectual disability ORPHA:88616,0.8922466888454011
UBAP2L,ADNP syndrome ORPHA:404448,0.8922466888454011
UBAP2L,Intellectual disability-facial dysmorphism syndrome due to SETD5 haploinsufficiency ORPHA:404440,0.8922466888454011
UBAP2L,SMARCA4-deficient sarcoma of thorax ORPHA:466962,0.8922466888454011
UBAP2L,Small cell carcinoma of the ovary ORPHA:370396,0.8922466888454011
UBAP2L,Isolated polycystic liver disease ORPHA:2924,0.8922466888454011
UBAP2L,Lujan-Fryns syndrome ORPHA:776,0.8922466888454011
UBAP2L,Endometrial stromal sarcoma ORPHA:213711,0.8922466888454011
UBAP2L,Extraskeletal myxoid chondrosarcoma ORPHA:209916,0.8922466888454011
UBAP2L,Clear cell sarcoma of kidney ORPHA:457246,0.8922466888454011
UBAP2L,MiT family translocation renal cell carcinoma ORPHA:319308,0.8922466888454011
UBAP2L,Mitochondrial non-syndromic sensorineural deafness ORPHA:90641,0.8922466888454011
UBAP2L,Autoimmune interstitial lung disease-arthritis syndrome ORPHA:444092,0.8922466888454011
UBAP2L,Schimke immuno-osseous dysplasia ORPHA:1830,0.8922466888454011
UBE2Q2,Carcinogenesis,0.7333611688795861
UBE2Q2,Erythrocyte Mean Corpuscular Hemoglobin Test,0.7333611688795861
UBE2Q2,Finding of Mean Corpuscular Hemoglobin,0.7333611688795861
UBE2Q2,Uric acid measurement (procedure),0.7765852775619541
UBE2Q2,Squamous cell carcinoma of the head and neck,0.7880542567584415
UBE2Q2,Hypopharyngeal Carcinoma,0.7880542567584415
UBE2Q2,Head and Neck Carcinoma,0.8648405521677974
UBE2Q2,Glomerular filtration rate finding,0.8806784681730055
UBE2Q2,Creatinine measurement serum (procedure),0.8867509400747969
UBE2Q2,Chronic Kidney Diseases,0.9393256300017014
UBE2Q2,Gout,0.7765582368651238
UBE2Q2,Gouty Arthritis,0.7765582368651238
UBE2Q2,Diabetes,0.8115918568696846
UBE2Q2,Kidney Disease,0.8210988731657684
UBE2Q2,Diabetes Mellitus,0.919442421650838
UBE2Q2,Kidney Failure,0.9658957825498884
UBE2Q2,Noonan syndrome-like disorder with loose anagen hair ORPHA:2701,0.8922466888454011
UBE2Q2,Oral-facial-digital syndrome with short stature and brachymesophalangy ORPHA:508501,0.8922466888454011
UBE2Q2,Human herpesvirus 3 strain Dumas ring-finger protein,0.8999095837312036
UBE2Q2,Human alphaherpesvirus 3 ubiquitin E3 ligase ICP0 (gene: ORF61),0.8999095837312036
UBXN11,Malignant neoplasm of ovary,0.7333611688795861
UBXN11,Colon Carcinoma,0.7765852775619541
UBXN11,Malignant tumor of colon,0.7765852775619541
UBXN11,Colorectal Neoplasms,0.7765852775619541
UBXN11,melanoma,0.7880542567584415
UBXN11,Diabetes Mellitus Insulin-Dependent,0.8145035474981049
UBXN11,Alzheimer Disease,0.8457525389282121
UBXN11,Beta-propeller protein-associated neurodegeneration ORPHA:329284,0.1991445465001551
UBXN11,Hermansky-Pudlak syndrome with pulmonary fibrosis ORPHA:231500,0.3832844616405875
UBXN11,Crimean-Congo hemorrhagic fever virus full_polyprotein 1..3945 (gene: RdRp),0.8999095837312036
UBXN11,Dugbe virus L protein,0.8999095837312036
UBXN11,Rotavirus A NSP4,0.8999095837312036
UNC119,Retinal pigment epithelial abnormality,0.7765852775619541
UNC119,Abnormality of retinal pigmentation,0.7765852775619541
UNC119,Lymphopenia,0.7880542567584415
UNC119,Cone-Rod Dystrophies,0.7880542567584415
UNC119,Immunologic Deficiency Syndromes,0.7880542567584415
UNC119,Retinal Diseases,0.7880542567584415
UNC119,Difficulties with night vision,0.7880542567584415
UNC119,Night Blindness,0.7880542567584415
UNC119,Bronchiolitis Obliterans Organizing Pneumonia,0.7880542567584415
UNC119,Photophobia,0.7880542567584415
UNC119,LATE-ONSET RETINAL DEGENERATION (disorder),0.7880542567584415
UNC119,Photoreceptor degeneration,0.7880542567584415
UNC119,IMMUNODEFICIENCY 13,0.7880542567584415
UNC119,Photodysphoria,0.7880542567584415
UNC119,Lung diseases,0.8019075543217649
UNC119,Recurrent otitis media,0.8168901801930506
UNC119,Recurrent sinus disease,0.8212681436603975
UNC119,Recurrent sinusitis,0.8212681436603975
UNC119,Amyotrophic Lateral Sclerosis,0.8402911822757345
UNC119,Color vision defect severe,0.8402911822757345
UNC119,Abnormal color vision,0.8402911822757345
UNC119,Loss in color vision,0.8402911822757345
UNC119,Retinitis Pigmentosa,0.8402911822757345
UNC119,Color vision defect,0.8523465762428218
UNC119,Frontotemporal Lobar Degeneration,0.9325666311629114
UNC119,Immunologic Deficiency Syndromes,0.7765582368651238
UNC119,Severe Combined Immunodeficiency Disease,0.7765582368651238
UNC119,Lymphopenia,0.7765582368651238
UNC119,Nyctalopia,0.7765582368651238
UNC119,Disorder Of Eye,0.7765582368651238
UNC119,Otitis Media,0.8115918568696846
UNC119,Cone-rod Dystrophy,0.8115918568696846
UNC119,Immunodeficiency,0.8115918568696846
UNC119,Retinitis Pigmentosa,0.861756360478846
UNC119,Sinusitis,0.8897718769742773
UNC119,Idiopathic CD4 lymphocytopenia ORPHA:228000,0.0155394890951578
UNC119,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.1040670578681756
UNC119,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.1040670578681756
UNC119,Cone rod dystrophy ORPHA:1872,0.9157590847454716
UNK,Eosinophil count procedure,0.7880542567584415
UNK,Eosinophil count result,0.7880542567584415
UNK,Blood basophil count (lab test),0.8190761496232595
USP16,Fanconi Anemia,0.7880542567584415
USP16,Down Syndrome,0.8420665668584452
USP16,Alacrimia-choreoathetosis-liver dysfunction syndrome ORPHA:404454,0.3832844616405875
USP16,Alazami syndrome ORPHA:319671,0.5867963421058087
USP16,12q15q21.1 microdeletion syndrome ORPHA:289513,0.7929682744768703
USP16,6q terminal deletion syndrome ORPHA:75857,0.7929682744768703
USP16,Ferro-cerebro-cutaneous syndrome ORPHA:397922,0.7929682744768703
USP16,Multiple congenital anomalies-hypotonia-seizures syndrome type 2 ORPHA:300496,0.7929682744768703
USP16,Paroxysmal nocturnal hemoglobinuria ORPHA:447,0.7929682744768703
USP16,Primary ciliary dyskinesia-retinitis pigmentosa syndrome ORPHA:247522,0.8922466888454011
USP20,Homocystinuria due to methylene tetrahydrofolate reductase deficiency ORPHA:395,0.0081550609410495
USP20,Charcot-Marie-Tooth disease type 4G ORPHA:99953,0.0144185025972157
USP20,Non-spherocytic hemolytic anemia due to hexokinase deficiency ORPHA:90031,0.0144185025972157
USP20,Familial lipase maturation factor 1 deficiency ORPHA:535453,0.0155394890951578
USP20,Intellectual disability-obesity-brain malformations-facial dysmorphism syndrome ORPHA:352530,0.0155394890951578
USP20,Susceptibility to infection due to TYK2 deficiency ORPHA:331226,0.0155394890951578
USP20,VPS11-related autosomal recessive hypomyelinating leukodystrophy ORPHA:466934,0.0155394890951578
USP20,Adult-onset dystonia-parkinsonism ORPHA:199351,0.0414176838632111
USP20,Barth syndrome ORPHA:111,0.0414176838632111
USP20,Infantile neuroaxonal dystrophy ORPHA:35069,0.0414176838632111
USP20,Polyhydramnios-megalencephaly-symptomatic epilepsy syndrome ORPHA:500533,0.0414176838632111
USP20,Familial isolated pituitary adenoma ORPHA:314777,0.0414176838632111
USP20,Autosomal recessive spastic paraplegia type 63 ORPHA:401805,0.1040670578681756
USP20,Pontocerebellar hypoplasia type 9 ORPHA:369920,0.1040670578681756
USP20,X-linked dominant chondrodysplasia Chassaing-Lacombe type ORPHA:163966,0.1040670578681756
USP20,Autosomal recessive spinocerebellar ataxia-blindness-deafness syndrome ORPHA:95433,0.1991445465001551
USP20,Leukonychia totalis ORPHA:2387,0.1991445465001551
USP20,Microcephalic primordial dwarfism due to ZNF335 deficiency ORPHA:329228,0.1991445465001551
USP20,Cerebellar ataxia-hypogonadism syndrome ORPHA:1173,0.1991445465001551
USP20,Craniosynostosis-dental anomalies ORPHA:284149,0.3832844616405875
USP20,Distal 22q11.2 microdeletion syndrome ORPHA:261330,0.3832844616405875
USP20,Infantile-onset mesial temporal lobe epilepsy with severe cognitive regression ORPHA:391316,0.3832844616405875
USP20,Severe combined immunodeficiency due to CARMIL2 deficiency ORPHA:542301,0.3832844616405875
USP20,Familial focal epilepsy with variable foci ORPHA:98820,0.3832844616405875
USP20,Prolactinoma ORPHA:2965,0.3832844616405875
USP20,Arnold-Chiari malformation type II ORPHA:1136,0.5867963421058087
USP20,Combined immunodeficiency due to STIM1 deficiency ORPHA:317430,0.5867963421058087
USP20,Hereditary sensory and autonomic neuropathy type 4 ORPHA:642,0.5867963421058087
USP20,Isobutyryl-CoA dehydrogenase deficiency ORPHA:79159,0.5867963421058087
USP20,Primary intraosseous venous malformation ORPHA:140436,0.5867963421058087
USP20,Ramon syndrome ORPHA:3019,0.5867963421058087
USP20,Congenital erythropoietic porphyria ORPHA:79277,0.7929682744768703
USP20,Tubular aggregate myopathy ORPHA:2593,0.7929682744768703
VASN,Liver carcinoma,0.7880542567584415
VASN,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
VASN,Malignant neoplasm of liver,0.7880542567584415
VASN,Hepatitis,0.939985154445373
VASN,Hepatitis A,0.9459312971127588
VASN,Liver Carcinoma,0.7765582368651238
VASN,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
VASN,Crisponi syndrome ORPHA:1545,0.0155394890951578
VASN,Cold-induced sweating syndrome ORPHA:157820,0.1068643725150898
VASN,Autosomal dominant generalized dystrophic epidermolysis bullosa ORPHA:231568,0.1991445465001551
VASN,Autosomal recessive generalized dystrophic epidermolysis bullosa intermediate form ORPHA:89842,0.1991445465001551
VASN,Brachyolmia-amelogenesis imperfecta syndrome ORPHA:2899,0.1991445465001551
VASN,Dystrophic epidermolysis bullosa pruriginosa ORPHA:89843,0.1991445465001551
VASN,Knobloch syndrome ORPHA:1571,0.1991445465001551
VASN,Localized dystrophic epidermolysis bullosa acral form ORPHA:158673,0.1991445465001551
VASN,Localized dystrophic epidermolysis bullosa nails only ORPHA:158676,0.1991445465001551
VASN,Localized dystrophic epidermolysis bullosa pretibial form ORPHA:79410,0.1991445465001551
VASN,Recessive dystrophic epidermolysis bullosa inversa ORPHA:79409,0.1991445465001551
VASN,Self-improving dystrophic epidermolysis bullosa ORPHA:79411,0.1991445465001551
VASN,Van den Ende-Gupta syndrome ORPHA:2460,0.3832844616405875
VASN,Congenital short bowel syndrome ORPHA:2301,0.3832844616405875
VASN,Shprintzen-Goldberg syndrome ORPHA:2462,0.3832844616405875
VASN,Truncus arteriosus ORPHA:3384,0.5867963421058087
VASN,Isolated scaphocephaly ORPHA:35093,0.5867963421058087
VASN,Acromesomelic dysplasia Hunter-Thompson type ORPHA:968,0.7929682744768703
VASN,Angel-shaped phalango-epiphyseal dysplasia ORPHA:63442,0.7929682744768703
VASN,Body skin hyperlaxity due to vitamin K-dependent coagulation factor deficiency ORPHA:91135,0.7929682744768703
VASN,Pseudoxanthoma elasticum-like skin manifestations with retinitis pigmentosa ORPHA:436274,0.7929682744768703
VASN,Osteogenesis imperfecta type 2 ORPHA:216804,0.8029813443753846
VASN,Osteogenesis imperfecta type 3 ORPHA:216812,0.8211968342881582
VASN,Autosomal recessive spastic paraplegia type 66 ORPHA:401815,0.8922466888454011
VASN,Caffey disease ORPHA:1310,0.8922466888454011
VASN,NON RARE IN EUROPE: Exfoliation syndrome ORPHA:529819,0.8922466888454011
VASN,Acromicric dysplasia ORPHA:969,0.8922466888454011
VASN,Lethal arteriopathy syndrome due to fibulin-4 deficiency ORPHA:314718,0.8922466888454011
VAT1,Malignant neoplasm of breast,0.4084380369379369
VAT1,Breast Carcinoma,0.7333611688795861
VAT1,Glioma,0.7880542567584415
VAT1,Glioblastoma,0.7880542567584415
VAT1,Benign Prostatic Hyperplasia,0.7880542567584415
VAT1,Carcinoma Ehrlich Tumor,0.8232134984476662
VAT1,Coronary Artery Disease,0.887595340546704
VAT1,Coronary Artery Disease,0.861756360478846
VAT1,Nephrotic syndrome-epidermolysis bullosa-sensorineural deafness syndrome ORPHA:300333,0.1040670578681756
VAT1,Cold-induced sweating syndrome ORPHA:157820,0.1068643725150898
VAT1,Classic Hodgkin lymphoma nodular sclerosis type ORPHA:98843,0.1991445465001551
VAT1,Kyphoscoliotic Ehlers-Danlos syndrome due to lysyl hydroxylase 1 deficiency ORPHA:1900,0.1991445465001551
VAT1,Giant cell glioblastoma ORPHA:251579,0.2844858212863536
VAT1,Gliosarcoma ORPHA:251576,0.2844858212863536
VAT1,Connective tissue disorder due to lysyl hydroxylase-3 deficiency ORPHA:300284,0.3832844616405875
VAT1,Adult-onset autosomal recessive cerebellar ataxia ORPHA:284289,0.5867963421058087
VAT1,Autosomal dominant omodysplasia ORPHA:93328,0.5867963421058087
VAT1,Cleft lip and palate-craniofacial dysmorphism-congenital heart defect-hearing loss syndrome ORPHA:508476,0.5867963421058087
VAT1,Seizures-scoliosis-macrocephaly syndrome ORPHA:466926,0.5867963421058087
VAT1,Hereditary combined deficiency of vitamin K-dependent clotting factors ORPHA:98434,0.5867963421058087
VAT1,Truncus arteriosus ORPHA:3384,0.5867963421058087
VAT1,Polyneuropathy-hearing loss-ataxia-retinitis pigmentosa-cataract syndrome ORPHA:171848,0.7929682744768703
VAT1,Roussy-Levy syndrome ORPHA:3115,0.7929682744768703
VAT1,Dejerine-Sottas syndrome ORPHA:64748,0.8922466888454011
VAT1,Familial multiple meningioma ORPHA:263662,0.8922466888454011
VAT1,Gaucher disease type 1 ORPHA:77259,0.8922466888454011
VNN1,Colorectal Carcinoma,0.7765852775619541
VNN1,Acute asthma,0.7765852775619541
VNN1,Colorectal Cancer,0.7880542567584415
VNN1,Malignant neoplasm of large intestine,0.7880542567584415
VNN1,Tumor Progression,0.7880542567584415
VNN1,Cardiovascular Diseases,0.7880542567584415
VNN1,Dyslipoproteinemias,0.8009048756462318
VNN1,Psoriasis,0.8019075543217649
VNN1,Dyslipidemias,0.8138488881521341
VNN1,Ulcerative Colitis,0.8190761496232595
VNN1,Immune thrombocytopenic purpura,0.8232134984476662
VNN1,Eczema Infantile,0.834094492023826
VNN1,Steatohepatitis,0.8402911822757345
VNN1,Hypertensive disease,0.8474481237156937
VNN1,Inflammatory Bowel Diseases,0.8815127642200768
VNN1,Pustulosis of Palms and Soles,0.882453254162044
VNN1,Dermatitis Atopic,0.8867509400747969
VNN1,Malaria,0.9512505437112568
VNN1,Asthma,0.9672478180546946
VNN1,Colitis,0.9738491767258852
VNN1,Dyslipidemias,0.8115918568696846
VNN1,Dermatitis,0.861756360478846
VNN1,Inflammatory Bowel Disease,0.861756360478846
VNN1,Palmoplantar Pustules,0.8903301324869451
VNN1,Celiac Disease,0.9246807042779188
VNN1,Eczema,0.9658957825498884
VNN1,Psoriasis,0.974502015052702
VNN1,Alkaptonuria ORPHA:56,0.1991445465001551
VNN1,Hemochromatosis type 4 ORPHA:139491,0.3832844616405875
VNN1,Autosomal dominant mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319581,0.5867963421058087
VNN1,Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency ORPHA:319569,0.5867963421058087
VNN1,Fatal congenital hypertrophic cardiomyopathy due to glycogen storage disease ORPHA:439854,0.5867963421058087
VNN1,Mendelian susceptibility to mycobacterial diseases due to complete IFNgammaR1 deficiency ORPHA:99898,0.5867963421058087
VNN1,NON RARE IN EUROPE: Wolff-Parkinson-White syndrome ORPHA:907,0.5867963421058087
VNN1,Alpha-1-antitrypsin deficiency ORPHA:60,0.7929682744768703
VNN1,Chronic infantile diarrhea due to guanylate cyclase 2C overactivity ORPHA:314373,0.7929682744768703
VNN1,Hemorrhagic disease due to alpha-1-antitrypsin Pittsburgh mutation ORPHA:178396,0.7929682744768703
VNN1,Intestinal obstruction in the newborn due to guanylate cyclase 2C deficiency ORPHA:314376,0.7929682744768703
VNN1,Congenital factor XIII deficiency ORPHA:331,0.7929682744768703
VNN1,Congenital factor V deficiency ORPHA:326,0.8922466888454011
VNN1,East Texas bleeding disorder ORPHA:391320,0.8922466888454011
VNN1,Hyperlipidemia due to hepatic triacylglycerol lipase deficiency ORPHA:140905,0.8922466888454011
VNN1,Peroxisomal acyl-CoA oxidase deficiency ORPHA:2971,0.8922466888454011
VNN1,Hereditary renal hypouricemia ORPHA:94088,0.8922466888454011
VNN1,Congenital vertebral-cardiac-renal anomalies syndrome ORPHA:521438,0.8922466888454011
VNN1,Argininemia ORPHA:90,0.8922466888454011
VNN1,Autosomal dominant Charcot-Marie-Tooth disease type 2 due to DGAT2 mutation ORPHA:487814,0.8922466888454011
VNN1,Glycerol kinase deficiency adult form ORPHA:284414,0.8922466888454011
VNN1,Glycerol kinase deficiency juvenile form ORPHA:284411,0.8922466888454011
VWA5B2,Autosomal dominant spastic paraplegia type 6 ORPHA:100988,0.1040670578681756
VWA5B2,Bilateral generalized polymicrogyria ORPHA:208447,0.1991445465001551
VWA5B2,Familial infantile myoclonic epilepsy ORPHA:352582,0.1991445465001551
VWA5B2,Autosomal dominant hyperinsulinism due to Kir6.2 deficiency ORPHA:276580,0.5867963421058087
VWA5B2,Autosomal recessive hyperinsulinism due to Kir6.2 deficiency ORPHA:79644,0.5867963421058087
VWA5B2,Diazoxide-resistant focal hyperinsulinism due to Kir6.2 deficiency ORPHA:276603,0.5867963421058087
VWA5B2,Familial gastric type 1 neuroendocrine tumor ORPHA:464756,0.5867963421058087
VWA5B2,Intermediate DEND syndrome ORPHA:99989,0.5867963421058087
VWA5B2,Leukoencephalopathy with mild cerebellar ataxia and white matter edema ORPHA:363540,0.5867963421058087
VWA5B2,Permanent neonatal diabetes mellitus ORPHA:99885,0.5959529547720634
VWA5B2,DEND syndrome ORPHA:79134,0.7929682744768703
VWA5B2,Autosomal dominant keratitis ORPHA:2334,0.7929682744768703
VWA5B2,Foveal hypoplasia-presenile cataract syndrome ORPHA:2253,0.7929682744768703
VWA5B2,Isolated optic nerve hypoplasia/aplasia ORPHA:137902,0.7929682744768703
VWA5B2,Morning glory disc anomaly ORPHA:35737,0.7929682744768703
VWA5B2,Spinocerebellar ataxia type 14 ORPHA:98763,0.7929682744768703
VWA5B2,Partial pancreatic agenesis ORPHA:2805,0.8922466888454011
VWA5B2,Autosomal dominant hyperinsulinism due to SUR1 deficiency ORPHA:276575,0.8922466888454011
VWA5B2,Autosomal recessive hyperinsulinism due to SUR1 deficiency ORPHA:79643,0.8922466888454011
VWA5B2,Diazoxide-resistant focal hyperinsulinism due to SUR1 deficiency ORPHA:276598,0.8922466888454011
VWA5B2,Foveal hypoplasia-optic nerve decussation defect-anterior segment dysgenesis syndrome ORPHA:397618,0.8922466888454011
VWA5B2,Renal coloboma syndrome ORPHA:1475,0.8922466888454011
VWA5B2,MODY ORPHA:552,0.8922466888454011
VWA5B2,Corpus callosum agenesis-abnormal genitalia syndrome ORPHA:2508,0.8922466888454011
VWA5B2,Infantile epileptic-dyskinetic encephalopathy ORPHA:364063,0.8922466888454011
VWA5B2,Intellectual disability Birk-Barel type ORPHA:166108,0.8922466888454011
VWA5B2,Partington syndrome ORPHA:94083,0.8922466888454011
VWA5B2,X-linked lissencephaly with abnormal genitalia ORPHA:452,0.8922466888454011
VWA5B2,X-linked spasticity-intellectual disability-epilepsy syndrome ORPHA:3175,0.8922466888454011
VWA5B2,Horsepox virus HSPV177 (Immunoglobulin like),0.9057542447893764
VWA5B2,Vaccinia virus hemagglutinin (gene: A56R),0.9058994261255549
WARS2,Malignant neoplasm of pancreas,0.7688485284765829
WARS2,Pancreatic carcinoma,0.7765852775619541
WARS2,Neoplasm Metastasis,0.7880542567584415
WARS2,Triple Negative Breast Neoplasms,0.7880542567584415
WARS2,Neuroblastoma,0.7880542567584415
WARS2,Central neuroblastoma,0.7880542567584415
WARS2,Alzheimer's Disease,0.7880542567584415
WARS2,Rheumatoid Arthritis,0.7880542567584415
WARS2,Mitochondrial encephalopathy,0.7880542567584415
WARS2,Myocardial Infarction,0.8019075543217649
WARS2,Physical Activity Measurement,0.8019075543217649
WARS2,Lip and Oral Cavity Carcinoma,0.8190761496232595
WARS2,Malignant neoplasm of mouth,0.8946938397586319
WARS2,Mitochondrial Diseases,0.8989612563669234
WARS2,Intellectual Disability,0.9478210444156088
WARS2,Graves Disease,0.94939825643792
WARS2,Metabolic Diseases,0.9564633032157428
WARS2,Stereotyped Behavior,0.7765582368651238
WARS2,Spastic Quadriplegia,0.7765582368651238
WARS2,Dyskinetic Syndrome,0.7765582368651238
WARS2,Salaam Seizures,0.7765582368651238
WARS2,Hypoglycemia,0.7765582368651238
WARS2,Nystagmus,0.7765582368651238
WARS2,Cortical Dysplasia,0.7765582368651238
WARS2,Combined Oxidative Phosphorylation Deficiency,0.7765582368651238
WARS2,Developmental Delay,0.7765582368651238
WARS2,Polymicrogyria,0.7765582368651238
WARS2,Hypoplasia Of Corpus Callosum,0.7949861636679444
WARS2,Optic Atrophy,0.8115918568696846
WARS2,Central Visual Impairment,0.8115918568696846
WARS2,Dyssomnia,0.8201196687803188
WARS2,Exotropia,0.8201196687803188
WARS2,Motor Delay,0.8210988731657684
WARS2,Cerebellar Atrophy,0.8337953215113012
WARS2,Mental Retardation,0.8337953215113012
WARS2,Cerebral Atrophy,0.8339308890552987
WARS2,Absence Of Septum Pellucidum,0.8476516371290275
WARS2,Sleep Disorders,0.8601151608808731
WARS2,Seizure,0.861756360478846
WARS2,Microcephaly,0.8903630091389316
WARS2,Mental Depression,0.8903630091389316
WARS2,Autism,0.911896615143974
WARS2,Alopecia,0.9367173114041438
WARS2,Liver Failure,0.9543024119762946
WARS2,Lethal left ventricular non-compaction-seizures-hypotonia-cataract-developmental delay syndrome ORPHA:478049,0.7929682744768703
WARS2,Combined oxidative phosphorylation defect type 11 ORPHA:324535,0.8922466888454011
WARS2,FASTKD2-related infantile mitochondrial encephalomyopathy ORPHA:166105,0.8922466888454011
WARS2,WARS2-related combined oxidative phosphorylation defect ORPHA:572798,0.8922466888454011
WARS2,ALG2-CDG ORPHA:79326,0.8922466888454011
WARS2,Progressive myoclonic epilepsy type 6 ORPHA:280620,0.8922466888454011
WARS2,X-linked sideroblastic anemia and spinocerebellar ataxia ORPHA:2802,0.8922466888454011
WARS2,Leigh syndrome with nephrotic syndrome ORPHA:255249,0.8922466888454011
WDR45,Nonverbal,0.7880542567584415
WDR45,Absent speech,0.7880542567584415
WDR45,Supratentorial atrophy,0.7880542567584415
WDR45,Dementia,0.7880542567584415
WDR45,Hypoplasia of corpus callosum,0.7880542567584415
WDR45,Alzheimer's Disease,0.7880542567584415
WDR45,Cognitive delay,0.7880542567584415
WDR45,Degenerative brain disorder,0.7880542567584415
WDR45,Global developmental delay,0.7880542567584415
WDR45,Mental and motor retardation,0.7880542567584415
WDR45,Nerve Degeneration,0.8009048756462318
WDR45,Neurodegeneration with brain iron accumulation (NBIA),0.8019075543217649
WDR45,Neuro-degenerative disease,0.8019075543217649
WDR45,Cerebral atrophy,0.8019075543217649
WDR45,Abnormal ocular motility,0.8019075543217649
WDR45,West Syndrome,0.8019075543217649
WDR45,Difficulty speaking,0.8138488881521341
WDR45,Problems speaking,0.8138488881521341
WDR45,Delayed speech and language development,0.8168901801930506
WDR45,Poor speech,0.8168901801930506
WDR45,Tremor,0.8190761496232595
WDR45,Dysautonomia,0.8232134984476662
WDR45,Dystonia Disorders,0.8232134984476662
WDR45,Neurodegenerative Disorders,0.8272008757995397
WDR45,Gross motor development delay,0.834094492023826
WDR45,Dystonia,0.8402911822757345
WDR45,Dystonic disease,0.8402911822757345
WDR45,Mental deficiency,0.8402911822757345
WDR45,Autonomic nervous system disorders,0.8402911822757345
WDR45,Parkinsonian Disorders,0.8486035047899471
WDR45,Infantile Spasm,0.8486035047899471
WDR45,Muscle Rigidity,0.8648405521677974
WDR45,Paraparesis Spastic,0.8690346447728063
WDR45,Dull intelligence,0.8757755363384367
WDR45,Low intelligence,0.8757755363384367
WDR45,Bradykinesia,0.876210765330195
WDR45,Parkinson Disease,0.8772392350816924
WDR45,Cerebellar atrophy,0.8815127642200768
WDR45,Cerebellar degeneration,0.8838621755797691
WDR45,Poor school performance,0.8913141512402477
WDR45,Neurodevelopmental Disorders,0.9015731019095328
WDR45,Epileptic encephalopathy,0.917543617287358
WDR45,Mental Retardation,0.922229272318747
WDR45,Encephalopathies,0.9265708351135048
WDR45,Infratentorial atrophy,0.9265708351135048
WDR45,Intellectual Disability,0.9478210444156088
WDR45,Seizures,0.9478210444156088
WDR45,Muscle Spasticity,0.9564633032157428
WDR45,Brain Diseases,0.9740616963450036
WDR45,Genetic Diseases Inborn,0.9926099929361648
WDR45,Dysautonomia,0.7765582368651238
WDR45,Nephropathy With Pretibial Epidermolysis Bullosa And Deafness,0.7765582368651238
WDR45,Neurodevelopmental Disorders,0.7765582368651238
WDR45,Developmental Delay,0.7765582368651238
WDR45,Spasms Syndrome,0.7860378120955526
WDR45,Hypoplasia Of Corpus Callosum,0.7949861636679444
WDR45,Optic Atrophy,0.8115918568696846
WDR45,Infantile Spasms,0.8115918568696846
WDR45,Parkinson Disease,0.8182883735985873
WDR45,Dyssomnia,0.8201196687803188
WDR45,Movement Disorders,0.829560580336605
WDR45,Cerebellar Atrophy,0.8337953215113012
WDR45,Mental Retardation,0.8337953215113012
WDR45,Cerebral Atrophy,0.8339308890552987
WDR45,Sleep Disorders,0.8601151608808731
WDR45,Epilepsy,0.8611702959552964
WDR45,Dementia,0.861756360478846
WDR45,West Syndrome,0.8903301324869451
WDR45,Heart Failure,0.9024492468099392
WDR45,Multiple Congenital Anomalies,0.963385108667098
WDR45,Dysmorphic Features,0.9726139569926774
WDR45,Marinesco-Sjogren syndrome ORPHA:559,0.1054066549396977
WDR45,Beta-propeller protein-associated neurodegeneration ORPHA:329284,0.1991445465001551
WDR45,Mucolipidosis type IV ORPHA:578,0.1991445465001551
WDR45,Classic galactosemia ORPHA:79239,0.3832844616405875
WDR45,Mucolipidosis type III gamma ORPHA:423470,0.3832844616405875
WDR45,Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome ORPHA:480864,0.3832844616405875
WDR45,Hereditary myopathy with lactic acidosis due to ISCU deficiency ORPHA:43115,0.5867963421058087
WDR45,Infantile spasms syndrome ORPHA:3451,0.9039465713743752
WDR6,Autosomal recessive cerebellar ataxia with late-onset spasticity ORPHA:352641,0.0155394890951578
WDR6,Autosomal recessive spastic paraplegia type 46 ORPHA:320391,0.0155394890951578
WDR6,Early-onset epilepsy-intellectual disability-brain anomalies syndrome ORPHA:488635,0.1991445465001551
WDR6,Methylmalonic acidemia with homocystinuria type cblJ ORPHA:369955,0.1991445465001551
WDR6,NAD(P)HX dehydratase deficiency ORPHA:555402,0.1991445465001551
WDR6,POMT1-related  limb-girdle muscular dystrophy R11 ORPHA:86812,0.1991445465001551
WDR6,Rhizomelic chondrodysplasia punctata type 5 ORPHA:468717,0.1991445465001551
WDR6,TMEM94-associated congenital heart defect-facial dysmorphism-developmental delay syndrome ORPHA:562569,0.1991445465001551
WDR6,Autosomal dominant Charcot-Marie-Tooth disease type 2 with giant axons ORPHA:401964,0.3832844616405875
WDR6,MOGS-CDG ORPHA:79330,0.3832844616405875
WDR6,QRICH1-related intellectual disability-chondrodysplasia syndrome ORPHA:580940,0.3832844616405875
WDR6,Congenital muscular dystrophy with intellectual disability ORPHA:370968,0.3977968344535308
WDR6,Wolf-Hirschhorn syndrome ORPHA:280,0.4100904865085126
WDR6,Craniofacial dysplasia-short stature-ectodermal anomalies-intellectual disability syndrome ORPHA:459061,0.5867963421058087
WDR6,Frontorhiny ORPHA:391474,0.5867963421058087
WDR6,MAN1B1-CDG ORPHA:397941,0.5867963421058087
WDR6,Infantile-onset X-linked spinal muscular atrophy ORPHA:1145,0.7929682744768703
WDR6,Porphyria variegata ORPHA:79473,0.7929682744768703
WDR6,Short stature-brachydactyly-obesity-global developmental delay syndrome ORPHA:464288,0.7929682744768703
WDR6,Congenital dyserythropoietic anemia type I ORPHA:98869,0.7929682744768703
WDR6,Congenital muscular dystrophy without intellectual disability ORPHA:370980,0.795266832401002
WDR6,Diffuse cerebral and cerebellar atrophy-intractable seizures-progressive microcephaly syndrome ORPHA:404437,0.8922466888454011
WDR6,Glycogen storage disease due to glucose-6-phosphatase deficiency type Ib ORPHA:79259,0.8922466888454011
WDR6,Isovaleric acidemia ORPHA:33,0.8922466888454011
WDR6,Microcephaly-corpus callosum hypoplasia-intellectual disability-facial dysmorphism syndrome ORPHA:457284,0.8922466888454011
WDR6,Microcephaly-short stature-intellectual disability-facial dysmorphism syndrome ORPHA:423306,0.8922466888454011
WDR6,Congenital muscular dystrophy with cerebellar involvement ORPHA:370959,0.8922466888454011
WDR6,COG4-CDG ORPHA:263501,0.8922466888454011
WDR6,Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome ORPHA:496641,0.8922466888454011
WDR6,Microcephalic osteodysplastic dysplasia Saul-Wilson type ORPHA:85172,0.8922466888454011
WFIKKN1,Hereditary hypophosphatemic rickets with hypercalciuria ORPHA:157215,0.1991445465001551
WFIKKN1,IMAGe syndrome ORPHA:85173,0.7929682744768703
WFIKKN1,Persistent Mullerian duct syndrome ORPHA:2856,0.8922466888454011
WFIKKN1,Japanese encephalitis virus hypothetical protein,0.8999095837312036
WFIKKN1,Ntaya virus full_polyprotein 1..3427,0.8999095837312036
WFIKKN1,Ilheus virus full_polyprotein 1..3424,0.8999095837312036
WFIKKN1,Dengue virus 3 nonstructural protein NS3 (gene: flavivirus polyprotein),0.8999095837312036
WFIKKN1,Human betaherpesvirus 6B glycoprotein (gene: U85),0.8999095837312036
WFIKKN1,Wesselsbron virus full_polyprotein 1..3405,0.8999095837312036
WFIKKN1,Murray Valley encephalitis virus NS3,0.8999095837312036
WFIKKN1,Karshi virus (Royal Farm virus) full_polyprotein 1..3416,0.8999095837312036
WFIKKN1,Omsk hemorrhagic fever virus full_polyprotein 1..3414,0.8999095837312036
WFIKKN1,Saint Louis encephalitis virus full_polyprotein 1..3430,0.8999095837312036
WFIKKN1,Japanese encephalitis virus non-structural protein NS3,0.8999095837312036
WFIKKN1,West Nile virus H442 non-structural protein 3,0.8999095837312036
WFIKKN1,West Nile virus SA381/00 non-structural protein 3,0.8999095837312036
WFIKKN1,West Nile virus SA93/01 non-structural protein 3,0.8999095837312036
WFIKKN1,West Nile virus SPU116/89 non-structural protein 3,0.8999095837312036
WFIKKN1,West Nile virus lineage 1 nonstructural protein NS3 (gene: flavivirus polyprotein),0.8999095837312036
WFIKKN1,Powassan virus non-structural protein NS3,0.8999095837312036
WFIKKN1,West Nile virus lineage 2 nonstructural protein NS3 (gene: flavivirus polyprotein),0.8999095837312036
WFIKKN1,Yellow fever virus non-structural protein NS3,0.8999095837312036
WFIKKN1,Langat virus nonstructural protein NS3,0.8999095837312036
WFIKKN1,Alkhumra hemorrhagic fever virus non-structural protein NS3,0.9056300531913352
WFIKKN1,Rio Bravo virus non-structural protein NS3,0.9056300531913352
WFIKKN1,West Nile virus lineage 2 excised_polyprotein 1..2273 (gene: flavivirus polyprotein),0.9057542447893764
WFIKKN1,Orf virus ORF132 vascular endothelial growth factor-like protein,0.9057542447893764
WFIKKN1,Kyasanur Forest disease virus NS3,0.9057542447893764
WFIKKN1,Louping ill virus nonstructural protein NS3,0.9057542447893764
WFIKKN1,Modoc virus non-structural protein 3,0.9057542447893764
WFIKKN1,Human adenovirus 18 CR1-beta protein (gene: E3),0.9197295331382644
WFIKKN1,Human adenovirus 31 cr1 beta protein (gene: E3 cr1 beta),0.9237501457186692
YIF1B,Anhidrotic ectodermal dysplasia-immunodeficiency-osteopetrosis-lymphedema syndrome ORPHA:69088,0.0414176838632111
YIF1B,Incontinentia pigmenti ORPHA:464,0.0414176838632111
YIF1B,X-linked mendelian susceptibility to mycobacterial diseases due to IKBKG deficiency ORPHA:319612,0.0414176838632111
YIF1B,CADDS ORPHA:369942,0.1991445465001551
YIF1B,Galactokinase deficiency ORPHA:79237,0.3832844616405875
YIF1B,Familial hypocalciuric hypercalcemia type 3 ORPHA:101050,0.5867963421058087
YIF1B,Autism-epilepsy syndrome due to branched chain ketoacid dehydrogenase kinase deficiency ORPHA:308410,0.7929682744768703
YIF1B,Glycogen storage disease due to aldolase A deficiency ORPHA:57,0.7929682744768703
YIF1B,Larsen-like syndrome B3GAT3 type ORPHA:284139,0.7929682744768703
YIF1B,Navajo neurohepatopathy ORPHA:255229,0.7929682744768703
YIF1B,PYCR2-related microcephaly-progressive leukoencephalopathy ORPHA:481152,0.7929682744768703
YIF1B,Tyrosinemia type 1 ORPHA:882,0.7929682744768703
YIF1B,Congenital erythropoietic porphyria ORPHA:79277,0.7929682744768703
YIF1B,Hereditary isolated aplastic anemia ORPHA:397692,0.7929682744768703
YIF1B,Autosomal recessive severe congenital neutropenia due to G6PC3 deficiency ORPHA:331176,0.8922466888454011
YIF1B,Congenital muscular dystrophy with intellectual disability and severe epilepsy ORPHA:329178,0.8922466888454011
YIF1B,Primary familial polycythemia ORPHA:90042,0.8922466888454011
ZBED1,Malignant neoplasm of breast,0.4084380369379369
ZBED1,Breast Carcinoma,0.7333611688795861
ZBED1,Carcinogenesis,0.7333611688795861
ZBED1,Adenocarcinoma,0.750391252594775
ZBED1,Prostatic Intraepithelial Neoplasias,0.7765852775619541
ZBED1,Malignant neoplasm of prostate,0.7880542567584415
ZBED1,Prostate carcinoma,0.7880542567584415
ZBED1,Sudden infant death syndrome,0.7880542567584415
ZBED1,Neoplasm Metastasis,0.7880542567584415
ZBED1,Prostatic Neoplasms,0.7880542567584415
ZBED1,Familial lichen amyloidosis,0.7880542567584415
ZBED1,Vesicular Stomatitis,0.7880542567584415
ZBED1,Adenocarcinoma of prostate,0.7880542567584415
ZBED1,Global developmental delay,0.7880542567584415
ZBED1,Febrile Convulsions,0.8019075543217649
ZBED1,Carcinoma Neuroendocrine,0.8232134984476662
ZBED1,Obesity,0.8989612563669234
ZBED1,Status Epilepticus,0.914995991166204
ZBED1,Prostate Cancer,0.7765582368651238
ZBED1,Prostatic Neoplasms,0.7765582368651238
ZBTB33,Adenocarcinoma,0.750391252594775
ZBTB33,Colorectal Neoplasms,0.7765852775619541
ZBTB33,Invasive Lobular Breast Carcinoma,0.7880542567584415
ZBTB33,Colonic Neoplasms,0.8212681436603975
ZBTB33,Familial multinodular goiter ORPHA:276399,0.3832844616405875
ZBTB33,X-linked intellectual disability Cabezas type ORPHA:85293,0.5867963421058087
ZBTB33,Christianson syndrome ORPHA:85278,0.7929682744768703
ZBTB33,Ferro-cerebro-cutaneous syndrome ORPHA:397922,0.7929682744768703
ZBTB33,Multiple congenital anomalies-hypotonia-seizures syndrome type 2 ORPHA:300496,0.7929682744768703
ZBTB33,Paroxysmal nocturnal hemoglobinuria ORPHA:447,0.7929682744768703
ZBTB33,Severe myopia-generalized joint laxity-short stature syndrome ORPHA:527450,0.7929682744768703
ZBTB33,Xq25 microduplication syndrome ORPHA:521258,0.7929682744768703
ZBTB33,RAS-associated autoimmune leukoproliferative disease ORPHA:268114,0.7929682744768703
ZBTB33,Autosomal dominant spastic paraplegia type 4 ORPHA:100985,0.8922466888454011
ZBTB33,Autosomal recessive spastic paraplegia type 60 ORPHA:401800,0.8922466888454011
ZBTB33,Buschke-Ollendorff syndrome ORPHA:1306,0.8922466888454011
ZBTB33,Hereditary neuroendocrine tumor of small intestine ORPHA:456333,0.8922466888454011
ZBTB33,Isolated osteopoikilosis ORPHA:166119,0.8922466888454011
ZBTB33,Melorheostosis with osteopoikilosis ORPHA:1879,0.8922466888454011
ZBTB33,Reticular dystrophy of the retinal pigment epithelium ORPHA:99002,0.8922466888454011
ZBTB33,Toriello-Carey syndrome ORPHA:3338,0.8922466888454011
ZBTB33,Toriello-Lacassie-Droste syndrome ORPHA:3339,0.8922466888454011
ZBTB33,X-linked intellectual disability-hypotonia-movement disorder syndrome ORPHA:457260,0.8922466888454011
ZBTB33,NON RARE IN EUROPE: Melanoma ORPHA:411533,0.8922466888454011
ZBTB33,Monosomy 13q14 ORPHA:1587,0.8922466888454011
ZBTB33,Multiple self-healing squamous epithelioma ORPHA:65748,0.8922466888454011
ZBTB33,Primary microcephaly-mild intellectual disability-young-onset diabetes syndrome ORPHA:391408,0.8922466888454011
ZBTB33,Horsepox virus HSPV197 (Hypothetical protein),0.8999095837312036
ZBTB33,Yaba-like disease virus 140R protein (gene: 140R),0.8999095837312036
ZBTB33,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.8999095837312036
ZBTB33,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.8999095837312036
ZBTB33,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.8999095837312036
ZBTB33,Horsepox virus HSPV008,0.8999095837312036
ZBTB33,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.8999095837312036
ZBTB33,Yaba-like disease virus 19L protein (gene: 19L),0.8999095837312036
ZBTB33,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.8999095837312036
ZBTB33,Ectromelia virus ERPV kelch-like protein,0.8999095837312036
ZBTB33,Vaccinia virus Kelch-like protein (gene: F3L),0.8999095837312036
ZBTB33,Vaccinia virus Ankara Kelch-like protein,0.8999095837312036
ZBTB33,Vaccinia virus kelch-like protein (gene: A55R),0.8999095837312036
ZBTB33,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.8999095837312036
ZBTB33,Yaba monkey tumor virus kelch-like protein,0.8999095837312036
ZBTB33,Horsepox virus HSPV043 (Kelch-like protein,0.8999095837312036
ZBTB33,Provisional),0.8999095837312036
ZBTB33,Horsepox virus HSPV029 (kelch-like protein,0.8999095837312036
ZBTB33,Cowpox virus CPXV035 protein (gene: CPXV035 CDS),0.8999095837312036
ZBTB33,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.8999095837312036
ZBTB33,Vaccinia virus kelch-like protein (gene: C2L),0.8999095837312036
ZBTB33,Horsepox virus HSPV176 (kelch-like protein,0.8999095837312036
ZBTB33,Provisional),0.9057542447893764
ZBTB5,Thyroid carcinoma,0.7880542567584415
ZBTB5,Malignant neoplasm of thyroid,0.7880542567584415
ZBTB5,Malignant neoplasm of muscle,0.7880542567584415
ZBTB5,Retinoblastoma,0.7880542567584415
ZBTB5,X-linked intellectual disability Siderius type ORPHA:85287,0.1991445465001551
ZBTB5,Severe myopia-generalized joint laxity-short stature syndrome ORPHA:527450,0.7929682744768703
ZBTB5,Osteopathia striata-cranial sclerosis syndrome ORPHA:2780,0.8922466888454011
ZBTB5,Wolcott-Rallison syndrome ORPHA:1667,0.8922466888454011
ZBTB5,Horsepox virus HSPV197 (Hypothetical protein),0.8999095837312036
ZBTB5,Yaba-like disease virus 140R protein (gene: 140R),0.8999095837312036
ZBTB5,Cowpox virus CPXV215 Protein (gene: CPXV215 CDS),0.8999095837312036
ZBTB5,Vaccinia virus Ankara Kelch-like protein modulator of inflammation,0.8999095837312036
ZBTB5,Cowpox virus CPXV050 (gene: CPXV050 CDS),0.8999095837312036
ZBTB5,Horsepox virus HSPV008,0.8999095837312036
ZBTB5,Cowpox virus CPXV013 protein (gene: CPXV013 CDS),0.8999095837312036
ZBTB5,Yaba-like disease virus 19L protein (gene: 19L),0.8999095837312036
ZBTB5,Cowpox virus CPXV193 protein (gene: CPXV193 CDS),0.8999095837312036
ZBTB5,Ectromelia virus ERPV kelch-like protein,0.8999095837312036
ZBTB5,Vaccinia virus Kelch-like protein (gene: F3L),0.8999095837312036
ZBTB5,Vaccinia virus Ankara Kelch-like protein,0.8999095837312036
ZBTB5,Vaccinia virus kelch-like protein (gene: A55R),0.8999095837312036
ZBTB5,Monkeypox virus Zaire-96-I-16 Kelch-like protein (gene: C9L),0.8999095837312036
ZBTB5,Yaba monkey tumor virus kelch-like protein,0.8999095837312036
ZBTB5,Horsepox virus HSPV043 (Kelch-like protein,0.8999095837312036
ZBTB5,Provisional),0.8999095837312036
ZBTB5,Horsepox virus HSPV029 (kelch-like protein,0.8999095837312036
ZBTB5,Variola virus hypothetical protein (gene: B22R),0.8999095837312036
ZBTB5,Cowpox virus CPXV035 protein (gene: CPXV035 CDS),0.8999095837312036
ZBTB5,Vaccinia virus Ankara 64.7k Kelch-like protein f1,0.8999095837312036
ZBTB5,Vaccinia virus kelch-like protein (gene: C2L),0.8999095837312036
ZBTB5,Horsepox virus HSPV176 (kelch-like protein,0.8999095837312036
ZFAND2A,Cardiovascular Diseases,0.924275664330454
ZFAND2A,Spinocerebellar ataxia type 18 ORPHA:98771,0.7929682744768703
ZNF277,Malignant neoplasm of breast,0.4084380369379369
ZNF277,Carcinogenesis,0.7333611688795861
ZNF277,Colon Carcinoma,0.7765852775619541
ZNF277,Malignant tumor of colon,0.7765852775619541
ZNF277,Specific language impairment,0.7880542567584415
ZNF277,Autistic Disorder,0.8019075543217649
ZNF277,Breast Cancer,0.8903630091389316
ZNF277,Vitamin B12-responsive methylmalonic acidemia type cblA ORPHA:79310,0.8922466888454011
ZNF277,Smith-McCort dysplasia ORPHA:178355,0.8922466888454011
ZNF516,Colorectal Carcinoma,0.7765852775619541
ZNF516,Colorectal Cancer,0.7880542567584415
ZNF516,Hereditary sensory and autonomic neuropathy due to TECPR2 mutation ORPHA:320385,0.0155394890951578
ZNF516,Acromelic frontonasal dysplasia ORPHA:1827,0.1040670578681756
ZNF516,Wagner disease ORPHA:898,0.8922466888454011
ZNF598,Charcot-Marie-Tooth disease type 4B3 ORPHA:363981,0.0414176838632111
ZNF598,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
ZNF598,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
ZNF598,Albers Schonberg osteopetrosis ORPHA:53,0.1040670578681756
ZNF598,BAP1-related tumor predisposition syndrome ORPHA:289539,0.1040670578681756
ZNF598,Smith-Magenis syndrome ORPHA:819,0.1117946631214258
ZNF598,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160,0.1991445465001551
ZNF598,Early myoclonic encephalopathy ORPHA:1935,0.1991445465001551
ZNF598,Early-onset posterior subcapsular cataract ORPHA:441447,0.220389120533256
ZNF598,Ichthyosis-prematurity syndrome ORPHA:88621,0.3832844616405875
ZNF598,Intellectual disability-strabismus syndrome ORPHA:363528,0.3832844616405875
ZNF598,MOGS-CDG ORPHA:79330,0.3832844616405875
ZNF598,Spondylo-ocular syndrome ORPHA:85194,0.3832844616405875
ZNF598,TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642,0.3832844616405875
ZNF598,Testicular regression syndrome ORPHA:983,0.3832844616405875
ZNF598,Wolf-Hirschhorn syndrome ORPHA:280,0.4100904865085126
ZNF598,Alpers-Huttenlocher syndrome ORPHA:726,0.5867963421058087
ZNF598,Autosomal recessive ataxia due to PEX10 deficiency ORPHA:247815,0.5867963421058087
ZNF598,Baller-Gerold syndrome ORPHA:1225,0.5867963421058087
ZNF598,Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026,0.5867963421058087
ZNF598,Combined oxidative phosphorylation defect type 23 ORPHA:444013,0.5867963421058087
ZNF598,Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431,0.5867963421058087
ZNF598,Congenital factor XII deficiency ORPHA:330,0.5867963421058087
ZNF598,F12-related hereditary angioedema with normal C1Inh ORPHA:100054,0.5867963421058087
ZNF598,Familial lambdoid synostosis ORPHA:3267,0.5867963421058087
ZNF598,Frontorhiny ORPHA:391474,0.5867963421058087
ZNF598,Isolated cloverleaf skull syndrome ORPHA:2343,0.5867963421058087
ZNF598,Lethal brain and heart developmental defects ORPHA:580933,0.5867963421058087
ZNF598,Lethal neonatal spasticity-epileptic encephalopathy syndrome ORPHA:435845,0.5867963421058087
ZNF598,Methylmalonic acidemia with homocystinuria type cblX ORPHA:369962,0.5867963421058087
ZNF598,NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362,0.5867963421058087
ZNF598,Neuralgic amyotrophy ORPHA:2901,0.5867963421058087
ZNF598,Ocular anomalies-axonal neuropathy-developmental delay syndrome ORPHA:496790,0.5867963421058087
ZNF598,Peutz-Jeghers syndrome ORPHA:2869,0.5867963421058087
ZNF598,RAPADILINO syndrome ORPHA:3021,0.5867963421058087
ZNF598,RFVT2-related riboflavin transporter deficiency ORPHA:572543,0.5867963421058087
ZNF598,Recessive mitochondrial ataxia syndrome ORPHA:94125,0.5867963421058087
ZNF598,Rothmund-Thomson syndrome type 2 ORPHA:221016,0.5867963421058087
ZNF598,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract ORPHA:500545,0.5867963421058087
ZNF598,Spinocerebellar ataxia with epilepsy ORPHA:254881,0.5867963421058087
ZNF598,Transketolase deficiency ORPHA:488618,0.5867963421058087
ZNF598,Sensory ataxic neuropathy-dysarthria-ophthalmoparesis syndrome ORPHA:70595,0.5867963421058087
ZNF598,22q11.2 deletion syndrome ORPHA:567,0.6599133692748571
ZNF598,AKT2-related familial partial lipodystrophy ORPHA:79085,0.7929682744768703
ZNF598,Acute infantile liver failure-cerebellar ataxia-peripheral sensory motor neuropathy syndrome ORPHA:466794,0.7929682744768703
ZNF598,Adult-onset cervical dystonia DYT23 type ORPHA:420492,0.7929682744768703
ZNF598,Childhood-onset motor and cognitive regression syndrome with extrapyramidal movement disorder ORPHA:500180,0.7929682744768703
ZNF598,Congenital cataract-progressive muscular hypotonia-hearing loss-developmental delay syndrome ORPHA:330054,0.7929682744768703
ZNF598,FLNA-related X-linked myxomatous valvular dysplasia ORPHA:555877,0.7929682744768703
ZNF598,Hypoinsulinemic hypoglycemia and body hemihypertrophy ORPHA:293964,0.7929682744768703
ZNF598,Leydig cell hypoplasia due to LHB deficiency ORPHA:325448,0.7929682744768703
ZNF598,Mandibular hypoplasia-deafness-progeroid features-lipodystrophy syndrome ORPHA:363649,0.7929682744768703
ZNF598,Melnick-Needles syndrome ORPHA:2484,0.7929682744768703
ZNF598,Neuronal intestinal pseudoobstruction ORPHA:99811,0.7929682744768703
ZNF598,Opsismodysplasia ORPHA:2746,0.7929682744768703
ZNF598,Otopalatodigital syndrome type 1 ORPHA:90650,0.7929682744768703
ZNF598,Otopalatodigital syndrome type 2 ORPHA:90652,0.7929682744768703
ZNF598,Spinocerebellar ataxia type 4 ORPHA:98765,0.7929682744768703
ZNF598,Syndromic X-linked intellectual disability due to JARID1C mutation ORPHA:85279,0.7929682744768703
ZNF598,Terminal osseous dysplasia-pigmentary defects syndrome ORPHA:88630,0.7929682744768703
ZNF598,X-linked Ehlers-Danlos syndrome ORPHA:75497,0.7929682744768703
ZNF598,X-linked keloid scarring-reduced joint mobility-increased optic cup-to-disc ratio syndrome ORPHA:482606,0.7929682744768703
ZNF598,Congenital dyserythropoietic anemia type I ORPHA:98869,0.7929682744768703
ZNF598,Insulinoma ORPHA:97279,0.7929682744768703
ZNF598,Lymphomatoid papulosis ORPHA:98842,0.7929682744768703
ZNF598,MEDNIK syndrome ORPHA:171851,0.7929682744768703
ZNF598,Microlissencephaly ORPHA:1083,0.7929682744768703
ZNF598,Primary cutaneous anaplastic large cell lymphoma ORPHA:300865,0.7929682744768703
ZNF598,Chronic myeloid leukemia ORPHA:521,0.7929682744768703
ZNF598,NON RARE IN EUROPE: Paget disease of bone ORPHA:280110,0.7929682744768703
ZNF598,B3GALT6-related spondylodysplastic Ehlers-Danlos syndrome ORPHA:536467,0.8922466888454011
ZNF598,CODAS syndrome ORPHA:1458,0.8922466888454011
ZNF598,Costello syndrome ORPHA:3071,0.8922466888454011
ZNF598,MORM syndrome ORPHA:75858,0.8922466888454011
ZNF598,Ocular albinism ORPHA:284804,0.8922466888454011
ZNF598,Oculopharyngeal muscular dystrophy ORPHA:270,0.8922466888454011
ZNF598,Phakomatosis pigmentokeratotica ORPHA:2874,0.8922466888454011
ZNF598,TARP syndrome ORPHA:2886,0.8922466888454011
ZNF598,Woolly hair nevus ORPHA:79414,0.8922466888454011
ZNF598,MiT family translocation renal cell carcinoma ORPHA:319308,0.8922466888454011
ZNF598,Williams syndrome ORPHA:904,0.8922466888454011
ZNF598,Familial rhabdoid tumor ORPHA:231108,0.8922466888454011
ZNF598,Spinocerebellar ataxia type 26 ORPHA:101112,0.8922466888454011
ZNF598,Microphthalmia Lenz type ORPHA:568,0.8922466888454011
ZNF598,Meningioma ORPHA:2495,0.896422440954666
ZNF628,Alzheimer's Disease,0.7880542567584415
ZNF628,Atrial septal defect sinus venosus type ORPHA:99105,0.0155394890951578
ZNF628,Crisponi syndrome ORPHA:1545,0.0155394890951578
ZNF628,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
ZNF628,Multiple endocrine neoplasia type 1 ORPHA:652,0.0473879273649914
ZNF628,BAP1-related tumor predisposition syndrome ORPHA:289539,0.1040670578681756
ZNF628,Focal dermal hypoplasia ORPHA:2092,0.1040670578681756
ZNF628,Smith-Magenis syndrome ORPHA:819,0.1117946631214258
ZNF628,Adrenomyeloneuropathy ORPHA:139399,0.1991445465001551
ZNF628,Charcot-Marie-Tooth disease type 4F ORPHA:99952,0.1991445465001551
ZNF628,Neutral lipid storage myopathy ORPHA:98908,0.1991445465001551
ZNF628,Triglyceride deposit cardiomyovasculopathy ORPHA:565612,0.1991445465001551
ZNF628,X-linked cerebral adrenoleukodystrophy ORPHA:139396,0.1991445465001551
ZNF628,Early myoclonic encephalopathy ORPHA:1935,0.1991445465001551
ZNF628,Charcot-Marie-Tooth disease type 2B2 ORPHA:101101,0.3832844616405875
ZNF628,Ataxia-oculomotor apraxia type 4 ORPHA:459033,0.3832844616405875
ZNF628,Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738,0.3832844616405875
ZNF628,Intellectual disability-strabismus syndrome ORPHA:363528,0.3832844616405875
ZNF628,TELO2-related intellectual disability-neurodevelopmental disorder ORPHA:488642,0.3832844616405875
ZNF628,Testicular regression syndrome ORPHA:983,0.3832844616405875
ZNF628,Ependymoma ORPHA:251636,0.3832844616405875
ZNF628,RELA fusion-positive ependymoma ORPHA:530792,0.3832844616405875
ZNF628,Class I glucose-6-phosphate dehydrogenase deficiency ORPHA:466026,0.5867963421058087
ZNF628,Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431,0.5867963421058087
ZNF628,Familial lambdoid synostosis ORPHA:3267,0.5867963421058087
ZNF628,Isolated cloverleaf skull syndrome ORPHA:2343,0.5867963421058087
ZNF628,Lethal brain and heart developmental defects ORPHA:580933,0.5867963421058087
ZNF628,NON RARE IN EUROPE: Glucose-6-phosphate-dehydrogenase deficiency ORPHA:362,0.5867963421058087
ZNF628,Neuralgic amyotrophy ORPHA:2901,0.5867963421058087
ZNF628,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract ORPHA:500545,0.5867963421058087
ZNF628,22q11.2 deletion syndrome ORPHA:567,0.6599133692748571
ZNF628,AKT2-related familial partial lipodystrophy ORPHA:79085,0.7929682744768703
ZNF628,Adult-onset cervical dystonia DYT23 type ORPHA:420492,0.7929682744768703
ZNF628,Charcot-Marie-Tooth disease type 2S ORPHA:443073,0.7929682744768703
ZNF628,Hypoinsulinemic hypoglycemia and body hemihypertrophy ORPHA:293964,0.7929682744768703
ZNF628,Spinal muscular atrophy with respiratory distress type 1 ORPHA:98920,0.7929682744768703
ZNF628,Alveolar soft tissue sarcoma ORPHA:163699,0.7929682744768703
ZNF628,Fibrolamellar hepatocellular carcinoma ORPHA:401920,0.7929682744768703
ZNF628,Insulinoma ORPHA:97279,0.7929682744768703
ZNF628,Childhood-onset basal ganglia degeneration syndrome ORPHA:497906,0.8922466888454011
ZNF628,FKRP-related  limb-girdle muscular dystrophy R9 ORPHA:34515,0.8922466888454011
ZNF653,Charcot-Marie-Tooth disease type 2P ORPHA:300319,0.0414176838632111
ZNF653,Cushing syndrome due to macronodular adrenal hyperplasia ORPHA:189427,0.0414176838632111
ZNF653,Autosomal recessive spastic paraplegia type 44 ORPHA:320401,0.1040670578681756
ZNF653,BAP1-related tumor predisposition syndrome ORPHA:289539,0.1040670578681756
ZNF653,Pelizaeus-Merzbacher-like disease due to GJC2 mutation ORPHA:280282,0.1040670578681756
ZNF653,CLN4B disease ORPHA:228343,0.1991445465001551
ZNF653,Charcot-Marie-Tooth disease type 4F ORPHA:99952,0.1991445465001551
ZNF653,Congenital myopathy with internal nuclei and atypical cores ORPHA:319160,0.1991445465001551
ZNF653,Basel-Vanagaite-Smirin-Yosef syndrome ORPHA:464738,0.3832844616405875
ZNF653,Intellectual disability-strabismus syndrome ORPHA:363528,0.3832844616405875
ZNF653,Congenital cataracts-facial dysmorphism-neuropathy syndrome ORPHA:48431,0.5867963421058087
ZNF653,Familial lambdoid synostosis ORPHA:3267,0.5867963421058087
ZNF653,Frontorhiny ORPHA:391474,0.5867963421058087
ZNF653,Isolated cloverleaf skull syndrome ORPHA:2343,0.5867963421058087
ZNF653,Peutz-Jeghers syndrome ORPHA:2869,0.5867963421058087
ZNF653,Severe neurodevelopmental disorder with feeding difficulties-stereotypic hand movement-bilateral cataract ORPHA:500545,0.5867963421058087
ZNF653,Human papillomavirus type 6 E5B (gene: E5B),0.8999095837312036
ZNF689,Liver carcinoma,0.7880542567584415
ZNF689,Liver and Intrahepatic Biliary Tract Carcinoma,0.7880542567584415
ZNF689,Hepatocarcinogenesis,0.7880542567584415
ZNF689,Malignant neoplasm of liver,0.7880542567584415
ZNF689,Lipoyl transferase 2 deficiency ORPHA:447795,0.3832844616405875
ZNF689,Schnyder corneal dystrophy ORPHA:98967,0.5867963421058087
ZNF689,Mucopolysaccharidosis-like syndrome with congenital heart defects and hematopoietic disorders ORPHA:505248,0.8922466888454011
ZNF689,Human papillomavirus type 6 E5B (gene: E5B),0.8999095837312036
ZNF697,Skeletal dysplasia-T-cell immunodeficiency-developmental delay syndrome ORPHA:508533,0.1040670578681756
ZNF697,Congenital insensitivity to pain with severe intellectual disability ORPHA:453510,0.3832844616405875
ZNF697,Micrognathia-recurrent infections-behavioral abnormalities-mild intellectual disability syndrome ORPHA:476126,0.3832844616405875
ZNF697,Dent disease type 1 ORPHA:93622,0.5867963421058087
ZNF697,Congenital contractural arachnodactyly ORPHA:115,0.8922466888454011
ZNF697,Human papillomavirus type 6 E5B (gene: E5B),0.8999095837312036
ZNF830,TMEM199-CDG ORPHA:466703,0.3832844616405875
ZNF830,Lipoyl transferase 1 deficiency ORPHA:401862,0.5867963421058087
ZNF830,Primary dystonia DYT6 type ORPHA:98806,0.8922466888454011
ZNF830,Severe hypotonia-psychomotor developmental delay-strabismus-cardiac septal defect syndrome ORPHA:467176,0.8922466888454011
ZNF830,Spinocerebellar ataxia type 17 ORPHA:98759,0.8922466888454011
ZWINT,Malignant neoplasm of breast,0.4084380369379369
ZWINT,Breast Carcinoma,0.7333611688795861
ZWINT,Malignant neoplasm of prostate,0.7880542567584415
ZWINT,Prostate carcinoma,0.7880542567584415
ZWINT,Sarcoma,0.7880542567584415
ZWINT,Scoliosis unspecified,0.8648405521677974
ZWINT,Liver Carcinoma,0.7765582368651238
ZWINT,Multinucleated neurons-anhydramnios-renal dysplasia-cerebellar hypoplasia-hydranencephaly syndrome ORPHA:500135,0.0144185025972157
ZWINT,Mosaic variegated aneuploidy syndrome ORPHA:1052,0.0149557947723539
ZWINT,21q22.11q22.12 microdeletion syndrome ORPHA:261323,0.0155394890951578
ZWINT,Adult-onset autosomal dominant leukodystrophy ORPHA:99027,0.0155394890951578
ZWINT,Congenital dyserythropoietic anemia type III ORPHA:98870,0.0155394890951578
ZWINT,Constitutional megaloblastic anemia with severe neurologic disease ORPHA:319651,0.0155394890951578
ZWINT,Currarino syndrome ORPHA:1552,0.0155394890951578
ZWINT,Filippi syndrome ORPHA:3255,0.0155394890951578
ZWINT,Lethal fetal brain malformation-duodenal atresia-bilateral renal hypoplasia syndrome ORPHA:444069,0.0155394890951578
ZWINT,Microcephaly-lymphedema-chorioretinopathy syndrome ORPHA:2526,0.0155394890951578
ZWINT,PCNA-related progressive neurodegenerative photosensitivity syndrome ORPHA:438134,0.0155394890951578
ZWINT,Short stature-onychodysplasia-facial dysmorphism-hypotrichosis syndrome ORPHA:314394,0.0155394890951578
ZWINT,Stromme syndrome ORPHA:506307,0.0155394890951578
ZWINT,Intrauterine growth restriction-congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome ORPHA:508512,0.0155394890951578
ZWINT,Ear-patella-short stature syndrome ORPHA:2554,0.0184072076199886
ZWINT,Citrullinemia type II ORPHA:247585,0.0414176838632111
ZWINT,Microcephaly-micromelia syndrome ORPHA:572768,0.0414176838632111
ZWINT,Microcephaly-short stature-limb abnormalities syndrome ORPHA:572773,0.0414176838632111
ZWINT,Mutilating hereditary sensory neuropathy with spastic paraplegia ORPHA:139578,0.0414176838632111
ZWINT,Neonatal intrahepatic cholestasis due to citrin deficiency ORPHA:247598,0.0414176838632111
ZWINT,Primary immunodeficiency with natural-killer cell deficiency and adrenal insufficiency ORPHA:75391,0.0414176838632111
ZWINT,X-linked intellectual disability Snyder type ORPHA:3063,0.0414176838632111
ZWINT,Large congenital melanocytic nevus ORPHA:626,0.0414176838632111
ZWINT,Small cell lung cancer ORPHA:70573,0.0429491792829903
ZWINT,Hyper-IgM syndrome type 5 ORPHA:101092,0.1040670578681756
ZWINT,Hyperornithinemia-hyperammonemia-homocitrullinuria syndrome ORPHA:415,0.1040670578681756
ZWINT,Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome ORPHA:137898,0.1040670578681756
ZWINT,Progressive external ophthalmoplegia-myopathy-emaciation syndrome ORPHA:352447,0.1040670578681756
ZWINT,Severe combined immunodeficiency due to CTPS1 deficiency ORPHA:420573,0.1040670578681756
ZWINT,Hydrolethalus ORPHA:2189,0.1054066549396977
ZWINT,46XX gonadal dysgenesis ORPHA:243,0.1419890644363008
ZWINT,3-phosphoserine phosphatase deficiency infantile/juvenile form ORPHA:79350,0.1991445465001551
ZWINT,Autosomal recessive cutis laxa type 2B ORPHA:357064,0.1991445465001551
ZWINT,Global developmental delay-alopecia-macrocephaly-facial dysmorphism-structural brain anomalies syndrome ORPHA:544488,0.1991445465001551
ZWINT,Hereditary coproporphyria ORPHA:79273,0.1991445465001551
ZWINT,PYCR1-related De Barsy syndrome ORPHA:293633,0.1991445465001551
ZWINT,Spondylo-megaepiphyseal-metaphyseal dysplasia ORPHA:228387,0.1991445465001551
ZWINT,Linear nevus sebaceus syndrome ORPHA:2612,0.2047219337649946
ZWINT,Autosomal recessive spastic paraplegia type 62 ORPHA:401785,0.3832844616405875
ZWINT,Inclusion body myopathy with Paget disease of bone and frontotemporal dementia ORPHA:52430,0.3832844616405875
ZWINT,Acquired partial lipodystrophy ORPHA:79087,0.5867963421058087
ZWINT,Acute intermittent porphyria ORPHA:79276,0.5867963421058087
ZWINT,Acute myeloid leukemia with NPM1 somatic mutations ORPHA:402026,0.5867963421058087
ZWINT,Athabaskan brainstem dysgenesis syndrome ORPHA:69739,0.5867963421058087
ZWINT,Autosomal dominant spastic paraplegia type 13 ORPHA:100994,0.5867963421058087
ZWINT,Baller-Gerold syndrome ORPHA:1225,0.5867963421058087
ZWINT,Bosley-Salih-Alorainy syndrome ORPHA:69737,0.5867963421058087
ZWINT,Hemolytic anemia due to glutathione reductase deficiency ORPHA:90030,0.5867963421058087
ZWINT,Pelizaeus-Merzbacher-like disease due to HSPD1 mutation ORPHA:280288,0.5867963421058087
ZWINT,Progressive myoclonic epilepsy type 9 ORPHA:457265,0.5867963421058087
ZWINT,RAPADILINO syndrome ORPHA:3021,0.5867963421058087
ZWINT,Rothmund-Thomson syndrome type 2 ORPHA:221016,0.5867963421058087
ZWINT,ALDH18A1-related De Barsy syndrome ORPHA:35664,0.7929682744768703
ZWINT,ALG8-CDG ORPHA:79325,0.7929682744768703
ZWINT,Adrenocortical carcinoma ORPHA:1501,0.7929682744768703
ZWINT,Autosomal dominant spastic paraplegia type 9A ORPHA:447753,0.7929682744768703
ZWINT,Autosomal dominant spastic paraplegia type 9B ORPHA:447757,0.7929682744768703
ZWINT,Autosomal recessive spastic paraplegia type 9B ORPHA:447760,0.7929682744768703
ZWINT,Choroid plexus carcinoma ORPHA:251899,0.7929682744768703
ZWINT,Macrocephaly-intellectual disability-left ventricular non compaction syndrome ORPHA:466791,0.7929682744768703
ZWINT,Papilloma of choroid plexus ORPHA:2807,0.7929682744768703
ZWINT,Richieri Costa-Pereira syndrome ORPHA:3102,0.7929682744768703
ZWINT,S-adenosylhomocysteine hydrolase deficiency ORPHA:88618,0.7929682744768703
ZWINT,STT3A-CDG ORPHA:370921,0.7929682744768703
ZWINT,Spondyloepimetaphyseal dysplasia with multiple dislocations ORPHA:93360,0.7929682744768703
ZWINT,Desmoplastic small round cell tumor ORPHA:83469,0.7929682744768703
ZWINT,Familial isolated congenital asplenia ORPHA:101351,0.7929682744768703
ZWINT,Geroderma osteodysplastica ORPHA:2078,0.7929682744768703
ZWINT,Lymphomatoid papulosis ORPHA:98842,0.7929682744768703
ZWINT,Primary cutaneous anaplastic large cell lymphoma ORPHA:300865,0.7929682744768703
ZWINT,AICA-ribosiduria ORPHA:250977,0.8922466888454011
ZWINT,Combined immunodeficiency due to TFRC deficiency ORPHA:476113,0.8922466888454011
ZWINT,Mandibulofacial dysostosis-microcephaly syndrome ORPHA:79113,0.8922466888454011
ZWINT,Reticular dysgenesis ORPHA:33355,0.8922466888454011
ZWINT,SPONASTRIME dysplasia ORPHA:93357,0.8922466888454011
ZWINT,Spinocerebellar ataxia type 36 ORPHA:276198,0.8922466888454011
ZWINT,Caudal regression sequence ORPHA:3027,0.8922466888454011
ZWINT,Hypocalcemic vitamin D-dependent rickets ORPHA:289157,0.8922466888454011
ZWINT,Leukoencephalopathy-spondyloepimetaphyseal dysplasia syndrome ORPHA:83629,0.8922466888454011
ZWINT,Severe X-linked mitochondrial encephalomyopathy ORPHA:238329,0.8922466888454011
ZWINT,Warsaw breakage syndrome ORPHA:280558,0.8922466888454011
ZWINT,X-linked Charcot-Marie-Tooth disease type 4 ORPHA:101078,0.8922466888454011
ZWINT,X-linked hereditary sensory and autonomic neuropathy with deafness ORPHA:139583,0.8922466888454011
ZWINT,Polymerase proofreading-related adenomatous polyposis ORPHA:447877,0.8922466888454011
